data_2l4o_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l4o _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 47.0 p . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 113.914 1.079 . . . . 1.91 113.914 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.7 p -90.58 -6.17 55.0 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.776 1.23 . . . . 2.24 113.01 175.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 m -156.5 153.93 29.54 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.223 2.209 . . . . 3.01 109.455 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.1 p -109.54 4.49 22.28 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.306 1.595 . . . . 1.93 115.306 -170.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 m -147.58 161.38 41.24 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.275 1.83 . . . . 2.4 112.501 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.42 141.69 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 126.513 1.925 . . . . 1.42 109.869 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.3 m -111.3 114.83 28.29 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.474 0.654 . . . . 1.04 109.916 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 p -93.17 128.51 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.256 1.022 . . . . 1.94 109.274 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -107.23 -177.85 3.47 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.152 1.381 . . . . 1.79 110.118 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -139.14 122.7 17.36 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.753 -1.217 . . . . 2.8 111.124 168.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.7 mt -107.94 154.24 21.9 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.106 0.962 . . . . 2.06 110.936 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.26 167.37 22.6 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.843 1.657 . . . . 2.58 110.092 176.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.38 158.34 16.13 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.751 0.821 . . . . 1.24 112.249 170.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.1 p -80.72 -41.13 24.11 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.413 1.085 . . . . 1.79 112.485 174.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -131.66 38.03 3.6 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.3 1.04 . . . . 2.68 112.996 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.72 12.29 82.99 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.228 1.394 . . . . 0.88 115.264 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -71.65 18.17 0.08 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.474 2.31 . . . . 1.95 116.075 -171.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.21 -26.03 66.07 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.377 -1.452 . . . . 0.9 113.025 -175.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.45 -50.51 63.11 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.926 1.29 . . . . 2.33 112.709 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -68.34 -39.93 81.72 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.849 -1.157 . . . . 3.08 112.219 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -53.96 -49.42 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.417 1.008 . . . . 0.95 111.123 171.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.05 -23.71 67.26 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.477 -1.389 . . . . 2.06 113.424 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -82.17 -30.07 31.2 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.308 -0.87 . . . . 1.12 112.822 169.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -70.67 -11.87 61.21 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.61 1.564 . . . . 2.07 113.516 168.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.3 mt -106.65 -31.81 8.3 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.774 1.63 . . . . 1.09 114.256 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.47 -22.31 66.73 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 120.461 1.482 . . . . 2.41 113.176 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 t -71.16 -31.08 67.24 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.436 1.094 . . . . 2.0 112.466 171.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.4 162.62 35.02 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.247 0.927 . . . . 0.89 113.22 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -83.23 30.58 0.46 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.936 -1.332 . . . . 1.77 112.813 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -71.78 19.23 0.07 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.124 1.898 . . . . 3.26 116.124 -168.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.16 -27.85 62.85 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.367 1.067 . . . . 1.41 109.802 164.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.23 -63.79 0.26 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.211 1.386 . . . . 0.73 113.341 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -78.82 158.92 28.07 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.177 1.547 . . . . 1.85 115.177 -171.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -70.76 135.74 48.4 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.997 1.719 . . . . 4.13 112.991 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 80.0 t -54.38 110.57 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.883 0.873 . . . . 1.05 111.246 -174.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.72 -25.21 60.89 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 114.708 0.643 . . . . 1.11 114.708 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 p -142.07 104.11 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.528 1.131 . . . . 5.33 111.89 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.1 mt -89.79 146.8 36.12 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 126.966 2.107 . . . . 1.73 111.451 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.27 158.21 19.96 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.282 2.654 . . . . 0.62 113.18 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.37 -22.9 63.69 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.877 -1.139 . . . . 2.12 112.356 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -79.34 0.5 28.71 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.946 1.298 . . . . 1.95 114.28 169.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.32 157.85 16.48 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.743 1.217 . . . . 0.63 112.599 168.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -150.84 172.02 16.3 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.178 1.791 . . . . 2.46 111.206 173.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -126.54 146.82 49.99 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.287 1.435 . . . . 2.25 111.028 -174.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.1 pt -136.65 130.67 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 114.042 1.127 . . . . 1.45 114.042 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.7 156.86 17.78 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.725 0.81 . . . . 1.38 111.71 169.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.4 15.78 56.5 Favored Glycine 0 CA--C 1.537 1.43 0 N-CA-C 116.102 1.201 . . . . 0.62 116.102 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.5 p -90.14 145.78 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-N 120.153 1.977 . . . . 1.91 109.125 167.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 1.8 tpp -102.42 137.69 40.33 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.701 1.2 . . . . 1.43 111.798 174.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.66 153.71 47.35 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 122.188 0.994 . . . . 2.92 112.875 170.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.7 m -118.71 146.39 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 C-N-CA 126.948 2.099 . . . . 1.55 109.125 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -87.64 147.03 25.45 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.433 1.111 . . . . 0.33 111.926 169.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.2 p -141.49 173.65 11.3 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.328 1.851 . . . . 1.62 112.098 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.53 177.6 4.97 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.78 1.632 . . . . 1.81 113.407 172.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.0 p -68.18 -20.76 64.89 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.978 1.103 . . . . 1.95 113.978 -171.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -97.97 26.46 5.21 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.602 1.561 . . . . 2.5 112.834 169.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 62.26 23.98 14.24 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.226 2.21 . . . . 0.56 114.349 169.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -84.38 140.38 31.61 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.069 0.948 . . . . 2.55 111.117 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.7 mt -76.86 126.09 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.193 -0.669 . . . . 1.63 109.193 176.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 pt -117.86 156.91 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 114.57 1.322 . . . . 1.12 114.57 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -85.27 165.4 17.36 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.232 1.413 . . . . 1.44 110.741 167.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -64.95 2.86 0.64 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 128.05 2.54 . . . . 3.05 115.904 -174.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -117.54 -3.5 11.34 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 127.59 2.356 . . . . 2.98 114.276 172.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.05 5.8 59.4 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.362 1.458 . . . . 0.81 116.443 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -72.33 137.34 46.58 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.092 1.946 . . . . 2.63 110.454 170.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.9 p -96.36 134.23 39.76 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.603 1.161 . . . . 2.0 111.662 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.7 -0.95 57.27 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.538 1.681 . . . . 1.79 115.538 -167.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.86 15.61 69.84 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-N 119.214 0.915 . . . . 0.72 113.931 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.0 t -125.08 147.1 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.938 1.295 . . . . 1.7 109.293 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -133.55 157.85 44.65 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 128.115 2.566 . . . . 1.33 110.138 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 55.8 mt -136.03 134.23 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.931 1.292 . . . . 1.61 110.53 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -73.09 135.02 80.26 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 121.072 -1.017 . . . . 1.8 110.308 173.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -66.71 -22.92 49.42 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.573 2.182 . . . . 1.67 113.816 172.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -96.9 -45.06 6.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.916 1.686 . . . . 1.35 112.762 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.8 p -90.71 -22.98 20.85 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.61 1.164 . . . . 1.8 113.565 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 53.39 19.46 1.63 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.75 1.62 . . . . 3.54 113.846 -170.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.41 146.65 30.18 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.745 -1.222 . . . . 3.77 111.524 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.3 mt -90.29 135.66 33.54 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.215 1.406 . . . . 1.11 111.288 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 92.2 p -66.23 -0.58 2.62 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.382 1.252 . . . . 1.54 114.382 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.38 -152.8 9.08 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 126.39 1.948 . . . . 0.93 112.218 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.1 162.65 15.21 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.113 1.365 . . . . 1.59 113.439 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.3 mmt -54.01 128.12 55.53 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.75 1.22 . . . . 2.35 113.055 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -72.08 163.42 38.83 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.106 3.204 . . . . 0.74 113.129 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.41 -81.24 0.09 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.165 0.986 . . . . 1.07 112.127 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 78.1 p -83.58 2.05 39.14 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 116.07 1.878 . . . . 1.95 116.07 -167.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -49.87 149.17 2.74 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.382 1.473 . . . . 0.59 114.974 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.1 tpt -77.52 98.11 5.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.784 2.034 . . . . 1.67 111.256 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -150.14 147.78 28.17 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.413 1.485 . . . . 1.96 112.221 -172.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -166.82 156.96 11.53 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 125.392 1.477 . . . . 2.56 111.241 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 mp -94.68 150.4 20.26 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.481 1.289 . . . . 0.79 114.481 172.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 16.7 p -63.84 134.52 55.35 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.323 -0.86 . . . . 1.26 112.058 170.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -92.3 -54.41 3.82 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.464 1.653 . . . . 2.19 115.464 -171.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.73 -37.7 0.08 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.902 1.281 . . . . 1.7 111.509 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -119.65 -22.52 6.87 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.073 1.138 . . . . 5.25 114.073 171.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 175.87 -159.09 26.43 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.686 1.612 . . . . 0.73 111.117 -170.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -147.06 133.64 19.84 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.589 1.955 . . . . 1.18 111.967 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -86.77 137.42 32.45 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.506 1.122 . . . . 2.38 113.088 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -128.97 124.07 34.08 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.495 2.318 . . . . 2.91 108.556 174.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -77.49 128.75 34.72 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.354 -0.841 . . . . 3.12 110.201 175.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 66.8 p -105.73 -10.74 16.59 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.796 1.776 . . . . 1.64 115.796 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.64 -33.95 16.88 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.798 1.181 . . . . 1.72 114.014 -172.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -16.37 44.27 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.807 1.643 . . . . 3.15 113.291 -176.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -72.18 144.18 86.91 Favored Pre-proline 0 C--O 1.237 0.434 0 CA-C-N 119.976 1.262 . . . . 0.85 112.166 173.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.45 167.1 27.92 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.357 2.038 . . . . 0.78 110.47 167.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.38 93.77 1.98 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.149 1.38 . . . . 1.2 109.609 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -152.71 -178.29 6.78 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.945 0.898 . . . . 1.57 112.427 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -91.13 152.39 20.61 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.392 1.877 . . . . 4.29 111.956 168.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -149.27 170.96 17.3 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.661 2.385 . . . . 0.52 110.372 -170.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -138.63 160.86 38.56 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.424 1.09 . . . . 2.58 113.337 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.2 134.46 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.357 1.463 . . . . 1.76 110.065 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -122.14 137.38 54.84 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.475 1.51 . . . . 3.21 111.569 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -104.69 100.61 10.26 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.907 1.683 . . . . 2.63 110.469 -169.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 28.2 mm -106.84 113.88 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.613 1.165 . . . . 1.84 110.653 -167.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -87.1 22.82 1.95 Allowed 'General case' 0 CA--C 1.553 1.09 0 O-C-N 120.936 -1.102 . . . . 4.88 112.854 -178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.2 m . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 114.578 1.325 . . . . 2.33 114.578 -176.718 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? . . . . . 0 C--O 1.24 0.565 0 N-CA-C 112.441 0.534 . . . . 2.95 112.441 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.55 147.1 28.82 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.514 1.126 . . . . 1.46 111.06 168.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.36 147.88 34.62 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 123.282 0.633 . . . . 1.08 110.449 170.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.29 159.28 52.3 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.708 2.939 . . . . 0.71 113.365 -173.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -109.07 148.11 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.514 1.126 . . . . 2.99 111.467 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.58 148.45 41.9 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.789 1.636 . . . . 4.83 111.252 168.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.6 tt -151.56 146.81 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 124.157 0.983 . . . . 1.55 111.705 -174.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -122.97 142.92 50.3 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.555 1.542 . . . . 1.84 109.495 169.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 23.4 mt -64.79 149.61 95.85 Favored Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 113.808 1.04 . . . . 1.53 113.808 -170.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.54 110.72 2.36 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.269 2.646 . . . . 0.76 113.832 -169.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.45 60.88 1.4 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.569 2.348 . . . . 3.39 106.016 166.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -151.66 147.86 27.25 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.981 2.112 . . . . 3.1 109.896 -166.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -72.48 23.41 0.06 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 126.075 1.75 . . . . 4.01 114.679 -174.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.4 m -76.28 149.51 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 120.434 -1.417 . . . . 1.31 111.759 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 88.7 t -78.96 -35.7 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.733 0.813 . . . . 2.93 111.405 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -145.42 148.56 33.45 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.67 1.988 . . . . 3.0 109.747 173.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -94.66 141.74 28.26 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.952 0.797 . . . . 1.83 111.916 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -138.85 170.54 15.8 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.348 1.24 . . . . 0.68 114.348 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.27 141.26 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 125.201 1.401 . . . . 1.11 112.845 -177.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.38 83.28 59.73 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 124.729 1.212 . . . . 3.45 113.844 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -67.96 138.39 44.04 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.36 3.374 . . . . 0.67 113.068 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -124.6 163.23 22.38 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.176 1.79 . . . . 2.96 112.57 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -103.56 164.74 11.47 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.826 1.25 . . . . 2.86 110.774 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 114.042 1.127 . . . . 2.95 114.042 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 113.997 1.11 . . . . 1.89 113.997 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 78.0 p -91.8 -9.13 44.62 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.629 1.172 . . . . 2.51 114.149 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.7 t -147.88 154.67 40.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.875 1.67 . . . . 2.39 109.405 169.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.7 p -98.27 -0.62 43.62 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.918 1.687 . . . . 1.84 114.32 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.4 m -151.68 158.9 44.04 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.312 1.445 . . . . 2.62 110.607 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.68 141.9 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 126.39 1.876 . . . . 1.79 109.317 177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 m -115.76 121.77 43.45 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.508 0.723 . . . . 1.31 110.307 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -103.37 131.61 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.683 1.193 . . . . 1.16 110.998 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -130.32 100.39 5.36 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.11 1.364 . . . . 1.88 110.82 -172.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.417 ' HE3' ' CD2' ' A' ' 43' ' ' LEU . 6.9 tmtm? -74.81 120.88 20.95 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.788 -1.195 . . . . 2.72 110.916 -174.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.3 mt -106.84 153.45 22.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.952 1.301 . . . . 1.22 112.195 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.417 ' CD2' ' HE3' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -141.65 171.77 13.6 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.965 1.706 . . . . 2.45 110.894 176.158 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.35 158.49 16.43 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.171 1.388 . . . . 1.46 112.219 170.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.4 p -81.01 -25.59 37.11 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.39 1.256 . . . . 1.83 114.39 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -149.64 38.04 0.75 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.427 1.091 . . . . 3.58 112.64 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.09 10.35 75.13 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 116.44 1.336 . . . . 1.34 116.44 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.13 14.62 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 129.128 2.971 . . . . 2.18 116.632 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -26.13 68.61 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.283 -1.51 . . . . 0.93 113.087 -170.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -72.12 -43.37 64.82 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.626 1.103 . . . . 2.04 113.103 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -70.22 -41.86 73.06 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.465 -1.397 . . . . 3.22 111.746 172.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.9 mt -54.07 -44.2 62.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.333 1.053 . . . . 1.09 112.231 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.88 -31.17 69.54 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 120.967 1.712 . . . . 1.28 112.768 176.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -76.03 -35.76 59.36 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.969 0.908 . . . . 1.47 112.86 171.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -63.15 -22.87 67.15 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.179 0.991 . . . . 2.2 112.97 170.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.3 mt -91.93 -41.48 10.56 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.097 1.147 . . . . 1.25 114.097 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.65 -18.9 65.37 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.781 1.173 . . . . 4.13 113.692 -175.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.8 t -75.68 -23.37 56.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.655 1.182 . . . . 2.42 113.883 172.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.64 157.68 21.32 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.346 0.974 . . . . 1.27 112.578 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -77.37 43.28 0.38 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.474 1.11 . . . . 2.03 113.031 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -78.74 13.37 1.69 Allowed 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.516 -1.365 . . . . 3.42 113.971 -170.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.83 -17.63 58.88 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.237 1.415 . . . . 1.67 111.155 165.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.82 -74.07 0.14 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.738 1.161 . . . . 0.93 112.792 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.42 161.33 29.92 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.41 1.263 . . . . 1.79 114.41 -173.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.04 158.67 27.75 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.898 1.073 . . . . 4.18 113.898 -173.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.02 119.44 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.894 -0.504 . . . . 1.12 110.175 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.28 -29.33 45.62 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.828 0.728 . . . . 1.36 114.15 -176.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.9 t -146.15 125.92 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.259 1.423 . . . . 2.91 111.41 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.2 mt -96.88 134.46 23.01 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.903 1.681 . . . . 2.49 110.771 167.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.86 160.49 43.29 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.042 1.828 . . . . 0.78 111.42 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.26 -21.82 66.78 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.836 -1.165 . . . . 2.1 113.715 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -88.3 -5.01 58.59 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.659 1.584 . . . . 2.45 114.443 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.3 155.16 20.77 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.108 0.867 . . . . 0.78 111.113 168.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.6 pttt -152.46 170.01 21.18 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.396 1.078 . . . . 2.4 111.83 169.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -120.32 137.78 54.07 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.905 1.682 . . . . 2.02 108.718 -172.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.7 pt -126.24 131.98 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 120.018 1.281 . . . . 2.14 113.464 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.76 160.06 14.92 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.0 1.32 . . . . 1.71 111.286 169.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.03 16.11 68.21 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.086 0.851 . . . . 0.57 115.089 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.3 p -101.85 141.71 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.491 1.516 . . . . 1.78 110.288 169.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.7 tpp -99.88 141.8 32.21 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.524 1.53 . . . . 1.76 112.642 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -144.32 149.44 36.21 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.146 1.378 . . . . 2.77 111.471 173.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.8 m -120.44 146.13 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.584 1.953 . . . . 1.65 109.41 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -87.21 144.49 26.8 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.882 1.325 . . . . 0.47 110.903 168.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.7 p -137.35 170.46 16.05 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.127 2.171 . . . . 1.5 110.473 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -87.26 171.8 10.36 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.491 -0.755 . . . . 2.09 111.651 167.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.5 t -61.46 -24.59 66.67 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.06 -1.025 . . . . 3.99 113.275 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -69.42 10.37 0.35 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 127.274 2.23 . . . . 3.29 115.048 169.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.43 22.55 5.09 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 128.144 2.578 . . . . 0.69 113.354 -172.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -83.06 136.27 34.54 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.481 1.512 . . . . 2.23 111.068 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.6 mt -73.99 127.26 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 109.65 -0.5 . . . . 1.69 109.65 175.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.2 pt -120.09 150.28 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 115.174 1.546 . . . . 1.03 115.174 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.45 159.57 28.19 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.081 2.153 . . . . 2.1 109.298 165.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -64.32 -15.01 59.47 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.595 1.332 . . . . 2.05 114.595 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -92.63 4.24 54.04 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.62 1.168 . . . . 3.48 111.993 174.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.61 5.54 81.64 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 126.47 1.986 . . . . 0.48 115.376 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -67.96 143.72 55.5 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.222 1.011 . . . . 2.5 109.859 171.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.6 p -103.58 136.04 44.05 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.539 1.135 . . . . 1.54 111.198 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.26 -8.98 58.87 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.022 1.119 . . . . 2.01 114.022 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.32 19.73 56.39 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.341 0.972 . . . . 0.72 113.53 -174.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.52 147.6 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.873 1.269 . . . . 1.77 110.213 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.11 160.7 30.4 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.86 2.464 . . . . 1.57 110.81 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.4 mt -133.88 134.83 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.388 1.475 . . . . 1.76 111.32 -175.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.04 139.04 87.56 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 117.725 -1.131 . . . . 2.4 111.314 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -71.4 -27.46 19.22 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 CA-C-N 122.095 1.784 . . . . 1.31 112.839 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -86.98 -48.59 7.99 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.582 1.153 . . . . 1.72 111.736 -175.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.8 p -91.05 -24.35 20.07 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.426 1.09 . . . . 2.17 113.356 -174.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 53.45 29.31 8.72 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 125.174 1.39 . . . . 4.05 112.162 -167.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.76 153.07 17.94 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.396 1.479 . . . . 3.12 111.535 174.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.8 mt -94.46 151.82 19.07 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.768 1.627 . . . . 1.15 113.303 -169.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.3 p -73.42 -2.77 23.74 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.558 0.947 . . . . 1.65 113.558 168.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.82 -147.92 6.05 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 126.861 2.172 . . . . 0.91 112.515 -169.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.7 175.72 6.92 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.542 1.537 . . . . 1.72 113.671 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.6 mmt -64.41 138.04 97.31 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.521 1.128 . . . . 2.52 112.273 173.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -86.1 150.48 9.47 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 124.105 3.203 . . . . 0.82 113.564 -174.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.1 -54.08 8.56 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.431 1.271 . . . . 1.14 114.431 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 64.8 p -107.91 -1.61 20.54 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.871 1.434 . . . . 1.82 114.871 -168.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.14 149.39 2.87 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 115.035 1.495 . . . . 0.57 115.035 -173.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.5 tpt -75.96 99.39 4.53 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.099 2.159 . . . . 1.7 111.186 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -153.6 147.14 25.02 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.201 1.4 . . . . 2.03 112.594 -173.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -164.69 158.17 17.49 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.63 1.572 . . . . 2.37 110.626 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -98.65 149.98 22.24 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.47 1.108 . . . . 0.86 112.523 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.0 p -65.57 128.53 36.29 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.834 0.743 . . . . 1.42 109.861 170.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.23 -55.14 4.34 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.012 1.115 . . . . 2.06 114.012 -173.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.35 -43.69 0.14 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.16 1.384 . . . . 1.62 110.565 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -113.88 -25.45 8.6 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.5 0.926 . . . . 3.81 113.5 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 177.24 -166.8 37.61 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.249 0.928 . . . . 0.84 111.865 -169.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.98 142.01 34.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.878 1.671 . . . . 1.32 112.137 169.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -92.69 138.01 31.87 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.133 1.373 . . . . 2.03 113.185 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -128.71 125.98 39.11 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.519 1.928 . . . . 3.41 109.106 173.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -88.42 108.53 19.42 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 118.953 0.797 . . . . 1.7 111.054 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.6 p -93.98 0.61 56.13 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.092 1.357 . . . . 1.85 113.764 -174.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.97 -8.84 3.49 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.095 1.516 . . . . 1.97 115.095 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -102.12 -21.78 14.35 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.15 1.38 . . . . 2.81 113.134 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -79.03 147.68 70.32 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 113.251 0.834 . . . . 0.94 113.251 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.59 166.98 21.38 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.965 2.443 . . . . 0.86 111.605 168.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.86 86.01 3.43 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.629 1.972 . . . . 1.15 111.857 -172.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -147.11 -175.53 4.86 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.823 0.849 . . . . 2.0 111.678 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -93.34 142.68 27.04 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.751 1.22 . . . . 3.25 113.868 170.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -135.72 169.12 18.05 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.342 2.257 . . . . 0.59 110.029 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -137.95 152.91 49.41 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.526 0.73 . . . . 2.58 112.809 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.0 mp -112.12 138.9 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.166 0.986 . . . . 1.37 110.023 173.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -128.47 131.04 48.36 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.79 1.636 . . . . 3.13 110.229 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -95.11 78.92 3.54 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.038 0.935 . . . . 1.92 111.448 -171.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.6 mm -82.95 101.66 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.519 0.727 . . . . 1.77 110.17 -174.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -80.66 -1.44 42.47 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.422 1.267 . . . . 5.92 114.422 -175.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 58.2 p . . . . . 0 N--CA 1.471 0.588 0 O-C-N 120.288 -1.507 . . . . 2.03 115.057 -176.436 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 43.9 tptt . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 113.093 0.775 . . . . 4.72 113.093 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.03 132.52 36.01 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.266 0.555 . . . . 1.29 109.695 167.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.1 149.08 35.96 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 123.684 0.794 . . . . 0.88 110.759 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.99 159.39 48.05 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.843 2.362 . . . . 0.67 112.182 -172.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.4 mp -123.93 134.44 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.014 1.725 . . . . 2.54 109.168 -168.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -99.35 134.55 42.04 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.342 0.974 . . . . 4.22 111.343 170.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.7 tt -130.73 140.58 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.936 1.694 . . . . 1.9 110.284 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -107.91 150.5 26.98 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.489 1.116 . . . . 2.11 108.911 170.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.1 mt -62.8 143.4 96.97 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 119.493 1.042 . . . . 1.41 111.91 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.9 107.25 1.07 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.292 2.662 . . . . 0.95 111.799 -169.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.69 25.1 10.23 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.254 1.822 . . . . 4.16 110.14 174.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -115.54 144.44 43.86 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.631 2.772 . . . . 2.97 109.154 -171.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -73.14 42.7 0.12 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.756 1.622 . . . . 4.55 114.993 -171.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 10.4 m -90.84 157.75 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.802 1.641 . . . . 1.55 113.176 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 76.3 t -72.57 -37.99 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.755 1.622 . . . . 3.22 111.355 173.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.52 158.16 31.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.669 0.788 . . . . 3.54 111.525 169.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -96.03 140.07 31.3 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.025 0.93 . . . . 1.54 112.179 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -136.63 165.16 26.52 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.066 1.506 . . . . 0.92 115.066 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.33 142.93 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 126.241 1.816 . . . . 1.96 111.119 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -136.38 70.61 60.85 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.448 1.499 . . . . 4.1 113.236 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -69.32 114.73 3.73 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.293 2.662 . . . . 0.92 113.714 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -89.83 174.97 7.41 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 128.299 2.64 . . . . 3.21 111.939 173.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -108.3 167.28 10.13 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.432 1.493 . . . . 3.22 111.363 170.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.479 0.995 0 C-N-CA 123.855 0.862 . . . . 2.74 112.951 179.362 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.474 0.773 0 CA-C-O 119.922 -0.085 . . . . 3.32 110.997 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.5 p -125.73 -9.67 6.73 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 117.797 2.518 . . . . 2.49 117.797 -167.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 t -147.2 156.42 42.95 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 121.432 1.923 . . . . 2.05 114.622 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.7 p -100.89 -6.28 24.88 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.759 1.624 . . . . 2.27 115.06 -172.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.5 p -147.5 156.73 43.12 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.878 1.671 . . . . 2.84 113.794 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.76 140.45 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 127.893 2.477 . . . . 1.55 109.112 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 36.2 m -114.17 127.54 55.95 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.353 0.979 . . . . 1.11 111.383 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 p -96.34 136.55 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.202 1.001 . . . . 1.93 110.695 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -131.37 107.21 8.77 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.824 1.65 . . . . 1.72 110.576 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.54 114.5 20.98 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 120.901 -1.125 . . . . 2.0 111.436 -170.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.1 mt -99.36 154.41 18.22 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.539 1.136 . . . . 1.07 112.416 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.6 mt -141.03 169.52 17.46 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.331 1.852 . . . . 2.37 110.209 169.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.5 150.4 23.43 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.89 0.876 . . . . 1.39 111.016 169.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.9 p -76.64 -21.94 54.77 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.345 0.868 . . . . 1.98 113.345 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -137.61 34.75 2.45 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.102 1.761 . . . . 2.13 111.762 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.69 15.79 75.82 Favored Glycine 0 CA--C 1.539 1.551 0 O-C-N 119.864 -1.772 . . . . 1.22 115.383 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.28 26.27 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 128.936 2.894 . . . . 1.82 115.231 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -26.09 67.82 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.133 -1.604 . . . . 0.85 113.367 -172.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -73.69 -46.36 46.77 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.41 1.004 . . . . 1.98 112.814 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -65.94 -43.27 88.51 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.203 -0.935 . . . . 2.86 111.117 173.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 91.9 mt -50.65 -50.13 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 118.965 0.802 . . . . 1.04 110.721 168.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.16 -32.64 70.07 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 120.807 1.639 . . . . 1.04 113.657 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -74.31 -32.96 63.06 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.618 0.767 . . . . 0.95 112.68 172.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -71.24 -23.66 62.04 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.626 1.171 . . . . 1.95 112.842 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.7 mt -92.32 -35.69 13.6 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.037 1.125 . . . . 0.94 114.037 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -67.96 -28.14 67.21 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.977 0.808 . . . . 2.48 112.975 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 t -73.92 -12.49 60.67 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.42 1.488 . . . . 2.12 113.007 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.53 175.93 36.3 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.287 1.422 . . . . 0.99 112.518 170.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -93.39 34.46 1.16 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.091 1.356 . . . . 2.35 111.617 169.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -75.74 17.85 0.28 Allowed 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.459 -1.401 . . . . 3.11 114.202 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.57 -23.83 49.93 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.261 1.024 . . . . 1.42 110.11 165.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -118.73 -59.33 0.27 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.862 1.696 . . . . 0.87 112.709 172.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.281 0.0 OUTLIER -85.19 156.1 21.15 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.403 1.631 . . . . 1.79 115.403 -169.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -60.09 149.17 33.35 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.447 0.906 . . . . 3.2 113.447 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.5 t -62.68 124.42 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 121.87 -0.519 . . . . 1.81 110.103 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.2 -47.02 25.04 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.709 -0.495 . . . . 0.9 114.033 -171.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.0 t -145.59 116.21 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.66 1.584 . . . . 2.81 108.551 176.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.2 mt -74.35 146.68 84.42 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 123.921 0.889 . . . . 1.29 111.214 171.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.79 161.97 43.88 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.737 1.624 . . . . 0.62 112.028 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.17 -33.72 65.53 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.198 0.599 . . . . 1.65 112.257 174.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -83.39 1.54 40.89 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.393 1.877 . . . . 1.92 115.629 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -95.97 152.04 18.88 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.963 1.256 . . . . 0.77 112.677 169.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -148.95 167.62 25.27 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.71 1.604 . . . . 2.98 111.462 169.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.26 141.68 51.38 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.828 0.851 . . . . 2.61 110.774 -175.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.5 pt -126.82 141.55 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.403 1.081 . . . . 2.01 112.144 -176.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.06 163.9 12.9 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.678 1.191 . . . . 1.35 112.304 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.28 14.37 58.9 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.274 1.416 . . . . 0.64 115.314 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.3 p -97.97 144.55 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.489 1.916 . . . . 1.92 110.256 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 7.7 tpp -104.79 140.44 38.09 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.728 1.611 . . . . 1.7 111.891 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.92 157.03 44.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.492 1.517 . . . . 2.86 111.64 174.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.08 144.52 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 126.565 1.946 . . . . 1.72 109.751 -176.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -85.81 146.99 26.52 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.916 1.341 . . . . 0.5 111.392 169.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.0 p -141.83 170.73 15.16 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.271 1.828 . . . . 1.62 111.487 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.79 170.92 9.5 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.556 1.142 . . . . 1.93 112.414 168.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.5 p -33.32 -46.06 0.17 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.55 1.94 . . . . 2.16 114.351 172.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -90.98 29.49 1.36 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.574 1.15 . . . . 2.55 112.976 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.28 25.01 8.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 127.873 2.469 . . . . 1.15 113.414 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -86.56 136.11 33.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.957 1.303 . . . . 1.78 111.515 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.9 mt -74.27 125.85 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 118.402 0.547 . . . . 1.56 110.253 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.1 pp -120.37 152.15 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.289 1.436 . . . . 1.82 114.273 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -84.07 162.28 20.39 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.621 1.969 . . . . 1.4 111.439 168.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -70.95 10.54 0.52 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 115.948 1.833 . . . . 2.4 115.948 -169.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -115.22 -2.75 12.62 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.956 2.503 . . . . 2.72 113.174 168.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.47 10.71 67.5 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.795 2.141 . . . . 0.6 115.744 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -68.73 144.23 54.45 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.843 1.321 . . . . 2.28 108.799 167.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.0 p -101.25 146.27 27.75 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.938 0.895 . . . . 1.72 112.076 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.88 -9.83 27.74 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.19 1.182 . . . . 1.71 114.19 -171.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.63 25.33 42.76 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 119.738 1.154 . . . . 0.66 113.903 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.1 t -133.66 150.41 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.939 1.695 . . . . 1.69 109.417 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -135.59 160.78 37.42 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 129.114 2.966 . . . . 1.47 110.688 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 57.2 mt -137.85 137.29 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.761 1.225 . . . . 1.69 110.417 -173.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -70.74 140.92 86.88 Favored Pre-proline 0 N--CA 1.476 0.837 0 CA-C-O 116.882 -1.532 . . . . 2.15 111.05 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -72.32 -27.39 16.35 Favored 'Trans proline' 0 C--N 1.351 0.705 0 CA-C-N 122.935 2.084 . . . . 1.16 112.567 174.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -88.19 -46.38 9.31 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 125.663 1.585 . . . . 1.71 112.795 -175.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.3 p -89.24 -24.66 22.05 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.357 0.873 . . . . 2.5 113.357 -176.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 56.42 22.77 6.74 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.108 1.363 . . . . 3.07 113.407 -168.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.98 148.75 21.86 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.956 1.303 . . . . 3.65 112.488 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.1 mt -82.29 145.22 30.1 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.077 1.751 . . . . 1.13 113.42 -174.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.1 p -76.38 5.56 6.96 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.348 1.24 . . . . 1.54 114.348 170.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 177.12 -157.64 22.69 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.535 1.064 . . . . 0.92 113.652 -171.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -86.25 149.89 24.75 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.996 1.11 . . . . 2.08 113.996 -174.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.5 tpt -51.43 126.05 28.26 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.962 1.705 . . . . 2.36 112.607 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.42 161.42 37.56 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.852 2.368 . . . . 0.79 113.321 -170.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.62 -87.8 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 122.265 1.031 . . . . 1.07 111.682 172.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 78.3 p -78.04 -1.05 30.36 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 116.067 1.876 . . . . 1.84 116.067 -167.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.59 152.68 3.51 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.828 1.418 . . . . 0.66 114.828 -171.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.7 ttt -78.6 95.1 5.14 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.993 1.317 . . . . 1.85 111.426 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.67 155.17 44.88 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.687 1.595 . . . . 3.43 111.458 -177.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -169.2 164.26 11.02 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.785 1.634 . . . . 4.11 111.301 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.9 mp -106.8 150.1 26.69 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.374 1.07 . . . . 0.87 113.577 172.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.6 p -77.48 135.28 38.24 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 118.839 0.745 . . . . 1.46 110.845 170.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -96.26 -58.65 2.02 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 115.345 1.609 . . . . 2.57 115.345 -169.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -153.61 -35.23 0.11 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.101 1.36 . . . . 1.6 112.142 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -100.67 -38.72 8.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.242 1.017 . . . . 3.71 112.075 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.86 -160.81 30.97 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.425 1.012 . . . . 1.15 112.446 -174.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -134.82 123.68 23.93 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.381 1.872 . . . . 1.73 112.229 170.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -81.61 133.61 35.39 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.037 0.935 . . . . 3.6 112.29 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -120.58 141.27 50.46 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 128.955 2.902 . . . . 3.36 109.493 174.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -94.29 112.74 24.56 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.337 1.055 . . . . 2.91 111.429 -174.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.2 p -94.25 1.27 56.0 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.21 1.189 . . . . 1.91 114.21 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.91 -23.37 63.44 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.012 1.116 . . . . 1.6 114.012 -176.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.14 -6.24 13.67 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.573 1.323 . . . . 3.01 114.573 -170.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.22 132.16 70.78 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 119.278 0.945 . . . . 0.84 113.324 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.08 168.45 23.98 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.468 2.112 . . . . 0.94 111.106 169.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.0 83.13 0.68 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.468 1.907 . . . . 1.8 110.921 -177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -135.38 173.57 11.57 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.505 1.522 . . . . 2.18 110.355 173.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -93.67 140.23 29.88 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.728 1.252 . . . . 4.56 111.17 168.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -126.24 165.97 17.96 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.514 1.925 . . . . 0.8 109.45 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -141.3 153.45 45.19 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.644 0.777 . . . . 2.47 111.793 175.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.08 139.33 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.623 0.769 . . . . 1.78 110.449 173.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -127.62 140.31 52.18 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.486 1.914 . . . . 3.14 110.488 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -102.43 130.76 49.31 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.065 1.346 . . . . 1.81 111.108 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 37.6 mm -130.57 113.74 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.748 0.819 . . . . 2.05 109.846 -169.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -77.08 -8.44 57.47 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.198 1.185 . . . . 4.34 114.198 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 115.149 1.537 . . . . 3.26 115.149 -176.466 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 113.131 0.789 . . . . 2.96 113.131 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.47 154.99 34.21 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.99 0.737 . . . . 1.23 112.99 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.33 145.48 36.12 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.328 1.051 . . . . 0.9 112.012 170.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.47 146.56 44.71 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.311 2.674 . . . . 0.5 113.366 -168.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.2 mp -117.1 128.93 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.359 1.863 . . . . 2.24 108.81 -168.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -94.94 145.23 25.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.332 1.053 . . . . 2.94 112.356 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.4 tt -150.84 157.28 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 125.625 1.57 . . . . 1.87 110.533 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.44 ' HG2' ' H ' ' A' ' 170' ' ' LEU . 10.5 tt0 -136.56 -178.65 5.27 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.584 1.554 . . . . 2.55 109.708 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.44 ' H ' ' HG2' ' A' ' 169' ' ' GLU . 3.4 mm? -68.48 156.43 90.55 Favored Pre-proline 0 CA--C 1.552 1.051 0 O-C-N 120.811 -1.181 . . . . 2.99 112.315 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -83.27 75.99 4.12 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.061 3.174 . . . . 1.99 114.213 -167.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 4.5 tt -94.29 80.84 3.98 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 105.915 -1.883 . . . . 4.14 105.915 166.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -147.2 160.35 42.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.093 1.357 . . . . 3.83 112.304 -168.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -74.37 -18.23 60.7 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.921 1.288 . . . . 3.21 113.553 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.2 m -65.83 150.72 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.887 1.675 . . . . 1.93 113.734 -173.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.13 -40.61 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.553 1.141 . . . . 2.83 109.934 173.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -132.33 141.54 48.99 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.469 1.508 . . . . 2.9 109.509 172.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -92.45 156.03 17.46 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.313 0.645 . . . . 1.66 111.777 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -137.13 165.04 27.02 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.835 1.421 . . . . 0.62 114.835 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.55 142.16 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 126.216 1.806 . . . . 0.97 110.952 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -134.42 71.7 71.41 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 113.382 0.882 . . . . 3.17 113.382 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.75 144.35 93.66 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 124.006 3.137 . . . . 0.68 113.824 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -120.25 158.01 27.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.088 2.155 . . . . 2.39 112.184 -171.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -110.56 159.13 17.82 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.355 1.074 . . . . 3.66 113.481 175.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 CA--C 1.54 0.57 0 C-N-CA 127.66 2.384 . . . . 3.0 109.091 175.185 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.9 p . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 114.194 1.183 . . . . 2.12 114.194 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.2 p -88.73 -65.5 1.01 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.506 0.722 . . . . 2.36 112.487 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 m -91.92 144.71 25.19 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.917 1.287 . . . . 2.75 113.019 -169.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.5 p -101.43 -2.13 31.56 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.975 1.71 . . . . 1.76 114.665 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.1 m -151.29 150.71 30.86 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.267 -1.52 . . . . 2.77 110.952 170.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.24 149.09 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.864 2.066 . . . . 1.5 109.936 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.5 m -117.16 124.94 50.37 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.18 0.592 . . . . 1.06 111.305 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.42 131.73 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.387 1.075 . . . . 1.15 110.637 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -126.76 96.63 4.71 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.017 1.327 . . . . 1.76 110.814 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -71.48 121.53 18.81 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.723 -1.236 . . . . 2.38 110.805 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.5 mt -109.02 159.9 16.46 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.594 1.158 . . . . 1.26 112.187 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.4 mt -142.45 161.07 39.0 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.624 1.97 . . . . 2.46 109.973 168.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.2 163.98 15.88 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.839 0.856 . . . . 1.43 111.783 168.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.1 p -85.59 -32.83 21.88 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.279 -0.888 . . . . 1.77 113.275 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -146.87 55.83 1.13 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.523 1.129 . . . . 2.65 111.05 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.62 11.36 82.98 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.728 1.632 . . . . 1.21 115.446 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -69.94 18.09 0.05 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.339 2.255 . . . . 1.81 115.534 -172.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -61.38 -31.09 70.99 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.875 -1.14 . . . . 0.97 112.291 -176.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -61.47 -49.89 74.96 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.593 1.157 . . . . 2.25 112.636 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -72.44 -43.14 64.21 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.058 -1.026 . . . . 3.46 111.511 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.5 mt -48.98 -48.78 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 119.491 1.041 . . . . 1.04 110.976 169.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.19 -30.46 70.43 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.072 1.305 . . . . 1.26 113.052 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -77.3 -31.41 54.71 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.717 0.807 . . . . 1.08 112.631 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -69.53 -20.35 63.7 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.276 1.03 . . . . 1.92 113.558 169.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.6 mt -96.96 -36.06 10.66 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.08 1.141 . . . . 1.97 114.08 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -21.91 66.85 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.414 1.006 . . . . 4.31 112.919 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.5 t -69.29 -29.75 67.69 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.277 1.031 . . . . 2.59 113.509 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.21 165.92 26.75 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.809 1.195 . . . . 1.33 113.568 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -83.89 43.04 0.89 Allowed 'General case' 0 N--CA 1.481 1.09 0 O-C-N 121.458 -1.025 . . . . 2.4 112.748 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -80.8 1.04 32.18 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.894 1.278 . . . . 3.5 114.282 -169.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.2 -25.87 65.93 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.715 -1.241 . . . . 1.58 112.406 169.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.74 -51.66 0.41 Allowed Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.541 1.067 . . . . 0.76 112.503 169.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -75.82 162.93 27.74 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.056 1.132 . . . . 3.64 114.056 -171.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -63.7 156.82 25.85 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.116 0.566 . . . . 3.92 111.6 167.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.6 t -66.01 143.3 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 122.996 0.518 . . . . 1.04 110.063 170.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.32 -64.78 2.83 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 123.807 0.718 . . . . 1.14 113.508 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.2 t -142.88 134.16 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.88 1.672 . . . . 3.69 110.157 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.5 mt -83.35 146.82 51.65 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.538 0.735 . . . . 1.59 111.962 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.01 159.17 54.17 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.639 1.559 . . . . 1.25 111.476 172.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.51 -24.87 66.46 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.565 -1.334 . . . . 2.98 111.147 169.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.71 4.56 6.08 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.968 1.47 . . . . 2.26 114.968 169.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.2 155.16 29.88 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.595 1.958 . . . . 0.96 111.98 169.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.24 163.34 34.75 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.738 0.815 . . . . 2.42 113.181 167.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -107.05 137.96 44.14 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.39 1.876 . . . . 2.75 110.353 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.51 145.96 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.546 1.138 . . . . 1.65 111.78 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.93 153.37 33.71 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.645 1.178 . . . . 1.54 112.642 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.36 19.71 40.85 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.41 1.005 . . . . 0.62 114.161 -170.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 p -97.79 143.64 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.042 1.337 . . . . 1.74 108.889 168.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -105.4 142.93 34.29 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.194 1.397 . . . . 1.94 112.667 -174.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -148.82 152.32 36.3 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.304 1.442 . . . . 2.85 111.716 175.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.23 146.57 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 127.002 2.121 . . . . 1.58 109.313 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -88.99 143.07 27.11 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.176 0.988 . . . . 0.45 112.502 170.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.5 p -133.96 164.15 27.95 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.451 1.901 . . . . 1.74 112.845 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -88.18 169.62 11.74 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.922 1.289 . . . . 1.95 110.723 166.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.57 -21.51 66.6 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.301 1.223 . . . . 3.19 114.301 -170.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -77.55 19.36 0.37 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.886 0.874 . . . . 2.13 112.817 168.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 56.25 29.14 14.36 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.257 1.823 . . . . 0.76 113.117 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -90.0 140.54 29.53 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.099 1.359 . . . . 2.37 111.39 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.1 mt -80.77 126.5 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 118.087 0.403 . . . . 1.55 110.378 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.2 pp -122.21 151.51 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.605 1.562 . . . . 1.87 114.134 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.28 164.64 19.95 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 127.21 2.204 . . . . 2.34 112.103 169.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.5 -17.93 48.57 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.823 1.786 . . . . 3.35 115.823 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -92.72 4.71 53.24 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.913 1.285 . . . . 3.83 111.557 172.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.51 10.38 85.75 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 127.294 2.378 . . . . 0.72 115.492 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -63.88 135.89 56.93 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.236 1.018 . . . . 3.47 108.553 169.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 51.9 p -90.79 139.88 30.31 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.111 0.482 . . . . 1.61 111.726 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.18 -6.09 51.33 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.818 -1.176 . . . . 1.76 113.913 -169.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.88 27.44 34.48 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 119.898 1.226 . . . . 1.0 113.695 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.3 t -136.9 148.93 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.267 1.427 . . . . 1.9 109.583 177.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -137.44 154.78 49.87 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 128.568 2.747 . . . . 1.28 110.745 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 33.0 mt -133.31 136.64 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.248 1.419 . . . . 1.68 110.179 -173.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -77.82 141.62 64.26 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-O 117.543 -1.217 . . . . 2.19 111.933 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.0 -16.28 18.14 Favored 'Trans proline' 0 C--N 1.352 0.733 0 CA-C-N 122.139 1.8 . . . . 0.94 113.416 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -101.92 -48.09 4.37 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.99 1.716 . . . . 1.96 111.28 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 p -83.92 -28.65 27.73 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.953 0.723 . . . . 2.32 112.953 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 56.34 23.28 7.12 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.883 1.673 . . . . 3.02 113.484 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.85 153.67 21.14 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.528 -1.358 . . . . 3.32 111.817 174.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 29.6 mt -92.04 139.03 31.04 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.679 1.192 . . . . 1.03 112.375 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.5 p -74.24 6.69 3.34 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.716 1.206 . . . . 1.69 113.956 175.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.21 -158.72 20.44 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 126.446 1.974 . . . . 1.02 111.068 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.99 155.14 32.83 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 122.065 -0.667 . . . . 1.69 112.429 175.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.8 tpt -59.48 125.28 78.99 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.877 0.871 . . . . 2.71 109.926 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -70.4 167.45 25.22 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 124.39 3.393 . . . . 0.94 113.9 -172.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.69 -97.59 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.176 1.391 . . . . 1.64 111.032 170.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 50.7 p -71.3 11.43 0.44 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.522 2.045 . . . . 2.3 116.522 -167.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.67 150.35 3.96 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.25 -0.906 . . . . 0.63 112.943 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.2 tpt -78.27 88.45 4.32 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.081 2.152 . . . . 1.67 110.713 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -147.66 135.05 20.69 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.039 1.736 . . . . 1.98 111.32 -171.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -169.24 145.98 3.46 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.23 1.412 . . . . 4.38 110.2 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.09 156.12 21.21 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.572 1.323 . . . . 0.83 114.572 -175.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.9 p -66.3 137.87 57.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 119.866 -1.771 . . . . 1.29 110.319 169.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -98.82 -56.57 2.4 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.462 1.105 . . . . 2.65 113.344 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -167.84 -39.95 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.598 1.959 . . . . 1.61 110.742 168.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -96.6 25.5 5.1 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.847 1.659 . . . . 5.1 112.574 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.6 -150.94 19.74 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.033 1.778 . . . . 0.98 111.348 -169.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.53 128.37 21.84 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.279 1.832 . . . . 1.22 110.347 168.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -75.62 136.13 40.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.941 1.297 . . . . 2.49 110.927 172.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -128.11 117.46 21.65 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.282 1.833 . . . . 2.96 108.876 169.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -77.27 122.03 24.52 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.177 -0.952 . . . . 2.04 110.82 175.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.7 p -112.03 -4.64 14.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.934 1.294 . . . . 1.89 114.069 -171.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.9 -15.69 5.34 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 115.918 1.822 . . . . 1.44 115.918 -172.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -106.39 0.9 25.25 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.086 1.355 . . . . 2.74 114.076 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.84 146.01 87.39 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 120.521 1.509 . . . . 0.87 113.122 170.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.99 164.83 32.6 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.934 1.756 . . . . 1.27 110.364 165.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.39 88.52 1.58 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.454 1.501 . . . . 2.62 110.3 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -139.95 -179.22 5.83 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.042 1.337 . . . . 2.01 111.185 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -92.69 140.84 29.12 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.574 1.15 . . . . 2.97 111.813 168.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -132.55 169.93 15.9 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.988 1.715 . . . . 1.03 110.298 -169.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -152.53 147.59 26.38 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.43 1.092 . . . . 4.76 112.264 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -105.25 136.38 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 123.797 0.839 . . . . 1.45 109.024 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -123.44 122.41 38.19 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.376 1.47 . . . . 3.21 110.019 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -83.36 75.75 9.96 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.993 1.317 . . . . 2.13 111.109 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.0 mm -80.82 113.85 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.41 -0.959 . . . . 1.87 108.41 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -116.35 28.34 8.65 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.703 0.801 . . . . 5.2 113.131 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.2 p . . . . . 0 N--CA 1.471 0.599 0 C-N-CA 124.226 1.01 . . . . 2.22 111.572 168.544 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 111.54 0.2 . . . . 3.5 111.54 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.87 154.16 34.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.478 0.711 . . . . 1.38 111.275 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.04 143.21 40.14 Favored Pre-proline 0 N--CA 1.477 0.898 0 O-C-N 121.521 -0.737 . . . . 1.14 111.202 174.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.21 145.41 72.4 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.825 3.016 . . . . 0.56 111.653 -168.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 1.3 mp -103.94 124.01 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.129 0.971 . . . . 2.41 109.492 -171.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.87 138.05 32.44 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.84 0.746 . . . . 3.07 112.894 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.3 tt -147.92 156.15 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.18 0.992 . . . . 1.57 111.682 -172.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -134.46 166.55 22.6 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.099 1.76 . . . . 2.61 109.481 169.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -61.5 155.55 58.29 Favored Pre-proline 0 CA--C 1.551 1.017 0 O-C-N 120.973 -1.079 . . . . 2.59 111.932 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.42 94.9 0.92 Allowed 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.919 3.079 . . . . 1.14 112.111 -169.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.44 45.58 2.63 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.379 1.871 . . . . 3.65 108.803 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -128.81 18.4 6.18 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 127.214 2.206 . . . . 3.12 113.024 -167.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.3 t70 60.96 17.75 8.2 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 128.171 2.588 . . . . 4.08 115.639 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.3 m -86.58 153.03 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 114.282 1.215 . . . . 1.48 114.282 -172.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.13 -32.26 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.083 1.753 . . . . 2.96 112.095 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -153.78 141.03 19.55 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.737 1.215 . . . . 2.43 110.19 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -101.86 140.77 35.7 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.208 0.818 . . . . 1.4 113.208 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -136.8 166.04 24.54 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.032 1.493 . . . . 0.6 115.032 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.76 143.55 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 127.2 2.2 . . . . 1.03 111.485 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -133.06 82.74 53.66 Favored Pre-proline 0 CA--C 1.553 1.066 0 N-CA-C 113.584 0.957 . . . . 3.15 113.584 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -58.0 143.99 95.28 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.699 2.932 . . . . 1.03 115.51 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -133.6 165.93 23.78 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 128.55 2.74 . . . . 2.38 112.623 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -119.62 173.3 7.09 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.002 2.121 . . . . 3.28 111.154 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 117.352 2.352 . . . . 2.93 117.352 -169.95 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.0 p . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 115.774 1.768 . . . . 2.29 115.774 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.2 p -121.7 0.11 9.78 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.324 1.45 . . . . 2.25 114.029 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 m -156.41 158.32 37.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.976 1.711 . . . . 3.2 110.42 -170.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 43.1 p -117.27 -11.66 10.6 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 126.425 1.89 . . . . 2.2 115.552 -174.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 p -143.68 153.31 42.35 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.903 1.681 . . . . 3.09 113.064 -175.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.3 p -130.93 135.2 60.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 126.426 1.891 . . . . 1.47 109.119 174.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.8 m -114.62 126.04 54.44 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 118.254 0.479 . . . . 1.13 110.509 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.2 p -96.89 132.38 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.225 1.01 . . . . 2.15 110.318 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -129.59 98.31 4.8 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.584 1.554 . . . . 2.07 109.732 -174.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.09 126.18 30.49 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.619 -1.3 . . . . 1.97 111.842 -169.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.6 mt -103.59 151.67 22.64 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.37 1.068 . . . . 1.3 113.322 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.53 161.63 35.33 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.567 1.547 . . . . 2.8 109.451 169.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.18 154.03 17.63 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.732 0.813 . . . . 1.78 112.027 172.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.4 p -87.64 -20.19 26.68 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.29 1.219 . . . . 1.81 114.29 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -151.5 51.99 0.83 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.882 1.673 . . . . 2.17 112.455 170.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.99 23.79 70.92 Favored Glycine 0 CA--C 1.536 1.388 0 O-C-N 120.439 -1.413 . . . . 1.11 115.989 172.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.1 10.95 4.54 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 128.213 2.605 . . . . 1.86 115.622 -174.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -57.81 -31.25 66.41 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.37 -1.456 . . . . 0.97 112.629 -171.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.42 -49.75 52.17 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.788 1.235 . . . . 2.31 113.465 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -69.7 -33.06 72.01 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 120.968 -1.082 . . . . 4.18 111.495 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.42 -52.67 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.502 1.121 . . . . 2.28 110.095 168.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.86 -34.99 70.34 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.127 0.876 . . . . 1.24 112.484 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -67.62 -32.47 73.21 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.405 0.891 . . . . 0.96 113.405 173.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.99 -28.24 65.36 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.063 1.301 . . . . 1.98 113.017 171.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.4 mt -87.2 -40.95 14.11 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.673 0.99 . . . . 1.33 113.673 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -67.41 -21.21 65.59 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.437 0.903 . . . . 2.85 113.437 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.4 t -75.79 -25.69 56.62 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 121.393 -0.817 . . . . 1.94 112.88 169.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.46 161.19 32.3 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 126.141 1.829 . . . . 1.19 113.918 174.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -84.27 33.47 0.5 Allowed 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.945 -1.326 . . . . 2.61 113.78 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -72.1 8.44 1.28 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.595 1.702 . . . . 3.56 115.595 -169.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.1 -30.17 71.09 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.219 -0.925 . . . . 1.45 109.881 165.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.25 -83.74 1.75 Allowed Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.067 1.318 . . . . 0.91 112.476 171.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -65.99 151.8 46.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.608 1.336 . . . . 1.69 114.608 -173.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -59.16 143.37 49.06 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.075 1.35 . . . . 5.01 111.3 172.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.8 t -53.89 136.24 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.343 0.657 . . . . 1.36 111.181 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.7 -64.42 3.32 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.682 0.658 . . . . 1.12 112.515 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.4 t -137.52 125.86 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.581 1.152 . . . . 2.81 110.623 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.8 mt -80.73 143.78 54.95 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.316 0.647 . . . . 1.46 110.896 172.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.91 162.18 42.7 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.141 1.894 . . . . 0.75 112.158 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.63 -21.63 66.47 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.646 0.98 . . . . 2.11 113.646 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -92.55 -1.48 56.9 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 115.082 1.512 . . . . 2.51 115.082 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.41 152.41 21.5 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.853 0.861 . . . . 0.8 113.147 169.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.7 pttt -146.43 167.73 22.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.577 1.551 . . . . 2.82 111.77 168.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -118.4 143.44 46.66 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.864 1.666 . . . . 2.4 109.931 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.1 pt -126.93 142.91 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 114.468 1.285 . . . . 1.48 114.468 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.66 153.22 20.34 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.823 1.649 . . . . 1.88 112.316 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.63 7.07 61.93 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.964 1.745 . . . . 0.65 115.28 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.0 p -90.42 143.75 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 118.547 1.173 . . . . 2.0 110.112 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 1.3 tpp -111.67 132.85 54.31 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.105 1.762 . . . . 1.65 112.016 -172.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.55 153.06 48.69 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.39 1.476 . . . . 2.88 111.53 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.81 143.19 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 126.346 1.859 . . . . 1.75 109.514 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -84.78 145.99 27.6 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 122.817 1.294 . . . . 0.41 111.244 169.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.3 p -140.27 170.69 15.35 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.29 1.836 . . . . 1.44 111.527 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.75 173.23 9.59 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.525 0.73 . . . . 2.01 112.926 169.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.7 p -64.1 -16.91 62.82 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 120.744 -1.223 . . . . 2.34 113.513 170.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 -80.96 8.1 9.18 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.418 1.487 . . . . 3.31 113.014 168.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.52 25.54 9.89 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.129 2.172 . . . . 0.72 113.28 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -89.29 141.46 28.52 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.633 1.573 . . . . 2.52 110.612 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.8 mt -76.66 126.98 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.416 -0.587 . . . . 1.52 109.416 177.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.2 pt -122.07 154.38 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 114.637 1.347 . . . . 0.98 114.637 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.29 163.32 24.04 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.168 2.187 . . . . 1.74 111.336 167.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.74 -1.18 3.53 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 115.499 1.666 . . . . 2.33 115.499 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -105.14 -1.57 25.34 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.907 1.683 . . . . 3.96 113.218 169.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.16 -0.68 64.21 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.436 1.969 . . . . 0.66 115.853 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -69.66 139.18 53.48 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 119.185 1.492 . . . . 2.49 110.893 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.5 p -99.21 141.26 32.21 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.732 0.813 . . . . 1.62 112.402 -172.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.23 -8.0 46.62 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.475 1.287 . . . . 2.1 114.475 -168.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.5 24.0 57.32 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.052 0.842 . . . . 0.82 113.661 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.95 147.08 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.214 1.406 . . . . 1.76 109.311 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -133.67 158.22 43.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.839 1.656 . . . . 1.29 111.656 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 60.0 mt -133.19 141.04 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.912 1.285 . . . . 1.51 110.684 -170.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -81.98 145.91 54.37 Favored Pre-proline 0 N--CA 1.477 0.91 0 O-C-N 120.862 -1.149 . . . . 1.81 112.659 174.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.68 -19.38 12.84 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 CA-C-N 122.139 1.8 . . . . 1.08 113.243 175.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -97.93 -47.74 5.43 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.821 1.649 . . . . 1.42 112.47 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.8 p -80.49 -29.18 37.35 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.286 0.635 . . . . 1.81 111.879 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 57.74 16.34 3.46 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.531 1.532 . . . . 3.09 113.539 -170.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.79 149.23 21.41 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.742 1.217 . . . . 3.6 111.718 -175.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.2 mt -84.17 138.64 32.89 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.932 1.293 . . . . 2.3 111.955 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.1 t -87.02 20.24 2.75 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.685 0.994 . . . . 2.84 113.685 172.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -177.42 174.07 46.67 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 126.882 2.182 . . . . 1.21 111.905 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.6 162.78 28.84 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.306 0.854 . . . . 1.7 113.306 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 mmt -51.91 132.45 39.01 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.712 1.205 . . . . 2.41 113.074 -175.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -78.59 155.67 27.85 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.323 3.349 . . . . 1.07 113.682 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.15 -35.92 23.26 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.893 1.812 . . . . 1.58 115.893 -176.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.2 p -131.46 10.22 4.79 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.832 1.653 . . . . 1.95 113.035 -168.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.85 152.29 16.22 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.689 1.366 . . . . 0.81 114.689 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.1 ttt -80.19 85.31 5.74 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.85 1.66 . . . . 2.05 111.712 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -135.45 153.85 51.63 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.005 1.722 . . . . 2.37 112.456 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -164.02 158.34 19.4 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.124 1.77 . . . . 2.72 110.747 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 mp -98.28 147.29 24.79 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.31 1.044 . . . . 0.85 112.469 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.2 p -65.1 125.68 25.72 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 120.329 1.422 . . . . 1.42 109.822 169.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.52 -52.02 7.24 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.372 1.619 . . . . 2.02 115.372 -169.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.78 -46.07 0.1 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.784 1.634 . . . . 1.93 109.075 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -116.01 -17.03 11.02 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.524 1.305 . . . . 4.09 114.524 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 172.57 -169.5 42.62 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.093 1.33 . . . . 0.76 112.593 -172.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.52 126.82 18.64 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.281 1.832 . . . . 1.91 112.413 170.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -80.19 136.7 36.54 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.873 1.269 . . . . 2.25 112.388 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -127.52 142.38 51.4 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.321 2.649 . . . . 3.49 108.671 171.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -105.91 111.97 24.84 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.93 0.892 . . . . 3.47 110.619 -175.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.0 p -94.15 -8.41 39.53 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.314 1.228 . . . . 1.97 114.314 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.23 -14.85 1.26 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.885 1.674 . . . . 1.98 115.357 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.92 -21.71 13.09 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.556 1.542 . . . . 3.43 112.866 -176.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -72.21 144.57 87.33 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 119.779 1.172 . . . . 0.85 112.523 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.94 168.16 25.45 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.84 2.36 . . . . 0.79 111.99 172.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -72.35 76.38 1.01 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.625 1.97 . . . . 1.24 111.818 -176.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -142.03 -173.54 3.84 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.115 1.366 . . . . 1.98 111.305 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -104.66 154.7 19.63 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.233 1.413 . . . . 4.05 112.201 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -145.3 169.8 17.55 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 127.456 2.302 . . . . 0.66 110.178 -173.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -137.97 154.66 49.34 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.866 1.061 . . . . 2.44 113.866 175.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.6 mp -113.58 136.9 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.566 1.146 . . . . 1.46 110.763 174.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -125.9 149.65 48.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.746 2.018 . . . . 3.18 110.558 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -112.05 120.16 40.89 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.581 1.152 . . . . 1.89 110.72 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 22.9 mm -129.07 113.96 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.352 1.061 . . . . 1.66 109.421 -169.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -98.91 15.32 25.98 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.687 1.195 . . . . 6.69 113.544 -174.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 82.5 p . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 114.253 1.205 . . . . 2.46 114.253 -176.484 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 112.436 0.532 . . . . 4.56 112.436 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.07 155.45 40.29 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.091 0.775 . . . . 1.89 113.091 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.74 150.78 37.34 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 124.469 1.108 . . . . 0.84 110.018 167.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.6 140.51 32.89 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.894 2.396 . . . . 0.8 113.244 -168.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.9 mp -111.23 139.27 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.146 1.779 . . . . 2.23 109.874 -173.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -107.45 141.32 39.04 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.914 1.079 . . . . 2.76 113.914 173.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.8 tt -145.38 155.37 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 125.326 1.45 . . . . 1.42 111.779 -170.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -134.89 160.21 38.98 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.669 1.988 . . . . 1.99 110.382 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.95 144.54 81.85 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.347 -0.846 . . . . 3.12 112.573 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.4 113.57 3.52 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.148 2.565 . . . . 0.97 113.793 -169.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 4.2 tt -126.18 79.05 1.81 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 105.388 -2.079 . . . . 4.37 105.388 166.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -149.79 156.07 41.2 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.085 2.154 . . . . 3.49 109.686 -169.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -80.54 33.47 0.31 Allowed 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.787 -1.196 . . . . 4.08 113.94 -177.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 32.9 m -110.25 169.18 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.216 1.406 . . . . 3.76 112.481 -173.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 61.4 t -101.93 -29.06 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.651 1.181 . . . . 3.14 110.384 171.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.49 140.79 41.39 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.266 1.426 . . . . 3.26 111.434 173.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -91.31 152.88 20.29 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.848 0.859 . . . . 2.06 110.626 173.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -138.87 153.13 48.28 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.337 0.865 . . . . 0.97 113.337 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.38 140.57 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.106 1.762 . . . . 1.21 111.002 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -128.97 74.11 81.31 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.735 0.814 . . . . 3.44 112.907 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.61 150.05 44.77 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.141 3.227 . . . . 1.32 113.818 -175.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -132.01 165.01 24.93 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.48 2.312 . . . . 2.46 113.014 -169.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -108.67 161.0 15.5 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.415 1.486 . . . . 3.48 113.613 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.469 0.475 0 C-N-CA 126.075 1.75 . . . . 3.15 108.613 167.202 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.5 p . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 113.678 0.992 . . . . 1.84 113.678 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.4 p -89.9 -20.4 23.43 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 115.014 1.487 . . . . 2.61 115.014 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.6 t -154.51 156.07 36.0 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.376 1.47 . . . . 2.63 110.775 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.4 p -80.67 -4.56 54.73 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.497 1.666 . . . . 2.51 115.497 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.404 ' CB ' ' HE3' ' A' ' 128' ' ' LYS . 2.9 p -149.69 161.87 41.35 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.596 1.702 . . . . 2.55 115.596 -170.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.6 p -128.4 143.65 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 127.043 2.137 . . . . 1.62 110.003 173.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.0 m -113.89 118.39 34.06 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.223 1.009 . . . . 1.25 109.073 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 p -94.49 130.93 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 122.061 0.934 . . . . 1.36 109.289 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -108.56 -179.47 3.88 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.174 1.79 . . . . 1.92 109.424 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.53 122.3 9.29 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 120.168 -1.583 . . . . 1.99 111.656 169.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.6 mt -111.63 151.21 29.07 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.249 1.02 . . . . 2.03 112.688 -171.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.78 159.85 38.56 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.163 1.785 . . . . 3.28 110.917 175.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.61 165.27 11.32 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.513 1.125 . . . . 1.25 112.358 173.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.6 p -97.84 -17.12 19.49 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.874 1.435 . . . . 1.9 114.874 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -152.04 49.05 0.78 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.903 1.681 . . . . 2.82 110.572 169.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.29 11.28 85.11 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 116.497 1.359 . . . . 1.1 116.497 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.56 16.02 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 128.674 2.789 . . . . 2.31 116.749 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -19.92 60.2 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.572 -1.33 . . . . 2.02 112.926 -176.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -82.3 -47.65 12.13 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.409 1.483 . . . . 2.87 113.167 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -65.25 -41.3 94.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.7 1.136 . . . . 3.69 111.099 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.8 mt -52.05 -52.96 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 119.56 1.073 . . . . 1.04 110.282 168.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.8 -30.88 62.07 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 120.676 1.58 . . . . 1.15 113.618 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -77.49 -37.22 51.68 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.504 0.927 . . . . 1.18 113.504 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -63.85 -22.68 67.03 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.856 0.863 . . . . 1.95 112.631 169.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.7 mt -88.79 -44.86 10.21 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.337 0.865 . . . . 0.95 113.337 173.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -69.57 -15.08 63.15 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.851 1.205 . . . . 2.65 114.092 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.7 t -75.19 -28.36 59.99 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.515 1.126 . . . . 2.2 112.242 169.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.73 166.98 38.05 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.944 1.259 . . . . 1.1 112.786 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -85.76 35.73 0.63 Allowed 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.947 -1.325 . . . . 2.0 111.743 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -75.64 4.77 7.11 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.938 1.088 . . . . 3.2 113.938 -171.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.72 -30.87 71.04 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.517 1.127 . . . . 1.64 110.003 164.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.32 -76.56 0.75 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.358 1.456 . . . . 0.78 112.51 171.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.254 0.0 OUTLIER -71.01 154.74 41.56 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.212 1.56 . . . . 1.81 115.212 -169.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.56 151.05 29.74 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.949 0.9 . . . . 6.13 112.522 -177.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.6 t -60.36 123.3 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 109.751 -0.463 . . . . 1.97 109.751 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.84 -53.45 40.77 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.262 0.458 . . . . 1.26 113.823 -170.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.8 t -150.5 127.73 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.942 1.697 . . . . 3.8 108.408 171.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.8 mt -75.99 152.55 84.53 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.343 1.057 . . . . 1.78 112.808 173.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.35 162.72 41.48 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.396 2.064 . . . . 0.71 112.071 175.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.4 -30.9 69.89 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.373 -0.829 . . . . 2.06 111.916 170.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.29 5.66 8.16 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 115.68 1.733 . . . . 2.11 115.68 173.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.84 157.02 21.9 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.433 1.493 . . . . 0.65 113.435 170.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -148.02 169.55 19.68 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.427 1.491 . . . . 2.59 111.736 169.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -121.11 139.12 53.76 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.798 1.239 . . . . 1.91 110.288 -173.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.3 pt -127.98 142.36 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 121.421 -0.799 . . . . 1.41 112.272 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.98 145.25 43.77 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.012 1.325 . . . . 1.84 111.699 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.16 23.98 6.16 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.225 1.393 . . . . 0.91 114.969 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.3 p -109.78 142.86 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 127.373 2.269 . . . . 1.98 110.337 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.0 tpp -98.78 143.79 28.73 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.36 1.464 . . . . 1.86 113.415 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -148.09 151.94 36.5 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.672 1.589 . . . . 2.83 111.512 174.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 m -125.29 144.9 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.166 1.786 . . . . 1.73 110.153 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -86.04 149.06 25.43 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.69 1.233 . . . . 0.41 112.477 170.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.0 p -144.45 170.92 15.11 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.737 2.015 . . . . 1.72 111.661 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.66 177.52 5.99 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.208 1.003 . . . . 2.22 113.121 169.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 42.3 p -59.96 -29.8 68.66 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.84 0.856 . . . . 1.91 113.225 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -78.06 13.74 1.35 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.896 1.279 . . . . 2.51 113.823 173.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.7 28.19 15.44 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.332 1.853 . . . . 0.93 112.044 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -88.62 138.58 31.29 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.086 1.754 . . . . 2.1 110.466 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -78.2 127.22 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.818 -0.438 . . . . 1.69 109.818 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.0 pt -120.69 157.31 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.812 1.245 . . . . 1.1 114.109 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -86.16 163.92 17.54 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.409 1.884 . . . . 1.85 110.473 166.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -61.42 -12.72 15.65 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.981 1.474 . . . . 2.29 114.981 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -94.71 0.25 54.86 Favored 'General case' 0 CA--C 1.55 0.947 0 O-C-N 120.656 -1.277 . . . . 3.89 112.165 172.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.18 7.47 86.81 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 126.092 1.806 . . . . 0.6 115.293 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -64.55 131.17 46.29 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.599 1.2 . . . . 2.67 107.974 168.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.9 p -89.95 145.94 24.75 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.66 0.664 . . . . 1.93 110.605 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.94 -6.07 49.37 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.177 0.806 . . . . 1.78 113.177 -169.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.71 32.43 57.25 Favored Glycine 0 CA--C 1.531 1.073 0 O-C-N 121.399 -0.813 . . . . 1.01 112.468 -173.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.1 t -135.7 148.53 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.797 1.639 . . . . 2.05 109.805 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -135.97 154.69 51.01 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.473 2.309 . . . . 1.65 111.079 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 54.8 mt -132.77 134.9 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.99 1.316 . . . . 1.94 112.248 -171.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -69.25 135.12 89.05 Favored Pre-proline 0 CA--C 1.546 0.804 0 O-C-N 120.635 -1.291 . . . . 2.13 111.166 170.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.65 -17.71 25.99 Favored 'Trans proline' 0 C--N 1.35 0.617 0 CA-C-N 122.548 1.946 . . . . 1.16 113.657 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -96.08 -43.66 7.67 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.009 1.723 . . . . 1.9 112.555 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.3 p -94.24 -22.55 18.34 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.5 1.12 . . . . 2.26 113.948 -174.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 53.95 20.41 2.39 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 125.421 1.488 . . . . 3.92 113.975 -169.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.73 144.77 31.94 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.404 -1.435 . . . . 4.0 111.511 176.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 mt -90.42 148.24 22.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.899 1.68 . . . . 1.16 112.073 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.2 p -74.28 9.75 1.54 Allowed 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.152 1.167 . . . . 1.9 114.152 170.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.32 -160.47 24.63 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 126.081 1.801 . . . . 1.18 113.034 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.89 160.91 21.02 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.808 1.243 . . . . 1.64 112.101 172.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -52.27 130.92 42.59 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.378 1.071 . . . . 2.06 113.484 -174.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -68.94 152.35 73.49 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.975 3.117 . . . . 1.03 114.368 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.31 -64.27 0.89 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.763 1.225 . . . . 1.05 113.653 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.7 p -101.61 7.78 42.03 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.173 1.546 . . . . 1.79 115.173 -168.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.78 146.67 13.22 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.205 1.187 . . . . 0.61 114.205 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.6 ttt -77.06 89.36 3.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.942 1.697 . . . . 2.14 111.513 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -143.87 145.16 32.11 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.894 1.678 . . . . 2.09 112.244 -174.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -164.85 159.88 18.86 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.89 1.676 . . . . 2.87 111.046 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.38 146.97 26.89 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.815 1.246 . . . . 1.21 113.365 174.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.2 p -65.05 125.82 26.13 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.533 -0.73 . . . . 1.33 110.814 172.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -87.94 -57.53 2.9 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.471 1.286 . . . . 2.7 114.471 -172.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -151.11 -41.25 0.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.02 0.928 . . . . 2.46 111.654 -172.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -118.62 -22.44 7.49 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.83 1.252 . . . . 4.4 113.503 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 171.52 -160.0 31.84 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 126.079 1.799 . . . . 0.87 111.326 -175.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -139.9 132.94 29.51 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.657 1.983 . . . . 1.27 111.272 169.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.404 ' HE3' ' CB ' ' A' ' 36' ' ' SER . 71.4 tttt -87.32 139.91 30.08 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.299 1.44 . . . . 2.82 113.72 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -132.32 129.79 39.95 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.538 2.735 . . . . 3.0 108.594 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -92.55 120.78 33.34 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.515 -0.741 . . . . 1.74 110.092 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.6 p -103.42 -2.0 27.63 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.398 1.479 . . . . 1.77 113.367 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -52.68 -29.25 25.49 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.872 1.269 . . . . 1.62 113.521 173.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -97.42 -15.54 20.6 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.113 1.765 . . . . 2.74 114.437 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.52 154.8 81.55 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 119.623 1.101 . . . . 0.81 113.064 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -82.72 170.2 12.93 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.303 2.669 . . . . 0.78 110.419 165.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.94 98.85 3.67 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.752 1.221 . . . . 1.18 109.956 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -153.29 179.08 9.08 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.025 0.93 . . . . 1.54 111.878 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -91.12 150.88 21.21 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.091 1.356 . . . . 3.23 111.211 168.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -146.13 170.7 16.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.28 1.832 . . . . 0.67 110.056 -173.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -140.64 154.63 46.5 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.043 0.937 . . . . 2.63 113.043 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.9 mp -114.94 141.52 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.907 1.283 . . . . 1.82 110.768 172.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -126.9 117.97 23.63 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.075 2.15 . . . . 3.2 110.571 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -82.53 75.4 9.44 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.251 1.02 . . . . 1.79 111.398 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 40.7 mm -71.54 114.26 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 123.232 0.613 . . . . 2.1 109.383 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.36 -5.84 59.28 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.995 1.48 . . . . 5.36 114.995 -169.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.476 0.836 0 C-N-CA 125.536 1.535 . . . . 2.15 114.054 -177.135 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 111.828 0.307 . . . . 3.28 111.828 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.6 147.32 35.71 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.103 0.561 . . . . 1.27 111.212 168.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.7 m -110.86 151.93 43.24 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.761 1.224 . . . . 2.32 110.002 172.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.71 161.22 46.81 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.52 2.147 . . . . 0.93 113.378 -170.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.3 mp -124.87 128.66 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.783 1.233 . . . . 2.79 110.522 -169.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -96.0 138.29 33.83 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.244 1.018 . . . . 2.98 112.955 172.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.4 tt -143.43 151.2 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.376 1.47 . . . . 1.57 111.863 -172.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -130.03 149.87 51.56 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.756 1.622 . . . . 2.08 109.373 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 15.2 mt -65.71 154.68 88.12 Favored Pre-proline 0 N--CA 1.478 0.95 0 N-CA-C 115.008 1.484 . . . . 1.49 115.008 -168.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.8 102.85 1.25 Allowed 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 123.296 2.664 . . . . 0.81 114.437 -168.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 16.1 mt -137.39 21.08 2.95 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.262 2.625 . . . . 3.8 110.86 170.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -85.78 19.72 2.41 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.958 1.703 . . . . 3.4 113.106 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 21.1 t70 61.72 25.72 15.54 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.674 2.39 . . . . 3.59 114.367 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 16.5 m -99.1 144.48 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.979 1.312 . . . . 1.45 113.093 -174.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 57.6 t -70.78 -34.61 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.705 0.802 . . . . 2.1 111.511 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -140.59 142.34 35.1 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.177 1.391 . . . . 2.68 111.807 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -107.38 141.67 38.4 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.411 1.085 . . . . 1.25 112.661 -174.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -140.59 166.74 23.92 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.595 1.702 . . . . 0.72 115.595 -175.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.91 139.77 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.421 1.888 . . . . 1.05 111.56 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -133.33 74.38 72.21 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.723 1.209 . . . . 3.49 113.373 -177.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.81 152.13 77.77 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 124.976 3.784 . . . . 0.73 113.622 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -133.19 -156.94 0.78 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.389 2.676 . . . . 3.09 111.008 -167.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -144.15 163.59 33.16 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.41 1.484 . . . . 3.9 112.08 168.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 4.6 t . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 114.45 1.278 . . . . 2.48 114.45 -176.536 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.5 p . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 114.467 1.284 . . . . 2.03 114.467 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.3 p -93.22 -14.55 26.94 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.755 0.822 . . . . 2.44 112.89 169.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.474 HG23 ' H ' ' A' ' 36' ' ' SER . 9.3 m -146.38 148.26 32.15 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.201 2.2 . . . . 2.59 109.708 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 p -111.45 16.65 20.67 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.964 1.706 . . . . 2.83 113.937 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.474 ' H ' HG23 ' A' ' 34' ' ' THR . 29.0 m -147.6 159.75 43.42 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.347 1.459 . . . . 2.4 111.736 170.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -136.04 144.12 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.615 1.966 . . . . 1.54 110.209 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.0 m -120.75 125.8 48.54 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.564 0.746 . . . . 1.76 111.512 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p -100.28 138.15 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.571 1.148 . . . . 2.06 111.183 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -136.21 113.71 10.88 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.364 1.465 . . . . 1.75 113.091 -171.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -81.79 127.43 32.96 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.043 -1.661 . . . . 2.72 113.069 -174.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.9 mt -114.25 155.36 26.29 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.552 1.541 . . . . 1.22 112.767 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.5 mt -141.19 173.14 11.77 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.409 1.884 . . . . 2.28 110.265 168.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.96 172.56 6.95 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.501 1.121 . . . . 1.34 112.032 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.4 p -95.91 -31.75 12.96 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.042 0.756 . . . . 2.16 113.042 170.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -143.02 52.03 1.39 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.656 1.582 . . . . 2.61 111.414 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.22 16.36 77.0 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 124.602 1.096 . . . . 1.1 115.52 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.75 12.97 0.16 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.118 2.167 . . . . 2.16 115.302 -174.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -61.53 -29.27 69.89 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 120.567 -1.333 . . . . 0.97 112.27 -173.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -75.9 -40.46 54.31 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.643 1.177 . . . . 2.26 113.247 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -72.66 -38.64 67.58 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-O 117.945 -1.026 . . . . 3.06 111.782 170.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 71.8 mt -53.23 -50.98 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.396 1.078 . . . . 1.03 110.28 167.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.32 -31.11 68.86 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.731 1.151 . . . . 1.15 112.571 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -77.81 -26.9 49.87 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.124 1.157 . . . . 1.26 114.124 171.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -71.21 -30.77 66.79 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.754 -1.216 . . . . 1.99 111.929 168.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.2 mt -90.63 -40.26 12.01 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.727 1.38 . . . . 1.09 114.727 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -67.27 -25.18 65.94 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 120.123 1.329 . . . . 2.91 112.714 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.7 t -80.2 -3.28 48.42 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.215 1.806 . . . . 2.67 112.961 173.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.34 160.88 14.9 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 126.321 1.915 . . . . 1.06 112.164 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -79.29 35.56 0.27 Allowed 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.111 -1.229 . . . . 1.99 113.153 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -78.45 7.7 6.24 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.447 1.099 . . . . 3.47 113.599 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.54 -31.38 67.88 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.115 1.366 . . . . 1.91 110.488 165.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.34 -48.34 0.15 Allowed Glycine 0 C--N 1.344 1.005 0 CA-C-O 119.748 -0.473 . . . . 1.12 114.007 171.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -67.91 145.83 54.2 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.636 0.718 . . . . 3.21 111.648 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -68.34 149.09 49.83 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.04 0.836 . . . . 4.0 112.144 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 69.5 t -59.81 126.28 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 122.832 0.453 . . . . 1.7 111.313 -173.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.19 -50.71 31.71 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.107 1.337 . . . . 0.96 113.924 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 98.3 t -142.73 120.12 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.097 1.359 . . . . 2.66 110.198 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.4 mt -82.91 141.92 44.4 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.26 0.624 . . . . 1.39 110.137 168.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.8 161.24 42.92 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 121.381 1.388 . . . . 0.64 112.36 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.56 -26.87 65.74 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.358 -0.839 . . . . 1.64 112.233 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.77 5.39 40.27 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.948 1.699 . . . . 1.93 115.292 174.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.16 152.75 21.07 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.739 1.215 . . . . 0.68 111.189 168.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -142.73 164.47 30.01 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.093 1.357 . . . . 3.46 111.74 174.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -125.35 134.7 52.1 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.984 1.313 . . . . 2.26 110.534 -169.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.8 pt -136.33 151.41 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.833 1.253 . . . . 1.76 111.832 -176.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -119.86 174.04 6.69 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.44 1.496 . . . . 1.71 111.964 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.24 12.96 64.61 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.504 1.526 . . . . 0.53 115.532 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.9 p -96.71 146.06 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.174 1.39 . . . . 1.65 111.336 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 15.1 tpp -101.9 138.69 38.54 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.056 2.142 . . . . 1.76 112.223 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -145.73 152.78 40.13 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.565 1.546 . . . . 2.88 111.919 177.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.45 145.76 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 126.802 2.041 . . . . 1.46 110.494 -174.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -87.8 146.26 25.71 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 122.552 1.168 . . . . 0.42 113.084 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.8 p -143.26 167.87 21.13 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.104 1.761 . . . . 1.63 112.793 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -92.0 175.3 6.92 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.201 1.001 . . . . 2.22 112.328 168.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.8 p -67.94 -20.27 65.05 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.382 -1.449 . . . . 2.67 113.657 -174.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -80.65 14.07 2.27 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.505 1.122 . . . . 2.12 111.976 167.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.41 31.85 19.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.944 2.497 . . . . 0.58 113.213 175.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -87.23 138.96 31.04 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.322 1.049 . . . . 2.34 110.489 176.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.9 mt -76.53 124.06 34.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.788 -0.819 . . . . 1.93 108.788 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.1 pt -118.86 154.69 21.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 123.169 1.461 . . . . 1.98 113.432 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.56 160.12 19.72 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.298 2.239 . . . . 2.68 108.041 166.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.54 -13.25 28.72 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.949 1.463 . . . . 2.1 114.949 -169.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -93.87 2.55 56.14 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.711 1.204 . . . . 3.46 111.668 176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.39 3.27 81.84 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.701 1.619 . . . . 0.56 114.69 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -68.93 142.76 54.63 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 123.98 0.912 . . . . 2.52 109.676 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 30.4 p -102.58 145.35 29.75 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.161 0.984 . . . . 1.68 111.553 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -97.95 -4.5 36.22 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.907 1.077 . . . . 1.49 113.907 -170.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.0 25.3 45.5 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.029 0.824 . . . . 0.69 113.412 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 p -141.06 152.31 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.07 1.348 . . . . 3.92 109.687 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -138.21 155.47 48.63 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 128.471 2.709 . . . . 1.34 110.193 -169.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 47.3 mt -136.36 131.23 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.3 1.44 . . . . 1.87 110.668 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -75.25 138.83 71.79 Favored Pre-proline 0 N--CA 1.476 0.844 0 O-C-N 121.124 -0.985 . . . . 2.26 110.759 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.03 -24.07 28.84 Favored 'Trans proline' 0 C--N 1.35 0.648 0 CA-C-N 121.737 1.656 . . . . 0.96 112.743 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -90.18 -47.6 7.7 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.255 1.422 . . . . 1.35 111.73 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.4 p -84.23 -27.37 28.0 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.524 0.73 . . . . 2.31 112.961 -174.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 54.99 25.39 6.83 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.07 1.348 . . . . 2.97 113.041 -172.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.83 153.79 19.5 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.164 1.385 . . . . 3.25 111.616 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 18.0 mt -92.52 140.67 29.32 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.186 1.794 . . . . 2.09 112.918 -172.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.9 p -71.49 -3.01 18.77 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.989 1.316 . . . . 1.6 114.492 172.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.14 -162.01 16.54 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 126.599 2.047 . . . . 0.89 111.379 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.67 167.91 20.81 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.696 1.199 . . . . 2.05 112.829 173.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.7 mmt -57.34 143.23 74.34 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.868 1.267 . . . . 2.29 113.586 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -79.61 165.98 22.24 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.867 3.711 . . . . 0.77 114.045 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.86 -48.62 9.16 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.344 1.609 . . . . 1.31 115.344 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.4 p -130.38 13.89 5.55 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.243 1.417 . . . . 2.23 113.807 -169.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.22 148.11 6.85 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.479 0.918 . . . . 0.55 113.479 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 7.2 ttt -74.02 106.32 5.66 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 126.867 2.067 . . . . 1.81 110.237 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.5 pttp -158.86 151.49 21.84 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.387 1.475 . . . . 1.9 112.16 -172.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -161.98 171.74 17.12 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.682 1.193 . . . . 2.4 110.919 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.5 mp -113.01 144.42 42.62 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.874 1.269 . . . . 0.76 112.038 170.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.5 p -73.27 133.88 44.07 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.037 0.835 . . . . 1.35 111.295 173.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -94.77 -52.88 4.08 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.02 1.489 . . . . 2.23 115.02 -171.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -175.07 -32.1 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 128.176 2.59 . . . . 1.85 110.881 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -116.5 24.38 11.37 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.889 2.076 . . . . 4.45 112.181 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.55 -158.76 22.21 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.788 1.661 . . . . 0.86 113.794 -173.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -136.66 132.39 34.91 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.983 2.113 . . . . 1.69 111.834 169.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -91.27 134.06 34.89 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.097 1.359 . . . . 2.07 113.534 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -127.31 119.09 25.48 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.46 2.704 . . . . 2.89 108.21 176.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -84.12 124.48 31.17 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.153 -0.967 . . . . 1.91 109.765 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 47.5 p -108.94 5.56 24.45 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.828 1.651 . . . . 1.78 113.589 -170.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.17 -27.46 54.45 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.829 0.852 . . . . 1.84 112.968 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -89.52 -13.46 37.33 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.911 1.284 . . . . 2.49 113.074 -173.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -83.53 145.3 47.62 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 114.02 1.119 . . . . 0.76 114.02 175.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.33 166.96 21.92 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.406 2.071 . . . . 0.83 110.968 165.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.39 82.95 3.13 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.458 1.903 . . . . 2.32 111.598 -174.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -138.63 -177.27 4.79 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.676 1.191 . . . . 1.8 111.625 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -93.18 151.49 19.8 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.712 0.768 . . . . 4.83 111.201 167.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -142.0 169.13 18.17 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.024 2.13 . . . . 0.71 109.647 -173.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -139.41 145.31 38.76 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.16 0.984 . . . . 2.59 112.001 174.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -102.82 138.1 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.152 0.981 . . . . 1.74 109.572 171.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -121.69 133.88 54.96 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.893 1.677 . . . . 3.19 110.24 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -99.83 124.65 45.34 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.459 1.104 . . . . 1.9 110.185 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 15.6 mm -132.35 110.55 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.044 0.937 . . . . 1.88 110.281 -169.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -73.2 -11.15 60.42 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 120.408 -1.432 . . . . 4.74 114.158 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 CA--C 1.541 0.619 0 N-CA-C 115.644 1.72 . . . . 2.21 115.644 -169.805 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 121.499 0.666 . . . . 3.15 111.149 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.87 139.15 42.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.109 0.964 . . . . 2.17 110.672 171.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.9 m -99.78 145.97 31.06 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 123.883 0.873 . . . . 1.18 110.312 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.63 132.98 21.31 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.553 2.169 . . . . 0.7 111.943 -169.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.1 mp -95.95 115.62 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 124.559 1.143 . . . . 2.18 108.415 -171.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -84.82 142.36 29.82 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.022 0.374 . . . . 3.09 111.628 172.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.4 tt -146.36 150.02 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.926 1.29 . . . . 1.51 110.648 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -122.05 157.23 31.86 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.341 1.457 . . . . 2.12 109.862 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.31 143.93 92.27 Favored Pre-proline 0 CA--C 1.545 0.77 0 O-C-N 120.905 -1.122 . . . . 2.63 111.64 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.27 110.75 1.63 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.662 2.908 . . . . 0.84 112.221 -169.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 20.0 tp -143.0 56.57 1.4 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.468 1.907 . . . . 3.93 109.589 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -144.95 23.31 1.54 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.472 1.509 . . . . 3.5 112.594 -169.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 54.03 32.39 15.45 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 127.124 2.169 . . . . 4.17 114.113 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.3 m -91.57 147.26 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.52 1.128 . . . . 1.98 110.127 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.84 -39.73 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.402 0.681 . . . . 2.24 110.025 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -128.13 137.26 52.03 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.905 1.682 . . . . 3.01 109.921 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -96.29 144.75 26.18 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.667 0.787 . . . . 1.24 111.82 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -137.99 171.5 14.33 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.991 1.478 . . . . 0.65 114.991 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -139.4 142.7 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 127.204 2.202 . . . . 2.0 110.669 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -130.31 74.66 80.13 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 113.742 1.015 . . . . 3.26 113.742 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.63 148.91 90.51 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 124.367 3.378 . . . . 0.79 112.972 175.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -136.69 -155.86 0.65 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.932 2.093 . . . . 3.2 109.876 -168.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -134.74 164.32 27.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.518 1.527 . . . . 4.07 109.096 166.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 113.361 0.875 . . . . 2.5 113.361 169.628 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 115.676 1.732 . . . . 2.62 115.676 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.6 p -85.57 -23.68 27.54 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 114.412 1.264 . . . . 2.6 114.412 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.7 t -132.59 158.28 42.61 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 128.442 2.697 . . . . 2.91 109.126 172.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.6 p -110.47 8.09 22.96 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.408 1.483 . . . . 1.75 113.595 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.2 m -137.52 163.47 31.08 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.938 1.295 . . . . 2.32 111.11 168.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.14 140.43 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.291 1.836 . . . . 1.44 109.457 173.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.6 m -115.95 121.32 41.95 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.236 0.615 . . . . 1.92 111.388 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -99.55 137.49 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.929 1.292 . . . . 1.9 111.364 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -134.54 112.27 10.74 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.335 1.454 . . . . 1.69 111.372 -174.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.73 126.86 35.52 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 120.541 -1.349 . . . . 2.15 112.468 -171.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.7 mt -116.28 150.88 36.89 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.048 1.339 . . . . 1.84 112.855 -171.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.0 mt -140.97 178.93 7.02 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.849 2.059 . . . . 2.05 110.081 168.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.07 160.93 18.36 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.901 1.28 . . . . 2.08 112.44 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -89.14 -21.21 23.45 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 114.863 1.431 . . . . 1.71 114.863 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -129.23 28.67 5.23 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.31 1.444 . . . . 2.45 111.132 168.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.71 15.31 80.76 Favored Glycine 0 CA--C 1.538 1.501 0 O-C-N 120.456 -1.402 . . . . 1.04 114.792 -177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.56 28.6 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 129.744 3.218 . . . . 1.98 117.069 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -18.56 65.15 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.07 -1.643 . . . . 1.05 113.56 -172.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -81.89 -45.34 15.6 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.393 0.997 . . . . 2.23 112.678 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -66.28 -43.6 85.95 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.549 1.068 . . . . 3.37 111.167 172.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.2 mt -50.14 -49.34 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.106 0.962 . . . . 1.95 110.997 169.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.62 70.86 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 120.043 1.292 . . . . 1.06 113.479 178.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -74.75 -31.05 61.68 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.217 -0.927 . . . . 1.03 113.21 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -65.54 -18.21 65.15 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.26 -0.9 . . . . 2.06 112.514 169.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.4 mt -95.43 -36.81 11.2 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 114.453 1.279 . . . . 1.52 114.453 176.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -64.85 -19.81 66.08 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.836 1.198 . . . . 2.85 113.759 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.5 t -72.22 -19.52 61.71 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.687 1.365 . . . . 2.1 114.687 170.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.41 179.22 33.27 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.878 1.704 . . . . 1.54 114.801 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -102.64 36.17 2.26 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.852 1.261 . . . . 3.91 111.21 174.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -74.11 3.98 6.24 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 115.18 1.548 . . . . 3.5 115.18 -168.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.58 -19.95 63.66 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 121.283 -0.886 . . . . 1.65 112.08 168.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.6 -65.86 0.37 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.139 1.352 . . . . 1.03 112.288 169.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.283 0.0 OUTLIER -76.89 155.37 32.91 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.831 1.419 . . . . 1.93 114.831 -173.032 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -56.98 154.08 10.19 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.327 0.651 . . . . 3.3 112.505 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.49 129.73 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 109.835 -0.432 . . . . 2.21 109.835 171.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.47 -55.09 16.42 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 122.932 0.301 . . . . 1.21 112.853 -176.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.0 t -141.66 121.89 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.029 0.932 . . . . 2.43 109.855 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.0 mt -78.63 137.35 58.83 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-O 118.919 -0.562 . . . . 1.84 109.528 168.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.56 166.36 29.62 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.859 2.373 . . . . 0.7 112.712 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -51.59 -41.95 61.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.263 0.625 . . . . 2.25 112.547 172.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -76.21 -3.07 34.37 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.894 2.078 . . . . 1.87 115.657 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.05 153.7 18.55 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.563 1.074 . . . . 0.64 113.344 172.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.6 pttt -144.7 167.01 23.58 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.883 1.673 . . . . 3.24 111.824 171.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -122.02 151.7 40.55 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.275 1.43 . . . . 2.1 110.061 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.7 pt -139.97 137.65 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.356 0.662 . . . . 1.52 111.528 171.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -112.68 161.39 16.91 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.592 1.557 . . . . 1.86 112.276 173.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.71 29.19 36.13 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.136 1.351 . . . . 0.66 113.423 -170.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 p -107.95 141.93 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.618 1.967 . . . . 1.66 109.195 169.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -104.98 137.47 42.68 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.695 1.598 . . . . 1.58 112.354 -173.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -143.52 152.86 41.97 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.545 1.138 . . . . 3.53 111.784 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.13 144.85 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.968 2.107 . . . . 1.54 109.612 -174.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -85.9 147.64 26.17 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 122.886 1.326 . . . . 0.45 112.462 169.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.6 p -142.32 171.23 14.34 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.783 2.033 . . . . 1.5 111.747 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.16 -178.92 4.63 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.048 1.129 . . . . 2.08 114.048 171.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.9 p -59.16 -28.08 66.26 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.899 1.074 . . . . 2.26 113.899 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -85.54 16.73 3.64 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.48 1.112 . . . . 2.17 113.12 173.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 58.76 24.89 12.79 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.07 2.148 . . . . 0.66 112.901 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -88.03 137.03 32.69 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.845 1.258 . . . . 2.23 110.747 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.4 mt -72.26 124.19 28.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.358 -0.608 . . . . 1.51 109.358 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.2 pt -113.21 152.15 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 125.543 1.537 . . . . 1.04 115.109 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -81.21 160.66 24.25 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.647 2.379 . . . . 1.38 108.944 165.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -62.48 -15.46 50.12 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.754 -1.216 . . . . 1.95 114.043 -176.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -89.19 3.45 51.88 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.173 1.389 . . . . 3.63 112.675 174.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.47 0.07 89.32 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 126.494 1.997 . . . . 0.62 115.24 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -68.08 136.74 54.24 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.76 1.224 . . . . 2.52 109.984 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.2 p -98.33 145.68 26.44 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.456 0.702 . . . . 1.8 111.225 -175.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -94.5 -7.64 40.7 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.428 1.27 . . . . 2.01 114.428 -168.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.14 30.16 47.62 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 118.935 0.789 . . . . 0.78 113.797 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.8 t -140.22 145.2 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.677 1.591 . . . . 1.75 109.235 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -125.86 162.84 24.25 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.439 2.696 . . . . 1.49 111.015 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.6 mt -135.24 135.35 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.597 1.159 . . . . 1.57 110.947 -173.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.45 143.74 90.8 Favored Pre-proline 0 N--CA 1.477 0.904 0 CA-C-O 117.424 -1.274 . . . . 2.25 111.225 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.84 -20.76 10.17 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 122.325 1.866 . . . . 1.17 112.944 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -88.97 -47.01 8.43 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.089 0.955 . . . . 1.47 112.315 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.5 p -92.8 -28.5 16.52 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.41 1.084 . . . . 2.05 113.242 -172.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 57.25 19.01 4.6 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.407 1.483 . . . . 3.71 113.677 -167.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 146.63 49.73 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.018 -1.676 . . . . 4.43 110.376 172.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.3 mt -86.68 138.88 31.3 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.338 1.055 . . . . 0.99 111.314 176.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.1 p -71.49 0.23 8.89 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.132 1.16 . . . . 1.95 114.132 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -171.93 -156.54 12.3 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 127.367 2.413 . . . . 1.26 111.5 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.32 171.83 12.97 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.86 1.059 . . . . 2.15 113.86 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.4 tpt -66.41 136.72 95.13 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.985 0.914 . . . . 2.06 109.629 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.39 164.99 25.94 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.793 2.329 . . . . 0.87 113.329 -174.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.8 -77.23 0.26 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.592 1.157 . . . . 2.27 112.346 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 69.3 p -83.07 5.83 21.05 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.656 2.095 . . . . 2.22 116.656 -167.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.67 143.0 43.14 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.203 1.557 . . . . 0.57 115.203 -171.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.6 ttt -74.34 102.27 4.33 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.626 1.97 . . . . 1.8 111.036 177.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -153.64 146.8 24.66 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.955 1.302 . . . . 1.71 112.368 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -161.01 157.5 26.37 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.798 1.239 . . . . 2.65 110.613 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 mp -91.91 144.59 25.32 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.048 0.939 . . . . 0.96 112.677 168.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.0 p -65.01 131.43 46.57 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.754 -0.591 . . . . 1.25 109.43 169.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -85.83 -56.25 3.57 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.361 0.875 . . . . 2.51 113.361 -173.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -159.79 -45.79 0.05 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.251 1.421 . . . . 2.13 110.122 169.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -89.35 -18.81 26.16 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.273 1.029 . . . . 4.79 113.191 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 153.43 -159.55 28.68 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.879 2.181 . . . . 0.78 110.718 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.81 132.12 23.42 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.907 2.083 . . . . 1.64 110.237 168.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -93.34 143.45 26.26 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.605 0.965 . . . . 3.14 113.605 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -128.75 121.96 29.57 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 127.276 2.23 . . . . 3.42 107.274 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -83.33 106.34 15.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 118.433 0.56 . . . . 1.67 109.768 -173.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.1 p -84.28 -5.12 59.22 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.831 1.048 . . . . 1.63 113.831 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -55.1 -20.08 9.03 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.894 1.442 . . . . 2.03 114.894 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -96.17 -15.11 22.28 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.091 1.356 . . . . 2.62 113.635 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -80.64 151.62 71.6 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 119.908 1.231 . . . . 0.94 113.427 176.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.88 170.38 9.95 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.597 2.865 . . . . 1.11 111.208 166.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.42 98.07 1.74 Allowed 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.59 1.156 . . . . 2.48 109.414 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -153.12 177.54 10.7 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.631 1.173 . . . . 2.13 111.78 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -90.49 151.34 21.41 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.38 1.072 . . . . 3.45 112.663 168.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -144.69 174.4 11.01 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.84 2.056 . . . . 0.7 110.892 -174.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -142.7 160.67 39.86 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.805 1.242 . . . . 2.4 113.177 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.8 145.77 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.375 1.47 . . . . 1.56 110.921 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -131.45 140.52 49.61 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.245 1.818 . . . . 3.21 110.964 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -97.66 108.66 21.42 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.391 1.077 . . . . 2.11 111.062 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.0 mm -117.34 113.61 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.181 0.993 . . . . 1.78 109.836 -173.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -91.36 -5.79 53.97 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.059 1.133 . . . . 6.63 114.059 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 86.9 p . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 115.148 1.536 . . . . 2.34 115.148 -175.033 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 109.602 -0.518 . . . . 2.87 109.602 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.18 147.86 47.89 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.309 0.644 . . . . 1.34 110.657 171.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.7 146.23 41.11 Favored Pre-proline 0 N--CA 1.473 0.677 0 C-N-CA 123.783 0.833 . . . . 0.83 109.734 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.17 152.76 45.61 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.845 2.363 . . . . 0.54 112.796 -167.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.6 mp -107.33 132.2 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.984 1.314 . . . . 2.15 109.233 -171.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -97.94 140.16 32.7 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.873 0.76 . . . . 4.21 111.279 169.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.8 tt -147.42 150.56 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.217 1.007 . . . . 1.56 112.396 -171.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -127.33 158.27 37.69 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.418 1.887 . . . . 2.06 109.121 169.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.22 159.79 84.46 Favored Pre-proline 0 CA--C 1.554 1.104 0 N-CA-C 113.913 1.079 . . . . 1.66 113.913 -173.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -79.4 80.36 3.1 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.372 2.715 . . . . 1.22 113.298 -169.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 48.9 mt -107.02 46.79 0.91 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.043 2.137 . . . . 4.3 108.938 169.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -123.36 175.37 6.76 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 128.199 2.6 . . . . 3.18 109.653 -172.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -74.78 12.7 0.77 Allowed 'General case' 0 CA--C 1.557 1.222 0 O-C-N 120.035 -1.666 . . . . 3.55 114.699 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.3 m -89.51 152.82 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.073 1.749 . . . . 1.41 113.661 -168.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.17 -30.17 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.668 1.187 . . . . 2.75 111.964 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.03 156.22 42.39 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.688 0.795 . . . . 2.98 111.302 169.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -102.72 141.61 35.24 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.554 1.141 . . . . 1.65 111.878 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -136.64 167.96 20.41 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.496 1.295 . . . . 0.67 114.496 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -138.29 142.82 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.234 1.414 . . . . 1.03 111.901 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -130.77 84.07 59.69 Favored Pre-proline 0 N--CA 1.465 0.304 0 C-N-CA 125.484 1.514 . . . . 3.82 111.553 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -72.82 133.2 19.71 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.25 2.633 . . . . 0.83 110.177 167.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.7 167.46 21.09 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.697 1.999 . . . . 3.16 110.969 175.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -95.8 178.61 5.39 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.855 1.262 . . . . 3.33 110.861 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 115.421 1.637 . . . . 2.87 115.421 175.998 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.5 p . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 120.304 0.097 . . . . 1.6 111.04 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.6 t -101.47 -16.98 16.65 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.351 0.871 . . . . 3.81 113.351 170.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.3 m -141.97 137.5 31.26 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.971 1.309 . . . . 2.55 112.394 -171.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.4 p -83.56 -18.3 38.8 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.804 1.779 . . . . 2.07 115.804 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.7 p -145.65 155.64 43.14 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.505 1.502 . . . . 2.4 113.834 174.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.5 p -113.21 140.99 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 127.335 2.254 . . . . 1.54 109.98 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.9 m -107.94 116.45 31.98 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.383 0.673 . . . . 1.86 109.601 173.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 p -92.38 124.6 44.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 123.947 0.899 . . . . 1.25 109.18 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -102.78 176.78 5.05 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.084 1.754 . . . . 1.78 109.608 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.67 120.74 12.13 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 120.292 -1.505 . . . . 1.99 112.383 168.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.0 mt -106.62 159.45 16.19 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.749 1.22 . . . . 1.28 111.958 -173.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.414 ' CD1' ' H ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -145.97 168.13 21.62 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.969 1.308 . . . . 2.84 109.972 169.435 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.414 ' H ' ' CD1' ' A' ' 43' ' ' LEU . . . -88.07 156.97 19.01 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.191 0.996 . . . . 2.23 111.532 171.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.1 p -81.88 -32.6 30.93 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.323 -0.861 . . . . 2.64 113.194 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -138.19 34.92 2.32 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.607 1.563 . . . . 3.62 111.367 -174.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.35 11.35 82.26 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 125.209 1.385 . . . . 2.03 116.538 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.08 31.48 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 129.485 3.114 . . . . 2.35 116.514 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -31.86 72.92 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.405 -1.434 . . . . 1.27 113.395 -175.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.86 -52.04 65.76 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.395 0.998 . . . . 2.71 113.678 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -67.69 -39.59 84.43 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 118.366 -0.826 . . . . 3.92 111.432 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.1 mt -55.84 -49.98 71.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 119.075 0.852 . . . . 1.23 110.599 171.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.39 -34.85 77.52 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.862 1.21 . . . . 1.67 113.057 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -74.06 -27.29 60.84 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.217 0.821 . . . . 1.49 113.217 172.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -73.13 -22.45 60.53 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.026 -1.046 . . . . 2.15 113.109 169.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.6 mt -94.24 -39.78 10.35 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.1 1.148 . . . . 1.49 114.1 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -65.59 -22.01 66.64 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.054 0.843 . . . . 3.73 112.685 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 t -75.87 -26.58 57.22 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.126 0.97 . . . . 2.5 113.181 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.04 164.71 46.49 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.571 1.081 . . . . 1.63 113.512 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -83.42 35.07 0.49 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.17 1.388 . . . . 3.34 112.81 169.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -76.61 1.5 16.7 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.183 1.179 . . . . 3.47 114.183 -169.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.55 -23.9 67.58 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.04 -1.037 . . . . 2.92 111.036 166.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.13 -82.3 1.48 Allowed Glycine 0 CA--C 1.535 1.329 0 C-N-CA 123.829 0.728 . . . . 0.97 112.448 168.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.02 154.06 40.64 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 116.435 2.013 . . . . 1.7 116.435 -169.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -60.78 146.72 45.09 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.384 1.474 . . . . 3.22 112.461 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.7 t -58.02 133.34 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.799 1.24 . . . . 1.27 111.848 -172.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.08 -52.71 45.65 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 123.117 0.389 . . . . 1.77 113.978 -175.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.1 t -149.44 134.36 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 127.648 2.379 . . . . 2.69 109.175 176.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.15 144.04 40.53 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 125.753 1.621 . . . . 1.69 111.119 169.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.02 158.24 49.87 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.337 2.025 . . . . 0.87 111.371 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.72 -23.67 67.32 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.197 -0.939 . . . . 2.06 112.562 172.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -80.89 1.9 28.87 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.799 1.407 . . . . 2.17 114.799 172.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.81 159.42 15.07 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.841 1.256 . . . . 0.95 113.567 170.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -150.59 169.76 20.76 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.098 1.759 . . . . 2.93 111.446 167.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -124.4 135.58 53.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.367 1.067 . . . . 2.2 111.155 -168.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.1 pt -135.35 151.91 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.798 1.239 . . . . 1.62 112.65 -175.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.21 -179.24 4.63 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.339 1.456 . . . . 1.79 113.027 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.23 10.78 81.89 Favored Glycine 0 N--CA 1.476 1.301 0 O-C-N 121.37 -0.831 . . . . 0.62 115.164 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.3 p -101.14 144.66 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.569 1.948 . . . . 1.85 110.042 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 2.9 tpp -101.57 138.74 38.16 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.305 1.442 . . . . 1.74 112.166 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.22 149.88 41.96 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.611 1.165 . . . . 2.74 111.365 173.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.1 m -120.43 149.57 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.924 2.09 . . . . 1.74 109.328 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -94.42 148.01 22.66 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 122.433 1.111 . . . . 0.58 112.217 171.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.4 p -143.56 166.99 23.3 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.482 1.513 . . . . 1.6 112.551 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -85.19 172.58 11.07 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.598 -0.689 . . . . 2.03 111.308 166.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.0 p -58.2 -30.45 66.46 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.056 0.943 . . . . 2.7 113.518 -172.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -87.43 29.24 0.88 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.659 1.183 . . . . 3.34 113.86 171.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 57.12 28.77 15.48 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.782 2.033 . . . . 1.17 113.476 169.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -84.4 135.12 34.41 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.489 1.116 . . . . 2.0 110.941 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.2 mt -77.2 126.01 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.563 -0.532 . . . . 1.52 109.563 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.6 pt -122.53 157.63 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 114.766 1.395 . . . . 1.22 114.766 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -88.08 164.66 15.62 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.594 1.958 . . . . 1.53 110.494 167.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.49 -1.55 6.85 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.942 1.83 . . . . 2.34 115.942 -169.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -105.29 -1.64 24.98 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.072 1.749 . . . . 2.66 113.489 169.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.96 8.24 59.24 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 125.234 1.397 . . . . 0.74 116.443 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -70.07 127.55 33.23 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.733 1.213 . . . . 4.9 110.333 171.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.0 128.77 42.08 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.458 0.703 . . . . 2.02 111.984 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.64 -6.04 50.39 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 114.11 1.152 . . . . 1.75 114.11 -167.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.7 15.95 62.58 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.601 1.572 . . . . 0.79 114.027 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.4 t -122.05 146.93 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.501 1.52 . . . . 2.06 109.335 -176.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -136.05 159.61 41.17 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.407 1.883 . . . . 1.33 111.363 -175.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 48.4 mt -137.03 143.37 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 125.668 1.587 . . . . 1.58 110.311 -171.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -78.97 147.35 69.93 Favored Pre-proline 0 N--CA 1.479 1.009 0 O-C-N 120.026 -1.671 . . . . 1.83 111.933 173.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.28 -20.0 11.5 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 CA-C-N 122.468 1.917 . . . . 1.18 113.683 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -98.4 -37.76 9.48 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.64 1.976 . . . . 2.08 113.317 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.2 p -95.3 -26.74 15.8 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.03 0.932 . . . . 1.94 112.76 -178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 54.82 19.47 2.6 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.901 1.28 . . . . 2.79 113.245 -169.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.11 148.18 24.58 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.085 1.354 . . . . 3.66 111.072 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 mt -85.94 147.29 26.31 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.558 1.543 . . . . 0.97 112.733 -173.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 96.7 p -66.41 -16.66 64.27 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.599 0.963 . . . . 2.08 113.599 172.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.98 -150.44 6.42 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 126.426 1.965 . . . . 0.94 112.36 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.37 167.69 21.27 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.078 1.14 . . . . 2.17 114.078 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.4 mmt -55.92 136.92 72.89 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.626 1.171 . . . . 2.28 112.717 171.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -80.84 164.52 20.34 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.837 3.025 . . . . 0.87 112.906 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.11 -90.39 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.022 0.929 . . . . 1.36 111.246 169.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.5 p -77.65 15.27 0.85 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 116.514 2.042 . . . . 1.99 116.514 -167.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.7 146.06 32.23 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.527 1.131 . . . . 0.67 113.802 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.1 tpt -73.75 102.11 3.9 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.571 2.349 . . . . 1.59 110.636 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.3 pttp -156.04 149.59 24.85 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.575 1.55 . . . . 1.94 112.305 -173.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -165.83 160.54 17.1 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.761 1.624 . . . . 3.94 110.105 169.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.7 mp -91.71 146.9 23.4 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.411 1.084 . . . . 0.81 112.062 170.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.2 p -65.67 133.71 51.7 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 119.289 0.95 . . . . 1.26 109.751 169.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -84.72 -70.56 0.57 Allowed 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 113.951 1.093 . . . . 2.48 113.951 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.47 -39.85 0.43 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.526 1.131 . . . . 1.68 111.447 173.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -99.54 -29.45 12.7 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.613 0.968 . . . . 4.45 113.613 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 168.76 -164.37 38.0 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.595 1.093 . . . . 1.02 111.678 -170.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -139.98 131.79 27.5 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.464 1.906 . . . . 1.37 111.453 169.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -80.42 135.53 36.17 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.771 1.228 . . . . 2.17 112.453 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -126.79 123.15 36.72 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.747 2.019 . . . . 3.09 108.406 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -71.37 130.15 40.62 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 121.166 -0.959 . . . . 2.15 110.951 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 34.1 p -116.79 5.91 13.13 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.742 1.617 . . . . 1.69 113.402 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.17 -20.56 64.26 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.196 1.398 . . . . 1.49 114.19 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -111.99 -14.08 13.51 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.523 1.129 . . . . 2.49 113.216 -171.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.3 142.62 84.73 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 119.083 0.856 . . . . 2.11 112.258 171.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.85 163.66 28.48 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.442 2.095 . . . . 1.29 111.37 167.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.13 53.87 0.13 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 128.79 2.836 . . . . 2.33 115.969 -169.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -116.71 -179.65 3.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.862 2.065 . . . . 1.97 112.829 -170.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -90.22 148.38 22.96 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.733 1.213 . . . . 4.02 112.123 169.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -143.84 172.65 12.56 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.268 2.627 . . . . 0.68 109.998 -174.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -141.5 149.94 41.56 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.069 0.948 . . . . 2.54 112.947 173.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.15 139.06 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.307 1.043 . . . . 1.58 110.351 172.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -125.11 129.92 51.18 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.157 1.783 . . . . 3.18 110.285 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -92.87 118.93 31.67 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.474 1.11 . . . . 2.08 110.261 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 47.1 mm -116.28 110.74 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 118.708 0.685 . . . . 1.8 109.629 -171.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -79.4 -15.35 57.99 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.567 0.951 . . . . 5.12 113.567 -169.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 115.265 1.58 . . . . 2.28 115.265 -178.015 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 111.803 0.297 . . . . 3.35 111.803 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -94.3 156.51 16.48 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.084 1.142 . . . . 1.2 114.084 173.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.91 150.86 51.63 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 126.47 1.908 . . . . 1.14 110.501 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.2 145.38 38.9 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.452 2.101 . . . . 0.65 113.737 -167.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.7 mp -113.35 125.12 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.695 1.198 . . . . 2.31 110.105 -171.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -86.1 139.77 30.82 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.678 1.191 . . . . 2.81 111.475 174.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.1 tt -146.87 146.99 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.633 1.173 . . . . 1.58 112.104 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -118.6 154.42 32.66 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.209 1.403 . . . . 2.0 109.041 168.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.0 mt -61.61 154.66 64.36 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 114.157 1.169 . . . . 1.4 114.157 -175.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.86 103.55 0.88 Allowed 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.035 2.49 . . . . 0.78 110.957 -173.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.1 mt -139.27 42.37 2.06 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.717 2.407 . . . . 4.32 109.084 174.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -117.51 12.91 14.28 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 128.636 2.774 . . . . 3.53 111.698 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 18.3 t0 57.2 28.51 15.19 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.558 2.343 . . . . 4.61 114.74 -174.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.3 m -81.49 150.58 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.626 0.77 . . . . 1.42 112.734 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.83 -38.47 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.554 1.142 . . . . 2.13 110.701 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -147.23 142.81 27.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.54 1.536 . . . . 2.43 110.084 -175.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -105.71 141.48 37.08 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.246 1.018 . . . . 1.84 111.92 -173.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -139.18 165.96 25.79 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.974 1.472 . . . . 0.61 114.974 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.1 t -135.9 139.11 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 125.677 1.591 . . . . 1.99 111.957 176.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -131.66 78.87 69.92 Favored Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 124.927 1.291 . . . . 3.43 112.241 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.79 149.18 87.01 Favored 'Trans proline' 0 C--N 1.349 0.57 1 C-N-CA 125.387 4.058 . . . . 0.68 114.013 176.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -131.62 167.41 19.49 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.893 2.077 . . . . 2.3 111.974 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -116.58 162.54 17.46 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.061 0.934 . . . . 3.63 113.517 -174.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 9.3 t . . . . . 0 N--CA 1.469 0.492 0 C-N-CA 126.632 1.973 . . . . 3.32 109.317 169.838 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.5 p . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 114.673 1.361 . . . . 2.0 114.673 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.7 p -79.01 -13.66 59.66 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.046 1.128 . . . . 2.16 114.046 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 t -148.28 159.46 43.96 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.282 1.433 . . . . 2.72 111.684 170.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 p -94.35 -7.89 40.44 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.69 1.996 . . . . 2.26 114.641 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.6 m -144.16 154.19 42.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.7 1.2 . . . . 2.5 113.243 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.3 p -117.77 147.53 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 127.622 2.369 . . . . 1.53 110.182 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.5 m -110.8 116.28 31.0 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.481 0.658 . . . . 1.06 111.067 173.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 p -98.02 131.19 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.764 1.226 . . . . 2.28 109.294 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -112.63 -171.05 1.78 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.384 1.874 . . . . 2.12 110.96 -174.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.426 ' HZ2' ' CD ' ' A' ' 143' ' ' GLU . 46.9 tptt -145.53 123.41 11.98 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.163 -0.961 . . . . 2.85 111.349 166.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.4 mt -110.49 150.96 28.14 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.857 0.863 . . . . 1.19 111.281 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.28 165.92 27.03 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.676 1.59 . . . . 2.58 110.966 -171.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.33 143.83 39.96 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.277 1.031 . . . . 1.88 111.064 168.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.7 p -85.5 -44.67 12.5 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.326 1.45 . . . . 3.03 111.452 174.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -115.13 25.49 10.84 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 127.823 2.449 . . . . 3.2 111.745 -171.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.63 7.43 84.41 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 126.267 1.889 . . . . 1.71 116.764 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -72.39 25.13 0.05 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.611 2.364 . . . . 2.06 116.977 -171.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -27.0 66.72 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 119.369 -2.082 . . . . 1.36 114.072 -173.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -81.72 -41.35 21.4 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.567 0.951 . . . . 2.66 113.567 -174.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -66.86 -38.29 86.06 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 120.284 1.402 . . . . 4.24 111.286 169.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.2 mt -56.58 -48.39 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 120.014 1.279 . . . . 1.3 110.72 168.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.05 -36.92 75.84 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.833 1.197 . . . . 1.76 112.486 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -69.27 -32.84 72.29 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.859 0.864 . . . . 1.58 113.305 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -65.84 -35.02 79.5 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.262 0.937 . . . . 2.04 112.269 172.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.5 mt -84.31 -31.25 24.97 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.328 0.862 . . . . 1.58 113.328 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -67.29 -30.49 70.37 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.141 0.882 . . . . 3.28 113.261 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 t -80.09 -21.4 43.34 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.809 0.844 . . . . 2.11 113.194 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.37 164.99 52.78 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.552 1.072 . . . . 1.45 113.099 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -84.42 18.98 2.04 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.179 0.991 . . . . 1.81 112.425 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -68.93 0.6 4.26 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 115.765 1.765 . . . . 3.6 115.765 -167.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.66 -23.01 66.88 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 121.364 -0.835 . . . . 1.31 111.273 165.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.85 -83.41 1.19 Allowed Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.898 1.713 . . . . 0.72 113.176 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.22 160.4 26.92 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.623 1.342 . . . . 1.6 114.623 -169.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -60.7 156.55 16.58 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.302 1.223 . . . . 3.85 114.302 -173.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.3 t -58.16 129.53 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 121.815 -0.553 . . . . 1.35 110.484 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.77 -43.17 68.04 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.592 0.615 . . . . 1.02 114.163 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.1 p -160.97 142.72 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.814 1.245 . . . . 3.95 110.241 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.9 mt -88.3 145.93 36.85 Favored Pre-proline 0 C--O 1.241 0.647 0 C-N-CA 123.774 0.829 . . . . 1.57 112.099 176.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.95 158.98 54.94 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.563 1.509 . . . . 0.85 112.131 173.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.18 -1.64 3.47 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.894 1.278 . . . . 2.11 114.388 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.11 8.13 11.49 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 127.028 2.131 . . . . 2.39 114.028 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.63 162.15 14.07 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.908 1.818 . . . . 0.9 115.908 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -142.63 150.62 40.5 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 128.062 2.545 . . . . 5.16 111.042 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -121.92 139.97 53.0 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.866 1.667 . . . . 2.15 110.059 174.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.9 pt -132.79 152.73 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 113.53 0.937 . . . . 1.57 113.53 -177.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.0 165.55 11.64 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.28 1.432 . . . . 1.68 110.801 169.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.0 8.3 79.26 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 115.562 0.985 . . . . 0.76 115.562 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.7 p -84.53 143.93 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 119.648 1.724 . . . . 2.36 110.216 169.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -102.01 136.42 41.88 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.417 1.487 . . . . 1.99 112.113 175.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -141.44 155.03 45.91 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.106 0.962 . . . . 2.9 112.802 171.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.15 146.57 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 126.99 2.116 . . . . 1.69 109.969 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -90.94 146.53 23.81 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.322 1.058 . . . . 0.49 112.716 172.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.6 p -143.6 170.78 15.19 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.979 1.712 . . . . 1.72 112.521 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -97.8 174.74 6.45 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.448 1.099 . . . . 2.02 112.573 168.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.2 p -64.49 -18.45 64.8 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.476 -1.39 . . . . 2.6 114.321 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -76.22 7.35 4.32 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 126.029 1.732 . . . . 2.23 113.241 167.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 55.71 33.31 21.09 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.4 2.28 . . . . 0.77 111.603 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -94.37 138.94 31.73 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.697 1.599 . . . . 2.16 110.395 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.4 mt -79.37 130.81 35.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 109.573 -0.528 . . . . 1.69 109.573 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.9 pt -125.3 155.53 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 114.689 1.366 . . . . 2.39 114.689 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -81.29 164.46 22.2 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 126.46 1.904 . . . . 1.54 109.536 167.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -64.67 -12.51 47.08 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.556 -1.34 . . . . 2.33 114.0 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -97.66 4.86 50.0 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.714 1.605 . . . . 2.67 112.992 173.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.75 10.48 85.08 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 120.551 -1.343 . . . . 0.72 115.103 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -68.24 130.03 41.69 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.193 1.497 . . . . 4.23 108.924 168.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.3 p -87.92 141.66 28.41 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.68 0.392 . . . . 1.82 111.043 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -94.3 -11.07 30.84 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.688 1.366 . . . . 1.61 114.688 -169.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.76 30.85 25.49 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.555 1.074 . . . . 0.69 114.322 -172.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.0 t -133.95 146.06 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.37 1.585 . . . . 1.97 110.447 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -130.61 159.98 35.56 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.58 1.952 . . . . 1.28 110.641 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 54.1 mt -135.96 137.03 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 125.059 1.344 . . . . 1.75 111.207 -174.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -71.53 141.22 85.1 Favored Pre-proline 0 N--CA 1.48 1.028 0 O-C-N 120.814 -1.179 . . . . 1.77 111.188 171.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.56 -24.41 13.85 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 122.494 1.926 . . . . 0.91 112.64 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -89.77 -54.43 4.06 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.706 1.602 . . . . 1.46 111.79 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.4 p -78.91 -26.79 43.78 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.875 0.695 . . . . 1.6 112.875 -174.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 56.37 19.14 3.82 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.792 1.237 . . . . 2.82 113.896 -170.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.91 150.83 24.69 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.377 -1.452 . . . . 3.98 111.528 176.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.9 mt -90.37 141.96 28.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.241 1.417 . . . . 1.14 111.712 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.1 p -66.56 -4.11 7.84 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.535 1.309 . . . . 1.53 114.535 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.4 -158.53 18.73 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 127.331 2.396 . . . . 0.92 111.53 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.52 154.09 42.2 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.543 0.942 . . . . 1.57 113.543 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.3 tpt -60.26 130.22 89.34 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 125.384 1.474 . . . . 2.88 111.21 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -72.46 158.89 50.39 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.61 2.874 . . . . 1.06 114.488 -173.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.91 -53.62 8.71 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.064 1.746 . . . . 1.09 114.557 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.7 p -114.13 11.35 17.57 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.395 1.478 . . . . 1.63 114.148 -167.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.36 151.42 19.82 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.729 1.011 . . . . 0.7 113.729 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.4 tpt -75.19 95.32 3.1 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.907 2.083 . . . . 1.82 111.227 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -154.48 135.86 14.13 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.443 1.497 . . . . 1.71 112.557 -173.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -168.46 142.65 3.26 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.971 1.309 . . . . 3.46 111.342 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.76 150.87 25.53 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.717 1.377 . . . . 0.93 114.717 -173.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.4 p -62.12 132.8 54.03 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.243 -0.911 . . . . 1.94 111.798 169.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -93.83 -55.0 3.39 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.587 1.155 . . . . 2.52 113.688 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -165.73 -52.78 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.2 2.2 . . . . 2.21 109.422 174.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -93.23 23.49 4.38 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.182 1.793 . . . . 5.27 113.35 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.77 -151.78 17.73 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.244 1.878 . . . . 0.8 111.692 -168.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.77 129.96 20.89 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.068 2.147 . . . . 1.84 111.14 169.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -82.04 133.5 35.29 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.531 1.133 . . . . 2.18 111.556 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -124.77 124.48 42.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.299 1.84 . . . . 3.55 109.143 173.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -73.68 118.43 16.63 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.462 1.105 . . . . 2.29 110.576 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 22.5 p -101.97 -0.65 33.43 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.554 1.142 . . . . 1.81 113.347 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.13 -16.01 4.54 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.61 1.707 . . . . 1.78 115.61 -176.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -106.77 -4.57 19.22 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.904 1.076 . . . . 2.6 113.904 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.46 152.73 67.64 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 114.131 1.16 . . . . 0.9 114.131 172.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.54 174.29 5.93 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.205 3.27 . . . . 1.17 112.218 167.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.47 100.08 3.74 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.328 -0.857 . . . . 1.56 109.365 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -152.2 177.38 10.6 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.479 1.512 . . . . 1.55 110.587 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -90.39 146.77 23.9 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.217 1.007 . . . . 3.1 112.04 168.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -140.07 167.9 21.06 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.879 2.071 . . . . 0.76 109.294 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -139.72 148.01 41.72 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.928 0.891 . . . . 2.63 112.306 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -111.25 132.98 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.024 0.93 . . . . 1.46 109.7 175.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -120.78 128.43 52.89 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.417 1.887 . . . . 3.32 110.287 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.426 ' CD ' ' HZ2' ' A' ' 41' ' ' LYS . 48.5 tt0 -104.39 105.3 15.38 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.79 1.636 . . . . 2.54 110.961 -169.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.6 mm -108.06 113.72 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.686 1.194 . . . . 1.8 111.62 -167.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -88.7 23.08 2.4 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.291 1.219 . . . . 5.98 114.291 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 52.1 m . . . . . 0 N--CA 1.473 0.689 0 O-C-N 121.094 -1.004 . . . . 1.98 112.298 173.771 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 112.563 0.579 . . . . 2.72 112.563 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -98.66 152.03 20.08 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.849 1.259 . . . . 1.42 111.738 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.8 m -111.57 144.49 30.68 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 124.482 1.113 . . . . 0.9 111.831 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.49 159.24 51.95 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.406 2.737 . . . . 0.81 114.022 -167.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 1.3 mt -112.36 143.66 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.005 1.322 . . . . 2.82 110.273 -176.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -110.15 140.83 43.84 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.54 1.136 . . . . 2.93 111.694 171.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.6 tt -146.3 147.31 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.663 1.185 . . . . 1.78 111.578 -175.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -126.18 151.51 47.25 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.011 1.325 . . . . 1.93 109.484 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 5.3 mt -65.58 149.91 96.69 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 114.269 1.211 . . . . 1.37 114.269 -171.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.31 92.43 0.92 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.632 2.888 . . . . 0.86 114.382 -169.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -118.82 70.67 0.83 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 103.678 -2.712 . . . . 3.71 103.678 164.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -145.7 -179.94 7.02 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.069 1.748 . . . . 2.69 109.229 -166.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -79.74 6.58 10.47 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.871 1.668 . . . . 3.93 114.57 -174.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -99.99 153.56 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.833 1.653 . . . . 1.35 113.517 -168.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 44.8 t -96.76 -32.62 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.586 1.554 . . . . 2.51 110.967 172.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -131.34 135.3 47.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.021 1.328 . . . . 4.44 113.211 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -103.7 138.79 39.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.623 1.169 . . . . 1.41 111.121 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -134.63 168.54 18.8 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.481 1.289 . . . . 0.55 114.481 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.72 137.22 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.787 1.235 . . . . 1.16 112.549 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -134.96 86.65 31.8 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 125.418 1.487 . . . . 3.5 112.118 -173.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -71.5 152.77 60.36 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.325 3.35 . . . . 0.73 113.756 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -132.18 172.47 12.36 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.974 2.509 . . . . 3.04 112.338 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -101.73 -173.0 2.25 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.204 1.402 . . . . 3.14 109.767 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 116.698 2.11 . . . . 2.82 116.698 -175.298 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 112.776 0.658 . . . . 2.28 112.776 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.8 p -98.75 -7.34 27.81 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.819 1.415 . . . . 2.29 114.819 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.1 t -151.72 157.83 42.57 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.866 0.757 . . . . 2.49 112.518 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 p -98.55 -4.46 34.16 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.95 2.9 . . . . 1.95 114.82 -173.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.3 m -147.25 151.48 36.75 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.89 1.676 . . . . 2.42 112.863 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.1 p -119.61 148.6 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 127.762 2.425 . . . . 1.84 110.291 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.2 m -121.48 127.54 51.16 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 121.414 -0.803 . . . . 1.13 111.591 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 p -101.27 137.58 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.116 1.366 . . . . 1.9 110.717 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -136.38 113.97 11.0 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.002 1.721 . . . . 1.75 111.209 -171.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.48 127.82 38.11 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 120.178 -1.576 . . . . 1.98 114.225 -168.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.6 mt -114.77 152.82 31.45 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.683 1.193 . . . . 1.83 113.835 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.3 mt -140.3 176.33 8.86 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.86 2.064 . . . . 2.6 110.464 169.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.51 163.82 12.56 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.925 1.083 . . . . 1.37 113.925 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.3 p -84.13 -38.45 20.69 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.488 1.115 . . . . 2.08 113.352 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -146.89 63.19 1.19 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.953 1.701 . . . . 2.52 110.703 169.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.11 27.88 73.55 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 120.893 -1.129 . . . . 1.17 115.419 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.41 15.27 0.36 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.053 2.141 . . . . 2.4 114.448 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.33 -28.96 69.67 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.129 -1.607 . . . . 0.94 113.01 -173.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -69.64 -45.79 67.67 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.246 0.93 . . . . 2.25 112.519 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -71.08 -41.86 70.12 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 118.18 -0.914 . . . . 2.77 111.463 176.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 86.6 mt -51.74 -50.21 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.441 1.019 . . . . 1.05 110.34 167.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.51 -31.33 70.4 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.566 -1.334 . . . . 1.15 113.231 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -74.08 -34.56 64.05 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.51 1.124 . . . . 1.15 113.199 172.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -66.26 -32.64 74.19 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.863 -1.148 . . . . 1.94 112.174 170.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.1 mt -83.63 -36.7 23.65 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.854 1.057 . . . . 1.12 113.854 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -65.33 -29.75 70.53 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.487 1.04 . . . . 2.99 112.481 177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.0 t -79.7 -24.54 41.63 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.346 0.869 . . . . 2.09 113.346 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.65 160.31 39.28 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.53 1.062 . . . . 0.97 113.345 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -83.01 26.06 0.64 Allowed 'General case' 0 CA--C 1.552 1.035 0 O-C-N 121.367 -1.078 . . . . 1.95 112.369 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -68.82 0.28 4.55 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 116.339 1.977 . . . . 3.43 116.339 -167.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.75 -25.18 66.29 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.694 1.134 . . . . 2.0 112.704 171.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.04 -81.42 1.34 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.709 1.147 . . . . 0.85 113.122 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.46 163.07 25.92 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.538 1.135 . . . . 1.63 113.035 -176.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -59.08 161.23 5.34 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.993 1.479 . . . . 2.79 114.993 -171.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.84 109.88 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.115 -0.698 . . . . 1.21 109.115 168.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.81 -25.16 65.35 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 119.171 -0.794 . . . . 1.51 114.134 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.2 t -142.07 118.24 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.275 1.43 . . . . 2.77 110.939 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -88.32 146.91 38.91 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.548 1.539 . . . . 2.15 109.809 167.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.69 157.51 39.87 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.098 1.866 . . . . 0.82 111.552 171.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.23 -24.03 67.23 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.213 -0.929 . . . . 2.1 112.716 173.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 40.7 p30 -77.76 -8.89 58.63 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.844 1.424 . . . . 2.61 114.844 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.2 155.78 19.19 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.372 1.469 . . . . 0.7 111.922 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.5 pttt -141.25 159.72 41.62 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.958 1.303 . . . . 3.04 111.885 170.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -122.68 146.74 47.21 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.914 1.286 . . . . 2.33 110.042 -175.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.6 pt -141.07 151.2 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.26 1.024 . . . . 2.31 111.795 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -113.65 170.0 8.57 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.716 1.607 . . . . 1.97 111.242 173.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.2 15.53 74.18 Favored Glycine 0 CA--C 1.534 1.267 0 O-C-N 121.388 -0.82 . . . . 0.63 114.702 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.5 p -98.8 139.73 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 127.179 2.192 . . . . 2.24 109.611 173.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.8 tpp -103.87 136.87 42.74 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.769 2.027 . . . . 1.5 112.84 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.65 152.83 44.3 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.656 1.583 . . . . 2.82 111.761 174.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.12 143.53 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 126.757 2.023 . . . . 1.61 109.474 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -86.8 149.04 25.13 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 122.2 1.0 . . . . 0.43 111.847 169.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 57.3 p -145.62 165.92 27.28 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.789 1.635 . . . . 1.78 112.532 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -89.59 167.29 13.06 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.807 0.843 . . . . 2.27 111.082 166.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 49.3 p -61.57 -26.46 67.97 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.436 1.273 . . . . 2.49 114.436 -168.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -76.29 16.66 0.44 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.367 1.467 . . . . 2.74 114.477 169.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.52 30.2 17.12 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 128.142 2.577 . . . . 0.9 113.204 175.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -92.65 140.03 29.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.28 1.432 . . . . 2.31 111.775 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -82.95 124.84 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.037 0.446 . . . . 1.66 110.273 -178.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.9 pt -120.63 156.15 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 114.815 1.413 . . . . 2.08 114.815 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -79.89 158.94 26.57 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.85 2.86 . . . . 2.04 111.227 168.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -56.82 -8.05 0.54 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 127.282 2.233 . . . . 2.37 116.317 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.86 1.32 19.16 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.476 1.51 . . . . 3.41 115.021 172.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.79 4.2 63.7 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.359 1.457 . . . . 0.62 115.27 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -67.97 143.55 55.56 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.883 1.341 . . . . 2.56 109.371 170.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 60.5 p -102.7 147.8 26.38 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.915 1.286 . . . . 1.73 111.368 -175.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -104.45 -5.86 21.24 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.847 1.425 . . . . 1.53 114.847 -168.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.78 28.93 40.58 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 121.193 -0.942 . . . . 1.24 113.396 -177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.8 t -133.48 147.26 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.969 1.308 . . . . 2.78 110.063 177.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -134.73 155.06 51.22 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 128.205 2.602 . . . . 1.47 110.447 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 49.4 mt -133.42 133.82 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.213 1.405 . . . . 1.72 110.854 -173.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -68.61 142.65 94.3 Favored Pre-proline 0 N--CA 1.476 0.849 0 O-C-N 120.633 -1.292 . . . . 2.09 111.296 173.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.35 -24.12 16.89 Favored 'Trans proline' 0 C--N 1.35 0.636 0 CA-C-N 122.38 1.886 . . . . 0.92 112.94 175.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -92.91 -52.19 4.71 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.382 1.873 . . . . 1.33 112.692 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.9 p -80.73 -23.67 39.28 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.983 0.735 . . . . 2.14 112.983 -175.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 54.89 18.06 2.05 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.747 1.619 . . . . 3.65 113.839 -171.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.15 149.88 24.35 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.648 -1.283 . . . . 3.22 111.789 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.6 mt -87.17 146.38 26.04 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.156 1.782 . . . . 1.38 113.222 -175.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 97.3 p -76.98 0.64 20.4 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.446 1.276 . . . . 1.62 114.446 174.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.11 -158.26 15.86 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 127.176 2.322 . . . . 1.43 110.762 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.07 156.18 25.95 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.534 1.167 . . . . 2.56 112.917 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 tpt -56.35 130.01 75.21 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 124.068 0.947 . . . . 2.9 111.663 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.93 166.1 30.49 Favored 'Trans proline' 0 CA--C 1.537 0.64 1 C-N-CA 125.53 4.154 . . . . 1.15 115.587 -172.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.63 -81.17 0.07 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.492 1.517 . . . . 1.52 113.281 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.9 p -86.48 12.36 10.49 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.664 1.357 . . . . 1.62 114.664 -169.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.7 148.59 16.01 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.21 -0.931 . . . . 0.62 113.082 174.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.1 tpt -77.36 87.88 3.75 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.775 2.03 . . . . 1.65 110.881 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -142.6 146.24 34.35 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.218 1.407 . . . . 1.78 112.761 -173.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 43.5 tttp -162.01 159.73 26.74 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.524 1.13 . . . . 2.67 112.046 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 mp -102.2 145.74 28.97 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.595 1.158 . . . . 0.75 112.824 169.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.7 p -70.26 139.78 52.24 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 119.335 0.97 . . . . 2.12 112.332 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.63 -69.44 0.67 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.835 1.254 . . . . 3.12 114.1 -174.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.43 -41.28 0.08 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.681 2.393 . . . . 1.59 109.143 169.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -91.55 -10.62 39.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.986 1.714 . . . . 4.28 114.216 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 143.23 -156.31 26.44 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.845 1.688 . . . . 0.99 112.304 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.72 127.58 20.54 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.233 1.813 . . . . 1.26 109.958 167.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -77.16 139.69 39.99 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.962 1.305 . . . . 2.19 111.565 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -130.03 116.33 18.4 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.971 1.708 . . . . 3.37 109.198 169.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.34 115.44 11.6 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.915 1.286 . . . . 2.88 111.006 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.8 p -104.02 -5.75 21.86 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.565 1.321 . . . . 1.81 114.565 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.78 -27.69 43.33 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.456 1.28 . . . . 1.42 114.456 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.68 -14.99 31.16 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.551 0.945 . . . . 3.16 113.551 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.52 147.91 85.2 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 119.603 1.092 . . . . 0.85 112.792 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -75.44 167.24 27.04 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.21 1.94 . . . . 0.85 110.95 167.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.03 94.8 1.93 Allowed 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.532 1.533 . . . . 2.13 109.539 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -152.32 175.55 12.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.831 1.253 . . . . 1.7 111.418 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -86.36 149.89 24.71 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.786 1.235 . . . . 3.59 111.139 168.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -142.03 171.95 13.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.257 2.223 . . . . 0.51 109.735 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -142.19 154.82 45.13 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.359 1.064 . . . . 2.47 111.962 176.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.09 135.93 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.939 0.895 . . . . 1.75 110.773 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -121.65 142.31 50.26 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.801 2.04 . . . . 3.18 110.575 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -108.69 118.09 35.88 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.076 0.951 . . . . 2.19 110.648 -176.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.6 mm -114.08 113.51 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 108.67 -0.863 . . . . 1.94 108.67 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -74.26 -20.95 59.98 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.038 -1.039 . . . . 4.62 113.077 -175.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 116.894 2.183 . . . . 2.94 116.894 -175.796 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 112.503 0.557 . . . . 3.34 112.503 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.59 154.9 39.6 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.777 -1.202 . . . . 1.34 111.428 172.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.63 149.6 72.38 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 125.492 1.517 . . . . 0.96 110.625 174.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -74.47 145.81 34.16 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.282 2.654 . . . . 0.56 114.64 -166.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 4.5 mt -98.35 140.2 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.191 1.396 . . . . 2.76 110.019 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -113.89 121.46 44.03 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.988 1.315 . . . . 3.07 111.491 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.7 tt -135.16 156.68 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.127 1.371 . . . . 1.42 112.673 -168.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -138.49 159.66 41.51 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.953 1.701 . . . . 2.07 109.022 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 19.0 mt -67.38 152.25 96.36 Favored Pre-proline 0 CA--C 1.551 1.008 0 O-C-N 121.282 -0.886 . . . . 1.42 112.925 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.52 79.44 3.19 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 124.139 3.226 . . . . 0.96 114.764 -167.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 1.6 tt -102.62 72.78 1.26 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.108 -1.442 . . . . 3.15 107.108 167.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -146.44 -176.7 5.28 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.609 1.964 . . . . 2.87 109.833 -168.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -79.85 0.0 32.87 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.127 1.528 . . . . 4.35 115.127 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 1.4 m -80.41 159.05 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.535 1.134 . . . . 1.52 114.02 -169.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.2 t -99.23 -32.02 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 125.63 1.572 . . . . 2.65 111.507 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -142.25 128.61 20.0 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.736 1.614 . . . . 2.51 108.781 -173.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -99.52 141.44 32.31 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.148 0.979 . . . . 1.45 111.983 -172.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -142.38 169.59 17.29 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 115.725 1.75 . . . . 0.98 115.725 -176.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.07 140.08 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.65 1.98 . . . . 1.15 112.239 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -137.09 84.52 24.65 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 124.815 1.246 . . . . 3.81 112.093 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -69.34 148.47 67.89 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 124.08 3.186 . . . . 0.64 113.689 174.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -131.82 162.94 29.35 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 127.773 2.429 . . . . 2.79 111.242 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -109.92 169.62 8.6 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.68 1.192 . . . . 3.8 113.04 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 CA--C 1.549 0.942 0 C-N-CA 127.123 2.169 . . . . 2.61 111.575 177.928 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.4 p . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 113.442 0.904 . . . . 1.73 113.442 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.7 p -105.21 -1.62 25.14 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.825 1.25 . . . . 2.49 113.809 170.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 m -146.74 148.66 32.19 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.683 1.993 . . . . 3.42 109.05 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 42.2 p -111.0 -11.82 14.28 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.222 1.409 . . . . 2.15 114.72 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.1 p -147.67 159.07 44.19 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.765 1.394 . . . . 2.36 114.765 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.74 138.19 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.825 2.05 . . . . 1.79 110.194 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.0 m -114.72 122.15 45.54 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.846 0.858 . . . . 1.08 110.962 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.62 135.12 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.667 1.187 . . . . 1.18 111.852 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -133.27 106.67 7.68 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.015 1.726 . . . . 1.81 112.163 -172.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.58 132.98 34.88 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 120.138 -1.601 . . . . 2.03 112.98 -171.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.5 mt -122.43 163.17 20.31 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.495 1.518 . . . . 1.38 112.904 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 42.7 mt -143.12 167.95 20.89 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.593 1.957 . . . . 2.03 110.914 168.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.15 169.95 10.01 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.54 1.136 . . . . 1.56 113.373 169.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.6 p -94.49 -32.99 13.26 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.578 1.325 . . . . 2.1 114.578 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -140.53 44.49 1.85 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.598 1.159 . . . . 2.59 111.963 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.75 12.9 82.26 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.515 1.531 . . . . 1.48 115.832 177.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.16 19.65 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 127.767 2.427 . . . . 2.65 116.572 -171.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mmt -64.14 -19.55 65.37 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.103 -1.623 . . . . 1.05 114.678 -173.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -76.39 -51.9 10.96 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.934 0.894 . . . . 2.4 111.613 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -62.05 -40.91 97.35 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.881 -1.137 . . . . 3.22 111.372 172.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 98.8 mt -53.32 -47.92 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 119.613 1.097 . . . . 1.14 110.9 169.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.03 -29.28 70.17 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.715 1.143 . . . . 1.2 113.3 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -73.31 -39.04 65.62 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.922 0.783 . . . . 1.09 111.993 171.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -61.7 -32.83 73.06 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.428 1.091 . . . . 1.89 112.444 172.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.7 mt -88.49 -36.12 16.62 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.789 1.403 . . . . 1.05 114.789 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.38 -20.53 64.69 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.613 1.097 . . . . 2.39 113.121 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.2 t -80.93 -12.19 59.44 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.079 1.352 . . . . 2.37 114.525 175.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.39 161.33 21.4 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.261 1.41 . . . . 1.3 112.236 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -79.02 37.59 0.31 Allowed 'General case' 0 N--CA 1.477 0.92 0 O-C-N 120.855 -1.379 . . . . 2.38 112.27 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -77.19 -0.88 26.76 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.246 1.202 . . . . 3.62 114.246 -173.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.79 -27.08 66.25 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 121.091 -1.005 . . . . 1.77 110.593 166.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.28 -54.62 0.38 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.204 0.907 . . . . 1.1 113.347 169.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -76.02 160.34 29.93 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.478 1.111 . . . . 3.23 113.343 -169.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -68.72 155.36 40.26 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.222 -0.924 . . . . 3.73 111.687 171.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.2 t -67.9 119.82 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 109.795 -0.446 . . . . 2.27 109.795 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.11 -42.77 83.4 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 119.624 -0.542 . . . . 1.6 113.93 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.9 t -142.44 130.77 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.722 1.609 . . . . 2.94 110.671 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.69 142.94 29.66 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.489 1.116 . . . . 1.72 110.956 168.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.16 162.57 42.13 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.442 2.095 . . . . 0.97 112.215 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.8 -29.01 69.96 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.865 -1.147 . . . . 2.34 112.531 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -79.8 1.88 25.17 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.806 1.642 . . . . 1.94 114.966 173.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.43 157.06 16.91 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.705 1.202 . . . . 1.16 112.815 169.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -147.32 167.97 22.96 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.774 1.63 . . . . 4.14 112.067 170.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -126.8 144.17 51.04 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.533 1.133 . . . . 2.68 112.296 -169.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.1 pt -142.15 146.2 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.72 1.608 . . . . 1.65 111.046 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.03 158.82 43.49 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.315 1.046 . . . . 2.06 111.99 173.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.65 15.86 21.5 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.03 1.3 . . . . 0.79 114.855 -171.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 p -101.4 144.44 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 127.997 2.519 . . . . 1.88 110.501 175.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.4 tpp -97.38 139.33 33.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.555 1.942 . . . . 1.5 113.374 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.64 154.34 45.31 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.988 1.315 . . . . 2.79 111.31 171.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.5 m -125.68 146.13 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.097 1.759 . . . . 1.59 109.82 -174.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -85.67 147.0 26.58 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.76 1.266 . . . . 0.46 112.548 169.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.6 p -141.33 172.02 13.25 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.761 2.024 . . . . 1.5 112.493 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.11 -169.75 1.91 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 115.283 1.586 . . . . 1.87 115.283 177.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 66.9 p -62.19 -33.68 75.0 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.663 -1.273 . . . . 2.78 112.143 173.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -80.53 12.96 2.71 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.342 1.057 . . . . 2.65 113.289 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.39 26.74 14.48 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.498 1.519 . . . . 0.68 111.761 -172.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -93.35 143.48 26.24 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.93 1.292 . . . . 1.93 111.751 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.4 mt -78.38 124.46 36.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.358 0.663 . . . . 1.68 110.36 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.2 pt -113.83 154.3 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.605 1.562 . . . . 1.02 114.95 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.14 157.74 18.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.429 2.692 . . . . 1.79 108.666 167.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -54.76 -24.42 22.36 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.634 1.716 . . . . 2.38 115.634 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . 0.261 0.0 OUTLIER -86.89 7.05 28.93 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 119.355 0.98 . . . . 3.56 112.42 176.855 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.42 19.05 77.1 Favored Glycine 0 C--N 1.343 0.931 0 C-N-CA 125.909 1.719 . . . . 0.76 113.417 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -80.66 137.88 36.36 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.299 0.64 . . . . 2.3 110.261 169.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 20.1 p -96.19 146.17 24.91 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.829 0.852 . . . . 1.66 111.099 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.1 -6.04 29.09 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.579 1.325 . . . . 1.74 114.579 -168.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.27 28.03 46.26 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.193 0.902 . . . . 0.69 113.802 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 36.6 t -134.48 147.89 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.103 1.361 . . . . 1.77 110.501 176.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -129.8 158.44 39.43 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 128.973 2.909 . . . . 1.33 111.091 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 74.7 mt -132.83 139.33 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 125.559 1.544 . . . . 1.6 111.13 -174.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -75.79 139.06 69.8 Favored Pre-proline 0 CA--C 1.546 0.806 0 O-C-N 120.272 -1.518 . . . . 2.16 111.97 171.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.19 -20.6 24.6 Favored 'Trans proline' 0 C--N 1.349 0.602 0 CA-C-N 122.645 1.981 . . . . 0.87 113.517 176.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -98.21 -44.4 6.6 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.934 1.693 . . . . 2.08 112.018 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.9 p -90.2 -21.29 22.24 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.992 0.738 . . . . 1.78 112.992 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 54.5 18.92 2.14 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.48 1.512 . . . . 2.99 113.943 -172.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.1 148.92 21.81 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.728 -1.232 . . . . 3.52 112.73 -177.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.9 mt -87.74 142.53 27.75 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.069 1.748 . . . . 2.24 113.313 -170.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.8 p -71.26 -7.26 45.77 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.042 1.127 . . . . 1.61 114.042 171.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.99 -161.26 14.64 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.959 1.266 . . . . 1.11 112.881 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.83 162.56 29.33 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.359 1.063 . . . . 2.07 113.333 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -51.51 137.09 32.12 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.777 1.231 . . . . 2.21 112.91 174.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.8 154.79 26.65 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.858 3.038 . . . . 1.01 114.199 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.17 -60.92 2.11 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.337 1.236 . . . . 1.46 114.337 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.6 p -119.84 15.64 12.61 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 114.363 1.245 . . . . 1.75 114.363 -169.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.35 146.78 11.57 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.914 1.079 . . . . 0.64 113.914 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.6 ttt -74.77 102.86 4.81 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.655 1.982 . . . . 1.97 110.605 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -156.25 146.21 21.22 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.018 1.727 . . . . 1.84 112.211 -173.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -163.75 156.81 18.36 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.448 1.499 . . . . 2.68 110.627 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.1 mp -92.72 146.74 23.42 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.527 0.731 . . . . 0.94 112.03 173.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.2 p -65.3 140.57 58.7 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 121.054 -1.029 . . . . 1.77 110.183 169.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -98.08 -62.81 1.19 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.473 0.916 . . . . 2.17 113.473 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -170.37 -31.14 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.439 2.296 . . . . 1.9 110.682 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.14 24.03 10.75 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.045 2.138 . . . . 4.75 112.32 172.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.9 -151.63 27.71 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.94 1.257 . . . . 0.92 112.801 -170.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.3 129.77 24.06 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.63 1.972 . . . . 1.24 111.416 169.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -83.75 135.85 34.39 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.677 1.591 . . . . 2.16 112.89 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -127.35 130.61 49.75 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.27 2.228 . . . . 2.94 108.602 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -93.17 104.09 16.31 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.428 -0.795 . . . . 2.05 111.608 -173.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.1 p -86.41 -0.8 56.74 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.69 1.196 . . . . 2.01 113.49 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.39 -25.49 59.58 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.94 0.896 . . . . 2.06 113.222 169.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -87.74 -14.94 38.4 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.329 1.451 . . . . 2.27 113.433 -174.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -90.4 150.19 42.41 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 113.881 1.067 . . . . 0.81 113.881 177.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -85.45 172.21 8.28 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.09 3.194 . . . . 0.83 111.011 166.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.6 85.27 2.08 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.995 2.118 . . . . 1.33 111.054 -174.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -141.56 176.1 9.16 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.159 1.384 . . . . 1.71 111.256 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -91.28 145.7 24.44 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.621 1.2 . . . . 3.7 111.981 169.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -136.11 176.17 8.94 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.854 2.062 . . . . 0.59 109.983 -172.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.95 156.74 43.0 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.642 1.177 . . . . 4.49 113.411 177.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.0 142.38 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.66 1.184 . . . . 1.5 111.354 172.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -131.1 142.21 50.24 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.722 2.009 . . . . 3.15 111.891 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -103.78 126.85 51.2 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.246 1.418 . . . . 2.11 112.843 -175.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 25.0 mm -128.01 143.64 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.434 1.493 . . . . 1.91 110.246 -169.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -114.7 -1.48 13.28 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.093 1.516 . . . . 6.06 115.093 -178.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 N--CA 1.479 0.997 0 O-C-N 120.06 -1.65 . . . . 2.59 113.221 171.186 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 115.306 1.595 . . . . 3.05 115.306 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -87.47 158.5 18.94 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.089 1.356 . . . . 1.25 112.526 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.7 m -122.91 145.23 45.03 Favored Pre-proline 0 N--CA 1.468 0.472 0 C-N-CA 124.497 1.119 . . . . 0.93 111.198 178.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.9 161.95 43.39 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.049 2.499 . . . . 0.52 112.476 -170.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.3 mp -126.85 119.33 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.861 1.264 . . . . 2.29 111.067 -168.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -74.33 140.26 44.74 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.818 0.735 . . . . 3.29 110.853 168.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.9 tt -144.81 144.62 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.55 1.14 . . . . 1.58 111.622 174.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -115.81 157.68 24.03 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.434 1.094 . . . . 2.11 110.975 169.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.79 151.48 72.55 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.407 1.483 . . . . 1.74 112.949 177.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -83.16 116.57 2.42 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.85 2.366 . . . . 1.11 113.998 -169.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.75 57.64 1.67 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 104.864 -2.273 . . . . 3.58 104.864 165.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -128.37 170.17 13.41 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 127.226 2.211 . . . . 3.57 110.478 -167.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -71.88 -11.13 60.65 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 120.632 -1.293 . . . . 3.19 114.242 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.0 m -77.41 148.69 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 114.733 1.383 . . . . 1.83 114.733 -171.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.1 t -80.58 -38.36 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.982 1.313 . . . . 2.33 111.689 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -149.35 147.32 28.18 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.229 1.412 . . . . 3.21 110.728 170.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -97.05 161.57 13.77 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.524 1.305 . . . . 1.61 114.524 -168.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -133.97 169.89 16.44 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.074 1.509 . . . . 0.65 115.074 174.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -138.55 144.78 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.623 1.969 . . . . 1.07 111.148 173.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -137.06 83.25 28.31 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.685 1.594 . . . . 3.44 111.032 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -69.72 151.15 69.24 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.501 2.801 . . . . 0.75 113.241 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -131.17 156.62 45.01 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.968 2.107 . . . . 2.61 112.037 -171.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -89.61 177.31 6.57 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 122.913 1.339 . . . . 4.52 113.369 173.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 32.3 p . . . . . 0 N--CA 1.466 0.339 0 C-N-CA 126.321 1.848 . . . . 4.37 112.171 178.894 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.4 p . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 115.688 1.736 . . . . 1.88 115.688 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.7 p -89.13 -14.53 35.97 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.558 1.318 . . . . 2.01 114.558 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 t -147.18 165.29 30.46 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.452 1.901 . . . . 2.6 111.365 171.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -103.89 -0.09 29.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.971 2.509 . . . . 2.07 114.83 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 88.6 p -149.28 165.43 31.94 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.553 1.141 . . . . 2.17 113.349 175.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.66 136.63 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 127.474 2.309 . . . . 1.6 109.757 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.0 m -104.89 115.28 30.02 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.771 0.796 . . . . 1.16 110.796 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 p -95.24 134.56 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.28 1.432 . . . . 1.38 110.486 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -116.98 179.1 4.12 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.583 1.953 . . . . 1.84 109.988 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.96 129.35 18.93 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 120.35 1.432 . . . . 1.94 113.204 171.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.3 mt -115.0 148.24 39.08 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.422 1.089 . . . . 1.1 113.85 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.5 mt -135.94 177.13 8.07 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.24 2.216 . . . . 2.6 109.995 169.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.96 166.8 10.9 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.845 1.258 . . . . 1.37 112.545 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.3 p -85.67 -32.98 21.68 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.593 -1.317 . . . . 1.84 113.309 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -133.24 15.37 4.15 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.106 1.363 . . . . 2.49 113.624 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.22 34.86 8.41 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 120.722 -1.236 . . . . 1.13 113.379 -173.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.59 12.5 2.51 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.977 2.511 . . . . 2.04 114.614 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -60.17 -20.22 57.56 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.768 -1.207 . . . . 0.87 113.081 -172.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.44 -56.04 19.38 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.033 1.733 . . . . 2.9 113.041 172.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -38.87 70.45 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.173 -0.954 . . . . 5.6 111.704 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 84.4 mt -53.21 -50.28 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.352 1.061 . . . . 1.05 110.922 169.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.08 -32.66 72.31 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.826 1.194 . . . . 1.22 112.987 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -70.51 -34.34 72.22 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.998 0.74 . . . . 1.3 112.998 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -67.79 -28.05 67.27 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.717 0.69 . . . . 1.95 112.57 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.9 mt -85.99 -36.28 19.88 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.952 1.093 . . . . 2.25 113.952 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -65.42 -25.48 67.55 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.214 0.916 . . . . 2.86 113.137 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.1 t -76.37 -34.05 58.91 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.42 -0.8 . . . . 2.19 112.868 173.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.62 167.86 48.99 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.559 1.076 . . . . 1.23 113.876 176.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -93.85 32.12 1.5 Allowed 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.199 -1.177 . . . . 2.45 112.99 -173.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -70.95 3.01 3.64 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 116.057 1.873 . . . . 3.57 116.057 -167.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.0 -23.98 67.71 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.103 -0.998 . . . . 1.68 111.942 167.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.98 -76.68 0.85 Allowed Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.405 1.478 . . . . 1.0 112.581 170.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.36 158.13 31.73 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.983 1.475 . . . . 1.79 114.983 -170.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -62.92 147.75 49.43 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.188 0.995 . . . . 4.91 111.58 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.5 t -56.52 140.29 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.848 0.859 . . . . 1.85 111.867 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.58 -66.21 2.65 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.404 1.002 . . . . 1.58 112.861 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.0 t -149.14 125.01 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.975 2.11 . . . . 2.92 109.62 174.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt -74.89 145.48 81.39 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.316 -0.865 . . . . 1.86 112.505 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -72.59 161.69 43.36 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.937 2.425 . . . . 0.68 112.188 -176.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.38 -15.62 63.79 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.405 1.261 . . . . 1.64 114.405 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -96.52 -1.3 47.44 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.607 1.563 . . . . 2.52 114.193 173.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.49 150.86 24.98 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.291 -0.881 . . . . 0.67 112.556 169.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -141.6 151.44 43.15 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.595 1.558 . . . . 3.35 110.975 169.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.14 138.75 53.7 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.051 0.941 . . . . 3.1 110.7 -171.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.4 pt -131.85 153.03 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 115.403 1.631 . . . . 1.68 115.403 -169.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -113.53 156.54 23.4 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.292 1.837 . . . . 1.67 112.31 172.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.29 13.69 59.83 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.953 1.263 . . . . 0.53 114.882 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.86 142.35 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.079 1.751 . . . . 2.03 110.613 172.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -103.74 136.83 42.7 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.8 1.64 . . . . 1.6 113.661 -175.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -141.85 152.29 43.51 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.121 1.368 . . . . 2.8 111.76 175.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.15 146.74 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 127.306 2.242 . . . . 1.65 109.361 -176.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -88.91 147.61 24.26 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.396 1.093 . . . . 0.46 112.287 169.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.2 p -136.68 165.1 26.68 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.025 1.73 . . . . 1.69 112.395 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.02 168.67 13.1 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.092 1.357 . . . . 1.9 111.22 167.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . 0.267 1.3 t -67.15 -14.65 63.1 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 115.0 1.481 . . . . 2.98 115.0 -168.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -83.69 19.07 1.73 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.717 1.607 . . . . 4.74 113.055 167.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.72 23.31 12.16 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.233 1.813 . . . . 0.64 113.558 -175.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -83.89 136.67 34.01 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.659 1.584 . . . . 2.61 112.904 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.4 mt -77.79 128.79 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 121.602 -0.686 . . . . 1.62 110.516 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.78 150.66 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 126.386 1.874 . . . . 1.83 114.326 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -77.73 161.61 27.59 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.331 2.252 . . . . 1.58 110.965 168.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -56.6 -21.78 29.33 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 116.025 1.861 . . . . 2.46 116.025 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . 0.257 0.0 OUTLIER -87.87 -0.58 57.15 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 120.829 1.65 . . . . 3.25 113.558 171.438 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.62 17.6 65.71 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.895 1.236 . . . . 0.75 114.405 -175.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -75.27 145.3 41.99 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.107 0.953 . . . . 2.95 108.966 167.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.4 p -106.21 145.42 31.59 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.084 0.954 . . . . 2.0 112.416 -171.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -103.06 -4.98 23.8 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.126 1.158 . . . . 1.65 114.126 -170.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.85 30.17 52.72 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 119.722 1.146 . . . . 0.71 113.905 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 45.1 t -138.85 145.81 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.124 1.369 . . . . 1.68 110.308 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -126.49 159.29 33.83 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.644 2.778 . . . . 1.5 110.942 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 51.4 mt -136.91 134.15 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.302 1.441 . . . . 1.58 110.387 -174.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -75.56 140.06 71.49 Favored Pre-proline 0 N--CA 1.476 0.854 0 CA-C-O 117.687 -1.149 . . . . 2.24 111.836 176.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -72.17 -24.12 20.46 Favored 'Trans proline' 0 C--N 1.351 0.679 0 CA-C-N 122.154 1.805 . . . . 1.11 113.136 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -88.01 -52.03 5.49 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.814 1.646 . . . . 1.74 111.777 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.0 p -83.21 -23.8 32.66 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.959 0.904 . . . . 2.06 113.15 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 52.52 23.4 2.54 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.056 1.743 . . . . 3.58 113.653 -173.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . 0.252 2.2 ptmt -104.38 162.61 13.08 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.052 -1.03 . . . . 4.62 112.887 176.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.9 mt -94.48 149.57 21.11 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.474 1.51 . . . . 1.15 114.629 -167.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.8 p -75.1 0.76 15.07 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.986 1.106 . . . . 1.45 113.986 169.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.23 -152.33 9.54 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.187 1.375 . . . . 1.09 112.277 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.76 155.07 19.44 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.017 0.927 . . . . 2.2 113.345 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 tpt -51.08 130.78 30.96 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.806 1.642 . . . . 2.05 112.069 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.34 168.03 25.46 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.706 2.937 . . . . 1.0 113.425 -175.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.19 -91.53 0.07 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.764 1.226 . . . . 1.64 110.83 168.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.4 p -74.56 10.87 1.17 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 116.49 2.033 . . . . 1.77 116.49 -167.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.57 147.46 14.22 Favored 'General case' 0 CA--C 1.55 0.95 0 O-C-N 120.437 -1.415 . . . . 0.61 113.259 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.3 ttt -74.51 102.53 4.53 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.469 1.508 . . . . 1.82 109.98 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -156.85 145.29 19.71 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.622 1.569 . . . . 1.74 111.656 -174.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -168.13 156.82 9.04 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.272 1.829 . . . . 3.73 109.93 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.2 mp -87.45 150.08 24.0 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.335 1.454 . . . . 0.78 113.585 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.2 p -63.98 129.77 41.37 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.218 -0.927 . . . . 1.99 110.193 169.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -80.75 -57.38 3.58 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 120.771 -1.206 . . . . 2.08 114.032 -174.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -153.03 -43.12 0.1 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.921 1.688 . . . . 1.98 109.796 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -104.6 -33.15 8.62 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.039 0.936 . . . . 4.58 113.239 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 172.61 -170.65 43.72 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 126.218 1.866 . . . . 0.98 110.865 -169.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -135.12 136.39 41.89 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.175 1.79 . . . . 2.06 110.637 171.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -97.05 128.9 44.45 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.016 0.926 . . . . 2.29 111.949 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -117.98 136.23 53.64 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.8 2.04 . . . . 2.98 107.738 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -96.66 104.41 16.4 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.553 -1.342 . . . . 1.9 111.817 -169.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.4 p -86.77 1.65 51.51 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.655 1.182 . . . . 1.69 113.349 -174.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.3 -29.12 68.64 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.412 -0.805 . . . . 1.88 112.093 169.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.7 m120 -86.92 -20.78 26.87 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.35 1.46 . . . . 2.3 113.187 -175.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -79.06 144.22 62.82 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 119.474 1.034 . . . . 0.92 113.253 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.22 169.46 20.18 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.643 2.229 . . . . 1.3 110.733 166.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.97 89.68 1.92 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.054 1.742 . . . . 1.55 110.771 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -149.09 177.81 9.27 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.827 0.851 . . . . 1.97 112.052 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -87.04 146.37 26.12 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.107 0.963 . . . . 3.52 111.628 166.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -135.84 170.49 15.9 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.993 2.117 . . . . 0.72 109.718 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -140.25 149.72 43.21 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.549 0.739 . . . . 2.58 111.788 171.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.2 mp -104.03 140.4 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.281 0.632 . . . . 1.75 110.072 173.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -124.75 135.94 53.42 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.926 1.69 . . . . 3.21 109.852 174.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -97.55 123.84 41.58 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.122 0.969 . . . . 1.84 109.392 178.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 40.3 mm -122.57 97.12 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.743 0.817 . . . . 1.93 109.074 -172.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.7 -12.03 60.32 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.579 1.325 . . . . 5.34 114.579 -169.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 79.8 p . . . . . 0 N--CA 1.469 0.478 0 N-CA-C 114.271 1.211 . . . . 2.5 114.271 177.632 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 115.209 1.559 . . . . 3.36 115.209 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.62 152.96 29.74 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.099 0.96 . . . . 1.16 111.857 168.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.56 149.04 54.63 Favored Pre-proline 0 N--CA 1.478 0.975 0 C-N-CA 125.337 1.455 . . . . 0.94 110.784 174.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.9 162.72 29.21 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.894 3.063 . . . . 0.78 115.299 -165.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.6 mp -126.41 133.47 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.742 2.017 . . . . 2.11 110.701 -168.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -98.14 130.88 44.89 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.438 1.095 . . . . 3.39 111.838 174.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.4 tt -135.94 147.84 28.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.927 1.291 . . . . 1.74 110.816 -174.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -127.48 152.93 46.94 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.986 1.315 . . . . 1.95 109.125 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.09 143.97 98.97 Favored Pre-proline 0 CA--C 1.543 0.688 0 O-C-N 120.94 -1.1 . . . . 1.42 111.614 -176.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -66.81 92.04 0.31 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 124.506 3.47 . . . . 0.8 115.599 -165.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.2 tt -122.73 77.53 1.44 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.678 1.991 . . . . 3.29 105.783 168.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -157.63 177.02 11.86 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.155 2.182 . . . . 2.65 108.574 -167.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -84.33 34.36 0.52 Allowed 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.163 -1.585 . . . . 3.23 114.135 -175.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.63 156.51 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.845 1.258 . . . . 1.62 111.637 -174.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 78.2 t -108.88 -33.85 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.267 1.827 . . . . 2.68 111.558 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -129.07 134.64 48.18 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.265 1.426 . . . . 3.74 109.167 172.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -98.34 137.82 36.5 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.226 1.01 . . . . 1.38 111.494 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -133.72 166.93 21.49 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.068 1.136 . . . . 0.71 114.068 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.28 135.91 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.2 1.4 . . . . 2.1 111.568 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -134.18 82.52 47.5 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.569 1.147 . . . . 3.33 111.466 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.78 151.08 68.87 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 124.559 3.506 . . . . 0.81 112.274 175.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -131.58 158.94 39.65 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.083 1.753 . . . . 3.0 111.679 -178.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -88.64 175.01 7.72 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.311 1.044 . . . . 2.87 110.997 168.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 13.2 t . . . . . 0 N--CA 1.482 1.145 0 O-C-N 121.409 -0.807 . . . . 2.48 113.063 169.701 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.9 p . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 113.416 0.895 . . . . 1.74 113.416 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 43.4 p -98.21 -8.48 27.33 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.343 1.457 . . . . 2.58 114.067 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.0 m -147.5 146.02 29.34 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.478 1.911 . . . . 3.57 110.054 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.4 p -108.96 -14.48 14.55 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 116.901 2.186 . . . . 2.04 116.901 -172.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.6 m -138.61 149.62 45.43 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.019 1.328 . . . . 2.29 111.589 170.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.5 p -115.7 142.66 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 127.071 2.149 . . . . 1.45 110.382 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 36.0 m -111.0 121.61 45.8 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.582 0.753 . . . . 1.18 109.564 172.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 p -96.65 127.38 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.945 0.879 . . . . 1.27 109.346 174.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -103.66 -172.47 2.12 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.02 1.728 . . . . 1.9 109.029 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.8 134.19 13.47 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 120.411 -1.431 . . . . 1.88 112.611 168.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.0 mt -121.06 150.57 40.98 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.852 1.261 . . . . 1.84 112.971 -172.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.3 mt -140.81 169.66 17.22 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.332 1.853 . . . . 2.32 109.761 167.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.98 172.97 7.07 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.993 0.917 . . . . 2.09 112.029 173.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.8 p -102.31 -25.78 13.54 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 114.417 1.266 . . . . 1.86 114.417 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -134.95 45.22 2.55 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.668 1.987 . . . . 2.55 110.365 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.47 14.63 67.17 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 120.741 -1.224 . . . . 1.0 116.007 175.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.63 27.24 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.982 2.513 . . . . 2.2 115.921 -171.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.13 -19.06 65.8 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 119.617 -1.927 . . . . 0.99 114.13 -171.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -85.14 -43.38 13.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.385 1.474 . . . . 2.28 112.583 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -69.94 -39.09 76.28 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-O 117.941 -1.028 . . . . 4.34 110.955 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.3 mt -51.6 -50.37 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.499 1.12 . . . . 2.14 110.09 167.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.37 -27.47 66.0 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.554 0.946 . . . . 2.41 113.554 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -79.72 -32.22 41.23 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.063 -1.023 . . . . 1.23 112.937 174.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -67.97 -16.01 63.86 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.792 0.837 . . . . 2.1 112.596 169.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.4 mt -97.46 -37.61 9.92 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.072 1.349 . . . . 1.93 114.22 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -70.15 -15.93 63.02 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.57 -1.331 . . . . 2.51 114.448 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.4 t -71.78 -30.2 65.3 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.01 0.924 . . . . 2.45 113.25 170.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.38 164.6 28.29 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.48 1.514 . . . . 1.27 113.053 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -87.32 53.41 2.8 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.131 -1.217 . . . . 1.88 111.412 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -89.41 8.01 33.0 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.378 1.251 . . . . 3.15 114.378 -170.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.03 -25.79 63.74 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.139 -0.976 . . . . 1.97 111.69 168.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.28 -82.53 1.21 Allowed Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.064 0.84 . . . . 0.72 111.888 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 161.52 29.67 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.774 1.23 . . . . 2.16 112.708 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -60.36 158.13 12.44 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.804 1.242 . . . . 3.28 114.341 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 52.6 t -59.04 126.73 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 121.881 -0.512 . . . . 1.11 110.6 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.38 -48.84 75.19 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.061 1.315 . . . . 1.12 113.301 -175.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.0 129.16 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.804 1.241 . . . . 3.87 111.228 173.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.9 mt -79.62 144.54 61.04 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.066 0.946 . . . . 1.5 111.532 174.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.64 166.94 28.51 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.65 2.234 . . . . 0.73 113.045 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.64 -23.83 65.38 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 121.015 -1.053 . . . . 2.04 113.452 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -83.92 -1.43 54.52 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.373 1.249 . . . . 2.85 114.373 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.09 158.19 16.47 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.282 1.433 . . . . 0.65 114.162 172.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.77 159.45 44.34 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.55 1.14 . . . . 2.78 112.729 166.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -105.29 150.04 25.51 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.847 1.659 . . . . 2.9 111.263 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.9 pt -137.92 139.29 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 120.067 1.303 . . . . 1.62 114.282 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.74 146.95 25.97 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.759 1.223 . . . . 1.44 113.102 172.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.8 14.36 27.25 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.341 1.448 . . . . 0.54 115.42 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.43 144.44 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 125.287 1.435 . . . . 1.74 109.795 169.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 1.3 tpt -105.25 140.26 38.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.554 1.542 . . . . 1.67 112.115 176.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.52 155.67 43.23 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.841 1.257 . . . . 3.54 112.625 172.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.3 m -120.23 149.62 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 127.033 2.133 . . . . 1.7 109.709 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -90.26 147.58 23.44 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 122.619 1.199 . . . . 0.42 112.106 169.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.4 p -139.72 166.85 23.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.31 1.844 . . . . 1.86 111.385 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.78 172.93 11.73 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.544 -0.722 . . . . 1.99 112.529 168.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.8 t -61.58 -23.98 66.36 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.437 1.273 . . . . 3.21 114.437 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -87.9 20.99 2.83 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 125.379 1.472 . . . . 2.83 113.347 171.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 56.75 27.47 12.81 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.779 2.832 . . . . 0.66 114.742 175.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -82.7 140.56 33.03 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.013 0.925 . . . . 2.16 110.31 172.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.4 mt -76.21 125.68 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.225 -0.657 . . . . 1.6 109.225 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.3 pt -121.86 156.91 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 114.644 1.35 . . . . 1.83 114.644 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -90.1 164.09 14.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.619 2.367 . . . . 1.57 110.115 168.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -68.97 2.9 2.31 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 116.689 2.107 . . . . 2.4 116.689 -168.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -110.89 0.79 17.27 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.422 1.489 . . . . 2.84 114.105 168.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.24 3.0 60.35 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.255 1.407 . . . . 0.63 115.644 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -65.31 132.13 48.25 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.042 1.421 . . . . 3.99 108.932 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.05 142.41 28.29 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 118.134 0.425 . . . . 1.86 111.43 176.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.22 -12.76 45.83 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.233 1.198 . . . . 1.84 114.233 -168.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.56 22.72 23.34 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.053 1.311 . . . . 0.78 114.511 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.0 t -134.79 149.55 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.373 1.469 . . . . 1.88 110.195 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -128.28 157.5 40.74 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.68 2.792 . . . . 1.29 111.292 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 57.1 mt -134.04 126.82 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.423 1.489 . . . . 1.88 110.321 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -68.64 137.71 90.71 Favored Pre-proline 0 N--CA 1.477 0.888 0 O-C-N 121.029 -1.045 . . . . 2.33 111.046 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.06 -15.17 29.14 Favored 'Trans proline' 0 C--N 1.35 0.623 0 CA-C-N 121.924 1.723 . . . . 1.04 113.785 176.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -97.19 -47.43 5.75 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.627 1.571 . . . . 2.15 111.419 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.9 p -90.34 -22.03 21.73 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.728 1.211 . . . . 2.25 113.458 -174.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 56.43 16.32 2.4 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.582 1.553 . . . . 2.88 113.923 -171.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.81 146.13 24.01 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.94 -1.1 . . . . 3.86 113.124 -175.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.9 mt -81.56 142.73 32.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.102 1.361 . . . . 1.26 112.648 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 83.8 p -77.67 4.4 11.57 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.418 1.266 . . . . 1.67 114.418 172.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.83 -162.52 29.63 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 126.106 1.813 . . . . 1.19 112.388 -176.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.66 154.75 39.57 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.827 1.047 . . . . 2.53 113.827 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 mtp -51.8 138.18 33.4 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.39 1.076 . . . . 3.26 112.64 174.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -83.48 171.2 11.23 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.536 3.491 . . . . 0.83 113.895 -172.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.12 -96.19 0.09 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.583 1.553 . . . . 1.39 110.545 168.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.1 p -72.77 13.51 0.36 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 116.627 2.084 . . . . 1.95 116.627 -168.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.61 145.09 19.78 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.042 -1.036 . . . . 0.66 112.812 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.1 ttt -75.0 107.89 7.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.872 2.469 . . . . 1.87 110.353 176.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -157.73 143.24 17.11 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 127.303 2.241 . . . . 1.83 112.702 -174.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -164.91 158.1 16.84 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.013 1.325 . . . . 2.73 111.859 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.8 mp -101.79 144.99 29.78 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.991 1.317 . . . . 0.79 113.981 175.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.8 p -64.54 136.17 56.76 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.721 0.638 . . . . 1.33 112.721 173.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.03 -59.13 1.86 Allowed 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 114.965 1.468 . . . . 2.33 114.965 -172.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.25 -39.61 0.14 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.184 0.994 . . . . 1.77 111.871 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -115.35 -27.01 7.36 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.09 0.956 . . . . 5.2 112.515 174.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 179.64 -156.04 17.2 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 123.836 0.732 . . . . 0.9 112.263 -178.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.74 131.12 23.67 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.023 2.129 . . . . 1.18 111.5 171.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -83.49 140.64 32.19 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.945 1.298 . . . . 2.09 113.579 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -134.39 118.74 17.77 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.989 2.516 . . . . 2.94 108.977 175.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.475 ' ND2' HD22 ' A' ' 133' ' ' ASN . 17.0 t30 -76.27 113.14 13.5 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.569 1.148 . . . . 2.05 109.427 177.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 35.9 p -103.61 0.66 31.08 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.921 1.288 . . . . 1.82 113.219 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -53.41 -18.48 2.66 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.756 2.422 . . . . 1.88 115.276 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.475 HD22 ' ND2' ' A' ' 130' ' ' ASN . 0.0 OUTLIER -105.81 -23.81 12.62 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.373 1.869 . . . . 3.23 113.088 -174.508 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.57 140.03 96.31 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 119.318 0.963 . . . . 0.95 112.458 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.09 169.18 23.14 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.581 2.187 . . . . 0.9 111.482 169.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.47 93.05 2.4 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.978 1.311 . . . . 1.65 109.614 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -144.51 178.79 7.7 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.478 1.111 . . . . 1.97 111.079 174.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -94.95 141.69 28.35 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.335 1.054 . . . . 4.25 110.988 169.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -135.34 166.72 22.5 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.222 1.809 . . . . 0.75 110.272 -172.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -141.49 149.17 40.56 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.24 0.83 . . . . 2.53 113.24 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 mp -105.91 142.34 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.572 1.149 . . . . 1.47 110.201 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -129.43 127.29 40.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.891 1.676 . . . . 3.29 111.491 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -91.84 75.21 5.68 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.967 0.907 . . . . 1.95 112.656 -171.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.0 mm -77.75 107.99 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.742 0.817 . . . . 1.74 109.908 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.78 9.07 40.43 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.763 1.023 . . . . 5.35 113.763 -174.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 113.752 1.019 . . . . 2.85 113.752 -176.551 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 119.478 -0.296 . . . . 3.22 111.788 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.33 128.85 36.66 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.996 0.816 . . . . 1.47 111.79 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.2 m -100.46 149.6 36.24 Favored Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 124.24 1.016 . . . . 1.02 110.356 172.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.74 161.29 46.59 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.797 2.331 . . . . 0.75 113.058 -170.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 1.5 mp -121.84 127.87 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.347 1.059 . . . . 2.36 110.761 -169.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -93.02 139.37 30.6 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.896 1.279 . . . . 2.72 112.466 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.8 tt -147.48 146.57 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.965 1.306 . . . . 1.6 111.964 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -120.88 155.73 33.52 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.047 1.339 . . . . 2.3 110.639 169.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -67.53 148.61 98.6 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 123.793 0.837 . . . . 1.93 112.139 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.0 112.1 3.04 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.527 2.818 . . . . 1.14 114.008 -168.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 tp -119.04 0.98 11.39 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 125.239 1.416 . . . . 3.83 110.854 165.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -76.85 169.16 18.82 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 129.585 3.154 . . . . 2.9 111.53 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -74.16 19.54 0.12 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 116.46 2.022 . . . . 4.21 116.46 -171.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . 0.252 1.2 m -95.41 147.53 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 O-C-N 121.04 -1.038 . . . . 1.7 113.672 -169.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 41.2 t -88.31 -32.35 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.079 1.352 . . . . 2.66 112.129 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -147.13 127.38 13.86 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.544 1.537 . . . . 2.54 108.645 -174.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -101.57 143.15 31.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.561 1.144 . . . . 1.58 112.449 -169.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -139.02 170.62 15.65 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.329 1.603 . . . . 0.77 115.329 -178.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.4 t -139.74 139.94 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.752 2.021 . . . . 2.04 111.336 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -132.97 82.79 54.03 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.96 1.304 . . . . 3.66 112.988 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -65.89 143.53 73.44 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.689 3.593 . . . . 0.78 113.913 171.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -140.71 166.68 24.1 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 129.08 2.952 . . . . 3.16 111.027 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -117.93 169.52 9.57 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.927 0.891 . . . . 3.61 113.06 -171.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.472 0.645 0 C-N-CA 126.662 1.985 . . . . 2.54 111.74 -178.218 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 112.8 0.667 . . . . 2.25 112.8 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.4 p -92.8 -15.4 26.58 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.391 1.076 . . . . 2.11 113.754 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.9 m -148.37 124.44 10.73 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.008 1.723 . . . . 2.98 108.9 171.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 45.2 p -90.86 23.63 3.07 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.181 1.548 . . . . 3.12 115.181 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 m -149.17 165.79 30.76 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.057 1.343 . . . . 2.51 110.523 168.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.4 p -144.05 142.6 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.007 1.723 . . . . 1.49 109.793 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.2 m -116.01 124.83 51.47 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.717 0.807 . . . . 1.04 110.273 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -101.98 131.19 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.803 1.241 . . . . 1.14 110.599 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -128.15 104.67 7.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.227 1.411 . . . . 1.81 110.888 -172.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.74 116.95 20.21 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.493 -1.379 . . . . 2.35 111.575 -172.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.3 mt -106.6 151.75 24.63 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.039 1.336 . . . . 1.18 111.762 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.9 mt -138.16 171.55 14.24 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.33 1.452 . . . . 2.21 111.137 169.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.56 162.77 13.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.356 1.063 . . . . 1.22 112.678 170.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.6 p -91.39 -24.73 19.66 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 114.751 1.389 . . . . 1.73 114.751 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -138.11 38.61 2.33 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.113 1.765 . . . . 2.1 111.601 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.19 14.39 79.08 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 120.84 -1.163 . . . . 1.01 115.659 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.01 25.26 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 128.889 2.876 . . . . 1.84 116.221 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -24.59 67.59 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 119.883 -1.761 . . . . 1.07 113.202 -173.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -75.28 -40.13 59.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.769 1.168 . . . . 2.12 113.481 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.1 ptmm? -70.48 -41.41 72.75 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 117.448 -1.263 . . . . 3.89 111.357 170.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.6 mt -55.64 -52.88 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 120.252 1.387 . . . . 2.15 111.47 170.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.61 -34.08 70.73 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.08 -1.013 . . . . 1.39 112.785 -178.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -77.2 -30.75 54.88 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.715 1.005 . . . . 1.41 113.715 175.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -66.35 -30.71 71.16 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.133 0.879 . . . . 2.12 111.789 169.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.6 mt -86.4 -37.57 18.26 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.483 1.29 . . . . 1.34 114.483 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -72.64 -23.89 60.97 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.063 0.764 . . . . 3.68 113.063 -177.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.0 t -76.81 -28.43 55.57 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.673 0.62 . . . . 3.19 112.673 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.6 156.65 35.23 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.106 1.336 . . . . 1.43 112.745 172.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -83.57 31.45 0.47 Allowed 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.21 -1.171 . . . . 2.79 112.817 -173.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -71.08 5.42 2.1 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.786 1.402 . . . . 3.31 114.786 -169.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.95 -22.35 62.37 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.007 -1.058 . . . . 1.51 112.289 167.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.69 -82.11 1.15 Allowed Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.263 1.411 . . . . 0.87 113.455 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.42 157.09 38.66 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.491 1.916 . . . . 1.68 114.933 -172.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.9 157.14 19.06 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.687 1.195 . . . . 4.49 113.793 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.1 t -63.67 130.98 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.907 0.883 . . . . 2.02 110.539 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.67 -51.65 29.41 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 119.776 -0.458 . . . . 1.32 113.723 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 t -146.73 136.36 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.227 1.411 . . . . 2.78 109.629 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.1 mt -84.96 150.71 56.17 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.723 0.809 . . . . 2.09 113.151 171.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.99 159.13 48.62 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.566 2.178 . . . . 0.91 111.564 171.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.29 -30.17 66.41 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.421 -0.799 . . . . 2.27 112.889 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -87.43 1.89 52.07 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.635 1.717 . . . . 2.28 115.635 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.95 154.35 20.3 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.771 1.169 . . . . 0.76 113.915 172.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -146.78 169.86 18.21 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.699 2.0 . . . . 2.99 112.329 171.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -128.31 138.42 52.38 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.3 1.44 . . . . 2.2 111.248 -173.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.0 pt -126.96 141.56 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 114.096 1.147 . . . . 2.02 114.096 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -112.97 158.31 20.41 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.833 1.253 . . . . 2.0 112.993 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.64 4.88 82.44 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.789 1.185 . . . . 0.75 114.654 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -86.61 141.2 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.052 1.341 . . . . 2.11 110.75 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -104.81 134.3 48.18 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.851 1.66 . . . . 1.77 113.193 -173.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -141.02 154.03 45.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.761 1.224 . . . . 2.84 112.278 177.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 m -127.04 144.32 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 126.513 1.925 . . . . 1.63 110.067 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -87.18 147.69 25.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.595 1.188 . . . . 0.46 112.024 170.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.5 p -140.99 167.24 22.66 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.881 2.072 . . . . 1.52 111.13 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.8 171.57 11.46 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.949 0.722 . . . . 2.15 112.949 169.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.2 t -63.13 -23.99 67.69 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.566 1.321 . . . . 3.57 114.566 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -87.6 24.42 1.7 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.649 1.18 . . . . 2.61 113.085 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.52 27.44 16.61 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 128.105 2.562 . . . . 0.8 114.602 172.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -89.88 143.26 26.95 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.169 1.388 . . . . 1.81 111.795 174.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.2 mt -79.3 127.48 39.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 123.28 0.632 . . . . 1.9 110.034 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.3 pt -121.61 153.94 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.991 1.716 . . . . 1.96 115.139 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -84.6 165.55 17.88 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.429 2.291 . . . . 2.1 110.574 167.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -64.91 -12.57 50.67 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.139 1.533 . . . . 2.51 115.139 -170.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -96.98 6.11 49.24 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.319 1.448 . . . . 2.62 113.564 173.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.62 5.12 82.21 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.938 1.256 . . . . 0.69 115.066 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -73.69 142.71 46.39 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 124.321 1.048 . . . . 2.48 110.403 173.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 30.6 p -104.94 147.29 27.94 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.974 0.91 . . . . 1.83 112.499 -171.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.12 2.54 37.56 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.229 1.566 . . . . 1.77 115.229 -168.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.88 23.43 74.82 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 120.529 -1.357 . . . . 0.75 114.733 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.2 p -138.05 143.38 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.709 1.204 . . . . 4.12 109.749 177.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.14 164.59 18.37 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.7 2.4 . . . . 1.49 110.755 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 66.5 mt -135.61 131.13 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 124.873 1.269 . . . . 1.66 110.321 -177.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -69.02 138.81 90.1 Favored Pre-proline 0 CA--C 1.543 0.696 0 O-C-N 121.038 -1.039 . . . . 2.29 110.813 175.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.07 -18.4 21.26 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 CA-C-N 122.12 1.793 . . . . 0.88 113.21 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.77 -52.4 3.75 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.416 1.886 . . . . 1.82 110.892 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.3 p -80.45 -25.75 38.73 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.019 0.748 . . . . 1.7 113.019 -176.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 58.24 12.86 2.09 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.406 1.482 . . . . 2.85 113.842 -171.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.02 150.66 26.21 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.624 -1.297 . . . . 3.24 111.737 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.3 mt -85.52 140.63 30.49 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.68 0.993 . . . . 1.05 113.68 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.2 t -88.66 35.93 0.79 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.533 1.533 . . . . 3.13 111.397 169.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 170.46 -168.81 41.81 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.678 2.085 . . . . 1.36 111.702 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.54 163.09 26.6 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.425 0.69 . . . . 2.06 111.396 170.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.7 tpt -59.87 127.19 85.09 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.081 0.952 . . . . 2.41 110.778 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -69.91 171.57 14.39 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 124.818 3.679 . . . . 0.84 113.671 -172.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.37 -92.18 0.07 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.332 1.053 . . . . 1.57 110.722 169.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.8 p -73.83 6.65 3.09 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.7 2.0 . . . . 1.71 116.398 -167.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.12 147.16 7.82 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.427 1.091 . . . . 0.56 113.8 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.1 tpt -74.76 92.03 2.45 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.933 2.093 . . . . 1.64 112.196 -177.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.9 pttm -143.61 148.16 35.44 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.013 1.325 . . . . 3.36 113.636 -175.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -162.85 165.6 25.07 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.186 1.395 . . . . 3.6 111.356 172.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.2 mp -98.14 150.03 21.9 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.876 1.67 . . . . 2.35 113.25 172.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.5 p -67.23 135.9 54.13 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 119.632 1.105 . . . . 1.37 111.131 168.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -89.01 -53.04 4.77 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 115.225 1.565 . . . . 2.11 115.225 -175.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.55 -45.51 0.07 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.911 1.284 . . . . 1.5 110.647 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -116.72 -18.77 10.18 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.015 1.117 . . . . 5.38 114.015 176.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 177.35 -163.93 32.83 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.986 1.279 . . . . 0.77 112.216 -176.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -143.17 132.15 22.91 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.542 2.337 . . . . 1.23 110.942 169.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -84.51 144.18 28.86 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.246 1.418 . . . . 2.16 112.323 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -135.5 124.37 24.05 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.969 2.107 . . . . 3.08 108.708 172.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -73.11 134.59 44.56 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.504 -0.748 . . . . 2.06 111.216 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 71.9 p -121.37 6.14 10.16 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.412 1.485 . . . . 1.72 113.671 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.7 -36.24 69.41 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.654 1.115 . . . . 1.71 113.168 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -91.36 -21.48 20.99 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.835 1.254 . . . . 2.62 111.088 -169.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.1 139.95 96.0 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 119.819 1.19 . . . . 0.81 112.663 170.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.67 169.65 20.48 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.997 2.464 . . . . 0.77 111.192 167.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.2 89.34 3.67 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.547 1.539 . . . . 1.14 111.26 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -146.84 -179.56 6.88 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.355 1.062 . . . . 1.75 112.394 -175.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -98.4 137.54 36.94 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.199 1.399 . . . . 3.9 112.183 173.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -135.91 167.47 21.14 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.327 1.451 . . . . 0.52 111.287 -169.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -139.78 153.17 47.07 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.159 0.799 . . . . 2.54 113.159 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.9 mp -110.54 144.58 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.437 1.095 . . . . 1.52 110.367 170.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -130.57 144.09 51.19 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.792 2.037 . . . . 3.22 110.691 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -103.66 112.33 25.21 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.349 1.06 . . . . 2.14 109.849 -175.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 19.7 mm -124.33 85.9 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.389 1.076 . . . . 1.99 110.061 -168.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -14.79 60.64 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.438 -0.789 . . . . 5.35 113.063 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.47 0.541 0 C-N-CA 124.651 1.18 . . . . 2.77 113.62 170.131 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 114.043 1.127 . . . . 3.3 114.043 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.21 150.94 45.93 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.357 -0.84 . . . . 1.4 112.308 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.35 147.43 40.54 Favored Pre-proline 0 N--CA 1.478 0.975 0 C-N-CA 125.069 1.347 . . . . 1.06 111.169 174.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.93 138.69 23.54 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.411 2.741 . . . . 0.58 112.825 -168.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.74 119.6 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 124.854 1.261 . . . . 2.46 109.982 -171.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.2 pm0 -88.51 138.99 30.93 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.829 0.852 . . . . 4.78 113.161 174.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.2 tt -148.49 156.67 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.316 1.446 . . . . 1.61 111.408 -173.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -127.58 152.49 47.58 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.473 1.509 . . . . 1.84 110.092 170.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.2 138.68 97.32 Favored Pre-proline 0 CA--C 1.548 0.897 0 O-C-N 120.98 -1.075 . . . . 1.76 111.226 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -72.64 111.6 3.28 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.575 2.183 . . . . 1.06 114.844 -168.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.91 58.48 1.09 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 104.936 -2.246 . . . . 3.76 104.936 165.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -144.15 144.59 31.64 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.13 2.572 . . . . 2.7 108.512 -166.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -76.68 57.79 1.31 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.451 1.278 . . . . 3.91 114.451 -170.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 1.6 m -112.94 151.15 14.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 125.114 1.365 . . . . 1.64 110.538 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 96.4 t -88.13 -30.68 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.129 1.372 . . . . 2.03 110.802 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -146.95 142.36 27.47 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.108 0.963 . . . . 2.55 111.512 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -102.93 143.81 32.04 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.267 -0.896 . . . . 1.72 112.702 -175.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -139.95 170.87 15.07 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.682 1.734 . . . . 0.59 115.682 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -140.37 142.89 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.673 1.989 . . . . 0.95 111.508 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -131.77 76.42 74.39 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 113.814 1.042 . . . . 3.22 113.814 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -62.51 146.9 95.5 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.528 2.819 . . . . 0.93 113.912 176.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 15.8 mtmt -121.4 -168.7 1.73 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 128.609 2.764 . . . . 2.7 111.057 -174.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.259 0.6 OUTLIER -137.41 172.84 12.38 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.868 1.667 . . . . 3.43 110.793 167.454 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 CA--C 1.539 0.534 0 C-N-CA 125.18 1.392 . . . . 2.71 109.711 173.166 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.7 p . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 111.541 0.2 . . . . 1.77 111.541 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.7 p -88.74 -17.12 30.55 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.335 0.865 . . . . 2.36 113.335 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 84.9 m -146.12 128.45 15.84 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.675 1.59 . . . . 3.11 110.149 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 p -88.43 7.77 31.08 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 116.1 1.889 . . . . 2.32 116.1 -173.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.6 m -150.65 165.76 32.41 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.461 1.504 . . . . 2.61 111.811 171.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.73 144.59 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.266 1.827 . . . . 1.77 110.938 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.01 111.33 17.76 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.934 1.293 . . . . 1.73 110.704 -170.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 p -98.9 133.73 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 120.376 -1.453 . . . . 1.22 110.696 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -134.95 104.75 6.09 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.451 1.5 . . . . 1.81 111.669 -171.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.53 126.03 30.72 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 119.887 -1.758 . . . . 2.0 111.738 -173.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.4 mt -112.99 155.88 24.02 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.918 1.287 . . . . 1.18 112.64 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.98 167.77 21.1 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.211 1.404 . . . . 2.63 111.063 175.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.81 168.87 8.82 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.143 1.377 . . . . 1.3 112.219 173.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.0 p -97.04 -27.69 14.49 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.612 0.968 . . . . 1.74 113.612 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -145.3 37.59 1.13 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.455 1.102 . . . . 2.47 112.807 172.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.62 14.38 59.88 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.87 1.224 . . . . 1.03 115.449 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.38 14.34 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 128.232 2.613 . . . . 1.97 116.411 -174.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -63.09 -20.29 65.22 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.217 -1.552 . . . . 2.03 113.939 -172.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -84.8 -38.84 19.1 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.647 1.179 . . . . 2.46 112.721 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -68.37 -40.39 81.46 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 120.901 -1.124 . . . . 3.55 110.016 169.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.8 mt -54.86 -46.7 75.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 118.954 0.797 . . . . 1.07 110.375 168.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.55 -29.46 69.16 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 120.372 1.442 . . . . 2.32 113.655 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -77.44 -29.78 53.06 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.076 0.95 . . . . 1.41 113.401 170.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -64.57 -28.08 69.39 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.135 -0.978 . . . . 2.47 110.911 167.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.0 mt -87.82 -38.95 15.26 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.454 1.279 . . . . 1.29 114.454 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.15 -25.78 67.95 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.833 1.049 . . . . 3.12 113.833 -176.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.9 t -74.51 -25.81 59.59 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.534 0.734 . . . . 2.36 112.977 174.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.16 166.69 38.86 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.174 1.369 . . . . 1.3 113.323 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -90.63 31.19 1.06 Allowed 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.323 -1.104 . . . . 2.03 113.381 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -69.29 5.72 1.2 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.213 1.56 . . . . 3.52 115.213 -169.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.32 -22.3 66.9 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.108 -0.995 . . . . 1.6 111.486 166.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.87 -81.63 1.16 Allowed Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.881 1.705 . . . . 0.86 113.52 170.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.24 172.19 12.26 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.031 1.332 . . . . 1.69 114.582 -175.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -76.02 162.03 28.4 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 115.293 1.59 . . . . 4.0 115.293 -169.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -55.18 130.64 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.433 1.093 . . . . 2.51 110.526 172.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.36 -46.8 24.91 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 121.801 -0.562 . . . . 1.1 113.808 -177.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.0 p -160.73 141.26 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.864 2.066 . . . . 4.53 110.267 177.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.4 mt -84.84 147.67 49.16 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 121.466 -0.771 . . . . 2.61 112.744 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.58 158.02 51.57 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.232 1.954 . . . . 0.91 111.53 169.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.58 -19.6 65.98 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 120.708 -1.245 . . . . 2.03 113.023 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -89.54 0.77 56.68 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.576 1.95 . . . . 2.02 114.962 172.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.0 162.76 12.89 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.212 1.005 . . . . 0.67 111.852 168.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -156.25 171.46 20.16 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.376 1.47 . . . . 2.82 111.56 169.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -123.35 148.87 45.59 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.643 1.177 . . . . 2.08 110.592 -175.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.2 pt -137.24 137.01 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.683 1.193 . . . . 1.38 110.715 175.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.95 161.59 14.07 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.321 1.048 . . . . 1.45 111.005 171.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.01 15.84 62.12 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 121.315 -0.866 . . . . 0.52 114.747 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.13 140.99 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.457 1.503 . . . . 1.84 109.358 168.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -104.62 137.49 42.37 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.296 1.438 . . . . 1.56 113.321 -173.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -142.17 151.15 41.93 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.472 1.109 . . . . 2.73 112.922 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 m -122.37 145.75 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.962 2.105 . . . . 1.87 110.133 -176.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -86.61 145.94 26.53 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 122.301 1.048 . . . . 0.44 112.124 169.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 35.8 p -140.88 170.15 16.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.66 1.984 . . . . 1.45 112.223 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.36 -170.46 2.75 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 115.731 1.752 . . . . 1.91 115.731 174.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.9 p -54.85 -42.37 71.9 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.641 1.176 . . . . 2.8 111.646 171.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -88.94 20.03 3.8 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.974 1.31 . . . . 2.75 112.877 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.88 29.04 16.95 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.336 1.454 . . . . 0.75 111.781 175.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -84.41 141.57 30.75 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 125.927 1.691 . . . . 2.55 109.84 174.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.9 mt -78.69 125.31 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 109.356 -0.609 . . . . 1.83 109.356 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.3 pt -120.44 155.13 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.614 1.166 . . . . 1.03 114.118 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -86.38 166.11 15.83 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.372 1.869 . . . . 1.47 110.405 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -59.62 -21.36 60.31 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.921 1.452 . . . . 2.14 114.921 -174.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -90.86 4.52 51.58 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.894 1.277 . . . . 2.82 112.816 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.35 9.73 86.19 Favored Glycine 0 CA--C 1.533 1.195 0 O-C-N 120.523 -1.36 . . . . 0.55 114.866 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -69.47 143.99 53.37 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.588 1.194 . . . . 2.6 109.192 168.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.9 p -105.45 140.04 39.16 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.112 1.365 . . . . 1.77 111.765 -172.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.26 2.68 54.9 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.601 0.963 . . . . 1.7 113.601 -170.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.44 25.35 70.61 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.75 -1.219 . . . . 0.73 113.663 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 54.1 t -131.69 149.04 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.488 1.915 . . . . 2.34 109.397 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -130.03 158.16 40.36 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.999 2.52 . . . . 1.42 111.52 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.0 mt -135.94 128.37 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.631 1.572 . . . . 1.66 109.802 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -69.02 141.44 92.03 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 117.565 -1.207 . . . . 1.81 111.012 174.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -73.91 -22.13 17.75 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 CA-C-N 122.828 2.046 . . . . 0.8 113.236 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 68.6 mm-40 -93.29 -53.46 4.09 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 127.034 2.134 . . . . 1.45 112.158 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.9 p -78.29 -24.36 46.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.093 0.557 . . . . 1.9 112.381 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 53.8 17.27 1.24 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.721 1.209 . . . . 2.78 112.718 -171.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.46 138.2 31.68 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.021 0.928 . . . . 3.32 111.257 -174.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.0 mt -78.08 144.18 36.77 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.021 0.928 . . . . 1.04 111.394 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 95.2 p -72.72 3.93 4.58 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.892 1.071 . . . . 1.97 113.892 170.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.16 -153.85 13.04 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.719 1.152 . . . . 1.38 113.941 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.28 160.12 21.78 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.046 1.339 . . . . 1.9 112.712 176.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 mmt -51.42 140.95 24.13 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.57 1.548 . . . . 2.49 114.062 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.71 167.26 27.0 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 124.543 3.495 . . . . 0.95 114.242 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.37 -48.15 13.37 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 116.072 1.878 . . . . 1.72 116.072 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 46.1 p -134.11 10.84 3.88 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.408 1.083 . . . . 1.75 113.887 -169.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.95 152.74 7.09 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 116.062 1.875 . . . . 0.65 116.062 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.6 tpt -75.41 96.75 3.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.638 2.375 . . . . 1.77 111.889 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -150.81 150.27 30.75 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.711 1.204 . . . . 1.98 113.317 -174.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -160.74 161.89 32.31 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.624 1.17 . . . . 4.24 111.789 173.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.7 mp -93.37 152.14 19.32 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.154 0.982 . . . . 0.97 111.924 167.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.7 p -67.56 128.49 36.66 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 108.796 -0.816 . . . . 1.38 108.796 167.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -80.35 -60.31 2.37 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.569 0.951 . . . . 2.1 113.569 -173.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.51 -37.58 0.16 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.675 1.19 . . . . 2.07 111.254 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -121.56 -9.27 8.97 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.637 1.347 . . . . 3.83 114.637 176.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 164.95 -168.31 39.08 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.141 1.353 . . . . 0.7 112.619 -174.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.88 133.6 27.04 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.975 1.71 . . . . 1.89 112.713 169.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -90.05 134.08 34.45 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.984 1.713 . . . . 2.35 112.378 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -126.35 128.47 47.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.292 1.837 . . . . 2.96 108.353 173.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -83.01 122.56 28.46 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.511 -0.743 . . . . 1.68 110.989 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.9 p -103.56 -2.67 26.36 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.534 1.134 . . . . 1.81 113.265 -176.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.07 -17.85 8.12 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.802 1.241 . . . . 1.53 113.868 176.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -94.76 -17.34 22.26 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.595 1.958 . . . . 2.42 114.127 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -90.42 147.23 36.15 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 114.455 1.28 . . . . 0.88 114.455 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -84.27 170.5 10.68 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.796 2.997 . . . . 0.81 111.991 167.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.42 79.1 2.47 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.912 2.085 . . . . 1.39 112.607 -172.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.52 177.49 7.81 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.16 1.384 . . . . 1.92 110.797 -177.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -97.7 140.34 32.24 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 123.049 1.404 . . . . 3.67 112.08 171.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -129.04 177.73 6.92 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.87 1.668 . . . . 0.63 109.911 -173.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.79 152.74 40.02 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.375 1.07 . . . . 4.69 112.276 175.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.0 mp -115.76 134.23 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.055 0.942 . . . . 1.74 110.06 172.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -122.13 140.9 51.99 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.692 1.997 . . . . 3.26 110.535 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -107.42 114.22 28.09 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.697 1.199 . . . . 2.05 110.08 -175.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.5 mm -117.36 114.26 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.464 1.106 . . . . 1.76 109.854 -168.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -80.92 -13.64 58.72 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.381 1.252 . . . . 5.42 114.381 -171.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 56.1 p . . . . . 0 N--CA 1.473 0.705 0 CA-C-N 119.799 1.182 . . . . 2.49 113.742 177.369 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 113.476 0.917 . . . . 3.2 113.476 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.72 157.57 30.03 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.696 0.76 . . . . 1.45 111.767 170.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.57 151.65 57.18 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 126.579 1.951 . . . . 1.2 110.668 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -79.2 155.18 25.45 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.624 2.216 . . . . 0.63 111.301 -172.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 5.3 mt -109.48 133.19 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.492 1.117 . . . . 3.21 109.622 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -93.75 136.65 33.82 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.165 0.893 . . . . 3.63 111.137 168.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.0 tt -141.54 151.27 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.876 1.27 . . . . 1.81 111.471 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -121.09 157.53 29.89 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.306 1.842 . . . . 1.84 108.026 169.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 5.7 mt -65.41 155.39 85.27 Favored Pre-proline 0 CA--C 1.544 0.748 0 O-C-N 120.536 -1.353 . . . . 1.44 113.71 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -69.32 114.37 3.61 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.364 2.043 . . . . 1.07 111.825 -176.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 17.0 tp -122.01 22.99 10.16 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.323 1.849 . . . . 3.97 110.462 168.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -105.15 148.19 27.15 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.582 2.353 . . . . 3.22 110.65 -169.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -75.87 61.48 1.46 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.148 1.379 . . . . 4.11 111.976 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.0 m -122.01 158.22 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 127.541 2.336 . . . . 1.42 112.405 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 59.2 t -82.98 -37.07 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.889 0.875 . . . . 2.21 111.07 174.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -142.35 147.65 36.63 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.314 1.046 . . . . 2.99 110.684 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -98.57 144.41 27.91 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.576 0.751 . . . . 1.28 111.009 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -133.43 166.36 22.71 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.314 1.227 . . . . 0.94 114.314 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.57 146.64 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 127.089 2.156 . . . . 1.26 111.437 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -135.63 81.94 40.28 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 113.512 0.93 . . . . 3.49 113.512 -177.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -65.41 146.26 84.99 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.467 2.778 . . . . 0.89 113.345 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -124.2 -165.16 1.32 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.613 2.365 . . . . 3.57 110.823 -173.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -134.02 169.81 16.58 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.0 1.32 . . . . 3.6 110.579 168.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 13.6 t . . . . . 0 N--CA 1.474 0.745 0 C-N-CA 124.179 0.992 . . . . 2.22 110.724 -176.62 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 38.9 p . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 112.161 0.43 . . . . 1.9 112.161 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.6 p -98.5 -16.77 19.05 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.356 0.872 . . . . 2.36 113.356 174.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.8 t -144.92 167.55 22.37 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.022 1.729 . . . . 2.52 110.002 169.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.4 p -112.68 5.49 17.74 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.614 1.966 . . . . 1.79 114.416 -169.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.8 p -138.57 162.58 34.21 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.114 1.153 . . . . 3.45 114.114 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.67 146.7 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 126.516 1.926 . . . . 1.59 109.408 169.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -125.12 114.2 18.72 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.591 1.156 . . . . 2.29 110.401 -171.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.28 129.87 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 120.886 -1.134 . . . . 1.13 111.312 -175.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -128.92 101.9 6.28 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.092 1.357 . . . . 1.78 111.157 -172.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.23 123.66 24.95 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.654 -1.279 . . . . 2.45 111.548 -173.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.9 mt -106.04 156.42 18.41 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.129 1.372 . . . . 1.07 112.681 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.64 161.89 37.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.313 1.845 . . . . 2.44 109.912 175.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.8 162.14 13.27 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.682 0.793 . . . . 1.92 111.852 169.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.3 p -86.76 -27.48 23.59 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.252 0.834 . . . . 1.77 113.252 176.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -146.67 46.77 1.19 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.482 1.113 . . . . 3.13 113.025 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.0 7.19 88.19 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 125.186 1.374 . . . . 1.03 116.053 175.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.04 18.92 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 128.145 2.578 . . . . 1.88 115.731 -174.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -59.91 -31.51 69.9 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.497 -1.377 . . . . 0.99 112.315 -177.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.58 -52.84 63.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.75 1.62 . . . . 2.44 112.548 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -71.71 -39.62 70.02 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-O 118.033 -0.984 . . . . 2.88 111.583 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.2 mt -51.59 -55.04 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 119.266 0.939 . . . . 1.98 110.34 168.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.73 -32.01 71.29 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.643 1.11 . . . . 1.4 113.137 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -69.69 -27.26 64.86 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.786 1.032 . . . . 1.16 113.786 172.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -73.77 -28.71 61.8 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.764 0.711 . . . . 2.13 111.419 168.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.0 mt -85.1 -34.97 22.08 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.113 -0.992 . . . . 1.06 113.292 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -71.3 -25.47 62.44 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.236 0.828 . . . . 3.16 113.236 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.4 t -84.17 -24.13 30.3 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.274 1.03 . . . . 2.34 113.633 177.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.69 171.69 55.15 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.39 0.995 . . . . 1.26 113.233 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -85.35 34.01 0.57 Allowed 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.959 -1.319 . . . . 2.06 113.116 171.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -77.53 4.72 10.5 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 120.253 -1.529 . . . . 3.37 113.385 -170.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.56 -10.82 60.2 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.035 -1.041 . . . . 1.7 113.12 168.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.05 -74.07 0.26 Allowed Glycine 0 N--CA 1.474 1.178 0 CA-C-N 119.713 1.142 . . . . 1.22 113.033 169.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -68.73 159.35 32.41 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.158 1.383 . . . . 1.97 113.052 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -61.18 155.99 19.45 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.749 1.22 . . . . 3.1 113.199 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.2 t -56.83 117.95 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 109.077 -0.712 . . . . 1.85 109.077 172.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.77 -41.62 73.27 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.052 0.358 . . . . 0.97 112.908 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.1 t -138.51 123.95 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.29 1.036 . . . . 2.92 111.165 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt -92.46 144.14 28.36 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.069 1.348 . . . . 1.37 110.544 168.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.19 159.32 37.12 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.949 2.433 . . . . 0.81 112.0 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.84 -26.13 68.61 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.365 -0.835 . . . . 2.46 112.86 172.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.99 3.65 22.25 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.398 1.629 . . . . 2.3 115.398 172.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.68 153.98 20.04 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.823 1.249 . . . . 0.73 113.577 170.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -143.89 160.69 40.35 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.562 1.545 . . . . 2.6 111.641 169.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.96 139.54 50.04 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.268 1.027 . . . . 2.59 110.414 -174.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 20.2 pt -133.48 147.23 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 116.396 1.999 . . . . 2.63 116.396 -169.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.81 167.66 12.3 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.446 1.898 . . . . 1.74 110.14 167.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.99 17.78 62.43 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 116.242 1.257 . . . . 0.7 116.242 168.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.2 p -118.42 138.21 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.271 1.428 . . . . 1.59 110.832 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 8.9 tpp -96.84 134.91 39.54 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.14 1.376 . . . . 1.61 113.584 -177.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -137.12 148.49 46.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.332 1.453 . . . . 3.53 112.002 174.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.7 m -121.48 144.28 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.769 2.027 . . . . 1.57 109.766 -175.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -88.23 148.39 24.38 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 122.648 1.213 . . . . 0.48 112.754 171.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.9 p -143.93 172.79 12.38 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.848 2.059 . . . . 1.59 112.217 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -94.61 169.31 10.27 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.453 1.501 . . . . 1.68 112.242 168.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 67.9 p -62.66 -25.21 68.02 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.818 0.847 . . . . 2.67 112.702 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -74.78 7.31 3.19 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.686 1.594 . . . . 2.3 113.383 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . 0.252 0.3 OUTLIER 63.18 26.38 15.22 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.744 2.418 . . . . 0.64 114.291 179.217 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -88.77 145.04 25.85 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.655 1.582 . . . . 2.1 111.631 175.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.7 mt -80.83 128.72 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.342 0.657 . . . . 1.66 111.087 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.2 pp -121.44 149.35 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 115.045 1.498 . . . . 1.77 115.045 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -79.64 161.71 25.71 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 127.873 2.469 . . . . 2.37 110.598 169.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -58.39 -22.61 54.45 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.315 1.228 . . . . 2.3 114.315 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -90.52 3.71 53.21 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.306 1.043 . . . . 3.62 111.955 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.59 20.93 75.98 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 127.234 2.349 . . . . 0.51 115.471 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -75.25 137.39 41.18 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.074 -1.084 . . . . 3.1 108.074 167.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.6 p -93.74 135.17 35.31 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.945 0.898 . . . . 1.73 111.414 178.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.69 -4.84 59.27 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.954 1.094 . . . . 1.56 113.954 -168.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.02 25.96 56.65 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.265 0.936 . . . . 0.63 113.779 -176.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.8 t -130.36 146.7 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.886 1.674 . . . . 1.7 109.471 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -124.22 165.2 18.02 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.94 2.096 . . . . 3.86 111.183 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.7 mt -134.87 140.78 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.887 1.275 . . . . 1.66 109.841 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -76.31 137.91 68.02 Favored Pre-proline 0 CA--C 1.545 0.784 0 O-C-N 120.742 -1.224 . . . . 1.78 112.313 173.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.49 -11.46 20.61 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.061 1.841 . . . . 0.91 113.854 174.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.48 -53.79 3.11 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.945 1.698 . . . . 2.0 111.102 177.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 p -80.48 -25.38 38.87 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.859 0.864 . . . . 1.58 113.027 -174.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 59.13 15.89 4.43 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.771 1.629 . . . . 2.83 113.9 -172.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.51 152.0 19.45 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.21 1.004 . . . . 3.52 111.79 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.6 mt -78.56 145.21 34.95 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.682 1.593 . . . . 1.06 112.648 -174.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.1 p -72.25 -8.19 53.46 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.665 0.987 . . . . 1.59 113.665 173.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -171.9 -152.11 8.23 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.213 1.863 . . . . 0.97 111.848 -171.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.91 148.86 26.03 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.809 0.844 . . . . 1.99 113.024 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.6 tpt -52.96 128.69 47.38 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.945 1.698 . . . . 2.25 111.867 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.48 161.32 28.39 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.809 3.006 . . . . 0.87 114.441 -174.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.28 -61.79 1.89 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.272 1.829 . . . . 1.13 114.105 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.1 p -105.88 10.79 32.37 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.855 1.262 . . . . 1.77 114.266 -169.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.2 145.73 16.73 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.965 -1.084 . . . . 0.59 113.002 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.3 tpt -74.38 94.62 2.58 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.846 2.059 . . . . 1.67 110.574 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -148.71 140.15 23.4 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.462 1.105 . . . . 1.65 113.454 -169.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -160.04 160.96 33.82 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.482 1.113 . . . . 2.66 111.842 -175.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.4 mp -103.04 149.52 24.49 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.804 1.242 . . . . 2.07 112.214 173.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.9 p -66.83 132.05 47.2 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.759 -0.588 . . . . 1.34 109.997 171.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.84 -61.13 1.95 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.646 1.178 . . . . 2.47 113.79 -170.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -146.63 -34.43 0.28 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.999 1.319 . . . . 2.09 111.37 176.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -126.31 -17.97 5.05 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.524 1.305 . . . . 4.17 114.524 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 179.61 -166.28 35.45 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.57 1.081 . . . . 0.74 111.894 -172.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -145.25 134.32 22.67 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.869 1.668 . . . . 1.26 111.891 169.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -87.43 138.17 31.7 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.96 1.304 . . . . 2.38 112.858 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -128.51 130.02 46.88 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.162 2.185 . . . . 2.99 107.716 171.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -91.49 101.99 14.65 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.953 -1.092 . . . . 2.02 110.489 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.1 p -82.47 -0.54 46.86 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.118 1.367 . . . . 1.8 113.727 -172.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -55.48 -32.0 62.47 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.766 0.826 . . . . 1.52 112.987 172.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -83.66 -20.86 32.84 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.006 0.922 . . . . 2.28 112.682 -173.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.44 145.34 82.36 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 123.811 0.844 . . . . 0.84 113.009 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -74.49 168.45 24.79 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.658 2.239 . . . . 1.01 110.938 167.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.49 91.97 1.08 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.926 1.29 . . . . 1.25 110.359 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -149.51 175.17 11.74 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.884 0.85 . . . . 2.06 113.169 -174.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -94.15 147.19 23.4 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.385 1.874 . . . . 4.54 109.347 169.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -143.9 170.12 16.51 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.651 1.581 . . . . 0.55 110.438 -169.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.2 mttt -137.68 159.78 41.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.193 0.997 . . . . 3.19 113.127 171.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.7 mp -118.56 142.2 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.02 1.328 . . . . 1.84 109.899 172.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -129.58 147.21 51.36 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.435 1.894 . . . . 3.24 110.495 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -109.16 124.26 50.54 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.637 1.175 . . . . 1.87 111.26 -175.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 29.9 mm -128.09 98.96 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.921 0.888 . . . . 1.68 109.83 -169.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -73.12 4.32 4.54 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 115.064 1.505 . . . . 5.62 115.064 -172.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.475 0.816 0 O-C-N 120.548 -1.345 . . . . 2.39 112.406 172.249 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 113.121 0.785 . . . . 3.33 113.121 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.36 150.31 47.46 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.016 1.327 . . . . 1.19 113.323 174.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.51 153.71 52.07 Favored Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 124.515 1.126 . . . . 1.01 111.604 -178.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.15 130.26 12.96 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.879 2.386 . . . . 0.74 114.08 -166.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.409 HD13 ' H ' ' A' ' 166' ' ' ILE . 2.6 mp -94.12 130.35 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 125.677 1.591 . . . . 2.33 109.259 -173.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.6 129.88 54.95 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.716 1.206 . . . . 4.96 112.129 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.2 tt -137.73 156.45 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.206 1.402 . . . . 1.51 111.038 -169.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -139.89 148.91 42.72 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.794 1.238 . . . . 1.89 109.871 170.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 12.4 mt -62.68 153.67 77.54 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 116.152 1.908 . . . . 1.57 116.152 -168.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.1 116.73 4.82 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.84 2.36 . . . . 0.75 113.258 -170.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.6 tp -123.41 34.17 5.17 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.023 1.729 . . . . 3.34 111.061 166.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -116.44 157.53 24.99 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 128.499 2.719 . . . . 2.68 111.487 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.47 30.98 0.18 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.324 1.85 . . . . 4.13 114.445 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 30.2 m -93.81 155.09 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.287 1.435 . . . . 2.37 112.319 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 54.8 t -74.34 -35.95 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.185 0.994 . . . . 2.9 110.137 173.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -152.26 146.72 25.63 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.46 1.504 . . . . 3.44 110.643 -174.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -98.75 156.7 16.71 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.036 0.934 . . . . 1.47 112.304 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -136.71 162.02 34.32 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.04 1.496 . . . . 0.67 115.04 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.64 144.65 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 127.225 2.21 . . . . 0.95 110.815 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -134.94 76.48 58.88 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 113.96 1.096 . . . . 3.43 113.96 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -65.87 146.38 82.95 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.011 3.141 . . . . 0.73 114.468 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -140.0 167.27 22.5 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 128.699 2.8 . . . . 3.24 111.952 -169.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -117.51 167.03 11.66 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.656 1.354 . . . . 3.25 114.656 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 10.8 t . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 115.504 1.668 . . . . 2.47 115.504 -179.745 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 111.488 0.181 . . . . 2.39 111.488 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 65.8 p -82.81 -10.32 58.92 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 113.966 1.098 . . . . 2.65 113.966 176.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 t -151.89 163.17 39.81 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.705 2.002 . . . . 2.8 110.032 174.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.7 p -92.76 5.11 52.33 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.086 1.755 . . . . 2.43 114.252 176.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.9 p -151.26 164.86 35.66 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.23 1.196 . . . . 2.58 114.23 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.5 p -131.21 143.5 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.486 1.915 . . . . 1.46 109.964 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.7 m -110.74 112.62 24.61 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.676 0.79 . . . . 1.1 111.411 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -93.11 132.9 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.004 -1.06 . . . . 1.24 110.432 176.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -115.73 -173.93 2.43 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.69 1.596 . . . . 1.74 110.998 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -140.26 129.98 24.41 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 120.929 -1.107 . . . . 2.9 111.439 168.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.4 mt -111.84 146.06 38.34 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.749 1.219 . . . . 1.46 110.835 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.9 168.29 19.6 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.341 1.856 . . . . 2.64 111.186 176.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.57 145.58 40.08 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.788 1.235 . . . . 1.86 112.281 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.0 p -80.92 -32.54 34.62 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.318 1.229 . . . . 1.84 114.318 -173.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -114.45 -15.55 12.05 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 119.882 1.219 . . . . 2.37 113.295 175.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.68 11.08 1.95 Allowed Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.478 1.513 . . . . 1.5 115.413 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.66 24.23 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 130.175 3.39 . . . . 1.84 116.738 -169.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.94 -31.92 73.11 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 119.6 -1.937 . . . . 0.93 114.022 -174.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -71.3 -43.79 66.44 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.114 0.87 . . . . 2.52 111.727 -175.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt -72.44 -38.85 68.19 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.267 -0.896 . . . . 5.1 111.939 175.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.6 mt -52.68 -48.17 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 119.471 1.032 . . . . 1.02 109.956 167.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.1 -34.83 75.57 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 121.092 -1.005 . . . . 1.26 113.453 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -65.33 -39.28 92.22 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.794 0.838 . . . . 1.57 112.069 171.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.15 -23.82 64.92 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.972 -1.08 . . . . 2.68 112.841 177.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.1 mt -91.28 -32.24 15.8 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.315 1.228 . . . . 1.18 114.315 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -70.61 -20.59 62.74 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.065 1.135 . . . . 2.96 114.065 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.7 t -78.86 -21.26 47.79 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.986 0.914 . . . . 2.44 113.375 169.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.55 172.32 53.44 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.544 1.068 . . . . 1.32 112.909 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -94.74 21.57 7.3 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.036 -1.273 . . . . 2.32 112.348 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -70.87 18.05 0.06 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.421 1.488 . . . . 3.56 114.962 -170.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.98 -23.15 55.3 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 120.814 -1.179 . . . . 1.66 110.249 166.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -114.86 -57.35 0.36 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.52 1.057 . . . . 1.03 113.684 172.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -81.68 162.81 22.87 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.952 1.301 . . . . 3.15 113.381 -172.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -63.54 151.94 40.01 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.056 0.762 . . . . 3.39 113.056 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 71.7 t -66.32 120.48 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 122.844 0.458 . . . . 1.96 109.895 172.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.59 -37.9 33.89 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 114.83 0.692 . . . . 1.1 114.83 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.6 t -142.61 116.59 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 118.387 1.093 . . . . 2.99 111.041 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.8 mt -83.23 144.36 46.75 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.842 1.257 . . . . 2.35 111.621 170.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.09 161.46 38.48 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.914 2.409 . . . . 0.96 112.371 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.2 -8.84 42.4 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.039 1.126 . . . . 2.03 114.039 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.2 p30 -98.87 -3.92 34.24 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.548 1.539 . . . . 2.65 114.496 171.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.22 158.83 17.02 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.778 1.029 . . . . 0.72 113.778 174.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.9 pttt -150.38 169.04 22.37 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.809 1.643 . . . . 3.28 111.741 167.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -124.37 130.62 52.82 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.013 1.325 . . . . 2.63 112.146 -174.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.0 pt -121.81 151.46 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.075 0.95 . . . . 2.18 113.397 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.98 156.02 29.27 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.263 1.425 . . . . 2.29 111.97 171.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.57 12.93 42.8 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.09 1.328 . . . . 0.74 115.654 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 p -86.02 148.12 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 119.228 1.514 . . . . 1.98 110.679 169.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -105.64 137.75 42.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.483 1.513 . . . . 1.55 112.565 176.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.67 157.79 44.31 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.097 1.359 . . . . 2.8 112.441 173.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 m -125.62 147.35 30.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 126.771 2.028 . . . . 1.58 110.083 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -89.91 149.08 22.77 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.397 1.079 . . . . 0.42 112.975 171.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.7 p -144.8 167.71 21.94 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.409 1.884 . . . . 1.64 112.618 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -90.83 171.54 9.25 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.199 1.0 . . . . 2.22 112.074 167.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 66.9 p -61.04 -23.53 65.5 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.154 -0.966 . . . . 2.35 113.577 -177.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -70.86 4.83 2.29 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 126.222 1.809 . . . . 3.95 114.003 169.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.26 27.79 14.2 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.916 2.087 . . . . 0.66 112.964 -172.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -86.01 138.61 31.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.458 1.503 . . . . 2.53 110.414 177.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.3 mt -81.2 129.33 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.139 0.495 . . . . 2.2 110.164 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.2 pt -123.86 154.27 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 114.567 1.321 . . . . 1.06 114.567 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -84.84 159.44 20.39 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.972 2.109 . . . . 1.49 108.37 166.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -62.8 -8.69 7.34 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.862 1.801 . . . . 2.29 115.862 -172.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -91.31 -1.22 57.7 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.556 1.143 . . . . 3.45 112.706 172.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.34 3.72 84.27 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.65 1.595 . . . . 0.5 114.476 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -68.14 140.38 56.17 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.813 1.245 . . . . 2.61 109.1 173.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 16.2 p -103.56 146.07 29.1 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.594 0.758 . . . . 1.87 112.077 -173.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.62 -11.02 25.84 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.983 0.734 . . . . 2.06 112.983 -169.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.74 21.91 48.67 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.706 1.146 . . . . 1.06 114.616 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.3 p -138.57 146.19 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.626 1.57 . . . . 4.02 110.262 -173.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -127.89 155.04 44.8 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 128.087 2.555 . . . . 1.45 111.364 -172.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 61.4 mt -126.96 142.85 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.97 1.308 . . . . 1.58 110.849 -174.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -76.23 132.69 72.86 Favored Pre-proline 0 CA--C 1.54 0.565 0 O-C-N 120.611 -1.306 . . . . 2.4 110.57 170.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -70.09 -8.46 23.67 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.074 1.849 . . . . 1.52 114.819 174.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -106.98 -47.55 3.68 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.06 1.344 . . . . 1.62 112.346 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.7 p -87.86 -23.16 24.07 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.131 0.972 . . . . 1.88 113.331 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 55.52 17.07 2.09 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.896 1.678 . . . . 2.92 114.146 -169.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.64 156.46 20.68 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.909 -1.119 . . . . 3.23 111.387 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 mt -98.1 146.44 25.55 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.701 1.2 . . . . 1.17 112.623 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 90.7 p -73.1 3.3 5.69 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.204 1.002 . . . . 1.5 113.475 171.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.55 -157.75 16.03 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.689 2.09 . . . . 1.09 111.306 -172.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.02 155.27 27.69 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 117.96 0.88 . . . . 2.13 112.159 174.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.63 131.66 88.53 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.796 0.838 . . . . 2.76 110.701 175.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.18 156.26 46.76 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 125.197 3.931 . . . . 1.42 115.634 -172.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.29 -62.67 1.28 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.745 1.618 . . . . 1.4 114.383 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.8 p -102.26 5.9 40.29 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.804 1.409 . . . . 2.19 114.804 -168.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.85 149.86 10.78 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.0 1.111 . . . . 0.74 114.0 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.1 ttt -76.62 90.74 3.37 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.031 1.732 . . . . 1.74 111.629 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -141.81 144.62 34.02 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.552 1.541 . . . . 2.46 111.97 -173.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -166.47 156.73 12.1 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 126.337 1.855 . . . . 3.06 111.028 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.9 mp -97.49 148.8 22.86 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.168 1.173 . . . . 0.8 114.168 174.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.7 p -64.45 124.6 22.23 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 121.354 -0.841 . . . . 1.18 111.34 170.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -80.41 -57.6 3.52 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.373 -0.83 . . . . 2.2 112.457 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -173.06 -51.37 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.727 2.811 . . . . 1.89 107.963 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -74.18 20.9 0.1 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.121 2.168 . . . . 6.15 113.962 173.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.04 -152.31 31.21 Favored Glycine 0 CA--C 1.538 1.53 0 N-CA-C 110.526 -1.03 . . . . 0.86 110.526 -165.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -135.33 130.93 35.79 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.587 1.955 . . . . 1.25 109.625 169.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -93.82 139.69 30.56 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.479 0.711 . . . . 2.59 112.87 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -125.56 124.59 41.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.171 2.589 . . . . 2.93 107.893 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -85.58 100.11 11.72 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.423 -0.798 . . . . 1.73 110.074 -174.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 73.1 p -78.66 -6.68 56.37 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.139 -0.975 . . . . 1.71 113.48 -175.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -51.25 -27.1 8.32 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.568 1.147 . . . . 1.7 113.459 175.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -92.98 -10.39 36.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.641 1.576 . . . . 2.52 113.697 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -89.59 148.42 40.14 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 120.182 1.356 . . . . 2.05 114.163 170.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.18 170.18 13.74 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.937 3.092 . . . . 0.84 112.293 168.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.56 63.91 2.14 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.958 2.103 . . . . 1.53 114.397 -170.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -125.54 178.33 5.71 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.756 1.622 . . . . 1.54 112.941 -175.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -87.58 151.66 22.81 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.271 1.428 . . . . 3.37 110.807 168.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -145.39 171.37 14.72 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.666 1.987 . . . . 0.59 109.253 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -137.83 148.31 45.35 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.725 0.81 . . . . 2.86 112.648 170.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.4 mp -105.44 138.28 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.247 1.019 . . . . 1.66 109.747 171.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -123.65 131.58 53.65 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.405 1.882 . . . . 3.24 110.25 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -95.36 104.51 16.41 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.777 0.831 . . . . 2.26 110.635 -173.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 38.9 mm -113.0 94.5 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.998 0.919 . . . . 1.78 109.611 -169.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -84.45 12.54 6.7 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.537 0.94 . . . . 5.52 113.537 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.0 m . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 114.021 1.119 . . . . 2.79 114.021 176.556 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 114.032 1.123 . . . . 3.01 114.032 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.41 166.59 22.92 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.568 1.547 . . . . 1.38 111.808 169.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.44 144.97 54.53 Favored Pre-proline 0 N--CA 1.483 1.211 0 O-C-N 120.541 -1.349 . . . . 0.93 112.224 176.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.08 151.88 61.94 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.584 3.522 . . . . 0.58 114.255 -167.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.1 mp -114.19 125.68 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.742 1.217 . . . . 1.96 111.139 -169.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -86.78 136.22 33.07 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.006 1.322 . . . . 3.03 111.578 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.7 tt -144.78 150.14 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 125.227 1.411 . . . . 1.63 111.741 -177.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -127.0 149.25 49.98 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.87 1.268 . . . . 2.26 110.031 169.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 13.3 mt -61.44 142.56 93.86 Favored Pre-proline 0 CA--C 1.548 0.868 0 O-C-N 120.778 -1.201 . . . . 1.58 112.771 -176.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -71.54 99.29 0.92 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.961 3.108 . . . . 1.02 114.273 -167.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 1.2 tt -116.58 39.42 3.16 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.14 1.776 . . . . 3.37 108.053 167.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -104.93 172.72 6.64 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.552 2.341 . . . . 3.46 111.378 -168.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -76.35 40.17 0.21 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.098 0.959 . . . . 3.87 113.561 169.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.7 m -121.24 144.54 29.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.106 1.362 . . . . 1.5 112.699 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.9 p -64.87 -45.4 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.937 2.095 . . . . 4.78 113.375 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -156.22 156.77 34.69 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.686 1.995 . . . . 2.98 110.956 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -103.6 146.63 28.28 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.815 1.413 . . . . 1.28 114.815 -168.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -135.44 168.52 19.07 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.745 1.387 . . . . 0.8 114.745 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.5 t -137.88 139.96 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.524 1.53 . . . . 0.95 112.027 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -131.76 86.15 49.34 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 125.688 1.595 . . . . 3.4 112.548 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -71.14 147.4 53.98 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.574 3.516 . . . . 0.81 113.59 172.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -131.68 176.42 8.35 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.644 2.378 . . . . 2.81 111.386 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -111.9 174.52 5.84 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.614 1.566 . . . . 2.79 112.121 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.477 0.887 0 N-CA-C 113.862 1.06 . . . . 2.35 113.862 173.514 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.4 p . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 122.254 1.026 . . . . 2.22 113.38 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.3 p -110.08 -1.12 17.7 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.659 1.984 . . . . 2.35 113.138 175.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -164.1 157.72 18.51 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.638 1.575 . . . . 2.52 111.095 -178.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.9 p -112.78 -6.23 13.85 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.404 1.882 . . . . 1.98 115.555 -170.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 94.4 p -148.18 166.13 28.82 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.728 2.011 . . . . 2.8 112.517 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.96 136.75 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.23 1.812 . . . . 1.58 110.343 177.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.5 m -104.69 112.33 25.37 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.366 0.603 . . . . 1.87 110.725 176.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 p -93.19 125.84 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.723 1.209 . . . . 1.14 109.679 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -105.19 -170.23 1.72 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.307 1.843 . . . . 1.73 110.81 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -148.72 127.53 12.59 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.246 -1.534 . . . . 2.89 113.889 170.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.9 mt -118.59 160.56 21.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.86 1.264 . . . . 1.35 113.181 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.7 mt -145.41 165.12 29.44 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 128.002 2.521 . . . . 2.16 109.572 168.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.97 165.8 16.43 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.758 -0.589 . . . . 1.46 112.224 169.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.5 p -89.12 -35.98 15.98 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.508 0.929 . . . . 2.13 113.508 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -141.77 50.38 1.56 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.614 1.166 . . . . 2.11 111.637 174.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.2 14.68 76.27 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 116.621 1.408 . . . . 1.17 116.621 173.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.89 15.69 0.1 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.999 2.119 . . . . 2.4 115.633 -177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.4 mmt -61.09 -27.81 68.63 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 119.824 -1.798 . . . . 1.13 112.887 -177.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -66.93 -38.17 85.67 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.314 0.961 . . . . 2.15 113.178 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -81.74 -38.69 25.3 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.605 -1.309 . . . . 3.34 112.582 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 89.1 mt -54.46 -47.83 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 119.915 1.234 . . . . 1.01 110.796 168.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.74 -34.96 73.63 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 120.242 -1.536 . . . . 1.1 112.557 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -71.23 -34.83 71.16 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.321 1.048 . . . . 1.13 112.759 172.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -62.97 -36.07 82.27 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.339 0.972 . . . . 2.05 112.225 171.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.3 mt -82.07 -41.21 20.89 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.173 0.805 . . . . 1.21 113.173 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -68.26 -25.68 65.3 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.527 1.058 . . . . 3.34 113.384 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 t -78.28 -16.44 57.77 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.148 0.979 . . . . 3.06 113.055 174.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.32 163.7 32.96 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 127.172 2.32 . . . . 1.32 113.993 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -88.8 33.86 0.78 Allowed 'General case' 0 N--CA 1.478 0.953 0 O-C-N 120.866 -1.373 . . . . 2.56 112.409 172.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -73.98 0.18 14.35 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.031 -1.043 . . . . 3.42 113.466 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.94 -30.0 63.63 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.996 -1.065 . . . . 2.11 110.815 167.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.02 -49.67 0.62 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 123.933 0.777 . . . . 0.71 113.194 169.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -75.67 158.51 32.26 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.348 1.24 . . . . 3.41 114.348 -169.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.18 159.88 33.14 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.559 -0.713 . . . . 4.5 110.29 165.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.31 127.2 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 116.54 -0.3 . . . . 1.19 110.259 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.94 -48.7 25.75 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.826 -0.546 . . . . 1.04 113.243 -176.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.4 t -137.32 127.97 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.048 1.339 . . . . 2.7 110.147 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.5 mt -85.57 143.7 38.95 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.731 0.813 . . . . 1.59 110.567 169.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.85 162.6 37.14 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.219 1.946 . . . . 0.76 111.958 172.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.36 -19.22 65.75 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.266 -0.896 . . . . 1.93 112.682 172.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -87.12 0.06 55.89 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.662 1.585 . . . . 2.95 115.0 174.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.81 146.4 25.97 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 114.429 1.27 . . . . 0.65 114.429 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -130.72 149.04 52.56 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.461 2.704 . . . . 3.54 111.614 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -123.4 137.57 54.79 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.409 1.484 . . . . 2.26 112.684 -175.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.3 pt -141.29 149.17 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.375 1.47 . . . . 1.56 112.136 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -108.51 169.56 8.57 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.563 1.545 . . . . 1.45 111.698 169.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.45 20.93 55.76 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.376 0.989 . . . . 0.68 115.53 175.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.5 p -88.09 149.52 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 118.422 1.111 . . . . 1.98 109.736 168.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -107.66 137.6 45.4 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.932 1.293 . . . . 1.75 112.164 175.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -141.11 156.92 45.9 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.893 1.277 . . . . 2.93 112.633 172.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.5 m -122.04 147.01 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 126.874 2.07 . . . . 1.67 109.874 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -89.09 148.18 23.83 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 122.582 1.182 . . . . 0.34 113.12 169.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.1 p -142.6 168.56 19.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.806 2.042 . . . . 1.52 112.246 178.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -88.71 172.93 8.88 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.734 0.814 . . . . 2.05 112.924 168.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.1 p -57.77 -27.97 63.54 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.378 1.071 . . . . 2.56 113.426 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -90.24 24.07 2.67 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.692 1.197 . . . . 2.76 113.79 172.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.54 25.25 14.06 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.562 2.345 . . . . 0.59 115.15 173.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -83.09 139.49 33.19 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.281 -0.887 . . . . 1.94 109.499 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.7 mt -75.76 128.68 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 118.457 0.571 . . . . 1.53 109.821 174.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.4 pt -122.02 155.68 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 123.181 1.467 . . . . 2.13 114.613 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -87.01 164.44 16.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.003 1.721 . . . . 1.66 110.234 167.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.15 2.27 1.22 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.135 1.774 . . . . 2.65 115.351 -176.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -107.0 5.17 27.85 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.71 2.404 . . . . 3.21 113.319 169.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.48 6.32 80.39 Favored Glycine 0 CA--C 1.532 1.153 0 O-C-N 120.073 -1.642 . . . . 0.68 114.011 -176.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -68.8 139.32 55.26 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 117.905 0.852 . . . . 2.2 109.226 169.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.3 p -101.29 139.7 36.61 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.382 1.073 . . . . 2.03 110.778 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.99 -9.98 54.27 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.296 1.221 . . . . 1.66 114.296 -168.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.48 21.62 47.34 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.897 1.237 . . . . 0.94 113.414 -173.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.7 t -130.48 148.17 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.688 1.595 . . . . 2.58 109.512 -177.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -127.9 159.35 35.19 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.334 1.854 . . . . 4.18 111.802 174.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 73.5 mt -131.41 127.85 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.978 1.311 . . . . 1.55 110.658 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.61 136.74 94.88 Favored Pre-proline 0 N--CA 1.476 0.833 0 CA-C-O 117.986 -1.007 . . . . 1.85 111.081 174.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -69.76 -20.31 35.0 Favored 'Trans proline' 0 C--N 1.352 0.756 0 CA-C-N 122.082 1.779 . . . . 0.81 112.774 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -96.42 -43.65 7.55 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.254 1.422 . . . . 1.22 112.553 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 p -86.29 -25.33 25.53 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.099 0.96 . . . . 1.95 112.61 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 52.65 24.42 3.14 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.34 1.456 . . . . 2.8 113.329 -171.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.63 157.64 16.8 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.888 -1.133 . . . . 3.27 111.578 -177.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.2 mt -94.38 146.96 23.69 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.256 1.422 . . . . 2.19 113.028 -169.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.0 p -72.07 -7.64 50.03 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.236 1.199 . . . . 1.74 114.236 173.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.87 -158.45 10.04 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 128.165 2.793 . . . . 0.97 110.446 177.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.59 166.7 21.62 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 119.411 1.605 . . . . 2.19 112.274 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 mmt -51.16 143.3 17.13 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 125.229 1.411 . . . . 2.18 113.882 -177.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.7 165.41 26.89 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 124.166 3.244 . . . . 0.9 114.526 174.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.37 -52.19 6.75 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.138 1.775 . . . . 1.13 115.001 -177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.9 p -109.18 -3.12 17.52 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.107 1.363 . . . . 2.12 114.477 -169.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.68 151.18 2.47 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.186 1.394 . . . . 0.6 114.069 -173.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.4 ttt -76.13 89.56 3.05 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.404 1.082 . . . . 1.83 111.139 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -146.01 123.13 11.47 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.044 1.737 . . . . 2.15 113.896 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -164.73 145.32 7.65 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.532 1.133 . . . . 3.98 111.221 -169.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.36 157.19 17.24 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.081 1.512 . . . . 0.83 115.081 -171.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 80.1 p -72.97 139.52 46.76 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.34 -0.85 . . . . 2.0 112.993 169.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.63 -54.97 3.06 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 116.152 1.908 . . . . 2.46 116.152 -169.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.09 -40.57 0.15 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.628 1.171 . . . . 1.66 110.837 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -116.17 -26.15 7.33 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.795 1.035 . . . . 3.8 113.795 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.33 -163.31 34.74 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.62 1.105 . . . . 0.75 110.73 -169.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -137.17 130.75 31.54 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.345 1.858 . . . . 1.19 110.54 173.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.7 ttpt -82.02 134.98 35.4 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.36 0.527 . . . . 2.67 110.922 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -122.78 130.87 53.42 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.95 2.1 . . . . 3.51 108.211 173.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -85.05 121.77 28.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.513 1.125 . . . . 3.2 110.503 -176.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 46.0 p -109.38 -3.81 16.83 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.743 1.386 . . . . 1.61 114.743 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.94 -19.69 19.43 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.385 1.474 . . . . 1.57 114.944 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.02 -4.29 20.66 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.848 1.259 . . . . 3.23 113.613 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.25 141.83 54.16 Favored Pre-proline 0 CA--C 1.535 0.386 0 O-C-N 121.006 -1.059 . . . . 0.8 111.233 167.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.56 168.29 24.74 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.633 2.222 . . . . 0.75 110.928 168.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.71 91.88 0.64 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.955 1.702 . . . . 1.24 109.697 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -147.9 -178.64 6.38 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.415 1.086 . . . . 1.54 111.077 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -97.17 153.98 17.66 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.253 1.421 . . . . 5.53 110.792 168.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -146.01 170.21 17.1 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.226 1.81 . . . . 0.58 109.893 -169.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -138.89 145.98 40.56 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.354 0.872 . . . . 2.54 113.354 174.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.2 mp -104.1 135.97 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.483 1.113 . . . . 1.55 110.075 173.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -119.86 128.02 53.27 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.101 1.761 . . . . 3.17 110.062 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -87.85 109.89 20.1 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.678 0.791 . . . . 1.92 110.3 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 41.5 mm -116.5 87.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.188 0.995 . . . . 1.77 108.605 -173.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . 0.283 7.6 p80 -94.91 44.2 1.1 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.195 -0.941 . . . . 4.52 112.492 -178.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.7 p . . . . . 0 N--CA 1.475 0.809 0 C-N-CA 125.897 1.679 . . . . 2.46 112.743 169.637 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 113.014 0.746 . . . . 2.99 113.014 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.46 159.73 19.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.143 0.973 . . . . 1.4 112.807 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.6 m -116.6 144.99 34.31 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 125.119 1.368 . . . . 1.12 109.549 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.18 139.69 42.9 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.445 2.097 . . . . 0.61 112.646 -167.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 3.0 mp -105.28 129.33 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.424 1.09 . . . . 2.03 111.187 -168.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -89.17 133.61 34.34 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.475 1.51 . . . . 4.57 112.619 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.3 tt -141.71 156.92 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 125.779 1.632 . . . . 1.76 111.188 -175.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -132.65 152.15 51.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.531 1.532 . . . . 2.03 109.983 173.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.63 155.98 46.89 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 113.001 0.741 . . . . 1.33 113.001 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.26 96.88 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.086 1.857 . . . . 1.15 111.643 -169.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 28.7 tp -124.5 59.18 1.19 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 104.361 -2.459 . . . . 3.39 104.361 166.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -139.5 151.67 46.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.283 2.633 . . . . 3.86 109.334 -166.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -82.26 41.01 0.67 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.185 0.994 . . . . 3.35 113.286 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.9 m -110.45 138.88 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 125.57 1.548 . . . . 1.91 111.419 -175.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.97 -46.92 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.261 1.824 . . . . 4.59 112.281 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -153.07 152.89 31.85 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 127.336 2.255 . . . . 3.23 110.571 174.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -92.98 149.42 21.24 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.081 0.953 . . . . 1.86 112.644 -173.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -139.28 167.26 22.48 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 115.128 1.529 . . . . 0.6 115.128 175.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.34 139.06 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.032 1.733 . . . . 1.12 110.644 172.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -130.8 81.09 68.32 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 126.235 1.814 . . . . 4.17 109.357 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.98 159.59 52.01 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 125.107 3.871 . . . . 0.97 112.731 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -125.77 -157.63 0.8 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.33 1.852 . . . . 3.2 112.582 -167.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -143.54 167.14 22.94 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 130.473 3.509 . . . . 3.88 107.953 174.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 12.7 t . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 113.244 0.831 . . . . 2.4 113.244 174.444 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 111.928 0.344 . . . . 1.85 111.928 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.8 p -93.9 -7.08 44.12 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.347 1.24 . . . . 2.14 114.347 -173.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 t -152.43 154.42 35.52 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.625 1.97 . . . . 2.7 109.135 166.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.6 p -95.27 4.91 53.01 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 127.341 2.256 . . . . 2.02 114.856 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.1 m -153.19 154.19 34.23 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 120.069 -1.644 . . . . 2.78 113.195 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -129.53 147.0 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 127.793 2.437 . . . . 1.44 110.537 -175.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.4 m -113.55 117.7 32.39 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.082 0.953 . . . . 1.36 110.806 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.91 135.82 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.685 0.794 . . . . 2.26 109.513 172.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -114.08 -179.25 3.58 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.25 1.82 . . . . 1.9 111.006 -176.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -138.02 118.24 13.6 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 120.534 -1.354 . . . . 3.36 112.176 165.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.6 mt -107.28 152.93 23.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.222 1.409 . . . . 1.16 111.19 177.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.6 mt -144.25 172.23 13.2 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.143 1.777 . . . . 2.04 110.422 169.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.04 164.21 12.27 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.675 1.19 . . . . 1.41 112.272 170.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.4 p -90.98 -23.33 20.44 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.691 1.367 . . . . 1.78 114.691 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -139.15 41.45 2.09 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.861 1.21 . . . . 2.38 112.073 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.9 14.32 82.29 Favored Glycine 0 CA--C 1.536 1.362 0 O-C-N 120.796 -1.19 . . . . 0.94 114.971 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.42 19.85 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.94 2.496 . . . . 2.38 116.067 -175.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.1 mmt -62.83 -28.39 69.98 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 119.592 -1.942 . . . . 1.01 114.33 -171.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -71.84 -45.77 60.29 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.405 1.002 . . . . 2.7 112.999 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -67.49 -35.98 80.2 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.693 -1.255 . . . . 2.77 111.677 173.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.6 mt -58.41 -44.91 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 119.306 0.957 . . . . 1.03 110.547 167.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.405 ' HA ' ' HE3' ' A' ' 183' ' ' LYS . . . -59.68 -37.04 77.69 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.372 -1.455 . . . . 2.23 112.489 177.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -68.28 -35.89 78.54 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.631 0.772 . . . . 0.97 112.484 170.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -63.03 -19.3 64.24 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 119.431 1.014 . . . . 1.9 113.179 170.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 25.8 mt -101.76 -36.2 8.79 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.745 1.757 . . . . 1.03 115.745 177.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -64.24 -24.42 67.66 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.583 1.083 . . . . 2.34 112.503 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.9 t -74.01 -20.24 60.38 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.5 2.32 . . . . 2.12 114.45 175.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.64 172.16 27.07 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.547 1.07 . . . . 1.03 113.743 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -84.18 29.15 0.58 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.633 1.173 . . . . 2.48 113.02 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -75.42 3.88 8.36 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.928 1.455 . . . . 3.21 114.928 -168.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.66 -26.53 68.71 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.034 -1.042 . . . . 1.73 111.577 168.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.86 -82.02 1.36 Allowed Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.56 1.076 . . . . 0.97 112.993 174.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.5 163.03 28.23 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.436 1.273 . . . . 1.93 114.436 -172.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -55.64 152.78 8.8 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.306 1.042 . . . . 3.08 113.058 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.8 t -69.9 98.37 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 107.915 -1.143 . . . . 1.25 107.915 169.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.38 -25.74 75.21 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.229 0.443 . . . . 2.07 114.191 -173.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.5 t -141.13 125.04 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.444 1.498 . . . . 2.6 109.037 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.5 mt -92.62 160.2 34.94 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 126.08 1.752 . . . . 1.63 111.079 169.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.17 166.89 28.76 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 121.413 1.409 . . . . 1.02 111.169 168.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.43 -20.74 58.68 Favored 'General case' 0 CA--C 1.548 0.865 0 O-C-N 120.864 -1.147 . . . . 2.23 113.296 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.0 p30 -79.68 -4.79 53.33 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.558 1.543 . . . . 2.82 114.406 170.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.75 154.31 20.38 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 113.997 1.11 . . . . 0.77 113.997 174.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.8 pttt -145.92 161.75 39.34 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.71 2.004 . . . . 3.39 112.066 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -133.45 123.57 25.52 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.608 1.163 . . . . 2.23 112.424 -169.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.7 pt -120.98 143.63 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.151 0.98 . . . . 2.05 112.129 -177.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -114.49 163.41 15.4 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.654 1.181 . . . . 1.68 112.263 173.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.75 3.74 55.99 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.101 1.81 . . . . 0.72 115.919 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.0 p -83.03 145.85 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 125.733 1.613 . . . . 1.7 112.127 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -101.83 136.25 41.99 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.599 1.56 . . . . 1.7 113.46 175.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -141.41 158.5 43.79 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.621 1.568 . . . . 2.78 112.319 173.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.2 m -124.18 146.16 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 126.873 2.069 . . . . 1.76 109.726 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -87.41 148.03 25.17 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 122.312 1.053 . . . . 0.52 112.283 170.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.3 p -142.46 171.26 14.3 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.601 1.96 . . . . 1.75 112.952 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.21 -176.44 3.42 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 115.279 1.585 . . . . 1.98 115.279 174.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 47.3 p -57.73 -30.99 66.0 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.037 -1.04 . . . . 2.31 113.187 175.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -86.98 18.22 3.68 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.806 1.242 . . . . 2.4 113.192 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.97 22.09 4.14 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.288 1.835 . . . . 0.57 113.634 -176.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -77.7 140.36 39.53 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.867 1.267 . . . . 2.1 110.31 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.7 mt -79.79 124.5 37.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.082 -0.71 . . . . 1.66 109.082 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.6 pt -123.55 157.19 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 114.23 1.196 . . . . 1.09 114.23 -174.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -89.96 166.0 13.74 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.364 1.466 . . . . 1.67 110.221 167.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.35 5.43 1.31 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.978 1.711 . . . . 2.06 115.332 -171.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -112.96 4.42 16.76 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 128.291 2.636 . . . . 2.74 112.841 172.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.55 10.72 84.92 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.682 1.134 . . . . 0.58 114.666 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -75.37 138.57 41.83 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.082 1.441 . . . . 2.33 110.066 168.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.8 140.57 37.91 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.095 0.958 . . . . 1.87 112.339 -173.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -95.21 6.28 49.46 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 115.647 1.721 . . . . 2.06 115.647 -166.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.1 28.64 61.91 Favored Glycine 0 CA--C 1.533 1.177 0 O-C-N 121.248 -0.908 . . . . 0.64 113.73 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.7 t -137.64 149.52 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.579 1.152 . . . . 1.74 109.9 175.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -132.97 153.41 51.47 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 129.011 2.924 . . . . 1.33 110.906 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 51.9 mt -131.93 128.83 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.924 1.289 . . . . 1.99 112.034 -173.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -70.6 141.0 87.31 Favored Pre-proline 0 N--CA 1.477 0.907 0 CA-C-O 117.423 -1.275 . . . . 2.1 111.84 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -73.84 -24.53 15.34 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 CA-C-N 122.355 1.877 . . . . 0.99 112.967 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -91.13 -38.11 12.95 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.53 1.532 . . . . 1.22 113.104 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.4 p -93.62 -27.72 16.42 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.0 0.92 . . . . 1.65 113.19 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 55.13 19.91 3.07 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.271 1.428 . . . . 3.67 112.932 -169.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.59 147.09 25.46 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.575 1.15 . . . . 3.94 111.69 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.3 mt -88.78 141.39 28.55 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.645 1.578 . . . . 1.14 112.73 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.0 p -75.25 10.63 1.48 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.353 1.061 . . . . 1.61 113.746 172.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.39 -155.21 13.87 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.552 2.025 . . . . 1.11 111.632 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -96.4 163.97 12.83 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.357 1.463 . . . . 1.78 112.698 175.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.5 mmt -51.58 139.32 29.16 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 114.289 1.218 . . . . 2.27 114.289 -176.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -78.41 163.89 26.83 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 124.617 3.544 . . . . 0.88 113.78 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.45 -67.31 0.7 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.222 1.193 . . . . 1.11 114.222 174.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.5 p -101.83 4.88 40.77 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 115.884 1.809 . . . . 1.74 115.884 -167.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.82 147.76 11.35 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.682 1.364 . . . . 0.69 114.682 -175.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.8 ttt -73.08 95.04 1.98 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.517 1.927 . . . . 1.94 111.561 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.6 pttp -147.07 137.58 23.57 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.803 1.641 . . . . 2.09 111.65 -174.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -161.55 158.18 25.99 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.605 1.562 . . . . 2.69 110.211 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -96.25 150.04 20.98 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.908 1.447 . . . . 0.8 114.908 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.0 p -65.73 134.99 54.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.35 -0.844 . . . . 1.33 111.968 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -94.26 -65.04 1.01 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.778 1.399 . . . . 2.3 114.778 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.72 -45.91 0.1 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.053 0.941 . . . . 1.47 111.666 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -93.49 -35.32 13.01 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.854 0.462 . . . . 4.13 111.648 173.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 176.42 -149.96 10.17 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.216 1.389 . . . . 1.04 111.034 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -137.16 129.05 29.04 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.947 1.699 . . . . 1.78 110.492 169.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -90.09 138.33 31.6 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.318 1.047 . . . . 4.13 112.286 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -130.34 130.87 45.0 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 128.591 2.756 . . . . 3.37 109.214 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -88.37 123.76 33.26 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.772 1.229 . . . . 2.35 109.677 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.2 p -109.81 2.65 20.08 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.062 1.345 . . . . 1.69 113.342 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.26 -21.72 9.87 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 115.13 1.53 . . . . 2.21 115.13 -176.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -108.36 -9.56 15.44 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.808 1.04 . . . . 2.35 113.808 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.04 149.0 92.09 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 120.481 1.492 . . . . 0.84 113.313 175.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -83.91 168.8 12.1 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.898 3.066 . . . . 0.87 111.344 167.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.39 90.46 2.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.847 2.059 . . . . 1.28 110.567 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -147.3 179.24 7.79 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.416 1.086 . . . . 1.97 111.743 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -90.13 152.49 21.1 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.99 0.916 . . . . 4.47 110.618 167.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -142.74 176.86 8.72 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.132 1.773 . . . . 0.56 109.441 -173.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.89 155.88 43.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.006 0.922 . . . . 4.31 113.199 175.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.6 mp -121.98 134.53 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.172 0.989 . . . . 1.67 110.618 172.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -122.28 135.1 54.68 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.411 1.885 . . . . 3.26 111.148 -176.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -86.84 109.66 19.44 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.822 0.849 . . . . 2.77 110.931 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 28.3 mm -116.64 92.29 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.871 0.868 . . . . 1.96 108.76 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -83.14 2.4 35.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.518 1.127 . . . . 6.13 113.854 -174.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.9 p . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 115.087 1.514 . . . . 2.2 115.087 -174.418 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 114.799 1.407 . . . . 3.64 114.799 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.55 137.05 47.76 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.993 1.717 . . . . 1.28 110.157 168.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.54 148.55 37.67 Favored Pre-proline 0 N--CA 1.481 1.097 0 CA-C-N 119.629 1.104 . . . . 0.99 112.386 174.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -72.56 140.46 32.93 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.65 2.233 . . . . 0.75 111.202 -173.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 4.6 mt -88.52 127.27 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.611 0.765 . . . . 2.75 110.377 -171.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -86.25 127.96 34.83 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.371 1.468 . . . . 3.67 109.573 168.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.3 tt -144.23 147.67 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 119.087 0.858 . . . . 1.83 112.951 -173.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -124.8 149.38 47.46 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.927 1.691 . . . . 2.06 109.513 169.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 28.1 mt -64.74 162.06 39.75 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 114.377 1.251 . . . . 1.74 114.377 -171.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.66 98.32 1.2 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.011 2.474 . . . . 0.82 111.893 -173.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.2 tt -123.05 62.29 1.01 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 104.823 -2.288 . . . . 3.24 104.823 167.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -140.67 156.82 46.13 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.907 2.083 . . . . 3.33 108.853 -168.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -70.33 17.62 0.06 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.966 1.839 . . . . 3.92 115.966 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.7 m -95.97 144.32 10.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 124.367 1.067 . . . . 1.47 112.886 -168.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 50.8 t -73.69 -36.66 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.935 -0.478 . . . . 2.21 110.739 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -140.29 131.29 26.19 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.195 1.398 . . . . 2.61 110.763 -170.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -97.11 140.97 30.82 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.971 0.908 . . . . 1.4 112.396 -176.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -137.19 166.48 23.63 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.106 1.521 . . . . 0.67 115.106 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.43 137.32 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.64 1.976 . . . . 1.18 113.152 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -131.01 89.8 41.34 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.502 1.521 . . . . 3.09 111.58 -177.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.87 154.36 71.13 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.157 3.238 . . . . 1.16 112.819 175.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' A' ' 53' ' ' ALA . 36.3 mtmm -133.17 163.07 30.11 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.207 1.403 . . . . 2.43 112.772 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -100.68 146.61 26.98 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.615 2.366 . . . . 3.71 110.328 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.486 1.349 0 N-CA-C 113.788 1.033 . . . . 2.29 113.788 171.357 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.5 tmt? . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 119.925 -0.083 . . . . 24.21 110.835 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -96.61 113.33 24.88 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.032 0.933 . . . . 21.61 111.522 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.6 t -106.6 21.52 17.33 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.316 1.846 . . . . 18.74 113.263 -175.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.31 -4.78 27.87 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 115.913 1.82 . . . . 17.02 115.913 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.0 m 65.2 146.84 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.493 2.317 . . . . 13.75 113.351 -168.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.57 5.89 6.71 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.484 1.114 . . . . 13.94 113.551 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.75 176.34 12.23 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.9 2.48 . . . . 11.57 110.068 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.8 t -70.26 128.19 35.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.107 1.763 . . . . 10.64 114.081 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.1 m -127.4 154.32 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 126.758 2.023 . . . . 8.29 111.97 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 38.2 -142.41 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.167 2.187 . . . . 4.21 115.422 169.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 56.1 -158.28 0.24 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 127.308 2.243 . . . . 6.03 115.449 168.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.05 23.22 6.59 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.778 2.031 . . . . 5.95 115.993 -174.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.09 -2.42 10.14 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.875 1.702 . . . . 2.67 115.418 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 47.0 p -139.75 167.57 21.81 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.919 1.688 . . . . 1.91 113.914 -175.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.7 p -90.58 -6.17 55.0 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.776 1.23 . . . . 2.24 113.01 175.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 m -156.5 153.93 29.54 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.223 2.209 . . . . 3.01 109.455 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.1 p -109.54 4.49 22.28 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.306 1.595 . . . . 1.93 115.306 -170.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 m -147.58 161.38 41.24 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.275 1.83 . . . . 2.4 112.501 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.42 141.69 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 126.513 1.925 . . . . 1.42 109.869 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.3 m -111.3 114.83 28.29 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.474 0.654 . . . . 1.04 109.916 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 p -93.17 128.51 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.256 1.022 . . . . 1.94 109.274 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -107.23 -177.85 3.47 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.152 1.381 . . . . 1.79 110.118 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -139.14 122.7 17.36 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.753 -1.217 . . . . 2.8 111.124 168.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.7 mt -107.94 154.24 21.9 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.106 0.962 . . . . 2.06 110.936 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.26 167.37 22.6 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.843 1.657 . . . . 2.58 110.092 176.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.38 158.34 16.13 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.751 0.821 . . . . 1.24 112.249 170.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.1 p -80.72 -41.13 24.11 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.413 1.085 . . . . 1.79 112.485 174.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -131.66 38.03 3.6 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.3 1.04 . . . . 2.68 112.996 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.72 12.29 82.99 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.228 1.394 . . . . 0.88 115.264 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -71.65 18.17 0.08 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.474 2.31 . . . . 1.95 116.075 -171.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.21 -26.03 66.07 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.377 -1.452 . . . . 0.9 113.025 -175.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.45 -50.51 63.11 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.926 1.29 . . . . 2.33 112.709 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -68.34 -39.93 81.72 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.849 -1.157 . . . . 3.08 112.219 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -53.96 -49.42 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.417 1.008 . . . . 0.95 111.123 171.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.05 -23.71 67.26 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.477 -1.389 . . . . 2.06 113.424 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -82.17 -30.07 31.2 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.308 -0.87 . . . . 1.12 112.822 169.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -70.67 -11.87 61.21 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.61 1.564 . . . . 2.07 113.516 168.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.3 mt -106.65 -31.81 8.3 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.774 1.63 . . . . 1.09 114.256 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.47 -22.31 66.73 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 120.461 1.482 . . . . 2.41 113.176 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 t -71.16 -31.08 67.24 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.436 1.094 . . . . 2.0 112.466 171.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.4 162.62 35.02 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.247 0.927 . . . . 0.89 113.22 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -83.23 30.58 0.46 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.936 -1.332 . . . . 1.77 112.813 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -71.78 19.23 0.07 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.124 1.898 . . . . 3.26 116.124 -168.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.16 -27.85 62.85 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.367 1.067 . . . . 1.41 109.802 164.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.23 -63.79 0.26 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.211 1.386 . . . . 0.73 113.341 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -78.82 158.92 28.07 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.177 1.547 . . . . 1.85 115.177 -171.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -70.76 135.74 48.4 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.997 1.719 . . . . 4.13 112.991 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 80.0 t -54.38 110.57 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.883 0.873 . . . . 1.05 111.246 -174.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.72 -25.21 60.89 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 114.708 0.643 . . . . 1.11 114.708 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 p -142.07 104.11 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.528 1.131 . . . . 5.33 111.89 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.1 mt -89.79 146.8 36.12 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 126.966 2.107 . . . . 1.73 111.451 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.27 158.21 19.96 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.282 2.654 . . . . 0.62 113.18 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.37 -22.9 63.69 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.877 -1.139 . . . . 2.12 112.356 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -79.34 0.5 28.71 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.946 1.298 . . . . 1.95 114.28 169.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.32 157.85 16.48 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.743 1.217 . . . . 0.63 112.599 168.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -150.84 172.02 16.3 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.178 1.791 . . . . 2.46 111.206 173.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -126.54 146.82 49.99 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.287 1.435 . . . . 2.25 111.028 -174.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.1 pt -136.65 130.67 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 114.042 1.127 . . . . 1.45 114.042 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.7 156.86 17.78 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.725 0.81 . . . . 1.38 111.71 169.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.4 15.78 56.5 Favored Glycine 0 CA--C 1.537 1.43 0 N-CA-C 116.102 1.201 . . . . 0.62 116.102 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.5 p -90.14 145.78 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-N 120.153 1.977 . . . . 1.91 109.125 167.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 1.8 tpp -102.42 137.69 40.33 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.701 1.2 . . . . 1.43 111.798 174.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.66 153.71 47.35 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 122.188 0.994 . . . . 2.92 112.875 170.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.7 m -118.71 146.39 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 C-N-CA 126.948 2.099 . . . . 1.55 109.125 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -87.64 147.03 25.45 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.433 1.111 . . . . 0.33 111.926 169.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.2 p -141.49 173.65 11.3 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.328 1.851 . . . . 1.62 112.098 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.53 177.6 4.97 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.78 1.632 . . . . 1.81 113.407 172.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.0 p -68.18 -20.76 64.89 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.978 1.103 . . . . 1.95 113.978 -171.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -97.97 26.46 5.21 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.602 1.561 . . . . 2.5 112.834 169.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 62.26 23.98 14.24 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.226 2.21 . . . . 0.56 114.349 169.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -84.38 140.38 31.61 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.069 0.948 . . . . 2.55 111.117 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.7 mt -76.86 126.09 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.193 -0.669 . . . . 1.63 109.193 176.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 pt -117.86 156.91 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 114.57 1.322 . . . . 1.12 114.57 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -85.27 165.4 17.36 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.232 1.413 . . . . 1.44 110.741 167.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -64.95 2.86 0.64 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 128.05 2.54 . . . . 3.05 115.904 -174.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -117.54 -3.5 11.34 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 127.59 2.356 . . . . 2.98 114.276 172.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.05 5.8 59.4 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.362 1.458 . . . . 0.81 116.443 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -72.33 137.34 46.58 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.092 1.946 . . . . 2.63 110.454 170.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.9 p -96.36 134.23 39.76 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.603 1.161 . . . . 2.0 111.662 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.7 -0.95 57.27 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.538 1.681 . . . . 1.79 115.538 -167.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.86 15.61 69.84 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-N 119.214 0.915 . . . . 0.72 113.931 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.0 t -125.08 147.1 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.938 1.295 . . . . 1.7 109.293 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -133.55 157.85 44.65 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 128.115 2.566 . . . . 1.33 110.138 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 55.8 mt -136.03 134.23 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.931 1.292 . . . . 1.61 110.53 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -73.09 135.02 80.26 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 121.072 -1.017 . . . . 1.8 110.308 173.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -66.71 -22.92 49.42 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.573 2.182 . . . . 1.67 113.816 172.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -96.9 -45.06 6.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.916 1.686 . . . . 1.35 112.762 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.8 p -90.71 -22.98 20.85 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.61 1.164 . . . . 1.8 113.565 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 53.39 19.46 1.63 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.75 1.62 . . . . 3.54 113.846 -170.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.41 146.65 30.18 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.745 -1.222 . . . . 3.77 111.524 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.3 mt -90.29 135.66 33.54 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.215 1.406 . . . . 1.11 111.288 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 92.2 p -66.23 -0.58 2.62 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.382 1.252 . . . . 1.54 114.382 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.38 -152.8 9.08 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 126.39 1.948 . . . . 0.93 112.218 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.1 162.65 15.21 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.113 1.365 . . . . 1.59 113.439 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.3 mmt -54.01 128.12 55.53 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.75 1.22 . . . . 2.35 113.055 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -72.08 163.42 38.83 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.106 3.204 . . . . 0.74 113.129 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.41 -81.24 0.09 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.165 0.986 . . . . 1.07 112.127 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 78.1 p -83.58 2.05 39.14 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 116.07 1.878 . . . . 1.95 116.07 -167.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -49.87 149.17 2.74 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.382 1.473 . . . . 0.59 114.974 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.1 tpt -77.52 98.11 5.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.784 2.034 . . . . 1.67 111.256 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -150.14 147.78 28.17 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.413 1.485 . . . . 1.96 112.221 -172.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -166.82 156.96 11.53 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 125.392 1.477 . . . . 2.56 111.241 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 mp -94.68 150.4 20.26 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.481 1.289 . . . . 0.79 114.481 172.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 16.7 p -63.84 134.52 55.35 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.323 -0.86 . . . . 1.26 112.058 170.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -92.3 -54.41 3.82 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.464 1.653 . . . . 2.19 115.464 -171.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.73 -37.7 0.08 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.902 1.281 . . . . 1.7 111.509 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -119.65 -22.52 6.87 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.073 1.138 . . . . 5.25 114.073 171.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 175.87 -159.09 26.43 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.686 1.612 . . . . 0.73 111.117 -170.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -147.06 133.64 19.84 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.589 1.955 . . . . 1.18 111.967 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -86.77 137.42 32.45 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.506 1.122 . . . . 2.38 113.088 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -128.97 124.07 34.08 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.495 2.318 . . . . 2.91 108.556 174.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -77.49 128.75 34.72 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.354 -0.841 . . . . 3.12 110.201 175.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 66.8 p -105.73 -10.74 16.59 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.796 1.776 . . . . 1.64 115.796 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.64 -33.95 16.88 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.798 1.181 . . . . 1.72 114.014 -172.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -16.37 44.27 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.807 1.643 . . . . 3.15 113.291 -176.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -72.18 144.18 86.91 Favored Pre-proline 0 C--O 1.237 0.434 0 CA-C-N 119.976 1.262 . . . . 0.85 112.166 173.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.45 167.1 27.92 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.357 2.038 . . . . 0.78 110.47 167.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.38 93.77 1.98 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.149 1.38 . . . . 1.2 109.609 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -152.71 -178.29 6.78 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.945 0.898 . . . . 1.57 112.427 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -91.13 152.39 20.61 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.392 1.877 . . . . 4.29 111.956 168.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -149.27 170.96 17.3 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.661 2.385 . . . . 0.52 110.372 -170.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -138.63 160.86 38.56 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.424 1.09 . . . . 2.58 113.337 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.2 134.46 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.357 1.463 . . . . 1.76 110.065 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -122.14 137.38 54.84 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.475 1.51 . . . . 3.21 111.569 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -104.69 100.61 10.26 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.907 1.683 . . . . 2.63 110.469 -169.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 28.2 mm -106.84 113.88 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.613 1.165 . . . . 1.84 110.653 -167.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -87.1 22.82 1.95 Allowed 'General case' 0 CA--C 1.553 1.09 0 O-C-N 120.936 -1.102 . . . . 4.88 112.854 -178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.2 m -88.45 -21.84 24.01 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.578 1.325 . . . . 2.33 114.578 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.32 150.46 20.83 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.456 1.103 . . . . 2.57 109.421 170.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 95.0 p -59.23 116.54 3.96 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 122.805 1.288 . . . . 6.44 112.941 -170.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.7 t -106.49 169.77 8.32 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.832 2.053 . . . . 6.31 111.12 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -59.91 146.99 40.22 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.695 -1.253 . . . . 7.94 111.42 170.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 67.9 t -75.41 93.68 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.571 1.148 . . . . 5.3 110.809 -174.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -106.24 -37.58 2.46 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.513 1.054 . . . . 2.38 113.44 172.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -71.75 8.37 1.19 Allowed 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 116.674 2.101 . . . . 4.91 116.674 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -117.38 31.76 6.54 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.963 1.305 . . . . 5.36 112.688 -171.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 91.4 12.43 59.78 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.167 1.365 . . . . 4.4 115.514 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.3 176.46 9.28 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.646 1.178 . . . . 3.06 113.399 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.4 -2.6 0.74 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 115.725 1.75 . . . . 3.86 115.725 172.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.0 mt -79.68 152.98 29.64 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.966 1.257 . . . . 2.8 112.122 170.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 23.4 m -91.49 -34.2 14.89 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.8 1.407 . . . . 3.8 114.8 -168.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.06 20.65 79.21 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-N 119.195 0.907 . . . . 2.85 114.228 -169.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.9 p -77.96 142.27 38.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.957 1.303 . . . . 3.21 112.219 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -63.64 128.39 35.59 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.775 1.23 . . . . 2.95 112.441 174.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.55 147.1 28.82 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.514 1.126 . . . . 1.46 111.06 168.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.36 147.88 34.62 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 123.282 0.633 . . . . 1.08 110.449 170.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.29 159.28 52.3 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.708 2.939 . . . . 0.71 113.365 -173.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -109.07 148.11 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.514 1.126 . . . . 2.99 111.467 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.58 148.45 41.9 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.789 1.636 . . . . 4.83 111.252 168.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.6 tt -151.56 146.81 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 124.157 0.983 . . . . 1.55 111.705 -174.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -122.97 142.92 50.3 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.555 1.542 . . . . 1.84 109.495 169.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 23.4 mt -64.79 149.61 95.85 Favored Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 113.808 1.04 . . . . 1.53 113.808 -170.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.54 110.72 2.36 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.269 2.646 . . . . 0.76 113.832 -169.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.45 60.88 1.4 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.569 2.348 . . . . 3.39 106.016 166.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -151.66 147.86 27.25 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.981 2.112 . . . . 3.1 109.896 -166.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -72.48 23.41 0.06 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 126.075 1.75 . . . . 4.01 114.679 -174.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.4 m -76.28 149.51 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 120.434 -1.417 . . . . 1.31 111.759 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 88.7 t -78.96 -35.7 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.733 0.813 . . . . 2.93 111.405 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -145.42 148.56 33.45 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.67 1.988 . . . . 3.0 109.747 173.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -94.66 141.74 28.26 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.952 0.797 . . . . 1.83 111.916 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -138.85 170.54 15.8 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.348 1.24 . . . . 0.68 114.348 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.27 141.26 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 125.201 1.401 . . . . 1.11 112.845 -177.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.38 83.28 59.73 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 124.729 1.212 . . . . 3.45 113.844 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -67.96 138.39 44.04 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.36 3.374 . . . . 0.67 113.068 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -124.6 163.23 22.38 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.176 1.79 . . . . 2.96 112.57 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -103.56 164.74 11.47 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.826 1.25 . . . . 2.86 110.774 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 7.2 t -141.34 -20.1 0.77 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.042 1.127 . . . . 2.95 114.042 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -78.85 154.97 29.38 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.744 1.618 . . . . 6.7 110.615 167.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -119.04 170.23 9.22 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.312 1.445 . . . . 8.43 112.093 176.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.49 148.66 64.4 Favored Pre-proline 0 N--CA 1.479 0.994 0 O-C-N 121.226 -0.921 . . . . 14.7 112.628 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.52 139.95 32.22 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.632 2.222 . . . . 10.39 112.818 -175.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -87.0 -6.99 58.57 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.119 1.526 . . . . 15.25 115.119 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.425 HD13 ' H ' ' A' ' 191' ' ' ILE . 4.2 mp -74.39 -44.38 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.807 1.243 . . . . 13.51 111.205 -178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.1 mt -87.13 127.6 35.13 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.314 1.446 . . . . 14.07 112.572 -171.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 . . . . . 0 N--CA 1.473 0.723 0 C-N-CA 124.521 1.128 . . . . 19.07 113.763 -178.292 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.6 mpp? . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 110.411 -0.218 . . . . 23.67 110.411 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . 0.259 51.7 mt-10 65.26 150.55 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.959 2.503 . . . . 26.14 115.529 -170.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.9 m 62.45 -27.6 0.07 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 129.214 3.006 . . . . 23.87 117.615 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.47 148.21 43.52 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.203 1.365 . . . . 18.58 113.333 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.5 m -73.68 -27.63 61.33 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.947 1.462 . . . . 17.09 114.947 -173.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -147.22 172.0 14.5 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.98 1.312 . . . . 12.9 113.56 -173.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.24 163.51 12.54 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.813 1.645 . . . . 9.8 112.444 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 t -52.47 144.21 13.85 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.887 1.275 . . . . 8.45 112.201 171.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.3 m -67.72 150.43 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 113.995 1.109 . . . . 8.03 113.995 -168.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -84.52 157.54 21.26 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.719 1.207 . . . . 4.82 113.579 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.84 137.76 23.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.121 1.369 . . . . 4.42 111.486 173.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.66 109.24 20.99 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.704 1.202 . . . . 6.29 111.23 -172.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.48 44.54 3.18 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.797 1.665 . . . . 2.68 112.547 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.0 p -144.66 167.04 23.49 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.39 1.476 . . . . 1.89 113.997 -167.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 78.0 p -91.8 -9.13 44.62 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.629 1.172 . . . . 2.51 114.149 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.7 t -147.88 154.67 40.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.875 1.67 . . . . 2.39 109.405 169.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.7 p -98.27 -0.62 43.62 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.918 1.687 . . . . 1.84 114.32 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.4 m -151.68 158.9 44.04 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.312 1.445 . . . . 2.62 110.607 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.68 141.9 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 126.39 1.876 . . . . 1.79 109.317 177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 m -115.76 121.77 43.45 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.508 0.723 . . . . 1.31 110.307 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -103.37 131.61 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.683 1.193 . . . . 1.16 110.998 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -130.32 100.39 5.36 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.11 1.364 . . . . 1.88 110.82 -172.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.417 ' HE3' ' CD2' ' A' ' 43' ' ' LEU . 6.9 tmtm? -74.81 120.88 20.95 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.788 -1.195 . . . . 2.72 110.916 -174.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.3 mt -106.84 153.45 22.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.952 1.301 . . . . 1.22 112.195 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.417 ' CD2' ' HE3' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -141.65 171.77 13.6 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.965 1.706 . . . . 2.45 110.894 176.158 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.35 158.49 16.43 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.171 1.388 . . . . 1.46 112.219 170.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.4 p -81.01 -25.59 37.11 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.39 1.256 . . . . 1.83 114.39 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -149.64 38.04 0.75 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.427 1.091 . . . . 3.58 112.64 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.09 10.35 75.13 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 116.44 1.336 . . . . 1.34 116.44 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.13 14.62 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 129.128 2.971 . . . . 2.18 116.632 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -26.13 68.61 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.283 -1.51 . . . . 0.93 113.087 -170.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -72.12 -43.37 64.82 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.626 1.103 . . . . 2.04 113.103 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -70.22 -41.86 73.06 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.465 -1.397 . . . . 3.22 111.746 172.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.9 mt -54.07 -44.2 62.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.333 1.053 . . . . 1.09 112.231 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.88 -31.17 69.54 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 120.967 1.712 . . . . 1.28 112.768 176.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -76.03 -35.76 59.36 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.969 0.908 . . . . 1.47 112.86 171.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -63.15 -22.87 67.15 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.179 0.991 . . . . 2.2 112.97 170.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.3 mt -91.93 -41.48 10.56 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.097 1.147 . . . . 1.25 114.097 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.65 -18.9 65.37 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.781 1.173 . . . . 4.13 113.692 -175.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.8 t -75.68 -23.37 56.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.655 1.182 . . . . 2.42 113.883 172.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.64 157.68 21.32 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.346 0.974 . . . . 1.27 112.578 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -77.37 43.28 0.38 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.474 1.11 . . . . 2.03 113.031 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -78.74 13.37 1.69 Allowed 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.516 -1.365 . . . . 3.42 113.971 -170.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.83 -17.63 58.88 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.237 1.415 . . . . 1.67 111.155 165.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.82 -74.07 0.14 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.738 1.161 . . . . 0.93 112.792 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.42 161.33 29.92 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.41 1.263 . . . . 1.79 114.41 -173.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.04 158.67 27.75 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.898 1.073 . . . . 4.18 113.898 -173.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.02 119.44 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.894 -0.504 . . . . 1.12 110.175 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.28 -29.33 45.62 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.828 0.728 . . . . 1.36 114.15 -176.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.9 t -146.15 125.92 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.259 1.423 . . . . 2.91 111.41 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.2 mt -96.88 134.46 23.01 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.903 1.681 . . . . 2.49 110.771 167.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.86 160.49 43.29 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.042 1.828 . . . . 0.78 111.42 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.26 -21.82 66.78 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.836 -1.165 . . . . 2.1 113.715 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -88.3 -5.01 58.59 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.659 1.584 . . . . 2.45 114.443 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.3 155.16 20.77 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.108 0.867 . . . . 0.78 111.113 168.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.6 pttt -152.46 170.01 21.18 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.396 1.078 . . . . 2.4 111.83 169.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -120.32 137.78 54.07 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.905 1.682 . . . . 2.02 108.718 -172.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.7 pt -126.24 131.98 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 120.018 1.281 . . . . 2.14 113.464 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.76 160.06 14.92 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.0 1.32 . . . . 1.71 111.286 169.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.03 16.11 68.21 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.086 0.851 . . . . 0.57 115.089 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.3 p -101.85 141.71 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.491 1.516 . . . . 1.78 110.288 169.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.7 tpp -99.88 141.8 32.21 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.524 1.53 . . . . 1.76 112.642 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -144.32 149.44 36.21 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.146 1.378 . . . . 2.77 111.471 173.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.8 m -120.44 146.13 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.584 1.953 . . . . 1.65 109.41 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -87.21 144.49 26.8 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.882 1.325 . . . . 0.47 110.903 168.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.7 p -137.35 170.46 16.05 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.127 2.171 . . . . 1.5 110.473 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -87.26 171.8 10.36 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.491 -0.755 . . . . 2.09 111.651 167.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.5 t -61.46 -24.59 66.67 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.06 -1.025 . . . . 3.99 113.275 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -69.42 10.37 0.35 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 127.274 2.23 . . . . 3.29 115.048 169.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.43 22.55 5.09 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 128.144 2.578 . . . . 0.69 113.354 -172.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -83.06 136.27 34.54 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.481 1.512 . . . . 2.23 111.068 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.6 mt -73.99 127.26 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 109.65 -0.5 . . . . 1.69 109.65 175.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.2 pt -120.09 150.28 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 115.174 1.546 . . . . 1.03 115.174 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.45 159.57 28.19 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.081 2.153 . . . . 2.1 109.298 165.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -64.32 -15.01 59.47 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.595 1.332 . . . . 2.05 114.595 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -92.63 4.24 54.04 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.62 1.168 . . . . 3.48 111.993 174.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.61 5.54 81.64 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 126.47 1.986 . . . . 0.48 115.376 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -67.96 143.72 55.5 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.222 1.011 . . . . 2.5 109.859 171.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.6 p -103.58 136.04 44.05 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.539 1.135 . . . . 1.54 111.198 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.26 -8.98 58.87 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.022 1.119 . . . . 2.01 114.022 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.32 19.73 56.39 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.341 0.972 . . . . 0.72 113.53 -174.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.52 147.6 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.873 1.269 . . . . 1.77 110.213 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.11 160.7 30.4 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.86 2.464 . . . . 1.57 110.81 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.4 mt -133.88 134.83 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.388 1.475 . . . . 1.76 111.32 -175.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.04 139.04 87.56 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 117.725 -1.131 . . . . 2.4 111.314 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -71.4 -27.46 19.22 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 CA-C-N 122.095 1.784 . . . . 1.31 112.839 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -86.98 -48.59 7.99 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.582 1.153 . . . . 1.72 111.736 -175.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.8 p -91.05 -24.35 20.07 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.426 1.09 . . . . 2.17 113.356 -174.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 53.45 29.31 8.72 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 125.174 1.39 . . . . 4.05 112.162 -167.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.76 153.07 17.94 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.396 1.479 . . . . 3.12 111.535 174.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.8 mt -94.46 151.82 19.07 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.768 1.627 . . . . 1.15 113.303 -169.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.3 p -73.42 -2.77 23.74 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.558 0.947 . . . . 1.65 113.558 168.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.82 -147.92 6.05 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 126.861 2.172 . . . . 0.91 112.515 -169.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.7 175.72 6.92 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.542 1.537 . . . . 1.72 113.671 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.6 mmt -64.41 138.04 97.31 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.521 1.128 . . . . 2.52 112.273 173.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -86.1 150.48 9.47 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 124.105 3.203 . . . . 0.82 113.564 -174.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.1 -54.08 8.56 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.431 1.271 . . . . 1.14 114.431 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 64.8 p -107.91 -1.61 20.54 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.871 1.434 . . . . 1.82 114.871 -168.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.14 149.39 2.87 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 115.035 1.495 . . . . 0.57 115.035 -173.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.5 tpt -75.96 99.39 4.53 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.099 2.159 . . . . 1.7 111.186 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -153.6 147.14 25.02 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.201 1.4 . . . . 2.03 112.594 -173.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -164.69 158.17 17.49 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.63 1.572 . . . . 2.37 110.626 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -98.65 149.98 22.24 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.47 1.108 . . . . 0.86 112.523 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.0 p -65.57 128.53 36.29 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.834 0.743 . . . . 1.42 109.861 170.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.23 -55.14 4.34 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.012 1.115 . . . . 2.06 114.012 -173.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.35 -43.69 0.14 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.16 1.384 . . . . 1.62 110.565 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -113.88 -25.45 8.6 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.5 0.926 . . . . 3.81 113.5 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 177.24 -166.8 37.61 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.249 0.928 . . . . 0.84 111.865 -169.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.98 142.01 34.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.878 1.671 . . . . 1.32 112.137 169.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -92.69 138.01 31.87 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.133 1.373 . . . . 2.03 113.185 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -128.71 125.98 39.11 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.519 1.928 . . . . 3.41 109.106 173.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -88.42 108.53 19.42 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 118.953 0.797 . . . . 1.7 111.054 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.6 p -93.98 0.61 56.13 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.092 1.357 . . . . 1.85 113.764 -174.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.97 -8.84 3.49 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.095 1.516 . . . . 1.97 115.095 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -102.12 -21.78 14.35 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.15 1.38 . . . . 2.81 113.134 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -79.03 147.68 70.32 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 113.251 0.834 . . . . 0.94 113.251 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.59 166.98 21.38 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.965 2.443 . . . . 0.86 111.605 168.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.86 86.01 3.43 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.629 1.972 . . . . 1.15 111.857 -172.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -147.11 -175.53 4.86 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.823 0.849 . . . . 2.0 111.678 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -93.34 142.68 27.04 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.751 1.22 . . . . 3.25 113.868 170.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -135.72 169.12 18.05 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.342 2.257 . . . . 0.59 110.029 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -137.95 152.91 49.41 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.526 0.73 . . . . 2.58 112.809 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.0 mp -112.12 138.9 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.166 0.986 . . . . 1.37 110.023 173.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -128.47 131.04 48.36 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.79 1.636 . . . . 3.13 110.229 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -95.11 78.92 3.54 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.038 0.935 . . . . 1.92 111.448 -171.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.6 mm -82.95 101.66 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.519 0.727 . . . . 1.77 110.17 -174.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -80.66 -1.44 42.47 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.422 1.267 . . . . 5.92 114.422 -175.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 58.2 p -75.99 -15.36 60.17 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.288 -1.507 . . . . 2.03 115.057 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.38 -47.73 26.19 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.714 1.143 . . . . 3.0 112.581 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.2 t -168.12 140.6 3.03 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.905 2.082 . . . . 5.93 108.949 -176.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.3 m -134.74 146.76 49.72 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.174 1.176 . . . . 6.97 114.174 -175.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -75.77 168.8 19.34 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 130.205 3.402 . . . . 6.68 112.12 169.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 93.0 t -68.71 120.59 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 O-C-N 120.776 -1.203 . . . . 6.49 109.816 172.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -165.19 -51.24 0.02 OUTLIER Glycine 0 CA--C 1.526 0.749 0 N-CA-C 115.87 1.108 . . . . 2.46 115.87 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.03 -7.04 25.79 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 119.106 1.453 . . . . 4.53 113.347 173.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.13 4.81 0.81 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 130.046 3.338 . . . . 6.06 115.709 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 105.23 2.07 41.46 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.59 1.566 . . . . 5.32 114.842 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -77.82 174.87 10.53 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.646 1.578 . . . . 4.23 113.776 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 22.5 p -69.5 41.36 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 127.283 2.233 . . . . 5.15 112.941 167.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 36.1 mt -150.94 5.46 0.49 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 130.514 3.526 . . . . 3.79 110.544 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 13.3 t -84.77 139.89 31.63 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 115.463 1.653 . . . . 7.2 115.463 -168.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.47 25.25 19.79 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 125.893 1.711 . . . . 3.59 116.076 168.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.8 t -103.66 132.14 50.18 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.266 1.426 . . . . 3.14 111.32 -169.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -91.88 115.86 28.42 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.479 1.912 . . . . 4.72 113.093 -168.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.03 132.52 36.01 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.266 0.555 . . . . 1.29 109.695 167.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.1 149.08 35.96 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 123.684 0.794 . . . . 0.88 110.759 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.99 159.39 48.05 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.843 2.362 . . . . 0.67 112.182 -172.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.4 mp -123.93 134.44 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.014 1.725 . . . . 2.54 109.168 -168.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -99.35 134.55 42.04 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.342 0.974 . . . . 4.22 111.343 170.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.7 tt -130.73 140.58 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.936 1.694 . . . . 1.9 110.284 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -107.91 150.5 26.98 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.489 1.116 . . . . 2.11 108.911 170.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.1 mt -62.8 143.4 96.97 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 119.493 1.042 . . . . 1.41 111.91 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.9 107.25 1.07 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.292 2.662 . . . . 0.95 111.799 -169.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.69 25.1 10.23 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.254 1.822 . . . . 4.16 110.14 174.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -115.54 144.44 43.86 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.631 2.772 . . . . 2.97 109.154 -171.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -73.14 42.7 0.12 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.756 1.622 . . . . 4.55 114.993 -171.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 10.4 m -90.84 157.75 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.802 1.641 . . . . 1.55 113.176 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 76.3 t -72.57 -37.99 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.755 1.622 . . . . 3.22 111.355 173.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.52 158.16 31.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.669 0.788 . . . . 3.54 111.525 169.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -96.03 140.07 31.3 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.025 0.93 . . . . 1.54 112.179 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -136.63 165.16 26.52 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.066 1.506 . . . . 0.92 115.066 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.33 142.93 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 126.241 1.816 . . . . 1.96 111.119 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -136.38 70.61 60.85 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.448 1.499 . . . . 4.1 113.236 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -69.32 114.73 3.73 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.293 2.662 . . . . 0.92 113.714 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -89.83 174.97 7.41 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 128.299 2.64 . . . . 3.21 111.939 173.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -108.3 167.28 10.13 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.432 1.493 . . . . 3.22 111.363 170.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 9.0 t -114.37 -56.6 2.37 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.855 0.862 . . . . 2.74 112.951 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -142.62 168.72 19.05 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.924 1.238 . . . . 5.39 113.316 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -148.88 151.8 35.32 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.174 0.805 . . . . 7.01 113.174 -176.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.14 164.64 20.31 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 126.038 1.735 . . . . 10.33 111.287 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.49 155.87 45.38 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.5 2.8 . . . . 9.74 113.506 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -128.82 -14.71 4.47 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.853 1.797 . . . . 16.41 115.853 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.53 9.31 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 114.993 1.479 . . . . 15.54 114.993 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 80.8 mt -91.75 113.84 26.22 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.414 -0.804 . . . . 13.86 110.676 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 . . . . . 0 CA--C 1.552 1.056 0 C-N-CA 127.285 2.234 . . . . 16.91 111.236 -179.606 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 62.3 ttp . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 112.355 0.502 . . . . 29.27 112.355 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -78.98 163.32 25.31 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.358 1.614 . . . . 28.15 115.358 -168.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 t -146.9 151.3 36.82 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.646 1.978 . . . . 23.15 111.948 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.0 -12.33 47.75 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 115.406 1.632 . . . . 23.9 115.406 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.7 m -146.64 153.25 40.1 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.803 1.183 . . . . 19.34 113.087 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.6 -10.63 19.11 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.017 1.727 . . . . 15.08 115.486 -172.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.4 177.59 10.43 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.952 1.093 . . . . 13.19 113.952 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.9 t -78.64 153.62 30.89 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.617 1.567 . . . . 12.05 110.349 167.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.5 p -69.89 150.83 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.052 1.341 . . . . 11.89 113.617 -176.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -75.8 -179.84 5.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.053 1.741 . . . . 5.86 112.257 169.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.73 -173.73 0.1 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.678 1.591 . . . . 7.22 114.159 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -126.87 135.21 50.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.17 1.788 . . . . 7.47 109.901 177.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.25 62.01 3.05 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.127 0.87 . . . . 4.79 111.625 -169.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 p -139.91 144.61 37.23 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.304 1.442 . . . . 3.32 110.997 -177.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.5 p -125.73 -9.67 6.73 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 117.797 2.518 . . . . 2.49 117.797 -167.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 t -147.2 156.42 42.95 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 121.432 1.923 . . . . 2.05 114.622 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.7 p -100.89 -6.28 24.88 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.759 1.624 . . . . 2.27 115.06 -172.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.5 p -147.5 156.73 43.12 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.878 1.671 . . . . 2.84 113.794 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.76 140.45 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 127.893 2.477 . . . . 1.55 109.112 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 36.2 m -114.17 127.54 55.95 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.353 0.979 . . . . 1.11 111.383 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 p -96.34 136.55 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.202 1.001 . . . . 1.93 110.695 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -131.37 107.21 8.77 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.824 1.65 . . . . 1.72 110.576 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.54 114.5 20.98 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 120.901 -1.125 . . . . 2.0 111.436 -170.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.1 mt -99.36 154.41 18.22 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.539 1.136 . . . . 1.07 112.416 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.6 mt -141.03 169.52 17.46 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.331 1.852 . . . . 2.37 110.209 169.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.5 150.4 23.43 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.89 0.876 . . . . 1.39 111.016 169.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.9 p -76.64 -21.94 54.77 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.345 0.868 . . . . 1.98 113.345 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -137.61 34.75 2.45 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.102 1.761 . . . . 2.13 111.762 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.69 15.79 75.82 Favored Glycine 0 CA--C 1.539 1.551 0 O-C-N 119.864 -1.772 . . . . 1.22 115.383 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.28 26.27 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 128.936 2.894 . . . . 1.82 115.231 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -26.09 67.82 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.133 -1.604 . . . . 0.85 113.367 -172.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -73.69 -46.36 46.77 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.41 1.004 . . . . 1.98 112.814 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -65.94 -43.27 88.51 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.203 -0.935 . . . . 2.86 111.117 173.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 91.9 mt -50.65 -50.13 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 118.965 0.802 . . . . 1.04 110.721 168.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.16 -32.64 70.07 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 120.807 1.639 . . . . 1.04 113.657 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -74.31 -32.96 63.06 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.618 0.767 . . . . 0.95 112.68 172.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -71.24 -23.66 62.04 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.626 1.171 . . . . 1.95 112.842 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.7 mt -92.32 -35.69 13.6 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.037 1.125 . . . . 0.94 114.037 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -67.96 -28.14 67.21 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.977 0.808 . . . . 2.48 112.975 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 t -73.92 -12.49 60.67 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.42 1.488 . . . . 2.12 113.007 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.53 175.93 36.3 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.287 1.422 . . . . 0.99 112.518 170.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -93.39 34.46 1.16 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.091 1.356 . . . . 2.35 111.617 169.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -75.74 17.85 0.28 Allowed 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.459 -1.401 . . . . 3.11 114.202 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.57 -23.83 49.93 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.261 1.024 . . . . 1.42 110.11 165.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -118.73 -59.33 0.27 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.862 1.696 . . . . 0.87 112.709 172.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.281 0.0 OUTLIER -85.19 156.1 21.15 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.403 1.631 . . . . 1.79 115.403 -169.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -60.09 149.17 33.35 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.447 0.906 . . . . 3.2 113.447 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.5 t -62.68 124.42 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 121.87 -0.519 . . . . 1.81 110.103 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.2 -47.02 25.04 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.709 -0.495 . . . . 0.9 114.033 -171.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.0 t -145.59 116.21 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.66 1.584 . . . . 2.81 108.551 176.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.2 mt -74.35 146.68 84.42 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 123.921 0.889 . . . . 1.29 111.214 171.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.79 161.97 43.88 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.737 1.624 . . . . 0.62 112.028 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.17 -33.72 65.53 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.198 0.599 . . . . 1.65 112.257 174.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -83.39 1.54 40.89 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.393 1.877 . . . . 1.92 115.629 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -95.97 152.04 18.88 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.963 1.256 . . . . 0.77 112.677 169.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -148.95 167.62 25.27 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.71 1.604 . . . . 2.98 111.462 169.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.26 141.68 51.38 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.828 0.851 . . . . 2.61 110.774 -175.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.5 pt -126.82 141.55 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.403 1.081 . . . . 2.01 112.144 -176.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.06 163.9 12.9 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.678 1.191 . . . . 1.35 112.304 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.28 14.37 58.9 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.274 1.416 . . . . 0.64 115.314 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.3 p -97.97 144.55 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.489 1.916 . . . . 1.92 110.256 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 7.7 tpp -104.79 140.44 38.09 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.728 1.611 . . . . 1.7 111.891 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.92 157.03 44.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.492 1.517 . . . . 2.86 111.64 174.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.08 144.52 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 126.565 1.946 . . . . 1.72 109.751 -176.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -85.81 146.99 26.52 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.916 1.341 . . . . 0.5 111.392 169.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.0 p -141.83 170.73 15.16 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.271 1.828 . . . . 1.62 111.487 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.79 170.92 9.5 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.556 1.142 . . . . 1.93 112.414 168.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.5 p -33.32 -46.06 0.17 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.55 1.94 . . . . 2.16 114.351 172.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -90.98 29.49 1.36 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.574 1.15 . . . . 2.55 112.976 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.28 25.01 8.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 127.873 2.469 . . . . 1.15 113.414 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -86.56 136.11 33.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.957 1.303 . . . . 1.78 111.515 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.9 mt -74.27 125.85 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 118.402 0.547 . . . . 1.56 110.253 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.1 pp -120.37 152.15 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.289 1.436 . . . . 1.82 114.273 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -84.07 162.28 20.39 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.621 1.969 . . . . 1.4 111.439 168.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -70.95 10.54 0.52 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 115.948 1.833 . . . . 2.4 115.948 -169.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -115.22 -2.75 12.62 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.956 2.503 . . . . 2.72 113.174 168.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.47 10.71 67.5 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.795 2.141 . . . . 0.6 115.744 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -68.73 144.23 54.45 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.843 1.321 . . . . 2.28 108.799 167.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.0 p -101.25 146.27 27.75 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.938 0.895 . . . . 1.72 112.076 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.88 -9.83 27.74 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.19 1.182 . . . . 1.71 114.19 -171.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.63 25.33 42.76 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 119.738 1.154 . . . . 0.66 113.903 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.1 t -133.66 150.41 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.939 1.695 . . . . 1.69 109.417 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -135.59 160.78 37.42 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 129.114 2.966 . . . . 1.47 110.688 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 57.2 mt -137.85 137.29 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.761 1.225 . . . . 1.69 110.417 -173.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -70.74 140.92 86.88 Favored Pre-proline 0 N--CA 1.476 0.837 0 CA-C-O 116.882 -1.532 . . . . 2.15 111.05 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -72.32 -27.39 16.35 Favored 'Trans proline' 0 C--N 1.351 0.705 0 CA-C-N 122.935 2.084 . . . . 1.16 112.567 174.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -88.19 -46.38 9.31 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 125.663 1.585 . . . . 1.71 112.795 -175.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.3 p -89.24 -24.66 22.05 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.357 0.873 . . . . 2.5 113.357 -176.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 56.42 22.77 6.74 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.108 1.363 . . . . 3.07 113.407 -168.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.98 148.75 21.86 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.956 1.303 . . . . 3.65 112.488 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.1 mt -82.29 145.22 30.1 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.077 1.751 . . . . 1.13 113.42 -174.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.1 p -76.38 5.56 6.96 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.348 1.24 . . . . 1.54 114.348 170.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 177.12 -157.64 22.69 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.535 1.064 . . . . 0.92 113.652 -171.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -86.25 149.89 24.75 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.996 1.11 . . . . 2.08 113.996 -174.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.5 tpt -51.43 126.05 28.26 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.962 1.705 . . . . 2.36 112.607 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.42 161.42 37.56 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.852 2.368 . . . . 0.79 113.321 -170.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.62 -87.8 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 122.265 1.031 . . . . 1.07 111.682 172.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 78.3 p -78.04 -1.05 30.36 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 116.067 1.876 . . . . 1.84 116.067 -167.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.59 152.68 3.51 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.828 1.418 . . . . 0.66 114.828 -171.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.7 ttt -78.6 95.1 5.14 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.993 1.317 . . . . 1.85 111.426 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.67 155.17 44.88 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.687 1.595 . . . . 3.43 111.458 -177.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -169.2 164.26 11.02 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.785 1.634 . . . . 4.11 111.301 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.9 mp -106.8 150.1 26.69 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.374 1.07 . . . . 0.87 113.577 172.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.6 p -77.48 135.28 38.24 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 118.839 0.745 . . . . 1.46 110.845 170.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -96.26 -58.65 2.02 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 115.345 1.609 . . . . 2.57 115.345 -169.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -153.61 -35.23 0.11 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.101 1.36 . . . . 1.6 112.142 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -100.67 -38.72 8.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.242 1.017 . . . . 3.71 112.075 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.86 -160.81 30.97 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.425 1.012 . . . . 1.15 112.446 -174.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -134.82 123.68 23.93 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.381 1.872 . . . . 1.73 112.229 170.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -81.61 133.61 35.39 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.037 0.935 . . . . 3.6 112.29 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -120.58 141.27 50.46 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 128.955 2.902 . . . . 3.36 109.493 174.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -94.29 112.74 24.56 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.337 1.055 . . . . 2.91 111.429 -174.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.2 p -94.25 1.27 56.0 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.21 1.189 . . . . 1.91 114.21 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.91 -23.37 63.44 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.012 1.116 . . . . 1.6 114.012 -176.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.14 -6.24 13.67 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.573 1.323 . . . . 3.01 114.573 -170.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.22 132.16 70.78 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 119.278 0.945 . . . . 0.84 113.324 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.08 168.45 23.98 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.468 2.112 . . . . 0.94 111.106 169.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.0 83.13 0.68 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.468 1.907 . . . . 1.8 110.921 -177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -135.38 173.57 11.57 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.505 1.522 . . . . 2.18 110.355 173.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -93.67 140.23 29.88 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.728 1.252 . . . . 4.56 111.17 168.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -126.24 165.97 17.96 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.514 1.925 . . . . 0.8 109.45 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -141.3 153.45 45.19 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.644 0.777 . . . . 2.47 111.793 175.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.08 139.33 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.623 0.769 . . . . 1.78 110.449 173.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -127.62 140.31 52.18 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.486 1.914 . . . . 3.14 110.488 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -102.43 130.76 49.31 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.065 1.346 . . . . 1.81 111.108 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 37.6 mm -130.57 113.74 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.748 0.819 . . . . 2.05 109.846 -169.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -77.08 -8.44 57.47 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.198 1.185 . . . . 4.34 114.198 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.0 t -62.58 -28.74 70.09 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.149 1.537 . . . . 3.26 115.149 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.48 6.79 16.02 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.927 1.691 . . . . 3.23 114.255 -171.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 43.7 p -74.06 167.65 21.1 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.733 1.753 . . . . 4.99 115.733 -169.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 79.9 p -114.47 -28.29 7.24 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.304 1.442 . . . . 6.22 111.816 168.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -77.46 156.43 31.09 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.696 0.798 . . . . 6.27 112.372 170.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.7 t -135.42 125.55 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.891 0.876 . . . . 5.61 110.198 169.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -119.32 -12.88 6.6 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.329 1.442 . . . . 3.74 115.196 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -87.85 -17.09 32.26 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.331 1.452 . . . . 5.49 114.794 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -97.24 27.98 3.88 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 116.529 2.048 . . . . 7.15 116.529 -166.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 91.54 10.88 61.41 Favored Glycine 0 N--CA 1.477 1.399 0 O-C-N 120.671 -1.268 . . . . 5.54 114.484 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.23 175.79 0.39 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.153 2.181 . . . . 3.82 112.767 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.5 m -78.38 40.52 0.36 Allowed 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.211 -1.555 . . . . 3.36 111.328 169.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 80.2 mt -137.4 143.15 41.77 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 128.417 2.687 . . . . 2.73 107.694 -171.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 77.3 p -73.55 -2.83 24.41 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 117.696 2.48 . . . . 4.24 117.696 -166.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 65.12 9.32 40.78 Favored Glycine 0 CA--C 1.542 1.753 0 O-C-N 120.742 -1.224 . . . . 2.79 115.221 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 75.3 m -74.05 163.49 27.82 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 127.404 2.282 . . . . 2.93 112.916 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.67 147.65 32.73 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.548 1.539 . . . . 2.96 113.131 -175.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.47 154.99 34.21 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.99 0.737 . . . . 1.23 112.99 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.33 145.48 36.12 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.328 1.051 . . . . 0.9 112.012 170.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.47 146.56 44.71 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.311 2.674 . . . . 0.5 113.366 -168.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.2 mp -117.1 128.93 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.359 1.863 . . . . 2.24 108.81 -168.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -94.94 145.23 25.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.332 1.053 . . . . 2.94 112.356 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.4 tt -150.84 157.28 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 125.625 1.57 . . . . 1.87 110.533 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.44 ' HG2' ' H ' ' A' ' 170' ' ' LEU . 10.5 tt0 -136.56 -178.65 5.27 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.584 1.554 . . . . 2.55 109.708 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.44 ' H ' ' HG2' ' A' ' 169' ' ' GLU . 3.4 mm? -68.48 156.43 90.55 Favored Pre-proline 0 CA--C 1.552 1.051 0 O-C-N 120.811 -1.181 . . . . 2.99 112.315 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -83.27 75.99 4.12 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.061 3.174 . . . . 1.99 114.213 -167.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 4.5 tt -94.29 80.84 3.98 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 105.915 -1.883 . . . . 4.14 105.915 166.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -147.2 160.35 42.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.093 1.357 . . . . 3.83 112.304 -168.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -74.37 -18.23 60.7 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.921 1.288 . . . . 3.21 113.553 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.2 m -65.83 150.72 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.887 1.675 . . . . 1.93 113.734 -173.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.13 -40.61 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.553 1.141 . . . . 2.83 109.934 173.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -132.33 141.54 48.99 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.469 1.508 . . . . 2.9 109.509 172.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -92.45 156.03 17.46 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.313 0.645 . . . . 1.66 111.777 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -137.13 165.04 27.02 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.835 1.421 . . . . 0.62 114.835 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.55 142.16 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 126.216 1.806 . . . . 0.97 110.952 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -134.42 71.7 71.41 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 113.382 0.882 . . . . 3.17 113.382 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.75 144.35 93.66 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 124.006 3.137 . . . . 0.68 113.824 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -120.25 158.01 27.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.088 2.155 . . . . 2.39 112.184 -171.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -110.56 159.13 17.82 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.355 1.074 . . . . 3.66 113.481 175.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 6.0 t -146.22 -169.57 3.29 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.66 2.384 . . . . 3.0 109.091 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -123.62 150.17 44.48 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.904 1.281 . . . . 5.85 111.91 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -154.23 135.36 13.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.208 1.003 . . . . 7.42 111.972 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -133.81 156.48 79.35 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 126.143 1.777 . . . . 10.75 111.035 170.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.58 162.71 39.24 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.019 2.479 . . . . 12.08 112.845 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -134.11 -8.59 2.65 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 115.818 1.784 . . . . 17.84 115.818 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.98 9.05 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 115.198 1.555 . . . . 19.84 115.198 172.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.1 tt -80.9 118.69 22.62 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.169 1.388 . . . . 16.58 109.883 176.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 . . . . . 0 C--O 1.24 0.584 0 C-N-CA 124.81 1.244 . . . . 22.29 112.417 -173.492 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 119.549 -0.262 . . . . 26.77 110.877 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.11 133.34 48.78 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.166 -0.679 . . . . 21.62 109.166 168.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.7 t -158.61 140.99 14.18 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.227 0.825 . . . . 21.37 113.227 177.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.52 0.82 1.02 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.13 2.172 . . . . 16.76 113.509 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.9 t -149.19 172.69 14.43 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.054 1.742 . . . . 17.5 114.269 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.98 -35.71 23.73 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.746 1.387 . . . . 19.61 114.746 -171.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -159.69 -29.61 0.06 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 116.194 1.924 . . . . 17.46 116.194 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.4 p -130.08 175.46 8.88 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.627 1.171 . . . . 14.63 113.006 -165.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.8 m -66.39 161.23 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.01 1.324 . . . . 9.4 112.412 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -64.78 139.01 58.72 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.505 -0.554 . . . . 4.89 109.505 167.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 61.81 160.07 0.06 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 127.179 2.191 . . . . 6.25 116.109 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.84 110.31 4.45 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.862 -1.148 . . . . 7.33 112.577 172.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.84 12.53 48.49 Favored Glycine 0 N--CA 1.475 1.27 0 N-CA-C 118.066 1.986 . . . . 3.91 118.066 175.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.9 p -70.65 155.02 41.28 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.673 1.989 . . . . 2.12 114.194 -172.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.2 p -88.73 -65.5 1.01 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.506 0.722 . . . . 2.36 112.487 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 m -91.92 144.71 25.19 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.917 1.287 . . . . 2.75 113.019 -169.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.5 p -101.43 -2.13 31.56 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.975 1.71 . . . . 1.76 114.665 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.1 m -151.29 150.71 30.86 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.267 -1.52 . . . . 2.77 110.952 170.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.24 149.09 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.864 2.066 . . . . 1.5 109.936 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.5 m -117.16 124.94 50.37 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.18 0.592 . . . . 1.06 111.305 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.42 131.73 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.387 1.075 . . . . 1.15 110.637 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -126.76 96.63 4.71 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.017 1.327 . . . . 1.76 110.814 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -71.48 121.53 18.81 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.723 -1.236 . . . . 2.38 110.805 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.5 mt -109.02 159.9 16.46 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.594 1.158 . . . . 1.26 112.187 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.4 mt -142.45 161.07 39.0 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.624 1.97 . . . . 2.46 109.973 168.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.2 163.98 15.88 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.839 0.856 . . . . 1.43 111.783 168.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.1 p -85.59 -32.83 21.88 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.279 -0.888 . . . . 1.77 113.275 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -146.87 55.83 1.13 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.523 1.129 . . . . 2.65 111.05 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.62 11.36 82.98 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.728 1.632 . . . . 1.21 115.446 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -69.94 18.09 0.05 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.339 2.255 . . . . 1.81 115.534 -172.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -61.38 -31.09 70.99 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.875 -1.14 . . . . 0.97 112.291 -176.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -61.47 -49.89 74.96 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.593 1.157 . . . . 2.25 112.636 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -72.44 -43.14 64.21 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.058 -1.026 . . . . 3.46 111.511 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.5 mt -48.98 -48.78 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 119.491 1.041 . . . . 1.04 110.976 169.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.19 -30.46 70.43 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.072 1.305 . . . . 1.26 113.052 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -77.3 -31.41 54.71 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.717 0.807 . . . . 1.08 112.631 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -69.53 -20.35 63.7 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.276 1.03 . . . . 1.92 113.558 169.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.6 mt -96.96 -36.06 10.66 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.08 1.141 . . . . 1.97 114.08 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -21.91 66.85 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.414 1.006 . . . . 4.31 112.919 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.5 t -69.29 -29.75 67.69 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.277 1.031 . . . . 2.59 113.509 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.21 165.92 26.75 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.809 1.195 . . . . 1.33 113.568 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -83.89 43.04 0.89 Allowed 'General case' 0 N--CA 1.481 1.09 0 O-C-N 121.458 -1.025 . . . . 2.4 112.748 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -80.8 1.04 32.18 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.894 1.278 . . . . 3.5 114.282 -169.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.2 -25.87 65.93 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.715 -1.241 . . . . 1.58 112.406 169.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.74 -51.66 0.41 Allowed Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.541 1.067 . . . . 0.76 112.503 169.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -75.82 162.93 27.74 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.056 1.132 . . . . 3.64 114.056 -171.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -63.7 156.82 25.85 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.116 0.566 . . . . 3.92 111.6 167.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.6 t -66.01 143.3 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 122.996 0.518 . . . . 1.04 110.063 170.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.32 -64.78 2.83 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 123.807 0.718 . . . . 1.14 113.508 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.2 t -142.88 134.16 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.88 1.672 . . . . 3.69 110.157 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.5 mt -83.35 146.82 51.65 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.538 0.735 . . . . 1.59 111.962 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.01 159.17 54.17 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.639 1.559 . . . . 1.25 111.476 172.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.51 -24.87 66.46 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.565 -1.334 . . . . 2.98 111.147 169.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.71 4.56 6.08 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.968 1.47 . . . . 2.26 114.968 169.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.2 155.16 29.88 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.595 1.958 . . . . 0.96 111.98 169.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.24 163.34 34.75 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.738 0.815 . . . . 2.42 113.181 167.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -107.05 137.96 44.14 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.39 1.876 . . . . 2.75 110.353 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.51 145.96 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.546 1.138 . . . . 1.65 111.78 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.93 153.37 33.71 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.645 1.178 . . . . 1.54 112.642 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.36 19.71 40.85 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.41 1.005 . . . . 0.62 114.161 -170.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 p -97.79 143.64 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.042 1.337 . . . . 1.74 108.889 168.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -105.4 142.93 34.29 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.194 1.397 . . . . 1.94 112.667 -174.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -148.82 152.32 36.3 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.304 1.442 . . . . 2.85 111.716 175.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.23 146.57 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 127.002 2.121 . . . . 1.58 109.313 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -88.99 143.07 27.11 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.176 0.988 . . . . 0.45 112.502 170.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.5 p -133.96 164.15 27.95 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.451 1.901 . . . . 1.74 112.845 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -88.18 169.62 11.74 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.922 1.289 . . . . 1.95 110.723 166.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.57 -21.51 66.6 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.301 1.223 . . . . 3.19 114.301 -170.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -77.55 19.36 0.37 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.886 0.874 . . . . 2.13 112.817 168.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 56.25 29.14 14.36 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.257 1.823 . . . . 0.76 113.117 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -90.0 140.54 29.53 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.099 1.359 . . . . 2.37 111.39 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.1 mt -80.77 126.5 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 118.087 0.403 . . . . 1.55 110.378 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.2 pp -122.21 151.51 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.605 1.562 . . . . 1.87 114.134 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.28 164.64 19.95 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 127.21 2.204 . . . . 2.34 112.103 169.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.5 -17.93 48.57 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.823 1.786 . . . . 3.35 115.823 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -92.72 4.71 53.24 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.913 1.285 . . . . 3.83 111.557 172.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.51 10.38 85.75 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 127.294 2.378 . . . . 0.72 115.492 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -63.88 135.89 56.93 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.236 1.018 . . . . 3.47 108.553 169.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 51.9 p -90.79 139.88 30.31 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.111 0.482 . . . . 1.61 111.726 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.18 -6.09 51.33 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.818 -1.176 . . . . 1.76 113.913 -169.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.88 27.44 34.48 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 119.898 1.226 . . . . 1.0 113.695 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.3 t -136.9 148.93 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.267 1.427 . . . . 1.9 109.583 177.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -137.44 154.78 49.87 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 128.568 2.747 . . . . 1.28 110.745 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 33.0 mt -133.31 136.64 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.248 1.419 . . . . 1.68 110.179 -173.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -77.82 141.62 64.26 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-O 117.543 -1.217 . . . . 2.19 111.933 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.0 -16.28 18.14 Favored 'Trans proline' 0 C--N 1.352 0.733 0 CA-C-N 122.139 1.8 . . . . 0.94 113.416 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -101.92 -48.09 4.37 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.99 1.716 . . . . 1.96 111.28 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 p -83.92 -28.65 27.73 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.953 0.723 . . . . 2.32 112.953 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 56.34 23.28 7.12 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.883 1.673 . . . . 3.02 113.484 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.85 153.67 21.14 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.528 -1.358 . . . . 3.32 111.817 174.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 29.6 mt -92.04 139.03 31.04 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.679 1.192 . . . . 1.03 112.375 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.5 p -74.24 6.69 3.34 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.716 1.206 . . . . 1.69 113.956 175.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.21 -158.72 20.44 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 126.446 1.974 . . . . 1.02 111.068 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.99 155.14 32.83 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 122.065 -0.667 . . . . 1.69 112.429 175.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.8 tpt -59.48 125.28 78.99 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.877 0.871 . . . . 2.71 109.926 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -70.4 167.45 25.22 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 124.39 3.393 . . . . 0.94 113.9 -172.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.69 -97.59 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.176 1.391 . . . . 1.64 111.032 170.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 50.7 p -71.3 11.43 0.44 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.522 2.045 . . . . 2.3 116.522 -167.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.67 150.35 3.96 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.25 -0.906 . . . . 0.63 112.943 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.2 tpt -78.27 88.45 4.32 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.081 2.152 . . . . 1.67 110.713 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -147.66 135.05 20.69 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.039 1.736 . . . . 1.98 111.32 -171.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -169.24 145.98 3.46 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.23 1.412 . . . . 4.38 110.2 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.09 156.12 21.21 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.572 1.323 . . . . 0.83 114.572 -175.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.9 p -66.3 137.87 57.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 119.866 -1.771 . . . . 1.29 110.319 169.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -98.82 -56.57 2.4 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.462 1.105 . . . . 2.65 113.344 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -167.84 -39.95 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.598 1.959 . . . . 1.61 110.742 168.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -96.6 25.5 5.1 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.847 1.659 . . . . 5.1 112.574 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.6 -150.94 19.74 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.033 1.778 . . . . 0.98 111.348 -169.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.53 128.37 21.84 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.279 1.832 . . . . 1.22 110.347 168.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -75.62 136.13 40.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.941 1.297 . . . . 2.49 110.927 172.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -128.11 117.46 21.65 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.282 1.833 . . . . 2.96 108.876 169.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -77.27 122.03 24.52 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.177 -0.952 . . . . 2.04 110.82 175.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.7 p -112.03 -4.64 14.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.934 1.294 . . . . 1.89 114.069 -171.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.9 -15.69 5.34 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 115.918 1.822 . . . . 1.44 115.918 -172.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -106.39 0.9 25.25 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.086 1.355 . . . . 2.74 114.076 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.84 146.01 87.39 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 120.521 1.509 . . . . 0.87 113.122 170.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.99 164.83 32.6 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.934 1.756 . . . . 1.27 110.364 165.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.39 88.52 1.58 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.454 1.501 . . . . 2.62 110.3 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -139.95 -179.22 5.83 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.042 1.337 . . . . 2.01 111.185 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -92.69 140.84 29.12 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.574 1.15 . . . . 2.97 111.813 168.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -132.55 169.93 15.9 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.988 1.715 . . . . 1.03 110.298 -169.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -152.53 147.59 26.38 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.43 1.092 . . . . 4.76 112.264 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -105.25 136.38 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 123.797 0.839 . . . . 1.45 109.024 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -123.44 122.41 38.19 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.376 1.47 . . . . 3.21 110.019 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -83.36 75.75 9.96 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.993 1.317 . . . . 2.13 111.109 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.0 mm -80.82 113.85 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.41 -0.959 . . . . 1.87 108.41 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -116.35 28.34 8.65 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.703 0.801 . . . . 5.2 113.131 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.2 p -67.96 -26.61 66.02 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.226 1.01 . . . . 2.22 111.572 168.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -76.77 47.5 0.51 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.324 1.85 . . . . 2.64 108.776 165.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.3 m -54.15 118.06 3.75 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.178 1.791 . . . . 6.44 111.687 -167.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.8 m -132.89 -52.29 0.91 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 117.501 -1.237 . . . . 5.03 114.172 -168.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -73.13 153.62 40.68 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 120.607 1.549 . . . . 5.83 112.805 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.6 t -89.57 129.84 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.522 1.129 . . . . 5.52 112.095 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -143.48 -15.04 0.28 Allowed Glycine 0 CA--C 1.536 1.35 0 N-CA-C 117.434 1.734 . . . . 2.5 117.434 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -103.48 -20.25 14.11 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 120.799 2.299 . . . . 4.9 114.718 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -83.22 39.98 0.68 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.242 1.417 . . . . 5.47 113.503 -171.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 89.26 -8.97 78.66 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.502 1.525 . . . . 4.41 115.257 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.53 158.64 9.47 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.903 1.681 . . . . 3.03 114.006 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.1 m -74.38 52.5 0.49 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 127.625 2.37 . . . . 3.38 112.46 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -125.08 159.7 30.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.79 2.036 . . . . 3.54 111.366 -171.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.5 t -110.49 143.93 40.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.257 1.423 . . . . 3.71 113.108 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -82.21 64.68 4.21 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.705 1.145 . . . . 3.21 110.393 168.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.9 t -112.23 145.92 39.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.067 0.947 . . . . 3.2 113.095 -172.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -81.48 124.35 29.38 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.047 1.739 . . . . 3.5 111.54 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.87 154.16 34.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.478 0.711 . . . . 1.38 111.275 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.04 143.21 40.14 Favored Pre-proline 0 N--CA 1.477 0.898 0 O-C-N 121.521 -0.737 . . . . 1.14 111.202 174.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.21 145.41 72.4 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.825 3.016 . . . . 0.56 111.653 -168.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 1.3 mp -103.94 124.01 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.129 0.971 . . . . 2.41 109.492 -171.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.87 138.05 32.44 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.84 0.746 . . . . 3.07 112.894 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.3 tt -147.92 156.15 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.18 0.992 . . . . 1.57 111.682 -172.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -134.46 166.55 22.6 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.099 1.76 . . . . 2.61 109.481 169.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -61.5 155.55 58.29 Favored Pre-proline 0 CA--C 1.551 1.017 0 O-C-N 120.973 -1.079 . . . . 2.59 111.932 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.42 94.9 0.92 Allowed 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.919 3.079 . . . . 1.14 112.111 -169.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.44 45.58 2.63 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.379 1.871 . . . . 3.65 108.803 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -128.81 18.4 6.18 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 127.214 2.206 . . . . 3.12 113.024 -167.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.3 t70 60.96 17.75 8.2 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 128.171 2.588 . . . . 4.08 115.639 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.3 m -86.58 153.03 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 114.282 1.215 . . . . 1.48 114.282 -172.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.13 -32.26 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.083 1.753 . . . . 2.96 112.095 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -153.78 141.03 19.55 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.737 1.215 . . . . 2.43 110.19 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -101.86 140.77 35.7 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.208 0.818 . . . . 1.4 113.208 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -136.8 166.04 24.54 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.032 1.493 . . . . 0.6 115.032 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.76 143.55 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 127.2 2.2 . . . . 1.03 111.485 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -133.06 82.74 53.66 Favored Pre-proline 0 CA--C 1.553 1.066 0 N-CA-C 113.584 0.957 . . . . 3.15 113.584 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -58.0 143.99 95.28 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.699 2.932 . . . . 1.03 115.51 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -133.6 165.93 23.78 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 128.55 2.74 . . . . 2.38 112.623 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -119.62 173.3 7.09 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.002 2.121 . . . . 3.28 111.154 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 6.5 t -150.46 -23.96 0.24 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 117.352 2.352 . . . . 2.93 117.352 -169.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -150.82 169.92 20.51 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 120.712 -1.243 . . . . 6.69 114.348 -175.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -90.07 142.99 27.17 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.555 1.142 . . . . 6.0 113.451 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -142.39 160.26 55.08 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 125.193 1.397 . . . . 13.96 112.119 176.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.5 144.4 55.26 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.227 1.951 . . . . 10.07 111.765 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -102.47 -4.85 24.77 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 115.576 1.695 . . . . 15.85 115.576 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.74 -8.09 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 125.934 1.694 . . . . 15.64 114.642 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.35 118.6 36.28 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.539 1.136 . . . . 13.5 109.511 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 . . . . . 0 CA--C 1.539 0.523 0 C-N-CA 124.694 1.198 . . . . 19.51 112.265 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 109.961 -0.385 . . . . 27.77 109.961 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.94 151.64 51.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.748 1.619 . . . . 22.82 111.584 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 59.3 p -109.83 3.56 20.83 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.805 1.242 . . . . 20.75 113.844 175.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.28 151.69 12.31 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.672 1.189 . . . . 16.4 113.331 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.6 p -158.44 0.04 0.1 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 116.656 2.095 . . . . 16.31 116.656 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -111.68 -6.18 14.38 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.832 1.79 . . . . 12.49 115.832 -172.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 59.8 -52.9 0.07 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 129.284 3.034 . . . . 11.43 118.9 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 35.5 p -121.13 173.3 7.38 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.876 1.27 . . . . 9.64 113.91 -166.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.7 m -67.0 151.73 10.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 124.424 1.09 . . . . 6.91 111.804 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -86.71 131.16 34.22 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.82 0.848 . . . . 4.12 112.581 -172.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.77 137.77 6.72 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.932 1.293 . . . . 4.67 111.208 -171.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.75 14.5 0.55 Allowed 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.257 1.577 . . . . 7.28 115.257 175.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.92 39.38 88.66 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 126.046 1.784 . . . . 2.95 114.268 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.0 p -92.86 179.21 5.53 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.543 1.937 . . . . 2.29 115.774 -168.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.2 p -121.7 0.11 9.78 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.324 1.45 . . . . 2.25 114.029 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 m -156.41 158.32 37.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.976 1.711 . . . . 3.2 110.42 -170.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 43.1 p -117.27 -11.66 10.6 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 126.425 1.89 . . . . 2.2 115.552 -174.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 p -143.68 153.31 42.35 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.903 1.681 . . . . 3.09 113.064 -175.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.3 p -130.93 135.2 60.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 126.426 1.891 . . . . 1.47 109.119 174.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.8 m -114.62 126.04 54.44 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 118.254 0.479 . . . . 1.13 110.509 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.2 p -96.89 132.38 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.225 1.01 . . . . 2.15 110.318 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -129.59 98.31 4.8 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.584 1.554 . . . . 2.07 109.732 -174.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.09 126.18 30.49 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.619 -1.3 . . . . 1.97 111.842 -169.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.6 mt -103.59 151.67 22.64 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.37 1.068 . . . . 1.3 113.322 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.53 161.63 35.33 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.567 1.547 . . . . 2.8 109.451 169.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.18 154.03 17.63 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.732 0.813 . . . . 1.78 112.027 172.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.4 p -87.64 -20.19 26.68 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.29 1.219 . . . . 1.81 114.29 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -151.5 51.99 0.83 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.882 1.673 . . . . 2.17 112.455 170.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.99 23.79 70.92 Favored Glycine 0 CA--C 1.536 1.388 0 O-C-N 120.439 -1.413 . . . . 1.11 115.989 172.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.1 10.95 4.54 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 128.213 2.605 . . . . 1.86 115.622 -174.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -57.81 -31.25 66.41 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.37 -1.456 . . . . 0.97 112.629 -171.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.42 -49.75 52.17 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.788 1.235 . . . . 2.31 113.465 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -69.7 -33.06 72.01 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 120.968 -1.082 . . . . 4.18 111.495 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.42 -52.67 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.502 1.121 . . . . 2.28 110.095 168.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.86 -34.99 70.34 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.127 0.876 . . . . 1.24 112.484 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -67.62 -32.47 73.21 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.405 0.891 . . . . 0.96 113.405 173.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.99 -28.24 65.36 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.063 1.301 . . . . 1.98 113.017 171.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.4 mt -87.2 -40.95 14.11 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.673 0.99 . . . . 1.33 113.673 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -67.41 -21.21 65.59 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.437 0.903 . . . . 2.85 113.437 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.4 t -75.79 -25.69 56.62 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 121.393 -0.817 . . . . 1.94 112.88 169.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.46 161.19 32.3 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 126.141 1.829 . . . . 1.19 113.918 174.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -84.27 33.47 0.5 Allowed 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.945 -1.326 . . . . 2.61 113.78 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -72.1 8.44 1.28 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.595 1.702 . . . . 3.56 115.595 -169.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.1 -30.17 71.09 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.219 -0.925 . . . . 1.45 109.881 165.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.25 -83.74 1.75 Allowed Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.067 1.318 . . . . 0.91 112.476 171.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -65.99 151.8 46.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.608 1.336 . . . . 1.69 114.608 -173.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -59.16 143.37 49.06 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.075 1.35 . . . . 5.01 111.3 172.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.8 t -53.89 136.24 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.343 0.657 . . . . 1.36 111.181 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.7 -64.42 3.32 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.682 0.658 . . . . 1.12 112.515 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.4 t -137.52 125.86 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.581 1.152 . . . . 2.81 110.623 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.8 mt -80.73 143.78 54.95 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.316 0.647 . . . . 1.46 110.896 172.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.91 162.18 42.7 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.141 1.894 . . . . 0.75 112.158 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.63 -21.63 66.47 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.646 0.98 . . . . 2.11 113.646 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -92.55 -1.48 56.9 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 115.082 1.512 . . . . 2.51 115.082 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.41 152.41 21.5 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.853 0.861 . . . . 0.8 113.147 169.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.7 pttt -146.43 167.73 22.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.577 1.551 . . . . 2.82 111.77 168.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -118.4 143.44 46.66 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.864 1.666 . . . . 2.4 109.931 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.1 pt -126.93 142.91 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 114.468 1.285 . . . . 1.48 114.468 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.66 153.22 20.34 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.823 1.649 . . . . 1.88 112.316 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.63 7.07 61.93 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.964 1.745 . . . . 0.65 115.28 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.0 p -90.42 143.75 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 118.547 1.173 . . . . 2.0 110.112 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 1.3 tpp -111.67 132.85 54.31 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.105 1.762 . . . . 1.65 112.016 -172.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.55 153.06 48.69 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.39 1.476 . . . . 2.88 111.53 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.81 143.19 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 126.346 1.859 . . . . 1.75 109.514 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -84.78 145.99 27.6 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 122.817 1.294 . . . . 0.41 111.244 169.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.3 p -140.27 170.69 15.35 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.29 1.836 . . . . 1.44 111.527 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.75 173.23 9.59 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.525 0.73 . . . . 2.01 112.926 169.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.7 p -64.1 -16.91 62.82 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 120.744 -1.223 . . . . 2.34 113.513 170.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 -80.96 8.1 9.18 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.418 1.487 . . . . 3.31 113.014 168.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.52 25.54 9.89 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.129 2.172 . . . . 0.72 113.28 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -89.29 141.46 28.52 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.633 1.573 . . . . 2.52 110.612 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.8 mt -76.66 126.98 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.416 -0.587 . . . . 1.52 109.416 177.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.2 pt -122.07 154.38 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 114.637 1.347 . . . . 0.98 114.637 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.29 163.32 24.04 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.168 2.187 . . . . 1.74 111.336 167.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.74 -1.18 3.53 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 115.499 1.666 . . . . 2.33 115.499 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -105.14 -1.57 25.34 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.907 1.683 . . . . 3.96 113.218 169.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.16 -0.68 64.21 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.436 1.969 . . . . 0.66 115.853 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -69.66 139.18 53.48 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 119.185 1.492 . . . . 2.49 110.893 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.5 p -99.21 141.26 32.21 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.732 0.813 . . . . 1.62 112.402 -172.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.23 -8.0 46.62 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.475 1.287 . . . . 2.1 114.475 -168.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.5 24.0 57.32 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.052 0.842 . . . . 0.82 113.661 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.95 147.08 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.214 1.406 . . . . 1.76 109.311 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -133.67 158.22 43.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.839 1.656 . . . . 1.29 111.656 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 60.0 mt -133.19 141.04 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.912 1.285 . . . . 1.51 110.684 -170.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -81.98 145.91 54.37 Favored Pre-proline 0 N--CA 1.477 0.91 0 O-C-N 120.862 -1.149 . . . . 1.81 112.659 174.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.68 -19.38 12.84 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 CA-C-N 122.139 1.8 . . . . 1.08 113.243 175.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -97.93 -47.74 5.43 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.821 1.649 . . . . 1.42 112.47 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.8 p -80.49 -29.18 37.35 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.286 0.635 . . . . 1.81 111.879 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 57.74 16.34 3.46 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.531 1.532 . . . . 3.09 113.539 -170.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.79 149.23 21.41 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.742 1.217 . . . . 3.6 111.718 -175.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.2 mt -84.17 138.64 32.89 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.932 1.293 . . . . 2.3 111.955 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.1 t -87.02 20.24 2.75 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.685 0.994 . . . . 2.84 113.685 172.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -177.42 174.07 46.67 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 126.882 2.182 . . . . 1.21 111.905 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.6 162.78 28.84 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.306 0.854 . . . . 1.7 113.306 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 mmt -51.91 132.45 39.01 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.712 1.205 . . . . 2.41 113.074 -175.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -78.59 155.67 27.85 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.323 3.349 . . . . 1.07 113.682 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.15 -35.92 23.26 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.893 1.812 . . . . 1.58 115.893 -176.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.2 p -131.46 10.22 4.79 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.832 1.653 . . . . 1.95 113.035 -168.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.85 152.29 16.22 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.689 1.366 . . . . 0.81 114.689 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.1 ttt -80.19 85.31 5.74 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.85 1.66 . . . . 2.05 111.712 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -135.45 153.85 51.63 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.005 1.722 . . . . 2.37 112.456 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -164.02 158.34 19.4 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.124 1.77 . . . . 2.72 110.747 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 mp -98.28 147.29 24.79 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.31 1.044 . . . . 0.85 112.469 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.2 p -65.1 125.68 25.72 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 120.329 1.422 . . . . 1.42 109.822 169.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.52 -52.02 7.24 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.372 1.619 . . . . 2.02 115.372 -169.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.78 -46.07 0.1 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.784 1.634 . . . . 1.93 109.075 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -116.01 -17.03 11.02 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.524 1.305 . . . . 4.09 114.524 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 172.57 -169.5 42.62 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.093 1.33 . . . . 0.76 112.593 -172.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.52 126.82 18.64 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.281 1.832 . . . . 1.91 112.413 170.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -80.19 136.7 36.54 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.873 1.269 . . . . 2.25 112.388 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -127.52 142.38 51.4 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.321 2.649 . . . . 3.49 108.671 171.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -105.91 111.97 24.84 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.93 0.892 . . . . 3.47 110.619 -175.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.0 p -94.15 -8.41 39.53 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.314 1.228 . . . . 1.97 114.314 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.23 -14.85 1.26 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.885 1.674 . . . . 1.98 115.357 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.92 -21.71 13.09 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.556 1.542 . . . . 3.43 112.866 -176.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -72.21 144.57 87.33 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 119.779 1.172 . . . . 0.85 112.523 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.94 168.16 25.45 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.84 2.36 . . . . 0.79 111.99 172.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -72.35 76.38 1.01 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.625 1.97 . . . . 1.24 111.818 -176.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -142.03 -173.54 3.84 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.115 1.366 . . . . 1.98 111.305 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -104.66 154.7 19.63 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.233 1.413 . . . . 4.05 112.201 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -145.3 169.8 17.55 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 127.456 2.302 . . . . 0.66 110.178 -173.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -137.97 154.66 49.34 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.866 1.061 . . . . 2.44 113.866 175.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.6 mp -113.58 136.9 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.566 1.146 . . . . 1.46 110.763 174.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -125.9 149.65 48.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.746 2.018 . . . . 3.18 110.558 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -112.05 120.16 40.89 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.581 1.152 . . . . 1.89 110.72 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 22.9 mm -129.07 113.96 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.352 1.061 . . . . 1.66 109.421 -169.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -98.91 15.32 25.98 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.687 1.195 . . . . 6.69 113.544 -174.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 82.5 p -77.51 -21.89 52.02 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.253 1.205 . . . . 2.46 114.253 -176.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.35 177.03 1.2 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.464 1.105 . . . . 3.04 110.168 167.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 28.7 t -44.03 -53.44 6.3 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.624 1.17 . . . . 6.67 112.45 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.1 m 58.19 158.1 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 128.355 2.662 . . . . 6.33 116.432 167.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -62.24 172.63 1.4 Allowed 'General case' 0 CA--C 1.547 0.837 0 O-C-N 120.49 -1.381 . . . . 6.61 112.247 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.1 p -127.89 148.13 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.775 1.23 . . . . 4.24 111.545 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.66 -29.37 0.83 Allowed Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.799 1.19 . . . . 2.45 113.211 171.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -76.36 -10.96 59.79 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.984 2.114 . . . . 4.18 115.451 -171.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -90.0 16.68 7.87 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.3 1.44 . . . . 5.37 113.92 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 101.68 13.23 32.87 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.055 1.312 . . . . 4.25 115.222 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.37 165.24 22.83 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.16 0.984 . . . . 2.85 112.606 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.0 m -81.37 55.9 2.74 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.117 1.367 . . . . 3.19 110.378 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.6 mt -142.71 163.8 31.84 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.88 2.072 . . . . 2.79 110.3 -173.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 34.5 p -92.58 -34.46 14.02 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 115.755 1.761 . . . . 4.63 115.755 -168.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.88 25.04 75.74 Favored Glycine 0 CA--C 1.539 1.563 0 O-C-N 120.97 -1.081 . . . . 2.96 112.083 -166.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 68.1 p -89.42 -168.38 2.14 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.114 1.365 . . . . 2.94 112.135 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.81 152.58 40.53 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.402 1.481 . . . . 4.56 112.436 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.07 155.45 40.29 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.091 0.775 . . . . 1.89 113.091 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.74 150.78 37.34 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 124.469 1.108 . . . . 0.84 110.018 167.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.6 140.51 32.89 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.894 2.396 . . . . 0.8 113.244 -168.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.9 mp -111.23 139.27 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.146 1.779 . . . . 2.23 109.874 -173.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -107.45 141.32 39.04 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.914 1.079 . . . . 2.76 113.914 173.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.8 tt -145.38 155.37 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 125.326 1.45 . . . . 1.42 111.779 -170.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -134.89 160.21 38.98 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.669 1.988 . . . . 1.99 110.382 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.95 144.54 81.85 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.347 -0.846 . . . . 3.12 112.573 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.4 113.57 3.52 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.148 2.565 . . . . 0.97 113.793 -169.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 4.2 tt -126.18 79.05 1.81 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 105.388 -2.079 . . . . 4.37 105.388 166.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -149.79 156.07 41.2 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.085 2.154 . . . . 3.49 109.686 -169.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -80.54 33.47 0.31 Allowed 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.787 -1.196 . . . . 4.08 113.94 -177.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 32.9 m -110.25 169.18 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.216 1.406 . . . . 3.76 112.481 -173.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 61.4 t -101.93 -29.06 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.651 1.181 . . . . 3.14 110.384 171.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.49 140.79 41.39 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.266 1.426 . . . . 3.26 111.434 173.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -91.31 152.88 20.29 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.848 0.859 . . . . 2.06 110.626 173.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -138.87 153.13 48.28 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.337 0.865 . . . . 0.97 113.337 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.38 140.57 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.106 1.762 . . . . 1.21 111.002 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -128.97 74.11 81.31 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.735 0.814 . . . . 3.44 112.907 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.61 150.05 44.77 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.141 3.227 . . . . 1.32 113.818 -175.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -132.01 165.01 24.93 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.48 2.312 . . . . 2.46 113.014 -169.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -108.67 161.0 15.5 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.415 1.486 . . . . 3.48 113.613 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 5.3 t -147.82 170.78 16.89 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 126.075 1.75 . . . . 3.15 108.613 167.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -88.84 -90.06 0.14 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.726 0.811 . . . . 5.44 111.676 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . 53.4 -79.29 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.884 2.474 . . . . 8.08 115.635 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . 0.275 23.6 pttm 49.48 148.1 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.094 1 C-N-CA 133.611 4.765 . . . . 9.24 118.117 -176.506 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -79.71 160.84 24.79 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.637 2.891 . . . . 14.61 115.743 -172.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -125.32 -11.54 6.9 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.025 1.861 . . . . 15.96 116.025 -173.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.0 mp -93.85 -62.21 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 120.4 1.455 . . . . 21.61 109.943 -175.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.8 mt 53.1 177.09 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 129.346 3.059 . . . . 21.22 116.024 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.531 0 C-N-CA 126.853 2.061 . . . . 27.49 110.01 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 15.9 tpt . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 110.428 -0.212 . . . . 23.1 110.428 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 61.27 -72.58 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 127.819 2.447 . . . . 22.01 114.992 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 p -75.54 155.09 36.41 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.342 0.974 . . . . 19.69 112.317 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 58.71 23.79 11.49 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.115 1.766 . . . . 15.02 115.146 -174.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.3 m -74.47 -24.67 59.07 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.826 1.417 . . . . 13.27 114.826 -171.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.52 -25.43 21.41 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.143 0.883 . . . . 10.92 112.502 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.75 -37.87 20.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.421 1.488 . . . . 10.18 113.668 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.0 p -125.09 135.11 52.38 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.716 1.006 . . . . 8.99 113.716 -169.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.5 m -61.31 158.65 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.162 1.385 . . . . 7.02 114.108 -171.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -88.22 46.13 1.35 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.392 1.477 . . . . 4.76 112.154 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 56.06 -173.64 0.06 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 126.039 1.735 . . . . 4.66 114.877 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.05 133.41 35.42 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.862 1.665 . . . . 5.68 110.562 173.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.14 26.93 0.06 OUTLIER Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.942 -0.921 . . . . 2.39 115.21 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.5 p -150.79 171.85 16.54 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 118.993 1.396 . . . . 1.84 113.678 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.4 p -89.9 -20.4 23.43 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 115.014 1.487 . . . . 2.61 115.014 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.6 t -154.51 156.07 36.0 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.376 1.47 . . . . 2.63 110.775 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.4 p -80.67 -4.56 54.73 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.497 1.666 . . . . 2.51 115.497 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.404 ' CB ' ' HE3' ' A' ' 128' ' ' LYS . 2.9 p -149.69 161.87 41.35 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.596 1.702 . . . . 2.55 115.596 -170.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.6 p -128.4 143.65 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 127.043 2.137 . . . . 1.62 110.003 173.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.0 m -113.89 118.39 34.06 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.223 1.009 . . . . 1.25 109.073 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 p -94.49 130.93 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 122.061 0.934 . . . . 1.36 109.289 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -108.56 -179.47 3.88 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.174 1.79 . . . . 1.92 109.424 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.53 122.3 9.29 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 120.168 -1.583 . . . . 1.99 111.656 169.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.6 mt -111.63 151.21 29.07 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.249 1.02 . . . . 2.03 112.688 -171.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.78 159.85 38.56 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.163 1.785 . . . . 3.28 110.917 175.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.61 165.27 11.32 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.513 1.125 . . . . 1.25 112.358 173.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.6 p -97.84 -17.12 19.49 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.874 1.435 . . . . 1.9 114.874 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -152.04 49.05 0.78 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.903 1.681 . . . . 2.82 110.572 169.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.29 11.28 85.11 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 116.497 1.359 . . . . 1.1 116.497 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.56 16.02 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 128.674 2.789 . . . . 2.31 116.749 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -19.92 60.2 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.572 -1.33 . . . . 2.02 112.926 -176.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -82.3 -47.65 12.13 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.409 1.483 . . . . 2.87 113.167 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -65.25 -41.3 94.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.7 1.136 . . . . 3.69 111.099 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.8 mt -52.05 -52.96 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 119.56 1.073 . . . . 1.04 110.282 168.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.8 -30.88 62.07 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 120.676 1.58 . . . . 1.15 113.618 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -77.49 -37.22 51.68 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.504 0.927 . . . . 1.18 113.504 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -63.85 -22.68 67.03 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.856 0.863 . . . . 1.95 112.631 169.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.7 mt -88.79 -44.86 10.21 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.337 0.865 . . . . 0.95 113.337 173.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -69.57 -15.08 63.15 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.851 1.205 . . . . 2.65 114.092 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.7 t -75.19 -28.36 59.99 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.515 1.126 . . . . 2.2 112.242 169.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.73 166.98 38.05 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.944 1.259 . . . . 1.1 112.786 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -85.76 35.73 0.63 Allowed 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.947 -1.325 . . . . 2.0 111.743 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -75.64 4.77 7.11 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.938 1.088 . . . . 3.2 113.938 -171.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.72 -30.87 71.04 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.517 1.127 . . . . 1.64 110.003 164.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.32 -76.56 0.75 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.358 1.456 . . . . 0.78 112.51 171.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.254 0.0 OUTLIER -71.01 154.74 41.56 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.212 1.56 . . . . 1.81 115.212 -169.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.56 151.05 29.74 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.949 0.9 . . . . 6.13 112.522 -177.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.6 t -60.36 123.3 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 109.751 -0.463 . . . . 1.97 109.751 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.84 -53.45 40.77 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.262 0.458 . . . . 1.26 113.823 -170.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.8 t -150.5 127.73 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.942 1.697 . . . . 3.8 108.408 171.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.8 mt -75.99 152.55 84.53 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.343 1.057 . . . . 1.78 112.808 173.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.35 162.72 41.48 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.396 2.064 . . . . 0.71 112.071 175.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.4 -30.9 69.89 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.373 -0.829 . . . . 2.06 111.916 170.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.29 5.66 8.16 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 115.68 1.733 . . . . 2.11 115.68 173.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.84 157.02 21.9 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.433 1.493 . . . . 0.65 113.435 170.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -148.02 169.55 19.68 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.427 1.491 . . . . 2.59 111.736 169.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -121.11 139.12 53.76 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.798 1.239 . . . . 1.91 110.288 -173.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.3 pt -127.98 142.36 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 121.421 -0.799 . . . . 1.41 112.272 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.98 145.25 43.77 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.012 1.325 . . . . 1.84 111.699 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.16 23.98 6.16 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.225 1.393 . . . . 0.91 114.969 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.3 p -109.78 142.86 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 127.373 2.269 . . . . 1.98 110.337 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.0 tpp -98.78 143.79 28.73 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.36 1.464 . . . . 1.86 113.415 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -148.09 151.94 36.5 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.672 1.589 . . . . 2.83 111.512 174.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 m -125.29 144.9 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.166 1.786 . . . . 1.73 110.153 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -86.04 149.06 25.43 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.69 1.233 . . . . 0.41 112.477 170.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.0 p -144.45 170.92 15.11 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.737 2.015 . . . . 1.72 111.661 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.66 177.52 5.99 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.208 1.003 . . . . 2.22 113.121 169.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 42.3 p -59.96 -29.8 68.66 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.84 0.856 . . . . 1.91 113.225 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -78.06 13.74 1.35 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.896 1.279 . . . . 2.51 113.823 173.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.7 28.19 15.44 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.332 1.853 . . . . 0.93 112.044 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -88.62 138.58 31.29 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.086 1.754 . . . . 2.1 110.466 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -78.2 127.22 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.818 -0.438 . . . . 1.69 109.818 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.0 pt -120.69 157.31 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.812 1.245 . . . . 1.1 114.109 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -86.16 163.92 17.54 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.409 1.884 . . . . 1.85 110.473 166.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -61.42 -12.72 15.65 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.981 1.474 . . . . 2.29 114.981 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -94.71 0.25 54.86 Favored 'General case' 0 CA--C 1.55 0.947 0 O-C-N 120.656 -1.277 . . . . 3.89 112.165 172.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.18 7.47 86.81 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 126.092 1.806 . . . . 0.6 115.293 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -64.55 131.17 46.29 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.599 1.2 . . . . 2.67 107.974 168.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.9 p -89.95 145.94 24.75 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.66 0.664 . . . . 1.93 110.605 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.94 -6.07 49.37 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.177 0.806 . . . . 1.78 113.177 -169.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.71 32.43 57.25 Favored Glycine 0 CA--C 1.531 1.073 0 O-C-N 121.399 -0.813 . . . . 1.01 112.468 -173.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.1 t -135.7 148.53 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.797 1.639 . . . . 2.05 109.805 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -135.97 154.69 51.01 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.473 2.309 . . . . 1.65 111.079 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 54.8 mt -132.77 134.9 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.99 1.316 . . . . 1.94 112.248 -171.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -69.25 135.12 89.05 Favored Pre-proline 0 CA--C 1.546 0.804 0 O-C-N 120.635 -1.291 . . . . 2.13 111.166 170.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.65 -17.71 25.99 Favored 'Trans proline' 0 C--N 1.35 0.617 0 CA-C-N 122.548 1.946 . . . . 1.16 113.657 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -96.08 -43.66 7.67 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.009 1.723 . . . . 1.9 112.555 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.3 p -94.24 -22.55 18.34 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.5 1.12 . . . . 2.26 113.948 -174.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 53.95 20.41 2.39 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 125.421 1.488 . . . . 3.92 113.975 -169.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.73 144.77 31.94 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.404 -1.435 . . . . 4.0 111.511 176.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 mt -90.42 148.24 22.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.899 1.68 . . . . 1.16 112.073 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.2 p -74.28 9.75 1.54 Allowed 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.152 1.167 . . . . 1.9 114.152 170.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.32 -160.47 24.63 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 126.081 1.801 . . . . 1.18 113.034 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.89 160.91 21.02 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.808 1.243 . . . . 1.64 112.101 172.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -52.27 130.92 42.59 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.378 1.071 . . . . 2.06 113.484 -174.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -68.94 152.35 73.49 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.975 3.117 . . . . 1.03 114.368 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.31 -64.27 0.89 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.763 1.225 . . . . 1.05 113.653 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.7 p -101.61 7.78 42.03 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.173 1.546 . . . . 1.79 115.173 -168.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.78 146.67 13.22 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.205 1.187 . . . . 0.61 114.205 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.6 ttt -77.06 89.36 3.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.942 1.697 . . . . 2.14 111.513 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -143.87 145.16 32.11 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.894 1.678 . . . . 2.09 112.244 -174.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -164.85 159.88 18.86 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.89 1.676 . . . . 2.87 111.046 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.38 146.97 26.89 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.815 1.246 . . . . 1.21 113.365 174.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.2 p -65.05 125.82 26.13 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.533 -0.73 . . . . 1.33 110.814 172.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -87.94 -57.53 2.9 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.471 1.286 . . . . 2.7 114.471 -172.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -151.11 -41.25 0.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.02 0.928 . . . . 2.46 111.654 -172.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -118.62 -22.44 7.49 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.83 1.252 . . . . 4.4 113.503 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 171.52 -160.0 31.84 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 126.079 1.799 . . . . 0.87 111.326 -175.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -139.9 132.94 29.51 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.657 1.983 . . . . 1.27 111.272 169.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.404 ' HE3' ' CB ' ' A' ' 36' ' ' SER . 71.4 tttt -87.32 139.91 30.08 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.299 1.44 . . . . 2.82 113.72 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -132.32 129.79 39.95 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.538 2.735 . . . . 3.0 108.594 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -92.55 120.78 33.34 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.515 -0.741 . . . . 1.74 110.092 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.6 p -103.42 -2.0 27.63 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.398 1.479 . . . . 1.77 113.367 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -52.68 -29.25 25.49 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.872 1.269 . . . . 1.62 113.521 173.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -97.42 -15.54 20.6 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.113 1.765 . . . . 2.74 114.437 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.52 154.8 81.55 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 119.623 1.101 . . . . 0.81 113.064 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -82.72 170.2 12.93 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.303 2.669 . . . . 0.78 110.419 165.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.94 98.85 3.67 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.752 1.221 . . . . 1.18 109.956 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -153.29 179.08 9.08 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.025 0.93 . . . . 1.54 111.878 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -91.12 150.88 21.21 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.091 1.356 . . . . 3.23 111.211 168.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -146.13 170.7 16.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.28 1.832 . . . . 0.67 110.056 -173.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -140.64 154.63 46.5 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.043 0.937 . . . . 2.63 113.043 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.9 mp -114.94 141.52 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.907 1.283 . . . . 1.82 110.768 172.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -126.9 117.97 23.63 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.075 2.15 . . . . 3.2 110.571 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -82.53 75.4 9.44 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.251 1.02 . . . . 1.79 111.398 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 40.7 mm -71.54 114.26 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 123.232 0.613 . . . . 2.1 109.383 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.36 -5.84 59.28 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.995 1.48 . . . . 5.36 114.995 -169.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.6 m -51.78 -35.91 45.65 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.536 1.535 . . . . 2.15 114.054 -177.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.11 -9.0 34.88 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.143 1.164 . . . . 3.29 114.143 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 74.8 m -58.31 135.19 57.11 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.706 1.139 . . . . 7.33 111.935 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.3 t -125.64 -7.69 6.82 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.451 1.5 . . . . 5.31 114.066 -169.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -65.6 161.03 21.23 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.761 0.825 . . . . 5.6 111.784 171.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.4 138.96 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.542 0.737 . . . . 4.8 112.716 -174.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -120.31 -17.31 4.46 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.953 1.263 . . . . 3.23 114.115 174.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -93.74 -8.92 39.34 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.208 2.203 . . . . 5.94 115.19 -173.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -96.8 30.54 2.62 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.36 1.064 . . . . 7.1 113.35 -172.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 110.58 -13.78 30.09 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.403 1.477 . . . . 6.06 115.361 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.62 167.91 5.29 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.279 1.432 . . . . 4.24 113.394 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 15.3 t -110.66 69.34 0.69 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.708 1.242 . . . . 4.74 109.841 172.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.0 tt -133.99 122.96 23.79 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.679 1.192 . . . . 3.11 111.232 -167.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 15.2 t -85.18 140.14 31.13 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.094 0.958 . . . . 3.6 113.39 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -81.62 49.2 4.0 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.938 1.732 . . . . 2.57 114.517 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 88.5 p -63.2 166.59 5.95 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 117.147 2.277 . . . . 4.26 117.147 -169.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.73 116.22 32.25 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.276 1.83 . . . . 3.28 111.828 172.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.6 147.32 35.71 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.103 0.561 . . . . 1.27 111.212 168.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.7 m -110.86 151.93 43.24 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.761 1.224 . . . . 2.32 110.002 172.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.71 161.22 46.81 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.52 2.147 . . . . 0.93 113.378 -170.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.3 mp -124.87 128.66 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.783 1.233 . . . . 2.79 110.522 -169.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -96.0 138.29 33.83 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.244 1.018 . . . . 2.98 112.955 172.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.4 tt -143.43 151.2 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.376 1.47 . . . . 1.57 111.863 -172.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -130.03 149.87 51.56 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.756 1.622 . . . . 2.08 109.373 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 15.2 mt -65.71 154.68 88.12 Favored Pre-proline 0 N--CA 1.478 0.95 0 N-CA-C 115.008 1.484 . . . . 1.49 115.008 -168.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.8 102.85 1.25 Allowed 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 123.296 2.664 . . . . 0.81 114.437 -168.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 16.1 mt -137.39 21.08 2.95 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.262 2.625 . . . . 3.8 110.86 170.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -85.78 19.72 2.41 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.958 1.703 . . . . 3.4 113.106 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 21.1 t70 61.72 25.72 15.54 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.674 2.39 . . . . 3.59 114.367 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 16.5 m -99.1 144.48 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.979 1.312 . . . . 1.45 113.093 -174.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 57.6 t -70.78 -34.61 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.705 0.802 . . . . 2.1 111.511 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -140.59 142.34 35.1 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.177 1.391 . . . . 2.68 111.807 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -107.38 141.67 38.4 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.411 1.085 . . . . 1.25 112.661 -174.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -140.59 166.74 23.92 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.595 1.702 . . . . 0.72 115.595 -175.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.91 139.77 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.421 1.888 . . . . 1.05 111.56 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -133.33 74.38 72.21 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.723 1.209 . . . . 3.49 113.373 -177.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.81 152.13 77.77 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 124.976 3.784 . . . . 0.73 113.622 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -133.19 -156.94 0.78 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.389 2.676 . . . . 3.09 111.008 -167.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -144.15 163.59 33.16 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.41 1.484 . . . . 3.9 112.08 168.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 4.6 t -127.89 -30.13 2.52 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.45 1.278 . . . . 2.48 114.45 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -145.96 169.57 18.36 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.043 1.127 . . . . 6.42 114.043 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -79.17 146.71 32.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.132 0.973 . . . . 6.31 112.305 170.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 3.0 pptp? -142.5 152.43 60.15 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 125.422 1.489 . . . . 14.27 110.49 170.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.77 129.83 14.97 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.319 2.013 . . . . 10.98 112.148 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -85.33 -40.66 16.28 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.732 0.641 . . . . 18.54 112.732 168.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.524 HD12 ' H ' ' A' ' 191' ' ' ILE . 1.8 mp -73.7 -49.3 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.4 1.08 . . . . 16.31 110.575 -175.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.2 tt 48.4 101.24 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 129.272 3.029 . . . . 14.78 113.732 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 . . . . . 0 CA--C 1.539 0.553 0 C-N-CA 124.151 0.98 . . . . 15.93 112.42 -178.324 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.024 -0.732 . . . . 27.35 109.024 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -81.46 -26.4 35.3 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.799 0.727 . . . . 29.03 111.605 168.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.4 m -51.48 141.04 16.58 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.928 1.291 . . . . 23.68 111.877 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.52 154.95 5.88 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.379 1.072 . . . . 19.81 113.429 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.2 t -132.87 150.64 52.14 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.064 1.345 . . . . 17.74 111.207 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 54.05 60.1 3.82 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.212 1.805 . . . . 13.6 114.493 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.54 -20.27 64.49 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.48 1.289 . . . . 13.0 114.48 174.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.9 p -129.74 70.98 1.43 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.323 1.849 . . . . 11.41 110.667 -168.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.1 p -56.58 142.91 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 117.332 2.345 . . . . 7.32 117.332 -167.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -136.6 177.03 8.17 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 129.195 2.998 . . . . 4.54 108.815 168.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.67 139.75 40.43 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.534 1.134 . . . . 4.12 111.299 172.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.82 105.66 4.52 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.681 1.192 . . . . 6.07 111.936 -173.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.86 67.53 3.38 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.656 1.122 . . . . 2.48 112.899 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.5 p -136.44 170.54 15.89 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.745 1.618 . . . . 2.03 114.467 -169.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.3 p -93.22 -14.55 26.94 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.755 0.822 . . . . 2.44 112.89 169.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.474 HG23 ' H ' ' A' ' 36' ' ' SER . 9.3 m -146.38 148.26 32.15 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.201 2.2 . . . . 2.59 109.708 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 p -111.45 16.65 20.67 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.964 1.706 . . . . 2.83 113.937 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.474 ' H ' HG23 ' A' ' 34' ' ' THR . 29.0 m -147.6 159.75 43.42 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.347 1.459 . . . . 2.4 111.736 170.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -136.04 144.12 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.615 1.966 . . . . 1.54 110.209 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.0 m -120.75 125.8 48.54 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.564 0.746 . . . . 1.76 111.512 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p -100.28 138.15 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.571 1.148 . . . . 2.06 111.183 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -136.21 113.71 10.88 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.364 1.465 . . . . 1.75 113.091 -171.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -81.79 127.43 32.96 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.043 -1.661 . . . . 2.72 113.069 -174.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.9 mt -114.25 155.36 26.29 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.552 1.541 . . . . 1.22 112.767 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.5 mt -141.19 173.14 11.77 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.409 1.884 . . . . 2.28 110.265 168.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.96 172.56 6.95 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.501 1.121 . . . . 1.34 112.032 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.4 p -95.91 -31.75 12.96 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.042 0.756 . . . . 2.16 113.042 170.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -143.02 52.03 1.39 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.656 1.582 . . . . 2.61 111.414 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.22 16.36 77.0 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 124.602 1.096 . . . . 1.1 115.52 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.75 12.97 0.16 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.118 2.167 . . . . 2.16 115.302 -174.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -61.53 -29.27 69.89 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 120.567 -1.333 . . . . 0.97 112.27 -173.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -75.9 -40.46 54.31 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.643 1.177 . . . . 2.26 113.247 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -72.66 -38.64 67.58 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-O 117.945 -1.026 . . . . 3.06 111.782 170.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 71.8 mt -53.23 -50.98 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.396 1.078 . . . . 1.03 110.28 167.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.32 -31.11 68.86 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.731 1.151 . . . . 1.15 112.571 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -77.81 -26.9 49.87 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.124 1.157 . . . . 1.26 114.124 171.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -71.21 -30.77 66.79 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.754 -1.216 . . . . 1.99 111.929 168.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.2 mt -90.63 -40.26 12.01 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.727 1.38 . . . . 1.09 114.727 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -67.27 -25.18 65.94 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 120.123 1.329 . . . . 2.91 112.714 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.7 t -80.2 -3.28 48.42 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.215 1.806 . . . . 2.67 112.961 173.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.34 160.88 14.9 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 126.321 1.915 . . . . 1.06 112.164 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -79.29 35.56 0.27 Allowed 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.111 -1.229 . . . . 1.99 113.153 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -78.45 7.7 6.24 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.447 1.099 . . . . 3.47 113.599 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.54 -31.38 67.88 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.115 1.366 . . . . 1.91 110.488 165.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.34 -48.34 0.15 Allowed Glycine 0 C--N 1.344 1.005 0 CA-C-O 119.748 -0.473 . . . . 1.12 114.007 171.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -67.91 145.83 54.2 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.636 0.718 . . . . 3.21 111.648 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -68.34 149.09 49.83 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.04 0.836 . . . . 4.0 112.144 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 69.5 t -59.81 126.28 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 122.832 0.453 . . . . 1.7 111.313 -173.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.19 -50.71 31.71 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.107 1.337 . . . . 0.96 113.924 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 98.3 t -142.73 120.12 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.097 1.359 . . . . 2.66 110.198 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.4 mt -82.91 141.92 44.4 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.26 0.624 . . . . 1.39 110.137 168.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.8 161.24 42.92 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 121.381 1.388 . . . . 0.64 112.36 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.56 -26.87 65.74 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.358 -0.839 . . . . 1.64 112.233 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.77 5.39 40.27 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.948 1.699 . . . . 1.93 115.292 174.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.16 152.75 21.07 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.739 1.215 . . . . 0.68 111.189 168.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -142.73 164.47 30.01 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.093 1.357 . . . . 3.46 111.74 174.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -125.35 134.7 52.1 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.984 1.313 . . . . 2.26 110.534 -169.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.8 pt -136.33 151.41 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.833 1.253 . . . . 1.76 111.832 -176.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -119.86 174.04 6.69 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.44 1.496 . . . . 1.71 111.964 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.24 12.96 64.61 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.504 1.526 . . . . 0.53 115.532 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.9 p -96.71 146.06 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.174 1.39 . . . . 1.65 111.336 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 15.1 tpp -101.9 138.69 38.54 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.056 2.142 . . . . 1.76 112.223 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -145.73 152.78 40.13 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.565 1.546 . . . . 2.88 111.919 177.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.45 145.76 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 126.802 2.041 . . . . 1.46 110.494 -174.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -87.8 146.26 25.71 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 122.552 1.168 . . . . 0.42 113.084 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.8 p -143.26 167.87 21.13 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.104 1.761 . . . . 1.63 112.793 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -92.0 175.3 6.92 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.201 1.001 . . . . 2.22 112.328 168.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.8 p -67.94 -20.27 65.05 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.382 -1.449 . . . . 2.67 113.657 -174.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -80.65 14.07 2.27 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.505 1.122 . . . . 2.12 111.976 167.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.41 31.85 19.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.944 2.497 . . . . 0.58 113.213 175.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -87.23 138.96 31.04 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.322 1.049 . . . . 2.34 110.489 176.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.9 mt -76.53 124.06 34.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.788 -0.819 . . . . 1.93 108.788 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.1 pt -118.86 154.69 21.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 123.169 1.461 . . . . 1.98 113.432 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.56 160.12 19.72 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.298 2.239 . . . . 2.68 108.041 166.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.54 -13.25 28.72 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.949 1.463 . . . . 2.1 114.949 -169.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -93.87 2.55 56.14 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.711 1.204 . . . . 3.46 111.668 176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.39 3.27 81.84 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.701 1.619 . . . . 0.56 114.69 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -68.93 142.76 54.63 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 123.98 0.912 . . . . 2.52 109.676 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 30.4 p -102.58 145.35 29.75 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.161 0.984 . . . . 1.68 111.553 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -97.95 -4.5 36.22 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.907 1.077 . . . . 1.49 113.907 -170.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.0 25.3 45.5 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.029 0.824 . . . . 0.69 113.412 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 p -141.06 152.31 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.07 1.348 . . . . 3.92 109.687 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -138.21 155.47 48.63 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 128.471 2.709 . . . . 1.34 110.193 -169.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 47.3 mt -136.36 131.23 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.3 1.44 . . . . 1.87 110.668 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -75.25 138.83 71.79 Favored Pre-proline 0 N--CA 1.476 0.844 0 O-C-N 121.124 -0.985 . . . . 2.26 110.759 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.03 -24.07 28.84 Favored 'Trans proline' 0 C--N 1.35 0.648 0 CA-C-N 121.737 1.656 . . . . 0.96 112.743 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -90.18 -47.6 7.7 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.255 1.422 . . . . 1.35 111.73 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.4 p -84.23 -27.37 28.0 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.524 0.73 . . . . 2.31 112.961 -174.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 54.99 25.39 6.83 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.07 1.348 . . . . 2.97 113.041 -172.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.83 153.79 19.5 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.164 1.385 . . . . 3.25 111.616 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 18.0 mt -92.52 140.67 29.32 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.186 1.794 . . . . 2.09 112.918 -172.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.9 p -71.49 -3.01 18.77 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.989 1.316 . . . . 1.6 114.492 172.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.14 -162.01 16.54 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 126.599 2.047 . . . . 0.89 111.379 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.67 167.91 20.81 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.696 1.199 . . . . 2.05 112.829 173.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.7 mmt -57.34 143.23 74.34 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.868 1.267 . . . . 2.29 113.586 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -79.61 165.98 22.24 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.867 3.711 . . . . 0.77 114.045 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.86 -48.62 9.16 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.344 1.609 . . . . 1.31 115.344 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.4 p -130.38 13.89 5.55 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.243 1.417 . . . . 2.23 113.807 -169.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.22 148.11 6.85 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.479 0.918 . . . . 0.55 113.479 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 7.2 ttt -74.02 106.32 5.66 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 126.867 2.067 . . . . 1.81 110.237 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.5 pttp -158.86 151.49 21.84 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.387 1.475 . . . . 1.9 112.16 -172.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -161.98 171.74 17.12 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.682 1.193 . . . . 2.4 110.919 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.5 mp -113.01 144.42 42.62 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.874 1.269 . . . . 0.76 112.038 170.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.5 p -73.27 133.88 44.07 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.037 0.835 . . . . 1.35 111.295 173.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -94.77 -52.88 4.08 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.02 1.489 . . . . 2.23 115.02 -171.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -175.07 -32.1 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 128.176 2.59 . . . . 1.85 110.881 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -116.5 24.38 11.37 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.889 2.076 . . . . 4.45 112.181 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.55 -158.76 22.21 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.788 1.661 . . . . 0.86 113.794 -173.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -136.66 132.39 34.91 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.983 2.113 . . . . 1.69 111.834 169.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -91.27 134.06 34.89 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.097 1.359 . . . . 2.07 113.534 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -127.31 119.09 25.48 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.46 2.704 . . . . 2.89 108.21 176.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -84.12 124.48 31.17 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.153 -0.967 . . . . 1.91 109.765 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 47.5 p -108.94 5.56 24.45 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.828 1.651 . . . . 1.78 113.589 -170.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.17 -27.46 54.45 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.829 0.852 . . . . 1.84 112.968 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -89.52 -13.46 37.33 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.911 1.284 . . . . 2.49 113.074 -173.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -83.53 145.3 47.62 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 114.02 1.119 . . . . 0.76 114.02 175.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.33 166.96 21.92 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.406 2.071 . . . . 0.83 110.968 165.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.39 82.95 3.13 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.458 1.903 . . . . 2.32 111.598 -174.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -138.63 -177.27 4.79 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.676 1.191 . . . . 1.8 111.625 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -93.18 151.49 19.8 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.712 0.768 . . . . 4.83 111.201 167.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -142.0 169.13 18.17 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.024 2.13 . . . . 0.71 109.647 -173.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -139.41 145.31 38.76 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.16 0.984 . . . . 2.59 112.001 174.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -102.82 138.1 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.152 0.981 . . . . 1.74 109.572 171.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -121.69 133.88 54.96 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.893 1.677 . . . . 3.19 110.24 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -99.83 124.65 45.34 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.459 1.104 . . . . 1.9 110.185 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 15.6 mm -132.35 110.55 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.044 0.937 . . . . 1.88 110.281 -169.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -73.2 -11.15 60.42 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 120.408 -1.432 . . . . 4.74 114.158 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 2.9 m -74.72 -10.27 59.37 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 115.644 1.72 . . . . 2.21 115.644 -169.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 57.9 tp -129.12 67.98 1.41 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.594 1.958 . . . . 3.24 109.125 -173.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 32.8 t 69.08 137.76 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 128.019 2.528 . . . . 6.01 113.639 -166.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.1 t -158.11 147.64 19.72 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.681 0.753 . . . . 6.63 112.386 172.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -66.89 162.04 22.65 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 107.612 -1.255 . . . . 7.94 107.612 164.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.5 p -118.12 122.43 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.632 0.73 . . . . 4.31 111.561 176.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -97.81 -54.71 1.19 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.076 1.322 . . . . 2.45 111.942 175.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -62.79 -11.49 18.18 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.541 1.682 . . . . 5.11 115.541 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.67 -24.14 65.4 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.959 1.304 . . . . 4.82 113.644 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 148.95 1.26 0.42 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.757 1.17 . . . . 4.16 115.07 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.55 170.35 13.56 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.861 1.664 . . . . 3.0 111.291 169.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.8 m -84.37 35.11 0.53 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.412 -1.43 . . . . 3.44 112.738 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.89 177.06 11.76 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.964 1.706 . . . . 3.42 111.898 -175.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.9 t -147.01 153.69 40.33 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.53 1.532 . . . . 5.5 111.088 173.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.452 ' HA3' ' HE3' ' A' ' 190' ' ' LYS . . . -76.68 55.27 3.38 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.771 1.177 . . . . 4.87 114.451 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 11.1 p -65.09 164.42 13.01 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.234 2.213 . . . . 3.53 115.684 -174.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -70.58 98.29 1.46 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.41 1.884 . . . . 3.15 111.149 -172.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.87 139.15 42.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.109 0.964 . . . . 2.17 110.672 171.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.9 m -99.78 145.97 31.06 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 123.883 0.873 . . . . 1.18 110.312 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.63 132.98 21.31 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.553 2.169 . . . . 0.7 111.943 -169.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.1 mp -95.95 115.62 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 124.559 1.143 . . . . 2.18 108.415 -171.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -84.82 142.36 29.82 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.022 0.374 . . . . 3.09 111.628 172.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.4 tt -146.36 150.02 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.926 1.29 . . . . 1.51 110.648 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -122.05 157.23 31.86 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.341 1.457 . . . . 2.12 109.862 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.31 143.93 92.27 Favored Pre-proline 0 CA--C 1.545 0.77 0 O-C-N 120.905 -1.122 . . . . 2.63 111.64 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.27 110.75 1.63 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.662 2.908 . . . . 0.84 112.221 -169.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 20.0 tp -143.0 56.57 1.4 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.468 1.907 . . . . 3.93 109.589 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -144.95 23.31 1.54 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.472 1.509 . . . . 3.5 112.594 -169.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 54.03 32.39 15.45 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 127.124 2.169 . . . . 4.17 114.113 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.3 m -91.57 147.26 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.52 1.128 . . . . 1.98 110.127 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.84 -39.73 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.402 0.681 . . . . 2.24 110.025 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -128.13 137.26 52.03 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.905 1.682 . . . . 3.01 109.921 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -96.29 144.75 26.18 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.667 0.787 . . . . 1.24 111.82 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -137.99 171.5 14.33 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.991 1.478 . . . . 0.65 114.991 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -139.4 142.7 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 127.204 2.202 . . . . 2.0 110.669 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -130.31 74.66 80.13 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 113.742 1.015 . . . . 3.26 113.742 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.63 148.91 90.51 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 124.367 3.378 . . . . 0.79 112.972 175.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -136.69 -155.86 0.65 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.932 2.093 . . . . 3.2 109.876 -168.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -134.74 164.32 27.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.518 1.527 . . . . 4.07 109.096 166.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 7.5 t -123.94 -27.38 3.92 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.361 0.875 . . . . 2.5 113.361 169.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -133.65 142.81 48.23 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.641 1.976 . . . . 6.22 109.224 -174.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -104.4 9.05 35.87 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.938 1.459 . . . . 7.04 114.938 -169.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -56.01 141.86 66.73 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 112.614 0.598 . . . . 10.66 112.614 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -72.02 153.75 57.73 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.122 2.548 . . . . 10.07 112.107 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.452 ' HE3' ' HA3' ' A' ' 160' ' ' GLY . 21.4 pttp -94.57 -23.13 17.79 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.243 1.201 . . . . 18.11 114.243 174.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.05 -23.44 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 114.482 1.29 . . . . 17.02 114.482 176.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 53.06 36.13 21.38 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 127.062 2.145 . . . . 12.24 114.705 176.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 . . . . . 0 C--N 1.324 -0.508 0 C-N-CA 126.114 1.765 . . . . 17.45 110.349 177.596 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 113.358 0.873 . . . . 30.93 113.358 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -117.76 155.72 29.54 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.812 1.645 . . . . 27.74 112.272 -172.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.9 m -73.22 145.57 46.13 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.675 1.19 . . . . 22.23 112.858 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.81 -6.46 0.51 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.917 1.687 . . . . 19.58 114.19 173.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 p -131.43 -173.58 3.16 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.729 -1.232 . . . . 16.12 113.359 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.17 -4.73 59.0 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.24 1.016 . . . . 11.95 113.503 173.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.26 -136.63 1.09 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.601 1.56 . . . . 12.22 113.76 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.2 p -70.72 152.89 43.34 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.172 1.389 . . . . 11.95 113.716 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 p -60.98 133.95 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.017 1.727 . . . . 9.14 113.605 -173.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -75.01 177.15 6.56 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.869 1.268 . . . . 4.75 112.234 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.58 157.41 0.07 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.045 2.138 . . . . 5.07 115.203 -175.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.56 18.72 2.71 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.211 1.804 . . . . 6.86 113.923 -175.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.7 17.2 62.3 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.517 2.008 . . . . 3.78 116.65 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 67.4 p -73.68 172.42 11.48 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.447 1.899 . . . . 2.62 115.676 -168.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.6 p -85.57 -23.68 27.54 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 114.412 1.264 . . . . 2.6 114.412 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.7 t -132.59 158.28 42.61 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 128.442 2.697 . . . . 2.91 109.126 172.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.6 p -110.47 8.09 22.96 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.408 1.483 . . . . 1.75 113.595 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.2 m -137.52 163.47 31.08 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.938 1.295 . . . . 2.32 111.11 168.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.14 140.43 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.291 1.836 . . . . 1.44 109.457 173.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.6 m -115.95 121.32 41.95 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.236 0.615 . . . . 1.92 111.388 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -99.55 137.49 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.929 1.292 . . . . 1.9 111.364 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -134.54 112.27 10.74 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.335 1.454 . . . . 1.69 111.372 -174.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.73 126.86 35.52 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 120.541 -1.349 . . . . 2.15 112.468 -171.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.7 mt -116.28 150.88 36.89 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.048 1.339 . . . . 1.84 112.855 -171.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.0 mt -140.97 178.93 7.02 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.849 2.059 . . . . 2.05 110.081 168.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.07 160.93 18.36 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.901 1.28 . . . . 2.08 112.44 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -89.14 -21.21 23.45 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 114.863 1.431 . . . . 1.71 114.863 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -129.23 28.67 5.23 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.31 1.444 . . . . 2.45 111.132 168.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.71 15.31 80.76 Favored Glycine 0 CA--C 1.538 1.501 0 O-C-N 120.456 -1.402 . . . . 1.04 114.792 -177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.56 28.6 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 129.744 3.218 . . . . 1.98 117.069 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -18.56 65.15 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.07 -1.643 . . . . 1.05 113.56 -172.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -81.89 -45.34 15.6 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.393 0.997 . . . . 2.23 112.678 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -66.28 -43.6 85.95 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.549 1.068 . . . . 3.37 111.167 172.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.2 mt -50.14 -49.34 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.106 0.962 . . . . 1.95 110.997 169.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.62 70.86 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 120.043 1.292 . . . . 1.06 113.479 178.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -74.75 -31.05 61.68 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.217 -0.927 . . . . 1.03 113.21 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -65.54 -18.21 65.15 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.26 -0.9 . . . . 2.06 112.514 169.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.4 mt -95.43 -36.81 11.2 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 114.453 1.279 . . . . 1.52 114.453 176.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -64.85 -19.81 66.08 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.836 1.198 . . . . 2.85 113.759 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.5 t -72.22 -19.52 61.71 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.687 1.365 . . . . 2.1 114.687 170.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.41 179.22 33.27 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.878 1.704 . . . . 1.54 114.801 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -102.64 36.17 2.26 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.852 1.261 . . . . 3.91 111.21 174.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -74.11 3.98 6.24 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 115.18 1.548 . . . . 3.5 115.18 -168.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.58 -19.95 63.66 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 121.283 -0.886 . . . . 1.65 112.08 168.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.6 -65.86 0.37 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.139 1.352 . . . . 1.03 112.288 169.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.283 0.0 OUTLIER -76.89 155.37 32.91 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.831 1.419 . . . . 1.93 114.831 -173.032 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -56.98 154.08 10.19 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.327 0.651 . . . . 3.3 112.505 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.49 129.73 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 109.835 -0.432 . . . . 2.21 109.835 171.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.47 -55.09 16.42 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 122.932 0.301 . . . . 1.21 112.853 -176.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.0 t -141.66 121.89 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.029 0.932 . . . . 2.43 109.855 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.0 mt -78.63 137.35 58.83 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-O 118.919 -0.562 . . . . 1.84 109.528 168.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.56 166.36 29.62 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.859 2.373 . . . . 0.7 112.712 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -51.59 -41.95 61.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.263 0.625 . . . . 2.25 112.547 172.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -76.21 -3.07 34.37 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.894 2.078 . . . . 1.87 115.657 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.05 153.7 18.55 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.563 1.074 . . . . 0.64 113.344 172.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.6 pttt -144.7 167.01 23.58 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.883 1.673 . . . . 3.24 111.824 171.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -122.02 151.7 40.55 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.275 1.43 . . . . 2.1 110.061 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.7 pt -139.97 137.65 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.356 0.662 . . . . 1.52 111.528 171.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -112.68 161.39 16.91 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.592 1.557 . . . . 1.86 112.276 173.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.71 29.19 36.13 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.136 1.351 . . . . 0.66 113.423 -170.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 p -107.95 141.93 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.618 1.967 . . . . 1.66 109.195 169.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -104.98 137.47 42.68 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.695 1.598 . . . . 1.58 112.354 -173.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -143.52 152.86 41.97 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.545 1.138 . . . . 3.53 111.784 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.13 144.85 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.968 2.107 . . . . 1.54 109.612 -174.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -85.9 147.64 26.17 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 122.886 1.326 . . . . 0.45 112.462 169.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.6 p -142.32 171.23 14.34 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.783 2.033 . . . . 1.5 111.747 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.16 -178.92 4.63 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.048 1.129 . . . . 2.08 114.048 171.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.9 p -59.16 -28.08 66.26 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.899 1.074 . . . . 2.26 113.899 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -85.54 16.73 3.64 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.48 1.112 . . . . 2.17 113.12 173.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 58.76 24.89 12.79 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.07 2.148 . . . . 0.66 112.901 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -88.03 137.03 32.69 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.845 1.258 . . . . 2.23 110.747 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.4 mt -72.26 124.19 28.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.358 -0.608 . . . . 1.51 109.358 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.2 pt -113.21 152.15 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 125.543 1.537 . . . . 1.04 115.109 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -81.21 160.66 24.25 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.647 2.379 . . . . 1.38 108.944 165.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -62.48 -15.46 50.12 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.754 -1.216 . . . . 1.95 114.043 -176.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -89.19 3.45 51.88 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.173 1.389 . . . . 3.63 112.675 174.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.47 0.07 89.32 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 126.494 1.997 . . . . 0.62 115.24 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -68.08 136.74 54.24 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.76 1.224 . . . . 2.52 109.984 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.2 p -98.33 145.68 26.44 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.456 0.702 . . . . 1.8 111.225 -175.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -94.5 -7.64 40.7 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.428 1.27 . . . . 2.01 114.428 -168.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.14 30.16 47.62 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 118.935 0.789 . . . . 0.78 113.797 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.8 t -140.22 145.2 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.677 1.591 . . . . 1.75 109.235 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -125.86 162.84 24.25 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.439 2.696 . . . . 1.49 111.015 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.6 mt -135.24 135.35 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.597 1.159 . . . . 1.57 110.947 -173.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.45 143.74 90.8 Favored Pre-proline 0 N--CA 1.477 0.904 0 CA-C-O 117.424 -1.274 . . . . 2.25 111.225 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.84 -20.76 10.17 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 122.325 1.866 . . . . 1.17 112.944 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -88.97 -47.01 8.43 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.089 0.955 . . . . 1.47 112.315 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.5 p -92.8 -28.5 16.52 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.41 1.084 . . . . 2.05 113.242 -172.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 57.25 19.01 4.6 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.407 1.483 . . . . 3.71 113.677 -167.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 146.63 49.73 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.018 -1.676 . . . . 4.43 110.376 172.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.3 mt -86.68 138.88 31.3 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.338 1.055 . . . . 0.99 111.314 176.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.1 p -71.49 0.23 8.89 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.132 1.16 . . . . 1.95 114.132 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -171.93 -156.54 12.3 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 127.367 2.413 . . . . 1.26 111.5 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.32 171.83 12.97 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.86 1.059 . . . . 2.15 113.86 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.4 tpt -66.41 136.72 95.13 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.985 0.914 . . . . 2.06 109.629 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.39 164.99 25.94 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.793 2.329 . . . . 0.87 113.329 -174.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.8 -77.23 0.26 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.592 1.157 . . . . 2.27 112.346 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 69.3 p -83.07 5.83 21.05 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.656 2.095 . . . . 2.22 116.656 -167.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.67 143.0 43.14 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.203 1.557 . . . . 0.57 115.203 -171.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.6 ttt -74.34 102.27 4.33 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.626 1.97 . . . . 1.8 111.036 177.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -153.64 146.8 24.66 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.955 1.302 . . . . 1.71 112.368 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -161.01 157.5 26.37 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.798 1.239 . . . . 2.65 110.613 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 mp -91.91 144.59 25.32 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.048 0.939 . . . . 0.96 112.677 168.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.0 p -65.01 131.43 46.57 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.754 -0.591 . . . . 1.25 109.43 169.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -85.83 -56.25 3.57 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.361 0.875 . . . . 2.51 113.361 -173.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -159.79 -45.79 0.05 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.251 1.421 . . . . 2.13 110.122 169.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -89.35 -18.81 26.16 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.273 1.029 . . . . 4.79 113.191 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 153.43 -159.55 28.68 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.879 2.181 . . . . 0.78 110.718 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.81 132.12 23.42 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.907 2.083 . . . . 1.64 110.237 168.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -93.34 143.45 26.26 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.605 0.965 . . . . 3.14 113.605 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -128.75 121.96 29.57 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 127.276 2.23 . . . . 3.42 107.274 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -83.33 106.34 15.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 118.433 0.56 . . . . 1.67 109.768 -173.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.1 p -84.28 -5.12 59.22 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.831 1.048 . . . . 1.63 113.831 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -55.1 -20.08 9.03 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.894 1.442 . . . . 2.03 114.894 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -96.17 -15.11 22.28 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.091 1.356 . . . . 2.62 113.635 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -80.64 151.62 71.6 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 119.908 1.231 . . . . 0.94 113.427 176.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.88 170.38 9.95 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.597 2.865 . . . . 1.11 111.208 166.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.42 98.07 1.74 Allowed 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.59 1.156 . . . . 2.48 109.414 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -153.12 177.54 10.7 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.631 1.173 . . . . 2.13 111.78 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -90.49 151.34 21.41 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.38 1.072 . . . . 3.45 112.663 168.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -144.69 174.4 11.01 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.84 2.056 . . . . 0.7 110.892 -174.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -142.7 160.67 39.86 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.805 1.242 . . . . 2.4 113.177 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.8 145.77 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.375 1.47 . . . . 1.56 110.921 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -131.45 140.52 49.61 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.245 1.818 . . . . 3.21 110.964 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -97.66 108.66 21.42 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.391 1.077 . . . . 2.11 111.062 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.0 mm -117.34 113.61 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.181 0.993 . . . . 1.78 109.836 -173.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -91.36 -5.79 53.97 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.059 1.133 . . . . 6.63 114.059 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 86.9 p -72.94 0.83 10.11 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.148 1.536 . . . . 2.34 115.148 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -95.4 -57.55 2.37 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.227 1.411 . . . . 3.4 111.133 173.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.1 t -156.63 162.49 39.85 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.302 1.841 . . . . 5.5 110.135 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.5 m -154.8 144.16 21.24 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.053 -1.03 . . . . 6.65 111.324 173.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -60.37 159.25 10.43 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.977 1.311 . . . . 8.23 111.98 168.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 98.0 t -77.29 100.54 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.47 1.108 . . . . 6.68 110.165 176.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -109.87 -30.04 3.61 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.762 0.696 . . . . 3.13 112.814 172.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -75.8 1.34 15.16 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 116.046 1.869 . . . . 5.91 116.046 -173.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -116.48 33.86 5.34 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.891 2.076 . . . . 6.17 112.771 -169.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 101.76 -0.09 52.39 Favored Glycine 0 N--CA 1.478 1.475 0 O-C-N 120.719 -1.238 . . . . 4.91 116.114 176.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -73.88 157.52 36.16 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 118.462 1.131 . . . . 3.41 111.394 169.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.9 m -86.92 55.36 3.54 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 120.819 -1.176 . . . . 3.74 111.672 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.2 mt -100.32 146.14 27.31 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.928 -1.107 . . . . 2.85 113.243 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.9 m -101.21 133.31 45.97 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.005 1.722 . . . . 3.61 111.746 -173.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -74.52 34.96 0.98 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.617 2.056 . . . . 2.81 114.512 175.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 24.6 p -84.87 173.73 10.38 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.458 1.503 . . . . 3.1 112.49 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.3 118.84 35.72 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.694 1.998 . . . . 2.87 109.602 -172.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.18 147.86 47.89 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.309 0.644 . . . . 1.34 110.657 171.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.7 146.23 41.11 Favored Pre-proline 0 N--CA 1.473 0.677 0 C-N-CA 123.783 0.833 . . . . 0.83 109.734 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.17 152.76 45.61 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.845 2.363 . . . . 0.54 112.796 -167.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.6 mp -107.33 132.2 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.984 1.314 . . . . 2.15 109.233 -171.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -97.94 140.16 32.7 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.873 0.76 . . . . 4.21 111.279 169.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.8 tt -147.42 150.56 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.217 1.007 . . . . 1.56 112.396 -171.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -127.33 158.27 37.69 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.418 1.887 . . . . 2.06 109.121 169.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.22 159.79 84.46 Favored Pre-proline 0 CA--C 1.554 1.104 0 N-CA-C 113.913 1.079 . . . . 1.66 113.913 -173.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -79.4 80.36 3.1 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.372 2.715 . . . . 1.22 113.298 -169.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 48.9 mt -107.02 46.79 0.91 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.043 2.137 . . . . 4.3 108.938 169.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -123.36 175.37 6.76 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 128.199 2.6 . . . . 3.18 109.653 -172.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -74.78 12.7 0.77 Allowed 'General case' 0 CA--C 1.557 1.222 0 O-C-N 120.035 -1.666 . . . . 3.55 114.699 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.3 m -89.51 152.82 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.073 1.749 . . . . 1.41 113.661 -168.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.17 -30.17 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.668 1.187 . . . . 2.75 111.964 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.03 156.22 42.39 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.688 0.795 . . . . 2.98 111.302 169.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -102.72 141.61 35.24 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.554 1.141 . . . . 1.65 111.878 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -136.64 167.96 20.41 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.496 1.295 . . . . 0.67 114.496 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -138.29 142.82 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.234 1.414 . . . . 1.03 111.901 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -130.77 84.07 59.69 Favored Pre-proline 0 N--CA 1.465 0.304 0 C-N-CA 125.484 1.514 . . . . 3.82 111.553 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -72.82 133.2 19.71 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.25 2.633 . . . . 0.83 110.177 167.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.7 167.46 21.09 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.697 1.999 . . . . 3.16 110.969 175.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -95.8 178.61 5.39 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.855 1.262 . . . . 3.33 110.861 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 15.0 t -152.19 -26.17 0.17 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 115.421 1.637 . . . . 2.87 115.421 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -135.61 171.24 14.74 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.617 1.567 . . . . 6.7 111.831 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -83.76 154.37 23.62 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.24 1.016 . . . . 5.68 112.658 173.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -66.23 152.72 93.72 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-O 118.804 -0.617 . . . . 13.55 111.336 169.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.4 158.73 56.39 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.775 2.316 . . . . 10.61 113.484 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -93.11 -30.12 15.42 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.336 1.606 . . . . 12.77 115.336 -173.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.03 5.03 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.397 1.479 . . . . 13.43 113.335 -176.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 94.8 mt -126.0 157.77 37.0 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.051 1.741 . . . . 15.54 110.252 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.411 0 C-N-CA 124.711 1.204 . . . . 17.49 110.283 172.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 61.3 mtt . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 110.715 -0.105 . . . . 21.05 110.715 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.67 159.19 43.78 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.243 1.417 . . . . 20.3 112.514 173.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.0 p -90.61 -4.27 56.95 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.696 1.369 . . . . 17.05 114.696 -176.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.13 -27.78 62.13 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.986 1.476 . . . . 16.91 114.986 -170.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.4 m -125.47 33.22 5.17 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.857 1.663 . . . . 17.83 111.869 175.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.33 149.68 16.13 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 115.505 1.668 . . . . 12.18 115.505 -169.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.86 166.7 25.9 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.076 2.15 . . . . 11.32 110.391 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 77.6 p 43.62 41.79 3.72 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.76 1.624 . . . . 10.58 114.961 170.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.6 m -63.71 156.13 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 113.09 0.774 . . . . 7.56 113.09 -168.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -69.53 157.84 36.38 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.191 0.596 . . . . 4.05 112.226 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.82 160.96 41.03 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.249 1.02 . . . . 4.23 113.512 -168.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.43 31.66 0.29 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.599 1.559 . . . . 6.21 114.776 -176.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.03 14.77 1.11 Allowed Glycine 0 CA--C 1.541 1.697 0 C-N-CA 126.142 1.829 . . . . 2.23 117.654 -169.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.5 p -137.91 -172.69 3.31 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.848 2.459 . . . . 1.6 111.04 -176.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.6 t -101.47 -16.98 16.65 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.351 0.871 . . . . 3.81 113.351 170.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.3 m -141.97 137.5 31.26 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.971 1.309 . . . . 2.55 112.394 -171.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.4 p -83.56 -18.3 38.8 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.804 1.779 . . . . 2.07 115.804 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.7 p -145.65 155.64 43.14 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.505 1.502 . . . . 2.4 113.834 174.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.5 p -113.21 140.99 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 127.335 2.254 . . . . 1.54 109.98 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.9 m -107.94 116.45 31.98 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.383 0.673 . . . . 1.86 109.601 173.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 p -92.38 124.6 44.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 123.947 0.899 . . . . 1.25 109.18 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -102.78 176.78 5.05 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.084 1.754 . . . . 1.78 109.608 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.67 120.74 12.13 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 120.292 -1.505 . . . . 1.99 112.383 168.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.0 mt -106.62 159.45 16.19 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.749 1.22 . . . . 1.28 111.958 -173.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.414 ' CD1' ' H ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -145.97 168.13 21.62 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.969 1.308 . . . . 2.84 109.972 169.435 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.414 ' H ' ' CD1' ' A' ' 43' ' ' LEU . . . -88.07 156.97 19.01 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.191 0.996 . . . . 2.23 111.532 171.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.1 p -81.88 -32.6 30.93 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.323 -0.861 . . . . 2.64 113.194 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -138.19 34.92 2.32 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.607 1.563 . . . . 3.62 111.367 -174.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.35 11.35 82.26 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 125.209 1.385 . . . . 2.03 116.538 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.08 31.48 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 129.485 3.114 . . . . 2.35 116.514 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -31.86 72.92 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.405 -1.434 . . . . 1.27 113.395 -175.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.86 -52.04 65.76 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.395 0.998 . . . . 2.71 113.678 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -67.69 -39.59 84.43 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 118.366 -0.826 . . . . 3.92 111.432 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.1 mt -55.84 -49.98 71.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 119.075 0.852 . . . . 1.23 110.599 171.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.39 -34.85 77.52 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.862 1.21 . . . . 1.67 113.057 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -74.06 -27.29 60.84 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.217 0.821 . . . . 1.49 113.217 172.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -73.13 -22.45 60.53 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.026 -1.046 . . . . 2.15 113.109 169.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.6 mt -94.24 -39.78 10.35 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.1 1.148 . . . . 1.49 114.1 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -65.59 -22.01 66.64 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.054 0.843 . . . . 3.73 112.685 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 t -75.87 -26.58 57.22 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.126 0.97 . . . . 2.5 113.181 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.04 164.71 46.49 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.571 1.081 . . . . 1.63 113.512 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -83.42 35.07 0.49 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.17 1.388 . . . . 3.34 112.81 169.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -76.61 1.5 16.7 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.183 1.179 . . . . 3.47 114.183 -169.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.55 -23.9 67.58 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.04 -1.037 . . . . 2.92 111.036 166.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.13 -82.3 1.48 Allowed Glycine 0 CA--C 1.535 1.329 0 C-N-CA 123.829 0.728 . . . . 0.97 112.448 168.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.02 154.06 40.64 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 116.435 2.013 . . . . 1.7 116.435 -169.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -60.78 146.72 45.09 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.384 1.474 . . . . 3.22 112.461 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.7 t -58.02 133.34 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.799 1.24 . . . . 1.27 111.848 -172.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.08 -52.71 45.65 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 123.117 0.389 . . . . 1.77 113.978 -175.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.1 t -149.44 134.36 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 127.648 2.379 . . . . 2.69 109.175 176.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.15 144.04 40.53 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 125.753 1.621 . . . . 1.69 111.119 169.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.02 158.24 49.87 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.337 2.025 . . . . 0.87 111.371 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.72 -23.67 67.32 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.197 -0.939 . . . . 2.06 112.562 172.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -80.89 1.9 28.87 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.799 1.407 . . . . 2.17 114.799 172.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.81 159.42 15.07 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.841 1.256 . . . . 0.95 113.567 170.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -150.59 169.76 20.76 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.098 1.759 . . . . 2.93 111.446 167.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -124.4 135.58 53.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.367 1.067 . . . . 2.2 111.155 -168.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.1 pt -135.35 151.91 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.798 1.239 . . . . 1.62 112.65 -175.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.21 -179.24 4.63 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.339 1.456 . . . . 1.79 113.027 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.23 10.78 81.89 Favored Glycine 0 N--CA 1.476 1.301 0 O-C-N 121.37 -0.831 . . . . 0.62 115.164 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.3 p -101.14 144.66 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.569 1.948 . . . . 1.85 110.042 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 2.9 tpp -101.57 138.74 38.16 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.305 1.442 . . . . 1.74 112.166 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.22 149.88 41.96 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.611 1.165 . . . . 2.74 111.365 173.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.1 m -120.43 149.57 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.924 2.09 . . . . 1.74 109.328 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -94.42 148.01 22.66 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 122.433 1.111 . . . . 0.58 112.217 171.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.4 p -143.56 166.99 23.3 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.482 1.513 . . . . 1.6 112.551 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -85.19 172.58 11.07 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.598 -0.689 . . . . 2.03 111.308 166.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.0 p -58.2 -30.45 66.46 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.056 0.943 . . . . 2.7 113.518 -172.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -87.43 29.24 0.88 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.659 1.183 . . . . 3.34 113.86 171.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 57.12 28.77 15.48 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.782 2.033 . . . . 1.17 113.476 169.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -84.4 135.12 34.41 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.489 1.116 . . . . 2.0 110.941 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.2 mt -77.2 126.01 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.563 -0.532 . . . . 1.52 109.563 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.6 pt -122.53 157.63 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 114.766 1.395 . . . . 1.22 114.766 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -88.08 164.66 15.62 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.594 1.958 . . . . 1.53 110.494 167.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.49 -1.55 6.85 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.942 1.83 . . . . 2.34 115.942 -169.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -105.29 -1.64 24.98 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.072 1.749 . . . . 2.66 113.489 169.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.96 8.24 59.24 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 125.234 1.397 . . . . 0.74 116.443 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -70.07 127.55 33.23 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.733 1.213 . . . . 4.9 110.333 171.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.0 128.77 42.08 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.458 0.703 . . . . 2.02 111.984 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.64 -6.04 50.39 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 114.11 1.152 . . . . 1.75 114.11 -167.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.7 15.95 62.58 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.601 1.572 . . . . 0.79 114.027 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.4 t -122.05 146.93 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.501 1.52 . . . . 2.06 109.335 -176.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -136.05 159.61 41.17 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.407 1.883 . . . . 1.33 111.363 -175.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 48.4 mt -137.03 143.37 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 125.668 1.587 . . . . 1.58 110.311 -171.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -78.97 147.35 69.93 Favored Pre-proline 0 N--CA 1.479 1.009 0 O-C-N 120.026 -1.671 . . . . 1.83 111.933 173.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.28 -20.0 11.5 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 CA-C-N 122.468 1.917 . . . . 1.18 113.683 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -98.4 -37.76 9.48 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.64 1.976 . . . . 2.08 113.317 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.2 p -95.3 -26.74 15.8 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.03 0.932 . . . . 1.94 112.76 -178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 54.82 19.47 2.6 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.901 1.28 . . . . 2.79 113.245 -169.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.11 148.18 24.58 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.085 1.354 . . . . 3.66 111.072 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 mt -85.94 147.29 26.31 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.558 1.543 . . . . 0.97 112.733 -173.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 96.7 p -66.41 -16.66 64.27 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.599 0.963 . . . . 2.08 113.599 172.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.98 -150.44 6.42 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 126.426 1.965 . . . . 0.94 112.36 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.37 167.69 21.27 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.078 1.14 . . . . 2.17 114.078 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.4 mmt -55.92 136.92 72.89 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.626 1.171 . . . . 2.28 112.717 171.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -80.84 164.52 20.34 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.837 3.025 . . . . 0.87 112.906 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.11 -90.39 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.022 0.929 . . . . 1.36 111.246 169.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.5 p -77.65 15.27 0.85 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 116.514 2.042 . . . . 1.99 116.514 -167.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.7 146.06 32.23 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.527 1.131 . . . . 0.67 113.802 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.1 tpt -73.75 102.11 3.9 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.571 2.349 . . . . 1.59 110.636 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.3 pttp -156.04 149.59 24.85 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.575 1.55 . . . . 1.94 112.305 -173.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -165.83 160.54 17.1 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.761 1.624 . . . . 3.94 110.105 169.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.7 mp -91.71 146.9 23.4 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.411 1.084 . . . . 0.81 112.062 170.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.2 p -65.67 133.71 51.7 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 119.289 0.95 . . . . 1.26 109.751 169.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -84.72 -70.56 0.57 Allowed 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 113.951 1.093 . . . . 2.48 113.951 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.47 -39.85 0.43 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.526 1.131 . . . . 1.68 111.447 173.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -99.54 -29.45 12.7 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.613 0.968 . . . . 4.45 113.613 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 168.76 -164.37 38.0 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.595 1.093 . . . . 1.02 111.678 -170.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -139.98 131.79 27.5 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.464 1.906 . . . . 1.37 111.453 169.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -80.42 135.53 36.17 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.771 1.228 . . . . 2.17 112.453 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -126.79 123.15 36.72 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.747 2.019 . . . . 3.09 108.406 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -71.37 130.15 40.62 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 121.166 -0.959 . . . . 2.15 110.951 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 34.1 p -116.79 5.91 13.13 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.742 1.617 . . . . 1.69 113.402 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.17 -20.56 64.26 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.196 1.398 . . . . 1.49 114.19 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -111.99 -14.08 13.51 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.523 1.129 . . . . 2.49 113.216 -171.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.3 142.62 84.73 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 119.083 0.856 . . . . 2.11 112.258 171.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.85 163.66 28.48 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.442 2.095 . . . . 1.29 111.37 167.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.13 53.87 0.13 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 128.79 2.836 . . . . 2.33 115.969 -169.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -116.71 -179.65 3.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.862 2.065 . . . . 1.97 112.829 -170.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -90.22 148.38 22.96 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.733 1.213 . . . . 4.02 112.123 169.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -143.84 172.65 12.56 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.268 2.627 . . . . 0.68 109.998 -174.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -141.5 149.94 41.56 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.069 0.948 . . . . 2.54 112.947 173.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.15 139.06 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.307 1.043 . . . . 1.58 110.351 172.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -125.11 129.92 51.18 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.157 1.783 . . . . 3.18 110.285 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -92.87 118.93 31.67 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.474 1.11 . . . . 2.08 110.261 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 47.1 mm -116.28 110.74 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 118.708 0.685 . . . . 1.8 109.629 -171.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -79.4 -15.35 57.99 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.567 0.951 . . . . 5.12 113.567 -169.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.9 p -66.92 -15.31 63.58 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.265 1.58 . . . . 2.28 115.265 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -103.8 -5.63 22.23 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 119.865 1.211 . . . . 2.63 113.141 170.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.8 t -62.38 140.48 58.55 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.665 1.586 . . . . 6.11 115.06 -167.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 33.9 m -91.6 -30.11 16.54 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.197 1.399 . . . . 5.87 109.81 167.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.61 153.03 43.27 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.313 2.245 . . . . 6.69 112.955 171.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.9 p -153.14 141.5 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 126.601 1.961 . . . . 5.6 108.634 166.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -120.85 -29.38 1.54 Allowed Glycine 0 N--CA 1.475 1.247 0 N-CA-C 115.071 0.789 . . . . 3.35 115.071 -176.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -86.3 -10.55 54.27 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.168 1.787 . . . . 6.27 115.12 -174.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -96.99 34.22 1.77 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.34 1.856 . . . . 7.09 112.589 -170.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.68 3.73 58.24 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.553 1.549 . . . . 5.03 115.679 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -69.78 167.84 16.33 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.482 1.513 . . . . 3.67 113.823 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 28.2 m -80.13 54.26 1.91 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.712 1.205 . . . . 3.57 110.008 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.6 mt -137.04 144.86 43.44 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.919 2.088 . . . . 2.69 108.247 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 22.2 m -61.71 -17.62 56.43 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 119.158 0.89 . . . . 4.75 113.39 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 79.94 -5.22 62.89 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 120.755 -1.216 . . . . 3.31 115.552 172.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 12.5 m -57.55 158.14 6.22 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.873 1.669 . . . . 3.14 113.781 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.51 164.53 13.41 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.499 1.12 . . . . 3.35 111.803 174.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -94.3 156.51 16.48 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.084 1.142 . . . . 1.2 114.084 173.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.91 150.86 51.63 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 126.47 1.908 . . . . 1.14 110.501 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.2 145.38 38.9 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.452 2.101 . . . . 0.65 113.737 -167.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.7 mp -113.35 125.12 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.695 1.198 . . . . 2.31 110.105 -171.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -86.1 139.77 30.82 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.678 1.191 . . . . 2.81 111.475 174.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.1 tt -146.87 146.99 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.633 1.173 . . . . 1.58 112.104 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -118.6 154.42 32.66 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.209 1.403 . . . . 2.0 109.041 168.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.0 mt -61.61 154.66 64.36 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 114.157 1.169 . . . . 1.4 114.157 -175.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.86 103.55 0.88 Allowed 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.035 2.49 . . . . 0.78 110.957 -173.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.1 mt -139.27 42.37 2.06 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.717 2.407 . . . . 4.32 109.084 174.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -117.51 12.91 14.28 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 128.636 2.774 . . . . 3.53 111.698 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 18.3 t0 57.2 28.51 15.19 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.558 2.343 . . . . 4.61 114.74 -174.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.3 m -81.49 150.58 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.626 0.77 . . . . 1.42 112.734 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.83 -38.47 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.554 1.142 . . . . 2.13 110.701 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -147.23 142.81 27.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.54 1.536 . . . . 2.43 110.084 -175.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -105.71 141.48 37.08 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.246 1.018 . . . . 1.84 111.92 -173.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -139.18 165.96 25.79 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.974 1.472 . . . . 0.61 114.974 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.1 t -135.9 139.11 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 125.677 1.591 . . . . 1.99 111.957 176.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -131.66 78.87 69.92 Favored Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 124.927 1.291 . . . . 3.43 112.241 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.79 149.18 87.01 Favored 'Trans proline' 0 C--N 1.349 0.57 1 C-N-CA 125.387 4.058 . . . . 0.68 114.013 176.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -131.62 167.41 19.49 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.893 2.077 . . . . 2.3 111.974 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -116.58 162.54 17.46 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.061 0.934 . . . . 3.63 113.517 -174.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 9.3 t -152.92 170.14 21.12 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.632 1.973 . . . . 3.32 109.317 169.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 50.49 113.89 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.255 2.222 . . . . 6.54 116.515 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -71.35 -36.57 71.54 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.471 -1.393 . . . . 7.19 114.075 -175.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -149.54 154.58 38.33 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 125.286 1.435 . . . . 10.63 111.968 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -76.42 175.17 11.69 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.528 2.818 . . . . 9.61 111.811 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -69.17 -22.35 63.92 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.378 1.622 . . . . 15.04 115.378 -175.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.413 ' H ' HD13 ' A' ' 191' ' ' ILE . 0.2 OUTLIER -129.86 21.08 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 116.273 1.953 . . . . 13.87 116.273 -166.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.9 mt -137.17 116.04 12.28 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 119.397 0.998 . . . . 13.3 110.972 170.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.862 0 C-N-CA 125.433 1.493 . . . . 13.52 112.034 -170.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 118.011 -0.995 . . . . 32.92 111.868 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -64.58 100.78 0.4 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.889 1.222 . . . . 26.98 112.988 -174.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.4 p -133.72 -27.59 1.48 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.931 1.692 . . . . 26.82 113.118 -170.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -110.71 152.21 26.83 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.891 1.276 . . . . 22.54 111.467 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.3 m -109.35 164.69 12.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.572 1.149 . . . . 18.41 111.9 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.64 -47.85 68.4 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.954 0.902 . . . . 14.91 113.1 -173.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.3 -68.44 0.93 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.957 1.303 . . . . 12.88 110.88 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.3 p -141.46 130.96 23.84 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.74 1.616 . . . . 11.7 110.169 -176.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.5 p -68.49 127.98 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 122.182 0.992 . . . . 11.21 112.893 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -99.44 147.77 24.92 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.26 1.424 . . . . 4.38 107.425 167.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 64.75 -27.47 0.09 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 117.481 2.4 . . . . 5.77 117.481 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 44.74 45.97 8.42 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.869 2.068 . . . . 6.55 116.376 169.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.94 33.83 80.49 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 124.785 1.183 . . . . 3.08 115.672 169.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.5 p -86.33 154.98 20.82 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.245 1.818 . . . . 2.0 114.673 -172.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.7 p -79.01 -13.66 59.66 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.046 1.128 . . . . 2.16 114.046 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 t -148.28 159.46 43.96 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.282 1.433 . . . . 2.72 111.684 170.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 p -94.35 -7.89 40.44 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.69 1.996 . . . . 2.26 114.641 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.6 m -144.16 154.19 42.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.7 1.2 . . . . 2.5 113.243 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.3 p -117.77 147.53 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 127.622 2.369 . . . . 1.53 110.182 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.5 m -110.8 116.28 31.0 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.481 0.658 . . . . 1.06 111.067 173.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 p -98.02 131.19 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.764 1.226 . . . . 2.28 109.294 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -112.63 -171.05 1.78 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.384 1.874 . . . . 2.12 110.96 -174.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.426 ' HZ2' ' CD ' ' A' ' 143' ' ' GLU . 46.9 tptt -145.53 123.41 11.98 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.163 -0.961 . . . . 2.85 111.349 166.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.4 mt -110.49 150.96 28.14 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.857 0.863 . . . . 1.19 111.281 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.28 165.92 27.03 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.676 1.59 . . . . 2.58 110.966 -171.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.33 143.83 39.96 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.277 1.031 . . . . 1.88 111.064 168.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.7 p -85.5 -44.67 12.5 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.326 1.45 . . . . 3.03 111.452 174.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -115.13 25.49 10.84 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 127.823 2.449 . . . . 3.2 111.745 -171.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.63 7.43 84.41 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 126.267 1.889 . . . . 1.71 116.764 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -72.39 25.13 0.05 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.611 2.364 . . . . 2.06 116.977 -171.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -27.0 66.72 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 119.369 -2.082 . . . . 1.36 114.072 -173.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -81.72 -41.35 21.4 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.567 0.951 . . . . 2.66 113.567 -174.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -66.86 -38.29 86.06 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 120.284 1.402 . . . . 4.24 111.286 169.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.2 mt -56.58 -48.39 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 120.014 1.279 . . . . 1.3 110.72 168.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.05 -36.92 75.84 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.833 1.197 . . . . 1.76 112.486 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -69.27 -32.84 72.29 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.859 0.864 . . . . 1.58 113.305 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -65.84 -35.02 79.5 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.262 0.937 . . . . 2.04 112.269 172.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.5 mt -84.31 -31.25 24.97 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.328 0.862 . . . . 1.58 113.328 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -67.29 -30.49 70.37 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.141 0.882 . . . . 3.28 113.261 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 t -80.09 -21.4 43.34 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.809 0.844 . . . . 2.11 113.194 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.37 164.99 52.78 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.552 1.072 . . . . 1.45 113.099 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -84.42 18.98 2.04 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.179 0.991 . . . . 1.81 112.425 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -68.93 0.6 4.26 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 115.765 1.765 . . . . 3.6 115.765 -167.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.66 -23.01 66.88 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 121.364 -0.835 . . . . 1.31 111.273 165.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.85 -83.41 1.19 Allowed Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.898 1.713 . . . . 0.72 113.176 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.22 160.4 26.92 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.623 1.342 . . . . 1.6 114.623 -169.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -60.7 156.55 16.58 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.302 1.223 . . . . 3.85 114.302 -173.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.3 t -58.16 129.53 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 121.815 -0.553 . . . . 1.35 110.484 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.77 -43.17 68.04 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.592 0.615 . . . . 1.02 114.163 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.1 p -160.97 142.72 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.814 1.245 . . . . 3.95 110.241 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.9 mt -88.3 145.93 36.85 Favored Pre-proline 0 C--O 1.241 0.647 0 C-N-CA 123.774 0.829 . . . . 1.57 112.099 176.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.95 158.98 54.94 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.563 1.509 . . . . 0.85 112.131 173.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.18 -1.64 3.47 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.894 1.278 . . . . 2.11 114.388 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.11 8.13 11.49 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 127.028 2.131 . . . . 2.39 114.028 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.63 162.15 14.07 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.908 1.818 . . . . 0.9 115.908 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -142.63 150.62 40.5 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 128.062 2.545 . . . . 5.16 111.042 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -121.92 139.97 53.0 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.866 1.667 . . . . 2.15 110.059 174.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.9 pt -132.79 152.73 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 113.53 0.937 . . . . 1.57 113.53 -177.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.0 165.55 11.64 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.28 1.432 . . . . 1.68 110.801 169.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.0 8.3 79.26 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 115.562 0.985 . . . . 0.76 115.562 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.7 p -84.53 143.93 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 119.648 1.724 . . . . 2.36 110.216 169.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -102.01 136.42 41.88 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.417 1.487 . . . . 1.99 112.113 175.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -141.44 155.03 45.91 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.106 0.962 . . . . 2.9 112.802 171.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.15 146.57 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 126.99 2.116 . . . . 1.69 109.969 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -90.94 146.53 23.81 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.322 1.058 . . . . 0.49 112.716 172.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.6 p -143.6 170.78 15.19 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.979 1.712 . . . . 1.72 112.521 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -97.8 174.74 6.45 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.448 1.099 . . . . 2.02 112.573 168.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.2 p -64.49 -18.45 64.8 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.476 -1.39 . . . . 2.6 114.321 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -76.22 7.35 4.32 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 126.029 1.732 . . . . 2.23 113.241 167.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 55.71 33.31 21.09 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.4 2.28 . . . . 0.77 111.603 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -94.37 138.94 31.73 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.697 1.599 . . . . 2.16 110.395 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.4 mt -79.37 130.81 35.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 109.573 -0.528 . . . . 1.69 109.573 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.9 pt -125.3 155.53 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 114.689 1.366 . . . . 2.39 114.689 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -81.29 164.46 22.2 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 126.46 1.904 . . . . 1.54 109.536 167.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -64.67 -12.51 47.08 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.556 -1.34 . . . . 2.33 114.0 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -97.66 4.86 50.0 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.714 1.605 . . . . 2.67 112.992 173.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.75 10.48 85.08 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 120.551 -1.343 . . . . 0.72 115.103 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -68.24 130.03 41.69 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.193 1.497 . . . . 4.23 108.924 168.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.3 p -87.92 141.66 28.41 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.68 0.392 . . . . 1.82 111.043 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -94.3 -11.07 30.84 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.688 1.366 . . . . 1.61 114.688 -169.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.76 30.85 25.49 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.555 1.074 . . . . 0.69 114.322 -172.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.0 t -133.95 146.06 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.37 1.585 . . . . 1.97 110.447 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -130.61 159.98 35.56 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.58 1.952 . . . . 1.28 110.641 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 54.1 mt -135.96 137.03 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 125.059 1.344 . . . . 1.75 111.207 -174.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -71.53 141.22 85.1 Favored Pre-proline 0 N--CA 1.48 1.028 0 O-C-N 120.814 -1.179 . . . . 1.77 111.188 171.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.56 -24.41 13.85 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 122.494 1.926 . . . . 0.91 112.64 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -89.77 -54.43 4.06 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.706 1.602 . . . . 1.46 111.79 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.4 p -78.91 -26.79 43.78 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.875 0.695 . . . . 1.6 112.875 -174.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 56.37 19.14 3.82 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.792 1.237 . . . . 2.82 113.896 -170.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.91 150.83 24.69 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.377 -1.452 . . . . 3.98 111.528 176.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.9 mt -90.37 141.96 28.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.241 1.417 . . . . 1.14 111.712 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.1 p -66.56 -4.11 7.84 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.535 1.309 . . . . 1.53 114.535 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.4 -158.53 18.73 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 127.331 2.396 . . . . 0.92 111.53 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.52 154.09 42.2 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.543 0.942 . . . . 1.57 113.543 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.3 tpt -60.26 130.22 89.34 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 125.384 1.474 . . . . 2.88 111.21 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -72.46 158.89 50.39 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.61 2.874 . . . . 1.06 114.488 -173.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.91 -53.62 8.71 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.064 1.746 . . . . 1.09 114.557 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.7 p -114.13 11.35 17.57 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.395 1.478 . . . . 1.63 114.148 -167.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.36 151.42 19.82 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.729 1.011 . . . . 0.7 113.729 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.4 tpt -75.19 95.32 3.1 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.907 2.083 . . . . 1.82 111.227 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -154.48 135.86 14.13 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.443 1.497 . . . . 1.71 112.557 -173.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -168.46 142.65 3.26 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.971 1.309 . . . . 3.46 111.342 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.76 150.87 25.53 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.717 1.377 . . . . 0.93 114.717 -173.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.4 p -62.12 132.8 54.03 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.243 -0.911 . . . . 1.94 111.798 169.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -93.83 -55.0 3.39 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.587 1.155 . . . . 2.52 113.688 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -165.73 -52.78 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.2 2.2 . . . . 2.21 109.422 174.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -93.23 23.49 4.38 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.182 1.793 . . . . 5.27 113.35 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.77 -151.78 17.73 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.244 1.878 . . . . 0.8 111.692 -168.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.77 129.96 20.89 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.068 2.147 . . . . 1.84 111.14 169.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -82.04 133.5 35.29 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.531 1.133 . . . . 2.18 111.556 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -124.77 124.48 42.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.299 1.84 . . . . 3.55 109.143 173.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -73.68 118.43 16.63 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.462 1.105 . . . . 2.29 110.576 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 22.5 p -101.97 -0.65 33.43 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.554 1.142 . . . . 1.81 113.347 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.13 -16.01 4.54 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.61 1.707 . . . . 1.78 115.61 -176.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -106.77 -4.57 19.22 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.904 1.076 . . . . 2.6 113.904 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.46 152.73 67.64 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 114.131 1.16 . . . . 0.9 114.131 172.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.54 174.29 5.93 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.205 3.27 . . . . 1.17 112.218 167.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.47 100.08 3.74 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.328 -0.857 . . . . 1.56 109.365 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -152.2 177.38 10.6 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.479 1.512 . . . . 1.55 110.587 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -90.39 146.77 23.9 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.217 1.007 . . . . 3.1 112.04 168.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -140.07 167.9 21.06 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.879 2.071 . . . . 0.76 109.294 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -139.72 148.01 41.72 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.928 0.891 . . . . 2.63 112.306 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -111.25 132.98 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.024 0.93 . . . . 1.46 109.7 175.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -120.78 128.43 52.89 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.417 1.887 . . . . 3.32 110.287 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.426 ' CD ' ' HZ2' ' A' ' 41' ' ' LYS . 48.5 tt0 -104.39 105.3 15.38 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.79 1.636 . . . . 2.54 110.961 -169.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.6 mm -108.06 113.72 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.686 1.194 . . . . 1.8 111.62 -167.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -88.7 23.08 2.4 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.291 1.219 . . . . 5.98 114.291 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 52.1 m -69.27 -39.72 78.24 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.094 -1.004 . . . . 1.98 112.298 173.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.0 mp -77.63 88.47 3.92 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.137 0.88 . . . . 4.55 111.49 172.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 14.2 m -54.57 118.14 3.93 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.954 1.302 . . . . 7.06 110.413 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 52.1 m -148.31 -36.03 0.2 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.414 1.086 . . . . 5.0 113.466 -169.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -138.65 160.88 38.53 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.831 1.653 . . . . 6.68 111.607 176.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.7 t -121.84 136.14 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 113.157 0.799 . . . . 4.46 113.157 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -117.74 -29.03 2.13 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 126.229 1.871 . . . . 2.63 113.416 169.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.32 -13.99 62.51 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.647 1.721 . . . . 5.2 115.647 -175.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -84.11 25.84 0.8 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.428 1.491 . . . . 5.94 113.44 -171.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.84 14.55 77.34 Favored Glycine 0 CA--C 1.537 1.415 0 O-C-N 120.965 -1.084 . . . . 5.43 114.408 -174.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.52 162.85 12.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.331 1.053 . . . . 3.71 113.152 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.7 t -75.68 44.02 0.27 Allowed 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 123.417 1.579 . . . . 4.83 111.695 169.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.4 tt -139.76 116.31 10.71 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.33 -1.481 . . . . 3.21 109.812 -167.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 60.3 m -73.48 79.78 1.43 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.753 1.221 . . . . 4.83 110.816 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -66.14 18.39 0.19 Allowed Glycine 0 CA--C 1.54 1.6 0 C-N-CA 127.409 2.433 . . . . 3.26 117.343 -169.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 36.2 m -62.05 168.41 3.28 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 127.874 2.469 . . . . 3.32 114.164 175.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.7 147.91 44.49 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.851 0.86 . . . . 2.72 112.563 174.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -98.66 152.03 20.08 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.849 1.259 . . . . 1.42 111.738 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.8 m -111.57 144.49 30.68 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 124.482 1.113 . . . . 0.9 111.831 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.49 159.24 51.95 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.406 2.737 . . . . 0.81 114.022 -167.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 1.3 mt -112.36 143.66 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.005 1.322 . . . . 2.82 110.273 -176.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -110.15 140.83 43.84 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.54 1.136 . . . . 2.93 111.694 171.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.6 tt -146.3 147.31 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.663 1.185 . . . . 1.78 111.578 -175.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -126.18 151.51 47.25 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.011 1.325 . . . . 1.93 109.484 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 5.3 mt -65.58 149.91 96.69 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 114.269 1.211 . . . . 1.37 114.269 -171.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.31 92.43 0.92 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.632 2.888 . . . . 0.86 114.382 -169.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -118.82 70.67 0.83 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 103.678 -2.712 . . . . 3.71 103.678 164.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -145.7 -179.94 7.02 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.069 1.748 . . . . 2.69 109.229 -166.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -79.74 6.58 10.47 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.871 1.668 . . . . 3.93 114.57 -174.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -99.99 153.56 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.833 1.653 . . . . 1.35 113.517 -168.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 44.8 t -96.76 -32.62 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.586 1.554 . . . . 2.51 110.967 172.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -131.34 135.3 47.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.021 1.328 . . . . 4.44 113.211 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -103.7 138.79 39.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.623 1.169 . . . . 1.41 111.121 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -134.63 168.54 18.8 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.481 1.289 . . . . 0.55 114.481 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.72 137.22 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.787 1.235 . . . . 1.16 112.549 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -134.96 86.65 31.8 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 125.418 1.487 . . . . 3.5 112.118 -173.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -71.5 152.77 60.36 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.325 3.35 . . . . 0.73 113.756 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -132.18 172.47 12.36 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.974 2.509 . . . . 3.04 112.338 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -101.73 -173.0 2.25 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.204 1.402 . . . . 3.14 109.767 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 14.1 t -152.25 -36.45 0.12 Allowed 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 116.698 2.11 . . . . 2.82 116.698 -175.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -108.05 157.3 18.38 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.485 1.039 . . . . 6.3 113.704 -174.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . 61.13 175.51 0.11 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.528 1.931 . . . . 6.9 115.793 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -141.79 156.66 65.75 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 126.094 1.758 . . . . 14.24 110.525 170.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -61.03 141.28 93.81 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.066 1.844 . . . . 15.22 113.086 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -88.32 -9.72 51.85 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.645 1.35 . . . . 16.2 114.645 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.49 -56.03 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.244 1.418 . . . . 20.6 108.008 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.2 mt 68.56 145.97 0.05 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 117.68 2.474 . . . . 20.89 117.68 168.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 CA--C 1.545 0.766 0 C-N-CA 126.719 2.008 . . . . 27.16 110.723 168.73 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 109.15 -0.685 . . . . 25.84 109.15 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . 0.272 15.2 tt0 61.53 -124.01 0.83 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.205 1.802 . . . . 21.87 111.729 -169.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.0 m -81.93 -28.94 32.53 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.788 1.631 . . . . 18.18 113.446 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 55.3 24.71 6.72 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 116.419 2.007 . . . . 14.6 116.419 174.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.8 p -67.29 -12.72 60.86 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.101 1.519 . . . . 13.38 115.101 -174.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -139.67 162.84 34.13 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.641 1.576 . . . . 9.86 111.081 169.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.94 -41.31 96.02 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.183 0.993 . . . . 9.55 112.362 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.0 p -145.6 -173.85 4.24 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.201 1.801 . . . . 8.21 109.785 -171.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.7 m -88.49 8.9 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.619 1.168 . . . . 6.71 113.803 169.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 52.26 24.07 2.67 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.358 2.263 . . . . 4.49 116.077 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 53.65 -162.89 0.11 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.342 1.857 . . . . 5.07 114.314 176.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.56 153.83 46.28 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.07 1.748 . . . . 5.52 110.618 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 159.61 26.43 0.02 OUTLIER Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.902 1.239 . . . . 2.51 114.659 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.4 p -150.76 156.05 40.49 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.024 1.412 . . . . 2.28 112.776 -170.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.8 p -98.75 -7.34 27.81 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.819 1.415 . . . . 2.29 114.819 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.1 t -151.72 157.83 42.57 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.866 0.757 . . . . 2.49 112.518 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 p -98.55 -4.46 34.16 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.95 2.9 . . . . 1.95 114.82 -173.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.3 m -147.25 151.48 36.75 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.89 1.676 . . . . 2.42 112.863 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.1 p -119.61 148.6 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 127.762 2.425 . . . . 1.84 110.291 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.2 m -121.48 127.54 51.16 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 121.414 -0.803 . . . . 1.13 111.591 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 p -101.27 137.58 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.116 1.366 . . . . 1.9 110.717 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -136.38 113.97 11.0 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.002 1.721 . . . . 1.75 111.209 -171.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.48 127.82 38.11 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 120.178 -1.576 . . . . 1.98 114.225 -168.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.6 mt -114.77 152.82 31.45 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.683 1.193 . . . . 1.83 113.835 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.3 mt -140.3 176.33 8.86 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.86 2.064 . . . . 2.6 110.464 169.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.51 163.82 12.56 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.925 1.083 . . . . 1.37 113.925 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.3 p -84.13 -38.45 20.69 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.488 1.115 . . . . 2.08 113.352 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -146.89 63.19 1.19 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.953 1.701 . . . . 2.52 110.703 169.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.11 27.88 73.55 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 120.893 -1.129 . . . . 1.17 115.419 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.41 15.27 0.36 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.053 2.141 . . . . 2.4 114.448 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.33 -28.96 69.67 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.129 -1.607 . . . . 0.94 113.01 -173.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -69.64 -45.79 67.67 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.246 0.93 . . . . 2.25 112.519 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -71.08 -41.86 70.12 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 118.18 -0.914 . . . . 2.77 111.463 176.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 86.6 mt -51.74 -50.21 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.441 1.019 . . . . 1.05 110.34 167.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.51 -31.33 70.4 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.566 -1.334 . . . . 1.15 113.231 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -74.08 -34.56 64.05 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.51 1.124 . . . . 1.15 113.199 172.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -66.26 -32.64 74.19 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.863 -1.148 . . . . 1.94 112.174 170.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.1 mt -83.63 -36.7 23.65 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.854 1.057 . . . . 1.12 113.854 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -65.33 -29.75 70.53 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.487 1.04 . . . . 2.99 112.481 177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.0 t -79.7 -24.54 41.63 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.346 0.869 . . . . 2.09 113.346 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.65 160.31 39.28 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.53 1.062 . . . . 0.97 113.345 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -83.01 26.06 0.64 Allowed 'General case' 0 CA--C 1.552 1.035 0 O-C-N 121.367 -1.078 . . . . 1.95 112.369 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -68.82 0.28 4.55 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 116.339 1.977 . . . . 3.43 116.339 -167.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.75 -25.18 66.29 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.694 1.134 . . . . 2.0 112.704 171.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.04 -81.42 1.34 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.709 1.147 . . . . 0.85 113.122 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.46 163.07 25.92 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.538 1.135 . . . . 1.63 113.035 -176.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -59.08 161.23 5.34 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.993 1.479 . . . . 2.79 114.993 -171.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.84 109.88 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.115 -0.698 . . . . 1.21 109.115 168.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.81 -25.16 65.35 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 119.171 -0.794 . . . . 1.51 114.134 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.2 t -142.07 118.24 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.275 1.43 . . . . 2.77 110.939 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -88.32 146.91 38.91 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.548 1.539 . . . . 2.15 109.809 167.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.69 157.51 39.87 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.098 1.866 . . . . 0.82 111.552 171.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.23 -24.03 67.23 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.213 -0.929 . . . . 2.1 112.716 173.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 40.7 p30 -77.76 -8.89 58.63 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.844 1.424 . . . . 2.61 114.844 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.2 155.78 19.19 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.372 1.469 . . . . 0.7 111.922 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.5 pttt -141.25 159.72 41.62 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.958 1.303 . . . . 3.04 111.885 170.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -122.68 146.74 47.21 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.914 1.286 . . . . 2.33 110.042 -175.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.6 pt -141.07 151.2 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.26 1.024 . . . . 2.31 111.795 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -113.65 170.0 8.57 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.716 1.607 . . . . 1.97 111.242 173.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.2 15.53 74.18 Favored Glycine 0 CA--C 1.534 1.267 0 O-C-N 121.388 -0.82 . . . . 0.63 114.702 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.5 p -98.8 139.73 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 127.179 2.192 . . . . 2.24 109.611 173.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.8 tpp -103.87 136.87 42.74 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.769 2.027 . . . . 1.5 112.84 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.65 152.83 44.3 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.656 1.583 . . . . 2.82 111.761 174.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.12 143.53 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 126.757 2.023 . . . . 1.61 109.474 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -86.8 149.04 25.13 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 122.2 1.0 . . . . 0.43 111.847 169.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 57.3 p -145.62 165.92 27.28 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.789 1.635 . . . . 1.78 112.532 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -89.59 167.29 13.06 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.807 0.843 . . . . 2.27 111.082 166.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 49.3 p -61.57 -26.46 67.97 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.436 1.273 . . . . 2.49 114.436 -168.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -76.29 16.66 0.44 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.367 1.467 . . . . 2.74 114.477 169.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.52 30.2 17.12 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 128.142 2.577 . . . . 0.9 113.204 175.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -92.65 140.03 29.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.28 1.432 . . . . 2.31 111.775 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -82.95 124.84 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.037 0.446 . . . . 1.66 110.273 -178.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.9 pt -120.63 156.15 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 114.815 1.413 . . . . 2.08 114.815 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -79.89 158.94 26.57 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.85 2.86 . . . . 2.04 111.227 168.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -56.82 -8.05 0.54 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 127.282 2.233 . . . . 2.37 116.317 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.86 1.32 19.16 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.476 1.51 . . . . 3.41 115.021 172.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.79 4.2 63.7 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.359 1.457 . . . . 0.62 115.27 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -67.97 143.55 55.56 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.883 1.341 . . . . 2.56 109.371 170.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 60.5 p -102.7 147.8 26.38 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.915 1.286 . . . . 1.73 111.368 -175.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -104.45 -5.86 21.24 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.847 1.425 . . . . 1.53 114.847 -168.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.78 28.93 40.58 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 121.193 -0.942 . . . . 1.24 113.396 -177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.8 t -133.48 147.26 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.969 1.308 . . . . 2.78 110.063 177.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -134.73 155.06 51.22 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 128.205 2.602 . . . . 1.47 110.447 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 49.4 mt -133.42 133.82 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.213 1.405 . . . . 1.72 110.854 -173.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -68.61 142.65 94.3 Favored Pre-proline 0 N--CA 1.476 0.849 0 O-C-N 120.633 -1.292 . . . . 2.09 111.296 173.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.35 -24.12 16.89 Favored 'Trans proline' 0 C--N 1.35 0.636 0 CA-C-N 122.38 1.886 . . . . 0.92 112.94 175.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -92.91 -52.19 4.71 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.382 1.873 . . . . 1.33 112.692 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.9 p -80.73 -23.67 39.28 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.983 0.735 . . . . 2.14 112.983 -175.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 54.89 18.06 2.05 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.747 1.619 . . . . 3.65 113.839 -171.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.15 149.88 24.35 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.648 -1.283 . . . . 3.22 111.789 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.6 mt -87.17 146.38 26.04 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.156 1.782 . . . . 1.38 113.222 -175.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 97.3 p -76.98 0.64 20.4 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.446 1.276 . . . . 1.62 114.446 174.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.11 -158.26 15.86 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 127.176 2.322 . . . . 1.43 110.762 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.07 156.18 25.95 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.534 1.167 . . . . 2.56 112.917 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 tpt -56.35 130.01 75.21 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 124.068 0.947 . . . . 2.9 111.663 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.93 166.1 30.49 Favored 'Trans proline' 0 CA--C 1.537 0.64 1 C-N-CA 125.53 4.154 . . . . 1.15 115.587 -172.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.63 -81.17 0.07 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.492 1.517 . . . . 1.52 113.281 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.9 p -86.48 12.36 10.49 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.664 1.357 . . . . 1.62 114.664 -169.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.7 148.59 16.01 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.21 -0.931 . . . . 0.62 113.082 174.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.1 tpt -77.36 87.88 3.75 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.775 2.03 . . . . 1.65 110.881 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -142.6 146.24 34.35 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.218 1.407 . . . . 1.78 112.761 -173.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 43.5 tttp -162.01 159.73 26.74 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.524 1.13 . . . . 2.67 112.046 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 mp -102.2 145.74 28.97 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.595 1.158 . . . . 0.75 112.824 169.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.7 p -70.26 139.78 52.24 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 119.335 0.97 . . . . 2.12 112.332 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.63 -69.44 0.67 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.835 1.254 . . . . 3.12 114.1 -174.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.43 -41.28 0.08 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.681 2.393 . . . . 1.59 109.143 169.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -91.55 -10.62 39.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.986 1.714 . . . . 4.28 114.216 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 143.23 -156.31 26.44 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.845 1.688 . . . . 0.99 112.304 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.72 127.58 20.54 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.233 1.813 . . . . 1.26 109.958 167.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -77.16 139.69 39.99 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.962 1.305 . . . . 2.19 111.565 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -130.03 116.33 18.4 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.971 1.708 . . . . 3.37 109.198 169.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.34 115.44 11.6 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.915 1.286 . . . . 2.88 111.006 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.8 p -104.02 -5.75 21.86 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.565 1.321 . . . . 1.81 114.565 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.78 -27.69 43.33 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.456 1.28 . . . . 1.42 114.456 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.68 -14.99 31.16 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.551 0.945 . . . . 3.16 113.551 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.52 147.91 85.2 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 119.603 1.092 . . . . 0.85 112.792 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -75.44 167.24 27.04 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.21 1.94 . . . . 0.85 110.95 167.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.03 94.8 1.93 Allowed 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.532 1.533 . . . . 2.13 109.539 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -152.32 175.55 12.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.831 1.253 . . . . 1.7 111.418 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -86.36 149.89 24.71 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.786 1.235 . . . . 3.59 111.139 168.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -142.03 171.95 13.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.257 2.223 . . . . 0.51 109.735 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -142.19 154.82 45.13 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.359 1.064 . . . . 2.47 111.962 176.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.09 135.93 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.939 0.895 . . . . 1.75 110.773 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -121.65 142.31 50.26 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.801 2.04 . . . . 3.18 110.575 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -108.69 118.09 35.88 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.076 0.951 . . . . 2.19 110.648 -176.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.6 mm -114.08 113.51 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 108.67 -0.863 . . . . 1.94 108.67 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -74.26 -20.95 59.98 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.038 -1.039 . . . . 4.62 113.077 -175.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.3 m -58.83 -16.65 18.18 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 116.894 2.183 . . . . 2.94 116.894 -175.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -111.5 0.54 16.53 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 119.979 1.263 . . . . 2.96 112.94 175.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.6 p -65.47 143.52 57.63 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.814 -1.179 . . . . 5.61 113.652 -170.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.5 m -97.62 -28.38 13.95 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.061 1.345 . . . . 6.25 111.909 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.15 165.62 24.93 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.324 1.05 . . . . 5.67 112.547 172.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.4 t -123.23 124.74 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.55 1.14 . . . . 4.25 110.224 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -142.75 -29.62 0.13 Allowed Glycine 0 N--CA 1.474 1.18 0 N-CA-C 116.119 1.208 . . . . 3.04 116.119 177.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -95.81 -16.9 21.56 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.687 1.595 . . . . 6.39 114.077 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -89.42 55.3 3.2 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.953 1.094 . . . . 8.03 113.953 -168.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.12 -3.88 84.75 Favored Glycine 0 CA--C 1.535 1.324 0 O-C-N 121.192 -0.942 . . . . 6.69 114.377 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -80.82 165.65 21.67 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.862 1.265 . . . . 4.81 111.492 171.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.7 m -94.96 -10.74 30.12 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.224 1.41 . . . . 6.24 112.305 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.19 -33.94 72.91 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.32 1.048 . . . . 3.6 113.54 -173.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.0 m -146.02 106.71 4.1 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.177 0.898 . . . . 6.9 112.938 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -99.42 -21.12 15.58 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.14 1.353 . . . . 4.54 113.428 168.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 37.3 m -93.01 156.28 16.99 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.292 1.437 . . . . 3.12 113.498 -173.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -91.91 142.53 27.46 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.858 1.663 . . . . 3.34 112.503 173.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.59 154.9 39.6 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.777 -1.202 . . . . 1.34 111.428 172.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.63 149.6 72.38 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 125.492 1.517 . . . . 0.96 110.625 174.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -74.47 145.81 34.16 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.282 2.654 . . . . 0.56 114.64 -166.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 4.5 mt -98.35 140.2 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.191 1.396 . . . . 2.76 110.019 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -113.89 121.46 44.03 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.988 1.315 . . . . 3.07 111.491 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.7 tt -135.16 156.68 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.127 1.371 . . . . 1.42 112.673 -168.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -138.49 159.66 41.51 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.953 1.701 . . . . 2.07 109.022 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 19.0 mt -67.38 152.25 96.36 Favored Pre-proline 0 CA--C 1.551 1.008 0 O-C-N 121.282 -0.886 . . . . 1.42 112.925 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.52 79.44 3.19 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 124.139 3.226 . . . . 0.96 114.764 -167.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 1.6 tt -102.62 72.78 1.26 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.108 -1.442 . . . . 3.15 107.108 167.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -146.44 -176.7 5.28 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.609 1.964 . . . . 2.87 109.833 -168.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -79.85 0.0 32.87 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.127 1.528 . . . . 4.35 115.127 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 1.4 m -80.41 159.05 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.535 1.134 . . . . 1.52 114.02 -169.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.2 t -99.23 -32.02 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 125.63 1.572 . . . . 2.65 111.507 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -142.25 128.61 20.0 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.736 1.614 . . . . 2.51 108.781 -173.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -99.52 141.44 32.31 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.148 0.979 . . . . 1.45 111.983 -172.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -142.38 169.59 17.29 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 115.725 1.75 . . . . 0.98 115.725 -176.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.07 140.08 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.65 1.98 . . . . 1.15 112.239 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -137.09 84.52 24.65 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 124.815 1.246 . . . . 3.81 112.093 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -69.34 148.47 67.89 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 124.08 3.186 . . . . 0.64 113.689 174.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -131.82 162.94 29.35 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 127.773 2.429 . . . . 2.79 111.242 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -109.92 169.62 8.6 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.68 1.192 . . . . 3.8 113.04 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 6.5 t -151.16 -163.23 1.72 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.123 2.169 . . . . 2.61 111.575 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -124.92 145.1 50.0 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.858 1.663 . . . . 6.35 113.071 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -165.55 -164.04 0.71 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.557 1.943 . . . . 7.06 109.508 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -69.5 150.55 96.92 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-O 118.536 -0.745 . . . . 14.83 110.116 167.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -54.62 144.1 65.62 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.855 3.037 . . . . 10.38 115.264 -169.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.74 10.13 11.58 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.976 1.71 . . . . 16.87 114.645 175.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.3 mt -99.0 -52.54 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 126.198 1.799 . . . . 16.02 111.236 176.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 60.78 128.56 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 130.276 3.43 . . . . 15.37 115.857 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 . . . . . 0 CA--C 1.544 0.725 0 C-N-CA 126.457 1.903 . . . . 15.84 111.102 179.467 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 118.957 -0.544 . . . . 26.45 109.758 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -138.4 138.43 38.22 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.095 0.776 . . . . 23.62 113.095 170.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.0 p 60.5 151.29 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 127.935 2.494 . . . . 19.22 114.845 -171.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.17 178.29 7.39 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.0 1.32 . . . . 17.93 111.914 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.0 m -52.58 115.36 1.74 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.852 0.861 . . . . 16.47 111.12 170.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -127.09 -6.48 6.04 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.612 1.338 . . . . 12.05 114.612 -172.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 59.52 143.28 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.741 2.816 . . . . 10.3 116.212 -174.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.9 p 52.9 -155.95 0.18 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.865 1.666 . . . . 8.81 113.911 170.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.3 m -135.38 170.26 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 128.071 2.548 . . . . 7.86 111.767 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -99.79 167.8 10.31 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.05 1.34 . . . . 4.87 110.734 168.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -125.6 152.97 44.42 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.546 1.138 . . . . 4.63 112.702 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.07 96.94 10.91 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.724 1.21 . . . . 6.15 113.233 -169.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.81 8.63 23.67 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.847 1.213 . . . . 2.53 115.262 -176.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.4 p -134.45 177.47 7.74 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.668 1.587 . . . . 1.73 113.442 -169.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.7 p -105.21 -1.62 25.14 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.825 1.25 . . . . 2.49 113.809 170.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 m -146.74 148.66 32.19 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.683 1.993 . . . . 3.42 109.05 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 42.2 p -111.0 -11.82 14.28 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.222 1.409 . . . . 2.15 114.72 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.1 p -147.67 159.07 44.19 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.765 1.394 . . . . 2.36 114.765 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.74 138.19 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.825 2.05 . . . . 1.79 110.194 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.0 m -114.72 122.15 45.54 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.846 0.858 . . . . 1.08 110.962 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.62 135.12 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.667 1.187 . . . . 1.18 111.852 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -133.27 106.67 7.68 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.015 1.726 . . . . 1.81 112.163 -172.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.58 132.98 34.88 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 120.138 -1.601 . . . . 2.03 112.98 -171.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.5 mt -122.43 163.17 20.31 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.495 1.518 . . . . 1.38 112.904 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 42.7 mt -143.12 167.95 20.89 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.593 1.957 . . . . 2.03 110.914 168.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.15 169.95 10.01 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.54 1.136 . . . . 1.56 113.373 169.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.6 p -94.49 -32.99 13.26 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.578 1.325 . . . . 2.1 114.578 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -140.53 44.49 1.85 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.598 1.159 . . . . 2.59 111.963 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.75 12.9 82.26 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.515 1.531 . . . . 1.48 115.832 177.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.16 19.65 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 127.767 2.427 . . . . 2.65 116.572 -171.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mmt -64.14 -19.55 65.37 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.103 -1.623 . . . . 1.05 114.678 -173.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -76.39 -51.9 10.96 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.934 0.894 . . . . 2.4 111.613 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -62.05 -40.91 97.35 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.881 -1.137 . . . . 3.22 111.372 172.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 98.8 mt -53.32 -47.92 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 119.613 1.097 . . . . 1.14 110.9 169.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.03 -29.28 70.17 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.715 1.143 . . . . 1.2 113.3 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -73.31 -39.04 65.62 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.922 0.783 . . . . 1.09 111.993 171.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -61.7 -32.83 73.06 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.428 1.091 . . . . 1.89 112.444 172.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.7 mt -88.49 -36.12 16.62 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.789 1.403 . . . . 1.05 114.789 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.38 -20.53 64.69 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.613 1.097 . . . . 2.39 113.121 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.2 t -80.93 -12.19 59.44 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.079 1.352 . . . . 2.37 114.525 175.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.39 161.33 21.4 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.261 1.41 . . . . 1.3 112.236 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -79.02 37.59 0.31 Allowed 'General case' 0 N--CA 1.477 0.92 0 O-C-N 120.855 -1.379 . . . . 2.38 112.27 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -77.19 -0.88 26.76 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.246 1.202 . . . . 3.62 114.246 -173.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.79 -27.08 66.25 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 121.091 -1.005 . . . . 1.77 110.593 166.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.28 -54.62 0.38 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.204 0.907 . . . . 1.1 113.347 169.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -76.02 160.34 29.93 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.478 1.111 . . . . 3.23 113.343 -169.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -68.72 155.36 40.26 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.222 -0.924 . . . . 3.73 111.687 171.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.2 t -67.9 119.82 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 109.795 -0.446 . . . . 2.27 109.795 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.11 -42.77 83.4 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 119.624 -0.542 . . . . 1.6 113.93 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.9 t -142.44 130.77 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.722 1.609 . . . . 2.94 110.671 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.69 142.94 29.66 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.489 1.116 . . . . 1.72 110.956 168.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.16 162.57 42.13 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.442 2.095 . . . . 0.97 112.215 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.8 -29.01 69.96 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.865 -1.147 . . . . 2.34 112.531 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -79.8 1.88 25.17 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.806 1.642 . . . . 1.94 114.966 173.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.43 157.06 16.91 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.705 1.202 . . . . 1.16 112.815 169.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -147.32 167.97 22.96 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.774 1.63 . . . . 4.14 112.067 170.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -126.8 144.17 51.04 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.533 1.133 . . . . 2.68 112.296 -169.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.1 pt -142.15 146.2 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.72 1.608 . . . . 1.65 111.046 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.03 158.82 43.49 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.315 1.046 . . . . 2.06 111.99 173.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.65 15.86 21.5 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.03 1.3 . . . . 0.79 114.855 -171.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 p -101.4 144.44 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 127.997 2.519 . . . . 1.88 110.501 175.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.4 tpp -97.38 139.33 33.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.555 1.942 . . . . 1.5 113.374 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.64 154.34 45.31 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.988 1.315 . . . . 2.79 111.31 171.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.5 m -125.68 146.13 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.097 1.759 . . . . 1.59 109.82 -174.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -85.67 147.0 26.58 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.76 1.266 . . . . 0.46 112.548 169.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.6 p -141.33 172.02 13.25 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.761 2.024 . . . . 1.5 112.493 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.11 -169.75 1.91 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 115.283 1.586 . . . . 1.87 115.283 177.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 66.9 p -62.19 -33.68 75.0 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.663 -1.273 . . . . 2.78 112.143 173.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -80.53 12.96 2.71 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.342 1.057 . . . . 2.65 113.289 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.39 26.74 14.48 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.498 1.519 . . . . 0.68 111.761 -172.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -93.35 143.48 26.24 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.93 1.292 . . . . 1.93 111.751 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.4 mt -78.38 124.46 36.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.358 0.663 . . . . 1.68 110.36 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.2 pt -113.83 154.3 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.605 1.562 . . . . 1.02 114.95 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.14 157.74 18.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.429 2.692 . . . . 1.79 108.666 167.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -54.76 -24.42 22.36 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.634 1.716 . . . . 2.38 115.634 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . 0.261 0.0 OUTLIER -86.89 7.05 28.93 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 119.355 0.98 . . . . 3.56 112.42 176.855 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.42 19.05 77.1 Favored Glycine 0 C--N 1.343 0.931 0 C-N-CA 125.909 1.719 . . . . 0.76 113.417 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -80.66 137.88 36.36 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.299 0.64 . . . . 2.3 110.261 169.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 20.1 p -96.19 146.17 24.91 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.829 0.852 . . . . 1.66 111.099 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.1 -6.04 29.09 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.579 1.325 . . . . 1.74 114.579 -168.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.27 28.03 46.26 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.193 0.902 . . . . 0.69 113.802 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 36.6 t -134.48 147.89 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.103 1.361 . . . . 1.77 110.501 176.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -129.8 158.44 39.43 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 128.973 2.909 . . . . 1.33 111.091 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 74.7 mt -132.83 139.33 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 125.559 1.544 . . . . 1.6 111.13 -174.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -75.79 139.06 69.8 Favored Pre-proline 0 CA--C 1.546 0.806 0 O-C-N 120.272 -1.518 . . . . 2.16 111.97 171.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.19 -20.6 24.6 Favored 'Trans proline' 0 C--N 1.349 0.602 0 CA-C-N 122.645 1.981 . . . . 0.87 113.517 176.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -98.21 -44.4 6.6 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.934 1.693 . . . . 2.08 112.018 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.9 p -90.2 -21.29 22.24 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.992 0.738 . . . . 1.78 112.992 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 54.5 18.92 2.14 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.48 1.512 . . . . 2.99 113.943 -172.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.1 148.92 21.81 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.728 -1.232 . . . . 3.52 112.73 -177.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.9 mt -87.74 142.53 27.75 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.069 1.748 . . . . 2.24 113.313 -170.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.8 p -71.26 -7.26 45.77 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.042 1.127 . . . . 1.61 114.042 171.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.99 -161.26 14.64 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.959 1.266 . . . . 1.11 112.881 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.83 162.56 29.33 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.359 1.063 . . . . 2.07 113.333 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -51.51 137.09 32.12 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.777 1.231 . . . . 2.21 112.91 174.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.8 154.79 26.65 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.858 3.038 . . . . 1.01 114.199 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.17 -60.92 2.11 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.337 1.236 . . . . 1.46 114.337 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.6 p -119.84 15.64 12.61 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 114.363 1.245 . . . . 1.75 114.363 -169.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.35 146.78 11.57 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.914 1.079 . . . . 0.64 113.914 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.6 ttt -74.77 102.86 4.81 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.655 1.982 . . . . 1.97 110.605 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -156.25 146.21 21.22 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.018 1.727 . . . . 1.84 112.211 -173.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -163.75 156.81 18.36 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.448 1.499 . . . . 2.68 110.627 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.1 mp -92.72 146.74 23.42 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.527 0.731 . . . . 0.94 112.03 173.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.2 p -65.3 140.57 58.7 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 121.054 -1.029 . . . . 1.77 110.183 169.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -98.08 -62.81 1.19 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.473 0.916 . . . . 2.17 113.473 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -170.37 -31.14 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.439 2.296 . . . . 1.9 110.682 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.14 24.03 10.75 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.045 2.138 . . . . 4.75 112.32 172.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.9 -151.63 27.71 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.94 1.257 . . . . 0.92 112.801 -170.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.3 129.77 24.06 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.63 1.972 . . . . 1.24 111.416 169.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -83.75 135.85 34.39 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.677 1.591 . . . . 2.16 112.89 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -127.35 130.61 49.75 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.27 2.228 . . . . 2.94 108.602 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -93.17 104.09 16.31 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.428 -0.795 . . . . 2.05 111.608 -173.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.1 p -86.41 -0.8 56.74 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.69 1.196 . . . . 2.01 113.49 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.39 -25.49 59.58 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.94 0.896 . . . . 2.06 113.222 169.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -87.74 -14.94 38.4 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.329 1.451 . . . . 2.27 113.433 -174.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -90.4 150.19 42.41 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 113.881 1.067 . . . . 0.81 113.881 177.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -85.45 172.21 8.28 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.09 3.194 . . . . 0.83 111.011 166.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.6 85.27 2.08 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.995 2.118 . . . . 1.33 111.054 -174.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -141.56 176.1 9.16 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.159 1.384 . . . . 1.71 111.256 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -91.28 145.7 24.44 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.621 1.2 . . . . 3.7 111.981 169.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -136.11 176.17 8.94 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.854 2.062 . . . . 0.59 109.983 -172.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.95 156.74 43.0 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.642 1.177 . . . . 4.49 113.411 177.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.0 142.38 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.66 1.184 . . . . 1.5 111.354 172.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -131.1 142.21 50.24 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.722 2.009 . . . . 3.15 111.891 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -103.78 126.85 51.2 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.246 1.418 . . . . 2.11 112.843 -175.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 25.0 mm -128.01 143.64 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.434 1.493 . . . . 1.91 110.246 -169.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -114.7 -1.48 13.28 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.093 1.516 . . . . 6.06 115.093 -178.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.4 p -64.08 -17.85 63.81 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 120.06 -1.65 . . . . 2.59 113.221 171.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -118.1 123.17 44.94 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 105.826 -1.916 . . . . 3.06 105.826 165.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 28.9 t -159.15 142.17 14.41 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.372 0.669 . . . . 5.64 111.241 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.5 t -136.51 31.12 2.86 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.177 0.991 . . . . 6.34 111.958 175.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -128.85 175.63 8.48 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.492 1.117 . . . . 6.63 111.776 172.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.8 p -146.52 148.91 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.913 1.285 . . . . 4.41 110.598 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -110.78 -32.5 2.65 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.273 0.463 . . . . 2.95 113.626 170.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -80.22 5.19 15.25 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.326 1.85 . . . . 5.71 115.33 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -97.37 21.94 9.43 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.968 1.707 . . . . 6.56 113.333 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.42 0.51 89.4 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.629 1.109 . . . . 5.36 114.099 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.96 158.78 7.9 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.217 1.407 . . . . 3.56 112.365 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.9 m -81.12 56.06 2.71 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.062 -1.024 . . . . 4.61 111.717 -174.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -107.23 165.54 11.3 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.412 1.485 . . . . 3.33 114.022 -170.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.9 m -142.62 125.51 16.11 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.415 1.486 . . . . 3.97 107.555 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.55 -10.84 61.28 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 115.846 1.099 . . . . 2.58 115.846 -170.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 69.8 m -54.17 143.86 21.48 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.969 1.708 . . . . 3.48 114.273 -176.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.64 149.66 24.75 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.306 1.595 . . . . 3.05 115.306 -168.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -87.47 158.5 18.94 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.089 1.356 . . . . 1.25 112.526 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.7 m -122.91 145.23 45.03 Favored Pre-proline 0 N--CA 1.468 0.472 0 C-N-CA 124.497 1.119 . . . . 0.93 111.198 178.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.9 161.95 43.39 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.049 2.499 . . . . 0.52 112.476 -170.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.3 mp -126.85 119.33 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.861 1.264 . . . . 2.29 111.067 -168.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -74.33 140.26 44.74 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.818 0.735 . . . . 3.29 110.853 168.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.9 tt -144.81 144.62 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.55 1.14 . . . . 1.58 111.622 174.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -115.81 157.68 24.03 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.434 1.094 . . . . 2.11 110.975 169.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.79 151.48 72.55 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.407 1.483 . . . . 1.74 112.949 177.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -83.16 116.57 2.42 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.85 2.366 . . . . 1.11 113.998 -169.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.75 57.64 1.67 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 104.864 -2.273 . . . . 3.58 104.864 165.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -128.37 170.17 13.41 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 127.226 2.211 . . . . 3.57 110.478 -167.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -71.88 -11.13 60.65 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 120.632 -1.293 . . . . 3.19 114.242 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.0 m -77.41 148.69 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 114.733 1.383 . . . . 1.83 114.733 -171.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.1 t -80.58 -38.36 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.982 1.313 . . . . 2.33 111.689 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -149.35 147.32 28.18 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.229 1.412 . . . . 3.21 110.728 170.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -97.05 161.57 13.77 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.524 1.305 . . . . 1.61 114.524 -168.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -133.97 169.89 16.44 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.074 1.509 . . . . 0.65 115.074 174.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -138.55 144.78 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.623 1.969 . . . . 1.07 111.148 173.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -137.06 83.25 28.31 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.685 1.594 . . . . 3.44 111.032 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -69.72 151.15 69.24 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.501 2.801 . . . . 0.75 113.241 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -131.17 156.62 45.01 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.968 2.107 . . . . 2.61 112.037 -171.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -89.61 177.31 6.57 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 122.913 1.339 . . . . 4.52 113.369 173.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 32.3 p -125.14 178.39 5.58 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.321 1.848 . . . . 4.37 112.171 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -71.61 -5.52 34.08 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.107 2.163 . . . . 7.59 114.991 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -102.64 149.93 23.94 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.919 1.288 . . . . 5.67 113.569 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -131.16 151.08 78.27 Favored Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 125.389 1.476 . . . . 10.09 113.626 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -84.96 163.44 11.76 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.724 2.949 . . . . 10.71 114.464 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -108.36 -15.77 14.39 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.116 1.766 . . . . 13.12 115.486 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.61 3.79 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 116.762 2.134 . . . . 14.98 116.762 -167.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 40.8 mt -90.05 62.85 5.71 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 123.118 1.437 . . . . 16.26 111.348 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 CA--C 1.538 0.482 0 C-N-CA 124.958 1.303 . . . . 16.16 113.429 -168.941 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.3 ppp? . . . . . 0 N--CA 1.476 0.862 0 CA-C-O 120.97 0.414 . . . . 27.0 110.982 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -84.01 101.33 11.67 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.794 0.807 . . . . 24.15 112.595 -170.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.5 t -149.75 151.48 33.68 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.69 1.996 . . . . 20.74 110.638 169.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -100.69 154.83 18.27 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.343 1.057 . . . . 16.49 113.353 -174.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 m -93.5 -28.91 15.8 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.182 0.993 . . . . 16.64 113.266 174.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -138.5 137.33 37.01 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.249 1.82 . . . . 11.97 111.179 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.38 166.95 14.46 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.741 1.386 . . . . 10.25 114.741 -169.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.4 t -64.78 141.69 58.69 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.329 1.451 . . . . 9.8 111.173 169.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.5 p -135.25 148.86 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.043 1.337 . . . . 6.86 110.643 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -126.18 156.64 39.86 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.255 1.022 . . . . 5.98 112.046 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.99 134.12 49.23 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.108 1.363 . . . . 4.36 111.119 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -159.25 151.84 21.55 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.675 1.59 . . . . 6.0 110.418 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.78 31.14 0.28 Allowed Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.802 1.667 . . . . 3.36 116.59 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.4 p -80.43 145.47 31.94 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 115.688 1.736 . . . . 1.88 115.688 -168.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.7 p -89.13 -14.53 35.97 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.558 1.318 . . . . 2.01 114.558 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 t -147.18 165.29 30.46 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.452 1.901 . . . . 2.6 111.365 171.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -103.89 -0.09 29.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.971 2.509 . . . . 2.07 114.83 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 88.6 p -149.28 165.43 31.94 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.553 1.141 . . . . 2.17 113.349 175.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.66 136.63 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 127.474 2.309 . . . . 1.6 109.757 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.0 m -104.89 115.28 30.02 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.771 0.796 . . . . 1.16 110.796 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 p -95.24 134.56 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.28 1.432 . . . . 1.38 110.486 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -116.98 179.1 4.12 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.583 1.953 . . . . 1.84 109.988 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.96 129.35 18.93 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 120.35 1.432 . . . . 1.94 113.204 171.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.3 mt -115.0 148.24 39.08 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.422 1.089 . . . . 1.1 113.85 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.5 mt -135.94 177.13 8.07 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.24 2.216 . . . . 2.6 109.995 169.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.96 166.8 10.9 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.845 1.258 . . . . 1.37 112.545 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.3 p -85.67 -32.98 21.68 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.593 -1.317 . . . . 1.84 113.309 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -133.24 15.37 4.15 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.106 1.363 . . . . 2.49 113.624 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.22 34.86 8.41 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 120.722 -1.236 . . . . 1.13 113.379 -173.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.59 12.5 2.51 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.977 2.511 . . . . 2.04 114.614 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -60.17 -20.22 57.56 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.768 -1.207 . . . . 0.87 113.081 -172.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.44 -56.04 19.38 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.033 1.733 . . . . 2.9 113.041 172.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -38.87 70.45 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.173 -0.954 . . . . 5.6 111.704 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 84.4 mt -53.21 -50.28 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.352 1.061 . . . . 1.05 110.922 169.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.08 -32.66 72.31 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.826 1.194 . . . . 1.22 112.987 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -70.51 -34.34 72.22 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.998 0.74 . . . . 1.3 112.998 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -67.79 -28.05 67.27 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.717 0.69 . . . . 1.95 112.57 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.9 mt -85.99 -36.28 19.88 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.952 1.093 . . . . 2.25 113.952 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -65.42 -25.48 67.55 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.214 0.916 . . . . 2.86 113.137 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.1 t -76.37 -34.05 58.91 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.42 -0.8 . . . . 2.19 112.868 173.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.62 167.86 48.99 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.559 1.076 . . . . 1.23 113.876 176.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -93.85 32.12 1.5 Allowed 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.199 -1.177 . . . . 2.45 112.99 -173.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -70.95 3.01 3.64 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 116.057 1.873 . . . . 3.57 116.057 -167.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.0 -23.98 67.71 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.103 -0.998 . . . . 1.68 111.942 167.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.98 -76.68 0.85 Allowed Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.405 1.478 . . . . 1.0 112.581 170.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.36 158.13 31.73 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.983 1.475 . . . . 1.79 114.983 -170.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -62.92 147.75 49.43 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.188 0.995 . . . . 4.91 111.58 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.5 t -56.52 140.29 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.848 0.859 . . . . 1.85 111.867 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.58 -66.21 2.65 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.404 1.002 . . . . 1.58 112.861 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.0 t -149.14 125.01 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.975 2.11 . . . . 2.92 109.62 174.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt -74.89 145.48 81.39 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.316 -0.865 . . . . 1.86 112.505 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -72.59 161.69 43.36 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.937 2.425 . . . . 0.68 112.188 -176.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.38 -15.62 63.79 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.405 1.261 . . . . 1.64 114.405 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -96.52 -1.3 47.44 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.607 1.563 . . . . 2.52 114.193 173.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.49 150.86 24.98 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.291 -0.881 . . . . 0.67 112.556 169.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -141.6 151.44 43.15 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.595 1.558 . . . . 3.35 110.975 169.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.14 138.75 53.7 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.051 0.941 . . . . 3.1 110.7 -171.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.4 pt -131.85 153.03 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 115.403 1.631 . . . . 1.68 115.403 -169.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -113.53 156.54 23.4 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.292 1.837 . . . . 1.67 112.31 172.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.29 13.69 59.83 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.953 1.263 . . . . 0.53 114.882 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.86 142.35 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.079 1.751 . . . . 2.03 110.613 172.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -103.74 136.83 42.7 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.8 1.64 . . . . 1.6 113.661 -175.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -141.85 152.29 43.51 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.121 1.368 . . . . 2.8 111.76 175.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.15 146.74 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 127.306 2.242 . . . . 1.65 109.361 -176.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -88.91 147.61 24.26 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.396 1.093 . . . . 0.46 112.287 169.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.2 p -136.68 165.1 26.68 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.025 1.73 . . . . 1.69 112.395 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.02 168.67 13.1 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.092 1.357 . . . . 1.9 111.22 167.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . 0.267 1.3 t -67.15 -14.65 63.1 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 115.0 1.481 . . . . 2.98 115.0 -168.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -83.69 19.07 1.73 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.717 1.607 . . . . 4.74 113.055 167.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.72 23.31 12.16 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.233 1.813 . . . . 0.64 113.558 -175.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -83.89 136.67 34.01 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.659 1.584 . . . . 2.61 112.904 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.4 mt -77.79 128.79 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 121.602 -0.686 . . . . 1.62 110.516 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.78 150.66 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 126.386 1.874 . . . . 1.83 114.326 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -77.73 161.61 27.59 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.331 2.252 . . . . 1.58 110.965 168.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -56.6 -21.78 29.33 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 116.025 1.861 . . . . 2.46 116.025 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . 0.257 0.0 OUTLIER -87.87 -0.58 57.15 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 120.829 1.65 . . . . 3.25 113.558 171.438 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.62 17.6 65.71 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.895 1.236 . . . . 0.75 114.405 -175.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -75.27 145.3 41.99 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.107 0.953 . . . . 2.95 108.966 167.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.4 p -106.21 145.42 31.59 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.084 0.954 . . . . 2.0 112.416 -171.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -103.06 -4.98 23.8 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.126 1.158 . . . . 1.65 114.126 -170.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.85 30.17 52.72 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 119.722 1.146 . . . . 0.71 113.905 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 45.1 t -138.85 145.81 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.124 1.369 . . . . 1.68 110.308 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -126.49 159.29 33.83 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.644 2.778 . . . . 1.5 110.942 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 51.4 mt -136.91 134.15 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.302 1.441 . . . . 1.58 110.387 -174.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -75.56 140.06 71.49 Favored Pre-proline 0 N--CA 1.476 0.854 0 CA-C-O 117.687 -1.149 . . . . 2.24 111.836 176.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -72.17 -24.12 20.46 Favored 'Trans proline' 0 C--N 1.351 0.679 0 CA-C-N 122.154 1.805 . . . . 1.11 113.136 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -88.01 -52.03 5.49 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.814 1.646 . . . . 1.74 111.777 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.0 p -83.21 -23.8 32.66 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.959 0.904 . . . . 2.06 113.15 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 52.52 23.4 2.54 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.056 1.743 . . . . 3.58 113.653 -173.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . 0.252 2.2 ptmt -104.38 162.61 13.08 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.052 -1.03 . . . . 4.62 112.887 176.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.9 mt -94.48 149.57 21.11 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.474 1.51 . . . . 1.15 114.629 -167.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.8 p -75.1 0.76 15.07 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.986 1.106 . . . . 1.45 113.986 169.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.23 -152.33 9.54 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.187 1.375 . . . . 1.09 112.277 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.76 155.07 19.44 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.017 0.927 . . . . 2.2 113.345 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 tpt -51.08 130.78 30.96 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.806 1.642 . . . . 2.05 112.069 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.34 168.03 25.46 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.706 2.937 . . . . 1.0 113.425 -175.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.19 -91.53 0.07 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.764 1.226 . . . . 1.64 110.83 168.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.4 p -74.56 10.87 1.17 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 116.49 2.033 . . . . 1.77 116.49 -167.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.57 147.46 14.22 Favored 'General case' 0 CA--C 1.55 0.95 0 O-C-N 120.437 -1.415 . . . . 0.61 113.259 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.3 ttt -74.51 102.53 4.53 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.469 1.508 . . . . 1.82 109.98 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -156.85 145.29 19.71 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.622 1.569 . . . . 1.74 111.656 -174.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -168.13 156.82 9.04 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.272 1.829 . . . . 3.73 109.93 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.2 mp -87.45 150.08 24.0 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.335 1.454 . . . . 0.78 113.585 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.2 p -63.98 129.77 41.37 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.218 -0.927 . . . . 1.99 110.193 169.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -80.75 -57.38 3.58 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 120.771 -1.206 . . . . 2.08 114.032 -174.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -153.03 -43.12 0.1 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.921 1.688 . . . . 1.98 109.796 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -104.6 -33.15 8.62 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.039 0.936 . . . . 4.58 113.239 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 172.61 -170.65 43.72 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 126.218 1.866 . . . . 0.98 110.865 -169.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -135.12 136.39 41.89 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.175 1.79 . . . . 2.06 110.637 171.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -97.05 128.9 44.45 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.016 0.926 . . . . 2.29 111.949 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -117.98 136.23 53.64 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.8 2.04 . . . . 2.98 107.738 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -96.66 104.41 16.4 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.553 -1.342 . . . . 1.9 111.817 -169.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.4 p -86.77 1.65 51.51 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.655 1.182 . . . . 1.69 113.349 -174.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.3 -29.12 68.64 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.412 -0.805 . . . . 1.88 112.093 169.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.7 m120 -86.92 -20.78 26.87 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.35 1.46 . . . . 2.3 113.187 -175.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -79.06 144.22 62.82 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 119.474 1.034 . . . . 0.92 113.253 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.22 169.46 20.18 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.643 2.229 . . . . 1.3 110.733 166.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.97 89.68 1.92 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.054 1.742 . . . . 1.55 110.771 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -149.09 177.81 9.27 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.827 0.851 . . . . 1.97 112.052 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -87.04 146.37 26.12 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.107 0.963 . . . . 3.52 111.628 166.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -135.84 170.49 15.9 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.993 2.117 . . . . 0.72 109.718 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -140.25 149.72 43.21 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.549 0.739 . . . . 2.58 111.788 171.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.2 mp -104.03 140.4 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.281 0.632 . . . . 1.75 110.072 173.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -124.75 135.94 53.42 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.926 1.69 . . . . 3.21 109.852 174.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -97.55 123.84 41.58 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.122 0.969 . . . . 1.84 109.392 178.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 40.3 mm -122.57 97.12 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.743 0.817 . . . . 1.93 109.074 -172.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.45 ' CD2' ' HG ' ' A' ' 148' ' ' SER . 0.2 OUTLIER -74.7 -12.03 60.32 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.579 1.325 . . . . 5.34 114.579 -169.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 79.8 p -63.76 -19.97 65.39 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.271 1.211 . . . . 2.5 114.271 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -108.33 -4.61 17.3 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.543 1.537 . . . . 3.29 113.326 172.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.45 ' HG ' ' CD2' ' A' ' 145' ' ' HIS . 56.2 m -59.28 135.56 57.69 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.245 1.384 . . . . 7.03 111.722 177.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 16.7 p -82.74 -35.73 26.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.649 0.78 . . . . 6.04 113.008 178.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -90.03 114.13 25.94 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.387 0.675 . . . . 7.92 111.275 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.75 132.35 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 122.772 0.429 . . . . 4.57 110.683 176.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -110.14 -27.29 4.58 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 114.496 0.559 . . . . 2.23 114.496 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -77.36 -8.5 57.78 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.977 1.473 . . . . 4.73 114.977 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -79.96 -13.34 59.42 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.285 1.834 . . . . 5.05 114.609 -171.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 134.74 -10.26 4.57 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.115 1.341 . . . . 4.12 115.175 -173.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.34 168.99 1.81 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.036 1.335 . . . . 2.94 112.61 172.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.8 t -70.19 9.03 0.64 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.416 -1.428 . . . . 4.48 114.739 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 11.2 mt -88.9 -176.74 5.29 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.864 1.665 . . . . 2.66 111.018 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 34.2 p -133.04 153.7 51.24 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.599 1.56 . . . . 3.9 110.444 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -77.2 29.42 1.65 Allowed Glycine 0 CA--C 1.541 1.661 0 C-N-CA 124.686 1.136 . . . . 2.63 114.94 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.4 t -78.3 -176.75 4.83 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.764 1.226 . . . . 3.21 112.582 -172.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -116.46 132.56 56.64 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 115.209 1.559 . . . . 3.36 115.209 -171.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.62 152.96 29.74 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.099 0.96 . . . . 1.16 111.857 168.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.56 149.04 54.63 Favored Pre-proline 0 N--CA 1.478 0.975 0 C-N-CA 125.337 1.455 . . . . 0.94 110.784 174.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.9 162.72 29.21 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.894 3.063 . . . . 0.78 115.299 -165.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.6 mp -126.41 133.47 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.742 2.017 . . . . 2.11 110.701 -168.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -98.14 130.88 44.89 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.438 1.095 . . . . 3.39 111.838 174.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.4 tt -135.94 147.84 28.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.927 1.291 . . . . 1.74 110.816 -174.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -127.48 152.93 46.94 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.986 1.315 . . . . 1.95 109.125 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.09 143.97 98.97 Favored Pre-proline 0 CA--C 1.543 0.688 0 O-C-N 120.94 -1.1 . . . . 1.42 111.614 -176.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -66.81 92.04 0.31 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 124.506 3.47 . . . . 0.8 115.599 -165.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.2 tt -122.73 77.53 1.44 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.678 1.991 . . . . 3.29 105.783 168.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -157.63 177.02 11.86 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.155 2.182 . . . . 2.65 108.574 -167.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -84.33 34.36 0.52 Allowed 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.163 -1.585 . . . . 3.23 114.135 -175.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.63 156.51 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.845 1.258 . . . . 1.62 111.637 -174.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 78.2 t -108.88 -33.85 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.267 1.827 . . . . 2.68 111.558 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -129.07 134.64 48.18 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.265 1.426 . . . . 3.74 109.167 172.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -98.34 137.82 36.5 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.226 1.01 . . . . 1.38 111.494 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -133.72 166.93 21.49 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.068 1.136 . . . . 0.71 114.068 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.28 135.91 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.2 1.4 . . . . 2.1 111.568 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -134.18 82.52 47.5 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.569 1.147 . . . . 3.33 111.466 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.78 151.08 68.87 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 124.559 3.506 . . . . 0.81 112.274 175.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -131.58 158.94 39.65 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.083 1.753 . . . . 3.0 111.679 -178.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -88.64 175.01 7.72 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.311 1.044 . . . . 2.87 110.997 168.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 13.2 t -147.56 -56.6 0.24 Allowed 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.409 -0.807 . . . . 2.48 113.063 169.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 64.53 129.6 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.67 1.988 . . . . 6.4 115.453 -174.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -96.57 -41.07 8.72 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.069 1.348 . . . . 7.91 112.607 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -149.69 151.89 33.76 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 126.317 1.847 . . . . 11.37 110.906 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.91 149.5 83.06 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.031 2.488 . . . . 9.01 113.909 -171.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -147.28 26.78 1.06 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.642 1.977 . . . . 13.33 112.984 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.32 -9.34 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 115.902 1.816 . . . . 14.59 115.902 -167.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.87 168.08 20.69 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.072 0.949 . . . . 12.84 112.953 -171.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 . . . . . 0 CA--C 1.549 0.936 0 C-N-CA 127.385 2.274 . . . . 16.06 114.532 -178.53 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 109.638 -0.505 . . . . 27.1 109.638 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -121.57 172.73 7.89 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.939 1.296 . . . . 24.98 112.571 -170.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.7 p -71.52 10.02 0.72 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 115.16 1.541 . . . . 22.33 115.16 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.27 132.89 53.11 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.657 1.183 . . . . 18.15 113.819 -169.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.3 t -89.53 120.25 30.67 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.712 1.205 . . . . 14.25 110.822 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -116.24 174.02 6.28 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.885 1.274 . . . . 12.71 113.021 -174.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 65.19 -71.28 0.08 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.11 2.564 . . . . 9.71 115.04 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.4 p -112.92 145.78 40.15 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.042 1.497 . . . . 7.56 115.042 -167.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.1 m -98.93 3.13 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 126.58 1.952 . . . . 8.92 115.493 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 55.61 168.92 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.75 2.02 . . . . 5.44 113.696 -169.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.43 -37.95 0.09 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 116.33 1.974 . . . . 6.11 116.33 -170.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.49 -162.96 1.66 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.628 1.171 . . . . 5.81 112.06 -167.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.49 1.07 43.62 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 126.888 2.185 . . . . 2.68 114.454 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.9 p -152.7 164.7 37.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.204 1.802 . . . . 1.74 113.416 -168.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 43.4 p -98.21 -8.48 27.33 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.343 1.457 . . . . 2.58 114.067 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.0 m -147.5 146.02 29.34 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.478 1.911 . . . . 3.57 110.054 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.4 p -108.96 -14.48 14.55 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 116.901 2.186 . . . . 2.04 116.901 -172.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.6 m -138.61 149.62 45.43 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.019 1.328 . . . . 2.29 111.589 170.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.5 p -115.7 142.66 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 127.071 2.149 . . . . 1.45 110.382 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 36.0 m -111.0 121.61 45.8 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.582 0.753 . . . . 1.18 109.564 172.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 p -96.65 127.38 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.945 0.879 . . . . 1.27 109.346 174.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -103.66 -172.47 2.12 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.02 1.728 . . . . 1.9 109.029 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.8 134.19 13.47 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 120.411 -1.431 . . . . 1.88 112.611 168.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.0 mt -121.06 150.57 40.98 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.852 1.261 . . . . 1.84 112.971 -172.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.3 mt -140.81 169.66 17.22 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.332 1.853 . . . . 2.32 109.761 167.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.98 172.97 7.07 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.993 0.917 . . . . 2.09 112.029 173.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.8 p -102.31 -25.78 13.54 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 114.417 1.266 . . . . 1.86 114.417 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -134.95 45.22 2.55 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.668 1.987 . . . . 2.55 110.365 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.47 14.63 67.17 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 120.741 -1.224 . . . . 1.0 116.007 175.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.63 27.24 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.982 2.513 . . . . 2.2 115.921 -171.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.13 -19.06 65.8 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 119.617 -1.927 . . . . 0.99 114.13 -171.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -85.14 -43.38 13.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.385 1.474 . . . . 2.28 112.583 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -69.94 -39.09 76.28 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-O 117.941 -1.028 . . . . 4.34 110.955 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.3 mt -51.6 -50.37 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.499 1.12 . . . . 2.14 110.09 167.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.37 -27.47 66.0 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.554 0.946 . . . . 2.41 113.554 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -79.72 -32.22 41.23 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.063 -1.023 . . . . 1.23 112.937 174.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -67.97 -16.01 63.86 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.792 0.837 . . . . 2.1 112.596 169.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.4 mt -97.46 -37.61 9.92 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.072 1.349 . . . . 1.93 114.22 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -70.15 -15.93 63.02 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.57 -1.331 . . . . 2.51 114.448 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.4 t -71.78 -30.2 65.3 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.01 0.924 . . . . 2.45 113.25 170.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.38 164.6 28.29 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.48 1.514 . . . . 1.27 113.053 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -87.32 53.41 2.8 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.131 -1.217 . . . . 1.88 111.412 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -89.41 8.01 33.0 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.378 1.251 . . . . 3.15 114.378 -170.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.03 -25.79 63.74 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.139 -0.976 . . . . 1.97 111.69 168.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.28 -82.53 1.21 Allowed Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.064 0.84 . . . . 0.72 111.888 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 161.52 29.67 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.774 1.23 . . . . 2.16 112.708 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -60.36 158.13 12.44 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.804 1.242 . . . . 3.28 114.341 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 52.6 t -59.04 126.73 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 121.881 -0.512 . . . . 1.11 110.6 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.38 -48.84 75.19 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.061 1.315 . . . . 1.12 113.301 -175.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.0 129.16 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.804 1.241 . . . . 3.87 111.228 173.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.9 mt -79.62 144.54 61.04 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.066 0.946 . . . . 1.5 111.532 174.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.64 166.94 28.51 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.65 2.234 . . . . 0.73 113.045 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.64 -23.83 65.38 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 121.015 -1.053 . . . . 2.04 113.452 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -83.92 -1.43 54.52 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.373 1.249 . . . . 2.85 114.373 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.09 158.19 16.47 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.282 1.433 . . . . 0.65 114.162 172.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.77 159.45 44.34 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.55 1.14 . . . . 2.78 112.729 166.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -105.29 150.04 25.51 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.847 1.659 . . . . 2.9 111.263 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.9 pt -137.92 139.29 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 120.067 1.303 . . . . 1.62 114.282 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.74 146.95 25.97 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.759 1.223 . . . . 1.44 113.102 172.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.8 14.36 27.25 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.341 1.448 . . . . 0.54 115.42 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.43 144.44 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 125.287 1.435 . . . . 1.74 109.795 169.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 1.3 tpt -105.25 140.26 38.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.554 1.542 . . . . 1.67 112.115 176.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.52 155.67 43.23 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.841 1.257 . . . . 3.54 112.625 172.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.3 m -120.23 149.62 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 127.033 2.133 . . . . 1.7 109.709 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -90.26 147.58 23.44 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 122.619 1.199 . . . . 0.42 112.106 169.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.4 p -139.72 166.85 23.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.31 1.844 . . . . 1.86 111.385 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.78 172.93 11.73 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.544 -0.722 . . . . 1.99 112.529 168.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.8 t -61.58 -23.98 66.36 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.437 1.273 . . . . 3.21 114.437 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -87.9 20.99 2.83 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 125.379 1.472 . . . . 2.83 113.347 171.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 56.75 27.47 12.81 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.779 2.832 . . . . 0.66 114.742 175.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -82.7 140.56 33.03 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.013 0.925 . . . . 2.16 110.31 172.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.4 mt -76.21 125.68 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.225 -0.657 . . . . 1.6 109.225 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.3 pt -121.86 156.91 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 114.644 1.35 . . . . 1.83 114.644 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -90.1 164.09 14.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.619 2.367 . . . . 1.57 110.115 168.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -68.97 2.9 2.31 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 116.689 2.107 . . . . 2.4 116.689 -168.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -110.89 0.79 17.27 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.422 1.489 . . . . 2.84 114.105 168.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.24 3.0 60.35 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.255 1.407 . . . . 0.63 115.644 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -65.31 132.13 48.25 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.042 1.421 . . . . 3.99 108.932 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.05 142.41 28.29 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 118.134 0.425 . . . . 1.86 111.43 176.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.22 -12.76 45.83 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.233 1.198 . . . . 1.84 114.233 -168.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.56 22.72 23.34 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.053 1.311 . . . . 0.78 114.511 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.0 t -134.79 149.55 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.373 1.469 . . . . 1.88 110.195 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -128.28 157.5 40.74 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.68 2.792 . . . . 1.29 111.292 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 57.1 mt -134.04 126.82 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.423 1.489 . . . . 1.88 110.321 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -68.64 137.71 90.71 Favored Pre-proline 0 N--CA 1.477 0.888 0 O-C-N 121.029 -1.045 . . . . 2.33 111.046 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.06 -15.17 29.14 Favored 'Trans proline' 0 C--N 1.35 0.623 0 CA-C-N 121.924 1.723 . . . . 1.04 113.785 176.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -97.19 -47.43 5.75 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.627 1.571 . . . . 2.15 111.419 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.9 p -90.34 -22.03 21.73 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.728 1.211 . . . . 2.25 113.458 -174.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 56.43 16.32 2.4 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.582 1.553 . . . . 2.88 113.923 -171.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.81 146.13 24.01 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.94 -1.1 . . . . 3.86 113.124 -175.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.9 mt -81.56 142.73 32.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.102 1.361 . . . . 1.26 112.648 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 83.8 p -77.67 4.4 11.57 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.418 1.266 . . . . 1.67 114.418 172.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.83 -162.52 29.63 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 126.106 1.813 . . . . 1.19 112.388 -176.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.66 154.75 39.57 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.827 1.047 . . . . 2.53 113.827 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 mtp -51.8 138.18 33.4 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.39 1.076 . . . . 3.26 112.64 174.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -83.48 171.2 11.23 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.536 3.491 . . . . 0.83 113.895 -172.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.12 -96.19 0.09 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.583 1.553 . . . . 1.39 110.545 168.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.1 p -72.77 13.51 0.36 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 116.627 2.084 . . . . 1.95 116.627 -168.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.61 145.09 19.78 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.042 -1.036 . . . . 0.66 112.812 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.1 ttt -75.0 107.89 7.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.872 2.469 . . . . 1.87 110.353 176.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -157.73 143.24 17.11 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 127.303 2.241 . . . . 1.83 112.702 -174.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -164.91 158.1 16.84 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.013 1.325 . . . . 2.73 111.859 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.8 mp -101.79 144.99 29.78 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.991 1.317 . . . . 0.79 113.981 175.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.8 p -64.54 136.17 56.76 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.721 0.638 . . . . 1.33 112.721 173.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.03 -59.13 1.86 Allowed 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 114.965 1.468 . . . . 2.33 114.965 -172.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.25 -39.61 0.14 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.184 0.994 . . . . 1.77 111.871 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -115.35 -27.01 7.36 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.09 0.956 . . . . 5.2 112.515 174.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 179.64 -156.04 17.2 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 123.836 0.732 . . . . 0.9 112.263 -178.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.74 131.12 23.67 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.023 2.129 . . . . 1.18 111.5 171.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -83.49 140.64 32.19 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.945 1.298 . . . . 2.09 113.579 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -134.39 118.74 17.77 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.989 2.516 . . . . 2.94 108.977 175.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.475 ' ND2' HD22 ' A' ' 133' ' ' ASN . 17.0 t30 -76.27 113.14 13.5 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.569 1.148 . . . . 2.05 109.427 177.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 35.9 p -103.61 0.66 31.08 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.921 1.288 . . . . 1.82 113.219 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -53.41 -18.48 2.66 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.756 2.422 . . . . 1.88 115.276 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.475 HD22 ' ND2' ' A' ' 130' ' ' ASN . 0.0 OUTLIER -105.81 -23.81 12.62 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.373 1.869 . . . . 3.23 113.088 -174.508 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.57 140.03 96.31 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 119.318 0.963 . . . . 0.95 112.458 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.09 169.18 23.14 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.581 2.187 . . . . 0.9 111.482 169.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.47 93.05 2.4 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.978 1.311 . . . . 1.65 109.614 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -144.51 178.79 7.7 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.478 1.111 . . . . 1.97 111.079 174.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -94.95 141.69 28.35 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.335 1.054 . . . . 4.25 110.988 169.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -135.34 166.72 22.5 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.222 1.809 . . . . 0.75 110.272 -172.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -141.49 149.17 40.56 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.24 0.83 . . . . 2.53 113.24 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 mp -105.91 142.34 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.572 1.149 . . . . 1.47 110.201 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -129.43 127.29 40.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.891 1.676 . . . . 3.29 111.491 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -91.84 75.21 5.68 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.967 0.907 . . . . 1.95 112.656 -171.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.0 mm -77.75 107.99 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.742 0.817 . . . . 1.74 109.908 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.78 9.07 40.43 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.763 1.023 . . . . 5.35 113.763 -174.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.9 t -70.68 -19.15 62.81 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.752 1.019 . . . . 2.85 113.752 -176.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.3 mp -86.26 166.19 15.88 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.158 0.983 . . . . 3.48 111.533 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.79 112.08 1.35 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.008 0.923 . . . . 6.22 111.743 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.4 p -141.63 171.09 14.53 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.498 2.319 . . . . 6.14 113.269 -167.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -56.97 155.82 7.62 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.694 1.597 . . . . 5.59 113.642 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 91.1 t -110.73 133.4 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.952 1.301 . . . . 4.15 112.501 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -121.89 -35.81 0.76 Allowed Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.539 1.542 . . . . 2.36 115.253 170.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.63 -6.35 48.18 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.38 1.622 . . . . 4.78 115.38 -170.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -69.21 -15.54 63.41 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.244 1.817 . . . . 5.58 114.459 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 126.98 -2.23 7.32 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.302 1.43 . . . . 4.33 114.625 -175.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.96 168.05 2.59 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.066 1.747 . . . . 3.03 113.937 175.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . 0.269 6.5 t -78.36 43.66 0.47 Allowed 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 123.249 1.5 . . . . 4.0 113.406 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -122.02 130.31 53.18 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.143 2.577 . . . . 3.68 107.966 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -100.07 158.27 15.96 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 118.939 0.79 . . . . 3.97 112.793 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -79.1 42.1 2.3 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.615 1.579 . . . . 2.98 115.276 -174.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 t -76.14 153.75 35.99 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.089 1.356 . . . . 3.3 112.705 -174.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -104.66 119.14 38.3 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.403 1.081 . . . . 3.22 111.788 -170.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.33 128.85 36.66 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.996 0.816 . . . . 1.47 111.79 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.2 m -100.46 149.6 36.24 Favored Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 124.24 1.016 . . . . 1.02 110.356 172.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.74 161.29 46.59 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.797 2.331 . . . . 0.75 113.058 -170.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 1.5 mp -121.84 127.87 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.347 1.059 . . . . 2.36 110.761 -169.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -93.02 139.37 30.6 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.896 1.279 . . . . 2.72 112.466 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.8 tt -147.48 146.57 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.965 1.306 . . . . 1.6 111.964 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -120.88 155.73 33.52 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.047 1.339 . . . . 2.3 110.639 169.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -67.53 148.61 98.6 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 123.793 0.837 . . . . 1.93 112.139 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.0 112.1 3.04 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.527 2.818 . . . . 1.14 114.008 -168.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 tp -119.04 0.98 11.39 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 125.239 1.416 . . . . 3.83 110.854 165.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -76.85 169.16 18.82 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 129.585 3.154 . . . . 2.9 111.53 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -74.16 19.54 0.12 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 116.46 2.022 . . . . 4.21 116.46 -171.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . 0.252 1.2 m -95.41 147.53 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 O-C-N 121.04 -1.038 . . . . 1.7 113.672 -169.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 41.2 t -88.31 -32.35 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.079 1.352 . . . . 2.66 112.129 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -147.13 127.38 13.86 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.544 1.537 . . . . 2.54 108.645 -174.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -101.57 143.15 31.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.561 1.144 . . . . 1.58 112.449 -169.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -139.02 170.62 15.65 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.329 1.603 . . . . 0.77 115.329 -178.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.4 t -139.74 139.94 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.752 2.021 . . . . 2.04 111.336 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -132.97 82.79 54.03 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.96 1.304 . . . . 3.66 112.988 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -65.89 143.53 73.44 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.689 3.593 . . . . 0.78 113.913 171.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -140.71 166.68 24.1 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 129.08 2.952 . . . . 3.16 111.027 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -117.93 169.52 9.57 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.927 0.891 . . . . 3.61 113.06 -171.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 12.8 t -144.77 171.44 14.41 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.662 1.985 . . . . 2.54 111.74 -178.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 53.41 -63.25 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 130.604 3.562 . . . . 5.88 118.087 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . 61.89 173.94 0.13 Allowed 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 127.182 2.193 . . . . 6.46 115.6 -169.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -147.22 155.7 46.6 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 125.621 1.568 . . . . 11.03 111.733 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.03 160.01 51.65 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.759 2.306 . . . . 9.41 112.99 177.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 23.3 mtmm -85.33 -25.14 27.31 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 116.402 2.001 . . . . 16.16 116.402 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.5 mp -83.99 -68.36 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 118.827 0.74 . . . . 15.01 111.726 -169.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 77.8 mt 56.62 177.41 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 126.047 1.739 . . . . 12.35 115.058 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 . . . . . 0 N--CA 1.474 0.737 0 O-C-N 120.595 -1.316 . . . . 15.85 112.265 -176.88 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.702 0.287 . . . . 29.04 111.388 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -120.87 135.89 55.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.11 1.364 . . . . 25.62 112.224 176.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.6 p -96.65 175.41 6.39 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.006 1.323 . . . . 22.72 109.079 166.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.88 -25.09 26.58 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 120.84 -1.162 . . . . 18.87 113.471 173.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.0 m 51.24 28.75 4.38 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.816 2.046 . . . . 19.13 116.057 168.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.99 155.87 30.17 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.152 1.381 . . . . 14.61 112.209 -175.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.07 -83.86 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.332 1.053 . . . . 12.21 112.85 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.3 p -101.08 143.34 31.31 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.236 1.415 . . . . 10.0 112.885 -169.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.29 144.05 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.421 1.088 . . . . 8.61 112.649 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -124.12 156.07 37.3 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.95 2.1 . . . . 5.28 111.279 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -147.47 157.74 43.69 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 117.172 2.286 . . . . 6.13 117.172 -166.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 40.86 20.43 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 131.59 3.956 . . . . 6.48 121.332 167.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.54 -16.31 73.8 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.765 1.174 . . . . 3.38 114.111 174.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.1 p -146.12 172.18 13.81 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.088 1.755 . . . . 2.25 112.8 -171.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.4 p -92.8 -15.4 26.58 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.391 1.076 . . . . 2.11 113.754 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.9 m -148.37 124.44 10.73 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.008 1.723 . . . . 2.98 108.9 171.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 45.2 p -90.86 23.63 3.07 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.181 1.548 . . . . 3.12 115.181 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 m -149.17 165.79 30.76 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.057 1.343 . . . . 2.51 110.523 168.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.4 p -144.05 142.6 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.007 1.723 . . . . 1.49 109.793 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.2 m -116.01 124.83 51.47 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.717 0.807 . . . . 1.04 110.273 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -101.98 131.19 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.803 1.241 . . . . 1.14 110.599 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -128.15 104.67 7.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.227 1.411 . . . . 1.81 110.888 -172.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.74 116.95 20.21 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.493 -1.379 . . . . 2.35 111.575 -172.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.3 mt -106.6 151.75 24.63 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.039 1.336 . . . . 1.18 111.762 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.9 mt -138.16 171.55 14.24 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.33 1.452 . . . . 2.21 111.137 169.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.56 162.77 13.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.356 1.063 . . . . 1.22 112.678 170.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.6 p -91.39 -24.73 19.66 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 114.751 1.389 . . . . 1.73 114.751 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -138.11 38.61 2.33 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.113 1.765 . . . . 2.1 111.601 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.19 14.39 79.08 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 120.84 -1.163 . . . . 1.01 115.659 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.01 25.26 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 128.889 2.876 . . . . 1.84 116.221 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -24.59 67.59 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 119.883 -1.761 . . . . 1.07 113.202 -173.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -75.28 -40.13 59.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.769 1.168 . . . . 2.12 113.481 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.1 ptmm? -70.48 -41.41 72.75 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 117.448 -1.263 . . . . 3.89 111.357 170.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.6 mt -55.64 -52.88 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 120.252 1.387 . . . . 2.15 111.47 170.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.61 -34.08 70.73 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.08 -1.013 . . . . 1.39 112.785 -178.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -77.2 -30.75 54.88 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.715 1.005 . . . . 1.41 113.715 175.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -66.35 -30.71 71.16 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.133 0.879 . . . . 2.12 111.789 169.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.6 mt -86.4 -37.57 18.26 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.483 1.29 . . . . 1.34 114.483 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -72.64 -23.89 60.97 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.063 0.764 . . . . 3.68 113.063 -177.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.0 t -76.81 -28.43 55.57 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.673 0.62 . . . . 3.19 112.673 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.6 156.65 35.23 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.106 1.336 . . . . 1.43 112.745 172.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -83.57 31.45 0.47 Allowed 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.21 -1.171 . . . . 2.79 112.817 -173.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -71.08 5.42 2.1 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.786 1.402 . . . . 3.31 114.786 -169.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.95 -22.35 62.37 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.007 -1.058 . . . . 1.51 112.289 167.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.69 -82.11 1.15 Allowed Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.263 1.411 . . . . 0.87 113.455 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.42 157.09 38.66 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.491 1.916 . . . . 1.68 114.933 -172.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.9 157.14 19.06 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.687 1.195 . . . . 4.49 113.793 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.1 t -63.67 130.98 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.907 0.883 . . . . 2.02 110.539 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.67 -51.65 29.41 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 119.776 -0.458 . . . . 1.32 113.723 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 t -146.73 136.36 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.227 1.411 . . . . 2.78 109.629 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.1 mt -84.96 150.71 56.17 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.723 0.809 . . . . 2.09 113.151 171.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.99 159.13 48.62 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.566 2.178 . . . . 0.91 111.564 171.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.29 -30.17 66.41 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.421 -0.799 . . . . 2.27 112.889 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -87.43 1.89 52.07 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.635 1.717 . . . . 2.28 115.635 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.95 154.35 20.3 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.771 1.169 . . . . 0.76 113.915 172.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -146.78 169.86 18.21 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.699 2.0 . . . . 2.99 112.329 171.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -128.31 138.42 52.38 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.3 1.44 . . . . 2.2 111.248 -173.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.0 pt -126.96 141.56 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 114.096 1.147 . . . . 2.02 114.096 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -112.97 158.31 20.41 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.833 1.253 . . . . 2.0 112.993 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.64 4.88 82.44 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.789 1.185 . . . . 0.75 114.654 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -86.61 141.2 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.052 1.341 . . . . 2.11 110.75 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -104.81 134.3 48.18 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.851 1.66 . . . . 1.77 113.193 -173.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -141.02 154.03 45.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.761 1.224 . . . . 2.84 112.278 177.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 m -127.04 144.32 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 126.513 1.925 . . . . 1.63 110.067 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -87.18 147.69 25.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.595 1.188 . . . . 0.46 112.024 170.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.5 p -140.99 167.24 22.66 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.881 2.072 . . . . 1.52 111.13 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.8 171.57 11.46 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.949 0.722 . . . . 2.15 112.949 169.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.2 t -63.13 -23.99 67.69 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.566 1.321 . . . . 3.57 114.566 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -87.6 24.42 1.7 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.649 1.18 . . . . 2.61 113.085 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.52 27.44 16.61 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 128.105 2.562 . . . . 0.8 114.602 172.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -89.88 143.26 26.95 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.169 1.388 . . . . 1.81 111.795 174.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.2 mt -79.3 127.48 39.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 123.28 0.632 . . . . 1.9 110.034 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.3 pt -121.61 153.94 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.991 1.716 . . . . 1.96 115.139 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -84.6 165.55 17.88 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.429 2.291 . . . . 2.1 110.574 167.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -64.91 -12.57 50.67 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.139 1.533 . . . . 2.51 115.139 -170.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -96.98 6.11 49.24 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.319 1.448 . . . . 2.62 113.564 173.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.62 5.12 82.21 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.938 1.256 . . . . 0.69 115.066 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -73.69 142.71 46.39 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 124.321 1.048 . . . . 2.48 110.403 173.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 30.6 p -104.94 147.29 27.94 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.974 0.91 . . . . 1.83 112.499 -171.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.12 2.54 37.56 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.229 1.566 . . . . 1.77 115.229 -168.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.88 23.43 74.82 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 120.529 -1.357 . . . . 0.75 114.733 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.2 p -138.05 143.38 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.709 1.204 . . . . 4.12 109.749 177.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.14 164.59 18.37 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.7 2.4 . . . . 1.49 110.755 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 66.5 mt -135.61 131.13 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 124.873 1.269 . . . . 1.66 110.321 -177.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -69.02 138.81 90.1 Favored Pre-proline 0 CA--C 1.543 0.696 0 O-C-N 121.038 -1.039 . . . . 2.29 110.813 175.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.07 -18.4 21.26 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 CA-C-N 122.12 1.793 . . . . 0.88 113.21 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.77 -52.4 3.75 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.416 1.886 . . . . 1.82 110.892 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.3 p -80.45 -25.75 38.73 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.019 0.748 . . . . 1.7 113.019 -176.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 58.24 12.86 2.09 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.406 1.482 . . . . 2.85 113.842 -171.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.02 150.66 26.21 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.624 -1.297 . . . . 3.24 111.737 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.3 mt -85.52 140.63 30.49 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.68 0.993 . . . . 1.05 113.68 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.2 t -88.66 35.93 0.79 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.533 1.533 . . . . 3.13 111.397 169.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 170.46 -168.81 41.81 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.678 2.085 . . . . 1.36 111.702 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.54 163.09 26.6 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.425 0.69 . . . . 2.06 111.396 170.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.7 tpt -59.87 127.19 85.09 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.081 0.952 . . . . 2.41 110.778 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -69.91 171.57 14.39 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 124.818 3.679 . . . . 0.84 113.671 -172.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.37 -92.18 0.07 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.332 1.053 . . . . 1.57 110.722 169.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.8 p -73.83 6.65 3.09 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.7 2.0 . . . . 1.71 116.398 -167.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.12 147.16 7.82 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.427 1.091 . . . . 0.56 113.8 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.1 tpt -74.76 92.03 2.45 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.933 2.093 . . . . 1.64 112.196 -177.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.9 pttm -143.61 148.16 35.44 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.013 1.325 . . . . 3.36 113.636 -175.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -162.85 165.6 25.07 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.186 1.395 . . . . 3.6 111.356 172.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.2 mp -98.14 150.03 21.9 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.876 1.67 . . . . 2.35 113.25 172.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.5 p -67.23 135.9 54.13 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 119.632 1.105 . . . . 1.37 111.131 168.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -89.01 -53.04 4.77 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 115.225 1.565 . . . . 2.11 115.225 -175.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.55 -45.51 0.07 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.911 1.284 . . . . 1.5 110.647 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -116.72 -18.77 10.18 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.015 1.117 . . . . 5.38 114.015 176.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 177.35 -163.93 32.83 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.986 1.279 . . . . 0.77 112.216 -176.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -143.17 132.15 22.91 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.542 2.337 . . . . 1.23 110.942 169.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -84.51 144.18 28.86 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.246 1.418 . . . . 2.16 112.323 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -135.5 124.37 24.05 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.969 2.107 . . . . 3.08 108.708 172.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -73.11 134.59 44.56 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.504 -0.748 . . . . 2.06 111.216 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 71.9 p -121.37 6.14 10.16 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.412 1.485 . . . . 1.72 113.671 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.7 -36.24 69.41 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.654 1.115 . . . . 1.71 113.168 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -91.36 -21.48 20.99 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.835 1.254 . . . . 2.62 111.088 -169.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.1 139.95 96.0 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 119.819 1.19 . . . . 0.81 112.663 170.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.67 169.65 20.48 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.997 2.464 . . . . 0.77 111.192 167.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.2 89.34 3.67 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.547 1.539 . . . . 1.14 111.26 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -146.84 -179.56 6.88 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.355 1.062 . . . . 1.75 112.394 -175.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -98.4 137.54 36.94 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.199 1.399 . . . . 3.9 112.183 173.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -135.91 167.47 21.14 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.327 1.451 . . . . 0.52 111.287 -169.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -139.78 153.17 47.07 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.159 0.799 . . . . 2.54 113.159 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.9 mp -110.54 144.58 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.437 1.095 . . . . 1.52 110.367 170.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -130.57 144.09 51.19 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.792 2.037 . . . . 3.22 110.691 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -103.66 112.33 25.21 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.349 1.06 . . . . 2.14 109.849 -175.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 19.7 mm -124.33 85.9 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.389 1.076 . . . . 1.99 110.061 -168.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -14.79 60.64 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.438 -0.789 . . . . 5.35 113.063 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.4 t -59.24 -27.49 65.82 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.651 1.18 . . . . 2.77 113.62 170.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.9 tp -86.75 -35.26 19.29 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 120.298 1.408 . . . . 3.72 111.442 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.3 m -158.23 132.68 8.19 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.564 1.146 . . . . 6.38 109.67 169.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.3 m -108.3 143.46 37.14 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.181 0.993 . . . . 7.1 112.414 -169.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -100.84 140.05 35.66 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.404 1.082 . . . . 6.7 108.923 168.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -69.79 149.58 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 O-C-N 121.641 -0.662 . . . . 4.36 111.405 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -135.03 -40.42 0.16 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 123.426 0.536 . . . . 2.66 113.44 168.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -79.26 1.43 24.84 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 116.593 2.071 . . . . 5.27 116.593 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -91.42 21.94 4.23 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.209 1.804 . . . . 6.47 113.559 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 103.47 -9.2 52.9 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.228 1.394 . . . . 5.45 115.334 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.92 151.13 31.07 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 117.889 0.844 . . . . 3.63 111.193 169.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.7 m -83.15 40.44 0.7 Allowed 'General case' 0 N--CA 1.482 1.148 0 O-C-N 120.813 -1.18 . . . . 3.69 111.809 -173.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.1 mt -96.11 166.29 11.82 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.776 2.03 . . . . 3.14 114.274 -169.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.8 p -134.47 155.72 49.86 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.618 1.967 . . . . 3.56 112.829 -170.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -78.9 -0.69 82.61 Favored Glycine 0 CA--C 1.54 1.651 0 N-CA-C 116.314 1.286 . . . . 3.2 116.314 -177.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 4.9 m -57.18 147.71 24.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.973 1.709 . . . . 3.21 113.533 176.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.44 143.18 31.77 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.868 1.267 . . . . 3.3 114.043 -170.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.21 150.94 45.93 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.357 -0.84 . . . . 1.4 112.308 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.35 147.43 40.54 Favored Pre-proline 0 N--CA 1.478 0.975 0 C-N-CA 125.069 1.347 . . . . 1.06 111.169 174.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.93 138.69 23.54 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.411 2.741 . . . . 0.58 112.825 -168.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.74 119.6 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 124.854 1.261 . . . . 2.46 109.982 -171.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.2 pm0 -88.51 138.99 30.93 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.829 0.852 . . . . 4.78 113.161 174.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.2 tt -148.49 156.67 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.316 1.446 . . . . 1.61 111.408 -173.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -127.58 152.49 47.58 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.473 1.509 . . . . 1.84 110.092 170.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.2 138.68 97.32 Favored Pre-proline 0 CA--C 1.548 0.897 0 O-C-N 120.98 -1.075 . . . . 1.76 111.226 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -72.64 111.6 3.28 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.575 2.183 . . . . 1.06 114.844 -168.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.91 58.48 1.09 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 104.936 -2.246 . . . . 3.76 104.936 165.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -144.15 144.59 31.64 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.13 2.572 . . . . 2.7 108.512 -166.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -76.68 57.79 1.31 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.451 1.278 . . . . 3.91 114.451 -170.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 1.6 m -112.94 151.15 14.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 125.114 1.365 . . . . 1.64 110.538 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 96.4 t -88.13 -30.68 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.129 1.372 . . . . 2.03 110.802 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -146.95 142.36 27.47 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.108 0.963 . . . . 2.55 111.512 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -102.93 143.81 32.04 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.267 -0.896 . . . . 1.72 112.702 -175.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -139.95 170.87 15.07 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.682 1.734 . . . . 0.59 115.682 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -140.37 142.89 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.673 1.989 . . . . 0.95 111.508 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -131.77 76.42 74.39 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 113.814 1.042 . . . . 3.22 113.814 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -62.51 146.9 95.5 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.528 2.819 . . . . 0.93 113.912 176.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 15.8 mtmt -121.4 -168.7 1.73 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 128.609 2.764 . . . . 2.7 111.057 -174.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.259 0.6 OUTLIER -137.41 172.84 12.38 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.868 1.667 . . . . 3.43 110.793 167.454 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 15.2 t -152.46 -178.32 6.76 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.18 1.392 . . . . 2.71 109.711 173.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.46 135.94 38.61 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 115.694 1.739 . . . . 6.58 115.694 -167.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -166.09 173.3 10.44 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.523 2.729 . . . . 5.94 108.337 168.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -59.82 140.89 89.68 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 121.771 -0.58 . . . . 11.55 112.248 173.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -74.21 127.92 11.68 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.376 2.718 . . . . 9.67 114.01 -168.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.74 44.51 0.83 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.8 1.037 . . . . 15.49 113.8 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.33 -18.99 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 127.645 2.378 . . . . 16.35 114.042 175.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 85.1 mt -116.68 99.05 6.87 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.99 1.316 . . . . 13.45 110.286 -177.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 115.574 1.694 . . . . 16.24 115.574 -179.534 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 110.022 -0.362 . . . . 22.56 110.022 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -135.06 128.82 33.0 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.938 1.295 . . . . 18.07 111.204 172.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.5 p -136.43 156.31 48.8 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.765 1.626 . . . . 16.88 112.898 -168.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.92 162.75 39.72 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.818 1.247 . . . . 13.79 112.816 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.9 m -84.8 -17.52 37.89 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.121 1.156 . . . . 14.29 114.121 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 62.93 -5.39 0.21 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 127.657 2.383 . . . . 12.82 115.9 -173.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -162.8 151.52 14.64 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.091 2.157 . . . . 12.73 111.553 169.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . 0.317 44.0 p 48.98 54.81 10.26 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.708 2.403 . . . . 12.5 115.244 176.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.7 p -70.34 158.5 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.74 1.216 . . . . 6.83 112.298 174.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.71 25.45 0.07 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 128.597 2.759 . . . . 5.56 116.485 -168.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.76 134.78 40.36 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 125.965 1.706 . . . . 5.42 113.066 -169.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 49.45 26.93 1.82 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.881 1.672 . . . . 6.73 114.693 -171.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.44 -11.5 84.1 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.034 1.302 . . . . 2.79 114.474 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.7 p -144.47 164.23 31.48 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 127.168 2.187 . . . . 1.77 111.541 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.7 p -88.74 -17.12 30.55 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.335 0.865 . . . . 2.36 113.335 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 84.9 m -146.12 128.45 15.84 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.675 1.59 . . . . 3.11 110.149 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 p -88.43 7.77 31.08 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 116.1 1.889 . . . . 2.32 116.1 -173.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.6 m -150.65 165.76 32.41 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.461 1.504 . . . . 2.61 111.811 171.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.73 144.59 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.266 1.827 . . . . 1.77 110.938 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.01 111.33 17.76 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.934 1.293 . . . . 1.73 110.704 -170.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 p -98.9 133.73 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 120.376 -1.453 . . . . 1.22 110.696 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -134.95 104.75 6.09 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.451 1.5 . . . . 1.81 111.669 -171.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.53 126.03 30.72 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 119.887 -1.758 . . . . 2.0 111.738 -173.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.4 mt -112.99 155.88 24.02 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.918 1.287 . . . . 1.18 112.64 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.98 167.77 21.1 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.211 1.404 . . . . 2.63 111.063 175.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.81 168.87 8.82 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.143 1.377 . . . . 1.3 112.219 173.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.0 p -97.04 -27.69 14.49 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.612 0.968 . . . . 1.74 113.612 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -145.3 37.59 1.13 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.455 1.102 . . . . 2.47 112.807 172.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.62 14.38 59.88 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.87 1.224 . . . . 1.03 115.449 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.38 14.34 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 128.232 2.613 . . . . 1.97 116.411 -174.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -63.09 -20.29 65.22 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.217 -1.552 . . . . 2.03 113.939 -172.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -84.8 -38.84 19.1 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.647 1.179 . . . . 2.46 112.721 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -68.37 -40.39 81.46 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 120.901 -1.124 . . . . 3.55 110.016 169.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.8 mt -54.86 -46.7 75.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 118.954 0.797 . . . . 1.07 110.375 168.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.55 -29.46 69.16 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 120.372 1.442 . . . . 2.32 113.655 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -77.44 -29.78 53.06 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.076 0.95 . . . . 1.41 113.401 170.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -64.57 -28.08 69.39 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.135 -0.978 . . . . 2.47 110.911 167.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.0 mt -87.82 -38.95 15.26 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.454 1.279 . . . . 1.29 114.454 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.15 -25.78 67.95 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.833 1.049 . . . . 3.12 113.833 -176.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.9 t -74.51 -25.81 59.59 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.534 0.734 . . . . 2.36 112.977 174.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.16 166.69 38.86 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.174 1.369 . . . . 1.3 113.323 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -90.63 31.19 1.06 Allowed 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.323 -1.104 . . . . 2.03 113.381 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -69.29 5.72 1.2 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.213 1.56 . . . . 3.52 115.213 -169.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.32 -22.3 66.9 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.108 -0.995 . . . . 1.6 111.486 166.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.87 -81.63 1.16 Allowed Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.881 1.705 . . . . 0.86 113.52 170.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.24 172.19 12.26 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.031 1.332 . . . . 1.69 114.582 -175.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -76.02 162.03 28.4 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 115.293 1.59 . . . . 4.0 115.293 -169.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -55.18 130.64 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.433 1.093 . . . . 2.51 110.526 172.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.36 -46.8 24.91 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 121.801 -0.562 . . . . 1.1 113.808 -177.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.0 p -160.73 141.26 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.864 2.066 . . . . 4.53 110.267 177.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.4 mt -84.84 147.67 49.16 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 121.466 -0.771 . . . . 2.61 112.744 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.58 158.02 51.57 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.232 1.954 . . . . 0.91 111.53 169.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.58 -19.6 65.98 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 120.708 -1.245 . . . . 2.03 113.023 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -89.54 0.77 56.68 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.576 1.95 . . . . 2.02 114.962 172.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.0 162.76 12.89 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.212 1.005 . . . . 0.67 111.852 168.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -156.25 171.46 20.16 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.376 1.47 . . . . 2.82 111.56 169.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -123.35 148.87 45.59 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.643 1.177 . . . . 2.08 110.592 -175.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.2 pt -137.24 137.01 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.683 1.193 . . . . 1.38 110.715 175.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.95 161.59 14.07 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.321 1.048 . . . . 1.45 111.005 171.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.01 15.84 62.12 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 121.315 -0.866 . . . . 0.52 114.747 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.13 140.99 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.457 1.503 . . . . 1.84 109.358 168.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -104.62 137.49 42.37 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.296 1.438 . . . . 1.56 113.321 -173.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -142.17 151.15 41.93 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.472 1.109 . . . . 2.73 112.922 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 m -122.37 145.75 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.962 2.105 . . . . 1.87 110.133 -176.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -86.61 145.94 26.53 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 122.301 1.048 . . . . 0.44 112.124 169.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 35.8 p -140.88 170.15 16.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.66 1.984 . . . . 1.45 112.223 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.36 -170.46 2.75 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 115.731 1.752 . . . . 1.91 115.731 174.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.9 p -54.85 -42.37 71.9 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.641 1.176 . . . . 2.8 111.646 171.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -88.94 20.03 3.8 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.974 1.31 . . . . 2.75 112.877 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.88 29.04 16.95 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.336 1.454 . . . . 0.75 111.781 175.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -84.41 141.57 30.75 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 125.927 1.691 . . . . 2.55 109.84 174.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.9 mt -78.69 125.31 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 109.356 -0.609 . . . . 1.83 109.356 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.3 pt -120.44 155.13 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.614 1.166 . . . . 1.03 114.118 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -86.38 166.11 15.83 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.372 1.869 . . . . 1.47 110.405 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -59.62 -21.36 60.31 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.921 1.452 . . . . 2.14 114.921 -174.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -90.86 4.52 51.58 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.894 1.277 . . . . 2.82 112.816 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.35 9.73 86.19 Favored Glycine 0 CA--C 1.533 1.195 0 O-C-N 120.523 -1.36 . . . . 0.55 114.866 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -69.47 143.99 53.37 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.588 1.194 . . . . 2.6 109.192 168.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.9 p -105.45 140.04 39.16 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.112 1.365 . . . . 1.77 111.765 -172.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.26 2.68 54.9 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.601 0.963 . . . . 1.7 113.601 -170.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.44 25.35 70.61 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.75 -1.219 . . . . 0.73 113.663 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 54.1 t -131.69 149.04 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.488 1.915 . . . . 2.34 109.397 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -130.03 158.16 40.36 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.999 2.52 . . . . 1.42 111.52 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.0 mt -135.94 128.37 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.631 1.572 . . . . 1.66 109.802 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -69.02 141.44 92.03 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 117.565 -1.207 . . . . 1.81 111.012 174.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -73.91 -22.13 17.75 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 CA-C-N 122.828 2.046 . . . . 0.8 113.236 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 68.6 mm-40 -93.29 -53.46 4.09 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 127.034 2.134 . . . . 1.45 112.158 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.9 p -78.29 -24.36 46.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.093 0.557 . . . . 1.9 112.381 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 53.8 17.27 1.24 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.721 1.209 . . . . 2.78 112.718 -171.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.46 138.2 31.68 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.021 0.928 . . . . 3.32 111.257 -174.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.0 mt -78.08 144.18 36.77 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.021 0.928 . . . . 1.04 111.394 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 95.2 p -72.72 3.93 4.58 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.892 1.071 . . . . 1.97 113.892 170.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.16 -153.85 13.04 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.719 1.152 . . . . 1.38 113.941 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.28 160.12 21.78 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.046 1.339 . . . . 1.9 112.712 176.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 mmt -51.42 140.95 24.13 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.57 1.548 . . . . 2.49 114.062 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.71 167.26 27.0 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 124.543 3.495 . . . . 0.95 114.242 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.37 -48.15 13.37 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 116.072 1.878 . . . . 1.72 116.072 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 46.1 p -134.11 10.84 3.88 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.408 1.083 . . . . 1.75 113.887 -169.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.95 152.74 7.09 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 116.062 1.875 . . . . 0.65 116.062 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.6 tpt -75.41 96.75 3.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.638 2.375 . . . . 1.77 111.889 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -150.81 150.27 30.75 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.711 1.204 . . . . 1.98 113.317 -174.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -160.74 161.89 32.31 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.624 1.17 . . . . 4.24 111.789 173.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.7 mp -93.37 152.14 19.32 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.154 0.982 . . . . 0.97 111.924 167.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.7 p -67.56 128.49 36.66 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 108.796 -0.816 . . . . 1.38 108.796 167.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -80.35 -60.31 2.37 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.569 0.951 . . . . 2.1 113.569 -173.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.51 -37.58 0.16 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.675 1.19 . . . . 2.07 111.254 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -121.56 -9.27 8.97 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.637 1.347 . . . . 3.83 114.637 176.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 164.95 -168.31 39.08 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.141 1.353 . . . . 0.7 112.619 -174.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.88 133.6 27.04 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.975 1.71 . . . . 1.89 112.713 169.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -90.05 134.08 34.45 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.984 1.713 . . . . 2.35 112.378 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -126.35 128.47 47.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.292 1.837 . . . . 2.96 108.353 173.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -83.01 122.56 28.46 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.511 -0.743 . . . . 1.68 110.989 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.9 p -103.56 -2.67 26.36 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.534 1.134 . . . . 1.81 113.265 -176.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.07 -17.85 8.12 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.802 1.241 . . . . 1.53 113.868 176.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -94.76 -17.34 22.26 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.595 1.958 . . . . 2.42 114.127 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -90.42 147.23 36.15 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 114.455 1.28 . . . . 0.88 114.455 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -84.27 170.5 10.68 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.796 2.997 . . . . 0.81 111.991 167.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.42 79.1 2.47 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.912 2.085 . . . . 1.39 112.607 -172.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.52 177.49 7.81 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.16 1.384 . . . . 1.92 110.797 -177.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -97.7 140.34 32.24 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 123.049 1.404 . . . . 3.67 112.08 171.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -129.04 177.73 6.92 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.87 1.668 . . . . 0.63 109.911 -173.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.79 152.74 40.02 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.375 1.07 . . . . 4.69 112.276 175.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.0 mp -115.76 134.23 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.055 0.942 . . . . 1.74 110.06 172.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -122.13 140.9 51.99 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.692 1.997 . . . . 3.26 110.535 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -107.42 114.22 28.09 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.697 1.199 . . . . 2.05 110.08 -175.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.5 mm -117.36 114.26 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.464 1.106 . . . . 1.76 109.854 -168.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -80.92 -13.64 58.72 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.381 1.252 . . . . 5.42 114.381 -171.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 56.1 p -60.2 -30.84 69.63 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.799 1.182 . . . . 2.49 113.742 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -104.45 1.29 29.85 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.517 1.127 . . . . 3.2 113.578 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.9 m -65.07 138.46 58.34 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.565 1.075 . . . . 6.9 112.001 176.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 24.8 m -84.74 -39.5 18.39 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.794 1.237 . . . . 6.01 111.463 174.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.74 166.94 19.83 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.934 0.894 . . . . 6.89 112.33 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p -147.61 157.45 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.139 1.376 . . . . 4.37 110.938 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -115.89 -37.33 1.06 Allowed Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.158 0.885 . . . . 2.38 114.252 171.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -69.79 -7.53 40.5 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 115.022 1.49 . . . . 4.71 115.022 -176.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -75.91 18.78 0.24 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.745 1.618 . . . . 4.9 113.314 175.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 91.21 7.02 66.0 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.536 1.541 . . . . 4.17 114.741 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -77.0 156.63 31.72 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.464 1.132 . . . . 2.77 112.724 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 28.9 m -73.82 70.24 1.42 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.131 1.772 . . . . 3.53 110.834 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.7 mt -144.42 126.09 15.12 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.299 2.24 . . . . 3.12 109.392 -177.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.4 t -71.68 -20.04 61.99 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 115.876 1.806 . . . . 4.09 115.876 -169.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 77.93 3.81 84.91 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 117.015 1.566 . . . . 2.78 117.015 169.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 5.4 m -62.09 157.21 19.54 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.465 1.133 . . . . 3.26 112.559 171.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.77 143.01 44.25 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.476 0.917 . . . . 3.2 113.476 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.72 157.57 30.03 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.696 0.76 . . . . 1.45 111.767 170.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.57 151.65 57.18 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 126.579 1.951 . . . . 1.2 110.668 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -79.2 155.18 25.45 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.624 2.216 . . . . 0.63 111.301 -172.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 5.3 mt -109.48 133.19 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.492 1.117 . . . . 3.21 109.622 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -93.75 136.65 33.82 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.165 0.893 . . . . 3.63 111.137 168.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.0 tt -141.54 151.27 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.876 1.27 . . . . 1.81 111.471 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -121.09 157.53 29.89 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.306 1.842 . . . . 1.84 108.026 169.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 5.7 mt -65.41 155.39 85.27 Favored Pre-proline 0 CA--C 1.544 0.748 0 O-C-N 120.536 -1.353 . . . . 1.44 113.71 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -69.32 114.37 3.61 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.364 2.043 . . . . 1.07 111.825 -176.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 17.0 tp -122.01 22.99 10.16 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.323 1.849 . . . . 3.97 110.462 168.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -105.15 148.19 27.15 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.582 2.353 . . . . 3.22 110.65 -169.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -75.87 61.48 1.46 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.148 1.379 . . . . 4.11 111.976 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.0 m -122.01 158.22 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 127.541 2.336 . . . . 1.42 112.405 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 59.2 t -82.98 -37.07 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.889 0.875 . . . . 2.21 111.07 174.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -142.35 147.65 36.63 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.314 1.046 . . . . 2.99 110.684 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -98.57 144.41 27.91 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.576 0.751 . . . . 1.28 111.009 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -133.43 166.36 22.71 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.314 1.227 . . . . 0.94 114.314 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.57 146.64 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 127.089 2.156 . . . . 1.26 111.437 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -135.63 81.94 40.28 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 113.512 0.93 . . . . 3.49 113.512 -177.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -65.41 146.26 84.99 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.467 2.778 . . . . 0.89 113.345 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -124.2 -165.16 1.32 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.613 2.365 . . . . 3.57 110.823 -173.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -134.02 169.81 16.58 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.0 1.32 . . . . 3.6 110.579 168.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 13.6 t -134.92 -171.08 2.7 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.179 0.992 . . . . 2.22 110.724 -176.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -66.57 160.01 26.2 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.19 1.796 . . . . 6.57 113.123 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . 0.251 . . 80.36 117.72 0.06 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 129.569 3.148 . . . . 5.89 115.514 -173.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -137.22 158.29 72.74 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 128.073 2.549 . . . . 12.08 110.858 174.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -60.95 157.4 38.91 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.526 2.817 . . . . 9.94 112.58 175.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -87.26 -1.09 57.66 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.328 1.603 . . . . 11.24 115.328 173.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.84 45.16 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.391 1.877 . . . . 13.21 111.763 -169.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 53.8 mt -70.83 77.72 0.62 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.234 1.413 . . . . 14.29 112.167 174.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 CA--C 1.539 0.539 0 C-N-CA 126.251 1.82 . . . . 16.54 113.536 178.714 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 109.936 -0.394 . . . . 28.52 109.936 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 59.62 179.87 0.09 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.92 1.688 . . . . 26.47 115.538 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.3 m -101.09 145.63 28.5 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 127.01 2.124 . . . . 22.16 110.955 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -107.2 -12.01 15.47 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.27 1.428 . . . . 17.7 114.828 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.4 m 55.44 21.03 4.01 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.114 1.766 . . . . 18.12 115.58 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.03 158.26 16.14 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.468 1.507 . . . . 12.93 112.954 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.09 -179.99 5.67 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.119 1.367 . . . . 9.24 113.299 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -72.33 22.49 0.06 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 127.022 2.129 . . . . 9.26 114.213 176.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.8 p -153.0 146.24 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 127.472 2.309 . . . . 7.73 108.575 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -129.58 22.05 5.52 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.906 1.076 . . . . 4.57 113.906 175.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.47 -32.86 0.1 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 128.944 2.898 . . . . 5.01 117.796 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.15 36.01 21.3 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 120.147 1.339 . . . . 5.72 114.356 -178.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.11 23.92 4.28 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 127.037 2.256 . . . . 2.42 115.876 -173.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 38.9 p -126.42 174.8 8.34 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.256 1.822 . . . . 1.9 112.161 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.6 p -98.5 -16.77 19.05 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.356 0.872 . . . . 2.36 113.356 174.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.8 t -144.92 167.55 22.37 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.022 1.729 . . . . 2.52 110.002 169.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.4 p -112.68 5.49 17.74 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.614 1.966 . . . . 1.79 114.416 -169.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.8 p -138.57 162.58 34.21 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.114 1.153 . . . . 3.45 114.114 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.67 146.7 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 126.516 1.926 . . . . 1.59 109.408 169.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -125.12 114.2 18.72 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.591 1.156 . . . . 2.29 110.401 -171.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.28 129.87 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 120.886 -1.134 . . . . 1.13 111.312 -175.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -128.92 101.9 6.28 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.092 1.357 . . . . 1.78 111.157 -172.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.23 123.66 24.95 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.654 -1.279 . . . . 2.45 111.548 -173.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.9 mt -106.04 156.42 18.41 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.129 1.372 . . . . 1.07 112.681 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.64 161.89 37.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.313 1.845 . . . . 2.44 109.912 175.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.8 162.14 13.27 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.682 0.793 . . . . 1.92 111.852 169.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.3 p -86.76 -27.48 23.59 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.252 0.834 . . . . 1.77 113.252 176.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -146.67 46.77 1.19 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.482 1.113 . . . . 3.13 113.025 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.0 7.19 88.19 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 125.186 1.374 . . . . 1.03 116.053 175.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.04 18.92 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 128.145 2.578 . . . . 1.88 115.731 -174.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -59.91 -31.51 69.9 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.497 -1.377 . . . . 0.99 112.315 -177.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.58 -52.84 63.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.75 1.62 . . . . 2.44 112.548 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -71.71 -39.62 70.02 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-O 118.033 -0.984 . . . . 2.88 111.583 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.2 mt -51.59 -55.04 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 119.266 0.939 . . . . 1.98 110.34 168.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.73 -32.01 71.29 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.643 1.11 . . . . 1.4 113.137 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -69.69 -27.26 64.86 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.786 1.032 . . . . 1.16 113.786 172.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -73.77 -28.71 61.8 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.764 0.711 . . . . 2.13 111.419 168.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.0 mt -85.1 -34.97 22.08 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.113 -0.992 . . . . 1.06 113.292 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -71.3 -25.47 62.44 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.236 0.828 . . . . 3.16 113.236 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.4 t -84.17 -24.13 30.3 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.274 1.03 . . . . 2.34 113.633 177.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.69 171.69 55.15 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.39 0.995 . . . . 1.26 113.233 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -85.35 34.01 0.57 Allowed 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.959 -1.319 . . . . 2.06 113.116 171.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -77.53 4.72 10.5 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 120.253 -1.529 . . . . 3.37 113.385 -170.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.56 -10.82 60.2 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.035 -1.041 . . . . 1.7 113.12 168.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.05 -74.07 0.26 Allowed Glycine 0 N--CA 1.474 1.178 0 CA-C-N 119.713 1.142 . . . . 1.22 113.033 169.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -68.73 159.35 32.41 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.158 1.383 . . . . 1.97 113.052 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -61.18 155.99 19.45 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.749 1.22 . . . . 3.1 113.199 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.2 t -56.83 117.95 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 109.077 -0.712 . . . . 1.85 109.077 172.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.77 -41.62 73.27 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.052 0.358 . . . . 0.97 112.908 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.1 t -138.51 123.95 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.29 1.036 . . . . 2.92 111.165 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt -92.46 144.14 28.36 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.069 1.348 . . . . 1.37 110.544 168.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.19 159.32 37.12 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.949 2.433 . . . . 0.81 112.0 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.84 -26.13 68.61 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.365 -0.835 . . . . 2.46 112.86 172.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.99 3.65 22.25 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.398 1.629 . . . . 2.3 115.398 172.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.68 153.98 20.04 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.823 1.249 . . . . 0.73 113.577 170.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -143.89 160.69 40.35 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.562 1.545 . . . . 2.6 111.641 169.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.96 139.54 50.04 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.268 1.027 . . . . 2.59 110.414 -174.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 20.2 pt -133.48 147.23 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 116.396 1.999 . . . . 2.63 116.396 -169.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.81 167.66 12.3 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.446 1.898 . . . . 1.74 110.14 167.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.99 17.78 62.43 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 116.242 1.257 . . . . 0.7 116.242 168.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.2 p -118.42 138.21 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.271 1.428 . . . . 1.59 110.832 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 8.9 tpp -96.84 134.91 39.54 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.14 1.376 . . . . 1.61 113.584 -177.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -137.12 148.49 46.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.332 1.453 . . . . 3.53 112.002 174.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.7 m -121.48 144.28 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.769 2.027 . . . . 1.57 109.766 -175.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -88.23 148.39 24.38 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 122.648 1.213 . . . . 0.48 112.754 171.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.9 p -143.93 172.79 12.38 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.848 2.059 . . . . 1.59 112.217 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -94.61 169.31 10.27 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.453 1.501 . . . . 1.68 112.242 168.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 67.9 p -62.66 -25.21 68.02 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.818 0.847 . . . . 2.67 112.702 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -74.78 7.31 3.19 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.686 1.594 . . . . 2.3 113.383 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . 0.252 0.3 OUTLIER 63.18 26.38 15.22 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.744 2.418 . . . . 0.64 114.291 179.217 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -88.77 145.04 25.85 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.655 1.582 . . . . 2.1 111.631 175.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.7 mt -80.83 128.72 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.342 0.657 . . . . 1.66 111.087 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.2 pp -121.44 149.35 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 115.045 1.498 . . . . 1.77 115.045 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -79.64 161.71 25.71 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 127.873 2.469 . . . . 2.37 110.598 169.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -58.39 -22.61 54.45 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.315 1.228 . . . . 2.3 114.315 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -90.52 3.71 53.21 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.306 1.043 . . . . 3.62 111.955 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.59 20.93 75.98 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 127.234 2.349 . . . . 0.51 115.471 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -75.25 137.39 41.18 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.074 -1.084 . . . . 3.1 108.074 167.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.6 p -93.74 135.17 35.31 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.945 0.898 . . . . 1.73 111.414 178.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.69 -4.84 59.27 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.954 1.094 . . . . 1.56 113.954 -168.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.02 25.96 56.65 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.265 0.936 . . . . 0.63 113.779 -176.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.8 t -130.36 146.7 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.886 1.674 . . . . 1.7 109.471 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -124.22 165.2 18.02 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.94 2.096 . . . . 3.86 111.183 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.7 mt -134.87 140.78 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.887 1.275 . . . . 1.66 109.841 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -76.31 137.91 68.02 Favored Pre-proline 0 CA--C 1.545 0.784 0 O-C-N 120.742 -1.224 . . . . 1.78 112.313 173.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.49 -11.46 20.61 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.061 1.841 . . . . 0.91 113.854 174.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.48 -53.79 3.11 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.945 1.698 . . . . 2.0 111.102 177.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 p -80.48 -25.38 38.87 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.859 0.864 . . . . 1.58 113.027 -174.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 59.13 15.89 4.43 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.771 1.629 . . . . 2.83 113.9 -172.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.51 152.0 19.45 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.21 1.004 . . . . 3.52 111.79 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.6 mt -78.56 145.21 34.95 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.682 1.593 . . . . 1.06 112.648 -174.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.1 p -72.25 -8.19 53.46 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.665 0.987 . . . . 1.59 113.665 173.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -171.9 -152.11 8.23 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.213 1.863 . . . . 0.97 111.848 -171.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.91 148.86 26.03 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.809 0.844 . . . . 1.99 113.024 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.6 tpt -52.96 128.69 47.38 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.945 1.698 . . . . 2.25 111.867 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.48 161.32 28.39 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.809 3.006 . . . . 0.87 114.441 -174.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.28 -61.79 1.89 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.272 1.829 . . . . 1.13 114.105 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.1 p -105.88 10.79 32.37 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.855 1.262 . . . . 1.77 114.266 -169.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.2 145.73 16.73 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.965 -1.084 . . . . 0.59 113.002 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.3 tpt -74.38 94.62 2.58 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.846 2.059 . . . . 1.67 110.574 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -148.71 140.15 23.4 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.462 1.105 . . . . 1.65 113.454 -169.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -160.04 160.96 33.82 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.482 1.113 . . . . 2.66 111.842 -175.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.4 mp -103.04 149.52 24.49 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.804 1.242 . . . . 2.07 112.214 173.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.9 p -66.83 132.05 47.2 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.759 -0.588 . . . . 1.34 109.997 171.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.84 -61.13 1.95 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.646 1.178 . . . . 2.47 113.79 -170.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -146.63 -34.43 0.28 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.999 1.319 . . . . 2.09 111.37 176.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -126.31 -17.97 5.05 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.524 1.305 . . . . 4.17 114.524 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 179.61 -166.28 35.45 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.57 1.081 . . . . 0.74 111.894 -172.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -145.25 134.32 22.67 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.869 1.668 . . . . 1.26 111.891 169.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -87.43 138.17 31.7 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.96 1.304 . . . . 2.38 112.858 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -128.51 130.02 46.88 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.162 2.185 . . . . 2.99 107.716 171.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -91.49 101.99 14.65 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.953 -1.092 . . . . 2.02 110.489 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.1 p -82.47 -0.54 46.86 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.118 1.367 . . . . 1.8 113.727 -172.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -55.48 -32.0 62.47 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.766 0.826 . . . . 1.52 112.987 172.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -83.66 -20.86 32.84 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.006 0.922 . . . . 2.28 112.682 -173.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.44 145.34 82.36 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 123.811 0.844 . . . . 0.84 113.009 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -74.49 168.45 24.79 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.658 2.239 . . . . 1.01 110.938 167.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.49 91.97 1.08 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.926 1.29 . . . . 1.25 110.359 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -149.51 175.17 11.74 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.884 0.85 . . . . 2.06 113.169 -174.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -94.15 147.19 23.4 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.385 1.874 . . . . 4.54 109.347 169.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -143.9 170.12 16.51 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.651 1.581 . . . . 0.55 110.438 -169.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.2 mttt -137.68 159.78 41.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.193 0.997 . . . . 3.19 113.127 171.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.7 mp -118.56 142.2 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.02 1.328 . . . . 1.84 109.899 172.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -129.58 147.21 51.36 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.435 1.894 . . . . 3.24 110.495 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -109.16 124.26 50.54 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.637 1.175 . . . . 1.87 111.26 -175.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 29.9 mm -128.09 98.96 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.921 0.888 . . . . 1.68 109.83 -169.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -73.12 4.32 4.54 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 115.064 1.505 . . . . 5.62 115.064 -172.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.4 m -57.99 -31.26 66.75 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.548 -1.345 . . . . 2.39 112.406 172.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.85 120.47 42.6 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.888 1.275 . . . . 4.22 108.181 168.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 33.3 t -154.3 146.24 23.53 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.02 0.748 . . . . 6.17 113.02 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 26.0 m -127.46 4.77 6.23 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.755 2.422 . . . . 6.95 111.08 171.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.63 86.79 2.18 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.663 1.585 . . . . 7.12 108.657 171.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.21 129.92 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.501 -0.749 . . . . 4.7 109.541 172.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -122.73 -3.36 9.23 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.715 1.626 . . . . 3.37 113.582 -175.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -112.15 34.98 3.95 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.024 1.73 . . . . 5.57 113.726 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -138.32 3.66 2.38 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 115.179 1.548 . . . . 6.69 115.179 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 110.81 15.17 11.23 Favored Glycine 0 N--CA 1.482 1.715 0 O-C-N 120.72 -1.237 . . . . 4.74 114.867 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -72.75 -178.21 2.61 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.644 1.978 . . . . 3.1 113.665 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 16.0 p -66.79 -21.88 66.03 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.28 1.032 . . . . 5.36 112.845 168.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.19 169.0 14.27 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 120.917 -1.115 . . . . 3.72 113.01 169.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 12.2 t -118.05 154.35 32.18 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.052 1.341 . . . . 3.47 112.169 168.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -81.31 21.33 6.13 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 126.193 1.854 . . . . 2.46 117.328 -171.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 68.4 m -64.71 159.01 23.15 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.897 1.848 . . . . 3.24 114.104 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.431 ' H ' ' HB3' ' A' ' 186' ' ' GLU . 0.5 OUTLIER -94.65 119.55 33.47 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.614 1.565 . . . . 3.33 113.121 -168.663 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.36 150.31 47.46 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.016 1.327 . . . . 1.19 113.323 174.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.51 153.71 52.07 Favored Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 124.515 1.126 . . . . 1.01 111.604 -178.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.15 130.26 12.96 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.879 2.386 . . . . 0.74 114.08 -166.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.409 HD13 ' H ' ' A' ' 166' ' ' ILE . 2.6 mp -94.12 130.35 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 125.677 1.591 . . . . 2.33 109.259 -173.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.6 129.88 54.95 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.716 1.206 . . . . 4.96 112.129 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.2 tt -137.73 156.45 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.206 1.402 . . . . 1.51 111.038 -169.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -139.89 148.91 42.72 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.794 1.238 . . . . 1.89 109.871 170.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 12.4 mt -62.68 153.67 77.54 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 116.152 1.908 . . . . 1.57 116.152 -168.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.1 116.73 4.82 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.84 2.36 . . . . 0.75 113.258 -170.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.6 tp -123.41 34.17 5.17 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.023 1.729 . . . . 3.34 111.061 166.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -116.44 157.53 24.99 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 128.499 2.719 . . . . 2.68 111.487 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.47 30.98 0.18 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.324 1.85 . . . . 4.13 114.445 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 30.2 m -93.81 155.09 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.287 1.435 . . . . 2.37 112.319 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 54.8 t -74.34 -35.95 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.185 0.994 . . . . 2.9 110.137 173.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -152.26 146.72 25.63 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.46 1.504 . . . . 3.44 110.643 -174.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -98.75 156.7 16.71 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.036 0.934 . . . . 1.47 112.304 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -136.71 162.02 34.32 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.04 1.496 . . . . 0.67 115.04 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.64 144.65 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 127.225 2.21 . . . . 0.95 110.815 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -134.94 76.48 58.88 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 113.96 1.096 . . . . 3.43 113.96 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -65.87 146.38 82.95 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.011 3.141 . . . . 0.73 114.468 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -140.0 167.27 22.5 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 128.699 2.8 . . . . 3.24 111.952 -169.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -117.51 167.03 11.66 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.656 1.354 . . . . 3.25 114.656 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 10.8 t -149.84 -33.01 0.19 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.504 1.668 . . . . 2.47 115.504 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.431 ' HB3' ' H ' ' A' ' 162' ' ' LYS . 12.2 pt-20 46.48 27.57 0.63 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 115.72 1.748 . . . . 6.64 115.72 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.74 152.49 44.57 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.974 1.472 . . . . 8.26 114.974 -168.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -70.66 154.4 94.37 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 123.952 0.901 . . . . 13.61 113.058 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -66.99 170.47 12.9 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.209 2.606 . . . . 15.33 114.139 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -131.08 -8.82 3.85 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.182 1.393 . . . . 21.62 114.611 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.44 -32.22 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 126.322 1.849 . . . . 24.86 113.138 176.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 48.31 81.89 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.174 2.59 . . . . 21.36 113.867 -176.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 CA--C 1.545 0.752 0 C-N-CA 128.51 2.724 . . . . 25.55 114.187 -169.99 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 34.7 mtt . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 110.202 -0.296 . . . . 28.26 110.202 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.34 152.04 42.51 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.743 1.386 . . . . 27.15 114.743 -169.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.3 t -153.18 156.74 39.15 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.195 1.398 . . . . 21.96 113.342 174.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.03 172.66 8.68 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 115.098 1.518 . . . . 18.52 115.098 -170.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.3 p -72.88 -5.5 38.74 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 116.578 2.066 . . . . 19.01 116.578 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.99 170.79 16.14 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.413 1.485 . . . . 14.04 113.914 -174.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.79 -114.94 0.05 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.427 1.491 . . . . 10.35 110.694 171.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.9 t -148.1 123.19 10.13 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.358 -0.839 . . . . 9.34 112.959 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 p -135.04 136.8 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 125.831 1.652 . . . . 8.07 111.421 170.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -138.91 178.03 7.45 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.109 2.164 . . . . 4.47 109.458 169.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -135.23 148.28 49.56 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.69 1.196 . . . . 4.24 113.05 -172.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.74 57.09 1.57 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.574 1.949 . . . . 6.59 111.355 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.02 42.72 1.38 Allowed Glycine 0 CA--C 1.536 1.346 0 C-N-CA 126.508 2.004 . . . . 2.61 112.556 169.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.4 p -129.9 168.98 15.8 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.124 2.169 . . . . 2.39 111.488 -171.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 65.8 p -82.81 -10.32 58.92 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 113.966 1.098 . . . . 2.65 113.966 176.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 t -151.89 163.17 39.81 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.705 2.002 . . . . 2.8 110.032 174.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.7 p -92.76 5.11 52.33 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.086 1.755 . . . . 2.43 114.252 176.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.9 p -151.26 164.86 35.66 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.23 1.196 . . . . 2.58 114.23 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.5 p -131.21 143.5 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.486 1.915 . . . . 1.46 109.964 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.7 m -110.74 112.62 24.61 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.676 0.79 . . . . 1.1 111.411 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -93.11 132.9 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.004 -1.06 . . . . 1.24 110.432 176.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -115.73 -173.93 2.43 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.69 1.596 . . . . 1.74 110.998 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -140.26 129.98 24.41 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 120.929 -1.107 . . . . 2.9 111.439 168.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.4 mt -111.84 146.06 38.34 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.749 1.219 . . . . 1.46 110.835 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.9 168.29 19.6 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.341 1.856 . . . . 2.64 111.186 176.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.57 145.58 40.08 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.788 1.235 . . . . 1.86 112.281 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.0 p -80.92 -32.54 34.62 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.318 1.229 . . . . 1.84 114.318 -173.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -114.45 -15.55 12.05 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 119.882 1.219 . . . . 2.37 113.295 175.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.68 11.08 1.95 Allowed Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.478 1.513 . . . . 1.5 115.413 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.66 24.23 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 130.175 3.39 . . . . 1.84 116.738 -169.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.94 -31.92 73.11 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 119.6 -1.937 . . . . 0.93 114.022 -174.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -71.3 -43.79 66.44 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.114 0.87 . . . . 2.52 111.727 -175.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt -72.44 -38.85 68.19 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.267 -0.896 . . . . 5.1 111.939 175.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.6 mt -52.68 -48.17 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 119.471 1.032 . . . . 1.02 109.956 167.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.1 -34.83 75.57 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 121.092 -1.005 . . . . 1.26 113.453 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -65.33 -39.28 92.22 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.794 0.838 . . . . 1.57 112.069 171.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.15 -23.82 64.92 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.972 -1.08 . . . . 2.68 112.841 177.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.1 mt -91.28 -32.24 15.8 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.315 1.228 . . . . 1.18 114.315 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -70.61 -20.59 62.74 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.065 1.135 . . . . 2.96 114.065 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.7 t -78.86 -21.26 47.79 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.986 0.914 . . . . 2.44 113.375 169.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.55 172.32 53.44 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.544 1.068 . . . . 1.32 112.909 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -94.74 21.57 7.3 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.036 -1.273 . . . . 2.32 112.348 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -70.87 18.05 0.06 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.421 1.488 . . . . 3.56 114.962 -170.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.98 -23.15 55.3 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 120.814 -1.179 . . . . 1.66 110.249 166.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -114.86 -57.35 0.36 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.52 1.057 . . . . 1.03 113.684 172.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -81.68 162.81 22.87 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.952 1.301 . . . . 3.15 113.381 -172.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -63.54 151.94 40.01 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.056 0.762 . . . . 3.39 113.056 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 71.7 t -66.32 120.48 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 122.844 0.458 . . . . 1.96 109.895 172.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.59 -37.9 33.89 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 114.83 0.692 . . . . 1.1 114.83 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.6 t -142.61 116.59 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 118.387 1.093 . . . . 2.99 111.041 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.8 mt -83.23 144.36 46.75 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.842 1.257 . . . . 2.35 111.621 170.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.09 161.46 38.48 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.914 2.409 . . . . 0.96 112.371 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.2 -8.84 42.4 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.039 1.126 . . . . 2.03 114.039 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.2 p30 -98.87 -3.92 34.24 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.548 1.539 . . . . 2.65 114.496 171.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.22 158.83 17.02 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.778 1.029 . . . . 0.72 113.778 174.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.9 pttt -150.38 169.04 22.37 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.809 1.643 . . . . 3.28 111.741 167.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -124.37 130.62 52.82 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.013 1.325 . . . . 2.63 112.146 -174.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.0 pt -121.81 151.46 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.075 0.95 . . . . 2.18 113.397 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.98 156.02 29.27 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.263 1.425 . . . . 2.29 111.97 171.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.57 12.93 42.8 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.09 1.328 . . . . 0.74 115.654 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 p -86.02 148.12 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 119.228 1.514 . . . . 1.98 110.679 169.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -105.64 137.75 42.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.483 1.513 . . . . 1.55 112.565 176.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.67 157.79 44.31 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.097 1.359 . . . . 2.8 112.441 173.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 m -125.62 147.35 30.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 126.771 2.028 . . . . 1.58 110.083 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -89.91 149.08 22.77 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.397 1.079 . . . . 0.42 112.975 171.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.7 p -144.8 167.71 21.94 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.409 1.884 . . . . 1.64 112.618 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -90.83 171.54 9.25 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.199 1.0 . . . . 2.22 112.074 167.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 66.9 p -61.04 -23.53 65.5 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.154 -0.966 . . . . 2.35 113.577 -177.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -70.86 4.83 2.29 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 126.222 1.809 . . . . 3.95 114.003 169.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.26 27.79 14.2 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.916 2.087 . . . . 0.66 112.964 -172.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -86.01 138.61 31.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.458 1.503 . . . . 2.53 110.414 177.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.3 mt -81.2 129.33 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.139 0.495 . . . . 2.2 110.164 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.2 pt -123.86 154.27 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 114.567 1.321 . . . . 1.06 114.567 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -84.84 159.44 20.39 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.972 2.109 . . . . 1.49 108.37 166.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -62.8 -8.69 7.34 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.862 1.801 . . . . 2.29 115.862 -172.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -91.31 -1.22 57.7 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.556 1.143 . . . . 3.45 112.706 172.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.34 3.72 84.27 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.65 1.595 . . . . 0.5 114.476 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -68.14 140.38 56.17 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.813 1.245 . . . . 2.61 109.1 173.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 16.2 p -103.56 146.07 29.1 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.594 0.758 . . . . 1.87 112.077 -173.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.62 -11.02 25.84 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.983 0.734 . . . . 2.06 112.983 -169.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.74 21.91 48.67 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.706 1.146 . . . . 1.06 114.616 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.3 p -138.57 146.19 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.626 1.57 . . . . 4.02 110.262 -173.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -127.89 155.04 44.8 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 128.087 2.555 . . . . 1.45 111.364 -172.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 61.4 mt -126.96 142.85 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.97 1.308 . . . . 1.58 110.849 -174.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -76.23 132.69 72.86 Favored Pre-proline 0 CA--C 1.54 0.565 0 O-C-N 120.611 -1.306 . . . . 2.4 110.57 170.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -70.09 -8.46 23.67 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.074 1.849 . . . . 1.52 114.819 174.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -106.98 -47.55 3.68 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.06 1.344 . . . . 1.62 112.346 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.7 p -87.86 -23.16 24.07 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.131 0.972 . . . . 1.88 113.331 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 55.52 17.07 2.09 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.896 1.678 . . . . 2.92 114.146 -169.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.64 156.46 20.68 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.909 -1.119 . . . . 3.23 111.387 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 mt -98.1 146.44 25.55 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.701 1.2 . . . . 1.17 112.623 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 90.7 p -73.1 3.3 5.69 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.204 1.002 . . . . 1.5 113.475 171.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.55 -157.75 16.03 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.689 2.09 . . . . 1.09 111.306 -172.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.02 155.27 27.69 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 117.96 0.88 . . . . 2.13 112.159 174.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.63 131.66 88.53 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.796 0.838 . . . . 2.76 110.701 175.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.18 156.26 46.76 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 125.197 3.931 . . . . 1.42 115.634 -172.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.29 -62.67 1.28 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.745 1.618 . . . . 1.4 114.383 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.8 p -102.26 5.9 40.29 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.804 1.409 . . . . 2.19 114.804 -168.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.85 149.86 10.78 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.0 1.111 . . . . 0.74 114.0 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.1 ttt -76.62 90.74 3.37 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.031 1.732 . . . . 1.74 111.629 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -141.81 144.62 34.02 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.552 1.541 . . . . 2.46 111.97 -173.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -166.47 156.73 12.1 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 126.337 1.855 . . . . 3.06 111.028 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.9 mp -97.49 148.8 22.86 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.168 1.173 . . . . 0.8 114.168 174.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.7 p -64.45 124.6 22.23 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 121.354 -0.841 . . . . 1.18 111.34 170.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -80.41 -57.6 3.52 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.373 -0.83 . . . . 2.2 112.457 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -173.06 -51.37 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.727 2.811 . . . . 1.89 107.963 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -74.18 20.9 0.1 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.121 2.168 . . . . 6.15 113.962 173.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.04 -152.31 31.21 Favored Glycine 0 CA--C 1.538 1.53 0 N-CA-C 110.526 -1.03 . . . . 0.86 110.526 -165.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -135.33 130.93 35.79 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.587 1.955 . . . . 1.25 109.625 169.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -93.82 139.69 30.56 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.479 0.711 . . . . 2.59 112.87 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -125.56 124.59 41.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.171 2.589 . . . . 2.93 107.893 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -85.58 100.11 11.72 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.423 -0.798 . . . . 1.73 110.074 -174.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 73.1 p -78.66 -6.68 56.37 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.139 -0.975 . . . . 1.71 113.48 -175.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -51.25 -27.1 8.32 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.568 1.147 . . . . 1.7 113.459 175.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -92.98 -10.39 36.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.641 1.576 . . . . 2.52 113.697 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -89.59 148.42 40.14 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 120.182 1.356 . . . . 2.05 114.163 170.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.18 170.18 13.74 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.937 3.092 . . . . 0.84 112.293 168.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.56 63.91 2.14 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.958 2.103 . . . . 1.53 114.397 -170.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -125.54 178.33 5.71 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.756 1.622 . . . . 1.54 112.941 -175.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -87.58 151.66 22.81 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.271 1.428 . . . . 3.37 110.807 168.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -145.39 171.37 14.72 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.666 1.987 . . . . 0.59 109.253 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -137.83 148.31 45.35 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.725 0.81 . . . . 2.86 112.648 170.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.4 mp -105.44 138.28 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.247 1.019 . . . . 1.66 109.747 171.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -123.65 131.58 53.65 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.405 1.882 . . . . 3.24 110.25 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -95.36 104.51 16.41 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.777 0.831 . . . . 2.26 110.635 -173.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 38.9 mm -113.0 94.5 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.998 0.919 . . . . 1.78 109.611 -169.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -84.45 12.54 6.7 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.537 0.94 . . . . 5.52 113.537 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.0 m -68.58 -21.54 64.52 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.021 1.119 . . . . 2.79 114.021 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.0 mp -92.12 163.05 14.09 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.223 1.009 . . . . 3.4 111.329 173.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 54.0 m -52.65 117.56 2.99 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.648 1.579 . . . . 6.23 111.485 -178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.1 t -140.64 170.01 16.58 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.257 1.823 . . . . 6.06 112.119 -167.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -66.22 112.58 4.02 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.446 1.098 . . . . 8.59 109.608 169.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.5 p -76.59 130.53 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 121.583 -0.698 . . . . 4.29 110.719 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -115.27 -20.56 5.5 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.531 1.062 . . . . 2.15 113.901 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -82.61 -16.36 48.69 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.033 1.494 . . . . 4.49 115.033 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -97.72 24.49 6.74 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 116.414 2.005 . . . . 5.51 116.414 -164.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 109.29 9.06 26.27 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.09 1.329 . . . . 4.35 115.003 -178.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -93.44 168.36 11.11 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.754 1.621 . . . . 3.26 112.542 174.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.6 m -79.63 44.55 0.63 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.027 1.731 . . . . 3.5 113.202 -172.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 15.4 mt -130.86 164.7 24.66 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.678 1.591 . . . . 2.59 113.241 -170.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.8 t -95.36 -35.75 11.64 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.371 1.468 . . . . 4.04 112.663 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.92 -16.63 0.8 Allowed Glycine 0 CA--C 1.541 1.678 0 C-N-CA 126.307 1.908 . . . . 3.67 115.164 -174.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 36.6 m -56.21 159.48 3.46 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.134 2.573 . . . . 3.44 116.127 -169.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.61 114.99 1.73 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.003 2.121 . . . . 3.01 114.032 -169.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.41 166.59 22.92 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.568 1.547 . . . . 1.38 111.808 169.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.44 144.97 54.53 Favored Pre-proline 0 N--CA 1.483 1.211 0 O-C-N 120.541 -1.349 . . . . 0.93 112.224 176.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.08 151.88 61.94 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.584 3.522 . . . . 0.58 114.255 -167.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.1 mp -114.19 125.68 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.742 1.217 . . . . 1.96 111.139 -169.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -86.78 136.22 33.07 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.006 1.322 . . . . 3.03 111.578 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.7 tt -144.78 150.14 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 125.227 1.411 . . . . 1.63 111.741 -177.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -127.0 149.25 49.98 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.87 1.268 . . . . 2.26 110.031 169.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 13.3 mt -61.44 142.56 93.86 Favored Pre-proline 0 CA--C 1.548 0.868 0 O-C-N 120.778 -1.201 . . . . 1.58 112.771 -176.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -71.54 99.29 0.92 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.961 3.108 . . . . 1.02 114.273 -167.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 1.2 tt -116.58 39.42 3.16 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.14 1.776 . . . . 3.37 108.053 167.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -104.93 172.72 6.64 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.552 2.341 . . . . 3.46 111.378 -168.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -76.35 40.17 0.21 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.098 0.959 . . . . 3.87 113.561 169.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.7 m -121.24 144.54 29.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.106 1.362 . . . . 1.5 112.699 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.9 p -64.87 -45.4 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.937 2.095 . . . . 4.78 113.375 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -156.22 156.77 34.69 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.686 1.995 . . . . 2.98 110.956 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -103.6 146.63 28.28 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.815 1.413 . . . . 1.28 114.815 -168.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -135.44 168.52 19.07 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.745 1.387 . . . . 0.8 114.745 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.5 t -137.88 139.96 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.524 1.53 . . . . 0.95 112.027 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -131.76 86.15 49.34 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 125.688 1.595 . . . . 3.4 112.548 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -71.14 147.4 53.98 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.574 3.516 . . . . 0.81 113.59 172.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -131.68 176.42 8.35 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.644 2.378 . . . . 2.81 111.386 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -111.9 174.52 5.84 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.614 1.566 . . . . 2.79 112.121 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 4.9 t -136.83 -36.41 0.69 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.862 1.06 . . . . 2.35 113.862 173.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -66.38 135.31 54.15 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.541 0.736 . . . . 7.42 110.731 172.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -80.71 164.31 22.89 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.719 1.208 . . . . 7.79 113.102 -176.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -64.25 150.32 92.85 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 114.336 1.236 . . . . 15.58 114.336 -173.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.37 159.51 49.17 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.401 2.734 . . . . 12.16 116.42 -169.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -72.18 -26.46 62.08 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.213 0.82 . . . . 14.2 113.213 168.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 4.3 mp -73.48 -76.35 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.822 1.249 . . . . 16.26 109.556 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 44.16 54.98 5.73 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.516 1.926 . . . . 18.02 113.57 169.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 116.276 1.954 . . . . 20.35 116.276 -168.308 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.9 ttt . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 119.464 -0.303 . . . . 25.14 111.061 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -63.62 -23.46 67.39 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.772 1.397 . . . . 23.94 114.772 -169.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 59.8 p -88.06 -4.76 58.74 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.567 1.321 . . . . 18.82 114.567 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 44.9 -99.75 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.788 2.035 . . . . 17.04 115.403 169.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.7 m -63.95 -11.32 27.34 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.962 1.468 . . . . 15.58 114.962 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -121.23 151.79 39.59 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.22 1.808 . . . . 11.74 111.686 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.94 165.76 26.57 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.54 1.536 . . . . 9.71 111.197 176.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.2 t -57.14 158.79 4.86 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.356 1.062 . . . . 9.56 113.106 175.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.7 p -84.54 139.78 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.164 -0.96 . . . . 7.97 111.7 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -109.34 24.24 13.36 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.693 1.368 . . . . 5.43 114.693 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.07 -27.27 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 129.932 3.293 . . . . 5.46 118.805 169.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.0 30.06 15.49 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 127.281 2.232 . . . . 5.55 115.877 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.68 53.76 3.29 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.38 1.467 . . . . 2.16 113.645 177.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.4 p -136.27 172.61 12.76 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.251 1.82 . . . . 2.22 113.38 -169.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.3 p -110.08 -1.12 17.7 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.659 1.984 . . . . 2.35 113.138 175.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -164.1 157.72 18.51 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.638 1.575 . . . . 2.52 111.095 -178.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.9 p -112.78 -6.23 13.85 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.404 1.882 . . . . 1.98 115.555 -170.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 94.4 p -148.18 166.13 28.82 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.728 2.011 . . . . 2.8 112.517 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.96 136.75 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.23 1.812 . . . . 1.58 110.343 177.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.5 m -104.69 112.33 25.37 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.366 0.603 . . . . 1.87 110.725 176.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 p -93.19 125.84 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.723 1.209 . . . . 1.14 109.679 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -105.19 -170.23 1.72 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.307 1.843 . . . . 1.73 110.81 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -148.72 127.53 12.59 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.246 -1.534 . . . . 2.89 113.889 170.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.9 mt -118.59 160.56 21.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.86 1.264 . . . . 1.35 113.181 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.7 mt -145.41 165.12 29.44 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 128.002 2.521 . . . . 2.16 109.572 168.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.97 165.8 16.43 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.758 -0.589 . . . . 1.46 112.224 169.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.5 p -89.12 -35.98 15.98 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.508 0.929 . . . . 2.13 113.508 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -141.77 50.38 1.56 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.614 1.166 . . . . 2.11 111.637 174.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.2 14.68 76.27 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 116.621 1.408 . . . . 1.17 116.621 173.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.89 15.69 0.1 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.999 2.119 . . . . 2.4 115.633 -177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.4 mmt -61.09 -27.81 68.63 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 119.824 -1.798 . . . . 1.13 112.887 -177.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -66.93 -38.17 85.67 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.314 0.961 . . . . 2.15 113.178 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -81.74 -38.69 25.3 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.605 -1.309 . . . . 3.34 112.582 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 89.1 mt -54.46 -47.83 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 119.915 1.234 . . . . 1.01 110.796 168.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.74 -34.96 73.63 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 120.242 -1.536 . . . . 1.1 112.557 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -71.23 -34.83 71.16 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.321 1.048 . . . . 1.13 112.759 172.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -62.97 -36.07 82.27 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.339 0.972 . . . . 2.05 112.225 171.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.3 mt -82.07 -41.21 20.89 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.173 0.805 . . . . 1.21 113.173 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -68.26 -25.68 65.3 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.527 1.058 . . . . 3.34 113.384 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 t -78.28 -16.44 57.77 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.148 0.979 . . . . 3.06 113.055 174.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.32 163.7 32.96 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 127.172 2.32 . . . . 1.32 113.993 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -88.8 33.86 0.78 Allowed 'General case' 0 N--CA 1.478 0.953 0 O-C-N 120.866 -1.373 . . . . 2.56 112.409 172.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -73.98 0.18 14.35 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.031 -1.043 . . . . 3.42 113.466 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.94 -30.0 63.63 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.996 -1.065 . . . . 2.11 110.815 167.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.02 -49.67 0.62 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 123.933 0.777 . . . . 0.71 113.194 169.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -75.67 158.51 32.26 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.348 1.24 . . . . 3.41 114.348 -169.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.18 159.88 33.14 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.559 -0.713 . . . . 4.5 110.29 165.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.31 127.2 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 116.54 -0.3 . . . . 1.19 110.259 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.94 -48.7 25.75 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.826 -0.546 . . . . 1.04 113.243 -176.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.4 t -137.32 127.97 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.048 1.339 . . . . 2.7 110.147 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.5 mt -85.57 143.7 38.95 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.731 0.813 . . . . 1.59 110.567 169.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.85 162.6 37.14 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.219 1.946 . . . . 0.76 111.958 172.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.36 -19.22 65.75 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.266 -0.896 . . . . 1.93 112.682 172.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -87.12 0.06 55.89 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.662 1.585 . . . . 2.95 115.0 174.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.81 146.4 25.97 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 114.429 1.27 . . . . 0.65 114.429 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -130.72 149.04 52.56 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.461 2.704 . . . . 3.54 111.614 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -123.4 137.57 54.79 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.409 1.484 . . . . 2.26 112.684 -175.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.3 pt -141.29 149.17 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.375 1.47 . . . . 1.56 112.136 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -108.51 169.56 8.57 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.563 1.545 . . . . 1.45 111.698 169.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.45 20.93 55.76 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.376 0.989 . . . . 0.68 115.53 175.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.5 p -88.09 149.52 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 118.422 1.111 . . . . 1.98 109.736 168.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -107.66 137.6 45.4 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.932 1.293 . . . . 1.75 112.164 175.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -141.11 156.92 45.9 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.893 1.277 . . . . 2.93 112.633 172.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.5 m -122.04 147.01 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 126.874 2.07 . . . . 1.67 109.874 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -89.09 148.18 23.83 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 122.582 1.182 . . . . 0.34 113.12 169.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.1 p -142.6 168.56 19.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.806 2.042 . . . . 1.52 112.246 178.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -88.71 172.93 8.88 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.734 0.814 . . . . 2.05 112.924 168.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.1 p -57.77 -27.97 63.54 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.378 1.071 . . . . 2.56 113.426 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -90.24 24.07 2.67 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.692 1.197 . . . . 2.76 113.79 172.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.54 25.25 14.06 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.562 2.345 . . . . 0.59 115.15 173.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -83.09 139.49 33.19 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.281 -0.887 . . . . 1.94 109.499 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.7 mt -75.76 128.68 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 118.457 0.571 . . . . 1.53 109.821 174.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.4 pt -122.02 155.68 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 123.181 1.467 . . . . 2.13 114.613 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -87.01 164.44 16.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.003 1.721 . . . . 1.66 110.234 167.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.15 2.27 1.22 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.135 1.774 . . . . 2.65 115.351 -176.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -107.0 5.17 27.85 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.71 2.404 . . . . 3.21 113.319 169.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.48 6.32 80.39 Favored Glycine 0 CA--C 1.532 1.153 0 O-C-N 120.073 -1.642 . . . . 0.68 114.011 -176.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -68.8 139.32 55.26 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 117.905 0.852 . . . . 2.2 109.226 169.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.3 p -101.29 139.7 36.61 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.382 1.073 . . . . 2.03 110.778 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.99 -9.98 54.27 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.296 1.221 . . . . 1.66 114.296 -168.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.48 21.62 47.34 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.897 1.237 . . . . 0.94 113.414 -173.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.7 t -130.48 148.17 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.688 1.595 . . . . 2.58 109.512 -177.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -127.9 159.35 35.19 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.334 1.854 . . . . 4.18 111.802 174.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 73.5 mt -131.41 127.85 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.978 1.311 . . . . 1.55 110.658 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.61 136.74 94.88 Favored Pre-proline 0 N--CA 1.476 0.833 0 CA-C-O 117.986 -1.007 . . . . 1.85 111.081 174.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -69.76 -20.31 35.0 Favored 'Trans proline' 0 C--N 1.352 0.756 0 CA-C-N 122.082 1.779 . . . . 0.81 112.774 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -96.42 -43.65 7.55 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.254 1.422 . . . . 1.22 112.553 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 p -86.29 -25.33 25.53 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.099 0.96 . . . . 1.95 112.61 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 52.65 24.42 3.14 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.34 1.456 . . . . 2.8 113.329 -171.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.63 157.64 16.8 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.888 -1.133 . . . . 3.27 111.578 -177.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.2 mt -94.38 146.96 23.69 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.256 1.422 . . . . 2.19 113.028 -169.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.0 p -72.07 -7.64 50.03 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.236 1.199 . . . . 1.74 114.236 173.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.87 -158.45 10.04 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 128.165 2.793 . . . . 0.97 110.446 177.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.59 166.7 21.62 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 119.411 1.605 . . . . 2.19 112.274 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 mmt -51.16 143.3 17.13 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 125.229 1.411 . . . . 2.18 113.882 -177.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.7 165.41 26.89 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 124.166 3.244 . . . . 0.9 114.526 174.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.37 -52.19 6.75 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.138 1.775 . . . . 1.13 115.001 -177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.9 p -109.18 -3.12 17.52 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.107 1.363 . . . . 2.12 114.477 -169.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.68 151.18 2.47 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.186 1.394 . . . . 0.6 114.069 -173.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.4 ttt -76.13 89.56 3.05 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.404 1.082 . . . . 1.83 111.139 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -146.01 123.13 11.47 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.044 1.737 . . . . 2.15 113.896 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -164.73 145.32 7.65 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.532 1.133 . . . . 3.98 111.221 -169.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.36 157.19 17.24 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.081 1.512 . . . . 0.83 115.081 -171.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 80.1 p -72.97 139.52 46.76 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.34 -0.85 . . . . 2.0 112.993 169.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.63 -54.97 3.06 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 116.152 1.908 . . . . 2.46 116.152 -169.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.09 -40.57 0.15 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.628 1.171 . . . . 1.66 110.837 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -116.17 -26.15 7.33 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.795 1.035 . . . . 3.8 113.795 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.33 -163.31 34.74 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.62 1.105 . . . . 0.75 110.73 -169.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -137.17 130.75 31.54 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.345 1.858 . . . . 1.19 110.54 173.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.7 ttpt -82.02 134.98 35.4 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.36 0.527 . . . . 2.67 110.922 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -122.78 130.87 53.42 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.95 2.1 . . . . 3.51 108.211 173.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -85.05 121.77 28.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.513 1.125 . . . . 3.2 110.503 -176.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 46.0 p -109.38 -3.81 16.83 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.743 1.386 . . . . 1.61 114.743 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.94 -19.69 19.43 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.385 1.474 . . . . 1.57 114.944 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.02 -4.29 20.66 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.848 1.259 . . . . 3.23 113.613 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.25 141.83 54.16 Favored Pre-proline 0 CA--C 1.535 0.386 0 O-C-N 121.006 -1.059 . . . . 0.8 111.233 167.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.56 168.29 24.74 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.633 2.222 . . . . 0.75 110.928 168.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.71 91.88 0.64 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.955 1.702 . . . . 1.24 109.697 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -147.9 -178.64 6.38 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.415 1.086 . . . . 1.54 111.077 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -97.17 153.98 17.66 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.253 1.421 . . . . 5.53 110.792 168.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -146.01 170.21 17.1 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.226 1.81 . . . . 0.58 109.893 -169.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -138.89 145.98 40.56 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.354 0.872 . . . . 2.54 113.354 174.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.2 mp -104.1 135.97 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.483 1.113 . . . . 1.55 110.075 173.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -119.86 128.02 53.27 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.101 1.761 . . . . 3.17 110.062 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -87.85 109.89 20.1 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.678 0.791 . . . . 1.92 110.3 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 41.5 mm -116.5 87.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.188 0.995 . . . . 1.77 108.605 -173.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . 0.283 7.6 p80 -94.91 44.2 1.1 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.195 -0.941 . . . . 4.52 112.492 -178.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.7 p -92.95 -21.08 20.01 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.897 1.679 . . . . 2.46 112.743 169.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.85 167.0 22.32 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.555 1.142 . . . . 3.07 111.983 170.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 15.9 m -57.97 122.98 14.31 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.582 -0.698 . . . . 6.1 109.56 168.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.9 p -148.91 174.56 12.12 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.96 2.104 . . . . 6.06 111.252 -167.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -60.05 126.97 29.58 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.579 -1.326 . . . . 8.48 111.159 173.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.4 p -80.64 125.09 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.14 0.976 . . . . 4.13 111.674 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -111.65 -12.53 14.53 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.379 0.99 . . . . 2.2 115.024 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -100.76 18.07 20.37 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.59 1.956 . . . . 4.76 114.618 -177.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.51 8.64 5.44 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.739 1.385 . . . . 5.11 114.739 -171.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 132.84 -7.55 5.19 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.808 1.671 . . . . 4.82 115.597 174.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -69.34 169.75 11.68 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.551 1.54 . . . . 3.19 113.992 178.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.7 m -77.29 49.4 0.7 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.566 1.946 . . . . 4.35 112.514 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.9 mt -135.02 163.09 30.66 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.611 1.564 . . . . 2.88 112.192 -170.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.6 t -140.48 -179.96 6.32 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.703 1.601 . . . . 3.9 110.936 -175.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -76.95 48.27 2.68 Favored Glycine 0 CA--C 1.535 1.328 0 O-C-N 120.746 -1.221 . . . . 3.09 114.134 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.7 p -74.46 158.52 33.69 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.549 1.939 . . . . 4.94 113.934 -177.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.67 136.82 36.26 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.912 0.885 . . . . 2.99 113.014 170.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.46 159.73 19.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.143 0.973 . . . . 1.4 112.807 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.6 m -116.6 144.99 34.31 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 125.119 1.368 . . . . 1.12 109.549 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.18 139.69 42.9 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.445 2.097 . . . . 0.61 112.646 -167.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 3.0 mp -105.28 129.33 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.424 1.09 . . . . 2.03 111.187 -168.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -89.17 133.61 34.34 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.475 1.51 . . . . 4.57 112.619 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.3 tt -141.71 156.92 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 125.779 1.632 . . . . 1.76 111.188 -175.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -132.65 152.15 51.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.531 1.532 . . . . 2.03 109.983 173.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.63 155.98 46.89 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 113.001 0.741 . . . . 1.33 113.001 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.26 96.88 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.086 1.857 . . . . 1.15 111.643 -169.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 28.7 tp -124.5 59.18 1.19 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 104.361 -2.459 . . . . 3.39 104.361 166.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -139.5 151.67 46.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.283 2.633 . . . . 3.86 109.334 -166.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -82.26 41.01 0.67 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.185 0.994 . . . . 3.35 113.286 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.9 m -110.45 138.88 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 125.57 1.548 . . . . 1.91 111.419 -175.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.97 -46.92 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.261 1.824 . . . . 4.59 112.281 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -153.07 152.89 31.85 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 127.336 2.255 . . . . 3.23 110.571 174.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -92.98 149.42 21.24 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.081 0.953 . . . . 1.86 112.644 -173.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -139.28 167.26 22.48 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 115.128 1.529 . . . . 0.6 115.128 175.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.34 139.06 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.032 1.733 . . . . 1.12 110.644 172.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -130.8 81.09 68.32 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 126.235 1.814 . . . . 4.17 109.357 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.98 159.59 52.01 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 125.107 3.871 . . . . 0.97 112.731 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -125.77 -157.63 0.8 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.33 1.852 . . . . 3.2 112.582 -167.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -143.54 167.14 22.94 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 130.473 3.509 . . . . 3.88 107.953 174.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 12.7 t -143.92 -33.89 0.4 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.244 0.831 . . . . 2.4 113.244 174.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -130.72 137.39 49.5 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.126 1.37 . . . . 6.22 111.177 -169.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -117.72 143.24 46.39 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.779 1.231 . . . . 7.1 111.104 171.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -146.16 157.98 48.85 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 124.991 1.316 . . . . 10.79 111.679 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.35 157.9 59.47 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.168 2.579 . . . . 9.44 114.495 -172.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -65.99 -24.17 66.72 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.223 1.194 . . . . 16.41 114.223 172.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.89 -30.75 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.003 1.321 . . . . 13.9 110.953 -174.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.8 mt -89.51 78.79 7.02 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.503 1.121 . . . . 12.2 111.743 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 N--CA 1.473 0.685 0 C-N-CA 125.286 1.434 . . . . 17.41 110.569 172.531 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 15.0 mmt . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 109.264 -0.643 . . . . 31.78 109.264 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -83.27 -28.14 29.37 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.692 0.797 . . . . 32.15 112.421 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.9 p -144.5 161.7 38.41 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.734 1.613 . . . . 26.21 111.199 170.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.55 39.31 3.5 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.572 1.549 . . . . 22.42 112.56 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.5 m -79.5 126.78 31.31 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.509 1.123 . . . . 21.21 111.647 -173.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -150.4 -171.56 3.95 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.917 0.887 . . . . 16.52 112.83 -168.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.93 176.02 9.91 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.17 1.788 . . . . 15.25 114.073 171.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -69.92 157.48 37.36 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.396 1.878 . . . . 11.52 113.008 173.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.6 p -148.86 155.56 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 126.919 2.088 . . . . 8.1 110.355 -175.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -113.1 72.0 0.76 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.758 1.623 . . . . 4.39 109.234 168.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.02 156.93 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 118.851 2.908 . . . . 4.25 118.851 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.39 49.59 1.01 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.304 1.842 . . . . 6.44 114.096 -174.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.29 -4.17 90.51 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.095 1.331 . . . . 2.16 114.973 175.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.4 p -134.83 160.65 37.56 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.68 1.592 . . . . 1.85 111.928 -175.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.8 p -93.9 -7.08 44.12 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.347 1.24 . . . . 2.14 114.347 -173.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 t -152.43 154.42 35.52 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.625 1.97 . . . . 2.7 109.135 166.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.6 p -95.27 4.91 53.01 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 127.341 2.256 . . . . 2.02 114.856 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.1 m -153.19 154.19 34.23 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 120.069 -1.644 . . . . 2.78 113.195 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -129.53 147.0 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 127.793 2.437 . . . . 1.44 110.537 -175.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.4 m -113.55 117.7 32.39 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.082 0.953 . . . . 1.36 110.806 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.91 135.82 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.685 0.794 . . . . 2.26 109.513 172.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -114.08 -179.25 3.58 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.25 1.82 . . . . 1.9 111.006 -176.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -138.02 118.24 13.6 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 120.534 -1.354 . . . . 3.36 112.176 165.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.6 mt -107.28 152.93 23.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.222 1.409 . . . . 1.16 111.19 177.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.6 mt -144.25 172.23 13.2 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.143 1.777 . . . . 2.04 110.422 169.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.04 164.21 12.27 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.675 1.19 . . . . 1.41 112.272 170.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.4 p -90.98 -23.33 20.44 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.691 1.367 . . . . 1.78 114.691 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -139.15 41.45 2.09 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.861 1.21 . . . . 2.38 112.073 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.9 14.32 82.29 Favored Glycine 0 CA--C 1.536 1.362 0 O-C-N 120.796 -1.19 . . . . 0.94 114.971 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.42 19.85 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.94 2.496 . . . . 2.38 116.067 -175.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.1 mmt -62.83 -28.39 69.98 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 119.592 -1.942 . . . . 1.01 114.33 -171.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -71.84 -45.77 60.29 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.405 1.002 . . . . 2.7 112.999 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -67.49 -35.98 80.2 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.693 -1.255 . . . . 2.77 111.677 173.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.6 mt -58.41 -44.91 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 119.306 0.957 . . . . 1.03 110.547 167.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.405 ' HA ' ' HE3' ' A' ' 183' ' ' LYS . . . -59.68 -37.04 77.69 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.372 -1.455 . . . . 2.23 112.489 177.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -68.28 -35.89 78.54 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.631 0.772 . . . . 0.97 112.484 170.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -63.03 -19.3 64.24 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 119.431 1.014 . . . . 1.9 113.179 170.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 25.8 mt -101.76 -36.2 8.79 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.745 1.757 . . . . 1.03 115.745 177.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -64.24 -24.42 67.66 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.583 1.083 . . . . 2.34 112.503 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.9 t -74.01 -20.24 60.38 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.5 2.32 . . . . 2.12 114.45 175.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.64 172.16 27.07 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.547 1.07 . . . . 1.03 113.743 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -84.18 29.15 0.58 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.633 1.173 . . . . 2.48 113.02 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -75.42 3.88 8.36 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.928 1.455 . . . . 3.21 114.928 -168.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.66 -26.53 68.71 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.034 -1.042 . . . . 1.73 111.577 168.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.86 -82.02 1.36 Allowed Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.56 1.076 . . . . 0.97 112.993 174.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.5 163.03 28.23 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.436 1.273 . . . . 1.93 114.436 -172.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -55.64 152.78 8.8 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.306 1.042 . . . . 3.08 113.058 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.8 t -69.9 98.37 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 107.915 -1.143 . . . . 1.25 107.915 169.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.38 -25.74 75.21 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.229 0.443 . . . . 2.07 114.191 -173.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.5 t -141.13 125.04 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.444 1.498 . . . . 2.6 109.037 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.5 mt -92.62 160.2 34.94 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 126.08 1.752 . . . . 1.63 111.079 169.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.17 166.89 28.76 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 121.413 1.409 . . . . 1.02 111.169 168.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.43 -20.74 58.68 Favored 'General case' 0 CA--C 1.548 0.865 0 O-C-N 120.864 -1.147 . . . . 2.23 113.296 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.0 p30 -79.68 -4.79 53.33 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.558 1.543 . . . . 2.82 114.406 170.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.75 154.31 20.38 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 113.997 1.11 . . . . 0.77 113.997 174.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.8 pttt -145.92 161.75 39.34 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.71 2.004 . . . . 3.39 112.066 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -133.45 123.57 25.52 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.608 1.163 . . . . 2.23 112.424 -169.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.7 pt -120.98 143.63 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.151 0.98 . . . . 2.05 112.129 -177.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -114.49 163.41 15.4 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.654 1.181 . . . . 1.68 112.263 173.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.75 3.74 55.99 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.101 1.81 . . . . 0.72 115.919 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.0 p -83.03 145.85 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 125.733 1.613 . . . . 1.7 112.127 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -101.83 136.25 41.99 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.599 1.56 . . . . 1.7 113.46 175.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -141.41 158.5 43.79 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.621 1.568 . . . . 2.78 112.319 173.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.2 m -124.18 146.16 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 126.873 2.069 . . . . 1.76 109.726 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -87.41 148.03 25.17 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 122.312 1.053 . . . . 0.52 112.283 170.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.3 p -142.46 171.26 14.3 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.601 1.96 . . . . 1.75 112.952 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.21 -176.44 3.42 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 115.279 1.585 . . . . 1.98 115.279 174.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 47.3 p -57.73 -30.99 66.0 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.037 -1.04 . . . . 2.31 113.187 175.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -86.98 18.22 3.68 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.806 1.242 . . . . 2.4 113.192 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.97 22.09 4.14 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.288 1.835 . . . . 0.57 113.634 -176.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -77.7 140.36 39.53 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.867 1.267 . . . . 2.1 110.31 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.7 mt -79.79 124.5 37.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.082 -0.71 . . . . 1.66 109.082 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.6 pt -123.55 157.19 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 114.23 1.196 . . . . 1.09 114.23 -174.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -89.96 166.0 13.74 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.364 1.466 . . . . 1.67 110.221 167.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.35 5.43 1.31 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.978 1.711 . . . . 2.06 115.332 -171.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -112.96 4.42 16.76 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 128.291 2.636 . . . . 2.74 112.841 172.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.55 10.72 84.92 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.682 1.134 . . . . 0.58 114.666 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -75.37 138.57 41.83 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.082 1.441 . . . . 2.33 110.066 168.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.8 140.57 37.91 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.095 0.958 . . . . 1.87 112.339 -173.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -95.21 6.28 49.46 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 115.647 1.721 . . . . 2.06 115.647 -166.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.1 28.64 61.91 Favored Glycine 0 CA--C 1.533 1.177 0 O-C-N 121.248 -0.908 . . . . 0.64 113.73 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.7 t -137.64 149.52 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.579 1.152 . . . . 1.74 109.9 175.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -132.97 153.41 51.47 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 129.011 2.924 . . . . 1.33 110.906 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 51.9 mt -131.93 128.83 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.924 1.289 . . . . 1.99 112.034 -173.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -70.6 141.0 87.31 Favored Pre-proline 0 N--CA 1.477 0.907 0 CA-C-O 117.423 -1.275 . . . . 2.1 111.84 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -73.84 -24.53 15.34 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 CA-C-N 122.355 1.877 . . . . 0.99 112.967 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -91.13 -38.11 12.95 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.53 1.532 . . . . 1.22 113.104 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.4 p -93.62 -27.72 16.42 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.0 0.92 . . . . 1.65 113.19 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 55.13 19.91 3.07 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.271 1.428 . . . . 3.67 112.932 -169.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.59 147.09 25.46 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.575 1.15 . . . . 3.94 111.69 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.3 mt -88.78 141.39 28.55 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.645 1.578 . . . . 1.14 112.73 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.0 p -75.25 10.63 1.48 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.353 1.061 . . . . 1.61 113.746 172.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.39 -155.21 13.87 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.552 2.025 . . . . 1.11 111.632 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -96.4 163.97 12.83 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.357 1.463 . . . . 1.78 112.698 175.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.5 mmt -51.58 139.32 29.16 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 114.289 1.218 . . . . 2.27 114.289 -176.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -78.41 163.89 26.83 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 124.617 3.544 . . . . 0.88 113.78 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.45 -67.31 0.7 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.222 1.193 . . . . 1.11 114.222 174.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.5 p -101.83 4.88 40.77 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 115.884 1.809 . . . . 1.74 115.884 -167.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.82 147.76 11.35 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.682 1.364 . . . . 0.69 114.682 -175.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.8 ttt -73.08 95.04 1.98 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.517 1.927 . . . . 1.94 111.561 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.6 pttp -147.07 137.58 23.57 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.803 1.641 . . . . 2.09 111.65 -174.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -161.55 158.18 25.99 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.605 1.562 . . . . 2.69 110.211 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -96.25 150.04 20.98 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.908 1.447 . . . . 0.8 114.908 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.0 p -65.73 134.99 54.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.35 -0.844 . . . . 1.33 111.968 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -94.26 -65.04 1.01 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.778 1.399 . . . . 2.3 114.778 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.72 -45.91 0.1 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.053 0.941 . . . . 1.47 111.666 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -93.49 -35.32 13.01 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.854 0.462 . . . . 4.13 111.648 173.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 176.42 -149.96 10.17 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.216 1.389 . . . . 1.04 111.034 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -137.16 129.05 29.04 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.947 1.699 . . . . 1.78 110.492 169.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -90.09 138.33 31.6 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.318 1.047 . . . . 4.13 112.286 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -130.34 130.87 45.0 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 128.591 2.756 . . . . 3.37 109.214 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -88.37 123.76 33.26 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.772 1.229 . . . . 2.35 109.677 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.2 p -109.81 2.65 20.08 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.062 1.345 . . . . 1.69 113.342 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.26 -21.72 9.87 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 115.13 1.53 . . . . 2.21 115.13 -176.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -108.36 -9.56 15.44 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.808 1.04 . . . . 2.35 113.808 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.04 149.0 92.09 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 120.481 1.492 . . . . 0.84 113.313 175.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -83.91 168.8 12.1 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.898 3.066 . . . . 0.87 111.344 167.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.39 90.46 2.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.847 2.059 . . . . 1.28 110.567 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -147.3 179.24 7.79 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.416 1.086 . . . . 1.97 111.743 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -90.13 152.49 21.1 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.99 0.916 . . . . 4.47 110.618 167.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -142.74 176.86 8.72 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.132 1.773 . . . . 0.56 109.441 -173.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.89 155.88 43.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.006 0.922 . . . . 4.31 113.199 175.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.6 mp -121.98 134.53 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.172 0.989 . . . . 1.67 110.618 172.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -122.28 135.1 54.68 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.411 1.885 . . . . 3.26 111.148 -176.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -86.84 109.66 19.44 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.822 0.849 . . . . 2.77 110.931 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 28.3 mm -116.64 92.29 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.871 0.868 . . . . 1.96 108.76 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -83.14 2.4 35.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.518 1.127 . . . . 6.13 113.854 -174.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.9 p -71.29 -20.16 62.24 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 115.087 1.514 . . . . 2.2 115.087 -174.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.0 mp -80.84 -62.19 1.74 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.265 1.393 . . . . 3.47 109.032 168.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 34.4 t -157.61 160.97 38.63 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.314 1.846 . . . . 4.93 109.608 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.6 t -147.3 -175.11 4.71 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.469 1.108 . . . . 7.38 110.287 168.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -66.02 167.1 10.36 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.378 1.471 . . . . 6.3 112.664 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 55.0 t -89.52 124.42 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.929 0.892 . . . . 6.41 111.275 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -136.19 -29.21 0.34 Allowed Glycine 0 CA--C 1.541 1.66 0 CA-C-O 118.112 -1.382 . . . . 2.92 115.973 174.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . 0.276 10.9 pt-20 -88.05 -0.87 57.58 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 121.318 2.559 . . . . 6.31 115.186 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -79.84 24.85 0.38 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.241 1.417 . . . . 7.32 113.49 176.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 102.68 8.82 42.08 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.483 1.516 . . . . 5.39 116.143 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -87.93 161.25 17.56 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 118.721 1.26 . . . . 3.59 113.315 -178.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.8 t -80.63 54.65 2.14 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.378 1.471 . . . . 4.73 112.061 174.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 30.1 mt -129.63 150.25 51.03 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.979 1.712 . . . . 3.21 110.734 -174.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 42.9 p -135.15 150.07 50.1 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.691 0.796 . . . . 4.95 111.622 174.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -74.34 46.84 1.63 Allowed Glycine 0 CA--C 1.537 1.457 0 C-N-CA 126.046 1.784 . . . . 3.36 114.348 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.4 t -81.18 160.25 24.4 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.178 1.391 . . . . 3.64 112.241 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.2 115.66 24.75 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.799 1.407 . . . . 3.64 114.799 -167.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.55 137.05 47.76 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.993 1.717 . . . . 1.28 110.157 168.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.54 148.55 37.67 Favored Pre-proline 0 N--CA 1.481 1.097 0 CA-C-N 119.629 1.104 . . . . 0.99 112.386 174.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -72.56 140.46 32.93 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.65 2.233 . . . . 0.75 111.202 -173.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 4.6 mt -88.52 127.27 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.611 0.765 . . . . 2.75 110.377 -171.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -86.25 127.96 34.83 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.371 1.468 . . . . 3.67 109.573 168.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.3 tt -144.23 147.67 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 119.087 0.858 . . . . 1.83 112.951 -173.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -124.8 149.38 47.46 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.927 1.691 . . . . 2.06 109.513 169.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 28.1 mt -64.74 162.06 39.75 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 114.377 1.251 . . . . 1.74 114.377 -171.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.66 98.32 1.2 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.011 2.474 . . . . 0.82 111.893 -173.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.2 tt -123.05 62.29 1.01 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 104.823 -2.288 . . . . 3.24 104.823 167.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -140.67 156.82 46.13 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.907 2.083 . . . . 3.33 108.853 -168.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -70.33 17.62 0.06 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.966 1.839 . . . . 3.92 115.966 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.7 m -95.97 144.32 10.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 124.367 1.067 . . . . 1.47 112.886 -168.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 50.8 t -73.69 -36.66 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.935 -0.478 . . . . 2.21 110.739 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -140.29 131.29 26.19 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.195 1.398 . . . . 2.61 110.763 -170.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -97.11 140.97 30.82 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.971 0.908 . . . . 1.4 112.396 -176.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -137.19 166.48 23.63 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.106 1.521 . . . . 0.67 115.106 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.43 137.32 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.64 1.976 . . . . 1.18 113.152 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -131.01 89.8 41.34 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.502 1.521 . . . . 3.09 111.58 -177.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.87 154.36 71.13 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.157 3.238 . . . . 1.16 112.819 175.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' A' ' 53' ' ' ALA . 36.3 mtmm -133.17 163.07 30.11 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.207 1.403 . . . . 2.43 112.772 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -100.68 146.61 26.98 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.615 2.366 . . . . 3.71 110.328 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 7.1 t -135.93 -47.83 0.67 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 113.788 1.033 . . . . 2.29 113.788 171.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 43.34 122.77 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 130.761 3.625 . . . . 7.21 119.053 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -144.53 124.86 13.81 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.047 1.739 . . . . 7.56 109.912 168.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -127.07 155.24 76.26 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 125.468 1.507 . . . . 9.37 112.463 -170.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -62.8 148.41 93.46 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.589 2.193 . . . . 11.61 112.637 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -81.7 -38.62 25.53 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.706 1.002 . . . . 16.34 113.706 175.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 191' ' ' ILE . 0.2 OUTLIER -114.97 -28.27 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.755 1.222 . . . . 16.08 114.18 -174.006 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.6 tt 59.21 106.32 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.829 2.451 . . . . 15.75 112.99 -176.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 CA--C 1.544 0.735 0 C-N-CA 126.24 1.816 . . . . 21.25 112.711 -172.614 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 47.0 p . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 113.914 1.079 . . . . 1.0900000000000001 113.914 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.7 p -90.58 -6.17 55.0 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.776 1.23 . . . . 1.4299999999999999 113.01 175.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 m -156.5 153.93 29.54 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.223 2.209 . . . . 2.23 109.455 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.1 p -109.54 4.49 22.28 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.306 1.595 . . . . 0.89000000000000001 115.306 -170.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 m -147.58 161.38 41.24 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.275 1.83 . . . . 1.74 112.501 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.42 141.69 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 126.513 1.925 . . . . 0.35999999999999999 109.869 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.3 m -111.3 114.83 28.29 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.474 0.654 . . . . 0.71999999999999997 109.916 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 p -93.17 128.51 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.256 1.022 . . . . 0.68000000000000005 109.274 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -107.23 -177.85 3.47 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.152 1.381 . . . . 1.79 110.118 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -139.14 122.7 17.36 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.753 -1.217 . . . . 1.6000000000000001 111.124 168.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.7 mt -107.94 154.24 21.9 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.106 0.962 . . . . 0.67000000000000004 110.936 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.26 167.37 22.6 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.843 1.657 . . . . 1.9099999999999999 110.092 176.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.38 158.34 16.13 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.751 0.821 . . . . 0.68000000000000005 112.249 170.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.1 p -80.72 -41.13 24.11 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.413 1.085 . . . . 0.93999999999999995 112.485 174.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -131.66 38.03 3.6 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.3 1.04 . . . . 2.6800000000000002 112.996 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.72 12.29 82.99 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.228 1.394 . . . . 0.79000000000000004 115.264 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -71.65 18.17 0.08 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.474 2.31 . . . . 1.95 116.075 -171.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.21 -26.03 66.07 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.377 -1.452 . . . . 0.59999999999999998 113.025 -175.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.45 -50.51 63.11 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.926 1.29 . . . . 2.3300000000000001 112.709 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -68.34 -39.93 81.72 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.849 -1.157 . . . . 2.2999999999999998 112.219 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -53.96 -49.42 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.417 1.008 . . . . 0.53000000000000003 111.123 171.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.05 -23.71 67.26 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.477 -1.389 . . . . 0.76000000000000001 113.424 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -82.17 -30.07 31.2 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.308 -0.87 . . . . 1.1200000000000001 112.822 169.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -70.67 -11.87 61.21 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.61 1.564 . . . . 2.0699999999999998 113.516 168.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.3 mt -106.65 -31.81 8.3 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.774 1.63 . . . . 0.80000000000000004 114.256 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.47 -22.31 66.73 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 120.461 1.482 . . . . 2.4100000000000001 113.176 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 t -71.16 -31.08 67.24 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.436 1.094 . . . . 1.3799999999999999 112.466 171.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.4 162.62 35.02 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.247 0.927 . . . . 0.87 113.22 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -83.23 30.58 0.46 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.936 -1.332 . . . . 1.6100000000000001 112.813 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -71.78 19.23 0.07 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.124 1.898 . . . . 1.96 116.124 -168.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.16 -27.85 62.85 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.367 1.067 . . . . 0.93999999999999995 109.802 164.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.23 -63.79 0.26 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.211 1.386 . . . . 0.68999999999999995 113.341 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -78.82 158.92 28.07 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.177 1.547 . . . . 1.8100000000000001 115.177 -171.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -70.76 135.74 48.4 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.997 1.719 . . . . 3.27 112.991 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 80.0 t -54.38 110.57 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.883 0.873 . . . . 0.80000000000000004 111.246 -174.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.72 -25.21 60.89 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 114.708 0.643 . . . . 1.0600000000000001 114.708 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 p -142.07 104.11 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.528 1.131 . . . . 4.25 111.89 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.1 mt -89.79 146.8 36.12 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 126.966 2.107 . . . . 1.1299999999999999 111.451 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.27 158.21 19.96 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.282 2.654 . . . . 0.56999999999999995 113.18 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.37 -22.9 63.69 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.877 -1.139 . . . . 0.93000000000000005 112.356 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -79.34 0.5 28.71 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.946 1.298 . . . . 1.3100000000000001 114.28 169.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.32 157.85 16.48 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.743 1.217 . . . . 0.56999999999999995 112.599 168.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -150.84 172.02 16.3 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.178 1.791 . . . . 1.8100000000000001 111.206 173.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -126.54 146.82 49.99 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.287 1.435 . . . . 2.25 111.028 -174.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.1 pt -136.65 130.67 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 114.042 1.127 . . . . 0.77000000000000002 114.042 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.7 156.86 17.78 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.725 0.81 . . . . 0.63 111.71 169.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.4 15.78 56.5 Favored Glycine 0 CA--C 1.537 1.43 0 N-CA-C 116.102 1.201 . . . . 0.62 116.102 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.5 p -90.14 145.78 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-N 120.153 1.977 . . . . 0.93999999999999995 109.125 167.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 1.8 tpp -102.42 137.69 40.33 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.701 1.2 . . . . 0.45000000000000001 111.798 174.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.66 153.71 47.35 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 122.188 0.994 . . . . 1.74 112.875 170.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.7 m -118.71 146.39 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 C-N-CA 126.948 2.099 . . . . 0.33000000000000002 109.125 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -87.64 147.03 25.45 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.433 1.111 . . . . 0.29999999999999999 111.926 169.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.2 p -141.49 173.65 11.3 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.328 1.851 . . . . 0.40000000000000002 112.098 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.53 177.6 4.97 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.78 1.632 . . . . 1.8100000000000001 113.407 172.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.0 p -68.18 -20.76 64.89 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.978 1.103 . . . . 1.4099999999999999 113.978 -171.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -97.97 26.46 5.21 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.602 1.561 . . . . 2.1200000000000001 112.834 169.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 62.26 23.98 14.24 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.226 2.21 . . . . 0.56000000000000005 114.349 169.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -84.38 140.38 31.61 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.069 0.948 . . . . 2.5499999999999998 111.117 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.7 mt -76.86 126.09 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.193 -0.669 . . . . 0.5 109.193 176.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.555 HG22 HG22 ' A' ' 97' ' ' THR . 4.7 pt -117.86 156.91 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 114.57 1.322 . . . . 0.58999999999999997 114.57 -176.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -85.27 165.4 17.36 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.232 1.413 . . . . 1.4399999999999999 110.741 167.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -64.95 2.86 0.64 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 128.05 2.54 . . . . 3.0499999999999998 115.904 -174.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -117.54 -3.5 11.34 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 127.59 2.356 . . . . 2.98 114.276 172.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.05 5.8 59.4 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.362 1.458 . . . . 0.81000000000000005 116.443 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -72.33 137.34 46.58 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.092 1.946 . . . . 2.0499999999999998 110.454 170.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.555 HG22 HG22 ' A' ' 91' ' ' ILE . 23.9 p -96.36 134.23 39.76 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.603 1.161 . . . . 0.98999999999999999 111.662 -175.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.7 -0.95 57.27 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.538 1.681 . . . . 0.62 115.538 -167.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.86 15.61 69.84 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-N 119.214 0.915 . . . . 0.71999999999999997 113.931 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.0 t -125.08 147.1 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.938 1.295 . . . . 1.1000000000000001 109.293 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -133.55 157.85 44.65 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 128.115 2.566 . . . . 1.3300000000000001 110.138 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.41 HG12 HD23 ' A' ' 109' ' ' LEU . 55.8 mt -136.03 134.23 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.931 1.292 . . . . 0.48999999999999999 110.53 -174.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -73.09 135.02 80.26 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 121.072 -1.017 . . . . 1.8 110.308 173.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -66.71 -22.92 49.42 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.573 2.182 . . . . 0.98999999999999999 113.816 172.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -96.9 -45.06 6.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.916 1.686 . . . . 1.1200000000000001 112.762 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.8 p -90.71 -22.98 20.85 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.61 1.164 . . . . 0.79000000000000004 113.565 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 53.39 19.46 1.63 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.75 1.62 . . . . 2.0499999999999998 113.846 -170.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.41 146.65 30.18 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.745 -1.222 . . . . 2.7599999999999998 111.524 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.41 HD23 HG12 ' A' ' 102' ' ' ILE . 31.3 mt -90.29 135.66 33.54 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.215 1.406 . . . . 0.83999999999999997 111.288 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 92.2 p -66.23 -0.58 2.62 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.382 1.252 . . . . 1.3300000000000001 114.382 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.38 -152.8 9.08 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 126.39 1.948 . . . . 0.85999999999999999 112.218 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.1 162.65 15.21 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.113 1.365 . . . . 0.93999999999999995 113.439 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.3 mmt -54.01 128.12 55.53 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.75 1.22 . . . . 1.51 113.055 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -72.08 163.42 38.83 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.106 3.204 . . . . 0.73999999999999999 113.129 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.41 -81.24 0.09 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.165 0.986 . . . . 1.0700000000000001 112.127 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 78.1 p -83.58 2.05 39.14 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 116.07 1.878 . . . . 0.78000000000000003 116.07 -167.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -49.87 149.17 2.74 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.382 1.473 . . . . 0.46999999999999997 114.974 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.1 tpt -77.52 98.11 5.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.784 2.034 . . . . 1.5800000000000001 111.256 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -150.14 147.78 28.17 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.413 1.485 . . . . 1.04 112.221 -172.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -166.82 156.96 11.53 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 125.392 1.477 . . . . 1.79 111.241 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 mp -94.68 150.4 20.26 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.481 1.289 . . . . 0.47999999999999998 114.481 172.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 16.7 p -63.84 134.52 55.35 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.323 -0.86 . . . . 0.46999999999999997 112.058 170.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -92.3 -54.41 3.82 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.464 1.653 . . . . 2.1899999999999999 115.464 -171.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.73 -37.7 0.08 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.902 1.281 . . . . 1.0800000000000001 111.509 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -119.65 -22.52 6.87 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.073 1.138 . . . . 5.25 114.073 171.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 175.87 -159.09 26.43 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.686 1.612 . . . . 0.65000000000000002 111.117 -170.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -147.06 133.64 19.84 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.589 1.955 . . . . 0.39000000000000001 111.967 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -86.77 137.42 32.45 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.506 1.122 . . . . 1.4199999999999999 113.088 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -128.97 124.07 34.08 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.495 2.318 . . . . 1.6699999999999999 108.556 174.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -77.49 128.75 34.72 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.354 -0.841 . . . . 2.5299999999999998 110.201 175.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 66.8 p -105.73 -10.74 16.59 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.796 1.776 . . . . 0.69999999999999996 115.796 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.64 -33.95 16.88 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.798 1.181 . . . . 0.96999999999999997 114.014 -172.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -16.37 44.27 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.807 1.643 . . . . 2.2400000000000002 113.291 -176.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -72.18 144.18 86.91 Favored Pre-proline 0 C--O 1.237 0.434 0 CA-C-N 119.976 1.262 . . . . 0.63 112.166 173.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.45 167.1 27.92 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.357 2.038 . . . . 0.70999999999999996 110.47 167.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.38 93.77 1.98 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.149 1.38 . . . . 0.97999999999999998 109.609 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -152.71 -178.29 6.78 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.945 0.898 . . . . 0.65000000000000002 112.427 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -91.13 152.39 20.61 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.392 1.877 . . . . 3.3999999999999999 111.956 168.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -149.27 170.96 17.3 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.661 2.385 . . . . 0.48999999999999999 110.372 -170.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -138.63 160.86 38.56 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.424 1.09 . . . . 1.74 113.337 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.2 134.46 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.357 1.463 . . . . 0.39000000000000001 110.065 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -122.14 137.38 54.84 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.475 1.51 . . . . 1.8600000000000001 111.569 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -104.69 100.61 10.26 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.907 1.683 . . . . 2.6299999999999999 110.469 -169.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 28.2 mm -106.84 113.88 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.613 1.165 . . . . 0.73999999999999999 110.653 -167.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -87.1 22.82 1.95 Allowed 'General case' 0 CA--C 1.553 1.09 0 O-C-N 120.936 -1.102 . . . . 3.7799999999999998 112.854 -178.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.2 m . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 114.578 1.325 . . . . 1.77 114.578 -176.718 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? . . . . . 0 C--O 1.24 0.565 0 N-CA-C 112.441 0.534 . . . . 1.8799999999999999 112.441 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.55 147.1 28.82 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.514 1.126 . . . . 1.0900000000000001 111.06 168.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.36 147.88 34.62 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 123.282 0.633 . . . . 0.94999999999999996 110.449 170.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.29 159.28 52.3 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.708 2.939 . . . . 0.70999999999999996 113.365 -173.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -109.07 148.11 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.514 1.126 . . . . 1.72 111.467 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.58 148.45 41.9 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.789 1.636 . . . . 4.8300000000000001 111.252 168.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.6 tt -151.56 146.81 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 124.157 0.983 . . . . 0.48999999999999999 111.705 -174.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -122.97 142.92 50.3 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.555 1.542 . . . . 1.8400000000000001 109.495 169.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 23.4 mt -64.79 149.61 95.85 Favored Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 113.808 1.04 . . . . 0.97999999999999998 113.808 -170.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.54 110.72 2.36 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.269 2.646 . . . . 0.73999999999999999 113.832 -169.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.45 60.88 1.4 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.569 2.348 . . . . 2.4300000000000002 106.016 166.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -151.66 147.86 27.25 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.981 2.112 . . . . 3.1000000000000001 109.896 -166.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -72.48 23.41 0.06 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 126.075 1.75 . . . . 4.0099999999999998 114.679 -174.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.4 m -76.28 149.51 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 120.434 -1.417 . . . . 1.21 111.759 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 88.7 t -78.96 -35.7 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.733 0.813 . . . . 2.1699999999999999 111.405 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -145.42 148.56 33.45 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.67 1.988 . . . . 3.0 109.747 173.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -94.66 141.74 28.26 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.952 0.797 . . . . 0.39000000000000001 111.916 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -138.85 170.54 15.8 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.348 1.24 . . . . 0.59999999999999998 114.348 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.27 141.26 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 125.201 1.401 . . . . 0.56999999999999995 112.845 -177.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.38 83.28 59.73 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 124.729 1.212 . . . . 2.25 113.844 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -67.96 138.39 44.04 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.36 3.374 . . . . 0.59999999999999998 113.068 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -124.6 163.23 22.38 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.176 1.79 . . . . 1.9299999999999999 112.57 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -103.56 164.74 11.47 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.826 1.25 . . . . 2.6499999999999999 110.774 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 114.042 1.127 . . . . 2.9500000000000002 114.042 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 113.997 1.11 . . . . 1.0800000000000001 113.997 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 78.0 p -91.8 -9.13 44.62 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.629 1.172 . . . . 1.72 114.149 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.7 t -147.88 154.67 40.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.875 1.67 . . . . 1.8 109.405 169.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.7 p -98.27 -0.62 43.62 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.918 1.687 . . . . 0.85999999999999999 114.32 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.4 m -151.68 158.9 44.04 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.312 1.445 . . . . 1.79 110.607 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.68 141.9 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 126.39 1.876 . . . . 0.40999999999999998 109.317 177.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 m -115.76 121.77 43.45 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.508 0.723 . . . . 0.91000000000000003 110.307 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -103.37 131.61 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.683 1.193 . . . . 0.62 110.998 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -130.32 100.39 5.36 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.11 1.364 . . . . 1.8799999999999999 110.82 -172.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.419 ' HE3' ' CD2' ' A' ' 43' ' ' LEU . 6.9 tmtm? -74.81 120.88 20.95 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.788 -1.195 . . . . 1.54 110.916 -174.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.3 mt -106.84 153.45 22.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.952 1.301 . . . . 0.67000000000000004 112.195 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.419 ' CD2' ' HE3' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -141.65 171.77 13.6 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.965 1.706 . . . . 1.8200000000000001 110.894 176.158 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.35 158.49 16.43 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.171 1.388 . . . . 0.96999999999999997 112.219 170.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.4 p -81.01 -25.59 37.11 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.39 1.256 . . . . 1.4399999999999999 114.39 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -149.64 38.04 0.75 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.427 1.091 . . . . 3.5800000000000001 112.64 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.09 10.35 75.13 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 116.44 1.336 . . . . 1.24 116.44 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.13 14.62 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 129.128 2.971 . . . . 2.1800000000000002 116.632 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -26.13 68.61 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.283 -1.51 . . . . 0.75 113.087 -170.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -72.12 -43.37 64.82 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.626 1.103 . . . . 2.04 113.103 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -70.22 -41.86 73.06 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.465 -1.397 . . . . 2.4500000000000002 111.746 172.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.9 mt -54.07 -44.2 62.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.333 1.053 . . . . 0.82999999999999996 112.231 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.88 -31.17 69.54 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 120.967 1.712 . . . . 0.95999999999999996 112.768 176.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -76.03 -35.76 59.36 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.969 0.908 . . . . 1.3999999999999999 112.86 171.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -63.15 -22.87 67.15 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.179 0.991 . . . . 2.2000000000000002 112.97 170.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.3 mt -91.93 -41.48 10.56 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.097 1.147 . . . . 1.25 114.097 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.65 -18.9 65.37 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.781 1.173 . . . . 4.1299999999999999 113.692 -175.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.8 t -75.68 -23.37 56.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.655 1.182 . . . . 2.0099999999999998 113.883 172.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.64 157.68 21.32 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.346 0.974 . . . . 1.27 112.578 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -77.37 43.28 0.38 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.474 1.11 . . . . 1.71 113.031 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -78.74 13.37 1.69 Allowed 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.516 -1.365 . . . . 2.0600000000000001 113.971 -170.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.83 -17.63 58.88 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.237 1.415 . . . . 1.28 111.155 165.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.82 -74.07 0.14 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.738 1.161 . . . . 0.90000000000000002 112.792 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.42 161.33 29.92 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.41 1.263 . . . . 1.5600000000000001 114.41 -173.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.04 158.67 27.75 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.898 1.073 . . . . 3.1400000000000001 113.898 -173.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.02 119.44 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.894 -0.504 . . . . 0.81000000000000005 110.175 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.28 -29.33 45.62 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.828 0.728 . . . . 1.3600000000000001 114.15 -176.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.9 t -146.15 125.92 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.259 1.423 . . . . 2.2000000000000002 111.41 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.2 mt -96.88 134.46 23.01 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.903 1.681 . . . . 1.22 110.771 167.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.86 160.49 43.29 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.042 1.828 . . . . 0.71999999999999997 111.42 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.26 -21.82 66.78 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.836 -1.165 . . . . 1.25 113.715 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -88.3 -5.01 58.59 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.659 1.584 . . . . 1.76 114.443 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.3 155.16 20.77 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.108 0.867 . . . . 0.78000000000000003 111.113 168.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.6 pttt -152.46 170.01 21.18 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.396 1.078 . . . . 1.79 111.83 169.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -120.32 137.78 54.07 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.905 1.682 . . . . 2.02 108.718 -172.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.7 pt -126.24 131.98 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 120.018 1.281 . . . . 0.81000000000000005 113.464 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.76 160.06 14.92 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.0 1.32 . . . . 0.68000000000000005 111.286 169.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.03 16.11 68.21 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.086 0.851 . . . . 0.56000000000000005 115.089 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.3 p -101.85 141.71 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.491 1.516 . . . . 0.64000000000000001 110.288 169.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.7 tpp -99.88 141.8 32.21 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.524 1.53 . . . . 0.56000000000000005 112.642 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.442 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.6 OUTLIER -144.32 149.44 36.21 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.146 1.378 . . . . 1.6299999999999999 111.471 173.092 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.8 m -120.44 146.13 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.584 1.953 . . . . 0.39000000000000001 109.41 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -87.21 144.49 26.8 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.882 1.325 . . . . 0.40000000000000002 110.903 168.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.7 p -137.35 170.46 16.05 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.127 2.171 . . . . 0.40000000000000002 110.473 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -87.26 171.8 10.36 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.491 -0.755 . . . . 2.0899999999999999 111.651 167.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.5 t -61.46 -24.59 66.67 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.06 -1.025 . . . . 3.0099999999999998 113.275 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -69.42 10.37 0.35 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 127.274 2.23 . . . . 3.29 115.048 169.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.43 22.55 5.09 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 128.144 2.578 . . . . 0.68999999999999995 113.354 -172.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -83.06 136.27 34.54 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.481 1.512 . . . . 2.23 111.068 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.6 mt -73.99 127.26 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 109.65 -0.5 . . . . 0.48999999999999999 109.65 175.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.583 HG22 HG22 ' A' ' 97' ' ' THR . 3.2 pt -120.09 150.28 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 115.174 1.546 . . . . 0.5 115.174 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.45 159.57 28.19 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.081 2.153 . . . . 2.1000000000000001 109.298 165.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -64.32 -15.01 59.47 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.595 1.332 . . . . 2.0499999999999998 114.595 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -92.63 4.24 54.04 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.62 1.168 . . . . 3.48 111.993 174.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.61 5.54 81.64 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 126.47 1.986 . . . . 0.47999999999999998 115.376 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -67.96 143.72 55.5 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.222 1.011 . . . . 2.3100000000000001 109.859 171.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.583 HG22 HG22 ' A' ' 91' ' ' ILE . 33.6 p -103.58 136.04 44.05 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.539 1.135 . . . . 0.68000000000000005 111.198 -177.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.26 -8.98 58.87 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.022 1.119 . . . . 0.65000000000000002 114.022 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.32 19.73 56.39 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.341 0.972 . . . . 0.71999999999999997 113.53 -174.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.52 147.6 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.873 1.269 . . . . 1.1299999999999999 110.213 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.11 160.7 30.4 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.86 2.464 . . . . 1.5700000000000001 110.81 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.4 mt -133.88 134.83 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.388 1.475 . . . . 0.68999999999999995 111.32 -175.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.04 139.04 87.56 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 117.725 -1.131 . . . . 2.3999999999999999 111.314 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -71.4 -27.46 19.22 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 CA-C-N 122.095 1.784 . . . . 1.1100000000000001 112.839 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -86.98 -48.59 7.99 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.582 1.153 . . . . 1.72 111.736 -175.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.8 p -91.05 -24.35 20.07 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.426 1.09 . . . . 1.22 113.356 -174.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 53.45 29.31 8.72 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 125.174 1.39 . . . . 2.5600000000000001 112.162 -167.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.76 153.07 17.94 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.396 1.479 . . . . 2.3599999999999999 111.535 174.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.8 mt -94.46 151.82 19.07 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.768 1.627 . . . . 0.82999999999999996 113.303 -169.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.3 p -73.42 -2.77 23.74 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.558 0.947 . . . . 1.27 113.558 168.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.82 -147.92 6.05 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 126.861 2.172 . . . . 0.90000000000000002 112.515 -169.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.7 175.72 6.92 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.542 1.537 . . . . 0.94999999999999996 113.671 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.6 mmt -64.41 138.04 97.31 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.521 1.128 . . . . 1.3700000000000001 112.273 173.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -86.1 150.48 9.47 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 124.105 3.203 . . . . 0.78000000000000003 113.564 -174.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.1 -54.08 8.56 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.431 1.271 . . . . 1.1399999999999999 114.431 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 64.8 p -107.91 -1.61 20.54 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.871 1.434 . . . . 0.82999999999999996 114.871 -168.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.14 149.39 2.87 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 115.035 1.495 . . . . 0.40000000000000002 115.035 -173.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.5 tpt -75.96 99.39 4.53 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.099 2.159 . . . . 1.6599999999999999 111.186 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -153.6 147.14 25.02 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.201 1.4 . . . . 0.93000000000000005 112.594 -173.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -164.69 158.17 17.49 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.63 1.572 . . . . 1.6899999999999999 110.626 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -98.65 149.98 22.24 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.47 1.108 . . . . 0.56000000000000005 112.523 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.513 HG22 ' HA2' ' A' ' 126' ' ' GLY . 2.0 p -65.57 128.53 36.29 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.834 0.743 . . . . 0.58999999999999997 109.861 170.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.23 -55.14 4.34 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.012 1.115 . . . . 2.0600000000000001 114.012 -173.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.35 -43.69 0.14 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.16 1.384 . . . . 1.03 110.565 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -113.88 -25.45 8.6 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.5 0.926 . . . . 3.8100000000000001 113.5 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.513 ' HA2' HG22 ' A' ' 122' ' ' THR . . . 177.24 -166.8 37.61 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.249 0.928 . . . . 0.57999999999999996 111.865 -169.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.98 142.01 34.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.878 1.671 . . . . 0.52000000000000002 112.137 169.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -92.69 138.01 31.87 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.133 1.373 . . . . 1.3300000000000001 113.185 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -128.71 125.98 39.11 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.519 1.928 . . . . 1.96 109.106 173.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -88.42 108.53 19.42 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 118.953 0.797 . . . . 1.6299999999999999 111.054 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.6 p -93.98 0.61 56.13 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.092 1.357 . . . . 0.57999999999999996 113.764 -174.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.97 -8.84 3.49 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.095 1.516 . . . . 0.77000000000000002 115.095 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -102.12 -21.78 14.35 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.15 1.38 . . . . 1.8500000000000001 113.134 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -79.03 147.68 70.32 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 113.251 0.834 . . . . 0.71999999999999997 113.251 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.59 166.98 21.38 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.965 2.443 . . . . 0.80000000000000004 111.605 168.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.86 86.01 3.43 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.629 1.972 . . . . 1.01 111.857 -172.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -147.11 -175.53 4.86 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.823 0.849 . . . . 0.78000000000000003 111.678 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -93.34 142.68 27.04 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.751 1.22 . . . . 2.46 113.868 170.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -135.72 169.12 18.05 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.342 2.257 . . . . 0.58999999999999997 110.029 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -137.95 152.91 49.41 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.526 0.73 . . . . 1.7 112.809 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.0 mp -112.12 138.9 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.166 0.986 . . . . 0.31 110.023 173.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -128.47 131.04 48.36 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.79 1.636 . . . . 1.8 110.229 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -95.11 78.92 3.54 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.038 0.935 . . . . 1.9199999999999999 111.448 -171.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.6 mm -82.95 101.66 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.519 0.727 . . . . 0.77000000000000002 110.17 -174.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -80.66 -1.44 42.47 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.422 1.267 . . . . 4.7800000000000002 114.422 -175.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 58.2 p . . . . . 0 N--CA 1.471 0.588 0 O-C-N 120.288 -1.507 . . . . 1.71 115.057 -176.436 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 43.9 tptt . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 113.093 0.775 . . . . 3.52 113.093 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.03 132.52 36.01 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.266 0.555 . . . . 0.83999999999999997 109.695 167.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.1 149.08 35.96 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 123.684 0.794 . . . . 0.54000000000000004 110.759 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.99 159.39 48.05 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.843 2.362 . . . . 0.57999999999999996 112.182 -172.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.516 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.4 mp -123.93 134.44 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.014 1.725 . . . . 1.3100000000000001 109.168 -168.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -99.35 134.55 42.04 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.342 0.974 . . . . 4.2199999999999998 111.343 170.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.7 tt -130.73 140.58 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.936 1.694 . . . . 0.55000000000000004 110.284 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -107.91 150.5 26.98 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.489 1.116 . . . . 2.1099999999999999 108.911 170.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.1 mt -62.8 143.4 96.97 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 119.493 1.042 . . . . 1.05 111.91 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.9 107.25 1.07 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.292 2.662 . . . . 0.94999999999999996 111.799 -169.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.69 25.1 10.23 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.254 1.822 . . . . 3.0800000000000001 110.14 174.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -115.54 144.44 43.86 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.631 2.772 . . . . 2.9700000000000002 109.154 -171.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -73.14 42.7 0.12 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.756 1.622 . . . . 4.5499999999999998 114.993 -171.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 10.4 m -90.84 157.75 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.802 1.641 . . . . 1.1599999999999999 113.176 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 76.3 t -72.57 -37.99 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.755 1.622 . . . . 2.46 111.355 173.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.52 158.16 31.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.669 0.788 . . . . 3.54 111.525 169.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -96.03 140.07 31.3 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.025 0.93 . . . . 0.78000000000000003 112.179 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -136.63 165.16 26.52 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.066 1.506 . . . . 0.81999999999999995 115.066 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.33 142.93 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 126.241 1.816 . . . . 0.46999999999999997 111.119 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -136.38 70.61 60.85 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.448 1.499 . . . . 2.6200000000000001 113.236 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' PRO . . . . . 0.516 ' HB3' HD11 ' A' ' 166' ' ' ILE . 18.6 Cg_endo -69.32 114.73 3.73 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.293 2.662 . . . . 0.92000000000000004 113.714 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -89.83 174.97 7.41 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 128.299 2.64 . . . . 2.0 111.939 173.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -108.3 167.28 10.13 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.432 1.493 . . . . 2.9399999999999999 111.363 170.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.479 0.995 0 C-N-CA 123.855 0.862 . . . . 2.7400000000000002 112.951 179.362 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.474 0.773 0 CA-C-O 119.922 -0.085 . . . . 3.0499999999999998 110.997 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.5 p -125.73 -9.67 6.73 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 117.797 2.518 . . . . 1.3200000000000001 117.797 -167.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 t -147.2 156.42 42.95 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 121.432 1.923 . . . . 1.99 114.622 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.7 p -100.89 -6.28 24.88 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.759 1.624 . . . . 1.1499999999999999 115.06 -172.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.5 p -147.5 156.73 43.12 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.878 1.671 . . . . 1.8899999999999999 113.794 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.76 140.45 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 127.893 2.477 . . . . 0.42999999999999999 109.112 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 36.2 m -114.17 127.54 55.95 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.353 0.979 . . . . 0.93000000000000005 111.383 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 p -96.34 136.55 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.202 1.001 . . . . 0.78000000000000003 110.695 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -131.37 107.21 8.77 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.824 1.65 . . . . 1.72 110.576 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.54 114.5 20.98 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 120.901 -1.125 . . . . 0.97999999999999998 111.436 -170.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.1 mt -99.36 154.41 18.22 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.539 1.136 . . . . 0.53000000000000003 112.416 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.6 mt -141.03 169.52 17.46 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.331 1.852 . . . . 1.73 110.209 169.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.5 150.4 23.43 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.89 0.876 . . . . 0.68999999999999995 111.016 169.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.9 p -76.64 -21.94 54.77 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.345 0.868 . . . . 1.1299999999999999 113.345 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -137.61 34.75 2.45 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.102 1.761 . . . . 2.1299999999999999 111.762 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.69 15.79 75.82 Favored Glycine 0 CA--C 1.539 1.551 0 O-C-N 119.864 -1.772 . . . . 1.0700000000000001 115.383 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.28 26.27 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 128.936 2.894 . . . . 1.8200000000000001 115.231 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -26.09 67.82 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.133 -1.604 . . . . 0.56000000000000005 113.367 -172.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -73.69 -46.36 46.77 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.41 1.004 . . . . 1.98 112.814 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -65.94 -43.27 88.51 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.203 -0.935 . . . . 2.0800000000000001 111.117 173.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 91.9 mt -50.65 -50.13 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 118.965 0.802 . . . . 0.60999999999999999 110.721 168.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.16 -32.64 70.07 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 120.807 1.639 . . . . 0.76000000000000001 113.657 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -74.31 -32.96 63.06 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.618 0.767 . . . . 0.94999999999999996 112.68 172.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -71.24 -23.66 62.04 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.626 1.171 . . . . 1.95 112.842 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.7 mt -92.32 -35.69 13.6 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.037 1.125 . . . . 0.93000000000000005 114.037 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -67.96 -28.14 67.21 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.977 0.808 . . . . 2.48 112.975 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 t -73.92 -12.49 60.67 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.42 1.488 . . . . 1.26 113.007 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.53 175.93 36.3 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.287 1.422 . . . . 0.96999999999999997 112.518 170.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -93.39 34.46 1.16 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.091 1.356 . . . . 2.3500000000000001 111.617 169.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -75.74 17.85 0.28 Allowed 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.459 -1.401 . . . . 1.8500000000000001 114.202 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.57 -23.83 49.93 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.261 1.024 . . . . 1.01 110.11 165.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -118.73 -59.33 0.27 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.862 1.696 . . . . 0.80000000000000004 112.709 172.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.281 0.0 OUTLIER -85.19 156.1 21.15 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.403 1.631 . . . . 1.4399999999999999 115.403 -169.829 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -60.09 149.17 33.35 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.447 0.906 . . . . 2.5099999999999998 113.447 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.5 t -62.68 124.42 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 121.87 -0.519 . . . . 0.68000000000000005 110.103 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.2 -47.02 25.04 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.709 -0.495 . . . . 0.80000000000000004 114.033 -171.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.0 t -145.59 116.21 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.66 1.584 . . . . 1.8400000000000001 108.551 176.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.2 mt -74.35 146.68 84.42 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 123.921 0.889 . . . . 0.73999999999999999 111.214 171.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.79 161.97 43.88 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.737 1.624 . . . . 0.58999999999999997 112.028 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.17 -33.72 65.53 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.198 0.599 . . . . 0.91000000000000003 112.257 174.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -83.39 1.54 40.89 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.393 1.877 . . . . 1.4099999999999999 115.629 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -95.97 152.04 18.88 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.963 1.256 . . . . 0.72999999999999998 112.677 169.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -148.95 167.62 25.27 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.71 1.604 . . . . 2.1400000000000001 111.462 169.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.26 141.68 51.38 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.828 0.851 . . . . 2.6099999999999999 110.774 -175.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.5 pt -126.82 141.55 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.403 1.081 . . . . 0.67000000000000004 112.144 -176.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.06 163.9 12.9 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.678 1.191 . . . . 0.57999999999999996 112.304 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.28 14.37 58.9 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.274 1.416 . . . . 0.64000000000000001 115.314 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.3 p -97.97 144.55 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.489 1.916 . . . . 0.72999999999999998 110.256 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 7.7 tpp -104.79 140.44 38.09 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.728 1.611 . . . . 0.55000000000000004 111.891 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.576 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.4 OUTLIER -143.92 157.03 44.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.492 1.517 . . . . 1.72 111.64 174.518 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.08 144.52 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 126.565 1.946 . . . . 0.40000000000000002 109.751 -176.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -85.81 146.99 26.52 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.916 1.341 . . . . 0.44 111.392 169.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.0 p -141.83 170.73 15.16 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.271 1.828 . . . . 0.41999999999999998 111.487 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.79 170.92 9.5 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.556 1.142 . . . . 1.5 112.414 168.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.5 p -33.32 -46.06 0.17 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.55 1.94 . . . . 1.79 114.351 172.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -90.98 29.49 1.36 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.574 1.15 . . . . 1.99 112.976 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.28 25.01 8.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 127.873 2.469 . . . . 1.1499999999999999 113.414 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -86.56 136.11 33.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.957 1.303 . . . . 1.78 111.515 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.9 mt -74.27 125.85 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 118.402 0.547 . . . . 0.47999999999999998 110.253 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.474 HG22 HG22 ' A' ' 97' ' ' THR . 2.1 pp -120.37 152.15 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.289 1.436 . . . . 1.0600000000000001 114.273 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -84.07 162.28 20.39 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.621 1.969 . . . . 1.3999999999999999 111.439 168.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -70.95 10.54 0.52 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 115.948 1.833 . . . . 2.3999999999999999 115.948 -169.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -115.22 -2.75 12.62 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.956 2.503 . . . . 2.7200000000000002 113.174 168.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.47 10.71 67.5 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.795 2.141 . . . . 0.57999999999999996 115.744 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -68.73 144.23 54.45 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.843 1.321 . . . . 2.2000000000000002 108.799 167.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.474 HG22 HG22 ' A' ' 91' ' ' ILE . 34.0 p -101.25 146.27 27.75 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.938 0.895 . . . . 0.63 112.076 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.88 -9.83 27.74 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.19 1.182 . . . . 0.65000000000000002 114.19 -171.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.63 25.33 42.76 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 119.738 1.154 . . . . 0.66000000000000003 113.903 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.1 t -133.66 150.41 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.939 1.695 . . . . 1.05 109.417 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -135.59 160.78 37.42 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 129.114 2.966 . . . . 1.47 110.688 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 57.2 mt -137.85 137.29 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.761 1.225 . . . . 0.75 110.417 -173.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -70.74 140.92 86.88 Favored Pre-proline 0 N--CA 1.476 0.837 0 CA-C-O 116.882 -1.532 . . . . 2.1499999999999999 111.05 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -72.32 -27.39 16.35 Favored 'Trans proline' 0 C--N 1.351 0.705 0 CA-C-N 122.935 2.084 . . . . 0.92000000000000004 112.567 174.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -88.19 -46.38 9.31 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 125.663 1.585 . . . . 1.71 112.795 -175.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.3 p -89.24 -24.66 22.05 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.357 0.873 . . . . 1.3899999999999999 113.357 -176.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 56.42 22.77 6.74 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.108 1.363 . . . . 1.9099999999999999 113.407 -168.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.98 148.75 21.86 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.956 1.303 . . . . 2.6000000000000001 112.488 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.1 mt -82.29 145.22 30.1 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.077 1.751 . . . . 0.95999999999999996 113.42 -174.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.1 p -76.38 5.56 6.96 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.348 1.24 . . . . 1.3799999999999999 114.348 170.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 177.12 -157.64 22.69 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.535 1.064 . . . . 0.88 113.652 -171.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -86.25 149.89 24.75 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.996 1.11 . . . . 0.93999999999999995 113.996 -174.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.5 tpt -51.43 126.05 28.26 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.962 1.705 . . . . 1.46 112.607 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.42 161.42 37.56 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.852 2.368 . . . . 0.79000000000000004 113.321 -170.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.62 -87.8 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 122.265 1.031 . . . . 1.0700000000000001 111.682 172.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 78.3 p -78.04 -1.05 30.36 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 116.067 1.876 . . . . 0.79000000000000004 116.067 -167.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.59 152.68 3.51 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.828 1.418 . . . . 0.48999999999999999 114.828 -171.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.7 ttt -78.6 95.1 5.14 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.993 1.317 . . . . 1.74 111.426 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.67 155.17 44.88 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.687 1.595 . . . . 2.3900000000000001 111.458 -177.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -169.2 164.26 11.02 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.785 1.634 . . . . 2.8700000000000001 111.301 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.9 mp -106.8 150.1 26.69 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.374 1.07 . . . . 0.58999999999999997 113.577 172.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.576 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 19.6 p -77.48 135.28 38.24 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 118.839 0.745 . . . . 0.60999999999999999 110.845 170.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -96.26 -58.65 2.02 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 115.345 1.609 . . . . 2.5699999999999998 115.345 -169.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -153.61 -35.23 0.11 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.101 1.36 . . . . 1.1100000000000001 112.142 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -100.67 -38.72 8.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.242 1.017 . . . . 3.71 112.075 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.86 -160.81 30.97 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.425 1.012 . . . . 0.68999999999999995 112.446 -174.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -134.82 123.68 23.93 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.381 1.872 . . . . 0.44 112.229 170.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -81.61 133.61 35.39 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.037 0.935 . . . . 2.46 112.29 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -120.58 141.27 50.46 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 128.955 2.902 . . . . 1.9199999999999999 109.493 174.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.436 HD21 ' HB3' ' A' ' 132' ' ' ALA . 2.8 t-20 -94.29 112.74 24.56 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.337 1.055 . . . . 2.9100000000000001 111.429 -174.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.2 p -94.25 1.27 56.0 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.21 1.189 . . . . 0.72999999999999998 114.21 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.436 ' HB3' HD21 ' A' ' 130' ' ' ASN . . . -59.91 -23.37 63.44 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.012 1.116 . . . . 0.71999999999999997 114.012 -176.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.14 -6.24 13.67 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.573 1.323 . . . . 2.1200000000000001 114.573 -170.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.22 132.16 70.78 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 119.278 0.945 . . . . 0.78000000000000003 113.324 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.08 168.45 23.98 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.468 2.112 . . . . 0.82999999999999996 111.106 169.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.0 83.13 0.68 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.468 1.907 . . . . 1.53 110.921 -177.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -135.38 173.57 11.57 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.505 1.522 . . . . 1.21 110.355 173.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -93.67 140.23 29.88 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.728 1.252 . . . . 3.4399999999999999 111.17 168.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -126.24 165.97 17.96 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.514 1.925 . . . . 0.71999999999999997 109.45 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -141.3 153.45 45.19 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.644 0.777 . . . . 1.6299999999999999 111.793 175.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.08 139.33 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.623 0.769 . . . . 0.44 110.449 173.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -127.62 140.31 52.18 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.486 1.914 . . . . 1.8200000000000001 110.488 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -102.43 130.76 49.31 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.065 1.346 . . . . 1.8100000000000001 111.108 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 37.6 mm -130.57 113.74 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.748 0.819 . . . . 0.92000000000000004 109.846 -169.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -77.08 -8.44 57.47 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.198 1.185 . . . . 3.5099999999999998 114.198 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 115.149 1.537 . . . . 3.1299999999999999 115.149 -176.466 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 113.131 0.789 . . . . 1.8400000000000001 113.131 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.47 154.99 34.21 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.99 0.737 . . . . 0.82999999999999996 112.99 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.33 145.48 36.12 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.328 1.051 . . . . 0.56000000000000005 112.012 170.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.47 146.56 44.71 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.311 2.674 . . . . 0.5 113.366 -168.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.419 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.2 mp -117.1 128.93 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.359 1.863 . . . . 1.3500000000000001 108.81 -168.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -94.94 145.23 25.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.332 1.053 . . . . 2.9399999999999999 112.356 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.4 tt -150.84 157.28 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 125.625 1.57 . . . . 0.71999999999999997 110.533 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -136.56 -178.65 5.27 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.584 1.554 . . . . 2.5499999999999998 109.708 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.48 156.43 90.55 Favored Pre-proline 0 CA--C 1.552 1.051 0 O-C-N 120.811 -1.181 . . . . 2.1000000000000001 112.315 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -83.27 75.99 4.12 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.061 3.174 . . . . 1.6000000000000001 114.213 -167.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 4.5 tt -94.29 80.84 3.98 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 105.915 -1.883 . . . . 3.25 105.915 166.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -147.2 160.35 42.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.093 1.357 . . . . 3.8300000000000001 112.304 -168.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -74.37 -18.23 60.7 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.921 1.288 . . . . 3.21 113.553 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.2 m -65.83 150.72 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.887 1.675 . . . . 1.55 113.734 -173.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.13 -40.61 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.553 1.141 . . . . 2.0499999999999998 109.934 173.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -132.33 141.54 48.99 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.469 1.508 . . . . 2.8999999999999999 109.509 172.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -92.45 156.03 17.46 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.313 0.645 . . . . 0.56000000000000005 111.777 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -137.13 165.04 27.02 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.835 1.421 . . . . 0.54000000000000004 114.835 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.55 142.16 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 126.216 1.806 . . . . 0.51000000000000001 110.952 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -134.42 71.7 71.41 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 113.382 0.882 . . . . 1.9299999999999999 113.382 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' PRO . . . . . 0.419 ' HB3' HD11 ' A' ' 166' ' ' ILE . 20.5 Cg_endo -62.75 144.35 93.66 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 124.006 3.137 . . . . 0.51000000000000001 113.824 -176.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -120.25 158.01 27.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.088 2.155 . . . . 1.55 112.184 -171.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -110.56 159.13 17.82 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.355 1.074 . . . . 3.1200000000000001 113.481 175.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 CA--C 1.54 0.57 0 C-N-CA 127.66 2.384 . . . . 3.0 109.091 175.185 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.9 p . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 114.194 1.183 . . . . 1.55 114.194 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.2 p -88.73 -65.5 1.01 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.506 0.722 . . . . 1.8600000000000001 112.487 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 m -91.92 144.71 25.19 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.917 1.287 . . . . 2.3199999999999998 113.019 -169.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.5 p -101.43 -2.13 31.56 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.975 1.71 . . . . 0.81000000000000005 114.665 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.1 m -151.29 150.71 30.86 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.267 -1.52 . . . . 1.98 110.952 170.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.24 149.09 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.864 2.066 . . . . 0.41999999999999998 109.936 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.5 m -117.16 124.94 50.37 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.18 0.592 . . . . 0.68999999999999995 111.305 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.42 131.73 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.387 1.075 . . . . 0.48999999999999999 110.637 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -126.76 96.63 4.71 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.017 1.327 . . . . 1.76 110.814 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -71.48 121.53 18.81 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.723 -1.236 . . . . 1.1399999999999999 110.805 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.5 mt -109.02 159.9 16.46 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.594 1.158 . . . . 0.67000000000000004 112.187 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.4 mt -142.45 161.07 39.0 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.624 1.97 . . . . 1.8700000000000001 109.973 168.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.2 163.98 15.88 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.839 0.856 . . . . 0.92000000000000004 111.783 168.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.1 p -85.59 -32.83 21.88 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.279 -0.888 . . . . 1.22 113.275 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -146.87 55.83 1.13 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.523 1.129 . . . . 2.6499999999999999 111.05 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.62 11.36 82.98 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.728 1.632 . . . . 1.04 115.446 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -69.94 18.09 0.05 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.339 2.255 . . . . 1.8100000000000001 115.534 -172.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -61.38 -31.09 70.99 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.875 -1.14 . . . . 0.82999999999999996 112.291 -176.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -61.47 -49.89 74.96 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.593 1.157 . . . . 2.25 112.636 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -72.44 -43.14 64.21 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.058 -1.026 . . . . 2.48 111.511 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.5 mt -48.98 -48.78 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 119.491 1.041 . . . . 0.65000000000000002 110.976 169.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.19 -30.46 70.43 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.072 1.305 . . . . 0.91000000000000003 113.052 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -77.3 -31.41 54.71 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.717 0.807 . . . . 1.0800000000000001 112.631 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -69.53 -20.35 63.7 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.276 1.03 . . . . 1.9199999999999999 113.558 169.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.6 mt -96.96 -36.06 10.66 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.08 1.141 . . . . 1.0900000000000001 114.08 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -21.91 66.85 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.414 1.006 . . . . 4.3099999999999996 112.919 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.5 t -69.29 -29.75 67.69 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.277 1.031 . . . . 1.8300000000000001 113.509 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.21 165.92 26.75 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.809 1.195 . . . . 1.29 113.568 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -83.89 43.04 0.89 Allowed 'General case' 0 N--CA 1.481 1.09 0 O-C-N 121.458 -1.025 . . . . 1.98 112.748 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -80.8 1.04 32.18 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.894 1.278 . . . . 2.23 114.282 -169.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.2 -25.87 65.93 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.715 -1.241 . . . . 1.0700000000000001 112.406 169.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.74 -51.66 0.41 Allowed Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.541 1.067 . . . . 0.70999999999999996 112.503 169.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -75.82 162.93 27.74 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.056 1.132 . . . . 2.98 114.056 -171.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -63.7 156.82 25.85 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.116 0.566 . . . . 3.0 111.6 167.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.411 HG23 ' CE2' ' A' ' 181' ' ' TYR . 73.6 t -66.01 143.3 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 122.996 0.518 . . . . 0.87 110.063 170.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.32 -64.78 2.83 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 123.807 0.718 . . . . 1.1399999999999999 113.508 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.2 t -142.88 134.16 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.88 1.672 . . . . 2.8300000000000001 110.157 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.5 mt -83.35 146.82 51.65 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.538 0.735 . . . . 1.29 111.962 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.01 159.17 54.17 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.639 1.559 . . . . 1.23 111.476 172.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.51 -24.87 66.46 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.565 -1.334 . . . . 2.0299999999999998 111.147 169.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.71 4.56 6.08 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.968 1.47 . . . . 1.45 114.968 169.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.2 155.16 29.88 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.595 1.958 . . . . 0.78000000000000003 111.98 169.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.24 163.34 34.75 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.738 0.815 . . . . 1.8 113.181 167.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -107.05 137.96 44.14 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.39 1.876 . . . . 2.75 110.353 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.51 145.96 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.546 1.138 . . . . 0.85999999999999999 111.78 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.93 153.37 33.71 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.645 1.178 . . . . 0.90000000000000002 112.642 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.36 19.71 40.85 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.41 1.005 . . . . 0.60999999999999999 114.161 -170.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 p -97.79 143.64 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.042 1.337 . . . . 0.72999999999999998 108.889 168.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -105.4 142.93 34.29 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.194 1.397 . . . . 0.52000000000000002 112.667 -174.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.545 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.5 OUTLIER -148.82 152.32 36.3 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.304 1.442 . . . . 1.6899999999999999 111.716 175.654 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.23 146.57 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 127.002 2.121 . . . . 0.29999999999999999 109.313 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -88.99 143.07 27.11 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.176 0.988 . . . . 0.40999999999999998 112.502 170.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.5 p -133.96 164.15 27.95 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.451 1.901 . . . . 0.40000000000000002 112.845 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.18 169.62 11.74 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.922 1.289 . . . . 1.72 110.723 166.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.57 -21.51 66.6 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.301 1.223 . . . . 2.8100000000000001 114.301 -170.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -77.55 19.36 0.37 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.886 0.874 . . . . 1.74 112.817 168.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 56.25 29.14 14.36 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.257 1.823 . . . . 0.76000000000000001 113.117 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -90.0 140.54 29.53 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.099 1.359 . . . . 2.3700000000000001 111.39 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.1 mt -80.77 126.5 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 118.087 0.403 . . . . 0.54000000000000004 110.378 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.45 HG22 HG22 ' A' ' 97' ' ' THR . 2.2 pp -122.21 151.51 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.605 1.562 . . . . 1.2 114.134 -175.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.28 164.64 19.95 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 127.21 2.204 . . . . 2.3399999999999999 112.103 169.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.5 -17.93 48.57 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.823 1.786 . . . . 3.3500000000000001 115.823 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -92.72 4.71 53.24 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.913 1.285 . . . . 3.8300000000000001 111.557 172.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.51 10.38 85.75 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 127.294 2.378 . . . . 0.66000000000000003 115.492 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -63.88 135.89 56.93 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.236 1.018 . . . . 2.6600000000000001 108.553 169.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.45 HG22 HG22 ' A' ' 91' ' ' ILE . 51.9 p -90.79 139.88 30.31 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.111 0.482 . . . . 0.83999999999999997 111.726 178.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.18 -6.09 51.33 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.818 -1.176 . . . . 0.89000000000000001 113.913 -169.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.88 27.44 34.48 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 119.898 1.226 . . . . 1.0 113.695 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.3 t -136.9 148.93 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.267 1.427 . . . . 1.23 109.583 177.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -137.44 154.78 49.87 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 128.568 2.747 . . . . 1.28 110.745 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.434 HG12 HD23 ' A' ' 109' ' ' LEU . 33.0 mt -133.31 136.64 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.248 1.419 . . . . 0.63 110.179 -173.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -77.82 141.62 64.26 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-O 117.543 -1.217 . . . . 2.1899999999999999 111.933 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.0 -16.28 18.14 Favored 'Trans proline' 0 C--N 1.352 0.733 0 CA-C-N 122.139 1.8 . . . . 0.84999999999999998 113.416 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -101.92 -48.09 4.37 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.99 1.716 . . . . 1.3500000000000001 111.28 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 p -83.92 -28.65 27.73 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.953 0.723 . . . . 1.3999999999999999 112.953 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 56.34 23.28 7.12 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.883 1.673 . . . . 1.8500000000000001 113.484 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.85 153.67 21.14 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.528 -1.358 . . . . 2.4399999999999999 111.817 174.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.434 HD23 HG12 ' A' ' 102' ' ' ILE . 29.6 mt -92.04 139.03 31.04 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.679 1.192 . . . . 0.87 112.375 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.5 p -74.24 6.69 3.34 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.716 1.206 . . . . 1.4299999999999999 113.956 175.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.21 -158.72 20.44 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 126.446 1.974 . . . . 0.93999999999999995 111.068 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.99 155.14 32.83 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 122.065 -0.667 . . . . 1.04 112.429 175.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.8 tpt -59.48 125.28 78.99 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.877 0.871 . . . . 1.79 109.926 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -70.4 167.45 25.22 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 124.39 3.393 . . . . 0.93000000000000005 113.9 -172.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.69 -97.59 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.176 1.391 . . . . 1.6399999999999999 111.032 170.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 50.7 p -71.3 11.43 0.44 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.522 2.045 . . . . 1.01 116.522 -167.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.67 150.35 3.96 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.25 -0.906 . . . . 0.48999999999999999 112.943 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.2 tpt -78.27 88.45 4.32 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.081 2.152 . . . . 1.6599999999999999 110.713 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -147.66 135.05 20.69 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.039 1.736 . . . . 0.94999999999999996 111.32 -171.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -169.24 145.98 3.46 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.23 1.412 . . . . 3.5600000000000001 110.2 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.09 156.12 21.21 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.572 1.323 . . . . 0.5 114.572 -175.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.545 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 3.9 p -66.3 137.87 57.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 119.866 -1.771 . . . . 0.48999999999999999 110.319 169.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -98.82 -56.57 2.4 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.462 1.105 . . . . 2.6499999999999999 113.344 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -167.84 -39.95 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.598 1.959 . . . . 1.24 110.742 168.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -96.6 25.5 5.1 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.847 1.659 . . . . 5.0999999999999996 112.574 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.6 -150.94 19.74 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.033 1.778 . . . . 0.67000000000000004 111.348 -169.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.53 128.37 21.84 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.279 1.832 . . . . 0.39000000000000001 110.347 168.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -75.62 136.13 40.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.941 1.297 . . . . 1.55 110.927 172.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -128.11 117.46 21.65 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.282 1.833 . . . . 1.74 108.876 169.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -77.27 122.03 24.52 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.177 -0.952 . . . . 1.47 110.82 175.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.7 p -112.03 -4.64 14.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.934 1.294 . . . . 0.92000000000000004 114.069 -171.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.9 -15.69 5.34 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 115.918 1.822 . . . . 0.68000000000000005 115.918 -172.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -106.39 0.9 25.25 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.086 1.355 . . . . 2.7400000000000002 114.076 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.84 146.01 87.39 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 120.521 1.509 . . . . 0.83999999999999997 113.122 170.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.99 164.83 32.6 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.934 1.756 . . . . 1.1599999999999999 110.364 165.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.39 88.52 1.58 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.454 1.501 . . . . 1.47 110.3 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -139.95 -179.22 5.83 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.042 1.337 . . . . 1.1200000000000001 111.185 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -92.69 140.84 29.12 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.574 1.15 . . . . 2.25 111.813 168.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -132.55 169.93 15.9 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.988 1.715 . . . . 0.75 110.298 -169.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -152.53 147.59 26.38 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.43 1.092 . . . . 3.6299999999999999 112.264 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -105.25 136.38 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 123.797 0.839 . . . . 0.40999999999999998 109.024 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -123.44 122.41 38.19 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.376 1.47 . . . . 1.8500000000000001 110.019 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -83.36 75.75 9.96 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.993 1.317 . . . . 2.1299999999999999 111.109 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.0 mm -80.82 113.85 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.41 -0.959 . . . . 1.03 108.41 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -116.35 28.34 8.65 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.703 0.801 . . . . 5.0199999999999996 113.131 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.2 p . . . . . 0 N--CA 1.471 0.599 0 C-N-CA 124.226 1.01 . . . . 1.8400000000000001 111.572 168.544 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.428 ' HE3' HG13 ' A' ' 164' ' ' VAL . 21.9 ttpt . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 111.54 0.2 . . . . 2.5600000000000001 111.54 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.87 154.16 34.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.478 0.711 . . . . 0.98999999999999999 111.275 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.428 HG13 ' HE3' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -123.04 143.21 40.14 Favored Pre-proline 0 N--CA 1.477 0.898 0 O-C-N 121.521 -0.737 . . . . 0.84999999999999998 111.202 174.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.21 145.41 72.4 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.825 3.016 . . . . 0.56000000000000005 111.653 -168.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.461 HD11 ' HB3' ' A' ' 182' ' ' PRO . 1.3 mp -103.94 124.01 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.129 0.971 . . . . 1.3200000000000001 109.492 -171.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.87 138.05 32.44 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.84 0.746 . . . . 3.0699999999999998 112.894 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.3 tt -147.92 156.15 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.18 0.992 . . . . 0.42999999999999999 111.682 -172.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -134.46 166.55 22.6 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.099 1.76 . . . . 2.6099999999999999 109.481 169.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -61.5 155.55 58.29 Favored Pre-proline 0 CA--C 1.551 1.017 0 O-C-N 120.973 -1.079 . . . . 1.6100000000000001 111.932 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.42 94.9 0.92 Allowed 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.919 3.079 . . . . 0.87 112.111 -169.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.44 45.58 2.63 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.379 1.871 . . . . 2.3500000000000001 108.803 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -128.81 18.4 6.18 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 127.214 2.206 . . . . 3.1200000000000001 113.024 -167.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.3 t70 60.96 17.75 8.2 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 128.171 2.588 . . . . 4.0800000000000001 115.639 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.3 m -86.58 153.03 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 114.282 1.215 . . . . 1.1000000000000001 114.282 -172.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.13 -32.26 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.083 1.753 . . . . 1.74 112.095 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -153.78 141.03 19.55 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.737 1.215 . . . . 2.4300000000000002 110.19 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -101.86 140.77 35.7 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.208 0.818 . . . . 0.48999999999999999 113.208 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -136.8 166.04 24.54 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.032 1.493 . . . . 0.53000000000000003 115.032 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.76 143.55 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 127.2 2.2 . . . . 0.46999999999999997 111.485 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.411 ' CE2' HG23 ' A' ' 66' ' ' VAL . 97.7 m-85 -133.06 82.74 53.66 Favored Pre-proline 0 CA--C 1.553 1.066 0 N-CA-C 113.584 0.957 . . . . 1.9299999999999999 113.584 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' PRO . . . . . 0.461 ' HB3' HD11 ' A' ' 166' ' ' ILE . 6.6 Cg_exo -58.0 143.99 95.28 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.699 2.932 . . . . 0.60999999999999999 115.51 175.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -133.6 165.93 23.78 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 128.55 2.74 . . . . 1.5 112.623 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -119.62 173.3 7.09 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.002 2.121 . . . . 2.8799999999999999 111.154 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 117.352 2.352 . . . . 2.9300000000000002 117.352 -169.95 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.0 p . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 115.774 1.768 . . . . 1.5700000000000001 115.774 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.2 p -121.7 0.11 9.78 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.324 1.45 . . . . 1.45 114.029 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 m -156.41 158.32 37.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.976 1.711 . . . . 2.6000000000000001 110.42 -170.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 43.1 p -117.27 -11.66 10.6 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 126.425 1.89 . . . . 1.1899999999999999 115.552 -174.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 p -143.68 153.31 42.35 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.903 1.681 . . . . 2.2200000000000002 113.064 -175.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.3 p -130.93 135.2 60.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 126.426 1.891 . . . . 0.52000000000000002 109.119 174.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.8 m -114.62 126.04 54.44 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 118.254 0.479 . . . . 0.84999999999999998 110.509 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.2 p -96.89 132.38 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.225 1.01 . . . . 0.80000000000000004 110.318 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -129.59 98.31 4.8 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.584 1.554 . . . . 2.0699999999999998 109.732 -174.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.09 126.18 30.49 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.619 -1.3 . . . . 0.94999999999999996 111.842 -169.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.6 mt -103.59 151.67 22.64 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.37 1.068 . . . . 0.60999999999999999 113.322 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.53 161.63 35.33 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.567 1.547 . . . . 2.0600000000000001 109.451 169.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.553 ' HB1' ' H ' ' A' ' 48' ' ' ASP . . . -97.18 154.03 17.63 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.732 0.813 . . . . 0.66000000000000003 112.027 172.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.4 p -87.64 -20.19 26.68 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.29 1.219 . . . . 1.1000000000000001 114.29 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -151.5 51.99 0.83 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.882 1.673 . . . . 2.1699999999999999 112.455 170.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.99 23.79 70.92 Favored Glycine 0 CA--C 1.536 1.388 0 O-C-N 120.439 -1.413 . . . . 1.1100000000000001 115.989 172.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.553 ' H ' ' HB1' ' A' ' 44' ' ' ALA . 4.2 m-20 -81.1 10.95 4.54 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 128.213 2.605 . . . . 1.8600000000000001 115.622 -174.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -57.81 -31.25 66.41 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.37 -1.456 . . . . 0.82999999999999996 112.629 -171.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.42 -49.75 52.17 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.788 1.235 . . . . 2.3100000000000001 113.465 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -69.7 -33.06 72.01 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 120.968 -1.082 . . . . 3.1800000000000002 111.495 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.42 -52.67 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.502 1.121 . . . . 0.78000000000000003 110.095 168.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.86 -34.99 70.34 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.127 0.876 . . . . 0.84999999999999998 112.484 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -67.62 -32.47 73.21 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.405 0.891 . . . . 0.95999999999999996 113.405 173.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.99 -28.24 65.36 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.063 1.301 . . . . 1.98 113.017 171.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.4 mt -87.2 -40.95 14.11 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.673 0.99 . . . . 1.01 113.673 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -67.41 -21.21 65.59 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.437 0.903 . . . . 2.8500000000000001 113.437 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.4 t -75.79 -25.69 56.62 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 121.393 -0.817 . . . . 1.54 112.88 169.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.46 161.19 32.3 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 126.141 1.829 . . . . 1.0600000000000001 113.918 174.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -84.27 33.47 0.5 Allowed 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.945 -1.326 . . . . 2.3100000000000001 113.78 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -72.1 8.44 1.28 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.595 1.702 . . . . 2.2999999999999998 115.595 -169.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.1 -30.17 71.09 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.219 -0.925 . . . . 1.04 109.881 165.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.25 -83.74 1.75 Allowed Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.067 1.318 . . . . 0.79000000000000004 112.476 171.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -65.99 151.8 46.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.608 1.336 . . . . 1.5700000000000001 114.608 -173.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -59.16 143.37 49.06 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.075 1.35 . . . . 4.0300000000000002 111.3 172.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.8 t -53.89 136.24 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.343 0.657 . . . . 1.03 111.181 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.7 -64.42 3.32 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.682 0.658 . . . . 0.91000000000000003 112.515 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.4 t -137.52 125.86 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.581 1.152 . . . . 1.9299999999999999 110.623 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.8 mt -80.73 143.78 54.95 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.316 0.647 . . . . 0.85999999999999999 110.896 172.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.91 162.18 42.7 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.141 1.894 . . . . 0.68999999999999995 112.158 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.63 -21.63 66.47 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.646 0.98 . . . . 0.93000000000000005 113.646 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -92.55 -1.48 56.9 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 115.082 1.512 . . . . 1.53 115.082 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.41 152.41 21.5 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.853 0.861 . . . . 0.80000000000000004 113.147 169.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.7 pttt -146.43 167.73 22.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.577 1.551 . . . . 1.95 111.77 168.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -118.4 143.44 46.66 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.864 1.666 . . . . 2.3999999999999999 109.931 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.1 pt -126.93 142.91 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 114.468 1.285 . . . . 0.71999999999999997 114.468 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.66 153.22 20.34 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.823 1.649 . . . . 0.67000000000000004 112.316 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.63 7.07 61.93 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.964 1.745 . . . . 0.65000000000000002 115.28 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.0 p -90.42 143.75 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 118.547 1.173 . . . . 0.80000000000000004 110.112 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 1.3 tpp -111.67 132.85 54.31 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.105 1.762 . . . . 0.62 112.016 -172.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.55 153.06 48.69 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.39 1.476 . . . . 1.73 111.53 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.81 143.19 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 126.346 1.859 . . . . 0.41999999999999998 109.514 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -84.78 145.99 27.6 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 122.817 1.294 . . . . 0.34999999999999998 111.244 169.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.3 p -140.27 170.69 15.35 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.29 1.836 . . . . 0.33000000000000002 111.527 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.75 173.23 9.59 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.525 0.73 . . . . 2.0099999999999998 112.926 169.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.7 p -64.1 -16.91 62.82 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 120.744 -1.223 . . . . 1.4199999999999999 113.513 170.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 -80.96 8.1 9.18 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.418 1.487 . . . . 2.73 113.014 168.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.52 25.54 9.89 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.129 2.172 . . . . 0.71999999999999997 113.28 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -89.29 141.46 28.52 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.633 1.573 . . . . 2.52 110.612 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.423 HD11 ' CD2' ' A' ' 109' ' ' LEU . 10.8 mt -76.66 126.98 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.416 -0.587 . . . . 0.5 109.416 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.459 HG22 HG22 ' A' ' 97' ' ' THR . 3.2 pt -122.07 154.38 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 114.637 1.347 . . . . 0.5 114.637 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.29 163.32 24.04 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.168 2.187 . . . . 1.74 111.336 167.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.74 -1.18 3.53 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 115.499 1.666 . . . . 2.3300000000000001 115.499 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -105.14 -1.57 25.34 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.907 1.683 . . . . 3.96 113.218 169.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.16 -0.68 64.21 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.436 1.969 . . . . 0.66000000000000003 115.853 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -69.66 139.18 53.48 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 119.185 1.492 . . . . 2.3199999999999998 110.893 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.459 HG22 HG22 ' A' ' 91' ' ' ILE . 5.5 p -99.21 141.26 32.21 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.732 0.813 . . . . 0.77000000000000002 112.402 -172.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.23 -8.0 46.62 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.475 1.287 . . . . 0.80000000000000004 114.475 -168.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.5 24.0 57.32 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.052 0.842 . . . . 0.81999999999999995 113.661 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.95 147.08 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.214 1.406 . . . . 1.1699999999999999 109.311 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -133.67 158.22 43.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.839 1.656 . . . . 1.29 111.656 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 60.0 mt -133.19 141.04 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.912 1.285 . . . . 0.62 110.684 -170.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -81.98 145.91 54.37 Favored Pre-proline 0 N--CA 1.477 0.91 0 O-C-N 120.862 -1.149 . . . . 1.8100000000000001 112.659 174.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.68 -19.38 12.84 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 CA-C-N 122.139 1.8 . . . . 0.85999999999999999 113.243 175.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -97.93 -47.74 5.43 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.821 1.649 . . . . 1.4199999999999999 112.47 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.8 p -80.49 -29.18 37.35 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.286 0.635 . . . . 0.92000000000000004 111.879 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 57.74 16.34 3.46 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.531 1.532 . . . . 1.9299999999999999 113.539 -170.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.79 149.23 21.41 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.742 1.217 . . . . 2.6499999999999999 111.718 -175.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.423 ' CD2' HD11 ' A' ' 90' ' ' ILE . 8.2 mt -84.17 138.64 32.89 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.932 1.293 . . . . 0.93999999999999995 111.955 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.1 t -87.02 20.24 2.75 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.685 0.994 . . . . 2.8399999999999999 113.685 172.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -177.42 174.07 46.67 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 126.882 2.182 . . . . 1.21 111.905 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.6 162.78 28.84 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.306 0.854 . . . . 1.01 113.306 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 mmt -51.91 132.45 39.01 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.712 1.205 . . . . 1.6299999999999999 113.074 -175.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -78.59 155.67 27.85 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.323 3.349 . . . . 1.0700000000000001 113.682 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.15 -35.92 23.26 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.893 1.812 . . . . 1.5800000000000001 115.893 -176.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.2 p -131.46 10.22 4.79 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.832 1.653 . . . . 0.90000000000000002 113.035 -168.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.85 152.29 16.22 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.689 1.366 . . . . 0.54000000000000004 114.689 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.1 ttt -80.19 85.31 5.74 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.85 1.66 . . . . 1.8899999999999999 111.712 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -135.45 153.85 51.63 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.005 1.722 . . . . 1.23 112.456 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -164.02 158.34 19.4 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.124 1.77 . . . . 1.8700000000000001 110.747 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 mp -98.28 147.29 24.79 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.31 1.044 . . . . 0.57999999999999996 112.469 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.2 p -65.1 125.68 25.72 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 120.329 1.422 . . . . 0.64000000000000001 109.822 169.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.52 -52.02 7.24 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.372 1.619 . . . . 2.02 115.372 -169.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.78 -46.07 0.1 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.784 1.634 . . . . 1.3700000000000001 109.075 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -116.01 -17.03 11.02 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.524 1.305 . . . . 4.0899999999999999 114.524 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 172.57 -169.5 42.62 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.093 1.33 . . . . 0.65000000000000002 112.593 -172.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.52 126.82 18.64 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.281 1.832 . . . . 0.45000000000000001 112.413 170.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -80.19 136.7 36.54 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.873 1.269 . . . . 1.25 112.388 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -127.52 142.38 51.4 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.321 2.649 . . . . 2.0699999999999998 108.671 171.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.46 HD21 ' HB3' ' A' ' 132' ' ' ALA . 2.2 t-20 -105.91 111.97 24.84 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.93 0.892 . . . . 2.1400000000000001 110.619 -175.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.0 p -94.15 -8.41 39.53 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.314 1.228 . . . . 0.80000000000000004 114.314 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.46 ' HB3' HD21 ' A' ' 130' ' ' ASN . . . -54.23 -14.85 1.26 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.885 1.674 . . . . 0.96999999999999997 115.357 -176.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.92 -21.71 13.09 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.556 1.542 . . . . 2.6200000000000001 112.866 -176.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -72.21 144.57 87.33 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 119.779 1.172 . . . . 0.77000000000000002 112.523 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.94 168.16 25.45 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.84 2.36 . . . . 0.73999999999999999 111.99 172.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -72.35 76.38 1.01 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.625 1.97 . . . . 1.0700000000000001 111.818 -176.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -142.03 -173.54 3.84 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.115 1.366 . . . . 0.78000000000000003 111.305 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -104.66 154.7 19.63 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.233 1.413 . . . . 3.0099999999999998 112.201 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -145.3 169.8 17.55 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 127.456 2.302 . . . . 0.58999999999999997 110.178 -173.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -137.97 154.66 49.34 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.866 1.061 . . . . 1.6699999999999999 113.866 175.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.6 mp -113.58 136.9 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.566 1.146 . . . . 0.45000000000000001 110.763 174.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -125.9 149.65 48.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.746 2.018 . . . . 1.8400000000000001 110.558 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -112.05 120.16 40.89 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.581 1.152 . . . . 1.8899999999999999 110.72 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 22.9 mm -129.07 113.96 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.352 1.061 . . . . 0.58999999999999997 109.421 -169.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -98.91 15.32 25.98 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.687 1.195 . . . . 5.3200000000000003 113.544 -174.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 82.5 p . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 114.253 1.205 . . . . 2.1099999999999999 114.253 -176.484 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 112.436 0.532 . . . . 3.3700000000000001 112.436 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.07 155.45 40.29 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.091 0.775 . . . . 1.48 113.091 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.74 150.78 37.34 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 124.469 1.108 . . . . 0.60999999999999999 110.018 167.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.6 140.51 32.89 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.894 2.396 . . . . 0.80000000000000004 113.244 -168.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.9 mp -111.23 139.27 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.146 1.779 . . . . 1.3899999999999999 109.874 -173.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -107.45 141.32 39.04 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.914 1.079 . . . . 2.7599999999999998 113.914 173.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.8 tt -145.38 155.37 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 125.326 1.45 . . . . 0.56999999999999995 111.779 -170.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -134.89 160.21 38.98 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.669 1.988 . . . . 1.99 110.382 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.95 144.54 81.85 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.347 -0.846 . . . . 2.0600000000000001 112.573 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.4 113.57 3.52 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.148 2.565 . . . . 0.82999999999999996 113.793 -169.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 4.2 tt -126.18 79.05 1.81 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 105.388 -2.079 . . . . 3.5099999999999998 105.388 166.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -149.79 156.07 41.2 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.085 2.154 . . . . 3.4900000000000002 109.686 -169.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -80.54 33.47 0.31 Allowed 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.787 -1.196 . . . . 4.0800000000000001 113.94 -177.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 32.9 m -110.25 169.18 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.216 1.406 . . . . 2.0699999999999998 112.481 -173.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 61.4 t -101.93 -29.06 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.651 1.181 . . . . 2.77 110.384 171.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.49 140.79 41.39 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.266 1.426 . . . . 3.2599999999999998 111.434 173.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -91.31 152.88 20.29 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.848 0.859 . . . . 0.47999999999999998 110.626 173.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -138.87 153.13 48.28 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.337 0.865 . . . . 0.96999999999999997 113.337 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.38 140.57 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.106 1.762 . . . . 0.72999999999999998 111.002 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -128.97 74.11 81.31 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.735 0.814 . . . . 2.2400000000000002 112.907 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.61 150.05 44.77 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.141 3.227 . . . . 0.88 113.818 -175.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -132.01 165.01 24.93 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.48 2.312 . . . . 1.5 113.014 -169.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -108.67 161.0 15.5 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.415 1.486 . . . . 3.0499999999999998 113.613 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.469 0.475 0 C-N-CA 126.075 1.75 . . . . 3.1499999999999999 108.613 167.202 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.5 p . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 113.678 0.992 . . . . 1.1499999999999999 113.678 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.4 p -89.9 -20.4 23.43 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 115.014 1.487 . . . . 1.71 115.014 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.6 t -154.51 156.07 36.0 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.376 1.47 . . . . 2.2400000000000002 110.775 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.4 p -80.67 -4.56 54.73 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.497 1.666 . . . . 1.3700000000000001 115.497 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.9 p -149.69 161.87 41.35 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.596 1.702 . . . . 1.7 115.596 -170.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.6 p -128.4 143.65 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 127.043 2.137 . . . . 0.44 110.003 173.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.0 m -113.89 118.39 34.06 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.223 1.009 . . . . 0.70999999999999996 109.073 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 p -94.49 130.93 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 122.061 0.934 . . . . 0.65000000000000002 109.289 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -108.56 -179.47 3.88 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.174 1.79 . . . . 1.9199999999999999 109.424 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.53 122.3 9.29 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 120.168 -1.583 . . . . 1.3200000000000001 111.656 169.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.6 mt -111.63 151.21 29.07 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.249 1.02 . . . . 0.56999999999999995 112.688 -171.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.78 159.85 38.56 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.163 1.785 . . . . 1.9199999999999999 110.917 175.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.61 165.27 11.32 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.513 1.125 . . . . 0.77000000000000002 112.358 173.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.6 p -97.84 -17.12 19.49 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.874 1.435 . . . . 1.3999999999999999 114.874 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -152.04 49.05 0.78 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.903 1.681 . . . . 2.8199999999999998 110.572 169.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.29 11.28 85.11 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 116.497 1.359 . . . . 1.04 116.497 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.56 16.02 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 128.674 2.789 . . . . 2.3100000000000001 116.749 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -19.92 60.2 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.572 -1.33 . . . . 0.77000000000000002 112.926 -176.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -82.3 -47.65 12.13 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.409 1.483 . . . . 2.8700000000000001 113.167 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -65.25 -41.3 94.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.7 1.136 . . . . 2.79 111.099 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.8 mt -52.05 -52.96 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 119.56 1.073 . . . . 0.58999999999999997 110.282 168.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.8 -30.88 62.07 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 120.676 1.58 . . . . 0.81000000000000005 113.618 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -77.49 -37.22 51.68 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.504 0.927 . . . . 1.1799999999999999 113.504 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -63.85 -22.68 67.03 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.856 0.863 . . . . 1.95 112.631 169.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.7 mt -88.79 -44.86 10.21 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.337 0.865 . . . . 0.94999999999999996 113.337 173.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -69.57 -15.08 63.15 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.851 1.205 . . . . 2.6499999999999999 114.092 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.7 t -75.19 -28.36 59.99 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.515 1.126 . . . . 1.3500000000000001 112.242 169.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.73 166.98 38.05 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.944 1.259 . . . . 1.03 112.786 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -85.76 35.73 0.63 Allowed 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.947 -1.325 . . . . 1.6799999999999999 111.743 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -75.64 4.77 7.11 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.938 1.088 . . . . 1.9399999999999999 113.938 -171.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.72 -30.87 71.04 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.517 1.127 . . . . 1.0700000000000001 110.003 164.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.32 -76.56 0.75 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.358 1.456 . . . . 0.68000000000000005 112.51 171.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.254 0.0 OUTLIER -71.01 154.74 41.56 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.212 1.56 . . . . 1.5600000000000001 115.212 -169.547 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.56 151.05 29.74 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.949 0.9 . . . . 4.8099999999999996 112.522 -177.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.412 HG23 ' CE2' ' A' ' 181' ' ' TYR . 73.6 t -60.36 123.3 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 109.751 -0.463 . . . . 0.91000000000000003 109.751 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.84 -53.45 40.77 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.262 0.458 . . . . 1.26 113.823 -170.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.8 t -150.5 127.73 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.942 1.697 . . . . 2.9100000000000001 108.408 171.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.8 mt -75.99 152.55 84.53 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.343 1.057 . . . . 1.1899999999999999 112.808 173.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.35 162.72 41.48 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.396 2.064 . . . . 0.64000000000000001 112.071 175.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.4 -30.9 69.89 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.373 -0.829 . . . . 0.90000000000000002 111.916 170.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.29 5.66 8.16 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 115.68 1.733 . . . . 1.3600000000000001 115.68 173.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.84 157.02 21.9 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.433 1.493 . . . . 0.53000000000000003 113.435 170.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -148.02 169.55 19.68 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.427 1.491 . . . . 1.8799999999999999 111.736 169.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -121.11 139.12 53.76 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.798 1.239 . . . . 1.9099999999999999 110.288 -173.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.3 pt -127.98 142.36 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 121.421 -0.799 . . . . 0.76000000000000001 112.272 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.98 145.25 43.77 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.012 1.325 . . . . 0.67000000000000004 111.699 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.16 23.98 6.16 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.225 1.393 . . . . 0.80000000000000004 114.969 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.3 p -109.78 142.86 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 127.373 2.269 . . . . 0.82999999999999996 110.337 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.0 tpp -98.78 143.79 28.73 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.36 1.464 . . . . 0.70999999999999996 113.415 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -148.09 151.94 36.5 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.672 1.589 . . . . 1.7 111.512 174.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 m -125.29 144.9 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.166 1.786 . . . . 0.53000000000000003 110.153 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -86.04 149.06 25.43 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.69 1.233 . . . . 0.40999999999999998 112.477 170.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.0 p -144.45 170.92 15.11 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.737 2.015 . . . . 0.53000000000000003 111.661 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.66 177.52 5.99 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.208 1.003 . . . . 2.2200000000000002 113.121 169.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 42.3 p -59.96 -29.8 68.66 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.84 0.856 . . . . 1.6000000000000001 113.225 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -78.06 13.74 1.35 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.896 1.279 . . . . 2.0800000000000001 113.823 173.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.7 28.19 15.44 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.332 1.853 . . . . 0.93000000000000005 112.044 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -88.62 138.58 31.29 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.086 1.754 . . . . 2.1000000000000001 110.466 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -78.2 127.22 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.818 -0.438 . . . . 0.68000000000000005 109.818 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.469 HG22 HG22 ' A' ' 97' ' ' THR . 3.0 pt -120.69 157.31 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.812 1.245 . . . . 0.67000000000000004 114.109 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -86.16 163.92 17.54 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.409 1.884 . . . . 1.8500000000000001 110.473 166.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -61.42 -12.72 15.65 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.981 1.474 . . . . 2.29 114.981 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -94.71 0.25 54.86 Favored 'General case' 0 CA--C 1.55 0.947 0 O-C-N 120.656 -1.277 . . . . 3.8900000000000001 112.165 172.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.18 7.47 86.81 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 126.092 1.806 . . . . 0.59999999999999998 115.293 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -64.55 131.17 46.29 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.599 1.2 . . . . 2.5899999999999999 107.974 168.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.469 HG22 HG22 ' A' ' 91' ' ' ILE . 5.9 p -89.95 145.94 24.75 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.66 0.664 . . . . 0.70999999999999996 110.605 175.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.94 -6.07 49.37 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.177 0.806 . . . . 0.88 113.177 -169.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.71 32.43 57.25 Favored Glycine 0 CA--C 1.531 1.073 0 O-C-N 121.399 -0.813 . . . . 1.01 112.468 -173.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.1 t -135.7 148.53 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.797 1.639 . . . . 1.3799999999999999 109.805 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -135.97 154.69 51.01 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.473 2.309 . . . . 1.6499999999999999 111.079 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 54.8 mt -132.77 134.9 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.99 1.316 . . . . 0.91000000000000003 112.248 -171.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -69.25 135.12 89.05 Favored Pre-proline 0 CA--C 1.546 0.804 0 O-C-N 120.635 -1.291 . . . . 2.1299999999999999 111.166 170.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.65 -17.71 25.99 Favored 'Trans proline' 0 C--N 1.35 0.617 0 CA-C-N 122.548 1.946 . . . . 0.98999999999999999 113.657 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -96.08 -43.66 7.67 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.009 1.723 . . . . 1.8999999999999999 112.555 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.3 p -94.24 -22.55 18.34 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.5 1.12 . . . . 1.1299999999999999 113.948 -174.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 53.95 20.41 2.39 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 125.421 1.488 . . . . 2.46 113.975 -169.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.73 144.77 31.94 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.404 -1.435 . . . . 3.0299999999999998 111.511 176.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 mt -90.42 148.24 22.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.899 1.68 . . . . 1.1599999999999999 112.073 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.2 p -74.28 9.75 1.54 Allowed 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.152 1.167 . . . . 1.6499999999999999 114.152 170.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.32 -160.47 24.63 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 126.081 1.801 . . . . 1.0700000000000001 113.034 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.89 160.91 21.02 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.808 1.243 . . . . 0.98999999999999999 112.101 172.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -52.27 130.92 42.59 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.378 1.071 . . . . 1.8 113.484 -174.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -68.94 152.35 73.49 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.975 3.117 . . . . 1.03 114.368 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.31 -64.27 0.89 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.763 1.225 . . . . 1.05 113.653 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.7 p -101.61 7.78 42.03 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.173 1.546 . . . . 0.79000000000000004 115.173 -168.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.78 146.67 13.22 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.205 1.187 . . . . 0.52000000000000002 114.205 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.6 ttt -77.06 89.36 3.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.942 1.697 . . . . 2.1000000000000001 111.513 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -143.87 145.16 32.11 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.894 1.678 . . . . 1.0800000000000001 112.244 -174.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -164.85 159.88 18.86 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.89 1.676 . . . . 1.9099999999999999 111.046 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.38 146.97 26.89 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.815 1.246 . . . . 0.85999999999999999 113.365 174.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.2 p -65.05 125.82 26.13 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.533 -0.73 . . . . 0.67000000000000004 110.814 172.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -87.94 -57.53 2.9 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.471 1.286 . . . . 2.7000000000000002 114.471 -172.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -151.11 -41.25 0.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.02 0.928 . . . . 1.1499999999999999 111.654 -172.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -118.62 -22.44 7.49 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.83 1.252 . . . . 4.4000000000000004 113.503 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 171.52 -160.0 31.84 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 126.079 1.799 . . . . 0.75 111.326 -175.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -139.9 132.94 29.51 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.657 1.983 . . . . 0.53000000000000003 111.272 169.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -87.32 139.91 30.08 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.299 1.44 . . . . 1.6899999999999999 113.72 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -132.32 129.79 39.95 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.538 2.735 . . . . 1.77 108.594 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -92.55 120.78 33.34 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.515 -0.741 . . . . 1.74 110.092 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.6 p -103.42 -2.0 27.63 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.398 1.479 . . . . 0.67000000000000004 113.367 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -52.68 -29.25 25.49 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.872 1.269 . . . . 0.68999999999999995 113.521 173.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -97.42 -15.54 20.6 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.113 1.765 . . . . 1.8899999999999999 114.437 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.52 154.8 81.55 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 119.623 1.101 . . . . 0.72999999999999998 113.064 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -82.72 170.2 12.93 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.303 2.669 . . . . 0.72999999999999998 110.419 165.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.94 98.85 3.67 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.752 1.221 . . . . 0.96999999999999997 109.956 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -153.29 179.08 9.08 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.025 0.93 . . . . 0.66000000000000003 111.878 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -91.12 150.88 21.21 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.091 1.356 . . . . 2.5099999999999998 111.211 168.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -146.13 170.7 16.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.28 1.832 . . . . 0.56999999999999995 110.056 -173.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -140.64 154.63 46.5 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.043 0.937 . . . . 1.8200000000000001 113.043 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.9 mp -114.94 141.52 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.907 1.283 . . . . 0.69999999999999996 110.768 172.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -126.9 117.97 23.63 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.075 2.15 . . . . 1.8999999999999999 110.571 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -82.53 75.4 9.44 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.251 1.02 . . . . 1.79 111.398 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 40.7 mm -71.54 114.26 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 123.232 0.613 . . . . 1.2 109.383 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.36 -5.84 59.28 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.995 1.48 . . . . 3.9199999999999999 114.995 -169.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.476 0.836 0 C-N-CA 125.536 1.535 . . . . 1.6799999999999999 114.054 -177.135 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 111.828 0.307 . . . . 2.3900000000000001 111.828 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.6 147.32 35.71 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.103 0.561 . . . . 0.87 111.212 168.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.7 m -110.86 151.93 43.24 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.761 1.224 . . . . 0.94999999999999996 110.002 172.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.71 161.22 46.81 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.52 2.147 . . . . 0.81000000000000005 113.378 -170.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.3 mp -124.87 128.66 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.783 1.233 . . . . 1.6699999999999999 110.522 -169.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -96.0 138.29 33.83 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.244 1.018 . . . . 2.98 112.955 172.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.4 tt -143.43 151.2 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.376 1.47 . . . . 0.51000000000000001 111.863 -172.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -130.03 149.87 51.56 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.756 1.622 . . . . 2.0800000000000001 109.373 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 15.2 mt -65.71 154.68 88.12 Favored Pre-proline 0 N--CA 1.478 0.95 0 N-CA-C 115.008 1.484 . . . . 0.96999999999999997 115.008 -168.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.8 102.85 1.25 Allowed 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 123.296 2.664 . . . . 0.77000000000000002 114.437 -168.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 16.1 mt -137.39 21.08 2.95 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.262 2.625 . . . . 2.6699999999999999 110.86 170.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -85.78 19.72 2.41 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.958 1.703 . . . . 3.3999999999999999 113.106 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 21.1 t70 61.72 25.72 15.54 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.674 2.39 . . . . 3.5899999999999999 114.367 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 16.5 m -99.1 144.48 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.979 1.312 . . . . 1.0700000000000001 113.093 -174.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 57.6 t -70.78 -34.61 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.705 0.802 . . . . 1.49 111.511 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -140.59 142.34 35.1 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.177 1.391 . . . . 2.6800000000000002 111.807 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -107.38 141.67 38.4 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.411 1.085 . . . . 0.52000000000000002 112.661 -174.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -140.59 166.74 23.92 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.595 1.702 . . . . 0.70999999999999996 115.595 -175.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.91 139.77 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.421 1.888 . . . . 0.66000000000000003 111.56 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.412 ' CE2' HG23 ' A' ' 66' ' ' VAL . 80.6 m-85 -133.33 74.38 72.21 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.723 1.209 . . . . 2.0699999999999998 113.373 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.81 152.13 77.77 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 124.976 3.784 . . . . 0.59999999999999998 113.622 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -133.19 -156.94 0.78 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.389 2.676 . . . . 2.1099999999999999 111.008 -167.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -144.15 163.59 33.16 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.41 1.484 . . . . 2.8900000000000001 112.08 168.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 4.6 t . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 114.45 1.278 . . . . 2.48 114.45 -176.536 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.5 p . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 114.467 1.284 . . . . 1.3100000000000001 114.467 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.3 p -93.22 -14.55 26.94 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.755 0.822 . . . . 1.5900000000000001 112.89 169.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.541 HG22 ' H ' ' A' ' 36' ' ' SER . 9.3 m -146.38 148.26 32.15 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.201 2.2 . . . . 2.5899999999999999 109.708 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 p -111.45 16.65 20.67 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.964 1.706 . . . . 1.6599999999999999 113.937 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.541 ' H ' HG22 ' A' ' 34' ' ' THR . 29.0 m -147.6 159.75 43.42 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.347 1.459 . . . . 1.6000000000000001 111.736 170.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -136.04 144.12 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.615 1.966 . . . . 0.33000000000000002 110.209 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.0 m -120.75 125.8 48.54 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.564 0.746 . . . . 0.65000000000000002 111.512 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p -100.28 138.15 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.571 1.148 . . . . 0.64000000000000001 111.183 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -136.21 113.71 10.88 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.364 1.465 . . . . 1.75 113.091 -171.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -81.79 127.43 32.96 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.043 -1.661 . . . . 1.28 113.069 -174.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.9 mt -114.25 155.36 26.29 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.552 1.541 . . . . 0.54000000000000004 112.767 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.5 mt -141.19 173.14 11.77 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.409 1.884 . . . . 1.6599999999999999 110.265 168.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.96 172.56 6.95 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.501 1.121 . . . . 0.92000000000000004 112.032 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.4 p -95.91 -31.75 12.96 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.042 0.756 . . . . 1.21 113.042 170.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -143.02 52.03 1.39 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.656 1.582 . . . . 2.6099999999999999 111.414 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.22 16.36 77.0 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 124.602 1.096 . . . . 0.97999999999999998 115.52 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.75 12.97 0.16 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.118 2.167 . . . . 2.1600000000000001 115.302 -174.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -61.53 -29.27 69.89 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 120.567 -1.333 . . . . 0.63 112.27 -173.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -75.9 -40.46 54.31 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.643 1.177 . . . . 2.2599999999999998 113.247 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -72.66 -38.64 67.58 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-O 117.945 -1.026 . . . . 2.2200000000000002 111.782 170.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 71.8 mt -53.23 -50.98 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.396 1.078 . . . . 0.59999999999999998 110.28 167.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.32 -31.11 68.86 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.731 1.151 . . . . 0.78000000000000003 112.571 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -77.81 -26.9 49.87 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.124 1.157 . . . . 1.26 114.124 171.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -71.21 -30.77 66.79 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.754 -1.216 . . . . 1.99 111.929 168.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.2 mt -90.63 -40.26 12.01 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.727 1.38 . . . . 0.82999999999999996 114.727 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -67.27 -25.18 65.94 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 120.123 1.329 . . . . 2.9100000000000001 112.714 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.7 t -80.2 -3.28 48.42 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.215 1.806 . . . . 1.7 112.961 173.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.34 160.88 14.9 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 126.321 1.915 . . . . 0.93000000000000005 112.164 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -79.29 35.56 0.27 Allowed 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.111 -1.229 . . . . 1.6499999999999999 113.153 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -78.45 7.7 6.24 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.447 1.099 . . . . 2.1200000000000001 113.599 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.54 -31.38 67.88 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.115 1.366 . . . . 1.3100000000000001 110.488 165.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.34 -48.34 0.15 Allowed Glycine 0 C--N 1.344 1.005 0 CA-C-O 119.748 -0.473 . . . . 0.94999999999999996 114.007 171.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -67.91 145.83 54.2 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.636 0.718 . . . . 2.77 111.648 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -68.34 149.09 49.83 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.04 0.836 . . . . 3.0600000000000001 112.144 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 69.5 t -59.81 126.28 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 122.832 0.453 . . . . 0.77000000000000002 111.313 -173.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.19 -50.71 31.71 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.107 1.337 . . . . 0.91000000000000003 113.924 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 98.3 t -142.73 120.12 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.097 1.359 . . . . 1.77 110.198 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.4 mt -82.91 141.92 44.4 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.26 0.624 . . . . 0.82999999999999996 110.137 168.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.8 161.24 42.92 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 121.381 1.388 . . . . 0.57999999999999996 112.36 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.56 -26.87 65.74 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.358 -0.839 . . . . 0.83999999999999997 112.233 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.77 5.39 40.27 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.948 1.699 . . . . 1.49 115.292 174.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.16 152.75 21.07 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.739 1.215 . . . . 0.65000000000000002 111.189 168.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -142.73 164.47 30.01 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.093 1.357 . . . . 2.5800000000000001 111.74 174.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -125.35 134.7 52.1 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.984 1.313 . . . . 2.2599999999999998 110.534 -169.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.8 pt -136.33 151.41 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.833 1.253 . . . . 0.79000000000000004 111.832 -176.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -119.86 174.04 6.69 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.44 1.496 . . . . 0.75 111.964 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.24 12.96 64.61 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.504 1.526 . . . . 0.51000000000000001 115.532 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.9 p -96.71 146.06 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.174 1.39 . . . . 0.66000000000000003 111.336 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 15.1 tpp -101.9 138.69 38.54 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.056 2.142 . . . . 1.0900000000000001 112.223 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.552 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.8 OUTLIER -145.73 152.78 40.13 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.565 1.546 . . . . 1.73 111.919 177.345 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.45 145.76 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 126.802 2.041 . . . . 0.29999999999999999 110.494 -174.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -87.8 146.26 25.71 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 122.552 1.168 . . . . 0.34999999999999998 113.084 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.8 p -143.26 167.87 21.13 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.104 1.761 . . . . 0.33000000000000002 112.793 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -92.0 175.3 6.92 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.201 1.001 . . . . 2.2200000000000002 112.328 168.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.8 p -67.94 -20.27 65.05 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.382 -1.449 . . . . 1.4399999999999999 113.657 -174.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -80.65 14.07 2.27 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.505 1.122 . . . . 1.73 111.976 167.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.41 31.85 19.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.944 2.497 . . . . 0.57999999999999996 113.213 175.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -87.23 138.96 31.04 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.322 1.049 . . . . 2.3399999999999999 110.489 176.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.9 mt -76.53 124.06 34.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.788 -0.819 . . . . 0.41999999999999998 108.788 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.489 HG22 HG22 ' A' ' 97' ' ' THR . 6.1 pt -118.86 154.69 21.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 123.169 1.461 . . . . 0.58999999999999997 113.432 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.56 160.12 19.72 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.298 2.239 . . . . 2.6800000000000002 108.041 166.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.54 -13.25 28.72 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.949 1.463 . . . . 2.1000000000000001 114.949 -169.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -93.87 2.55 56.14 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.711 1.204 . . . . 3.46 111.668 176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.39 3.27 81.84 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.701 1.619 . . . . 0.56000000000000005 114.69 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -68.93 142.76 54.63 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 123.98 0.912 . . . . 2.4900000000000002 109.676 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.489 HG22 HG22 ' A' ' 91' ' ' ILE . 30.4 p -102.58 145.35 29.75 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.161 0.984 . . . . 0.68999999999999995 111.553 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -97.95 -4.5 36.22 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.907 1.077 . . . . 0.65000000000000002 113.907 -170.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.0 25.3 45.5 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.029 0.824 . . . . 0.68999999999999995 113.412 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 p -141.06 152.31 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.07 1.348 . . . . 2.3999999999999999 109.687 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -138.21 155.47 48.63 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 128.471 2.709 . . . . 1.3400000000000001 110.193 -169.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 47.3 mt -136.36 131.23 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.3 1.44 . . . . 0.56000000000000005 110.668 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -75.25 138.83 71.79 Favored Pre-proline 0 N--CA 1.476 0.844 0 O-C-N 121.124 -0.985 . . . . 2.2599999999999998 110.759 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.03 -24.07 28.84 Favored 'Trans proline' 0 C--N 1.35 0.648 0 CA-C-N 121.737 1.656 . . . . 0.78000000000000003 112.743 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -90.18 -47.6 7.7 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.255 1.422 . . . . 1.3500000000000001 111.73 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.4 p -84.23 -27.37 28.0 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.524 0.73 . . . . 1.1299999999999999 112.961 -174.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 54.99 25.39 6.83 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.07 1.348 . . . . 1.8100000000000001 113.041 -172.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.83 153.79 19.5 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.164 1.385 . . . . 2.4500000000000002 111.616 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 18.0 mt -92.52 140.67 29.32 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.186 1.794 . . . . 0.70999999999999996 112.918 -172.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.9 p -71.49 -3.01 18.77 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.989 1.316 . . . . 1.24 114.492 172.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.14 -162.01 16.54 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 126.599 2.047 . . . . 0.81000000000000005 111.379 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.67 167.91 20.81 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.696 1.199 . . . . 0.94999999999999996 112.829 173.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.7 mmt -57.34 143.23 74.34 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.868 1.267 . . . . 1.3100000000000001 113.586 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -79.61 165.98 22.24 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.867 3.711 . . . . 0.77000000000000002 114.045 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.86 -48.62 9.16 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.344 1.609 . . . . 1.3100000000000001 115.344 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.4 p -130.38 13.89 5.55 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.243 1.417 . . . . 0.94999999999999996 113.807 -169.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.22 148.11 6.85 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.479 0.918 . . . . 0.40000000000000002 113.479 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 7.2 ttt -74.02 106.32 5.66 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 126.867 2.067 . . . . 1.8100000000000001 110.237 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.5 pttp -158.86 151.49 21.84 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.387 1.475 . . . . 0.93000000000000005 112.16 -172.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -161.98 171.74 17.12 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.682 1.193 . . . . 1.6599999999999999 110.919 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.5 mp -113.01 144.42 42.62 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.874 1.269 . . . . 0.41999999999999998 112.038 170.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.552 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 21.5 p -73.27 133.88 44.07 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.037 0.835 . . . . 0.56000000000000005 111.295 173.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -94.77 -52.88 4.08 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.02 1.489 . . . . 2.23 115.02 -171.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -175.07 -32.1 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 128.176 2.59 . . . . 1.4399999999999999 110.881 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -116.5 24.38 11.37 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.889 2.076 . . . . 4.4500000000000002 112.181 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.55 -158.76 22.21 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.788 1.661 . . . . 0.56000000000000005 113.794 -173.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -136.66 132.39 34.91 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.983 2.113 . . . . 0.35999999999999999 111.834 169.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -91.27 134.06 34.89 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.097 1.359 . . . . 1.26 113.534 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -127.31 119.09 25.48 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.46 2.704 . . . . 1.6499999999999999 108.21 176.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -84.12 124.48 31.17 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.153 -0.967 . . . . 1.9099999999999999 109.765 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 47.5 p -108.94 5.56 24.45 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.828 1.651 . . . . 0.56999999999999995 113.589 -170.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.17 -27.46 54.45 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.829 0.852 . . . . 0.80000000000000004 112.968 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -89.52 -13.46 37.33 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.911 1.284 . . . . 1.72 113.074 -173.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -83.53 145.3 47.62 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 114.02 1.119 . . . . 0.64000000000000001 114.02 175.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.33 166.96 21.92 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.406 2.071 . . . . 0.77000000000000002 110.968 165.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.39 82.95 3.13 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.458 1.903 . . . . 1.1100000000000001 111.598 -174.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -138.63 -177.27 4.79 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.676 1.191 . . . . 0.79000000000000004 111.625 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -93.18 151.49 19.8 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.712 0.768 . . . . 3.96 111.201 167.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -142.0 169.13 18.17 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.024 2.13 . . . . 0.56000000000000005 109.647 -173.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -139.41 145.31 38.76 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.16 0.984 . . . . 1.75 112.001 174.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -102.82 138.1 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.152 0.981 . . . . 0.37 109.572 171.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -121.69 133.88 54.96 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.893 1.677 . . . . 1.8600000000000001 110.24 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -99.83 124.65 45.34 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.459 1.104 . . . . 1.8999999999999999 110.185 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 15.6 mm -132.35 110.55 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.044 0.937 . . . . 0.67000000000000004 110.281 -169.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -73.2 -11.15 60.42 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 120.408 -1.432 . . . . 3.5 114.158 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 CA--C 1.541 0.619 0 N-CA-C 115.644 1.72 . . . . 1.95 115.644 -169.805 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 121.499 0.666 . . . . 2.4100000000000001 111.149 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.87 139.15 42.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.109 0.964 . . . . 0.90000000000000002 110.672 171.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.9 m -99.78 145.97 31.06 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 123.883 0.873 . . . . 0.88 110.312 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.63 132.98 21.31 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.553 2.169 . . . . 0.69999999999999996 111.943 -169.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.403 ' H ' HD12 ' A' ' 166' ' ' ILE . 2.1 mp -95.95 115.62 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 124.559 1.143 . . . . 1.3600000000000001 108.415 -171.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -84.82 142.36 29.82 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.022 0.374 . . . . 3.0899999999999999 111.628 172.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.4 tt -146.36 150.02 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.926 1.29 . . . . 0.48999999999999999 110.648 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -122.05 157.23 31.86 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.341 1.457 . . . . 2.1200000000000001 109.862 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.31 143.93 92.27 Favored Pre-proline 0 CA--C 1.545 0.77 0 O-C-N 120.905 -1.122 . . . . 1.6699999999999999 111.64 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.27 110.75 1.63 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.662 2.908 . . . . 0.83999999999999997 112.221 -169.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 20.0 tp -143.0 56.57 1.4 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.468 1.907 . . . . 2.71 109.589 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -144.95 23.31 1.54 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.472 1.509 . . . . 3.2599999999999998 112.594 -169.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 54.03 32.39 15.45 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 127.124 2.169 . . . . 4.1699999999999999 114.113 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.3 m -91.57 147.26 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.52 1.128 . . . . 0.91000000000000003 110.127 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.84 -39.73 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.402 0.681 . . . . 1.48 110.025 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -128.13 137.26 52.03 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.905 1.682 . . . . 3.0099999999999998 109.921 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -96.29 144.75 26.18 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.667 0.787 . . . . 0.35999999999999999 111.82 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -137.99 171.5 14.33 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.991 1.478 . . . . 0.56999999999999995 114.991 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -139.4 142.7 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 127.204 2.202 . . . . 0.54000000000000004 110.669 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -130.31 74.66 80.13 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 113.742 1.015 . . . . 2.0499999999999998 113.742 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.63 148.91 90.51 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 124.367 3.378 . . . . 0.79000000000000004 112.972 175.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -136.69 -155.86 0.65 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.932 2.093 . . . . 2.1299999999999999 109.876 -168.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -134.74 164.32 27.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.518 1.527 . . . . 3.96 109.096 166.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 113.361 0.875 . . . . 2.5 113.361 169.628 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 115.676 1.732 . . . . 1.72 115.676 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.6 p -85.57 -23.68 27.54 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 114.412 1.264 . . . . 1.8600000000000001 114.412 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.7 t -132.59 158.28 42.61 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 128.442 2.697 . . . . 2.48 109.126 172.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.423 ' HB ' ' HB2' ' A' ' 132' ' ' ALA . 15.6 p -110.47 8.09 22.96 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.408 1.483 . . . . 0.93000000000000005 113.595 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.2 m -137.52 163.47 31.08 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.938 1.295 . . . . 1.8400000000000001 111.11 168.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.14 140.43 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.291 1.836 . . . . 0.39000000000000001 109.457 173.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.6 m -115.95 121.32 41.95 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.236 0.615 . . . . 0.64000000000000001 111.388 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -99.55 137.49 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.929 1.292 . . . . 0.57999999999999996 111.364 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -134.54 112.27 10.74 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.335 1.454 . . . . 1.6899999999999999 111.372 -174.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.73 126.86 35.52 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 120.541 -1.349 . . . . 1.02 112.468 -171.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.7 mt -116.28 150.88 36.89 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.048 1.339 . . . . 0.56999999999999995 112.855 -171.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.0 mt -140.97 178.93 7.02 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.849 2.059 . . . . 1.46 110.081 168.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.07 160.93 18.36 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.901 1.28 . . . . 0.72999999999999998 112.44 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -89.14 -21.21 23.45 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 114.863 1.431 . . . . 1.05 114.863 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -129.23 28.67 5.23 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.31 1.444 . . . . 2.4500000000000002 111.132 168.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.71 15.31 80.76 Favored Glycine 0 CA--C 1.538 1.501 0 O-C-N 120.456 -1.402 . . . . 0.90000000000000002 114.792 -177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.56 28.6 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 129.744 3.218 . . . . 1.98 117.069 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -18.56 65.15 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.07 -1.643 . . . . 0.64000000000000001 113.56 -172.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -81.89 -45.34 15.6 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.393 0.997 . . . . 2.23 112.678 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -66.28 -43.6 85.95 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.549 1.068 . . . . 2.48 111.167 172.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.2 mt -50.14 -49.34 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.106 0.962 . . . . 0.67000000000000004 110.997 169.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.62 70.86 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 120.043 1.292 . . . . 0.84999999999999998 113.479 178.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -74.75 -31.05 61.68 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.217 -0.927 . . . . 1.03 113.21 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -65.54 -18.21 65.15 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.26 -0.9 . . . . 2.0600000000000001 112.514 169.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.4 mt -95.43 -36.81 11.2 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 114.453 1.279 . . . . 1.29 114.453 176.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -64.85 -19.81 66.08 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.836 1.198 . . . . 2.8500000000000001 113.759 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.5 t -72.22 -19.52 61.71 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.687 1.365 . . . . 1.3700000000000001 114.687 170.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.41 179.22 33.27 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.878 1.704 . . . . 1.54 114.801 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -102.64 36.17 2.26 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.852 1.261 . . . . 3.1299999999999999 111.21 174.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.402 ' CE1' ' HA ' ' A' ' 66' ' ' VAL . 15.6 m-85 -74.11 3.98 6.24 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 115.18 1.548 . . . . 2.2000000000000002 115.18 -168.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.58 -19.95 63.66 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 121.283 -0.886 . . . . 1.26 112.08 168.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.6 -65.86 0.37 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.139 1.352 . . . . 0.95999999999999996 112.288 169.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.283 0.0 OUTLIER -76.89 155.37 32.91 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.831 1.419 . . . . 1.72 114.831 -173.032 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -56.98 154.08 10.19 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.327 0.651 . . . . 2.5299999999999998 112.505 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.402 ' HA ' ' CE1' ' A' ' 61' ' ' TYR . 55.9 t -64.49 129.73 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 109.835 -0.432 . . . . 1.02 109.835 171.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.47 -55.09 16.42 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 122.932 0.301 . . . . 1.05 112.853 -176.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.0 t -141.66 121.89 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.029 0.932 . . . . 1.75 109.855 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.0 mt -78.63 137.35 58.83 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-O 118.919 -0.562 . . . . 1.1899999999999999 109.528 168.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.56 166.36 29.62 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.859 2.373 . . . . 0.59999999999999998 112.712 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -51.59 -41.95 61.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.263 0.625 . . . . 0.95999999999999996 112.547 172.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -76.21 -3.07 34.37 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.894 2.078 . . . . 1.4399999999999999 115.657 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.05 153.7 18.55 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.563 1.074 . . . . 0.56000000000000005 113.344 172.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.6 pttt -144.7 167.01 23.58 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.883 1.673 . . . . 2.2200000000000002 111.824 171.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -122.02 151.7 40.55 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.275 1.43 . . . . 2.1000000000000001 110.061 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.7 pt -139.97 137.65 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.356 0.662 . . . . 0.90000000000000002 111.528 171.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -112.68 161.39 16.91 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.592 1.557 . . . . 0.73999999999999999 112.276 173.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.71 29.19 36.13 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.136 1.351 . . . . 0.66000000000000003 113.423 -170.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 p -107.95 141.93 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.618 1.967 . . . . 0.69999999999999996 109.195 169.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -104.98 137.47 42.68 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.695 1.598 . . . . 0.51000000000000001 112.354 -173.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.559 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.7 OUTLIER -143.52 152.86 41.97 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.545 1.138 . . . . 2.02 111.784 177.678 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.13 144.85 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.968 2.107 . . . . 0.31 109.612 -174.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -85.9 147.64 26.17 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 122.886 1.326 . . . . 0.38 112.462 169.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.6 p -142.32 171.23 14.34 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.783 2.033 . . . . 0.31 111.747 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.16 -178.92 4.63 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.048 1.129 . . . . 2.0800000000000001 114.048 171.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.9 p -59.16 -28.08 66.26 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.899 1.074 . . . . 1.6100000000000001 113.899 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -85.54 16.73 3.64 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.48 1.112 . . . . 1.76 113.12 173.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 58.76 24.89 12.79 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.07 2.148 . . . . 0.65000000000000002 112.901 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -88.03 137.03 32.69 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.845 1.258 . . . . 2.23 110.747 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.4 mt -72.26 124.19 28.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.358 -0.608 . . . . 0.42999999999999999 109.358 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.509 HG22 HG22 ' A' ' 97' ' ' THR . 3.2 pt -113.21 152.15 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 125.543 1.537 . . . . 0.56999999999999995 115.109 175.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -81.21 160.66 24.25 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.647 2.379 . . . . 1.3799999999999999 108.944 165.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -62.48 -15.46 50.12 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.754 -1.216 . . . . 1.95 114.043 -176.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -89.19 3.45 51.88 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.173 1.389 . . . . 3.6299999999999999 112.675 174.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.47 0.07 89.32 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 126.494 1.997 . . . . 0.62 115.24 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -68.08 136.74 54.24 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.76 1.224 . . . . 2.2599999999999998 109.984 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.509 HG22 HG22 ' A' ' 91' ' ' ILE . 2.2 p -98.33 145.68 26.44 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.456 0.702 . . . . 0.83999999999999997 111.225 -175.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -94.5 -7.64 40.7 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.428 1.27 . . . . 0.73999999999999999 114.428 -168.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.14 30.16 47.62 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 118.935 0.789 . . . . 0.71999999999999997 113.797 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.8 t -140.22 145.2 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.677 1.591 . . . . 1.24 109.235 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -125.86 162.84 24.25 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.439 2.696 . . . . 1.49 111.015 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.6 mt -135.24 135.35 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.597 1.159 . . . . 0.63 110.947 -173.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.45 143.74 90.8 Favored Pre-proline 0 N--CA 1.477 0.904 0 CA-C-O 117.424 -1.274 . . . . 2.25 111.225 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.84 -20.76 10.17 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 122.325 1.866 . . . . 0.91000000000000003 112.944 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.7 mm100 -88.97 -47.01 8.43 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.089 0.955 . . . . 1.3200000000000001 112.315 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.5 p -92.8 -28.5 16.52 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.41 1.084 . . . . 0.85999999999999999 113.242 -172.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 57.25 19.01 4.6 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.407 1.483 . . . . 2.1899999999999999 113.677 -167.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 146.63 49.73 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.018 -1.676 . . . . 3.3700000000000001 110.376 172.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.3 mt -86.68 138.88 31.3 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.338 1.055 . . . . 0.76000000000000001 111.314 176.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.1 p -71.49 0.23 8.89 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.132 1.16 . . . . 1.4099999999999999 114.132 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -171.93 -156.54 12.3 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 127.367 2.413 . . . . 1.1699999999999999 111.5 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.32 171.83 12.97 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.86 1.059 . . . . 1.3999999999999999 113.86 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.4 tpt -66.41 136.72 95.13 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.985 0.914 . . . . 1.8700000000000001 109.629 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.39 164.99 25.94 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.793 2.329 . . . . 0.87 113.329 -174.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.8 -77.23 0.26 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.592 1.157 . . . . 1.1399999999999999 112.346 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 69.3 p -83.07 5.83 21.05 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.656 2.095 . . . . 1.24 116.656 -167.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.67 143.0 43.14 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.203 1.557 . . . . 0.44 115.203 -171.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.6 ttt -74.34 102.27 4.33 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.626 1.97 . . . . 1.8 111.036 177.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -153.64 146.8 24.66 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.955 1.302 . . . . 0.93000000000000005 112.368 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -161.01 157.5 26.37 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.798 1.239 . . . . 1.9299999999999999 110.613 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 mp -91.91 144.59 25.32 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.048 0.939 . . . . 0.63 112.677 168.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.559 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 2.0 p -65.01 131.43 46.57 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.754 -0.591 . . . . 0.51000000000000001 109.43 169.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -85.83 -56.25 3.57 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.361 0.875 . . . . 2.5099999999999998 113.361 -173.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -159.79 -45.79 0.05 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.251 1.421 . . . . 1.05 110.122 169.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -89.35 -18.81 26.16 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.273 1.029 . . . . 4.79 113.191 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 153.43 -159.55 28.68 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.879 2.181 . . . . 0.58999999999999997 110.718 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.412 ' HB2' ' HA ' ' A' ' 122' ' ' THR . . . -142.81 132.12 23.42 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.907 2.083 . . . . 0.35999999999999999 110.237 168.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -93.34 143.45 26.26 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.605 0.965 . . . . 1.73 113.605 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -128.75 121.96 29.57 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 127.276 2.23 . . . . 1.96 107.274 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -83.33 106.34 15.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 118.433 0.56 . . . . 1.6699999999999999 109.768 -173.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.1 p -84.28 -5.12 59.22 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.831 1.048 . . . . 0.72999999999999998 113.831 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.423 ' HB2' ' HB ' ' A' ' 35' ' ' THR . . . -55.1 -20.08 9.03 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.894 1.442 . . . . 1.0700000000000001 114.894 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -96.17 -15.11 22.28 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.091 1.356 . . . . 1.8600000000000001 113.635 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -80.64 151.62 71.6 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 119.908 1.231 . . . . 0.93999999999999995 113.427 176.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.88 170.38 9.95 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.597 2.865 . . . . 1.02 111.208 166.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.42 98.07 1.74 Allowed 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.59 1.156 . . . . 1.1899999999999999 109.414 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -153.12 177.54 10.7 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.631 1.173 . . . . 0.84999999999999998 111.78 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -90.49 151.34 21.41 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.38 1.072 . . . . 2.6099999999999999 112.663 168.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -144.69 174.4 11.01 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.84 2.056 . . . . 0.66000000000000003 110.892 -174.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -142.7 160.67 39.86 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.805 1.242 . . . . 1.5800000000000001 113.177 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.8 145.77 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.375 1.47 . . . . 0.42999999999999999 110.921 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -131.45 140.52 49.61 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.245 1.818 . . . . 1.8700000000000001 110.964 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -97.66 108.66 21.42 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.391 1.077 . . . . 2.1099999999999999 111.062 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.0 mm -117.34 113.61 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.181 0.993 . . . . 0.77000000000000002 109.836 -173.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -91.36 -5.79 53.97 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.059 1.133 . . . . 5.2800000000000002 114.059 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 86.9 p . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 115.148 1.536 . . . . 2.1899999999999999 115.148 -175.033 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 109.602 -0.518 . . . . 1.8100000000000001 109.602 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.18 147.86 47.89 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.309 0.644 . . . . 0.88 110.657 171.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.7 146.23 41.11 Favored Pre-proline 0 N--CA 1.473 0.677 0 C-N-CA 123.783 0.833 . . . . 0.59999999999999998 109.734 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.17 152.76 45.61 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.845 2.363 . . . . 0.48999999999999999 112.796 -167.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.656 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.6 mp -107.33 132.2 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.984 1.314 . . . . 1.28 109.233 -171.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -97.94 140.16 32.7 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.873 0.76 . . . . 4.21 111.279 169.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.8 tt -147.42 150.56 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.217 1.007 . . . . 0.46999999999999997 112.396 -171.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -127.33 158.27 37.69 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.418 1.887 . . . . 2.0600000000000001 109.121 169.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.22 159.79 84.46 Favored Pre-proline 0 CA--C 1.554 1.104 0 N-CA-C 113.913 1.079 . . . . 1.1299999999999999 113.913 -173.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -79.4 80.36 3.1 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.372 2.715 . . . . 1.22 113.298 -169.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 48.9 mt -107.02 46.79 0.91 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.043 2.137 . . . . 3.2799999999999998 108.938 169.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -123.36 175.37 6.76 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 128.199 2.6 . . . . 3.1800000000000002 109.653 -172.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -74.78 12.7 0.77 Allowed 'General case' 0 CA--C 1.557 1.222 0 O-C-N 120.035 -1.666 . . . . 3.5499999999999998 114.699 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.3 m -89.51 152.82 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.073 1.749 . . . . 1.05 113.661 -168.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.17 -30.17 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.668 1.187 . . . . 1.6799999999999999 111.964 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.03 156.22 42.39 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.688 0.795 . . . . 2.98 111.302 169.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -102.72 141.61 35.24 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.554 1.141 . . . . 0.40999999999999998 111.878 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -136.64 167.96 20.41 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.496 1.295 . . . . 0.58999999999999997 114.496 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -138.29 142.82 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.234 1.414 . . . . 0.54000000000000004 111.901 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -130.77 84.07 59.69 Favored Pre-proline 0 N--CA 1.465 0.304 0 C-N-CA 125.484 1.514 . . . . 2.3999999999999999 111.553 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' PRO . . . . . 0.656 ' HB3' HD11 ' A' ' 166' ' ' ILE . 18.8 Cg_endo -72.82 133.2 19.71 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.25 2.633 . . . . 0.81999999999999995 110.177 167.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.7 167.46 21.09 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.697 1.999 . . . . 2.29 110.969 175.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -95.8 178.61 5.39 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.855 1.262 . . . . 2.9100000000000001 110.861 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 115.421 1.637 . . . . 2.8700000000000001 115.421 175.998 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.5 p . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 120.304 0.097 . . . . 1.0700000000000001 111.04 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.6 t -101.47 -16.98 16.65 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.351 0.871 . . . . 2.46 113.351 170.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.3 m -141.97 137.5 31.26 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.971 1.309 . . . . 2.5499999999999998 112.394 -171.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.4 p -83.56 -18.3 38.8 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.804 1.779 . . . . 0.97999999999999998 115.804 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.7 p -145.65 155.64 43.14 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.505 1.502 . . . . 1.46 113.834 174.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.5 p -113.21 140.99 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 127.335 2.254 . . . . 0.34000000000000002 109.98 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.9 m -107.94 116.45 31.98 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.383 0.673 . . . . 0.78000000000000003 109.601 173.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 p -92.38 124.6 44.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 123.947 0.899 . . . . 0.59999999999999998 109.18 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -102.78 176.78 5.05 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.084 1.754 . . . . 1.78 109.608 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.67 120.74 12.13 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 120.292 -1.505 . . . . 1.03 112.383 168.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.0 mt -106.62 159.45 16.19 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.749 1.22 . . . . 0.90000000000000002 111.958 -173.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.97 168.13 21.62 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.969 1.308 . . . . 2.1899999999999999 109.972 169.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.07 156.97 19.01 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.191 0.996 . . . . 1.3899999999999999 111.532 171.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.1 p -81.88 -32.6 30.93 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.323 -0.861 . . . . 2.0899999999999999 113.194 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -138.19 34.92 2.32 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.607 1.563 . . . . 3.6200000000000001 111.367 -174.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.35 11.35 82.26 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 125.209 1.385 . . . . 1.8200000000000001 116.538 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.08 31.48 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 129.485 3.114 . . . . 2.3500000000000001 116.514 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -31.86 72.92 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.405 -1.434 . . . . 1.1200000000000001 113.395 -175.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.86 -52.04 65.76 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.395 0.998 . . . . 2.71 113.678 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -67.69 -39.59 84.43 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 118.366 -0.826 . . . . 3.0099999999999998 111.432 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.1 mt -55.84 -49.98 71.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 119.075 0.852 . . . . 0.90000000000000002 110.599 171.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.39 -34.85 77.52 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.862 1.21 . . . . 1.28 113.057 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -74.06 -27.29 60.84 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.217 0.821 . . . . 1.49 113.217 172.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -73.13 -22.45 60.53 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.026 -1.046 . . . . 2.1499999999999999 113.109 169.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.6 mt -94.24 -39.78 10.35 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.1 1.148 . . . . 1.49 114.1 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -65.59 -22.01 66.64 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.054 0.843 . . . . 3.73 112.685 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 t -75.87 -26.58 57.22 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.126 0.97 . . . . 2.0899999999999999 113.181 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.04 164.71 46.49 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.571 1.081 . . . . 1.6299999999999999 113.512 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.42 35.07 0.49 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.17 1.388 . . . . 3.3399999999999999 112.81 169.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -76.61 1.5 16.7 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.183 1.179 . . . . 2.1699999999999999 114.183 -169.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.55 -23.9 67.58 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.04 -1.037 . . . . 1.49 111.036 166.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.13 -82.3 1.48 Allowed Glycine 0 CA--C 1.535 1.329 0 C-N-CA 123.829 0.728 . . . . 0.91000000000000003 112.448 168.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -73.02 154.06 40.64 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 116.435 2.013 . . . . 1.5700000000000001 116.435 -169.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -60.78 146.72 45.09 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.384 1.474 . . . . 2.4300000000000002 112.461 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.404 HG23 ' CE2' ' A' ' 181' ' ' TYR . 47.7 t -58.02 133.34 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.799 1.24 . . . . 1.26 111.848 -172.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.08 -52.71 45.65 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 123.117 0.389 . . . . 1.51 113.978 -175.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.1 t -149.44 134.36 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 127.648 2.379 . . . . 2.0 109.175 176.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.15 144.04 40.53 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 125.753 1.621 . . . . 1.1899999999999999 111.119 169.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.02 158.24 49.87 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.337 2.025 . . . . 0.87 111.371 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.72 -23.67 67.32 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.197 -0.939 . . . . 1.2 112.562 172.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -80.89 1.9 28.87 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.799 1.407 . . . . 1.52 114.799 172.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.81 159.42 15.07 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.841 1.256 . . . . 0.94999999999999996 113.567 170.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -150.59 169.76 20.76 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.098 1.759 . . . . 2.1699999999999999 111.446 167.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -124.4 135.58 53.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.367 1.067 . . . . 2.2000000000000002 111.155 -168.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.1 pt -135.35 151.91 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.798 1.239 . . . . 0.82999999999999996 112.65 -175.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.21 -179.24 4.63 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.339 1.456 . . . . 0.75 113.027 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.23 10.78 81.89 Favored Glycine 0 N--CA 1.476 1.301 0 O-C-N 121.37 -0.831 . . . . 0.62 115.164 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.3 p -101.14 144.66 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.569 1.948 . . . . 0.69999999999999996 110.042 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 2.9 tpp -101.57 138.74 38.16 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.305 1.442 . . . . 0.57999999999999996 112.166 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.494 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.6 OUTLIER -141.22 149.88 41.96 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.611 1.165 . . . . 1.6100000000000001 111.365 173.451 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.1 m -120.43 149.57 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.924 2.09 . . . . 0.42999999999999999 109.328 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -94.42 148.01 22.66 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 122.433 1.111 . . . . 0.5 112.217 171.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.4 p -143.56 166.99 23.3 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.482 1.513 . . . . 0.38 112.551 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -85.19 172.58 11.07 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.598 -0.689 . . . . 1.96 111.308 166.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.0 p -58.2 -30.45 66.46 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.056 0.943 . . . . 1.45 113.518 -172.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -87.43 29.24 0.88 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.659 1.183 . . . . 2.77 113.86 171.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 57.12 28.77 15.48 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.782 2.033 . . . . 1.1699999999999999 113.476 169.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -84.4 135.12 34.41 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.489 1.116 . . . . 2.0 110.941 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.2 mt -77.2 126.01 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.563 -0.532 . . . . 0.54000000000000004 109.563 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.424 HG22 HG22 ' A' ' 97' ' ' THR . 6.6 pt -122.53 157.63 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 114.766 1.395 . . . . 0.67000000000000004 114.766 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -88.08 164.66 15.62 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.594 1.958 . . . . 1.53 110.494 167.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.49 -1.55 6.85 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.942 1.83 . . . . 2.3399999999999999 115.942 -169.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -105.29 -1.64 24.98 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.072 1.749 . . . . 2.6600000000000001 113.489 169.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.96 8.24 59.24 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 125.234 1.397 . . . . 0.73999999999999999 116.443 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -70.07 127.55 33.23 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.733 1.213 . . . . 3.7999999999999998 110.333 171.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.424 HG22 HG22 ' A' ' 91' ' ' ILE . 1.0 OUTLIER -95.0 128.77 42.08 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.458 0.703 . . . . 1.1100000000000001 111.984 -178.128 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.64 -6.04 50.39 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 114.11 1.152 . . . . 0.91000000000000003 114.11 -167.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.7 15.95 62.58 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.601 1.572 . . . . 0.79000000000000004 114.027 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.4 t -122.05 146.93 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.501 1.52 . . . . 1.3799999999999999 109.335 -176.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -136.05 159.61 41.17 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.407 1.883 . . . . 1.3300000000000001 111.363 -175.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 48.4 mt -137.03 143.37 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 125.668 1.587 . . . . 0.75 110.311 -171.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -78.97 147.35 69.93 Favored Pre-proline 0 N--CA 1.479 1.009 0 O-C-N 120.026 -1.671 . . . . 1.8300000000000001 111.933 173.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.28 -20.0 11.5 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 CA-C-N 122.468 1.917 . . . . 0.94999999999999996 113.683 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -98.4 -37.76 9.48 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.64 1.976 . . . . 1.6200000000000001 113.317 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.2 p -95.3 -26.74 15.8 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.03 0.932 . . . . 1.04 112.76 -178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 54.82 19.47 2.6 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.901 1.28 . . . . 1.6399999999999999 113.245 -169.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.11 148.18 24.58 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.085 1.354 . . . . 2.7400000000000002 111.072 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 mt -85.94 147.29 26.31 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.558 1.543 . . . . 0.75 112.733 -173.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 96.7 p -66.41 -16.66 64.27 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.599 0.963 . . . . 1.55 113.599 172.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.98 -150.44 6.42 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 126.426 1.965 . . . . 0.88 112.36 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.37 167.69 21.27 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.078 1.14 . . . . 1.05 114.078 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.4 mmt -55.92 136.92 72.89 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.626 1.171 . . . . 1.6200000000000001 112.717 171.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -80.84 164.52 20.34 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.837 3.025 . . . . 0.80000000000000004 112.906 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.11 -90.39 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.022 0.929 . . . . 1.3600000000000001 111.246 169.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.5 p -77.65 15.27 0.85 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 116.514 2.042 . . . . 0.91000000000000003 116.514 -167.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.7 146.06 32.23 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.527 1.131 . . . . 0.57999999999999996 113.802 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.1 tpt -73.75 102.11 3.9 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.571 2.349 . . . . 1.46 110.636 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.3 pttp -156.04 149.59 24.85 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.575 1.55 . . . . 1.0900000000000001 112.305 -173.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -165.83 160.54 17.1 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.761 1.624 . . . . 2.6099999999999999 110.105 169.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.7 mp -91.71 146.9 23.4 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.411 1.084 . . . . 0.5 112.062 170.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.494 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 1.2 p -65.67 133.71 51.7 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 119.289 0.95 . . . . 0.5 109.751 169.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -84.72 -70.56 0.57 Allowed 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 113.951 1.093 . . . . 2.48 113.951 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.47 -39.85 0.43 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.526 1.131 . . . . 1.0600000000000001 111.447 173.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -99.54 -29.45 12.7 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.613 0.968 . . . . 4.4500000000000002 113.613 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.483 ' HA2' HG22 ' A' ' 122' ' ' THR . . . 168.76 -164.37 38.0 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.595 1.093 . . . . 0.68999999999999995 111.678 -170.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -139.98 131.79 27.5 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.464 1.906 . . . . 0.5 111.453 169.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -80.42 135.53 36.17 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.771 1.228 . . . . 1.29 112.453 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -126.79 123.15 36.72 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.747 2.019 . . . . 1.8300000000000001 108.406 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -71.37 130.15 40.62 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 121.166 -0.959 . . . . 2.0099999999999998 110.951 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 34.1 p -116.79 5.91 13.13 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.742 1.617 . . . . 0.89000000000000001 113.402 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.17 -20.56 64.26 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.196 1.398 . . . . 0.89000000000000001 114.19 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -111.99 -14.08 13.51 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.523 1.129 . . . . 2.4900000000000002 113.216 -171.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.3 142.62 84.73 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 119.083 0.856 . . . . 0.95999999999999996 112.258 171.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.85 163.66 28.48 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.442 2.095 . . . . 1.1699999999999999 111.37 167.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.13 53.87 0.13 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 128.79 2.836 . . . . 2.3300000000000001 115.969 -169.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -116.71 -179.65 3.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.862 2.065 . . . . 0.95999999999999996 112.829 -170.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -90.22 148.38 22.96 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.733 1.213 . . . . 3.1299999999999999 112.123 169.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -143.84 172.65 12.56 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.268 2.627 . . . . 0.63 109.998 -174.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -141.5 149.94 41.56 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.069 0.948 . . . . 1.77 112.947 173.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.15 139.06 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.307 1.043 . . . . 0.46000000000000002 110.351 172.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -125.11 129.92 51.18 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.157 1.783 . . . . 1.8400000000000001 110.285 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -92.87 118.93 31.67 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.474 1.11 . . . . 2.0800000000000001 110.261 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 47.1 mm -116.28 110.74 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 118.708 0.685 . . . . 0.67000000000000004 109.629 -171.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -79.4 -15.35 57.99 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.567 0.951 . . . . 3.98 113.567 -169.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 115.265 1.58 . . . . 1.74 115.265 -178.015 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 111.803 0.297 . . . . 2.3399999999999999 111.803 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -94.3 156.51 16.48 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.084 1.142 . . . . 0.93999999999999995 114.084 173.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.91 150.86 51.63 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 126.47 1.908 . . . . 0.92000000000000004 110.501 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.2 145.38 38.9 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.452 2.101 . . . . 0.63 113.737 -167.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.7 mp -113.35 125.12 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.695 1.198 . . . . 1.47 110.105 -171.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -86.1 139.77 30.82 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.678 1.191 . . . . 2.8100000000000001 111.475 174.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.1 tt -146.87 146.99 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.633 1.173 . . . . 0.56000000000000005 112.104 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -118.6 154.42 32.66 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.209 1.403 . . . . 2.0 109.041 168.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.0 mt -61.61 154.66 64.36 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 114.157 1.169 . . . . 0.93999999999999995 114.157 -175.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.86 103.55 0.88 Allowed 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.035 2.49 . . . . 0.76000000000000001 110.957 -173.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.1 mt -139.27 42.37 2.06 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.717 2.407 . . . . 3.2200000000000002 109.084 174.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -117.51 12.91 14.28 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 128.636 2.774 . . . . 3.5299999999999998 111.698 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 18.3 t0 57.2 28.51 15.19 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.558 2.343 . . . . 4.6100000000000003 114.74 -174.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.3 m -81.49 150.58 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.626 0.77 . . . . 1.1299999999999999 112.734 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.83 -38.47 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.554 1.142 . . . . 1.5 110.701 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -147.23 142.81 27.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.54 1.536 . . . . 2.4300000000000002 110.084 -175.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -105.71 141.48 37.08 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.246 1.018 . . . . 0.51000000000000001 111.92 -173.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -139.18 165.96 25.79 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.974 1.472 . . . . 0.54000000000000004 114.974 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.1 t -135.9 139.11 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 125.677 1.591 . . . . 0.51000000000000001 111.957 176.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.404 ' CE2' HG23 ' A' ' 66' ' ' VAL . 99.1 m-85 -131.66 78.87 69.92 Favored Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 124.927 1.291 . . . . 2.0099999999999998 112.241 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.79 149.18 87.01 Favored 'Trans proline' 0 C--N 1.349 0.57 1 C-N-CA 125.387 4.058 . . . . 0.52000000000000002 114.013 176.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -131.62 167.41 19.49 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.893 2.077 . . . . 1.54 111.974 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -116.58 162.54 17.46 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.061 0.934 . . . . 3.1200000000000001 113.517 -174.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 9.3 t . . . . . 0 N--CA 1.469 0.492 0 C-N-CA 126.632 1.973 . . . . 3.3199999999999998 109.317 169.838 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.5 p . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 114.673 1.361 . . . . 1.5800000000000001 114.673 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.7 p -79.01 -13.66 59.66 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.046 1.128 . . . . 1.52 114.046 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 t -148.28 159.46 43.96 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.282 1.433 . . . . 2.52 111.684 170.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 p -94.35 -7.89 40.44 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.69 1.996 . . . . 1.1699999999999999 114.641 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.6 m -144.16 154.19 42.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.7 1.2 . . . . 2.04 113.243 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.3 p -117.77 147.53 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 127.622 2.369 . . . . 0.46000000000000002 110.182 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.5 m -110.8 116.28 31.0 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.481 0.658 . . . . 0.63 111.067 173.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 p -98.02 131.19 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.764 1.226 . . . . 0.88 109.294 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -112.63 -171.05 1.78 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.384 1.874 . . . . 2.1200000000000001 110.96 -174.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -145.53 123.41 11.98 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.163 -0.961 . . . . 1.3999999999999999 111.349 166.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.4 mt -110.49 150.96 28.14 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.857 0.863 . . . . 0.54000000000000004 111.281 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.28 165.92 27.03 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.676 1.59 . . . . 1.5900000000000001 110.966 -171.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.33 143.83 39.96 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.277 1.031 . . . . 1.3400000000000001 111.064 168.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.7 p -85.5 -44.67 12.5 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.326 1.45 . . . . 1.96 111.452 174.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -115.13 25.49 10.84 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 127.823 2.449 . . . . 3.2000000000000002 111.745 -171.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.63 7.43 84.41 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 126.267 1.889 . . . . 1.53 116.764 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -72.39 25.13 0.05 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.611 2.364 . . . . 2.0600000000000001 116.977 -171.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -27.0 66.72 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 119.369 -2.082 . . . . 1.29 114.072 -173.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -81.72 -41.35 21.4 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.567 0.951 . . . . 2.6600000000000001 113.567 -174.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -66.86 -38.29 86.06 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 120.284 1.402 . . . . 3.0499999999999998 111.286 169.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.2 mt -56.58 -48.39 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 120.014 1.279 . . . . 1.1499999999999999 110.72 168.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.05 -36.92 75.84 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.833 1.197 . . . . 1.4299999999999999 112.486 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -69.27 -32.84 72.29 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.859 0.864 . . . . 1.55 113.305 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -65.84 -35.02 79.5 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.262 0.937 . . . . 2.04 112.269 172.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.5 mt -84.31 -31.25 24.97 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.328 0.862 . . . . 1.5800000000000001 113.328 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -67.29 -30.49 70.37 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.141 0.882 . . . . 3.2799999999999998 113.261 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 t -80.09 -21.4 43.34 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.809 0.844 . . . . 1.9299999999999999 113.194 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.37 164.99 52.78 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.552 1.072 . . . . 1.4199999999999999 113.099 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -84.42 18.98 2.04 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.179 0.991 . . . . 1.8100000000000001 112.425 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -68.93 0.6 4.26 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 115.765 1.765 . . . . 2.3199999999999998 115.765 -167.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.66 -23.01 66.88 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 121.364 -0.835 . . . . 0.92000000000000004 111.273 165.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.85 -83.41 1.19 Allowed Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.898 1.713 . . . . 0.68000000000000005 113.176 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.22 160.4 26.92 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.623 1.342 . . . . 1.3999999999999999 114.623 -169.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -60.7 156.55 16.58 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.302 1.223 . . . . 2.9500000000000002 114.302 -173.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.3 t -58.16 129.53 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 121.815 -0.553 . . . . 0.75 110.484 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.77 -43.17 68.04 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.592 0.615 . . . . 0.79000000000000004 114.163 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.1 p -160.97 142.72 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.814 1.245 . . . . 2.73 110.241 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.9 mt -88.3 145.93 36.85 Favored Pre-proline 0 C--O 1.241 0.647 0 C-N-CA 123.774 0.829 . . . . 1.1599999999999999 112.099 176.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.492 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 37.6 Cg_endo -67.95 158.98 54.94 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.563 1.509 . . . . 0.76000000000000001 112.131 173.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.18 -1.64 3.47 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.894 1.278 . . . . 1.29 114.388 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.11 8.13 11.49 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 127.028 2.131 . . . . 1.5700000000000001 114.028 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.492 ' HB2' ' HG2' ' A' ' 70' ' ' PRO . . . -93.63 162.15 14.07 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.908 1.818 . . . . 0.90000000000000002 115.908 172.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -142.63 150.62 40.5 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 128.062 2.545 . . . . 4.0599999999999996 111.042 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -121.92 139.97 53.0 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.866 1.667 . . . . 2.1499999999999999 110.059 174.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.9 pt -132.79 152.73 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 113.53 0.937 . . . . 0.92000000000000004 113.53 -177.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.0 165.55 11.64 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.28 1.432 . . . . 0.81000000000000005 110.801 169.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.0 8.3 79.26 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 115.562 0.985 . . . . 0.76000000000000001 115.562 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.7 p -84.53 143.93 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 119.648 1.724 . . . . 1.05 110.216 169.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -102.01 136.42 41.88 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.417 1.487 . . . . 0.64000000000000001 112.113 175.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.45 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.3 OUTLIER -141.44 155.03 45.91 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.106 0.962 . . . . 1.73 112.802 171.784 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.15 146.57 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 126.99 2.116 . . . . 0.45000000000000001 109.969 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -90.94 146.53 23.81 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.322 1.058 . . . . 0.48999999999999999 112.716 172.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.6 p -143.6 170.78 15.19 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.979 1.712 . . . . 0.46000000000000002 112.521 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -97.8 174.74 6.45 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.448 1.099 . . . . 1.95 112.573 168.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.2 p -64.49 -18.45 64.8 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.476 -1.39 . . . . 1.45 114.321 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -76.22 7.35 4.32 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 126.029 1.732 . . . . 1.8500000000000001 113.241 167.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 55.71 33.31 21.09 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.4 2.28 . . . . 0.77000000000000002 111.603 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -94.37 138.94 31.73 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.697 1.599 . . . . 2.1600000000000001 110.395 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.4 mt -79.37 130.81 35.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 109.573 -0.528 . . . . 0.53000000000000003 109.573 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.483 HG22 HG22 ' A' ' 97' ' ' THR . 4.9 pt -125.3 155.53 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 114.689 1.366 . . . . 0.75 114.689 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -81.29 164.46 22.2 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 126.46 1.904 . . . . 1.54 109.536 167.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -64.67 -12.51 47.08 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.556 -1.34 . . . . 2.3300000000000001 114.0 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -97.66 4.86 50.0 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.714 1.605 . . . . 2.6699999999999999 112.992 173.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.75 10.48 85.08 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 120.551 -1.343 . . . . 0.71999999999999997 115.103 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -68.24 130.03 41.69 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.193 1.497 . . . . 3.0699999999999998 108.924 168.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.483 HG22 HG22 ' A' ' 91' ' ' ILE . 17.3 p -87.92 141.66 28.41 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.68 0.392 . . . . 0.73999999999999999 111.043 174.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -94.3 -11.07 30.84 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.688 1.366 . . . . 0.80000000000000004 114.688 -169.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.76 30.85 25.49 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.555 1.074 . . . . 0.68999999999999995 114.322 -172.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.0 t -133.95 146.06 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.37 1.585 . . . . 1.25 110.447 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -130.61 159.98 35.56 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.58 1.952 . . . . 1.28 110.641 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 54.1 mt -135.96 137.03 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 125.059 1.344 . . . . 0.52000000000000002 111.207 -174.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -71.53 141.22 85.1 Favored Pre-proline 0 N--CA 1.48 1.028 0 O-C-N 120.814 -1.179 . . . . 1.77 111.188 171.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.56 -24.41 13.85 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 122.494 1.926 . . . . 0.65000000000000002 112.64 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -89.77 -54.43 4.06 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.706 1.602 . . . . 1.46 111.79 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.4 p -78.91 -26.79 43.78 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.875 0.695 . . . . 0.78000000000000003 112.875 -174.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 56.37 19.14 3.82 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.792 1.237 . . . . 1.6699999999999999 113.896 -170.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.91 150.83 24.69 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.377 -1.452 . . . . 3.0699999999999998 111.528 176.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.9 mt -90.37 141.96 28.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.241 1.417 . . . . 0.82999999999999996 111.712 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.1 p -66.56 -4.11 7.84 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.535 1.309 . . . . 1.3100000000000001 114.535 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.4 -158.53 18.73 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 127.331 2.396 . . . . 0.89000000000000001 111.53 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.52 154.09 42.2 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.543 0.942 . . . . 0.91000000000000003 113.543 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.3 tpt -60.26 130.22 89.34 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 125.384 1.474 . . . . 1.6799999999999999 111.21 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -72.46 158.89 50.39 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.61 2.874 . . . . 0.94999999999999996 114.488 -173.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.91 -53.62 8.71 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.064 1.746 . . . . 1.0900000000000001 114.557 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.7 p -114.13 11.35 17.57 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.395 1.478 . . . . 1.01 114.148 -167.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.36 151.42 19.82 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.729 1.011 . . . . 0.60999999999999999 113.729 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.4 tpt -75.19 95.32 3.1 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.907 2.083 . . . . 1.5700000000000001 111.227 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -154.48 135.86 14.13 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.443 1.497 . . . . 0.93999999999999995 112.557 -173.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -168.46 142.65 3.26 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.971 1.309 . . . . 2.54 111.342 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.76 150.87 25.53 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.717 1.377 . . . . 0.67000000000000004 114.717 -173.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.45 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 11.4 p -62.12 132.8 54.03 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.243 -0.911 . . . . 0.67000000000000004 111.798 169.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -93.83 -55.0 3.39 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.587 1.155 . . . . 2.52 113.688 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -165.73 -52.78 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.2 2.2 . . . . 1.27 109.422 174.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -93.23 23.49 4.38 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.182 1.793 . . . . 5.2699999999999996 113.35 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.77 -151.78 17.73 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.244 1.878 . . . . 0.57999999999999996 111.692 -168.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.417 ' HB2' ' HA ' ' A' ' 122' ' ' THR . . . -142.77 129.96 20.89 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.068 2.147 . . . . 0.40000000000000002 111.14 169.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -82.04 133.5 35.29 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.531 1.133 . . . . 1.4199999999999999 111.556 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -124.77 124.48 42.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.299 1.84 . . . . 2.0899999999999999 109.143 173.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -73.68 118.43 16.63 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.462 1.105 . . . . 1.6599999999999999 110.576 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 22.5 p -101.97 -0.65 33.43 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.554 1.142 . . . . 0.66000000000000003 113.347 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.13 -16.01 4.54 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.61 1.707 . . . . 0.85999999999999999 115.61 -176.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -106.77 -4.57 19.22 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.904 1.076 . . . . 2.6000000000000001 113.904 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.46 152.73 67.64 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 114.131 1.16 . . . . 0.71999999999999997 114.131 172.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.54 174.29 5.93 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.205 3.27 . . . . 1.0800000000000001 112.218 167.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.47 100.08 3.74 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.328 -0.857 . . . . 1.1799999999999999 109.365 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -152.2 177.38 10.6 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.479 1.512 . . . . 0.79000000000000004 110.587 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -90.39 146.77 23.9 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.217 1.007 . . . . 2.27 112.04 168.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -140.07 167.9 21.06 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.879 2.071 . . . . 0.73999999999999999 109.294 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -139.72 148.01 41.72 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.928 0.891 . . . . 1.77 112.306 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -111.25 132.98 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.024 0.93 . . . . 0.42999999999999999 109.7 175.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -120.78 128.43 52.89 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.417 1.887 . . . . 1.98 110.287 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -104.39 105.3 15.38 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.79 1.636 . . . . 2.54 110.961 -169.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.6 mm -108.06 113.72 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.686 1.194 . . . . 0.72999999999999998 111.62 -167.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -88.7 23.08 2.4 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.291 1.219 . . . . 4.46 114.291 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 52.1 m . . . . . 0 N--CA 1.473 0.689 0 O-C-N 121.094 -1.004 . . . . 1.5900000000000001 112.298 173.771 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 112.563 0.579 . . . . 1.77 112.563 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -98.66 152.03 20.08 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.849 1.259 . . . . 0.94999999999999996 111.738 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.8 m -111.57 144.49 30.68 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 124.482 1.113 . . . . 0.56999999999999995 111.831 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.49 159.24 51.95 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.406 2.737 . . . . 0.81000000000000005 114.022 -167.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.405 HD13 HG12 ' A' ' 180' ' ' VAL . 1.3 mt -112.36 143.66 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.005 1.322 . . . . 1.8600000000000001 110.273 -176.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -110.15 140.83 43.84 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.54 1.136 . . . . 2.9300000000000002 111.694 171.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.6 tt -146.3 147.31 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.663 1.185 . . . . 0.68000000000000005 111.578 -175.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -126.18 151.51 47.25 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.011 1.325 . . . . 1.9299999999999999 109.484 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 5.3 mt -65.58 149.91 96.69 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 114.269 1.211 . . . . 0.96999999999999997 114.269 -171.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.31 92.43 0.92 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.632 2.888 . . . . 0.85999999999999999 114.382 -169.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -118.82 70.67 0.83 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 103.678 -2.712 . . . . 2.6699999999999999 103.678 164.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -145.7 -179.94 7.02 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.069 1.748 . . . . 2.6899999999999999 109.229 -166.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -79.74 6.58 10.47 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.871 1.668 . . . . 3.9300000000000002 114.57 -174.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -99.99 153.56 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.833 1.653 . . . . 0.97999999999999998 113.517 -168.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 44.8 t -96.76 -32.62 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.586 1.554 . . . . 1.6499999999999999 110.967 172.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -131.34 135.3 47.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.021 1.328 . . . . 4.4400000000000004 113.211 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -103.7 138.79 39.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.623 1.169 . . . . 0.44 111.121 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -134.63 168.54 18.8 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.481 1.289 . . . . 0.48999999999999999 114.481 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.405 HG12 HD13 ' A' ' 166' ' ' ILE . 0.2 OUTLIER -141.72 137.22 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.787 1.235 . . . . 0.62 112.549 -178.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -134.96 86.65 31.8 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 125.418 1.487 . . . . 2.0699999999999998 112.118 -173.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -71.5 152.77 60.36 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.325 3.35 . . . . 0.57999999999999996 113.756 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -132.18 172.47 12.36 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.974 2.509 . . . . 1.6200000000000001 112.338 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -101.73 -173.0 2.25 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.204 1.402 . . . . 2.77 109.767 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 116.698 2.11 . . . . 2.8199999999999998 116.698 -175.298 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 112.776 0.658 . . . . 1.27 112.776 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.8 p -98.75 -7.34 27.81 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.819 1.415 . . . . 1.3999999999999999 114.819 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.1 t -151.72 157.83 42.57 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.866 0.757 . . . . 2.1899999999999999 112.518 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 p -98.55 -4.46 34.16 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.95 2.9 . . . . 0.83999999999999997 114.82 -173.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.3 m -147.25 151.48 36.75 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.89 1.676 . . . . 1.9399999999999999 112.863 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.1 p -119.61 148.6 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 127.762 2.425 . . . . 0.44 110.291 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.2 m -121.48 127.54 51.16 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 121.414 -0.803 . . . . 0.72999999999999998 111.591 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 p -101.27 137.58 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.116 1.366 . . . . 0.64000000000000001 110.717 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -136.38 113.97 11.0 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.002 1.721 . . . . 1.75 111.209 -171.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.48 127.82 38.11 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 120.178 -1.576 . . . . 1.05 114.225 -168.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.6 mt -114.77 152.82 31.45 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.683 1.193 . . . . 0.53000000000000003 113.835 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.3 mt -140.3 176.33 8.86 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.86 2.064 . . . . 1.98 110.464 169.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.492 ' HB1' ' H ' ' A' ' 48' ' ' ASP . . . -106.51 163.82 12.56 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.925 1.083 . . . . 0.85999999999999999 113.925 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.3 p -84.13 -38.45 20.69 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.488 1.115 . . . . 1.0 113.352 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -146.89 63.19 1.19 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.953 1.701 . . . . 2.52 110.703 169.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.11 27.88 73.55 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 120.893 -1.129 . . . . 1.1699999999999999 115.419 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.492 ' H ' ' HB1' ' A' ' 44' ' ' ALA . 1.6 m-20 -74.41 15.27 0.36 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.053 2.141 . . . . 2.3999999999999999 114.448 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.33 -28.96 69.67 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.129 -1.607 . . . . 0.67000000000000004 113.01 -173.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -69.64 -45.79 67.67 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.246 0.93 . . . . 2.25 112.519 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -71.08 -41.86 70.12 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 118.18 -0.914 . . . . 2.0899999999999999 111.463 176.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 86.6 mt -51.74 -50.21 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.441 1.019 . . . . 0.57999999999999996 110.34 167.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.51 -31.33 70.4 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.566 -1.334 . . . . 0.81000000000000005 113.231 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -74.08 -34.56 64.05 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.51 1.124 . . . . 1.1499999999999999 113.199 172.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -66.26 -32.64 74.19 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.863 -1.148 . . . . 1.9399999999999999 112.174 170.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.1 mt -83.63 -36.7 23.65 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.854 1.057 . . . . 1.0 113.854 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -65.33 -29.75 70.53 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.487 1.04 . . . . 2.9900000000000002 112.481 177.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.0 t -79.7 -24.54 41.63 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.346 0.869 . . . . 1.3300000000000001 113.346 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.65 160.31 39.28 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.53 1.062 . . . . 0.93000000000000005 113.345 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -83.01 26.06 0.64 Allowed 'General case' 0 CA--C 1.552 1.035 0 O-C-N 121.367 -1.078 . . . . 1.95 112.369 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -68.82 0.28 4.55 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 116.339 1.977 . . . . 2.1200000000000001 116.339 -167.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.75 -25.18 66.29 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.694 1.134 . . . . 0.92000000000000004 112.704 171.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.04 -81.42 1.34 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.709 1.147 . . . . 0.72999999999999998 113.122 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.46 163.07 25.92 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.538 1.135 . . . . 1.48 113.035 -176.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -59.08 161.23 5.34 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.993 1.479 . . . . 2.2000000000000002 114.993 -171.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.84 109.88 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.115 -0.698 . . . . 0.93000000000000005 109.115 168.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.81 -25.16 65.35 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 119.171 -0.794 . . . . 1.1599999999999999 114.134 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.2 t -142.07 118.24 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.275 1.43 . . . . 2.1099999999999999 110.939 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -88.32 146.91 38.91 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.548 1.539 . . . . 0.91000000000000003 109.809 167.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.69 157.51 39.87 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.098 1.866 . . . . 0.81999999999999995 111.552 171.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.23 -24.03 67.23 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.213 -0.929 . . . . 1.3 112.716 173.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 40.7 p30 -77.76 -8.89 58.63 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.844 1.424 . . . . 2.1000000000000001 114.844 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.2 155.78 19.19 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.372 1.469 . . . . 0.58999999999999997 111.922 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.5 pttt -141.25 159.72 41.62 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.958 1.303 . . . . 2.1899999999999999 111.885 170.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -122.68 146.74 47.21 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.914 1.286 . . . . 2.3300000000000001 110.042 -175.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.6 pt -141.07 151.2 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.26 1.024 . . . . 0.88 111.795 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -113.65 170.0 8.57 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.716 1.607 . . . . 0.64000000000000001 111.242 173.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.2 15.53 74.18 Favored Glycine 0 CA--C 1.534 1.267 0 O-C-N 121.388 -0.82 . . . . 0.55000000000000004 114.702 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.5 p -98.8 139.73 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 127.179 2.192 . . . . 0.91000000000000003 109.611 173.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.8 tpp -103.87 136.87 42.74 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.769 2.027 . . . . 0.44 112.84 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.581 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.6 OUTLIER -141.65 152.83 44.3 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.656 1.583 . . . . 1.6699999999999999 111.761 174.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.12 143.53 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 126.757 2.023 . . . . 0.33000000000000002 109.474 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -86.8 149.04 25.13 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 122.2 1.0 . . . . 0.37 111.847 169.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 57.3 p -145.62 165.92 27.28 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.789 1.635 . . . . 0.46000000000000002 112.532 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -89.59 167.29 13.06 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.807 0.843 . . . . 2.27 111.082 166.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 49.3 p -61.57 -26.46 67.97 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.436 1.273 . . . . 1.3899999999999999 114.436 -168.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -76.29 16.66 0.44 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.367 1.467 . . . . 2.2000000000000002 114.477 169.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.52 30.2 17.12 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 128.142 2.577 . . . . 0.90000000000000002 113.204 175.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -92.65 140.03 29.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.28 1.432 . . . . 2.3100000000000001 111.775 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -82.95 124.84 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.037 0.446 . . . . 0.69999999999999996 110.273 -178.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.475 HG22 HG22 ' A' ' 97' ' ' THR . 5.9 pt -120.63 156.15 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 114.815 1.413 . . . . 0.58999999999999997 114.815 -177.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -79.89 158.94 26.57 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.85 2.86 . . . . 2.04 111.227 168.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -56.82 -8.05 0.54 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 127.282 2.233 . . . . 2.3700000000000001 116.317 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.86 1.32 19.16 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.476 1.51 . . . . 2.8900000000000001 115.021 172.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.79 4.2 63.7 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.359 1.457 . . . . 0.62 115.27 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -67.97 143.55 55.56 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.883 1.341 . . . . 2.5600000000000001 109.371 170.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.475 HG22 HG22 ' A' ' 91' ' ' ILE . 60.5 p -102.7 147.8 26.38 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.81000000000000005 111.368 -175.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -104.45 -5.86 21.24 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.847 1.425 . . . . 0.90000000000000002 114.847 -168.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.78 28.93 40.58 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 121.193 -0.942 . . . . 1.24 113.396 -177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.8 t -133.48 147.26 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.969 1.308 . . . . 1.3400000000000001 110.063 177.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -134.73 155.06 51.22 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 128.205 2.602 . . . . 1.47 110.447 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.409 HG12 HD23 ' A' ' 109' ' ' LEU . 49.4 mt -133.42 133.82 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.213 1.405 . . . . 0.64000000000000001 110.854 -173.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -68.61 142.65 94.3 Favored Pre-proline 0 N--CA 1.476 0.849 0 O-C-N 120.633 -1.292 . . . . 2.0899999999999999 111.296 173.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.35 -24.12 16.89 Favored 'Trans proline' 0 C--N 1.35 0.636 0 CA-C-N 122.38 1.886 . . . . 0.70999999999999996 112.94 175.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -92.91 -52.19 4.71 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.382 1.873 . . . . 1.3300000000000001 112.692 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.9 p -80.73 -23.67 39.28 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.983 0.735 . . . . 0.94999999999999996 112.983 -175.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 54.89 18.06 2.05 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.747 1.619 . . . . 2.1499999999999999 113.839 -171.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.15 149.88 24.35 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.648 -1.283 . . . . 2.2799999999999998 111.789 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.409 HD23 HG12 ' A' ' 102' ' ' ILE . 38.6 mt -87.17 146.38 26.04 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.156 1.782 . . . . 1.1299999999999999 113.222 -175.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 97.3 p -76.98 0.64 20.4 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.446 1.276 . . . . 1.53 114.446 174.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.11 -158.26 15.86 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 127.176 2.322 . . . . 1.3100000000000001 110.762 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.07 156.18 25.95 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.534 1.167 . . . . 1.8 112.917 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 tpt -56.35 130.01 75.21 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 124.068 0.947 . . . . 2.0499999999999998 111.663 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.93 166.1 30.49 Favored 'Trans proline' 0 CA--C 1.537 0.64 1 C-N-CA 125.53 4.154 . . . . 1.1499999999999999 115.587 -172.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.63 -81.17 0.07 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.492 1.517 . . . . 1.3999999999999999 113.281 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.9 p -86.48 12.36 10.49 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.664 1.357 . . . . 0.91000000000000003 114.664 -169.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.7 148.59 16.01 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.21 -0.931 . . . . 0.41999999999999998 113.082 174.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.1 tpt -77.36 87.88 3.75 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.775 2.03 . . . . 1.6000000000000001 110.881 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -142.6 146.24 34.35 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.218 1.407 . . . . 1.0600000000000001 112.761 -173.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 43.5 tttp -162.01 159.73 26.74 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.524 1.13 . . . . 1.78 112.046 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 mp -102.2 145.74 28.97 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.595 1.158 . . . . 0.46999999999999997 112.824 169.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.581 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 8.7 p -70.26 139.78 52.24 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 119.335 0.97 . . . . 0.78000000000000003 112.332 174.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.63 -69.44 0.67 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.835 1.254 . . . . 3.1200000000000001 114.1 -174.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.43 -41.28 0.08 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.681 2.393 . . . . 1.1499999999999999 109.143 169.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -91.55 -10.62 39.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.986 1.714 . . . . 4.2800000000000002 114.216 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 143.23 -156.31 26.44 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.845 1.688 . . . . 0.91000000000000003 112.304 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.72 127.58 20.54 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.233 1.813 . . . . 0.52000000000000002 109.958 167.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -77.16 139.69 39.99 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.962 1.305 . . . . 1.3899999999999999 111.565 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -130.03 116.33 18.4 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.971 1.708 . . . . 1.9299999999999999 109.198 169.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.424 HD21 ' HB3' ' A' ' 132' ' ' ALA . 2.6 t-20 -72.34 115.44 11.6 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.915 1.286 . . . . 2.8799999999999999 111.006 176.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.8 p -104.02 -5.75 21.86 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.565 1.321 . . . . 0.56000000000000005 114.565 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.424 ' HB3' HD21 ' A' ' 130' ' ' ASN . . . -54.78 -27.69 43.33 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.456 1.28 . . . . 0.67000000000000004 114.456 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.68 -14.99 31.16 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.551 0.945 . . . . 2.25 113.551 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.52 147.91 85.2 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 119.603 1.092 . . . . 0.70999999999999996 112.792 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -75.44 167.24 27.04 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.21 1.94 . . . . 0.77000000000000002 110.95 167.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.03 94.8 1.93 Allowed 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.532 1.533 . . . . 1.1299999999999999 109.539 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -152.32 175.55 12.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.831 1.253 . . . . 0.65000000000000002 111.418 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -86.36 149.89 24.71 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.786 1.235 . . . . 2.7599999999999998 111.139 168.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -142.03 171.95 13.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.257 2.223 . . . . 0.44 109.735 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -142.19 154.82 45.13 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.359 1.064 . . . . 1.6399999999999999 111.962 176.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.09 135.93 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.939 0.895 . . . . 0.40000000000000002 110.773 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -121.65 142.31 50.26 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.801 2.04 . . . . 1.8500000000000001 110.575 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -108.69 118.09 35.88 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.076 0.951 . . . . 2.1899999999999999 110.648 -176.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.6 mm -114.08 113.51 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 108.67 -0.863 . . . . 0.87 108.67 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -74.26 -20.95 59.98 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.038 -1.039 . . . . 3.5800000000000001 113.077 -175.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 116.894 2.183 . . . . 1.9399999999999999 116.894 -175.796 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 112.503 0.557 . . . . 2.1200000000000001 112.503 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.59 154.9 39.6 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.777 -1.202 . . . . 0.90000000000000002 111.428 172.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.63 149.6 72.38 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 125.492 1.517 . . . . 0.63 110.625 174.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -74.47 145.81 34.16 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.282 2.654 . . . . 0.55000000000000004 114.64 -166.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.461 HD11 ' HB3' ' A' ' 182' ' ' PRO . 4.5 mt -98.35 140.2 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.191 1.396 . . . . 1.8300000000000001 110.019 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -113.89 121.46 44.03 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.988 1.315 . . . . 3.0699999999999998 111.491 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.7 tt -135.16 156.68 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.127 1.371 . . . . 0.40999999999999998 112.673 -168.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -138.49 159.66 41.51 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.953 1.701 . . . . 2.0699999999999998 109.022 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 19.0 mt -67.38 152.25 96.36 Favored Pre-proline 0 CA--C 1.551 1.008 0 O-C-N 121.282 -0.886 . . . . 0.94999999999999996 112.925 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.52 79.44 3.19 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 124.139 3.226 . . . . 0.95999999999999996 114.764 -167.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 1.6 tt -102.62 72.78 1.26 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.108 -1.442 . . . . 2.2400000000000002 107.108 167.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -146.44 -176.7 5.28 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.609 1.964 . . . . 2.8700000000000001 109.833 -168.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -79.85 0.0 32.87 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.127 1.528 . . . . 4.3499999999999996 115.127 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 1.4 m -80.41 159.05 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.535 1.134 . . . . 1.21 114.02 -169.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.2 t -99.23 -32.02 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 125.63 1.572 . . . . 1.73 111.507 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -142.25 128.61 20.0 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.736 1.614 . . . . 2.5099999999999998 108.781 -173.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -99.52 141.44 32.31 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.148 0.979 . . . . 0.54000000000000004 111.983 -172.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -142.38 169.59 17.29 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 115.725 1.75 . . . . 0.82999999999999996 115.725 -176.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.07 140.08 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.65 1.98 . . . . 0.59999999999999998 112.239 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -137.09 84.52 24.65 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 124.815 1.246 . . . . 2.3399999999999999 112.093 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' PRO . . . . . 0.461 ' HB3' HD11 ' A' ' 166' ' ' ILE . 14.4 Cg_endo -69.34 148.47 67.89 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 124.08 3.186 . . . . 0.56000000000000005 113.689 174.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -131.82 162.94 29.35 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 127.773 2.429 . . . . 1.51 111.242 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -109.92 169.62 8.6 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.68 1.192 . . . . 3.1899999999999999 113.04 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 CA--C 1.549 0.942 0 C-N-CA 127.123 2.169 . . . . 2.6099999999999999 111.575 177.928 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.4 p . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 113.442 0.904 . . . . 1.1399999999999999 113.442 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.7 p -105.21 -1.62 25.14 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.825 1.25 . . . . 1.8799999999999999 113.809 170.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 m -146.74 148.66 32.19 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.683 1.993 . . . . 2.7799999999999998 109.05 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 42.2 p -111.0 -11.82 14.28 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.222 1.409 . . . . 1.1200000000000001 114.72 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.1 p -147.67 159.07 44.19 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.765 1.394 . . . . 2.0600000000000001 114.765 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.74 138.19 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.825 2.05 . . . . 0.56000000000000005 110.194 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.0 m -114.72 122.15 45.54 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.846 0.858 . . . . 0.67000000000000004 110.962 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.62 135.12 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.667 1.187 . . . . 0.59999999999999998 111.852 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -133.27 106.67 7.68 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.015 1.726 . . . . 1.8100000000000001 112.163 -172.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.58 132.98 34.88 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 120.138 -1.601 . . . . 1.28 112.98 -171.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.5 mt -122.43 163.17 20.31 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.495 1.518 . . . . 0.78000000000000003 112.904 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 42.7 mt -143.12 167.95 20.89 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.593 1.957 . . . . 1.5700000000000001 110.914 168.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.15 169.95 10.01 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.54 1.136 . . . . 1.02 113.373 169.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.6 p -94.49 -32.99 13.26 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.578 1.325 . . . . 1.5700000000000001 114.578 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -140.53 44.49 1.85 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.598 1.159 . . . . 2.5899999999999999 111.963 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.75 12.9 82.26 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.515 1.531 . . . . 1.3899999999999999 115.832 177.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.16 19.65 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 127.767 2.427 . . . . 2.6499999999999999 116.572 -171.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mmt -64.14 -19.55 65.37 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.103 -1.623 . . . . 0.83999999999999997 114.678 -173.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -76.39 -51.9 10.96 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.934 0.894 . . . . 2.3999999999999999 111.613 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -62.05 -40.91 97.35 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.881 -1.137 . . . . 2.3599999999999999 111.372 172.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 98.8 mt -53.32 -47.92 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 119.613 1.097 . . . . 0.76000000000000001 110.9 169.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.03 -29.28 70.17 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.715 1.143 . . . . 0.81999999999999995 113.3 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -73.31 -39.04 65.62 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.922 0.783 . . . . 1.0900000000000001 111.993 171.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -61.7 -32.83 73.06 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.428 1.091 . . . . 1.8899999999999999 112.444 172.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.7 mt -88.49 -36.12 16.62 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.789 1.403 . . . . 1.01 114.789 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.38 -20.53 64.69 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.613 1.097 . . . . 2.3900000000000001 113.121 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.2 t -80.93 -12.19 59.44 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.079 1.352 . . . . 1.4099999999999999 114.525 175.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.39 161.33 21.4 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.261 1.41 . . . . 1.3 112.236 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -79.02 37.59 0.31 Allowed 'General case' 0 N--CA 1.477 0.92 0 O-C-N 120.855 -1.379 . . . . 2.0299999999999998 112.27 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -77.19 -0.88 26.76 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.246 1.202 . . . . 2.3100000000000001 114.246 -173.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.79 -27.08 66.25 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 121.091 -1.005 . . . . 1.21 110.593 166.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.28 -54.62 0.38 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.204 0.907 . . . . 1.0 113.347 169.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -76.02 160.34 29.93 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.478 1.111 . . . . 2.7000000000000002 113.343 -169.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -68.72 155.36 40.26 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.222 -0.924 . . . . 2.8300000000000001 111.687 171.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.2 t -67.9 119.82 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 109.795 -0.446 . . . . 1.26 109.795 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.11 -42.77 83.4 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 119.624 -0.542 . . . . 1.5900000000000001 113.93 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.9 t -142.44 130.77 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.722 1.609 . . . . 2.21 110.671 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.69 142.94 29.66 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.489 1.116 . . . . 1.2 110.956 168.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.16 162.57 42.13 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.442 2.095 . . . . 0.96999999999999997 112.215 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.8 -29.01 69.96 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.865 -1.147 . . . . 1.29 112.531 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -79.8 1.88 25.17 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.806 1.642 . . . . 1.4099999999999999 114.966 173.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.43 157.06 16.91 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.705 1.202 . . . . 1.1599999999999999 112.815 169.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -147.32 167.97 22.96 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.774 1.63 . . . . 3.1400000000000001 112.067 170.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -126.8 144.17 51.04 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.533 1.133 . . . . 2.6800000000000002 112.296 -169.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.1 pt -142.15 146.2 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.72 1.608 . . . . 1.1200000000000001 111.046 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.03 158.82 43.49 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.315 1.046 . . . . 1.1000000000000001 111.99 173.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.65 15.86 21.5 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.03 1.3 . . . . 0.65000000000000002 114.855 -171.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 p -101.4 144.44 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 127.997 2.519 . . . . 0.87 110.501 175.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.4 tpp -97.38 139.33 33.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.555 1.942 . . . . 0.57999999999999996 113.374 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.569 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.6 OUTLIER -141.64 154.34 45.31 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.988 1.315 . . . . 1.6499999999999999 111.31 171.775 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.5 m -125.68 146.13 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.097 1.759 . . . . 0.34000000000000002 109.82 -174.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -85.67 147.0 26.58 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.76 1.266 . . . . 0.40000000000000002 112.548 169.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.6 p -141.33 172.02 13.25 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.761 2.024 . . . . 0.35999999999999999 112.493 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.11 -169.75 1.91 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 115.283 1.586 . . . . 1.8700000000000001 115.283 177.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 66.9 p -62.19 -33.68 75.0 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.663 -1.273 . . . . 2.1899999999999999 112.143 173.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -80.53 12.96 2.71 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.342 1.057 . . . . 2.1899999999999999 113.289 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.39 26.74 14.48 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.498 1.519 . . . . 0.68000000000000005 111.761 -172.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -93.35 143.48 26.24 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.93 1.292 . . . . 1.9299999999999999 111.751 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.4 mt -78.38 124.46 36.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.358 0.663 . . . . 0.46999999999999997 110.36 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.533 HG22 HG22 ' A' ' 97' ' ' THR . 2.2 pt -113.83 154.3 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.605 1.562 . . . . 0.53000000000000003 114.95 177.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.14 157.74 18.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.429 2.692 . . . . 1.79 108.666 167.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -54.76 -24.42 22.36 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.634 1.716 . . . . 2.3799999999999999 115.634 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . 0.261 0.0 OUTLIER -86.89 7.05 28.93 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 119.355 0.98 . . . . 2.9300000000000002 112.42 176.855 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.42 19.05 77.1 Favored Glycine 0 C--N 1.343 0.931 0 C-N-CA 125.909 1.719 . . . . 0.76000000000000001 113.417 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -80.66 137.88 36.36 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.299 0.64 . . . . 2.1499999999999999 110.261 169.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.533 HG22 HG22 ' A' ' 91' ' ' ILE . 20.1 p -96.19 146.17 24.91 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.829 0.852 . . . . 0.76000000000000001 111.099 -177.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.1 -6.04 29.09 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.579 1.325 . . . . 0.75 114.579 -168.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.27 28.03 46.26 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.193 0.902 . . . . 0.67000000000000004 113.802 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 36.6 t -134.48 147.89 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.103 1.361 . . . . 1.1299999999999999 110.501 176.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -129.8 158.44 39.43 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 128.973 2.909 . . . . 1.3300000000000001 111.091 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 74.7 mt -132.83 139.33 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 125.559 1.544 . . . . 0.54000000000000004 111.13 -174.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -75.79 139.06 69.8 Favored Pre-proline 0 CA--C 1.546 0.806 0 O-C-N 120.272 -1.518 . . . . 2.1600000000000001 111.97 171.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.19 -20.6 24.6 Favored 'Trans proline' 0 C--N 1.349 0.602 0 CA-C-N 122.645 1.981 . . . . 0.66000000000000003 113.517 176.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -98.21 -44.4 6.6 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.934 1.693 . . . . 1.28 112.018 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.9 p -90.2 -21.29 22.24 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.992 0.738 . . . . 0.81000000000000005 112.992 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 54.5 18.92 2.14 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.48 1.512 . . . . 1.8200000000000001 113.943 -172.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.1 148.92 21.81 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.728 -1.232 . . . . 2.6600000000000001 112.73 -177.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.9 mt -87.74 142.53 27.75 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.069 1.748 . . . . 0.83999999999999997 113.313 -170.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.8 p -71.26 -7.26 45.77 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.042 1.127 . . . . 1.3200000000000001 114.042 171.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.99 -161.26 14.64 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.959 1.266 . . . . 1.02 112.881 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.83 162.56 29.33 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.359 1.063 . . . . 1.29 113.333 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -51.51 137.09 32.12 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.777 1.231 . . . . 2.02 112.91 174.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.8 154.79 26.65 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.858 3.038 . . . . 1.01 114.199 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.17 -60.92 2.11 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.337 1.236 . . . . 1.24 114.337 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.6 p -119.84 15.64 12.61 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 114.363 1.245 . . . . 0.96999999999999997 114.363 -169.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.35 146.78 11.57 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.914 1.079 . . . . 0.46000000000000002 113.914 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.6 ttt -74.77 102.86 4.81 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.655 1.982 . . . . 1.97 110.605 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -156.25 146.21 21.22 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.018 1.727 . . . . 0.94999999999999996 112.211 -173.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -163.75 156.81 18.36 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.448 1.499 . . . . 1.79 110.627 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.1 mp -92.72 146.74 23.42 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.527 0.731 . . . . 0.62 112.03 173.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.569 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 5.2 p -65.3 140.57 58.7 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 121.054 -1.029 . . . . 0.62 110.183 169.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -98.08 -62.81 1.19 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.473 0.916 . . . . 2.1699999999999999 113.473 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -170.37 -31.14 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.439 2.296 . . . . 1.3899999999999999 110.682 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.14 24.03 10.75 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.045 2.138 . . . . 4.75 112.32 172.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.9 -151.63 27.71 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.94 1.257 . . . . 0.62 112.801 -170.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.3 129.77 24.06 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.63 1.972 . . . . 0.44 111.416 169.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -83.75 135.85 34.39 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.677 1.591 . . . . 1.3899999999999999 112.89 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -127.35 130.61 49.75 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.27 2.228 . . . . 1.6899999999999999 108.602 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -93.17 104.09 16.31 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.428 -0.795 . . . . 2.0499999999999998 111.608 -173.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.1 p -86.41 -0.8 56.74 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.69 1.196 . . . . 1.01 113.49 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.39 -25.49 59.58 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.94 0.896 . . . . 0.91000000000000003 113.222 169.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -87.74 -14.94 38.4 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.329 1.451 . . . . 2.1400000000000001 113.433 -174.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -90.4 150.19 42.41 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 113.881 1.067 . . . . 0.63 113.881 177.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -85.45 172.21 8.28 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.09 3.194 . . . . 0.77000000000000002 111.011 166.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.6 85.27 2.08 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.995 2.118 . . . . 1.1000000000000001 111.054 -174.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -141.56 176.1 9.16 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.159 1.384 . . . . 0.80000000000000004 111.256 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -91.28 145.7 24.44 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.621 1.2 . . . . 2.71 111.981 169.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -136.11 176.17 8.94 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.854 2.062 . . . . 0.58999999999999997 109.983 -172.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.95 156.74 43.0 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.642 1.177 . . . . 3.5899999999999999 113.411 177.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.0 142.38 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.66 1.184 . . . . 0.45000000000000001 111.354 172.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -131.1 142.21 50.24 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.722 2.009 . . . . 1.8100000000000001 111.891 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -103.78 126.85 51.2 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.246 1.418 . . . . 2.1099999999999999 112.843 -175.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 25.0 mm -128.01 143.64 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.434 1.493 . . . . 1.1299999999999999 110.246 -169.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -114.7 -1.48 13.28 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.093 1.516 . . . . 4.9100000000000001 115.093 -178.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 N--CA 1.479 0.997 0 O-C-N 120.06 -1.65 . . . . 2.3100000000000001 113.221 171.186 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 115.306 1.595 . . . . 1.96 115.306 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -87.47 158.5 18.94 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.089 1.356 . . . . 0.91000000000000003 112.526 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.7 m -122.91 145.23 45.03 Favored Pre-proline 0 N--CA 1.468 0.472 0 C-N-CA 124.497 1.119 . . . . 0.57999999999999996 111.198 178.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.9 161.95 43.39 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.049 2.499 . . . . 0.52000000000000002 112.476 -170.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.3 mp -126.85 119.33 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.861 1.264 . . . . 1.3899999999999999 111.067 -168.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -74.33 140.26 44.74 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.818 0.735 . . . . 3.29 110.853 168.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.9 tt -144.81 144.62 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.55 1.14 . . . . 0.47999999999999998 111.622 174.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -115.81 157.68 24.03 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.434 1.094 . . . . 2.1099999999999999 110.975 169.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.79 151.48 72.55 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.407 1.483 . . . . 1.1399999999999999 112.949 177.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -83.16 116.57 2.42 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.85 2.366 . . . . 1.1100000000000001 113.998 -169.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.75 57.64 1.67 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 104.864 -2.273 . . . . 2.3999999999999999 104.864 165.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -128.37 170.17 13.41 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 127.226 2.211 . . . . 3.5699999999999998 110.478 -167.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -71.88 -11.13 60.65 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 120.632 -1.293 . . . . 3.1899999999999999 114.242 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.0 m -77.41 148.69 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 114.733 1.383 . . . . 1.03 114.733 -171.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.1 t -80.58 -38.36 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.982 1.313 . . . . 1.8400000000000001 111.689 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -149.35 147.32 28.18 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.229 1.412 . . . . 2.5899999999999999 110.728 170.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -97.05 161.57 13.77 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.524 1.305 . . . . 0.59999999999999998 114.524 -168.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -133.97 169.89 16.44 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.074 1.509 . . . . 0.64000000000000001 115.074 174.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -138.55 144.78 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.623 1.969 . . . . 0.59999999999999998 111.148 173.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -137.06 83.25 28.31 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.685 1.594 . . . . 2.2200000000000002 111.032 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -69.72 151.15 69.24 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.501 2.801 . . . . 0.56000000000000005 113.241 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -131.17 156.62 45.01 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.968 2.107 . . . . 1.5900000000000001 112.037 -171.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -89.61 177.31 6.57 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 122.913 1.339 . . . . 3.79 113.369 173.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 32.3 p . . . . . 0 N--CA 1.466 0.339 0 C-N-CA 126.321 1.848 . . . . 3.3100000000000001 112.171 178.894 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.4 p . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 115.688 1.736 . . . . 1.1299999999999999 115.688 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.7 p -89.13 -14.53 35.97 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.558 1.318 . . . . 1.45 114.558 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 t -147.18 165.29 30.46 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.452 1.901 . . . . 2.3599999999999999 111.365 171.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -103.89 -0.09 29.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.971 2.509 . . . . 1.02 114.83 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.413 ' HA ' ' H ' ' A' ' 131' ' ' THR . 88.6 p -149.28 165.43 31.94 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.553 1.141 . . . . 1.73 113.349 175.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.66 136.63 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 127.474 2.309 . . . . 0.53000000000000003 109.757 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.0 m -104.89 115.28 30.02 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.771 0.796 . . . . 0.88 110.796 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 p -95.24 134.56 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.28 1.432 . . . . 0.82999999999999996 110.486 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -116.98 179.1 4.12 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.583 1.953 . . . . 1.8400000000000001 109.988 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.96 129.35 18.93 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 120.35 1.432 . . . . 1.01 113.204 171.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.3 mt -115.0 148.24 39.08 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.422 1.089 . . . . 0.56000000000000005 113.85 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.5 mt -135.94 177.13 8.07 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.24 2.216 . . . . 1.99 109.995 169.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.418 ' HB1' ' H ' ' A' ' 48' ' ' ASP . . . -111.96 166.8 10.9 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.845 1.258 . . . . 0.81000000000000005 112.545 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.3 p -85.67 -32.98 21.68 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.593 -1.317 . . . . 0.92000000000000004 113.309 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -133.24 15.37 4.15 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.106 1.363 . . . . 2.4900000000000002 113.624 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.22 34.86 8.41 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 120.722 -1.236 . . . . 1.1299999999999999 113.379 -173.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.418 ' H ' ' HB1' ' A' ' 44' ' ' ALA . 1.7 m-20 -79.59 12.5 2.51 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.977 2.511 . . . . 2.04 114.614 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -60.17 -20.22 57.56 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.768 -1.207 . . . . 0.79000000000000004 113.081 -172.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.44 -56.04 19.38 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.033 1.733 . . . . 2.8999999999999999 113.041 172.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -38.87 70.45 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.173 -0.954 . . . . 4.3799999999999999 111.704 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 84.4 mt -53.21 -50.28 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.352 1.061 . . . . 0.67000000000000004 110.922 169.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.08 -32.66 72.31 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.826 1.194 . . . . 0.92000000000000004 112.987 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -70.51 -34.34 72.22 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.998 0.74 . . . . 1.3 112.998 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -67.79 -28.05 67.27 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.717 0.69 . . . . 1.95 112.57 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.9 mt -85.99 -36.28 19.88 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.952 1.093 . . . . 1.25 113.952 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -65.42 -25.48 67.55 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.214 0.916 . . . . 2.8599999999999999 113.137 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.1 t -76.37 -34.05 58.91 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.42 -0.8 . . . . 1.6799999999999999 112.868 173.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.62 167.86 48.99 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.559 1.076 . . . . 1.23 113.876 176.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -93.85 32.12 1.5 Allowed 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.199 -1.177 . . . . 2.1699999999999999 112.99 -173.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -70.95 3.01 3.64 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 116.057 1.873 . . . . 2.27 116.057 -167.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.0 -23.98 67.71 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.103 -0.998 . . . . 1.29 111.942 167.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.98 -76.68 0.85 Allowed Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.405 1.478 . . . . 0.95999999999999996 112.581 170.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.36 158.13 31.73 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.983 1.475 . . . . 1.48 114.983 -170.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -62.92 147.75 49.43 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.188 0.995 . . . . 4.0599999999999996 111.58 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.5 t -56.52 140.29 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.848 0.859 . . . . 1.1499999999999999 111.867 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.58 -66.21 2.65 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.404 1.002 . . . . 1.21 112.861 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.0 t -149.14 125.01 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.975 2.11 . . . . 2.02 109.62 174.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt -74.89 145.48 81.39 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.316 -0.865 . . . . 1.21 112.505 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -72.59 161.69 43.36 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.937 2.425 . . . . 0.62 112.188 -176.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.38 -15.62 63.79 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.405 1.261 . . . . 0.87 114.405 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -96.52 -1.3 47.44 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.607 1.563 . . . . 1.73 114.193 173.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.49 150.86 24.98 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.291 -0.881 . . . . 0.56000000000000005 112.556 169.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -141.6 151.44 43.15 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.595 1.558 . . . . 2.4100000000000001 110.975 169.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.14 138.75 53.7 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.051 0.941 . . . . 3.1000000000000001 110.7 -171.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.4 pt -131.85 153.03 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 115.403 1.631 . . . . 0.83999999999999997 115.403 -169.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -113.53 156.54 23.4 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.292 1.837 . . . . 0.65000000000000002 112.31 172.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.29 13.69 59.83 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.953 1.263 . . . . 0.53000000000000003 114.882 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.86 142.35 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.079 1.751 . . . . 0.81999999999999995 110.613 172.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -103.74 136.83 42.7 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.8 1.64 . . . . 0.55000000000000004 113.661 -175.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.462 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.9 OUTLIER -141.85 152.29 43.51 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.121 1.368 . . . . 1.6499999999999999 111.76 175.867 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.15 146.74 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 127.306 2.242 . . . . 0.41999999999999998 109.361 -176.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -88.91 147.61 24.26 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.396 1.093 . . . . 0.40000000000000002 112.287 169.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.2 p -136.68 165.1 26.68 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.025 1.73 . . . . 0.34000000000000002 112.395 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.02 168.67 13.1 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.092 1.357 . . . . 1.55 111.22 167.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . 0.267 1.3 t -67.15 -14.65 63.1 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 115.0 1.481 . . . . 2.8199999999999998 115.0 -168.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -83.69 19.07 1.73 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.717 1.607 . . . . 3.3799999999999999 113.055 167.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.72 23.31 12.16 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.233 1.813 . . . . 0.64000000000000001 113.558 -175.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -83.89 136.67 34.01 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.659 1.584 . . . . 2.6099999999999999 112.904 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.4 mt -77.79 128.79 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 121.602 -0.686 . . . . 0.47999999999999998 110.516 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.78 150.66 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 126.386 1.874 . . . . 1.03 114.326 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -77.73 161.61 27.59 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.331 2.252 . . . . 1.5800000000000001 110.965 168.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -56.6 -21.78 29.33 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 116.025 1.861 . . . . 2.46 116.025 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . 0.257 0.0 OUTLIER -87.87 -0.58 57.15 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 120.829 1.65 . . . . 2.7200000000000002 113.558 171.438 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.62 17.6 65.71 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.895 1.236 . . . . 0.75 114.405 -175.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -75.27 145.3 41.99 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.107 0.953 . . . . 2.6899999999999999 108.966 167.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.4 p -106.21 145.42 31.59 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.084 0.954 . . . . 1.0 112.416 -171.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -103.06 -4.98 23.8 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.126 1.158 . . . . 0.78000000000000003 114.126 -170.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.85 30.17 52.72 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 119.722 1.146 . . . . 0.70999999999999996 113.905 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 45.1 t -138.85 145.81 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.124 1.369 . . . . 1.2 110.308 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -126.49 159.29 33.83 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.644 2.778 . . . . 1.5 110.942 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 51.4 mt -136.91 134.15 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.302 1.441 . . . . 0.76000000000000001 110.387 -174.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -75.56 140.06 71.49 Favored Pre-proline 0 N--CA 1.476 0.854 0 CA-C-O 117.687 -1.149 . . . . 2.2400000000000002 111.836 176.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -72.17 -24.12 20.46 Favored 'Trans proline' 0 C--N 1.351 0.679 0 CA-C-N 122.154 1.805 . . . . 0.93999999999999995 113.136 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -88.01 -52.03 5.49 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.814 1.646 . . . . 1.3 111.777 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.0 p -83.21 -23.8 32.66 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.959 0.904 . . . . 1.0 113.15 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 52.52 23.4 2.54 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.056 1.743 . . . . 2.1200000000000001 113.653 -173.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . 0.252 2.2 ptmt -104.38 162.61 13.08 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.052 -1.03 . . . . 3.71 112.887 176.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.9 mt -94.48 149.57 21.11 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.474 1.51 . . . . 1.0900000000000001 114.629 -167.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.8 p -75.1 0.76 15.07 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.986 1.106 . . . . 1.29 113.986 169.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.23 -152.33 9.54 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.187 1.375 . . . . 1.01 112.277 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.76 155.07 19.44 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.017 0.927 . . . . 1.0900000000000001 113.345 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 tpt -51.08 130.78 30.96 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.806 1.642 . . . . 1.96 112.069 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.34 168.03 25.46 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.706 2.937 . . . . 1.0 113.425 -175.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.19 -91.53 0.07 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.764 1.226 . . . . 1.6399999999999999 110.83 168.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.4 p -74.56 10.87 1.17 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 116.49 2.033 . . . . 0.75 116.49 -167.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.57 147.46 14.22 Favored 'General case' 0 CA--C 1.55 0.95 0 O-C-N 120.437 -1.415 . . . . 0.46000000000000002 113.259 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.3 ttt -74.51 102.53 4.53 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.469 1.508 . . . . 1.72 109.98 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -156.85 145.29 19.71 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.622 1.569 . . . . 0.93999999999999995 111.656 -174.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -168.13 156.82 9.04 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.272 1.829 . . . . 2.6099999999999999 109.93 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.2 mp -87.45 150.08 24.0 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.335 1.454 . . . . 0.48999999999999999 113.585 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.531 HG22 ' HA2' ' A' ' 126' ' ' GLY . 1.2 p -63.98 129.77 41.37 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.218 -0.927 . . . . 0.55000000000000004 110.193 169.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -80.75 -57.38 3.58 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 120.771 -1.206 . . . . 2.0800000000000001 114.032 -174.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -153.03 -43.12 0.1 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.921 1.688 . . . . 1.1799999999999999 109.796 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -104.6 -33.15 8.62 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.039 0.936 . . . . 4.5800000000000001 113.239 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.531 ' HA2' HG22 ' A' ' 122' ' ' THR . . . 172.61 -170.65 43.72 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 126.218 1.866 . . . . 0.71999999999999997 110.865 -169.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -135.12 136.39 41.89 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.175 1.79 . . . . 0.56999999999999995 110.637 171.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -97.05 128.9 44.45 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.016 0.926 . . . . 1.3600000000000001 111.949 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -117.98 136.23 53.64 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.8 2.04 . . . . 1.75 107.738 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -96.66 104.41 16.4 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.553 -1.342 . . . . 1.8999999999999999 111.817 -169.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.413 ' H ' ' HA ' ' A' ' 36' ' ' SER . 39.4 p -86.77 1.65 51.51 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.655 1.182 . . . . 0.72999999999999998 113.349 -174.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.3 -29.12 68.64 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.412 -0.805 . . . . 0.88 112.093 169.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.7 m120 -86.92 -20.78 26.87 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.35 1.46 . . . . 2.2999999999999998 113.187 -175.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -79.06 144.22 62.82 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 119.474 1.034 . . . . 0.92000000000000004 113.253 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.22 169.46 20.18 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.643 2.229 . . . . 1.1899999999999999 110.733 166.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.97 89.68 1.92 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.054 1.742 . . . . 1.3300000000000001 110.771 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -149.09 177.81 9.27 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.827 0.851 . . . . 0.90000000000000002 112.052 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -87.04 146.37 26.12 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.107 0.963 . . . . 2.7200000000000002 111.628 166.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -135.84 170.49 15.9 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.993 2.117 . . . . 0.68999999999999995 109.718 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -140.25 149.72 43.21 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.549 0.739 . . . . 1.6699999999999999 111.788 171.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.2 mp -104.03 140.4 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.281 0.632 . . . . 0.44 110.072 173.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -124.75 135.94 53.42 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.926 1.69 . . . . 1.8700000000000001 109.852 174.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -97.55 123.84 41.58 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.122 0.969 . . . . 1.8400000000000001 109.392 178.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 40.3 mm -122.57 97.12 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.743 0.817 . . . . 0.70999999999999996 109.074 -172.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.7 -12.03 60.32 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.579 1.325 . . . . 4.21 114.579 -169.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 79.8 p . . . . . 0 N--CA 1.469 0.478 0 N-CA-C 114.271 1.211 . . . . 1.7 114.271 177.632 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 115.209 1.559 . . . . 2.1400000000000001 115.209 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.62 152.96 29.74 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.099 0.96 . . . . 0.80000000000000004 111.857 168.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.56 149.04 54.63 Favored Pre-proline 0 N--CA 1.478 0.975 0 C-N-CA 125.337 1.455 . . . . 0.66000000000000003 110.784 174.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.9 162.72 29.21 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.894 3.063 . . . . 0.78000000000000003 115.299 -165.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.6 mp -126.41 133.47 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.742 2.017 . . . . 1.25 110.701 -168.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -98.14 130.88 44.89 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.438 1.095 . . . . 3.3900000000000001 111.838 174.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.4 tt -135.94 147.84 28.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.927 1.291 . . . . 0.67000000000000004 110.816 -174.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -127.48 152.93 46.94 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.986 1.315 . . . . 1.95 109.125 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.09 143.97 98.97 Favored Pre-proline 0 CA--C 1.543 0.688 0 O-C-N 120.94 -1.1 . . . . 1.05 111.614 -176.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -66.81 92.04 0.31 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 124.506 3.47 . . . . 0.79000000000000004 115.599 -165.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.2 tt -122.73 77.53 1.44 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.678 1.991 . . . . 2.3700000000000001 105.783 168.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -157.63 177.02 11.86 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.155 2.182 . . . . 2.6499999999999999 108.574 -167.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -84.33 34.36 0.52 Allowed 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.163 -1.585 . . . . 3.23 114.135 -175.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.63 156.51 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.845 1.258 . . . . 1.22 111.637 -174.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 78.2 t -108.88 -33.85 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.267 1.827 . . . . 1.8100000000000001 111.558 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -129.07 134.64 48.18 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.265 1.426 . . . . 3.7400000000000002 109.167 172.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -98.34 137.82 36.5 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.226 1.01 . . . . 0.40999999999999998 111.494 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -133.72 166.93 21.49 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.068 1.136 . . . . 0.63 114.068 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.28 135.91 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.2 1.4 . . . . 0.59999999999999998 111.568 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -134.18 82.52 47.5 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.569 1.147 . . . . 2.0800000000000001 111.466 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' PRO . . . . . 0.605 ' HB3' HD11 ' A' ' 166' ' ' ILE . 60.4 Cg_endo -69.78 151.08 68.87 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 124.559 3.506 . . . . 0.58999999999999997 112.274 175.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -131.58 158.94 39.65 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.083 1.753 . . . . 1.6899999999999999 111.679 -178.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -88.64 175.01 7.72 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.311 1.044 . . . . 2.71 110.997 168.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 13.2 t . . . . . 0 N--CA 1.482 1.145 0 O-C-N 121.409 -0.807 . . . . 2.48 113.063 169.701 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.9 p . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 113.416 0.895 . . . . 1.1299999999999999 113.416 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 43.4 p -98.21 -8.48 27.33 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.343 1.457 . . . . 1.9399999999999999 114.067 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.0 m -147.5 146.02 29.34 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.478 1.911 . . . . 2.73 110.054 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.4 p -108.96 -14.48 14.55 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 116.901 2.186 . . . . 1.05 116.901 -172.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.6 m -138.61 149.62 45.43 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.019 1.328 . . . . 1.8200000000000001 111.589 170.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.5 p -115.7 142.66 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 127.071 2.149 . . . . 0.37 110.382 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 36.0 m -111.0 121.61 45.8 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.582 0.753 . . . . 0.73999999999999999 109.564 172.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 p -96.65 127.38 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.945 0.879 . . . . 0.58999999999999997 109.346 174.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -103.66 -172.47 2.12 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.02 1.728 . . . . 1.8999999999999999 109.029 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.8 134.19 13.47 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 120.411 -1.431 . . . . 0.93999999999999995 112.611 168.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.0 mt -121.06 150.57 40.98 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.852 1.261 . . . . 0.66000000000000003 112.971 -172.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.3 mt -140.81 169.66 17.22 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.332 1.853 . . . . 1.6899999999999999 109.761 167.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.98 172.97 7.07 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.993 0.917 . . . . 0.80000000000000004 112.029 173.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.8 p -102.31 -25.78 13.54 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 114.417 1.266 . . . . 1.02 114.417 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -134.95 45.22 2.55 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.668 1.987 . . . . 2.5499999999999998 110.365 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.47 14.63 67.17 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 120.741 -1.224 . . . . 0.87 116.007 175.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.63 27.24 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.982 2.513 . . . . 2.2000000000000002 115.921 -171.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.13 -19.06 65.8 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 119.617 -1.927 . . . . 0.68000000000000005 114.13 -171.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -85.14 -43.38 13.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.385 1.474 . . . . 2.2799999999999998 112.583 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -69.94 -39.09 76.28 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-O 117.941 -1.028 . . . . 3.4100000000000001 110.955 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.3 mt -51.6 -50.37 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.499 1.12 . . . . 0.98999999999999999 110.09 167.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.37 -27.47 66.0 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.554 0.946 . . . . 1.04 113.554 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -79.72 -32.22 41.23 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.063 -1.023 . . . . 1.23 112.937 174.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -67.97 -16.01 63.86 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.792 0.837 . . . . 2.1000000000000001 112.596 169.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.4 mt -97.46 -37.61 9.92 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.072 1.349 . . . . 1.1100000000000001 114.22 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -70.15 -15.93 63.02 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.57 -1.331 . . . . 2.5099999999999998 114.448 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.4 t -71.78 -30.2 65.3 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.01 0.924 . . . . 1.8999999999999999 113.25 170.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.38 164.6 28.29 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.48 1.514 . . . . 1.22 113.053 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -87.32 53.41 2.8 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.131 -1.217 . . . . 1.6299999999999999 111.412 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -89.41 8.01 33.0 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.378 1.251 . . . . 1.8899999999999999 114.378 -170.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.03 -25.79 63.74 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.139 -0.976 . . . . 0.92000000000000004 111.69 168.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.28 -82.53 1.21 Allowed Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.064 0.84 . . . . 0.67000000000000004 111.888 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 161.52 29.67 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.774 1.23 . . . . 1.74 112.708 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -60.36 158.13 12.44 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.804 1.242 . . . . 2.5099999999999998 114.341 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 52.6 t -59.04 126.73 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 121.881 -0.512 . . . . 0.71999999999999997 110.6 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.38 -48.84 75.19 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.061 1.315 . . . . 0.90000000000000002 113.301 -175.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.0 129.16 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.804 1.241 . . . . 2.5899999999999999 111.228 173.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.9 mt -79.62 144.54 61.04 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.066 0.946 . . . . 0.88 111.532 174.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.64 166.94 28.51 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.65 2.234 . . . . 0.65000000000000002 113.045 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.64 -23.83 65.38 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 121.015 -1.053 . . . . 0.90000000000000002 113.452 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -83.92 -1.43 54.52 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.373 1.249 . . . . 1.6399999999999999 114.373 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.09 158.19 16.47 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.282 1.433 . . . . 0.54000000000000004 114.162 172.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.77 159.45 44.34 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.55 1.14 . . . . 1.97 112.729 166.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -105.29 150.04 25.51 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.847 1.659 . . . . 2.8999999999999999 111.263 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.9 pt -137.92 139.29 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 120.067 1.303 . . . . 0.78000000000000003 114.282 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.74 146.95 25.97 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.759 1.223 . . . . 0.84999999999999998 113.102 172.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.8 14.36 27.25 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.341 1.448 . . . . 0.54000000000000004 115.42 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.43 144.44 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 125.287 1.435 . . . . 0.76000000000000001 109.795 169.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 1.3 tpt -105.25 140.26 38.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.554 1.542 . . . . 0.48999999999999999 112.115 176.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.52 155.67 43.23 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.841 1.257 . . . . 2.04 112.625 172.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.3 m -120.23 149.62 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 127.033 2.133 . . . . 0.40999999999999998 109.709 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -90.26 147.58 23.44 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 122.619 1.199 . . . . 0.35999999999999999 112.106 169.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.4 p -139.72 166.85 23.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.31 1.844 . . . . 0.42999999999999999 111.385 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.78 172.93 11.73 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.544 -0.722 . . . . 1.99 112.529 168.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.8 t -61.58 -23.98 66.36 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.437 1.273 . . . . 2.8999999999999999 114.437 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -87.9 20.99 2.83 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 125.379 1.472 . . . . 2.2599999999999998 113.347 171.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.75 27.47 12.81 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.779 2.832 . . . . 0.65000000000000002 114.742 175.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -82.7 140.56 33.03 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.013 0.925 . . . . 2.1600000000000001 110.31 172.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.4 mt -76.21 125.68 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.225 -0.657 . . . . 0.58999999999999997 109.225 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.471 HG22 HG22 ' A' ' 97' ' ' THR . 3.3 pt -121.86 156.91 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 114.644 1.35 . . . . 0.52000000000000002 114.644 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -90.1 164.09 14.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.619 2.367 . . . . 1.5700000000000001 110.115 168.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -68.97 2.9 2.31 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 116.689 2.107 . . . . 2.3999999999999999 116.689 -168.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -110.89 0.79 17.27 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.422 1.489 . . . . 2.8399999999999999 114.105 168.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.24 3.0 60.35 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.255 1.407 . . . . 0.62 115.644 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -65.31 132.13 48.25 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.042 1.421 . . . . 2.8799999999999999 108.932 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.471 HG22 HG22 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -96.05 142.41 28.29 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 118.134 0.425 . . . . 0.92000000000000004 111.43 176.886 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.22 -12.76 45.83 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.233 1.198 . . . . 1.1000000000000001 114.233 -168.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.56 22.72 23.34 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.053 1.311 . . . . 0.78000000000000003 114.511 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.0 t -134.79 149.55 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.373 1.469 . . . . 1.26 110.195 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -128.28 157.5 40.74 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.68 2.792 . . . . 1.29 111.292 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 57.1 mt -134.04 126.82 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.423 1.489 . . . . 0.63 110.321 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -68.64 137.71 90.71 Favored Pre-proline 0 N--CA 1.477 0.888 0 O-C-N 121.029 -1.045 . . . . 2.3300000000000001 111.046 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.06 -15.17 29.14 Favored 'Trans proline' 0 C--N 1.35 0.623 0 CA-C-N 121.924 1.723 . . . . 0.84999999999999998 113.785 176.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -97.19 -47.43 5.75 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.627 1.571 . . . . 2.1499999999999999 111.419 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.9 p -90.34 -22.03 21.73 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.728 1.211 . . . . 1.1499999999999999 113.458 -174.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 56.43 16.32 2.4 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.582 1.553 . . . . 1.74 113.923 -171.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.81 146.13 24.01 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.94 -1.1 . . . . 2.79 113.124 -175.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.9 mt -81.56 142.73 32.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.102 1.361 . . . . 0.95999999999999996 112.648 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 83.8 p -77.67 4.4 11.57 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.418 1.266 . . . . 1.3700000000000001 114.418 172.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.83 -162.52 29.63 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 126.106 1.813 . . . . 1.1599999999999999 112.388 -176.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.66 154.75 39.57 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.827 1.047 . . . . 1.3899999999999999 113.827 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 mtp -51.8 138.18 33.4 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.39 1.076 . . . . 2.1299999999999999 112.64 174.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -83.48 171.2 11.23 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.536 3.491 . . . . 0.82999999999999996 113.895 -172.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.12 -96.19 0.09 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.583 1.553 . . . . 1.3899999999999999 110.545 168.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.1 p -72.77 13.51 0.36 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 116.627 2.084 . . . . 1.02 116.627 -168.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.61 145.09 19.78 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.042 -1.036 . . . . 0.53000000000000003 112.812 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.1 ttt -75.0 107.89 7.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.872 2.469 . . . . 1.8100000000000001 110.353 176.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -157.73 143.24 17.11 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 127.303 2.241 . . . . 1.04 112.702 -174.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -164.91 158.1 16.84 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.013 1.325 . . . . 1.8700000000000001 111.859 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.8 mp -101.79 144.99 29.78 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.991 1.317 . . . . 0.53000000000000003 113.981 175.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.8 p -64.54 136.17 56.76 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.721 0.638 . . . . 0.54000000000000004 112.721 173.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.03 -59.13 1.86 Allowed 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 114.965 1.468 . . . . 2.3300000000000001 114.965 -172.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.25 -39.61 0.14 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.184 0.994 . . . . 1.0 111.871 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -115.35 -27.01 7.36 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.09 0.956 . . . . 5.2000000000000002 112.515 174.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 179.64 -156.04 17.2 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 123.836 0.732 . . . . 0.58999999999999997 112.263 -178.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.74 131.12 23.67 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.023 2.129 . . . . 0.41999999999999998 111.5 171.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -83.49 140.64 32.19 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.945 1.298 . . . . 1.27 113.579 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -134.39 118.74 17.77 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.989 2.516 . . . . 1.7 108.977 175.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.435 HD22 ' HB3' ' A' ' 132' ' ' ALA . 7.3 t-20 -76.27 113.14 13.5 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.569 1.148 . . . . 1.6000000000000001 109.427 177.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 35.9 p -103.61 0.66 31.08 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.921 1.288 . . . . 0.69999999999999996 113.219 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.435 ' HB3' HD22 ' A' ' 130' ' ' ASN . . . -53.41 -18.48 2.66 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.756 2.422 . . . . 1.0600000000000001 115.276 -178.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -105.81 -23.81 12.62 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.373 1.869 . . . . 2.4199999999999999 113.088 -174.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.57 140.03 96.31 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 119.318 0.963 . . . . 0.94999999999999996 112.458 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.09 169.18 23.14 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.581 2.187 . . . . 0.82999999999999996 111.482 169.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.47 93.05 2.4 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.978 1.311 . . . . 1.3300000000000001 109.614 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -144.51 178.79 7.7 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.478 1.111 . . . . 0.96999999999999997 111.079 174.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -94.95 141.69 28.35 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.335 1.054 . . . . 3.29 110.988 169.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -135.34 166.72 22.5 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.222 1.809 . . . . 0.63 110.272 -172.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -141.49 149.17 40.56 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.24 0.83 . . . . 1.74 113.24 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 mp -105.91 142.34 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.572 1.149 . . . . 0.46000000000000002 110.201 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -129.43 127.29 40.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.891 1.676 . . . . 1.96 111.491 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -91.84 75.21 5.68 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.967 0.907 . . . . 1.95 112.656 -171.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.0 mm -77.75 107.99 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.742 0.817 . . . . 0.72999999999999998 109.908 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.78 9.07 40.43 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.763 1.023 . . . . 4.2400000000000002 113.763 -174.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 113.752 1.019 . . . . 2.3900000000000001 113.752 -176.551 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 119.478 -0.296 . . . . 2.29 111.788 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.33 128.85 36.66 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.996 0.816 . . . . 1.04 111.79 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.2 m -100.46 149.6 36.24 Favored Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 124.24 1.016 . . . . 0.76000000000000001 110.356 172.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.74 161.29 46.59 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.797 2.331 . . . . 0.75 113.058 -170.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 1.5 mp -121.84 127.87 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.347 1.059 . . . . 1.55 110.761 -169.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -93.02 139.37 30.6 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.896 1.279 . . . . 2.7200000000000002 112.466 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.8 tt -147.48 146.57 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.965 1.306 . . . . 0.48999999999999999 111.964 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -120.88 155.73 33.52 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.047 1.339 . . . . 2.2999999999999998 110.639 169.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -67.53 148.61 98.6 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 123.793 0.837 . . . . 1.3 112.139 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.0 112.1 3.04 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.527 2.818 . . . . 1.1399999999999999 114.008 -168.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 tp -119.04 0.98 11.39 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 125.239 1.416 . . . . 2.79 110.854 165.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -76.85 169.16 18.82 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 129.585 3.154 . . . . 2.8999999999999999 111.53 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -74.16 19.54 0.12 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 116.46 2.022 . . . . 4.21 116.46 -171.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . 0.252 1.2 m -95.41 147.53 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 O-C-N 121.04 -1.038 . . . . 1.27 113.672 -169.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 41.2 t -88.31 -32.35 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.079 1.352 . . . . 1.6399999999999999 112.129 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -147.13 127.38 13.86 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.544 1.537 . . . . 2.54 108.645 -174.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -101.57 143.15 31.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.561 1.144 . . . . 0.41999999999999998 112.449 -169.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -139.02 170.62 15.65 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.329 1.603 . . . . 0.65000000000000002 115.329 -178.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.4 t -139.74 139.94 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.752 2.021 . . . . 0.57999999999999996 111.336 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -132.97 82.79 54.03 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.96 1.304 . . . . 2.23 112.988 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -65.89 143.53 73.44 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.689 3.593 . . . . 0.58999999999999997 113.913 171.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -140.71 166.68 24.1 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 129.08 2.952 . . . . 1.8999999999999999 111.027 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -117.93 169.52 9.57 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.927 0.891 . . . . 2.9500000000000002 113.06 -171.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.472 0.645 0 C-N-CA 126.662 1.985 . . . . 2.54 111.74 -178.218 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 112.8 0.667 . . . . 1.3100000000000001 112.8 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.4 p -92.8 -15.4 26.58 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.391 1.076 . . . . 1.47 113.754 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.4 HG21 ' HA ' ' A' ' 177' ' ' ASP . 98.9 m -148.37 124.44 10.73 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.008 1.723 . . . . 2.2599999999999998 108.9 171.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 45.2 p -90.86 23.63 3.07 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.181 1.548 . . . . 1.8500000000000001 115.181 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 m -149.17 165.79 30.76 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.057 1.343 . . . . 1.75 110.523 168.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.4 p -144.05 142.6 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.007 1.723 . . . . 0.34000000000000002 109.793 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.2 m -116.01 124.83 51.47 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.717 0.807 . . . . 0.65000000000000002 110.273 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -101.98 131.19 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.803 1.241 . . . . 0.63 110.599 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -128.15 104.67 7.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.227 1.411 . . . . 1.8100000000000001 110.888 -172.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.74 116.95 20.21 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.493 -1.379 . . . . 1.24 111.575 -172.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.3 mt -106.6 151.75 24.63 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.039 1.336 . . . . 0.66000000000000003 111.762 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.9 mt -138.16 171.55 14.24 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.33 1.452 . . . . 1.6000000000000001 111.137 169.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.56 162.77 13.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.356 1.063 . . . . 0.71999999999999997 112.678 170.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.6 p -91.39 -24.73 19.66 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 114.751 1.389 . . . . 0.93000000000000005 114.751 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -138.11 38.61 2.33 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.113 1.765 . . . . 2.1000000000000001 111.601 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.19 14.39 79.08 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 120.84 -1.163 . . . . 0.92000000000000004 115.659 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.01 25.26 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 128.889 2.876 . . . . 1.8400000000000001 116.221 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -24.59 67.59 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 119.883 -1.761 . . . . 0.69999999999999996 113.202 -173.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -75.28 -40.13 59.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.769 1.168 . . . . 2.1200000000000001 113.481 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.1 ptmm? -70.48 -41.41 72.75 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 117.448 -1.263 . . . . 2.79 111.357 170.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.6 mt -55.64 -52.88 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 120.252 1.387 . . . . 0.81999999999999995 111.47 170.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.61 -34.08 70.73 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.08 -1.013 . . . . 1.1699999999999999 112.785 -178.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -77.2 -30.75 54.88 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.715 1.005 . . . . 1.4099999999999999 113.715 175.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -66.35 -30.71 71.16 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.133 0.879 . . . . 2.1200000000000001 111.789 169.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.6 mt -86.4 -37.57 18.26 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.483 1.29 . . . . 1.3400000000000001 114.483 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -72.64 -23.89 60.97 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.063 0.764 . . . . 3.6800000000000002 113.063 -177.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.0 t -76.81 -28.43 55.57 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.673 0.62 . . . . 2.2000000000000002 112.673 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.6 156.65 35.23 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.106 1.336 . . . . 1.3500000000000001 112.745 172.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -83.57 31.45 0.47 Allowed 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.21 -1.171 . . . . 2.3500000000000001 112.817 -173.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -71.08 5.42 2.1 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.786 1.402 . . . . 2.0699999999999998 114.786 -169.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.95 -22.35 62.37 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.007 -1.058 . . . . 1.1299999999999999 112.289 167.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.69 -82.11 1.15 Allowed Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.263 1.411 . . . . 0.84999999999999998 113.455 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -71.42 157.09 38.66 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.491 1.916 . . . . 1.5 114.933 -172.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.9 157.14 19.06 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.687 1.195 . . . . 3.4900000000000002 113.793 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.477 HG23 ' CE2' ' A' ' 181' ' ' TYR . 25.1 t -63.67 130.98 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.907 0.883 . . . . 1.0800000000000001 110.539 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.67 -51.65 29.41 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 119.776 -0.458 . . . . 1.1100000000000001 113.723 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 t -146.73 136.36 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.227 1.411 . . . . 2.0600000000000001 109.629 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.1 mt -84.96 150.71 56.17 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.723 0.809 . . . . 1.04 113.151 171.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.429 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 72.9 Cg_endo -72.99 159.13 48.62 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.566 2.178 . . . . 0.73999999999999999 111.564 171.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.29 -30.17 66.41 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.421 -0.799 . . . . 1.1299999999999999 112.889 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -87.43 1.89 52.07 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.635 1.717 . . . . 1.48 115.635 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HB2' ' HG2' ' A' ' 70' ' ' PRO . . . -88.95 154.35 20.3 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.771 1.169 . . . . 0.56000000000000005 113.915 172.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -146.78 169.86 18.21 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.699 2.0 . . . . 2.04 112.329 171.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -128.31 138.42 52.38 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.3 1.44 . . . . 2.2000000000000002 111.248 -173.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.0 pt -126.96 141.56 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 114.096 1.147 . . . . 0.80000000000000004 114.096 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -112.97 158.31 20.41 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.833 1.253 . . . . 0.70999999999999996 112.993 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.64 4.88 82.44 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.789 1.185 . . . . 0.75 114.654 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -86.61 141.2 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.052 1.341 . . . . 0.80000000000000004 110.75 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -104.81 134.3 48.18 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.851 1.66 . . . . 0.66000000000000003 113.193 -173.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.438 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.7 OUTLIER -141.02 154.03 45.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.761 1.224 . . . . 1.71 112.278 177.874 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 m -127.04 144.32 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 126.513 1.925 . . . . 0.40999999999999998 110.067 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -87.18 147.69 25.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.595 1.188 . . . . 0.41999999999999998 112.024 170.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.5 p -140.99 167.24 22.66 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.881 2.072 . . . . 0.40000000000000002 111.13 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.8 171.57 11.46 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.949 0.722 . . . . 2.1499999999999999 112.949 169.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.2 t -63.13 -23.99 67.69 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.566 1.321 . . . . 3.1499999999999999 114.566 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -87.6 24.42 1.7 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.649 1.18 . . . . 2.3100000000000001 113.085 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.52 27.44 16.61 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 128.105 2.562 . . . . 0.80000000000000004 114.602 172.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -89.88 143.26 26.95 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.169 1.388 . . . . 1.8100000000000001 111.795 174.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.2 mt -79.3 127.48 39.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 123.28 0.632 . . . . 0.48999999999999999 110.034 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.731 HG22 HG22 ' A' ' 97' ' ' THR . 3.3 pt -121.61 153.94 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.991 1.716 . . . . 0.52000000000000002 115.139 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -84.6 165.55 17.88 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.429 2.291 . . . . 2.1000000000000001 110.574 167.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -64.91 -12.57 50.67 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.139 1.533 . . . . 2.5099999999999998 115.139 -170.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -96.98 6.11 49.24 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.319 1.448 . . . . 2.6200000000000001 113.564 173.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.62 5.12 82.21 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.938 1.256 . . . . 0.68999999999999995 115.066 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -73.69 142.71 46.39 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 124.321 1.048 . . . . 2.1099999999999999 110.403 173.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.731 HG22 HG22 ' A' ' 91' ' ' ILE . 30.6 p -104.94 147.29 27.94 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.974 0.91 . . . . 0.72999999999999998 112.499 -171.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.12 2.54 37.56 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.229 1.566 . . . . 0.81000000000000005 115.229 -168.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.88 23.43 74.82 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 120.529 -1.357 . . . . 0.75 114.733 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.2 p -138.05 143.38 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.709 1.204 . . . . 2.7400000000000002 109.749 177.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.14 164.59 18.37 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.7 2.4 . . . . 1.49 110.755 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 66.5 mt -135.61 131.13 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 124.873 1.269 . . . . 0.67000000000000004 110.321 -177.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -69.02 138.81 90.1 Favored Pre-proline 0 CA--C 1.543 0.696 0 O-C-N 121.038 -1.039 . . . . 2.29 110.813 175.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.07 -18.4 21.26 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 CA-C-N 122.12 1.793 . . . . 0.71999999999999997 113.21 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -97.77 -52.4 3.75 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.416 1.886 . . . . 1.8200000000000001 110.892 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.3 p -80.45 -25.75 38.73 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.019 0.748 . . . . 0.91000000000000003 113.019 -176.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 58.24 12.86 2.09 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.406 1.482 . . . . 1.6699999999999999 113.842 -171.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.02 150.66 26.21 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.624 -1.297 . . . . 2.4700000000000002 111.737 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.3 mt -85.52 140.63 30.49 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.68 0.993 . . . . 0.84999999999999998 113.68 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.2 t -88.66 35.93 0.79 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.533 1.533 . . . . 2.6899999999999999 111.397 169.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 170.46 -168.81 41.81 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.678 2.085 . . . . 1.1699999999999999 111.702 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.54 163.09 26.6 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.425 0.69 . . . . 1.01 111.396 170.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.7 tpt -59.87 127.19 85.09 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.081 0.952 . . . . 1.6299999999999999 110.778 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -69.91 171.57 14.39 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 124.818 3.679 . . . . 0.83999999999999997 113.671 -172.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.37 -92.18 0.07 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.332 1.053 . . . . 1.5700000000000001 110.722 169.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.8 p -73.83 6.65 3.09 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.7 2.0 . . . . 0.70999999999999996 116.398 -167.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.12 147.16 7.82 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.427 1.091 . . . . 0.42999999999999999 113.8 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.1 tpt -74.76 92.03 2.45 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.933 2.093 . . . . 1.55 112.196 -177.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.9 pttm -143.61 148.16 35.44 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.013 1.325 . . . . 2.1800000000000002 113.636 -175.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -162.85 165.6 25.07 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.186 1.395 . . . . 2.3300000000000001 111.356 172.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.2 mp -98.14 150.03 21.9 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.876 1.67 . . . . 0.63 113.25 172.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.438 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 2.5 p -67.23 135.9 54.13 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 119.632 1.105 . . . . 0.53000000000000003 111.131 168.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -89.01 -53.04 4.77 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 115.225 1.565 . . . . 2.1099999999999999 115.225 -175.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.55 -45.51 0.07 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.911 1.284 . . . . 1.1799999999999999 110.647 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -116.72 -18.77 10.18 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.015 1.117 . . . . 5.3799999999999999 114.015 176.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 177.35 -163.93 32.83 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.986 1.279 . . . . 0.62 112.216 -176.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -143.17 132.15 22.91 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.542 2.337 . . . . 0.41999999999999998 110.942 169.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -84.51 144.18 28.86 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.246 1.418 . . . . 1.3 112.323 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -135.5 124.37 24.05 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.969 2.107 . . . . 1.8300000000000001 108.708 172.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -73.11 134.59 44.56 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.504 -0.748 . . . . 1.76 111.216 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 71.9 p -121.37 6.14 10.16 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.412 1.485 . . . . 0.56000000000000005 113.671 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.7 -36.24 69.41 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.654 1.115 . . . . 0.94999999999999996 113.168 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -91.36 -21.48 20.99 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.835 1.254 . . . . 1.78 111.088 -169.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.1 139.95 96.0 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 119.819 1.19 . . . . 0.59999999999999998 112.663 170.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.67 169.65 20.48 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.997 2.464 . . . . 0.71999999999999997 111.192 167.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.2 89.34 3.67 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.547 1.539 . . . . 0.94999999999999996 111.26 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -146.84 -179.56 6.88 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.355 1.062 . . . . 0.67000000000000004 112.394 -175.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -98.4 137.54 36.94 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.199 1.399 . . . . 2.96 112.183 173.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -135.91 167.47 21.14 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.327 1.451 . . . . 0.52000000000000002 111.287 -169.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -139.78 153.17 47.07 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.159 0.799 . . . . 1.6399999999999999 113.159 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.9 mp -110.54 144.58 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.437 1.095 . . . . 0.40000000000000002 110.367 170.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -130.57 144.09 51.19 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.792 2.037 . . . . 1.8899999999999999 110.691 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -103.66 112.33 25.21 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.349 1.06 . . . . 2.1400000000000001 109.849 -175.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 19.7 mm -124.33 85.9 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.389 1.076 . . . . 0.97999999999999998 110.061 -168.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -14.79 60.64 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.438 -0.789 . . . . 4.04 113.063 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.47 0.541 0 C-N-CA 124.651 1.18 . . . . 2.1899999999999999 113.62 170.131 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 114.043 1.127 . . . . 2.1600000000000001 114.043 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.21 150.94 45.93 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.357 -0.84 . . . . 0.95999999999999996 112.308 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.35 147.43 40.54 Favored Pre-proline 0 N--CA 1.478 0.975 0 C-N-CA 125.069 1.347 . . . . 0.68999999999999995 111.169 174.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.93 138.69 23.54 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.411 2.741 . . . . 0.5 112.825 -168.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.0 mp -100.74 119.6 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 124.854 1.261 . . . . 1.3 109.982 -171.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.2 pm0 -88.51 138.99 30.93 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.829 0.852 . . . . 4.7800000000000002 113.161 174.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.2 tt -148.49 156.67 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.316 1.446 . . . . 0.59999999999999998 111.408 -173.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -127.58 152.49 47.58 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.473 1.509 . . . . 1.8400000000000001 110.092 170.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.2 138.68 97.32 Favored Pre-proline 0 CA--C 1.548 0.897 0 O-C-N 120.98 -1.075 . . . . 1.3100000000000001 111.226 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -72.64 111.6 3.28 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.575 2.183 . . . . 0.84999999999999998 114.844 -168.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.91 58.48 1.09 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 104.936 -2.246 . . . . 2.6400000000000001 104.936 165.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -144.15 144.59 31.64 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.13 2.572 . . . . 2.7000000000000002 108.512 -166.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -76.68 57.79 1.31 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.451 1.278 . . . . 3.9100000000000001 114.451 -170.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 1.6 m -112.94 151.15 14.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 125.114 1.365 . . . . 1.1599999999999999 110.538 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 96.4 t -88.13 -30.68 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.129 1.372 . . . . 1.53 110.802 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.4 ' HA ' HG21 ' A' ' 34' ' ' THR . 8.1 t0 -146.95 142.36 27.47 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.108 0.963 . . . . 2.5499999999999998 111.512 175.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -102.93 143.81 32.04 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.267 -0.896 . . . . 0.40000000000000002 112.702 -175.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -139.95 170.87 15.07 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.682 1.734 . . . . 0.52000000000000002 115.682 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -140.37 142.89 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.673 1.989 . . . . 0.45000000000000001 111.508 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.477 ' CE2' HG23 ' A' ' 66' ' ' VAL . 98.0 m-85 -131.77 76.42 74.39 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 113.814 1.042 . . . . 1.98 113.814 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' PRO . . . . . 0.534 ' HB3' HD11 ' A' ' 166' ' ' ILE . 5.1 Cg_endo -62.51 146.9 95.5 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.528 2.819 . . . . 0.68000000000000005 113.912 176.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 15.8 mtmt -121.4 -168.7 1.73 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 128.609 2.764 . . . . 1.73 111.057 -174.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.259 0.6 OUTLIER -137.41 172.84 12.38 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.868 1.667 . . . . 3.4300000000000002 110.793 167.454 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 CA--C 1.539 0.534 0 C-N-CA 125.18 1.392 . . . . 2.71 109.711 173.166 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.7 p . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 111.541 0.2 . . . . 1.1799999999999999 111.541 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.7 p -88.74 -17.12 30.55 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.335 0.865 . . . . 1.8 113.335 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 84.9 m -146.12 128.45 15.84 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.675 1.59 . . . . 2.7999999999999998 110.149 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 p -88.43 7.77 31.08 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 116.1 1.889 . . . . 1.26 116.1 -173.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.6 m -150.65 165.76 32.41 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.461 1.504 . . . . 1.77 111.811 171.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.73 144.59 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.266 1.827 . . . . 0.52000000000000002 110.938 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.01 111.33 17.76 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.934 1.293 . . . . 1.46 110.704 -170.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 p -98.9 133.73 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 120.376 -1.453 . . . . 0.54000000000000004 110.696 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -134.95 104.75 6.09 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.451 1.5 . . . . 1.8100000000000001 111.669 -171.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.53 126.03 30.72 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 119.887 -1.758 . . . . 1.1699999999999999 111.738 -173.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.4 mt -112.99 155.88 24.02 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.918 1.287 . . . . 0.48999999999999999 112.64 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.98 167.77 21.1 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.211 1.404 . . . . 1.9199999999999999 111.063 175.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.81 168.87 8.82 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.143 1.377 . . . . 0.68999999999999995 112.219 173.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.0 p -97.04 -27.69 14.49 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.612 0.968 . . . . 0.94999999999999996 113.612 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -145.3 37.59 1.13 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.455 1.102 . . . . 2.4700000000000002 112.807 172.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.62 14.38 59.88 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.87 1.224 . . . . 0.93999999999999995 115.449 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.38 14.34 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 128.232 2.613 . . . . 1.97 116.411 -174.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -63.09 -20.29 65.22 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.217 -1.552 . . . . 0.78000000000000003 113.939 -172.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -84.8 -38.84 19.1 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.647 1.179 . . . . 2.46 112.721 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -68.37 -40.39 81.46 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 120.901 -1.124 . . . . 2.6200000000000001 110.016 169.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.8 mt -54.86 -46.7 75.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 118.954 0.797 . . . . 0.71999999999999997 110.375 168.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.55 -29.46 69.16 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 120.372 1.442 . . . . 0.96999999999999997 113.655 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -77.44 -29.78 53.06 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.076 0.95 . . . . 1.4099999999999999 113.401 170.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -64.57 -28.08 69.39 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.135 -0.978 . . . . 2.4700000000000002 110.911 167.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.0 mt -87.82 -38.95 15.26 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.454 1.279 . . . . 1.1799999999999999 114.454 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.15 -25.78 67.95 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.833 1.049 . . . . 3.1200000000000001 113.833 -176.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.9 t -74.51 -25.81 59.59 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.534 0.734 . . . . 1.8799999999999999 112.977 174.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.16 166.69 38.86 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.174 1.369 . . . . 1.3 113.323 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -90.63 31.19 1.06 Allowed 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.323 -1.104 . . . . 1.6699999999999999 113.381 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -69.29 5.72 1.2 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.213 1.56 . . . . 2.1899999999999999 115.213 -169.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.32 -22.3 66.9 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.108 -0.995 . . . . 1.0800000000000001 111.486 166.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.87 -81.63 1.16 Allowed Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.881 1.705 . . . . 0.80000000000000004 113.52 170.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.24 172.19 12.26 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.031 1.332 . . . . 1.6100000000000001 114.582 -175.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -76.02 162.03 28.4 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 115.293 1.59 . . . . 3.3300000000000001 115.293 -169.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.422 HG23 ' CE2' ' A' ' 181' ' ' TYR . 21.9 t -55.18 130.64 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.433 1.093 . . . . 1.3500000000000001 110.526 172.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.36 -46.8 24.91 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 121.801 -0.562 . . . . 0.96999999999999997 113.808 -177.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.0 p -160.73 141.26 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.864 2.066 . . . . 3.1899999999999999 110.267 177.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.4 mt -84.84 147.67 49.16 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 121.466 -0.771 . . . . 1.3999999999999999 112.744 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.58 158.02 51.57 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.232 1.954 . . . . 0.81999999999999995 111.53 169.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.58 -19.6 65.98 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 120.708 -1.245 . . . . 1.1100000000000001 113.023 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -89.54 0.77 56.68 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.576 1.95 . . . . 1.3999999999999999 114.962 172.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.0 162.76 12.89 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.212 1.005 . . . . 0.67000000000000004 111.852 168.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -156.25 171.46 20.16 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.376 1.47 . . . . 2.02 111.56 169.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -123.35 148.87 45.59 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.643 1.177 . . . . 2.0800000000000001 110.592 -175.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.2 pt -137.24 137.01 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.683 1.193 . . . . 0.68999999999999995 110.715 175.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.95 161.59 14.07 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.321 1.048 . . . . 0.56999999999999995 111.005 171.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.01 15.84 62.12 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 121.315 -0.866 . . . . 0.51000000000000001 114.747 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.13 140.99 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.457 1.503 . . . . 0.68000000000000005 109.358 168.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -104.62 137.49 42.37 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.296 1.438 . . . . 0.53000000000000003 113.321 -173.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.43 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.8 OUTLIER -142.17 151.15 41.93 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.472 1.109 . . . . 1.5800000000000001 112.922 177.197 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 m -122.37 145.75 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.962 2.105 . . . . 0.34000000000000002 110.133 -176.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -86.61 145.94 26.53 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 122.301 1.048 . . . . 0.39000000000000001 112.124 169.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 35.8 p -140.88 170.15 16.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.66 1.984 . . . . 0.35999999999999999 112.223 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.36 -170.46 2.75 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 115.731 1.752 . . . . 1.9099999999999999 115.731 174.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.9 p -54.85 -42.37 71.9 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.641 1.176 . . . . 2.3100000000000001 111.646 171.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -88.94 20.03 3.8 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.974 1.31 . . . . 2.27 112.877 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.88 29.04 16.95 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.336 1.454 . . . . 0.67000000000000004 111.781 175.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -84.41 141.57 30.75 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 125.927 1.691 . . . . 2.5499999999999998 109.84 174.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.9 mt -78.69 125.31 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 109.356 -0.609 . . . . 0.52000000000000002 109.356 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.3 pt -120.44 155.13 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.614 1.166 . . . . 0.55000000000000004 114.118 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -86.38 166.11 15.83 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.372 1.869 . . . . 1.47 110.405 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -59.62 -21.36 60.31 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.921 1.452 . . . . 2.1400000000000001 114.921 -174.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -90.86 4.52 51.58 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.894 1.277 . . . . 2.8199999999999998 112.816 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.35 9.73 86.19 Favored Glycine 0 CA--C 1.533 1.195 0 O-C-N 120.523 -1.36 . . . . 0.55000000000000004 114.866 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -69.47 143.99 53.37 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.588 1.194 . . . . 2.23 109.192 168.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.9 p -105.45 140.04 39.16 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.112 1.365 . . . . 0.81000000000000005 111.765 -172.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.26 2.68 54.9 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.601 0.963 . . . . 0.76000000000000001 113.601 -170.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.44 25.35 70.61 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.75 -1.219 . . . . 0.72999999999999998 113.663 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 54.1 t -131.69 149.04 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.488 1.915 . . . . 1.1599999999999999 109.397 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -130.03 158.16 40.36 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.999 2.52 . . . . 1.4199999999999999 111.52 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.0 mt -135.94 128.37 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.631 1.572 . . . . 0.58999999999999997 109.802 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -69.02 141.44 92.03 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 117.565 -1.207 . . . . 1.8100000000000001 111.012 174.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -73.91 -22.13 17.75 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 CA-C-N 122.828 2.046 . . . . 0.60999999999999999 113.236 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 68.6 mm-40 -93.29 -53.46 4.09 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 127.034 2.134 . . . . 1.4099999999999999 112.158 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.9 p -78.29 -24.36 46.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.093 0.557 . . . . 0.81000000000000005 112.381 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 53.8 17.27 1.24 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.721 1.209 . . . . 1.6299999999999999 112.718 -171.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.46 138.2 31.68 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.021 0.928 . . . . 2.5699999999999998 111.257 -174.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.0 mt -78.08 144.18 36.77 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.021 0.928 . . . . 0.85999999999999999 111.394 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 95.2 p -72.72 3.93 4.58 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.892 1.071 . . . . 1.47 113.892 170.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.16 -153.85 13.04 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.719 1.152 . . . . 1.26 113.941 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.28 160.12 21.78 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.046 1.339 . . . . 1.26 112.712 176.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 mmt -51.42 140.95 24.13 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.57 1.548 . . . . 1.5800000000000001 114.062 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.71 167.26 27.0 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 124.543 3.495 . . . . 0.91000000000000003 114.242 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.37 -48.15 13.37 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 116.072 1.878 . . . . 1.72 116.072 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 46.1 p -134.11 10.84 3.88 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.408 1.083 . . . . 0.81999999999999995 113.887 -169.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.95 152.74 7.09 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 116.062 1.875 . . . . 0.55000000000000004 116.062 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.6 tpt -75.41 96.75 3.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.638 2.375 . . . . 1.52 111.889 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -150.81 150.27 30.75 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.711 1.204 . . . . 1.1599999999999999 113.317 -174.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -160.74 161.89 32.31 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.624 1.17 . . . . 3.2000000000000002 111.789 173.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.7 mp -93.37 152.14 19.32 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.154 0.982 . . . . 0.63 111.924 167.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.43 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 1.7 p -67.56 128.49 36.66 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 108.796 -0.816 . . . . 0.59999999999999998 108.796 167.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -80.35 -60.31 2.37 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.569 0.951 . . . . 2.1000000000000001 113.569 -173.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.51 -37.58 0.16 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.675 1.19 . . . . 1.04 111.254 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -121.56 -9.27 8.97 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.637 1.347 . . . . 3.8300000000000001 114.637 176.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 164.95 -168.31 39.08 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.141 1.353 . . . . 0.60999999999999999 112.619 -174.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.88 133.6 27.04 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.975 1.71 . . . . 0.55000000000000004 112.713 169.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -90.05 134.08 34.45 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.984 1.713 . . . . 1.53 112.378 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -126.35 128.47 47.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.292 1.837 . . . . 1.7 108.353 173.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -83.01 122.56 28.46 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.511 -0.743 . . . . 1.6699999999999999 110.989 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.9 p -103.56 -2.67 26.36 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.534 1.134 . . . . 0.65000000000000002 113.265 -176.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.07 -17.85 8.12 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.802 1.241 . . . . 0.73999999999999999 113.868 176.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -94.76 -17.34 22.26 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.595 1.958 . . . . 1.8899999999999999 114.127 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -90.42 147.23 36.15 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 114.455 1.28 . . . . 0.68000000000000005 114.455 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -84.27 170.5 10.68 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.796 2.997 . . . . 0.77000000000000002 111.991 167.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.42 79.1 2.47 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.912 2.085 . . . . 1.1699999999999999 112.607 -172.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.52 177.49 7.81 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.16 1.384 . . . . 0.84999999999999998 110.797 -177.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -97.7 140.34 32.24 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 123.049 1.404 . . . . 2.8500000000000001 112.08 171.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -129.04 177.73 6.92 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.87 1.668 . . . . 0.63 109.911 -173.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.79 152.74 40.02 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.375 1.07 . . . . 3.6499999999999999 112.276 175.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.0 mp -115.76 134.23 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.055 0.942 . . . . 0.34000000000000002 110.06 172.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -122.13 140.9 51.99 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.692 1.997 . . . . 1.9299999999999999 110.535 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -107.42 114.22 28.09 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.697 1.199 . . . . 2.0499999999999998 110.08 -175.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.5 mm -117.36 114.26 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.464 1.106 . . . . 0.69999999999999996 109.854 -168.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -80.92 -13.64 58.72 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.381 1.252 . . . . 3.9199999999999999 114.381 -171.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 56.1 p . . . . . 0 N--CA 1.473 0.705 0 CA-C-N 119.799 1.182 . . . . 2.0499999999999998 113.742 177.369 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 113.476 0.917 . . . . 1.98 113.476 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.72 157.57 30.03 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.696 0.76 . . . . 1.05 111.767 170.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.57 151.65 57.18 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 126.579 1.951 . . . . 0.89000000000000001 110.668 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -79.2 155.18 25.45 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.624 2.216 . . . . 0.63 111.301 -172.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 5.3 mt -109.48 133.19 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.492 1.117 . . . . 1.8999999999999999 109.622 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -93.75 136.65 33.82 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.165 0.893 . . . . 3.6299999999999999 111.137 168.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.0 tt -141.54 151.27 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.876 1.27 . . . . 0.63 111.471 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -121.09 157.53 29.89 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.306 1.842 . . . . 1.8400000000000001 108.026 169.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 5.7 mt -65.41 155.39 85.27 Favored Pre-proline 0 CA--C 1.544 0.748 0 O-C-N 120.536 -1.353 . . . . 1.0700000000000001 113.71 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -69.32 114.37 3.61 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.364 2.043 . . . . 1.0700000000000001 111.825 -176.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 17.0 tp -122.01 22.99 10.16 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.323 1.849 . . . . 2.8900000000000001 110.462 168.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -105.15 148.19 27.15 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.582 2.353 . . . . 3.2200000000000002 110.65 -169.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -75.87 61.48 1.46 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.148 1.379 . . . . 4.1100000000000003 111.976 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.0 m -122.01 158.22 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 127.541 2.336 . . . . 1.0900000000000001 112.405 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 59.2 t -82.98 -37.07 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.889 0.875 . . . . 1.6200000000000001 111.07 174.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -142.35 147.65 36.63 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.314 1.046 . . . . 2.9900000000000002 110.684 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -98.57 144.41 27.91 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.576 0.751 . . . . 0.38 111.009 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -133.43 166.36 22.71 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.314 1.227 . . . . 0.81000000000000005 114.314 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.57 146.64 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 127.089 2.156 . . . . 0.69999999999999996 111.437 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.422 ' CE2' HG23 ' A' ' 66' ' ' VAL . 87.9 m-85 -135.63 81.94 40.28 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 113.512 0.93 . . . . 2.0800000000000001 113.512 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -65.41 146.26 84.99 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.467 2.778 . . . . 0.63 113.345 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -124.2 -165.16 1.32 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.613 2.365 . . . . 2.3100000000000001 110.823 -173.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -134.02 169.81 16.58 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.0 1.32 . . . . 3.6000000000000001 110.579 168.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 13.6 t . . . . . 0 N--CA 1.474 0.745 0 C-N-CA 124.179 0.992 . . . . 2.0899999999999999 110.724 -176.62 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 38.9 p . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 112.161 0.43 . . . . 1.1499999999999999 112.161 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.6 p -98.5 -16.77 19.05 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.356 0.872 . . . . 1.5700000000000001 113.356 174.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.8 t -144.92 167.55 22.37 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.022 1.729 . . . . 1.8200000000000001 110.002 169.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.4 p -112.68 5.49 17.74 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.614 1.966 . . . . 0.84999999999999998 114.416 -169.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.8 p -138.57 162.58 34.21 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.114 1.153 . . . . 2.6200000000000001 114.114 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.67 146.7 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 126.516 1.926 . . . . 0.53000000000000003 109.408 169.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -125.12 114.2 18.72 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.591 1.156 . . . . 1.4399999999999999 110.401 -171.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.28 129.87 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 120.886 -1.134 . . . . 0.51000000000000001 111.312 -175.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -128.92 101.9 6.28 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.092 1.357 . . . . 1.78 111.157 -172.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.23 123.66 24.95 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.654 -1.279 . . . . 1.6000000000000001 111.548 -173.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.9 mt -106.04 156.42 18.41 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.129 1.372 . . . . 0.56000000000000005 112.681 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.64 161.89 37.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.313 1.845 . . . . 1.6799999999999999 109.912 175.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.8 162.14 13.27 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.682 0.793 . . . . 0.80000000000000004 111.852 169.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.3 p -86.76 -27.48 23.59 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.252 0.834 . . . . 0.95999999999999996 113.252 176.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -146.67 46.77 1.19 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.482 1.113 . . . . 3.1299999999999999 113.025 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.0 7.19 88.19 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 125.186 1.374 . . . . 0.93999999999999995 116.053 175.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.04 18.92 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 128.145 2.578 . . . . 1.8799999999999999 115.731 -174.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -59.91 -31.51 69.9 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.497 -1.377 . . . . 0.68999999999999995 112.315 -177.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.58 -52.84 63.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.75 1.62 . . . . 2.4399999999999999 112.548 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -71.71 -39.62 70.02 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-O 118.033 -0.984 . . . . 2.0699999999999998 111.583 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.2 mt -51.59 -55.04 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 119.266 0.939 . . . . 0.57999999999999996 110.34 168.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.73 -32.01 71.29 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.643 1.11 . . . . 0.94999999999999996 113.137 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -69.69 -27.26 64.86 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.786 1.032 . . . . 1.1599999999999999 113.786 172.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -73.77 -28.71 61.8 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.764 0.711 . . . . 2.1299999999999999 111.419 168.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.0 mt -85.1 -34.97 22.08 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.113 -0.992 . . . . 1.0600000000000001 113.292 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -71.3 -25.47 62.44 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.236 0.828 . . . . 3.1600000000000001 113.236 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.4 t -84.17 -24.13 30.3 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.274 1.03 . . . . 1.8 113.633 177.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.69 171.69 55.15 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.39 0.995 . . . . 1.0900000000000001 113.233 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -85.35 34.01 0.57 Allowed 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.959 -1.319 . . . . 1.8600000000000001 113.116 171.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -77.53 4.72 10.5 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 120.253 -1.529 . . . . 2.0800000000000001 113.385 -170.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.56 -10.82 60.2 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.035 -1.041 . . . . 1.6000000000000001 113.12 168.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.05 -74.07 0.26 Allowed Glycine 0 N--CA 1.474 1.178 0 CA-C-N 119.713 1.142 . . . . 1.1699999999999999 113.033 169.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -68.73 159.35 32.41 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.158 1.383 . . . . 1.96 113.052 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -61.18 155.99 19.45 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.749 1.22 . . . . 2.27 113.199 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.4 HG23 ' CD2' ' A' ' 181' ' ' TYR . 55.2 t -56.83 117.95 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 109.077 -0.712 . . . . 0.77000000000000002 109.077 172.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.77 -41.62 73.27 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.052 0.358 . . . . 0.88 112.908 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.1 t -138.51 123.95 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.29 1.036 . . . . 2.2000000000000002 111.165 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt -92.46 144.14 28.36 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.069 1.348 . . . . 0.87 110.544 168.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.19 159.32 37.12 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.949 2.433 . . . . 0.71999999999999997 112.0 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.84 -26.13 68.61 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.365 -0.835 . . . . 1.1799999999999999 112.86 172.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.99 3.65 22.25 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.398 1.629 . . . . 1.4299999999999999 115.398 172.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.68 153.98 20.04 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.823 1.249 . . . . 0.72999999999999998 113.577 170.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -143.89 160.69 40.35 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.562 1.545 . . . . 1.8100000000000001 111.641 169.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.96 139.54 50.04 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.268 1.027 . . . . 2.5899999999999999 110.414 -174.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 20.2 pt -133.48 147.23 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 116.396 1.999 . . . . 1.1299999999999999 116.396 -169.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.81 167.66 12.3 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.446 1.898 . . . . 0.96999999999999997 110.14 167.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.99 17.78 62.43 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 116.242 1.257 . . . . 0.64000000000000001 116.242 168.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.2 p -118.42 138.21 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.271 1.428 . . . . 0.66000000000000003 110.832 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 8.9 tpp -96.84 134.91 39.54 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.14 1.376 . . . . 0.52000000000000002 113.584 -177.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.44 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.8 OUTLIER -137.12 148.49 46.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.332 1.453 . . . . 2.0299999999999998 112.002 174.359 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.7 m -121.48 144.28 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.769 2.027 . . . . 0.34999999999999998 109.766 -175.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -88.23 148.39 24.38 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 122.648 1.213 . . . . 0.41999999999999998 112.754 171.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.9 p -143.93 172.79 12.38 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.848 2.059 . . . . 0.40999999999999998 112.217 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -94.61 169.31 10.27 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.453 1.501 . . . . 1.6000000000000001 112.242 168.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 67.9 p -62.66 -25.21 68.02 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.818 0.847 . . . . 1.45 112.702 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -74.78 7.31 3.19 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.686 1.594 . . . . 1.8200000000000001 113.383 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . 0.252 0.3 OUTLIER 63.18 26.38 15.22 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.744 2.418 . . . . 0.64000000000000001 114.291 179.217 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -88.77 145.04 25.85 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.655 1.582 . . . . 2.1000000000000001 111.631 175.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.7 mt -80.83 128.72 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.342 0.657 . . . . 0.42999999999999999 111.087 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.515 HG22 HG22 ' A' ' 97' ' ' THR . 2.2 pp -121.44 149.35 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 115.045 1.498 . . . . 0.95999999999999996 115.045 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -79.64 161.71 25.71 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 127.873 2.469 . . . . 2.3700000000000001 110.598 169.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -58.39 -22.61 54.45 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.315 1.228 . . . . 2.2999999999999998 114.315 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -90.52 3.71 53.21 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.306 1.043 . . . . 3.6200000000000001 111.955 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.59 20.93 75.98 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 127.234 2.349 . . . . 0.5 115.471 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -75.25 137.39 41.18 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.074 -1.084 . . . . 3.0699999999999998 108.074 167.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.515 HG22 HG22 ' A' ' 91' ' ' ILE . 17.6 p -93.74 135.17 35.31 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.945 0.898 . . . . 0.69999999999999996 111.414 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.69 -4.84 59.27 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.954 1.094 . . . . 0.59999999999999998 113.954 -168.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.02 25.96 56.65 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.265 0.936 . . . . 0.63 113.779 -176.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.8 t -130.36 146.7 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.886 1.674 . . . . 1.05 109.471 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -124.22 165.2 18.02 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.94 2.096 . . . . 3.8599999999999999 111.183 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.7 mt -134.87 140.78 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.887 1.275 . . . . 0.52000000000000002 109.841 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -76.31 137.91 68.02 Favored Pre-proline 0 CA--C 1.545 0.784 0 O-C-N 120.742 -1.224 . . . . 1.78 112.313 173.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.49 -11.46 20.61 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.061 1.841 . . . . 0.91000000000000003 113.854 174.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -99.48 -53.79 3.11 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.945 1.698 . . . . 2.0 111.102 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 p -80.48 -25.38 38.87 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.859 0.864 . . . . 0.77000000000000002 113.027 -174.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 59.13 15.89 4.43 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.771 1.629 . . . . 1.6799999999999999 113.9 -172.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.51 152.0 19.45 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.21 1.004 . . . . 2.6099999999999999 111.79 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.6 mt -78.56 145.21 34.95 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.682 1.593 . . . . 0.92000000000000004 112.648 -174.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.1 p -72.25 -8.19 53.46 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.665 0.987 . . . . 1.3400000000000001 113.665 173.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -171.9 -152.11 8.23 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.213 1.863 . . . . 0.87 111.848 -171.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.91 148.86 26.03 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.809 0.844 . . . . 0.93000000000000005 113.024 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.6 tpt -52.96 128.69 47.38 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.945 1.698 . . . . 1.3500000000000001 111.867 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.48 161.32 28.39 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.809 3.006 . . . . 0.87 114.441 -174.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.28 -61.79 1.89 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.272 1.829 . . . . 1.1100000000000001 114.105 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.1 p -105.88 10.79 32.37 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.855 1.262 . . . . 0.71999999999999997 114.266 -169.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.2 145.73 16.73 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.965 -1.084 . . . . 0.44 113.002 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.3 tpt -74.38 94.62 2.58 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.846 2.059 . . . . 1.53 110.574 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -148.71 140.15 23.4 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.462 1.105 . . . . 0.94999999999999996 113.454 -169.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -160.04 160.96 33.82 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.482 1.113 . . . . 1.78 111.842 -175.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.4 mp -103.04 149.52 24.49 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.804 1.242 . . . . 0.47999999999999998 112.214 173.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.44 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 1.9 p -66.83 132.05 47.2 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.759 -0.588 . . . . 0.54000000000000004 109.997 171.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.84 -61.13 1.95 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.646 1.178 . . . . 2.4700000000000002 113.79 -170.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -146.63 -34.43 0.28 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.999 1.319 . . . . 1.23 111.37 176.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -126.31 -17.97 5.05 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.524 1.305 . . . . 4.1699999999999999 114.524 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 179.61 -166.28 35.45 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.57 1.081 . . . . 0.59999999999999998 111.894 -172.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -145.25 134.32 22.67 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.869 1.668 . . . . 0.5 111.891 169.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -87.43 138.17 31.7 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.96 1.304 . . . . 1.53 112.858 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -128.51 130.02 46.88 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.162 2.185 . . . . 1.75 107.716 171.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -91.49 101.99 14.65 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.953 -1.092 . . . . 2.02 110.489 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.1 p -82.47 -0.54 46.86 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.118 1.367 . . . . 0.65000000000000002 113.727 -172.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -55.48 -32.0 62.47 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.766 0.826 . . . . 0.88 112.987 172.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -83.66 -20.86 32.84 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.006 0.922 . . . . 1.9299999999999999 112.682 -173.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.44 145.34 82.36 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 123.811 0.844 . . . . 0.68000000000000005 113.009 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -74.49 168.45 24.79 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.658 2.239 . . . . 0.89000000000000001 110.938 167.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.49 91.97 1.08 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.926 1.29 . . . . 1.0900000000000001 110.359 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -149.51 175.17 11.74 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.884 0.85 . . . . 0.77000000000000002 113.169 -174.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -94.15 147.19 23.4 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.385 1.874 . . . . 3.5499999999999998 109.347 169.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -143.9 170.12 16.51 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.651 1.581 . . . . 0.55000000000000004 110.438 -169.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.2 mttt -137.68 159.78 41.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.193 0.997 . . . . 2.0800000000000001 113.127 171.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.7 mp -118.56 142.2 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.02 1.328 . . . . 0.46999999999999997 109.899 172.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -129.58 147.21 51.36 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.435 1.894 . . . . 1.8999999999999999 110.495 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -109.16 124.26 50.54 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.637 1.175 . . . . 1.8700000000000001 111.26 -175.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 29.9 mm -128.09 98.96 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.921 0.888 . . . . 0.75 109.83 -169.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -73.12 4.32 4.54 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 115.064 1.505 . . . . 4.5300000000000002 115.064 -172.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.475 0.816 0 O-C-N 120.548 -1.345 . . . . 1.75 112.406 172.249 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 113.121 0.785 . . . . 2.27 113.121 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.36 150.31 47.46 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.016 1.327 . . . . 0.81999999999999995 113.323 174.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.51 153.71 52.07 Favored Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 124.515 1.126 . . . . 0.64000000000000001 111.604 -178.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.15 130.26 12.96 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.879 2.386 . . . . 0.73999999999999999 114.08 -166.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.447 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.6 mp -94.12 130.35 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 125.677 1.591 . . . . 1.47 109.259 -173.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.6 129.88 54.95 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.716 1.206 . . . . 4.96 112.129 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.2 tt -137.73 156.45 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.206 1.402 . . . . 0.53000000000000003 111.038 -169.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -139.89 148.91 42.72 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.794 1.238 . . . . 1.8899999999999999 109.871 170.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 12.4 mt -62.68 153.67 77.54 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 116.152 1.908 . . . . 1.0700000000000001 116.152 -168.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.1 116.73 4.82 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.84 2.36 . . . . 0.75 113.258 -170.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.6 tp -123.41 34.17 5.17 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.023 1.729 . . . . 2.2599999999999998 111.061 166.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -116.44 157.53 24.99 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 128.499 2.719 . . . . 2.6800000000000002 111.487 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.47 30.98 0.18 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.324 1.85 . . . . 4.1299999999999999 114.445 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 30.2 m -93.81 155.09 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.287 1.435 . . . . 1.8300000000000001 112.319 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 54.8 t -74.34 -35.95 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.185 0.994 . . . . 2.25 110.137 173.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -152.26 146.72 25.63 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.46 1.504 . . . . 3.4399999999999999 110.643 -174.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -98.75 156.7 16.71 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.036 0.934 . . . . 0.52000000000000002 112.304 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -136.71 162.02 34.32 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.04 1.496 . . . . 0.60999999999999999 115.04 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.64 144.65 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 127.225 2.21 . . . . 0.45000000000000001 110.815 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.4 ' CD2' HG23 ' A' ' 66' ' ' VAL . 97.1 m-85 -134.94 76.48 58.88 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 113.96 1.096 . . . . 2.0 113.96 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' PRO . . . . . 0.447 ' HB3' HD11 ' A' ' 166' ' ' ILE . 13.5 Cg_endo -65.87 146.38 82.95 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.011 3.141 . . . . 0.62 114.468 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -140.0 167.27 22.5 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 128.699 2.8 . . . . 1.9399999999999999 111.952 -169.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -117.51 167.03 11.66 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.656 1.354 . . . . 3.25 114.656 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 10.8 t . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 115.504 1.668 . . . . 2.2000000000000002 115.504 -179.745 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 111.488 0.181 . . . . 1.5600000000000001 111.488 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 65.8 p -82.81 -10.32 58.92 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 113.966 1.098 . . . . 1.8200000000000001 113.966 176.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 t -151.89 163.17 39.81 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.705 2.002 . . . . 2.5499999999999998 110.032 174.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.7 p -92.76 5.11 52.33 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.086 1.755 . . . . 1.1399999999999999 114.252 176.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.402 ' HA ' ' H ' ' A' ' 131' ' ' THR . 54.9 p -151.26 164.86 35.66 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.23 1.196 . . . . 1.72 114.23 -175.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.5 p -131.21 143.5 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.486 1.915 . . . . 0.38 109.964 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.7 m -110.74 112.62 24.61 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.676 0.79 . . . . 0.68999999999999995 111.411 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -93.11 132.9 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.004 -1.06 . . . . 0.58999999999999997 110.432 176.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -115.73 -173.93 2.43 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.69 1.596 . . . . 1.74 110.998 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -140.26 129.98 24.41 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 120.929 -1.107 . . . . 1.3400000000000001 111.439 168.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.4 mt -111.84 146.06 38.34 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.749 1.219 . . . . 0.85999999999999999 110.835 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.9 168.29 19.6 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.341 1.856 . . . . 1.6299999999999999 111.186 176.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.57 145.58 40.08 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.788 1.235 . . . . 0.72999999999999998 112.281 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.0 p -80.92 -32.54 34.62 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.318 1.229 . . . . 1.1499999999999999 114.318 -173.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -114.45 -15.55 12.05 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 119.882 1.219 . . . . 2.3700000000000001 113.295 175.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.68 11.08 1.95 Allowed Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.478 1.513 . . . . 1.1599999999999999 115.413 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.66 24.23 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 130.175 3.39 . . . . 1.8400000000000001 116.738 -169.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.94 -31.92 73.11 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 119.6 -1.937 . . . . 0.77000000000000002 114.022 -174.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -71.3 -43.79 66.44 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.114 0.87 . . . . 2.52 111.727 -175.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt -72.44 -38.85 68.19 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.267 -0.896 . . . . 4.0999999999999996 111.939 175.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.6 mt -52.68 -48.17 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 119.471 1.032 . . . . 0.66000000000000003 109.956 167.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.1 -34.83 75.57 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 121.092 -1.005 . . . . 0.93000000000000005 113.453 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -65.33 -39.28 92.22 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.794 0.838 . . . . 1.5700000000000001 112.069 171.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.15 -23.82 64.92 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.972 -1.08 . . . . 2.6800000000000002 112.841 177.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.1 mt -91.28 -32.24 15.8 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.315 1.228 . . . . 1.1799999999999999 114.315 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -70.61 -20.59 62.74 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.065 1.135 . . . . 2.96 114.065 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.7 t -78.86 -21.26 47.79 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.986 0.914 . . . . 1.5800000000000001 113.375 169.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.55 172.32 53.44 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.544 1.068 . . . . 1.3200000000000001 112.909 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -94.74 21.57 7.3 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.036 -1.273 . . . . 2.0099999999999998 112.348 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -70.87 18.05 0.06 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.421 1.488 . . . . 2.23 114.962 -170.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.98 -23.15 55.3 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 120.814 -1.179 . . . . 1.21 110.249 166.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -114.86 -57.35 0.36 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.52 1.057 . . . . 0.92000000000000004 113.684 172.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -81.68 162.81 22.87 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.952 1.301 . . . . 3.1499999999999999 113.381 -172.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -63.54 151.94 40.01 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.056 0.762 . . . . 2.3999999999999999 113.056 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 71.7 t -66.32 120.48 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 122.844 0.458 . . . . 0.81999999999999995 109.895 172.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.59 -37.9 33.89 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 114.83 0.692 . . . . 1.1000000000000001 114.83 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.6 t -142.61 116.59 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 118.387 1.093 . . . . 2.3700000000000001 111.041 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.8 mt -83.23 144.36 46.75 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.842 1.257 . . . . 1.0700000000000001 111.621 170.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.09 161.46 38.48 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.914 2.409 . . . . 0.89000000000000001 112.371 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.2 -8.84 42.4 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.039 1.126 . . . . 1.29 114.039 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.2 p30 -98.87 -3.92 34.24 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.548 1.539 . . . . 1.74 114.496 171.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.22 158.83 17.02 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.778 1.029 . . . . 0.71999999999999997 113.778 174.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.9 pttt -150.38 169.04 22.37 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.809 1.643 . . . . 2.25 111.741 167.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -124.37 130.62 52.82 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.013 1.325 . . . . 2.6299999999999999 112.146 -174.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.0 pt -121.81 151.46 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.075 0.95 . . . . 0.92000000000000004 113.397 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.98 156.02 29.27 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.263 1.425 . . . . 0.90000000000000002 111.97 171.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.57 12.93 42.8 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.09 1.328 . . . . 0.71999999999999997 115.654 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 p -86.02 148.12 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 119.228 1.514 . . . . 0.92000000000000004 110.679 169.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -105.64 137.75 42.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.483 1.513 . . . . 0.52000000000000002 112.565 176.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.67 157.79 44.31 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.097 1.359 . . . . 1.6299999999999999 112.441 173.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 m -125.62 147.35 30.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 126.771 2.028 . . . . 0.33000000000000002 110.083 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -89.91 149.08 22.77 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.397 1.079 . . . . 0.34999999999999998 112.975 171.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.7 p -144.8 167.71 21.94 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.409 1.884 . . . . 0.34000000000000002 112.618 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -90.83 171.54 9.25 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.199 1.0 . . . . 2.2200000000000002 112.074 167.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 66.9 p -61.04 -23.53 65.5 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.154 -0.966 . . . . 1.3600000000000001 113.577 -177.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -70.86 4.83 2.29 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 126.222 1.809 . . . . 2.8700000000000001 114.003 169.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.26 27.79 14.2 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.916 2.087 . . . . 0.66000000000000003 112.964 -172.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -86.01 138.61 31.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.458 1.503 . . . . 2.5299999999999998 110.414 177.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.3 mt -81.2 129.33 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.139 0.495 . . . . 0.65000000000000002 110.164 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.478 HG22 HG22 ' A' ' 97' ' ' THR . 6.2 pt -123.86 154.27 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 114.567 1.321 . . . . 0.56000000000000005 114.567 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -84.84 159.44 20.39 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.972 2.109 . . . . 1.49 108.37 166.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -62.8 -8.69 7.34 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.862 1.801 . . . . 2.29 115.862 -172.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -91.31 -1.22 57.7 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.556 1.143 . . . . 3.4500000000000002 112.706 172.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.34 3.72 84.27 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.65 1.595 . . . . 0.48999999999999999 114.476 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -68.14 140.38 56.17 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.813 1.245 . . . . 2.6000000000000001 109.1 173.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.478 HG22 HG22 ' A' ' 91' ' ' ILE . 16.2 p -103.56 146.07 29.1 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.594 0.758 . . . . 0.66000000000000003 112.077 -173.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.62 -11.02 25.84 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.983 0.734 . . . . 0.80000000000000004 112.983 -169.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.74 21.91 48.67 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.706 1.146 . . . . 1.0600000000000001 114.616 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.3 p -138.57 146.19 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.626 1.57 . . . . 2.6000000000000001 110.262 -173.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -127.89 155.04 44.8 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 128.087 2.555 . . . . 1.45 111.364 -172.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 61.4 mt -126.96 142.85 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.97 1.308 . . . . 0.60999999999999999 110.849 -174.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -76.23 132.69 72.86 Favored Pre-proline 0 CA--C 1.54 0.565 0 O-C-N 120.611 -1.306 . . . . 2.3999999999999999 110.57 170.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -70.09 -8.46 23.67 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.074 1.849 . . . . 1.02 114.819 174.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -106.98 -47.55 3.68 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.06 1.344 . . . . 1.6200000000000001 112.346 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.7 p -87.86 -23.16 24.07 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.131 0.972 . . . . 0.93000000000000005 113.331 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 55.52 17.07 2.09 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.896 1.678 . . . . 1.75 114.146 -169.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.64 156.46 20.68 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.909 -1.119 . . . . 2.3700000000000001 111.387 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 mt -98.1 146.44 25.55 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.701 1.2 . . . . 0.92000000000000004 112.623 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 90.7 p -73.1 3.3 5.69 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.204 1.002 . . . . 1.26 113.475 171.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.55 -157.75 16.03 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.689 2.09 . . . . 1.0900000000000001 111.306 -172.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.02 155.27 27.69 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 117.96 0.88 . . . . 1.0700000000000001 112.159 174.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.63 131.66 88.53 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.796 0.838 . . . . 1.8 110.701 175.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.18 156.26 46.76 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 125.197 3.931 . . . . 1.1599999999999999 115.634 -172.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.29 -62.67 1.28 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.745 1.618 . . . . 1.23 114.383 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.8 p -102.26 5.9 40.29 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.804 1.409 . . . . 1.21 114.804 -168.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.85 149.86 10.78 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.0 1.111 . . . . 0.65000000000000002 114.0 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.1 ttt -76.62 90.74 3.37 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.031 1.732 . . . . 1.74 111.629 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -141.81 144.62 34.02 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.552 1.541 . . . . 1.3400000000000001 111.97 -173.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -166.47 156.73 12.1 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 126.337 1.855 . . . . 1.97 111.028 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.9 mp -97.49 148.8 22.86 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.168 1.173 . . . . 0.51000000000000001 114.168 174.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.7 p -64.45 124.6 22.23 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 121.354 -0.841 . . . . 0.58999999999999997 111.34 170.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -80.41 -57.6 3.52 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.373 -0.83 . . . . 2.2000000000000002 112.457 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -173.06 -51.37 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.727 2.811 . . . . 1.8899999999999999 107.963 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -74.18 20.9 0.1 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.121 2.168 . . . . 6.1500000000000004 113.962 173.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.04 -152.31 31.21 Favored Glycine 0 CA--C 1.538 1.53 0 N-CA-C 110.526 -1.03 . . . . 0.77000000000000002 110.526 -165.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -135.33 130.93 35.79 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.587 1.955 . . . . 0.39000000000000001 109.625 169.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -93.82 139.69 30.56 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.479 0.711 . . . . 1.6000000000000001 112.87 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -125.56 124.59 41.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.171 2.589 . . . . 1.6899999999999999 107.893 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -85.58 100.11 11.72 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.423 -0.798 . . . . 1.6699999999999999 110.074 -174.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.402 ' H ' ' HA ' ' A' ' 36' ' ' SER . 73.1 p -78.66 -6.68 56.37 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.139 -0.975 . . . . 0.64000000000000001 113.48 -175.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -51.25 -27.1 8.32 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.568 1.147 . . . . 0.90000000000000002 113.459 175.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -92.98 -10.39 36.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.641 1.576 . . . . 1.8300000000000001 113.697 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -89.59 148.42 40.14 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 120.182 1.356 . . . . 0.76000000000000001 114.163 170.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.18 170.18 13.74 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.937 3.092 . . . . 0.78000000000000003 112.293 168.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.56 63.91 2.14 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.958 2.103 . . . . 1.53 114.397 -170.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -125.54 178.33 5.71 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.756 1.622 . . . . 0.79000000000000004 112.941 -175.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -87.58 151.66 22.81 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.271 1.428 . . . . 2.5499999999999998 110.807 168.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -145.39 171.37 14.72 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.666 1.987 . . . . 0.51000000000000001 109.253 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -137.83 148.31 45.35 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.725 0.81 . . . . 1.8899999999999999 112.648 170.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.4 mp -105.44 138.28 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.247 1.019 . . . . 0.34999999999999998 109.747 171.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -123.65 131.58 53.65 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.405 1.882 . . . . 1.8999999999999999 110.25 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -95.36 104.51 16.41 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.777 0.831 . . . . 2.2599999999999998 110.635 -173.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 38.9 mm -113.0 94.5 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.998 0.919 . . . . 0.65000000000000002 109.611 -169.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -84.45 12.54 6.7 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.537 0.94 . . . . 4.3899999999999997 113.537 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.0 m . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 114.021 1.119 . . . . 2.0600000000000001 114.021 176.556 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 114.032 1.123 . . . . 1.95 114.032 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.41 166.59 22.92 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.568 1.547 . . . . 0.89000000000000001 111.808 169.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.44 144.97 54.53 Favored Pre-proline 0 N--CA 1.483 1.211 0 O-C-N 120.541 -1.349 . . . . 0.57999999999999996 112.224 176.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.08 151.88 61.94 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.584 3.522 . . . . 0.56000000000000005 114.255 -167.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.549 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.1 mp -114.19 125.68 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.742 1.217 . . . . 1.1599999999999999 111.139 -169.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -86.78 136.22 33.07 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.006 1.322 . . . . 3.0299999999999998 111.578 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.7 tt -144.78 150.14 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 125.227 1.411 . . . . 0.56000000000000005 111.741 -177.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -127.0 149.25 49.98 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.87 1.268 . . . . 2.2599999999999998 110.031 169.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 13.3 mt -61.44 142.56 93.86 Favored Pre-proline 0 CA--C 1.548 0.868 0 O-C-N 120.778 -1.201 . . . . 1.1699999999999999 112.771 -176.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -71.54 99.29 0.92 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.961 3.108 . . . . 0.90000000000000002 114.273 -167.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 1.2 tt -116.58 39.42 3.16 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.14 1.776 . . . . 2.3199999999999998 108.053 167.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -104.93 172.72 6.64 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.552 2.341 . . . . 3.46 111.378 -168.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -76.35 40.17 0.21 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.098 0.959 . . . . 3.8700000000000001 113.561 169.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.7 m -121.24 144.54 29.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.106 1.362 . . . . 1.1899999999999999 112.699 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.9 p -64.87 -45.4 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.937 2.095 . . . . 3.77 113.375 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -156.22 156.77 34.69 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.686 1.995 . . . . 2.98 110.956 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -103.6 146.63 28.28 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.815 1.413 . . . . 0.40999999999999998 114.815 -168.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -135.44 168.52 19.07 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.745 1.387 . . . . 0.69999999999999996 114.745 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.5 t -137.88 139.96 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.524 1.53 . . . . 0.46000000000000002 112.027 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -131.76 86.15 49.34 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 125.688 1.595 . . . . 2.1800000000000002 112.548 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' PRO . . . . . 0.549 ' HB3' HD11 ' A' ' 166' ' ' ILE . 30.4 Cg_endo -71.14 147.4 53.98 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.574 3.516 . . . . 0.59999999999999998 113.59 172.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -131.68 176.42 8.35 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.644 2.378 . . . . 1.48 111.386 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -111.9 174.52 5.84 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.614 1.566 . . . . 2.6000000000000001 112.121 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.477 0.887 0 N-CA-C 113.862 1.06 . . . . 2.3500000000000001 113.862 173.514 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.4 p . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 122.254 1.026 . . . . 1.27 113.38 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.3 p -110.08 -1.12 17.7 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.659 1.984 . . . . 1.29 113.138 175.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -164.1 157.72 18.51 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.638 1.575 . . . . 1.8700000000000001 111.095 -178.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.9 p -112.78 -6.23 13.85 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.404 1.882 . . . . 0.93000000000000005 115.555 -170.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 94.4 p -148.18 166.13 28.82 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.728 2.011 . . . . 1.72 112.517 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.96 136.75 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.23 1.812 . . . . 0.44 110.343 177.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.5 m -104.69 112.33 25.37 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.366 0.603 . . . . 0.68000000000000005 110.725 176.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 p -93.19 125.84 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.723 1.209 . . . . 0.52000000000000002 109.679 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -105.19 -170.23 1.72 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.307 1.843 . . . . 1.73 110.81 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -148.72 127.53 12.59 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.246 -1.534 . . . . 1.4099999999999999 113.889 170.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.9 mt -118.59 160.56 21.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.86 1.264 . . . . 0.93000000000000005 113.181 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.7 mt -145.41 165.12 29.44 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 128.002 2.521 . . . . 1.4399999999999999 109.572 168.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.97 165.8 16.43 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.758 -0.589 . . . . 0.80000000000000004 112.224 169.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.5 p -89.12 -35.98 15.98 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.508 0.929 . . . . 1.02 113.508 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -141.77 50.38 1.56 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.614 1.166 . . . . 2.1099999999999999 111.637 174.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.2 14.68 76.27 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 116.621 1.408 . . . . 1.1299999999999999 116.621 173.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.89 15.69 0.1 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.999 2.119 . . . . 2.3999999999999999 115.633 -177.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.4 mmt -61.09 -27.81 68.63 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 119.824 -1.798 . . . . 0.77000000000000002 112.887 -177.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -66.93 -38.17 85.67 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.314 0.961 . . . . 2.1499999999999999 113.178 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -81.74 -38.69 25.3 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.605 -1.309 . . . . 2.4500000000000002 112.582 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 89.1 mt -54.46 -47.83 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 119.915 1.234 . . . . 0.68999999999999995 110.796 168.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.74 -34.96 73.63 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 120.242 -1.536 . . . . 0.92000000000000004 112.557 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -71.23 -34.83 71.16 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.321 1.048 . . . . 1.1299999999999999 112.759 172.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -62.97 -36.07 82.27 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.339 0.972 . . . . 2.0499999999999998 112.225 171.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.3 mt -82.07 -41.21 20.89 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.173 0.805 . . . . 1.1299999999999999 113.173 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -68.26 -25.68 65.3 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.527 1.058 . . . . 3.3399999999999999 113.384 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 t -78.28 -16.44 57.77 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.148 0.979 . . . . 2.0899999999999999 113.055 174.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.32 163.7 32.96 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 127.172 2.32 . . . . 1.3200000000000001 113.993 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -88.8 33.86 0.78 Allowed 'General case' 0 N--CA 1.478 0.953 0 O-C-N 120.866 -1.373 . . . . 2.3199999999999998 112.409 172.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -73.98 0.18 14.35 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.031 -1.043 . . . . 2.0699999999999998 113.466 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.94 -30.0 63.63 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.996 -1.065 . . . . 0.92000000000000004 110.815 167.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.02 -49.67 0.62 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 123.933 0.777 . . . . 0.66000000000000003 113.194 169.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -75.67 158.51 32.26 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.348 1.24 . . . . 2.4399999999999999 114.348 -169.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.18 159.88 33.14 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.559 -0.713 . . . . 3.4199999999999999 110.29 165.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.31 127.2 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 116.54 -0.3 . . . . 0.76000000000000001 110.259 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.94 -48.7 25.75 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.826 -0.546 . . . . 0.91000000000000003 113.243 -176.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.4 t -137.32 127.97 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.048 1.339 . . . . 2.0600000000000001 110.147 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.5 mt -85.57 143.7 38.95 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.731 0.813 . . . . 1.1399999999999999 110.567 169.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.85 162.6 37.14 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.219 1.946 . . . . 0.71999999999999997 111.958 172.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.36 -19.22 65.75 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.266 -0.896 . . . . 1.0800000000000001 112.682 172.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -87.12 0.06 55.89 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.662 1.585 . . . . 1.9399999999999999 115.0 174.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.81 146.4 25.97 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 114.429 1.27 . . . . 0.56999999999999995 114.429 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -130.72 149.04 52.56 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.461 2.704 . . . . 2.4900000000000002 111.614 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -123.4 137.57 54.79 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.409 1.484 . . . . 2.2599999999999998 112.684 -175.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.3 pt -141.29 149.17 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.375 1.47 . . . . 0.85999999999999999 112.136 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -108.51 169.56 8.57 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.563 1.545 . . . . 0.67000000000000004 111.698 169.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.45 20.93 55.76 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.376 0.989 . . . . 0.68000000000000005 115.53 175.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.5 p -88.09 149.52 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 118.422 1.111 . . . . 1.01 109.736 168.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -107.66 137.6 45.4 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.932 1.293 . . . . 0.54000000000000004 112.164 175.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -141.11 156.92 45.9 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.893 1.277 . . . . 1.75 112.633 172.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.5 m -122.04 147.01 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 126.874 2.07 . . . . 0.40000000000000002 109.874 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -89.09 148.18 23.83 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 122.582 1.182 . . . . 0.33000000000000002 113.12 169.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.1 p -142.6 168.56 19.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.806 2.042 . . . . 0.37 112.246 178.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -88.71 172.93 8.88 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.734 0.814 . . . . 1.8999999999999999 112.924 168.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.1 p -57.77 -27.97 63.54 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.378 1.071 . . . . 1.5 113.426 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -90.24 24.07 2.67 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.692 1.197 . . . . 2.3799999999999999 113.79 172.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.54 25.25 14.06 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.562 2.345 . . . . 0.58999999999999997 115.15 173.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -83.09 139.49 33.19 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.281 -0.887 . . . . 1.9399999999999999 109.499 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.7 mt -75.76 128.68 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 118.457 0.571 . . . . 0.56999999999999995 109.821 174.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.761 HG22 HG22 ' A' ' 97' ' ' THR . 6.4 pt -122.02 155.68 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 123.181 1.467 . . . . 0.63 114.613 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -87.01 164.44 16.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.003 1.721 . . . . 1.6599999999999999 110.234 167.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.15 2.27 1.22 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.135 1.774 . . . . 2.6499999999999999 115.351 -176.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -107.0 5.17 27.85 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.71 2.404 . . . . 3.21 113.319 169.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.48 6.32 80.39 Favored Glycine 0 CA--C 1.532 1.153 0 O-C-N 120.073 -1.642 . . . . 0.68000000000000005 114.011 -176.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -68.8 139.32 55.26 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 117.905 0.852 . . . . 2.0499999999999998 109.226 169.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.761 HG22 HG22 ' A' ' 91' ' ' ILE . 76.3 p -101.29 139.7 36.61 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.382 1.073 . . . . 0.94999999999999996 110.778 -177.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.99 -9.98 54.27 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.296 1.221 . . . . 0.93000000000000005 114.296 -168.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.48 21.62 47.34 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.897 1.237 . . . . 0.93999999999999995 113.414 -173.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.7 t -130.48 148.17 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.688 1.595 . . . . 1.25 109.512 -177.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -127.9 159.35 35.19 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.334 1.854 . . . . 4.1799999999999997 111.802 174.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 73.5 mt -131.41 127.85 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.978 1.311 . . . . 0.56999999999999995 110.658 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.61 136.74 94.88 Favored Pre-proline 0 N--CA 1.476 0.833 0 CA-C-O 117.986 -1.007 . . . . 1.8500000000000001 111.081 174.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -69.76 -20.31 35.0 Favored 'Trans proline' 0 C--N 1.352 0.756 0 CA-C-N 122.082 1.779 . . . . 0.62 112.774 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -96.42 -43.65 7.55 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.254 1.422 . . . . 1.1200000000000001 112.553 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 p -86.29 -25.33 25.53 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.099 0.96 . . . . 0.89000000000000001 112.61 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 52.65 24.42 3.14 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.34 1.456 . . . . 1.6399999999999999 113.329 -171.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.63 157.64 16.8 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.888 -1.133 . . . . 2.4100000000000001 111.578 -177.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.2 mt -94.38 146.96 23.69 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.256 1.422 . . . . 0.75 113.028 -169.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.0 p -72.07 -7.64 50.03 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.236 1.199 . . . . 1.3300000000000001 114.236 173.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.87 -158.45 10.04 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 128.165 2.793 . . . . 0.87 110.446 177.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.59 166.7 21.62 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 119.411 1.605 . . . . 1.01 112.274 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 mmt -51.16 143.3 17.13 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 125.229 1.411 . . . . 1.6799999999999999 113.882 -177.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.7 165.41 26.89 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 124.166 3.244 . . . . 0.79000000000000004 114.526 174.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.37 -52.19 6.75 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.138 1.775 . . . . 1.1299999999999999 115.001 -177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.9 p -109.18 -3.12 17.52 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.107 1.363 . . . . 0.95999999999999996 114.477 -169.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.68 151.18 2.47 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.186 1.394 . . . . 0.41999999999999998 114.069 -173.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.4 ttt -76.13 89.56 3.05 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.404 1.082 . . . . 1.79 111.139 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -146.01 123.13 11.47 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.044 1.737 . . . . 1.4199999999999999 113.896 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -164.73 145.32 7.65 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.532 1.133 . . . . 2.8399999999999999 111.221 -169.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.36 157.19 17.24 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.081 1.512 . . . . 0.47999999999999998 115.081 -171.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 80.1 p -72.97 139.52 46.76 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.34 -0.85 . . . . 0.57999999999999996 112.993 169.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.63 -54.97 3.06 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 116.152 1.908 . . . . 2.46 116.152 -169.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.09 -40.57 0.15 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.628 1.171 . . . . 1.25 110.837 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -116.17 -26.15 7.33 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.795 1.035 . . . . 3.7999999999999998 113.795 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.33 -163.31 34.74 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.62 1.105 . . . . 0.67000000000000004 110.73 -169.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -137.17 130.75 31.54 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.345 1.858 . . . . 0.40999999999999998 110.54 173.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.7 ttpt -82.02 134.98 35.4 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.36 0.527 . . . . 1.77 110.922 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -122.78 130.87 53.42 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.95 2.1 . . . . 2.0600000000000001 108.211 173.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -85.05 121.77 28.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.513 1.125 . . . . 3.2000000000000002 110.503 -176.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 46.0 p -109.38 -3.81 16.83 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.743 1.386 . . . . 0.56999999999999995 114.743 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.94 -19.69 19.43 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.385 1.474 . . . . 0.69999999999999996 114.944 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.02 -4.29 20.66 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.848 1.259 . . . . 2.3700000000000001 113.613 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.25 141.83 54.16 Favored Pre-proline 0 CA--C 1.535 0.386 0 O-C-N 121.006 -1.059 . . . . 0.63 111.233 167.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.56 168.29 24.74 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.633 2.222 . . . . 0.69999999999999996 110.928 168.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.71 91.88 0.64 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.955 1.702 . . . . 0.96999999999999997 109.697 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -147.9 -178.64 6.38 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.415 1.086 . . . . 0.73999999999999999 111.077 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -97.17 153.98 17.66 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.253 1.421 . . . . 4.6399999999999997 110.792 168.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -146.01 170.21 17.1 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.226 1.81 . . . . 0.56000000000000005 109.893 -169.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -138.89 145.98 40.56 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.354 0.872 . . . . 1.74 113.354 174.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.2 mp -104.1 135.97 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.483 1.113 . . . . 0.45000000000000001 110.075 173.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -119.86 128.02 53.27 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.101 1.761 . . . . 1.8200000000000001 110.062 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -87.85 109.89 20.1 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.678 0.791 . . . . 1.9199999999999999 110.3 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 41.5 mm -116.5 87.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.188 0.995 . . . . 0.66000000000000003 108.605 -173.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . 0.283 7.6 p80 -94.91 44.2 1.1 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.195 -0.941 . . . . 3.8199999999999998 112.492 -178.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.7 p . . . . . 0 N--CA 1.475 0.809 0 C-N-CA 125.897 1.679 . . . . 1.75 112.743 169.637 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 113.014 0.746 . . . . 2.2200000000000002 113.014 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.46 159.73 19.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.143 0.973 . . . . 0.96999999999999997 112.807 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.6 m -116.6 144.99 34.31 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 125.119 1.368 . . . . 0.75 109.549 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.18 139.69 42.9 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.445 2.097 . . . . 0.60999999999999999 112.646 -167.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 3.0 mp -105.28 129.33 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.424 1.09 . . . . 1.25 111.187 -168.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -89.17 133.61 34.34 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.475 1.51 . . . . 4.5700000000000003 112.619 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.3 tt -141.71 156.92 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 125.779 1.632 . . . . 0.67000000000000004 111.188 -175.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -132.65 152.15 51.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.531 1.532 . . . . 2.0299999999999998 109.983 173.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.63 155.98 46.89 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 113.001 0.741 . . . . 0.93999999999999995 113.001 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.26 96.88 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.086 1.857 . . . . 1.03 111.643 -169.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 28.7 tp -124.5 59.18 1.19 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 104.361 -2.459 . . . . 2.2999999999999998 104.361 166.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -139.5 151.67 46.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.283 2.633 . . . . 3.8599999999999999 109.334 -166.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -82.26 41.01 0.67 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.185 0.994 . . . . 3.3500000000000001 113.286 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.9 m -110.45 138.88 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 125.57 1.548 . . . . 1.2 111.419 -175.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.97 -46.92 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.261 1.824 . . . . 3.6899999999999999 112.281 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -153.07 152.89 31.85 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 127.336 2.255 . . . . 3.23 110.571 174.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -92.98 149.42 21.24 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.081 0.953 . . . . 0.42999999999999999 112.644 -173.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -139.28 167.26 22.48 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 115.128 1.529 . . . . 0.55000000000000004 115.128 175.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.34 139.06 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.032 1.733 . . . . 0.60999999999999999 110.644 172.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -130.8 81.09 68.32 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 126.235 1.814 . . . . 2.73 109.357 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.98 159.59 52.01 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 125.107 3.871 . . . . 0.80000000000000004 112.731 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -125.77 -157.63 0.8 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.33 1.852 . . . . 2.2999999999999998 112.582 -167.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -143.54 167.14 22.94 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 130.473 3.509 . . . . 3.3100000000000001 107.953 174.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 12.7 t . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 113.244 0.831 . . . . 2.3999999999999999 113.244 174.444 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 111.928 0.344 . . . . 1.1599999999999999 111.928 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.8 p -93.9 -7.08 44.12 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.347 1.24 . . . . 1.3100000000000001 114.347 -173.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 t -152.43 154.42 35.52 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.625 1.97 . . . . 2.3500000000000001 109.135 166.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.6 p -95.27 4.91 53.01 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 127.341 2.256 . . . . 0.95999999999999996 114.856 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.1 m -153.19 154.19 34.23 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 120.069 -1.644 . . . . 1.9299999999999999 113.195 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -129.53 147.0 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 127.793 2.437 . . . . 0.40000000000000002 110.537 -175.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.4 m -113.55 117.7 32.39 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.082 0.953 . . . . 0.78000000000000003 110.806 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.91 135.82 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.685 0.794 . . . . 0.66000000000000003 109.513 172.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -114.08 -179.25 3.58 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.25 1.82 . . . . 1.8999999999999999 111.006 -176.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -138.02 118.24 13.6 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 120.534 -1.354 . . . . 2.21 112.176 165.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.6 mt -107.28 152.93 23.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.222 1.409 . . . . 0.55000000000000004 111.19 177.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.6 mt -144.25 172.23 13.2 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.143 1.777 . . . . 1.4199999999999999 110.422 169.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.04 164.21 12.27 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.675 1.19 . . . . 0.80000000000000004 112.272 170.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.4 p -90.98 -23.33 20.44 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.691 1.367 . . . . 1.02 114.691 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -139.15 41.45 2.09 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.861 1.21 . . . . 2.3799999999999999 112.073 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.9 14.32 82.29 Favored Glycine 0 CA--C 1.536 1.362 0 O-C-N 120.796 -1.19 . . . . 0.89000000000000001 114.971 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.42 19.85 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.94 2.496 . . . . 2.3799999999999999 116.067 -175.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.1 mmt -62.83 -28.39 69.98 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 119.592 -1.942 . . . . 0.68999999999999995 114.33 -171.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -71.84 -45.77 60.29 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.405 1.002 . . . . 2.7000000000000002 112.999 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -67.49 -35.98 80.2 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.693 -1.255 . . . . 2.0899999999999999 111.677 173.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.6 mt -58.41 -44.91 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 119.306 0.957 . . . . 0.64000000000000001 110.547 167.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.68 -37.04 77.69 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.372 -1.455 . . . . 0.77000000000000002 112.489 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -68.28 -35.89 78.54 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.631 0.772 . . . . 0.94999999999999996 112.484 170.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -63.03 -19.3 64.24 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 119.431 1.014 . . . . 1.8999999999999999 113.179 170.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 25.8 mt -101.76 -36.2 8.79 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.745 1.757 . . . . 0.83999999999999997 115.745 177.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -64.24 -24.42 67.66 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.583 1.083 . . . . 2.3399999999999999 112.503 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.9 t -74.01 -20.24 60.38 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.5 2.32 . . . . 1.25 114.45 175.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.64 172.16 27.07 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.547 1.07 . . . . 1.03 113.743 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -84.18 29.15 0.58 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.633 1.173 . . . . 2.1299999999999999 113.02 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -75.42 3.88 8.36 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.928 1.455 . . . . 1.9199999999999999 114.928 -168.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.66 -26.53 68.71 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.034 -1.042 . . . . 1.1899999999999999 111.577 168.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.86 -82.02 1.36 Allowed Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.56 1.076 . . . . 0.88 112.993 174.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.5 163.03 28.23 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.436 1.273 . . . . 1.79 114.436 -172.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -55.64 152.78 8.8 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.306 1.042 . . . . 2.3700000000000001 113.058 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.8 t -69.9 98.37 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 107.915 -1.143 . . . . 1.24 107.915 169.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.38 -25.74 75.21 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.229 0.443 . . . . 1.5900000000000001 114.191 -173.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.5 t -141.13 125.04 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.444 1.498 . . . . 1.9399999999999999 109.037 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.5 mt -92.62 160.2 34.94 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 126.08 1.752 . . . . 1.22 111.079 169.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.17 166.89 28.76 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 121.413 1.409 . . . . 0.92000000000000004 111.169 168.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.43 -20.74 58.68 Favored 'General case' 0 CA--C 1.548 0.865 0 O-C-N 120.864 -1.147 . . . . 1.0600000000000001 113.296 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.0 p30 -79.68 -4.79 53.33 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.558 1.543 . . . . 1.8200000000000001 114.406 170.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.75 154.31 20.38 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 113.997 1.11 . . . . 0.64000000000000001 113.997 174.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.8 pttt -145.92 161.75 39.34 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.71 2.004 . . . . 2.52 112.066 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -133.45 123.57 25.52 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.608 1.163 . . . . 2.23 112.424 -169.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.7 pt -120.98 143.63 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.151 0.98 . . . . 0.81000000000000005 112.129 -177.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -114.49 163.41 15.4 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.654 1.181 . . . . 0.71999999999999997 112.263 173.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.75 3.74 55.99 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.101 1.81 . . . . 0.71999999999999997 115.919 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.0 p -83.03 145.85 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 125.733 1.613 . . . . 0.68000000000000005 112.127 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -101.83 136.25 41.99 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.599 1.56 . . . . 0.56000000000000005 113.46 175.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.412 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.4 OUTLIER -141.41 158.5 43.79 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.621 1.568 . . . . 1.6200000000000001 112.319 173.58 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.2 m -124.18 146.16 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 126.873 2.069 . . . . 0.42999999999999999 109.726 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -87.41 148.03 25.17 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 122.312 1.053 . . . . 0.42999999999999999 112.283 170.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.3 p -142.46 171.26 14.3 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.601 1.96 . . . . 0.34000000000000002 112.952 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.21 -176.44 3.42 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 115.279 1.585 . . . . 1.98 115.279 174.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 47.3 p -57.73 -30.99 66.0 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.037 -1.04 . . . . 1.78 113.187 175.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -86.98 18.22 3.68 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.806 1.242 . . . . 1.95 113.192 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.97 22.09 4.14 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.288 1.835 . . . . 0.56999999999999995 113.634 -176.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -77.7 140.36 39.53 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.867 1.267 . . . . 2.1000000000000001 110.31 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.7 mt -79.79 124.5 37.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.082 -0.71 . . . . 0.53000000000000003 109.082 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.427 HG22 HG22 ' A' ' 97' ' ' THR . 4.6 pt -123.55 157.19 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 114.23 1.196 . . . . 0.58999999999999997 114.23 -174.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -89.96 166.0 13.74 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.364 1.466 . . . . 1.6699999999999999 110.221 167.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.35 5.43 1.31 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.978 1.711 . . . . 2.0600000000000001 115.332 -171.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -112.96 4.42 16.76 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 128.291 2.636 . . . . 2.7400000000000002 112.841 172.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.55 10.72 84.92 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.682 1.134 . . . . 0.57999999999999996 114.666 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -75.37 138.57 41.83 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.082 1.441 . . . . 2.0899999999999999 110.066 168.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.427 HG22 HG22 ' A' ' 91' ' ' ILE . 1.0 OUTLIER -104.8 140.57 37.91 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.095 0.958 . . . . 0.93000000000000005 112.339 -173.773 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -95.21 6.28 49.46 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 115.647 1.721 . . . . 0.77000000000000002 115.647 -166.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.1 28.64 61.91 Favored Glycine 0 CA--C 1.533 1.177 0 O-C-N 121.248 -0.908 . . . . 0.64000000000000001 113.73 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.7 t -137.64 149.52 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.579 1.152 . . . . 1.22 109.9 175.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -132.97 153.41 51.47 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 129.011 2.924 . . . . 1.3300000000000001 110.906 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 51.9 mt -131.93 128.83 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.924 1.289 . . . . 0.55000000000000004 112.034 -173.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -70.6 141.0 87.31 Favored Pre-proline 0 N--CA 1.477 0.907 0 CA-C-O 117.423 -1.275 . . . . 2.1000000000000001 111.84 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -73.84 -24.53 15.34 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 CA-C-N 122.355 1.877 . . . . 0.81000000000000005 112.967 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -91.13 -38.11 12.95 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.53 1.532 . . . . 1.22 113.104 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.4 p -93.62 -27.72 16.42 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.0 0.92 . . . . 0.89000000000000001 113.19 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 55.13 19.91 3.07 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.271 1.428 . . . . 2.1800000000000002 112.932 -169.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.59 147.09 25.46 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.575 1.15 . . . . 3.1299999999999999 111.69 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.3 mt -88.78 141.39 28.55 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.645 1.578 . . . . 0.92000000000000004 112.73 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.0 p -75.25 10.63 1.48 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.353 1.061 . . . . 1.3100000000000001 113.746 172.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.39 -155.21 13.87 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.552 2.025 . . . . 1.03 111.632 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -96.4 163.97 12.83 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.357 1.463 . . . . 1.05 112.698 175.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.5 mmt -51.58 139.32 29.16 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 114.289 1.218 . . . . 1.52 114.289 -176.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -78.41 163.89 26.83 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 124.617 3.544 . . . . 0.88 113.78 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.45 -67.31 0.7 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.222 1.193 . . . . 1.03 114.222 174.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.5 p -101.83 4.88 40.77 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 115.884 1.809 . . . . 0.69999999999999996 115.884 -167.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.82 147.76 11.35 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.682 1.364 . . . . 0.46999999999999997 114.682 -175.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.8 ttt -73.08 95.04 1.98 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.517 1.927 . . . . 1.75 111.561 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.6 pttp -147.07 137.58 23.57 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.803 1.641 . . . . 1.1799999999999999 111.65 -174.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -161.55 158.18 25.99 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.605 1.562 . . . . 1.8700000000000001 110.211 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -96.25 150.04 20.98 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.908 1.447 . . . . 0.46999999999999997 114.908 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.412 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 7.0 p -65.73 134.99 54.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.35 -0.844 . . . . 0.54000000000000004 111.968 169.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -94.26 -65.04 1.01 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.778 1.399 . . . . 2.2999999999999998 114.778 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.72 -45.91 0.1 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.053 0.941 . . . . 0.95999999999999996 111.666 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -93.49 -35.32 13.01 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.854 0.462 . . . . 4.1299999999999999 111.648 173.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 176.42 -149.96 10.17 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.216 1.389 . . . . 0.65000000000000002 111.034 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -137.16 129.05 29.04 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.947 1.699 . . . . 0.48999999999999999 110.492 169.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -90.09 138.33 31.6 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.318 1.047 . . . . 2.8300000000000001 112.286 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -130.34 130.87 45.0 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 128.591 2.756 . . . . 1.9399999999999999 109.214 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -88.37 123.76 33.26 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.772 1.229 . . . . 1.75 109.677 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.2 p -109.81 2.65 20.08 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.062 1.345 . . . . 0.56000000000000005 113.342 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.26 -21.72 9.87 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 115.13 1.53 . . . . 0.73999999999999999 115.13 -176.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -108.36 -9.56 15.44 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.808 1.04 . . . . 2.3399999999999999 113.808 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.04 149.0 92.09 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 120.481 1.492 . . . . 0.66000000000000003 113.313 175.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -83.91 168.8 12.1 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.898 3.066 . . . . 0.81999999999999995 111.344 167.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.39 90.46 2.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.847 2.059 . . . . 1.02 110.567 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -147.3 179.24 7.79 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.416 1.086 . . . . 0.78000000000000003 111.743 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -90.13 152.49 21.1 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.99 0.916 . . . . 3.5299999999999998 110.618 167.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -142.74 176.86 8.72 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.132 1.773 . . . . 0.53000000000000003 109.441 -173.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.89 155.88 43.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.006 0.922 . . . . 3.2599999999999998 113.199 175.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.6 mp -121.98 134.53 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.172 0.989 . . . . 0.46000000000000002 110.618 172.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -122.28 135.1 54.68 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.411 1.885 . . . . 1.9099999999999999 111.148 -176.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -86.84 109.66 19.44 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.822 0.849 . . . . 2.77 110.931 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 28.3 mm -116.64 92.29 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.871 0.868 . . . . 1.05 108.76 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -83.14 2.4 35.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.518 1.127 . . . . 4.79 113.854 -174.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.9 p . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 115.087 1.514 . . . . 1.8300000000000001 115.087 -174.418 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 114.799 1.407 . . . . 2.7799999999999998 114.799 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.55 137.05 47.76 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.993 1.717 . . . . 0.85999999999999999 110.157 168.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.54 148.55 37.67 Favored Pre-proline 0 N--CA 1.481 1.097 0 CA-C-N 119.629 1.104 . . . . 0.66000000000000003 112.386 174.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -72.56 140.46 32.93 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.65 2.233 . . . . 0.69999999999999996 111.202 -173.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 4.6 mt -88.52 127.27 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.611 0.765 . . . . 1.8200000000000001 110.377 -171.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -86.25 127.96 34.83 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.371 1.468 . . . . 3.6699999999999999 109.573 168.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.3 tt -144.23 147.67 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 119.087 0.858 . . . . 0.65000000000000002 112.951 -173.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -124.8 149.38 47.46 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.927 1.691 . . . . 2.0600000000000001 109.513 169.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 28.1 mt -64.74 162.06 39.75 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 114.377 1.251 . . . . 1.1899999999999999 114.377 -171.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.66 98.32 1.2 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.011 2.474 . . . . 0.77000000000000002 111.893 -173.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.2 tt -123.05 62.29 1.01 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 104.823 -2.288 . . . . 2.2400000000000002 104.823 167.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -140.67 156.82 46.13 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.907 2.083 . . . . 3.3300000000000001 108.853 -168.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -70.33 17.62 0.06 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.966 1.839 . . . . 3.9199999999999999 115.966 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.7 m -95.97 144.32 10.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 124.367 1.067 . . . . 1.1100000000000001 112.886 -168.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 50.8 t -73.69 -36.66 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.935 -0.478 . . . . 1.6100000000000001 110.739 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -140.29 131.29 26.19 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.195 1.398 . . . . 2.6099999999999999 110.763 -170.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -97.11 140.97 30.82 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.971 0.908 . . . . 0.47999999999999998 112.396 -176.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -137.19 166.48 23.63 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.106 1.521 . . . . 0.57999999999999996 115.106 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.43 137.32 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.64 1.976 . . . . 0.62 113.152 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -131.01 89.8 41.34 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.502 1.521 . . . . 1.8899999999999999 111.58 -177.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.87 154.36 71.13 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.157 3.238 . . . . 0.89000000000000001 112.819 175.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -133.17 163.07 30.11 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.207 1.403 . . . . 1.45 112.772 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -100.68 146.61 26.98 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.615 2.366 . . . . 3.71 110.328 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.486 1.349 0 N-CA-C 113.788 1.033 . . . . 2.29 113.788 171.357 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.5 tmt? . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 119.925 -0.083 . . . . 23.559999999999999 110.835 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -96.61 113.33 24.88 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.032 0.933 . . . . 21.609999999999999 111.522 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.6 t -106.6 21.52 17.33 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.316 1.846 . . . . 17.91 113.263 -175.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.31 -4.78 27.87 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 115.913 1.82 . . . . 15.970000000000001 115.913 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.0 m 65.2 146.84 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.493 2.317 . . . . 13.17 113.351 -168.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.57 5.89 6.71 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.484 1.114 . . . . 13.01 113.551 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.75 176.34 12.23 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.9 2.48 . . . . 10.859999999999999 110.068 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.8 t -70.26 128.19 35.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.107 1.763 . . . . 9.8699999999999992 114.081 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.1 m -127.4 154.32 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 126.758 2.023 . . . . 7.2300000000000004 111.97 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 38.2 -142.41 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.167 2.187 . . . . 3.3999999999999999 115.422 169.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 56.1 -158.28 0.24 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 127.308 2.243 . . . . 5.0 115.449 168.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.05 23.22 6.59 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.778 2.031 . . . . 5.1500000000000004 115.993 -174.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.09 -2.42 10.14 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.875 1.702 . . . . 1.8700000000000001 115.418 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 47.0 p -139.75 167.57 21.81 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.919 1.688 . . . . 1.0900000000000001 113.914 -175.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.7 p -90.58 -6.17 55.0 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.776 1.23 . . . . 1.4299999999999999 113.01 175.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 m -156.5 153.93 29.54 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.223 2.209 . . . . 2.23 109.455 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.1 p -109.54 4.49 22.28 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.306 1.595 . . . . 0.89000000000000001 115.306 -170.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 m -147.58 161.38 41.24 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.275 1.83 . . . . 1.74 112.501 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.42 141.69 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 126.513 1.925 . . . . 0.35999999999999999 109.869 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.3 m -111.3 114.83 28.29 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.474 0.654 . . . . 0.71999999999999997 109.916 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 p -93.17 128.51 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.256 1.022 . . . . 0.68000000000000005 109.274 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -107.23 -177.85 3.47 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.152 1.381 . . . . 1.79 110.118 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -139.14 122.7 17.36 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.753 -1.217 . . . . 1.6000000000000001 111.124 168.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.7 mt -107.94 154.24 21.9 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.106 0.962 . . . . 0.67000000000000004 110.936 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.26 167.37 22.6 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.843 1.657 . . . . 1.9099999999999999 110.092 176.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.38 158.34 16.13 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.751 0.821 . . . . 0.68000000000000005 112.249 170.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.1 p -80.72 -41.13 24.11 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.413 1.085 . . . . 0.93999999999999995 112.485 174.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -131.66 38.03 3.6 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.3 1.04 . . . . 2.6800000000000002 112.996 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.72 12.29 82.99 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.228 1.394 . . . . 0.79000000000000004 115.264 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -71.65 18.17 0.08 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.474 2.31 . . . . 1.95 116.075 -171.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.21 -26.03 66.07 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.377 -1.452 . . . . 0.59999999999999998 113.025 -175.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.45 -50.51 63.11 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.926 1.29 . . . . 2.3300000000000001 112.709 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -68.34 -39.93 81.72 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.849 -1.157 . . . . 2.2999999999999998 112.219 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -53.96 -49.42 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.417 1.008 . . . . 0.53000000000000003 111.123 171.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.05 -23.71 67.26 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.477 -1.389 . . . . 0.76000000000000001 113.424 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -82.17 -30.07 31.2 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.308 -0.87 . . . . 1.1200000000000001 112.822 169.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -70.67 -11.87 61.21 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.61 1.564 . . . . 2.0699999999999998 113.516 168.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.3 mt -106.65 -31.81 8.3 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.774 1.63 . . . . 0.80000000000000004 114.256 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.47 -22.31 66.73 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 120.461 1.482 . . . . 2.4100000000000001 113.176 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 t -71.16 -31.08 67.24 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.436 1.094 . . . . 1.3799999999999999 112.466 171.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.4 162.62 35.02 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.247 0.927 . . . . 0.87 113.22 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -83.23 30.58 0.46 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.936 -1.332 . . . . 1.6100000000000001 112.813 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -71.78 19.23 0.07 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.124 1.898 . . . . 1.96 116.124 -168.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.16 -27.85 62.85 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.367 1.067 . . . . 0.93999999999999995 109.802 164.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.23 -63.79 0.26 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.211 1.386 . . . . 0.68999999999999995 113.341 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -78.82 158.92 28.07 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.177 1.547 . . . . 1.8100000000000001 115.177 -171.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -70.76 135.74 48.4 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.997 1.719 . . . . 3.27 112.991 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 80.0 t -54.38 110.57 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.883 0.873 . . . . 0.80000000000000004 111.246 -174.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.72 -25.21 60.89 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 114.708 0.643 . . . . 1.0600000000000001 114.708 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 p -142.07 104.11 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.528 1.131 . . . . 4.25 111.89 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.1 mt -89.79 146.8 36.12 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 126.966 2.107 . . . . 1.1299999999999999 111.451 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.27 158.21 19.96 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.282 2.654 . . . . 0.56999999999999995 113.18 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.37 -22.9 63.69 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.877 -1.139 . . . . 0.93000000000000005 112.356 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -79.34 0.5 28.71 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.946 1.298 . . . . 1.3100000000000001 114.28 169.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.32 157.85 16.48 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.743 1.217 . . . . 0.56999999999999995 112.599 168.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -150.84 172.02 16.3 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.178 1.791 . . . . 1.8100000000000001 111.206 173.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -126.54 146.82 49.99 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.287 1.435 . . . . 2.25 111.028 -174.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.1 pt -136.65 130.67 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 114.042 1.127 . . . . 0.77000000000000002 114.042 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.7 156.86 17.78 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.725 0.81 . . . . 0.63 111.71 169.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.4 15.78 56.5 Favored Glycine 0 CA--C 1.537 1.43 0 N-CA-C 116.102 1.201 . . . . 0.62 116.102 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.5 p -90.14 145.78 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-N 120.153 1.977 . . . . 0.93999999999999995 109.125 167.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 1.8 tpp -102.42 137.69 40.33 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.701 1.2 . . . . 0.45000000000000001 111.798 174.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.66 153.71 47.35 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 122.188 0.994 . . . . 1.74 112.875 170.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.7 m -118.71 146.39 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 C-N-CA 126.948 2.099 . . . . 0.33000000000000002 109.125 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -87.64 147.03 25.45 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.433 1.111 . . . . 0.29999999999999999 111.926 169.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.2 p -141.49 173.65 11.3 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.328 1.851 . . . . 0.40000000000000002 112.098 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.53 177.6 4.97 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.78 1.632 . . . . 1.8100000000000001 113.407 172.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.0 p -68.18 -20.76 64.89 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.978 1.103 . . . . 1.4099999999999999 113.978 -171.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -97.97 26.46 5.21 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.602 1.561 . . . . 2.1200000000000001 112.834 169.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 62.26 23.98 14.24 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.226 2.21 . . . . 0.56000000000000005 114.349 169.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -84.38 140.38 31.61 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.069 0.948 . . . . 2.5499999999999998 111.117 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.7 mt -76.86 126.09 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.193 -0.669 . . . . 0.5 109.193 176.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.555 HG22 HG22 ' A' ' 97' ' ' THR . 4.7 pt -117.86 156.91 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 114.57 1.322 . . . . 0.58999999999999997 114.57 -176.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -85.27 165.4 17.36 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.232 1.413 . . . . 1.4399999999999999 110.741 167.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -64.95 2.86 0.64 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 128.05 2.54 . . . . 3.0499999999999998 115.904 -174.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -117.54 -3.5 11.34 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 127.59 2.356 . . . . 2.98 114.276 172.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.05 5.8 59.4 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.362 1.458 . . . . 0.81000000000000005 116.443 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -72.33 137.34 46.58 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.092 1.946 . . . . 2.0499999999999998 110.454 170.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.555 HG22 HG22 ' A' ' 91' ' ' ILE . 23.9 p -96.36 134.23 39.76 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.603 1.161 . . . . 0.98999999999999999 111.662 -175.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.7 -0.95 57.27 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.538 1.681 . . . . 0.62 115.538 -167.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.86 15.61 69.84 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-N 119.214 0.915 . . . . 0.71999999999999997 113.931 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.0 t -125.08 147.1 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.938 1.295 . . . . 1.1000000000000001 109.293 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -133.55 157.85 44.65 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 128.115 2.566 . . . . 1.3300000000000001 110.138 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.41 HG12 HD23 ' A' ' 109' ' ' LEU . 55.8 mt -136.03 134.23 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.931 1.292 . . . . 0.48999999999999999 110.53 -174.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -73.09 135.02 80.26 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 121.072 -1.017 . . . . 1.8 110.308 173.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -66.71 -22.92 49.42 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.573 2.182 . . . . 0.98999999999999999 113.816 172.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -96.9 -45.06 6.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.916 1.686 . . . . 1.1200000000000001 112.762 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.8 p -90.71 -22.98 20.85 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.61 1.164 . . . . 0.79000000000000004 113.565 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 53.39 19.46 1.63 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.75 1.62 . . . . 2.0499999999999998 113.846 -170.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.41 146.65 30.18 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.745 -1.222 . . . . 2.7599999999999998 111.524 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.41 HD23 HG12 ' A' ' 102' ' ' ILE . 31.3 mt -90.29 135.66 33.54 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.215 1.406 . . . . 0.83999999999999997 111.288 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 92.2 p -66.23 -0.58 2.62 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.382 1.252 . . . . 1.3300000000000001 114.382 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.38 -152.8 9.08 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 126.39 1.948 . . . . 0.85999999999999999 112.218 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.1 162.65 15.21 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.113 1.365 . . . . 0.93999999999999995 113.439 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.3 mmt -54.01 128.12 55.53 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.75 1.22 . . . . 1.51 113.055 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -72.08 163.42 38.83 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.106 3.204 . . . . 0.73999999999999999 113.129 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.41 -81.24 0.09 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.165 0.986 . . . . 1.0700000000000001 112.127 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 78.1 p -83.58 2.05 39.14 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 116.07 1.878 . . . . 0.78000000000000003 116.07 -167.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -49.87 149.17 2.74 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.382 1.473 . . . . 0.46999999999999997 114.974 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.1 tpt -77.52 98.11 5.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.784 2.034 . . . . 1.5800000000000001 111.256 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -150.14 147.78 28.17 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.413 1.485 . . . . 1.04 112.221 -172.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -166.82 156.96 11.53 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 125.392 1.477 . . . . 1.79 111.241 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 mp -94.68 150.4 20.26 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.481 1.289 . . . . 0.47999999999999998 114.481 172.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 16.7 p -63.84 134.52 55.35 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.323 -0.86 . . . . 0.46999999999999997 112.058 170.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -92.3 -54.41 3.82 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.464 1.653 . . . . 2.1899999999999999 115.464 -171.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.73 -37.7 0.08 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.902 1.281 . . . . 1.0800000000000001 111.509 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -119.65 -22.52 6.87 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.073 1.138 . . . . 5.25 114.073 171.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 175.87 -159.09 26.43 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.686 1.612 . . . . 0.65000000000000002 111.117 -170.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -147.06 133.64 19.84 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.589 1.955 . . . . 0.39000000000000001 111.967 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -86.77 137.42 32.45 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.506 1.122 . . . . 1.4199999999999999 113.088 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -128.97 124.07 34.08 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.495 2.318 . . . . 1.6699999999999999 108.556 174.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -77.49 128.75 34.72 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.354 -0.841 . . . . 2.5299999999999998 110.201 175.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 66.8 p -105.73 -10.74 16.59 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.796 1.776 . . . . 0.69999999999999996 115.796 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.64 -33.95 16.88 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.798 1.181 . . . . 0.96999999999999997 114.014 -172.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -16.37 44.27 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.807 1.643 . . . . 2.2400000000000002 113.291 -176.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -72.18 144.18 86.91 Favored Pre-proline 0 C--O 1.237 0.434 0 CA-C-N 119.976 1.262 . . . . 0.63 112.166 173.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.45 167.1 27.92 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.357 2.038 . . . . 0.70999999999999996 110.47 167.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.38 93.77 1.98 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.149 1.38 . . . . 0.97999999999999998 109.609 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -152.71 -178.29 6.78 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.945 0.898 . . . . 0.65000000000000002 112.427 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -91.13 152.39 20.61 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.392 1.877 . . . . 3.3999999999999999 111.956 168.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -149.27 170.96 17.3 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.661 2.385 . . . . 0.48999999999999999 110.372 -170.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -138.63 160.86 38.56 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.424 1.09 . . . . 1.74 113.337 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.2 134.46 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.357 1.463 . . . . 0.39000000000000001 110.065 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -122.14 137.38 54.84 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.475 1.51 . . . . 1.8600000000000001 111.569 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -104.69 100.61 10.26 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.907 1.683 . . . . 2.6299999999999999 110.469 -169.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 28.2 mm -106.84 113.88 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.613 1.165 . . . . 0.73999999999999999 110.653 -167.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -87.1 22.82 1.95 Allowed 'General case' 0 CA--C 1.553 1.09 0 O-C-N 120.936 -1.102 . . . . 3.7799999999999998 112.854 -178.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.2 m -88.45 -21.84 24.01 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.578 1.325 . . . . 1.77 114.578 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.32 150.46 20.83 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.456 1.103 . . . . 2.4199999999999999 109.421 170.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 95.0 p -59.23 116.54 3.96 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 122.805 1.288 . . . . 5.4400000000000004 112.941 -170.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.7 t -106.49 169.77 8.32 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.832 2.053 . . . . 5.29 111.12 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -59.91 146.99 40.22 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.695 -1.253 . . . . 7.5 111.42 170.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 67.9 t -75.41 93.68 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.571 1.148 . . . . 4.5300000000000002 110.809 -174.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -106.24 -37.58 2.46 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.513 1.054 . . . . 2.27 113.44 172.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -71.75 8.37 1.19 Allowed 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 116.674 2.101 . . . . 4.9100000000000001 116.674 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -117.38 31.76 6.54 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.963 1.305 . . . . 5.3600000000000003 112.688 -171.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 91.4 12.43 59.78 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.167 1.365 . . . . 3.8900000000000001 115.514 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.3 176.46 9.28 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.646 1.178 . . . . 2.8100000000000001 113.399 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.4 -2.6 0.74 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 115.725 1.75 . . . . 3.5099999999999998 115.725 172.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.0 mt -79.68 152.98 29.64 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.966 1.257 . . . . 1.78 112.122 170.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 23.4 m -91.49 -34.2 14.89 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.8 1.407 . . . . 3.5 114.8 -168.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.06 20.65 79.21 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-N 119.195 0.907 . . . . 2.1499999999999999 114.228 -169.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.9 p -77.96 142.27 38.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.957 1.303 . . . . 2.6899999999999999 112.219 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -63.64 128.39 35.59 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.775 1.23 . . . . 1.8799999999999999 112.441 174.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.55 147.1 28.82 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.514 1.126 . . . . 1.0900000000000001 111.06 168.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.36 147.88 34.62 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 123.282 0.633 . . . . 0.94999999999999996 110.449 170.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.29 159.28 52.3 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.708 2.939 . . . . 0.70999999999999996 113.365 -173.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -109.07 148.11 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.514 1.126 . . . . 1.72 111.467 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.58 148.45 41.9 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.789 1.636 . . . . 4.8300000000000001 111.252 168.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.6 tt -151.56 146.81 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 124.157 0.983 . . . . 0.48999999999999999 111.705 -174.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -122.97 142.92 50.3 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.555 1.542 . . . . 1.8400000000000001 109.495 169.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 23.4 mt -64.79 149.61 95.85 Favored Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 113.808 1.04 . . . . 0.97999999999999998 113.808 -170.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.54 110.72 2.36 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.269 2.646 . . . . 0.73999999999999999 113.832 -169.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.45 60.88 1.4 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.569 2.348 . . . . 2.4300000000000002 106.016 166.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -151.66 147.86 27.25 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.981 2.112 . . . . 3.1000000000000001 109.896 -166.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -72.48 23.41 0.06 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 126.075 1.75 . . . . 4.0099999999999998 114.679 -174.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.4 m -76.28 149.51 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 120.434 -1.417 . . . . 1.21 111.759 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 88.7 t -78.96 -35.7 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.733 0.813 . . . . 2.1699999999999999 111.405 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -145.42 148.56 33.45 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.67 1.988 . . . . 3.0 109.747 173.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -94.66 141.74 28.26 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.952 0.797 . . . . 0.39000000000000001 111.916 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -138.85 170.54 15.8 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.348 1.24 . . . . 0.59999999999999998 114.348 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.27 141.26 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 125.201 1.401 . . . . 0.56999999999999995 112.845 -177.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.38 83.28 59.73 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 124.729 1.212 . . . . 2.25 113.844 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -67.96 138.39 44.04 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.36 3.374 . . . . 0.59999999999999998 113.068 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -124.6 163.23 22.38 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.176 1.79 . . . . 1.9299999999999999 112.57 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -103.56 164.74 11.47 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.826 1.25 . . . . 2.6499999999999999 110.774 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 7.2 t -141.34 -20.1 0.77 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.042 1.127 . . . . 2.9500000000000002 114.042 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -78.85 154.97 29.38 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.744 1.618 . . . . 6.7000000000000002 110.615 167.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -119.04 170.23 9.22 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.312 1.445 . . . . 7.3200000000000003 112.093 176.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.49 148.66 64.4 Favored Pre-proline 0 N--CA 1.479 0.994 0 O-C-N 121.226 -0.921 . . . . 13.640000000000001 112.628 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.52 139.95 32.22 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.632 2.222 . . . . 10.390000000000001 112.818 -175.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -87.0 -6.99 58.57 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.119 1.526 . . . . 14.43 115.119 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.483 ' H ' HD12 ' A' ' 191' ' ' ILE . 4.2 mp -74.39 -44.38 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.807 1.243 . . . . 13.51 111.205 -178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.1 mt -87.13 127.6 35.13 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.314 1.446 . . . . 14.07 112.572 -171.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 . . . . . 0 N--CA 1.473 0.723 0 C-N-CA 124.521 1.128 . . . . 19.07 113.763 -178.292 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.6 mpp? . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 110.411 -0.218 . . . . 23.0 110.411 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . 0.259 51.7 mt-10 65.26 150.55 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.959 2.503 . . . . 26.140000000000001 115.529 -170.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.9 m 62.45 -27.6 0.07 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 129.214 3.006 . . . . 23.579999999999998 117.615 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.47 148.21 43.52 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.203 1.365 . . . . 18.550000000000001 113.333 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.5 m -73.68 -27.63 61.33 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.947 1.462 . . . . 16.690000000000001 114.947 -173.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -147.22 172.0 14.5 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.98 1.312 . . . . 12.51 113.56 -173.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.24 163.51 12.54 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.813 1.645 . . . . 9.5500000000000007 112.444 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 t -52.47 144.21 13.85 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.887 1.275 . . . . 7.8200000000000003 112.201 171.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.3 m -67.72 150.43 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 113.995 1.109 . . . . 7.5 113.995 -168.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -84.52 157.54 21.26 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.719 1.207 . . . . 4.5700000000000003 113.579 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.84 137.76 23.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.121 1.369 . . . . 3.73 111.486 173.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.66 109.24 20.99 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.704 1.202 . . . . 5.4299999999999997 111.23 -172.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.48 44.54 3.18 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.797 1.665 . . . . 2.1699999999999999 112.547 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.0 p -144.66 167.04 23.49 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.39 1.476 . . . . 1.0800000000000001 113.997 -167.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 78.0 p -91.8 -9.13 44.62 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.629 1.172 . . . . 1.72 114.149 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.7 t -147.88 154.67 40.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.875 1.67 . . . . 1.8 109.405 169.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.7 p -98.27 -0.62 43.62 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.918 1.687 . . . . 0.85999999999999999 114.32 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.4 m -151.68 158.9 44.04 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.312 1.445 . . . . 1.79 110.607 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.68 141.9 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 126.39 1.876 . . . . 0.40999999999999998 109.317 177.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 m -115.76 121.77 43.45 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.508 0.723 . . . . 0.91000000000000003 110.307 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -103.37 131.61 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.683 1.193 . . . . 0.62 110.998 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -130.32 100.39 5.36 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.11 1.364 . . . . 1.8799999999999999 110.82 -172.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.419 ' HE3' ' CD2' ' A' ' 43' ' ' LEU . 6.9 tmtm? -74.81 120.88 20.95 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.788 -1.195 . . . . 1.54 110.916 -174.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.3 mt -106.84 153.45 22.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.952 1.301 . . . . 0.67000000000000004 112.195 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.419 ' CD2' ' HE3' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -141.65 171.77 13.6 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.965 1.706 . . . . 1.8200000000000001 110.894 176.158 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.35 158.49 16.43 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.171 1.388 . . . . 0.96999999999999997 112.219 170.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.4 p -81.01 -25.59 37.11 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.39 1.256 . . . . 1.4399999999999999 114.39 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -149.64 38.04 0.75 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.427 1.091 . . . . 3.5800000000000001 112.64 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.09 10.35 75.13 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 116.44 1.336 . . . . 1.24 116.44 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.13 14.62 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 129.128 2.971 . . . . 2.1800000000000002 116.632 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -26.13 68.61 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.283 -1.51 . . . . 0.75 113.087 -170.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -72.12 -43.37 64.82 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.626 1.103 . . . . 2.04 113.103 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -70.22 -41.86 73.06 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.465 -1.397 . . . . 2.4500000000000002 111.746 172.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.9 mt -54.07 -44.2 62.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.333 1.053 . . . . 0.82999999999999996 112.231 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.88 -31.17 69.54 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 120.967 1.712 . . . . 0.95999999999999996 112.768 176.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -76.03 -35.76 59.36 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.969 0.908 . . . . 1.3999999999999999 112.86 171.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -63.15 -22.87 67.15 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.179 0.991 . . . . 2.2000000000000002 112.97 170.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.3 mt -91.93 -41.48 10.56 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.097 1.147 . . . . 1.25 114.097 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.65 -18.9 65.37 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.781 1.173 . . . . 4.1299999999999999 113.692 -175.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.8 t -75.68 -23.37 56.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.655 1.182 . . . . 2.0099999999999998 113.883 172.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.64 157.68 21.32 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.346 0.974 . . . . 1.27 112.578 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -77.37 43.28 0.38 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.474 1.11 . . . . 1.71 113.031 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -78.74 13.37 1.69 Allowed 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.516 -1.365 . . . . 2.0600000000000001 113.971 -170.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.83 -17.63 58.88 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.237 1.415 . . . . 1.28 111.155 165.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.82 -74.07 0.14 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.738 1.161 . . . . 0.90000000000000002 112.792 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.42 161.33 29.92 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.41 1.263 . . . . 1.5600000000000001 114.41 -173.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.04 158.67 27.75 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.898 1.073 . . . . 3.1400000000000001 113.898 -173.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.02 119.44 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.894 -0.504 . . . . 0.81000000000000005 110.175 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.28 -29.33 45.62 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.828 0.728 . . . . 1.3600000000000001 114.15 -176.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.9 t -146.15 125.92 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.259 1.423 . . . . 2.2000000000000002 111.41 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.2 mt -96.88 134.46 23.01 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.903 1.681 . . . . 1.22 110.771 167.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.86 160.49 43.29 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.042 1.828 . . . . 0.71999999999999997 111.42 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.26 -21.82 66.78 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.836 -1.165 . . . . 1.25 113.715 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -88.3 -5.01 58.59 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.659 1.584 . . . . 1.76 114.443 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.3 155.16 20.77 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.108 0.867 . . . . 0.78000000000000003 111.113 168.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.6 pttt -152.46 170.01 21.18 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.396 1.078 . . . . 1.79 111.83 169.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -120.32 137.78 54.07 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.905 1.682 . . . . 2.02 108.718 -172.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.7 pt -126.24 131.98 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 120.018 1.281 . . . . 0.81000000000000005 113.464 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.76 160.06 14.92 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.0 1.32 . . . . 0.68000000000000005 111.286 169.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.03 16.11 68.21 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.086 0.851 . . . . 0.56000000000000005 115.089 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.3 p -101.85 141.71 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.491 1.516 . . . . 0.64000000000000001 110.288 169.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.7 tpp -99.88 141.8 32.21 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.524 1.53 . . . . 0.56000000000000005 112.642 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.442 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.6 OUTLIER -144.32 149.44 36.21 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.146 1.378 . . . . 1.6299999999999999 111.471 173.092 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.8 m -120.44 146.13 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.584 1.953 . . . . 0.39000000000000001 109.41 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -87.21 144.49 26.8 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.882 1.325 . . . . 0.40000000000000002 110.903 168.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.7 p -137.35 170.46 16.05 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.127 2.171 . . . . 0.40000000000000002 110.473 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -87.26 171.8 10.36 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.491 -0.755 . . . . 2.0899999999999999 111.651 167.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.5 t -61.46 -24.59 66.67 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.06 -1.025 . . . . 3.0099999999999998 113.275 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -69.42 10.37 0.35 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 127.274 2.23 . . . . 3.29 115.048 169.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.43 22.55 5.09 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 128.144 2.578 . . . . 0.68999999999999995 113.354 -172.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -83.06 136.27 34.54 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.481 1.512 . . . . 2.23 111.068 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.6 mt -73.99 127.26 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 109.65 -0.5 . . . . 0.48999999999999999 109.65 175.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.583 HG22 HG22 ' A' ' 97' ' ' THR . 3.2 pt -120.09 150.28 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 115.174 1.546 . . . . 0.5 115.174 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.45 159.57 28.19 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.081 2.153 . . . . 2.1000000000000001 109.298 165.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -64.32 -15.01 59.47 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.595 1.332 . . . . 2.0499999999999998 114.595 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -92.63 4.24 54.04 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.62 1.168 . . . . 3.48 111.993 174.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.61 5.54 81.64 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 126.47 1.986 . . . . 0.47999999999999998 115.376 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -67.96 143.72 55.5 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.222 1.011 . . . . 2.3100000000000001 109.859 171.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.583 HG22 HG22 ' A' ' 91' ' ' ILE . 33.6 p -103.58 136.04 44.05 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.539 1.135 . . . . 0.68000000000000005 111.198 -177.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.26 -8.98 58.87 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.022 1.119 . . . . 0.65000000000000002 114.022 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.32 19.73 56.39 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.341 0.972 . . . . 0.71999999999999997 113.53 -174.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.52 147.6 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.873 1.269 . . . . 1.1299999999999999 110.213 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.11 160.7 30.4 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.86 2.464 . . . . 1.5700000000000001 110.81 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.4 mt -133.88 134.83 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.388 1.475 . . . . 0.68999999999999995 111.32 -175.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.04 139.04 87.56 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 117.725 -1.131 . . . . 2.3999999999999999 111.314 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -71.4 -27.46 19.22 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 CA-C-N 122.095 1.784 . . . . 1.1100000000000001 112.839 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -86.98 -48.59 7.99 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.582 1.153 . . . . 1.72 111.736 -175.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.8 p -91.05 -24.35 20.07 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.426 1.09 . . . . 1.22 113.356 -174.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 53.45 29.31 8.72 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 125.174 1.39 . . . . 2.5600000000000001 112.162 -167.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.76 153.07 17.94 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.396 1.479 . . . . 2.3599999999999999 111.535 174.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.8 mt -94.46 151.82 19.07 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.768 1.627 . . . . 0.82999999999999996 113.303 -169.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.3 p -73.42 -2.77 23.74 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.558 0.947 . . . . 1.27 113.558 168.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.82 -147.92 6.05 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 126.861 2.172 . . . . 0.90000000000000002 112.515 -169.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.7 175.72 6.92 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.542 1.537 . . . . 0.94999999999999996 113.671 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.6 mmt -64.41 138.04 97.31 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.521 1.128 . . . . 1.3700000000000001 112.273 173.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -86.1 150.48 9.47 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 124.105 3.203 . . . . 0.78000000000000003 113.564 -174.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.1 -54.08 8.56 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.431 1.271 . . . . 1.1399999999999999 114.431 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 64.8 p -107.91 -1.61 20.54 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.871 1.434 . . . . 0.82999999999999996 114.871 -168.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.14 149.39 2.87 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 115.035 1.495 . . . . 0.40000000000000002 115.035 -173.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.5 tpt -75.96 99.39 4.53 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.099 2.159 . . . . 1.6599999999999999 111.186 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -153.6 147.14 25.02 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.201 1.4 . . . . 0.93000000000000005 112.594 -173.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -164.69 158.17 17.49 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.63 1.572 . . . . 1.6899999999999999 110.626 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -98.65 149.98 22.24 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.47 1.108 . . . . 0.56000000000000005 112.523 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.513 HG22 ' HA2' ' A' ' 126' ' ' GLY . 2.0 p -65.57 128.53 36.29 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.834 0.743 . . . . 0.58999999999999997 109.861 170.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.23 -55.14 4.34 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.012 1.115 . . . . 2.0600000000000001 114.012 -173.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.35 -43.69 0.14 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.16 1.384 . . . . 1.03 110.565 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -113.88 -25.45 8.6 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.5 0.926 . . . . 3.8100000000000001 113.5 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.513 ' HA2' HG22 ' A' ' 122' ' ' THR . . . 177.24 -166.8 37.61 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.249 0.928 . . . . 0.57999999999999996 111.865 -169.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.98 142.01 34.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.878 1.671 . . . . 0.52000000000000002 112.137 169.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -92.69 138.01 31.87 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.133 1.373 . . . . 1.3300000000000001 113.185 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -128.71 125.98 39.11 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.519 1.928 . . . . 1.96 109.106 173.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -88.42 108.53 19.42 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 118.953 0.797 . . . . 1.6299999999999999 111.054 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.6 p -93.98 0.61 56.13 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.092 1.357 . . . . 0.57999999999999996 113.764 -174.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.97 -8.84 3.49 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.095 1.516 . . . . 0.77000000000000002 115.095 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -102.12 -21.78 14.35 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.15 1.38 . . . . 1.8500000000000001 113.134 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -79.03 147.68 70.32 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 113.251 0.834 . . . . 0.71999999999999997 113.251 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.59 166.98 21.38 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.965 2.443 . . . . 0.80000000000000004 111.605 168.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.86 86.01 3.43 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.629 1.972 . . . . 1.01 111.857 -172.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -147.11 -175.53 4.86 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.823 0.849 . . . . 0.78000000000000003 111.678 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -93.34 142.68 27.04 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.751 1.22 . . . . 2.46 113.868 170.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -135.72 169.12 18.05 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.342 2.257 . . . . 0.58999999999999997 110.029 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -137.95 152.91 49.41 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.526 0.73 . . . . 1.7 112.809 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.0 mp -112.12 138.9 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.166 0.986 . . . . 0.31 110.023 173.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -128.47 131.04 48.36 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.79 1.636 . . . . 1.8 110.229 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -95.11 78.92 3.54 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.038 0.935 . . . . 1.9199999999999999 111.448 -171.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.6 mm -82.95 101.66 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.519 0.727 . . . . 0.77000000000000002 110.17 -174.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -80.66 -1.44 42.47 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.422 1.267 . . . . 4.7800000000000002 114.422 -175.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 58.2 p -75.99 -15.36 60.17 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.288 -1.507 . . . . 1.71 115.057 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.38 -47.73 26.19 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.714 1.143 . . . . 2.9500000000000002 112.581 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.2 t -168.12 140.6 3.03 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.905 2.082 . . . . 4.8099999999999996 108.949 -176.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.3 m -134.74 146.76 49.72 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.174 1.176 . . . . 5.9400000000000004 114.174 -175.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -75.77 168.8 19.34 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 130.205 3.402 . . . . 5.8099999999999996 112.12 169.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 93.0 t -68.71 120.59 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 O-C-N 120.776 -1.203 . . . . 5.3799999999999999 109.816 172.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -165.19 -51.24 0.02 OUTLIER Glycine 0 CA--C 1.526 0.749 0 N-CA-C 115.87 1.108 . . . . 2.46 115.87 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.03 -7.04 25.79 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 119.106 1.453 . . . . 4.5300000000000002 113.347 173.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.13 4.81 0.81 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 130.046 3.338 . . . . 6.0599999999999996 115.709 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 105.23 2.07 41.46 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.59 1.566 . . . . 5.1600000000000001 114.842 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -77.82 174.87 10.53 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.646 1.578 . . . . 3.8799999999999999 113.776 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 22.5 p -69.5 41.36 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 127.283 2.233 . . . . 4.1600000000000001 112.941 167.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 36.1 mt -150.94 5.46 0.49 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 130.514 3.526 . . . . 3.79 110.544 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 13.3 t -84.77 139.89 31.63 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 115.463 1.653 . . . . 6.1900000000000004 115.463 -168.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.47 25.25 19.79 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 125.893 1.711 . . . . 2.8199999999999998 116.076 168.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.8 t -103.66 132.14 50.18 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.266 1.426 . . . . 2.6200000000000001 111.32 -169.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -91.88 115.86 28.42 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.479 1.912 . . . . 3.52 113.093 -168.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.03 132.52 36.01 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.266 0.555 . . . . 0.83999999999999997 109.695 167.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.1 149.08 35.96 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 123.684 0.794 . . . . 0.54000000000000004 110.759 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.99 159.39 48.05 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.843 2.362 . . . . 0.57999999999999996 112.182 -172.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.516 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.4 mp -123.93 134.44 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.014 1.725 . . . . 1.3100000000000001 109.168 -168.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -99.35 134.55 42.04 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.342 0.974 . . . . 4.2199999999999998 111.343 170.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.7 tt -130.73 140.58 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.936 1.694 . . . . 0.55000000000000004 110.284 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -107.91 150.5 26.98 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.489 1.116 . . . . 2.1099999999999999 108.911 170.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.1 mt -62.8 143.4 96.97 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 119.493 1.042 . . . . 1.05 111.91 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.9 107.25 1.07 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.292 2.662 . . . . 0.94999999999999996 111.799 -169.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.69 25.1 10.23 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.254 1.822 . . . . 3.0800000000000001 110.14 174.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -115.54 144.44 43.86 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.631 2.772 . . . . 2.9700000000000002 109.154 -171.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -73.14 42.7 0.12 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.756 1.622 . . . . 4.5499999999999998 114.993 -171.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 10.4 m -90.84 157.75 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.802 1.641 . . . . 1.1599999999999999 113.176 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 76.3 t -72.57 -37.99 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.755 1.622 . . . . 2.46 111.355 173.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.52 158.16 31.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.669 0.788 . . . . 3.54 111.525 169.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -96.03 140.07 31.3 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.025 0.93 . . . . 0.78000000000000003 112.179 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -136.63 165.16 26.52 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.066 1.506 . . . . 0.81999999999999995 115.066 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.33 142.93 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 126.241 1.816 . . . . 0.46999999999999997 111.119 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -136.38 70.61 60.85 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.448 1.499 . . . . 2.6200000000000001 113.236 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.516 ' HB3' HD11 ' A' ' 166' ' ' ILE . 18.6 Cg_endo -69.32 114.73 3.73 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.293 2.662 . . . . 0.92000000000000004 113.714 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -89.83 174.97 7.41 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 128.299 2.64 . . . . 2.0 111.939 173.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -108.3 167.28 10.13 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.432 1.493 . . . . 2.9399999999999999 111.363 170.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 9.0 t -114.37 -56.6 2.37 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.855 0.862 . . . . 2.7400000000000002 112.951 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -142.62 168.72 19.05 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.924 1.238 . . . . 5.3899999999999997 113.316 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -148.88 151.8 35.32 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.174 0.805 . . . . 6.21 113.174 -176.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.14 164.64 20.31 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 126.038 1.735 . . . . 9.5399999999999991 111.287 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.49 155.87 45.38 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.5 2.8 . . . . 9.0299999999999994 113.506 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -128.82 -14.71 4.47 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.853 1.797 . . . . 15.640000000000001 115.853 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.53 9.31 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 114.993 1.479 . . . . 14.56 114.993 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 80.8 mt -91.75 113.84 26.22 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.414 -0.804 . . . . 13.34 110.676 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 . . . . . 0 CA--C 1.552 1.056 0 C-N-CA 127.285 2.234 . . . . 16.91 111.236 -179.606 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 62.3 ttp . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 112.355 0.502 . . . . 28.710000000000001 112.355 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -78.98 163.32 25.31 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.358 1.614 . . . . 28.149999999999999 115.358 -168.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 t -146.9 151.3 36.82 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.646 1.978 . . . . 23.109999999999999 111.948 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.0 -12.33 47.75 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 115.406 1.632 . . . . 22.670000000000002 115.406 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.7 m -146.64 153.25 40.1 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.803 1.183 . . . . 18.890000000000001 113.087 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.6 -10.63 19.11 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.017 1.727 . . . . 15.06 115.486 -172.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.4 177.59 10.43 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.952 1.093 . . . . 12.9 113.952 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.9 t -78.64 153.62 30.89 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.617 1.567 . . . . 11.99 110.349 167.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.5 p -69.89 150.83 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.052 1.341 . . . . 10.51 113.617 -176.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -75.8 -179.84 5.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.053 1.741 . . . . 5.4000000000000004 112.257 169.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.73 -173.73 0.1 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.678 1.591 . . . . 6.5599999999999996 114.159 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -126.87 135.21 50.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.17 1.788 . . . . 6.7699999999999996 109.901 177.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.25 62.01 3.05 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.127 0.87 . . . . 4.1299999999999999 111.625 -169.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 p -139.91 144.61 37.23 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.304 1.442 . . . . 3.0499999999999998 110.997 -177.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.5 p -125.73 -9.67 6.73 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 117.797 2.518 . . . . 1.3200000000000001 117.797 -167.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 t -147.2 156.42 42.95 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 121.432 1.923 . . . . 1.99 114.622 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.7 p -100.89 -6.28 24.88 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.759 1.624 . . . . 1.1499999999999999 115.06 -172.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.5 p -147.5 156.73 43.12 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.878 1.671 . . . . 1.8899999999999999 113.794 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.76 140.45 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 127.893 2.477 . . . . 0.42999999999999999 109.112 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 36.2 m -114.17 127.54 55.95 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.353 0.979 . . . . 0.93000000000000005 111.383 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 p -96.34 136.55 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.202 1.001 . . . . 0.78000000000000003 110.695 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -131.37 107.21 8.77 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.824 1.65 . . . . 1.72 110.576 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.54 114.5 20.98 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 120.901 -1.125 . . . . 0.97999999999999998 111.436 -170.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.1 mt -99.36 154.41 18.22 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.539 1.136 . . . . 0.53000000000000003 112.416 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.6 mt -141.03 169.52 17.46 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.331 1.852 . . . . 1.73 110.209 169.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.5 150.4 23.43 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.89 0.876 . . . . 0.68999999999999995 111.016 169.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.9 p -76.64 -21.94 54.77 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.345 0.868 . . . . 1.1299999999999999 113.345 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -137.61 34.75 2.45 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.102 1.761 . . . . 2.1299999999999999 111.762 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.69 15.79 75.82 Favored Glycine 0 CA--C 1.539 1.551 0 O-C-N 119.864 -1.772 . . . . 1.0700000000000001 115.383 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.28 26.27 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 128.936 2.894 . . . . 1.8200000000000001 115.231 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -26.09 67.82 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.133 -1.604 . . . . 0.56000000000000005 113.367 -172.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -73.69 -46.36 46.77 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.41 1.004 . . . . 1.98 112.814 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -65.94 -43.27 88.51 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.203 -0.935 . . . . 2.0800000000000001 111.117 173.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 91.9 mt -50.65 -50.13 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 118.965 0.802 . . . . 0.60999999999999999 110.721 168.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.16 -32.64 70.07 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 120.807 1.639 . . . . 0.76000000000000001 113.657 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -74.31 -32.96 63.06 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.618 0.767 . . . . 0.94999999999999996 112.68 172.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -71.24 -23.66 62.04 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.626 1.171 . . . . 1.95 112.842 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.7 mt -92.32 -35.69 13.6 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.037 1.125 . . . . 0.93000000000000005 114.037 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -67.96 -28.14 67.21 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.977 0.808 . . . . 2.48 112.975 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 t -73.92 -12.49 60.67 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.42 1.488 . . . . 1.26 113.007 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.53 175.93 36.3 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.287 1.422 . . . . 0.96999999999999997 112.518 170.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -93.39 34.46 1.16 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.091 1.356 . . . . 2.3500000000000001 111.617 169.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -75.74 17.85 0.28 Allowed 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.459 -1.401 . . . . 1.8500000000000001 114.202 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.57 -23.83 49.93 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.261 1.024 . . . . 1.01 110.11 165.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -118.73 -59.33 0.27 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.862 1.696 . . . . 0.80000000000000004 112.709 172.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.281 0.0 OUTLIER -85.19 156.1 21.15 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.403 1.631 . . . . 1.4399999999999999 115.403 -169.829 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -60.09 149.17 33.35 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.447 0.906 . . . . 2.5099999999999998 113.447 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.5 t -62.68 124.42 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 121.87 -0.519 . . . . 0.68000000000000005 110.103 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.2 -47.02 25.04 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.709 -0.495 . . . . 0.80000000000000004 114.033 -171.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.0 t -145.59 116.21 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.66 1.584 . . . . 1.8400000000000001 108.551 176.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.2 mt -74.35 146.68 84.42 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 123.921 0.889 . . . . 0.73999999999999999 111.214 171.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.79 161.97 43.88 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.737 1.624 . . . . 0.58999999999999997 112.028 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.17 -33.72 65.53 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.198 0.599 . . . . 0.91000000000000003 112.257 174.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -83.39 1.54 40.89 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.393 1.877 . . . . 1.4099999999999999 115.629 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -95.97 152.04 18.88 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.963 1.256 . . . . 0.72999999999999998 112.677 169.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -148.95 167.62 25.27 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.71 1.604 . . . . 2.1400000000000001 111.462 169.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.26 141.68 51.38 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.828 0.851 . . . . 2.6099999999999999 110.774 -175.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.5 pt -126.82 141.55 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.403 1.081 . . . . 0.67000000000000004 112.144 -176.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.06 163.9 12.9 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.678 1.191 . . . . 0.57999999999999996 112.304 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.28 14.37 58.9 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.274 1.416 . . . . 0.64000000000000001 115.314 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.3 p -97.97 144.55 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.489 1.916 . . . . 0.72999999999999998 110.256 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 7.7 tpp -104.79 140.44 38.09 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.728 1.611 . . . . 0.55000000000000004 111.891 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.576 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.4 OUTLIER -143.92 157.03 44.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.492 1.517 . . . . 1.72 111.64 174.518 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.08 144.52 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 126.565 1.946 . . . . 0.40000000000000002 109.751 -176.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -85.81 146.99 26.52 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.916 1.341 . . . . 0.44 111.392 169.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.0 p -141.83 170.73 15.16 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.271 1.828 . . . . 0.41999999999999998 111.487 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.79 170.92 9.5 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.556 1.142 . . . . 1.5 112.414 168.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.5 p -33.32 -46.06 0.17 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.55 1.94 . . . . 1.79 114.351 172.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -90.98 29.49 1.36 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.574 1.15 . . . . 1.99 112.976 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.28 25.01 8.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 127.873 2.469 . . . . 1.1499999999999999 113.414 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -86.56 136.11 33.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.957 1.303 . . . . 1.78 111.515 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.9 mt -74.27 125.85 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 118.402 0.547 . . . . 0.47999999999999998 110.253 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.474 HG22 HG22 ' A' ' 97' ' ' THR . 2.1 pp -120.37 152.15 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.289 1.436 . . . . 1.0600000000000001 114.273 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -84.07 162.28 20.39 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.621 1.969 . . . . 1.3999999999999999 111.439 168.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -70.95 10.54 0.52 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 115.948 1.833 . . . . 2.3999999999999999 115.948 -169.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -115.22 -2.75 12.62 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.956 2.503 . . . . 2.7200000000000002 113.174 168.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.47 10.71 67.5 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.795 2.141 . . . . 0.57999999999999996 115.744 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -68.73 144.23 54.45 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.843 1.321 . . . . 2.2000000000000002 108.799 167.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.474 HG22 HG22 ' A' ' 91' ' ' ILE . 34.0 p -101.25 146.27 27.75 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.938 0.895 . . . . 0.63 112.076 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.88 -9.83 27.74 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.19 1.182 . . . . 0.65000000000000002 114.19 -171.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.63 25.33 42.76 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 119.738 1.154 . . . . 0.66000000000000003 113.903 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.1 t -133.66 150.41 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.939 1.695 . . . . 1.05 109.417 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -135.59 160.78 37.42 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 129.114 2.966 . . . . 1.47 110.688 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 57.2 mt -137.85 137.29 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.761 1.225 . . . . 0.75 110.417 -173.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -70.74 140.92 86.88 Favored Pre-proline 0 N--CA 1.476 0.837 0 CA-C-O 116.882 -1.532 . . . . 2.1499999999999999 111.05 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -72.32 -27.39 16.35 Favored 'Trans proline' 0 C--N 1.351 0.705 0 CA-C-N 122.935 2.084 . . . . 0.92000000000000004 112.567 174.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -88.19 -46.38 9.31 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 125.663 1.585 . . . . 1.71 112.795 -175.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.3 p -89.24 -24.66 22.05 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.357 0.873 . . . . 1.3899999999999999 113.357 -176.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 56.42 22.77 6.74 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.108 1.363 . . . . 1.9099999999999999 113.407 -168.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.98 148.75 21.86 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.956 1.303 . . . . 2.6000000000000001 112.488 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.1 mt -82.29 145.22 30.1 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.077 1.751 . . . . 0.95999999999999996 113.42 -174.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.1 p -76.38 5.56 6.96 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.348 1.24 . . . . 1.3799999999999999 114.348 170.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 177.12 -157.64 22.69 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.535 1.064 . . . . 0.88 113.652 -171.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -86.25 149.89 24.75 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.996 1.11 . . . . 0.93999999999999995 113.996 -174.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.5 tpt -51.43 126.05 28.26 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.962 1.705 . . . . 1.46 112.607 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.42 161.42 37.56 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.852 2.368 . . . . 0.79000000000000004 113.321 -170.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.62 -87.8 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 122.265 1.031 . . . . 1.0700000000000001 111.682 172.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 78.3 p -78.04 -1.05 30.36 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 116.067 1.876 . . . . 0.79000000000000004 116.067 -167.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.59 152.68 3.51 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.828 1.418 . . . . 0.48999999999999999 114.828 -171.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.7 ttt -78.6 95.1 5.14 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.993 1.317 . . . . 1.74 111.426 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.67 155.17 44.88 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.687 1.595 . . . . 2.3900000000000001 111.458 -177.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -169.2 164.26 11.02 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.785 1.634 . . . . 2.8700000000000001 111.301 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.9 mp -106.8 150.1 26.69 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.374 1.07 . . . . 0.58999999999999997 113.577 172.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.576 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 19.6 p -77.48 135.28 38.24 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 118.839 0.745 . . . . 0.60999999999999999 110.845 170.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -96.26 -58.65 2.02 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 115.345 1.609 . . . . 2.5699999999999998 115.345 -169.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -153.61 -35.23 0.11 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.101 1.36 . . . . 1.1100000000000001 112.142 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -100.67 -38.72 8.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.242 1.017 . . . . 3.71 112.075 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.86 -160.81 30.97 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.425 1.012 . . . . 0.68999999999999995 112.446 -174.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -134.82 123.68 23.93 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.381 1.872 . . . . 0.44 112.229 170.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -81.61 133.61 35.39 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.037 0.935 . . . . 2.46 112.29 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -120.58 141.27 50.46 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 128.955 2.902 . . . . 1.9199999999999999 109.493 174.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.436 HD21 ' HB3' ' A' ' 132' ' ' ALA . 2.8 t-20 -94.29 112.74 24.56 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.337 1.055 . . . . 2.9100000000000001 111.429 -174.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.2 p -94.25 1.27 56.0 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.21 1.189 . . . . 0.72999999999999998 114.21 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.436 ' HB3' HD21 ' A' ' 130' ' ' ASN . . . -59.91 -23.37 63.44 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.012 1.116 . . . . 0.71999999999999997 114.012 -176.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.14 -6.24 13.67 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.573 1.323 . . . . 2.1200000000000001 114.573 -170.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.22 132.16 70.78 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 119.278 0.945 . . . . 0.78000000000000003 113.324 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.08 168.45 23.98 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.468 2.112 . . . . 0.82999999999999996 111.106 169.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.0 83.13 0.68 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.468 1.907 . . . . 1.53 110.921 -177.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -135.38 173.57 11.57 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.505 1.522 . . . . 1.21 110.355 173.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -93.67 140.23 29.88 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.728 1.252 . . . . 3.4399999999999999 111.17 168.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -126.24 165.97 17.96 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.514 1.925 . . . . 0.71999999999999997 109.45 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -141.3 153.45 45.19 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.644 0.777 . . . . 1.6299999999999999 111.793 175.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.08 139.33 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.623 0.769 . . . . 0.44 110.449 173.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -127.62 140.31 52.18 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.486 1.914 . . . . 1.8200000000000001 110.488 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -102.43 130.76 49.31 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.065 1.346 . . . . 1.8100000000000001 111.108 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 37.6 mm -130.57 113.74 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.748 0.819 . . . . 0.92000000000000004 109.846 -169.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -77.08 -8.44 57.47 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.198 1.185 . . . . 3.5099999999999998 114.198 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.0 t -62.58 -28.74 70.09 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.149 1.537 . . . . 3.1299999999999999 115.149 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.48 6.79 16.02 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.927 1.691 . . . . 2.6800000000000002 114.255 -171.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 43.7 p -74.06 167.65 21.1 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.733 1.753 . . . . 4.6500000000000004 115.733 -169.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 79.9 p -114.47 -28.29 7.24 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.304 1.442 . . . . 5.2400000000000002 111.816 168.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -77.46 156.43 31.09 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.696 0.798 . . . . 6.1699999999999999 112.372 170.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.7 t -135.42 125.55 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.891 0.876 . . . . 4.3399999999999999 110.198 169.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -119.32 -12.88 6.6 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.329 1.442 . . . . 3.7400000000000002 115.196 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -87.85 -17.09 32.26 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.331 1.452 . . . . 5.46 114.794 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -97.24 27.98 3.88 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 116.529 2.048 . . . . 7.1500000000000004 116.529 -166.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 91.54 10.88 61.41 Favored Glycine 0 N--CA 1.477 1.399 0 O-C-N 120.671 -1.268 . . . . 4.9500000000000002 114.484 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.23 175.79 0.39 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.153 2.181 . . . . 3.5800000000000001 112.767 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.5 m -78.38 40.52 0.36 Allowed 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.211 -1.555 . . . . 2.98 111.328 169.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 80.2 mt -137.4 143.15 41.77 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 128.417 2.687 . . . . 1.8799999999999999 107.694 -171.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 77.3 p -73.55 -2.83 24.41 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 117.696 2.48 . . . . 3.6600000000000001 117.696 -166.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 65.12 9.32 40.78 Favored Glycine 0 CA--C 1.542 1.753 0 O-C-N 120.742 -1.224 . . . . 2.2000000000000002 115.221 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 75.3 m -74.05 163.49 27.82 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 127.404 2.282 . . . . 2.6699999999999999 112.916 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.67 147.65 32.73 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.548 1.539 . . . . 1.8400000000000001 113.131 -175.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.47 154.99 34.21 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.99 0.737 . . . . 0.82999999999999996 112.99 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.33 145.48 36.12 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.328 1.051 . . . . 0.56000000000000005 112.012 170.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.47 146.56 44.71 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.311 2.674 . . . . 0.5 113.366 -168.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.419 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.2 mp -117.1 128.93 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.359 1.863 . . . . 1.3500000000000001 108.81 -168.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -94.94 145.23 25.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.332 1.053 . . . . 2.9399999999999999 112.356 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.4 tt -150.84 157.28 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 125.625 1.57 . . . . 0.71999999999999997 110.533 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -136.56 -178.65 5.27 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.584 1.554 . . . . 2.5499999999999998 109.708 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.48 156.43 90.55 Favored Pre-proline 0 CA--C 1.552 1.051 0 O-C-N 120.811 -1.181 . . . . 2.1000000000000001 112.315 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -83.27 75.99 4.12 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.061 3.174 . . . . 1.6000000000000001 114.213 -167.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 4.5 tt -94.29 80.84 3.98 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 105.915 -1.883 . . . . 3.25 105.915 166.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -147.2 160.35 42.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.093 1.357 . . . . 3.8300000000000001 112.304 -168.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -74.37 -18.23 60.7 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.921 1.288 . . . . 3.21 113.553 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.2 m -65.83 150.72 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.887 1.675 . . . . 1.55 113.734 -173.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.13 -40.61 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.553 1.141 . . . . 2.0499999999999998 109.934 173.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -132.33 141.54 48.99 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.469 1.508 . . . . 2.8999999999999999 109.509 172.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -92.45 156.03 17.46 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.313 0.645 . . . . 0.56000000000000005 111.777 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -137.13 165.04 27.02 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.835 1.421 . . . . 0.54000000000000004 114.835 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.55 142.16 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 126.216 1.806 . . . . 0.51000000000000001 110.952 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -134.42 71.7 71.41 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 113.382 0.882 . . . . 1.9299999999999999 113.382 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.419 ' HB3' HD11 ' A' ' 166' ' ' ILE . 20.5 Cg_endo -62.75 144.35 93.66 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 124.006 3.137 . . . . 0.51000000000000001 113.824 -176.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -120.25 158.01 27.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.088 2.155 . . . . 1.55 112.184 -171.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -110.56 159.13 17.82 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.355 1.074 . . . . 3.1200000000000001 113.481 175.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 6.0 t -146.22 -169.57 3.29 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.66 2.384 . . . . 3.0 109.091 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -123.62 150.17 44.48 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.904 1.281 . . . . 5.8499999999999996 111.91 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -154.23 135.36 13.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.208 1.003 . . . . 6.2800000000000002 111.972 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -133.81 156.48 79.35 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 126.143 1.777 . . . . 10.01 111.035 170.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.58 162.71 39.24 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.019 2.479 . . . . 11.16 112.845 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -134.11 -8.59 2.65 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 115.818 1.784 . . . . 17.109999999999999 115.818 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.98 9.05 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 115.198 1.555 . . . . 18.899999999999999 115.198 172.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.1 tt -80.9 118.69 22.62 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.169 1.388 . . . . 16.07 109.883 176.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 . . . . . 0 C--O 1.24 0.584 0 C-N-CA 124.81 1.244 . . . . 22.289999999999999 112.417 -173.492 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 119.549 -0.262 . . . . 26.079999999999998 110.877 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.11 133.34 48.78 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.166 -0.679 . . . . 21.420000000000002 109.166 168.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.7 t -158.61 140.99 14.18 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.227 0.825 . . . . 20.670000000000002 113.227 177.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.52 0.82 1.02 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.13 2.172 . . . . 16.670000000000002 113.509 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.9 t -149.19 172.69 14.43 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.054 1.742 . . . . 17.170000000000002 114.269 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.98 -35.71 23.73 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.746 1.387 . . . . 18.66 114.746 -171.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -159.69 -29.61 0.06 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 116.194 1.924 . . . . 16.899999999999999 116.194 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.4 p -130.08 175.46 8.88 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.627 1.171 . . . . 13.83 113.006 -165.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.8 m -66.39 161.23 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.01 1.324 . . . . 8.8200000000000003 112.412 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -64.78 139.01 58.72 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.505 -0.554 . . . . 4.5999999999999996 109.505 167.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 61.81 160.07 0.06 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 127.179 2.191 . . . . 5.0999999999999996 116.109 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.84 110.31 4.45 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.862 -1.148 . . . . 6.6200000000000001 112.577 172.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.84 12.53 48.49 Favored Glycine 0 N--CA 1.475 1.27 0 N-CA-C 118.066 1.986 . . . . 3.48 118.066 175.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.9 p -70.65 155.02 41.28 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.673 1.989 . . . . 1.55 114.194 -172.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.2 p -88.73 -65.5 1.01 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.506 0.722 . . . . 1.8600000000000001 112.487 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 m -91.92 144.71 25.19 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.917 1.287 . . . . 2.3199999999999998 113.019 -169.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.5 p -101.43 -2.13 31.56 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.975 1.71 . . . . 0.81000000000000005 114.665 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.1 m -151.29 150.71 30.86 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.267 -1.52 . . . . 1.98 110.952 170.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.24 149.09 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.864 2.066 . . . . 0.41999999999999998 109.936 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.5 m -117.16 124.94 50.37 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.18 0.592 . . . . 0.68999999999999995 111.305 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.42 131.73 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.387 1.075 . . . . 0.48999999999999999 110.637 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -126.76 96.63 4.71 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.017 1.327 . . . . 1.76 110.814 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -71.48 121.53 18.81 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.723 -1.236 . . . . 1.1399999999999999 110.805 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.5 mt -109.02 159.9 16.46 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.594 1.158 . . . . 0.67000000000000004 112.187 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.4 mt -142.45 161.07 39.0 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.624 1.97 . . . . 1.8700000000000001 109.973 168.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.2 163.98 15.88 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.839 0.856 . . . . 0.92000000000000004 111.783 168.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.1 p -85.59 -32.83 21.88 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.279 -0.888 . . . . 1.22 113.275 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -146.87 55.83 1.13 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.523 1.129 . . . . 2.6499999999999999 111.05 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.62 11.36 82.98 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.728 1.632 . . . . 1.04 115.446 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -69.94 18.09 0.05 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.339 2.255 . . . . 1.8100000000000001 115.534 -172.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -61.38 -31.09 70.99 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.875 -1.14 . . . . 0.82999999999999996 112.291 -176.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -61.47 -49.89 74.96 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.593 1.157 . . . . 2.25 112.636 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -72.44 -43.14 64.21 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.058 -1.026 . . . . 2.48 111.511 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.5 mt -48.98 -48.78 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 119.491 1.041 . . . . 0.65000000000000002 110.976 169.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.19 -30.46 70.43 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.072 1.305 . . . . 0.91000000000000003 113.052 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -77.3 -31.41 54.71 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.717 0.807 . . . . 1.0800000000000001 112.631 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -69.53 -20.35 63.7 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.276 1.03 . . . . 1.9199999999999999 113.558 169.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.6 mt -96.96 -36.06 10.66 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.08 1.141 . . . . 1.0900000000000001 114.08 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -21.91 66.85 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.414 1.006 . . . . 4.3099999999999996 112.919 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.5 t -69.29 -29.75 67.69 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.277 1.031 . . . . 1.8300000000000001 113.509 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.21 165.92 26.75 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.809 1.195 . . . . 1.29 113.568 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -83.89 43.04 0.89 Allowed 'General case' 0 N--CA 1.481 1.09 0 O-C-N 121.458 -1.025 . . . . 1.98 112.748 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -80.8 1.04 32.18 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.894 1.278 . . . . 2.23 114.282 -169.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.2 -25.87 65.93 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.715 -1.241 . . . . 1.0700000000000001 112.406 169.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.74 -51.66 0.41 Allowed Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.541 1.067 . . . . 0.70999999999999996 112.503 169.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -75.82 162.93 27.74 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.056 1.132 . . . . 2.98 114.056 -171.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -63.7 156.82 25.85 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.116 0.566 . . . . 3.0 111.6 167.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.411 HG23 ' CE2' ' A' ' 181' ' ' TYR . 73.6 t -66.01 143.3 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 122.996 0.518 . . . . 0.87 110.063 170.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.32 -64.78 2.83 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 123.807 0.718 . . . . 1.1399999999999999 113.508 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.2 t -142.88 134.16 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.88 1.672 . . . . 2.8300000000000001 110.157 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.5 mt -83.35 146.82 51.65 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.538 0.735 . . . . 1.29 111.962 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.01 159.17 54.17 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.639 1.559 . . . . 1.23 111.476 172.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.51 -24.87 66.46 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.565 -1.334 . . . . 2.0299999999999998 111.147 169.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.71 4.56 6.08 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.968 1.47 . . . . 1.45 114.968 169.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.2 155.16 29.88 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.595 1.958 . . . . 0.78000000000000003 111.98 169.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.24 163.34 34.75 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.738 0.815 . . . . 1.8 113.181 167.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -107.05 137.96 44.14 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.39 1.876 . . . . 2.75 110.353 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.51 145.96 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.546 1.138 . . . . 0.85999999999999999 111.78 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.93 153.37 33.71 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.645 1.178 . . . . 0.90000000000000002 112.642 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.36 19.71 40.85 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.41 1.005 . . . . 0.60999999999999999 114.161 -170.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 p -97.79 143.64 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.042 1.337 . . . . 0.72999999999999998 108.889 168.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -105.4 142.93 34.29 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.194 1.397 . . . . 0.52000000000000002 112.667 -174.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.545 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.5 OUTLIER -148.82 152.32 36.3 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.304 1.442 . . . . 1.6899999999999999 111.716 175.654 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.23 146.57 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 127.002 2.121 . . . . 0.29999999999999999 109.313 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -88.99 143.07 27.11 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.176 0.988 . . . . 0.40999999999999998 112.502 170.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.5 p -133.96 164.15 27.95 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.451 1.901 . . . . 0.40000000000000002 112.845 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.18 169.62 11.74 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.922 1.289 . . . . 1.72 110.723 166.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.57 -21.51 66.6 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.301 1.223 . . . . 2.8100000000000001 114.301 -170.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -77.55 19.36 0.37 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.886 0.874 . . . . 1.74 112.817 168.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 56.25 29.14 14.36 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.257 1.823 . . . . 0.76000000000000001 113.117 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -90.0 140.54 29.53 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.099 1.359 . . . . 2.3700000000000001 111.39 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.1 mt -80.77 126.5 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 118.087 0.403 . . . . 0.54000000000000004 110.378 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.45 HG22 HG22 ' A' ' 97' ' ' THR . 2.2 pp -122.21 151.51 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.605 1.562 . . . . 1.2 114.134 -175.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.28 164.64 19.95 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 127.21 2.204 . . . . 2.3399999999999999 112.103 169.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.5 -17.93 48.57 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.823 1.786 . . . . 3.3500000000000001 115.823 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -92.72 4.71 53.24 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.913 1.285 . . . . 3.8300000000000001 111.557 172.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.51 10.38 85.75 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 127.294 2.378 . . . . 0.66000000000000003 115.492 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -63.88 135.89 56.93 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.236 1.018 . . . . 2.6600000000000001 108.553 169.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.45 HG22 HG22 ' A' ' 91' ' ' ILE . 51.9 p -90.79 139.88 30.31 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.111 0.482 . . . . 0.83999999999999997 111.726 178.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.18 -6.09 51.33 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.818 -1.176 . . . . 0.89000000000000001 113.913 -169.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.88 27.44 34.48 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 119.898 1.226 . . . . 1.0 113.695 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.3 t -136.9 148.93 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.267 1.427 . . . . 1.23 109.583 177.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -137.44 154.78 49.87 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 128.568 2.747 . . . . 1.28 110.745 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.434 HG12 HD23 ' A' ' 109' ' ' LEU . 33.0 mt -133.31 136.64 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.248 1.419 . . . . 0.63 110.179 -173.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -77.82 141.62 64.26 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-O 117.543 -1.217 . . . . 2.1899999999999999 111.933 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.0 -16.28 18.14 Favored 'Trans proline' 0 C--N 1.352 0.733 0 CA-C-N 122.139 1.8 . . . . 0.84999999999999998 113.416 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -101.92 -48.09 4.37 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.99 1.716 . . . . 1.3500000000000001 111.28 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 p -83.92 -28.65 27.73 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.953 0.723 . . . . 1.3999999999999999 112.953 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 56.34 23.28 7.12 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.883 1.673 . . . . 1.8500000000000001 113.484 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.85 153.67 21.14 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.528 -1.358 . . . . 2.4399999999999999 111.817 174.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.434 HD23 HG12 ' A' ' 102' ' ' ILE . 29.6 mt -92.04 139.03 31.04 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.679 1.192 . . . . 0.87 112.375 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.5 p -74.24 6.69 3.34 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.716 1.206 . . . . 1.4299999999999999 113.956 175.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.21 -158.72 20.44 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 126.446 1.974 . . . . 0.93999999999999995 111.068 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.99 155.14 32.83 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 122.065 -0.667 . . . . 1.04 112.429 175.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.8 tpt -59.48 125.28 78.99 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.877 0.871 . . . . 1.79 109.926 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -70.4 167.45 25.22 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 124.39 3.393 . . . . 0.93000000000000005 113.9 -172.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.69 -97.59 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.176 1.391 . . . . 1.6399999999999999 111.032 170.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 50.7 p -71.3 11.43 0.44 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.522 2.045 . . . . 1.01 116.522 -167.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.67 150.35 3.96 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.25 -0.906 . . . . 0.48999999999999999 112.943 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.2 tpt -78.27 88.45 4.32 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.081 2.152 . . . . 1.6599999999999999 110.713 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -147.66 135.05 20.69 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.039 1.736 . . . . 0.94999999999999996 111.32 -171.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -169.24 145.98 3.46 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.23 1.412 . . . . 3.5600000000000001 110.2 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.09 156.12 21.21 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.572 1.323 . . . . 0.5 114.572 -175.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.545 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 3.9 p -66.3 137.87 57.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 119.866 -1.771 . . . . 0.48999999999999999 110.319 169.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -98.82 -56.57 2.4 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.462 1.105 . . . . 2.6499999999999999 113.344 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -167.84 -39.95 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.598 1.959 . . . . 1.24 110.742 168.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -96.6 25.5 5.1 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.847 1.659 . . . . 5.0999999999999996 112.574 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.6 -150.94 19.74 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.033 1.778 . . . . 0.67000000000000004 111.348 -169.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.53 128.37 21.84 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.279 1.832 . . . . 0.39000000000000001 110.347 168.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -75.62 136.13 40.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.941 1.297 . . . . 1.55 110.927 172.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -128.11 117.46 21.65 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.282 1.833 . . . . 1.74 108.876 169.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -77.27 122.03 24.52 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.177 -0.952 . . . . 1.47 110.82 175.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.7 p -112.03 -4.64 14.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.934 1.294 . . . . 0.92000000000000004 114.069 -171.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.9 -15.69 5.34 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 115.918 1.822 . . . . 0.68000000000000005 115.918 -172.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -106.39 0.9 25.25 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.086 1.355 . . . . 2.7400000000000002 114.076 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.84 146.01 87.39 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 120.521 1.509 . . . . 0.83999999999999997 113.122 170.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.99 164.83 32.6 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.934 1.756 . . . . 1.1599999999999999 110.364 165.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.39 88.52 1.58 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.454 1.501 . . . . 1.47 110.3 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -139.95 -179.22 5.83 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.042 1.337 . . . . 1.1200000000000001 111.185 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -92.69 140.84 29.12 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.574 1.15 . . . . 2.25 111.813 168.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -132.55 169.93 15.9 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.988 1.715 . . . . 0.75 110.298 -169.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -152.53 147.59 26.38 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.43 1.092 . . . . 3.6299999999999999 112.264 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -105.25 136.38 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 123.797 0.839 . . . . 0.40999999999999998 109.024 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -123.44 122.41 38.19 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.376 1.47 . . . . 1.8500000000000001 110.019 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -83.36 75.75 9.96 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.993 1.317 . . . . 2.1299999999999999 111.109 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.0 mm -80.82 113.85 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.41 -0.959 . . . . 1.03 108.41 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -116.35 28.34 8.65 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.703 0.801 . . . . 5.0199999999999996 113.131 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.2 p -67.96 -26.61 66.02 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.226 1.01 . . . . 1.8400000000000001 111.572 168.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -76.77 47.5 0.51 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.324 1.85 . . . . 2.1699999999999999 108.776 165.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.3 m -54.15 118.06 3.75 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.178 1.791 . . . . 6.3099999999999996 111.687 -167.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.8 m -132.89 -52.29 0.91 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 117.501 -1.237 . . . . 4.29 114.172 -168.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -73.13 153.62 40.68 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 120.607 1.549 . . . . 5.6399999999999997 112.805 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.6 t -89.57 129.84 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.522 1.129 . . . . 4.6600000000000001 112.095 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -143.48 -15.04 0.28 Allowed Glycine 0 CA--C 1.536 1.35 0 N-CA-C 117.434 1.734 . . . . 2.2400000000000002 117.434 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -103.48 -20.25 14.11 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 120.799 2.299 . . . . 4.9000000000000004 114.718 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -83.22 39.98 0.68 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.242 1.417 . . . . 5.4699999999999998 113.503 -171.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 89.26 -8.97 78.66 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.502 1.525 . . . . 3.9399999999999999 115.257 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.53 158.64 9.47 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.903 1.681 . . . . 2.9300000000000002 114.006 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.1 m -74.38 52.5 0.49 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 127.625 2.37 . . . . 2.77 112.46 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -125.08 159.7 30.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.79 2.036 . . . . 2.2799999999999998 111.366 -171.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.5 t -110.49 143.93 40.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.257 1.423 . . . . 3.1600000000000001 113.108 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -82.21 64.68 4.21 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.705 1.145 . . . . 3.21 110.393 168.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.9 t -112.23 145.92 39.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.067 0.947 . . . . 2.9700000000000002 113.095 -172.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.428 ' HE3' HG13 ' A' ' 164' ' ' VAL . 21.9 ttpt -81.48 124.35 29.38 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.047 1.739 . . . . 2.5600000000000001 111.54 177.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.87 154.16 34.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.478 0.711 . . . . 0.98999999999999999 111.275 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.428 HG13 ' HE3' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -123.04 143.21 40.14 Favored Pre-proline 0 N--CA 1.477 0.898 0 O-C-N 121.521 -0.737 . . . . 0.84999999999999998 111.202 174.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.21 145.41 72.4 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.825 3.016 . . . . 0.56000000000000005 111.653 -168.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.461 HD11 ' HB3' ' A' ' 182' ' ' PRO . 1.3 mp -103.94 124.01 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.129 0.971 . . . . 1.3200000000000001 109.492 -171.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.87 138.05 32.44 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.84 0.746 . . . . 3.0699999999999998 112.894 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.3 tt -147.92 156.15 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.18 0.992 . . . . 0.42999999999999999 111.682 -172.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -134.46 166.55 22.6 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.099 1.76 . . . . 2.6099999999999999 109.481 169.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -61.5 155.55 58.29 Favored Pre-proline 0 CA--C 1.551 1.017 0 O-C-N 120.973 -1.079 . . . . 1.6100000000000001 111.932 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.42 94.9 0.92 Allowed 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.919 3.079 . . . . 0.87 112.111 -169.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.44 45.58 2.63 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.379 1.871 . . . . 2.3500000000000001 108.803 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -128.81 18.4 6.18 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 127.214 2.206 . . . . 3.1200000000000001 113.024 -167.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.3 t70 60.96 17.75 8.2 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 128.171 2.588 . . . . 4.0800000000000001 115.639 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.3 m -86.58 153.03 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 114.282 1.215 . . . . 1.1000000000000001 114.282 -172.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.13 -32.26 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.083 1.753 . . . . 1.74 112.095 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -153.78 141.03 19.55 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.737 1.215 . . . . 2.4300000000000002 110.19 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -101.86 140.77 35.7 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.208 0.818 . . . . 0.48999999999999999 113.208 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -136.8 166.04 24.54 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.032 1.493 . . . . 0.53000000000000003 115.032 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.76 143.55 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 127.2 2.2 . . . . 0.46999999999999997 111.485 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.411 ' CE2' HG23 ' A' ' 66' ' ' VAL . 97.7 m-85 -133.06 82.74 53.66 Favored Pre-proline 0 CA--C 1.553 1.066 0 N-CA-C 113.584 0.957 . . . . 1.9299999999999999 113.584 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.461 ' HB3' HD11 ' A' ' 166' ' ' ILE . 6.6 Cg_exo -58.0 143.99 95.28 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.699 2.932 . . . . 0.60999999999999999 115.51 175.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -133.6 165.93 23.78 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 128.55 2.74 . . . . 1.5 112.623 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -119.62 173.3 7.09 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.002 2.121 . . . . 2.8799999999999999 111.154 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 6.5 t -150.46 -23.96 0.24 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 117.352 2.352 . . . . 2.9300000000000002 117.352 -169.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -150.82 169.92 20.51 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 120.712 -1.243 . . . . 6.6900000000000004 114.348 -175.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -90.07 142.99 27.17 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.555 1.142 . . . . 5.1200000000000001 113.451 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -142.39 160.26 55.08 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 125.193 1.397 . . . . 12.960000000000001 112.119 176.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.5 144.4 55.26 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.227 1.951 . . . . 10.07 111.765 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -102.47 -4.85 24.77 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 115.576 1.695 . . . . 14.970000000000001 115.576 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.74 -8.09 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 125.934 1.694 . . . . 14.970000000000001 114.642 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.35 118.6 36.28 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.539 1.136 . . . . 13.5 109.511 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 . . . . . 0 CA--C 1.539 0.523 0 C-N-CA 124.694 1.198 . . . . 19.510000000000002 112.265 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 109.961 -0.385 . . . . 27.18 109.961 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.94 151.64 51.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.748 1.619 . . . . 22.82 111.584 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 59.3 p -109.83 3.56 20.83 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.805 1.242 . . . . 19.940000000000001 113.844 175.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.28 151.69 12.31 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.672 1.189 . . . . 16.18 113.331 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.6 p -158.44 0.04 0.1 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 116.656 2.095 . . . . 15.609999999999999 116.656 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -111.68 -6.18 14.38 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.832 1.79 . . . . 12.49 115.832 -172.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 59.8 -52.9 0.07 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 129.284 3.034 . . . . 10.84 118.9 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 35.5 p -121.13 173.3 7.38 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.876 1.27 . . . . 8.8900000000000006 113.91 -166.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.7 m -67.0 151.73 10.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 124.424 1.09 . . . . 6.1200000000000001 111.804 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -86.71 131.16 34.22 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.82 0.848 . . . . 3.1200000000000001 112.581 -172.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.77 137.77 6.72 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.932 1.293 . . . . 4.4900000000000002 111.208 -171.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.75 14.5 0.55 Allowed 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.257 1.577 . . . . 6.0199999999999996 115.257 175.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.92 39.38 88.66 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 126.046 1.784 . . . . 2.6000000000000001 114.268 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.0 p -92.86 179.21 5.53 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.543 1.937 . . . . 1.5700000000000001 115.774 -168.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.2 p -121.7 0.11 9.78 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.324 1.45 . . . . 1.45 114.029 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 m -156.41 158.32 37.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.976 1.711 . . . . 2.6000000000000001 110.42 -170.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 43.1 p -117.27 -11.66 10.6 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 126.425 1.89 . . . . 1.1899999999999999 115.552 -174.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 p -143.68 153.31 42.35 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.903 1.681 . . . . 2.2200000000000002 113.064 -175.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.3 p -130.93 135.2 60.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 126.426 1.891 . . . . 0.52000000000000002 109.119 174.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.8 m -114.62 126.04 54.44 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 118.254 0.479 . . . . 0.84999999999999998 110.509 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.2 p -96.89 132.38 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.225 1.01 . . . . 0.80000000000000004 110.318 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -129.59 98.31 4.8 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.584 1.554 . . . . 2.0699999999999998 109.732 -174.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.09 126.18 30.49 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.619 -1.3 . . . . 0.94999999999999996 111.842 -169.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.6 mt -103.59 151.67 22.64 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.37 1.068 . . . . 0.60999999999999999 113.322 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.53 161.63 35.33 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.567 1.547 . . . . 2.0600000000000001 109.451 169.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.553 ' HB1' ' H ' ' A' ' 48' ' ' ASP . . . -97.18 154.03 17.63 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.732 0.813 . . . . 0.66000000000000003 112.027 172.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.4 p -87.64 -20.19 26.68 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.29 1.219 . . . . 1.1000000000000001 114.29 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -151.5 51.99 0.83 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.882 1.673 . . . . 2.1699999999999999 112.455 170.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.99 23.79 70.92 Favored Glycine 0 CA--C 1.536 1.388 0 O-C-N 120.439 -1.413 . . . . 1.1100000000000001 115.989 172.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.553 ' H ' ' HB1' ' A' ' 44' ' ' ALA . 4.2 m-20 -81.1 10.95 4.54 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 128.213 2.605 . . . . 1.8600000000000001 115.622 -174.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -57.81 -31.25 66.41 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.37 -1.456 . . . . 0.82999999999999996 112.629 -171.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.42 -49.75 52.17 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.788 1.235 . . . . 2.3100000000000001 113.465 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -69.7 -33.06 72.01 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 120.968 -1.082 . . . . 3.1800000000000002 111.495 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.42 -52.67 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.502 1.121 . . . . 0.78000000000000003 110.095 168.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.86 -34.99 70.34 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.127 0.876 . . . . 0.84999999999999998 112.484 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -67.62 -32.47 73.21 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.405 0.891 . . . . 0.95999999999999996 113.405 173.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.99 -28.24 65.36 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.063 1.301 . . . . 1.98 113.017 171.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.4 mt -87.2 -40.95 14.11 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.673 0.99 . . . . 1.01 113.673 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -67.41 -21.21 65.59 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.437 0.903 . . . . 2.8500000000000001 113.437 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.4 t -75.79 -25.69 56.62 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 121.393 -0.817 . . . . 1.54 112.88 169.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.46 161.19 32.3 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 126.141 1.829 . . . . 1.0600000000000001 113.918 174.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -84.27 33.47 0.5 Allowed 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.945 -1.326 . . . . 2.3100000000000001 113.78 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -72.1 8.44 1.28 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.595 1.702 . . . . 2.2999999999999998 115.595 -169.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.1 -30.17 71.09 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.219 -0.925 . . . . 1.04 109.881 165.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.25 -83.74 1.75 Allowed Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.067 1.318 . . . . 0.79000000000000004 112.476 171.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -65.99 151.8 46.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.608 1.336 . . . . 1.5700000000000001 114.608 -173.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -59.16 143.37 49.06 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.075 1.35 . . . . 4.0300000000000002 111.3 172.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.8 t -53.89 136.24 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.343 0.657 . . . . 1.03 111.181 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.7 -64.42 3.32 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.682 0.658 . . . . 0.91000000000000003 112.515 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.4 t -137.52 125.86 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.581 1.152 . . . . 1.9299999999999999 110.623 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.8 mt -80.73 143.78 54.95 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.316 0.647 . . . . 0.85999999999999999 110.896 172.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.91 162.18 42.7 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.141 1.894 . . . . 0.68999999999999995 112.158 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.63 -21.63 66.47 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.646 0.98 . . . . 0.93000000000000005 113.646 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -92.55 -1.48 56.9 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 115.082 1.512 . . . . 1.53 115.082 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.41 152.41 21.5 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.853 0.861 . . . . 0.80000000000000004 113.147 169.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.7 pttt -146.43 167.73 22.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.577 1.551 . . . . 1.95 111.77 168.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -118.4 143.44 46.66 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.864 1.666 . . . . 2.3999999999999999 109.931 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.1 pt -126.93 142.91 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 114.468 1.285 . . . . 0.71999999999999997 114.468 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.66 153.22 20.34 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.823 1.649 . . . . 0.67000000000000004 112.316 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.63 7.07 61.93 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.964 1.745 . . . . 0.65000000000000002 115.28 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.0 p -90.42 143.75 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 118.547 1.173 . . . . 0.80000000000000004 110.112 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 1.3 tpp -111.67 132.85 54.31 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.105 1.762 . . . . 0.62 112.016 -172.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.55 153.06 48.69 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.39 1.476 . . . . 1.73 111.53 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.81 143.19 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 126.346 1.859 . . . . 0.41999999999999998 109.514 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -84.78 145.99 27.6 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 122.817 1.294 . . . . 0.34999999999999998 111.244 169.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.3 p -140.27 170.69 15.35 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.29 1.836 . . . . 0.33000000000000002 111.527 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.75 173.23 9.59 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.525 0.73 . . . . 2.0099999999999998 112.926 169.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.7 p -64.1 -16.91 62.82 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 120.744 -1.223 . . . . 1.4199999999999999 113.513 170.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 -80.96 8.1 9.18 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.418 1.487 . . . . 2.73 113.014 168.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.52 25.54 9.89 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.129 2.172 . . . . 0.71999999999999997 113.28 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -89.29 141.46 28.52 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.633 1.573 . . . . 2.52 110.612 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.423 HD11 ' CD2' ' A' ' 109' ' ' LEU . 10.8 mt -76.66 126.98 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.416 -0.587 . . . . 0.5 109.416 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.459 HG22 HG22 ' A' ' 97' ' ' THR . 3.2 pt -122.07 154.38 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 114.637 1.347 . . . . 0.5 114.637 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.29 163.32 24.04 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.168 2.187 . . . . 1.74 111.336 167.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.74 -1.18 3.53 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 115.499 1.666 . . . . 2.3300000000000001 115.499 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -105.14 -1.57 25.34 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.907 1.683 . . . . 3.96 113.218 169.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.16 -0.68 64.21 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.436 1.969 . . . . 0.66000000000000003 115.853 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -69.66 139.18 53.48 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 119.185 1.492 . . . . 2.3199999999999998 110.893 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.459 HG22 HG22 ' A' ' 91' ' ' ILE . 5.5 p -99.21 141.26 32.21 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.732 0.813 . . . . 0.77000000000000002 112.402 -172.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.23 -8.0 46.62 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.475 1.287 . . . . 0.80000000000000004 114.475 -168.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.5 24.0 57.32 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.052 0.842 . . . . 0.81999999999999995 113.661 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.95 147.08 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.214 1.406 . . . . 1.1699999999999999 109.311 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -133.67 158.22 43.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.839 1.656 . . . . 1.29 111.656 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 60.0 mt -133.19 141.04 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.912 1.285 . . . . 0.62 110.684 -170.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -81.98 145.91 54.37 Favored Pre-proline 0 N--CA 1.477 0.91 0 O-C-N 120.862 -1.149 . . . . 1.8100000000000001 112.659 174.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.68 -19.38 12.84 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 CA-C-N 122.139 1.8 . . . . 0.85999999999999999 113.243 175.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -97.93 -47.74 5.43 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.821 1.649 . . . . 1.4199999999999999 112.47 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.8 p -80.49 -29.18 37.35 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.286 0.635 . . . . 0.92000000000000004 111.879 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 57.74 16.34 3.46 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.531 1.532 . . . . 1.9299999999999999 113.539 -170.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.79 149.23 21.41 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.742 1.217 . . . . 2.6499999999999999 111.718 -175.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.423 ' CD2' HD11 ' A' ' 90' ' ' ILE . 8.2 mt -84.17 138.64 32.89 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.932 1.293 . . . . 0.93999999999999995 111.955 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.1 t -87.02 20.24 2.75 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.685 0.994 . . . . 2.8399999999999999 113.685 172.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -177.42 174.07 46.67 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 126.882 2.182 . . . . 1.21 111.905 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.6 162.78 28.84 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.306 0.854 . . . . 1.01 113.306 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 mmt -51.91 132.45 39.01 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.712 1.205 . . . . 1.6299999999999999 113.074 -175.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -78.59 155.67 27.85 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.323 3.349 . . . . 1.0700000000000001 113.682 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.15 -35.92 23.26 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.893 1.812 . . . . 1.5800000000000001 115.893 -176.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.2 p -131.46 10.22 4.79 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.832 1.653 . . . . 0.90000000000000002 113.035 -168.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.85 152.29 16.22 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.689 1.366 . . . . 0.54000000000000004 114.689 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.1 ttt -80.19 85.31 5.74 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.85 1.66 . . . . 1.8899999999999999 111.712 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -135.45 153.85 51.63 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.005 1.722 . . . . 1.23 112.456 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -164.02 158.34 19.4 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.124 1.77 . . . . 1.8700000000000001 110.747 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 mp -98.28 147.29 24.79 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.31 1.044 . . . . 0.57999999999999996 112.469 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.2 p -65.1 125.68 25.72 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 120.329 1.422 . . . . 0.64000000000000001 109.822 169.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.52 -52.02 7.24 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.372 1.619 . . . . 2.02 115.372 -169.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.78 -46.07 0.1 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.784 1.634 . . . . 1.3700000000000001 109.075 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -116.01 -17.03 11.02 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.524 1.305 . . . . 4.0899999999999999 114.524 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 172.57 -169.5 42.62 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.093 1.33 . . . . 0.65000000000000002 112.593 -172.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.52 126.82 18.64 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.281 1.832 . . . . 0.45000000000000001 112.413 170.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -80.19 136.7 36.54 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.873 1.269 . . . . 1.25 112.388 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -127.52 142.38 51.4 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.321 2.649 . . . . 2.0699999999999998 108.671 171.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.46 HD21 ' HB3' ' A' ' 132' ' ' ALA . 2.2 t-20 -105.91 111.97 24.84 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.93 0.892 . . . . 2.1400000000000001 110.619 -175.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.0 p -94.15 -8.41 39.53 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.314 1.228 . . . . 0.80000000000000004 114.314 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.46 ' HB3' HD21 ' A' ' 130' ' ' ASN . . . -54.23 -14.85 1.26 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.885 1.674 . . . . 0.96999999999999997 115.357 -176.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.92 -21.71 13.09 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.556 1.542 . . . . 2.6200000000000001 112.866 -176.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -72.21 144.57 87.33 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 119.779 1.172 . . . . 0.77000000000000002 112.523 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.94 168.16 25.45 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.84 2.36 . . . . 0.73999999999999999 111.99 172.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -72.35 76.38 1.01 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.625 1.97 . . . . 1.0700000000000001 111.818 -176.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -142.03 -173.54 3.84 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.115 1.366 . . . . 0.78000000000000003 111.305 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -104.66 154.7 19.63 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.233 1.413 . . . . 3.0099999999999998 112.201 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -145.3 169.8 17.55 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 127.456 2.302 . . . . 0.58999999999999997 110.178 -173.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -137.97 154.66 49.34 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.866 1.061 . . . . 1.6699999999999999 113.866 175.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.6 mp -113.58 136.9 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.566 1.146 . . . . 0.45000000000000001 110.763 174.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -125.9 149.65 48.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.746 2.018 . . . . 1.8400000000000001 110.558 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -112.05 120.16 40.89 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.581 1.152 . . . . 1.8899999999999999 110.72 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 22.9 mm -129.07 113.96 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.352 1.061 . . . . 0.58999999999999997 109.421 -169.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -98.91 15.32 25.98 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.687 1.195 . . . . 5.3200000000000003 113.544 -174.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 82.5 p -77.51 -21.89 52.02 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.253 1.205 . . . . 2.1099999999999999 114.253 -176.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.35 177.03 1.2 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.464 1.105 . . . . 3.04 110.168 167.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 28.7 t -44.03 -53.44 6.3 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.624 1.17 . . . . 5.71 112.45 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.1 m 58.19 158.1 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 128.355 2.662 . . . . 5.3399999999999999 116.432 167.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -62.24 172.63 1.4 Allowed 'General case' 0 CA--C 1.547 0.837 0 O-C-N 120.49 -1.381 . . . . 5.7400000000000002 112.247 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.1 p -127.89 148.13 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.775 1.23 . . . . 3.77 111.545 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.66 -29.37 0.83 Allowed Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.799 1.19 . . . . 2.4500000000000002 113.211 171.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -76.36 -10.96 59.79 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.984 2.114 . . . . 4.1799999999999997 115.451 -171.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -90.0 16.68 7.87 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.3 1.44 . . . . 5.3700000000000001 113.92 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 101.68 13.23 32.87 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.055 1.312 . . . . 3.79 115.222 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.37 165.24 22.83 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.16 0.984 . . . . 2.79 112.606 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.0 m -81.37 55.9 2.74 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.117 1.367 . . . . 2.7599999999999998 110.378 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.6 mt -142.71 163.8 31.84 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.88 2.072 . . . . 1.8899999999999999 110.3 -173.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 34.5 p -92.58 -34.46 14.02 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 115.755 1.761 . . . . 3.79 115.755 -168.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.88 25.04 75.74 Favored Glycine 0 CA--C 1.539 1.563 0 O-C-N 120.97 -1.081 . . . . 2.3199999999999998 112.083 -166.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 68.1 p -89.42 -168.38 2.14 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.114 1.365 . . . . 2.7400000000000002 112.135 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.81 152.58 40.53 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.402 1.481 . . . . 3.3700000000000001 112.436 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.07 155.45 40.29 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.091 0.775 . . . . 1.48 113.091 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.74 150.78 37.34 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 124.469 1.108 . . . . 0.60999999999999999 110.018 167.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.6 140.51 32.89 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.894 2.396 . . . . 0.80000000000000004 113.244 -168.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.9 mp -111.23 139.27 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.146 1.779 . . . . 1.3899999999999999 109.874 -173.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -107.45 141.32 39.04 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.914 1.079 . . . . 2.7599999999999998 113.914 173.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.8 tt -145.38 155.37 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 125.326 1.45 . . . . 0.56999999999999995 111.779 -170.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -134.89 160.21 38.98 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.669 1.988 . . . . 1.99 110.382 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.95 144.54 81.85 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.347 -0.846 . . . . 2.0600000000000001 112.573 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.4 113.57 3.52 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.148 2.565 . . . . 0.82999999999999996 113.793 -169.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 4.2 tt -126.18 79.05 1.81 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 105.388 -2.079 . . . . 3.5099999999999998 105.388 166.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -149.79 156.07 41.2 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.085 2.154 . . . . 3.4900000000000002 109.686 -169.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -80.54 33.47 0.31 Allowed 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.787 -1.196 . . . . 4.0800000000000001 113.94 -177.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 32.9 m -110.25 169.18 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.216 1.406 . . . . 2.0699999999999998 112.481 -173.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 61.4 t -101.93 -29.06 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.651 1.181 . . . . 2.77 110.384 171.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.49 140.79 41.39 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.266 1.426 . . . . 3.2599999999999998 111.434 173.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -91.31 152.88 20.29 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.848 0.859 . . . . 0.47999999999999998 110.626 173.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -138.87 153.13 48.28 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.337 0.865 . . . . 0.96999999999999997 113.337 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.38 140.57 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.106 1.762 . . . . 0.72999999999999998 111.002 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -128.97 74.11 81.31 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.735 0.814 . . . . 2.2400000000000002 112.907 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.61 150.05 44.77 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.141 3.227 . . . . 0.88 113.818 -175.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -132.01 165.01 24.93 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.48 2.312 . . . . 1.5 113.014 -169.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -108.67 161.0 15.5 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.415 1.486 . . . . 3.0499999999999998 113.613 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 5.3 t -147.82 170.78 16.89 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 126.075 1.75 . . . . 3.1499999999999999 108.613 167.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -88.84 -90.06 0.14 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.726 0.811 . . . . 5.4400000000000004 111.676 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . 53.4 -79.29 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.884 2.474 . . . . 7.1699999999999999 115.635 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . 0.275 23.6 pttm 49.48 148.1 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.094 1 C-N-CA 133.611 4.765 . . . . 9.2400000000000002 118.117 -176.506 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -79.71 160.84 24.79 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.637 2.891 . . . . 13.65 115.743 -172.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -125.32 -11.54 6.9 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.025 1.861 . . . . 15.76 116.025 -173.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 191' ' ' ILE . 3.0 mp -93.85 -62.21 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 120.4 1.455 . . . . 20.66 109.943 -175.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.8 mt 53.1 177.09 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 129.346 3.059 . . . . 21.219999999999999 116.024 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.531 0 C-N-CA 126.853 2.061 . . . . 27.489999999999998 110.01 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 15.9 tpt . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 110.428 -0.212 . . . . 22.469999999999999 110.428 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 61.27 -72.58 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 127.819 2.447 . . . . 22.010000000000002 114.992 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 p -75.54 155.09 36.41 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.342 0.974 . . . . 18.850000000000001 112.317 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 58.71 23.79 11.49 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.115 1.766 . . . . 14.68 115.146 -174.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.3 m -74.47 -24.67 59.07 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.826 1.417 . . . . 12.640000000000001 114.826 -171.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.52 -25.43 21.41 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.143 0.883 . . . . 10.460000000000001 112.502 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.75 -37.87 20.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.421 1.488 . . . . 9.5500000000000007 113.668 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.0 p -125.09 135.11 52.38 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.716 1.006 . . . . 8.4399999999999995 113.716 -169.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.5 m -61.31 158.65 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.162 1.385 . . . . 6.3899999999999997 114.108 -171.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -88.22 46.13 1.35 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.392 1.477 . . . . 3.6000000000000001 112.154 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 56.06 -173.64 0.06 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 126.039 1.735 . . . . 3.6499999999999999 114.877 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.05 133.41 35.42 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.862 1.665 . . . . 4.9100000000000001 110.562 173.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.14 26.93 0.06 OUTLIER Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.942 -0.921 . . . . 1.77 115.21 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.5 p -150.79 171.85 16.54 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 118.993 1.396 . . . . 1.1499999999999999 113.678 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.4 p -89.9 -20.4 23.43 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 115.014 1.487 . . . . 1.71 115.014 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.6 t -154.51 156.07 36.0 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.376 1.47 . . . . 2.2400000000000002 110.775 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.4 p -80.67 -4.56 54.73 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.497 1.666 . . . . 1.3700000000000001 115.497 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.9 p -149.69 161.87 41.35 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.596 1.702 . . . . 1.7 115.596 -170.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.6 p -128.4 143.65 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 127.043 2.137 . . . . 0.44 110.003 173.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.0 m -113.89 118.39 34.06 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.223 1.009 . . . . 0.70999999999999996 109.073 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 p -94.49 130.93 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 122.061 0.934 . . . . 0.65000000000000002 109.289 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -108.56 -179.47 3.88 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.174 1.79 . . . . 1.9199999999999999 109.424 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.53 122.3 9.29 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 120.168 -1.583 . . . . 1.3200000000000001 111.656 169.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.6 mt -111.63 151.21 29.07 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.249 1.02 . . . . 0.56999999999999995 112.688 -171.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.78 159.85 38.56 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.163 1.785 . . . . 1.9199999999999999 110.917 175.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.61 165.27 11.32 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.513 1.125 . . . . 0.77000000000000002 112.358 173.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.6 p -97.84 -17.12 19.49 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.874 1.435 . . . . 1.3999999999999999 114.874 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -152.04 49.05 0.78 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.903 1.681 . . . . 2.8199999999999998 110.572 169.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.29 11.28 85.11 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 116.497 1.359 . . . . 1.04 116.497 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.56 16.02 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 128.674 2.789 . . . . 2.3100000000000001 116.749 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -19.92 60.2 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.572 -1.33 . . . . 0.77000000000000002 112.926 -176.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -82.3 -47.65 12.13 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.409 1.483 . . . . 2.8700000000000001 113.167 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -65.25 -41.3 94.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.7 1.136 . . . . 2.79 111.099 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.8 mt -52.05 -52.96 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 119.56 1.073 . . . . 0.58999999999999997 110.282 168.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.8 -30.88 62.07 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 120.676 1.58 . . . . 0.81000000000000005 113.618 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -77.49 -37.22 51.68 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.504 0.927 . . . . 1.1799999999999999 113.504 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -63.85 -22.68 67.03 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.856 0.863 . . . . 1.95 112.631 169.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.7 mt -88.79 -44.86 10.21 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.337 0.865 . . . . 0.94999999999999996 113.337 173.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -69.57 -15.08 63.15 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.851 1.205 . . . . 2.6499999999999999 114.092 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.7 t -75.19 -28.36 59.99 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.515 1.126 . . . . 1.3500000000000001 112.242 169.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.73 166.98 38.05 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.944 1.259 . . . . 1.03 112.786 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -85.76 35.73 0.63 Allowed 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.947 -1.325 . . . . 1.6799999999999999 111.743 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -75.64 4.77 7.11 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.938 1.088 . . . . 1.9399999999999999 113.938 -171.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.72 -30.87 71.04 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.517 1.127 . . . . 1.0700000000000001 110.003 164.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.32 -76.56 0.75 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.358 1.456 . . . . 0.68000000000000005 112.51 171.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.254 0.0 OUTLIER -71.01 154.74 41.56 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.212 1.56 . . . . 1.5600000000000001 115.212 -169.547 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.56 151.05 29.74 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.949 0.9 . . . . 4.8099999999999996 112.522 -177.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.412 HG23 ' CE2' ' A' ' 181' ' ' TYR . 73.6 t -60.36 123.3 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 109.751 -0.463 . . . . 0.91000000000000003 109.751 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.84 -53.45 40.77 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.262 0.458 . . . . 1.26 113.823 -170.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.8 t -150.5 127.73 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.942 1.697 . . . . 2.9100000000000001 108.408 171.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.8 mt -75.99 152.55 84.53 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.343 1.057 . . . . 1.1899999999999999 112.808 173.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.35 162.72 41.48 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.396 2.064 . . . . 0.64000000000000001 112.071 175.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.4 -30.9 69.89 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.373 -0.829 . . . . 0.90000000000000002 111.916 170.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.29 5.66 8.16 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 115.68 1.733 . . . . 1.3600000000000001 115.68 173.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.84 157.02 21.9 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.433 1.493 . . . . 0.53000000000000003 113.435 170.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -148.02 169.55 19.68 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.427 1.491 . . . . 1.8799999999999999 111.736 169.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -121.11 139.12 53.76 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.798 1.239 . . . . 1.9099999999999999 110.288 -173.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.3 pt -127.98 142.36 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 121.421 -0.799 . . . . 0.76000000000000001 112.272 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.98 145.25 43.77 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.012 1.325 . . . . 0.67000000000000004 111.699 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.16 23.98 6.16 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.225 1.393 . . . . 0.80000000000000004 114.969 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.3 p -109.78 142.86 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 127.373 2.269 . . . . 0.82999999999999996 110.337 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.0 tpp -98.78 143.79 28.73 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.36 1.464 . . . . 0.70999999999999996 113.415 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -148.09 151.94 36.5 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.672 1.589 . . . . 1.7 111.512 174.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 m -125.29 144.9 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.166 1.786 . . . . 0.53000000000000003 110.153 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -86.04 149.06 25.43 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.69 1.233 . . . . 0.40999999999999998 112.477 170.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.0 p -144.45 170.92 15.11 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.737 2.015 . . . . 0.53000000000000003 111.661 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.66 177.52 5.99 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.208 1.003 . . . . 2.2200000000000002 113.121 169.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 42.3 p -59.96 -29.8 68.66 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.84 0.856 . . . . 1.6000000000000001 113.225 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -78.06 13.74 1.35 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.896 1.279 . . . . 2.0800000000000001 113.823 173.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.7 28.19 15.44 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.332 1.853 . . . . 0.93000000000000005 112.044 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -88.62 138.58 31.29 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.086 1.754 . . . . 2.1000000000000001 110.466 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -78.2 127.22 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.818 -0.438 . . . . 0.68000000000000005 109.818 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.469 HG22 HG22 ' A' ' 97' ' ' THR . 3.0 pt -120.69 157.31 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.812 1.245 . . . . 0.67000000000000004 114.109 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -86.16 163.92 17.54 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.409 1.884 . . . . 1.8500000000000001 110.473 166.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -61.42 -12.72 15.65 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.981 1.474 . . . . 2.29 114.981 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -94.71 0.25 54.86 Favored 'General case' 0 CA--C 1.55 0.947 0 O-C-N 120.656 -1.277 . . . . 3.8900000000000001 112.165 172.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.18 7.47 86.81 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 126.092 1.806 . . . . 0.59999999999999998 115.293 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -64.55 131.17 46.29 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.599 1.2 . . . . 2.5899999999999999 107.974 168.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.469 HG22 HG22 ' A' ' 91' ' ' ILE . 5.9 p -89.95 145.94 24.75 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.66 0.664 . . . . 0.70999999999999996 110.605 175.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.94 -6.07 49.37 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.177 0.806 . . . . 0.88 113.177 -169.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.71 32.43 57.25 Favored Glycine 0 CA--C 1.531 1.073 0 O-C-N 121.399 -0.813 . . . . 1.01 112.468 -173.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.1 t -135.7 148.53 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.797 1.639 . . . . 1.3799999999999999 109.805 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -135.97 154.69 51.01 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.473 2.309 . . . . 1.6499999999999999 111.079 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 54.8 mt -132.77 134.9 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.99 1.316 . . . . 0.91000000000000003 112.248 -171.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -69.25 135.12 89.05 Favored Pre-proline 0 CA--C 1.546 0.804 0 O-C-N 120.635 -1.291 . . . . 2.1299999999999999 111.166 170.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.65 -17.71 25.99 Favored 'Trans proline' 0 C--N 1.35 0.617 0 CA-C-N 122.548 1.946 . . . . 0.98999999999999999 113.657 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -96.08 -43.66 7.67 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.009 1.723 . . . . 1.8999999999999999 112.555 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.3 p -94.24 -22.55 18.34 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.5 1.12 . . . . 1.1299999999999999 113.948 -174.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 53.95 20.41 2.39 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 125.421 1.488 . . . . 2.46 113.975 -169.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.73 144.77 31.94 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.404 -1.435 . . . . 3.0299999999999998 111.511 176.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 mt -90.42 148.24 22.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.899 1.68 . . . . 1.1599999999999999 112.073 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.2 p -74.28 9.75 1.54 Allowed 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.152 1.167 . . . . 1.6499999999999999 114.152 170.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.32 -160.47 24.63 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 126.081 1.801 . . . . 1.0700000000000001 113.034 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.89 160.91 21.02 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.808 1.243 . . . . 0.98999999999999999 112.101 172.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -52.27 130.92 42.59 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.378 1.071 . . . . 1.8 113.484 -174.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -68.94 152.35 73.49 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.975 3.117 . . . . 1.03 114.368 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.31 -64.27 0.89 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.763 1.225 . . . . 1.05 113.653 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.7 p -101.61 7.78 42.03 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.173 1.546 . . . . 0.79000000000000004 115.173 -168.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.78 146.67 13.22 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.205 1.187 . . . . 0.52000000000000002 114.205 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.6 ttt -77.06 89.36 3.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.942 1.697 . . . . 2.1000000000000001 111.513 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -143.87 145.16 32.11 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.894 1.678 . . . . 1.0800000000000001 112.244 -174.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -164.85 159.88 18.86 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.89 1.676 . . . . 1.9099999999999999 111.046 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.38 146.97 26.89 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.815 1.246 . . . . 0.85999999999999999 113.365 174.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.2 p -65.05 125.82 26.13 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.533 -0.73 . . . . 0.67000000000000004 110.814 172.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -87.94 -57.53 2.9 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.471 1.286 . . . . 2.7000000000000002 114.471 -172.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -151.11 -41.25 0.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.02 0.928 . . . . 1.1499999999999999 111.654 -172.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -118.62 -22.44 7.49 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.83 1.252 . . . . 4.4000000000000004 113.503 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 171.52 -160.0 31.84 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 126.079 1.799 . . . . 0.75 111.326 -175.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -139.9 132.94 29.51 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.657 1.983 . . . . 0.53000000000000003 111.272 169.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -87.32 139.91 30.08 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.299 1.44 . . . . 1.6899999999999999 113.72 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -132.32 129.79 39.95 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.538 2.735 . . . . 1.77 108.594 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -92.55 120.78 33.34 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.515 -0.741 . . . . 1.74 110.092 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.6 p -103.42 -2.0 27.63 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.398 1.479 . . . . 0.67000000000000004 113.367 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -52.68 -29.25 25.49 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.872 1.269 . . . . 0.68999999999999995 113.521 173.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -97.42 -15.54 20.6 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.113 1.765 . . . . 1.8899999999999999 114.437 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.52 154.8 81.55 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 119.623 1.101 . . . . 0.72999999999999998 113.064 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -82.72 170.2 12.93 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.303 2.669 . . . . 0.72999999999999998 110.419 165.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.94 98.85 3.67 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.752 1.221 . . . . 0.96999999999999997 109.956 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -153.29 179.08 9.08 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.025 0.93 . . . . 0.66000000000000003 111.878 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -91.12 150.88 21.21 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.091 1.356 . . . . 2.5099999999999998 111.211 168.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -146.13 170.7 16.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.28 1.832 . . . . 0.56999999999999995 110.056 -173.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -140.64 154.63 46.5 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.043 0.937 . . . . 1.8200000000000001 113.043 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.9 mp -114.94 141.52 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.907 1.283 . . . . 0.69999999999999996 110.768 172.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -126.9 117.97 23.63 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.075 2.15 . . . . 1.8999999999999999 110.571 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -82.53 75.4 9.44 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.251 1.02 . . . . 1.79 111.398 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 40.7 mm -71.54 114.26 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 123.232 0.613 . . . . 1.2 109.383 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.36 -5.84 59.28 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.995 1.48 . . . . 3.9199999999999999 114.995 -169.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.6 m -51.78 -35.91 45.65 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.536 1.535 . . . . 1.6799999999999999 114.054 -177.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.11 -9.0 34.88 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.143 1.164 . . . . 2.1699999999999999 114.143 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 74.8 m -58.31 135.19 57.11 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.706 1.139 . . . . 6.3700000000000001 111.935 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.3 t -125.64 -7.69 6.82 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.451 1.5 . . . . 4.7800000000000002 114.066 -169.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -65.6 161.03 21.23 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.761 0.825 . . . . 5.4000000000000004 111.784 171.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.4 138.96 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.542 0.737 . . . . 4.1799999999999997 112.716 -174.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -120.31 -17.31 4.46 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.953 1.263 . . . . 3.23 114.115 174.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -93.74 -8.92 39.34 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.208 2.203 . . . . 5.8700000000000001 115.19 -173.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -96.8 30.54 2.62 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.36 1.064 . . . . 7.0999999999999996 113.35 -172.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 110.58 -13.78 30.09 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.403 1.477 . . . . 5.4699999999999998 115.361 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.62 167.91 5.29 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.279 1.432 . . . . 4.0700000000000003 113.394 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 15.3 t -110.66 69.34 0.69 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.708 1.242 . . . . 4.0999999999999996 109.841 172.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.0 tt -133.99 122.96 23.79 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.679 1.192 . . . . 1.95 111.232 -167.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 15.2 t -85.18 140.14 31.13 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.094 0.958 . . . . 3.0800000000000001 113.39 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -81.62 49.2 4.0 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.938 1.732 . . . . 2.1099999999999999 114.517 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 88.5 p -63.2 166.59 5.95 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 117.147 2.277 . . . . 3.6000000000000001 117.147 -169.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.73 116.22 32.25 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.276 1.83 . . . . 2.3900000000000001 111.828 172.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.6 147.32 35.71 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.103 0.561 . . . . 0.87 111.212 168.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.7 m -110.86 151.93 43.24 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.761 1.224 . . . . 0.94999999999999996 110.002 172.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.71 161.22 46.81 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.52 2.147 . . . . 0.81000000000000005 113.378 -170.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.3 mp -124.87 128.66 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.783 1.233 . . . . 1.6699999999999999 110.522 -169.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -96.0 138.29 33.83 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.244 1.018 . . . . 2.98 112.955 172.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.4 tt -143.43 151.2 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.376 1.47 . . . . 0.51000000000000001 111.863 -172.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -130.03 149.87 51.56 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.756 1.622 . . . . 2.0800000000000001 109.373 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 15.2 mt -65.71 154.68 88.12 Favored Pre-proline 0 N--CA 1.478 0.95 0 N-CA-C 115.008 1.484 . . . . 0.96999999999999997 115.008 -168.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.8 102.85 1.25 Allowed 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 123.296 2.664 . . . . 0.77000000000000002 114.437 -168.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 16.1 mt -137.39 21.08 2.95 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.262 2.625 . . . . 2.6699999999999999 110.86 170.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -85.78 19.72 2.41 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.958 1.703 . . . . 3.3999999999999999 113.106 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 21.1 t70 61.72 25.72 15.54 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.674 2.39 . . . . 3.5899999999999999 114.367 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 16.5 m -99.1 144.48 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.979 1.312 . . . . 1.0700000000000001 113.093 -174.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 57.6 t -70.78 -34.61 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.705 0.802 . . . . 1.49 111.511 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -140.59 142.34 35.1 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.177 1.391 . . . . 2.6800000000000002 111.807 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -107.38 141.67 38.4 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.411 1.085 . . . . 0.52000000000000002 112.661 -174.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -140.59 166.74 23.92 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.595 1.702 . . . . 0.70999999999999996 115.595 -175.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.91 139.77 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.421 1.888 . . . . 0.66000000000000003 111.56 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.412 ' CE2' HG23 ' A' ' 66' ' ' VAL . 80.6 m-85 -133.33 74.38 72.21 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.723 1.209 . . . . 2.0699999999999998 113.373 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.81 152.13 77.77 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 124.976 3.784 . . . . 0.59999999999999998 113.622 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -133.19 -156.94 0.78 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.389 2.676 . . . . 2.1099999999999999 111.008 -167.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -144.15 163.59 33.16 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.41 1.484 . . . . 2.8900000000000001 112.08 168.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 4.6 t -127.89 -30.13 2.52 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.45 1.278 . . . . 2.48 114.45 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -145.96 169.57 18.36 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.043 1.127 . . . . 6.4199999999999999 114.043 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -79.17 146.71 32.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.132 0.973 . . . . 5.5199999999999996 112.305 170.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 3.0 pptp? -142.5 152.43 60.15 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 125.422 1.489 . . . . 13.27 110.49 170.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.77 129.83 14.97 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.319 2.013 . . . . 10.98 112.148 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -85.33 -40.66 16.28 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.732 0.641 . . . . 17.469999999999999 112.732 168.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.561 ' H ' HD12 ' A' ' 191' ' ' ILE . 1.8 mp -73.7 -49.3 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.4 1.08 . . . . 15.43 110.575 -175.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.2 tt 48.4 101.24 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 129.272 3.029 . . . . 14.779999999999999 113.732 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 . . . . . 0 CA--C 1.539 0.553 0 C-N-CA 124.151 0.98 . . . . 15.93 112.42 -178.324 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.024 -0.732 . . . . 26.559999999999999 109.024 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -81.46 -26.4 35.3 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.799 0.727 . . . . 29.030000000000001 111.605 168.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.4 m -51.48 141.04 16.58 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.928 1.291 . . . . 23.100000000000001 111.877 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.52 154.95 5.88 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.379 1.072 . . . . 19.59 113.429 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.2 t -132.87 150.64 52.14 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.064 1.345 . . . . 16.949999999999999 111.207 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 54.05 60.1 3.82 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.212 1.805 . . . . 13.23 114.493 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.54 -20.27 64.49 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.48 1.289 . . . . 11.98 114.48 174.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.9 p -129.74 70.98 1.43 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.323 1.849 . . . . 10.609999999999999 110.667 -168.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.1 p -56.58 142.91 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 117.332 2.345 . . . . 6.4500000000000002 117.332 -167.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -136.6 177.03 8.17 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 129.195 2.998 . . . . 3.9700000000000002 108.815 168.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.67 139.75 40.43 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.534 1.134 . . . . 3.6000000000000001 111.299 172.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.82 105.66 4.52 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.681 1.192 . . . . 5.2699999999999996 111.936 -173.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.86 67.53 3.38 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.656 1.122 . . . . 1.8400000000000001 112.899 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.5 p -136.44 170.54 15.89 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.745 1.618 . . . . 1.3100000000000001 114.467 -169.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.3 p -93.22 -14.55 26.94 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.755 0.822 . . . . 1.5900000000000001 112.89 169.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.541 HG22 ' H ' ' A' ' 36' ' ' SER . 9.3 m -146.38 148.26 32.15 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.201 2.2 . . . . 2.5899999999999999 109.708 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 p -111.45 16.65 20.67 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.964 1.706 . . . . 1.6599999999999999 113.937 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.541 ' H ' HG22 ' A' ' 34' ' ' THR . 29.0 m -147.6 159.75 43.42 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.347 1.459 . . . . 1.6000000000000001 111.736 170.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -136.04 144.12 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.615 1.966 . . . . 0.33000000000000002 110.209 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.0 m -120.75 125.8 48.54 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.564 0.746 . . . . 0.65000000000000002 111.512 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p -100.28 138.15 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.571 1.148 . . . . 0.64000000000000001 111.183 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -136.21 113.71 10.88 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.364 1.465 . . . . 1.75 113.091 -171.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -81.79 127.43 32.96 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.043 -1.661 . . . . 1.28 113.069 -174.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.9 mt -114.25 155.36 26.29 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.552 1.541 . . . . 0.54000000000000004 112.767 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.5 mt -141.19 173.14 11.77 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.409 1.884 . . . . 1.6599999999999999 110.265 168.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.96 172.56 6.95 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.501 1.121 . . . . 0.92000000000000004 112.032 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.4 p -95.91 -31.75 12.96 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.042 0.756 . . . . 1.21 113.042 170.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -143.02 52.03 1.39 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.656 1.582 . . . . 2.6099999999999999 111.414 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.22 16.36 77.0 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 124.602 1.096 . . . . 0.97999999999999998 115.52 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.75 12.97 0.16 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.118 2.167 . . . . 2.1600000000000001 115.302 -174.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -61.53 -29.27 69.89 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 120.567 -1.333 . . . . 0.63 112.27 -173.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -75.9 -40.46 54.31 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.643 1.177 . . . . 2.2599999999999998 113.247 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -72.66 -38.64 67.58 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-O 117.945 -1.026 . . . . 2.2200000000000002 111.782 170.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 71.8 mt -53.23 -50.98 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.396 1.078 . . . . 0.59999999999999998 110.28 167.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.32 -31.11 68.86 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.731 1.151 . . . . 0.78000000000000003 112.571 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -77.81 -26.9 49.87 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.124 1.157 . . . . 1.26 114.124 171.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -71.21 -30.77 66.79 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.754 -1.216 . . . . 1.99 111.929 168.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.2 mt -90.63 -40.26 12.01 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.727 1.38 . . . . 0.82999999999999996 114.727 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -67.27 -25.18 65.94 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 120.123 1.329 . . . . 2.9100000000000001 112.714 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.7 t -80.2 -3.28 48.42 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.215 1.806 . . . . 1.7 112.961 173.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.34 160.88 14.9 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 126.321 1.915 . . . . 0.93000000000000005 112.164 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -79.29 35.56 0.27 Allowed 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.111 -1.229 . . . . 1.6499999999999999 113.153 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -78.45 7.7 6.24 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.447 1.099 . . . . 2.1200000000000001 113.599 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.54 -31.38 67.88 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.115 1.366 . . . . 1.3100000000000001 110.488 165.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.34 -48.34 0.15 Allowed Glycine 0 C--N 1.344 1.005 0 CA-C-O 119.748 -0.473 . . . . 0.94999999999999996 114.007 171.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -67.91 145.83 54.2 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.636 0.718 . . . . 2.77 111.648 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -68.34 149.09 49.83 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.04 0.836 . . . . 3.0600000000000001 112.144 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 69.5 t -59.81 126.28 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 122.832 0.453 . . . . 0.77000000000000002 111.313 -173.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.19 -50.71 31.71 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.107 1.337 . . . . 0.91000000000000003 113.924 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 98.3 t -142.73 120.12 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.097 1.359 . . . . 1.77 110.198 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.4 mt -82.91 141.92 44.4 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.26 0.624 . . . . 0.82999999999999996 110.137 168.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.8 161.24 42.92 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 121.381 1.388 . . . . 0.57999999999999996 112.36 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.56 -26.87 65.74 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.358 -0.839 . . . . 0.83999999999999997 112.233 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.77 5.39 40.27 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.948 1.699 . . . . 1.49 115.292 174.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.16 152.75 21.07 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.739 1.215 . . . . 0.65000000000000002 111.189 168.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -142.73 164.47 30.01 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.093 1.357 . . . . 2.5800000000000001 111.74 174.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -125.35 134.7 52.1 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.984 1.313 . . . . 2.2599999999999998 110.534 -169.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.8 pt -136.33 151.41 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.833 1.253 . . . . 0.79000000000000004 111.832 -176.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -119.86 174.04 6.69 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.44 1.496 . . . . 0.75 111.964 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.24 12.96 64.61 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.504 1.526 . . . . 0.51000000000000001 115.532 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.9 p -96.71 146.06 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.174 1.39 . . . . 0.66000000000000003 111.336 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 15.1 tpp -101.9 138.69 38.54 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.056 2.142 . . . . 1.0900000000000001 112.223 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.552 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.8 OUTLIER -145.73 152.78 40.13 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.565 1.546 . . . . 1.73 111.919 177.345 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.45 145.76 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 126.802 2.041 . . . . 0.29999999999999999 110.494 -174.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -87.8 146.26 25.71 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 122.552 1.168 . . . . 0.34999999999999998 113.084 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.8 p -143.26 167.87 21.13 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.104 1.761 . . . . 0.33000000000000002 112.793 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -92.0 175.3 6.92 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.201 1.001 . . . . 2.2200000000000002 112.328 168.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.8 p -67.94 -20.27 65.05 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.382 -1.449 . . . . 1.4399999999999999 113.657 -174.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -80.65 14.07 2.27 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.505 1.122 . . . . 1.73 111.976 167.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.41 31.85 19.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.944 2.497 . . . . 0.57999999999999996 113.213 175.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -87.23 138.96 31.04 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.322 1.049 . . . . 2.3399999999999999 110.489 176.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.9 mt -76.53 124.06 34.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.788 -0.819 . . . . 0.41999999999999998 108.788 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.489 HG22 HG22 ' A' ' 97' ' ' THR . 6.1 pt -118.86 154.69 21.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 123.169 1.461 . . . . 0.58999999999999997 113.432 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.56 160.12 19.72 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.298 2.239 . . . . 2.6800000000000002 108.041 166.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.54 -13.25 28.72 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.949 1.463 . . . . 2.1000000000000001 114.949 -169.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -93.87 2.55 56.14 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.711 1.204 . . . . 3.46 111.668 176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.39 3.27 81.84 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.701 1.619 . . . . 0.56000000000000005 114.69 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -68.93 142.76 54.63 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 123.98 0.912 . . . . 2.4900000000000002 109.676 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.489 HG22 HG22 ' A' ' 91' ' ' ILE . 30.4 p -102.58 145.35 29.75 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.161 0.984 . . . . 0.68999999999999995 111.553 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -97.95 -4.5 36.22 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.907 1.077 . . . . 0.65000000000000002 113.907 -170.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.0 25.3 45.5 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.029 0.824 . . . . 0.68999999999999995 113.412 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 p -141.06 152.31 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.07 1.348 . . . . 2.3999999999999999 109.687 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -138.21 155.47 48.63 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 128.471 2.709 . . . . 1.3400000000000001 110.193 -169.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 47.3 mt -136.36 131.23 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.3 1.44 . . . . 0.56000000000000005 110.668 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -75.25 138.83 71.79 Favored Pre-proline 0 N--CA 1.476 0.844 0 O-C-N 121.124 -0.985 . . . . 2.2599999999999998 110.759 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.03 -24.07 28.84 Favored 'Trans proline' 0 C--N 1.35 0.648 0 CA-C-N 121.737 1.656 . . . . 0.78000000000000003 112.743 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -90.18 -47.6 7.7 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.255 1.422 . . . . 1.3500000000000001 111.73 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.4 p -84.23 -27.37 28.0 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.524 0.73 . . . . 1.1299999999999999 112.961 -174.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 54.99 25.39 6.83 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.07 1.348 . . . . 1.8100000000000001 113.041 -172.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.83 153.79 19.5 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.164 1.385 . . . . 2.4500000000000002 111.616 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 18.0 mt -92.52 140.67 29.32 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.186 1.794 . . . . 0.70999999999999996 112.918 -172.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.9 p -71.49 -3.01 18.77 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.989 1.316 . . . . 1.24 114.492 172.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.14 -162.01 16.54 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 126.599 2.047 . . . . 0.81000000000000005 111.379 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.67 167.91 20.81 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.696 1.199 . . . . 0.94999999999999996 112.829 173.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.7 mmt -57.34 143.23 74.34 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.868 1.267 . . . . 1.3100000000000001 113.586 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -79.61 165.98 22.24 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.867 3.711 . . . . 0.77000000000000002 114.045 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.86 -48.62 9.16 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.344 1.609 . . . . 1.3100000000000001 115.344 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.4 p -130.38 13.89 5.55 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.243 1.417 . . . . 0.94999999999999996 113.807 -169.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.22 148.11 6.85 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.479 0.918 . . . . 0.40000000000000002 113.479 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 7.2 ttt -74.02 106.32 5.66 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 126.867 2.067 . . . . 1.8100000000000001 110.237 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.5 pttp -158.86 151.49 21.84 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.387 1.475 . . . . 0.93000000000000005 112.16 -172.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -161.98 171.74 17.12 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.682 1.193 . . . . 1.6599999999999999 110.919 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.5 mp -113.01 144.42 42.62 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.874 1.269 . . . . 0.41999999999999998 112.038 170.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.552 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 21.5 p -73.27 133.88 44.07 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.037 0.835 . . . . 0.56000000000000005 111.295 173.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -94.77 -52.88 4.08 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.02 1.489 . . . . 2.23 115.02 -171.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -175.07 -32.1 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 128.176 2.59 . . . . 1.4399999999999999 110.881 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -116.5 24.38 11.37 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.889 2.076 . . . . 4.4500000000000002 112.181 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.55 -158.76 22.21 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.788 1.661 . . . . 0.56000000000000005 113.794 -173.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -136.66 132.39 34.91 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.983 2.113 . . . . 0.35999999999999999 111.834 169.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -91.27 134.06 34.89 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.097 1.359 . . . . 1.26 113.534 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -127.31 119.09 25.48 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.46 2.704 . . . . 1.6499999999999999 108.21 176.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -84.12 124.48 31.17 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.153 -0.967 . . . . 1.9099999999999999 109.765 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 47.5 p -108.94 5.56 24.45 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.828 1.651 . . . . 0.56999999999999995 113.589 -170.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.17 -27.46 54.45 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.829 0.852 . . . . 0.80000000000000004 112.968 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -89.52 -13.46 37.33 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.911 1.284 . . . . 1.72 113.074 -173.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -83.53 145.3 47.62 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 114.02 1.119 . . . . 0.64000000000000001 114.02 175.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.33 166.96 21.92 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.406 2.071 . . . . 0.77000000000000002 110.968 165.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.39 82.95 3.13 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.458 1.903 . . . . 1.1100000000000001 111.598 -174.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -138.63 -177.27 4.79 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.676 1.191 . . . . 0.79000000000000004 111.625 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -93.18 151.49 19.8 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.712 0.768 . . . . 3.96 111.201 167.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -142.0 169.13 18.17 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.024 2.13 . . . . 0.56000000000000005 109.647 -173.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -139.41 145.31 38.76 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.16 0.984 . . . . 1.75 112.001 174.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -102.82 138.1 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.152 0.981 . . . . 0.37 109.572 171.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -121.69 133.88 54.96 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.893 1.677 . . . . 1.8600000000000001 110.24 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -99.83 124.65 45.34 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.459 1.104 . . . . 1.8999999999999999 110.185 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 15.6 mm -132.35 110.55 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.044 0.937 . . . . 0.67000000000000004 110.281 -169.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -73.2 -11.15 60.42 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 120.408 -1.432 . . . . 3.5 114.158 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 2.9 m -74.72 -10.27 59.37 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 115.644 1.72 . . . . 1.95 115.644 -169.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 57.9 tp -129.12 67.98 1.41 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.594 1.958 . . . . 3.1499999999999999 109.125 -173.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 32.8 t 69.08 137.76 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 128.019 2.528 . . . . 4.8700000000000001 113.639 -166.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.1 t -158.11 147.64 19.72 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.681 0.753 . . . . 5.6200000000000001 112.386 172.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -66.89 162.04 22.65 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 107.612 -1.255 . . . . 7.1299999999999999 107.612 164.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.5 p -118.12 122.43 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.632 0.73 . . . . 3.7200000000000002 111.561 176.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.634 ' HA2' ' HB3' ' A' ' 156' ' ' ALA . . . -97.81 -54.71 1.19 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.076 1.322 . . . . 2.4500000000000002 111.942 175.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -62.79 -11.49 18.18 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.541 1.682 . . . . 5.1100000000000003 115.541 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.67 -24.14 65.4 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.959 1.304 . . . . 4.8200000000000003 113.644 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 148.95 1.26 0.42 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.757 1.17 . . . . 3.7400000000000002 115.07 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.634 ' HB3' ' HA2' ' A' ' 152' ' ' GLY . . . -71.55 170.35 13.56 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.861 1.664 . . . . 2.8500000000000001 111.291 169.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.8 m -84.37 35.11 0.53 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.412 -1.43 . . . . 3.1000000000000001 112.738 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.89 177.06 11.76 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.964 1.706 . . . . 2.5800000000000001 111.898 -175.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.9 t -147.01 153.69 40.33 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.53 1.532 . . . . 4.8499999999999996 111.088 173.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.468 ' HA3' ' HE3' ' A' ' 190' ' ' LYS . . . -76.68 55.27 3.38 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.771 1.177 . . . . 3.8399999999999999 114.451 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 11.1 p -65.09 164.42 13.01 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.234 2.213 . . . . 3.25 115.684 -174.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -70.58 98.29 1.46 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.41 1.884 . . . . 2.4100000000000001 111.149 -172.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.87 139.15 42.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.109 0.964 . . . . 0.90000000000000002 110.672 171.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.9 m -99.78 145.97 31.06 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 123.883 0.873 . . . . 0.88 110.312 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.63 132.98 21.31 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.553 2.169 . . . . 0.69999999999999996 111.943 -169.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.403 ' H ' HD12 ' A' ' 166' ' ' ILE . 2.1 mp -95.95 115.62 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 124.559 1.143 . . . . 1.3600000000000001 108.415 -171.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -84.82 142.36 29.82 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.022 0.374 . . . . 3.0899999999999999 111.628 172.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.4 tt -146.36 150.02 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.926 1.29 . . . . 0.48999999999999999 110.648 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -122.05 157.23 31.86 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.341 1.457 . . . . 2.1200000000000001 109.862 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.31 143.93 92.27 Favored Pre-proline 0 CA--C 1.545 0.77 0 O-C-N 120.905 -1.122 . . . . 1.6699999999999999 111.64 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.27 110.75 1.63 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.662 2.908 . . . . 0.83999999999999997 112.221 -169.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 20.0 tp -143.0 56.57 1.4 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.468 1.907 . . . . 2.71 109.589 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -144.95 23.31 1.54 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.472 1.509 . . . . 3.2599999999999998 112.594 -169.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 54.03 32.39 15.45 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 127.124 2.169 . . . . 4.1699999999999999 114.113 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.3 m -91.57 147.26 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.52 1.128 . . . . 0.91000000000000003 110.127 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.84 -39.73 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.402 0.681 . . . . 1.48 110.025 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -128.13 137.26 52.03 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.905 1.682 . . . . 3.0099999999999998 109.921 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -96.29 144.75 26.18 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.667 0.787 . . . . 0.35999999999999999 111.82 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -137.99 171.5 14.33 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.991 1.478 . . . . 0.56999999999999995 114.991 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -139.4 142.7 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 127.204 2.202 . . . . 0.54000000000000004 110.669 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -130.31 74.66 80.13 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 113.742 1.015 . . . . 2.0499999999999998 113.742 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.63 148.91 90.51 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 124.367 3.378 . . . . 0.79000000000000004 112.972 175.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -136.69 -155.86 0.65 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.932 2.093 . . . . 2.1299999999999999 109.876 -168.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -134.74 164.32 27.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.518 1.527 . . . . 3.96 109.096 166.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 7.5 t -123.94 -27.38 3.92 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.361 0.875 . . . . 2.5 113.361 169.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -133.65 142.81 48.23 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.641 1.976 . . . . 6.2199999999999998 109.224 -174.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -104.4 9.05 35.87 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.938 1.459 . . . . 6.0800000000000001 114.938 -169.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -56.01 141.86 66.73 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 112.614 0.598 . . . . 9.8900000000000006 112.614 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -72.02 153.75 57.73 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.122 2.548 . . . . 9.5099999999999998 112.107 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.468 ' HE3' ' HA3' ' A' ' 160' ' ' GLY . 21.4 pttp -94.57 -23.13 17.79 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.243 1.201 . . . . 17.129999999999999 114.243 174.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.05 -23.44 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 114.482 1.29 . . . . 16.120000000000001 114.482 176.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 53.06 36.13 21.38 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 127.062 2.145 . . . . 12.24 114.705 176.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 . . . . . 0 C--N 1.324 -0.508 0 C-N-CA 126.114 1.765 . . . . 17.449999999999999 110.349 177.596 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 113.358 0.873 . . . . 30.350000000000001 113.358 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -117.76 155.72 29.54 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.812 1.645 . . . . 27.739999999999998 112.272 -172.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.9 m -73.22 145.57 46.13 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.675 1.19 . . . . 21.91 112.858 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.81 -6.46 0.51 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.917 1.687 . . . . 18.640000000000001 114.19 173.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 p -131.43 -173.58 3.16 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.729 -1.232 . . . . 15.42 113.359 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.17 -4.73 59.0 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.24 1.016 . . . . 11.710000000000001 113.503 173.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.26 -136.63 1.09 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.601 1.56 . . . . 11.51 113.76 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.2 p -70.72 152.89 43.34 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.172 1.389 . . . . 11.09 113.716 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 p -60.98 133.95 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.017 1.727 . . . . 8.1999999999999993 113.605 -173.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -75.01 177.15 6.56 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.869 1.268 . . . . 3.5899999999999999 112.234 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.58 157.41 0.07 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.045 2.138 . . . . 4.0499999999999998 115.203 -175.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.56 18.72 2.71 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.211 1.804 . . . . 6.0099999999999998 113.923 -175.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.7 17.2 62.3 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.517 2.008 . . . . 3.7799999999999998 116.65 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 67.4 p -73.68 172.42 11.48 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.447 1.899 . . . . 1.72 115.676 -168.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.6 p -85.57 -23.68 27.54 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 114.412 1.264 . . . . 1.8600000000000001 114.412 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.7 t -132.59 158.28 42.61 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 128.442 2.697 . . . . 2.48 109.126 172.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.423 ' HB ' ' HB2' ' A' ' 132' ' ' ALA . 15.6 p -110.47 8.09 22.96 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.408 1.483 . . . . 0.93000000000000005 113.595 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.2 m -137.52 163.47 31.08 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.938 1.295 . . . . 1.8400000000000001 111.11 168.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.14 140.43 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.291 1.836 . . . . 0.39000000000000001 109.457 173.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.6 m -115.95 121.32 41.95 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.236 0.615 . . . . 0.64000000000000001 111.388 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -99.55 137.49 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.929 1.292 . . . . 0.57999999999999996 111.364 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -134.54 112.27 10.74 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.335 1.454 . . . . 1.6899999999999999 111.372 -174.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.73 126.86 35.52 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 120.541 -1.349 . . . . 1.02 112.468 -171.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.7 mt -116.28 150.88 36.89 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.048 1.339 . . . . 0.56999999999999995 112.855 -171.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.0 mt -140.97 178.93 7.02 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.849 2.059 . . . . 1.46 110.081 168.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.07 160.93 18.36 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.901 1.28 . . . . 0.72999999999999998 112.44 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -89.14 -21.21 23.45 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 114.863 1.431 . . . . 1.05 114.863 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -129.23 28.67 5.23 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.31 1.444 . . . . 2.4500000000000002 111.132 168.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.71 15.31 80.76 Favored Glycine 0 CA--C 1.538 1.501 0 O-C-N 120.456 -1.402 . . . . 0.90000000000000002 114.792 -177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.56 28.6 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 129.744 3.218 . . . . 1.98 117.069 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -18.56 65.15 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.07 -1.643 . . . . 0.64000000000000001 113.56 -172.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -81.89 -45.34 15.6 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.393 0.997 . . . . 2.23 112.678 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -66.28 -43.6 85.95 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.549 1.068 . . . . 2.48 111.167 172.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.2 mt -50.14 -49.34 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.106 0.962 . . . . 0.67000000000000004 110.997 169.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.62 70.86 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 120.043 1.292 . . . . 0.84999999999999998 113.479 178.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -74.75 -31.05 61.68 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.217 -0.927 . . . . 1.03 113.21 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -65.54 -18.21 65.15 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.26 -0.9 . . . . 2.0600000000000001 112.514 169.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.4 mt -95.43 -36.81 11.2 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 114.453 1.279 . . . . 1.29 114.453 176.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -64.85 -19.81 66.08 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.836 1.198 . . . . 2.8500000000000001 113.759 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.5 t -72.22 -19.52 61.71 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.687 1.365 . . . . 1.3700000000000001 114.687 170.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.41 179.22 33.27 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.878 1.704 . . . . 1.54 114.801 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -102.64 36.17 2.26 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.852 1.261 . . . . 3.1299999999999999 111.21 174.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.402 ' CE1' ' HA ' ' A' ' 66' ' ' VAL . 15.6 m-85 -74.11 3.98 6.24 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 115.18 1.548 . . . . 2.2000000000000002 115.18 -168.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.58 -19.95 63.66 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 121.283 -0.886 . . . . 1.26 112.08 168.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.6 -65.86 0.37 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.139 1.352 . . . . 0.95999999999999996 112.288 169.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.283 0.0 OUTLIER -76.89 155.37 32.91 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.831 1.419 . . . . 1.72 114.831 -173.032 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -56.98 154.08 10.19 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.327 0.651 . . . . 2.5299999999999998 112.505 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.402 ' HA ' ' CE1' ' A' ' 61' ' ' TYR . 55.9 t -64.49 129.73 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 109.835 -0.432 . . . . 1.02 109.835 171.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.47 -55.09 16.42 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 122.932 0.301 . . . . 1.05 112.853 -176.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.0 t -141.66 121.89 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.029 0.932 . . . . 1.75 109.855 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.0 mt -78.63 137.35 58.83 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-O 118.919 -0.562 . . . . 1.1899999999999999 109.528 168.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.56 166.36 29.62 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.859 2.373 . . . . 0.59999999999999998 112.712 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -51.59 -41.95 61.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.263 0.625 . . . . 0.95999999999999996 112.547 172.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -76.21 -3.07 34.37 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.894 2.078 . . . . 1.4399999999999999 115.657 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.05 153.7 18.55 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.563 1.074 . . . . 0.56000000000000005 113.344 172.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.6 pttt -144.7 167.01 23.58 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.883 1.673 . . . . 2.2200000000000002 111.824 171.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -122.02 151.7 40.55 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.275 1.43 . . . . 2.1000000000000001 110.061 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.7 pt -139.97 137.65 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.356 0.662 . . . . 0.90000000000000002 111.528 171.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -112.68 161.39 16.91 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.592 1.557 . . . . 0.73999999999999999 112.276 173.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.71 29.19 36.13 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.136 1.351 . . . . 0.66000000000000003 113.423 -170.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 p -107.95 141.93 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.618 1.967 . . . . 0.69999999999999996 109.195 169.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -104.98 137.47 42.68 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.695 1.598 . . . . 0.51000000000000001 112.354 -173.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.559 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.7 OUTLIER -143.52 152.86 41.97 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.545 1.138 . . . . 2.02 111.784 177.678 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.13 144.85 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.968 2.107 . . . . 0.31 109.612 -174.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -85.9 147.64 26.17 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 122.886 1.326 . . . . 0.38 112.462 169.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.6 p -142.32 171.23 14.34 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.783 2.033 . . . . 0.31 111.747 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.16 -178.92 4.63 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.048 1.129 . . . . 2.0800000000000001 114.048 171.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.9 p -59.16 -28.08 66.26 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.899 1.074 . . . . 1.6100000000000001 113.899 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -85.54 16.73 3.64 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.48 1.112 . . . . 1.76 113.12 173.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 58.76 24.89 12.79 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.07 2.148 . . . . 0.65000000000000002 112.901 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -88.03 137.03 32.69 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.845 1.258 . . . . 2.23 110.747 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.4 mt -72.26 124.19 28.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.358 -0.608 . . . . 0.42999999999999999 109.358 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.509 HG22 HG22 ' A' ' 97' ' ' THR . 3.2 pt -113.21 152.15 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 125.543 1.537 . . . . 0.56999999999999995 115.109 175.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -81.21 160.66 24.25 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.647 2.379 . . . . 1.3799999999999999 108.944 165.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -62.48 -15.46 50.12 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.754 -1.216 . . . . 1.95 114.043 -176.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -89.19 3.45 51.88 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.173 1.389 . . . . 3.6299999999999999 112.675 174.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.47 0.07 89.32 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 126.494 1.997 . . . . 0.62 115.24 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -68.08 136.74 54.24 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.76 1.224 . . . . 2.2599999999999998 109.984 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.509 HG22 HG22 ' A' ' 91' ' ' ILE . 2.2 p -98.33 145.68 26.44 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.456 0.702 . . . . 0.83999999999999997 111.225 -175.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -94.5 -7.64 40.7 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.428 1.27 . . . . 0.73999999999999999 114.428 -168.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.14 30.16 47.62 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 118.935 0.789 . . . . 0.71999999999999997 113.797 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.8 t -140.22 145.2 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.677 1.591 . . . . 1.24 109.235 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -125.86 162.84 24.25 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.439 2.696 . . . . 1.49 111.015 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.6 mt -135.24 135.35 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.597 1.159 . . . . 0.63 110.947 -173.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.45 143.74 90.8 Favored Pre-proline 0 N--CA 1.477 0.904 0 CA-C-O 117.424 -1.274 . . . . 2.25 111.225 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.84 -20.76 10.17 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 122.325 1.866 . . . . 0.91000000000000003 112.944 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.7 mm100 -88.97 -47.01 8.43 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.089 0.955 . . . . 1.3200000000000001 112.315 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.5 p -92.8 -28.5 16.52 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.41 1.084 . . . . 0.85999999999999999 113.242 -172.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 57.25 19.01 4.6 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.407 1.483 . . . . 2.1899999999999999 113.677 -167.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 146.63 49.73 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.018 -1.676 . . . . 3.3700000000000001 110.376 172.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.3 mt -86.68 138.88 31.3 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.338 1.055 . . . . 0.76000000000000001 111.314 176.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.1 p -71.49 0.23 8.89 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.132 1.16 . . . . 1.4099999999999999 114.132 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -171.93 -156.54 12.3 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 127.367 2.413 . . . . 1.1699999999999999 111.5 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.32 171.83 12.97 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.86 1.059 . . . . 1.3999999999999999 113.86 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.4 tpt -66.41 136.72 95.13 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.985 0.914 . . . . 1.8700000000000001 109.629 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.39 164.99 25.94 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.793 2.329 . . . . 0.87 113.329 -174.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.8 -77.23 0.26 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.592 1.157 . . . . 1.1399999999999999 112.346 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 69.3 p -83.07 5.83 21.05 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.656 2.095 . . . . 1.24 116.656 -167.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.67 143.0 43.14 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.203 1.557 . . . . 0.44 115.203 -171.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.6 ttt -74.34 102.27 4.33 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.626 1.97 . . . . 1.8 111.036 177.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -153.64 146.8 24.66 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.955 1.302 . . . . 0.93000000000000005 112.368 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -161.01 157.5 26.37 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.798 1.239 . . . . 1.9299999999999999 110.613 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 mp -91.91 144.59 25.32 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.048 0.939 . . . . 0.63 112.677 168.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.559 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 2.0 p -65.01 131.43 46.57 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.754 -0.591 . . . . 0.51000000000000001 109.43 169.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -85.83 -56.25 3.57 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.361 0.875 . . . . 2.5099999999999998 113.361 -173.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -159.79 -45.79 0.05 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.251 1.421 . . . . 1.05 110.122 169.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -89.35 -18.81 26.16 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.273 1.029 . . . . 4.79 113.191 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 153.43 -159.55 28.68 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.879 2.181 . . . . 0.58999999999999997 110.718 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.412 ' HB2' ' HA ' ' A' ' 122' ' ' THR . . . -142.81 132.12 23.42 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.907 2.083 . . . . 0.35999999999999999 110.237 168.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -93.34 143.45 26.26 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.605 0.965 . . . . 1.73 113.605 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -128.75 121.96 29.57 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 127.276 2.23 . . . . 1.96 107.274 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -83.33 106.34 15.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 118.433 0.56 . . . . 1.6699999999999999 109.768 -173.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.1 p -84.28 -5.12 59.22 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.831 1.048 . . . . 0.72999999999999998 113.831 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.423 ' HB2' ' HB ' ' A' ' 35' ' ' THR . . . -55.1 -20.08 9.03 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.894 1.442 . . . . 1.0700000000000001 114.894 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -96.17 -15.11 22.28 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.091 1.356 . . . . 1.8600000000000001 113.635 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -80.64 151.62 71.6 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 119.908 1.231 . . . . 0.93999999999999995 113.427 176.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.88 170.38 9.95 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.597 2.865 . . . . 1.02 111.208 166.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.42 98.07 1.74 Allowed 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.59 1.156 . . . . 1.1899999999999999 109.414 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -153.12 177.54 10.7 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.631 1.173 . . . . 0.84999999999999998 111.78 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -90.49 151.34 21.41 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.38 1.072 . . . . 2.6099999999999999 112.663 168.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -144.69 174.4 11.01 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.84 2.056 . . . . 0.66000000000000003 110.892 -174.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -142.7 160.67 39.86 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.805 1.242 . . . . 1.5800000000000001 113.177 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.8 145.77 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.375 1.47 . . . . 0.42999999999999999 110.921 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -131.45 140.52 49.61 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.245 1.818 . . . . 1.8700000000000001 110.964 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -97.66 108.66 21.42 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.391 1.077 . . . . 2.1099999999999999 111.062 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.0 mm -117.34 113.61 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.181 0.993 . . . . 0.77000000000000002 109.836 -173.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -91.36 -5.79 53.97 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.059 1.133 . . . . 5.2800000000000002 114.059 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 86.9 p -72.94 0.83 10.11 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.148 1.536 . . . . 2.1899999999999999 115.148 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -95.4 -57.55 2.37 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.227 1.411 . . . . 3.3999999999999999 111.133 173.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.1 t -156.63 162.49 39.85 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.302 1.841 . . . . 4.6900000000000004 110.135 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.5 m -154.8 144.16 21.24 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.053 -1.03 . . . . 5.5999999999999996 111.324 173.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -60.37 159.25 10.43 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.977 1.311 . . . . 8.0 111.98 168.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 98.0 t -77.29 100.54 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.47 1.108 . . . . 5.4900000000000002 110.165 176.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -109.87 -30.04 3.61 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.762 0.696 . . . . 3.0800000000000001 112.814 172.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -75.8 1.34 15.16 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 116.046 1.869 . . . . 5.9100000000000001 116.046 -173.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -116.48 33.86 5.34 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.891 2.076 . . . . 6.1699999999999999 112.771 -169.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 101.76 -0.09 52.39 Favored Glycine 0 N--CA 1.478 1.475 0 O-C-N 120.719 -1.238 . . . . 4.3899999999999997 116.114 176.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -73.88 157.52 36.16 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 118.462 1.131 . . . . 3.3100000000000001 111.394 169.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.9 m -86.92 55.36 3.54 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 120.819 -1.176 . . . . 2.8500000000000001 111.672 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.2 mt -100.32 146.14 27.31 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.928 -1.107 . . . . 1.8999999999999999 113.243 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.9 m -101.21 133.31 45.97 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.005 1.722 . . . . 3.3599999999999999 111.746 -173.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -74.52 34.96 0.98 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.617 2.056 . . . . 2.6600000000000001 114.512 175.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 24.6 p -84.87 173.73 10.38 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.458 1.503 . . . . 2.6200000000000001 112.49 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.3 118.84 35.72 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.694 1.998 . . . . 1.8100000000000001 109.602 -172.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.18 147.86 47.89 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.309 0.644 . . . . 0.88 110.657 171.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.7 146.23 41.11 Favored Pre-proline 0 N--CA 1.473 0.677 0 C-N-CA 123.783 0.833 . . . . 0.59999999999999998 109.734 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.17 152.76 45.61 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.845 2.363 . . . . 0.48999999999999999 112.796 -167.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.656 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.6 mp -107.33 132.2 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.984 1.314 . . . . 1.28 109.233 -171.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -97.94 140.16 32.7 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.873 0.76 . . . . 4.21 111.279 169.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.8 tt -147.42 150.56 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.217 1.007 . . . . 0.46999999999999997 112.396 -171.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -127.33 158.27 37.69 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.418 1.887 . . . . 2.0600000000000001 109.121 169.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.22 159.79 84.46 Favored Pre-proline 0 CA--C 1.554 1.104 0 N-CA-C 113.913 1.079 . . . . 1.1299999999999999 113.913 -173.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -79.4 80.36 3.1 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.372 2.715 . . . . 1.22 113.298 -169.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 48.9 mt -107.02 46.79 0.91 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.043 2.137 . . . . 3.2799999999999998 108.938 169.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -123.36 175.37 6.76 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 128.199 2.6 . . . . 3.1800000000000002 109.653 -172.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -74.78 12.7 0.77 Allowed 'General case' 0 CA--C 1.557 1.222 0 O-C-N 120.035 -1.666 . . . . 3.5499999999999998 114.699 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.3 m -89.51 152.82 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.073 1.749 . . . . 1.05 113.661 -168.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.17 -30.17 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.668 1.187 . . . . 1.6799999999999999 111.964 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.03 156.22 42.39 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.688 0.795 . . . . 2.98 111.302 169.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -102.72 141.61 35.24 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.554 1.141 . . . . 0.40999999999999998 111.878 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -136.64 167.96 20.41 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.496 1.295 . . . . 0.58999999999999997 114.496 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -138.29 142.82 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.234 1.414 . . . . 0.54000000000000004 111.901 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -130.77 84.07 59.69 Favored Pre-proline 0 N--CA 1.465 0.304 0 C-N-CA 125.484 1.514 . . . . 2.3999999999999999 111.553 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.656 ' HB3' HD11 ' A' ' 166' ' ' ILE . 18.8 Cg_endo -72.82 133.2 19.71 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.25 2.633 . . . . 0.81999999999999995 110.177 167.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.7 167.46 21.09 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.697 1.999 . . . . 2.29 110.969 175.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -95.8 178.61 5.39 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.855 1.262 . . . . 2.9100000000000001 110.861 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 15.0 t -152.19 -26.17 0.17 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 115.421 1.637 . . . . 2.8700000000000001 115.421 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -135.61 171.24 14.74 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.617 1.567 . . . . 6.7000000000000002 111.831 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -83.76 154.37 23.62 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.24 1.016 . . . . 4.8099999999999996 112.658 173.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -66.23 152.72 93.72 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-O 118.804 -0.617 . . . . 12.76 111.336 169.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.4 158.73 56.39 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.775 2.316 . . . . 9.6099999999999994 113.484 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -93.11 -30.12 15.42 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.336 1.606 . . . . 12.039999999999999 115.336 -173.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.543 HD13 ' H ' ' A' ' 191' ' ' ILE . 0.2 OUTLIER -108.03 5.03 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.397 1.479 . . . . 13.289999999999999 113.335 -176.785 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 94.8 mt -126.0 157.77 37.0 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.051 1.741 . . . . 14.83 110.252 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.411 0 C-N-CA 124.711 1.204 . . . . 17.489999999999998 110.283 172.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 61.3 mtt . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 110.715 -0.105 . . . . 20.719999999999999 110.715 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.67 159.19 43.78 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.243 1.417 . . . . 20.300000000000001 112.514 173.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.0 p -90.61 -4.27 56.95 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.696 1.369 . . . . 16.489999999999998 114.696 -176.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.13 -27.78 62.13 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.986 1.476 . . . . 16.210000000000001 114.986 -170.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.4 m -125.47 33.22 5.17 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.857 1.663 . . . . 17.02 111.869 175.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.33 149.68 16.13 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 115.505 1.668 . . . . 12.08 115.505 -169.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.86 166.7 25.9 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.076 2.15 . . . . 10.57 110.391 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 77.6 p 43.62 41.79 3.72 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.76 1.624 . . . . 9.9199999999999999 114.961 170.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.6 m -63.71 156.13 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 113.09 0.774 . . . . 6.9699999999999998 113.09 -168.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -69.53 157.84 36.38 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.191 0.596 . . . . 3.9500000000000002 112.226 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.82 160.96 41.03 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.249 1.02 . . . . 3.4399999999999999 113.512 -168.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.43 31.66 0.29 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.599 1.559 . . . . 5.4400000000000004 114.776 -176.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.03 14.77 1.11 Allowed Glycine 0 CA--C 1.541 1.697 0 C-N-CA 126.142 1.829 . . . . 1.8700000000000001 117.654 -169.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.5 p -137.91 -172.69 3.31 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.848 2.459 . . . . 1.0700000000000001 111.04 -176.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.6 t -101.47 -16.98 16.65 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.351 0.871 . . . . 2.46 113.351 170.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.3 m -141.97 137.5 31.26 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.971 1.309 . . . . 2.5499999999999998 112.394 -171.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.4 p -83.56 -18.3 38.8 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.804 1.779 . . . . 0.97999999999999998 115.804 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.7 p -145.65 155.64 43.14 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.505 1.502 . . . . 1.46 113.834 174.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.5 p -113.21 140.99 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 127.335 2.254 . . . . 0.34000000000000002 109.98 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.9 m -107.94 116.45 31.98 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.383 0.673 . . . . 0.78000000000000003 109.601 173.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 p -92.38 124.6 44.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 123.947 0.899 . . . . 0.59999999999999998 109.18 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -102.78 176.78 5.05 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.084 1.754 . . . . 1.78 109.608 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.67 120.74 12.13 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 120.292 -1.505 . . . . 1.03 112.383 168.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.0 mt -106.62 159.45 16.19 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.749 1.22 . . . . 0.90000000000000002 111.958 -173.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.97 168.13 21.62 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.969 1.308 . . . . 2.1899999999999999 109.972 169.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.07 156.97 19.01 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.191 0.996 . . . . 1.3899999999999999 111.532 171.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.1 p -81.88 -32.6 30.93 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.323 -0.861 . . . . 2.0899999999999999 113.194 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -138.19 34.92 2.32 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.607 1.563 . . . . 3.6200000000000001 111.367 -174.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.35 11.35 82.26 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 125.209 1.385 . . . . 1.8200000000000001 116.538 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.08 31.48 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 129.485 3.114 . . . . 2.3500000000000001 116.514 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -31.86 72.92 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.405 -1.434 . . . . 1.1200000000000001 113.395 -175.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.86 -52.04 65.76 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.395 0.998 . . . . 2.71 113.678 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -67.69 -39.59 84.43 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 118.366 -0.826 . . . . 3.0099999999999998 111.432 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.1 mt -55.84 -49.98 71.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 119.075 0.852 . . . . 0.90000000000000002 110.599 171.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.39 -34.85 77.52 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.862 1.21 . . . . 1.28 113.057 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -74.06 -27.29 60.84 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.217 0.821 . . . . 1.49 113.217 172.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -73.13 -22.45 60.53 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.026 -1.046 . . . . 2.1499999999999999 113.109 169.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.6 mt -94.24 -39.78 10.35 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.1 1.148 . . . . 1.49 114.1 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -65.59 -22.01 66.64 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.054 0.843 . . . . 3.73 112.685 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 t -75.87 -26.58 57.22 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.126 0.97 . . . . 2.0899999999999999 113.181 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.04 164.71 46.49 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.571 1.081 . . . . 1.6299999999999999 113.512 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.42 35.07 0.49 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.17 1.388 . . . . 3.3399999999999999 112.81 169.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -76.61 1.5 16.7 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.183 1.179 . . . . 2.1699999999999999 114.183 -169.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.55 -23.9 67.58 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.04 -1.037 . . . . 1.49 111.036 166.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.13 -82.3 1.48 Allowed Glycine 0 CA--C 1.535 1.329 0 C-N-CA 123.829 0.728 . . . . 0.91000000000000003 112.448 168.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -73.02 154.06 40.64 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 116.435 2.013 . . . . 1.5700000000000001 116.435 -169.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -60.78 146.72 45.09 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.384 1.474 . . . . 2.4300000000000002 112.461 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.404 HG23 ' CE2' ' A' ' 181' ' ' TYR . 47.7 t -58.02 133.34 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.799 1.24 . . . . 1.26 111.848 -172.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.08 -52.71 45.65 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 123.117 0.389 . . . . 1.51 113.978 -175.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.1 t -149.44 134.36 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 127.648 2.379 . . . . 2.0 109.175 176.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.15 144.04 40.53 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 125.753 1.621 . . . . 1.1899999999999999 111.119 169.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.02 158.24 49.87 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.337 2.025 . . . . 0.87 111.371 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.72 -23.67 67.32 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.197 -0.939 . . . . 1.2 112.562 172.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -80.89 1.9 28.87 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.799 1.407 . . . . 1.52 114.799 172.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.81 159.42 15.07 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.841 1.256 . . . . 0.94999999999999996 113.567 170.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -150.59 169.76 20.76 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.098 1.759 . . . . 2.1699999999999999 111.446 167.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -124.4 135.58 53.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.367 1.067 . . . . 2.2000000000000002 111.155 -168.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.1 pt -135.35 151.91 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.798 1.239 . . . . 0.82999999999999996 112.65 -175.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.21 -179.24 4.63 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.339 1.456 . . . . 0.75 113.027 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.23 10.78 81.89 Favored Glycine 0 N--CA 1.476 1.301 0 O-C-N 121.37 -0.831 . . . . 0.62 115.164 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.3 p -101.14 144.66 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.569 1.948 . . . . 0.69999999999999996 110.042 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 2.9 tpp -101.57 138.74 38.16 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.305 1.442 . . . . 0.57999999999999996 112.166 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.494 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.6 OUTLIER -141.22 149.88 41.96 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.611 1.165 . . . . 1.6100000000000001 111.365 173.451 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.1 m -120.43 149.57 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.924 2.09 . . . . 0.42999999999999999 109.328 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -94.42 148.01 22.66 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 122.433 1.111 . . . . 0.5 112.217 171.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.4 p -143.56 166.99 23.3 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.482 1.513 . . . . 0.38 112.551 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -85.19 172.58 11.07 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.598 -0.689 . . . . 1.96 111.308 166.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.0 p -58.2 -30.45 66.46 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.056 0.943 . . . . 1.45 113.518 -172.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -87.43 29.24 0.88 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.659 1.183 . . . . 2.77 113.86 171.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 57.12 28.77 15.48 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.782 2.033 . . . . 1.1699999999999999 113.476 169.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -84.4 135.12 34.41 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.489 1.116 . . . . 2.0 110.941 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.2 mt -77.2 126.01 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.563 -0.532 . . . . 0.54000000000000004 109.563 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.424 HG22 HG22 ' A' ' 97' ' ' THR . 6.6 pt -122.53 157.63 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 114.766 1.395 . . . . 0.67000000000000004 114.766 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -88.08 164.66 15.62 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.594 1.958 . . . . 1.53 110.494 167.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.49 -1.55 6.85 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.942 1.83 . . . . 2.3399999999999999 115.942 -169.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -105.29 -1.64 24.98 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.072 1.749 . . . . 2.6600000000000001 113.489 169.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.96 8.24 59.24 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 125.234 1.397 . . . . 0.73999999999999999 116.443 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -70.07 127.55 33.23 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.733 1.213 . . . . 3.7999999999999998 110.333 171.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.424 HG22 HG22 ' A' ' 91' ' ' ILE . 1.0 OUTLIER -95.0 128.77 42.08 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.458 0.703 . . . . 1.1100000000000001 111.984 -178.128 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.64 -6.04 50.39 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 114.11 1.152 . . . . 0.91000000000000003 114.11 -167.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.7 15.95 62.58 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.601 1.572 . . . . 0.79000000000000004 114.027 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.4 t -122.05 146.93 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.501 1.52 . . . . 1.3799999999999999 109.335 -176.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -136.05 159.61 41.17 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.407 1.883 . . . . 1.3300000000000001 111.363 -175.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 48.4 mt -137.03 143.37 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 125.668 1.587 . . . . 0.75 110.311 -171.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -78.97 147.35 69.93 Favored Pre-proline 0 N--CA 1.479 1.009 0 O-C-N 120.026 -1.671 . . . . 1.8300000000000001 111.933 173.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.28 -20.0 11.5 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 CA-C-N 122.468 1.917 . . . . 0.94999999999999996 113.683 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -98.4 -37.76 9.48 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.64 1.976 . . . . 1.6200000000000001 113.317 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.2 p -95.3 -26.74 15.8 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.03 0.932 . . . . 1.04 112.76 -178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 54.82 19.47 2.6 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.901 1.28 . . . . 1.6399999999999999 113.245 -169.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.11 148.18 24.58 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.085 1.354 . . . . 2.7400000000000002 111.072 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 mt -85.94 147.29 26.31 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.558 1.543 . . . . 0.75 112.733 -173.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 96.7 p -66.41 -16.66 64.27 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.599 0.963 . . . . 1.55 113.599 172.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.98 -150.44 6.42 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 126.426 1.965 . . . . 0.88 112.36 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.37 167.69 21.27 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.078 1.14 . . . . 1.05 114.078 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.4 mmt -55.92 136.92 72.89 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.626 1.171 . . . . 1.6200000000000001 112.717 171.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -80.84 164.52 20.34 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.837 3.025 . . . . 0.80000000000000004 112.906 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.11 -90.39 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.022 0.929 . . . . 1.3600000000000001 111.246 169.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.5 p -77.65 15.27 0.85 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 116.514 2.042 . . . . 0.91000000000000003 116.514 -167.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.7 146.06 32.23 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.527 1.131 . . . . 0.57999999999999996 113.802 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.1 tpt -73.75 102.11 3.9 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.571 2.349 . . . . 1.46 110.636 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.3 pttp -156.04 149.59 24.85 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.575 1.55 . . . . 1.0900000000000001 112.305 -173.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -165.83 160.54 17.1 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.761 1.624 . . . . 2.6099999999999999 110.105 169.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.7 mp -91.71 146.9 23.4 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.411 1.084 . . . . 0.5 112.062 170.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.494 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 1.2 p -65.67 133.71 51.7 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 119.289 0.95 . . . . 0.5 109.751 169.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -84.72 -70.56 0.57 Allowed 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 113.951 1.093 . . . . 2.48 113.951 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.47 -39.85 0.43 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.526 1.131 . . . . 1.0600000000000001 111.447 173.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -99.54 -29.45 12.7 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.613 0.968 . . . . 4.4500000000000002 113.613 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.483 ' HA2' HG22 ' A' ' 122' ' ' THR . . . 168.76 -164.37 38.0 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.595 1.093 . . . . 0.68999999999999995 111.678 -170.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -139.98 131.79 27.5 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.464 1.906 . . . . 0.5 111.453 169.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -80.42 135.53 36.17 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.771 1.228 . . . . 1.29 112.453 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -126.79 123.15 36.72 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.747 2.019 . . . . 1.8300000000000001 108.406 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -71.37 130.15 40.62 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 121.166 -0.959 . . . . 2.0099999999999998 110.951 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 34.1 p -116.79 5.91 13.13 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.742 1.617 . . . . 0.89000000000000001 113.402 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.17 -20.56 64.26 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.196 1.398 . . . . 0.89000000000000001 114.19 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -111.99 -14.08 13.51 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.523 1.129 . . . . 2.4900000000000002 113.216 -171.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.3 142.62 84.73 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 119.083 0.856 . . . . 0.95999999999999996 112.258 171.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.85 163.66 28.48 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.442 2.095 . . . . 1.1699999999999999 111.37 167.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.13 53.87 0.13 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 128.79 2.836 . . . . 2.3300000000000001 115.969 -169.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -116.71 -179.65 3.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.862 2.065 . . . . 0.95999999999999996 112.829 -170.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -90.22 148.38 22.96 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.733 1.213 . . . . 3.1299999999999999 112.123 169.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -143.84 172.65 12.56 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.268 2.627 . . . . 0.63 109.998 -174.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -141.5 149.94 41.56 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.069 0.948 . . . . 1.77 112.947 173.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.15 139.06 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.307 1.043 . . . . 0.46000000000000002 110.351 172.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -125.11 129.92 51.18 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.157 1.783 . . . . 1.8400000000000001 110.285 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -92.87 118.93 31.67 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.474 1.11 . . . . 2.0800000000000001 110.261 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 47.1 mm -116.28 110.74 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 118.708 0.685 . . . . 0.67000000000000004 109.629 -171.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -79.4 -15.35 57.99 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.567 0.951 . . . . 3.98 113.567 -169.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.9 p -66.92 -15.31 63.58 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.265 1.58 . . . . 1.74 115.265 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -103.8 -5.63 22.23 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 119.865 1.211 . . . . 2.21 113.141 170.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.8 t -62.38 140.48 58.55 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.665 1.586 . . . . 5.5099999999999998 115.06 -167.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 33.9 m -91.6 -30.11 16.54 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.197 1.399 . . . . 5.0499999999999998 109.81 167.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.61 153.03 43.27 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.313 2.245 . . . . 5.9299999999999997 112.955 171.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.9 p -153.14 141.5 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 126.601 1.961 . . . . 5.0700000000000003 108.634 166.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -120.85 -29.38 1.54 Allowed Glycine 0 N--CA 1.475 1.247 0 N-CA-C 115.071 0.789 . . . . 3.3300000000000001 115.071 -176.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -86.3 -10.55 54.27 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.168 1.787 . . . . 5.4400000000000004 115.12 -174.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -96.99 34.22 1.77 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.34 1.856 . . . . 7.0899999999999999 112.589 -170.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.68 3.73 58.24 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.553 1.549 . . . . 4.6299999999999999 115.679 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -69.78 167.84 16.33 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.482 1.513 . . . . 3.3999999999999999 113.823 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 28.2 m -80.13 54.26 1.91 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.712 1.205 . . . . 3.0699999999999998 110.008 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.6 mt -137.04 144.86 43.44 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.919 2.088 . . . . 2.1899999999999999 108.247 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 22.2 m -61.71 -17.62 56.43 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 119.158 0.89 . . . . 4.6100000000000003 113.39 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 79.94 -5.22 62.89 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 120.755 -1.216 . . . . 2.7000000000000002 115.552 172.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 12.5 m -57.55 158.14 6.22 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.873 1.669 . . . . 2.7599999999999998 113.781 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.51 164.53 13.41 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.499 1.12 . . . . 2.3399999999999999 111.803 174.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -94.3 156.51 16.48 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.084 1.142 . . . . 0.93999999999999995 114.084 173.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.91 150.86 51.63 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 126.47 1.908 . . . . 0.92000000000000004 110.501 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.2 145.38 38.9 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.452 2.101 . . . . 0.63 113.737 -167.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.7 mp -113.35 125.12 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.695 1.198 . . . . 1.47 110.105 -171.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -86.1 139.77 30.82 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.678 1.191 . . . . 2.8100000000000001 111.475 174.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.1 tt -146.87 146.99 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.633 1.173 . . . . 0.56000000000000005 112.104 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -118.6 154.42 32.66 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.209 1.403 . . . . 2.0 109.041 168.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.0 mt -61.61 154.66 64.36 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 114.157 1.169 . . . . 0.93999999999999995 114.157 -175.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.86 103.55 0.88 Allowed 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.035 2.49 . . . . 0.76000000000000001 110.957 -173.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.1 mt -139.27 42.37 2.06 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.717 2.407 . . . . 3.2200000000000002 109.084 174.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -117.51 12.91 14.28 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 128.636 2.774 . . . . 3.5299999999999998 111.698 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 18.3 t0 57.2 28.51 15.19 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.558 2.343 . . . . 4.6100000000000003 114.74 -174.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.3 m -81.49 150.58 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.626 0.77 . . . . 1.1299999999999999 112.734 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.83 -38.47 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.554 1.142 . . . . 1.5 110.701 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -147.23 142.81 27.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.54 1.536 . . . . 2.4300000000000002 110.084 -175.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -105.71 141.48 37.08 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.246 1.018 . . . . 0.51000000000000001 111.92 -173.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -139.18 165.96 25.79 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.974 1.472 . . . . 0.54000000000000004 114.974 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.1 t -135.9 139.11 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 125.677 1.591 . . . . 0.51000000000000001 111.957 176.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.404 ' CE2' HG23 ' A' ' 66' ' ' VAL . 99.1 m-85 -131.66 78.87 69.92 Favored Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 124.927 1.291 . . . . 2.0099999999999998 112.241 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.79 149.18 87.01 Favored 'Trans proline' 0 C--N 1.349 0.57 1 C-N-CA 125.387 4.058 . . . . 0.52000000000000002 114.013 176.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -131.62 167.41 19.49 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.893 2.077 . . . . 1.54 111.974 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -116.58 162.54 17.46 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.061 0.934 . . . . 3.1200000000000001 113.517 -174.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 9.3 t -152.92 170.14 21.12 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.632 1.973 . . . . 3.3199999999999998 109.317 169.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 50.49 113.89 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.255 2.222 . . . . 6.54 116.515 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -71.35 -36.57 71.54 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.471 -1.393 . . . . 6.1500000000000004 114.075 -175.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -149.54 154.58 38.33 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 125.286 1.435 . . . . 10.119999999999999 111.968 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -76.42 175.17 11.69 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.528 2.818 . . . . 8.7699999999999996 111.811 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -69.17 -22.35 63.92 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.378 1.622 . . . . 14.449999999999999 115.378 -175.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.505 HD13 ' H ' ' A' ' 191' ' ' ILE . 0.2 OUTLIER -129.86 21.08 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 116.273 1.953 . . . . 13.140000000000001 116.273 -166.476 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.9 mt -137.17 116.04 12.28 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 119.397 0.998 . . . . 12.43 110.972 170.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.862 0 C-N-CA 125.433 1.493 . . . . 13.52 112.034 -170.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 118.011 -0.995 . . . . 32.409999999999997 111.868 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -64.58 100.78 0.4 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.889 1.222 . . . . 26.699999999999999 112.988 -174.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.4 p -133.72 -27.59 1.48 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.931 1.692 . . . . 25.780000000000001 113.118 -170.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -110.71 152.21 26.83 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.891 1.276 . . . . 21.510000000000002 111.467 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.3 m -109.35 164.69 12.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.572 1.149 . . . . 17.850000000000001 111.9 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.64 -47.85 68.4 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.954 0.902 . . . . 14.359999999999999 113.1 -173.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.3 -68.44 0.93 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.957 1.303 . . . . 12.539999999999999 110.88 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.3 p -141.46 130.96 23.84 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.74 1.616 . . . . 10.869999999999999 110.169 -176.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.5 p -68.49 127.98 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 122.182 0.992 . . . . 10.380000000000001 112.893 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -99.44 147.77 24.92 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.26 1.424 . . . . 4.0800000000000001 107.425 167.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 64.75 -27.47 0.09 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 117.481 2.4 . . . . 4.9299999999999997 117.481 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 44.74 45.97 8.42 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.869 2.068 . . . . 5.7599999999999998 116.376 169.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.94 33.83 80.49 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 124.785 1.183 . . . . 3.0800000000000001 115.672 169.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.5 p -86.33 154.98 20.82 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.245 1.818 . . . . 1.5800000000000001 114.673 -172.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.7 p -79.01 -13.66 59.66 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.046 1.128 . . . . 1.52 114.046 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 t -148.28 159.46 43.96 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.282 1.433 . . . . 2.52 111.684 170.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 p -94.35 -7.89 40.44 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.69 1.996 . . . . 1.1699999999999999 114.641 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.6 m -144.16 154.19 42.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.7 1.2 . . . . 2.04 113.243 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.3 p -117.77 147.53 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 127.622 2.369 . . . . 0.46000000000000002 110.182 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.5 m -110.8 116.28 31.0 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.481 0.658 . . . . 0.63 111.067 173.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 p -98.02 131.19 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.764 1.226 . . . . 0.88 109.294 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -112.63 -171.05 1.78 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.384 1.874 . . . . 2.1200000000000001 110.96 -174.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -145.53 123.41 11.98 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.163 -0.961 . . . . 1.3999999999999999 111.349 166.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.4 mt -110.49 150.96 28.14 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.857 0.863 . . . . 0.54000000000000004 111.281 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.28 165.92 27.03 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.676 1.59 . . . . 1.5900000000000001 110.966 -171.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.33 143.83 39.96 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.277 1.031 . . . . 1.3400000000000001 111.064 168.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.7 p -85.5 -44.67 12.5 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.326 1.45 . . . . 1.96 111.452 174.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -115.13 25.49 10.84 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 127.823 2.449 . . . . 3.2000000000000002 111.745 -171.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.63 7.43 84.41 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 126.267 1.889 . . . . 1.53 116.764 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -72.39 25.13 0.05 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.611 2.364 . . . . 2.0600000000000001 116.977 -171.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -27.0 66.72 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 119.369 -2.082 . . . . 1.29 114.072 -173.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -81.72 -41.35 21.4 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.567 0.951 . . . . 2.6600000000000001 113.567 -174.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -66.86 -38.29 86.06 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 120.284 1.402 . . . . 3.0499999999999998 111.286 169.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.2 mt -56.58 -48.39 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 120.014 1.279 . . . . 1.1499999999999999 110.72 168.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.05 -36.92 75.84 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.833 1.197 . . . . 1.4299999999999999 112.486 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -69.27 -32.84 72.29 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.859 0.864 . . . . 1.55 113.305 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -65.84 -35.02 79.5 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.262 0.937 . . . . 2.04 112.269 172.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.5 mt -84.31 -31.25 24.97 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.328 0.862 . . . . 1.5800000000000001 113.328 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -67.29 -30.49 70.37 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.141 0.882 . . . . 3.2799999999999998 113.261 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 t -80.09 -21.4 43.34 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.809 0.844 . . . . 1.9299999999999999 113.194 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.37 164.99 52.78 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.552 1.072 . . . . 1.4199999999999999 113.099 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -84.42 18.98 2.04 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.179 0.991 . . . . 1.8100000000000001 112.425 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -68.93 0.6 4.26 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 115.765 1.765 . . . . 2.3199999999999998 115.765 -167.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.66 -23.01 66.88 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 121.364 -0.835 . . . . 0.92000000000000004 111.273 165.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.85 -83.41 1.19 Allowed Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.898 1.713 . . . . 0.68000000000000005 113.176 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.22 160.4 26.92 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.623 1.342 . . . . 1.3999999999999999 114.623 -169.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -60.7 156.55 16.58 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.302 1.223 . . . . 2.9500000000000002 114.302 -173.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.3 t -58.16 129.53 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 121.815 -0.553 . . . . 0.75 110.484 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.77 -43.17 68.04 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.592 0.615 . . . . 0.79000000000000004 114.163 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.1 p -160.97 142.72 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.814 1.245 . . . . 2.73 110.241 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.9 mt -88.3 145.93 36.85 Favored Pre-proline 0 C--O 1.241 0.647 0 C-N-CA 123.774 0.829 . . . . 1.1599999999999999 112.099 176.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.492 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 37.6 Cg_endo -67.95 158.98 54.94 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.563 1.509 . . . . 0.76000000000000001 112.131 173.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.18 -1.64 3.47 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.894 1.278 . . . . 1.29 114.388 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.11 8.13 11.49 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 127.028 2.131 . . . . 1.5700000000000001 114.028 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.492 ' HB2' ' HG2' ' A' ' 70' ' ' PRO . . . -93.63 162.15 14.07 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.908 1.818 . . . . 0.90000000000000002 115.908 172.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -142.63 150.62 40.5 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 128.062 2.545 . . . . 4.0599999999999996 111.042 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -121.92 139.97 53.0 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.866 1.667 . . . . 2.1499999999999999 110.059 174.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.9 pt -132.79 152.73 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 113.53 0.937 . . . . 0.92000000000000004 113.53 -177.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.0 165.55 11.64 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.28 1.432 . . . . 0.81000000000000005 110.801 169.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.0 8.3 79.26 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 115.562 0.985 . . . . 0.76000000000000001 115.562 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.7 p -84.53 143.93 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 119.648 1.724 . . . . 1.05 110.216 169.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -102.01 136.42 41.88 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.417 1.487 . . . . 0.64000000000000001 112.113 175.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.45 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.3 OUTLIER -141.44 155.03 45.91 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.106 0.962 . . . . 1.73 112.802 171.784 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.15 146.57 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 126.99 2.116 . . . . 0.45000000000000001 109.969 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -90.94 146.53 23.81 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.322 1.058 . . . . 0.48999999999999999 112.716 172.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.6 p -143.6 170.78 15.19 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.979 1.712 . . . . 0.46000000000000002 112.521 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -97.8 174.74 6.45 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.448 1.099 . . . . 1.95 112.573 168.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.2 p -64.49 -18.45 64.8 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.476 -1.39 . . . . 1.45 114.321 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -76.22 7.35 4.32 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 126.029 1.732 . . . . 1.8500000000000001 113.241 167.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 55.71 33.31 21.09 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.4 2.28 . . . . 0.77000000000000002 111.603 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -94.37 138.94 31.73 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.697 1.599 . . . . 2.1600000000000001 110.395 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.4 mt -79.37 130.81 35.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 109.573 -0.528 . . . . 0.53000000000000003 109.573 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.483 HG22 HG22 ' A' ' 97' ' ' THR . 4.9 pt -125.3 155.53 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 114.689 1.366 . . . . 0.75 114.689 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -81.29 164.46 22.2 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 126.46 1.904 . . . . 1.54 109.536 167.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -64.67 -12.51 47.08 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.556 -1.34 . . . . 2.3300000000000001 114.0 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -97.66 4.86 50.0 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.714 1.605 . . . . 2.6699999999999999 112.992 173.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.75 10.48 85.08 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 120.551 -1.343 . . . . 0.71999999999999997 115.103 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -68.24 130.03 41.69 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.193 1.497 . . . . 3.0699999999999998 108.924 168.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.483 HG22 HG22 ' A' ' 91' ' ' ILE . 17.3 p -87.92 141.66 28.41 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.68 0.392 . . . . 0.73999999999999999 111.043 174.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -94.3 -11.07 30.84 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.688 1.366 . . . . 0.80000000000000004 114.688 -169.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.76 30.85 25.49 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.555 1.074 . . . . 0.68999999999999995 114.322 -172.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.0 t -133.95 146.06 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.37 1.585 . . . . 1.25 110.447 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -130.61 159.98 35.56 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.58 1.952 . . . . 1.28 110.641 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 54.1 mt -135.96 137.03 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 125.059 1.344 . . . . 0.52000000000000002 111.207 -174.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -71.53 141.22 85.1 Favored Pre-proline 0 N--CA 1.48 1.028 0 O-C-N 120.814 -1.179 . . . . 1.77 111.188 171.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.56 -24.41 13.85 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 122.494 1.926 . . . . 0.65000000000000002 112.64 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -89.77 -54.43 4.06 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.706 1.602 . . . . 1.46 111.79 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.4 p -78.91 -26.79 43.78 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.875 0.695 . . . . 0.78000000000000003 112.875 -174.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 56.37 19.14 3.82 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.792 1.237 . . . . 1.6699999999999999 113.896 -170.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.91 150.83 24.69 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.377 -1.452 . . . . 3.0699999999999998 111.528 176.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.9 mt -90.37 141.96 28.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.241 1.417 . . . . 0.82999999999999996 111.712 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.1 p -66.56 -4.11 7.84 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.535 1.309 . . . . 1.3100000000000001 114.535 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.4 -158.53 18.73 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 127.331 2.396 . . . . 0.89000000000000001 111.53 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.52 154.09 42.2 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.543 0.942 . . . . 0.91000000000000003 113.543 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.3 tpt -60.26 130.22 89.34 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 125.384 1.474 . . . . 1.6799999999999999 111.21 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -72.46 158.89 50.39 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.61 2.874 . . . . 0.94999999999999996 114.488 -173.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.91 -53.62 8.71 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.064 1.746 . . . . 1.0900000000000001 114.557 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.7 p -114.13 11.35 17.57 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.395 1.478 . . . . 1.01 114.148 -167.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.36 151.42 19.82 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.729 1.011 . . . . 0.60999999999999999 113.729 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.4 tpt -75.19 95.32 3.1 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.907 2.083 . . . . 1.5700000000000001 111.227 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -154.48 135.86 14.13 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.443 1.497 . . . . 0.93999999999999995 112.557 -173.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -168.46 142.65 3.26 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.971 1.309 . . . . 2.54 111.342 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.76 150.87 25.53 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.717 1.377 . . . . 0.67000000000000004 114.717 -173.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.45 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 11.4 p -62.12 132.8 54.03 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.243 -0.911 . . . . 0.67000000000000004 111.798 169.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -93.83 -55.0 3.39 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.587 1.155 . . . . 2.52 113.688 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -165.73 -52.78 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.2 2.2 . . . . 1.27 109.422 174.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -93.23 23.49 4.38 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.182 1.793 . . . . 5.2699999999999996 113.35 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.77 -151.78 17.73 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.244 1.878 . . . . 0.57999999999999996 111.692 -168.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.417 ' HB2' ' HA ' ' A' ' 122' ' ' THR . . . -142.77 129.96 20.89 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.068 2.147 . . . . 0.40000000000000002 111.14 169.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -82.04 133.5 35.29 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.531 1.133 . . . . 1.4199999999999999 111.556 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -124.77 124.48 42.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.299 1.84 . . . . 2.0899999999999999 109.143 173.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -73.68 118.43 16.63 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.462 1.105 . . . . 1.6599999999999999 110.576 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 22.5 p -101.97 -0.65 33.43 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.554 1.142 . . . . 0.66000000000000003 113.347 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.13 -16.01 4.54 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.61 1.707 . . . . 0.85999999999999999 115.61 -176.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -106.77 -4.57 19.22 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.904 1.076 . . . . 2.6000000000000001 113.904 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.46 152.73 67.64 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 114.131 1.16 . . . . 0.71999999999999997 114.131 172.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.54 174.29 5.93 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.205 3.27 . . . . 1.0800000000000001 112.218 167.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.47 100.08 3.74 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.328 -0.857 . . . . 1.1799999999999999 109.365 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -152.2 177.38 10.6 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.479 1.512 . . . . 0.79000000000000004 110.587 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -90.39 146.77 23.9 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.217 1.007 . . . . 2.27 112.04 168.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -140.07 167.9 21.06 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.879 2.071 . . . . 0.73999999999999999 109.294 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -139.72 148.01 41.72 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.928 0.891 . . . . 1.77 112.306 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -111.25 132.98 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.024 0.93 . . . . 0.42999999999999999 109.7 175.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -120.78 128.43 52.89 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.417 1.887 . . . . 1.98 110.287 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -104.39 105.3 15.38 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.79 1.636 . . . . 2.54 110.961 -169.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.6 mm -108.06 113.72 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.686 1.194 . . . . 0.72999999999999998 111.62 -167.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -88.7 23.08 2.4 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.291 1.219 . . . . 4.46 114.291 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 52.1 m -69.27 -39.72 78.24 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.094 -1.004 . . . . 1.5900000000000001 112.298 173.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.0 mp -77.63 88.47 3.92 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.137 0.88 . . . . 3.4399999999999999 111.49 172.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 14.2 m -54.57 118.14 3.93 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.954 1.302 . . . . 6.2300000000000004 110.413 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 52.1 m -148.31 -36.03 0.2 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.414 1.086 . . . . 4.3499999999999996 113.466 -169.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -138.65 160.88 38.53 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.831 1.653 . . . . 5.7699999999999996 111.607 176.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.7 t -121.84 136.14 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 113.157 0.799 . . . . 3.6899999999999999 113.157 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -117.74 -29.03 2.13 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 126.229 1.871 . . . . 2.6299999999999999 113.416 169.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.32 -13.99 62.51 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.647 1.721 . . . . 5.2000000000000002 115.647 -175.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -84.11 25.84 0.8 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.428 1.491 . . . . 5.9400000000000004 113.44 -171.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.84 14.55 77.34 Favored Glycine 0 CA--C 1.537 1.415 0 O-C-N 120.965 -1.084 . . . . 4.8300000000000001 114.408 -174.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.52 162.85 12.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.331 1.053 . . . . 3.71 113.152 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.7 t -75.68 44.02 0.27 Allowed 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 123.417 1.579 . . . . 4.54 111.695 169.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.4 tt -139.76 116.31 10.71 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.33 -1.481 . . . . 2.3300000000000001 109.812 -167.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 60.3 m -73.48 79.78 1.43 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.753 1.221 . . . . 4.3799999999999999 110.816 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -66.14 18.39 0.19 Allowed Glycine 0 CA--C 1.54 1.6 0 C-N-CA 127.409 2.433 . . . . 2.6699999999999999 117.343 -169.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 36.2 m -62.05 168.41 3.28 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 127.874 2.469 . . . . 2.98 114.164 175.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.7 147.91 44.49 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.851 0.86 . . . . 1.77 112.563 174.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -98.66 152.03 20.08 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.849 1.259 . . . . 0.94999999999999996 111.738 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.8 m -111.57 144.49 30.68 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 124.482 1.113 . . . . 0.56999999999999995 111.831 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.49 159.24 51.95 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.406 2.737 . . . . 0.81000000000000005 114.022 -167.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.405 HD13 HG12 ' A' ' 180' ' ' VAL . 1.3 mt -112.36 143.66 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.005 1.322 . . . . 1.8600000000000001 110.273 -176.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -110.15 140.83 43.84 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.54 1.136 . . . . 2.9300000000000002 111.694 171.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.6 tt -146.3 147.31 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.663 1.185 . . . . 0.68000000000000005 111.578 -175.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -126.18 151.51 47.25 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.011 1.325 . . . . 1.9299999999999999 109.484 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 5.3 mt -65.58 149.91 96.69 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 114.269 1.211 . . . . 0.96999999999999997 114.269 -171.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.31 92.43 0.92 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.632 2.888 . . . . 0.85999999999999999 114.382 -169.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -118.82 70.67 0.83 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 103.678 -2.712 . . . . 2.6699999999999999 103.678 164.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -145.7 -179.94 7.02 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.069 1.748 . . . . 2.6899999999999999 109.229 -166.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -79.74 6.58 10.47 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.871 1.668 . . . . 3.9300000000000002 114.57 -174.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -99.99 153.56 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.833 1.653 . . . . 0.97999999999999998 113.517 -168.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 44.8 t -96.76 -32.62 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.586 1.554 . . . . 1.6499999999999999 110.967 172.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -131.34 135.3 47.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.021 1.328 . . . . 4.4400000000000004 113.211 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -103.7 138.79 39.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.623 1.169 . . . . 0.44 111.121 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -134.63 168.54 18.8 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.481 1.289 . . . . 0.48999999999999999 114.481 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.405 HG12 HD13 ' A' ' 166' ' ' ILE . 0.2 OUTLIER -141.72 137.22 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.787 1.235 . . . . 0.62 112.549 -178.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -134.96 86.65 31.8 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 125.418 1.487 . . . . 2.0699999999999998 112.118 -173.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -71.5 152.77 60.36 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.325 3.35 . . . . 0.57999999999999996 113.756 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -132.18 172.47 12.36 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.974 2.509 . . . . 1.6200000000000001 112.338 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -101.73 -173.0 2.25 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.204 1.402 . . . . 2.77 109.767 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 14.1 t -152.25 -36.45 0.12 Allowed 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 116.698 2.11 . . . . 2.8199999999999998 116.698 -175.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -108.05 157.3 18.38 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.485 1.039 . . . . 6.2999999999999998 113.704 -174.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . 61.13 175.51 0.11 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.528 1.931 . . . . 6.9000000000000004 115.793 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -141.79 156.66 65.75 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 126.094 1.758 . . . . 13.390000000000001 110.525 170.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -61.03 141.28 93.81 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.066 1.844 . . . . 13.99 113.086 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -88.32 -9.72 51.85 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.645 1.35 . . . . 16.18 114.645 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 191' ' ' ILE . 1.4 mp -99.49 -56.03 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.244 1.418 . . . . 19.829999999999998 108.008 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.2 mt 68.56 145.97 0.05 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 117.68 2.474 . . . . 20.890000000000001 117.68 168.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 CA--C 1.545 0.766 0 C-N-CA 126.719 2.008 . . . . 27.16 110.723 168.73 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 109.15 -0.685 . . . . 25.059999999999999 109.15 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . 0.272 15.2 tt0 61.53 -124.01 0.83 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.205 1.802 . . . . 21.870000000000001 111.729 -169.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.0 m -81.93 -28.94 32.53 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.788 1.631 . . . . 17.469999999999999 113.446 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 55.3 24.71 6.72 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 116.419 2.007 . . . . 14.27 116.419 174.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.8 p -67.29 -12.72 60.86 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.101 1.519 . . . . 12.66 115.101 -174.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -139.67 162.84 34.13 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.641 1.576 . . . . 9.6899999999999995 111.081 169.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.94 -41.31 96.02 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.183 0.993 . . . . 8.8200000000000003 112.362 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.0 p -145.6 -173.85 4.24 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.201 1.801 . . . . 7.5099999999999998 109.785 -171.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.7 m -88.49 8.9 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.619 1.168 . . . . 6.1200000000000001 113.803 169.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 52.26 24.07 2.67 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.358 2.263 . . . . 3.3300000000000001 116.077 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 53.65 -162.89 0.11 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.342 1.857 . . . . 4.3200000000000003 114.314 176.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.56 153.83 46.28 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.07 1.748 . . . . 4.8600000000000003 110.618 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 159.61 26.43 0.02 OUTLIER Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.902 1.239 . . . . 1.95 114.659 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.4 p -150.76 156.05 40.49 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.024 1.412 . . . . 1.27 112.776 -170.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.8 p -98.75 -7.34 27.81 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.819 1.415 . . . . 1.3999999999999999 114.819 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.1 t -151.72 157.83 42.57 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.866 0.757 . . . . 2.1899999999999999 112.518 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 p -98.55 -4.46 34.16 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.95 2.9 . . . . 0.83999999999999997 114.82 -173.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.3 m -147.25 151.48 36.75 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.89 1.676 . . . . 1.9399999999999999 112.863 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.1 p -119.61 148.6 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 127.762 2.425 . . . . 0.44 110.291 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.2 m -121.48 127.54 51.16 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 121.414 -0.803 . . . . 0.72999999999999998 111.591 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 p -101.27 137.58 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.116 1.366 . . . . 0.64000000000000001 110.717 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -136.38 113.97 11.0 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.002 1.721 . . . . 1.75 111.209 -171.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.48 127.82 38.11 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 120.178 -1.576 . . . . 1.05 114.225 -168.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.6 mt -114.77 152.82 31.45 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.683 1.193 . . . . 0.53000000000000003 113.835 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.3 mt -140.3 176.33 8.86 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.86 2.064 . . . . 1.98 110.464 169.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.492 ' HB1' ' H ' ' A' ' 48' ' ' ASP . . . -106.51 163.82 12.56 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.925 1.083 . . . . 0.85999999999999999 113.925 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.3 p -84.13 -38.45 20.69 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.488 1.115 . . . . 1.0 113.352 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -146.89 63.19 1.19 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.953 1.701 . . . . 2.52 110.703 169.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.11 27.88 73.55 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 120.893 -1.129 . . . . 1.1699999999999999 115.419 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.492 ' H ' ' HB1' ' A' ' 44' ' ' ALA . 1.6 m-20 -74.41 15.27 0.36 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.053 2.141 . . . . 2.3999999999999999 114.448 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.33 -28.96 69.67 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.129 -1.607 . . . . 0.67000000000000004 113.01 -173.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -69.64 -45.79 67.67 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.246 0.93 . . . . 2.25 112.519 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -71.08 -41.86 70.12 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 118.18 -0.914 . . . . 2.0899999999999999 111.463 176.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 86.6 mt -51.74 -50.21 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.441 1.019 . . . . 0.57999999999999996 110.34 167.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.51 -31.33 70.4 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.566 -1.334 . . . . 0.81000000000000005 113.231 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -74.08 -34.56 64.05 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.51 1.124 . . . . 1.1499999999999999 113.199 172.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -66.26 -32.64 74.19 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.863 -1.148 . . . . 1.9399999999999999 112.174 170.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.1 mt -83.63 -36.7 23.65 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.854 1.057 . . . . 1.0 113.854 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -65.33 -29.75 70.53 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.487 1.04 . . . . 2.9900000000000002 112.481 177.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.0 t -79.7 -24.54 41.63 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.346 0.869 . . . . 1.3300000000000001 113.346 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.65 160.31 39.28 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.53 1.062 . . . . 0.93000000000000005 113.345 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -83.01 26.06 0.64 Allowed 'General case' 0 CA--C 1.552 1.035 0 O-C-N 121.367 -1.078 . . . . 1.95 112.369 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -68.82 0.28 4.55 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 116.339 1.977 . . . . 2.1200000000000001 116.339 -167.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.75 -25.18 66.29 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.694 1.134 . . . . 0.92000000000000004 112.704 171.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.04 -81.42 1.34 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.709 1.147 . . . . 0.72999999999999998 113.122 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.46 163.07 25.92 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.538 1.135 . . . . 1.48 113.035 -176.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -59.08 161.23 5.34 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.993 1.479 . . . . 2.2000000000000002 114.993 -171.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.84 109.88 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.115 -0.698 . . . . 0.93000000000000005 109.115 168.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.81 -25.16 65.35 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 119.171 -0.794 . . . . 1.1599999999999999 114.134 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.2 t -142.07 118.24 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.275 1.43 . . . . 2.1099999999999999 110.939 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -88.32 146.91 38.91 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.548 1.539 . . . . 0.91000000000000003 109.809 167.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.69 157.51 39.87 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.098 1.866 . . . . 0.81999999999999995 111.552 171.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.23 -24.03 67.23 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.213 -0.929 . . . . 1.3 112.716 173.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 40.7 p30 -77.76 -8.89 58.63 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.844 1.424 . . . . 2.1000000000000001 114.844 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.2 155.78 19.19 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.372 1.469 . . . . 0.58999999999999997 111.922 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.5 pttt -141.25 159.72 41.62 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.958 1.303 . . . . 2.1899999999999999 111.885 170.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -122.68 146.74 47.21 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.914 1.286 . . . . 2.3300000000000001 110.042 -175.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.6 pt -141.07 151.2 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.26 1.024 . . . . 0.88 111.795 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -113.65 170.0 8.57 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.716 1.607 . . . . 0.64000000000000001 111.242 173.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.2 15.53 74.18 Favored Glycine 0 CA--C 1.534 1.267 0 O-C-N 121.388 -0.82 . . . . 0.55000000000000004 114.702 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.5 p -98.8 139.73 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 127.179 2.192 . . . . 0.91000000000000003 109.611 173.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.8 tpp -103.87 136.87 42.74 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.769 2.027 . . . . 0.44 112.84 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.581 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.6 OUTLIER -141.65 152.83 44.3 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.656 1.583 . . . . 1.6699999999999999 111.761 174.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.12 143.53 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 126.757 2.023 . . . . 0.33000000000000002 109.474 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -86.8 149.04 25.13 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 122.2 1.0 . . . . 0.37 111.847 169.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 57.3 p -145.62 165.92 27.28 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.789 1.635 . . . . 0.46000000000000002 112.532 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -89.59 167.29 13.06 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.807 0.843 . . . . 2.27 111.082 166.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 49.3 p -61.57 -26.46 67.97 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.436 1.273 . . . . 1.3899999999999999 114.436 -168.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -76.29 16.66 0.44 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.367 1.467 . . . . 2.2000000000000002 114.477 169.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.52 30.2 17.12 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 128.142 2.577 . . . . 0.90000000000000002 113.204 175.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -92.65 140.03 29.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.28 1.432 . . . . 2.3100000000000001 111.775 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -82.95 124.84 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.037 0.446 . . . . 0.69999999999999996 110.273 -178.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.475 HG22 HG22 ' A' ' 97' ' ' THR . 5.9 pt -120.63 156.15 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 114.815 1.413 . . . . 0.58999999999999997 114.815 -177.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -79.89 158.94 26.57 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.85 2.86 . . . . 2.04 111.227 168.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -56.82 -8.05 0.54 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 127.282 2.233 . . . . 2.3700000000000001 116.317 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.86 1.32 19.16 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.476 1.51 . . . . 2.8900000000000001 115.021 172.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.79 4.2 63.7 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.359 1.457 . . . . 0.62 115.27 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -67.97 143.55 55.56 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.883 1.341 . . . . 2.5600000000000001 109.371 170.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.475 HG22 HG22 ' A' ' 91' ' ' ILE . 60.5 p -102.7 147.8 26.38 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.81000000000000005 111.368 -175.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -104.45 -5.86 21.24 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.847 1.425 . . . . 0.90000000000000002 114.847 -168.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.78 28.93 40.58 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 121.193 -0.942 . . . . 1.24 113.396 -177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.8 t -133.48 147.26 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.969 1.308 . . . . 1.3400000000000001 110.063 177.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -134.73 155.06 51.22 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 128.205 2.602 . . . . 1.47 110.447 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.409 HG12 HD23 ' A' ' 109' ' ' LEU . 49.4 mt -133.42 133.82 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.213 1.405 . . . . 0.64000000000000001 110.854 -173.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -68.61 142.65 94.3 Favored Pre-proline 0 N--CA 1.476 0.849 0 O-C-N 120.633 -1.292 . . . . 2.0899999999999999 111.296 173.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.35 -24.12 16.89 Favored 'Trans proline' 0 C--N 1.35 0.636 0 CA-C-N 122.38 1.886 . . . . 0.70999999999999996 112.94 175.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -92.91 -52.19 4.71 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.382 1.873 . . . . 1.3300000000000001 112.692 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.9 p -80.73 -23.67 39.28 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.983 0.735 . . . . 0.94999999999999996 112.983 -175.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 54.89 18.06 2.05 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.747 1.619 . . . . 2.1499999999999999 113.839 -171.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.15 149.88 24.35 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.648 -1.283 . . . . 2.2799999999999998 111.789 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.409 HD23 HG12 ' A' ' 102' ' ' ILE . 38.6 mt -87.17 146.38 26.04 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.156 1.782 . . . . 1.1299999999999999 113.222 -175.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 97.3 p -76.98 0.64 20.4 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.446 1.276 . . . . 1.53 114.446 174.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.11 -158.26 15.86 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 127.176 2.322 . . . . 1.3100000000000001 110.762 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.07 156.18 25.95 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.534 1.167 . . . . 1.8 112.917 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 tpt -56.35 130.01 75.21 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 124.068 0.947 . . . . 2.0499999999999998 111.663 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.93 166.1 30.49 Favored 'Trans proline' 0 CA--C 1.537 0.64 1 C-N-CA 125.53 4.154 . . . . 1.1499999999999999 115.587 -172.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.63 -81.17 0.07 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.492 1.517 . . . . 1.3999999999999999 113.281 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.9 p -86.48 12.36 10.49 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.664 1.357 . . . . 0.91000000000000003 114.664 -169.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.7 148.59 16.01 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.21 -0.931 . . . . 0.41999999999999998 113.082 174.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.1 tpt -77.36 87.88 3.75 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.775 2.03 . . . . 1.6000000000000001 110.881 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -142.6 146.24 34.35 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.218 1.407 . . . . 1.0600000000000001 112.761 -173.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 43.5 tttp -162.01 159.73 26.74 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.524 1.13 . . . . 1.78 112.046 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 mp -102.2 145.74 28.97 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.595 1.158 . . . . 0.46999999999999997 112.824 169.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.581 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 8.7 p -70.26 139.78 52.24 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 119.335 0.97 . . . . 0.78000000000000003 112.332 174.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.63 -69.44 0.67 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.835 1.254 . . . . 3.1200000000000001 114.1 -174.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.43 -41.28 0.08 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.681 2.393 . . . . 1.1499999999999999 109.143 169.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -91.55 -10.62 39.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.986 1.714 . . . . 4.2800000000000002 114.216 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 143.23 -156.31 26.44 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.845 1.688 . . . . 0.91000000000000003 112.304 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.72 127.58 20.54 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.233 1.813 . . . . 0.52000000000000002 109.958 167.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -77.16 139.69 39.99 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.962 1.305 . . . . 1.3899999999999999 111.565 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -130.03 116.33 18.4 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.971 1.708 . . . . 1.9299999999999999 109.198 169.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.424 HD21 ' HB3' ' A' ' 132' ' ' ALA . 2.6 t-20 -72.34 115.44 11.6 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.915 1.286 . . . . 2.8799999999999999 111.006 176.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.8 p -104.02 -5.75 21.86 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.565 1.321 . . . . 0.56000000000000005 114.565 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.424 ' HB3' HD21 ' A' ' 130' ' ' ASN . . . -54.78 -27.69 43.33 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.456 1.28 . . . . 0.67000000000000004 114.456 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.68 -14.99 31.16 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.551 0.945 . . . . 2.25 113.551 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.52 147.91 85.2 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 119.603 1.092 . . . . 0.70999999999999996 112.792 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -75.44 167.24 27.04 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.21 1.94 . . . . 0.77000000000000002 110.95 167.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.03 94.8 1.93 Allowed 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.532 1.533 . . . . 1.1299999999999999 109.539 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -152.32 175.55 12.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.831 1.253 . . . . 0.65000000000000002 111.418 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -86.36 149.89 24.71 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.786 1.235 . . . . 2.7599999999999998 111.139 168.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -142.03 171.95 13.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.257 2.223 . . . . 0.44 109.735 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -142.19 154.82 45.13 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.359 1.064 . . . . 1.6399999999999999 111.962 176.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.09 135.93 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.939 0.895 . . . . 0.40000000000000002 110.773 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -121.65 142.31 50.26 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.801 2.04 . . . . 1.8500000000000001 110.575 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -108.69 118.09 35.88 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.076 0.951 . . . . 2.1899999999999999 110.648 -176.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.6 mm -114.08 113.51 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 108.67 -0.863 . . . . 0.87 108.67 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -74.26 -20.95 59.98 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.038 -1.039 . . . . 3.5800000000000001 113.077 -175.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.3 m -58.83 -16.65 18.18 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 116.894 2.183 . . . . 1.9399999999999999 116.894 -175.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -111.5 0.54 16.53 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 119.979 1.263 . . . . 2.29 112.94 175.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.6 p -65.47 143.52 57.63 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.814 -1.179 . . . . 5.2300000000000004 113.652 -170.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.5 m -97.62 -28.38 13.95 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.061 1.345 . . . . 5.4100000000000001 111.909 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.15 165.62 24.93 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.324 1.05 . . . . 5.5099999999999998 112.547 172.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.4 t -123.23 124.74 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.55 1.14 . . . . 3.54 110.224 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -142.75 -29.62 0.13 Allowed Glycine 0 N--CA 1.474 1.18 0 N-CA-C 116.119 1.208 . . . . 3.04 116.119 177.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -95.81 -16.9 21.56 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.687 1.595 . . . . 5.5599999999999996 114.077 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -89.42 55.3 3.2 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.953 1.094 . . . . 8.0299999999999994 113.953 -168.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.12 -3.88 84.75 Favored Glycine 0 CA--C 1.535 1.324 0 O-C-N 121.192 -0.942 . . . . 6.1399999999999997 114.377 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -80.82 165.65 21.67 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.862 1.265 . . . . 4.8099999999999996 111.492 171.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.7 m -94.96 -10.74 30.12 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.224 1.41 . . . . 5.8099999999999996 112.305 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.19 -33.94 72.91 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.32 1.048 . . . . 3.6000000000000001 113.54 -173.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.0 m -146.02 106.71 4.1 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.177 0.898 . . . . 6.2000000000000002 112.938 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -99.42 -21.12 15.58 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.14 1.353 . . . . 3.3999999999999999 113.428 168.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 37.3 m -93.01 156.28 16.99 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.292 1.437 . . . . 3.04 113.498 -173.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -91.91 142.53 27.46 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.858 1.663 . . . . 2.1200000000000001 112.503 173.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.59 154.9 39.6 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.777 -1.202 . . . . 0.90000000000000002 111.428 172.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.63 149.6 72.38 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 125.492 1.517 . . . . 0.63 110.625 174.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -74.47 145.81 34.16 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.282 2.654 . . . . 0.55000000000000004 114.64 -166.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.461 HD11 ' HB3' ' A' ' 182' ' ' PRO . 4.5 mt -98.35 140.2 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.191 1.396 . . . . 1.8300000000000001 110.019 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -113.89 121.46 44.03 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.988 1.315 . . . . 3.0699999999999998 111.491 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.7 tt -135.16 156.68 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.127 1.371 . . . . 0.40999999999999998 112.673 -168.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -138.49 159.66 41.51 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.953 1.701 . . . . 2.0699999999999998 109.022 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 19.0 mt -67.38 152.25 96.36 Favored Pre-proline 0 CA--C 1.551 1.008 0 O-C-N 121.282 -0.886 . . . . 0.94999999999999996 112.925 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.52 79.44 3.19 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 124.139 3.226 . . . . 0.95999999999999996 114.764 -167.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 1.6 tt -102.62 72.78 1.26 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.108 -1.442 . . . . 2.2400000000000002 107.108 167.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -146.44 -176.7 5.28 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.609 1.964 . . . . 2.8700000000000001 109.833 -168.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -79.85 0.0 32.87 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.127 1.528 . . . . 4.3499999999999996 115.127 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 1.4 m -80.41 159.05 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.535 1.134 . . . . 1.21 114.02 -169.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.2 t -99.23 -32.02 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 125.63 1.572 . . . . 1.73 111.507 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -142.25 128.61 20.0 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.736 1.614 . . . . 2.5099999999999998 108.781 -173.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -99.52 141.44 32.31 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.148 0.979 . . . . 0.54000000000000004 111.983 -172.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -142.38 169.59 17.29 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 115.725 1.75 . . . . 0.82999999999999996 115.725 -176.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.07 140.08 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.65 1.98 . . . . 0.59999999999999998 112.239 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -137.09 84.52 24.65 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 124.815 1.246 . . . . 2.3399999999999999 112.093 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.461 ' HB3' HD11 ' A' ' 166' ' ' ILE . 14.4 Cg_endo -69.34 148.47 67.89 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 124.08 3.186 . . . . 0.56000000000000005 113.689 174.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -131.82 162.94 29.35 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 127.773 2.429 . . . . 1.51 111.242 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -109.92 169.62 8.6 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.68 1.192 . . . . 3.1899999999999999 113.04 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 6.5 t -151.16 -163.23 1.72 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.123 2.169 . . . . 2.6099999999999999 111.575 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -124.92 145.1 50.0 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.858 1.663 . . . . 6.3499999999999996 113.071 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -165.55 -164.04 0.71 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.557 1.943 . . . . 6.2300000000000004 109.508 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -69.5 150.55 96.92 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-O 118.536 -0.745 . . . . 13.92 110.116 167.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -54.62 144.1 65.62 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.855 3.037 . . . . 10.380000000000001 115.264 -169.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.74 10.13 11.58 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.976 1.71 . . . . 15.779999999999999 114.645 175.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.3 mt -99.0 -52.54 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 126.198 1.799 . . . . 15.77 111.236 176.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 60.78 128.56 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 130.276 3.43 . . . . 15.369999999999999 115.857 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 . . . . . 0 CA--C 1.544 0.725 0 C-N-CA 126.457 1.903 . . . . 15.619999999999999 111.102 179.467 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 118.957 -0.544 . . . . 25.670000000000002 109.758 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -138.4 138.43 38.22 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.095 0.776 . . . . 23.620000000000001 113.095 170.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.0 p 60.5 151.29 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 127.935 2.494 . . . . 18.850000000000001 114.845 -171.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.17 178.29 7.39 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.0 1.32 . . . . 16.98 111.914 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.0 m -52.58 115.36 1.74 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.852 0.861 . . . . 15.73 111.12 170.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -127.09 -6.48 6.04 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.612 1.338 . . . . 11.83 114.612 -172.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 59.52 143.28 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.741 2.816 . . . . 9.7200000000000006 116.212 -174.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.9 p 52.9 -155.95 0.18 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.865 1.666 . . . . 8.1999999999999993 113.911 170.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.3 m -135.38 170.26 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 128.071 2.548 . . . . 7.25 111.767 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -99.79 167.8 10.31 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.05 1.34 . . . . 4.6100000000000003 110.734 168.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -125.6 152.97 44.42 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.546 1.138 . . . . 3.9300000000000002 112.702 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.07 96.94 10.91 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.724 1.21 . . . . 5.3300000000000001 113.233 -169.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.81 8.63 23.67 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.847 1.213 . . . . 2.0699999999999998 115.262 -176.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.4 p -134.45 177.47 7.74 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.668 1.587 . . . . 1.1399999999999999 113.442 -169.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.7 p -105.21 -1.62 25.14 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.825 1.25 . . . . 1.8799999999999999 113.809 170.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 m -146.74 148.66 32.19 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.683 1.993 . . . . 2.7799999999999998 109.05 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 42.2 p -111.0 -11.82 14.28 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.222 1.409 . . . . 1.1200000000000001 114.72 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.1 p -147.67 159.07 44.19 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.765 1.394 . . . . 2.0600000000000001 114.765 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.74 138.19 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.825 2.05 . . . . 0.56000000000000005 110.194 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.0 m -114.72 122.15 45.54 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.846 0.858 . . . . 0.67000000000000004 110.962 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.62 135.12 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.667 1.187 . . . . 0.59999999999999998 111.852 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -133.27 106.67 7.68 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.015 1.726 . . . . 1.8100000000000001 112.163 -172.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.58 132.98 34.88 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 120.138 -1.601 . . . . 1.28 112.98 -171.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.5 mt -122.43 163.17 20.31 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.495 1.518 . . . . 0.78000000000000003 112.904 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 42.7 mt -143.12 167.95 20.89 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.593 1.957 . . . . 1.5700000000000001 110.914 168.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.15 169.95 10.01 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.54 1.136 . . . . 1.02 113.373 169.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.6 p -94.49 -32.99 13.26 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.578 1.325 . . . . 1.5700000000000001 114.578 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -140.53 44.49 1.85 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.598 1.159 . . . . 2.5899999999999999 111.963 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.75 12.9 82.26 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.515 1.531 . . . . 1.3899999999999999 115.832 177.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.16 19.65 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 127.767 2.427 . . . . 2.6499999999999999 116.572 -171.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mmt -64.14 -19.55 65.37 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.103 -1.623 . . . . 0.83999999999999997 114.678 -173.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -76.39 -51.9 10.96 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.934 0.894 . . . . 2.3999999999999999 111.613 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -62.05 -40.91 97.35 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.881 -1.137 . . . . 2.3599999999999999 111.372 172.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 98.8 mt -53.32 -47.92 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 119.613 1.097 . . . . 0.76000000000000001 110.9 169.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.03 -29.28 70.17 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.715 1.143 . . . . 0.81999999999999995 113.3 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -73.31 -39.04 65.62 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.922 0.783 . . . . 1.0900000000000001 111.993 171.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -61.7 -32.83 73.06 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.428 1.091 . . . . 1.8899999999999999 112.444 172.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.7 mt -88.49 -36.12 16.62 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.789 1.403 . . . . 1.01 114.789 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.38 -20.53 64.69 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.613 1.097 . . . . 2.3900000000000001 113.121 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.2 t -80.93 -12.19 59.44 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.079 1.352 . . . . 1.4099999999999999 114.525 175.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.39 161.33 21.4 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.261 1.41 . . . . 1.3 112.236 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -79.02 37.59 0.31 Allowed 'General case' 0 N--CA 1.477 0.92 0 O-C-N 120.855 -1.379 . . . . 2.0299999999999998 112.27 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -77.19 -0.88 26.76 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.246 1.202 . . . . 2.3100000000000001 114.246 -173.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.79 -27.08 66.25 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 121.091 -1.005 . . . . 1.21 110.593 166.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.28 -54.62 0.38 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.204 0.907 . . . . 1.0 113.347 169.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -76.02 160.34 29.93 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.478 1.111 . . . . 2.7000000000000002 113.343 -169.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -68.72 155.36 40.26 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.222 -0.924 . . . . 2.8300000000000001 111.687 171.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.2 t -67.9 119.82 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 109.795 -0.446 . . . . 1.26 109.795 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.11 -42.77 83.4 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 119.624 -0.542 . . . . 1.5900000000000001 113.93 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.9 t -142.44 130.77 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.722 1.609 . . . . 2.21 110.671 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.69 142.94 29.66 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.489 1.116 . . . . 1.2 110.956 168.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.16 162.57 42.13 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.442 2.095 . . . . 0.96999999999999997 112.215 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.8 -29.01 69.96 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.865 -1.147 . . . . 1.29 112.531 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -79.8 1.88 25.17 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.806 1.642 . . . . 1.4099999999999999 114.966 173.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.43 157.06 16.91 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.705 1.202 . . . . 1.1599999999999999 112.815 169.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -147.32 167.97 22.96 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.774 1.63 . . . . 3.1400000000000001 112.067 170.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -126.8 144.17 51.04 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.533 1.133 . . . . 2.6800000000000002 112.296 -169.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.1 pt -142.15 146.2 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.72 1.608 . . . . 1.1200000000000001 111.046 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.03 158.82 43.49 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.315 1.046 . . . . 1.1000000000000001 111.99 173.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.65 15.86 21.5 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.03 1.3 . . . . 0.65000000000000002 114.855 -171.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 p -101.4 144.44 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 127.997 2.519 . . . . 0.87 110.501 175.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.4 tpp -97.38 139.33 33.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.555 1.942 . . . . 0.57999999999999996 113.374 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.569 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.6 OUTLIER -141.64 154.34 45.31 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.988 1.315 . . . . 1.6499999999999999 111.31 171.775 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.5 m -125.68 146.13 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.097 1.759 . . . . 0.34000000000000002 109.82 -174.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -85.67 147.0 26.58 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.76 1.266 . . . . 0.40000000000000002 112.548 169.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.6 p -141.33 172.02 13.25 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.761 2.024 . . . . 0.35999999999999999 112.493 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.11 -169.75 1.91 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 115.283 1.586 . . . . 1.8700000000000001 115.283 177.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 66.9 p -62.19 -33.68 75.0 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.663 -1.273 . . . . 2.1899999999999999 112.143 173.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -80.53 12.96 2.71 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.342 1.057 . . . . 2.1899999999999999 113.289 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.39 26.74 14.48 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.498 1.519 . . . . 0.68000000000000005 111.761 -172.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -93.35 143.48 26.24 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.93 1.292 . . . . 1.9299999999999999 111.751 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.4 mt -78.38 124.46 36.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.358 0.663 . . . . 0.46999999999999997 110.36 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.533 HG22 HG22 ' A' ' 97' ' ' THR . 2.2 pt -113.83 154.3 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.605 1.562 . . . . 0.53000000000000003 114.95 177.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.14 157.74 18.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.429 2.692 . . . . 1.79 108.666 167.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -54.76 -24.42 22.36 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.634 1.716 . . . . 2.3799999999999999 115.634 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . 0.261 0.0 OUTLIER -86.89 7.05 28.93 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 119.355 0.98 . . . . 2.9300000000000002 112.42 176.855 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.42 19.05 77.1 Favored Glycine 0 C--N 1.343 0.931 0 C-N-CA 125.909 1.719 . . . . 0.76000000000000001 113.417 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -80.66 137.88 36.36 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.299 0.64 . . . . 2.1499999999999999 110.261 169.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.533 HG22 HG22 ' A' ' 91' ' ' ILE . 20.1 p -96.19 146.17 24.91 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.829 0.852 . . . . 0.76000000000000001 111.099 -177.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.1 -6.04 29.09 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.579 1.325 . . . . 0.75 114.579 -168.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.27 28.03 46.26 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.193 0.902 . . . . 0.67000000000000004 113.802 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 36.6 t -134.48 147.89 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.103 1.361 . . . . 1.1299999999999999 110.501 176.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -129.8 158.44 39.43 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 128.973 2.909 . . . . 1.3300000000000001 111.091 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 74.7 mt -132.83 139.33 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 125.559 1.544 . . . . 0.54000000000000004 111.13 -174.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -75.79 139.06 69.8 Favored Pre-proline 0 CA--C 1.546 0.806 0 O-C-N 120.272 -1.518 . . . . 2.1600000000000001 111.97 171.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.19 -20.6 24.6 Favored 'Trans proline' 0 C--N 1.349 0.602 0 CA-C-N 122.645 1.981 . . . . 0.66000000000000003 113.517 176.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -98.21 -44.4 6.6 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.934 1.693 . . . . 1.28 112.018 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.9 p -90.2 -21.29 22.24 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.992 0.738 . . . . 0.81000000000000005 112.992 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 54.5 18.92 2.14 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.48 1.512 . . . . 1.8200000000000001 113.943 -172.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.1 148.92 21.81 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.728 -1.232 . . . . 2.6600000000000001 112.73 -177.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.9 mt -87.74 142.53 27.75 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.069 1.748 . . . . 0.83999999999999997 113.313 -170.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.8 p -71.26 -7.26 45.77 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.042 1.127 . . . . 1.3200000000000001 114.042 171.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.99 -161.26 14.64 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.959 1.266 . . . . 1.02 112.881 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.83 162.56 29.33 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.359 1.063 . . . . 1.29 113.333 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -51.51 137.09 32.12 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.777 1.231 . . . . 2.02 112.91 174.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.8 154.79 26.65 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.858 3.038 . . . . 1.01 114.199 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.17 -60.92 2.11 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.337 1.236 . . . . 1.24 114.337 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.6 p -119.84 15.64 12.61 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 114.363 1.245 . . . . 0.96999999999999997 114.363 -169.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.35 146.78 11.57 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.914 1.079 . . . . 0.46000000000000002 113.914 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.6 ttt -74.77 102.86 4.81 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.655 1.982 . . . . 1.97 110.605 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -156.25 146.21 21.22 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.018 1.727 . . . . 0.94999999999999996 112.211 -173.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -163.75 156.81 18.36 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.448 1.499 . . . . 1.79 110.627 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.1 mp -92.72 146.74 23.42 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.527 0.731 . . . . 0.62 112.03 173.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.569 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 5.2 p -65.3 140.57 58.7 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 121.054 -1.029 . . . . 0.62 110.183 169.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -98.08 -62.81 1.19 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.473 0.916 . . . . 2.1699999999999999 113.473 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -170.37 -31.14 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.439 2.296 . . . . 1.3899999999999999 110.682 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.14 24.03 10.75 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.045 2.138 . . . . 4.75 112.32 172.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.9 -151.63 27.71 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.94 1.257 . . . . 0.62 112.801 -170.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.3 129.77 24.06 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.63 1.972 . . . . 0.44 111.416 169.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -83.75 135.85 34.39 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.677 1.591 . . . . 1.3899999999999999 112.89 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -127.35 130.61 49.75 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.27 2.228 . . . . 1.6899999999999999 108.602 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -93.17 104.09 16.31 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.428 -0.795 . . . . 2.0499999999999998 111.608 -173.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.1 p -86.41 -0.8 56.74 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.69 1.196 . . . . 1.01 113.49 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.39 -25.49 59.58 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.94 0.896 . . . . 0.91000000000000003 113.222 169.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -87.74 -14.94 38.4 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.329 1.451 . . . . 2.1400000000000001 113.433 -174.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -90.4 150.19 42.41 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 113.881 1.067 . . . . 0.63 113.881 177.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -85.45 172.21 8.28 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.09 3.194 . . . . 0.77000000000000002 111.011 166.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.6 85.27 2.08 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.995 2.118 . . . . 1.1000000000000001 111.054 -174.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -141.56 176.1 9.16 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.159 1.384 . . . . 0.80000000000000004 111.256 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -91.28 145.7 24.44 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.621 1.2 . . . . 2.71 111.981 169.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -136.11 176.17 8.94 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.854 2.062 . . . . 0.58999999999999997 109.983 -172.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.95 156.74 43.0 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.642 1.177 . . . . 3.5899999999999999 113.411 177.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.0 142.38 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.66 1.184 . . . . 0.45000000000000001 111.354 172.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -131.1 142.21 50.24 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.722 2.009 . . . . 1.8100000000000001 111.891 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -103.78 126.85 51.2 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.246 1.418 . . . . 2.1099999999999999 112.843 -175.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 25.0 mm -128.01 143.64 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.434 1.493 . . . . 1.1299999999999999 110.246 -169.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -114.7 -1.48 13.28 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.093 1.516 . . . . 4.9100000000000001 115.093 -178.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.4 p -64.08 -17.85 63.81 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 120.06 -1.65 . . . . 2.3100000000000001 113.221 171.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -118.1 123.17 44.94 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 105.826 -1.916 . . . . 2.9100000000000001 105.826 165.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 28.9 t -159.15 142.17 14.41 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.372 0.669 . . . . 4.8600000000000003 111.241 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.5 t -136.51 31.12 2.86 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.177 0.991 . . . . 5.7300000000000004 111.958 175.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -128.85 175.63 8.48 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.492 1.117 . . . . 5.79 111.776 172.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.8 p -146.52 148.91 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.913 1.285 . . . . 3.8399999999999999 110.598 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -110.78 -32.5 2.65 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.273 0.463 . . . . 2.9500000000000002 113.626 170.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -80.22 5.19 15.25 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.326 1.85 . . . . 5.4199999999999999 115.33 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -97.37 21.94 9.43 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.968 1.707 . . . . 6.5599999999999996 113.333 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.42 0.51 89.4 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.629 1.109 . . . . 4.7400000000000002 114.099 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.96 158.78 7.9 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.217 1.407 . . . . 3.52 112.365 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.9 m -81.12 56.06 2.71 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.062 -1.024 . . . . 3.7799999999999998 111.717 -174.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -107.23 165.54 11.3 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.412 1.485 . . . . 2.3799999999999999 114.022 -170.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.9 m -142.62 125.51 16.11 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.415 1.486 . . . . 3.71 107.555 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.55 -10.84 61.28 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 115.846 1.099 . . . . 2.1200000000000001 115.846 -170.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 69.8 m -54.17 143.86 21.48 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.969 1.708 . . . . 3.3100000000000001 114.273 -176.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.64 149.66 24.75 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.306 1.595 . . . . 1.96 115.306 -168.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -87.47 158.5 18.94 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.089 1.356 . . . . 0.91000000000000003 112.526 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.7 m -122.91 145.23 45.03 Favored Pre-proline 0 N--CA 1.468 0.472 0 C-N-CA 124.497 1.119 . . . . 0.57999999999999996 111.198 178.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.9 161.95 43.39 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.049 2.499 . . . . 0.52000000000000002 112.476 -170.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.3 mp -126.85 119.33 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.861 1.264 . . . . 1.3899999999999999 111.067 -168.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -74.33 140.26 44.74 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.818 0.735 . . . . 3.29 110.853 168.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.9 tt -144.81 144.62 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.55 1.14 . . . . 0.47999999999999998 111.622 174.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -115.81 157.68 24.03 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.434 1.094 . . . . 2.1099999999999999 110.975 169.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.79 151.48 72.55 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.407 1.483 . . . . 1.1399999999999999 112.949 177.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -83.16 116.57 2.42 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.85 2.366 . . . . 1.1100000000000001 113.998 -169.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.75 57.64 1.67 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 104.864 -2.273 . . . . 2.3999999999999999 104.864 165.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -128.37 170.17 13.41 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 127.226 2.211 . . . . 3.5699999999999998 110.478 -167.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -71.88 -11.13 60.65 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 120.632 -1.293 . . . . 3.1899999999999999 114.242 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.0 m -77.41 148.69 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 114.733 1.383 . . . . 1.03 114.733 -171.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.1 t -80.58 -38.36 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.982 1.313 . . . . 1.8400000000000001 111.689 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -149.35 147.32 28.18 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.229 1.412 . . . . 2.5899999999999999 110.728 170.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -97.05 161.57 13.77 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.524 1.305 . . . . 0.59999999999999998 114.524 -168.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -133.97 169.89 16.44 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.074 1.509 . . . . 0.64000000000000001 115.074 174.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -138.55 144.78 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.623 1.969 . . . . 0.59999999999999998 111.148 173.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -137.06 83.25 28.31 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.685 1.594 . . . . 2.2200000000000002 111.032 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -69.72 151.15 69.24 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.501 2.801 . . . . 0.56000000000000005 113.241 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -131.17 156.62 45.01 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.968 2.107 . . . . 1.5900000000000001 112.037 -171.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -89.61 177.31 6.57 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 122.913 1.339 . . . . 3.79 113.369 173.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 32.3 p -125.14 178.39 5.58 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.321 1.848 . . . . 3.3100000000000001 112.171 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -71.61 -5.52 34.08 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.107 2.163 . . . . 7.5899999999999999 114.991 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -102.64 149.93 23.94 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.919 1.288 . . . . 4.7999999999999998 113.569 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -131.16 151.08 78.27 Favored Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 125.389 1.476 . . . . 9.1899999999999995 113.626 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -84.96 163.44 11.76 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.724 2.949 . . . . 9.7200000000000006 114.464 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -108.36 -15.77 14.39 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.116 1.766 . . . . 12.550000000000001 115.486 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.61 3.79 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 116.762 2.134 . . . . 14.800000000000001 116.762 -167.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 40.8 mt -90.05 62.85 5.71 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 123.118 1.437 . . . . 15.34 111.348 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 CA--C 1.538 0.482 0 C-N-CA 124.958 1.303 . . . . 16.16 113.429 -168.941 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.3 ppp? . . . . . 0 N--CA 1.476 0.862 0 CA-C-O 120.97 0.414 . . . . 26.219999999999999 110.982 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -84.01 101.33 11.67 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.794 0.807 . . . . 24.149999999999999 112.595 -170.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.5 t -149.75 151.48 33.68 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.69 1.996 . . . . 20.260000000000002 110.638 169.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -100.69 154.83 18.27 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.343 1.057 . . . . 16.489999999999998 113.353 -174.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 m -93.5 -28.91 15.8 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.182 0.993 . . . . 16.149999999999999 113.266 174.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -138.5 137.33 37.01 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.249 1.82 . . . . 11.68 111.179 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.38 166.95 14.46 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.741 1.386 . . . . 9.4199999999999999 114.741 -169.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.4 t -64.78 141.69 58.69 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.329 1.451 . . . . 8.9299999999999997 111.173 169.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.5 p -135.25 148.86 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.043 1.337 . . . . 5.8799999999999999 110.643 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -126.18 156.64 39.86 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.255 1.022 . . . . 4.7400000000000002 112.046 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.99 134.12 49.23 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.108 1.363 . . . . 4.21 111.119 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -159.25 151.84 21.55 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.675 1.59 . . . . 5.0800000000000001 110.418 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.78 31.14 0.28 Allowed Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.802 1.667 . . . . 3.0499999999999998 116.59 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.4 p -80.43 145.47 31.94 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 115.688 1.736 . . . . 1.1299999999999999 115.688 -168.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.7 p -89.13 -14.53 35.97 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.558 1.318 . . . . 1.45 114.558 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 t -147.18 165.29 30.46 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.452 1.901 . . . . 2.3599999999999999 111.365 171.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -103.89 -0.09 29.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.971 2.509 . . . . 1.02 114.83 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.413 ' HA ' ' H ' ' A' ' 131' ' ' THR . 88.6 p -149.28 165.43 31.94 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.553 1.141 . . . . 1.73 113.349 175.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.66 136.63 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 127.474 2.309 . . . . 0.53000000000000003 109.757 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.0 m -104.89 115.28 30.02 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.771 0.796 . . . . 0.88 110.796 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 p -95.24 134.56 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.28 1.432 . . . . 0.82999999999999996 110.486 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -116.98 179.1 4.12 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.583 1.953 . . . . 1.8400000000000001 109.988 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.96 129.35 18.93 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 120.35 1.432 . . . . 1.01 113.204 171.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.3 mt -115.0 148.24 39.08 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.422 1.089 . . . . 0.56000000000000005 113.85 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.5 mt -135.94 177.13 8.07 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.24 2.216 . . . . 1.99 109.995 169.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.418 ' HB1' ' H ' ' A' ' 48' ' ' ASP . . . -111.96 166.8 10.9 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.845 1.258 . . . . 0.81000000000000005 112.545 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.3 p -85.67 -32.98 21.68 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.593 -1.317 . . . . 0.92000000000000004 113.309 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -133.24 15.37 4.15 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.106 1.363 . . . . 2.4900000000000002 113.624 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.22 34.86 8.41 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 120.722 -1.236 . . . . 1.1299999999999999 113.379 -173.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.418 ' H ' ' HB1' ' A' ' 44' ' ' ALA . 1.7 m-20 -79.59 12.5 2.51 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.977 2.511 . . . . 2.04 114.614 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -60.17 -20.22 57.56 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.768 -1.207 . . . . 0.79000000000000004 113.081 -172.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.44 -56.04 19.38 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.033 1.733 . . . . 2.8999999999999999 113.041 172.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -38.87 70.45 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.173 -0.954 . . . . 4.3799999999999999 111.704 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 84.4 mt -53.21 -50.28 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.352 1.061 . . . . 0.67000000000000004 110.922 169.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.08 -32.66 72.31 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.826 1.194 . . . . 0.92000000000000004 112.987 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -70.51 -34.34 72.22 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.998 0.74 . . . . 1.3 112.998 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -67.79 -28.05 67.27 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.717 0.69 . . . . 1.95 112.57 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.9 mt -85.99 -36.28 19.88 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.952 1.093 . . . . 1.25 113.952 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -65.42 -25.48 67.55 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.214 0.916 . . . . 2.8599999999999999 113.137 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.1 t -76.37 -34.05 58.91 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.42 -0.8 . . . . 1.6799999999999999 112.868 173.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.62 167.86 48.99 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.559 1.076 . . . . 1.23 113.876 176.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -93.85 32.12 1.5 Allowed 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.199 -1.177 . . . . 2.1699999999999999 112.99 -173.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -70.95 3.01 3.64 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 116.057 1.873 . . . . 2.27 116.057 -167.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.0 -23.98 67.71 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.103 -0.998 . . . . 1.29 111.942 167.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.98 -76.68 0.85 Allowed Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.405 1.478 . . . . 0.95999999999999996 112.581 170.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.36 158.13 31.73 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.983 1.475 . . . . 1.48 114.983 -170.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -62.92 147.75 49.43 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.188 0.995 . . . . 4.0599999999999996 111.58 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.5 t -56.52 140.29 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.848 0.859 . . . . 1.1499999999999999 111.867 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.58 -66.21 2.65 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.404 1.002 . . . . 1.21 112.861 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.0 t -149.14 125.01 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.975 2.11 . . . . 2.02 109.62 174.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt -74.89 145.48 81.39 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.316 -0.865 . . . . 1.21 112.505 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -72.59 161.69 43.36 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.937 2.425 . . . . 0.62 112.188 -176.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.38 -15.62 63.79 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.405 1.261 . . . . 0.87 114.405 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -96.52 -1.3 47.44 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.607 1.563 . . . . 1.73 114.193 173.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.49 150.86 24.98 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.291 -0.881 . . . . 0.56000000000000005 112.556 169.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -141.6 151.44 43.15 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.595 1.558 . . . . 2.4100000000000001 110.975 169.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.14 138.75 53.7 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.051 0.941 . . . . 3.1000000000000001 110.7 -171.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.4 pt -131.85 153.03 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 115.403 1.631 . . . . 0.83999999999999997 115.403 -169.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -113.53 156.54 23.4 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.292 1.837 . . . . 0.65000000000000002 112.31 172.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.29 13.69 59.83 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.953 1.263 . . . . 0.53000000000000003 114.882 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.86 142.35 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.079 1.751 . . . . 0.81999999999999995 110.613 172.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -103.74 136.83 42.7 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.8 1.64 . . . . 0.55000000000000004 113.661 -175.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.462 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.9 OUTLIER -141.85 152.29 43.51 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.121 1.368 . . . . 1.6499999999999999 111.76 175.867 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.15 146.74 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 127.306 2.242 . . . . 0.41999999999999998 109.361 -176.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -88.91 147.61 24.26 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.396 1.093 . . . . 0.40000000000000002 112.287 169.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.2 p -136.68 165.1 26.68 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.025 1.73 . . . . 0.34000000000000002 112.395 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.02 168.67 13.1 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.092 1.357 . . . . 1.55 111.22 167.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . 0.267 1.3 t -67.15 -14.65 63.1 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 115.0 1.481 . . . . 2.8199999999999998 115.0 -168.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -83.69 19.07 1.73 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.717 1.607 . . . . 3.3799999999999999 113.055 167.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.72 23.31 12.16 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.233 1.813 . . . . 0.64000000000000001 113.558 -175.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -83.89 136.67 34.01 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.659 1.584 . . . . 2.6099999999999999 112.904 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.4 mt -77.79 128.79 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 121.602 -0.686 . . . . 0.47999999999999998 110.516 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.78 150.66 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 126.386 1.874 . . . . 1.03 114.326 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -77.73 161.61 27.59 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.331 2.252 . . . . 1.5800000000000001 110.965 168.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -56.6 -21.78 29.33 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 116.025 1.861 . . . . 2.46 116.025 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . 0.257 0.0 OUTLIER -87.87 -0.58 57.15 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 120.829 1.65 . . . . 2.7200000000000002 113.558 171.438 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.62 17.6 65.71 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.895 1.236 . . . . 0.75 114.405 -175.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -75.27 145.3 41.99 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.107 0.953 . . . . 2.6899999999999999 108.966 167.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.4 p -106.21 145.42 31.59 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.084 0.954 . . . . 1.0 112.416 -171.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -103.06 -4.98 23.8 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.126 1.158 . . . . 0.78000000000000003 114.126 -170.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.85 30.17 52.72 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 119.722 1.146 . . . . 0.70999999999999996 113.905 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 45.1 t -138.85 145.81 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.124 1.369 . . . . 1.2 110.308 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -126.49 159.29 33.83 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.644 2.778 . . . . 1.5 110.942 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 51.4 mt -136.91 134.15 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.302 1.441 . . . . 0.76000000000000001 110.387 -174.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -75.56 140.06 71.49 Favored Pre-proline 0 N--CA 1.476 0.854 0 CA-C-O 117.687 -1.149 . . . . 2.2400000000000002 111.836 176.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -72.17 -24.12 20.46 Favored 'Trans proline' 0 C--N 1.351 0.679 0 CA-C-N 122.154 1.805 . . . . 0.93999999999999995 113.136 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -88.01 -52.03 5.49 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.814 1.646 . . . . 1.3 111.777 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.0 p -83.21 -23.8 32.66 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.959 0.904 . . . . 1.0 113.15 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 52.52 23.4 2.54 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.056 1.743 . . . . 2.1200000000000001 113.653 -173.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . 0.252 2.2 ptmt -104.38 162.61 13.08 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.052 -1.03 . . . . 3.71 112.887 176.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.9 mt -94.48 149.57 21.11 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.474 1.51 . . . . 1.0900000000000001 114.629 -167.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.8 p -75.1 0.76 15.07 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.986 1.106 . . . . 1.29 113.986 169.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.23 -152.33 9.54 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.187 1.375 . . . . 1.01 112.277 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.76 155.07 19.44 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.017 0.927 . . . . 1.0900000000000001 113.345 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 tpt -51.08 130.78 30.96 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.806 1.642 . . . . 1.96 112.069 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.34 168.03 25.46 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.706 2.937 . . . . 1.0 113.425 -175.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.19 -91.53 0.07 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.764 1.226 . . . . 1.6399999999999999 110.83 168.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.4 p -74.56 10.87 1.17 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 116.49 2.033 . . . . 0.75 116.49 -167.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.57 147.46 14.22 Favored 'General case' 0 CA--C 1.55 0.95 0 O-C-N 120.437 -1.415 . . . . 0.46000000000000002 113.259 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.3 ttt -74.51 102.53 4.53 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.469 1.508 . . . . 1.72 109.98 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -156.85 145.29 19.71 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.622 1.569 . . . . 0.93999999999999995 111.656 -174.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -168.13 156.82 9.04 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.272 1.829 . . . . 2.6099999999999999 109.93 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.2 mp -87.45 150.08 24.0 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.335 1.454 . . . . 0.48999999999999999 113.585 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.531 HG22 ' HA2' ' A' ' 126' ' ' GLY . 1.2 p -63.98 129.77 41.37 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.218 -0.927 . . . . 0.55000000000000004 110.193 169.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -80.75 -57.38 3.58 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 120.771 -1.206 . . . . 2.0800000000000001 114.032 -174.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -153.03 -43.12 0.1 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.921 1.688 . . . . 1.1799999999999999 109.796 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -104.6 -33.15 8.62 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.039 0.936 . . . . 4.5800000000000001 113.239 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.531 ' HA2' HG22 ' A' ' 122' ' ' THR . . . 172.61 -170.65 43.72 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 126.218 1.866 . . . . 0.71999999999999997 110.865 -169.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -135.12 136.39 41.89 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.175 1.79 . . . . 0.56999999999999995 110.637 171.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -97.05 128.9 44.45 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.016 0.926 . . . . 1.3600000000000001 111.949 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -117.98 136.23 53.64 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.8 2.04 . . . . 1.75 107.738 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -96.66 104.41 16.4 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.553 -1.342 . . . . 1.8999999999999999 111.817 -169.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.413 ' H ' ' HA ' ' A' ' 36' ' ' SER . 39.4 p -86.77 1.65 51.51 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.655 1.182 . . . . 0.72999999999999998 113.349 -174.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.3 -29.12 68.64 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.412 -0.805 . . . . 0.88 112.093 169.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.7 m120 -86.92 -20.78 26.87 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.35 1.46 . . . . 2.2999999999999998 113.187 -175.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -79.06 144.22 62.82 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 119.474 1.034 . . . . 0.92000000000000004 113.253 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.22 169.46 20.18 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.643 2.229 . . . . 1.1899999999999999 110.733 166.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.97 89.68 1.92 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.054 1.742 . . . . 1.3300000000000001 110.771 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -149.09 177.81 9.27 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.827 0.851 . . . . 0.90000000000000002 112.052 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -87.04 146.37 26.12 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.107 0.963 . . . . 2.7200000000000002 111.628 166.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -135.84 170.49 15.9 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.993 2.117 . . . . 0.68999999999999995 109.718 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -140.25 149.72 43.21 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.549 0.739 . . . . 1.6699999999999999 111.788 171.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.2 mp -104.03 140.4 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.281 0.632 . . . . 0.44 110.072 173.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -124.75 135.94 53.42 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.926 1.69 . . . . 1.8700000000000001 109.852 174.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -97.55 123.84 41.58 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.122 0.969 . . . . 1.8400000000000001 109.392 178.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 40.3 mm -122.57 97.12 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.743 0.817 . . . . 0.70999999999999996 109.074 -172.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.7 -12.03 60.32 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.579 1.325 . . . . 4.21 114.579 -169.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 79.8 p -63.76 -19.97 65.39 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.271 1.211 . . . . 1.7 114.271 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -108.33 -4.61 17.3 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.543 1.537 . . . . 2.6899999999999999 113.326 172.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 56.2 m -59.28 135.56 57.69 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.245 1.384 . . . . 6.1399999999999997 111.722 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 16.7 p -82.74 -35.73 26.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.649 0.78 . . . . 5.0999999999999996 113.008 178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -90.03 114.13 25.94 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.387 0.675 . . . . 7.5499999999999998 111.275 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.75 132.35 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 122.772 0.429 . . . . 3.9300000000000002 110.683 176.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -110.14 -27.29 4.58 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 114.496 0.559 . . . . 2.23 114.496 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -77.36 -8.5 57.78 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.977 1.473 . . . . 4.7300000000000004 114.977 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -79.96 -13.34 59.42 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.285 1.834 . . . . 5.0499999999999998 114.609 -171.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 134.74 -10.26 4.57 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.115 1.341 . . . . 3.6699999999999999 115.175 -173.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.34 168.99 1.81 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.036 1.335 . . . . 2.73 112.61 172.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.8 t -70.19 9.03 0.64 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.416 -1.428 . . . . 3.52 114.739 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 11.2 mt -88.9 -176.74 5.29 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.864 1.665 . . . . 1.8899999999999999 111.018 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 34.2 p -133.04 153.7 51.24 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.599 1.56 . . . . 2.8799999999999999 110.444 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -77.2 29.42 1.65 Allowed Glycine 0 CA--C 1.541 1.661 0 C-N-CA 124.686 1.136 . . . . 2.1899999999999999 114.94 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.4 t -78.3 -176.75 4.83 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.764 1.226 . . . . 2.7200000000000002 112.582 -172.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -116.46 132.56 56.64 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 115.209 1.559 . . . . 2.1400000000000001 115.209 -171.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.62 152.96 29.74 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.099 0.96 . . . . 0.80000000000000004 111.857 168.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.56 149.04 54.63 Favored Pre-proline 0 N--CA 1.478 0.975 0 C-N-CA 125.337 1.455 . . . . 0.66000000000000003 110.784 174.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.9 162.72 29.21 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.894 3.063 . . . . 0.78000000000000003 115.299 -165.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.6 mp -126.41 133.47 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.742 2.017 . . . . 1.25 110.701 -168.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -98.14 130.88 44.89 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.438 1.095 . . . . 3.3900000000000001 111.838 174.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.4 tt -135.94 147.84 28.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.927 1.291 . . . . 0.67000000000000004 110.816 -174.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -127.48 152.93 46.94 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.986 1.315 . . . . 1.95 109.125 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.09 143.97 98.97 Favored Pre-proline 0 CA--C 1.543 0.688 0 O-C-N 120.94 -1.1 . . . . 1.05 111.614 -176.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -66.81 92.04 0.31 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 124.506 3.47 . . . . 0.79000000000000004 115.599 -165.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.2 tt -122.73 77.53 1.44 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.678 1.991 . . . . 2.3700000000000001 105.783 168.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -157.63 177.02 11.86 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.155 2.182 . . . . 2.6499999999999999 108.574 -167.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -84.33 34.36 0.52 Allowed 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.163 -1.585 . . . . 3.23 114.135 -175.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.63 156.51 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.845 1.258 . . . . 1.22 111.637 -174.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 78.2 t -108.88 -33.85 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.267 1.827 . . . . 1.8100000000000001 111.558 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -129.07 134.64 48.18 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.265 1.426 . . . . 3.7400000000000002 109.167 172.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -98.34 137.82 36.5 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.226 1.01 . . . . 0.40999999999999998 111.494 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -133.72 166.93 21.49 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.068 1.136 . . . . 0.63 114.068 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.28 135.91 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.2 1.4 . . . . 0.59999999999999998 111.568 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -134.18 82.52 47.5 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.569 1.147 . . . . 2.0800000000000001 111.466 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.605 ' HB3' HD11 ' A' ' 166' ' ' ILE . 60.4 Cg_endo -69.78 151.08 68.87 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 124.559 3.506 . . . . 0.58999999999999997 112.274 175.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -131.58 158.94 39.65 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.083 1.753 . . . . 1.6899999999999999 111.679 -178.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -88.64 175.01 7.72 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.311 1.044 . . . . 2.71 110.997 168.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 13.2 t -147.56 -56.6 0.24 Allowed 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.409 -0.807 . . . . 2.48 113.063 169.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 64.53 129.6 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.67 1.988 . . . . 6.4000000000000004 115.453 -174.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -96.57 -41.07 8.72 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.069 1.348 . . . . 6.79 112.607 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -149.69 151.89 33.76 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 126.317 1.847 . . . . 10.67 110.906 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.91 149.5 83.06 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.031 2.488 . . . . 8.0299999999999994 113.909 -171.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -147.28 26.78 1.06 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.642 1.977 . . . . 12.67 112.984 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.32 -9.34 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 115.902 1.816 . . . . 13.539999999999999 115.902 -167.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.87 168.08 20.69 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.072 0.949 . . . . 12.27 112.953 -171.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 193' ' ' GLU . 2.5 pm0 . . . . . 0 CA--C 1.549 0.936 0 C-N-CA 127.385 2.274 . . . . 15.83 114.532 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 109.638 -0.505 . . . . 26.379999999999999 109.638 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -121.57 172.73 7.89 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.939 1.296 . . . . 24.98 112.571 -170.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.7 p -71.52 10.02 0.72 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 115.16 1.541 . . . . 21.809999999999999 115.16 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.27 132.89 53.11 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.657 1.183 . . . . 17.550000000000001 113.819 -169.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.3 t -89.53 120.25 30.67 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.712 1.205 . . . . 13.98 110.822 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -116.24 174.02 6.28 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.885 1.274 . . . . 11.98 113.021 -174.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 65.19 -71.28 0.08 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.11 2.564 . . . . 9.1199999999999992 115.04 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.4 p -112.92 145.78 40.15 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.042 1.497 . . . . 7.1100000000000003 115.042 -167.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.1 m -98.93 3.13 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 126.58 1.952 . . . . 8.1999999999999993 115.493 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 55.61 168.92 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.75 2.02 . . . . 5.0 113.696 -169.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.43 -37.95 0.09 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 116.33 1.974 . . . . 5.3600000000000003 116.33 -170.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.49 -162.96 1.66 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.628 1.171 . . . . 4.8399999999999999 112.06 -167.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.49 1.07 43.62 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 126.888 2.185 . . . . 2.0899999999999999 114.454 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.9 p -152.7 164.7 37.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.204 1.802 . . . . 1.1299999999999999 113.416 -168.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 43.4 p -98.21 -8.48 27.33 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.343 1.457 . . . . 1.9399999999999999 114.067 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.0 m -147.5 146.02 29.34 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.478 1.911 . . . . 2.73 110.054 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.4 p -108.96 -14.48 14.55 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 116.901 2.186 . . . . 1.05 116.901 -172.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.6 m -138.61 149.62 45.43 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.019 1.328 . . . . 1.8200000000000001 111.589 170.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.5 p -115.7 142.66 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 127.071 2.149 . . . . 0.37 110.382 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 36.0 m -111.0 121.61 45.8 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.582 0.753 . . . . 0.73999999999999999 109.564 172.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 p -96.65 127.38 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.945 0.879 . . . . 0.58999999999999997 109.346 174.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -103.66 -172.47 2.12 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.02 1.728 . . . . 1.8999999999999999 109.029 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.8 134.19 13.47 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 120.411 -1.431 . . . . 0.93999999999999995 112.611 168.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.0 mt -121.06 150.57 40.98 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.852 1.261 . . . . 0.66000000000000003 112.971 -172.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.3 mt -140.81 169.66 17.22 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.332 1.853 . . . . 1.6899999999999999 109.761 167.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.98 172.97 7.07 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.993 0.917 . . . . 0.80000000000000004 112.029 173.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.8 p -102.31 -25.78 13.54 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 114.417 1.266 . . . . 1.02 114.417 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -134.95 45.22 2.55 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.668 1.987 . . . . 2.5499999999999998 110.365 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.47 14.63 67.17 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 120.741 -1.224 . . . . 0.87 116.007 175.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.63 27.24 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.982 2.513 . . . . 2.2000000000000002 115.921 -171.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.13 -19.06 65.8 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 119.617 -1.927 . . . . 0.68000000000000005 114.13 -171.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -85.14 -43.38 13.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.385 1.474 . . . . 2.2799999999999998 112.583 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -69.94 -39.09 76.28 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-O 117.941 -1.028 . . . . 3.4100000000000001 110.955 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.3 mt -51.6 -50.37 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.499 1.12 . . . . 0.98999999999999999 110.09 167.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.37 -27.47 66.0 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.554 0.946 . . . . 1.04 113.554 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -79.72 -32.22 41.23 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.063 -1.023 . . . . 1.23 112.937 174.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -67.97 -16.01 63.86 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.792 0.837 . . . . 2.1000000000000001 112.596 169.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.4 mt -97.46 -37.61 9.92 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.072 1.349 . . . . 1.1100000000000001 114.22 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -70.15 -15.93 63.02 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.57 -1.331 . . . . 2.5099999999999998 114.448 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.4 t -71.78 -30.2 65.3 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.01 0.924 . . . . 1.8999999999999999 113.25 170.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.38 164.6 28.29 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.48 1.514 . . . . 1.22 113.053 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -87.32 53.41 2.8 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.131 -1.217 . . . . 1.6299999999999999 111.412 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -89.41 8.01 33.0 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.378 1.251 . . . . 1.8899999999999999 114.378 -170.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.03 -25.79 63.74 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.139 -0.976 . . . . 0.92000000000000004 111.69 168.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.28 -82.53 1.21 Allowed Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.064 0.84 . . . . 0.67000000000000004 111.888 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 161.52 29.67 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.774 1.23 . . . . 1.74 112.708 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -60.36 158.13 12.44 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.804 1.242 . . . . 2.5099999999999998 114.341 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 52.6 t -59.04 126.73 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 121.881 -0.512 . . . . 0.71999999999999997 110.6 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.38 -48.84 75.19 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.061 1.315 . . . . 0.90000000000000002 113.301 -175.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.0 129.16 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.804 1.241 . . . . 2.5899999999999999 111.228 173.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.9 mt -79.62 144.54 61.04 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.066 0.946 . . . . 0.88 111.532 174.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.64 166.94 28.51 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.65 2.234 . . . . 0.65000000000000002 113.045 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.64 -23.83 65.38 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 121.015 -1.053 . . . . 0.90000000000000002 113.452 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -83.92 -1.43 54.52 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.373 1.249 . . . . 1.6399999999999999 114.373 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.09 158.19 16.47 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.282 1.433 . . . . 0.54000000000000004 114.162 172.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.77 159.45 44.34 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.55 1.14 . . . . 1.97 112.729 166.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -105.29 150.04 25.51 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.847 1.659 . . . . 2.8999999999999999 111.263 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.9 pt -137.92 139.29 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 120.067 1.303 . . . . 0.78000000000000003 114.282 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.74 146.95 25.97 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.759 1.223 . . . . 0.84999999999999998 113.102 172.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.8 14.36 27.25 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.341 1.448 . . . . 0.54000000000000004 115.42 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.43 144.44 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 125.287 1.435 . . . . 0.76000000000000001 109.795 169.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 1.3 tpt -105.25 140.26 38.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.554 1.542 . . . . 0.48999999999999999 112.115 176.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.52 155.67 43.23 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.841 1.257 . . . . 2.04 112.625 172.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.3 m -120.23 149.62 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 127.033 2.133 . . . . 0.40999999999999998 109.709 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -90.26 147.58 23.44 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 122.619 1.199 . . . . 0.35999999999999999 112.106 169.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.4 p -139.72 166.85 23.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.31 1.844 . . . . 0.42999999999999999 111.385 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.78 172.93 11.73 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.544 -0.722 . . . . 1.99 112.529 168.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.8 t -61.58 -23.98 66.36 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.437 1.273 . . . . 2.8999999999999999 114.437 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -87.9 20.99 2.83 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 125.379 1.472 . . . . 2.2599999999999998 113.347 171.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.75 27.47 12.81 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.779 2.832 . . . . 0.65000000000000002 114.742 175.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -82.7 140.56 33.03 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.013 0.925 . . . . 2.1600000000000001 110.31 172.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.4 mt -76.21 125.68 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.225 -0.657 . . . . 0.58999999999999997 109.225 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.471 HG22 HG22 ' A' ' 97' ' ' THR . 3.3 pt -121.86 156.91 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 114.644 1.35 . . . . 0.52000000000000002 114.644 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -90.1 164.09 14.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.619 2.367 . . . . 1.5700000000000001 110.115 168.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -68.97 2.9 2.31 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 116.689 2.107 . . . . 2.3999999999999999 116.689 -168.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -110.89 0.79 17.27 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.422 1.489 . . . . 2.8399999999999999 114.105 168.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.24 3.0 60.35 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.255 1.407 . . . . 0.62 115.644 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -65.31 132.13 48.25 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.042 1.421 . . . . 2.8799999999999999 108.932 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.471 HG22 HG22 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -96.05 142.41 28.29 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 118.134 0.425 . . . . 0.92000000000000004 111.43 176.886 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.22 -12.76 45.83 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.233 1.198 . . . . 1.1000000000000001 114.233 -168.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.56 22.72 23.34 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.053 1.311 . . . . 0.78000000000000003 114.511 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.0 t -134.79 149.55 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.373 1.469 . . . . 1.26 110.195 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -128.28 157.5 40.74 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.68 2.792 . . . . 1.29 111.292 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 57.1 mt -134.04 126.82 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.423 1.489 . . . . 0.63 110.321 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -68.64 137.71 90.71 Favored Pre-proline 0 N--CA 1.477 0.888 0 O-C-N 121.029 -1.045 . . . . 2.3300000000000001 111.046 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.06 -15.17 29.14 Favored 'Trans proline' 0 C--N 1.35 0.623 0 CA-C-N 121.924 1.723 . . . . 0.84999999999999998 113.785 176.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -97.19 -47.43 5.75 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.627 1.571 . . . . 2.1499999999999999 111.419 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.9 p -90.34 -22.03 21.73 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.728 1.211 . . . . 1.1499999999999999 113.458 -174.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 56.43 16.32 2.4 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.582 1.553 . . . . 1.74 113.923 -171.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.81 146.13 24.01 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.94 -1.1 . . . . 2.79 113.124 -175.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.9 mt -81.56 142.73 32.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.102 1.361 . . . . 0.95999999999999996 112.648 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 83.8 p -77.67 4.4 11.57 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.418 1.266 . . . . 1.3700000000000001 114.418 172.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.83 -162.52 29.63 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 126.106 1.813 . . . . 1.1599999999999999 112.388 -176.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.66 154.75 39.57 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.827 1.047 . . . . 1.3899999999999999 113.827 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 mtp -51.8 138.18 33.4 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.39 1.076 . . . . 2.1299999999999999 112.64 174.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -83.48 171.2 11.23 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.536 3.491 . . . . 0.82999999999999996 113.895 -172.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.12 -96.19 0.09 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.583 1.553 . . . . 1.3899999999999999 110.545 168.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.1 p -72.77 13.51 0.36 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 116.627 2.084 . . . . 1.02 116.627 -168.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.61 145.09 19.78 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.042 -1.036 . . . . 0.53000000000000003 112.812 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.1 ttt -75.0 107.89 7.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.872 2.469 . . . . 1.8100000000000001 110.353 176.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -157.73 143.24 17.11 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 127.303 2.241 . . . . 1.04 112.702 -174.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -164.91 158.1 16.84 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.013 1.325 . . . . 1.8700000000000001 111.859 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.8 mp -101.79 144.99 29.78 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.991 1.317 . . . . 0.53000000000000003 113.981 175.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.8 p -64.54 136.17 56.76 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.721 0.638 . . . . 0.54000000000000004 112.721 173.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.03 -59.13 1.86 Allowed 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 114.965 1.468 . . . . 2.3300000000000001 114.965 -172.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.25 -39.61 0.14 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.184 0.994 . . . . 1.0 111.871 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -115.35 -27.01 7.36 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.09 0.956 . . . . 5.2000000000000002 112.515 174.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 179.64 -156.04 17.2 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 123.836 0.732 . . . . 0.58999999999999997 112.263 -178.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.74 131.12 23.67 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.023 2.129 . . . . 0.41999999999999998 111.5 171.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -83.49 140.64 32.19 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.945 1.298 . . . . 1.27 113.579 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -134.39 118.74 17.77 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.989 2.516 . . . . 1.7 108.977 175.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.435 HD22 ' HB3' ' A' ' 132' ' ' ALA . 7.3 t-20 -76.27 113.14 13.5 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.569 1.148 . . . . 1.6000000000000001 109.427 177.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 35.9 p -103.61 0.66 31.08 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.921 1.288 . . . . 0.69999999999999996 113.219 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.435 ' HB3' HD22 ' A' ' 130' ' ' ASN . . . -53.41 -18.48 2.66 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.756 2.422 . . . . 1.0600000000000001 115.276 -178.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -105.81 -23.81 12.62 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.373 1.869 . . . . 2.4199999999999999 113.088 -174.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.57 140.03 96.31 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 119.318 0.963 . . . . 0.94999999999999996 112.458 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.09 169.18 23.14 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.581 2.187 . . . . 0.82999999999999996 111.482 169.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.47 93.05 2.4 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.978 1.311 . . . . 1.3300000000000001 109.614 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -144.51 178.79 7.7 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.478 1.111 . . . . 0.96999999999999997 111.079 174.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -94.95 141.69 28.35 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.335 1.054 . . . . 3.29 110.988 169.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -135.34 166.72 22.5 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.222 1.809 . . . . 0.63 110.272 -172.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -141.49 149.17 40.56 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.24 0.83 . . . . 1.74 113.24 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 mp -105.91 142.34 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.572 1.149 . . . . 0.46000000000000002 110.201 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -129.43 127.29 40.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.891 1.676 . . . . 1.96 111.491 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -91.84 75.21 5.68 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.967 0.907 . . . . 1.95 112.656 -171.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.0 mm -77.75 107.99 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.742 0.817 . . . . 0.72999999999999998 109.908 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.78 9.07 40.43 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.763 1.023 . . . . 4.2400000000000002 113.763 -174.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.9 t -70.68 -19.15 62.81 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.752 1.019 . . . . 2.3900000000000001 113.752 -176.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.3 mp -86.26 166.19 15.88 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.158 0.983 . . . . 2.46 111.533 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.79 112.08 1.35 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.008 0.923 . . . . 5.9100000000000001 111.743 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.4 p -141.63 171.09 14.53 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.498 2.319 . . . . 5.0199999999999996 113.269 -167.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -56.97 155.82 7.62 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.694 1.597 . . . . 5.3899999999999997 113.642 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 91.1 t -110.73 133.4 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.952 1.301 . . . . 3.54 112.501 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -121.89 -35.81 0.76 Allowed Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.539 1.542 . . . . 2.3599999999999999 115.253 170.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.63 -6.35 48.18 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.38 1.622 . . . . 4.7800000000000002 115.38 -170.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -69.21 -15.54 63.41 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.244 1.817 . . . . 5.5800000000000001 114.459 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 126.98 -2.23 7.32 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.302 1.43 . . . . 3.8500000000000001 114.625 -175.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.96 168.05 2.59 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.066 1.747 . . . . 2.9300000000000002 113.937 175.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . 0.269 6.5 t -78.36 43.66 0.47 Allowed 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 123.249 1.5 . . . . 3.4399999999999999 113.406 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -122.02 130.31 53.18 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.143 2.577 . . . . 2.5299999999999998 107.966 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -100.07 158.27 15.96 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 118.939 0.79 . . . . 3.4399999999999999 112.793 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -79.1 42.1 2.3 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.615 1.579 . . . . 2.7200000000000002 115.276 -174.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 t -76.14 153.75 35.99 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.089 1.356 . . . . 3.04 112.705 -174.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -104.66 119.14 38.3 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.403 1.081 . . . . 2.29 111.788 -170.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.33 128.85 36.66 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.996 0.816 . . . . 1.04 111.79 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.2 m -100.46 149.6 36.24 Favored Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 124.24 1.016 . . . . 0.76000000000000001 110.356 172.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.74 161.29 46.59 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.797 2.331 . . . . 0.75 113.058 -170.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 1.5 mp -121.84 127.87 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.347 1.059 . . . . 1.55 110.761 -169.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -93.02 139.37 30.6 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.896 1.279 . . . . 2.7200000000000002 112.466 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.8 tt -147.48 146.57 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.965 1.306 . . . . 0.48999999999999999 111.964 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -120.88 155.73 33.52 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.047 1.339 . . . . 2.2999999999999998 110.639 169.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -67.53 148.61 98.6 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 123.793 0.837 . . . . 1.3 112.139 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.0 112.1 3.04 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.527 2.818 . . . . 1.1399999999999999 114.008 -168.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 tp -119.04 0.98 11.39 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 125.239 1.416 . . . . 2.79 110.854 165.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -76.85 169.16 18.82 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 129.585 3.154 . . . . 2.8999999999999999 111.53 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -74.16 19.54 0.12 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 116.46 2.022 . . . . 4.21 116.46 -171.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . 0.252 1.2 m -95.41 147.53 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 O-C-N 121.04 -1.038 . . . . 1.27 113.672 -169.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 41.2 t -88.31 -32.35 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.079 1.352 . . . . 1.6399999999999999 112.129 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -147.13 127.38 13.86 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.544 1.537 . . . . 2.54 108.645 -174.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -101.57 143.15 31.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.561 1.144 . . . . 0.41999999999999998 112.449 -169.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -139.02 170.62 15.65 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.329 1.603 . . . . 0.65000000000000002 115.329 -178.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.4 t -139.74 139.94 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.752 2.021 . . . . 0.57999999999999996 111.336 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -132.97 82.79 54.03 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.96 1.304 . . . . 2.23 112.988 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -65.89 143.53 73.44 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.689 3.593 . . . . 0.58999999999999997 113.913 171.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -140.71 166.68 24.1 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 129.08 2.952 . . . . 1.8999999999999999 111.027 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -117.93 169.52 9.57 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.927 0.891 . . . . 2.9500000000000002 113.06 -171.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 12.8 t -144.77 171.44 14.41 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.662 1.985 . . . . 2.54 111.74 -178.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 53.41 -63.25 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 130.604 3.562 . . . . 5.8799999999999999 118.087 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . 61.89 173.94 0.13 Allowed 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 127.182 2.193 . . . . 5.6600000000000001 115.6 -169.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -147.22 155.7 46.6 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 125.621 1.568 . . . . 10.140000000000001 111.733 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.03 160.01 51.65 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.759 2.306 . . . . 8.8000000000000007 112.99 177.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 23.3 mtmm -85.33 -25.14 27.31 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 116.402 2.001 . . . . 15.449999999999999 116.402 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.5 mp -83.99 -68.36 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 118.827 0.74 . . . . 14.24 111.726 -169.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 77.8 mt 56.62 177.41 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 126.047 1.739 . . . . 12.35 115.058 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 . . . . . 0 N--CA 1.474 0.737 0 O-C-N 120.595 -1.316 . . . . 15.85 112.265 -176.88 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.702 0.287 . . . . 28.370000000000001 111.388 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -120.87 135.89 55.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.11 1.364 . . . . 25.440000000000001 112.224 176.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.6 p -96.65 175.41 6.39 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.006 1.323 . . . . 22.030000000000001 109.079 166.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.88 -25.09 26.58 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 120.84 -1.162 . . . . 18.699999999999999 113.471 173.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.0 m 51.24 28.75 4.38 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.816 2.046 . . . . 18.949999999999999 116.057 168.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.99 155.87 30.17 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.152 1.381 . . . . 14.449999999999999 112.209 -175.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.07 -83.86 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.332 1.053 . . . . 11.779999999999999 112.85 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.3 p -101.08 143.34 31.31 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.236 1.415 . . . . 9.1999999999999993 112.885 -169.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.29 144.05 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.421 1.088 . . . . 7.7599999999999998 112.649 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -124.12 156.07 37.3 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.95 2.1 . . . . 5.2800000000000002 111.279 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -147.47 157.74 43.69 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 117.172 2.286 . . . . 5.4000000000000004 117.172 -166.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 40.86 20.43 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 131.59 3.956 . . . . 5.4400000000000004 121.332 167.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.54 -16.31 73.8 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.765 1.174 . . . . 2.3199999999999998 114.111 174.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.1 p -146.12 172.18 13.81 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.088 1.755 . . . . 1.3100000000000001 112.8 -171.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.4 p -92.8 -15.4 26.58 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.391 1.076 . . . . 1.47 113.754 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.4 HG21 ' HA ' ' A' ' 177' ' ' ASP . 98.9 m -148.37 124.44 10.73 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.008 1.723 . . . . 2.2599999999999998 108.9 171.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 45.2 p -90.86 23.63 3.07 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.181 1.548 . . . . 1.8500000000000001 115.181 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 m -149.17 165.79 30.76 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.057 1.343 . . . . 1.75 110.523 168.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.4 p -144.05 142.6 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.007 1.723 . . . . 0.34000000000000002 109.793 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.2 m -116.01 124.83 51.47 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.717 0.807 . . . . 0.65000000000000002 110.273 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -101.98 131.19 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.803 1.241 . . . . 0.63 110.599 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -128.15 104.67 7.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.227 1.411 . . . . 1.8100000000000001 110.888 -172.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.74 116.95 20.21 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.493 -1.379 . . . . 1.24 111.575 -172.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.3 mt -106.6 151.75 24.63 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.039 1.336 . . . . 0.66000000000000003 111.762 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.9 mt -138.16 171.55 14.24 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.33 1.452 . . . . 1.6000000000000001 111.137 169.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.56 162.77 13.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.356 1.063 . . . . 0.71999999999999997 112.678 170.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.6 p -91.39 -24.73 19.66 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 114.751 1.389 . . . . 0.93000000000000005 114.751 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -138.11 38.61 2.33 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.113 1.765 . . . . 2.1000000000000001 111.601 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.19 14.39 79.08 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 120.84 -1.163 . . . . 0.92000000000000004 115.659 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.01 25.26 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 128.889 2.876 . . . . 1.8400000000000001 116.221 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -24.59 67.59 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 119.883 -1.761 . . . . 0.69999999999999996 113.202 -173.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -75.28 -40.13 59.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.769 1.168 . . . . 2.1200000000000001 113.481 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.1 ptmm? -70.48 -41.41 72.75 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 117.448 -1.263 . . . . 2.79 111.357 170.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.6 mt -55.64 -52.88 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 120.252 1.387 . . . . 0.81999999999999995 111.47 170.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.61 -34.08 70.73 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.08 -1.013 . . . . 1.1699999999999999 112.785 -178.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -77.2 -30.75 54.88 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.715 1.005 . . . . 1.4099999999999999 113.715 175.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -66.35 -30.71 71.16 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.133 0.879 . . . . 2.1200000000000001 111.789 169.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.6 mt -86.4 -37.57 18.26 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.483 1.29 . . . . 1.3400000000000001 114.483 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -72.64 -23.89 60.97 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.063 0.764 . . . . 3.6800000000000002 113.063 -177.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.0 t -76.81 -28.43 55.57 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.673 0.62 . . . . 2.2000000000000002 112.673 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.6 156.65 35.23 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.106 1.336 . . . . 1.3500000000000001 112.745 172.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -83.57 31.45 0.47 Allowed 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.21 -1.171 . . . . 2.3500000000000001 112.817 -173.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -71.08 5.42 2.1 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.786 1.402 . . . . 2.0699999999999998 114.786 -169.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.95 -22.35 62.37 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.007 -1.058 . . . . 1.1299999999999999 112.289 167.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.69 -82.11 1.15 Allowed Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.263 1.411 . . . . 0.84999999999999998 113.455 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -71.42 157.09 38.66 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.491 1.916 . . . . 1.5 114.933 -172.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.9 157.14 19.06 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.687 1.195 . . . . 3.4900000000000002 113.793 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.477 HG23 ' CE2' ' A' ' 181' ' ' TYR . 25.1 t -63.67 130.98 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.907 0.883 . . . . 1.0800000000000001 110.539 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.67 -51.65 29.41 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 119.776 -0.458 . . . . 1.1100000000000001 113.723 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 t -146.73 136.36 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.227 1.411 . . . . 2.0600000000000001 109.629 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.1 mt -84.96 150.71 56.17 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.723 0.809 . . . . 1.04 113.151 171.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.429 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 72.9 Cg_endo -72.99 159.13 48.62 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.566 2.178 . . . . 0.73999999999999999 111.564 171.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.29 -30.17 66.41 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.421 -0.799 . . . . 1.1299999999999999 112.889 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -87.43 1.89 52.07 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.635 1.717 . . . . 1.48 115.635 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HB2' ' HG2' ' A' ' 70' ' ' PRO . . . -88.95 154.35 20.3 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.771 1.169 . . . . 0.56000000000000005 113.915 172.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -146.78 169.86 18.21 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.699 2.0 . . . . 2.04 112.329 171.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -128.31 138.42 52.38 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.3 1.44 . . . . 2.2000000000000002 111.248 -173.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.0 pt -126.96 141.56 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 114.096 1.147 . . . . 0.80000000000000004 114.096 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -112.97 158.31 20.41 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.833 1.253 . . . . 0.70999999999999996 112.993 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.64 4.88 82.44 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.789 1.185 . . . . 0.75 114.654 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -86.61 141.2 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.052 1.341 . . . . 0.80000000000000004 110.75 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -104.81 134.3 48.18 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.851 1.66 . . . . 0.66000000000000003 113.193 -173.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.438 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.7 OUTLIER -141.02 154.03 45.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.761 1.224 . . . . 1.71 112.278 177.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 m -127.04 144.32 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 126.513 1.925 . . . . 0.40999999999999998 110.067 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -87.18 147.69 25.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.595 1.188 . . . . 0.41999999999999998 112.024 170.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.5 p -140.99 167.24 22.66 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.881 2.072 . . . . 0.40000000000000002 111.13 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.8 171.57 11.46 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.949 0.722 . . . . 2.1499999999999999 112.949 169.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.2 t -63.13 -23.99 67.69 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.566 1.321 . . . . 3.1499999999999999 114.566 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -87.6 24.42 1.7 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.649 1.18 . . . . 2.3100000000000001 113.085 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.52 27.44 16.61 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 128.105 2.562 . . . . 0.80000000000000004 114.602 172.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -89.88 143.26 26.95 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.169 1.388 . . . . 1.8100000000000001 111.795 174.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.2 mt -79.3 127.48 39.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 123.28 0.632 . . . . 0.48999999999999999 110.034 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.731 HG22 HG22 ' A' ' 97' ' ' THR . 3.3 pt -121.61 153.94 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.991 1.716 . . . . 0.52000000000000002 115.139 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -84.6 165.55 17.88 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.429 2.291 . . . . 2.1000000000000001 110.574 167.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -64.91 -12.57 50.67 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.139 1.533 . . . . 2.5099999999999998 115.139 -170.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -96.98 6.11 49.24 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.319 1.448 . . . . 2.6200000000000001 113.564 173.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.62 5.12 82.21 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.938 1.256 . . . . 0.68999999999999995 115.066 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -73.69 142.71 46.39 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 124.321 1.048 . . . . 2.1099999999999999 110.403 173.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.731 HG22 HG22 ' A' ' 91' ' ' ILE . 30.6 p -104.94 147.29 27.94 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.974 0.91 . . . . 0.72999999999999998 112.499 -171.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.12 2.54 37.56 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.229 1.566 . . . . 0.81000000000000005 115.229 -168.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.88 23.43 74.82 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 120.529 -1.357 . . . . 0.75 114.733 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.2 p -138.05 143.38 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.709 1.204 . . . . 2.7400000000000002 109.749 177.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.14 164.59 18.37 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.7 2.4 . . . . 1.49 110.755 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 66.5 mt -135.61 131.13 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 124.873 1.269 . . . . 0.67000000000000004 110.321 -177.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -69.02 138.81 90.1 Favored Pre-proline 0 CA--C 1.543 0.696 0 O-C-N 121.038 -1.039 . . . . 2.29 110.813 175.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.07 -18.4 21.26 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 CA-C-N 122.12 1.793 . . . . 0.71999999999999997 113.21 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -97.77 -52.4 3.75 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.416 1.886 . . . . 1.8200000000000001 110.892 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.3 p -80.45 -25.75 38.73 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.019 0.748 . . . . 0.91000000000000003 113.019 -176.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 58.24 12.86 2.09 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.406 1.482 . . . . 1.6699999999999999 113.842 -171.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.02 150.66 26.21 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.624 -1.297 . . . . 2.4700000000000002 111.737 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.3 mt -85.52 140.63 30.49 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.68 0.993 . . . . 0.84999999999999998 113.68 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.2 t -88.66 35.93 0.79 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.533 1.533 . . . . 2.6899999999999999 111.397 169.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 170.46 -168.81 41.81 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.678 2.085 . . . . 1.1699999999999999 111.702 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.54 163.09 26.6 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.425 0.69 . . . . 1.01 111.396 170.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.7 tpt -59.87 127.19 85.09 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.081 0.952 . . . . 1.6299999999999999 110.778 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -69.91 171.57 14.39 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 124.818 3.679 . . . . 0.83999999999999997 113.671 -172.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.37 -92.18 0.07 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.332 1.053 . . . . 1.5700000000000001 110.722 169.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.8 p -73.83 6.65 3.09 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.7 2.0 . . . . 0.70999999999999996 116.398 -167.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.12 147.16 7.82 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.427 1.091 . . . . 0.42999999999999999 113.8 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.1 tpt -74.76 92.03 2.45 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.933 2.093 . . . . 1.55 112.196 -177.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.9 pttm -143.61 148.16 35.44 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.013 1.325 . . . . 2.1800000000000002 113.636 -175.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -162.85 165.6 25.07 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.186 1.395 . . . . 2.3300000000000001 111.356 172.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 148' ' ' SER . 5.2 mp -98.14 150.03 21.9 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.876 1.67 . . . . 0.63 113.25 172.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.438 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 2.5 p -67.23 135.9 54.13 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 119.632 1.105 . . . . 0.53000000000000003 111.131 168.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -89.01 -53.04 4.77 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 115.225 1.565 . . . . 2.1099999999999999 115.225 -175.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.55 -45.51 0.07 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.911 1.284 . . . . 1.1799999999999999 110.647 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -116.72 -18.77 10.18 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.015 1.117 . . . . 5.3799999999999999 114.015 176.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 177.35 -163.93 32.83 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.986 1.279 . . . . 0.62 112.216 -176.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -143.17 132.15 22.91 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.542 2.337 . . . . 0.41999999999999998 110.942 169.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -84.51 144.18 28.86 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.246 1.418 . . . . 1.3 112.323 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -135.5 124.37 24.05 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.969 2.107 . . . . 1.8300000000000001 108.708 172.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -73.11 134.59 44.56 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.504 -0.748 . . . . 1.76 111.216 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 71.9 p -121.37 6.14 10.16 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.412 1.485 . . . . 0.56000000000000005 113.671 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.7 -36.24 69.41 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.654 1.115 . . . . 0.94999999999999996 113.168 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -91.36 -21.48 20.99 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.835 1.254 . . . . 1.78 111.088 -169.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.1 139.95 96.0 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 119.819 1.19 . . . . 0.59999999999999998 112.663 170.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.67 169.65 20.48 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.997 2.464 . . . . 0.71999999999999997 111.192 167.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.2 89.34 3.67 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.547 1.539 . . . . 0.94999999999999996 111.26 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -146.84 -179.56 6.88 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.355 1.062 . . . . 0.67000000000000004 112.394 -175.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -98.4 137.54 36.94 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.199 1.399 . . . . 2.96 112.183 173.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -135.91 167.47 21.14 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.327 1.451 . . . . 0.52000000000000002 111.287 -169.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -139.78 153.17 47.07 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.159 0.799 . . . . 1.6399999999999999 113.159 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.9 mp -110.54 144.58 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.437 1.095 . . . . 0.40000000000000002 110.367 170.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -130.57 144.09 51.19 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.792 2.037 . . . . 1.8899999999999999 110.691 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -103.66 112.33 25.21 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.349 1.06 . . . . 2.1400000000000001 109.849 -175.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 19.7 mm -124.33 85.9 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.389 1.076 . . . . 0.97999999999999998 110.061 -168.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -14.79 60.64 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.438 -0.789 . . . . 4.04 113.063 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.4 t -59.24 -27.49 65.82 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.651 1.18 . . . . 2.1899999999999999 113.62 170.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.9 tp -86.75 -35.26 19.29 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 120.298 1.408 . . . . 3.6200000000000001 111.442 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.491 ' HB2' HD21 ' A' ' 121' ' ' LEU . 17.3 m -158.23 132.68 8.19 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.564 1.146 . . . . 5.8499999999999996 109.67 169.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.3 m -108.3 143.46 37.14 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.181 0.993 . . . . 6.3200000000000003 112.414 -169.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -100.84 140.05 35.66 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.404 1.082 . . . . 6.2999999999999998 108.923 168.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -69.79 149.58 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 O-C-N 121.641 -0.662 . . . . 3.6699999999999999 111.405 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -135.03 -40.42 0.16 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 123.426 0.536 . . . . 2.6600000000000001 113.44 168.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -79.26 1.43 24.84 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 116.593 2.071 . . . . 5.04 116.593 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -91.42 21.94 4.23 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.209 1.804 . . . . 6.4699999999999998 113.559 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 103.47 -9.2 52.9 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.228 1.394 . . . . 4.8200000000000003 115.334 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.92 151.13 31.07 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 117.889 0.844 . . . . 3.54 111.193 169.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.7 m -83.15 40.44 0.7 Allowed 'General case' 0 N--CA 1.482 1.148 0 O-C-N 120.813 -1.18 . . . . 2.8300000000000001 111.809 -173.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.1 mt -96.11 166.29 11.82 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.776 2.03 . . . . 2.0600000000000001 114.274 -169.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.8 p -134.47 155.72 49.86 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.618 1.967 . . . . 2.9900000000000002 112.829 -170.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -78.9 -0.69 82.61 Favored Glycine 0 CA--C 1.54 1.651 0 N-CA-C 116.314 1.286 . . . . 2.6499999999999999 116.314 -177.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 4.9 m -57.18 147.71 24.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.973 1.709 . . . . 3.1099999999999999 113.533 176.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.44 143.18 31.77 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.868 1.267 . . . . 2.1600000000000001 114.043 -170.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.21 150.94 45.93 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.357 -0.84 . . . . 0.95999999999999996 112.308 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.35 147.43 40.54 Favored Pre-proline 0 N--CA 1.478 0.975 0 C-N-CA 125.069 1.347 . . . . 0.68999999999999995 111.169 174.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.93 138.69 23.54 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.411 2.741 . . . . 0.5 112.825 -168.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.0 mp -100.74 119.6 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 124.854 1.261 . . . . 1.3 109.982 -171.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.2 pm0 -88.51 138.99 30.93 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.829 0.852 . . . . 4.7800000000000002 113.161 174.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.2 tt -148.49 156.67 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.316 1.446 . . . . 0.59999999999999998 111.408 -173.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -127.58 152.49 47.58 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.473 1.509 . . . . 1.8400000000000001 110.092 170.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.2 138.68 97.32 Favored Pre-proline 0 CA--C 1.548 0.897 0 O-C-N 120.98 -1.075 . . . . 1.3100000000000001 111.226 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -72.64 111.6 3.28 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.575 2.183 . . . . 0.84999999999999998 114.844 -168.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.91 58.48 1.09 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 104.936 -2.246 . . . . 2.6400000000000001 104.936 165.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -144.15 144.59 31.64 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.13 2.572 . . . . 2.7000000000000002 108.512 -166.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -76.68 57.79 1.31 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.451 1.278 . . . . 3.9100000000000001 114.451 -170.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 1.6 m -112.94 151.15 14.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 125.114 1.365 . . . . 1.1599999999999999 110.538 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 96.4 t -88.13 -30.68 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.129 1.372 . . . . 1.53 110.802 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.4 ' HA ' HG21 ' A' ' 34' ' ' THR . 8.1 t0 -146.95 142.36 27.47 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.108 0.963 . . . . 2.5499999999999998 111.512 175.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -102.93 143.81 32.04 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.267 -0.896 . . . . 0.40000000000000002 112.702 -175.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -139.95 170.87 15.07 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.682 1.734 . . . . 0.52000000000000002 115.682 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -140.37 142.89 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.673 1.989 . . . . 0.45000000000000001 111.508 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.477 ' CE2' HG23 ' A' ' 66' ' ' VAL . 98.0 m-85 -131.77 76.42 74.39 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 113.814 1.042 . . . . 1.98 113.814 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.534 ' HB3' HD11 ' A' ' 166' ' ' ILE . 5.1 Cg_endo -62.51 146.9 95.5 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.528 2.819 . . . . 0.68000000000000005 113.912 176.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 15.8 mtmt -121.4 -168.7 1.73 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 128.609 2.764 . . . . 1.73 111.057 -174.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.259 0.6 OUTLIER -137.41 172.84 12.38 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.868 1.667 . . . . 3.4300000000000002 110.793 167.454 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 15.2 t -152.46 -178.32 6.76 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.18 1.392 . . . . 2.71 109.711 173.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.46 135.94 38.61 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 115.694 1.739 . . . . 6.5800000000000001 115.694 -167.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -166.09 173.3 10.44 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.523 2.729 . . . . 5.2599999999999998 108.337 168.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -59.82 140.89 89.68 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 121.771 -0.58 . . . . 10.970000000000001 112.248 173.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -74.21 127.92 11.68 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.376 2.718 . . . . 9.1300000000000008 114.01 -168.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 190' ' ' LYS . 0.0 OUTLIER -81.74 44.51 0.83 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.8 1.037 . . . . 14.65 113.8 179.746 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.33 -18.99 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 127.645 2.378 . . . . 15.67 114.042 175.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 85.1 mt -116.68 99.05 6.87 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.99 1.316 . . . . 12.83 110.286 -177.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 115.574 1.694 . . . . 16.239999999999998 115.574 -179.534 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 110.022 -0.362 . . . . 22.140000000000001 110.022 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -135.06 128.82 33.0 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.938 1.295 . . . . 17.960000000000001 111.204 172.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.5 p -136.43 156.31 48.8 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.765 1.626 . . . . 16.27 112.898 -168.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.92 162.75 39.72 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.818 1.247 . . . . 13.41 112.816 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.9 m -84.8 -17.52 37.89 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.121 1.156 . . . . 13.529999999999999 114.121 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 62.93 -5.39 0.21 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 127.657 2.383 . . . . 12.220000000000001 115.9 -173.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -162.8 151.52 14.64 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.091 2.157 . . . . 12.039999999999999 111.553 169.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . 0.317 44.0 p 48.98 54.81 10.26 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.708 2.403 . . . . 11.66 115.244 176.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.7 p -70.34 158.5 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.74 1.216 . . . . 6.6399999999999997 112.298 174.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.71 25.45 0.07 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 128.597 2.759 . . . . 4.4500000000000002 116.485 -168.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.76 134.78 40.36 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 125.965 1.706 . . . . 4.6100000000000003 113.066 -169.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 49.45 26.93 1.82 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.881 1.672 . . . . 5.7699999999999996 114.693 -171.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.44 -11.5 84.1 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.034 1.302 . . . . 2.1699999999999999 114.474 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.7 p -144.47 164.23 31.48 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 127.168 2.187 . . . . 1.1799999999999999 111.541 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.7 p -88.74 -17.12 30.55 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.335 0.865 . . . . 1.8 113.335 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 84.9 m -146.12 128.45 15.84 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.675 1.59 . . . . 2.7999999999999998 110.149 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 p -88.43 7.77 31.08 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 116.1 1.889 . . . . 1.26 116.1 -173.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.6 m -150.65 165.76 32.41 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.461 1.504 . . . . 1.77 111.811 171.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.73 144.59 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.266 1.827 . . . . 0.52000000000000002 110.938 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.01 111.33 17.76 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.934 1.293 . . . . 1.46 110.704 -170.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 p -98.9 133.73 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 120.376 -1.453 . . . . 0.54000000000000004 110.696 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -134.95 104.75 6.09 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.451 1.5 . . . . 1.8100000000000001 111.669 -171.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.53 126.03 30.72 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 119.887 -1.758 . . . . 1.1699999999999999 111.738 -173.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.4 mt -112.99 155.88 24.02 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.918 1.287 . . . . 0.48999999999999999 112.64 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.98 167.77 21.1 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.211 1.404 . . . . 1.9199999999999999 111.063 175.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.81 168.87 8.82 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.143 1.377 . . . . 0.68999999999999995 112.219 173.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.0 p -97.04 -27.69 14.49 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.612 0.968 . . . . 0.94999999999999996 113.612 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -145.3 37.59 1.13 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.455 1.102 . . . . 2.4700000000000002 112.807 172.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.62 14.38 59.88 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.87 1.224 . . . . 0.93999999999999995 115.449 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.38 14.34 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 128.232 2.613 . . . . 1.97 116.411 -174.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -63.09 -20.29 65.22 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.217 -1.552 . . . . 0.78000000000000003 113.939 -172.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -84.8 -38.84 19.1 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.647 1.179 . . . . 2.46 112.721 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -68.37 -40.39 81.46 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 120.901 -1.124 . . . . 2.6200000000000001 110.016 169.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.8 mt -54.86 -46.7 75.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 118.954 0.797 . . . . 0.71999999999999997 110.375 168.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.55 -29.46 69.16 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 120.372 1.442 . . . . 0.96999999999999997 113.655 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -77.44 -29.78 53.06 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.076 0.95 . . . . 1.4099999999999999 113.401 170.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -64.57 -28.08 69.39 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.135 -0.978 . . . . 2.4700000000000002 110.911 167.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.0 mt -87.82 -38.95 15.26 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.454 1.279 . . . . 1.1799999999999999 114.454 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.15 -25.78 67.95 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.833 1.049 . . . . 3.1200000000000001 113.833 -176.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.9 t -74.51 -25.81 59.59 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.534 0.734 . . . . 1.8799999999999999 112.977 174.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.16 166.69 38.86 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.174 1.369 . . . . 1.3 113.323 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -90.63 31.19 1.06 Allowed 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.323 -1.104 . . . . 1.6699999999999999 113.381 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -69.29 5.72 1.2 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.213 1.56 . . . . 2.1899999999999999 115.213 -169.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.32 -22.3 66.9 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.108 -0.995 . . . . 1.0800000000000001 111.486 166.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.87 -81.63 1.16 Allowed Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.881 1.705 . . . . 0.80000000000000004 113.52 170.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.24 172.19 12.26 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.031 1.332 . . . . 1.6100000000000001 114.582 -175.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -76.02 162.03 28.4 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 115.293 1.59 . . . . 3.3300000000000001 115.293 -169.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.422 HG23 ' CE2' ' A' ' 181' ' ' TYR . 21.9 t -55.18 130.64 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.433 1.093 . . . . 1.3500000000000001 110.526 172.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.36 -46.8 24.91 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 121.801 -0.562 . . . . 0.96999999999999997 113.808 -177.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.0 p -160.73 141.26 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.864 2.066 . . . . 3.1899999999999999 110.267 177.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.4 mt -84.84 147.67 49.16 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 121.466 -0.771 . . . . 1.3999999999999999 112.744 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.58 158.02 51.57 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.232 1.954 . . . . 0.81999999999999995 111.53 169.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.58 -19.6 65.98 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 120.708 -1.245 . . . . 1.1100000000000001 113.023 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -89.54 0.77 56.68 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.576 1.95 . . . . 1.3999999999999999 114.962 172.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.0 162.76 12.89 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.212 1.005 . . . . 0.67000000000000004 111.852 168.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -156.25 171.46 20.16 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.376 1.47 . . . . 2.02 111.56 169.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -123.35 148.87 45.59 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.643 1.177 . . . . 2.0800000000000001 110.592 -175.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.2 pt -137.24 137.01 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.683 1.193 . . . . 0.68999999999999995 110.715 175.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.95 161.59 14.07 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.321 1.048 . . . . 0.56999999999999995 111.005 171.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.01 15.84 62.12 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 121.315 -0.866 . . . . 0.51000000000000001 114.747 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.13 140.99 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.457 1.503 . . . . 0.68000000000000005 109.358 168.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.42 ' HG2' ' HB2' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -104.62 137.49 42.37 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.296 1.438 . . . . 0.53000000000000003 113.321 -173.156 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.43 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.8 OUTLIER -142.17 151.15 41.93 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.472 1.109 . . . . 1.5800000000000001 112.922 177.197 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 m -122.37 145.75 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.962 2.105 . . . . 0.34000000000000002 110.133 -176.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -86.61 145.94 26.53 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 122.301 1.048 . . . . 0.39000000000000001 112.124 169.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 35.8 p -140.88 170.15 16.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.66 1.984 . . . . 0.35999999999999999 112.223 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.36 -170.46 2.75 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 115.731 1.752 . . . . 1.9099999999999999 115.731 174.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.9 p -54.85 -42.37 71.9 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.641 1.176 . . . . 2.3100000000000001 111.646 171.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -88.94 20.03 3.8 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.974 1.31 . . . . 2.27 112.877 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.88 29.04 16.95 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.336 1.454 . . . . 0.67000000000000004 111.781 175.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -84.41 141.57 30.75 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 125.927 1.691 . . . . 2.5499999999999998 109.84 174.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.9 mt -78.69 125.31 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 109.356 -0.609 . . . . 0.52000000000000002 109.356 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.3 pt -120.44 155.13 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.614 1.166 . . . . 0.55000000000000004 114.118 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -86.38 166.11 15.83 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.372 1.869 . . . . 1.47 110.405 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -59.62 -21.36 60.31 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.921 1.452 . . . . 2.1400000000000001 114.921 -174.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -90.86 4.52 51.58 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.894 1.277 . . . . 2.8199999999999998 112.816 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.35 9.73 86.19 Favored Glycine 0 CA--C 1.533 1.195 0 O-C-N 120.523 -1.36 . . . . 0.55000000000000004 114.866 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -69.47 143.99 53.37 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.588 1.194 . . . . 2.23 109.192 168.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.9 p -105.45 140.04 39.16 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.112 1.365 . . . . 0.81000000000000005 111.765 -172.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.26 2.68 54.9 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.601 0.963 . . . . 0.76000000000000001 113.601 -170.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.44 25.35 70.61 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.75 -1.219 . . . . 0.72999999999999998 113.663 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 54.1 t -131.69 149.04 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.488 1.915 . . . . 1.1599999999999999 109.397 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -130.03 158.16 40.36 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.999 2.52 . . . . 1.4199999999999999 111.52 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.0 mt -135.94 128.37 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.631 1.572 . . . . 0.58999999999999997 109.802 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -69.02 141.44 92.03 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 117.565 -1.207 . . . . 1.8100000000000001 111.012 174.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -73.91 -22.13 17.75 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 CA-C-N 122.828 2.046 . . . . 0.60999999999999999 113.236 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 68.6 mm-40 -93.29 -53.46 4.09 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 127.034 2.134 . . . . 1.4099999999999999 112.158 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.9 p -78.29 -24.36 46.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.093 0.557 . . . . 0.81000000000000005 112.381 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 53.8 17.27 1.24 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.721 1.209 . . . . 1.6299999999999999 112.718 -171.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.46 138.2 31.68 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.021 0.928 . . . . 2.5699999999999998 111.257 -174.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.0 mt -78.08 144.18 36.77 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.021 0.928 . . . . 0.85999999999999999 111.394 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 95.2 p -72.72 3.93 4.58 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.892 1.071 . . . . 1.47 113.892 170.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.16 -153.85 13.04 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.719 1.152 . . . . 1.26 113.941 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.28 160.12 21.78 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.046 1.339 . . . . 1.26 112.712 176.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 mmt -51.42 140.95 24.13 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.57 1.548 . . . . 1.5800000000000001 114.062 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.71 167.26 27.0 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 124.543 3.495 . . . . 0.91000000000000003 114.242 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.37 -48.15 13.37 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 116.072 1.878 . . . . 1.72 116.072 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 46.1 p -134.11 10.84 3.88 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.408 1.083 . . . . 0.81999999999999995 113.887 -169.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.95 152.74 7.09 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 116.062 1.875 . . . . 0.55000000000000004 116.062 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.6 tpt -75.41 96.75 3.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.638 2.375 . . . . 1.52 111.889 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -150.81 150.27 30.75 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.711 1.204 . . . . 1.1599999999999999 113.317 -174.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -160.74 161.89 32.31 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.624 1.17 . . . . 3.2000000000000002 111.789 173.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.7 mp -93.37 152.14 19.32 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.154 0.982 . . . . 0.63 111.924 167.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.43 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 1.7 p -67.56 128.49 36.66 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 108.796 -0.816 . . . . 0.59999999999999998 108.796 167.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -80.35 -60.31 2.37 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.569 0.951 . . . . 2.1000000000000001 113.569 -173.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.51 -37.58 0.16 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.675 1.19 . . . . 1.04 111.254 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -121.56 -9.27 8.97 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.637 1.347 . . . . 3.8300000000000001 114.637 176.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 164.95 -168.31 39.08 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.141 1.353 . . . . 0.60999999999999999 112.619 -174.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.88 133.6 27.04 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.975 1.71 . . . . 0.55000000000000004 112.713 169.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -90.05 134.08 34.45 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.984 1.713 . . . . 1.53 112.378 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -126.35 128.47 47.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.292 1.837 . . . . 1.7 108.353 173.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -83.01 122.56 28.46 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.511 -0.743 . . . . 1.6699999999999999 110.989 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.9 p -103.56 -2.67 26.36 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.534 1.134 . . . . 0.65000000000000002 113.265 -176.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.07 -17.85 8.12 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.802 1.241 . . . . 0.73999999999999999 113.868 176.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -94.76 -17.34 22.26 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.595 1.958 . . . . 1.8899999999999999 114.127 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -90.42 147.23 36.15 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 114.455 1.28 . . . . 0.68000000000000005 114.455 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -84.27 170.5 10.68 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.796 2.997 . . . . 0.77000000000000002 111.991 167.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.42 79.1 2.47 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.912 2.085 . . . . 1.1699999999999999 112.607 -172.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.52 177.49 7.81 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.16 1.384 . . . . 0.84999999999999998 110.797 -177.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -97.7 140.34 32.24 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 123.049 1.404 . . . . 2.8500000000000001 112.08 171.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -129.04 177.73 6.92 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.87 1.668 . . . . 0.63 109.911 -173.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.79 152.74 40.02 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.375 1.07 . . . . 3.6499999999999999 112.276 175.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.0 mp -115.76 134.23 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.055 0.942 . . . . 0.34000000000000002 110.06 172.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -122.13 140.9 51.99 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.692 1.997 . . . . 1.9299999999999999 110.535 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -107.42 114.22 28.09 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.697 1.199 . . . . 2.0499999999999998 110.08 -175.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.5 mm -117.36 114.26 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.464 1.106 . . . . 0.69999999999999996 109.854 -168.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -80.92 -13.64 58.72 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.381 1.252 . . . . 3.9199999999999999 114.381 -171.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 56.1 p -60.2 -30.84 69.63 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.799 1.182 . . . . 2.0499999999999998 113.742 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.42 ' HB2' ' HG2' ' A' ' 80' ' ' MET . 3.6 mm? -104.45 1.29 29.85 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.517 1.127 . . . . 2.5699999999999998 113.578 177.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.9 m -65.07 138.46 58.34 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.565 1.075 . . . . 6.0499999999999998 112.001 176.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 24.8 m -84.74 -39.5 18.39 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.794 1.237 . . . . 5.1299999999999999 111.463 174.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.74 166.94 19.83 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.934 0.894 . . . . 5.9900000000000002 112.33 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p -147.61 157.45 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.139 1.376 . . . . 3.8700000000000001 110.938 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -115.89 -37.33 1.06 Allowed Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.158 0.885 . . . . 2.3799999999999999 114.252 171.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -69.79 -7.53 40.5 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 115.022 1.49 . . . . 4.71 115.022 -176.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -75.91 18.78 0.24 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.745 1.618 . . . . 4.9000000000000004 113.314 175.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 91.21 7.02 66.0 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.536 1.541 . . . . 3.7599999999999998 114.741 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -77.0 156.63 31.72 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.464 1.132 . . . . 2.7599999999999998 112.724 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 28.9 m -73.82 70.24 1.42 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.131 1.772 . . . . 2.73 110.834 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.7 mt -144.42 126.09 15.12 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.299 2.24 . . . . 2.0 109.392 -177.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.4 t -71.68 -20.04 61.99 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 115.876 1.806 . . . . 3.6499999999999999 115.876 -169.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 77.93 3.81 84.91 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 117.015 1.566 . . . . 2.04 117.015 169.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 5.4 m -62.09 157.21 19.54 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.465 1.133 . . . . 3.1299999999999999 112.559 171.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.77 143.01 44.25 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.476 0.917 . . . . 1.98 113.476 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.72 157.57 30.03 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.696 0.76 . . . . 1.05 111.767 170.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.57 151.65 57.18 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 126.579 1.951 . . . . 0.89000000000000001 110.668 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -79.2 155.18 25.45 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.624 2.216 . . . . 0.63 111.301 -172.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 5.3 mt -109.48 133.19 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.492 1.117 . . . . 1.8999999999999999 109.622 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -93.75 136.65 33.82 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.165 0.893 . . . . 3.6299999999999999 111.137 168.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.0 tt -141.54 151.27 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.876 1.27 . . . . 0.63 111.471 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -121.09 157.53 29.89 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.306 1.842 . . . . 1.8400000000000001 108.026 169.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 5.7 mt -65.41 155.39 85.27 Favored Pre-proline 0 CA--C 1.544 0.748 0 O-C-N 120.536 -1.353 . . . . 1.0700000000000001 113.71 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -69.32 114.37 3.61 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.364 2.043 . . . . 1.0700000000000001 111.825 -176.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 17.0 tp -122.01 22.99 10.16 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.323 1.849 . . . . 2.8900000000000001 110.462 168.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -105.15 148.19 27.15 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.582 2.353 . . . . 3.2200000000000002 110.65 -169.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -75.87 61.48 1.46 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.148 1.379 . . . . 4.1100000000000003 111.976 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.0 m -122.01 158.22 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 127.541 2.336 . . . . 1.0900000000000001 112.405 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 59.2 t -82.98 -37.07 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.889 0.875 . . . . 1.6200000000000001 111.07 174.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -142.35 147.65 36.63 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.314 1.046 . . . . 2.9900000000000002 110.684 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -98.57 144.41 27.91 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.576 0.751 . . . . 0.38 111.009 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -133.43 166.36 22.71 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.314 1.227 . . . . 0.81000000000000005 114.314 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.57 146.64 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 127.089 2.156 . . . . 0.69999999999999996 111.437 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.422 ' CE2' HG23 ' A' ' 66' ' ' VAL . 87.9 m-85 -135.63 81.94 40.28 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 113.512 0.93 . . . . 2.0800000000000001 113.512 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -65.41 146.26 84.99 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.467 2.778 . . . . 0.63 113.345 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -124.2 -165.16 1.32 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.613 2.365 . . . . 2.3100000000000001 110.823 -173.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -134.02 169.81 16.58 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.0 1.32 . . . . 3.6000000000000001 110.579 168.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 13.6 t -134.92 -171.08 2.7 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.179 0.992 . . . . 2.0899999999999999 110.724 -176.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -66.57 160.01 26.2 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.19 1.796 . . . . 6.5700000000000003 113.123 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . 0.251 . . 80.36 117.72 0.06 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 129.569 3.148 . . . . 5.0099999999999998 115.514 -173.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -137.22 158.29 72.74 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 128.073 2.549 . . . . 11.19 110.858 174.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -60.95 157.4 38.91 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.526 2.817 . . . . 9.0099999999999998 112.58 175.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -87.26 -1.09 57.66 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.328 1.603 . . . . 11.140000000000001 115.328 173.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.416 ' N ' HD13 ' A' ' 191' ' ' ILE . 0.1 OUTLIER -140.84 45.16 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.391 1.877 . . . . 12.91 111.763 -169.584 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 53.8 mt -70.83 77.72 0.62 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.234 1.413 . . . . 14.289999999999999 112.167 174.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 CA--C 1.539 0.539 0 C-N-CA 126.251 1.82 . . . . 16.539999999999999 113.536 178.714 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 109.936 -0.394 . . . . 27.640000000000001 109.936 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 59.62 179.87 0.09 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.92 1.688 . . . . 26.469999999999999 115.538 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.3 m -101.09 145.63 28.5 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 127.01 2.124 . . . . 21.66 110.955 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -107.2 -12.01 15.47 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.27 1.428 . . . . 17.699999999999999 114.828 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.4 m 55.44 21.03 4.01 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.114 1.766 . . . . 17.649999999999999 115.58 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.03 158.26 16.14 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.468 1.507 . . . . 12.529999999999999 112.954 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.09 -179.99 5.67 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.119 1.367 . . . . 9.0199999999999996 113.299 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -72.33 22.49 0.06 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 127.022 2.129 . . . . 8.3599999999999994 114.213 176.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 29' ' ' ALA . 5.8 p -153.0 146.24 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 127.472 2.309 . . . . 6.9199999999999999 108.575 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -129.58 22.05 5.52 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.906 1.076 . . . . 3.46 113.906 175.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.432 ' H ' HG22 ' A' ' 27' ' ' VAL . . . 62.47 -32.86 0.1 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 128.944 2.898 . . . . 4.1600000000000001 117.796 177.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.15 36.01 21.3 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 120.147 1.339 . . . . 4.9800000000000004 114.356 -178.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.11 23.92 4.28 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 127.037 2.256 . . . . 1.98 115.876 -173.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 38.9 p -126.42 174.8 8.34 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.256 1.822 . . . . 1.1499999999999999 112.161 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.6 p -98.5 -16.77 19.05 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.356 0.872 . . . . 1.5700000000000001 113.356 174.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.8 t -144.92 167.55 22.37 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.022 1.729 . . . . 1.8200000000000001 110.002 169.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.4 p -112.68 5.49 17.74 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.614 1.966 . . . . 0.84999999999999998 114.416 -169.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.8 p -138.57 162.58 34.21 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.114 1.153 . . . . 2.6200000000000001 114.114 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.67 146.7 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 126.516 1.926 . . . . 0.53000000000000003 109.408 169.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -125.12 114.2 18.72 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.591 1.156 . . . . 1.4399999999999999 110.401 -171.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.28 129.87 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 120.886 -1.134 . . . . 0.51000000000000001 111.312 -175.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -128.92 101.9 6.28 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.092 1.357 . . . . 1.78 111.157 -172.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.23 123.66 24.95 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.654 -1.279 . . . . 1.6000000000000001 111.548 -173.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.9 mt -106.04 156.42 18.41 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.129 1.372 . . . . 0.56000000000000005 112.681 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.64 161.89 37.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.313 1.845 . . . . 1.6799999999999999 109.912 175.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.8 162.14 13.27 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.682 0.793 . . . . 0.80000000000000004 111.852 169.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.3 p -86.76 -27.48 23.59 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.252 0.834 . . . . 0.95999999999999996 113.252 176.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -146.67 46.77 1.19 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.482 1.113 . . . . 3.1299999999999999 113.025 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.0 7.19 88.19 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 125.186 1.374 . . . . 0.93999999999999995 116.053 175.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.04 18.92 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 128.145 2.578 . . . . 1.8799999999999999 115.731 -174.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -59.91 -31.51 69.9 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.497 -1.377 . . . . 0.68999999999999995 112.315 -177.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.58 -52.84 63.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.75 1.62 . . . . 2.4399999999999999 112.548 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -71.71 -39.62 70.02 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-O 118.033 -0.984 . . . . 2.0699999999999998 111.583 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.2 mt -51.59 -55.04 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 119.266 0.939 . . . . 0.57999999999999996 110.34 168.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.73 -32.01 71.29 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.643 1.11 . . . . 0.94999999999999996 113.137 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -69.69 -27.26 64.86 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.786 1.032 . . . . 1.1599999999999999 113.786 172.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -73.77 -28.71 61.8 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.764 0.711 . . . . 2.1299999999999999 111.419 168.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.0 mt -85.1 -34.97 22.08 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.113 -0.992 . . . . 1.0600000000000001 113.292 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -71.3 -25.47 62.44 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.236 0.828 . . . . 3.1600000000000001 113.236 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.4 t -84.17 -24.13 30.3 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.274 1.03 . . . . 1.8 113.633 177.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.69 171.69 55.15 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.39 0.995 . . . . 1.0900000000000001 113.233 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -85.35 34.01 0.57 Allowed 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.959 -1.319 . . . . 1.8600000000000001 113.116 171.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -77.53 4.72 10.5 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 120.253 -1.529 . . . . 2.0800000000000001 113.385 -170.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.56 -10.82 60.2 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.035 -1.041 . . . . 1.6000000000000001 113.12 168.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.05 -74.07 0.26 Allowed Glycine 0 N--CA 1.474 1.178 0 CA-C-N 119.713 1.142 . . . . 1.1699999999999999 113.033 169.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -68.73 159.35 32.41 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.158 1.383 . . . . 1.96 113.052 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -61.18 155.99 19.45 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.749 1.22 . . . . 2.27 113.199 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.4 HG23 ' CD2' ' A' ' 181' ' ' TYR . 55.2 t -56.83 117.95 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 109.077 -0.712 . . . . 0.77000000000000002 109.077 172.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.77 -41.62 73.27 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.052 0.358 . . . . 0.88 112.908 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.1 t -138.51 123.95 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.29 1.036 . . . . 2.2000000000000002 111.165 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt -92.46 144.14 28.36 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.069 1.348 . . . . 0.87 110.544 168.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.19 159.32 37.12 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.949 2.433 . . . . 0.71999999999999997 112.0 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.84 -26.13 68.61 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.365 -0.835 . . . . 1.1799999999999999 112.86 172.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.99 3.65 22.25 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.398 1.629 . . . . 1.4299999999999999 115.398 172.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.68 153.98 20.04 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.823 1.249 . . . . 0.72999999999999998 113.577 170.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -143.89 160.69 40.35 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.562 1.545 . . . . 1.8100000000000001 111.641 169.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.96 139.54 50.04 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.268 1.027 . . . . 2.5899999999999999 110.414 -174.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 20.2 pt -133.48 147.23 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 116.396 1.999 . . . . 1.1299999999999999 116.396 -169.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.81 167.66 12.3 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.446 1.898 . . . . 0.96999999999999997 110.14 167.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.99 17.78 62.43 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 116.242 1.257 . . . . 0.64000000000000001 116.242 168.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.2 p -118.42 138.21 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.271 1.428 . . . . 0.66000000000000003 110.832 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 8.9 tpp -96.84 134.91 39.54 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.14 1.376 . . . . 0.52000000000000002 113.584 -177.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.44 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.8 OUTLIER -137.12 148.49 46.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.332 1.453 . . . . 2.0299999999999998 112.002 174.359 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.7 m -121.48 144.28 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.769 2.027 . . . . 0.34999999999999998 109.766 -175.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -88.23 148.39 24.38 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 122.648 1.213 . . . . 0.41999999999999998 112.754 171.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.9 p -143.93 172.79 12.38 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.848 2.059 . . . . 0.40999999999999998 112.217 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -94.61 169.31 10.27 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.453 1.501 . . . . 1.6000000000000001 112.242 168.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 67.9 p -62.66 -25.21 68.02 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.818 0.847 . . . . 1.45 112.702 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -74.78 7.31 3.19 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.686 1.594 . . . . 1.8200000000000001 113.383 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . 0.252 0.3 OUTLIER 63.18 26.38 15.22 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.744 2.418 . . . . 0.64000000000000001 114.291 179.217 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -88.77 145.04 25.85 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.655 1.582 . . . . 2.1000000000000001 111.631 175.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.7 mt -80.83 128.72 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.342 0.657 . . . . 0.42999999999999999 111.087 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.515 HG22 HG22 ' A' ' 97' ' ' THR . 2.2 pp -121.44 149.35 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 115.045 1.498 . . . . 0.95999999999999996 115.045 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -79.64 161.71 25.71 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 127.873 2.469 . . . . 2.3700000000000001 110.598 169.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -58.39 -22.61 54.45 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.315 1.228 . . . . 2.2999999999999998 114.315 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -90.52 3.71 53.21 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.306 1.043 . . . . 3.6200000000000001 111.955 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.59 20.93 75.98 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 127.234 2.349 . . . . 0.5 115.471 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -75.25 137.39 41.18 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.074 -1.084 . . . . 3.0699999999999998 108.074 167.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.515 HG22 HG22 ' A' ' 91' ' ' ILE . 17.6 p -93.74 135.17 35.31 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.945 0.898 . . . . 0.69999999999999996 111.414 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.69 -4.84 59.27 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.954 1.094 . . . . 0.59999999999999998 113.954 -168.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.02 25.96 56.65 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.265 0.936 . . . . 0.63 113.779 -176.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.8 t -130.36 146.7 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.886 1.674 . . . . 1.05 109.471 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -124.22 165.2 18.02 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.94 2.096 . . . . 3.8599999999999999 111.183 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.7 mt -134.87 140.78 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.887 1.275 . . . . 0.52000000000000002 109.841 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -76.31 137.91 68.02 Favored Pre-proline 0 CA--C 1.545 0.784 0 O-C-N 120.742 -1.224 . . . . 1.78 112.313 173.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.49 -11.46 20.61 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.061 1.841 . . . . 0.91000000000000003 113.854 174.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -99.48 -53.79 3.11 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.945 1.698 . . . . 2.0 111.102 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 p -80.48 -25.38 38.87 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.859 0.864 . . . . 0.77000000000000002 113.027 -174.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 59.13 15.89 4.43 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.771 1.629 . . . . 1.6799999999999999 113.9 -172.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.51 152.0 19.45 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.21 1.004 . . . . 2.6099999999999999 111.79 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.6 mt -78.56 145.21 34.95 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.682 1.593 . . . . 0.92000000000000004 112.648 -174.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.1 p -72.25 -8.19 53.46 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.665 0.987 . . . . 1.3400000000000001 113.665 173.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -171.9 -152.11 8.23 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.213 1.863 . . . . 0.87 111.848 -171.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.91 148.86 26.03 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.809 0.844 . . . . 0.93000000000000005 113.024 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.6 tpt -52.96 128.69 47.38 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.945 1.698 . . . . 1.3500000000000001 111.867 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.48 161.32 28.39 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.809 3.006 . . . . 0.87 114.441 -174.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.28 -61.79 1.89 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.272 1.829 . . . . 1.1100000000000001 114.105 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.1 p -105.88 10.79 32.37 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.855 1.262 . . . . 0.71999999999999997 114.266 -169.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.2 145.73 16.73 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.965 -1.084 . . . . 0.44 113.002 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.3 tpt -74.38 94.62 2.58 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.846 2.059 . . . . 1.53 110.574 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -148.71 140.15 23.4 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.462 1.105 . . . . 0.94999999999999996 113.454 -169.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -160.04 160.96 33.82 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.482 1.113 . . . . 1.78 111.842 -175.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.4 mp -103.04 149.52 24.49 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.804 1.242 . . . . 0.47999999999999998 112.214 173.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.44 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 1.9 p -66.83 132.05 47.2 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.759 -0.588 . . . . 0.54000000000000004 109.997 171.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.84 -61.13 1.95 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.646 1.178 . . . . 2.4700000000000002 113.79 -170.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -146.63 -34.43 0.28 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.999 1.319 . . . . 1.23 111.37 176.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -126.31 -17.97 5.05 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.524 1.305 . . . . 4.1699999999999999 114.524 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 179.61 -166.28 35.45 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.57 1.081 . . . . 0.59999999999999998 111.894 -172.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -145.25 134.32 22.67 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.869 1.668 . . . . 0.5 111.891 169.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -87.43 138.17 31.7 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.96 1.304 . . . . 1.53 112.858 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -128.51 130.02 46.88 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.162 2.185 . . . . 1.75 107.716 171.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -91.49 101.99 14.65 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.953 -1.092 . . . . 2.02 110.489 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.1 p -82.47 -0.54 46.86 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.118 1.367 . . . . 0.65000000000000002 113.727 -172.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -55.48 -32.0 62.47 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.766 0.826 . . . . 0.88 112.987 172.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -83.66 -20.86 32.84 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.006 0.922 . . . . 1.9299999999999999 112.682 -173.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.44 145.34 82.36 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 123.811 0.844 . . . . 0.68000000000000005 113.009 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -74.49 168.45 24.79 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.658 2.239 . . . . 0.89000000000000001 110.938 167.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.49 91.97 1.08 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.926 1.29 . . . . 1.0900000000000001 110.359 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -149.51 175.17 11.74 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.884 0.85 . . . . 0.77000000000000002 113.169 -174.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -94.15 147.19 23.4 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.385 1.874 . . . . 3.5499999999999998 109.347 169.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -143.9 170.12 16.51 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.651 1.581 . . . . 0.55000000000000004 110.438 -169.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.2 mttt -137.68 159.78 41.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.193 0.997 . . . . 2.0800000000000001 113.127 171.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.7 mp -118.56 142.2 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.02 1.328 . . . . 0.46999999999999997 109.899 172.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -129.58 147.21 51.36 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.435 1.894 . . . . 1.8999999999999999 110.495 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -109.16 124.26 50.54 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.637 1.175 . . . . 1.8700000000000001 111.26 -175.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 29.9 mm -128.09 98.96 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.921 0.888 . . . . 0.75 109.83 -169.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -73.12 4.32 4.54 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 115.064 1.505 . . . . 4.5300000000000002 115.064 -172.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.4 m -57.99 -31.26 66.75 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.548 -1.345 . . . . 1.75 112.406 172.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.85 120.47 42.6 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.888 1.275 . . . . 3.3300000000000001 108.181 168.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 33.3 t -154.3 146.24 23.53 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.02 0.748 . . . . 5.4299999999999997 113.02 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 26.0 m -127.46 4.77 6.23 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.755 2.422 . . . . 6.1600000000000001 111.08 171.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.63 86.79 2.18 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.663 1.585 . . . . 6.8899999999999997 108.657 171.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.21 129.92 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.501 -0.749 . . . . 4.0800000000000001 109.541 172.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -122.73 -3.36 9.23 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.715 1.626 . . . . 3.3700000000000001 113.582 -175.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -112.15 34.98 3.95 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.024 1.73 . . . . 5.5700000000000003 113.726 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -138.32 3.66 2.38 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 115.179 1.548 . . . . 6.6900000000000004 115.179 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 110.81 15.17 11.23 Favored Glycine 0 N--CA 1.482 1.715 0 O-C-N 120.72 -1.237 . . . . 4.1799999999999997 114.867 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -72.75 -178.21 2.61 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.644 1.978 . . . . 3.0 113.665 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 16.0 p -66.79 -21.88 66.03 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.28 1.032 . . . . 4.7999999999999998 112.845 168.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.19 169.0 14.27 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 120.917 -1.115 . . . . 2.71 113.01 169.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 12.2 t -118.05 154.35 32.18 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.052 1.341 . . . . 3.2200000000000002 112.169 168.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -81.31 21.33 6.13 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 126.193 1.854 . . . . 2.04 117.328 -171.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 68.4 m -64.71 159.01 23.15 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.897 1.848 . . . . 2.6899999999999999 114.104 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.416 ' H ' ' HB3' ' A' ' 186' ' ' GLU . 0.5 OUTLIER -94.65 119.55 33.47 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.614 1.565 . . . . 2.27 113.121 -168.663 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.36 150.31 47.46 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.016 1.327 . . . . 0.81999999999999995 113.323 174.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.51 153.71 52.07 Favored Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 124.515 1.126 . . . . 0.64000000000000001 111.604 -178.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.15 130.26 12.96 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.879 2.386 . . . . 0.73999999999999999 114.08 -166.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.447 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.6 mp -94.12 130.35 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 125.677 1.591 . . . . 1.47 109.259 -173.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.6 129.88 54.95 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.716 1.206 . . . . 4.96 112.129 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.2 tt -137.73 156.45 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.206 1.402 . . . . 0.53000000000000003 111.038 -169.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -139.89 148.91 42.72 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.794 1.238 . . . . 1.8899999999999999 109.871 170.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 12.4 mt -62.68 153.67 77.54 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 116.152 1.908 . . . . 1.0700000000000001 116.152 -168.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.1 116.73 4.82 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.84 2.36 . . . . 0.75 113.258 -170.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.6 tp -123.41 34.17 5.17 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.023 1.729 . . . . 2.2599999999999998 111.061 166.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -116.44 157.53 24.99 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 128.499 2.719 . . . . 2.6800000000000002 111.487 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.47 30.98 0.18 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.324 1.85 . . . . 4.1299999999999999 114.445 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 30.2 m -93.81 155.09 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.287 1.435 . . . . 1.8300000000000001 112.319 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 54.8 t -74.34 -35.95 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.185 0.994 . . . . 2.25 110.137 173.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -152.26 146.72 25.63 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.46 1.504 . . . . 3.4399999999999999 110.643 -174.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -98.75 156.7 16.71 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.036 0.934 . . . . 0.52000000000000002 112.304 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -136.71 162.02 34.32 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.04 1.496 . . . . 0.60999999999999999 115.04 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.64 144.65 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 127.225 2.21 . . . . 0.45000000000000001 110.815 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.4 ' CD2' HG23 ' A' ' 66' ' ' VAL . 97.1 m-85 -134.94 76.48 58.88 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 113.96 1.096 . . . . 2.0 113.96 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.447 ' HB3' HD11 ' A' ' 166' ' ' ILE . 13.5 Cg_endo -65.87 146.38 82.95 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.011 3.141 . . . . 0.62 114.468 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -140.0 167.27 22.5 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 128.699 2.8 . . . . 1.9399999999999999 111.952 -169.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -117.51 167.03 11.66 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.656 1.354 . . . . 3.25 114.656 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 10.8 t -149.84 -33.01 0.19 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.504 1.668 . . . . 2.2000000000000002 115.504 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.416 ' HB3' ' H ' ' A' ' 162' ' ' LYS . 12.2 pt-20 46.48 27.57 0.63 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 115.72 1.748 . . . . 6.6399999999999997 115.72 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.74 152.49 44.57 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.974 1.472 . . . . 7.2300000000000004 114.974 -168.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -70.66 154.4 94.37 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 123.952 0.901 . . . . 12.59 113.058 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -66.99 170.47 12.9 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.209 2.606 . . . . 14.619999999999999 114.139 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -131.08 -8.82 3.85 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.182 1.393 . . . . 21.07 114.611 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.44 -32.22 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 126.322 1.849 . . . . 23.949999999999999 113.138 176.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 48.31 81.89 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.174 2.59 . . . . 21.359999999999999 113.867 -176.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 CA--C 1.545 0.752 0 C-N-CA 128.51 2.724 . . . . 24.77 114.187 -169.99 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 34.7 mtt . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 110.202 -0.296 . . . . 27.690000000000001 110.202 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.34 152.04 42.51 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.743 1.386 . . . . 27.149999999999999 114.743 -169.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.3 t -153.18 156.74 39.15 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.195 1.398 . . . . 21.350000000000001 113.342 174.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.03 172.66 8.68 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 115.098 1.518 . . . . 18.140000000000001 115.098 -170.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.3 p -72.88 -5.5 38.74 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 116.578 2.066 . . . . 18.16 116.578 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.99 170.79 16.14 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.413 1.485 . . . . 13.69 113.914 -174.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.79 -114.94 0.05 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.427 1.491 . . . . 10.01 110.694 171.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.9 t -148.1 123.19 10.13 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.358 -0.839 . . . . 8.6699999999999999 112.959 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 p -135.04 136.8 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 125.831 1.652 . . . . 7.4100000000000001 111.421 170.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -138.91 178.03 7.45 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.109 2.164 . . . . 3.5499999999999998 109.458 169.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -135.23 148.28 49.56 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.69 1.196 . . . . 4.1299999999999999 113.05 -172.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.74 57.09 1.57 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.574 1.949 . . . . 5.8899999999999997 111.355 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.02 42.72 1.38 Allowed Glycine 0 CA--C 1.536 1.346 0 C-N-CA 126.508 2.004 . . . . 2.2999999999999998 112.556 169.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.4 p -129.9 168.98 15.8 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.124 2.169 . . . . 1.5600000000000001 111.488 -171.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 65.8 p -82.81 -10.32 58.92 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 113.966 1.098 . . . . 1.8200000000000001 113.966 176.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 t -151.89 163.17 39.81 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.705 2.002 . . . . 2.5499999999999998 110.032 174.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.7 p -92.76 5.11 52.33 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.086 1.755 . . . . 1.1399999999999999 114.252 176.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.402 ' HA ' ' H ' ' A' ' 131' ' ' THR . 54.9 p -151.26 164.86 35.66 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.23 1.196 . . . . 1.72 114.23 -175.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.5 p -131.21 143.5 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.486 1.915 . . . . 0.38 109.964 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.7 m -110.74 112.62 24.61 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.676 0.79 . . . . 0.68999999999999995 111.411 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -93.11 132.9 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.004 -1.06 . . . . 0.58999999999999997 110.432 176.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -115.73 -173.93 2.43 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.69 1.596 . . . . 1.74 110.998 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -140.26 129.98 24.41 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 120.929 -1.107 . . . . 1.3400000000000001 111.439 168.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.4 mt -111.84 146.06 38.34 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.749 1.219 . . . . 0.85999999999999999 110.835 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.9 168.29 19.6 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.341 1.856 . . . . 1.6299999999999999 111.186 176.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.57 145.58 40.08 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.788 1.235 . . . . 0.72999999999999998 112.281 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.0 p -80.92 -32.54 34.62 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.318 1.229 . . . . 1.1499999999999999 114.318 -173.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -114.45 -15.55 12.05 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 119.882 1.219 . . . . 2.3700000000000001 113.295 175.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.68 11.08 1.95 Allowed Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.478 1.513 . . . . 1.1599999999999999 115.413 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.66 24.23 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 130.175 3.39 . . . . 1.8400000000000001 116.738 -169.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.94 -31.92 73.11 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 119.6 -1.937 . . . . 0.77000000000000002 114.022 -174.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -71.3 -43.79 66.44 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.114 0.87 . . . . 2.52 111.727 -175.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt -72.44 -38.85 68.19 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.267 -0.896 . . . . 4.0999999999999996 111.939 175.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.6 mt -52.68 -48.17 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 119.471 1.032 . . . . 0.66000000000000003 109.956 167.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.1 -34.83 75.57 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 121.092 -1.005 . . . . 0.93000000000000005 113.453 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -65.33 -39.28 92.22 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.794 0.838 . . . . 1.5700000000000001 112.069 171.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.15 -23.82 64.92 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.972 -1.08 . . . . 2.6800000000000002 112.841 177.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.1 mt -91.28 -32.24 15.8 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.315 1.228 . . . . 1.1799999999999999 114.315 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -70.61 -20.59 62.74 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.065 1.135 . . . . 2.96 114.065 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.7 t -78.86 -21.26 47.79 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.986 0.914 . . . . 1.5800000000000001 113.375 169.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.55 172.32 53.44 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.544 1.068 . . . . 1.3200000000000001 112.909 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -94.74 21.57 7.3 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.036 -1.273 . . . . 2.0099999999999998 112.348 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -70.87 18.05 0.06 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.421 1.488 . . . . 2.23 114.962 -170.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.98 -23.15 55.3 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 120.814 -1.179 . . . . 1.21 110.249 166.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -114.86 -57.35 0.36 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.52 1.057 . . . . 0.92000000000000004 113.684 172.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -81.68 162.81 22.87 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.952 1.301 . . . . 3.1499999999999999 113.381 -172.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -63.54 151.94 40.01 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.056 0.762 . . . . 2.3999999999999999 113.056 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 71.7 t -66.32 120.48 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 122.844 0.458 . . . . 0.81999999999999995 109.895 172.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.59 -37.9 33.89 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 114.83 0.692 . . . . 1.1000000000000001 114.83 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.6 t -142.61 116.59 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 118.387 1.093 . . . . 2.3700000000000001 111.041 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.8 mt -83.23 144.36 46.75 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.842 1.257 . . . . 1.0700000000000001 111.621 170.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.09 161.46 38.48 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.914 2.409 . . . . 0.89000000000000001 112.371 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.2 -8.84 42.4 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.039 1.126 . . . . 1.29 114.039 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.2 p30 -98.87 -3.92 34.24 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.548 1.539 . . . . 1.74 114.496 171.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.22 158.83 17.02 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.778 1.029 . . . . 0.71999999999999997 113.778 174.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.9 pttt -150.38 169.04 22.37 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.809 1.643 . . . . 2.25 111.741 167.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -124.37 130.62 52.82 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.013 1.325 . . . . 2.6299999999999999 112.146 -174.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.417 HG21 HD21 ' A' ' 158' ' ' LEU . 39.0 pt -121.81 151.46 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.075 0.95 . . . . 0.92000000000000004 113.397 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.98 156.02 29.27 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.263 1.425 . . . . 0.90000000000000002 111.97 171.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.57 12.93 42.8 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.09 1.328 . . . . 0.71999999999999997 115.654 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 p -86.02 148.12 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 119.228 1.514 . . . . 0.92000000000000004 110.679 169.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -105.64 137.75 42.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.483 1.513 . . . . 0.52000000000000002 112.565 176.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.67 157.79 44.31 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.097 1.359 . . . . 1.6299999999999999 112.441 173.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 m -125.62 147.35 30.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 126.771 2.028 . . . . 0.33000000000000002 110.083 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -89.91 149.08 22.77 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.397 1.079 . . . . 0.34999999999999998 112.975 171.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.7 p -144.8 167.71 21.94 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.409 1.884 . . . . 0.34000000000000002 112.618 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -90.83 171.54 9.25 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.199 1.0 . . . . 2.2200000000000002 112.074 167.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 66.9 p -61.04 -23.53 65.5 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.154 -0.966 . . . . 1.3600000000000001 113.577 -177.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -70.86 4.83 2.29 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 126.222 1.809 . . . . 2.8700000000000001 114.003 169.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.26 27.79 14.2 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.916 2.087 . . . . 0.66000000000000003 112.964 -172.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -86.01 138.61 31.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.458 1.503 . . . . 2.5299999999999998 110.414 177.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.3 mt -81.2 129.33 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.139 0.495 . . . . 0.65000000000000002 110.164 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.478 HG22 HG22 ' A' ' 97' ' ' THR . 6.2 pt -123.86 154.27 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 114.567 1.321 . . . . 0.56000000000000005 114.567 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -84.84 159.44 20.39 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.972 2.109 . . . . 1.49 108.37 166.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -62.8 -8.69 7.34 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.862 1.801 . . . . 2.29 115.862 -172.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -91.31 -1.22 57.7 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.556 1.143 . . . . 3.4500000000000002 112.706 172.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.34 3.72 84.27 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.65 1.595 . . . . 0.48999999999999999 114.476 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -68.14 140.38 56.17 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.813 1.245 . . . . 2.6000000000000001 109.1 173.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.478 HG22 HG22 ' A' ' 91' ' ' ILE . 16.2 p -103.56 146.07 29.1 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.594 0.758 . . . . 0.66000000000000003 112.077 -173.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.62 -11.02 25.84 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.983 0.734 . . . . 0.80000000000000004 112.983 -169.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.74 21.91 48.67 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.706 1.146 . . . . 1.0600000000000001 114.616 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.3 p -138.57 146.19 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.626 1.57 . . . . 2.6000000000000001 110.262 -173.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -127.89 155.04 44.8 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 128.087 2.555 . . . . 1.45 111.364 -172.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 61.4 mt -126.96 142.85 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.97 1.308 . . . . 0.60999999999999999 110.849 -174.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -76.23 132.69 72.86 Favored Pre-proline 0 CA--C 1.54 0.565 0 O-C-N 120.611 -1.306 . . . . 2.3999999999999999 110.57 170.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -70.09 -8.46 23.67 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.074 1.849 . . . . 1.02 114.819 174.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -106.98 -47.55 3.68 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.06 1.344 . . . . 1.6200000000000001 112.346 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.7 p -87.86 -23.16 24.07 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.131 0.972 . . . . 0.93000000000000005 113.331 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 55.52 17.07 2.09 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.896 1.678 . . . . 1.75 114.146 -169.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.64 156.46 20.68 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.909 -1.119 . . . . 2.3700000000000001 111.387 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 mt -98.1 146.44 25.55 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.701 1.2 . . . . 0.92000000000000004 112.623 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 90.7 p -73.1 3.3 5.69 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.204 1.002 . . . . 1.26 113.475 171.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.55 -157.75 16.03 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.689 2.09 . . . . 1.0900000000000001 111.306 -172.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.02 155.27 27.69 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 117.96 0.88 . . . . 1.0700000000000001 112.159 174.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.63 131.66 88.53 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.796 0.838 . . . . 1.8 110.701 175.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.18 156.26 46.76 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 125.197 3.931 . . . . 1.1599999999999999 115.634 -172.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.29 -62.67 1.28 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.745 1.618 . . . . 1.23 114.383 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.8 p -102.26 5.9 40.29 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.804 1.409 . . . . 1.21 114.804 -168.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.85 149.86 10.78 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.0 1.111 . . . . 0.65000000000000002 114.0 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.1 ttt -76.62 90.74 3.37 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.031 1.732 . . . . 1.74 111.629 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -141.81 144.62 34.02 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.552 1.541 . . . . 1.3400000000000001 111.97 -173.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -166.47 156.73 12.1 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 126.337 1.855 . . . . 1.97 111.028 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.9 mp -97.49 148.8 22.86 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.168 1.173 . . . . 0.51000000000000001 114.168 174.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.7 p -64.45 124.6 22.23 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 121.354 -0.841 . . . . 0.58999999999999997 111.34 170.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -80.41 -57.6 3.52 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.373 -0.83 . . . . 2.2000000000000002 112.457 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -173.06 -51.37 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.727 2.811 . . . . 1.8899999999999999 107.963 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -74.18 20.9 0.1 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.121 2.168 . . . . 6.1500000000000004 113.962 173.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.04 -152.31 31.21 Favored Glycine 0 CA--C 1.538 1.53 0 N-CA-C 110.526 -1.03 . . . . 0.77000000000000002 110.526 -165.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -135.33 130.93 35.79 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.587 1.955 . . . . 0.39000000000000001 109.625 169.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -93.82 139.69 30.56 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.479 0.711 . . . . 1.6000000000000001 112.87 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -125.56 124.59 41.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.171 2.589 . . . . 1.6899999999999999 107.893 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -85.58 100.11 11.72 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.423 -0.798 . . . . 1.6699999999999999 110.074 -174.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.402 ' H ' ' HA ' ' A' ' 36' ' ' SER . 73.1 p -78.66 -6.68 56.37 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.139 -0.975 . . . . 0.64000000000000001 113.48 -175.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -51.25 -27.1 8.32 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.568 1.147 . . . . 0.90000000000000002 113.459 175.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -92.98 -10.39 36.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.641 1.576 . . . . 1.8300000000000001 113.697 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -89.59 148.42 40.14 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 120.182 1.356 . . . . 0.76000000000000001 114.163 170.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.18 170.18 13.74 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.937 3.092 . . . . 0.78000000000000003 112.293 168.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.56 63.91 2.14 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.958 2.103 . . . . 1.53 114.397 -170.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -125.54 178.33 5.71 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.756 1.622 . . . . 0.79000000000000004 112.941 -175.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -87.58 151.66 22.81 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.271 1.428 . . . . 2.5499999999999998 110.807 168.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -145.39 171.37 14.72 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.666 1.987 . . . . 0.51000000000000001 109.253 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -137.83 148.31 45.35 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.725 0.81 . . . . 1.8899999999999999 112.648 170.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.4 mp -105.44 138.28 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.247 1.019 . . . . 0.34999999999999998 109.747 171.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -123.65 131.58 53.65 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.405 1.882 . . . . 1.8999999999999999 110.25 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -95.36 104.51 16.41 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.777 0.831 . . . . 2.2599999999999998 110.635 -173.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 38.9 mm -113.0 94.5 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.998 0.919 . . . . 0.65000000000000002 109.611 -169.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -84.45 12.54 6.7 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.537 0.94 . . . . 4.3899999999999997 113.537 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.0 m -68.58 -21.54 64.52 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.021 1.119 . . . . 2.0600000000000001 114.021 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.0 mp -92.12 163.05 14.09 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.223 1.009 . . . . 2.46 111.329 173.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 54.0 m -52.65 117.56 2.99 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.648 1.579 . . . . 5.8799999999999999 111.485 -178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.1 t -140.64 170.01 16.58 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.257 1.823 . . . . 5.0199999999999996 112.119 -167.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -66.22 112.58 4.02 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.446 1.098 . . . . 7.6299999999999999 109.608 169.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.5 p -76.59 130.53 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 121.583 -0.698 . . . . 3.6899999999999999 110.719 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -115.27 -20.56 5.5 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.531 1.062 . . . . 2.1499999999999999 113.901 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -82.61 -16.36 48.69 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.033 1.494 . . . . 4.4900000000000002 115.033 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -97.72 24.49 6.74 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 116.414 2.005 . . . . 5.5099999999999998 116.414 -164.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 109.29 9.06 26.27 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.09 1.329 . . . . 3.8599999999999999 115.003 -178.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -93.44 168.36 11.11 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.754 1.621 . . . . 2.8799999999999999 112.542 174.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.6 m -79.63 44.55 0.63 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.027 1.731 . . . . 3.4100000000000001 113.202 -172.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.417 HD21 HG21 ' A' ' 76' ' ' ILE . 15.4 mt -130.86 164.7 24.66 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.678 1.591 . . . . 1.78 113.241 -170.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.8 t -95.36 -35.75 11.64 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.371 1.468 . . . . 3.2200000000000002 112.663 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.92 -16.63 0.8 Allowed Glycine 0 CA--C 1.541 1.678 0 C-N-CA 126.307 1.908 . . . . 3.29 115.164 -174.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 36.6 m -56.21 159.48 3.46 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.134 2.573 . . . . 3.2200000000000002 116.127 -169.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.61 114.99 1.73 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.003 2.121 . . . . 1.95 114.032 -169.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.41 166.59 22.92 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.568 1.547 . . . . 0.89000000000000001 111.808 169.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.44 144.97 54.53 Favored Pre-proline 0 N--CA 1.483 1.211 0 O-C-N 120.541 -1.349 . . . . 0.57999999999999996 112.224 176.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.08 151.88 61.94 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.584 3.522 . . . . 0.56000000000000005 114.255 -167.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.549 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.1 mp -114.19 125.68 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.742 1.217 . . . . 1.1599999999999999 111.139 -169.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -86.78 136.22 33.07 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.006 1.322 . . . . 3.0299999999999998 111.578 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.7 tt -144.78 150.14 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 125.227 1.411 . . . . 0.56000000000000005 111.741 -177.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -127.0 149.25 49.98 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.87 1.268 . . . . 2.2599999999999998 110.031 169.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 13.3 mt -61.44 142.56 93.86 Favored Pre-proline 0 CA--C 1.548 0.868 0 O-C-N 120.778 -1.201 . . . . 1.1699999999999999 112.771 -176.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -71.54 99.29 0.92 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.961 3.108 . . . . 0.90000000000000002 114.273 -167.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 1.2 tt -116.58 39.42 3.16 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.14 1.776 . . . . 2.3199999999999998 108.053 167.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -104.93 172.72 6.64 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.552 2.341 . . . . 3.46 111.378 -168.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -76.35 40.17 0.21 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.098 0.959 . . . . 3.8700000000000001 113.561 169.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.7 m -121.24 144.54 29.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.106 1.362 . . . . 1.1899999999999999 112.699 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.9 p -64.87 -45.4 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.937 2.095 . . . . 3.77 113.375 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -156.22 156.77 34.69 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.686 1.995 . . . . 2.98 110.956 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -103.6 146.63 28.28 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.815 1.413 . . . . 0.40999999999999998 114.815 -168.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -135.44 168.52 19.07 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.745 1.387 . . . . 0.69999999999999996 114.745 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.5 t -137.88 139.96 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.524 1.53 . . . . 0.46000000000000002 112.027 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -131.76 86.15 49.34 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 125.688 1.595 . . . . 2.1800000000000002 112.548 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.549 ' HB3' HD11 ' A' ' 166' ' ' ILE . 30.4 Cg_endo -71.14 147.4 53.98 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.574 3.516 . . . . 0.59999999999999998 113.59 172.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -131.68 176.42 8.35 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.644 2.378 . . . . 1.48 111.386 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -111.9 174.52 5.84 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.614 1.566 . . . . 2.6000000000000001 112.121 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 4.9 t -136.83 -36.41 0.69 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.862 1.06 . . . . 2.3500000000000001 113.862 173.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -66.38 135.31 54.15 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.541 0.736 . . . . 7.4199999999999999 110.731 172.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -80.71 164.31 22.89 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.719 1.208 . . . . 6.6900000000000004 113.102 -176.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -64.25 150.32 92.85 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 114.336 1.236 . . . . 14.640000000000001 114.336 -173.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.37 159.51 49.17 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.401 2.734 . . . . 11.57 116.42 -169.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -72.18 -26.46 62.08 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.213 0.82 . . . . 14.19 113.213 168.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.419 ' H ' HD12 ' A' ' 191' ' ' ILE . 4.3 mp -73.48 -76.35 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.822 1.249 . . . . 15.949999999999999 109.556 -177.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 44.16 54.98 5.73 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.516 1.926 . . . . 17.530000000000001 113.57 169.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 116.276 1.954 . . . . 20.350000000000001 116.276 -168.308 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.9 ttt . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 119.464 -0.303 . . . . 24.469999999999999 111.061 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -63.62 -23.46 67.39 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.772 1.397 . . . . 23.940000000000001 114.772 -169.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 59.8 p -88.06 -4.76 58.74 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.567 1.321 . . . . 18.449999999999999 114.567 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 44.9 -99.75 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.788 2.035 . . . . 16.199999999999999 115.403 169.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.7 m -63.95 -11.32 27.34 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.962 1.468 . . . . 14.93 114.962 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -121.23 151.79 39.59 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.22 1.808 . . . . 11.08 111.686 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.94 165.76 26.57 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.54 1.536 . . . . 8.9499999999999993 111.197 176.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.2 t -57.14 158.79 4.86 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.356 1.062 . . . . 8.7100000000000009 113.106 175.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.7 p -84.54 139.78 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.164 -0.96 . . . . 7.3300000000000001 111.7 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -109.34 24.24 13.36 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.693 1.368 . . . . 4.1699999999999999 114.693 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.07 -27.27 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 129.932 3.293 . . . . 4.5899999999999999 118.805 169.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.0 30.06 15.49 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 127.281 2.232 . . . . 4.8899999999999997 115.877 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.68 53.76 3.29 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.38 1.467 . . . . 1.73 113.645 177.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.4 p -136.27 172.61 12.76 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.251 1.82 . . . . 1.27 113.38 -169.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.3 p -110.08 -1.12 17.7 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.659 1.984 . . . . 1.29 113.138 175.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -164.1 157.72 18.51 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.638 1.575 . . . . 1.8700000000000001 111.095 -178.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.9 p -112.78 -6.23 13.85 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.404 1.882 . . . . 0.93000000000000005 115.555 -170.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 94.4 p -148.18 166.13 28.82 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.728 2.011 . . . . 1.72 112.517 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.96 136.75 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.23 1.812 . . . . 0.44 110.343 177.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.5 m -104.69 112.33 25.37 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.366 0.603 . . . . 0.68000000000000005 110.725 176.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 p -93.19 125.84 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.723 1.209 . . . . 0.52000000000000002 109.679 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -105.19 -170.23 1.72 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.307 1.843 . . . . 1.73 110.81 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -148.72 127.53 12.59 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.246 -1.534 . . . . 1.4099999999999999 113.889 170.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.9 mt -118.59 160.56 21.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.86 1.264 . . . . 0.93000000000000005 113.181 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.7 mt -145.41 165.12 29.44 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 128.002 2.521 . . . . 1.4399999999999999 109.572 168.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.97 165.8 16.43 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.758 -0.589 . . . . 0.80000000000000004 112.224 169.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.5 p -89.12 -35.98 15.98 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.508 0.929 . . . . 1.02 113.508 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -141.77 50.38 1.56 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.614 1.166 . . . . 2.1099999999999999 111.637 174.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.2 14.68 76.27 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 116.621 1.408 . . . . 1.1299999999999999 116.621 173.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.89 15.69 0.1 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.999 2.119 . . . . 2.3999999999999999 115.633 -177.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.4 mmt -61.09 -27.81 68.63 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 119.824 -1.798 . . . . 0.77000000000000002 112.887 -177.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -66.93 -38.17 85.67 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.314 0.961 . . . . 2.1499999999999999 113.178 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -81.74 -38.69 25.3 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.605 -1.309 . . . . 2.4500000000000002 112.582 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 89.1 mt -54.46 -47.83 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 119.915 1.234 . . . . 0.68999999999999995 110.796 168.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.74 -34.96 73.63 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 120.242 -1.536 . . . . 0.92000000000000004 112.557 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -71.23 -34.83 71.16 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.321 1.048 . . . . 1.1299999999999999 112.759 172.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -62.97 -36.07 82.27 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.339 0.972 . . . . 2.0499999999999998 112.225 171.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.3 mt -82.07 -41.21 20.89 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.173 0.805 . . . . 1.1299999999999999 113.173 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -68.26 -25.68 65.3 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.527 1.058 . . . . 3.3399999999999999 113.384 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 t -78.28 -16.44 57.77 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.148 0.979 . . . . 2.0899999999999999 113.055 174.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.32 163.7 32.96 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 127.172 2.32 . . . . 1.3200000000000001 113.993 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -88.8 33.86 0.78 Allowed 'General case' 0 N--CA 1.478 0.953 0 O-C-N 120.866 -1.373 . . . . 2.3199999999999998 112.409 172.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -73.98 0.18 14.35 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.031 -1.043 . . . . 2.0699999999999998 113.466 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.94 -30.0 63.63 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.996 -1.065 . . . . 0.92000000000000004 110.815 167.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.02 -49.67 0.62 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 123.933 0.777 . . . . 0.66000000000000003 113.194 169.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -75.67 158.51 32.26 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.348 1.24 . . . . 2.4399999999999999 114.348 -169.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.18 159.88 33.14 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.559 -0.713 . . . . 3.4199999999999999 110.29 165.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.31 127.2 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 116.54 -0.3 . . . . 0.76000000000000001 110.259 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.94 -48.7 25.75 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.826 -0.546 . . . . 0.91000000000000003 113.243 -176.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.4 t -137.32 127.97 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.048 1.339 . . . . 2.0600000000000001 110.147 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.5 mt -85.57 143.7 38.95 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.731 0.813 . . . . 1.1399999999999999 110.567 169.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.85 162.6 37.14 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.219 1.946 . . . . 0.71999999999999997 111.958 172.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.36 -19.22 65.75 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.266 -0.896 . . . . 1.0800000000000001 112.682 172.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -87.12 0.06 55.89 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.662 1.585 . . . . 1.9399999999999999 115.0 174.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.81 146.4 25.97 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 114.429 1.27 . . . . 0.56999999999999995 114.429 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -130.72 149.04 52.56 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.461 2.704 . . . . 2.4900000000000002 111.614 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -123.4 137.57 54.79 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.409 1.484 . . . . 2.2599999999999998 112.684 -175.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.3 pt -141.29 149.17 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.375 1.47 . . . . 0.85999999999999999 112.136 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -108.51 169.56 8.57 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.563 1.545 . . . . 0.67000000000000004 111.698 169.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.45 20.93 55.76 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.376 0.989 . . . . 0.68000000000000005 115.53 175.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.5 p -88.09 149.52 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 118.422 1.111 . . . . 1.01 109.736 168.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -107.66 137.6 45.4 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.932 1.293 . . . . 0.54000000000000004 112.164 175.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -141.11 156.92 45.9 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.893 1.277 . . . . 1.75 112.633 172.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.5 m -122.04 147.01 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 126.874 2.07 . . . . 0.40000000000000002 109.874 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -89.09 148.18 23.83 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 122.582 1.182 . . . . 0.33000000000000002 113.12 169.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.1 p -142.6 168.56 19.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.806 2.042 . . . . 0.37 112.246 178.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -88.71 172.93 8.88 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.734 0.814 . . . . 1.8999999999999999 112.924 168.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.1 p -57.77 -27.97 63.54 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.378 1.071 . . . . 1.5 113.426 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -90.24 24.07 2.67 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.692 1.197 . . . . 2.3799999999999999 113.79 172.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.54 25.25 14.06 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.562 2.345 . . . . 0.58999999999999997 115.15 173.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -83.09 139.49 33.19 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.281 -0.887 . . . . 1.9399999999999999 109.499 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.7 mt -75.76 128.68 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 118.457 0.571 . . . . 0.56999999999999995 109.821 174.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.761 HG22 HG22 ' A' ' 97' ' ' THR . 6.4 pt -122.02 155.68 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 123.181 1.467 . . . . 0.63 114.613 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -87.01 164.44 16.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.003 1.721 . . . . 1.6599999999999999 110.234 167.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.15 2.27 1.22 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.135 1.774 . . . . 2.6499999999999999 115.351 -176.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -107.0 5.17 27.85 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.71 2.404 . . . . 3.21 113.319 169.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.48 6.32 80.39 Favored Glycine 0 CA--C 1.532 1.153 0 O-C-N 120.073 -1.642 . . . . 0.68000000000000005 114.011 -176.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -68.8 139.32 55.26 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 117.905 0.852 . . . . 2.0499999999999998 109.226 169.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.761 HG22 HG22 ' A' ' 91' ' ' ILE . 76.3 p -101.29 139.7 36.61 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.382 1.073 . . . . 0.94999999999999996 110.778 -177.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.99 -9.98 54.27 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.296 1.221 . . . . 0.93000000000000005 114.296 -168.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.48 21.62 47.34 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.897 1.237 . . . . 0.93999999999999995 113.414 -173.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.7 t -130.48 148.17 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.688 1.595 . . . . 1.25 109.512 -177.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -127.9 159.35 35.19 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.334 1.854 . . . . 4.1799999999999997 111.802 174.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 73.5 mt -131.41 127.85 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.978 1.311 . . . . 0.56999999999999995 110.658 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.61 136.74 94.88 Favored Pre-proline 0 N--CA 1.476 0.833 0 CA-C-O 117.986 -1.007 . . . . 1.8500000000000001 111.081 174.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -69.76 -20.31 35.0 Favored 'Trans proline' 0 C--N 1.352 0.756 0 CA-C-N 122.082 1.779 . . . . 0.62 112.774 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -96.42 -43.65 7.55 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.254 1.422 . . . . 1.1200000000000001 112.553 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 p -86.29 -25.33 25.53 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.099 0.96 . . . . 0.89000000000000001 112.61 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 52.65 24.42 3.14 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.34 1.456 . . . . 1.6399999999999999 113.329 -171.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.63 157.64 16.8 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.888 -1.133 . . . . 2.4100000000000001 111.578 -177.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.2 mt -94.38 146.96 23.69 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.256 1.422 . . . . 0.75 113.028 -169.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.0 p -72.07 -7.64 50.03 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.236 1.199 . . . . 1.3300000000000001 114.236 173.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.87 -158.45 10.04 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 128.165 2.793 . . . . 0.87 110.446 177.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.59 166.7 21.62 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 119.411 1.605 . . . . 1.01 112.274 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 mmt -51.16 143.3 17.13 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 125.229 1.411 . . . . 1.6799999999999999 113.882 -177.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.7 165.41 26.89 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 124.166 3.244 . . . . 0.79000000000000004 114.526 174.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.37 -52.19 6.75 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.138 1.775 . . . . 1.1299999999999999 115.001 -177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.9 p -109.18 -3.12 17.52 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.107 1.363 . . . . 0.95999999999999996 114.477 -169.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.68 151.18 2.47 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.186 1.394 . . . . 0.41999999999999998 114.069 -173.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.4 ttt -76.13 89.56 3.05 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.404 1.082 . . . . 1.79 111.139 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -146.01 123.13 11.47 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.044 1.737 . . . . 1.4199999999999999 113.896 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -164.73 145.32 7.65 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.532 1.133 . . . . 2.8399999999999999 111.221 -169.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.36 157.19 17.24 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.081 1.512 . . . . 0.47999999999999998 115.081 -171.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 80.1 p -72.97 139.52 46.76 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.34 -0.85 . . . . 0.57999999999999996 112.993 169.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.63 -54.97 3.06 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 116.152 1.908 . . . . 2.46 116.152 -169.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.09 -40.57 0.15 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.628 1.171 . . . . 1.25 110.837 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -116.17 -26.15 7.33 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.795 1.035 . . . . 3.7999999999999998 113.795 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.33 -163.31 34.74 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.62 1.105 . . . . 0.67000000000000004 110.73 -169.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -137.17 130.75 31.54 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.345 1.858 . . . . 0.40999999999999998 110.54 173.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.7 ttpt -82.02 134.98 35.4 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.36 0.527 . . . . 1.77 110.922 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -122.78 130.87 53.42 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.95 2.1 . . . . 2.0600000000000001 108.211 173.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -85.05 121.77 28.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.513 1.125 . . . . 3.2000000000000002 110.503 -176.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 46.0 p -109.38 -3.81 16.83 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.743 1.386 . . . . 0.56999999999999995 114.743 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.94 -19.69 19.43 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.385 1.474 . . . . 0.69999999999999996 114.944 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.02 -4.29 20.66 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.848 1.259 . . . . 2.3700000000000001 113.613 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.25 141.83 54.16 Favored Pre-proline 0 CA--C 1.535 0.386 0 O-C-N 121.006 -1.059 . . . . 0.63 111.233 167.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.56 168.29 24.74 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.633 2.222 . . . . 0.69999999999999996 110.928 168.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.71 91.88 0.64 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.955 1.702 . . . . 0.96999999999999997 109.697 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -147.9 -178.64 6.38 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.415 1.086 . . . . 0.73999999999999999 111.077 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -97.17 153.98 17.66 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.253 1.421 . . . . 4.6399999999999997 110.792 168.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -146.01 170.21 17.1 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.226 1.81 . . . . 0.56000000000000005 109.893 -169.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -138.89 145.98 40.56 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.354 0.872 . . . . 1.74 113.354 174.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.2 mp -104.1 135.97 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.483 1.113 . . . . 0.45000000000000001 110.075 173.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -119.86 128.02 53.27 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.101 1.761 . . . . 1.8200000000000001 110.062 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -87.85 109.89 20.1 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.678 0.791 . . . . 1.9199999999999999 110.3 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 41.5 mm -116.5 87.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.188 0.995 . . . . 0.66000000000000003 108.605 -173.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . 0.283 7.6 p80 -94.91 44.2 1.1 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.195 -0.941 . . . . 3.8199999999999998 112.492 -178.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.7 p -92.95 -21.08 20.01 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.897 1.679 . . . . 1.75 112.743 169.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.85 167.0 22.32 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.555 1.142 . . . . 2.8100000000000001 111.983 170.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 15.9 m -57.97 122.98 14.31 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.582 -0.698 . . . . 5.9199999999999999 109.56 168.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.9 p -148.91 174.56 12.12 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.96 2.104 . . . . 4.9800000000000004 111.252 -167.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -60.05 126.97 29.58 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.579 -1.326 . . . . 7.5300000000000002 111.159 173.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.4 p -80.64 125.09 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.14 0.976 . . . . 3.54 111.674 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -111.65 -12.53 14.53 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.379 0.99 . . . . 2.2000000000000002 115.024 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -100.76 18.07 20.37 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.59 1.956 . . . . 4.7599999999999998 114.618 -177.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.51 8.64 5.44 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.739 1.385 . . . . 5.1100000000000003 114.739 -171.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 132.84 -7.55 5.19 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.808 1.671 . . . . 4.2699999999999996 115.597 174.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -69.34 169.75 11.68 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.551 1.54 . . . . 3.1800000000000002 113.992 178.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.7 m -77.29 49.4 0.7 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.566 1.946 . . . . 3.54 112.514 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.9 mt -135.02 163.09 30.66 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.611 1.564 . . . . 2.1400000000000001 112.192 -170.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.6 t -140.48 -179.96 6.32 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.703 1.601 . . . . 3.7400000000000002 110.936 -175.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -76.95 48.27 2.68 Favored Glycine 0 CA--C 1.535 1.328 0 O-C-N 120.746 -1.221 . . . . 2.5600000000000001 114.134 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.7 p -74.46 158.52 33.69 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.549 1.939 . . . . 3.8199999999999998 113.934 -177.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.67 136.82 36.26 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.912 0.885 . . . . 2.2200000000000002 113.014 170.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.46 159.73 19.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.143 0.973 . . . . 0.96999999999999997 112.807 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.6 m -116.6 144.99 34.31 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 125.119 1.368 . . . . 0.75 109.549 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.18 139.69 42.9 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.445 2.097 . . . . 0.60999999999999999 112.646 -167.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 3.0 mp -105.28 129.33 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.424 1.09 . . . . 1.25 111.187 -168.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -89.17 133.61 34.34 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.475 1.51 . . . . 4.5700000000000003 112.619 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.3 tt -141.71 156.92 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 125.779 1.632 . . . . 0.67000000000000004 111.188 -175.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -132.65 152.15 51.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.531 1.532 . . . . 2.0299999999999998 109.983 173.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.63 155.98 46.89 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 113.001 0.741 . . . . 0.93999999999999995 113.001 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.26 96.88 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.086 1.857 . . . . 1.03 111.643 -169.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 28.7 tp -124.5 59.18 1.19 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 104.361 -2.459 . . . . 2.2999999999999998 104.361 166.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -139.5 151.67 46.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.283 2.633 . . . . 3.8599999999999999 109.334 -166.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -82.26 41.01 0.67 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.185 0.994 . . . . 3.3500000000000001 113.286 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.9 m -110.45 138.88 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 125.57 1.548 . . . . 1.2 111.419 -175.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.97 -46.92 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.261 1.824 . . . . 3.6899999999999999 112.281 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -153.07 152.89 31.85 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 127.336 2.255 . . . . 3.23 110.571 174.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -92.98 149.42 21.24 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.081 0.953 . . . . 0.42999999999999999 112.644 -173.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -139.28 167.26 22.48 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 115.128 1.529 . . . . 0.55000000000000004 115.128 175.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.34 139.06 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.032 1.733 . . . . 0.60999999999999999 110.644 172.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -130.8 81.09 68.32 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 126.235 1.814 . . . . 2.73 109.357 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.98 159.59 52.01 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 125.107 3.871 . . . . 0.80000000000000004 112.731 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -125.77 -157.63 0.8 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.33 1.852 . . . . 2.2999999999999998 112.582 -167.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -143.54 167.14 22.94 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 130.473 3.509 . . . . 3.3100000000000001 107.953 174.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 12.7 t -143.92 -33.89 0.4 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.244 0.831 . . . . 2.3999999999999999 113.244 174.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -130.72 137.39 49.5 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.126 1.37 . . . . 6.2199999999999998 111.177 -169.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -117.72 143.24 46.39 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.779 1.231 . . . . 6.2599999999999998 111.104 171.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -146.16 157.98 48.85 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 124.991 1.316 . . . . 9.8599999999999994 111.679 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.35 157.9 59.47 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.168 2.579 . . . . 9.1099999999999994 114.495 -172.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -65.99 -24.17 66.72 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.223 1.194 . . . . 15.789999999999999 114.223 172.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.89 -30.75 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.003 1.321 . . . . 12.949999999999999 110.953 -174.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.8 mt -89.51 78.79 7.02 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.503 1.121 . . . . 12.199999999999999 111.743 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 N--CA 1.473 0.685 0 C-N-CA 125.286 1.434 . . . . 17.41 110.569 172.531 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 15.0 mmt . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 109.264 -0.643 . . . . 31.18 109.264 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -83.27 -28.14 29.37 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.692 0.797 . . . . 32.149999999999999 112.421 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.9 p -144.5 161.7 38.41 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.734 1.613 . . . . 26.0 111.199 170.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.55 39.31 3.5 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.572 1.549 . . . . 22.379999999999999 112.56 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.5 m -79.5 126.78 31.31 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.509 1.123 . . . . 20.260000000000002 111.647 -173.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -150.4 -171.56 3.95 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.917 0.887 . . . . 16.41 112.83 -168.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.93 176.02 9.91 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.17 1.788 . . . . 14.279999999999999 114.073 171.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -69.92 157.48 37.36 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.396 1.878 . . . . 10.59 113.008 173.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.6 p -148.86 155.56 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 126.919 2.088 . . . . 7.0999999999999996 110.355 -175.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -113.1 72.0 0.76 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.758 1.623 . . . . 3.23 109.234 168.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.02 156.93 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 118.851 2.908 . . . . 3.5899999999999999 118.851 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.39 49.59 1.01 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.304 1.842 . . . . 5.6299999999999999 114.096 -174.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.29 -4.17 90.51 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.095 1.331 . . . . 1.8600000000000001 114.973 175.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.4 p -134.83 160.65 37.56 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.68 1.592 . . . . 1.1599999999999999 111.928 -175.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.8 p -93.9 -7.08 44.12 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.347 1.24 . . . . 1.3100000000000001 114.347 -173.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 t -152.43 154.42 35.52 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.625 1.97 . . . . 2.3500000000000001 109.135 166.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.6 p -95.27 4.91 53.01 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 127.341 2.256 . . . . 0.95999999999999996 114.856 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.1 m -153.19 154.19 34.23 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 120.069 -1.644 . . . . 1.9299999999999999 113.195 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -129.53 147.0 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 127.793 2.437 . . . . 0.40000000000000002 110.537 -175.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.4 m -113.55 117.7 32.39 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.082 0.953 . . . . 0.78000000000000003 110.806 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.91 135.82 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.685 0.794 . . . . 0.66000000000000003 109.513 172.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -114.08 -179.25 3.58 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.25 1.82 . . . . 1.8999999999999999 111.006 -176.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -138.02 118.24 13.6 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 120.534 -1.354 . . . . 2.21 112.176 165.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.6 mt -107.28 152.93 23.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.222 1.409 . . . . 0.55000000000000004 111.19 177.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.6 mt -144.25 172.23 13.2 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.143 1.777 . . . . 1.4199999999999999 110.422 169.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.04 164.21 12.27 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.675 1.19 . . . . 0.80000000000000004 112.272 170.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.4 p -90.98 -23.33 20.44 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.691 1.367 . . . . 1.02 114.691 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -139.15 41.45 2.09 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.861 1.21 . . . . 2.3799999999999999 112.073 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.9 14.32 82.29 Favored Glycine 0 CA--C 1.536 1.362 0 O-C-N 120.796 -1.19 . . . . 0.89000000000000001 114.971 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.42 19.85 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.94 2.496 . . . . 2.3799999999999999 116.067 -175.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.1 mmt -62.83 -28.39 69.98 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 119.592 -1.942 . . . . 0.68999999999999995 114.33 -171.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -71.84 -45.77 60.29 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.405 1.002 . . . . 2.7000000000000002 112.999 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -67.49 -35.98 80.2 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.693 -1.255 . . . . 2.0899999999999999 111.677 173.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.6 mt -58.41 -44.91 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 119.306 0.957 . . . . 0.64000000000000001 110.547 167.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.68 -37.04 77.69 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.372 -1.455 . . . . 0.77000000000000002 112.489 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -68.28 -35.89 78.54 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.631 0.772 . . . . 0.94999999999999996 112.484 170.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -63.03 -19.3 64.24 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 119.431 1.014 . . . . 1.8999999999999999 113.179 170.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 25.8 mt -101.76 -36.2 8.79 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.745 1.757 . . . . 0.83999999999999997 115.745 177.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -64.24 -24.42 67.66 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.583 1.083 . . . . 2.3399999999999999 112.503 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.9 t -74.01 -20.24 60.38 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.5 2.32 . . . . 1.25 114.45 175.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.64 172.16 27.07 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.547 1.07 . . . . 1.03 113.743 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -84.18 29.15 0.58 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.633 1.173 . . . . 2.1299999999999999 113.02 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -75.42 3.88 8.36 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.928 1.455 . . . . 1.9199999999999999 114.928 -168.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.66 -26.53 68.71 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.034 -1.042 . . . . 1.1899999999999999 111.577 168.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.86 -82.02 1.36 Allowed Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.56 1.076 . . . . 0.88 112.993 174.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.5 163.03 28.23 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.436 1.273 . . . . 1.79 114.436 -172.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -55.64 152.78 8.8 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.306 1.042 . . . . 2.3700000000000001 113.058 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.8 t -69.9 98.37 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 107.915 -1.143 . . . . 1.24 107.915 169.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.38 -25.74 75.21 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.229 0.443 . . . . 1.5900000000000001 114.191 -173.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.5 t -141.13 125.04 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.444 1.498 . . . . 1.9399999999999999 109.037 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.5 mt -92.62 160.2 34.94 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 126.08 1.752 . . . . 1.22 111.079 169.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.17 166.89 28.76 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 121.413 1.409 . . . . 0.92000000000000004 111.169 168.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.43 -20.74 58.68 Favored 'General case' 0 CA--C 1.548 0.865 0 O-C-N 120.864 -1.147 . . . . 1.0600000000000001 113.296 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.0 p30 -79.68 -4.79 53.33 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.558 1.543 . . . . 1.8200000000000001 114.406 170.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.75 154.31 20.38 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 113.997 1.11 . . . . 0.64000000000000001 113.997 174.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.8 pttt -145.92 161.75 39.34 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.71 2.004 . . . . 2.52 112.066 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -133.45 123.57 25.52 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.608 1.163 . . . . 2.23 112.424 -169.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.7 pt -120.98 143.63 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.151 0.98 . . . . 0.81000000000000005 112.129 -177.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -114.49 163.41 15.4 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.654 1.181 . . . . 0.71999999999999997 112.263 173.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.75 3.74 55.99 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.101 1.81 . . . . 0.71999999999999997 115.919 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.0 p -83.03 145.85 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 125.733 1.613 . . . . 0.68000000000000005 112.127 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -101.83 136.25 41.99 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.599 1.56 . . . . 0.56000000000000005 113.46 175.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.412 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.4 OUTLIER -141.41 158.5 43.79 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.621 1.568 . . . . 1.6200000000000001 112.319 173.58 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.2 m -124.18 146.16 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 126.873 2.069 . . . . 0.42999999999999999 109.726 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -87.41 148.03 25.17 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 122.312 1.053 . . . . 0.42999999999999999 112.283 170.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.3 p -142.46 171.26 14.3 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.601 1.96 . . . . 0.34000000000000002 112.952 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.21 -176.44 3.42 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 115.279 1.585 . . . . 1.98 115.279 174.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 47.3 p -57.73 -30.99 66.0 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.037 -1.04 . . . . 1.78 113.187 175.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -86.98 18.22 3.68 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.806 1.242 . . . . 1.95 113.192 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.97 22.09 4.14 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.288 1.835 . . . . 0.56999999999999995 113.634 -176.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -77.7 140.36 39.53 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.867 1.267 . . . . 2.1000000000000001 110.31 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.7 mt -79.79 124.5 37.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.082 -0.71 . . . . 0.53000000000000003 109.082 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.427 HG22 HG22 ' A' ' 97' ' ' THR . 4.6 pt -123.55 157.19 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 114.23 1.196 . . . . 0.58999999999999997 114.23 -174.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -89.96 166.0 13.74 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.364 1.466 . . . . 1.6699999999999999 110.221 167.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.35 5.43 1.31 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.978 1.711 . . . . 2.0600000000000001 115.332 -171.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -112.96 4.42 16.76 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 128.291 2.636 . . . . 2.7400000000000002 112.841 172.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.55 10.72 84.92 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.682 1.134 . . . . 0.57999999999999996 114.666 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -75.37 138.57 41.83 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.082 1.441 . . . . 2.0899999999999999 110.066 168.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.427 HG22 HG22 ' A' ' 91' ' ' ILE . 1.0 OUTLIER -104.8 140.57 37.91 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.095 0.958 . . . . 0.93000000000000005 112.339 -173.773 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -95.21 6.28 49.46 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 115.647 1.721 . . . . 0.77000000000000002 115.647 -166.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.1 28.64 61.91 Favored Glycine 0 CA--C 1.533 1.177 0 O-C-N 121.248 -0.908 . . . . 0.64000000000000001 113.73 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.7 t -137.64 149.52 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.579 1.152 . . . . 1.22 109.9 175.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -132.97 153.41 51.47 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 129.011 2.924 . . . . 1.3300000000000001 110.906 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 51.9 mt -131.93 128.83 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.924 1.289 . . . . 0.55000000000000004 112.034 -173.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -70.6 141.0 87.31 Favored Pre-proline 0 N--CA 1.477 0.907 0 CA-C-O 117.423 -1.275 . . . . 2.1000000000000001 111.84 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -73.84 -24.53 15.34 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 CA-C-N 122.355 1.877 . . . . 0.81000000000000005 112.967 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -91.13 -38.11 12.95 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.53 1.532 . . . . 1.22 113.104 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.4 p -93.62 -27.72 16.42 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.0 0.92 . . . . 0.89000000000000001 113.19 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 55.13 19.91 3.07 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.271 1.428 . . . . 2.1800000000000002 112.932 -169.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.59 147.09 25.46 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.575 1.15 . . . . 3.1299999999999999 111.69 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.3 mt -88.78 141.39 28.55 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.645 1.578 . . . . 0.92000000000000004 112.73 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.0 p -75.25 10.63 1.48 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.353 1.061 . . . . 1.3100000000000001 113.746 172.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.39 -155.21 13.87 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.552 2.025 . . . . 1.03 111.632 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -96.4 163.97 12.83 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.357 1.463 . . . . 1.05 112.698 175.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.5 mmt -51.58 139.32 29.16 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 114.289 1.218 . . . . 1.52 114.289 -176.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -78.41 163.89 26.83 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 124.617 3.544 . . . . 0.88 113.78 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.45 -67.31 0.7 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.222 1.193 . . . . 1.03 114.222 174.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.5 p -101.83 4.88 40.77 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 115.884 1.809 . . . . 0.69999999999999996 115.884 -167.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.82 147.76 11.35 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.682 1.364 . . . . 0.46999999999999997 114.682 -175.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.8 ttt -73.08 95.04 1.98 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.517 1.927 . . . . 1.75 111.561 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.6 pttp -147.07 137.58 23.57 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.803 1.641 . . . . 1.1799999999999999 111.65 -174.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -161.55 158.18 25.99 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.605 1.562 . . . . 1.8700000000000001 110.211 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -96.25 150.04 20.98 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.908 1.447 . . . . 0.46999999999999997 114.908 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.412 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 7.0 p -65.73 134.99 54.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.35 -0.844 . . . . 0.54000000000000004 111.968 169.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -94.26 -65.04 1.01 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.778 1.399 . . . . 2.2999999999999998 114.778 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.72 -45.91 0.1 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.053 0.941 . . . . 0.95999999999999996 111.666 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -93.49 -35.32 13.01 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.854 0.462 . . . . 4.1299999999999999 111.648 173.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 176.42 -149.96 10.17 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.216 1.389 . . . . 0.65000000000000002 111.034 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -137.16 129.05 29.04 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.947 1.699 . . . . 0.48999999999999999 110.492 169.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -90.09 138.33 31.6 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.318 1.047 . . . . 2.8300000000000001 112.286 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -130.34 130.87 45.0 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 128.591 2.756 . . . . 1.9399999999999999 109.214 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -88.37 123.76 33.26 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.772 1.229 . . . . 1.75 109.677 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.2 p -109.81 2.65 20.08 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.062 1.345 . . . . 0.56000000000000005 113.342 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.26 -21.72 9.87 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 115.13 1.53 . . . . 0.73999999999999999 115.13 -176.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -108.36 -9.56 15.44 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.808 1.04 . . . . 2.3399999999999999 113.808 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.04 149.0 92.09 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 120.481 1.492 . . . . 0.66000000000000003 113.313 175.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -83.91 168.8 12.1 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.898 3.066 . . . . 0.81999999999999995 111.344 167.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.39 90.46 2.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.847 2.059 . . . . 1.02 110.567 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -147.3 179.24 7.79 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.416 1.086 . . . . 0.78000000000000003 111.743 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -90.13 152.49 21.1 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.99 0.916 . . . . 3.5299999999999998 110.618 167.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -142.74 176.86 8.72 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.132 1.773 . . . . 0.53000000000000003 109.441 -173.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.89 155.88 43.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.006 0.922 . . . . 3.2599999999999998 113.199 175.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.6 mp -121.98 134.53 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.172 0.989 . . . . 0.46000000000000002 110.618 172.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -122.28 135.1 54.68 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.411 1.885 . . . . 1.9099999999999999 111.148 -176.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -86.84 109.66 19.44 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.822 0.849 . . . . 2.77 110.931 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 28.3 mm -116.64 92.29 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.871 0.868 . . . . 1.05 108.76 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -83.14 2.4 35.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.518 1.127 . . . . 4.79 113.854 -174.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.9 p -71.29 -20.16 62.24 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 115.087 1.514 . . . . 1.8300000000000001 115.087 -174.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.0 mp -80.84 -62.19 1.74 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.265 1.393 . . . . 3.3399999999999999 109.032 168.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 34.4 t -157.61 160.97 38.63 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.314 1.846 . . . . 4.2699999999999996 109.608 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.6 t -147.3 -175.11 4.71 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.469 1.108 . . . . 6.1699999999999999 110.287 168.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -66.02 167.1 10.36 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.378 1.471 . . . . 5.5899999999999999 112.664 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 55.0 t -89.52 124.42 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.929 0.892 . . . . 5.5099999999999998 111.275 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -136.19 -29.21 0.34 Allowed Glycine 0 CA--C 1.541 1.66 0 CA-C-O 118.112 -1.382 . . . . 2.9199999999999999 115.973 174.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . 0.276 10.9 pt-20 -88.05 -0.87 57.58 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 121.318 2.559 . . . . 6.3099999999999996 115.186 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -79.84 24.85 0.38 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.241 1.417 . . . . 7.3200000000000003 113.49 176.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 102.68 8.82 42.08 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.483 1.516 . . . . 4.7999999999999998 116.143 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -87.93 161.25 17.56 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 118.721 1.26 . . . . 3.4100000000000001 113.315 -178.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.8 t -80.63 54.65 2.14 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.378 1.471 . . . . 4.0999999999999996 112.061 174.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 30.1 mt -129.63 150.25 51.03 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.979 1.712 . . . . 2.2000000000000002 110.734 -174.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 42.9 p -135.15 150.07 50.1 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.691 0.796 . . . . 3.73 111.622 174.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -74.34 46.84 1.63 Allowed Glycine 0 CA--C 1.537 1.457 0 C-N-CA 126.046 1.784 . . . . 2.6400000000000001 114.348 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.4 t -81.18 160.25 24.4 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.178 1.391 . . . . 2.8900000000000001 112.241 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.2 115.66 24.75 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.799 1.407 . . . . 2.7799999999999998 114.799 -167.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.55 137.05 47.76 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.993 1.717 . . . . 0.85999999999999999 110.157 168.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.54 148.55 37.67 Favored Pre-proline 0 N--CA 1.481 1.097 0 CA-C-N 119.629 1.104 . . . . 0.66000000000000003 112.386 174.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -72.56 140.46 32.93 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.65 2.233 . . . . 0.69999999999999996 111.202 -173.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 4.6 mt -88.52 127.27 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.611 0.765 . . . . 1.8200000000000001 110.377 -171.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -86.25 127.96 34.83 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.371 1.468 . . . . 3.6699999999999999 109.573 168.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.3 tt -144.23 147.67 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 119.087 0.858 . . . . 0.65000000000000002 112.951 -173.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -124.8 149.38 47.46 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.927 1.691 . . . . 2.0600000000000001 109.513 169.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 28.1 mt -64.74 162.06 39.75 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 114.377 1.251 . . . . 1.1899999999999999 114.377 -171.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.66 98.32 1.2 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.011 2.474 . . . . 0.77000000000000002 111.893 -173.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.2 tt -123.05 62.29 1.01 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 104.823 -2.288 . . . . 2.2400000000000002 104.823 167.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -140.67 156.82 46.13 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.907 2.083 . . . . 3.3300000000000001 108.853 -168.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -70.33 17.62 0.06 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.966 1.839 . . . . 3.9199999999999999 115.966 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.7 m -95.97 144.32 10.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 124.367 1.067 . . . . 1.1100000000000001 112.886 -168.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 50.8 t -73.69 -36.66 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.935 -0.478 . . . . 1.6100000000000001 110.739 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -140.29 131.29 26.19 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.195 1.398 . . . . 2.6099999999999999 110.763 -170.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -97.11 140.97 30.82 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.971 0.908 . . . . 0.47999999999999998 112.396 -176.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -137.19 166.48 23.63 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.106 1.521 . . . . 0.57999999999999996 115.106 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.43 137.32 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.64 1.976 . . . . 0.62 113.152 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -131.01 89.8 41.34 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.502 1.521 . . . . 1.8899999999999999 111.58 -177.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.87 154.36 71.13 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.157 3.238 . . . . 0.89000000000000001 112.819 175.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -133.17 163.07 30.11 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.207 1.403 . . . . 1.45 112.772 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -100.68 146.61 26.98 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.615 2.366 . . . . 3.71 110.328 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 7.1 t -135.93 -47.83 0.67 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 113.788 1.033 . . . . 2.29 113.788 171.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 43.34 122.77 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 130.761 3.625 . . . . 7.21 119.053 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -144.53 124.86 13.81 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.047 1.739 . . . . 6.8099999999999996 109.912 168.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -127.07 155.24 76.26 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 125.468 1.507 . . . . 8.6799999999999997 112.463 -170.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -62.8 148.41 93.46 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.589 2.193 . . . . 10.699999999999999 112.637 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -81.7 -38.62 25.53 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.706 1.002 . . . . 15.56 113.706 175.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.482 HD13 ' H ' ' A' ' 191' ' ' ILE . 0.2 OUTLIER -114.97 -28.27 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.755 1.222 . . . . 15.119999999999999 114.18 -174.006 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.6 tt 59.21 106.32 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.829 2.451 . . . . 15.75 112.99 -176.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 CA--C 1.544 0.735 0 C-N-CA 126.24 1.816 . . . . 21.25 112.711 -172.614 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 47.0 p . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 113.914 1.079 . . . . 1.0900000000000001 113.914 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.7 p -90.58 -6.17 55.0 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.776 1.23 . . . . 1.4299999999999999 113.01 175.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 m -156.5 153.93 29.54 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.223 2.209 . . . . 2.23 109.455 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.1 p -109.54 4.49 22.28 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.306 1.595 . . . . 0.89000000000000001 115.306 -170.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 m -147.58 161.38 41.24 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.275 1.83 . . . . 1.74 112.501 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.42 141.69 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 126.513 1.925 . . . . 0.35999999999999999 109.869 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.3 m -111.3 114.83 28.29 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.474 0.654 . . . . 0.71999999999999997 109.916 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 p -93.17 128.51 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.256 1.022 . . . . 0.68000000000000005 109.274 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -107.23 -177.85 3.47 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.152 1.381 . . . . 1.79 110.118 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -139.14 122.7 17.36 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.753 -1.217 . . . . 1.6000000000000001 111.124 168.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.7 mt -107.94 154.24 21.9 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.106 0.962 . . . . 0.67000000000000004 110.936 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.26 167.37 22.6 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.843 1.657 . . . . 1.9099999999999999 110.092 176.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.38 158.34 16.13 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.751 0.821 . . . . 0.68000000000000005 112.249 170.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.1 p -80.72 -41.13 24.11 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.413 1.085 . . . . 0.93999999999999995 112.485 174.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -131.66 38.03 3.6 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.3 1.04 . . . . 2.6800000000000002 112.996 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.72 12.29 82.99 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.228 1.394 . . . . 0.79000000000000004 115.264 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -71.65 18.17 0.08 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.474 2.31 . . . . 1.95 116.075 -171.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.21 -26.03 66.07 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.377 -1.452 . . . . 0.59999999999999998 113.025 -175.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.45 -50.51 63.11 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.926 1.29 . . . . 2.3300000000000001 112.709 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -68.34 -39.93 81.72 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.849 -1.157 . . . . 2.2999999999999998 112.219 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -53.96 -49.42 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.417 1.008 . . . . 0.53000000000000003 111.123 171.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.05 -23.71 67.26 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.477 -1.389 . . . . 0.76000000000000001 113.424 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -82.17 -30.07 31.2 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.308 -0.87 . . . . 1.1200000000000001 112.822 169.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -70.67 -11.87 61.21 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.61 1.564 . . . . 2.0699999999999998 113.516 168.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.3 mt -106.65 -31.81 8.3 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.774 1.63 . . . . 0.80000000000000004 114.256 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.47 -22.31 66.73 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 120.461 1.482 . . . . 2.4100000000000001 113.176 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 t -71.16 -31.08 67.24 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.436 1.094 . . . . 1.3799999999999999 112.466 171.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.4 162.62 35.02 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.247 0.927 . . . . 0.87 113.22 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -83.23 30.58 0.46 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.936 -1.332 . . . . 1.6100000000000001 112.813 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -71.78 19.23 0.07 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.124 1.898 . . . . 1.96 116.124 -168.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.16 -27.85 62.85 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.367 1.067 . . . . 0.93999999999999995 109.802 164.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.23 -63.79 0.26 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.211 1.386 . . . . 0.68999999999999995 113.341 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -78.82 158.92 28.07 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.177 1.547 . . . . 1.8100000000000001 115.177 -171.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -70.76 135.74 48.4 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.997 1.719 . . . . 3.27 112.991 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 80.0 t -54.38 110.57 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.883 0.873 . . . . 0.80000000000000004 111.246 -174.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.72 -25.21 60.89 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 114.708 0.643 . . . . 1.0600000000000001 114.708 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 p -142.07 104.11 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.528 1.131 . . . . 4.25 111.89 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.1 mt -89.79 146.8 36.12 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 126.966 2.107 . . . . 1.1299999999999999 111.451 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.27 158.21 19.96 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.282 2.654 . . . . 0.56999999999999995 113.18 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.37 -22.9 63.69 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.877 -1.139 . . . . 0.93000000000000005 112.356 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -79.34 0.5 28.71 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.946 1.298 . . . . 1.3100000000000001 114.28 169.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.32 157.85 16.48 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.743 1.217 . . . . 0.56999999999999995 112.599 168.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -150.84 172.02 16.3 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.178 1.791 . . . . 1.8100000000000001 111.206 173.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -126.54 146.82 49.99 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.287 1.435 . . . . 2.25 111.028 -174.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.1 pt -136.65 130.67 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 114.042 1.127 . . . . 0.77000000000000002 114.042 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.7 156.86 17.78 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.725 0.81 . . . . 0.63 111.71 169.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.4 15.78 56.5 Favored Glycine 0 CA--C 1.537 1.43 0 N-CA-C 116.102 1.201 . . . . 0.62 116.102 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.5 p -90.14 145.78 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-N 120.153 1.977 . . . . 0.93999999999999995 109.125 167.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 1.8 tpp -102.42 137.69 40.33 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.701 1.2 . . . . 0.45000000000000001 111.798 174.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.66 153.71 47.35 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 122.188 0.994 . . . . 1.74 112.875 170.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.7 m -118.71 146.39 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 C-N-CA 126.948 2.099 . . . . 0.33000000000000002 109.125 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -87.64 147.03 25.45 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.433 1.111 . . . . 0.29999999999999999 111.926 169.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.2 p -141.49 173.65 11.3 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.328 1.851 . . . . 0.40000000000000002 112.098 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.53 177.6 4.97 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.78 1.632 . . . . 1.8100000000000001 113.407 172.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.0 p -68.18 -20.76 64.89 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.978 1.103 . . . . 1.4099999999999999 113.978 -171.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -97.97 26.46 5.21 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.602 1.561 . . . . 2.1200000000000001 112.834 169.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 62.26 23.98 14.24 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.226 2.21 . . . . 0.56000000000000005 114.349 169.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -84.38 140.38 31.61 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.069 0.948 . . . . 2.5499999999999998 111.117 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.7 mt -76.86 126.09 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.193 -0.669 . . . . 0.5 109.193 176.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.555 HG22 HG22 ' A' ' 97' ' ' THR . 4.7 pt -117.86 156.91 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 114.57 1.322 . . . . 0.58999999999999997 114.57 -176.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -85.27 165.4 17.36 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.232 1.413 . . . . 1.4399999999999999 110.741 167.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -64.95 2.86 0.64 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 128.05 2.54 . . . . 3.0499999999999998 115.904 -174.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -117.54 -3.5 11.34 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 127.59 2.356 . . . . 2.98 114.276 172.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.05 5.8 59.4 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.362 1.458 . . . . 0.81000000000000005 116.443 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -72.33 137.34 46.58 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.092 1.946 . . . . 2.0499999999999998 110.454 170.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.555 HG22 HG22 ' A' ' 91' ' ' ILE . 23.9 p -96.36 134.23 39.76 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.603 1.161 . . . . 0.98999999999999999 111.662 -175.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.7 -0.95 57.27 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.538 1.681 . . . . 0.62 115.538 -167.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.86 15.61 69.84 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-N 119.214 0.915 . . . . 0.71999999999999997 113.931 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.0 t -125.08 147.1 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.938 1.295 . . . . 1.1000000000000001 109.293 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -133.55 157.85 44.65 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 128.115 2.566 . . . . 1.3300000000000001 110.138 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.41 HG12 HD23 ' A' ' 109' ' ' LEU . 55.8 mt -136.03 134.23 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.931 1.292 . . . . 0.48999999999999999 110.53 -174.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -73.09 135.02 80.26 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 121.072 -1.017 . . . . 1.8 110.308 173.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -66.71 -22.92 49.42 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.573 2.182 . . . . 0.98999999999999999 113.816 172.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -96.9 -45.06 6.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.916 1.686 . . . . 1.1200000000000001 112.762 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.8 p -90.71 -22.98 20.85 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.61 1.164 . . . . 0.79000000000000004 113.565 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 53.39 19.46 1.63 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.75 1.62 . . . . 2.0499999999999998 113.846 -170.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.41 146.65 30.18 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.745 -1.222 . . . . 2.7599999999999998 111.524 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.41 HD23 HG12 ' A' ' 102' ' ' ILE . 31.3 mt -90.29 135.66 33.54 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.215 1.406 . . . . 0.83999999999999997 111.288 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 92.2 p -66.23 -0.58 2.62 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.382 1.252 . . . . 1.3300000000000001 114.382 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.38 -152.8 9.08 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 126.39 1.948 . . . . 0.85999999999999999 112.218 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.1 162.65 15.21 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.113 1.365 . . . . 0.93999999999999995 113.439 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.3 mmt -54.01 128.12 55.53 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.75 1.22 . . . . 1.51 113.055 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -72.08 163.42 38.83 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.106 3.204 . . . . 0.73999999999999999 113.129 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.41 -81.24 0.09 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.165 0.986 . . . . 1.0700000000000001 112.127 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 78.1 p -83.58 2.05 39.14 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 116.07 1.878 . . . . 0.78000000000000003 116.07 -167.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -49.87 149.17 2.74 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.382 1.473 . . . . 0.46999999999999997 114.974 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.1 tpt -77.52 98.11 5.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.784 2.034 . . . . 1.5800000000000001 111.256 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -150.14 147.78 28.17 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.413 1.485 . . . . 1.04 112.221 -172.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -166.82 156.96 11.53 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 125.392 1.477 . . . . 1.79 111.241 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 mp -94.68 150.4 20.26 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.481 1.289 . . . . 0.47999999999999998 114.481 172.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 16.7 p -63.84 134.52 55.35 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.323 -0.86 . . . . 0.46999999999999997 112.058 170.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -92.3 -54.41 3.82 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.464 1.653 . . . . 2.1899999999999999 115.464 -171.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.73 -37.7 0.08 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.902 1.281 . . . . 1.0800000000000001 111.509 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -119.65 -22.52 6.87 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.073 1.138 . . . . 5.25 114.073 171.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 175.87 -159.09 26.43 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.686 1.612 . . . . 0.65000000000000002 111.117 -170.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -147.06 133.64 19.84 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.589 1.955 . . . . 0.39000000000000001 111.967 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -86.77 137.42 32.45 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.506 1.122 . . . . 1.4199999999999999 113.088 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -128.97 124.07 34.08 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.495 2.318 . . . . 1.6699999999999999 108.556 174.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -77.49 128.75 34.72 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.354 -0.841 . . . . 2.5299999999999998 110.201 175.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 66.8 p -105.73 -10.74 16.59 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.796 1.776 . . . . 0.69999999999999996 115.796 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.64 -33.95 16.88 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.798 1.181 . . . . 0.96999999999999997 114.014 -172.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -16.37 44.27 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.807 1.643 . . . . 2.2400000000000002 113.291 -176.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -72.18 144.18 86.91 Favored Pre-proline 0 C--O 1.237 0.434 0 CA-C-N 119.976 1.262 . . . . 0.63 112.166 173.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.45 167.1 27.92 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.357 2.038 . . . . 0.70999999999999996 110.47 167.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.38 93.77 1.98 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.149 1.38 . . . . 0.97999999999999998 109.609 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -152.71 -178.29 6.78 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.945 0.898 . . . . 0.65000000000000002 112.427 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -91.13 152.39 20.61 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.392 1.877 . . . . 3.3999999999999999 111.956 168.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -149.27 170.96 17.3 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.661 2.385 . . . . 0.48999999999999999 110.372 -170.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -138.63 160.86 38.56 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.424 1.09 . . . . 1.74 113.337 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.2 134.46 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.357 1.463 . . . . 0.39000000000000001 110.065 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -122.14 137.38 54.84 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.475 1.51 . . . . 1.8600000000000001 111.569 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -104.69 100.61 10.26 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.907 1.683 . . . . 2.6299999999999999 110.469 -169.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 28.2 mm -106.84 113.88 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.613 1.165 . . . . 0.73999999999999999 110.653 -167.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -87.1 22.82 1.95 Allowed 'General case' 0 CA--C 1.553 1.09 0 O-C-N 120.936 -1.102 . . . . 3.7799999999999998 112.854 -178.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.2 m . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 114.578 1.325 . . . . 1.77 114.578 -176.718 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? . . . . . 0 C--O 1.24 0.565 0 N-CA-C 112.441 0.534 . . . . 1.8799999999999999 112.441 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.55 147.1 28.82 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.514 1.126 . . . . 1.0900000000000001 111.06 168.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.36 147.88 34.62 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 123.282 0.633 . . . . 0.94999999999999996 110.449 170.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.29 159.28 52.3 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.708 2.939 . . . . 0.70999999999999996 113.365 -173.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -109.07 148.11 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.514 1.126 . . . . 1.72 111.467 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.58 148.45 41.9 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.789 1.636 . . . . 4.8300000000000001 111.252 168.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.6 tt -151.56 146.81 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 124.157 0.983 . . . . 0.48999999999999999 111.705 -174.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -122.97 142.92 50.3 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.555 1.542 . . . . 1.8400000000000001 109.495 169.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 23.4 mt -64.79 149.61 95.85 Favored Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 113.808 1.04 . . . . 0.97999999999999998 113.808 -170.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.54 110.72 2.36 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.269 2.646 . . . . 0.73999999999999999 113.832 -169.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.45 60.88 1.4 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.569 2.348 . . . . 2.4300000000000002 106.016 166.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -151.66 147.86 27.25 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.981 2.112 . . . . 3.1000000000000001 109.896 -166.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -72.48 23.41 0.06 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 126.075 1.75 . . . . 4.0099999999999998 114.679 -174.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.4 m -76.28 149.51 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 120.434 -1.417 . . . . 1.21 111.759 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 88.7 t -78.96 -35.7 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.733 0.813 . . . . 2.1699999999999999 111.405 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -145.42 148.56 33.45 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.67 1.988 . . . . 3.0 109.747 173.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -94.66 141.74 28.26 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.952 0.797 . . . . 0.39000000000000001 111.916 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -138.85 170.54 15.8 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.348 1.24 . . . . 0.59999999999999998 114.348 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.27 141.26 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 125.201 1.401 . . . . 0.56999999999999995 112.845 -177.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.38 83.28 59.73 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 124.729 1.212 . . . . 2.25 113.844 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -67.96 138.39 44.04 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.36 3.374 . . . . 0.59999999999999998 113.068 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -124.6 163.23 22.38 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.176 1.79 . . . . 1.9299999999999999 112.57 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -103.56 164.74 11.47 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.826 1.25 . . . . 2.6499999999999999 110.774 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 114.042 1.127 . . . . 2.9500000000000002 114.042 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 113.997 1.11 . . . . 1.0800000000000001 113.997 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 78.0 p -91.8 -9.13 44.62 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.629 1.172 . . . . 1.72 114.149 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.7 t -147.88 154.67 40.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.875 1.67 . . . . 1.8 109.405 169.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.7 p -98.27 -0.62 43.62 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.918 1.687 . . . . 0.85999999999999999 114.32 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.4 m -151.68 158.9 44.04 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.312 1.445 . . . . 1.79 110.607 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.68 141.9 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 126.39 1.876 . . . . 0.40999999999999998 109.317 177.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 m -115.76 121.77 43.45 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.508 0.723 . . . . 0.91000000000000003 110.307 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -103.37 131.61 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.683 1.193 . . . . 0.62 110.998 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -130.32 100.39 5.36 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.11 1.364 . . . . 1.8799999999999999 110.82 -172.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.419 ' HE3' ' CD2' ' A' ' 43' ' ' LEU . 6.9 tmtm? -74.81 120.88 20.95 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.788 -1.195 . . . . 1.54 110.916 -174.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.3 mt -106.84 153.45 22.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.952 1.301 . . . . 0.67000000000000004 112.195 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.419 ' CD2' ' HE3' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -141.65 171.77 13.6 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.965 1.706 . . . . 1.8200000000000001 110.894 176.158 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.35 158.49 16.43 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.171 1.388 . . . . 0.96999999999999997 112.219 170.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.4 p -81.01 -25.59 37.11 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.39 1.256 . . . . 1.4399999999999999 114.39 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -149.64 38.04 0.75 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.427 1.091 . . . . 3.5800000000000001 112.64 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.09 10.35 75.13 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 116.44 1.336 . . . . 1.24 116.44 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.13 14.62 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 129.128 2.971 . . . . 2.1800000000000002 116.632 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -26.13 68.61 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.283 -1.51 . . . . 0.75 113.087 -170.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -72.12 -43.37 64.82 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.626 1.103 . . . . 2.04 113.103 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -70.22 -41.86 73.06 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.465 -1.397 . . . . 2.4500000000000002 111.746 172.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.9 mt -54.07 -44.2 62.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.333 1.053 . . . . 0.82999999999999996 112.231 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.88 -31.17 69.54 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 120.967 1.712 . . . . 0.95999999999999996 112.768 176.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -76.03 -35.76 59.36 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.969 0.908 . . . . 1.3999999999999999 112.86 171.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -63.15 -22.87 67.15 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.179 0.991 . . . . 2.2000000000000002 112.97 170.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.3 mt -91.93 -41.48 10.56 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.097 1.147 . . . . 1.25 114.097 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.65 -18.9 65.37 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.781 1.173 . . . . 4.1299999999999999 113.692 -175.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.8 t -75.68 -23.37 56.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.655 1.182 . . . . 2.0099999999999998 113.883 172.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.64 157.68 21.32 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.346 0.974 . . . . 1.27 112.578 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -77.37 43.28 0.38 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.474 1.11 . . . . 1.71 113.031 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -78.74 13.37 1.69 Allowed 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.516 -1.365 . . . . 2.0600000000000001 113.971 -170.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.83 -17.63 58.88 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.237 1.415 . . . . 1.28 111.155 165.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.82 -74.07 0.14 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.738 1.161 . . . . 0.90000000000000002 112.792 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.42 161.33 29.92 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.41 1.263 . . . . 1.5600000000000001 114.41 -173.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.04 158.67 27.75 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.898 1.073 . . . . 3.1400000000000001 113.898 -173.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.02 119.44 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.894 -0.504 . . . . 0.81000000000000005 110.175 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.28 -29.33 45.62 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.828 0.728 . . . . 1.3600000000000001 114.15 -176.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.9 t -146.15 125.92 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.259 1.423 . . . . 2.2000000000000002 111.41 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.2 mt -96.88 134.46 23.01 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.903 1.681 . . . . 1.22 110.771 167.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.86 160.49 43.29 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.042 1.828 . . . . 0.71999999999999997 111.42 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.26 -21.82 66.78 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.836 -1.165 . . . . 1.25 113.715 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -88.3 -5.01 58.59 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.659 1.584 . . . . 1.76 114.443 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.3 155.16 20.77 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.108 0.867 . . . . 0.78000000000000003 111.113 168.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.6 pttt -152.46 170.01 21.18 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.396 1.078 . . . . 1.79 111.83 169.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -120.32 137.78 54.07 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.905 1.682 . . . . 2.02 108.718 -172.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.7 pt -126.24 131.98 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 120.018 1.281 . . . . 0.81000000000000005 113.464 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.76 160.06 14.92 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.0 1.32 . . . . 0.68000000000000005 111.286 169.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.03 16.11 68.21 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.086 0.851 . . . . 0.56000000000000005 115.089 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.3 p -101.85 141.71 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.491 1.516 . . . . 0.64000000000000001 110.288 169.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.7 tpp -99.88 141.8 32.21 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.524 1.53 . . . . 0.56000000000000005 112.642 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.442 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.6 OUTLIER -144.32 149.44 36.21 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.146 1.378 . . . . 1.6299999999999999 111.471 173.092 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.8 m -120.44 146.13 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.584 1.953 . . . . 0.39000000000000001 109.41 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -87.21 144.49 26.8 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.882 1.325 . . . . 0.40000000000000002 110.903 168.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.7 p -137.35 170.46 16.05 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.127 2.171 . . . . 0.40000000000000002 110.473 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -87.26 171.8 10.36 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.491 -0.755 . . . . 2.0899999999999999 111.651 167.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.5 t -61.46 -24.59 66.67 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.06 -1.025 . . . . 3.0099999999999998 113.275 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -69.42 10.37 0.35 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 127.274 2.23 . . . . 3.29 115.048 169.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.43 22.55 5.09 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 128.144 2.578 . . . . 0.68999999999999995 113.354 -172.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -83.06 136.27 34.54 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.481 1.512 . . . . 2.23 111.068 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.6 mt -73.99 127.26 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 109.65 -0.5 . . . . 0.48999999999999999 109.65 175.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.583 HG22 HG22 ' A' ' 97' ' ' THR . 3.2 pt -120.09 150.28 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 115.174 1.546 . . . . 0.5 115.174 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.45 159.57 28.19 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.081 2.153 . . . . 2.1000000000000001 109.298 165.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -64.32 -15.01 59.47 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.595 1.332 . . . . 2.0499999999999998 114.595 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -92.63 4.24 54.04 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.62 1.168 . . . . 3.48 111.993 174.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.61 5.54 81.64 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 126.47 1.986 . . . . 0.47999999999999998 115.376 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -67.96 143.72 55.5 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.222 1.011 . . . . 2.3100000000000001 109.859 171.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.583 HG22 HG22 ' A' ' 91' ' ' ILE . 33.6 p -103.58 136.04 44.05 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.539 1.135 . . . . 0.68000000000000005 111.198 -177.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.26 -8.98 58.87 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.022 1.119 . . . . 0.65000000000000002 114.022 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.32 19.73 56.39 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.341 0.972 . . . . 0.71999999999999997 113.53 -174.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.52 147.6 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.873 1.269 . . . . 1.1299999999999999 110.213 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.11 160.7 30.4 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.86 2.464 . . . . 1.5700000000000001 110.81 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.4 mt -133.88 134.83 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.388 1.475 . . . . 0.68999999999999995 111.32 -175.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.04 139.04 87.56 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 117.725 -1.131 . . . . 2.3999999999999999 111.314 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -71.4 -27.46 19.22 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 CA-C-N 122.095 1.784 . . . . 1.1100000000000001 112.839 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -86.98 -48.59 7.99 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.582 1.153 . . . . 1.72 111.736 -175.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.8 p -91.05 -24.35 20.07 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.426 1.09 . . . . 1.22 113.356 -174.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 53.45 29.31 8.72 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 125.174 1.39 . . . . 2.5600000000000001 112.162 -167.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.76 153.07 17.94 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.396 1.479 . . . . 2.3599999999999999 111.535 174.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.8 mt -94.46 151.82 19.07 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.768 1.627 . . . . 0.82999999999999996 113.303 -169.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.3 p -73.42 -2.77 23.74 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.558 0.947 . . . . 1.27 113.558 168.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.82 -147.92 6.05 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 126.861 2.172 . . . . 0.90000000000000002 112.515 -169.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.7 175.72 6.92 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.542 1.537 . . . . 0.94999999999999996 113.671 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.6 mmt -64.41 138.04 97.31 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.521 1.128 . . . . 1.3700000000000001 112.273 173.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -86.1 150.48 9.47 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 124.105 3.203 . . . . 0.78000000000000003 113.564 -174.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.1 -54.08 8.56 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.431 1.271 . . . . 1.1399999999999999 114.431 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 64.8 p -107.91 -1.61 20.54 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.871 1.434 . . . . 0.82999999999999996 114.871 -168.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.14 149.39 2.87 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 115.035 1.495 . . . . 0.40000000000000002 115.035 -173.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.5 tpt -75.96 99.39 4.53 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.099 2.159 . . . . 1.6599999999999999 111.186 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -153.6 147.14 25.02 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.201 1.4 . . . . 0.93000000000000005 112.594 -173.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -164.69 158.17 17.49 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.63 1.572 . . . . 1.6899999999999999 110.626 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -98.65 149.98 22.24 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.47 1.108 . . . . 0.56000000000000005 112.523 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.513 HG22 ' HA2' ' A' ' 126' ' ' GLY . 2.0 p -65.57 128.53 36.29 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.834 0.743 . . . . 0.58999999999999997 109.861 170.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.23 -55.14 4.34 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.012 1.115 . . . . 2.0600000000000001 114.012 -173.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.35 -43.69 0.14 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.16 1.384 . . . . 1.03 110.565 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -113.88 -25.45 8.6 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.5 0.926 . . . . 3.8100000000000001 113.5 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.513 ' HA2' HG22 ' A' ' 122' ' ' THR . . . 177.24 -166.8 37.61 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.249 0.928 . . . . 0.57999999999999996 111.865 -169.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.98 142.01 34.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.878 1.671 . . . . 0.52000000000000002 112.137 169.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -92.69 138.01 31.87 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.133 1.373 . . . . 1.3300000000000001 113.185 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -128.71 125.98 39.11 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.519 1.928 . . . . 1.96 109.106 173.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.405 HD21 ' HB3' ' A' ' 132' ' ' ALA . 2.2 t30 -88.42 108.53 19.42 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 118.953 0.797 . . . . 1.6299999999999999 111.054 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.6 p -93.98 0.61 56.13 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.092 1.357 . . . . 0.57999999999999996 113.764 -174.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.405 ' HB3' HD21 ' A' ' 130' ' ' ASN . . . -60.97 -8.84 3.49 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.095 1.516 . . . . 0.77000000000000002 115.095 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -102.12 -21.78 14.35 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.15 1.38 . . . . 1.8500000000000001 113.134 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -79.03 147.68 70.32 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 113.251 0.834 . . . . 0.71999999999999997 113.251 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.59 166.98 21.38 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.965 2.443 . . . . 0.80000000000000004 111.605 168.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.86 86.01 3.43 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.629 1.972 . . . . 1.01 111.857 -172.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -147.11 -175.53 4.86 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.823 0.849 . . . . 0.78000000000000003 111.678 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -93.34 142.68 27.04 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.751 1.22 . . . . 2.46 113.868 170.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -135.72 169.12 18.05 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.342 2.257 . . . . 0.58999999999999997 110.029 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -137.95 152.91 49.41 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.526 0.73 . . . . 1.7 112.809 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.0 mp -112.12 138.9 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.166 0.986 . . . . 0.31 110.023 173.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -128.47 131.04 48.36 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.79 1.636 . . . . 1.8 110.229 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -95.11 78.92 3.54 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.038 0.935 . . . . 1.9199999999999999 111.448 -171.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.6 mm -82.95 101.66 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.519 0.727 . . . . 0.77000000000000002 110.17 -174.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -80.66 -1.44 42.47 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.422 1.267 . . . . 4.7800000000000002 114.422 -175.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 58.2 p . . . . . 0 N--CA 1.471 0.588 0 O-C-N 120.288 -1.507 . . . . 1.71 115.057 -176.436 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 43.9 tptt . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 113.093 0.775 . . . . 3.52 113.093 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.03 132.52 36.01 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.266 0.555 . . . . 0.83999999999999997 109.695 167.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.1 149.08 35.96 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 123.684 0.794 . . . . 0.54000000000000004 110.759 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.99 159.39 48.05 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.843 2.362 . . . . 0.57999999999999996 112.182 -172.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.516 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.4 mp -123.93 134.44 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.014 1.725 . . . . 1.3100000000000001 109.168 -168.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -99.35 134.55 42.04 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.342 0.974 . . . . 4.2199999999999998 111.343 170.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.7 tt -130.73 140.58 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.936 1.694 . . . . 0.55000000000000004 110.284 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -107.91 150.5 26.98 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.489 1.116 . . . . 2.1099999999999999 108.911 170.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.1 mt -62.8 143.4 96.97 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 119.493 1.042 . . . . 1.05 111.91 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.9 107.25 1.07 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.292 2.662 . . . . 0.94999999999999996 111.799 -169.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.69 25.1 10.23 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.254 1.822 . . . . 3.0800000000000001 110.14 174.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -115.54 144.44 43.86 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.631 2.772 . . . . 2.9700000000000002 109.154 -171.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -73.14 42.7 0.12 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.756 1.622 . . . . 4.5499999999999998 114.993 -171.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 10.4 m -90.84 157.75 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.802 1.641 . . . . 1.1599999999999999 113.176 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 76.3 t -72.57 -37.99 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.755 1.622 . . . . 2.46 111.355 173.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.52 158.16 31.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.669 0.788 . . . . 3.54 111.525 169.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -96.03 140.07 31.3 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.025 0.93 . . . . 0.78000000000000003 112.179 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -136.63 165.16 26.52 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.066 1.506 . . . . 0.81999999999999995 115.066 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.33 142.93 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 126.241 1.816 . . . . 0.46999999999999997 111.119 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -136.38 70.61 60.85 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.448 1.499 . . . . 2.6200000000000001 113.236 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . 0.516 ' HB3' HD11 ' A' ' 166' ' ' ILE . 18.6 Cg_endo -69.32 114.73 3.73 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.293 2.662 . . . . 0.92000000000000004 113.714 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -89.83 174.97 7.41 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 128.299 2.64 . . . . 2.0 111.939 173.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -108.3 167.28 10.13 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.432 1.493 . . . . 2.9399999999999999 111.363 170.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.479 0.995 0 C-N-CA 123.855 0.862 . . . . 2.7400000000000002 112.951 179.362 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.474 0.773 0 CA-C-O 119.922 -0.085 . . . . 3.0499999999999998 110.997 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.5 p -125.73 -9.67 6.73 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 117.797 2.518 . . . . 1.3200000000000001 117.797 -167.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 t -147.2 156.42 42.95 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 121.432 1.923 . . . . 1.99 114.622 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.7 p -100.89 -6.28 24.88 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.759 1.624 . . . . 1.1499999999999999 115.06 -172.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.5 p -147.5 156.73 43.12 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.878 1.671 . . . . 1.8899999999999999 113.794 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.76 140.45 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 127.893 2.477 . . . . 0.42999999999999999 109.112 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 36.2 m -114.17 127.54 55.95 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.353 0.979 . . . . 0.93000000000000005 111.383 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 p -96.34 136.55 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.202 1.001 . . . . 0.78000000000000003 110.695 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -131.37 107.21 8.77 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.824 1.65 . . . . 1.72 110.576 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.54 114.5 20.98 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 120.901 -1.125 . . . . 0.97999999999999998 111.436 -170.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.1 mt -99.36 154.41 18.22 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.539 1.136 . . . . 0.53000000000000003 112.416 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.6 mt -141.03 169.52 17.46 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.331 1.852 . . . . 1.73 110.209 169.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.5 150.4 23.43 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.89 0.876 . . . . 0.68999999999999995 111.016 169.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.9 p -76.64 -21.94 54.77 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.345 0.868 . . . . 1.1299999999999999 113.345 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -137.61 34.75 2.45 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.102 1.761 . . . . 2.1299999999999999 111.762 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.69 15.79 75.82 Favored Glycine 0 CA--C 1.539 1.551 0 O-C-N 119.864 -1.772 . . . . 1.0700000000000001 115.383 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.28 26.27 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 128.936 2.894 . . . . 1.8200000000000001 115.231 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -26.09 67.82 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.133 -1.604 . . . . 0.56000000000000005 113.367 -172.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -73.69 -46.36 46.77 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.41 1.004 . . . . 1.98 112.814 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -65.94 -43.27 88.51 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.203 -0.935 . . . . 2.0800000000000001 111.117 173.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 91.9 mt -50.65 -50.13 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 118.965 0.802 . . . . 0.60999999999999999 110.721 168.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.16 -32.64 70.07 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 120.807 1.639 . . . . 0.76000000000000001 113.657 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -74.31 -32.96 63.06 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.618 0.767 . . . . 0.94999999999999996 112.68 172.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -71.24 -23.66 62.04 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.626 1.171 . . . . 1.95 112.842 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.7 mt -92.32 -35.69 13.6 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.037 1.125 . . . . 0.93000000000000005 114.037 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -67.96 -28.14 67.21 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.977 0.808 . . . . 2.48 112.975 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 t -73.92 -12.49 60.67 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.42 1.488 . . . . 1.26 113.007 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.53 175.93 36.3 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.287 1.422 . . . . 0.96999999999999997 112.518 170.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -93.39 34.46 1.16 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.091 1.356 . . . . 2.3500000000000001 111.617 169.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -75.74 17.85 0.28 Allowed 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.459 -1.401 . . . . 1.8500000000000001 114.202 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.57 -23.83 49.93 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.261 1.024 . . . . 1.01 110.11 165.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -118.73 -59.33 0.27 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.862 1.696 . . . . 0.80000000000000004 112.709 172.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.281 0.0 OUTLIER -85.19 156.1 21.15 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.403 1.631 . . . . 1.4399999999999999 115.403 -169.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -60.09 149.17 33.35 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.447 0.906 . . . . 2.5099999999999998 113.447 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.5 t -62.68 124.42 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 121.87 -0.519 . . . . 0.68000000000000005 110.103 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.2 -47.02 25.04 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.709 -0.495 . . . . 0.80000000000000004 114.033 -171.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.0 t -145.59 116.21 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.66 1.584 . . . . 1.8400000000000001 108.551 176.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.2 mt -74.35 146.68 84.42 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 123.921 0.889 . . . . 0.73999999999999999 111.214 171.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.79 161.97 43.88 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.737 1.624 . . . . 0.58999999999999997 112.028 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.17 -33.72 65.53 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.198 0.599 . . . . 0.91000000000000003 112.257 174.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -83.39 1.54 40.89 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.393 1.877 . . . . 1.4099999999999999 115.629 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -95.97 152.04 18.88 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.963 1.256 . . . . 0.72999999999999998 112.677 169.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -148.95 167.62 25.27 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.71 1.604 . . . . 2.1400000000000001 111.462 169.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.26 141.68 51.38 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.828 0.851 . . . . 2.6099999999999999 110.774 -175.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.5 pt -126.82 141.55 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.403 1.081 . . . . 0.67000000000000004 112.144 -176.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.06 163.9 12.9 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.678 1.191 . . . . 0.57999999999999996 112.304 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.28 14.37 58.9 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.274 1.416 . . . . 0.64000000000000001 115.314 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.3 p -97.97 144.55 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.489 1.916 . . . . 0.72999999999999998 110.256 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 7.7 tpp -104.79 140.44 38.09 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.728 1.611 . . . . 0.55000000000000004 111.891 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.576 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.4 OUTLIER -143.92 157.03 44.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.492 1.517 . . . . 1.72 111.64 174.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.08 144.52 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 126.565 1.946 . . . . 0.40000000000000002 109.751 -176.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -85.81 146.99 26.52 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.916 1.341 . . . . 0.44 111.392 169.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.0 p -141.83 170.73 15.16 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.271 1.828 . . . . 0.41999999999999998 111.487 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.79 170.92 9.5 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.556 1.142 . . . . 1.5 112.414 168.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.5 p -33.32 -46.06 0.17 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.55 1.94 . . . . 1.79 114.351 172.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -90.98 29.49 1.36 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.574 1.15 . . . . 1.99 112.976 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.28 25.01 8.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 127.873 2.469 . . . . 1.1499999999999999 113.414 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -86.56 136.11 33.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.957 1.303 . . . . 1.78 111.515 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.9 mt -74.27 125.85 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 118.402 0.547 . . . . 0.47999999999999998 110.253 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.474 HG22 HG22 ' A' ' 97' ' ' THR . 2.1 pp -120.37 152.15 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.289 1.436 . . . . 1.0600000000000001 114.273 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -84.07 162.28 20.39 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.621 1.969 . . . . 1.3999999999999999 111.439 168.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -70.95 10.54 0.52 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 115.948 1.833 . . . . 2.3999999999999999 115.948 -169.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -115.22 -2.75 12.62 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.956 2.503 . . . . 2.7200000000000002 113.174 168.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.47 10.71 67.5 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.795 2.141 . . . . 0.57999999999999996 115.744 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -68.73 144.23 54.45 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.843 1.321 . . . . 2.2000000000000002 108.799 167.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.474 HG22 HG22 ' A' ' 91' ' ' ILE . 34.0 p -101.25 146.27 27.75 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.938 0.895 . . . . 0.63 112.076 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.88 -9.83 27.74 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.19 1.182 . . . . 0.65000000000000002 114.19 -171.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.63 25.33 42.76 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 119.738 1.154 . . . . 0.66000000000000003 113.903 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.1 t -133.66 150.41 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.939 1.695 . . . . 1.05 109.417 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -135.59 160.78 37.42 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 129.114 2.966 . . . . 1.47 110.688 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 57.2 mt -137.85 137.29 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.761 1.225 . . . . 0.75 110.417 -173.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -70.74 140.92 86.88 Favored Pre-proline 0 N--CA 1.476 0.837 0 CA-C-O 116.882 -1.532 . . . . 2.1499999999999999 111.05 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -72.32 -27.39 16.35 Favored 'Trans proline' 0 C--N 1.351 0.705 0 CA-C-N 122.935 2.084 . . . . 0.92000000000000004 112.567 174.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -88.19 -46.38 9.31 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 125.663 1.585 . . . . 1.71 112.795 -175.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.3 p -89.24 -24.66 22.05 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.357 0.873 . . . . 1.3899999999999999 113.357 -176.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 56.42 22.77 6.74 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.108 1.363 . . . . 1.9099999999999999 113.407 -168.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.98 148.75 21.86 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.956 1.303 . . . . 2.6000000000000001 112.488 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.1 mt -82.29 145.22 30.1 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.077 1.751 . . . . 0.95999999999999996 113.42 -174.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.1 p -76.38 5.56 6.96 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.348 1.24 . . . . 1.3799999999999999 114.348 170.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 177.12 -157.64 22.69 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.535 1.064 . . . . 0.88 113.652 -171.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -86.25 149.89 24.75 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.996 1.11 . . . . 0.93999999999999995 113.996 -174.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.5 tpt -51.43 126.05 28.26 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.962 1.705 . . . . 1.46 112.607 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.42 161.42 37.56 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.852 2.368 . . . . 0.79000000000000004 113.321 -170.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.62 -87.8 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 122.265 1.031 . . . . 1.0700000000000001 111.682 172.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 78.3 p -78.04 -1.05 30.36 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 116.067 1.876 . . . . 0.79000000000000004 116.067 -167.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.59 152.68 3.51 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.828 1.418 . . . . 0.48999999999999999 114.828 -171.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.7 ttt -78.6 95.1 5.14 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.993 1.317 . . . . 1.74 111.426 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.67 155.17 44.88 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.687 1.595 . . . . 2.3900000000000001 111.458 -177.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -169.2 164.26 11.02 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.785 1.634 . . . . 2.8700000000000001 111.301 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.9 mp -106.8 150.1 26.69 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.374 1.07 . . . . 0.58999999999999997 113.577 172.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.576 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 19.6 p -77.48 135.28 38.24 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 118.839 0.745 . . . . 0.60999999999999999 110.845 170.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -96.26 -58.65 2.02 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 115.345 1.609 . . . . 2.5699999999999998 115.345 -169.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -153.61 -35.23 0.11 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.101 1.36 . . . . 1.1100000000000001 112.142 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -100.67 -38.72 8.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.242 1.017 . . . . 3.71 112.075 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.86 -160.81 30.97 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.425 1.012 . . . . 0.68999999999999995 112.446 -174.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -134.82 123.68 23.93 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.381 1.872 . . . . 0.44 112.229 170.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -81.61 133.61 35.39 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.037 0.935 . . . . 2.46 112.29 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -120.58 141.27 50.46 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 128.955 2.902 . . . . 1.9199999999999999 109.493 174.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.436 HD21 ' HB3' ' A' ' 132' ' ' ALA . 2.8 t-20 -94.29 112.74 24.56 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.337 1.055 . . . . 2.9100000000000001 111.429 -174.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.2 p -94.25 1.27 56.0 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.21 1.189 . . . . 0.72999999999999998 114.21 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.436 ' HB3' HD21 ' A' ' 130' ' ' ASN . . . -59.91 -23.37 63.44 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.012 1.116 . . . . 0.71999999999999997 114.012 -176.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.14 -6.24 13.67 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.573 1.323 . . . . 2.1200000000000001 114.573 -170.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.22 132.16 70.78 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 119.278 0.945 . . . . 0.78000000000000003 113.324 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.08 168.45 23.98 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.468 2.112 . . . . 0.82999999999999996 111.106 169.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.0 83.13 0.68 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.468 1.907 . . . . 1.53 110.921 -177.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -135.38 173.57 11.57 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.505 1.522 . . . . 1.21 110.355 173.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -93.67 140.23 29.88 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.728 1.252 . . . . 3.4399999999999999 111.17 168.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -126.24 165.97 17.96 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.514 1.925 . . . . 0.71999999999999997 109.45 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -141.3 153.45 45.19 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.644 0.777 . . . . 1.6299999999999999 111.793 175.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.08 139.33 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.623 0.769 . . . . 0.44 110.449 173.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -127.62 140.31 52.18 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.486 1.914 . . . . 1.8200000000000001 110.488 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -102.43 130.76 49.31 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.065 1.346 . . . . 1.8100000000000001 111.108 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 37.6 mm -130.57 113.74 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.748 0.819 . . . . 0.92000000000000004 109.846 -169.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -77.08 -8.44 57.47 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.198 1.185 . . . . 3.5099999999999998 114.198 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 115.149 1.537 . . . . 3.1299999999999999 115.149 -176.466 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 113.131 0.789 . . . . 1.8400000000000001 113.131 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.47 154.99 34.21 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.99 0.737 . . . . 0.82999999999999996 112.99 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.33 145.48 36.12 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.328 1.051 . . . . 0.56000000000000005 112.012 170.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.47 146.56 44.71 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.311 2.674 . . . . 0.5 113.366 -168.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.419 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.2 mp -117.1 128.93 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.359 1.863 . . . . 1.3500000000000001 108.81 -168.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -94.94 145.23 25.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.332 1.053 . . . . 2.9399999999999999 112.356 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.4 tt -150.84 157.28 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 125.625 1.57 . . . . 0.71999999999999997 110.533 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -136.56 -178.65 5.27 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.584 1.554 . . . . 2.5499999999999998 109.708 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.48 156.43 90.55 Favored Pre-proline 0 CA--C 1.552 1.051 0 O-C-N 120.811 -1.181 . . . . 2.1000000000000001 112.315 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -83.27 75.99 4.12 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.061 3.174 . . . . 1.6000000000000001 114.213 -167.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 4.5 tt -94.29 80.84 3.98 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 105.915 -1.883 . . . . 3.25 105.915 166.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -147.2 160.35 42.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.093 1.357 . . . . 3.8300000000000001 112.304 -168.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -74.37 -18.23 60.7 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.921 1.288 . . . . 3.21 113.553 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.2 m -65.83 150.72 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.887 1.675 . . . . 1.55 113.734 -173.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.13 -40.61 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.553 1.141 . . . . 2.0499999999999998 109.934 173.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -132.33 141.54 48.99 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.469 1.508 . . . . 2.8999999999999999 109.509 172.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -92.45 156.03 17.46 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.313 0.645 . . . . 0.56000000000000005 111.777 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -137.13 165.04 27.02 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.835 1.421 . . . . 0.54000000000000004 114.835 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.55 142.16 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 126.216 1.806 . . . . 0.51000000000000001 110.952 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -134.42 71.7 71.41 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 113.382 0.882 . . . . 1.9299999999999999 113.382 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . 0.419 ' HB3' HD11 ' A' ' 166' ' ' ILE . 20.5 Cg_endo -62.75 144.35 93.66 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 124.006 3.137 . . . . 0.51000000000000001 113.824 -176.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -120.25 158.01 27.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.088 2.155 . . . . 1.55 112.184 -171.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -110.56 159.13 17.82 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.355 1.074 . . . . 3.1200000000000001 113.481 175.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 CA--C 1.54 0.57 0 C-N-CA 127.66 2.384 . . . . 3.0 109.091 175.185 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.9 p . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 114.194 1.183 . . . . 1.55 114.194 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.2 p -88.73 -65.5 1.01 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.506 0.722 . . . . 1.8600000000000001 112.487 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 m -91.92 144.71 25.19 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.917 1.287 . . . . 2.3199999999999998 113.019 -169.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.5 p -101.43 -2.13 31.56 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.975 1.71 . . . . 0.81000000000000005 114.665 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.1 m -151.29 150.71 30.86 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.267 -1.52 . . . . 1.98 110.952 170.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.24 149.09 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.864 2.066 . . . . 0.41999999999999998 109.936 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.5 m -117.16 124.94 50.37 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.18 0.592 . . . . 0.68999999999999995 111.305 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.42 131.73 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.387 1.075 . . . . 0.48999999999999999 110.637 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -126.76 96.63 4.71 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.017 1.327 . . . . 1.76 110.814 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -71.48 121.53 18.81 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.723 -1.236 . . . . 1.1399999999999999 110.805 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.5 mt -109.02 159.9 16.46 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.594 1.158 . . . . 0.67000000000000004 112.187 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.4 mt -142.45 161.07 39.0 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.624 1.97 . . . . 1.8700000000000001 109.973 168.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.2 163.98 15.88 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.839 0.856 . . . . 0.92000000000000004 111.783 168.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.1 p -85.59 -32.83 21.88 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.279 -0.888 . . . . 1.22 113.275 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -146.87 55.83 1.13 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.523 1.129 . . . . 2.6499999999999999 111.05 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.62 11.36 82.98 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.728 1.632 . . . . 1.04 115.446 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -69.94 18.09 0.05 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.339 2.255 . . . . 1.8100000000000001 115.534 -172.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -61.38 -31.09 70.99 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.875 -1.14 . . . . 0.82999999999999996 112.291 -176.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -61.47 -49.89 74.96 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.593 1.157 . . . . 2.25 112.636 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -72.44 -43.14 64.21 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.058 -1.026 . . . . 2.48 111.511 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.5 mt -48.98 -48.78 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 119.491 1.041 . . . . 0.65000000000000002 110.976 169.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.19 -30.46 70.43 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.072 1.305 . . . . 0.91000000000000003 113.052 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -77.3 -31.41 54.71 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.717 0.807 . . . . 1.0800000000000001 112.631 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -69.53 -20.35 63.7 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.276 1.03 . . . . 1.9199999999999999 113.558 169.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.6 mt -96.96 -36.06 10.66 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.08 1.141 . . . . 1.0900000000000001 114.08 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -21.91 66.85 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.414 1.006 . . . . 4.3099999999999996 112.919 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.5 t -69.29 -29.75 67.69 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.277 1.031 . . . . 1.8300000000000001 113.509 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.21 165.92 26.75 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.809 1.195 . . . . 1.29 113.568 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -83.89 43.04 0.89 Allowed 'General case' 0 N--CA 1.481 1.09 0 O-C-N 121.458 -1.025 . . . . 1.98 112.748 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -80.8 1.04 32.18 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.894 1.278 . . . . 2.23 114.282 -169.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.2 -25.87 65.93 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.715 -1.241 . . . . 1.0700000000000001 112.406 169.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.74 -51.66 0.41 Allowed Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.541 1.067 . . . . 0.70999999999999996 112.503 169.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -75.82 162.93 27.74 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.056 1.132 . . . . 2.98 114.056 -171.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -63.7 156.82 25.85 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.116 0.566 . . . . 3.0 111.6 167.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.411 HG23 ' CE2' ' A' ' 181' ' ' TYR . 73.6 t -66.01 143.3 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 122.996 0.518 . . . . 0.87 110.063 170.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.32 -64.78 2.83 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 123.807 0.718 . . . . 1.1399999999999999 113.508 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.2 t -142.88 134.16 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.88 1.672 . . . . 2.8300000000000001 110.157 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.5 mt -83.35 146.82 51.65 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.538 0.735 . . . . 1.29 111.962 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.01 159.17 54.17 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.639 1.559 . . . . 1.23 111.476 172.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.51 -24.87 66.46 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.565 -1.334 . . . . 2.0299999999999998 111.147 169.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.71 4.56 6.08 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.968 1.47 . . . . 1.45 114.968 169.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.2 155.16 29.88 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.595 1.958 . . . . 0.78000000000000003 111.98 169.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.24 163.34 34.75 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.738 0.815 . . . . 1.8 113.181 167.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -107.05 137.96 44.14 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.39 1.876 . . . . 2.75 110.353 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.51 145.96 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.546 1.138 . . . . 0.85999999999999999 111.78 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.93 153.37 33.71 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.645 1.178 . . . . 0.90000000000000002 112.642 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.36 19.71 40.85 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.41 1.005 . . . . 0.60999999999999999 114.161 -170.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 p -97.79 143.64 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.042 1.337 . . . . 0.72999999999999998 108.889 168.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -105.4 142.93 34.29 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.194 1.397 . . . . 0.52000000000000002 112.667 -174.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.545 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.5 OUTLIER -148.82 152.32 36.3 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.304 1.442 . . . . 1.6899999999999999 111.716 175.654 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.23 146.57 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 127.002 2.121 . . . . 0.29999999999999999 109.313 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -88.99 143.07 27.11 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.176 0.988 . . . . 0.40999999999999998 112.502 170.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.5 p -133.96 164.15 27.95 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.451 1.901 . . . . 0.40000000000000002 112.845 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -88.18 169.62 11.74 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.922 1.289 . . . . 1.72 110.723 166.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.57 -21.51 66.6 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.301 1.223 . . . . 2.8100000000000001 114.301 -170.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -77.55 19.36 0.37 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.886 0.874 . . . . 1.74 112.817 168.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 56.25 29.14 14.36 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.257 1.823 . . . . 0.76000000000000001 113.117 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -90.0 140.54 29.53 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.099 1.359 . . . . 2.3700000000000001 111.39 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.1 mt -80.77 126.5 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 118.087 0.403 . . . . 0.54000000000000004 110.378 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.45 HG22 HG22 ' A' ' 97' ' ' THR . 2.2 pp -122.21 151.51 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.605 1.562 . . . . 1.2 114.134 -175.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.28 164.64 19.95 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 127.21 2.204 . . . . 2.3399999999999999 112.103 169.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.5 -17.93 48.57 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.823 1.786 . . . . 3.3500000000000001 115.823 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -92.72 4.71 53.24 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.913 1.285 . . . . 3.8300000000000001 111.557 172.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.51 10.38 85.75 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 127.294 2.378 . . . . 0.66000000000000003 115.492 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -63.88 135.89 56.93 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.236 1.018 . . . . 2.6600000000000001 108.553 169.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.45 HG22 HG22 ' A' ' 91' ' ' ILE . 51.9 p -90.79 139.88 30.31 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.111 0.482 . . . . 0.83999999999999997 111.726 178.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.18 -6.09 51.33 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.818 -1.176 . . . . 0.89000000000000001 113.913 -169.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.88 27.44 34.48 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 119.898 1.226 . . . . 1.0 113.695 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.3 t -136.9 148.93 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.267 1.427 . . . . 1.23 109.583 177.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -137.44 154.78 49.87 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 128.568 2.747 . . . . 1.28 110.745 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.434 HG12 HD23 ' A' ' 109' ' ' LEU . 33.0 mt -133.31 136.64 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.248 1.419 . . . . 0.63 110.179 -173.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -77.82 141.62 64.26 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-O 117.543 -1.217 . . . . 2.1899999999999999 111.933 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.0 -16.28 18.14 Favored 'Trans proline' 0 C--N 1.352 0.733 0 CA-C-N 122.139 1.8 . . . . 0.84999999999999998 113.416 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -101.92 -48.09 4.37 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.99 1.716 . . . . 1.3500000000000001 111.28 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 p -83.92 -28.65 27.73 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.953 0.723 . . . . 1.3999999999999999 112.953 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 56.34 23.28 7.12 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.883 1.673 . . . . 1.8500000000000001 113.484 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.85 153.67 21.14 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.528 -1.358 . . . . 2.4399999999999999 111.817 174.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.434 HD23 HG12 ' A' ' 102' ' ' ILE . 29.6 mt -92.04 139.03 31.04 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.679 1.192 . . . . 0.87 112.375 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.5 p -74.24 6.69 3.34 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.716 1.206 . . . . 1.4299999999999999 113.956 175.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.21 -158.72 20.44 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 126.446 1.974 . . . . 0.93999999999999995 111.068 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.99 155.14 32.83 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 122.065 -0.667 . . . . 1.04 112.429 175.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.8 tpt -59.48 125.28 78.99 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.877 0.871 . . . . 1.79 109.926 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -70.4 167.45 25.22 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 124.39 3.393 . . . . 0.93000000000000005 113.9 -172.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.69 -97.59 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.176 1.391 . . . . 1.6399999999999999 111.032 170.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 50.7 p -71.3 11.43 0.44 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.522 2.045 . . . . 1.01 116.522 -167.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.67 150.35 3.96 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.25 -0.906 . . . . 0.48999999999999999 112.943 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.2 tpt -78.27 88.45 4.32 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.081 2.152 . . . . 1.6599999999999999 110.713 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -147.66 135.05 20.69 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.039 1.736 . . . . 0.94999999999999996 111.32 -171.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -169.24 145.98 3.46 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.23 1.412 . . . . 3.5600000000000001 110.2 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.09 156.12 21.21 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.572 1.323 . . . . 0.5 114.572 -175.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.545 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 3.9 p -66.3 137.87 57.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 119.866 -1.771 . . . . 0.48999999999999999 110.319 169.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -98.82 -56.57 2.4 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.462 1.105 . . . . 2.6499999999999999 113.344 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -167.84 -39.95 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.598 1.959 . . . . 1.24 110.742 168.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -96.6 25.5 5.1 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.847 1.659 . . . . 5.0999999999999996 112.574 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.6 -150.94 19.74 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.033 1.778 . . . . 0.67000000000000004 111.348 -169.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.53 128.37 21.84 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.279 1.832 . . . . 0.39000000000000001 110.347 168.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -75.62 136.13 40.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.941 1.297 . . . . 1.55 110.927 172.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -128.11 117.46 21.65 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.282 1.833 . . . . 1.74 108.876 169.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -77.27 122.03 24.52 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.177 -0.952 . . . . 1.47 110.82 175.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.7 p -112.03 -4.64 14.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.934 1.294 . . . . 0.92000000000000004 114.069 -171.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.9 -15.69 5.34 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 115.918 1.822 . . . . 0.68000000000000005 115.918 -172.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -106.39 0.9 25.25 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.086 1.355 . . . . 2.7400000000000002 114.076 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.84 146.01 87.39 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 120.521 1.509 . . . . 0.83999999999999997 113.122 170.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.99 164.83 32.6 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.934 1.756 . . . . 1.1599999999999999 110.364 165.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.39 88.52 1.58 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.454 1.501 . . . . 1.47 110.3 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -139.95 -179.22 5.83 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.042 1.337 . . . . 1.1200000000000001 111.185 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -92.69 140.84 29.12 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.574 1.15 . . . . 2.25 111.813 168.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -132.55 169.93 15.9 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.988 1.715 . . . . 0.75 110.298 -169.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -152.53 147.59 26.38 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.43 1.092 . . . . 3.6299999999999999 112.264 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -105.25 136.38 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 123.797 0.839 . . . . 0.40999999999999998 109.024 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -123.44 122.41 38.19 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.376 1.47 . . . . 1.8500000000000001 110.019 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -83.36 75.75 9.96 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.993 1.317 . . . . 2.1299999999999999 111.109 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.0 mm -80.82 113.85 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.41 -0.959 . . . . 1.03 108.41 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -116.35 28.34 8.65 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.703 0.801 . . . . 5.0199999999999996 113.131 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.2 p . . . . . 0 N--CA 1.471 0.599 0 C-N-CA 124.226 1.01 . . . . 1.8400000000000001 111.572 168.544 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.428 ' HE3' HG13 ' A' ' 164' ' ' VAL . 21.9 ttpt . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 111.54 0.2 . . . . 2.5600000000000001 111.54 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.87 154.16 34.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.478 0.711 . . . . 0.98999999999999999 111.275 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.428 HG13 ' HE3' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -123.04 143.21 40.14 Favored Pre-proline 0 N--CA 1.477 0.898 0 O-C-N 121.521 -0.737 . . . . 0.84999999999999998 111.202 174.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.21 145.41 72.4 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.825 3.016 . . . . 0.56000000000000005 111.653 -168.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.461 HD11 ' HB3' ' A' ' 182' ' ' PRO . 1.3 mp -103.94 124.01 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.129 0.971 . . . . 1.3200000000000001 109.492 -171.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.87 138.05 32.44 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.84 0.746 . . . . 3.0699999999999998 112.894 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.3 tt -147.92 156.15 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.18 0.992 . . . . 0.42999999999999999 111.682 -172.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -134.46 166.55 22.6 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.099 1.76 . . . . 2.6099999999999999 109.481 169.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -61.5 155.55 58.29 Favored Pre-proline 0 CA--C 1.551 1.017 0 O-C-N 120.973 -1.079 . . . . 1.6100000000000001 111.932 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.42 94.9 0.92 Allowed 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.919 3.079 . . . . 0.87 112.111 -169.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.44 45.58 2.63 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.379 1.871 . . . . 2.3500000000000001 108.803 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -128.81 18.4 6.18 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 127.214 2.206 . . . . 3.1200000000000001 113.024 -167.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.3 t70 60.96 17.75 8.2 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 128.171 2.588 . . . . 4.0800000000000001 115.639 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.3 m -86.58 153.03 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 114.282 1.215 . . . . 1.1000000000000001 114.282 -172.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.13 -32.26 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.083 1.753 . . . . 1.74 112.095 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -153.78 141.03 19.55 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.737 1.215 . . . . 2.4300000000000002 110.19 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -101.86 140.77 35.7 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.208 0.818 . . . . 0.48999999999999999 113.208 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -136.8 166.04 24.54 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.032 1.493 . . . . 0.53000000000000003 115.032 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.76 143.55 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 127.2 2.2 . . . . 0.46999999999999997 111.485 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.411 ' CE2' HG23 ' A' ' 66' ' ' VAL . 97.7 m-85 -133.06 82.74 53.66 Favored Pre-proline 0 CA--C 1.553 1.066 0 N-CA-C 113.584 0.957 . . . . 1.9299999999999999 113.584 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . 0.461 ' HB3' HD11 ' A' ' 166' ' ' ILE . 6.6 Cg_exo -58.0 143.99 95.28 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.699 2.932 . . . . 0.60999999999999999 115.51 175.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -133.6 165.93 23.78 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 128.55 2.74 . . . . 1.5 112.623 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -119.62 173.3 7.09 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.002 2.121 . . . . 2.8799999999999999 111.154 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 117.352 2.352 . . . . 2.9300000000000002 117.352 -169.95 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.0 p . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 115.774 1.768 . . . . 1.5700000000000001 115.774 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.2 p -121.7 0.11 9.78 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.324 1.45 . . . . 1.45 114.029 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 m -156.41 158.32 37.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.976 1.711 . . . . 2.6000000000000001 110.42 -170.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 43.1 p -117.27 -11.66 10.6 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 126.425 1.89 . . . . 1.1899999999999999 115.552 -174.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 p -143.68 153.31 42.35 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.903 1.681 . . . . 2.2200000000000002 113.064 -175.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.3 p -130.93 135.2 60.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 126.426 1.891 . . . . 0.52000000000000002 109.119 174.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.8 m -114.62 126.04 54.44 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 118.254 0.479 . . . . 0.84999999999999998 110.509 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.2 p -96.89 132.38 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.225 1.01 . . . . 0.80000000000000004 110.318 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -129.59 98.31 4.8 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.584 1.554 . . . . 2.0699999999999998 109.732 -174.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.09 126.18 30.49 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.619 -1.3 . . . . 0.94999999999999996 111.842 -169.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.6 mt -103.59 151.67 22.64 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.37 1.068 . . . . 0.60999999999999999 113.322 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.53 161.63 35.33 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.567 1.547 . . . . 2.0600000000000001 109.451 169.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.553 ' HB1' ' H ' ' A' ' 48' ' ' ASP . . . -97.18 154.03 17.63 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.732 0.813 . . . . 0.66000000000000003 112.027 172.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.4 p -87.64 -20.19 26.68 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.29 1.219 . . . . 1.1000000000000001 114.29 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -151.5 51.99 0.83 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.882 1.673 . . . . 2.1699999999999999 112.455 170.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.99 23.79 70.92 Favored Glycine 0 CA--C 1.536 1.388 0 O-C-N 120.439 -1.413 . . . . 1.1100000000000001 115.989 172.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.553 ' H ' ' HB1' ' A' ' 44' ' ' ALA . 4.2 m-20 -81.1 10.95 4.54 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 128.213 2.605 . . . . 1.8600000000000001 115.622 -174.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -57.81 -31.25 66.41 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.37 -1.456 . . . . 0.82999999999999996 112.629 -171.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.42 -49.75 52.17 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.788 1.235 . . . . 2.3100000000000001 113.465 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -69.7 -33.06 72.01 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 120.968 -1.082 . . . . 3.1800000000000002 111.495 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.42 -52.67 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.502 1.121 . . . . 0.78000000000000003 110.095 168.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.86 -34.99 70.34 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.127 0.876 . . . . 0.84999999999999998 112.484 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -67.62 -32.47 73.21 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.405 0.891 . . . . 0.95999999999999996 113.405 173.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.99 -28.24 65.36 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.063 1.301 . . . . 1.98 113.017 171.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.4 mt -87.2 -40.95 14.11 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.673 0.99 . . . . 1.01 113.673 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -67.41 -21.21 65.59 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.437 0.903 . . . . 2.8500000000000001 113.437 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.4 t -75.79 -25.69 56.62 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 121.393 -0.817 . . . . 1.54 112.88 169.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.46 161.19 32.3 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 126.141 1.829 . . . . 1.0600000000000001 113.918 174.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -84.27 33.47 0.5 Allowed 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.945 -1.326 . . . . 2.3100000000000001 113.78 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -72.1 8.44 1.28 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.595 1.702 . . . . 2.2999999999999998 115.595 -169.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.1 -30.17 71.09 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.219 -0.925 . . . . 1.04 109.881 165.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.25 -83.74 1.75 Allowed Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.067 1.318 . . . . 0.79000000000000004 112.476 171.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -65.99 151.8 46.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.608 1.336 . . . . 1.5700000000000001 114.608 -173.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -59.16 143.37 49.06 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.075 1.35 . . . . 4.0300000000000002 111.3 172.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.8 t -53.89 136.24 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.343 0.657 . . . . 1.03 111.181 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.7 -64.42 3.32 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.682 0.658 . . . . 0.91000000000000003 112.515 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.4 t -137.52 125.86 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.581 1.152 . . . . 1.9299999999999999 110.623 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.8 mt -80.73 143.78 54.95 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.316 0.647 . . . . 0.85999999999999999 110.896 172.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.91 162.18 42.7 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.141 1.894 . . . . 0.68999999999999995 112.158 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.63 -21.63 66.47 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.646 0.98 . . . . 0.93000000000000005 113.646 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -92.55 -1.48 56.9 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 115.082 1.512 . . . . 1.53 115.082 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.41 152.41 21.5 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.853 0.861 . . . . 0.80000000000000004 113.147 169.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.7 pttt -146.43 167.73 22.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.577 1.551 . . . . 1.95 111.77 168.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -118.4 143.44 46.66 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.864 1.666 . . . . 2.3999999999999999 109.931 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.1 pt -126.93 142.91 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 114.468 1.285 . . . . 0.71999999999999997 114.468 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.66 153.22 20.34 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.823 1.649 . . . . 0.67000000000000004 112.316 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.63 7.07 61.93 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.964 1.745 . . . . 0.65000000000000002 115.28 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.0 p -90.42 143.75 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 118.547 1.173 . . . . 0.80000000000000004 110.112 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 1.3 tpp -111.67 132.85 54.31 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.105 1.762 . . . . 0.62 112.016 -172.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.55 153.06 48.69 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.39 1.476 . . . . 1.73 111.53 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.81 143.19 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 126.346 1.859 . . . . 0.41999999999999998 109.514 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -84.78 145.99 27.6 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 122.817 1.294 . . . . 0.34999999999999998 111.244 169.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.3 p -140.27 170.69 15.35 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.29 1.836 . . . . 0.33000000000000002 111.527 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.75 173.23 9.59 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.525 0.73 . . . . 2.0099999999999998 112.926 169.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.7 p -64.1 -16.91 62.82 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 120.744 -1.223 . . . . 1.4199999999999999 113.513 170.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 -80.96 8.1 9.18 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.418 1.487 . . . . 2.73 113.014 168.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.52 25.54 9.89 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.129 2.172 . . . . 0.71999999999999997 113.28 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -89.29 141.46 28.52 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.633 1.573 . . . . 2.52 110.612 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.423 HD11 ' CD2' ' A' ' 109' ' ' LEU . 10.8 mt -76.66 126.98 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.416 -0.587 . . . . 0.5 109.416 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.459 HG22 HG22 ' A' ' 97' ' ' THR . 3.2 pt -122.07 154.38 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 114.637 1.347 . . . . 0.5 114.637 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.29 163.32 24.04 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.168 2.187 . . . . 1.74 111.336 167.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.74 -1.18 3.53 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 115.499 1.666 . . . . 2.3300000000000001 115.499 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -105.14 -1.57 25.34 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.907 1.683 . . . . 3.96 113.218 169.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.16 -0.68 64.21 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.436 1.969 . . . . 0.66000000000000003 115.853 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -69.66 139.18 53.48 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 119.185 1.492 . . . . 2.3199999999999998 110.893 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.459 HG22 HG22 ' A' ' 91' ' ' ILE . 5.5 p -99.21 141.26 32.21 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.732 0.813 . . . . 0.77000000000000002 112.402 -172.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.23 -8.0 46.62 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.475 1.287 . . . . 0.80000000000000004 114.475 -168.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.5 24.0 57.32 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.052 0.842 . . . . 0.81999999999999995 113.661 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.95 147.08 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.214 1.406 . . . . 1.1699999999999999 109.311 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -133.67 158.22 43.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.839 1.656 . . . . 1.29 111.656 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 60.0 mt -133.19 141.04 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.912 1.285 . . . . 0.62 110.684 -170.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -81.98 145.91 54.37 Favored Pre-proline 0 N--CA 1.477 0.91 0 O-C-N 120.862 -1.149 . . . . 1.8100000000000001 112.659 174.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.68 -19.38 12.84 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 CA-C-N 122.139 1.8 . . . . 0.85999999999999999 113.243 175.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -97.93 -47.74 5.43 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.821 1.649 . . . . 1.4199999999999999 112.47 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.8 p -80.49 -29.18 37.35 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.286 0.635 . . . . 0.92000000000000004 111.879 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 57.74 16.34 3.46 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.531 1.532 . . . . 1.9299999999999999 113.539 -170.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.79 149.23 21.41 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.742 1.217 . . . . 2.6499999999999999 111.718 -175.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.423 ' CD2' HD11 ' A' ' 90' ' ' ILE . 8.2 mt -84.17 138.64 32.89 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.932 1.293 . . . . 0.93999999999999995 111.955 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.1 t -87.02 20.24 2.75 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.685 0.994 . . . . 2.8399999999999999 113.685 172.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -177.42 174.07 46.67 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 126.882 2.182 . . . . 1.21 111.905 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.6 162.78 28.84 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.306 0.854 . . . . 1.01 113.306 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 mmt -51.91 132.45 39.01 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.712 1.205 . . . . 1.6299999999999999 113.074 -175.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -78.59 155.67 27.85 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.323 3.349 . . . . 1.0700000000000001 113.682 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.15 -35.92 23.26 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.893 1.812 . . . . 1.5800000000000001 115.893 -176.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.2 p -131.46 10.22 4.79 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.832 1.653 . . . . 0.90000000000000002 113.035 -168.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.85 152.29 16.22 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.689 1.366 . . . . 0.54000000000000004 114.689 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.1 ttt -80.19 85.31 5.74 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.85 1.66 . . . . 1.8899999999999999 111.712 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -135.45 153.85 51.63 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.005 1.722 . . . . 1.23 112.456 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -164.02 158.34 19.4 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.124 1.77 . . . . 1.8700000000000001 110.747 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 mp -98.28 147.29 24.79 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.31 1.044 . . . . 0.57999999999999996 112.469 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.2 p -65.1 125.68 25.72 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 120.329 1.422 . . . . 0.64000000000000001 109.822 169.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.52 -52.02 7.24 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.372 1.619 . . . . 2.02 115.372 -169.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.78 -46.07 0.1 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.784 1.634 . . . . 1.3700000000000001 109.075 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -116.01 -17.03 11.02 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.524 1.305 . . . . 4.0899999999999999 114.524 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 172.57 -169.5 42.62 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.093 1.33 . . . . 0.65000000000000002 112.593 -172.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.52 126.82 18.64 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.281 1.832 . . . . 0.45000000000000001 112.413 170.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -80.19 136.7 36.54 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.873 1.269 . . . . 1.25 112.388 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -127.52 142.38 51.4 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.321 2.649 . . . . 2.0699999999999998 108.671 171.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.46 HD21 ' HB3' ' A' ' 132' ' ' ALA . 2.2 t-20 -105.91 111.97 24.84 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.93 0.892 . . . . 2.1400000000000001 110.619 -175.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.0 p -94.15 -8.41 39.53 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.314 1.228 . . . . 0.80000000000000004 114.314 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.46 ' HB3' HD21 ' A' ' 130' ' ' ASN . . . -54.23 -14.85 1.26 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.885 1.674 . . . . 0.96999999999999997 115.357 -176.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.92 -21.71 13.09 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.556 1.542 . . . . 2.6200000000000001 112.866 -176.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -72.21 144.57 87.33 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 119.779 1.172 . . . . 0.77000000000000002 112.523 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.94 168.16 25.45 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.84 2.36 . . . . 0.73999999999999999 111.99 172.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -72.35 76.38 1.01 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.625 1.97 . . . . 1.0700000000000001 111.818 -176.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -142.03 -173.54 3.84 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.115 1.366 . . . . 0.78000000000000003 111.305 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -104.66 154.7 19.63 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.233 1.413 . . . . 3.0099999999999998 112.201 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -145.3 169.8 17.55 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 127.456 2.302 . . . . 0.58999999999999997 110.178 -173.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -137.97 154.66 49.34 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.866 1.061 . . . . 1.6699999999999999 113.866 175.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.6 mp -113.58 136.9 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.566 1.146 . . . . 0.45000000000000001 110.763 174.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -125.9 149.65 48.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.746 2.018 . . . . 1.8400000000000001 110.558 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -112.05 120.16 40.89 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.581 1.152 . . . . 1.8899999999999999 110.72 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 22.9 mm -129.07 113.96 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.352 1.061 . . . . 0.58999999999999997 109.421 -169.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -98.91 15.32 25.98 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.687 1.195 . . . . 5.3200000000000003 113.544 -174.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 82.5 p . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 114.253 1.205 . . . . 2.1099999999999999 114.253 -176.484 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 112.436 0.532 . . . . 3.3700000000000001 112.436 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.07 155.45 40.29 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.091 0.775 . . . . 1.48 113.091 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.74 150.78 37.34 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 124.469 1.108 . . . . 0.60999999999999999 110.018 167.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.6 140.51 32.89 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.894 2.396 . . . . 0.80000000000000004 113.244 -168.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.9 mp -111.23 139.27 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.146 1.779 . . . . 1.3899999999999999 109.874 -173.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -107.45 141.32 39.04 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.914 1.079 . . . . 2.7599999999999998 113.914 173.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.8 tt -145.38 155.37 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 125.326 1.45 . . . . 0.56999999999999995 111.779 -170.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -134.89 160.21 38.98 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.669 1.988 . . . . 1.99 110.382 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.95 144.54 81.85 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.347 -0.846 . . . . 2.0600000000000001 112.573 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.4 113.57 3.52 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.148 2.565 . . . . 0.82999999999999996 113.793 -169.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 4.2 tt -126.18 79.05 1.81 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 105.388 -2.079 . . . . 3.5099999999999998 105.388 166.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -149.79 156.07 41.2 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.085 2.154 . . . . 3.4900000000000002 109.686 -169.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -80.54 33.47 0.31 Allowed 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.787 -1.196 . . . . 4.0800000000000001 113.94 -177.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 32.9 m -110.25 169.18 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.216 1.406 . . . . 2.0699999999999998 112.481 -173.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 61.4 t -101.93 -29.06 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.651 1.181 . . . . 2.77 110.384 171.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.49 140.79 41.39 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.266 1.426 . . . . 3.2599999999999998 111.434 173.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -91.31 152.88 20.29 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.848 0.859 . . . . 0.47999999999999998 110.626 173.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -138.87 153.13 48.28 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.337 0.865 . . . . 0.96999999999999997 113.337 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.38 140.57 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.106 1.762 . . . . 0.72999999999999998 111.002 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -128.97 74.11 81.31 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.735 0.814 . . . . 2.2400000000000002 112.907 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.61 150.05 44.77 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.141 3.227 . . . . 0.88 113.818 -175.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -132.01 165.01 24.93 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.48 2.312 . . . . 1.5 113.014 -169.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -108.67 161.0 15.5 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.415 1.486 . . . . 3.0499999999999998 113.613 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.469 0.475 0 C-N-CA 126.075 1.75 . . . . 3.1499999999999999 108.613 167.202 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.5 p . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 113.678 0.992 . . . . 1.1499999999999999 113.678 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.4 p -89.9 -20.4 23.43 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 115.014 1.487 . . . . 1.71 115.014 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.6 t -154.51 156.07 36.0 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.376 1.47 . . . . 2.2400000000000002 110.775 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.4 p -80.67 -4.56 54.73 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.497 1.666 . . . . 1.3700000000000001 115.497 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.9 p -149.69 161.87 41.35 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.596 1.702 . . . . 1.7 115.596 -170.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.6 p -128.4 143.65 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 127.043 2.137 . . . . 0.44 110.003 173.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.0 m -113.89 118.39 34.06 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.223 1.009 . . . . 0.70999999999999996 109.073 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 p -94.49 130.93 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 122.061 0.934 . . . . 0.65000000000000002 109.289 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -108.56 -179.47 3.88 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.174 1.79 . . . . 1.9199999999999999 109.424 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.53 122.3 9.29 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 120.168 -1.583 . . . . 1.3200000000000001 111.656 169.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.6 mt -111.63 151.21 29.07 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.249 1.02 . . . . 0.56999999999999995 112.688 -171.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.78 159.85 38.56 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.163 1.785 . . . . 1.9199999999999999 110.917 175.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.61 165.27 11.32 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.513 1.125 . . . . 0.77000000000000002 112.358 173.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.6 p -97.84 -17.12 19.49 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.874 1.435 . . . . 1.3999999999999999 114.874 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -152.04 49.05 0.78 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.903 1.681 . . . . 2.8199999999999998 110.572 169.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.29 11.28 85.11 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 116.497 1.359 . . . . 1.04 116.497 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.56 16.02 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 128.674 2.789 . . . . 2.3100000000000001 116.749 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -19.92 60.2 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.572 -1.33 . . . . 0.77000000000000002 112.926 -176.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -82.3 -47.65 12.13 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.409 1.483 . . . . 2.8700000000000001 113.167 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -65.25 -41.3 94.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.7 1.136 . . . . 2.79 111.099 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.8 mt -52.05 -52.96 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 119.56 1.073 . . . . 0.58999999999999997 110.282 168.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.8 -30.88 62.07 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 120.676 1.58 . . . . 0.81000000000000005 113.618 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -77.49 -37.22 51.68 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.504 0.927 . . . . 1.1799999999999999 113.504 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -63.85 -22.68 67.03 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.856 0.863 . . . . 1.95 112.631 169.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.7 mt -88.79 -44.86 10.21 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.337 0.865 . . . . 0.94999999999999996 113.337 173.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -69.57 -15.08 63.15 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.851 1.205 . . . . 2.6499999999999999 114.092 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.7 t -75.19 -28.36 59.99 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.515 1.126 . . . . 1.3500000000000001 112.242 169.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.73 166.98 38.05 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.944 1.259 . . . . 1.03 112.786 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -85.76 35.73 0.63 Allowed 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.947 -1.325 . . . . 1.6799999999999999 111.743 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -75.64 4.77 7.11 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.938 1.088 . . . . 1.9399999999999999 113.938 -171.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.72 -30.87 71.04 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.517 1.127 . . . . 1.0700000000000001 110.003 164.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.32 -76.56 0.75 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.358 1.456 . . . . 0.68000000000000005 112.51 171.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.254 0.0 OUTLIER -71.01 154.74 41.56 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.212 1.56 . . . . 1.5600000000000001 115.212 -169.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.56 151.05 29.74 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.949 0.9 . . . . 4.8099999999999996 112.522 -177.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.412 HG23 ' CE2' ' A' ' 181' ' ' TYR . 73.6 t -60.36 123.3 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 109.751 -0.463 . . . . 0.91000000000000003 109.751 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.84 -53.45 40.77 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.262 0.458 . . . . 1.26 113.823 -170.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.8 t -150.5 127.73 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.942 1.697 . . . . 2.9100000000000001 108.408 171.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.8 mt -75.99 152.55 84.53 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.343 1.057 . . . . 1.1899999999999999 112.808 173.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.35 162.72 41.48 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.396 2.064 . . . . 0.64000000000000001 112.071 175.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.4 -30.9 69.89 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.373 -0.829 . . . . 0.90000000000000002 111.916 170.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.29 5.66 8.16 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 115.68 1.733 . . . . 1.3600000000000001 115.68 173.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.84 157.02 21.9 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.433 1.493 . . . . 0.53000000000000003 113.435 170.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -148.02 169.55 19.68 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.427 1.491 . . . . 1.8799999999999999 111.736 169.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -121.11 139.12 53.76 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.798 1.239 . . . . 1.9099999999999999 110.288 -173.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.3 pt -127.98 142.36 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 121.421 -0.799 . . . . 0.76000000000000001 112.272 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.98 145.25 43.77 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.012 1.325 . . . . 0.67000000000000004 111.699 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.16 23.98 6.16 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.225 1.393 . . . . 0.80000000000000004 114.969 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.3 p -109.78 142.86 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 127.373 2.269 . . . . 0.82999999999999996 110.337 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.0 tpp -98.78 143.79 28.73 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.36 1.464 . . . . 0.70999999999999996 113.415 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -148.09 151.94 36.5 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.672 1.589 . . . . 1.7 111.512 174.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 m -125.29 144.9 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.166 1.786 . . . . 0.53000000000000003 110.153 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -86.04 149.06 25.43 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.69 1.233 . . . . 0.40999999999999998 112.477 170.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.0 p -144.45 170.92 15.11 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.737 2.015 . . . . 0.53000000000000003 111.661 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.66 177.52 5.99 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.208 1.003 . . . . 2.2200000000000002 113.121 169.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 42.3 p -59.96 -29.8 68.66 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.84 0.856 . . . . 1.6000000000000001 113.225 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -78.06 13.74 1.35 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.896 1.279 . . . . 2.0800000000000001 113.823 173.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.7 28.19 15.44 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.332 1.853 . . . . 0.93000000000000005 112.044 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -88.62 138.58 31.29 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.086 1.754 . . . . 2.1000000000000001 110.466 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -78.2 127.22 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.818 -0.438 . . . . 0.68000000000000005 109.818 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.469 HG22 HG22 ' A' ' 97' ' ' THR . 3.0 pt -120.69 157.31 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.812 1.245 . . . . 0.67000000000000004 114.109 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -86.16 163.92 17.54 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.409 1.884 . . . . 1.8500000000000001 110.473 166.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -61.42 -12.72 15.65 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.981 1.474 . . . . 2.29 114.981 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -94.71 0.25 54.86 Favored 'General case' 0 CA--C 1.55 0.947 0 O-C-N 120.656 -1.277 . . . . 3.8900000000000001 112.165 172.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.18 7.47 86.81 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 126.092 1.806 . . . . 0.59999999999999998 115.293 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -64.55 131.17 46.29 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.599 1.2 . . . . 2.5899999999999999 107.974 168.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.469 HG22 HG22 ' A' ' 91' ' ' ILE . 5.9 p -89.95 145.94 24.75 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.66 0.664 . . . . 0.70999999999999996 110.605 175.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.94 -6.07 49.37 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.177 0.806 . . . . 0.88 113.177 -169.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.71 32.43 57.25 Favored Glycine 0 CA--C 1.531 1.073 0 O-C-N 121.399 -0.813 . . . . 1.01 112.468 -173.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.1 t -135.7 148.53 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.797 1.639 . . . . 1.3799999999999999 109.805 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -135.97 154.69 51.01 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.473 2.309 . . . . 1.6499999999999999 111.079 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 54.8 mt -132.77 134.9 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.99 1.316 . . . . 0.91000000000000003 112.248 -171.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -69.25 135.12 89.05 Favored Pre-proline 0 CA--C 1.546 0.804 0 O-C-N 120.635 -1.291 . . . . 2.1299999999999999 111.166 170.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.65 -17.71 25.99 Favored 'Trans proline' 0 C--N 1.35 0.617 0 CA-C-N 122.548 1.946 . . . . 0.98999999999999999 113.657 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -96.08 -43.66 7.67 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.009 1.723 . . . . 1.8999999999999999 112.555 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.3 p -94.24 -22.55 18.34 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.5 1.12 . . . . 1.1299999999999999 113.948 -174.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 53.95 20.41 2.39 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 125.421 1.488 . . . . 2.46 113.975 -169.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.73 144.77 31.94 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.404 -1.435 . . . . 3.0299999999999998 111.511 176.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 mt -90.42 148.24 22.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.899 1.68 . . . . 1.1599999999999999 112.073 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.2 p -74.28 9.75 1.54 Allowed 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.152 1.167 . . . . 1.6499999999999999 114.152 170.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.32 -160.47 24.63 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 126.081 1.801 . . . . 1.0700000000000001 113.034 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.89 160.91 21.02 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.808 1.243 . . . . 0.98999999999999999 112.101 172.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -52.27 130.92 42.59 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.378 1.071 . . . . 1.8 113.484 -174.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -68.94 152.35 73.49 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.975 3.117 . . . . 1.03 114.368 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.31 -64.27 0.89 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.763 1.225 . . . . 1.05 113.653 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.7 p -101.61 7.78 42.03 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.173 1.546 . . . . 0.79000000000000004 115.173 -168.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.78 146.67 13.22 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.205 1.187 . . . . 0.52000000000000002 114.205 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.6 ttt -77.06 89.36 3.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.942 1.697 . . . . 2.1000000000000001 111.513 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -143.87 145.16 32.11 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.894 1.678 . . . . 1.0800000000000001 112.244 -174.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -164.85 159.88 18.86 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.89 1.676 . . . . 1.9099999999999999 111.046 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.38 146.97 26.89 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.815 1.246 . . . . 0.85999999999999999 113.365 174.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.2 p -65.05 125.82 26.13 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.533 -0.73 . . . . 0.67000000000000004 110.814 172.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -87.94 -57.53 2.9 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.471 1.286 . . . . 2.7000000000000002 114.471 -172.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -151.11 -41.25 0.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.02 0.928 . . . . 1.1499999999999999 111.654 -172.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -118.62 -22.44 7.49 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.83 1.252 . . . . 4.4000000000000004 113.503 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 171.52 -160.0 31.84 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 126.079 1.799 . . . . 0.75 111.326 -175.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -139.9 132.94 29.51 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.657 1.983 . . . . 0.53000000000000003 111.272 169.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -87.32 139.91 30.08 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.299 1.44 . . . . 1.6899999999999999 113.72 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -132.32 129.79 39.95 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.538 2.735 . . . . 1.77 108.594 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -92.55 120.78 33.34 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.515 -0.741 . . . . 1.74 110.092 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.6 p -103.42 -2.0 27.63 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.398 1.479 . . . . 0.67000000000000004 113.367 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -52.68 -29.25 25.49 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.872 1.269 . . . . 0.68999999999999995 113.521 173.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -97.42 -15.54 20.6 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.113 1.765 . . . . 1.8899999999999999 114.437 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.52 154.8 81.55 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 119.623 1.101 . . . . 0.72999999999999998 113.064 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -82.72 170.2 12.93 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.303 2.669 . . . . 0.72999999999999998 110.419 165.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.94 98.85 3.67 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.752 1.221 . . . . 0.96999999999999997 109.956 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -153.29 179.08 9.08 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.025 0.93 . . . . 0.66000000000000003 111.878 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -91.12 150.88 21.21 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.091 1.356 . . . . 2.5099999999999998 111.211 168.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -146.13 170.7 16.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.28 1.832 . . . . 0.56999999999999995 110.056 -173.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -140.64 154.63 46.5 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.043 0.937 . . . . 1.8200000000000001 113.043 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.9 mp -114.94 141.52 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.907 1.283 . . . . 0.69999999999999996 110.768 172.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -126.9 117.97 23.63 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.075 2.15 . . . . 1.8999999999999999 110.571 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -82.53 75.4 9.44 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.251 1.02 . . . . 1.79 111.398 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 40.7 mm -71.54 114.26 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 123.232 0.613 . . . . 1.2 109.383 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.36 -5.84 59.28 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.995 1.48 . . . . 3.9199999999999999 114.995 -169.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.476 0.836 0 C-N-CA 125.536 1.535 . . . . 1.6799999999999999 114.054 -177.135 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 111.828 0.307 . . . . 2.3900000000000001 111.828 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.6 147.32 35.71 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.103 0.561 . . . . 0.87 111.212 168.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.7 m -110.86 151.93 43.24 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.761 1.224 . . . . 0.94999999999999996 110.002 172.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.71 161.22 46.81 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.52 2.147 . . . . 0.81000000000000005 113.378 -170.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.3 mp -124.87 128.66 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.783 1.233 . . . . 1.6699999999999999 110.522 -169.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -96.0 138.29 33.83 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.244 1.018 . . . . 2.98 112.955 172.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.4 tt -143.43 151.2 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.376 1.47 . . . . 0.51000000000000001 111.863 -172.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -130.03 149.87 51.56 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.756 1.622 . . . . 2.0800000000000001 109.373 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 15.2 mt -65.71 154.68 88.12 Favored Pre-proline 0 N--CA 1.478 0.95 0 N-CA-C 115.008 1.484 . . . . 0.96999999999999997 115.008 -168.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.8 102.85 1.25 Allowed 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 123.296 2.664 . . . . 0.77000000000000002 114.437 -168.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 16.1 mt -137.39 21.08 2.95 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.262 2.625 . . . . 2.6699999999999999 110.86 170.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -85.78 19.72 2.41 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.958 1.703 . . . . 3.3999999999999999 113.106 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 21.1 t70 61.72 25.72 15.54 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.674 2.39 . . . . 3.5899999999999999 114.367 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 16.5 m -99.1 144.48 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.979 1.312 . . . . 1.0700000000000001 113.093 -174.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 57.6 t -70.78 -34.61 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.705 0.802 . . . . 1.49 111.511 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -140.59 142.34 35.1 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.177 1.391 . . . . 2.6800000000000002 111.807 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -107.38 141.67 38.4 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.411 1.085 . . . . 0.52000000000000002 112.661 -174.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -140.59 166.74 23.92 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.595 1.702 . . . . 0.70999999999999996 115.595 -175.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.91 139.77 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.421 1.888 . . . . 0.66000000000000003 111.56 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.412 ' CE2' HG23 ' A' ' 66' ' ' VAL . 80.6 m-85 -133.33 74.38 72.21 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.723 1.209 . . . . 2.0699999999999998 113.373 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.81 152.13 77.77 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 124.976 3.784 . . . . 0.59999999999999998 113.622 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -133.19 -156.94 0.78 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.389 2.676 . . . . 2.1099999999999999 111.008 -167.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -144.15 163.59 33.16 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.41 1.484 . . . . 2.8900000000000001 112.08 168.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 4.6 t . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 114.45 1.278 . . . . 2.48 114.45 -176.536 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.5 p . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 114.467 1.284 . . . . 1.3100000000000001 114.467 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.3 p -93.22 -14.55 26.94 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.755 0.822 . . . . 1.5900000000000001 112.89 169.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.541 HG22 ' H ' ' A' ' 36' ' ' SER . 9.3 m -146.38 148.26 32.15 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.201 2.2 . . . . 2.5899999999999999 109.708 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 p -111.45 16.65 20.67 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.964 1.706 . . . . 1.6599999999999999 113.937 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.541 ' H ' HG22 ' A' ' 34' ' ' THR . 29.0 m -147.6 159.75 43.42 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.347 1.459 . . . . 1.6000000000000001 111.736 170.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -136.04 144.12 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.615 1.966 . . . . 0.33000000000000002 110.209 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.0 m -120.75 125.8 48.54 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.564 0.746 . . . . 0.65000000000000002 111.512 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p -100.28 138.15 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.571 1.148 . . . . 0.64000000000000001 111.183 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -136.21 113.71 10.88 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.364 1.465 . . . . 1.75 113.091 -171.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -81.79 127.43 32.96 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.043 -1.661 . . . . 1.28 113.069 -174.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.9 mt -114.25 155.36 26.29 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.552 1.541 . . . . 0.54000000000000004 112.767 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.5 mt -141.19 173.14 11.77 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.409 1.884 . . . . 1.6599999999999999 110.265 168.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.96 172.56 6.95 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.501 1.121 . . . . 0.92000000000000004 112.032 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.4 p -95.91 -31.75 12.96 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.042 0.756 . . . . 1.21 113.042 170.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -143.02 52.03 1.39 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.656 1.582 . . . . 2.6099999999999999 111.414 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.22 16.36 77.0 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 124.602 1.096 . . . . 0.97999999999999998 115.52 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.75 12.97 0.16 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.118 2.167 . . . . 2.1600000000000001 115.302 -174.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -61.53 -29.27 69.89 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 120.567 -1.333 . . . . 0.63 112.27 -173.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -75.9 -40.46 54.31 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.643 1.177 . . . . 2.2599999999999998 113.247 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -72.66 -38.64 67.58 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-O 117.945 -1.026 . . . . 2.2200000000000002 111.782 170.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 71.8 mt -53.23 -50.98 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.396 1.078 . . . . 0.59999999999999998 110.28 167.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.32 -31.11 68.86 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.731 1.151 . . . . 0.78000000000000003 112.571 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -77.81 -26.9 49.87 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.124 1.157 . . . . 1.26 114.124 171.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -71.21 -30.77 66.79 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.754 -1.216 . . . . 1.99 111.929 168.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.2 mt -90.63 -40.26 12.01 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.727 1.38 . . . . 0.82999999999999996 114.727 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -67.27 -25.18 65.94 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 120.123 1.329 . . . . 2.9100000000000001 112.714 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.7 t -80.2 -3.28 48.42 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.215 1.806 . . . . 1.7 112.961 173.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.34 160.88 14.9 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 126.321 1.915 . . . . 0.93000000000000005 112.164 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -79.29 35.56 0.27 Allowed 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.111 -1.229 . . . . 1.6499999999999999 113.153 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -78.45 7.7 6.24 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.447 1.099 . . . . 2.1200000000000001 113.599 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.54 -31.38 67.88 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.115 1.366 . . . . 1.3100000000000001 110.488 165.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.34 -48.34 0.15 Allowed Glycine 0 C--N 1.344 1.005 0 CA-C-O 119.748 -0.473 . . . . 0.94999999999999996 114.007 171.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -67.91 145.83 54.2 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.636 0.718 . . . . 2.77 111.648 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -68.34 149.09 49.83 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.04 0.836 . . . . 3.0600000000000001 112.144 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 69.5 t -59.81 126.28 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 122.832 0.453 . . . . 0.77000000000000002 111.313 -173.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.19 -50.71 31.71 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.107 1.337 . . . . 0.91000000000000003 113.924 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 98.3 t -142.73 120.12 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.097 1.359 . . . . 1.77 110.198 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.4 mt -82.91 141.92 44.4 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.26 0.624 . . . . 0.82999999999999996 110.137 168.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.8 161.24 42.92 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 121.381 1.388 . . . . 0.57999999999999996 112.36 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.56 -26.87 65.74 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.358 -0.839 . . . . 0.83999999999999997 112.233 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.77 5.39 40.27 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.948 1.699 . . . . 1.49 115.292 174.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.16 152.75 21.07 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.739 1.215 . . . . 0.65000000000000002 111.189 168.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -142.73 164.47 30.01 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.093 1.357 . . . . 2.5800000000000001 111.74 174.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -125.35 134.7 52.1 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.984 1.313 . . . . 2.2599999999999998 110.534 -169.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.8 pt -136.33 151.41 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.833 1.253 . . . . 0.79000000000000004 111.832 -176.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -119.86 174.04 6.69 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.44 1.496 . . . . 0.75 111.964 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.24 12.96 64.61 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.504 1.526 . . . . 0.51000000000000001 115.532 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.9 p -96.71 146.06 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.174 1.39 . . . . 0.66000000000000003 111.336 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 15.1 tpp -101.9 138.69 38.54 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.056 2.142 . . . . 1.0900000000000001 112.223 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.552 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.8 OUTLIER -145.73 152.78 40.13 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.565 1.546 . . . . 1.73 111.919 177.345 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.45 145.76 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 126.802 2.041 . . . . 0.29999999999999999 110.494 -174.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -87.8 146.26 25.71 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 122.552 1.168 . . . . 0.34999999999999998 113.084 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.8 p -143.26 167.87 21.13 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.104 1.761 . . . . 0.33000000000000002 112.793 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -92.0 175.3 6.92 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.201 1.001 . . . . 2.2200000000000002 112.328 168.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.8 p -67.94 -20.27 65.05 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.382 -1.449 . . . . 1.4399999999999999 113.657 -174.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -80.65 14.07 2.27 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.505 1.122 . . . . 1.73 111.976 167.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.41 31.85 19.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.944 2.497 . . . . 0.57999999999999996 113.213 175.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -87.23 138.96 31.04 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.322 1.049 . . . . 2.3399999999999999 110.489 176.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.9 mt -76.53 124.06 34.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.788 -0.819 . . . . 0.41999999999999998 108.788 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.489 HG22 HG22 ' A' ' 97' ' ' THR . 6.1 pt -118.86 154.69 21.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 123.169 1.461 . . . . 0.58999999999999997 113.432 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.56 160.12 19.72 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.298 2.239 . . . . 2.6800000000000002 108.041 166.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.54 -13.25 28.72 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.949 1.463 . . . . 2.1000000000000001 114.949 -169.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -93.87 2.55 56.14 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.711 1.204 . . . . 3.46 111.668 176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.39 3.27 81.84 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.701 1.619 . . . . 0.56000000000000005 114.69 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -68.93 142.76 54.63 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 123.98 0.912 . . . . 2.4900000000000002 109.676 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.489 HG22 HG22 ' A' ' 91' ' ' ILE . 30.4 p -102.58 145.35 29.75 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.161 0.984 . . . . 0.68999999999999995 111.553 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -97.95 -4.5 36.22 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.907 1.077 . . . . 0.65000000000000002 113.907 -170.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.0 25.3 45.5 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.029 0.824 . . . . 0.68999999999999995 113.412 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 p -141.06 152.31 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.07 1.348 . . . . 2.3999999999999999 109.687 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -138.21 155.47 48.63 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 128.471 2.709 . . . . 1.3400000000000001 110.193 -169.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 47.3 mt -136.36 131.23 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.3 1.44 . . . . 0.56000000000000005 110.668 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -75.25 138.83 71.79 Favored Pre-proline 0 N--CA 1.476 0.844 0 O-C-N 121.124 -0.985 . . . . 2.2599999999999998 110.759 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.03 -24.07 28.84 Favored 'Trans proline' 0 C--N 1.35 0.648 0 CA-C-N 121.737 1.656 . . . . 0.78000000000000003 112.743 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -90.18 -47.6 7.7 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.255 1.422 . . . . 1.3500000000000001 111.73 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.4 p -84.23 -27.37 28.0 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.524 0.73 . . . . 1.1299999999999999 112.961 -174.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 54.99 25.39 6.83 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.07 1.348 . . . . 1.8100000000000001 113.041 -172.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.83 153.79 19.5 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.164 1.385 . . . . 2.4500000000000002 111.616 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 18.0 mt -92.52 140.67 29.32 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.186 1.794 . . . . 0.70999999999999996 112.918 -172.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.9 p -71.49 -3.01 18.77 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.989 1.316 . . . . 1.24 114.492 172.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.14 -162.01 16.54 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 126.599 2.047 . . . . 0.81000000000000005 111.379 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.67 167.91 20.81 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.696 1.199 . . . . 0.94999999999999996 112.829 173.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.7 mmt -57.34 143.23 74.34 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.868 1.267 . . . . 1.3100000000000001 113.586 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -79.61 165.98 22.24 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.867 3.711 . . . . 0.77000000000000002 114.045 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.86 -48.62 9.16 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.344 1.609 . . . . 1.3100000000000001 115.344 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.4 p -130.38 13.89 5.55 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.243 1.417 . . . . 0.94999999999999996 113.807 -169.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.22 148.11 6.85 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.479 0.918 . . . . 0.40000000000000002 113.479 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 7.2 ttt -74.02 106.32 5.66 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 126.867 2.067 . . . . 1.8100000000000001 110.237 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.5 pttp -158.86 151.49 21.84 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.387 1.475 . . . . 0.93000000000000005 112.16 -172.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -161.98 171.74 17.12 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.682 1.193 . . . . 1.6599999999999999 110.919 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.5 mp -113.01 144.42 42.62 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.874 1.269 . . . . 0.41999999999999998 112.038 170.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.552 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 21.5 p -73.27 133.88 44.07 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.037 0.835 . . . . 0.56000000000000005 111.295 173.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -94.77 -52.88 4.08 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.02 1.489 . . . . 2.23 115.02 -171.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -175.07 -32.1 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 128.176 2.59 . . . . 1.4399999999999999 110.881 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -116.5 24.38 11.37 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.889 2.076 . . . . 4.4500000000000002 112.181 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.55 -158.76 22.21 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.788 1.661 . . . . 0.56000000000000005 113.794 -173.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -136.66 132.39 34.91 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.983 2.113 . . . . 0.35999999999999999 111.834 169.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -91.27 134.06 34.89 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.097 1.359 . . . . 1.26 113.534 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -127.31 119.09 25.48 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.46 2.704 . . . . 1.6499999999999999 108.21 176.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -84.12 124.48 31.17 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.153 -0.967 . . . . 1.9099999999999999 109.765 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 47.5 p -108.94 5.56 24.45 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.828 1.651 . . . . 0.56999999999999995 113.589 -170.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.17 -27.46 54.45 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.829 0.852 . . . . 0.80000000000000004 112.968 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -89.52 -13.46 37.33 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.911 1.284 . . . . 1.72 113.074 -173.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -83.53 145.3 47.62 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 114.02 1.119 . . . . 0.64000000000000001 114.02 175.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.33 166.96 21.92 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.406 2.071 . . . . 0.77000000000000002 110.968 165.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.39 82.95 3.13 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.458 1.903 . . . . 1.1100000000000001 111.598 -174.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -138.63 -177.27 4.79 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.676 1.191 . . . . 0.79000000000000004 111.625 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -93.18 151.49 19.8 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.712 0.768 . . . . 3.96 111.201 167.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -142.0 169.13 18.17 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.024 2.13 . . . . 0.56000000000000005 109.647 -173.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -139.41 145.31 38.76 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.16 0.984 . . . . 1.75 112.001 174.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -102.82 138.1 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.152 0.981 . . . . 0.37 109.572 171.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -121.69 133.88 54.96 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.893 1.677 . . . . 1.8600000000000001 110.24 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -99.83 124.65 45.34 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.459 1.104 . . . . 1.8999999999999999 110.185 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 15.6 mm -132.35 110.55 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.044 0.937 . . . . 0.67000000000000004 110.281 -169.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -73.2 -11.15 60.42 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 120.408 -1.432 . . . . 3.5 114.158 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 CA--C 1.541 0.619 0 N-CA-C 115.644 1.72 . . . . 1.95 115.644 -169.805 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 121.499 0.666 . . . . 2.4100000000000001 111.149 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.87 139.15 42.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.109 0.964 . . . . 0.90000000000000002 110.672 171.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.9 m -99.78 145.97 31.06 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 123.883 0.873 . . . . 0.88 110.312 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.63 132.98 21.31 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.553 2.169 . . . . 0.69999999999999996 111.943 -169.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.403 ' H ' HD12 ' A' ' 166' ' ' ILE . 2.1 mp -95.95 115.62 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 124.559 1.143 . . . . 1.3600000000000001 108.415 -171.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -84.82 142.36 29.82 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.022 0.374 . . . . 3.0899999999999999 111.628 172.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.4 tt -146.36 150.02 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.926 1.29 . . . . 0.48999999999999999 110.648 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -122.05 157.23 31.86 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.341 1.457 . . . . 2.1200000000000001 109.862 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.31 143.93 92.27 Favored Pre-proline 0 CA--C 1.545 0.77 0 O-C-N 120.905 -1.122 . . . . 1.6699999999999999 111.64 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.27 110.75 1.63 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.662 2.908 . . . . 0.83999999999999997 112.221 -169.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 20.0 tp -143.0 56.57 1.4 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.468 1.907 . . . . 2.71 109.589 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -144.95 23.31 1.54 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.472 1.509 . . . . 3.2599999999999998 112.594 -169.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 54.03 32.39 15.45 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 127.124 2.169 . . . . 4.1699999999999999 114.113 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.3 m -91.57 147.26 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.52 1.128 . . . . 0.91000000000000003 110.127 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.84 -39.73 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.402 0.681 . . . . 1.48 110.025 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -128.13 137.26 52.03 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.905 1.682 . . . . 3.0099999999999998 109.921 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -96.29 144.75 26.18 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.667 0.787 . . . . 0.35999999999999999 111.82 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -137.99 171.5 14.33 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.991 1.478 . . . . 0.56999999999999995 114.991 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -139.4 142.7 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 127.204 2.202 . . . . 0.54000000000000004 110.669 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -130.31 74.66 80.13 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 113.742 1.015 . . . . 2.0499999999999998 113.742 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.63 148.91 90.51 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 124.367 3.378 . . . . 0.79000000000000004 112.972 175.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -136.69 -155.86 0.65 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.932 2.093 . . . . 2.1299999999999999 109.876 -168.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -134.74 164.32 27.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.518 1.527 . . . . 3.96 109.096 166.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 113.361 0.875 . . . . 2.5 113.361 169.628 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 115.676 1.732 . . . . 1.72 115.676 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.6 p -85.57 -23.68 27.54 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 114.412 1.264 . . . . 1.8600000000000001 114.412 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.7 t -132.59 158.28 42.61 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 128.442 2.697 . . . . 2.48 109.126 172.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.423 ' HB ' ' HB2' ' A' ' 132' ' ' ALA . 15.6 p -110.47 8.09 22.96 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.408 1.483 . . . . 0.93000000000000005 113.595 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.2 m -137.52 163.47 31.08 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.938 1.295 . . . . 1.8400000000000001 111.11 168.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.14 140.43 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.291 1.836 . . . . 0.39000000000000001 109.457 173.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.6 m -115.95 121.32 41.95 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.236 0.615 . . . . 0.64000000000000001 111.388 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -99.55 137.49 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.929 1.292 . . . . 0.57999999999999996 111.364 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -134.54 112.27 10.74 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.335 1.454 . . . . 1.6899999999999999 111.372 -174.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.73 126.86 35.52 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 120.541 -1.349 . . . . 1.02 112.468 -171.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.7 mt -116.28 150.88 36.89 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.048 1.339 . . . . 0.56999999999999995 112.855 -171.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.0 mt -140.97 178.93 7.02 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.849 2.059 . . . . 1.46 110.081 168.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.07 160.93 18.36 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.901 1.28 . . . . 0.72999999999999998 112.44 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -89.14 -21.21 23.45 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 114.863 1.431 . . . . 1.05 114.863 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -129.23 28.67 5.23 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.31 1.444 . . . . 2.4500000000000002 111.132 168.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.71 15.31 80.76 Favored Glycine 0 CA--C 1.538 1.501 0 O-C-N 120.456 -1.402 . . . . 0.90000000000000002 114.792 -177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.56 28.6 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 129.744 3.218 . . . . 1.98 117.069 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -18.56 65.15 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.07 -1.643 . . . . 0.64000000000000001 113.56 -172.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -81.89 -45.34 15.6 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.393 0.997 . . . . 2.23 112.678 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -66.28 -43.6 85.95 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.549 1.068 . . . . 2.48 111.167 172.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.2 mt -50.14 -49.34 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.106 0.962 . . . . 0.67000000000000004 110.997 169.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.62 70.86 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 120.043 1.292 . . . . 0.84999999999999998 113.479 178.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -74.75 -31.05 61.68 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.217 -0.927 . . . . 1.03 113.21 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -65.54 -18.21 65.15 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.26 -0.9 . . . . 2.0600000000000001 112.514 169.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.4 mt -95.43 -36.81 11.2 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 114.453 1.279 . . . . 1.29 114.453 176.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -64.85 -19.81 66.08 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.836 1.198 . . . . 2.8500000000000001 113.759 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.5 t -72.22 -19.52 61.71 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.687 1.365 . . . . 1.3700000000000001 114.687 170.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.41 179.22 33.27 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.878 1.704 . . . . 1.54 114.801 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -102.64 36.17 2.26 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.852 1.261 . . . . 3.1299999999999999 111.21 174.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.402 ' CE1' ' HA ' ' A' ' 66' ' ' VAL . 15.6 m-85 -74.11 3.98 6.24 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 115.18 1.548 . . . . 2.2000000000000002 115.18 -168.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.58 -19.95 63.66 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 121.283 -0.886 . . . . 1.26 112.08 168.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.6 -65.86 0.37 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.139 1.352 . . . . 0.95999999999999996 112.288 169.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.283 0.0 OUTLIER -76.89 155.37 32.91 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.831 1.419 . . . . 1.72 114.831 -173.032 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -56.98 154.08 10.19 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.327 0.651 . . . . 2.5299999999999998 112.505 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.402 ' HA ' ' CE1' ' A' ' 61' ' ' TYR . 55.9 t -64.49 129.73 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 109.835 -0.432 . . . . 1.02 109.835 171.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.47 -55.09 16.42 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 122.932 0.301 . . . . 1.05 112.853 -176.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.0 t -141.66 121.89 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.029 0.932 . . . . 1.75 109.855 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.0 mt -78.63 137.35 58.83 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-O 118.919 -0.562 . . . . 1.1899999999999999 109.528 168.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.56 166.36 29.62 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.859 2.373 . . . . 0.59999999999999998 112.712 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -51.59 -41.95 61.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.263 0.625 . . . . 0.95999999999999996 112.547 172.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -76.21 -3.07 34.37 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.894 2.078 . . . . 1.4399999999999999 115.657 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.05 153.7 18.55 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.563 1.074 . . . . 0.56000000000000005 113.344 172.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.6 pttt -144.7 167.01 23.58 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.883 1.673 . . . . 2.2200000000000002 111.824 171.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -122.02 151.7 40.55 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.275 1.43 . . . . 2.1000000000000001 110.061 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.7 pt -139.97 137.65 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.356 0.662 . . . . 0.90000000000000002 111.528 171.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -112.68 161.39 16.91 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.592 1.557 . . . . 0.73999999999999999 112.276 173.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.71 29.19 36.13 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.136 1.351 . . . . 0.66000000000000003 113.423 -170.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 p -107.95 141.93 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.618 1.967 . . . . 0.69999999999999996 109.195 169.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -104.98 137.47 42.68 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.695 1.598 . . . . 0.51000000000000001 112.354 -173.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.559 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.7 OUTLIER -143.52 152.86 41.97 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.545 1.138 . . . . 2.02 111.784 177.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.13 144.85 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.968 2.107 . . . . 0.31 109.612 -174.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -85.9 147.64 26.17 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 122.886 1.326 . . . . 0.38 112.462 169.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.6 p -142.32 171.23 14.34 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.783 2.033 . . . . 0.31 111.747 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.16 -178.92 4.63 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.048 1.129 . . . . 2.0800000000000001 114.048 171.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.9 p -59.16 -28.08 66.26 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.899 1.074 . . . . 1.6100000000000001 113.899 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -85.54 16.73 3.64 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.48 1.112 . . . . 1.76 113.12 173.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 58.76 24.89 12.79 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.07 2.148 . . . . 0.65000000000000002 112.901 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -88.03 137.03 32.69 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.845 1.258 . . . . 2.23 110.747 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.4 mt -72.26 124.19 28.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.358 -0.608 . . . . 0.42999999999999999 109.358 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.509 HG22 HG22 ' A' ' 97' ' ' THR . 3.2 pt -113.21 152.15 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 125.543 1.537 . . . . 0.56999999999999995 115.109 175.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -81.21 160.66 24.25 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.647 2.379 . . . . 1.3799999999999999 108.944 165.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -62.48 -15.46 50.12 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.754 -1.216 . . . . 1.95 114.043 -176.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -89.19 3.45 51.88 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.173 1.389 . . . . 3.6299999999999999 112.675 174.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.47 0.07 89.32 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 126.494 1.997 . . . . 0.62 115.24 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -68.08 136.74 54.24 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.76 1.224 . . . . 2.2599999999999998 109.984 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.509 HG22 HG22 ' A' ' 91' ' ' ILE . 2.2 p -98.33 145.68 26.44 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.456 0.702 . . . . 0.83999999999999997 111.225 -175.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -94.5 -7.64 40.7 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.428 1.27 . . . . 0.73999999999999999 114.428 -168.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.14 30.16 47.62 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 118.935 0.789 . . . . 0.71999999999999997 113.797 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.8 t -140.22 145.2 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.677 1.591 . . . . 1.24 109.235 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -125.86 162.84 24.25 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.439 2.696 . . . . 1.49 111.015 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.6 mt -135.24 135.35 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.597 1.159 . . . . 0.63 110.947 -173.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.45 143.74 90.8 Favored Pre-proline 0 N--CA 1.477 0.904 0 CA-C-O 117.424 -1.274 . . . . 2.25 111.225 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.84 -20.76 10.17 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 122.325 1.866 . . . . 0.91000000000000003 112.944 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -88.97 -47.01 8.43 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.089 0.955 . . . . 1.3200000000000001 112.315 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.5 p -92.8 -28.5 16.52 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.41 1.084 . . . . 0.85999999999999999 113.242 -172.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 57.25 19.01 4.6 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.407 1.483 . . . . 2.1899999999999999 113.677 -167.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 146.63 49.73 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.018 -1.676 . . . . 3.3700000000000001 110.376 172.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.3 mt -86.68 138.88 31.3 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.338 1.055 . . . . 0.76000000000000001 111.314 176.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.1 p -71.49 0.23 8.89 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.132 1.16 . . . . 1.4099999999999999 114.132 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -171.93 -156.54 12.3 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 127.367 2.413 . . . . 1.1699999999999999 111.5 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.32 171.83 12.97 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.86 1.059 . . . . 1.3999999999999999 113.86 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.4 tpt -66.41 136.72 95.13 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.985 0.914 . . . . 1.8700000000000001 109.629 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.39 164.99 25.94 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.793 2.329 . . . . 0.87 113.329 -174.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.8 -77.23 0.26 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.592 1.157 . . . . 1.1399999999999999 112.346 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 69.3 p -83.07 5.83 21.05 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.656 2.095 . . . . 1.24 116.656 -167.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.67 143.0 43.14 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.203 1.557 . . . . 0.44 115.203 -171.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.6 ttt -74.34 102.27 4.33 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.626 1.97 . . . . 1.8 111.036 177.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -153.64 146.8 24.66 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.955 1.302 . . . . 0.93000000000000005 112.368 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -161.01 157.5 26.37 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.798 1.239 . . . . 1.9299999999999999 110.613 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 mp -91.91 144.59 25.32 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.048 0.939 . . . . 0.63 112.677 168.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.559 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 2.0 p -65.01 131.43 46.57 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.754 -0.591 . . . . 0.51000000000000001 109.43 169.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -85.83 -56.25 3.57 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.361 0.875 . . . . 2.5099999999999998 113.361 -173.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -159.79 -45.79 0.05 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.251 1.421 . . . . 1.05 110.122 169.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -89.35 -18.81 26.16 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.273 1.029 . . . . 4.79 113.191 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 153.43 -159.55 28.68 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.879 2.181 . . . . 0.58999999999999997 110.718 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.412 ' HB2' ' HA ' ' A' ' 122' ' ' THR . . . -142.81 132.12 23.42 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.907 2.083 . . . . 0.35999999999999999 110.237 168.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -93.34 143.45 26.26 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.605 0.965 . . . . 1.73 113.605 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -128.75 121.96 29.57 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 127.276 2.23 . . . . 1.96 107.274 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.563 HD21 ' HB3' ' A' ' 132' ' ' ALA . 11.4 t30 -83.33 106.34 15.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 118.433 0.56 . . . . 1.6699999999999999 109.768 -173.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.1 p -84.28 -5.12 59.22 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.831 1.048 . . . . 0.72999999999999998 113.831 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.563 ' HB3' HD21 ' A' ' 130' ' ' ASN . . . -55.1 -20.08 9.03 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.894 1.442 . . . . 1.0700000000000001 114.894 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -96.17 -15.11 22.28 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.091 1.356 . . . . 1.8600000000000001 113.635 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -80.64 151.62 71.6 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 119.908 1.231 . . . . 0.93999999999999995 113.427 176.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.88 170.38 9.95 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.597 2.865 . . . . 1.02 111.208 166.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.42 98.07 1.74 Allowed 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.59 1.156 . . . . 1.1899999999999999 109.414 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -153.12 177.54 10.7 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.631 1.173 . . . . 0.84999999999999998 111.78 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -90.49 151.34 21.41 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.38 1.072 . . . . 2.6099999999999999 112.663 168.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -144.69 174.4 11.01 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.84 2.056 . . . . 0.66000000000000003 110.892 -174.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -142.7 160.67 39.86 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.805 1.242 . . . . 1.5800000000000001 113.177 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.8 145.77 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.375 1.47 . . . . 0.42999999999999999 110.921 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -131.45 140.52 49.61 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.245 1.818 . . . . 1.8700000000000001 110.964 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -97.66 108.66 21.42 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.391 1.077 . . . . 2.1099999999999999 111.062 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.0 mm -117.34 113.61 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.181 0.993 . . . . 0.77000000000000002 109.836 -173.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -91.36 -5.79 53.97 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.059 1.133 . . . . 5.2800000000000002 114.059 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 86.9 p . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 115.148 1.536 . . . . 2.1899999999999999 115.148 -175.033 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 109.602 -0.518 . . . . 1.8100000000000001 109.602 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.18 147.86 47.89 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.309 0.644 . . . . 0.88 110.657 171.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.7 146.23 41.11 Favored Pre-proline 0 N--CA 1.473 0.677 0 C-N-CA 123.783 0.833 . . . . 0.59999999999999998 109.734 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.17 152.76 45.61 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.845 2.363 . . . . 0.48999999999999999 112.796 -167.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.656 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.6 mp -107.33 132.2 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.984 1.314 . . . . 1.28 109.233 -171.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -97.94 140.16 32.7 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.873 0.76 . . . . 4.21 111.279 169.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.8 tt -147.42 150.56 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.217 1.007 . . . . 0.46999999999999997 112.396 -171.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -127.33 158.27 37.69 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.418 1.887 . . . . 2.0600000000000001 109.121 169.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.22 159.79 84.46 Favored Pre-proline 0 CA--C 1.554 1.104 0 N-CA-C 113.913 1.079 . . . . 1.1299999999999999 113.913 -173.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -79.4 80.36 3.1 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.372 2.715 . . . . 1.22 113.298 -169.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 48.9 mt -107.02 46.79 0.91 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.043 2.137 . . . . 3.2799999999999998 108.938 169.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -123.36 175.37 6.76 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 128.199 2.6 . . . . 3.1800000000000002 109.653 -172.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -74.78 12.7 0.77 Allowed 'General case' 0 CA--C 1.557 1.222 0 O-C-N 120.035 -1.666 . . . . 3.5499999999999998 114.699 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.3 m -89.51 152.82 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.073 1.749 . . . . 1.05 113.661 -168.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.17 -30.17 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.668 1.187 . . . . 1.6799999999999999 111.964 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.03 156.22 42.39 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.688 0.795 . . . . 2.98 111.302 169.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -102.72 141.61 35.24 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.554 1.141 . . . . 0.40999999999999998 111.878 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -136.64 167.96 20.41 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.496 1.295 . . . . 0.58999999999999997 114.496 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -138.29 142.82 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.234 1.414 . . . . 0.54000000000000004 111.901 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -130.77 84.07 59.69 Favored Pre-proline 0 N--CA 1.465 0.304 0 C-N-CA 125.484 1.514 . . . . 2.3999999999999999 111.553 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . 0.656 ' HB3' HD11 ' A' ' 166' ' ' ILE . 18.8 Cg_endo -72.82 133.2 19.71 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.25 2.633 . . . . 0.81999999999999995 110.177 167.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.7 167.46 21.09 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.697 1.999 . . . . 2.29 110.969 175.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -95.8 178.61 5.39 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.855 1.262 . . . . 2.9100000000000001 110.861 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 115.421 1.637 . . . . 2.8700000000000001 115.421 175.998 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.5 p . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 120.304 0.097 . . . . 1.0700000000000001 111.04 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.6 t -101.47 -16.98 16.65 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.351 0.871 . . . . 2.46 113.351 170.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.3 m -141.97 137.5 31.26 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.971 1.309 . . . . 2.5499999999999998 112.394 -171.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.4 p -83.56 -18.3 38.8 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.804 1.779 . . . . 0.97999999999999998 115.804 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.7 p -145.65 155.64 43.14 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.505 1.502 . . . . 1.46 113.834 174.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.5 p -113.21 140.99 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 127.335 2.254 . . . . 0.34000000000000002 109.98 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.9 m -107.94 116.45 31.98 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.383 0.673 . . . . 0.78000000000000003 109.601 173.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 p -92.38 124.6 44.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 123.947 0.899 . . . . 0.59999999999999998 109.18 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -102.78 176.78 5.05 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.084 1.754 . . . . 1.78 109.608 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.67 120.74 12.13 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 120.292 -1.505 . . . . 1.03 112.383 168.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.0 mt -106.62 159.45 16.19 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.749 1.22 . . . . 0.90000000000000002 111.958 -173.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.97 168.13 21.62 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.969 1.308 . . . . 2.1899999999999999 109.972 169.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.07 156.97 19.01 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.191 0.996 . . . . 1.3899999999999999 111.532 171.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.1 p -81.88 -32.6 30.93 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.323 -0.861 . . . . 2.0899999999999999 113.194 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -138.19 34.92 2.32 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.607 1.563 . . . . 3.6200000000000001 111.367 -174.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.35 11.35 82.26 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 125.209 1.385 . . . . 1.8200000000000001 116.538 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.08 31.48 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 129.485 3.114 . . . . 2.3500000000000001 116.514 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -31.86 72.92 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.405 -1.434 . . . . 1.1200000000000001 113.395 -175.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.86 -52.04 65.76 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.395 0.998 . . . . 2.71 113.678 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -67.69 -39.59 84.43 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 118.366 -0.826 . . . . 3.0099999999999998 111.432 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.1 mt -55.84 -49.98 71.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 119.075 0.852 . . . . 0.90000000000000002 110.599 171.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.39 -34.85 77.52 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.862 1.21 . . . . 1.28 113.057 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -74.06 -27.29 60.84 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.217 0.821 . . . . 1.49 113.217 172.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -73.13 -22.45 60.53 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.026 -1.046 . . . . 2.1499999999999999 113.109 169.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.6 mt -94.24 -39.78 10.35 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.1 1.148 . . . . 1.49 114.1 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -65.59 -22.01 66.64 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.054 0.843 . . . . 3.73 112.685 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 t -75.87 -26.58 57.22 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.126 0.97 . . . . 2.0899999999999999 113.181 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.04 164.71 46.49 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.571 1.081 . . . . 1.6299999999999999 113.512 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -83.42 35.07 0.49 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.17 1.388 . . . . 3.3399999999999999 112.81 169.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -76.61 1.5 16.7 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.183 1.179 . . . . 2.1699999999999999 114.183 -169.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.55 -23.9 67.58 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.04 -1.037 . . . . 1.49 111.036 166.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.13 -82.3 1.48 Allowed Glycine 0 CA--C 1.535 1.329 0 C-N-CA 123.829 0.728 . . . . 0.91000000000000003 112.448 168.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.02 154.06 40.64 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 116.435 2.013 . . . . 1.5700000000000001 116.435 -169.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -60.78 146.72 45.09 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.384 1.474 . . . . 2.4300000000000002 112.461 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.404 HG23 ' CE2' ' A' ' 181' ' ' TYR . 47.7 t -58.02 133.34 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.799 1.24 . . . . 1.26 111.848 -172.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.08 -52.71 45.65 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 123.117 0.389 . . . . 1.51 113.978 -175.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.1 t -149.44 134.36 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 127.648 2.379 . . . . 2.0 109.175 176.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.15 144.04 40.53 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 125.753 1.621 . . . . 1.1899999999999999 111.119 169.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.02 158.24 49.87 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.337 2.025 . . . . 0.87 111.371 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.72 -23.67 67.32 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.197 -0.939 . . . . 1.2 112.562 172.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -80.89 1.9 28.87 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.799 1.407 . . . . 1.52 114.799 172.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.81 159.42 15.07 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.841 1.256 . . . . 0.94999999999999996 113.567 170.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -150.59 169.76 20.76 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.098 1.759 . . . . 2.1699999999999999 111.446 167.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -124.4 135.58 53.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.367 1.067 . . . . 2.2000000000000002 111.155 -168.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.1 pt -135.35 151.91 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.798 1.239 . . . . 0.82999999999999996 112.65 -175.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.21 -179.24 4.63 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.339 1.456 . . . . 0.75 113.027 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.23 10.78 81.89 Favored Glycine 0 N--CA 1.476 1.301 0 O-C-N 121.37 -0.831 . . . . 0.62 115.164 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.3 p -101.14 144.66 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.569 1.948 . . . . 0.69999999999999996 110.042 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 2.9 tpp -101.57 138.74 38.16 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.305 1.442 . . . . 0.57999999999999996 112.166 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.494 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.6 OUTLIER -141.22 149.88 41.96 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.611 1.165 . . . . 1.6100000000000001 111.365 173.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.1 m -120.43 149.57 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.924 2.09 . . . . 0.42999999999999999 109.328 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -94.42 148.01 22.66 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 122.433 1.111 . . . . 0.5 112.217 171.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.4 p -143.56 166.99 23.3 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.482 1.513 . . . . 0.38 112.551 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -85.19 172.58 11.07 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.598 -0.689 . . . . 1.96 111.308 166.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.0 p -58.2 -30.45 66.46 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.056 0.943 . . . . 1.45 113.518 -172.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -87.43 29.24 0.88 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.659 1.183 . . . . 2.77 113.86 171.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 57.12 28.77 15.48 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.782 2.033 . . . . 1.1699999999999999 113.476 169.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -84.4 135.12 34.41 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.489 1.116 . . . . 2.0 110.941 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.2 mt -77.2 126.01 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.563 -0.532 . . . . 0.54000000000000004 109.563 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.424 HG22 HG22 ' A' ' 97' ' ' THR . 6.6 pt -122.53 157.63 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 114.766 1.395 . . . . 0.67000000000000004 114.766 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -88.08 164.66 15.62 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.594 1.958 . . . . 1.53 110.494 167.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.49 -1.55 6.85 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.942 1.83 . . . . 2.3399999999999999 115.942 -169.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -105.29 -1.64 24.98 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.072 1.749 . . . . 2.6600000000000001 113.489 169.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.96 8.24 59.24 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 125.234 1.397 . . . . 0.73999999999999999 116.443 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -70.07 127.55 33.23 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.733 1.213 . . . . 3.7999999999999998 110.333 171.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.424 HG22 HG22 ' A' ' 91' ' ' ILE . 1.0 OUTLIER -95.0 128.77 42.08 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.458 0.703 . . . . 1.1100000000000001 111.984 -178.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.64 -6.04 50.39 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 114.11 1.152 . . . . 0.91000000000000003 114.11 -167.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.7 15.95 62.58 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.601 1.572 . . . . 0.79000000000000004 114.027 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.4 t -122.05 146.93 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.501 1.52 . . . . 1.3799999999999999 109.335 -176.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -136.05 159.61 41.17 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.407 1.883 . . . . 1.3300000000000001 111.363 -175.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 48.4 mt -137.03 143.37 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 125.668 1.587 . . . . 0.75 110.311 -171.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -78.97 147.35 69.93 Favored Pre-proline 0 N--CA 1.479 1.009 0 O-C-N 120.026 -1.671 . . . . 1.8300000000000001 111.933 173.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.28 -20.0 11.5 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 CA-C-N 122.468 1.917 . . . . 0.94999999999999996 113.683 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -98.4 -37.76 9.48 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.64 1.976 . . . . 1.6200000000000001 113.317 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.2 p -95.3 -26.74 15.8 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.03 0.932 . . . . 1.04 112.76 -178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 54.82 19.47 2.6 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.901 1.28 . . . . 1.6399999999999999 113.245 -169.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.11 148.18 24.58 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.085 1.354 . . . . 2.7400000000000002 111.072 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 mt -85.94 147.29 26.31 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.558 1.543 . . . . 0.75 112.733 -173.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 96.7 p -66.41 -16.66 64.27 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.599 0.963 . . . . 1.55 113.599 172.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.98 -150.44 6.42 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 126.426 1.965 . . . . 0.88 112.36 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.37 167.69 21.27 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.078 1.14 . . . . 1.05 114.078 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.4 mmt -55.92 136.92 72.89 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.626 1.171 . . . . 1.6200000000000001 112.717 171.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -80.84 164.52 20.34 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.837 3.025 . . . . 0.80000000000000004 112.906 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.11 -90.39 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.022 0.929 . . . . 1.3600000000000001 111.246 169.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.5 p -77.65 15.27 0.85 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 116.514 2.042 . . . . 0.91000000000000003 116.514 -167.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.7 146.06 32.23 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.527 1.131 . . . . 0.57999999999999996 113.802 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.1 tpt -73.75 102.11 3.9 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.571 2.349 . . . . 1.46 110.636 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.3 pttp -156.04 149.59 24.85 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.575 1.55 . . . . 1.0900000000000001 112.305 -173.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -165.83 160.54 17.1 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.761 1.624 . . . . 2.6099999999999999 110.105 169.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.7 mp -91.71 146.9 23.4 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.411 1.084 . . . . 0.5 112.062 170.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.494 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 1.2 p -65.67 133.71 51.7 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 119.289 0.95 . . . . 0.5 109.751 169.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -84.72 -70.56 0.57 Allowed 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 113.951 1.093 . . . . 2.48 113.951 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.47 -39.85 0.43 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.526 1.131 . . . . 1.0600000000000001 111.447 173.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -99.54 -29.45 12.7 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.613 0.968 . . . . 4.4500000000000002 113.613 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.483 ' HA2' HG22 ' A' ' 122' ' ' THR . . . 168.76 -164.37 38.0 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.595 1.093 . . . . 0.68999999999999995 111.678 -170.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -139.98 131.79 27.5 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.464 1.906 . . . . 0.5 111.453 169.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -80.42 135.53 36.17 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.771 1.228 . . . . 1.29 112.453 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -126.79 123.15 36.72 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.747 2.019 . . . . 1.8300000000000001 108.406 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -71.37 130.15 40.62 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 121.166 -0.959 . . . . 2.0099999999999998 110.951 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 34.1 p -116.79 5.91 13.13 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.742 1.617 . . . . 0.89000000000000001 113.402 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.17 -20.56 64.26 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.196 1.398 . . . . 0.89000000000000001 114.19 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -111.99 -14.08 13.51 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.523 1.129 . . . . 2.4900000000000002 113.216 -171.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.3 142.62 84.73 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 119.083 0.856 . . . . 0.95999999999999996 112.258 171.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.85 163.66 28.48 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.442 2.095 . . . . 1.1699999999999999 111.37 167.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.13 53.87 0.13 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 128.79 2.836 . . . . 2.3300000000000001 115.969 -169.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -116.71 -179.65 3.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.862 2.065 . . . . 0.95999999999999996 112.829 -170.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -90.22 148.38 22.96 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.733 1.213 . . . . 3.1299999999999999 112.123 169.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -143.84 172.65 12.56 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.268 2.627 . . . . 0.63 109.998 -174.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -141.5 149.94 41.56 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.069 0.948 . . . . 1.77 112.947 173.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.15 139.06 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.307 1.043 . . . . 0.46000000000000002 110.351 172.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -125.11 129.92 51.18 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.157 1.783 . . . . 1.8400000000000001 110.285 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -92.87 118.93 31.67 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.474 1.11 . . . . 2.0800000000000001 110.261 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 47.1 mm -116.28 110.74 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 118.708 0.685 . . . . 0.67000000000000004 109.629 -171.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -79.4 -15.35 57.99 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.567 0.951 . . . . 3.98 113.567 -169.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 115.265 1.58 . . . . 1.74 115.265 -178.015 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 111.803 0.297 . . . . 2.3399999999999999 111.803 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -94.3 156.51 16.48 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.084 1.142 . . . . 0.93999999999999995 114.084 173.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.91 150.86 51.63 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 126.47 1.908 . . . . 0.92000000000000004 110.501 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.2 145.38 38.9 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.452 2.101 . . . . 0.63 113.737 -167.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.7 mp -113.35 125.12 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.695 1.198 . . . . 1.47 110.105 -171.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -86.1 139.77 30.82 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.678 1.191 . . . . 2.8100000000000001 111.475 174.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.1 tt -146.87 146.99 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.633 1.173 . . . . 0.56000000000000005 112.104 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -118.6 154.42 32.66 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.209 1.403 . . . . 2.0 109.041 168.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.0 mt -61.61 154.66 64.36 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 114.157 1.169 . . . . 0.93999999999999995 114.157 -175.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.86 103.55 0.88 Allowed 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.035 2.49 . . . . 0.76000000000000001 110.957 -173.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.1 mt -139.27 42.37 2.06 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.717 2.407 . . . . 3.2200000000000002 109.084 174.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -117.51 12.91 14.28 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 128.636 2.774 . . . . 3.5299999999999998 111.698 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 18.3 t0 57.2 28.51 15.19 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.558 2.343 . . . . 4.6100000000000003 114.74 -174.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.3 m -81.49 150.58 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.626 0.77 . . . . 1.1299999999999999 112.734 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.83 -38.47 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.554 1.142 . . . . 1.5 110.701 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -147.23 142.81 27.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.54 1.536 . . . . 2.4300000000000002 110.084 -175.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -105.71 141.48 37.08 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.246 1.018 . . . . 0.51000000000000001 111.92 -173.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -139.18 165.96 25.79 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.974 1.472 . . . . 0.54000000000000004 114.974 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.1 t -135.9 139.11 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 125.677 1.591 . . . . 0.51000000000000001 111.957 176.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.404 ' CE2' HG23 ' A' ' 66' ' ' VAL . 99.1 m-85 -131.66 78.87 69.92 Favored Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 124.927 1.291 . . . . 2.0099999999999998 112.241 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.79 149.18 87.01 Favored 'Trans proline' 0 C--N 1.349 0.57 1 C-N-CA 125.387 4.058 . . . . 0.52000000000000002 114.013 176.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -131.62 167.41 19.49 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.893 2.077 . . . . 1.54 111.974 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -116.58 162.54 17.46 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.061 0.934 . . . . 3.1200000000000001 113.517 -174.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 9.3 t . . . . . 0 N--CA 1.469 0.492 0 C-N-CA 126.632 1.973 . . . . 3.3199999999999998 109.317 169.838 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.5 p . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 114.673 1.361 . . . . 1.5800000000000001 114.673 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.7 p -79.01 -13.66 59.66 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.046 1.128 . . . . 1.52 114.046 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 t -148.28 159.46 43.96 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.282 1.433 . . . . 2.52 111.684 170.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 p -94.35 -7.89 40.44 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.69 1.996 . . . . 1.1699999999999999 114.641 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.6 m -144.16 154.19 42.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.7 1.2 . . . . 2.04 113.243 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.3 p -117.77 147.53 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 127.622 2.369 . . . . 0.46000000000000002 110.182 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.5 m -110.8 116.28 31.0 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.481 0.658 . . . . 0.63 111.067 173.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 p -98.02 131.19 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.764 1.226 . . . . 0.88 109.294 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -112.63 -171.05 1.78 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.384 1.874 . . . . 2.1200000000000001 110.96 -174.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -145.53 123.41 11.98 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.163 -0.961 . . . . 1.3999999999999999 111.349 166.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.4 mt -110.49 150.96 28.14 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.857 0.863 . . . . 0.54000000000000004 111.281 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.28 165.92 27.03 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.676 1.59 . . . . 1.5900000000000001 110.966 -171.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.33 143.83 39.96 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.277 1.031 . . . . 1.3400000000000001 111.064 168.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.7 p -85.5 -44.67 12.5 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.326 1.45 . . . . 1.96 111.452 174.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -115.13 25.49 10.84 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 127.823 2.449 . . . . 3.2000000000000002 111.745 -171.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.63 7.43 84.41 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 126.267 1.889 . . . . 1.53 116.764 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -72.39 25.13 0.05 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.611 2.364 . . . . 2.0600000000000001 116.977 -171.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -27.0 66.72 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 119.369 -2.082 . . . . 1.29 114.072 -173.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -81.72 -41.35 21.4 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.567 0.951 . . . . 2.6600000000000001 113.567 -174.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -66.86 -38.29 86.06 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 120.284 1.402 . . . . 3.0499999999999998 111.286 169.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.2 mt -56.58 -48.39 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 120.014 1.279 . . . . 1.1499999999999999 110.72 168.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.05 -36.92 75.84 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.833 1.197 . . . . 1.4299999999999999 112.486 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -69.27 -32.84 72.29 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.859 0.864 . . . . 1.55 113.305 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -65.84 -35.02 79.5 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.262 0.937 . . . . 2.04 112.269 172.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.5 mt -84.31 -31.25 24.97 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.328 0.862 . . . . 1.5800000000000001 113.328 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -67.29 -30.49 70.37 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.141 0.882 . . . . 3.2799999999999998 113.261 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 t -80.09 -21.4 43.34 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.809 0.844 . . . . 1.9299999999999999 113.194 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.37 164.99 52.78 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.552 1.072 . . . . 1.4199999999999999 113.099 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -84.42 18.98 2.04 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.179 0.991 . . . . 1.8100000000000001 112.425 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -68.93 0.6 4.26 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 115.765 1.765 . . . . 2.3199999999999998 115.765 -167.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.66 -23.01 66.88 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 121.364 -0.835 . . . . 0.92000000000000004 111.273 165.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.85 -83.41 1.19 Allowed Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.898 1.713 . . . . 0.68000000000000005 113.176 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.22 160.4 26.92 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.623 1.342 . . . . 1.3999999999999999 114.623 -169.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -60.7 156.55 16.58 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.302 1.223 . . . . 2.9500000000000002 114.302 -173.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.3 t -58.16 129.53 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 121.815 -0.553 . . . . 0.75 110.484 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.77 -43.17 68.04 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.592 0.615 . . . . 0.79000000000000004 114.163 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.1 p -160.97 142.72 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.814 1.245 . . . . 2.73 110.241 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.9 mt -88.3 145.93 36.85 Favored Pre-proline 0 C--O 1.241 0.647 0 C-N-CA 123.774 0.829 . . . . 1.1599999999999999 112.099 176.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.492 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 37.6 Cg_endo -67.95 158.98 54.94 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.563 1.509 . . . . 0.76000000000000001 112.131 173.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.18 -1.64 3.47 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.894 1.278 . . . . 1.29 114.388 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.11 8.13 11.49 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 127.028 2.131 . . . . 1.5700000000000001 114.028 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.492 ' HB2' ' HG2' ' A' ' 70' ' ' PRO . . . -93.63 162.15 14.07 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.908 1.818 . . . . 0.90000000000000002 115.908 172.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -142.63 150.62 40.5 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 128.062 2.545 . . . . 4.0599999999999996 111.042 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -121.92 139.97 53.0 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.866 1.667 . . . . 2.1499999999999999 110.059 174.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.9 pt -132.79 152.73 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 113.53 0.937 . . . . 0.92000000000000004 113.53 -177.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.0 165.55 11.64 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.28 1.432 . . . . 0.81000000000000005 110.801 169.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.0 8.3 79.26 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 115.562 0.985 . . . . 0.76000000000000001 115.562 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.7 p -84.53 143.93 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 119.648 1.724 . . . . 1.05 110.216 169.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -102.01 136.42 41.88 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.417 1.487 . . . . 0.64000000000000001 112.113 175.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.45 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.3 OUTLIER -141.44 155.03 45.91 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.106 0.962 . . . . 1.73 112.802 171.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.15 146.57 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 126.99 2.116 . . . . 0.45000000000000001 109.969 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -90.94 146.53 23.81 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.322 1.058 . . . . 0.48999999999999999 112.716 172.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.6 p -143.6 170.78 15.19 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.979 1.712 . . . . 0.46000000000000002 112.521 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -97.8 174.74 6.45 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.448 1.099 . . . . 1.95 112.573 168.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.2 p -64.49 -18.45 64.8 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.476 -1.39 . . . . 1.45 114.321 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -76.22 7.35 4.32 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 126.029 1.732 . . . . 1.8500000000000001 113.241 167.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 55.71 33.31 21.09 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.4 2.28 . . . . 0.77000000000000002 111.603 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -94.37 138.94 31.73 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.697 1.599 . . . . 2.1600000000000001 110.395 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.4 mt -79.37 130.81 35.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 109.573 -0.528 . . . . 0.53000000000000003 109.573 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.483 HG22 HG22 ' A' ' 97' ' ' THR . 4.9 pt -125.3 155.53 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 114.689 1.366 . . . . 0.75 114.689 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -81.29 164.46 22.2 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 126.46 1.904 . . . . 1.54 109.536 167.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -64.67 -12.51 47.08 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.556 -1.34 . . . . 2.3300000000000001 114.0 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -97.66 4.86 50.0 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.714 1.605 . . . . 2.6699999999999999 112.992 173.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.75 10.48 85.08 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 120.551 -1.343 . . . . 0.71999999999999997 115.103 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -68.24 130.03 41.69 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.193 1.497 . . . . 3.0699999999999998 108.924 168.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.483 HG22 HG22 ' A' ' 91' ' ' ILE . 17.3 p -87.92 141.66 28.41 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.68 0.392 . . . . 0.73999999999999999 111.043 174.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -94.3 -11.07 30.84 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.688 1.366 . . . . 0.80000000000000004 114.688 -169.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.76 30.85 25.49 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.555 1.074 . . . . 0.68999999999999995 114.322 -172.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.0 t -133.95 146.06 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.37 1.585 . . . . 1.25 110.447 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -130.61 159.98 35.56 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.58 1.952 . . . . 1.28 110.641 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 54.1 mt -135.96 137.03 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 125.059 1.344 . . . . 0.52000000000000002 111.207 -174.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -71.53 141.22 85.1 Favored Pre-proline 0 N--CA 1.48 1.028 0 O-C-N 120.814 -1.179 . . . . 1.77 111.188 171.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.56 -24.41 13.85 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 122.494 1.926 . . . . 0.65000000000000002 112.64 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -89.77 -54.43 4.06 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.706 1.602 . . . . 1.46 111.79 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.4 p -78.91 -26.79 43.78 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.875 0.695 . . . . 0.78000000000000003 112.875 -174.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 56.37 19.14 3.82 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.792 1.237 . . . . 1.6699999999999999 113.896 -170.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.91 150.83 24.69 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.377 -1.452 . . . . 3.0699999999999998 111.528 176.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.9 mt -90.37 141.96 28.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.241 1.417 . . . . 0.82999999999999996 111.712 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.1 p -66.56 -4.11 7.84 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.535 1.309 . . . . 1.3100000000000001 114.535 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.4 -158.53 18.73 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 127.331 2.396 . . . . 0.89000000000000001 111.53 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.52 154.09 42.2 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.543 0.942 . . . . 0.91000000000000003 113.543 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.3 tpt -60.26 130.22 89.34 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 125.384 1.474 . . . . 1.6799999999999999 111.21 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -72.46 158.89 50.39 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.61 2.874 . . . . 0.94999999999999996 114.488 -173.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.91 -53.62 8.71 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.064 1.746 . . . . 1.0900000000000001 114.557 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.7 p -114.13 11.35 17.57 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.395 1.478 . . . . 1.01 114.148 -167.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.36 151.42 19.82 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.729 1.011 . . . . 0.60999999999999999 113.729 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.4 tpt -75.19 95.32 3.1 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.907 2.083 . . . . 1.5700000000000001 111.227 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -154.48 135.86 14.13 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.443 1.497 . . . . 0.93999999999999995 112.557 -173.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -168.46 142.65 3.26 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.971 1.309 . . . . 2.54 111.342 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.76 150.87 25.53 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.717 1.377 . . . . 0.67000000000000004 114.717 -173.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.45 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 11.4 p -62.12 132.8 54.03 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.243 -0.911 . . . . 0.67000000000000004 111.798 169.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -93.83 -55.0 3.39 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.587 1.155 . . . . 2.52 113.688 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -165.73 -52.78 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.2 2.2 . . . . 1.27 109.422 174.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -93.23 23.49 4.38 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.182 1.793 . . . . 5.2699999999999996 113.35 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.77 -151.78 17.73 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.244 1.878 . . . . 0.57999999999999996 111.692 -168.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.417 ' HB2' ' HA ' ' A' ' 122' ' ' THR . . . -142.77 129.96 20.89 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.068 2.147 . . . . 0.40000000000000002 111.14 169.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -82.04 133.5 35.29 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.531 1.133 . . . . 1.4199999999999999 111.556 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -124.77 124.48 42.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.299 1.84 . . . . 2.0899999999999999 109.143 173.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -73.68 118.43 16.63 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.462 1.105 . . . . 1.6599999999999999 110.576 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 22.5 p -101.97 -0.65 33.43 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.554 1.142 . . . . 0.66000000000000003 113.347 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.13 -16.01 4.54 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.61 1.707 . . . . 0.85999999999999999 115.61 -176.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -106.77 -4.57 19.22 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.904 1.076 . . . . 2.6000000000000001 113.904 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.46 152.73 67.64 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 114.131 1.16 . . . . 0.71999999999999997 114.131 172.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.54 174.29 5.93 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.205 3.27 . . . . 1.0800000000000001 112.218 167.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.47 100.08 3.74 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.328 -0.857 . . . . 1.1799999999999999 109.365 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -152.2 177.38 10.6 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.479 1.512 . . . . 0.79000000000000004 110.587 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -90.39 146.77 23.9 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.217 1.007 . . . . 2.27 112.04 168.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -140.07 167.9 21.06 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.879 2.071 . . . . 0.73999999999999999 109.294 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -139.72 148.01 41.72 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.928 0.891 . . . . 1.77 112.306 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -111.25 132.98 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.024 0.93 . . . . 0.42999999999999999 109.7 175.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -120.78 128.43 52.89 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.417 1.887 . . . . 1.98 110.287 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -104.39 105.3 15.38 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.79 1.636 . . . . 2.54 110.961 -169.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.6 mm -108.06 113.72 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.686 1.194 . . . . 0.72999999999999998 111.62 -167.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -88.7 23.08 2.4 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.291 1.219 . . . . 4.46 114.291 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 52.1 m . . . . . 0 N--CA 1.473 0.689 0 O-C-N 121.094 -1.004 . . . . 1.5900000000000001 112.298 173.771 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 112.563 0.579 . . . . 1.77 112.563 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -98.66 152.03 20.08 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.849 1.259 . . . . 0.94999999999999996 111.738 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.8 m -111.57 144.49 30.68 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 124.482 1.113 . . . . 0.56999999999999995 111.831 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.49 159.24 51.95 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.406 2.737 . . . . 0.81000000000000005 114.022 -167.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.405 HD13 HG12 ' A' ' 180' ' ' VAL . 1.3 mt -112.36 143.66 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.005 1.322 . . . . 1.8600000000000001 110.273 -176.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -110.15 140.83 43.84 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.54 1.136 . . . . 2.9300000000000002 111.694 171.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.6 tt -146.3 147.31 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.663 1.185 . . . . 0.68000000000000005 111.578 -175.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -126.18 151.51 47.25 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.011 1.325 . . . . 1.9299999999999999 109.484 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 5.3 mt -65.58 149.91 96.69 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 114.269 1.211 . . . . 0.96999999999999997 114.269 -171.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.31 92.43 0.92 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.632 2.888 . . . . 0.85999999999999999 114.382 -169.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -118.82 70.67 0.83 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 103.678 -2.712 . . . . 2.6699999999999999 103.678 164.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -145.7 -179.94 7.02 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.069 1.748 . . . . 2.6899999999999999 109.229 -166.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -79.74 6.58 10.47 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.871 1.668 . . . . 3.9300000000000002 114.57 -174.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -99.99 153.56 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.833 1.653 . . . . 0.97999999999999998 113.517 -168.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 44.8 t -96.76 -32.62 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.586 1.554 . . . . 1.6499999999999999 110.967 172.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -131.34 135.3 47.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.021 1.328 . . . . 4.4400000000000004 113.211 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -103.7 138.79 39.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.623 1.169 . . . . 0.44 111.121 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -134.63 168.54 18.8 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.481 1.289 . . . . 0.48999999999999999 114.481 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.405 HG12 HD13 ' A' ' 166' ' ' ILE . 0.2 OUTLIER -141.72 137.22 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.787 1.235 . . . . 0.62 112.549 -178.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -134.96 86.65 31.8 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 125.418 1.487 . . . . 2.0699999999999998 112.118 -173.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -71.5 152.77 60.36 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.325 3.35 . . . . 0.57999999999999996 113.756 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -132.18 172.47 12.36 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.974 2.509 . . . . 1.6200000000000001 112.338 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -101.73 -173.0 2.25 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.204 1.402 . . . . 2.77 109.767 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 116.698 2.11 . . . . 2.8199999999999998 116.698 -175.298 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 112.776 0.658 . . . . 1.27 112.776 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.8 p -98.75 -7.34 27.81 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.819 1.415 . . . . 1.3999999999999999 114.819 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.1 t -151.72 157.83 42.57 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.866 0.757 . . . . 2.1899999999999999 112.518 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 p -98.55 -4.46 34.16 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.95 2.9 . . . . 0.83999999999999997 114.82 -173.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.3 m -147.25 151.48 36.75 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.89 1.676 . . . . 1.9399999999999999 112.863 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.1 p -119.61 148.6 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 127.762 2.425 . . . . 0.44 110.291 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.2 m -121.48 127.54 51.16 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 121.414 -0.803 . . . . 0.72999999999999998 111.591 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 p -101.27 137.58 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.116 1.366 . . . . 0.64000000000000001 110.717 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -136.38 113.97 11.0 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.002 1.721 . . . . 1.75 111.209 -171.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.48 127.82 38.11 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 120.178 -1.576 . . . . 1.05 114.225 -168.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.6 mt -114.77 152.82 31.45 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.683 1.193 . . . . 0.53000000000000003 113.835 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.3 mt -140.3 176.33 8.86 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.86 2.064 . . . . 1.98 110.464 169.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.492 ' HB1' ' H ' ' A' ' 48' ' ' ASP . . . -106.51 163.82 12.56 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.925 1.083 . . . . 0.85999999999999999 113.925 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.3 p -84.13 -38.45 20.69 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.488 1.115 . . . . 1.0 113.352 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -146.89 63.19 1.19 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.953 1.701 . . . . 2.52 110.703 169.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.11 27.88 73.55 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 120.893 -1.129 . . . . 1.1699999999999999 115.419 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.492 ' H ' ' HB1' ' A' ' 44' ' ' ALA . 1.6 m-20 -74.41 15.27 0.36 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.053 2.141 . . . . 2.3999999999999999 114.448 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.33 -28.96 69.67 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.129 -1.607 . . . . 0.67000000000000004 113.01 -173.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -69.64 -45.79 67.67 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.246 0.93 . . . . 2.25 112.519 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -71.08 -41.86 70.12 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 118.18 -0.914 . . . . 2.0899999999999999 111.463 176.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 86.6 mt -51.74 -50.21 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.441 1.019 . . . . 0.57999999999999996 110.34 167.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.51 -31.33 70.4 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.566 -1.334 . . . . 0.81000000000000005 113.231 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -74.08 -34.56 64.05 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.51 1.124 . . . . 1.1499999999999999 113.199 172.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -66.26 -32.64 74.19 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.863 -1.148 . . . . 1.9399999999999999 112.174 170.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.1 mt -83.63 -36.7 23.65 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.854 1.057 . . . . 1.0 113.854 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -65.33 -29.75 70.53 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.487 1.04 . . . . 2.9900000000000002 112.481 177.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.0 t -79.7 -24.54 41.63 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.346 0.869 . . . . 1.3300000000000001 113.346 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.65 160.31 39.28 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.53 1.062 . . . . 0.93000000000000005 113.345 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -83.01 26.06 0.64 Allowed 'General case' 0 CA--C 1.552 1.035 0 O-C-N 121.367 -1.078 . . . . 1.95 112.369 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -68.82 0.28 4.55 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 116.339 1.977 . . . . 2.1200000000000001 116.339 -167.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.75 -25.18 66.29 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.694 1.134 . . . . 0.92000000000000004 112.704 171.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.04 -81.42 1.34 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.709 1.147 . . . . 0.72999999999999998 113.122 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.46 163.07 25.92 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.538 1.135 . . . . 1.48 113.035 -176.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -59.08 161.23 5.34 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.993 1.479 . . . . 2.2000000000000002 114.993 -171.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.84 109.88 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.115 -0.698 . . . . 0.93000000000000005 109.115 168.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.81 -25.16 65.35 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 119.171 -0.794 . . . . 1.1599999999999999 114.134 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.2 t -142.07 118.24 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.275 1.43 . . . . 2.1099999999999999 110.939 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -88.32 146.91 38.91 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.548 1.539 . . . . 0.91000000000000003 109.809 167.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.69 157.51 39.87 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.098 1.866 . . . . 0.81999999999999995 111.552 171.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.23 -24.03 67.23 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.213 -0.929 . . . . 1.3 112.716 173.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 40.7 p30 -77.76 -8.89 58.63 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.844 1.424 . . . . 2.1000000000000001 114.844 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.2 155.78 19.19 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.372 1.469 . . . . 0.58999999999999997 111.922 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.5 pttt -141.25 159.72 41.62 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.958 1.303 . . . . 2.1899999999999999 111.885 170.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -122.68 146.74 47.21 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.914 1.286 . . . . 2.3300000000000001 110.042 -175.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.6 pt -141.07 151.2 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.26 1.024 . . . . 0.88 111.795 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -113.65 170.0 8.57 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.716 1.607 . . . . 0.64000000000000001 111.242 173.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.2 15.53 74.18 Favored Glycine 0 CA--C 1.534 1.267 0 O-C-N 121.388 -0.82 . . . . 0.55000000000000004 114.702 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.5 p -98.8 139.73 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 127.179 2.192 . . . . 0.91000000000000003 109.611 173.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.8 tpp -103.87 136.87 42.74 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.769 2.027 . . . . 0.44 112.84 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.581 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.6 OUTLIER -141.65 152.83 44.3 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.656 1.583 . . . . 1.6699999999999999 111.761 174.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.12 143.53 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 126.757 2.023 . . . . 0.33000000000000002 109.474 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -86.8 149.04 25.13 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 122.2 1.0 . . . . 0.37 111.847 169.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 57.3 p -145.62 165.92 27.28 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.789 1.635 . . . . 0.46000000000000002 112.532 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -89.59 167.29 13.06 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.807 0.843 . . . . 2.27 111.082 166.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 49.3 p -61.57 -26.46 67.97 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.436 1.273 . . . . 1.3899999999999999 114.436 -168.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -76.29 16.66 0.44 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.367 1.467 . . . . 2.2000000000000002 114.477 169.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.52 30.2 17.12 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 128.142 2.577 . . . . 0.90000000000000002 113.204 175.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -92.65 140.03 29.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.28 1.432 . . . . 2.3100000000000001 111.775 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -82.95 124.84 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.037 0.446 . . . . 0.69999999999999996 110.273 -178.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.475 HG22 HG22 ' A' ' 97' ' ' THR . 5.9 pt -120.63 156.15 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 114.815 1.413 . . . . 0.58999999999999997 114.815 -177.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -79.89 158.94 26.57 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.85 2.86 . . . . 2.04 111.227 168.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -56.82 -8.05 0.54 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 127.282 2.233 . . . . 2.3700000000000001 116.317 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.86 1.32 19.16 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.476 1.51 . . . . 2.8900000000000001 115.021 172.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.79 4.2 63.7 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.359 1.457 . . . . 0.62 115.27 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -67.97 143.55 55.56 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.883 1.341 . . . . 2.5600000000000001 109.371 170.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.475 HG22 HG22 ' A' ' 91' ' ' ILE . 60.5 p -102.7 147.8 26.38 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.81000000000000005 111.368 -175.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -104.45 -5.86 21.24 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.847 1.425 . . . . 0.90000000000000002 114.847 -168.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.78 28.93 40.58 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 121.193 -0.942 . . . . 1.24 113.396 -177.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.8 t -133.48 147.26 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.969 1.308 . . . . 1.3400000000000001 110.063 177.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -134.73 155.06 51.22 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 128.205 2.602 . . . . 1.47 110.447 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.409 HG12 HD23 ' A' ' 109' ' ' LEU . 49.4 mt -133.42 133.82 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.213 1.405 . . . . 0.64000000000000001 110.854 -173.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -68.61 142.65 94.3 Favored Pre-proline 0 N--CA 1.476 0.849 0 O-C-N 120.633 -1.292 . . . . 2.0899999999999999 111.296 173.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.35 -24.12 16.89 Favored 'Trans proline' 0 C--N 1.35 0.636 0 CA-C-N 122.38 1.886 . . . . 0.70999999999999996 112.94 175.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -92.91 -52.19 4.71 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.382 1.873 . . . . 1.3300000000000001 112.692 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.9 p -80.73 -23.67 39.28 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.983 0.735 . . . . 0.94999999999999996 112.983 -175.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 54.89 18.06 2.05 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.747 1.619 . . . . 2.1499999999999999 113.839 -171.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.15 149.88 24.35 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.648 -1.283 . . . . 2.2799999999999998 111.789 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.409 HD23 HG12 ' A' ' 102' ' ' ILE . 38.6 mt -87.17 146.38 26.04 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.156 1.782 . . . . 1.1299999999999999 113.222 -175.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 97.3 p -76.98 0.64 20.4 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.446 1.276 . . . . 1.53 114.446 174.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.11 -158.26 15.86 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 127.176 2.322 . . . . 1.3100000000000001 110.762 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.07 156.18 25.95 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.534 1.167 . . . . 1.8 112.917 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 tpt -56.35 130.01 75.21 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 124.068 0.947 . . . . 2.0499999999999998 111.663 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.93 166.1 30.49 Favored 'Trans proline' 0 CA--C 1.537 0.64 1 C-N-CA 125.53 4.154 . . . . 1.1499999999999999 115.587 -172.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.63 -81.17 0.07 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.492 1.517 . . . . 1.3999999999999999 113.281 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.9 p -86.48 12.36 10.49 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.664 1.357 . . . . 0.91000000000000003 114.664 -169.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.7 148.59 16.01 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.21 -0.931 . . . . 0.41999999999999998 113.082 174.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.1 tpt -77.36 87.88 3.75 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.775 2.03 . . . . 1.6000000000000001 110.881 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -142.6 146.24 34.35 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.218 1.407 . . . . 1.0600000000000001 112.761 -173.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 43.5 tttp -162.01 159.73 26.74 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.524 1.13 . . . . 1.78 112.046 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 mp -102.2 145.74 28.97 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.595 1.158 . . . . 0.46999999999999997 112.824 169.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.581 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 8.7 p -70.26 139.78 52.24 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 119.335 0.97 . . . . 0.78000000000000003 112.332 174.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.63 -69.44 0.67 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.835 1.254 . . . . 3.1200000000000001 114.1 -174.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.43 -41.28 0.08 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.681 2.393 . . . . 1.1499999999999999 109.143 169.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -91.55 -10.62 39.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.986 1.714 . . . . 4.2800000000000002 114.216 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 143.23 -156.31 26.44 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.845 1.688 . . . . 0.91000000000000003 112.304 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.72 127.58 20.54 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.233 1.813 . . . . 0.52000000000000002 109.958 167.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -77.16 139.69 39.99 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.962 1.305 . . . . 1.3899999999999999 111.565 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -130.03 116.33 18.4 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.971 1.708 . . . . 1.9299999999999999 109.198 169.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.424 HD21 ' HB3' ' A' ' 132' ' ' ALA . 2.6 t-20 -72.34 115.44 11.6 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.915 1.286 . . . . 2.8799999999999999 111.006 176.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.8 p -104.02 -5.75 21.86 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.565 1.321 . . . . 0.56000000000000005 114.565 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.424 ' HB3' HD21 ' A' ' 130' ' ' ASN . . . -54.78 -27.69 43.33 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.456 1.28 . . . . 0.67000000000000004 114.456 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.68 -14.99 31.16 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.551 0.945 . . . . 2.25 113.551 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.52 147.91 85.2 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 119.603 1.092 . . . . 0.70999999999999996 112.792 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -75.44 167.24 27.04 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.21 1.94 . . . . 0.77000000000000002 110.95 167.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.03 94.8 1.93 Allowed 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.532 1.533 . . . . 1.1299999999999999 109.539 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -152.32 175.55 12.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.831 1.253 . . . . 0.65000000000000002 111.418 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -86.36 149.89 24.71 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.786 1.235 . . . . 2.7599999999999998 111.139 168.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -142.03 171.95 13.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.257 2.223 . . . . 0.44 109.735 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -142.19 154.82 45.13 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.359 1.064 . . . . 1.6399999999999999 111.962 176.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.09 135.93 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.939 0.895 . . . . 0.40000000000000002 110.773 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -121.65 142.31 50.26 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.801 2.04 . . . . 1.8500000000000001 110.575 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -108.69 118.09 35.88 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.076 0.951 . . . . 2.1899999999999999 110.648 -176.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.6 mm -114.08 113.51 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 108.67 -0.863 . . . . 0.87 108.67 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -74.26 -20.95 59.98 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.038 -1.039 . . . . 3.5800000000000001 113.077 -175.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 116.894 2.183 . . . . 1.9399999999999999 116.894 -175.796 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 112.503 0.557 . . . . 2.1200000000000001 112.503 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.59 154.9 39.6 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.777 -1.202 . . . . 0.90000000000000002 111.428 172.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.63 149.6 72.38 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 125.492 1.517 . . . . 0.63 110.625 174.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -74.47 145.81 34.16 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.282 2.654 . . . . 0.55000000000000004 114.64 -166.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.461 HD11 ' HB3' ' A' ' 182' ' ' PRO . 4.5 mt -98.35 140.2 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.191 1.396 . . . . 1.8300000000000001 110.019 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -113.89 121.46 44.03 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.988 1.315 . . . . 3.0699999999999998 111.491 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.7 tt -135.16 156.68 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.127 1.371 . . . . 0.40999999999999998 112.673 -168.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -138.49 159.66 41.51 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.953 1.701 . . . . 2.0699999999999998 109.022 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 19.0 mt -67.38 152.25 96.36 Favored Pre-proline 0 CA--C 1.551 1.008 0 O-C-N 121.282 -0.886 . . . . 0.94999999999999996 112.925 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.52 79.44 3.19 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 124.139 3.226 . . . . 0.95999999999999996 114.764 -167.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 1.6 tt -102.62 72.78 1.26 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.108 -1.442 . . . . 2.2400000000000002 107.108 167.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -146.44 -176.7 5.28 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.609 1.964 . . . . 2.8700000000000001 109.833 -168.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -79.85 0.0 32.87 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.127 1.528 . . . . 4.3499999999999996 115.127 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 1.4 m -80.41 159.05 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.535 1.134 . . . . 1.21 114.02 -169.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.2 t -99.23 -32.02 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 125.63 1.572 . . . . 1.73 111.507 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -142.25 128.61 20.0 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.736 1.614 . . . . 2.5099999999999998 108.781 -173.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -99.52 141.44 32.31 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.148 0.979 . . . . 0.54000000000000004 111.983 -172.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -142.38 169.59 17.29 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 115.725 1.75 . . . . 0.82999999999999996 115.725 -176.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.07 140.08 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.65 1.98 . . . . 0.59999999999999998 112.239 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -137.09 84.52 24.65 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 124.815 1.246 . . . . 2.3399999999999999 112.093 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . 0.461 ' HB3' HD11 ' A' ' 166' ' ' ILE . 14.4 Cg_endo -69.34 148.47 67.89 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 124.08 3.186 . . . . 0.56000000000000005 113.689 174.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -131.82 162.94 29.35 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 127.773 2.429 . . . . 1.51 111.242 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -109.92 169.62 8.6 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.68 1.192 . . . . 3.1899999999999999 113.04 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 CA--C 1.549 0.942 0 C-N-CA 127.123 2.169 . . . . 2.6099999999999999 111.575 177.928 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.4 p . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 113.442 0.904 . . . . 1.1399999999999999 113.442 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.7 p -105.21 -1.62 25.14 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.825 1.25 . . . . 1.8799999999999999 113.809 170.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 m -146.74 148.66 32.19 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.683 1.993 . . . . 2.7799999999999998 109.05 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 42.2 p -111.0 -11.82 14.28 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.222 1.409 . . . . 1.1200000000000001 114.72 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.1 p -147.67 159.07 44.19 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.765 1.394 . . . . 2.0600000000000001 114.765 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.74 138.19 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.825 2.05 . . . . 0.56000000000000005 110.194 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.0 m -114.72 122.15 45.54 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.846 0.858 . . . . 0.67000000000000004 110.962 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.62 135.12 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.667 1.187 . . . . 0.59999999999999998 111.852 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -133.27 106.67 7.68 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.015 1.726 . . . . 1.8100000000000001 112.163 -172.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.58 132.98 34.88 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 120.138 -1.601 . . . . 1.28 112.98 -171.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.5 mt -122.43 163.17 20.31 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.495 1.518 . . . . 0.78000000000000003 112.904 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 42.7 mt -143.12 167.95 20.89 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.593 1.957 . . . . 1.5700000000000001 110.914 168.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.15 169.95 10.01 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.54 1.136 . . . . 1.02 113.373 169.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.6 p -94.49 -32.99 13.26 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.578 1.325 . . . . 1.5700000000000001 114.578 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -140.53 44.49 1.85 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.598 1.159 . . . . 2.5899999999999999 111.963 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.75 12.9 82.26 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.515 1.531 . . . . 1.3899999999999999 115.832 177.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.16 19.65 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 127.767 2.427 . . . . 2.6499999999999999 116.572 -171.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mmt -64.14 -19.55 65.37 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.103 -1.623 . . . . 0.83999999999999997 114.678 -173.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -76.39 -51.9 10.96 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.934 0.894 . . . . 2.3999999999999999 111.613 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -62.05 -40.91 97.35 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.881 -1.137 . . . . 2.3599999999999999 111.372 172.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 98.8 mt -53.32 -47.92 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 119.613 1.097 . . . . 0.76000000000000001 110.9 169.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.03 -29.28 70.17 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.715 1.143 . . . . 0.81999999999999995 113.3 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -73.31 -39.04 65.62 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.922 0.783 . . . . 1.0900000000000001 111.993 171.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -61.7 -32.83 73.06 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.428 1.091 . . . . 1.8899999999999999 112.444 172.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.7 mt -88.49 -36.12 16.62 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.789 1.403 . . . . 1.01 114.789 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.38 -20.53 64.69 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.613 1.097 . . . . 2.3900000000000001 113.121 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.2 t -80.93 -12.19 59.44 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.079 1.352 . . . . 1.4099999999999999 114.525 175.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.39 161.33 21.4 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.261 1.41 . . . . 1.3 112.236 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -79.02 37.59 0.31 Allowed 'General case' 0 N--CA 1.477 0.92 0 O-C-N 120.855 -1.379 . . . . 2.0299999999999998 112.27 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -77.19 -0.88 26.76 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.246 1.202 . . . . 2.3100000000000001 114.246 -173.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.79 -27.08 66.25 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 121.091 -1.005 . . . . 1.21 110.593 166.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.28 -54.62 0.38 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.204 0.907 . . . . 1.0 113.347 169.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -76.02 160.34 29.93 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.478 1.111 . . . . 2.7000000000000002 113.343 -169.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -68.72 155.36 40.26 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.222 -0.924 . . . . 2.8300000000000001 111.687 171.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.2 t -67.9 119.82 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 109.795 -0.446 . . . . 1.26 109.795 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.11 -42.77 83.4 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 119.624 -0.542 . . . . 1.5900000000000001 113.93 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.9 t -142.44 130.77 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.722 1.609 . . . . 2.21 110.671 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.69 142.94 29.66 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.489 1.116 . . . . 1.2 110.956 168.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.16 162.57 42.13 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.442 2.095 . . . . 0.96999999999999997 112.215 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.8 -29.01 69.96 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.865 -1.147 . . . . 1.29 112.531 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -79.8 1.88 25.17 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.806 1.642 . . . . 1.4099999999999999 114.966 173.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.43 157.06 16.91 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.705 1.202 . . . . 1.1599999999999999 112.815 169.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -147.32 167.97 22.96 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.774 1.63 . . . . 3.1400000000000001 112.067 170.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -126.8 144.17 51.04 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.533 1.133 . . . . 2.6800000000000002 112.296 -169.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.1 pt -142.15 146.2 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.72 1.608 . . . . 1.1200000000000001 111.046 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.03 158.82 43.49 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.315 1.046 . . . . 1.1000000000000001 111.99 173.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.65 15.86 21.5 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.03 1.3 . . . . 0.65000000000000002 114.855 -171.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 p -101.4 144.44 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 127.997 2.519 . . . . 0.87 110.501 175.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.4 tpp -97.38 139.33 33.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.555 1.942 . . . . 0.57999999999999996 113.374 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.569 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.6 OUTLIER -141.64 154.34 45.31 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.988 1.315 . . . . 1.6499999999999999 111.31 171.775 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.5 m -125.68 146.13 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.097 1.759 . . . . 0.34000000000000002 109.82 -174.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -85.67 147.0 26.58 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.76 1.266 . . . . 0.40000000000000002 112.548 169.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.6 p -141.33 172.02 13.25 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.761 2.024 . . . . 0.35999999999999999 112.493 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.11 -169.75 1.91 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 115.283 1.586 . . . . 1.8700000000000001 115.283 177.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 66.9 p -62.19 -33.68 75.0 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.663 -1.273 . . . . 2.1899999999999999 112.143 173.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -80.53 12.96 2.71 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.342 1.057 . . . . 2.1899999999999999 113.289 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.39 26.74 14.48 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.498 1.519 . . . . 0.68000000000000005 111.761 -172.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -93.35 143.48 26.24 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.93 1.292 . . . . 1.9299999999999999 111.751 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.4 mt -78.38 124.46 36.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.358 0.663 . . . . 0.46999999999999997 110.36 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.533 HG22 HG22 ' A' ' 97' ' ' THR . 2.2 pt -113.83 154.3 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.605 1.562 . . . . 0.53000000000000003 114.95 177.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.14 157.74 18.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.429 2.692 . . . . 1.79 108.666 167.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -54.76 -24.42 22.36 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.634 1.716 . . . . 2.3799999999999999 115.634 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . 0.261 0.0 OUTLIER -86.89 7.05 28.93 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 119.355 0.98 . . . . 2.9300000000000002 112.42 176.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.42 19.05 77.1 Favored Glycine 0 C--N 1.343 0.931 0 C-N-CA 125.909 1.719 . . . . 0.76000000000000001 113.417 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -80.66 137.88 36.36 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.299 0.64 . . . . 2.1499999999999999 110.261 169.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.533 HG22 HG22 ' A' ' 91' ' ' ILE . 20.1 p -96.19 146.17 24.91 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.829 0.852 . . . . 0.76000000000000001 111.099 -177.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.1 -6.04 29.09 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.579 1.325 . . . . 0.75 114.579 -168.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.27 28.03 46.26 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.193 0.902 . . . . 0.67000000000000004 113.802 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 36.6 t -134.48 147.89 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.103 1.361 . . . . 1.1299999999999999 110.501 176.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -129.8 158.44 39.43 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 128.973 2.909 . . . . 1.3300000000000001 111.091 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 74.7 mt -132.83 139.33 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 125.559 1.544 . . . . 0.54000000000000004 111.13 -174.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -75.79 139.06 69.8 Favored Pre-proline 0 CA--C 1.546 0.806 0 O-C-N 120.272 -1.518 . . . . 2.1600000000000001 111.97 171.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.19 -20.6 24.6 Favored 'Trans proline' 0 C--N 1.349 0.602 0 CA-C-N 122.645 1.981 . . . . 0.66000000000000003 113.517 176.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -98.21 -44.4 6.6 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.934 1.693 . . . . 1.28 112.018 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.9 p -90.2 -21.29 22.24 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.992 0.738 . . . . 0.81000000000000005 112.992 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 54.5 18.92 2.14 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.48 1.512 . . . . 1.8200000000000001 113.943 -172.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.1 148.92 21.81 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.728 -1.232 . . . . 2.6600000000000001 112.73 -177.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.9 mt -87.74 142.53 27.75 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.069 1.748 . . . . 0.83999999999999997 113.313 -170.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.8 p -71.26 -7.26 45.77 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.042 1.127 . . . . 1.3200000000000001 114.042 171.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.99 -161.26 14.64 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.959 1.266 . . . . 1.02 112.881 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.83 162.56 29.33 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.359 1.063 . . . . 1.29 113.333 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -51.51 137.09 32.12 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.777 1.231 . . . . 2.02 112.91 174.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.8 154.79 26.65 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.858 3.038 . . . . 1.01 114.199 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.17 -60.92 2.11 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.337 1.236 . . . . 1.24 114.337 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.6 p -119.84 15.64 12.61 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 114.363 1.245 . . . . 0.96999999999999997 114.363 -169.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.35 146.78 11.57 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.914 1.079 . . . . 0.46000000000000002 113.914 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.6 ttt -74.77 102.86 4.81 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.655 1.982 . . . . 1.97 110.605 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -156.25 146.21 21.22 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.018 1.727 . . . . 0.94999999999999996 112.211 -173.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -163.75 156.81 18.36 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.448 1.499 . . . . 1.79 110.627 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.1 mp -92.72 146.74 23.42 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.527 0.731 . . . . 0.62 112.03 173.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.569 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 5.2 p -65.3 140.57 58.7 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 121.054 -1.029 . . . . 0.62 110.183 169.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -98.08 -62.81 1.19 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.473 0.916 . . . . 2.1699999999999999 113.473 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -170.37 -31.14 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.439 2.296 . . . . 1.3899999999999999 110.682 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.14 24.03 10.75 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.045 2.138 . . . . 4.75 112.32 172.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.9 -151.63 27.71 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.94 1.257 . . . . 0.62 112.801 -170.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.3 129.77 24.06 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.63 1.972 . . . . 0.44 111.416 169.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -83.75 135.85 34.39 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.677 1.591 . . . . 1.3899999999999999 112.89 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -127.35 130.61 49.75 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.27 2.228 . . . . 1.6899999999999999 108.602 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -93.17 104.09 16.31 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.428 -0.795 . . . . 2.0499999999999998 111.608 -173.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.1 p -86.41 -0.8 56.74 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.69 1.196 . . . . 1.01 113.49 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.39 -25.49 59.58 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.94 0.896 . . . . 0.91000000000000003 113.222 169.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -87.74 -14.94 38.4 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.329 1.451 . . . . 2.1400000000000001 113.433 -174.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -90.4 150.19 42.41 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 113.881 1.067 . . . . 0.63 113.881 177.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -85.45 172.21 8.28 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.09 3.194 . . . . 0.77000000000000002 111.011 166.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.6 85.27 2.08 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.995 2.118 . . . . 1.1000000000000001 111.054 -174.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -141.56 176.1 9.16 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.159 1.384 . . . . 0.80000000000000004 111.256 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -91.28 145.7 24.44 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.621 1.2 . . . . 2.71 111.981 169.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -136.11 176.17 8.94 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.854 2.062 . . . . 0.58999999999999997 109.983 -172.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.95 156.74 43.0 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.642 1.177 . . . . 3.5899999999999999 113.411 177.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.0 142.38 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.66 1.184 . . . . 0.45000000000000001 111.354 172.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -131.1 142.21 50.24 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.722 2.009 . . . . 1.8100000000000001 111.891 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -103.78 126.85 51.2 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.246 1.418 . . . . 2.1099999999999999 112.843 -175.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 25.0 mm -128.01 143.64 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.434 1.493 . . . . 1.1299999999999999 110.246 -169.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -114.7 -1.48 13.28 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.093 1.516 . . . . 4.9100000000000001 115.093 -178.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 N--CA 1.479 0.997 0 O-C-N 120.06 -1.65 . . . . 2.3100000000000001 113.221 171.186 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 115.306 1.595 . . . . 1.96 115.306 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -87.47 158.5 18.94 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.089 1.356 . . . . 0.91000000000000003 112.526 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.7 m -122.91 145.23 45.03 Favored Pre-proline 0 N--CA 1.468 0.472 0 C-N-CA 124.497 1.119 . . . . 0.57999999999999996 111.198 178.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.9 161.95 43.39 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.049 2.499 . . . . 0.52000000000000002 112.476 -170.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.3 mp -126.85 119.33 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.861 1.264 . . . . 1.3899999999999999 111.067 -168.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -74.33 140.26 44.74 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.818 0.735 . . . . 3.29 110.853 168.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.9 tt -144.81 144.62 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.55 1.14 . . . . 0.47999999999999998 111.622 174.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -115.81 157.68 24.03 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.434 1.094 . . . . 2.1099999999999999 110.975 169.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.79 151.48 72.55 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.407 1.483 . . . . 1.1399999999999999 112.949 177.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -83.16 116.57 2.42 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.85 2.366 . . . . 1.1100000000000001 113.998 -169.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.75 57.64 1.67 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 104.864 -2.273 . . . . 2.3999999999999999 104.864 165.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -128.37 170.17 13.41 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 127.226 2.211 . . . . 3.5699999999999998 110.478 -167.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -71.88 -11.13 60.65 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 120.632 -1.293 . . . . 3.1899999999999999 114.242 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.0 m -77.41 148.69 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 114.733 1.383 . . . . 1.03 114.733 -171.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.1 t -80.58 -38.36 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.982 1.313 . . . . 1.8400000000000001 111.689 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -149.35 147.32 28.18 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.229 1.412 . . . . 2.5899999999999999 110.728 170.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -97.05 161.57 13.77 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.524 1.305 . . . . 0.59999999999999998 114.524 -168.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -133.97 169.89 16.44 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.074 1.509 . . . . 0.64000000000000001 115.074 174.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -138.55 144.78 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.623 1.969 . . . . 0.59999999999999998 111.148 173.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -137.06 83.25 28.31 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.685 1.594 . . . . 2.2200000000000002 111.032 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -69.72 151.15 69.24 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.501 2.801 . . . . 0.56000000000000005 113.241 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -131.17 156.62 45.01 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.968 2.107 . . . . 1.5900000000000001 112.037 -171.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -89.61 177.31 6.57 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 122.913 1.339 . . . . 3.79 113.369 173.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 32.3 p . . . . . 0 N--CA 1.466 0.339 0 C-N-CA 126.321 1.848 . . . . 3.3100000000000001 112.171 178.894 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.4 p . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 115.688 1.736 . . . . 1.1299999999999999 115.688 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.7 p -89.13 -14.53 35.97 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.558 1.318 . . . . 1.45 114.558 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 t -147.18 165.29 30.46 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.452 1.901 . . . . 2.3599999999999999 111.365 171.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -103.89 -0.09 29.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.971 2.509 . . . . 1.02 114.83 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.413 ' HA ' ' H ' ' A' ' 131' ' ' THR . 88.6 p -149.28 165.43 31.94 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.553 1.141 . . . . 1.73 113.349 175.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.66 136.63 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 127.474 2.309 . . . . 0.53000000000000003 109.757 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.0 m -104.89 115.28 30.02 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.771 0.796 . . . . 0.88 110.796 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 p -95.24 134.56 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.28 1.432 . . . . 0.82999999999999996 110.486 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -116.98 179.1 4.12 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.583 1.953 . . . . 1.8400000000000001 109.988 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.96 129.35 18.93 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 120.35 1.432 . . . . 1.01 113.204 171.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.3 mt -115.0 148.24 39.08 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.422 1.089 . . . . 0.56000000000000005 113.85 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.5 mt -135.94 177.13 8.07 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.24 2.216 . . . . 1.99 109.995 169.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.418 ' HB1' ' H ' ' A' ' 48' ' ' ASP . . . -111.96 166.8 10.9 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.845 1.258 . . . . 0.81000000000000005 112.545 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.3 p -85.67 -32.98 21.68 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.593 -1.317 . . . . 0.92000000000000004 113.309 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -133.24 15.37 4.15 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.106 1.363 . . . . 2.4900000000000002 113.624 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.22 34.86 8.41 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 120.722 -1.236 . . . . 1.1299999999999999 113.379 -173.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.418 ' H ' ' HB1' ' A' ' 44' ' ' ALA . 1.7 m-20 -79.59 12.5 2.51 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.977 2.511 . . . . 2.04 114.614 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -60.17 -20.22 57.56 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.768 -1.207 . . . . 0.79000000000000004 113.081 -172.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.44 -56.04 19.38 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.033 1.733 . . . . 2.8999999999999999 113.041 172.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -38.87 70.45 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.173 -0.954 . . . . 4.3799999999999999 111.704 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 84.4 mt -53.21 -50.28 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.352 1.061 . . . . 0.67000000000000004 110.922 169.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.08 -32.66 72.31 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.826 1.194 . . . . 0.92000000000000004 112.987 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -70.51 -34.34 72.22 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.998 0.74 . . . . 1.3 112.998 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -67.79 -28.05 67.27 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.717 0.69 . . . . 1.95 112.57 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.9 mt -85.99 -36.28 19.88 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.952 1.093 . . . . 1.25 113.952 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -65.42 -25.48 67.55 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.214 0.916 . . . . 2.8599999999999999 113.137 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.1 t -76.37 -34.05 58.91 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.42 -0.8 . . . . 1.6799999999999999 112.868 173.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.62 167.86 48.99 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.559 1.076 . . . . 1.23 113.876 176.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -93.85 32.12 1.5 Allowed 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.199 -1.177 . . . . 2.1699999999999999 112.99 -173.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -70.95 3.01 3.64 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 116.057 1.873 . . . . 2.27 116.057 -167.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.0 -23.98 67.71 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.103 -0.998 . . . . 1.29 111.942 167.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.98 -76.68 0.85 Allowed Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.405 1.478 . . . . 0.95999999999999996 112.581 170.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.36 158.13 31.73 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.983 1.475 . . . . 1.48 114.983 -170.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -62.92 147.75 49.43 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.188 0.995 . . . . 4.0599999999999996 111.58 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.5 t -56.52 140.29 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.848 0.859 . . . . 1.1499999999999999 111.867 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.58 -66.21 2.65 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.404 1.002 . . . . 1.21 112.861 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.0 t -149.14 125.01 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.975 2.11 . . . . 2.02 109.62 174.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt -74.89 145.48 81.39 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.316 -0.865 . . . . 1.21 112.505 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -72.59 161.69 43.36 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.937 2.425 . . . . 0.62 112.188 -176.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.38 -15.62 63.79 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.405 1.261 . . . . 0.87 114.405 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -96.52 -1.3 47.44 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.607 1.563 . . . . 1.73 114.193 173.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.49 150.86 24.98 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.291 -0.881 . . . . 0.56000000000000005 112.556 169.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -141.6 151.44 43.15 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.595 1.558 . . . . 2.4100000000000001 110.975 169.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.14 138.75 53.7 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.051 0.941 . . . . 3.1000000000000001 110.7 -171.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.4 pt -131.85 153.03 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 115.403 1.631 . . . . 0.83999999999999997 115.403 -169.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -113.53 156.54 23.4 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.292 1.837 . . . . 0.65000000000000002 112.31 172.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.29 13.69 59.83 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.953 1.263 . . . . 0.53000000000000003 114.882 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.86 142.35 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.079 1.751 . . . . 0.81999999999999995 110.613 172.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -103.74 136.83 42.7 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.8 1.64 . . . . 0.55000000000000004 113.661 -175.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.462 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.9 OUTLIER -141.85 152.29 43.51 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.121 1.368 . . . . 1.6499999999999999 111.76 175.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.15 146.74 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 127.306 2.242 . . . . 0.41999999999999998 109.361 -176.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -88.91 147.61 24.26 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.396 1.093 . . . . 0.40000000000000002 112.287 169.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.2 p -136.68 165.1 26.68 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.025 1.73 . . . . 0.34000000000000002 112.395 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.02 168.67 13.1 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.092 1.357 . . . . 1.55 111.22 167.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . 0.267 1.3 t -67.15 -14.65 63.1 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 115.0 1.481 . . . . 2.8199999999999998 115.0 -168.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -83.69 19.07 1.73 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.717 1.607 . . . . 3.3799999999999999 113.055 167.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.72 23.31 12.16 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.233 1.813 . . . . 0.64000000000000001 113.558 -175.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -83.89 136.67 34.01 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.659 1.584 . . . . 2.6099999999999999 112.904 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.4 mt -77.79 128.79 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 121.602 -0.686 . . . . 0.47999999999999998 110.516 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.78 150.66 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 126.386 1.874 . . . . 1.03 114.326 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -77.73 161.61 27.59 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.331 2.252 . . . . 1.5800000000000001 110.965 168.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -56.6 -21.78 29.33 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 116.025 1.861 . . . . 2.46 116.025 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . 0.257 0.0 OUTLIER -87.87 -0.58 57.15 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 120.829 1.65 . . . . 2.7200000000000002 113.558 171.438 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.62 17.6 65.71 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.895 1.236 . . . . 0.75 114.405 -175.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -75.27 145.3 41.99 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.107 0.953 . . . . 2.6899999999999999 108.966 167.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.4 p -106.21 145.42 31.59 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.084 0.954 . . . . 1.0 112.416 -171.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -103.06 -4.98 23.8 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.126 1.158 . . . . 0.78000000000000003 114.126 -170.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.85 30.17 52.72 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 119.722 1.146 . . . . 0.70999999999999996 113.905 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 45.1 t -138.85 145.81 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.124 1.369 . . . . 1.2 110.308 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -126.49 159.29 33.83 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.644 2.778 . . . . 1.5 110.942 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 51.4 mt -136.91 134.15 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.302 1.441 . . . . 0.76000000000000001 110.387 -174.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -75.56 140.06 71.49 Favored Pre-proline 0 N--CA 1.476 0.854 0 CA-C-O 117.687 -1.149 . . . . 2.2400000000000002 111.836 176.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -72.17 -24.12 20.46 Favored 'Trans proline' 0 C--N 1.351 0.679 0 CA-C-N 122.154 1.805 . . . . 0.93999999999999995 113.136 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -88.01 -52.03 5.49 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.814 1.646 . . . . 1.3 111.777 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.0 p -83.21 -23.8 32.66 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.959 0.904 . . . . 1.0 113.15 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 52.52 23.4 2.54 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.056 1.743 . . . . 2.1200000000000001 113.653 -173.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . 0.252 2.2 ptmt -104.38 162.61 13.08 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.052 -1.03 . . . . 3.71 112.887 176.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.9 mt -94.48 149.57 21.11 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.474 1.51 . . . . 1.0900000000000001 114.629 -167.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.8 p -75.1 0.76 15.07 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.986 1.106 . . . . 1.29 113.986 169.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.23 -152.33 9.54 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.187 1.375 . . . . 1.01 112.277 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.76 155.07 19.44 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.017 0.927 . . . . 1.0900000000000001 113.345 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 tpt -51.08 130.78 30.96 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.806 1.642 . . . . 1.96 112.069 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.34 168.03 25.46 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.706 2.937 . . . . 1.0 113.425 -175.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.19 -91.53 0.07 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.764 1.226 . . . . 1.6399999999999999 110.83 168.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.4 p -74.56 10.87 1.17 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 116.49 2.033 . . . . 0.75 116.49 -167.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.57 147.46 14.22 Favored 'General case' 0 CA--C 1.55 0.95 0 O-C-N 120.437 -1.415 . . . . 0.46000000000000002 113.259 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.3 ttt -74.51 102.53 4.53 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.469 1.508 . . . . 1.72 109.98 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -156.85 145.29 19.71 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.622 1.569 . . . . 0.93999999999999995 111.656 -174.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -168.13 156.82 9.04 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.272 1.829 . . . . 2.6099999999999999 109.93 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.2 mp -87.45 150.08 24.0 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.335 1.454 . . . . 0.48999999999999999 113.585 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.531 HG22 ' HA2' ' A' ' 126' ' ' GLY . 1.2 p -63.98 129.77 41.37 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.218 -0.927 . . . . 0.55000000000000004 110.193 169.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -80.75 -57.38 3.58 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 120.771 -1.206 . . . . 2.0800000000000001 114.032 -174.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -153.03 -43.12 0.1 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.921 1.688 . . . . 1.1799999999999999 109.796 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -104.6 -33.15 8.62 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.039 0.936 . . . . 4.5800000000000001 113.239 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.531 ' HA2' HG22 ' A' ' 122' ' ' THR . . . 172.61 -170.65 43.72 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 126.218 1.866 . . . . 0.71999999999999997 110.865 -169.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -135.12 136.39 41.89 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.175 1.79 . . . . 0.56999999999999995 110.637 171.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -97.05 128.9 44.45 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.016 0.926 . . . . 1.3600000000000001 111.949 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -117.98 136.23 53.64 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.8 2.04 . . . . 1.75 107.738 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -96.66 104.41 16.4 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.553 -1.342 . . . . 1.8999999999999999 111.817 -169.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.413 ' H ' ' HA ' ' A' ' 36' ' ' SER . 39.4 p -86.77 1.65 51.51 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.655 1.182 . . . . 0.72999999999999998 113.349 -174.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.3 -29.12 68.64 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.412 -0.805 . . . . 0.88 112.093 169.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.7 m120 -86.92 -20.78 26.87 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.35 1.46 . . . . 2.2999999999999998 113.187 -175.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -79.06 144.22 62.82 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 119.474 1.034 . . . . 0.92000000000000004 113.253 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.22 169.46 20.18 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.643 2.229 . . . . 1.1899999999999999 110.733 166.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.97 89.68 1.92 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.054 1.742 . . . . 1.3300000000000001 110.771 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -149.09 177.81 9.27 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.827 0.851 . . . . 0.90000000000000002 112.052 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -87.04 146.37 26.12 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.107 0.963 . . . . 2.7200000000000002 111.628 166.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -135.84 170.49 15.9 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.993 2.117 . . . . 0.68999999999999995 109.718 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -140.25 149.72 43.21 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.549 0.739 . . . . 1.6699999999999999 111.788 171.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.2 mp -104.03 140.4 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.281 0.632 . . . . 0.44 110.072 173.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -124.75 135.94 53.42 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.926 1.69 . . . . 1.8700000000000001 109.852 174.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -97.55 123.84 41.58 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.122 0.969 . . . . 1.8400000000000001 109.392 178.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 40.3 mm -122.57 97.12 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.743 0.817 . . . . 0.70999999999999996 109.074 -172.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.7 -12.03 60.32 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.579 1.325 . . . . 4.21 114.579 -169.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 79.8 p . . . . . 0 N--CA 1.469 0.478 0 N-CA-C 114.271 1.211 . . . . 1.7 114.271 177.632 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 115.209 1.559 . . . . 2.1400000000000001 115.209 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.62 152.96 29.74 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.099 0.96 . . . . 0.80000000000000004 111.857 168.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.56 149.04 54.63 Favored Pre-proline 0 N--CA 1.478 0.975 0 C-N-CA 125.337 1.455 . . . . 0.66000000000000003 110.784 174.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.9 162.72 29.21 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.894 3.063 . . . . 0.78000000000000003 115.299 -165.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.6 mp -126.41 133.47 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.742 2.017 . . . . 1.25 110.701 -168.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -98.14 130.88 44.89 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.438 1.095 . . . . 3.3900000000000001 111.838 174.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.4 tt -135.94 147.84 28.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.927 1.291 . . . . 0.67000000000000004 110.816 -174.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -127.48 152.93 46.94 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.986 1.315 . . . . 1.95 109.125 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.09 143.97 98.97 Favored Pre-proline 0 CA--C 1.543 0.688 0 O-C-N 120.94 -1.1 . . . . 1.05 111.614 -176.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -66.81 92.04 0.31 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 124.506 3.47 . . . . 0.79000000000000004 115.599 -165.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.2 tt -122.73 77.53 1.44 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.678 1.991 . . . . 2.3700000000000001 105.783 168.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -157.63 177.02 11.86 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.155 2.182 . . . . 2.6499999999999999 108.574 -167.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -84.33 34.36 0.52 Allowed 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.163 -1.585 . . . . 3.23 114.135 -175.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.63 156.51 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.845 1.258 . . . . 1.22 111.637 -174.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 78.2 t -108.88 -33.85 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.267 1.827 . . . . 1.8100000000000001 111.558 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -129.07 134.64 48.18 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.265 1.426 . . . . 3.7400000000000002 109.167 172.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -98.34 137.82 36.5 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.226 1.01 . . . . 0.40999999999999998 111.494 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -133.72 166.93 21.49 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.068 1.136 . . . . 0.63 114.068 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.28 135.91 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.2 1.4 . . . . 0.59999999999999998 111.568 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -134.18 82.52 47.5 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.569 1.147 . . . . 2.0800000000000001 111.466 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . 0.605 ' HB3' HD11 ' A' ' 166' ' ' ILE . 60.4 Cg_endo -69.78 151.08 68.87 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 124.559 3.506 . . . . 0.58999999999999997 112.274 175.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -131.58 158.94 39.65 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.083 1.753 . . . . 1.6899999999999999 111.679 -178.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -88.64 175.01 7.72 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.311 1.044 . . . . 2.71 110.997 168.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 13.2 t . . . . . 0 N--CA 1.482 1.145 0 O-C-N 121.409 -0.807 . . . . 2.48 113.063 169.701 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.9 p . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 113.416 0.895 . . . . 1.1299999999999999 113.416 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 43.4 p -98.21 -8.48 27.33 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.343 1.457 . . . . 1.9399999999999999 114.067 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.0 m -147.5 146.02 29.34 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.478 1.911 . . . . 2.73 110.054 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.4 p -108.96 -14.48 14.55 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 116.901 2.186 . . . . 1.05 116.901 -172.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.6 m -138.61 149.62 45.43 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.019 1.328 . . . . 1.8200000000000001 111.589 170.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.5 p -115.7 142.66 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 127.071 2.149 . . . . 0.37 110.382 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 36.0 m -111.0 121.61 45.8 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.582 0.753 . . . . 0.73999999999999999 109.564 172.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 p -96.65 127.38 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.945 0.879 . . . . 0.58999999999999997 109.346 174.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -103.66 -172.47 2.12 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.02 1.728 . . . . 1.8999999999999999 109.029 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.8 134.19 13.47 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 120.411 -1.431 . . . . 0.93999999999999995 112.611 168.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.0 mt -121.06 150.57 40.98 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.852 1.261 . . . . 0.66000000000000003 112.971 -172.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.3 mt -140.81 169.66 17.22 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.332 1.853 . . . . 1.6899999999999999 109.761 167.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.98 172.97 7.07 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.993 0.917 . . . . 0.80000000000000004 112.029 173.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.8 p -102.31 -25.78 13.54 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 114.417 1.266 . . . . 1.02 114.417 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -134.95 45.22 2.55 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.668 1.987 . . . . 2.5499999999999998 110.365 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.47 14.63 67.17 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 120.741 -1.224 . . . . 0.87 116.007 175.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.63 27.24 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.982 2.513 . . . . 2.2000000000000002 115.921 -171.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.13 -19.06 65.8 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 119.617 -1.927 . . . . 0.68000000000000005 114.13 -171.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -85.14 -43.38 13.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.385 1.474 . . . . 2.2799999999999998 112.583 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -69.94 -39.09 76.28 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-O 117.941 -1.028 . . . . 3.4100000000000001 110.955 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.3 mt -51.6 -50.37 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.499 1.12 . . . . 0.98999999999999999 110.09 167.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.37 -27.47 66.0 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.554 0.946 . . . . 1.04 113.554 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -79.72 -32.22 41.23 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.063 -1.023 . . . . 1.23 112.937 174.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -67.97 -16.01 63.86 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.792 0.837 . . . . 2.1000000000000001 112.596 169.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.4 mt -97.46 -37.61 9.92 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.072 1.349 . . . . 1.1100000000000001 114.22 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -70.15 -15.93 63.02 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.57 -1.331 . . . . 2.5099999999999998 114.448 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.4 t -71.78 -30.2 65.3 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.01 0.924 . . . . 1.8999999999999999 113.25 170.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.38 164.6 28.29 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.48 1.514 . . . . 1.22 113.053 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -87.32 53.41 2.8 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.131 -1.217 . . . . 1.6299999999999999 111.412 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -89.41 8.01 33.0 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.378 1.251 . . . . 1.8899999999999999 114.378 -170.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.03 -25.79 63.74 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.139 -0.976 . . . . 0.92000000000000004 111.69 168.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.28 -82.53 1.21 Allowed Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.064 0.84 . . . . 0.67000000000000004 111.888 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 161.52 29.67 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.774 1.23 . . . . 1.74 112.708 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -60.36 158.13 12.44 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.804 1.242 . . . . 2.5099999999999998 114.341 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 52.6 t -59.04 126.73 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 121.881 -0.512 . . . . 0.71999999999999997 110.6 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.38 -48.84 75.19 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.061 1.315 . . . . 0.90000000000000002 113.301 -175.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.0 129.16 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.804 1.241 . . . . 2.5899999999999999 111.228 173.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.9 mt -79.62 144.54 61.04 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.066 0.946 . . . . 0.88 111.532 174.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.64 166.94 28.51 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.65 2.234 . . . . 0.65000000000000002 113.045 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.64 -23.83 65.38 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 121.015 -1.053 . . . . 0.90000000000000002 113.452 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -83.92 -1.43 54.52 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.373 1.249 . . . . 1.6399999999999999 114.373 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.09 158.19 16.47 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.282 1.433 . . . . 0.54000000000000004 114.162 172.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.77 159.45 44.34 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.55 1.14 . . . . 1.97 112.729 166.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -105.29 150.04 25.51 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.847 1.659 . . . . 2.8999999999999999 111.263 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.9 pt -137.92 139.29 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 120.067 1.303 . . . . 0.78000000000000003 114.282 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.74 146.95 25.97 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.759 1.223 . . . . 0.84999999999999998 113.102 172.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.8 14.36 27.25 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.341 1.448 . . . . 0.54000000000000004 115.42 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.43 144.44 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 125.287 1.435 . . . . 0.76000000000000001 109.795 169.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 1.3 tpt -105.25 140.26 38.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.554 1.542 . . . . 0.48999999999999999 112.115 176.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.52 155.67 43.23 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.841 1.257 . . . . 2.04 112.625 172.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.3 m -120.23 149.62 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 127.033 2.133 . . . . 0.40999999999999998 109.709 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -90.26 147.58 23.44 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 122.619 1.199 . . . . 0.35999999999999999 112.106 169.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.4 p -139.72 166.85 23.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.31 1.844 . . . . 0.42999999999999999 111.385 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.78 172.93 11.73 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.544 -0.722 . . . . 1.99 112.529 168.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.8 t -61.58 -23.98 66.36 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.437 1.273 . . . . 2.8999999999999999 114.437 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -87.9 20.99 2.83 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 125.379 1.472 . . . . 2.2599999999999998 113.347 171.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 56.75 27.47 12.81 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.779 2.832 . . . . 0.65000000000000002 114.742 175.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -82.7 140.56 33.03 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.013 0.925 . . . . 2.1600000000000001 110.31 172.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.4 mt -76.21 125.68 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.225 -0.657 . . . . 0.58999999999999997 109.225 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.471 HG22 HG22 ' A' ' 97' ' ' THR . 3.3 pt -121.86 156.91 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 114.644 1.35 . . . . 0.52000000000000002 114.644 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -90.1 164.09 14.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.619 2.367 . . . . 1.5700000000000001 110.115 168.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -68.97 2.9 2.31 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 116.689 2.107 . . . . 2.3999999999999999 116.689 -168.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -110.89 0.79 17.27 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.422 1.489 . . . . 2.8399999999999999 114.105 168.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.24 3.0 60.35 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.255 1.407 . . . . 0.62 115.644 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -65.31 132.13 48.25 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.042 1.421 . . . . 2.8799999999999999 108.932 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.471 HG22 HG22 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -96.05 142.41 28.29 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 118.134 0.425 . . . . 0.92000000000000004 111.43 176.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.22 -12.76 45.83 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.233 1.198 . . . . 1.1000000000000001 114.233 -168.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.56 22.72 23.34 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.053 1.311 . . . . 0.78000000000000003 114.511 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.0 t -134.79 149.55 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.373 1.469 . . . . 1.26 110.195 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -128.28 157.5 40.74 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.68 2.792 . . . . 1.29 111.292 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 57.1 mt -134.04 126.82 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.423 1.489 . . . . 0.63 110.321 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -68.64 137.71 90.71 Favored Pre-proline 0 N--CA 1.477 0.888 0 O-C-N 121.029 -1.045 . . . . 2.3300000000000001 111.046 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.06 -15.17 29.14 Favored 'Trans proline' 0 C--N 1.35 0.623 0 CA-C-N 121.924 1.723 . . . . 0.84999999999999998 113.785 176.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -97.19 -47.43 5.75 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.627 1.571 . . . . 2.1499999999999999 111.419 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.9 p -90.34 -22.03 21.73 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.728 1.211 . . . . 1.1499999999999999 113.458 -174.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 56.43 16.32 2.4 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.582 1.553 . . . . 1.74 113.923 -171.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.81 146.13 24.01 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.94 -1.1 . . . . 2.79 113.124 -175.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.9 mt -81.56 142.73 32.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.102 1.361 . . . . 0.95999999999999996 112.648 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 83.8 p -77.67 4.4 11.57 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.418 1.266 . . . . 1.3700000000000001 114.418 172.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.83 -162.52 29.63 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 126.106 1.813 . . . . 1.1599999999999999 112.388 -176.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.66 154.75 39.57 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.827 1.047 . . . . 1.3899999999999999 113.827 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 mtp -51.8 138.18 33.4 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.39 1.076 . . . . 2.1299999999999999 112.64 174.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -83.48 171.2 11.23 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.536 3.491 . . . . 0.82999999999999996 113.895 -172.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.12 -96.19 0.09 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.583 1.553 . . . . 1.3899999999999999 110.545 168.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.1 p -72.77 13.51 0.36 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 116.627 2.084 . . . . 1.02 116.627 -168.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.61 145.09 19.78 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.042 -1.036 . . . . 0.53000000000000003 112.812 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.1 ttt -75.0 107.89 7.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.872 2.469 . . . . 1.8100000000000001 110.353 176.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -157.73 143.24 17.11 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 127.303 2.241 . . . . 1.04 112.702 -174.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -164.91 158.1 16.84 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.013 1.325 . . . . 1.8700000000000001 111.859 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.8 mp -101.79 144.99 29.78 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.991 1.317 . . . . 0.53000000000000003 113.981 175.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.8 p -64.54 136.17 56.76 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.721 0.638 . . . . 0.54000000000000004 112.721 173.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.03 -59.13 1.86 Allowed 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 114.965 1.468 . . . . 2.3300000000000001 114.965 -172.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.25 -39.61 0.14 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.184 0.994 . . . . 1.0 111.871 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -115.35 -27.01 7.36 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.09 0.956 . . . . 5.2000000000000002 112.515 174.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 179.64 -156.04 17.2 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 123.836 0.732 . . . . 0.58999999999999997 112.263 -178.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.74 131.12 23.67 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.023 2.129 . . . . 0.41999999999999998 111.5 171.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -83.49 140.64 32.19 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.945 1.298 . . . . 1.27 113.579 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -134.39 118.74 17.77 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.989 2.516 . . . . 1.7 108.977 175.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.483 ' ND2' HD21 ' A' ' 133' ' ' ASN . 17.0 t30 -76.27 113.14 13.5 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.569 1.148 . . . . 1.6000000000000001 109.427 177.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 35.9 p -103.61 0.66 31.08 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.921 1.288 . . . . 0.69999999999999996 113.219 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -53.41 -18.48 2.66 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.756 2.422 . . . . 1.0600000000000001 115.276 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.483 HD21 ' ND2' ' A' ' 130' ' ' ASN . 0.0 OUTLIER -105.81 -23.81 12.62 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.373 1.869 . . . . 2.4199999999999999 113.088 -174.508 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.57 140.03 96.31 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 119.318 0.963 . . . . 0.94999999999999996 112.458 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.09 169.18 23.14 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.581 2.187 . . . . 0.82999999999999996 111.482 169.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.47 93.05 2.4 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.978 1.311 . . . . 1.3300000000000001 109.614 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -144.51 178.79 7.7 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.478 1.111 . . . . 0.96999999999999997 111.079 174.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -94.95 141.69 28.35 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.335 1.054 . . . . 3.29 110.988 169.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -135.34 166.72 22.5 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.222 1.809 . . . . 0.63 110.272 -172.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -141.49 149.17 40.56 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.24 0.83 . . . . 1.74 113.24 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 mp -105.91 142.34 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.572 1.149 . . . . 0.46000000000000002 110.201 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -129.43 127.29 40.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.891 1.676 . . . . 1.96 111.491 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -91.84 75.21 5.68 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.967 0.907 . . . . 1.95 112.656 -171.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.0 mm -77.75 107.99 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.742 0.817 . . . . 0.72999999999999998 109.908 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.78 9.07 40.43 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.763 1.023 . . . . 4.2400000000000002 113.763 -174.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 113.752 1.019 . . . . 2.3900000000000001 113.752 -176.551 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 119.478 -0.296 . . . . 2.29 111.788 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.33 128.85 36.66 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.996 0.816 . . . . 1.04 111.79 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.2 m -100.46 149.6 36.24 Favored Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 124.24 1.016 . . . . 0.76000000000000001 110.356 172.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.74 161.29 46.59 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.797 2.331 . . . . 0.75 113.058 -170.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 1.5 mp -121.84 127.87 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.347 1.059 . . . . 1.55 110.761 -169.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -93.02 139.37 30.6 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.896 1.279 . . . . 2.7200000000000002 112.466 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.8 tt -147.48 146.57 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.965 1.306 . . . . 0.48999999999999999 111.964 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -120.88 155.73 33.52 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.047 1.339 . . . . 2.2999999999999998 110.639 169.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -67.53 148.61 98.6 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 123.793 0.837 . . . . 1.3 112.139 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.0 112.1 3.04 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.527 2.818 . . . . 1.1399999999999999 114.008 -168.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 tp -119.04 0.98 11.39 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 125.239 1.416 . . . . 2.79 110.854 165.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -76.85 169.16 18.82 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 129.585 3.154 . . . . 2.8999999999999999 111.53 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -74.16 19.54 0.12 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 116.46 2.022 . . . . 4.21 116.46 -171.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . 0.252 1.2 m -95.41 147.53 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 O-C-N 121.04 -1.038 . . . . 1.27 113.672 -169.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 41.2 t -88.31 -32.35 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.079 1.352 . . . . 1.6399999999999999 112.129 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -147.13 127.38 13.86 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.544 1.537 . . . . 2.54 108.645 -174.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -101.57 143.15 31.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.561 1.144 . . . . 0.41999999999999998 112.449 -169.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -139.02 170.62 15.65 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.329 1.603 . . . . 0.65000000000000002 115.329 -178.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.4 t -139.74 139.94 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.752 2.021 . . . . 0.57999999999999996 111.336 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -132.97 82.79 54.03 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.96 1.304 . . . . 2.23 112.988 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -65.89 143.53 73.44 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.689 3.593 . . . . 0.58999999999999997 113.913 171.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -140.71 166.68 24.1 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 129.08 2.952 . . . . 1.8999999999999999 111.027 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -117.93 169.52 9.57 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.927 0.891 . . . . 2.9500000000000002 113.06 -171.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.472 0.645 0 C-N-CA 126.662 1.985 . . . . 2.54 111.74 -178.218 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 112.8 0.667 . . . . 1.3100000000000001 112.8 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.4 p -92.8 -15.4 26.58 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.391 1.076 . . . . 1.47 113.754 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.4 HG21 ' HA ' ' A' ' 177' ' ' ASP . 98.9 m -148.37 124.44 10.73 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.008 1.723 . . . . 2.2599999999999998 108.9 171.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 45.2 p -90.86 23.63 3.07 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.181 1.548 . . . . 1.8500000000000001 115.181 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 m -149.17 165.79 30.76 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.057 1.343 . . . . 1.75 110.523 168.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.4 p -144.05 142.6 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.007 1.723 . . . . 0.34000000000000002 109.793 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.2 m -116.01 124.83 51.47 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.717 0.807 . . . . 0.65000000000000002 110.273 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -101.98 131.19 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.803 1.241 . . . . 0.63 110.599 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -128.15 104.67 7.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.227 1.411 . . . . 1.8100000000000001 110.888 -172.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.74 116.95 20.21 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.493 -1.379 . . . . 1.24 111.575 -172.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.3 mt -106.6 151.75 24.63 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.039 1.336 . . . . 0.66000000000000003 111.762 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.9 mt -138.16 171.55 14.24 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.33 1.452 . . . . 1.6000000000000001 111.137 169.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.56 162.77 13.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.356 1.063 . . . . 0.71999999999999997 112.678 170.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.6 p -91.39 -24.73 19.66 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 114.751 1.389 . . . . 0.93000000000000005 114.751 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -138.11 38.61 2.33 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.113 1.765 . . . . 2.1000000000000001 111.601 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.19 14.39 79.08 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 120.84 -1.163 . . . . 0.92000000000000004 115.659 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.01 25.26 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 128.889 2.876 . . . . 1.8400000000000001 116.221 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -24.59 67.59 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 119.883 -1.761 . . . . 0.69999999999999996 113.202 -173.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -75.28 -40.13 59.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.769 1.168 . . . . 2.1200000000000001 113.481 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.1 ptmm? -70.48 -41.41 72.75 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 117.448 -1.263 . . . . 2.79 111.357 170.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.6 mt -55.64 -52.88 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 120.252 1.387 . . . . 0.81999999999999995 111.47 170.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.61 -34.08 70.73 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.08 -1.013 . . . . 1.1699999999999999 112.785 -178.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -77.2 -30.75 54.88 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.715 1.005 . . . . 1.4099999999999999 113.715 175.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -66.35 -30.71 71.16 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.133 0.879 . . . . 2.1200000000000001 111.789 169.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.6 mt -86.4 -37.57 18.26 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.483 1.29 . . . . 1.3400000000000001 114.483 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -72.64 -23.89 60.97 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.063 0.764 . . . . 3.6800000000000002 113.063 -177.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.0 t -76.81 -28.43 55.57 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.673 0.62 . . . . 2.2000000000000002 112.673 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.6 156.65 35.23 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.106 1.336 . . . . 1.3500000000000001 112.745 172.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -83.57 31.45 0.47 Allowed 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.21 -1.171 . . . . 2.3500000000000001 112.817 -173.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -71.08 5.42 2.1 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.786 1.402 . . . . 2.0699999999999998 114.786 -169.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.95 -22.35 62.37 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.007 -1.058 . . . . 1.1299999999999999 112.289 167.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.69 -82.11 1.15 Allowed Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.263 1.411 . . . . 0.84999999999999998 113.455 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.42 157.09 38.66 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.491 1.916 . . . . 1.5 114.933 -172.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.9 157.14 19.06 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.687 1.195 . . . . 3.4900000000000002 113.793 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.477 HG23 ' CE2' ' A' ' 181' ' ' TYR . 25.1 t -63.67 130.98 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.907 0.883 . . . . 1.0800000000000001 110.539 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.67 -51.65 29.41 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 119.776 -0.458 . . . . 1.1100000000000001 113.723 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 t -146.73 136.36 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.227 1.411 . . . . 2.0600000000000001 109.629 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.1 mt -84.96 150.71 56.17 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.723 0.809 . . . . 1.04 113.151 171.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.429 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 72.9 Cg_endo -72.99 159.13 48.62 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.566 2.178 . . . . 0.73999999999999999 111.564 171.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.29 -30.17 66.41 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.421 -0.799 . . . . 1.1299999999999999 112.889 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -87.43 1.89 52.07 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.635 1.717 . . . . 1.48 115.635 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HB2' ' HG2' ' A' ' 70' ' ' PRO . . . -88.95 154.35 20.3 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.771 1.169 . . . . 0.56000000000000005 113.915 172.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -146.78 169.86 18.21 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.699 2.0 . . . . 2.04 112.329 171.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -128.31 138.42 52.38 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.3 1.44 . . . . 2.2000000000000002 111.248 -173.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.0 pt -126.96 141.56 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 114.096 1.147 . . . . 0.80000000000000004 114.096 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -112.97 158.31 20.41 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.833 1.253 . . . . 0.70999999999999996 112.993 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.64 4.88 82.44 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.789 1.185 . . . . 0.75 114.654 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -86.61 141.2 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.052 1.341 . . . . 0.80000000000000004 110.75 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -104.81 134.3 48.18 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.851 1.66 . . . . 0.66000000000000003 113.193 -173.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.438 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.7 OUTLIER -141.02 154.03 45.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.761 1.224 . . . . 1.71 112.278 177.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 m -127.04 144.32 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 126.513 1.925 . . . . 0.40999999999999998 110.067 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -87.18 147.69 25.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.595 1.188 . . . . 0.41999999999999998 112.024 170.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.5 p -140.99 167.24 22.66 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.881 2.072 . . . . 0.40000000000000002 111.13 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.8 171.57 11.46 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.949 0.722 . . . . 2.1499999999999999 112.949 169.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.2 t -63.13 -23.99 67.69 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.566 1.321 . . . . 3.1499999999999999 114.566 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -87.6 24.42 1.7 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.649 1.18 . . . . 2.3100000000000001 113.085 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.52 27.44 16.61 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 128.105 2.562 . . . . 0.80000000000000004 114.602 172.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -89.88 143.26 26.95 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.169 1.388 . . . . 1.8100000000000001 111.795 174.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.2 mt -79.3 127.48 39.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 123.28 0.632 . . . . 0.48999999999999999 110.034 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.731 HG22 HG22 ' A' ' 97' ' ' THR . 3.3 pt -121.61 153.94 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.991 1.716 . . . . 0.52000000000000002 115.139 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -84.6 165.55 17.88 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.429 2.291 . . . . 2.1000000000000001 110.574 167.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -64.91 -12.57 50.67 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.139 1.533 . . . . 2.5099999999999998 115.139 -170.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -96.98 6.11 49.24 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.319 1.448 . . . . 2.6200000000000001 113.564 173.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.62 5.12 82.21 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.938 1.256 . . . . 0.68999999999999995 115.066 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -73.69 142.71 46.39 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 124.321 1.048 . . . . 2.1099999999999999 110.403 173.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.731 HG22 HG22 ' A' ' 91' ' ' ILE . 30.6 p -104.94 147.29 27.94 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.974 0.91 . . . . 0.72999999999999998 112.499 -171.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.12 2.54 37.56 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.229 1.566 . . . . 0.81000000000000005 115.229 -168.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.88 23.43 74.82 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 120.529 -1.357 . . . . 0.75 114.733 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.2 p -138.05 143.38 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.709 1.204 . . . . 2.7400000000000002 109.749 177.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.14 164.59 18.37 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.7 2.4 . . . . 1.49 110.755 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 66.5 mt -135.61 131.13 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 124.873 1.269 . . . . 0.67000000000000004 110.321 -177.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -69.02 138.81 90.1 Favored Pre-proline 0 CA--C 1.543 0.696 0 O-C-N 121.038 -1.039 . . . . 2.29 110.813 175.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.07 -18.4 21.26 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 CA-C-N 122.12 1.793 . . . . 0.71999999999999997 113.21 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.77 -52.4 3.75 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.416 1.886 . . . . 1.8200000000000001 110.892 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.3 p -80.45 -25.75 38.73 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.019 0.748 . . . . 0.91000000000000003 113.019 -176.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 58.24 12.86 2.09 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.406 1.482 . . . . 1.6699999999999999 113.842 -171.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.02 150.66 26.21 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.624 -1.297 . . . . 2.4700000000000002 111.737 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.3 mt -85.52 140.63 30.49 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.68 0.993 . . . . 0.84999999999999998 113.68 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.2 t -88.66 35.93 0.79 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.533 1.533 . . . . 2.6899999999999999 111.397 169.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 170.46 -168.81 41.81 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.678 2.085 . . . . 1.1699999999999999 111.702 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.54 163.09 26.6 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.425 0.69 . . . . 1.01 111.396 170.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.7 tpt -59.87 127.19 85.09 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.081 0.952 . . . . 1.6299999999999999 110.778 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -69.91 171.57 14.39 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 124.818 3.679 . . . . 0.83999999999999997 113.671 -172.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.37 -92.18 0.07 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.332 1.053 . . . . 1.5700000000000001 110.722 169.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.8 p -73.83 6.65 3.09 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.7 2.0 . . . . 0.70999999999999996 116.398 -167.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.12 147.16 7.82 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.427 1.091 . . . . 0.42999999999999999 113.8 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.1 tpt -74.76 92.03 2.45 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.933 2.093 . . . . 1.55 112.196 -177.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.9 pttm -143.61 148.16 35.44 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.013 1.325 . . . . 2.1800000000000002 113.636 -175.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -162.85 165.6 25.07 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.186 1.395 . . . . 2.3300000000000001 111.356 172.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.2 mp -98.14 150.03 21.9 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.876 1.67 . . . . 0.63 113.25 172.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.438 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 2.5 p -67.23 135.9 54.13 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 119.632 1.105 . . . . 0.53000000000000003 111.131 168.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -89.01 -53.04 4.77 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 115.225 1.565 . . . . 2.1099999999999999 115.225 -175.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.55 -45.51 0.07 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.911 1.284 . . . . 1.1799999999999999 110.647 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -116.72 -18.77 10.18 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.015 1.117 . . . . 5.3799999999999999 114.015 176.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 177.35 -163.93 32.83 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.986 1.279 . . . . 0.62 112.216 -176.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -143.17 132.15 22.91 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.542 2.337 . . . . 0.41999999999999998 110.942 169.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -84.51 144.18 28.86 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.246 1.418 . . . . 1.3 112.323 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -135.5 124.37 24.05 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.969 2.107 . . . . 1.8300000000000001 108.708 172.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -73.11 134.59 44.56 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.504 -0.748 . . . . 1.76 111.216 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 71.9 p -121.37 6.14 10.16 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.412 1.485 . . . . 0.56000000000000005 113.671 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.7 -36.24 69.41 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.654 1.115 . . . . 0.94999999999999996 113.168 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -91.36 -21.48 20.99 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.835 1.254 . . . . 1.78 111.088 -169.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.1 139.95 96.0 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 119.819 1.19 . . . . 0.59999999999999998 112.663 170.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.67 169.65 20.48 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.997 2.464 . . . . 0.71999999999999997 111.192 167.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.2 89.34 3.67 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.547 1.539 . . . . 0.94999999999999996 111.26 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -146.84 -179.56 6.88 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.355 1.062 . . . . 0.67000000000000004 112.394 -175.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -98.4 137.54 36.94 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.199 1.399 . . . . 2.96 112.183 173.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -135.91 167.47 21.14 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.327 1.451 . . . . 0.52000000000000002 111.287 -169.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -139.78 153.17 47.07 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.159 0.799 . . . . 1.6399999999999999 113.159 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.9 mp -110.54 144.58 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.437 1.095 . . . . 0.40000000000000002 110.367 170.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -130.57 144.09 51.19 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.792 2.037 . . . . 1.8899999999999999 110.691 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -103.66 112.33 25.21 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.349 1.06 . . . . 2.1400000000000001 109.849 -175.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 19.7 mm -124.33 85.9 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.389 1.076 . . . . 0.97999999999999998 110.061 -168.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -14.79 60.64 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.438 -0.789 . . . . 4.04 113.063 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.47 0.541 0 C-N-CA 124.651 1.18 . . . . 2.1899999999999999 113.62 170.131 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 114.043 1.127 . . . . 2.1600000000000001 114.043 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.21 150.94 45.93 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.357 -0.84 . . . . 0.95999999999999996 112.308 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.35 147.43 40.54 Favored Pre-proline 0 N--CA 1.478 0.975 0 C-N-CA 125.069 1.347 . . . . 0.68999999999999995 111.169 174.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.93 138.69 23.54 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.411 2.741 . . . . 0.5 112.825 -168.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.0 mp -100.74 119.6 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 124.854 1.261 . . . . 1.3 109.982 -171.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.2 pm0 -88.51 138.99 30.93 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.829 0.852 . . . . 4.7800000000000002 113.161 174.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.2 tt -148.49 156.67 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.316 1.446 . . . . 0.59999999999999998 111.408 -173.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -127.58 152.49 47.58 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.473 1.509 . . . . 1.8400000000000001 110.092 170.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.2 138.68 97.32 Favored Pre-proline 0 CA--C 1.548 0.897 0 O-C-N 120.98 -1.075 . . . . 1.3100000000000001 111.226 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -72.64 111.6 3.28 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.575 2.183 . . . . 0.84999999999999998 114.844 -168.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.91 58.48 1.09 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 104.936 -2.246 . . . . 2.6400000000000001 104.936 165.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -144.15 144.59 31.64 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.13 2.572 . . . . 2.7000000000000002 108.512 -166.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -76.68 57.79 1.31 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.451 1.278 . . . . 3.9100000000000001 114.451 -170.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 1.6 m -112.94 151.15 14.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 125.114 1.365 . . . . 1.1599999999999999 110.538 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 96.4 t -88.13 -30.68 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.129 1.372 . . . . 1.53 110.802 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.4 ' HA ' HG21 ' A' ' 34' ' ' THR . 8.1 t0 -146.95 142.36 27.47 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.108 0.963 . . . . 2.5499999999999998 111.512 175.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -102.93 143.81 32.04 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.267 -0.896 . . . . 0.40000000000000002 112.702 -175.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -139.95 170.87 15.07 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.682 1.734 . . . . 0.52000000000000002 115.682 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -140.37 142.89 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.673 1.989 . . . . 0.45000000000000001 111.508 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.477 ' CE2' HG23 ' A' ' 66' ' ' VAL . 98.0 m-85 -131.77 76.42 74.39 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 113.814 1.042 . . . . 1.98 113.814 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . 0.534 ' HB3' HD11 ' A' ' 166' ' ' ILE . 5.1 Cg_endo -62.51 146.9 95.5 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.528 2.819 . . . . 0.68000000000000005 113.912 176.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 15.8 mtmt -121.4 -168.7 1.73 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 128.609 2.764 . . . . 1.73 111.057 -174.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.259 0.6 OUTLIER -137.41 172.84 12.38 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.868 1.667 . . . . 3.4300000000000002 110.793 167.454 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 CA--C 1.539 0.534 0 C-N-CA 125.18 1.392 . . . . 2.71 109.711 173.166 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.7 p . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 111.541 0.2 . . . . 1.1799999999999999 111.541 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.7 p -88.74 -17.12 30.55 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.335 0.865 . . . . 1.8 113.335 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 84.9 m -146.12 128.45 15.84 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.675 1.59 . . . . 2.7999999999999998 110.149 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 p -88.43 7.77 31.08 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 116.1 1.889 . . . . 1.26 116.1 -173.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.6 m -150.65 165.76 32.41 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.461 1.504 . . . . 1.77 111.811 171.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.73 144.59 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.266 1.827 . . . . 0.52000000000000002 110.938 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.01 111.33 17.76 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.934 1.293 . . . . 1.46 110.704 -170.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 p -98.9 133.73 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 120.376 -1.453 . . . . 0.54000000000000004 110.696 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -134.95 104.75 6.09 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.451 1.5 . . . . 1.8100000000000001 111.669 -171.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.53 126.03 30.72 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 119.887 -1.758 . . . . 1.1699999999999999 111.738 -173.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.4 mt -112.99 155.88 24.02 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.918 1.287 . . . . 0.48999999999999999 112.64 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.98 167.77 21.1 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.211 1.404 . . . . 1.9199999999999999 111.063 175.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.81 168.87 8.82 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.143 1.377 . . . . 0.68999999999999995 112.219 173.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.0 p -97.04 -27.69 14.49 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.612 0.968 . . . . 0.94999999999999996 113.612 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -145.3 37.59 1.13 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.455 1.102 . . . . 2.4700000000000002 112.807 172.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.62 14.38 59.88 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.87 1.224 . . . . 0.93999999999999995 115.449 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.38 14.34 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 128.232 2.613 . . . . 1.97 116.411 -174.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -63.09 -20.29 65.22 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.217 -1.552 . . . . 0.78000000000000003 113.939 -172.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -84.8 -38.84 19.1 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.647 1.179 . . . . 2.46 112.721 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -68.37 -40.39 81.46 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 120.901 -1.124 . . . . 2.6200000000000001 110.016 169.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.8 mt -54.86 -46.7 75.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 118.954 0.797 . . . . 0.71999999999999997 110.375 168.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.55 -29.46 69.16 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 120.372 1.442 . . . . 0.96999999999999997 113.655 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -77.44 -29.78 53.06 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.076 0.95 . . . . 1.4099999999999999 113.401 170.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -64.57 -28.08 69.39 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.135 -0.978 . . . . 2.4700000000000002 110.911 167.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.0 mt -87.82 -38.95 15.26 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.454 1.279 . . . . 1.1799999999999999 114.454 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.15 -25.78 67.95 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.833 1.049 . . . . 3.1200000000000001 113.833 -176.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.9 t -74.51 -25.81 59.59 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.534 0.734 . . . . 1.8799999999999999 112.977 174.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.16 166.69 38.86 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.174 1.369 . . . . 1.3 113.323 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -90.63 31.19 1.06 Allowed 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.323 -1.104 . . . . 1.6699999999999999 113.381 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -69.29 5.72 1.2 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.213 1.56 . . . . 2.1899999999999999 115.213 -169.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.32 -22.3 66.9 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.108 -0.995 . . . . 1.0800000000000001 111.486 166.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.87 -81.63 1.16 Allowed Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.881 1.705 . . . . 0.80000000000000004 113.52 170.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.24 172.19 12.26 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.031 1.332 . . . . 1.6100000000000001 114.582 -175.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -76.02 162.03 28.4 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 115.293 1.59 . . . . 3.3300000000000001 115.293 -169.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.422 HG23 ' CE2' ' A' ' 181' ' ' TYR . 21.9 t -55.18 130.64 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.433 1.093 . . . . 1.3500000000000001 110.526 172.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.36 -46.8 24.91 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 121.801 -0.562 . . . . 0.96999999999999997 113.808 -177.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.0 p -160.73 141.26 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.864 2.066 . . . . 3.1899999999999999 110.267 177.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.4 mt -84.84 147.67 49.16 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 121.466 -0.771 . . . . 1.3999999999999999 112.744 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.58 158.02 51.57 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.232 1.954 . . . . 0.81999999999999995 111.53 169.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.58 -19.6 65.98 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 120.708 -1.245 . . . . 1.1100000000000001 113.023 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -89.54 0.77 56.68 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.576 1.95 . . . . 1.3999999999999999 114.962 172.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.0 162.76 12.89 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.212 1.005 . . . . 0.67000000000000004 111.852 168.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -156.25 171.46 20.16 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.376 1.47 . . . . 2.02 111.56 169.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -123.35 148.87 45.59 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.643 1.177 . . . . 2.0800000000000001 110.592 -175.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.2 pt -137.24 137.01 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.683 1.193 . . . . 0.68999999999999995 110.715 175.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.95 161.59 14.07 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.321 1.048 . . . . 0.56999999999999995 111.005 171.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.01 15.84 62.12 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 121.315 -0.866 . . . . 0.51000000000000001 114.747 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.13 140.99 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.457 1.503 . . . . 0.68000000000000005 109.358 168.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -104.62 137.49 42.37 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.296 1.438 . . . . 0.53000000000000003 113.321 -173.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.43 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.8 OUTLIER -142.17 151.15 41.93 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.472 1.109 . . . . 1.5800000000000001 112.922 177.197 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 m -122.37 145.75 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.962 2.105 . . . . 0.34000000000000002 110.133 -176.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -86.61 145.94 26.53 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 122.301 1.048 . . . . 0.39000000000000001 112.124 169.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 35.8 p -140.88 170.15 16.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.66 1.984 . . . . 0.35999999999999999 112.223 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.36 -170.46 2.75 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 115.731 1.752 . . . . 1.9099999999999999 115.731 174.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.9 p -54.85 -42.37 71.9 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.641 1.176 . . . . 2.3100000000000001 111.646 171.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -88.94 20.03 3.8 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.974 1.31 . . . . 2.27 112.877 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.88 29.04 16.95 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.336 1.454 . . . . 0.67000000000000004 111.781 175.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -84.41 141.57 30.75 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 125.927 1.691 . . . . 2.5499999999999998 109.84 174.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.9 mt -78.69 125.31 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 109.356 -0.609 . . . . 0.52000000000000002 109.356 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.3 pt -120.44 155.13 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.614 1.166 . . . . 0.55000000000000004 114.118 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -86.38 166.11 15.83 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.372 1.869 . . . . 1.47 110.405 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -59.62 -21.36 60.31 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.921 1.452 . . . . 2.1400000000000001 114.921 -174.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -90.86 4.52 51.58 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.894 1.277 . . . . 2.8199999999999998 112.816 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.35 9.73 86.19 Favored Glycine 0 CA--C 1.533 1.195 0 O-C-N 120.523 -1.36 . . . . 0.55000000000000004 114.866 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -69.47 143.99 53.37 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.588 1.194 . . . . 2.23 109.192 168.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.9 p -105.45 140.04 39.16 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.112 1.365 . . . . 0.81000000000000005 111.765 -172.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.26 2.68 54.9 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.601 0.963 . . . . 0.76000000000000001 113.601 -170.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.44 25.35 70.61 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.75 -1.219 . . . . 0.72999999999999998 113.663 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 54.1 t -131.69 149.04 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.488 1.915 . . . . 1.1599999999999999 109.397 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -130.03 158.16 40.36 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.999 2.52 . . . . 1.4199999999999999 111.52 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.0 mt -135.94 128.37 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.631 1.572 . . . . 0.58999999999999997 109.802 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -69.02 141.44 92.03 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 117.565 -1.207 . . . . 1.8100000000000001 111.012 174.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -73.91 -22.13 17.75 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 CA-C-N 122.828 2.046 . . . . 0.60999999999999999 113.236 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 68.6 mm-40 -93.29 -53.46 4.09 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 127.034 2.134 . . . . 1.4099999999999999 112.158 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.9 p -78.29 -24.36 46.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.093 0.557 . . . . 0.81000000000000005 112.381 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 53.8 17.27 1.24 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.721 1.209 . . . . 1.6299999999999999 112.718 -171.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.46 138.2 31.68 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.021 0.928 . . . . 2.5699999999999998 111.257 -174.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.0 mt -78.08 144.18 36.77 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.021 0.928 . . . . 0.85999999999999999 111.394 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 95.2 p -72.72 3.93 4.58 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.892 1.071 . . . . 1.47 113.892 170.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.16 -153.85 13.04 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.719 1.152 . . . . 1.26 113.941 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.28 160.12 21.78 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.046 1.339 . . . . 1.26 112.712 176.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 mmt -51.42 140.95 24.13 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.57 1.548 . . . . 1.5800000000000001 114.062 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.71 167.26 27.0 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 124.543 3.495 . . . . 0.91000000000000003 114.242 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.37 -48.15 13.37 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 116.072 1.878 . . . . 1.72 116.072 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 46.1 p -134.11 10.84 3.88 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.408 1.083 . . . . 0.81999999999999995 113.887 -169.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.95 152.74 7.09 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 116.062 1.875 . . . . 0.55000000000000004 116.062 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.6 tpt -75.41 96.75 3.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.638 2.375 . . . . 1.52 111.889 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -150.81 150.27 30.75 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.711 1.204 . . . . 1.1599999999999999 113.317 -174.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -160.74 161.89 32.31 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.624 1.17 . . . . 3.2000000000000002 111.789 173.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.7 mp -93.37 152.14 19.32 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.154 0.982 . . . . 0.63 111.924 167.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.43 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 1.7 p -67.56 128.49 36.66 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 108.796 -0.816 . . . . 0.59999999999999998 108.796 167.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -80.35 -60.31 2.37 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.569 0.951 . . . . 2.1000000000000001 113.569 -173.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.51 -37.58 0.16 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.675 1.19 . . . . 1.04 111.254 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -121.56 -9.27 8.97 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.637 1.347 . . . . 3.8300000000000001 114.637 176.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 164.95 -168.31 39.08 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.141 1.353 . . . . 0.60999999999999999 112.619 -174.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.88 133.6 27.04 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.975 1.71 . . . . 0.55000000000000004 112.713 169.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -90.05 134.08 34.45 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.984 1.713 . . . . 1.53 112.378 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -126.35 128.47 47.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.292 1.837 . . . . 1.7 108.353 173.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.514 HD21 ' HB3' ' A' ' 132' ' ' ALA . 16.1 t30 -83.01 122.56 28.46 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.511 -0.743 . . . . 1.6699999999999999 110.989 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.9 p -103.56 -2.67 26.36 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.534 1.134 . . . . 0.65000000000000002 113.265 -176.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.514 ' HB3' HD21 ' A' ' 130' ' ' ASN . . . -56.07 -17.85 8.12 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.802 1.241 . . . . 0.73999999999999999 113.868 176.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -94.76 -17.34 22.26 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.595 1.958 . . . . 1.8899999999999999 114.127 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -90.42 147.23 36.15 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 114.455 1.28 . . . . 0.68000000000000005 114.455 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -84.27 170.5 10.68 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.796 2.997 . . . . 0.77000000000000002 111.991 167.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.42 79.1 2.47 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.912 2.085 . . . . 1.1699999999999999 112.607 -172.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.52 177.49 7.81 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.16 1.384 . . . . 0.84999999999999998 110.797 -177.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -97.7 140.34 32.24 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 123.049 1.404 . . . . 2.8500000000000001 112.08 171.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -129.04 177.73 6.92 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.87 1.668 . . . . 0.63 109.911 -173.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.79 152.74 40.02 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.375 1.07 . . . . 3.6499999999999999 112.276 175.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.0 mp -115.76 134.23 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.055 0.942 . . . . 0.34000000000000002 110.06 172.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -122.13 140.9 51.99 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.692 1.997 . . . . 1.9299999999999999 110.535 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -107.42 114.22 28.09 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.697 1.199 . . . . 2.0499999999999998 110.08 -175.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.5 mm -117.36 114.26 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.464 1.106 . . . . 0.69999999999999996 109.854 -168.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -80.92 -13.64 58.72 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.381 1.252 . . . . 3.9199999999999999 114.381 -171.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 56.1 p . . . . . 0 N--CA 1.473 0.705 0 CA-C-N 119.799 1.182 . . . . 2.0499999999999998 113.742 177.369 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 113.476 0.917 . . . . 1.98 113.476 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.72 157.57 30.03 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.696 0.76 . . . . 1.05 111.767 170.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.57 151.65 57.18 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 126.579 1.951 . . . . 0.89000000000000001 110.668 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -79.2 155.18 25.45 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.624 2.216 . . . . 0.63 111.301 -172.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 5.3 mt -109.48 133.19 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.492 1.117 . . . . 1.8999999999999999 109.622 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -93.75 136.65 33.82 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.165 0.893 . . . . 3.6299999999999999 111.137 168.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.0 tt -141.54 151.27 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.876 1.27 . . . . 0.63 111.471 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -121.09 157.53 29.89 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.306 1.842 . . . . 1.8400000000000001 108.026 169.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 5.7 mt -65.41 155.39 85.27 Favored Pre-proline 0 CA--C 1.544 0.748 0 O-C-N 120.536 -1.353 . . . . 1.0700000000000001 113.71 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -69.32 114.37 3.61 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.364 2.043 . . . . 1.0700000000000001 111.825 -176.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 17.0 tp -122.01 22.99 10.16 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.323 1.849 . . . . 2.8900000000000001 110.462 168.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -105.15 148.19 27.15 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.582 2.353 . . . . 3.2200000000000002 110.65 -169.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -75.87 61.48 1.46 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.148 1.379 . . . . 4.1100000000000003 111.976 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.0 m -122.01 158.22 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 127.541 2.336 . . . . 1.0900000000000001 112.405 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 59.2 t -82.98 -37.07 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.889 0.875 . . . . 1.6200000000000001 111.07 174.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -142.35 147.65 36.63 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.314 1.046 . . . . 2.9900000000000002 110.684 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -98.57 144.41 27.91 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.576 0.751 . . . . 0.38 111.009 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -133.43 166.36 22.71 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.314 1.227 . . . . 0.81000000000000005 114.314 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.57 146.64 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 127.089 2.156 . . . . 0.69999999999999996 111.437 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.422 ' CE2' HG23 ' A' ' 66' ' ' VAL . 87.9 m-85 -135.63 81.94 40.28 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 113.512 0.93 . . . . 2.0800000000000001 113.512 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -65.41 146.26 84.99 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.467 2.778 . . . . 0.63 113.345 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -124.2 -165.16 1.32 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.613 2.365 . . . . 2.3100000000000001 110.823 -173.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -134.02 169.81 16.58 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.0 1.32 . . . . 3.6000000000000001 110.579 168.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 13.6 t . . . . . 0 N--CA 1.474 0.745 0 C-N-CA 124.179 0.992 . . . . 2.0899999999999999 110.724 -176.62 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 38.9 p . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 112.161 0.43 . . . . 1.1499999999999999 112.161 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.6 p -98.5 -16.77 19.05 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.356 0.872 . . . . 1.5700000000000001 113.356 174.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.8 t -144.92 167.55 22.37 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.022 1.729 . . . . 1.8200000000000001 110.002 169.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.4 p -112.68 5.49 17.74 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.614 1.966 . . . . 0.84999999999999998 114.416 -169.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.8 p -138.57 162.58 34.21 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.114 1.153 . . . . 2.6200000000000001 114.114 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.67 146.7 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 126.516 1.926 . . . . 0.53000000000000003 109.408 169.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -125.12 114.2 18.72 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.591 1.156 . . . . 1.4399999999999999 110.401 -171.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.28 129.87 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 120.886 -1.134 . . . . 0.51000000000000001 111.312 -175.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -128.92 101.9 6.28 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.092 1.357 . . . . 1.78 111.157 -172.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.23 123.66 24.95 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.654 -1.279 . . . . 1.6000000000000001 111.548 -173.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.9 mt -106.04 156.42 18.41 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.129 1.372 . . . . 0.56000000000000005 112.681 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.64 161.89 37.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.313 1.845 . . . . 1.6799999999999999 109.912 175.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.8 162.14 13.27 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.682 0.793 . . . . 0.80000000000000004 111.852 169.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.3 p -86.76 -27.48 23.59 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.252 0.834 . . . . 0.95999999999999996 113.252 176.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -146.67 46.77 1.19 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.482 1.113 . . . . 3.1299999999999999 113.025 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.0 7.19 88.19 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 125.186 1.374 . . . . 0.93999999999999995 116.053 175.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.04 18.92 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 128.145 2.578 . . . . 1.8799999999999999 115.731 -174.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -59.91 -31.51 69.9 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.497 -1.377 . . . . 0.68999999999999995 112.315 -177.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.58 -52.84 63.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.75 1.62 . . . . 2.4399999999999999 112.548 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -71.71 -39.62 70.02 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-O 118.033 -0.984 . . . . 2.0699999999999998 111.583 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.2 mt -51.59 -55.04 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 119.266 0.939 . . . . 0.57999999999999996 110.34 168.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.73 -32.01 71.29 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.643 1.11 . . . . 0.94999999999999996 113.137 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -69.69 -27.26 64.86 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.786 1.032 . . . . 1.1599999999999999 113.786 172.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -73.77 -28.71 61.8 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.764 0.711 . . . . 2.1299999999999999 111.419 168.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.0 mt -85.1 -34.97 22.08 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.113 -0.992 . . . . 1.0600000000000001 113.292 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -71.3 -25.47 62.44 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.236 0.828 . . . . 3.1600000000000001 113.236 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.4 t -84.17 -24.13 30.3 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.274 1.03 . . . . 1.8 113.633 177.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.69 171.69 55.15 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.39 0.995 . . . . 1.0900000000000001 113.233 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -85.35 34.01 0.57 Allowed 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.959 -1.319 . . . . 1.8600000000000001 113.116 171.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -77.53 4.72 10.5 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 120.253 -1.529 . . . . 2.0800000000000001 113.385 -170.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.56 -10.82 60.2 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.035 -1.041 . . . . 1.6000000000000001 113.12 168.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.05 -74.07 0.26 Allowed Glycine 0 N--CA 1.474 1.178 0 CA-C-N 119.713 1.142 . . . . 1.1699999999999999 113.033 169.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -68.73 159.35 32.41 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.158 1.383 . . . . 1.96 113.052 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -61.18 155.99 19.45 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.749 1.22 . . . . 2.27 113.199 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.4 HG23 ' CD2' ' A' ' 181' ' ' TYR . 55.2 t -56.83 117.95 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 109.077 -0.712 . . . . 0.77000000000000002 109.077 172.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.77 -41.62 73.27 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.052 0.358 . . . . 0.88 112.908 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.1 t -138.51 123.95 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.29 1.036 . . . . 2.2000000000000002 111.165 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt -92.46 144.14 28.36 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.069 1.348 . . . . 0.87 110.544 168.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.19 159.32 37.12 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.949 2.433 . . . . 0.71999999999999997 112.0 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.84 -26.13 68.61 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.365 -0.835 . . . . 1.1799999999999999 112.86 172.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.99 3.65 22.25 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.398 1.629 . . . . 1.4299999999999999 115.398 172.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.68 153.98 20.04 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.823 1.249 . . . . 0.72999999999999998 113.577 170.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -143.89 160.69 40.35 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.562 1.545 . . . . 1.8100000000000001 111.641 169.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.96 139.54 50.04 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.268 1.027 . . . . 2.5899999999999999 110.414 -174.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 20.2 pt -133.48 147.23 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 116.396 1.999 . . . . 1.1299999999999999 116.396 -169.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.81 167.66 12.3 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.446 1.898 . . . . 0.96999999999999997 110.14 167.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.99 17.78 62.43 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 116.242 1.257 . . . . 0.64000000000000001 116.242 168.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.2 p -118.42 138.21 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.271 1.428 . . . . 0.66000000000000003 110.832 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 8.9 tpp -96.84 134.91 39.54 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.14 1.376 . . . . 0.52000000000000002 113.584 -177.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.44 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.8 OUTLIER -137.12 148.49 46.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.332 1.453 . . . . 2.0299999999999998 112.002 174.359 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.7 m -121.48 144.28 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.769 2.027 . . . . 0.34999999999999998 109.766 -175.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -88.23 148.39 24.38 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 122.648 1.213 . . . . 0.41999999999999998 112.754 171.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.9 p -143.93 172.79 12.38 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.848 2.059 . . . . 0.40999999999999998 112.217 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -94.61 169.31 10.27 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.453 1.501 . . . . 1.6000000000000001 112.242 168.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 67.9 p -62.66 -25.21 68.02 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.818 0.847 . . . . 1.45 112.702 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -74.78 7.31 3.19 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.686 1.594 . . . . 1.8200000000000001 113.383 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . 0.252 0.3 OUTLIER 63.18 26.38 15.22 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.744 2.418 . . . . 0.64000000000000001 114.291 179.217 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -88.77 145.04 25.85 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.655 1.582 . . . . 2.1000000000000001 111.631 175.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.7 mt -80.83 128.72 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.342 0.657 . . . . 0.42999999999999999 111.087 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.515 HG22 HG22 ' A' ' 97' ' ' THR . 2.2 pp -121.44 149.35 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 115.045 1.498 . . . . 0.95999999999999996 115.045 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -79.64 161.71 25.71 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 127.873 2.469 . . . . 2.3700000000000001 110.598 169.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -58.39 -22.61 54.45 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.315 1.228 . . . . 2.2999999999999998 114.315 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -90.52 3.71 53.21 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.306 1.043 . . . . 3.6200000000000001 111.955 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.59 20.93 75.98 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 127.234 2.349 . . . . 0.5 115.471 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -75.25 137.39 41.18 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.074 -1.084 . . . . 3.0699999999999998 108.074 167.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.515 HG22 HG22 ' A' ' 91' ' ' ILE . 17.6 p -93.74 135.17 35.31 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.945 0.898 . . . . 0.69999999999999996 111.414 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.69 -4.84 59.27 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.954 1.094 . . . . 0.59999999999999998 113.954 -168.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.02 25.96 56.65 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.265 0.936 . . . . 0.63 113.779 -176.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.8 t -130.36 146.7 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.886 1.674 . . . . 1.05 109.471 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -124.22 165.2 18.02 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.94 2.096 . . . . 3.8599999999999999 111.183 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.7 mt -134.87 140.78 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.887 1.275 . . . . 0.52000000000000002 109.841 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -76.31 137.91 68.02 Favored Pre-proline 0 CA--C 1.545 0.784 0 O-C-N 120.742 -1.224 . . . . 1.78 112.313 173.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.49 -11.46 20.61 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.061 1.841 . . . . 0.91000000000000003 113.854 174.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.48 -53.79 3.11 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.945 1.698 . . . . 2.0 111.102 177.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 p -80.48 -25.38 38.87 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.859 0.864 . . . . 0.77000000000000002 113.027 -174.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 59.13 15.89 4.43 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.771 1.629 . . . . 1.6799999999999999 113.9 -172.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.51 152.0 19.45 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.21 1.004 . . . . 2.6099999999999999 111.79 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.6 mt -78.56 145.21 34.95 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.682 1.593 . . . . 0.92000000000000004 112.648 -174.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.1 p -72.25 -8.19 53.46 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.665 0.987 . . . . 1.3400000000000001 113.665 173.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -171.9 -152.11 8.23 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.213 1.863 . . . . 0.87 111.848 -171.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.91 148.86 26.03 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.809 0.844 . . . . 0.93000000000000005 113.024 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.6 tpt -52.96 128.69 47.38 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.945 1.698 . . . . 1.3500000000000001 111.867 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.48 161.32 28.39 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.809 3.006 . . . . 0.87 114.441 -174.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.28 -61.79 1.89 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.272 1.829 . . . . 1.1100000000000001 114.105 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.1 p -105.88 10.79 32.37 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.855 1.262 . . . . 0.71999999999999997 114.266 -169.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.2 145.73 16.73 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.965 -1.084 . . . . 0.44 113.002 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.3 tpt -74.38 94.62 2.58 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.846 2.059 . . . . 1.53 110.574 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -148.71 140.15 23.4 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.462 1.105 . . . . 0.94999999999999996 113.454 -169.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -160.04 160.96 33.82 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.482 1.113 . . . . 1.78 111.842 -175.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.4 mp -103.04 149.52 24.49 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.804 1.242 . . . . 0.47999999999999998 112.214 173.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.44 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 1.9 p -66.83 132.05 47.2 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.759 -0.588 . . . . 0.54000000000000004 109.997 171.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.84 -61.13 1.95 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.646 1.178 . . . . 2.4700000000000002 113.79 -170.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -146.63 -34.43 0.28 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.999 1.319 . . . . 1.23 111.37 176.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -126.31 -17.97 5.05 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.524 1.305 . . . . 4.1699999999999999 114.524 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 179.61 -166.28 35.45 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.57 1.081 . . . . 0.59999999999999998 111.894 -172.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -145.25 134.32 22.67 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.869 1.668 . . . . 0.5 111.891 169.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -87.43 138.17 31.7 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.96 1.304 . . . . 1.53 112.858 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -128.51 130.02 46.88 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.162 2.185 . . . . 1.75 107.716 171.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.428 HD21 ' HB3' ' A' ' 132' ' ' ALA . 8.0 t30 -91.49 101.99 14.65 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.953 -1.092 . . . . 2.02 110.489 -177.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.1 p -82.47 -0.54 46.86 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.118 1.367 . . . . 0.65000000000000002 113.727 -172.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.428 ' HB3' HD21 ' A' ' 130' ' ' ASN . . . -55.48 -32.0 62.47 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.766 0.826 . . . . 0.88 112.987 172.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -83.66 -20.86 32.84 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.006 0.922 . . . . 1.9299999999999999 112.682 -173.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.44 145.34 82.36 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 123.811 0.844 . . . . 0.68000000000000005 113.009 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -74.49 168.45 24.79 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.658 2.239 . . . . 0.89000000000000001 110.938 167.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.49 91.97 1.08 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.926 1.29 . . . . 1.0900000000000001 110.359 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -149.51 175.17 11.74 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.884 0.85 . . . . 0.77000000000000002 113.169 -174.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -94.15 147.19 23.4 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.385 1.874 . . . . 3.5499999999999998 109.347 169.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -143.9 170.12 16.51 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.651 1.581 . . . . 0.55000000000000004 110.438 -169.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.2 mttt -137.68 159.78 41.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.193 0.997 . . . . 2.0800000000000001 113.127 171.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.7 mp -118.56 142.2 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.02 1.328 . . . . 0.46999999999999997 109.899 172.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -129.58 147.21 51.36 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.435 1.894 . . . . 1.8999999999999999 110.495 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -109.16 124.26 50.54 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.637 1.175 . . . . 1.8700000000000001 111.26 -175.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 29.9 mm -128.09 98.96 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.921 0.888 . . . . 0.75 109.83 -169.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -73.12 4.32 4.54 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 115.064 1.505 . . . . 4.5300000000000002 115.064 -172.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.475 0.816 0 O-C-N 120.548 -1.345 . . . . 1.75 112.406 172.249 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 113.121 0.785 . . . . 2.27 113.121 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.36 150.31 47.46 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.016 1.327 . . . . 0.81999999999999995 113.323 174.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.51 153.71 52.07 Favored Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 124.515 1.126 . . . . 0.64000000000000001 111.604 -178.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.15 130.26 12.96 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.879 2.386 . . . . 0.73999999999999999 114.08 -166.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.447 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.6 mp -94.12 130.35 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 125.677 1.591 . . . . 1.47 109.259 -173.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.6 129.88 54.95 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.716 1.206 . . . . 4.96 112.129 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.2 tt -137.73 156.45 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.206 1.402 . . . . 0.53000000000000003 111.038 -169.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -139.89 148.91 42.72 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.794 1.238 . . . . 1.8899999999999999 109.871 170.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 12.4 mt -62.68 153.67 77.54 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 116.152 1.908 . . . . 1.0700000000000001 116.152 -168.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.1 116.73 4.82 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.84 2.36 . . . . 0.75 113.258 -170.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.6 tp -123.41 34.17 5.17 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.023 1.729 . . . . 2.2599999999999998 111.061 166.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -116.44 157.53 24.99 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 128.499 2.719 . . . . 2.6800000000000002 111.487 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.47 30.98 0.18 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.324 1.85 . . . . 4.1299999999999999 114.445 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 30.2 m -93.81 155.09 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.287 1.435 . . . . 1.8300000000000001 112.319 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 54.8 t -74.34 -35.95 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.185 0.994 . . . . 2.25 110.137 173.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -152.26 146.72 25.63 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.46 1.504 . . . . 3.4399999999999999 110.643 -174.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -98.75 156.7 16.71 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.036 0.934 . . . . 0.52000000000000002 112.304 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -136.71 162.02 34.32 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.04 1.496 . . . . 0.60999999999999999 115.04 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.64 144.65 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 127.225 2.21 . . . . 0.45000000000000001 110.815 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.4 ' CD2' HG23 ' A' ' 66' ' ' VAL . 97.1 m-85 -134.94 76.48 58.88 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 113.96 1.096 . . . . 2.0 113.96 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . 0.447 ' HB3' HD11 ' A' ' 166' ' ' ILE . 13.5 Cg_endo -65.87 146.38 82.95 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.011 3.141 . . . . 0.62 114.468 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -140.0 167.27 22.5 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 128.699 2.8 . . . . 1.9399999999999999 111.952 -169.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -117.51 167.03 11.66 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.656 1.354 . . . . 3.25 114.656 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 10.8 t . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 115.504 1.668 . . . . 2.2000000000000002 115.504 -179.745 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 111.488 0.181 . . . . 1.5600000000000001 111.488 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 65.8 p -82.81 -10.32 58.92 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 113.966 1.098 . . . . 1.8200000000000001 113.966 176.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 t -151.89 163.17 39.81 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.705 2.002 . . . . 2.5499999999999998 110.032 174.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.7 p -92.76 5.11 52.33 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.086 1.755 . . . . 1.1399999999999999 114.252 176.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.402 ' HA ' ' H ' ' A' ' 131' ' ' THR . 54.9 p -151.26 164.86 35.66 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.23 1.196 . . . . 1.72 114.23 -175.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.5 p -131.21 143.5 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.486 1.915 . . . . 0.38 109.964 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.7 m -110.74 112.62 24.61 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.676 0.79 . . . . 0.68999999999999995 111.411 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -93.11 132.9 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.004 -1.06 . . . . 0.58999999999999997 110.432 176.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -115.73 -173.93 2.43 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.69 1.596 . . . . 1.74 110.998 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -140.26 129.98 24.41 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 120.929 -1.107 . . . . 1.3400000000000001 111.439 168.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.4 mt -111.84 146.06 38.34 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.749 1.219 . . . . 0.85999999999999999 110.835 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.9 168.29 19.6 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.341 1.856 . . . . 1.6299999999999999 111.186 176.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.57 145.58 40.08 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.788 1.235 . . . . 0.72999999999999998 112.281 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.0 p -80.92 -32.54 34.62 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.318 1.229 . . . . 1.1499999999999999 114.318 -173.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -114.45 -15.55 12.05 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 119.882 1.219 . . . . 2.3700000000000001 113.295 175.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.68 11.08 1.95 Allowed Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.478 1.513 . . . . 1.1599999999999999 115.413 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.66 24.23 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 130.175 3.39 . . . . 1.8400000000000001 116.738 -169.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.94 -31.92 73.11 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 119.6 -1.937 . . . . 0.77000000000000002 114.022 -174.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -71.3 -43.79 66.44 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.114 0.87 . . . . 2.52 111.727 -175.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt -72.44 -38.85 68.19 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.267 -0.896 . . . . 4.0999999999999996 111.939 175.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.6 mt -52.68 -48.17 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 119.471 1.032 . . . . 0.66000000000000003 109.956 167.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.1 -34.83 75.57 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 121.092 -1.005 . . . . 0.93000000000000005 113.453 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -65.33 -39.28 92.22 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.794 0.838 . . . . 1.5700000000000001 112.069 171.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.15 -23.82 64.92 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.972 -1.08 . . . . 2.6800000000000002 112.841 177.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.1 mt -91.28 -32.24 15.8 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.315 1.228 . . . . 1.1799999999999999 114.315 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -70.61 -20.59 62.74 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.065 1.135 . . . . 2.96 114.065 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.7 t -78.86 -21.26 47.79 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.986 0.914 . . . . 1.5800000000000001 113.375 169.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.55 172.32 53.44 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.544 1.068 . . . . 1.3200000000000001 112.909 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -94.74 21.57 7.3 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.036 -1.273 . . . . 2.0099999999999998 112.348 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -70.87 18.05 0.06 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.421 1.488 . . . . 2.23 114.962 -170.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.98 -23.15 55.3 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 120.814 -1.179 . . . . 1.21 110.249 166.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -114.86 -57.35 0.36 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.52 1.057 . . . . 0.92000000000000004 113.684 172.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -81.68 162.81 22.87 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.952 1.301 . . . . 3.1499999999999999 113.381 -172.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -63.54 151.94 40.01 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.056 0.762 . . . . 2.3999999999999999 113.056 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 71.7 t -66.32 120.48 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 122.844 0.458 . . . . 0.81999999999999995 109.895 172.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.59 -37.9 33.89 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 114.83 0.692 . . . . 1.1000000000000001 114.83 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.6 t -142.61 116.59 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 118.387 1.093 . . . . 2.3700000000000001 111.041 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.8 mt -83.23 144.36 46.75 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.842 1.257 . . . . 1.0700000000000001 111.621 170.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.09 161.46 38.48 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.914 2.409 . . . . 0.89000000000000001 112.371 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.2 -8.84 42.4 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.039 1.126 . . . . 1.29 114.039 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.2 p30 -98.87 -3.92 34.24 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.548 1.539 . . . . 1.74 114.496 171.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.22 158.83 17.02 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.778 1.029 . . . . 0.71999999999999997 113.778 174.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.9 pttt -150.38 169.04 22.37 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.809 1.643 . . . . 2.25 111.741 167.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -124.37 130.62 52.82 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.013 1.325 . . . . 2.6299999999999999 112.146 -174.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.0 pt -121.81 151.46 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.075 0.95 . . . . 0.92000000000000004 113.397 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.98 156.02 29.27 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.263 1.425 . . . . 0.90000000000000002 111.97 171.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.57 12.93 42.8 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.09 1.328 . . . . 0.71999999999999997 115.654 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 p -86.02 148.12 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 119.228 1.514 . . . . 0.92000000000000004 110.679 169.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -105.64 137.75 42.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.483 1.513 . . . . 0.52000000000000002 112.565 176.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.67 157.79 44.31 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.097 1.359 . . . . 1.6299999999999999 112.441 173.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 m -125.62 147.35 30.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 126.771 2.028 . . . . 0.33000000000000002 110.083 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -89.91 149.08 22.77 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.397 1.079 . . . . 0.34999999999999998 112.975 171.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.7 p -144.8 167.71 21.94 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.409 1.884 . . . . 0.34000000000000002 112.618 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -90.83 171.54 9.25 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.199 1.0 . . . . 2.2200000000000002 112.074 167.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 66.9 p -61.04 -23.53 65.5 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.154 -0.966 . . . . 1.3600000000000001 113.577 -177.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -70.86 4.83 2.29 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 126.222 1.809 . . . . 2.8700000000000001 114.003 169.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.26 27.79 14.2 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.916 2.087 . . . . 0.66000000000000003 112.964 -172.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -86.01 138.61 31.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.458 1.503 . . . . 2.5299999999999998 110.414 177.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.3 mt -81.2 129.33 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.139 0.495 . . . . 0.65000000000000002 110.164 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.478 HG22 HG22 ' A' ' 97' ' ' THR . 6.2 pt -123.86 154.27 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 114.567 1.321 . . . . 0.56000000000000005 114.567 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -84.84 159.44 20.39 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.972 2.109 . . . . 1.49 108.37 166.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -62.8 -8.69 7.34 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.862 1.801 . . . . 2.29 115.862 -172.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -91.31 -1.22 57.7 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.556 1.143 . . . . 3.4500000000000002 112.706 172.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.34 3.72 84.27 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.65 1.595 . . . . 0.48999999999999999 114.476 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -68.14 140.38 56.17 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.813 1.245 . . . . 2.6000000000000001 109.1 173.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.478 HG22 HG22 ' A' ' 91' ' ' ILE . 16.2 p -103.56 146.07 29.1 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.594 0.758 . . . . 0.66000000000000003 112.077 -173.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.62 -11.02 25.84 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.983 0.734 . . . . 0.80000000000000004 112.983 -169.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.74 21.91 48.67 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.706 1.146 . . . . 1.0600000000000001 114.616 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.3 p -138.57 146.19 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.626 1.57 . . . . 2.6000000000000001 110.262 -173.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -127.89 155.04 44.8 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 128.087 2.555 . . . . 1.45 111.364 -172.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 61.4 mt -126.96 142.85 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.97 1.308 . . . . 0.60999999999999999 110.849 -174.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -76.23 132.69 72.86 Favored Pre-proline 0 CA--C 1.54 0.565 0 O-C-N 120.611 -1.306 . . . . 2.3999999999999999 110.57 170.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -70.09 -8.46 23.67 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.074 1.849 . . . . 1.02 114.819 174.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -106.98 -47.55 3.68 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.06 1.344 . . . . 1.6200000000000001 112.346 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.7 p -87.86 -23.16 24.07 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.131 0.972 . . . . 0.93000000000000005 113.331 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 55.52 17.07 2.09 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.896 1.678 . . . . 1.75 114.146 -169.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.64 156.46 20.68 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.909 -1.119 . . . . 2.3700000000000001 111.387 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 mt -98.1 146.44 25.55 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.701 1.2 . . . . 0.92000000000000004 112.623 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 90.7 p -73.1 3.3 5.69 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.204 1.002 . . . . 1.26 113.475 171.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.55 -157.75 16.03 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.689 2.09 . . . . 1.0900000000000001 111.306 -172.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.02 155.27 27.69 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 117.96 0.88 . . . . 1.0700000000000001 112.159 174.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.63 131.66 88.53 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.796 0.838 . . . . 1.8 110.701 175.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.18 156.26 46.76 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 125.197 3.931 . . . . 1.1599999999999999 115.634 -172.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.29 -62.67 1.28 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.745 1.618 . . . . 1.23 114.383 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.8 p -102.26 5.9 40.29 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.804 1.409 . . . . 1.21 114.804 -168.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.85 149.86 10.78 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.0 1.111 . . . . 0.65000000000000002 114.0 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.1 ttt -76.62 90.74 3.37 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.031 1.732 . . . . 1.74 111.629 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -141.81 144.62 34.02 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.552 1.541 . . . . 1.3400000000000001 111.97 -173.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -166.47 156.73 12.1 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 126.337 1.855 . . . . 1.97 111.028 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.9 mp -97.49 148.8 22.86 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.168 1.173 . . . . 0.51000000000000001 114.168 174.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.7 p -64.45 124.6 22.23 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 121.354 -0.841 . . . . 0.58999999999999997 111.34 170.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -80.41 -57.6 3.52 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.373 -0.83 . . . . 2.2000000000000002 112.457 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -173.06 -51.37 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.727 2.811 . . . . 1.8899999999999999 107.963 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -74.18 20.9 0.1 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.121 2.168 . . . . 6.1500000000000004 113.962 173.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.04 -152.31 31.21 Favored Glycine 0 CA--C 1.538 1.53 0 N-CA-C 110.526 -1.03 . . . . 0.77000000000000002 110.526 -165.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -135.33 130.93 35.79 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.587 1.955 . . . . 0.39000000000000001 109.625 169.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -93.82 139.69 30.56 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.479 0.711 . . . . 1.6000000000000001 112.87 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -125.56 124.59 41.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.171 2.589 . . . . 1.6899999999999999 107.893 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -85.58 100.11 11.72 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.423 -0.798 . . . . 1.6699999999999999 110.074 -174.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.402 ' H ' ' HA ' ' A' ' 36' ' ' SER . 73.1 p -78.66 -6.68 56.37 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.139 -0.975 . . . . 0.64000000000000001 113.48 -175.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -51.25 -27.1 8.32 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.568 1.147 . . . . 0.90000000000000002 113.459 175.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -92.98 -10.39 36.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.641 1.576 . . . . 1.8300000000000001 113.697 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -89.59 148.42 40.14 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 120.182 1.356 . . . . 0.76000000000000001 114.163 170.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.18 170.18 13.74 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.937 3.092 . . . . 0.78000000000000003 112.293 168.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.56 63.91 2.14 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.958 2.103 . . . . 1.53 114.397 -170.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -125.54 178.33 5.71 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.756 1.622 . . . . 0.79000000000000004 112.941 -175.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -87.58 151.66 22.81 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.271 1.428 . . . . 2.5499999999999998 110.807 168.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -145.39 171.37 14.72 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.666 1.987 . . . . 0.51000000000000001 109.253 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -137.83 148.31 45.35 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.725 0.81 . . . . 1.8899999999999999 112.648 170.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.4 mp -105.44 138.28 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.247 1.019 . . . . 0.34999999999999998 109.747 171.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -123.65 131.58 53.65 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.405 1.882 . . . . 1.8999999999999999 110.25 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -95.36 104.51 16.41 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.777 0.831 . . . . 2.2599999999999998 110.635 -173.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 38.9 mm -113.0 94.5 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.998 0.919 . . . . 0.65000000000000002 109.611 -169.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -84.45 12.54 6.7 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.537 0.94 . . . . 4.3899999999999997 113.537 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.0 m . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 114.021 1.119 . . . . 2.0600000000000001 114.021 176.556 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 114.032 1.123 . . . . 1.95 114.032 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.41 166.59 22.92 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.568 1.547 . . . . 0.89000000000000001 111.808 169.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.44 144.97 54.53 Favored Pre-proline 0 N--CA 1.483 1.211 0 O-C-N 120.541 -1.349 . . . . 0.57999999999999996 112.224 176.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.08 151.88 61.94 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.584 3.522 . . . . 0.56000000000000005 114.255 -167.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.549 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.1 mp -114.19 125.68 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.742 1.217 . . . . 1.1599999999999999 111.139 -169.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -86.78 136.22 33.07 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.006 1.322 . . . . 3.0299999999999998 111.578 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.7 tt -144.78 150.14 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 125.227 1.411 . . . . 0.56000000000000005 111.741 -177.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -127.0 149.25 49.98 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.87 1.268 . . . . 2.2599999999999998 110.031 169.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 13.3 mt -61.44 142.56 93.86 Favored Pre-proline 0 CA--C 1.548 0.868 0 O-C-N 120.778 -1.201 . . . . 1.1699999999999999 112.771 -176.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -71.54 99.29 0.92 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.961 3.108 . . . . 0.90000000000000002 114.273 -167.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 1.2 tt -116.58 39.42 3.16 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.14 1.776 . . . . 2.3199999999999998 108.053 167.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -104.93 172.72 6.64 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.552 2.341 . . . . 3.46 111.378 -168.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -76.35 40.17 0.21 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.098 0.959 . . . . 3.8700000000000001 113.561 169.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.7 m -121.24 144.54 29.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.106 1.362 . . . . 1.1899999999999999 112.699 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.9 p -64.87 -45.4 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.937 2.095 . . . . 3.77 113.375 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -156.22 156.77 34.69 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.686 1.995 . . . . 2.98 110.956 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -103.6 146.63 28.28 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.815 1.413 . . . . 0.40999999999999998 114.815 -168.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -135.44 168.52 19.07 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.745 1.387 . . . . 0.69999999999999996 114.745 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.5 t -137.88 139.96 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.524 1.53 . . . . 0.46000000000000002 112.027 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -131.76 86.15 49.34 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 125.688 1.595 . . . . 2.1800000000000002 112.548 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . 0.549 ' HB3' HD11 ' A' ' 166' ' ' ILE . 30.4 Cg_endo -71.14 147.4 53.98 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.574 3.516 . . . . 0.59999999999999998 113.59 172.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -131.68 176.42 8.35 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.644 2.378 . . . . 1.48 111.386 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -111.9 174.52 5.84 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.614 1.566 . . . . 2.6000000000000001 112.121 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.477 0.887 0 N-CA-C 113.862 1.06 . . . . 2.3500000000000001 113.862 173.514 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.4 p . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 122.254 1.026 . . . . 1.27 113.38 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.3 p -110.08 -1.12 17.7 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.659 1.984 . . . . 1.29 113.138 175.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -164.1 157.72 18.51 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.638 1.575 . . . . 1.8700000000000001 111.095 -178.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.9 p -112.78 -6.23 13.85 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.404 1.882 . . . . 0.93000000000000005 115.555 -170.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 94.4 p -148.18 166.13 28.82 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.728 2.011 . . . . 1.72 112.517 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.96 136.75 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.23 1.812 . . . . 0.44 110.343 177.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.5 m -104.69 112.33 25.37 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.366 0.603 . . . . 0.68000000000000005 110.725 176.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 p -93.19 125.84 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.723 1.209 . . . . 0.52000000000000002 109.679 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -105.19 -170.23 1.72 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.307 1.843 . . . . 1.73 110.81 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -148.72 127.53 12.59 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.246 -1.534 . . . . 1.4099999999999999 113.889 170.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.9 mt -118.59 160.56 21.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.86 1.264 . . . . 0.93000000000000005 113.181 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.7 mt -145.41 165.12 29.44 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 128.002 2.521 . . . . 1.4399999999999999 109.572 168.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.97 165.8 16.43 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.758 -0.589 . . . . 0.80000000000000004 112.224 169.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.5 p -89.12 -35.98 15.98 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.508 0.929 . . . . 1.02 113.508 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -141.77 50.38 1.56 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.614 1.166 . . . . 2.1099999999999999 111.637 174.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.2 14.68 76.27 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 116.621 1.408 . . . . 1.1299999999999999 116.621 173.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.89 15.69 0.1 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.999 2.119 . . . . 2.3999999999999999 115.633 -177.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.4 mmt -61.09 -27.81 68.63 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 119.824 -1.798 . . . . 0.77000000000000002 112.887 -177.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -66.93 -38.17 85.67 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.314 0.961 . . . . 2.1499999999999999 113.178 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -81.74 -38.69 25.3 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.605 -1.309 . . . . 2.4500000000000002 112.582 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 89.1 mt -54.46 -47.83 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 119.915 1.234 . . . . 0.68999999999999995 110.796 168.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.74 -34.96 73.63 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 120.242 -1.536 . . . . 0.92000000000000004 112.557 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -71.23 -34.83 71.16 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.321 1.048 . . . . 1.1299999999999999 112.759 172.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -62.97 -36.07 82.27 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.339 0.972 . . . . 2.0499999999999998 112.225 171.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.3 mt -82.07 -41.21 20.89 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.173 0.805 . . . . 1.1299999999999999 113.173 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -68.26 -25.68 65.3 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.527 1.058 . . . . 3.3399999999999999 113.384 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 t -78.28 -16.44 57.77 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.148 0.979 . . . . 2.0899999999999999 113.055 174.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.32 163.7 32.96 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 127.172 2.32 . . . . 1.3200000000000001 113.993 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -88.8 33.86 0.78 Allowed 'General case' 0 N--CA 1.478 0.953 0 O-C-N 120.866 -1.373 . . . . 2.3199999999999998 112.409 172.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -73.98 0.18 14.35 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.031 -1.043 . . . . 2.0699999999999998 113.466 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.94 -30.0 63.63 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.996 -1.065 . . . . 0.92000000000000004 110.815 167.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.02 -49.67 0.62 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 123.933 0.777 . . . . 0.66000000000000003 113.194 169.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -75.67 158.51 32.26 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.348 1.24 . . . . 2.4399999999999999 114.348 -169.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.18 159.88 33.14 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.559 -0.713 . . . . 3.4199999999999999 110.29 165.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.31 127.2 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 116.54 -0.3 . . . . 0.76000000000000001 110.259 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.94 -48.7 25.75 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.826 -0.546 . . . . 0.91000000000000003 113.243 -176.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.4 t -137.32 127.97 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.048 1.339 . . . . 2.0600000000000001 110.147 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.5 mt -85.57 143.7 38.95 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.731 0.813 . . . . 1.1399999999999999 110.567 169.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.85 162.6 37.14 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.219 1.946 . . . . 0.71999999999999997 111.958 172.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.36 -19.22 65.75 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.266 -0.896 . . . . 1.0800000000000001 112.682 172.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -87.12 0.06 55.89 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.662 1.585 . . . . 1.9399999999999999 115.0 174.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.81 146.4 25.97 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 114.429 1.27 . . . . 0.56999999999999995 114.429 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -130.72 149.04 52.56 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.461 2.704 . . . . 2.4900000000000002 111.614 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -123.4 137.57 54.79 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.409 1.484 . . . . 2.2599999999999998 112.684 -175.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.3 pt -141.29 149.17 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.375 1.47 . . . . 0.85999999999999999 112.136 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -108.51 169.56 8.57 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.563 1.545 . . . . 0.67000000000000004 111.698 169.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.45 20.93 55.76 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.376 0.989 . . . . 0.68000000000000005 115.53 175.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.5 p -88.09 149.52 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 118.422 1.111 . . . . 1.01 109.736 168.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -107.66 137.6 45.4 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.932 1.293 . . . . 0.54000000000000004 112.164 175.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -141.11 156.92 45.9 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.893 1.277 . . . . 1.75 112.633 172.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.5 m -122.04 147.01 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 126.874 2.07 . . . . 0.40000000000000002 109.874 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -89.09 148.18 23.83 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 122.582 1.182 . . . . 0.33000000000000002 113.12 169.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.1 p -142.6 168.56 19.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.806 2.042 . . . . 0.37 112.246 178.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -88.71 172.93 8.88 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.734 0.814 . . . . 1.8999999999999999 112.924 168.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.1 p -57.77 -27.97 63.54 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.378 1.071 . . . . 1.5 113.426 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -90.24 24.07 2.67 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.692 1.197 . . . . 2.3799999999999999 113.79 172.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.54 25.25 14.06 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.562 2.345 . . . . 0.58999999999999997 115.15 173.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -83.09 139.49 33.19 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.281 -0.887 . . . . 1.9399999999999999 109.499 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.7 mt -75.76 128.68 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 118.457 0.571 . . . . 0.56999999999999995 109.821 174.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.761 HG22 HG22 ' A' ' 97' ' ' THR . 6.4 pt -122.02 155.68 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 123.181 1.467 . . . . 0.63 114.613 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -87.01 164.44 16.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.003 1.721 . . . . 1.6599999999999999 110.234 167.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.15 2.27 1.22 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.135 1.774 . . . . 2.6499999999999999 115.351 -176.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -107.0 5.17 27.85 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.71 2.404 . . . . 3.21 113.319 169.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.48 6.32 80.39 Favored Glycine 0 CA--C 1.532 1.153 0 O-C-N 120.073 -1.642 . . . . 0.68000000000000005 114.011 -176.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -68.8 139.32 55.26 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 117.905 0.852 . . . . 2.0499999999999998 109.226 169.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.761 HG22 HG22 ' A' ' 91' ' ' ILE . 76.3 p -101.29 139.7 36.61 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.382 1.073 . . . . 0.94999999999999996 110.778 -177.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.99 -9.98 54.27 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.296 1.221 . . . . 0.93000000000000005 114.296 -168.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.48 21.62 47.34 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.897 1.237 . . . . 0.93999999999999995 113.414 -173.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.7 t -130.48 148.17 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.688 1.595 . . . . 1.25 109.512 -177.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -127.9 159.35 35.19 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.334 1.854 . . . . 4.1799999999999997 111.802 174.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 73.5 mt -131.41 127.85 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.978 1.311 . . . . 0.56999999999999995 110.658 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.61 136.74 94.88 Favored Pre-proline 0 N--CA 1.476 0.833 0 CA-C-O 117.986 -1.007 . . . . 1.8500000000000001 111.081 174.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -69.76 -20.31 35.0 Favored 'Trans proline' 0 C--N 1.352 0.756 0 CA-C-N 122.082 1.779 . . . . 0.62 112.774 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -96.42 -43.65 7.55 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.254 1.422 . . . . 1.1200000000000001 112.553 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 p -86.29 -25.33 25.53 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.099 0.96 . . . . 0.89000000000000001 112.61 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 52.65 24.42 3.14 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.34 1.456 . . . . 1.6399999999999999 113.329 -171.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.63 157.64 16.8 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.888 -1.133 . . . . 2.4100000000000001 111.578 -177.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.2 mt -94.38 146.96 23.69 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.256 1.422 . . . . 0.75 113.028 -169.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.0 p -72.07 -7.64 50.03 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.236 1.199 . . . . 1.3300000000000001 114.236 173.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.87 -158.45 10.04 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 128.165 2.793 . . . . 0.87 110.446 177.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.59 166.7 21.62 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 119.411 1.605 . . . . 1.01 112.274 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 mmt -51.16 143.3 17.13 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 125.229 1.411 . . . . 1.6799999999999999 113.882 -177.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.7 165.41 26.89 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 124.166 3.244 . . . . 0.79000000000000004 114.526 174.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.37 -52.19 6.75 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.138 1.775 . . . . 1.1299999999999999 115.001 -177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.9 p -109.18 -3.12 17.52 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.107 1.363 . . . . 0.95999999999999996 114.477 -169.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.68 151.18 2.47 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.186 1.394 . . . . 0.41999999999999998 114.069 -173.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.4 ttt -76.13 89.56 3.05 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.404 1.082 . . . . 1.79 111.139 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -146.01 123.13 11.47 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.044 1.737 . . . . 1.4199999999999999 113.896 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -164.73 145.32 7.65 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.532 1.133 . . . . 2.8399999999999999 111.221 -169.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.36 157.19 17.24 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.081 1.512 . . . . 0.47999999999999998 115.081 -171.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 80.1 p -72.97 139.52 46.76 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.34 -0.85 . . . . 0.57999999999999996 112.993 169.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.63 -54.97 3.06 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 116.152 1.908 . . . . 2.46 116.152 -169.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.09 -40.57 0.15 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.628 1.171 . . . . 1.25 110.837 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -116.17 -26.15 7.33 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.795 1.035 . . . . 3.7999999999999998 113.795 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.33 -163.31 34.74 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.62 1.105 . . . . 0.67000000000000004 110.73 -169.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -137.17 130.75 31.54 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.345 1.858 . . . . 0.40999999999999998 110.54 173.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.7 ttpt -82.02 134.98 35.4 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.36 0.527 . . . . 1.77 110.922 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -122.78 130.87 53.42 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.95 2.1 . . . . 2.0600000000000001 108.211 173.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -85.05 121.77 28.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.513 1.125 . . . . 3.2000000000000002 110.503 -176.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 46.0 p -109.38 -3.81 16.83 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.743 1.386 . . . . 0.56999999999999995 114.743 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.94 -19.69 19.43 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.385 1.474 . . . . 0.69999999999999996 114.944 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.02 -4.29 20.66 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.848 1.259 . . . . 2.3700000000000001 113.613 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.25 141.83 54.16 Favored Pre-proline 0 CA--C 1.535 0.386 0 O-C-N 121.006 -1.059 . . . . 0.63 111.233 167.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.56 168.29 24.74 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.633 2.222 . . . . 0.69999999999999996 110.928 168.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.71 91.88 0.64 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.955 1.702 . . . . 0.96999999999999997 109.697 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -147.9 -178.64 6.38 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.415 1.086 . . . . 0.73999999999999999 111.077 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -97.17 153.98 17.66 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.253 1.421 . . . . 4.6399999999999997 110.792 168.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -146.01 170.21 17.1 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.226 1.81 . . . . 0.56000000000000005 109.893 -169.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -138.89 145.98 40.56 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.354 0.872 . . . . 1.74 113.354 174.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.2 mp -104.1 135.97 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.483 1.113 . . . . 0.45000000000000001 110.075 173.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -119.86 128.02 53.27 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.101 1.761 . . . . 1.8200000000000001 110.062 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -87.85 109.89 20.1 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.678 0.791 . . . . 1.9199999999999999 110.3 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 41.5 mm -116.5 87.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.188 0.995 . . . . 0.66000000000000003 108.605 -173.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . 0.283 7.6 p80 -94.91 44.2 1.1 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.195 -0.941 . . . . 3.8199999999999998 112.492 -178.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.7 p . . . . . 0 N--CA 1.475 0.809 0 C-N-CA 125.897 1.679 . . . . 1.75 112.743 169.637 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 113.014 0.746 . . . . 2.2200000000000002 113.014 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.46 159.73 19.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.143 0.973 . . . . 0.96999999999999997 112.807 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.6 m -116.6 144.99 34.31 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 125.119 1.368 . . . . 0.75 109.549 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.18 139.69 42.9 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.445 2.097 . . . . 0.60999999999999999 112.646 -167.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 3.0 mp -105.28 129.33 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.424 1.09 . . . . 1.25 111.187 -168.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -89.17 133.61 34.34 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.475 1.51 . . . . 4.5700000000000003 112.619 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.3 tt -141.71 156.92 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 125.779 1.632 . . . . 0.67000000000000004 111.188 -175.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -132.65 152.15 51.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.531 1.532 . . . . 2.0299999999999998 109.983 173.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.63 155.98 46.89 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 113.001 0.741 . . . . 0.93999999999999995 113.001 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.26 96.88 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.086 1.857 . . . . 1.03 111.643 -169.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 28.7 tp -124.5 59.18 1.19 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 104.361 -2.459 . . . . 2.2999999999999998 104.361 166.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -139.5 151.67 46.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.283 2.633 . . . . 3.8599999999999999 109.334 -166.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -82.26 41.01 0.67 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.185 0.994 . . . . 3.3500000000000001 113.286 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.9 m -110.45 138.88 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 125.57 1.548 . . . . 1.2 111.419 -175.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.97 -46.92 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.261 1.824 . . . . 3.6899999999999999 112.281 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -153.07 152.89 31.85 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 127.336 2.255 . . . . 3.23 110.571 174.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -92.98 149.42 21.24 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.081 0.953 . . . . 0.42999999999999999 112.644 -173.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -139.28 167.26 22.48 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 115.128 1.529 . . . . 0.55000000000000004 115.128 175.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.34 139.06 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.032 1.733 . . . . 0.60999999999999999 110.644 172.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -130.8 81.09 68.32 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 126.235 1.814 . . . . 2.73 109.357 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.98 159.59 52.01 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 125.107 3.871 . . . . 0.80000000000000004 112.731 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -125.77 -157.63 0.8 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.33 1.852 . . . . 2.2999999999999998 112.582 -167.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -143.54 167.14 22.94 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 130.473 3.509 . . . . 3.3100000000000001 107.953 174.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 12.7 t . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 113.244 0.831 . . . . 2.3999999999999999 113.244 174.444 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 111.928 0.344 . . . . 1.1599999999999999 111.928 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.8 p -93.9 -7.08 44.12 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.347 1.24 . . . . 1.3100000000000001 114.347 -173.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 t -152.43 154.42 35.52 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.625 1.97 . . . . 2.3500000000000001 109.135 166.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.6 p -95.27 4.91 53.01 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 127.341 2.256 . . . . 0.95999999999999996 114.856 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.1 m -153.19 154.19 34.23 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 120.069 -1.644 . . . . 1.9299999999999999 113.195 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -129.53 147.0 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 127.793 2.437 . . . . 0.40000000000000002 110.537 -175.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.4 m -113.55 117.7 32.39 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.082 0.953 . . . . 0.78000000000000003 110.806 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.91 135.82 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.685 0.794 . . . . 0.66000000000000003 109.513 172.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -114.08 -179.25 3.58 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.25 1.82 . . . . 1.8999999999999999 111.006 -176.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -138.02 118.24 13.6 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 120.534 -1.354 . . . . 2.21 112.176 165.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.6 mt -107.28 152.93 23.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.222 1.409 . . . . 0.55000000000000004 111.19 177.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.6 mt -144.25 172.23 13.2 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.143 1.777 . . . . 1.4199999999999999 110.422 169.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.04 164.21 12.27 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.675 1.19 . . . . 0.80000000000000004 112.272 170.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.4 p -90.98 -23.33 20.44 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.691 1.367 . . . . 1.02 114.691 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -139.15 41.45 2.09 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.861 1.21 . . . . 2.3799999999999999 112.073 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.9 14.32 82.29 Favored Glycine 0 CA--C 1.536 1.362 0 O-C-N 120.796 -1.19 . . . . 0.89000000000000001 114.971 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.42 19.85 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.94 2.496 . . . . 2.3799999999999999 116.067 -175.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.1 mmt -62.83 -28.39 69.98 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 119.592 -1.942 . . . . 0.68999999999999995 114.33 -171.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -71.84 -45.77 60.29 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.405 1.002 . . . . 2.7000000000000002 112.999 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -67.49 -35.98 80.2 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.693 -1.255 . . . . 2.0899999999999999 111.677 173.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.6 mt -58.41 -44.91 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 119.306 0.957 . . . . 0.64000000000000001 110.547 167.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.68 -37.04 77.69 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.372 -1.455 . . . . 0.77000000000000002 112.489 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -68.28 -35.89 78.54 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.631 0.772 . . . . 0.94999999999999996 112.484 170.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -63.03 -19.3 64.24 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 119.431 1.014 . . . . 1.8999999999999999 113.179 170.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 25.8 mt -101.76 -36.2 8.79 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.745 1.757 . . . . 0.83999999999999997 115.745 177.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -64.24 -24.42 67.66 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.583 1.083 . . . . 2.3399999999999999 112.503 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.9 t -74.01 -20.24 60.38 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.5 2.32 . . . . 1.25 114.45 175.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.64 172.16 27.07 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.547 1.07 . . . . 1.03 113.743 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -84.18 29.15 0.58 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.633 1.173 . . . . 2.1299999999999999 113.02 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -75.42 3.88 8.36 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.928 1.455 . . . . 1.9199999999999999 114.928 -168.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.66 -26.53 68.71 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.034 -1.042 . . . . 1.1899999999999999 111.577 168.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.86 -82.02 1.36 Allowed Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.56 1.076 . . . . 0.88 112.993 174.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.5 163.03 28.23 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.436 1.273 . . . . 1.79 114.436 -172.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -55.64 152.78 8.8 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.306 1.042 . . . . 2.3700000000000001 113.058 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.8 t -69.9 98.37 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 107.915 -1.143 . . . . 1.24 107.915 169.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.38 -25.74 75.21 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.229 0.443 . . . . 1.5900000000000001 114.191 -173.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.5 t -141.13 125.04 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.444 1.498 . . . . 1.9399999999999999 109.037 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.5 mt -92.62 160.2 34.94 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 126.08 1.752 . . . . 1.22 111.079 169.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.17 166.89 28.76 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 121.413 1.409 . . . . 0.92000000000000004 111.169 168.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.43 -20.74 58.68 Favored 'General case' 0 CA--C 1.548 0.865 0 O-C-N 120.864 -1.147 . . . . 1.0600000000000001 113.296 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.0 p30 -79.68 -4.79 53.33 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.558 1.543 . . . . 1.8200000000000001 114.406 170.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.75 154.31 20.38 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 113.997 1.11 . . . . 0.64000000000000001 113.997 174.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.8 pttt -145.92 161.75 39.34 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.71 2.004 . . . . 2.52 112.066 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -133.45 123.57 25.52 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.608 1.163 . . . . 2.23 112.424 -169.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.7 pt -120.98 143.63 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.151 0.98 . . . . 0.81000000000000005 112.129 -177.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -114.49 163.41 15.4 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.654 1.181 . . . . 0.71999999999999997 112.263 173.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.75 3.74 55.99 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.101 1.81 . . . . 0.71999999999999997 115.919 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.0 p -83.03 145.85 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 125.733 1.613 . . . . 0.68000000000000005 112.127 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -101.83 136.25 41.99 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.599 1.56 . . . . 0.56000000000000005 113.46 175.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.412 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.4 OUTLIER -141.41 158.5 43.79 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.621 1.568 . . . . 1.6200000000000001 112.319 173.58 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.2 m -124.18 146.16 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 126.873 2.069 . . . . 0.42999999999999999 109.726 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -87.41 148.03 25.17 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 122.312 1.053 . . . . 0.42999999999999999 112.283 170.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.3 p -142.46 171.26 14.3 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.601 1.96 . . . . 0.34000000000000002 112.952 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.21 -176.44 3.42 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 115.279 1.585 . . . . 1.98 115.279 174.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 47.3 p -57.73 -30.99 66.0 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.037 -1.04 . . . . 1.78 113.187 175.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -86.98 18.22 3.68 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.806 1.242 . . . . 1.95 113.192 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.97 22.09 4.14 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.288 1.835 . . . . 0.56999999999999995 113.634 -176.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -77.7 140.36 39.53 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.867 1.267 . . . . 2.1000000000000001 110.31 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.7 mt -79.79 124.5 37.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.082 -0.71 . . . . 0.53000000000000003 109.082 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.427 HG22 HG22 ' A' ' 97' ' ' THR . 4.6 pt -123.55 157.19 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 114.23 1.196 . . . . 0.58999999999999997 114.23 -174.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -89.96 166.0 13.74 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.364 1.466 . . . . 1.6699999999999999 110.221 167.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.35 5.43 1.31 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.978 1.711 . . . . 2.0600000000000001 115.332 -171.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -112.96 4.42 16.76 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 128.291 2.636 . . . . 2.7400000000000002 112.841 172.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.55 10.72 84.92 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.682 1.134 . . . . 0.57999999999999996 114.666 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -75.37 138.57 41.83 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.082 1.441 . . . . 2.0899999999999999 110.066 168.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.427 HG22 HG22 ' A' ' 91' ' ' ILE . 1.0 OUTLIER -104.8 140.57 37.91 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.095 0.958 . . . . 0.93000000000000005 112.339 -173.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -95.21 6.28 49.46 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 115.647 1.721 . . . . 0.77000000000000002 115.647 -166.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.1 28.64 61.91 Favored Glycine 0 CA--C 1.533 1.177 0 O-C-N 121.248 -0.908 . . . . 0.64000000000000001 113.73 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.7 t -137.64 149.52 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.579 1.152 . . . . 1.22 109.9 175.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -132.97 153.41 51.47 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 129.011 2.924 . . . . 1.3300000000000001 110.906 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 51.9 mt -131.93 128.83 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.924 1.289 . . . . 0.55000000000000004 112.034 -173.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -70.6 141.0 87.31 Favored Pre-proline 0 N--CA 1.477 0.907 0 CA-C-O 117.423 -1.275 . . . . 2.1000000000000001 111.84 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -73.84 -24.53 15.34 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 CA-C-N 122.355 1.877 . . . . 0.81000000000000005 112.967 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -91.13 -38.11 12.95 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.53 1.532 . . . . 1.22 113.104 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.4 p -93.62 -27.72 16.42 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.0 0.92 . . . . 0.89000000000000001 113.19 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 55.13 19.91 3.07 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.271 1.428 . . . . 2.1800000000000002 112.932 -169.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.59 147.09 25.46 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.575 1.15 . . . . 3.1299999999999999 111.69 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.3 mt -88.78 141.39 28.55 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.645 1.578 . . . . 0.92000000000000004 112.73 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.0 p -75.25 10.63 1.48 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.353 1.061 . . . . 1.3100000000000001 113.746 172.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.39 -155.21 13.87 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.552 2.025 . . . . 1.03 111.632 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -96.4 163.97 12.83 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.357 1.463 . . . . 1.05 112.698 175.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.5 mmt -51.58 139.32 29.16 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 114.289 1.218 . . . . 1.52 114.289 -176.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -78.41 163.89 26.83 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 124.617 3.544 . . . . 0.88 113.78 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.45 -67.31 0.7 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.222 1.193 . . . . 1.03 114.222 174.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.5 p -101.83 4.88 40.77 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 115.884 1.809 . . . . 0.69999999999999996 115.884 -167.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.82 147.76 11.35 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.682 1.364 . . . . 0.46999999999999997 114.682 -175.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.8 ttt -73.08 95.04 1.98 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.517 1.927 . . . . 1.75 111.561 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.6 pttp -147.07 137.58 23.57 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.803 1.641 . . . . 1.1799999999999999 111.65 -174.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -161.55 158.18 25.99 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.605 1.562 . . . . 1.8700000000000001 110.211 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -96.25 150.04 20.98 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.908 1.447 . . . . 0.46999999999999997 114.908 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.412 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 7.0 p -65.73 134.99 54.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.35 -0.844 . . . . 0.54000000000000004 111.968 169.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -94.26 -65.04 1.01 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.778 1.399 . . . . 2.2999999999999998 114.778 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.72 -45.91 0.1 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.053 0.941 . . . . 0.95999999999999996 111.666 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -93.49 -35.32 13.01 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.854 0.462 . . . . 4.1299999999999999 111.648 173.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 176.42 -149.96 10.17 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.216 1.389 . . . . 0.65000000000000002 111.034 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -137.16 129.05 29.04 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.947 1.699 . . . . 0.48999999999999999 110.492 169.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -90.09 138.33 31.6 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.318 1.047 . . . . 2.8300000000000001 112.286 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -130.34 130.87 45.0 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 128.591 2.756 . . . . 1.9399999999999999 109.214 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -88.37 123.76 33.26 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.772 1.229 . . . . 1.75 109.677 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.2 p -109.81 2.65 20.08 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.062 1.345 . . . . 0.56000000000000005 113.342 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.26 -21.72 9.87 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 115.13 1.53 . . . . 0.73999999999999999 115.13 -176.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -108.36 -9.56 15.44 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.808 1.04 . . . . 2.3399999999999999 113.808 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.04 149.0 92.09 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 120.481 1.492 . . . . 0.66000000000000003 113.313 175.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -83.91 168.8 12.1 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.898 3.066 . . . . 0.81999999999999995 111.344 167.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.39 90.46 2.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.847 2.059 . . . . 1.02 110.567 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -147.3 179.24 7.79 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.416 1.086 . . . . 0.78000000000000003 111.743 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -90.13 152.49 21.1 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.99 0.916 . . . . 3.5299999999999998 110.618 167.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -142.74 176.86 8.72 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.132 1.773 . . . . 0.53000000000000003 109.441 -173.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.89 155.88 43.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.006 0.922 . . . . 3.2599999999999998 113.199 175.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.6 mp -121.98 134.53 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.172 0.989 . . . . 0.46000000000000002 110.618 172.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -122.28 135.1 54.68 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.411 1.885 . . . . 1.9099999999999999 111.148 -176.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -86.84 109.66 19.44 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.822 0.849 . . . . 2.77 110.931 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 28.3 mm -116.64 92.29 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.871 0.868 . . . . 1.05 108.76 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -83.14 2.4 35.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.518 1.127 . . . . 4.79 113.854 -174.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.9 p . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 115.087 1.514 . . . . 1.8300000000000001 115.087 -174.418 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 114.799 1.407 . . . . 2.7799999999999998 114.799 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.55 137.05 47.76 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.993 1.717 . . . . 0.85999999999999999 110.157 168.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.54 148.55 37.67 Favored Pre-proline 0 N--CA 1.481 1.097 0 CA-C-N 119.629 1.104 . . . . 0.66000000000000003 112.386 174.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -72.56 140.46 32.93 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.65 2.233 . . . . 0.69999999999999996 111.202 -173.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 4.6 mt -88.52 127.27 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.611 0.765 . . . . 1.8200000000000001 110.377 -171.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -86.25 127.96 34.83 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.371 1.468 . . . . 3.6699999999999999 109.573 168.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.3 tt -144.23 147.67 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 119.087 0.858 . . . . 0.65000000000000002 112.951 -173.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -124.8 149.38 47.46 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.927 1.691 . . . . 2.0600000000000001 109.513 169.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 28.1 mt -64.74 162.06 39.75 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 114.377 1.251 . . . . 1.1899999999999999 114.377 -171.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.66 98.32 1.2 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.011 2.474 . . . . 0.77000000000000002 111.893 -173.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.2 tt -123.05 62.29 1.01 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 104.823 -2.288 . . . . 2.2400000000000002 104.823 167.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -140.67 156.82 46.13 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.907 2.083 . . . . 3.3300000000000001 108.853 -168.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -70.33 17.62 0.06 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.966 1.839 . . . . 3.9199999999999999 115.966 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.7 m -95.97 144.32 10.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 124.367 1.067 . . . . 1.1100000000000001 112.886 -168.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 50.8 t -73.69 -36.66 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.935 -0.478 . . . . 1.6100000000000001 110.739 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -140.29 131.29 26.19 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.195 1.398 . . . . 2.6099999999999999 110.763 -170.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -97.11 140.97 30.82 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.971 0.908 . . . . 0.47999999999999998 112.396 -176.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -137.19 166.48 23.63 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.106 1.521 . . . . 0.57999999999999996 115.106 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.43 137.32 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.64 1.976 . . . . 0.62 113.152 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -131.01 89.8 41.34 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.502 1.521 . . . . 1.8899999999999999 111.58 -177.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.87 154.36 71.13 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.157 3.238 . . . . 0.89000000000000001 112.819 175.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -133.17 163.07 30.11 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.207 1.403 . . . . 1.45 112.772 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -100.68 146.61 26.98 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.615 2.366 . . . . 3.71 110.328 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.486 1.349 0 N-CA-C 113.788 1.033 . . . . 2.29 113.788 171.357 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.5 tmt? . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 119.925 -0.083 . . . . 23.559999999999999 110.835 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -96.61 113.33 24.88 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.032 0.933 . . . . 21.609999999999999 111.522 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.6 t -106.6 21.52 17.33 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.316 1.846 . . . . 17.91 113.263 -175.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.31 -4.78 27.87 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 115.913 1.82 . . . . 15.970000000000001 115.913 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.0 m 65.2 146.84 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.493 2.317 . . . . 13.17 113.351 -168.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.57 5.89 6.71 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.484 1.114 . . . . 13.01 113.551 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.75 176.34 12.23 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.9 2.48 . . . . 10.859999999999999 110.068 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.8 t -70.26 128.19 35.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.107 1.763 . . . . 9.8699999999999992 114.081 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.1 m -127.4 154.32 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 126.758 2.023 . . . . 7.2300000000000004 111.97 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 38.2 -142.41 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.167 2.187 . . . . 3.3999999999999999 115.422 169.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 56.1 -158.28 0.24 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 127.308 2.243 . . . . 5.0 115.449 168.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.05 23.22 6.59 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.778 2.031 . . . . 5.1500000000000004 115.993 -174.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.09 -2.42 10.14 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.875 1.702 . . . . 1.8700000000000001 115.418 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 47.0 p -139.75 167.57 21.81 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.919 1.688 . . . . 1.0900000000000001 113.914 -175.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.7 p -90.58 -6.17 55.0 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.776 1.23 . . . . 1.4299999999999999 113.01 175.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 m -156.5 153.93 29.54 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.223 2.209 . . . . 2.23 109.455 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.1 p -109.54 4.49 22.28 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.306 1.595 . . . . 0.89000000000000001 115.306 -170.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 m -147.58 161.38 41.24 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.275 1.83 . . . . 1.74 112.501 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.42 141.69 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 126.513 1.925 . . . . 0.35999999999999999 109.869 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.3 m -111.3 114.83 28.29 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.474 0.654 . . . . 0.71999999999999997 109.916 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 p -93.17 128.51 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.256 1.022 . . . . 0.68000000000000005 109.274 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -107.23 -177.85 3.47 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.152 1.381 . . . . 1.79 110.118 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -139.14 122.7 17.36 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.753 -1.217 . . . . 1.6000000000000001 111.124 168.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.7 mt -107.94 154.24 21.9 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.106 0.962 . . . . 0.67000000000000004 110.936 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.26 167.37 22.6 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.843 1.657 . . . . 1.9099999999999999 110.092 176.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.38 158.34 16.13 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.751 0.821 . . . . 0.68000000000000005 112.249 170.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.1 p -80.72 -41.13 24.11 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.413 1.085 . . . . 0.93999999999999995 112.485 174.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -131.66 38.03 3.6 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.3 1.04 . . . . 2.6800000000000002 112.996 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.72 12.29 82.99 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.228 1.394 . . . . 0.79000000000000004 115.264 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -71.65 18.17 0.08 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.474 2.31 . . . . 1.95 116.075 -171.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.21 -26.03 66.07 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.377 -1.452 . . . . 0.59999999999999998 113.025 -175.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.45 -50.51 63.11 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.926 1.29 . . . . 2.3300000000000001 112.709 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -68.34 -39.93 81.72 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.849 -1.157 . . . . 2.2999999999999998 112.219 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -53.96 -49.42 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.417 1.008 . . . . 0.53000000000000003 111.123 171.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.05 -23.71 67.26 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.477 -1.389 . . . . 0.76000000000000001 113.424 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -82.17 -30.07 31.2 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.308 -0.87 . . . . 1.1200000000000001 112.822 169.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -70.67 -11.87 61.21 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.61 1.564 . . . . 2.0699999999999998 113.516 168.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.3 mt -106.65 -31.81 8.3 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.774 1.63 . . . . 0.80000000000000004 114.256 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.47 -22.31 66.73 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 120.461 1.482 . . . . 2.4100000000000001 113.176 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 t -71.16 -31.08 67.24 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.436 1.094 . . . . 1.3799999999999999 112.466 171.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.4 162.62 35.02 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.247 0.927 . . . . 0.87 113.22 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -83.23 30.58 0.46 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.936 -1.332 . . . . 1.6100000000000001 112.813 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -71.78 19.23 0.07 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.124 1.898 . . . . 1.96 116.124 -168.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.16 -27.85 62.85 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.367 1.067 . . . . 0.93999999999999995 109.802 164.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.23 -63.79 0.26 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.211 1.386 . . . . 0.68999999999999995 113.341 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -78.82 158.92 28.07 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.177 1.547 . . . . 1.8100000000000001 115.177 -171.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -70.76 135.74 48.4 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.997 1.719 . . . . 3.27 112.991 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 80.0 t -54.38 110.57 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.883 0.873 . . . . 0.80000000000000004 111.246 -174.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.72 -25.21 60.89 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 114.708 0.643 . . . . 1.0600000000000001 114.708 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 p -142.07 104.11 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.528 1.131 . . . . 4.25 111.89 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.1 mt -89.79 146.8 36.12 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 126.966 2.107 . . . . 1.1299999999999999 111.451 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.27 158.21 19.96 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.282 2.654 . . . . 0.56999999999999995 113.18 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.37 -22.9 63.69 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.877 -1.139 . . . . 0.93000000000000005 112.356 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -79.34 0.5 28.71 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.946 1.298 . . . . 1.3100000000000001 114.28 169.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.32 157.85 16.48 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.743 1.217 . . . . 0.56999999999999995 112.599 168.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -150.84 172.02 16.3 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.178 1.791 . . . . 1.8100000000000001 111.206 173.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -126.54 146.82 49.99 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.287 1.435 . . . . 2.25 111.028 -174.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.1 pt -136.65 130.67 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 114.042 1.127 . . . . 0.77000000000000002 114.042 -177.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.7 156.86 17.78 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.725 0.81 . . . . 0.63 111.71 169.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.4 15.78 56.5 Favored Glycine 0 CA--C 1.537 1.43 0 N-CA-C 116.102 1.201 . . . . 0.62 116.102 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.5 p -90.14 145.78 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-N 120.153 1.977 . . . . 0.93999999999999995 109.125 167.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 1.8 tpp -102.42 137.69 40.33 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.701 1.2 . . . . 0.45000000000000001 111.798 174.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.66 153.71 47.35 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 122.188 0.994 . . . . 1.74 112.875 170.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.7 m -118.71 146.39 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 C-N-CA 126.948 2.099 . . . . 0.33000000000000002 109.125 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -87.64 147.03 25.45 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.433 1.111 . . . . 0.29999999999999999 111.926 169.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.2 p -141.49 173.65 11.3 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.328 1.851 . . . . 0.40000000000000002 112.098 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.53 177.6 4.97 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.78 1.632 . . . . 1.8100000000000001 113.407 172.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.0 p -68.18 -20.76 64.89 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.978 1.103 . . . . 1.4099999999999999 113.978 -171.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -97.97 26.46 5.21 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.602 1.561 . . . . 2.1200000000000001 112.834 169.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 62.26 23.98 14.24 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.226 2.21 . . . . 0.56000000000000005 114.349 169.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -84.38 140.38 31.61 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.069 0.948 . . . . 2.5499999999999998 111.117 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.7 mt -76.86 126.09 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.193 -0.669 . . . . 0.5 109.193 176.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.555 HG22 HG22 ' A' ' 97' ' ' THR . 4.7 pt -117.86 156.91 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 114.57 1.322 . . . . 0.58999999999999997 114.57 -176.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -85.27 165.4 17.36 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.232 1.413 . . . . 1.4399999999999999 110.741 167.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -64.95 2.86 0.64 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 128.05 2.54 . . . . 3.0499999999999998 115.904 -174.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -117.54 -3.5 11.34 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 127.59 2.356 . . . . 2.98 114.276 172.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.05 5.8 59.4 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.362 1.458 . . . . 0.81000000000000005 116.443 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -72.33 137.34 46.58 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.092 1.946 . . . . 2.0499999999999998 110.454 170.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.555 HG22 HG22 ' A' ' 91' ' ' ILE . 23.9 p -96.36 134.23 39.76 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.603 1.161 . . . . 0.98999999999999999 111.662 -175.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.7 -0.95 57.27 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.538 1.681 . . . . 0.62 115.538 -167.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.86 15.61 69.84 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-N 119.214 0.915 . . . . 0.71999999999999997 113.931 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.0 t -125.08 147.1 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.938 1.295 . . . . 1.1000000000000001 109.293 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -133.55 157.85 44.65 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 128.115 2.566 . . . . 1.3300000000000001 110.138 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.41 HG12 HD23 ' A' ' 109' ' ' LEU . 55.8 mt -136.03 134.23 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.931 1.292 . . . . 0.48999999999999999 110.53 -174.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -73.09 135.02 80.26 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 121.072 -1.017 . . . . 1.8 110.308 173.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -66.71 -22.92 49.42 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.573 2.182 . . . . 0.98999999999999999 113.816 172.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -96.9 -45.06 6.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.916 1.686 . . . . 1.1200000000000001 112.762 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.8 p -90.71 -22.98 20.85 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.61 1.164 . . . . 0.79000000000000004 113.565 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 53.39 19.46 1.63 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.75 1.62 . . . . 2.0499999999999998 113.846 -170.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.41 146.65 30.18 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.745 -1.222 . . . . 2.7599999999999998 111.524 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.41 HD23 HG12 ' A' ' 102' ' ' ILE . 31.3 mt -90.29 135.66 33.54 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.215 1.406 . . . . 0.83999999999999997 111.288 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 92.2 p -66.23 -0.58 2.62 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.382 1.252 . . . . 1.3300000000000001 114.382 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.38 -152.8 9.08 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 126.39 1.948 . . . . 0.85999999999999999 112.218 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.1 162.65 15.21 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.113 1.365 . . . . 0.93999999999999995 113.439 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.3 mmt -54.01 128.12 55.53 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.75 1.22 . . . . 1.51 113.055 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -72.08 163.42 38.83 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.106 3.204 . . . . 0.73999999999999999 113.129 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.41 -81.24 0.09 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.165 0.986 . . . . 1.0700000000000001 112.127 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 78.1 p -83.58 2.05 39.14 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 116.07 1.878 . . . . 0.78000000000000003 116.07 -167.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -49.87 149.17 2.74 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.382 1.473 . . . . 0.46999999999999997 114.974 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.1 tpt -77.52 98.11 5.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.784 2.034 . . . . 1.5800000000000001 111.256 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -150.14 147.78 28.17 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.413 1.485 . . . . 1.04 112.221 -172.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -166.82 156.96 11.53 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 125.392 1.477 . . . . 1.79 111.241 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 mp -94.68 150.4 20.26 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.481 1.289 . . . . 0.47999999999999998 114.481 172.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 16.7 p -63.84 134.52 55.35 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.323 -0.86 . . . . 0.46999999999999997 112.058 170.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -92.3 -54.41 3.82 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.464 1.653 . . . . 2.1899999999999999 115.464 -171.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.73 -37.7 0.08 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.902 1.281 . . . . 1.0800000000000001 111.509 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -119.65 -22.52 6.87 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.073 1.138 . . . . 5.25 114.073 171.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 175.87 -159.09 26.43 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.686 1.612 . . . . 0.65000000000000002 111.117 -170.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -147.06 133.64 19.84 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.589 1.955 . . . . 0.39000000000000001 111.967 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -86.77 137.42 32.45 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.506 1.122 . . . . 1.4199999999999999 113.088 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -128.97 124.07 34.08 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.495 2.318 . . . . 1.6699999999999999 108.556 174.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -77.49 128.75 34.72 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.354 -0.841 . . . . 2.5299999999999998 110.201 175.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 66.8 p -105.73 -10.74 16.59 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.796 1.776 . . . . 0.69999999999999996 115.796 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.64 -33.95 16.88 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.798 1.181 . . . . 0.96999999999999997 114.014 -172.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -16.37 44.27 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.807 1.643 . . . . 2.2400000000000002 113.291 -176.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -72.18 144.18 86.91 Favored Pre-proline 0 C--O 1.237 0.434 0 CA-C-N 119.976 1.262 . . . . 0.63 112.166 173.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.45 167.1 27.92 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.357 2.038 . . . . 0.70999999999999996 110.47 167.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.38 93.77 1.98 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.149 1.38 . . . . 0.97999999999999998 109.609 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -152.71 -178.29 6.78 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.945 0.898 . . . . 0.65000000000000002 112.427 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -91.13 152.39 20.61 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.392 1.877 . . . . 3.3999999999999999 111.956 168.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -149.27 170.96 17.3 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.661 2.385 . . . . 0.48999999999999999 110.372 -170.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -138.63 160.86 38.56 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.424 1.09 . . . . 1.74 113.337 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.2 134.46 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.357 1.463 . . . . 0.39000000000000001 110.065 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -122.14 137.38 54.84 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.475 1.51 . . . . 1.8600000000000001 111.569 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -104.69 100.61 10.26 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.907 1.683 . . . . 2.6299999999999999 110.469 -169.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 28.2 mm -106.84 113.88 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.613 1.165 . . . . 0.73999999999999999 110.653 -167.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -87.1 22.82 1.95 Allowed 'General case' 0 CA--C 1.553 1.09 0 O-C-N 120.936 -1.102 . . . . 3.7799999999999998 112.854 -178.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 14.2 m -88.45 -21.84 24.01 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.578 1.325 . . . . 1.77 114.578 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.32 150.46 20.83 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.456 1.103 . . . . 2.4199999999999999 109.421 170.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 95.0 p -59.23 116.54 3.96 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 122.805 1.288 . . . . 5.4400000000000004 112.941 -170.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.7 t -106.49 169.77 8.32 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.832 2.053 . . . . 5.29 111.12 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -59.91 146.99 40.22 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.695 -1.253 . . . . 7.5 111.42 170.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 67.9 t -75.41 93.68 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.571 1.148 . . . . 4.5300000000000002 110.809 -174.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -106.24 -37.58 2.46 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.513 1.054 . . . . 2.27 113.44 172.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -71.75 8.37 1.19 Allowed 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 116.674 2.101 . . . . 4.9100000000000001 116.674 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -117.38 31.76 6.54 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.963 1.305 . . . . 5.3600000000000003 112.688 -171.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 91.4 12.43 59.78 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.167 1.365 . . . . 3.8900000000000001 115.514 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.3 176.46 9.28 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.646 1.178 . . . . 2.8100000000000001 113.399 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.4 -2.6 0.74 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 115.725 1.75 . . . . 3.5099999999999998 115.725 172.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.0 mt -79.68 152.98 29.64 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.966 1.257 . . . . 1.78 112.122 170.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 23.4 m -91.49 -34.2 14.89 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.8 1.407 . . . . 3.5 114.8 -168.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.06 20.65 79.21 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-N 119.195 0.907 . . . . 2.1499999999999999 114.228 -169.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.9 p -77.96 142.27 38.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.957 1.303 . . . . 2.6899999999999999 112.219 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -63.64 128.39 35.59 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.775 1.23 . . . . 1.8799999999999999 112.441 174.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.55 147.1 28.82 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.514 1.126 . . . . 1.0900000000000001 111.06 168.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.36 147.88 34.62 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 123.282 0.633 . . . . 0.94999999999999996 110.449 170.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.29 159.28 52.3 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.708 2.939 . . . . 0.70999999999999996 113.365 -173.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -109.07 148.11 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.514 1.126 . . . . 1.72 111.467 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.58 148.45 41.9 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.789 1.636 . . . . 4.8300000000000001 111.252 168.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.6 tt -151.56 146.81 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 124.157 0.983 . . . . 0.48999999999999999 111.705 -174.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -122.97 142.92 50.3 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.555 1.542 . . . . 1.8400000000000001 109.495 169.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 23.4 mt -64.79 149.61 95.85 Favored Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 113.808 1.04 . . . . 0.97999999999999998 113.808 -170.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.54 110.72 2.36 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.269 2.646 . . . . 0.73999999999999999 113.832 -169.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.45 60.88 1.4 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.569 2.348 . . . . 2.4300000000000002 106.016 166.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -151.66 147.86 27.25 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.981 2.112 . . . . 3.1000000000000001 109.896 -166.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -72.48 23.41 0.06 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 126.075 1.75 . . . . 4.0099999999999998 114.679 -174.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.4 m -76.28 149.51 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 120.434 -1.417 . . . . 1.21 111.759 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 88.7 t -78.96 -35.7 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.733 0.813 . . . . 2.1699999999999999 111.405 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -145.42 148.56 33.45 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.67 1.988 . . . . 3.0 109.747 173.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -94.66 141.74 28.26 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.952 0.797 . . . . 0.39000000000000001 111.916 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -138.85 170.54 15.8 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.348 1.24 . . . . 0.59999999999999998 114.348 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.27 141.26 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 125.201 1.401 . . . . 0.56999999999999995 112.845 -177.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.38 83.28 59.73 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 124.729 1.212 . . . . 2.25 113.844 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -67.96 138.39 44.04 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.36 3.374 . . . . 0.59999999999999998 113.068 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -124.6 163.23 22.38 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.176 1.79 . . . . 1.9299999999999999 112.57 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -103.56 164.74 11.47 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.826 1.25 . . . . 2.6499999999999999 110.774 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 7.2 t -141.34 -20.1 0.77 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.042 1.127 . . . . 2.9500000000000002 114.042 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -78.85 154.97 29.38 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.744 1.618 . . . . 6.7000000000000002 110.615 167.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -119.04 170.23 9.22 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.312 1.445 . . . . 7.3200000000000003 112.093 176.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.49 148.66 64.4 Favored Pre-proline 0 N--CA 1.479 0.994 0 O-C-N 121.226 -0.921 . . . . 13.640000000000001 112.628 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.52 139.95 32.22 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.632 2.222 . . . . 10.390000000000001 112.818 -175.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -87.0 -6.99 58.57 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.119 1.526 . . . . 14.43 115.119 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.483 ' H ' HD12 ' A' ' 191' ' ' ILE . 4.2 mp -74.39 -44.38 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.807 1.243 . . . . 13.51 111.205 -178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.1 mt -87.13 127.6 35.13 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.314 1.446 . . . . 14.07 112.572 -171.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 . . . . . 0 N--CA 1.473 0.723 0 C-N-CA 124.521 1.128 . . . . 19.07 113.763 -178.292 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.6 mpp? . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 110.411 -0.218 . . . . 23.0 110.411 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . 0.259 51.7 mt-10 65.26 150.55 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.959 2.503 . . . . 26.140000000000001 115.529 -170.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.9 m 62.45 -27.6 0.07 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 129.214 3.006 . . . . 23.579999999999998 117.615 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.47 148.21 43.52 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 120.203 1.365 . . . . 18.550000000000001 113.333 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.5 m -73.68 -27.63 61.33 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.947 1.462 . . . . 16.690000000000001 114.947 -173.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -147.22 172.0 14.5 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.98 1.312 . . . . 12.51 113.56 -173.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.24 163.51 12.54 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.813 1.645 . . . . 9.5500000000000007 112.444 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 t -52.47 144.21 13.85 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.887 1.275 . . . . 7.8200000000000003 112.201 171.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.3 m -67.72 150.43 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 113.995 1.109 . . . . 7.5 113.995 -168.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -84.52 157.54 21.26 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.719 1.207 . . . . 4.5700000000000003 113.579 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.84 137.76 23.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.121 1.369 . . . . 3.73 111.486 173.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.66 109.24 20.99 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.704 1.202 . . . . 5.4299999999999997 111.23 -172.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.48 44.54 3.18 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.797 1.665 . . . . 2.1699999999999999 112.547 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.0 p -144.66 167.04 23.49 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.39 1.476 . . . . 1.0800000000000001 113.997 -167.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 78.0 p -91.8 -9.13 44.62 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.629 1.172 . . . . 1.72 114.149 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.7 t -147.88 154.67 40.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.875 1.67 . . . . 1.8 109.405 169.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.7 p -98.27 -0.62 43.62 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.918 1.687 . . . . 0.85999999999999999 114.32 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.4 m -151.68 158.9 44.04 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.312 1.445 . . . . 1.79 110.607 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.68 141.9 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 126.39 1.876 . . . . 0.40999999999999998 109.317 177.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 m -115.76 121.77 43.45 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.508 0.723 . . . . 0.91000000000000003 110.307 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -103.37 131.61 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.683 1.193 . . . . 0.62 110.998 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -130.32 100.39 5.36 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.11 1.364 . . . . 1.8799999999999999 110.82 -172.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.419 ' HE3' ' CD2' ' A' ' 43' ' ' LEU . 6.9 tmtm? -74.81 120.88 20.95 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.788 -1.195 . . . . 1.54 110.916 -174.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.3 mt -106.84 153.45 22.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.952 1.301 . . . . 0.67000000000000004 112.195 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.419 ' CD2' ' HE3' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -141.65 171.77 13.6 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.965 1.706 . . . . 1.8200000000000001 110.894 176.158 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.35 158.49 16.43 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.171 1.388 . . . . 0.96999999999999997 112.219 170.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.4 p -81.01 -25.59 37.11 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.39 1.256 . . . . 1.4399999999999999 114.39 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -149.64 38.04 0.75 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.427 1.091 . . . . 3.5800000000000001 112.64 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.09 10.35 75.13 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 116.44 1.336 . . . . 1.24 116.44 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.13 14.62 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 129.128 2.971 . . . . 2.1800000000000002 116.632 -177.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -26.13 68.61 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.283 -1.51 . . . . 0.75 113.087 -170.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -72.12 -43.37 64.82 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.626 1.103 . . . . 2.04 113.103 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -70.22 -41.86 73.06 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.465 -1.397 . . . . 2.4500000000000002 111.746 172.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.9 mt -54.07 -44.2 62.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.333 1.053 . . . . 0.82999999999999996 112.231 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.88 -31.17 69.54 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 120.967 1.712 . . . . 0.95999999999999996 112.768 176.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -76.03 -35.76 59.36 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.969 0.908 . . . . 1.3999999999999999 112.86 171.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -63.15 -22.87 67.15 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.179 0.991 . . . . 2.2000000000000002 112.97 170.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.3 mt -91.93 -41.48 10.56 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.097 1.147 . . . . 1.25 114.097 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.65 -18.9 65.37 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.781 1.173 . . . . 4.1299999999999999 113.692 -175.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.8 t -75.68 -23.37 56.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.655 1.182 . . . . 2.0099999999999998 113.883 172.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.64 157.68 21.32 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.346 0.974 . . . . 1.27 112.578 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -77.37 43.28 0.38 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.474 1.11 . . . . 1.71 113.031 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -78.74 13.37 1.69 Allowed 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.516 -1.365 . . . . 2.0600000000000001 113.971 -170.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.83 -17.63 58.88 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.237 1.415 . . . . 1.28 111.155 165.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.82 -74.07 0.14 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.738 1.161 . . . . 0.90000000000000002 112.792 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.42 161.33 29.92 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.41 1.263 . . . . 1.5600000000000001 114.41 -173.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.04 158.67 27.75 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.898 1.073 . . . . 3.1400000000000001 113.898 -173.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.02 119.44 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.894 -0.504 . . . . 0.81000000000000005 110.175 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.28 -29.33 45.62 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.828 0.728 . . . . 1.3600000000000001 114.15 -176.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.9 t -146.15 125.92 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.259 1.423 . . . . 2.2000000000000002 111.41 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.2 mt -96.88 134.46 23.01 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.903 1.681 . . . . 1.22 110.771 167.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.86 160.49 43.29 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.042 1.828 . . . . 0.71999999999999997 111.42 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.26 -21.82 66.78 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.836 -1.165 . . . . 1.25 113.715 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -88.3 -5.01 58.59 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.659 1.584 . . . . 1.76 114.443 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.3 155.16 20.77 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.108 0.867 . . . . 0.78000000000000003 111.113 168.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.6 pttt -152.46 170.01 21.18 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.396 1.078 . . . . 1.79 111.83 169.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -120.32 137.78 54.07 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.905 1.682 . . . . 2.02 108.718 -172.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.7 pt -126.24 131.98 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 120.018 1.281 . . . . 0.81000000000000005 113.464 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.76 160.06 14.92 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.0 1.32 . . . . 0.68000000000000005 111.286 169.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.03 16.11 68.21 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.086 0.851 . . . . 0.56000000000000005 115.089 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.3 p -101.85 141.71 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.491 1.516 . . . . 0.64000000000000001 110.288 169.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.7 tpp -99.88 141.8 32.21 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.524 1.53 . . . . 0.56000000000000005 112.642 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.442 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.6 OUTLIER -144.32 149.44 36.21 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.146 1.378 . . . . 1.6299999999999999 111.471 173.092 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.8 m -120.44 146.13 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 126.584 1.953 . . . . 0.39000000000000001 109.41 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -87.21 144.49 26.8 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.882 1.325 . . . . 0.40000000000000002 110.903 168.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.7 p -137.35 170.46 16.05 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.127 2.171 . . . . 0.40000000000000002 110.473 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -87.26 171.8 10.36 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.491 -0.755 . . . . 2.0899999999999999 111.651 167.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.5 t -61.46 -24.59 66.67 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.06 -1.025 . . . . 3.0099999999999998 113.275 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -69.42 10.37 0.35 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 127.274 2.23 . . . . 3.29 115.048 169.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.43 22.55 5.09 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 128.144 2.578 . . . . 0.68999999999999995 113.354 -172.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -83.06 136.27 34.54 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.481 1.512 . . . . 2.23 111.068 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.6 mt -73.99 127.26 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 109.65 -0.5 . . . . 0.48999999999999999 109.65 175.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.583 HG22 HG22 ' A' ' 97' ' ' THR . 3.2 pt -120.09 150.28 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 115.174 1.546 . . . . 0.5 115.174 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.45 159.57 28.19 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.081 2.153 . . . . 2.1000000000000001 109.298 165.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -64.32 -15.01 59.47 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.595 1.332 . . . . 2.0499999999999998 114.595 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -92.63 4.24 54.04 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.62 1.168 . . . . 3.48 111.993 174.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.61 5.54 81.64 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 126.47 1.986 . . . . 0.47999999999999998 115.376 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -67.96 143.72 55.5 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.222 1.011 . . . . 2.3100000000000001 109.859 171.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.583 HG22 HG22 ' A' ' 91' ' ' ILE . 33.6 p -103.58 136.04 44.05 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.539 1.135 . . . . 0.68000000000000005 111.198 -177.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.26 -8.98 58.87 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.022 1.119 . . . . 0.65000000000000002 114.022 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.32 19.73 56.39 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.341 0.972 . . . . 0.71999999999999997 113.53 -174.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.52 147.6 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.873 1.269 . . . . 1.1299999999999999 110.213 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.11 160.7 30.4 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.86 2.464 . . . . 1.5700000000000001 110.81 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.4 mt -133.88 134.83 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.388 1.475 . . . . 0.68999999999999995 111.32 -175.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.04 139.04 87.56 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 117.725 -1.131 . . . . 2.3999999999999999 111.314 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -71.4 -27.46 19.22 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 CA-C-N 122.095 1.784 . . . . 1.1100000000000001 112.839 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -86.98 -48.59 7.99 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.582 1.153 . . . . 1.72 111.736 -175.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.8 p -91.05 -24.35 20.07 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.426 1.09 . . . . 1.22 113.356 -174.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 53.45 29.31 8.72 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 125.174 1.39 . . . . 2.5600000000000001 112.162 -167.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.76 153.07 17.94 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.396 1.479 . . . . 2.3599999999999999 111.535 174.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.8 mt -94.46 151.82 19.07 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.768 1.627 . . . . 0.82999999999999996 113.303 -169.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.3 p -73.42 -2.77 23.74 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.558 0.947 . . . . 1.27 113.558 168.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.82 -147.92 6.05 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 126.861 2.172 . . . . 0.90000000000000002 112.515 -169.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.7 175.72 6.92 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.542 1.537 . . . . 0.94999999999999996 113.671 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.6 mmt -64.41 138.04 97.31 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.521 1.128 . . . . 1.3700000000000001 112.273 173.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -86.1 150.48 9.47 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 124.105 3.203 . . . . 0.78000000000000003 113.564 -174.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.1 -54.08 8.56 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.431 1.271 . . . . 1.1399999999999999 114.431 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 64.8 p -107.91 -1.61 20.54 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.871 1.434 . . . . 0.82999999999999996 114.871 -168.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.14 149.39 2.87 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 115.035 1.495 . . . . 0.40000000000000002 115.035 -173.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.5 tpt -75.96 99.39 4.53 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.099 2.159 . . . . 1.6599999999999999 111.186 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -153.6 147.14 25.02 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.201 1.4 . . . . 0.93000000000000005 112.594 -173.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -164.69 158.17 17.49 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.63 1.572 . . . . 1.6899999999999999 110.626 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -98.65 149.98 22.24 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.47 1.108 . . . . 0.56000000000000005 112.523 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.513 HG22 ' HA2' ' A' ' 126' ' ' GLY . 2.0 p -65.57 128.53 36.29 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.834 0.743 . . . . 0.58999999999999997 109.861 170.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.23 -55.14 4.34 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.012 1.115 . . . . 2.0600000000000001 114.012 -173.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.35 -43.69 0.14 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.16 1.384 . . . . 1.03 110.565 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -113.88 -25.45 8.6 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.5 0.926 . . . . 3.8100000000000001 113.5 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.513 ' HA2' HG22 ' A' ' 122' ' ' THR . . . 177.24 -166.8 37.61 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.249 0.928 . . . . 0.57999999999999996 111.865 -169.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.98 142.01 34.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.878 1.671 . . . . 0.52000000000000002 112.137 169.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -92.69 138.01 31.87 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.133 1.373 . . . . 1.3300000000000001 113.185 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -128.71 125.98 39.11 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.519 1.928 . . . . 1.96 109.106 173.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.405 HD21 ' HB3' ' A' ' 132' ' ' ALA . 2.2 t30 -88.42 108.53 19.42 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 118.953 0.797 . . . . 1.6299999999999999 111.054 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.6 p -93.98 0.61 56.13 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.092 1.357 . . . . 0.57999999999999996 113.764 -174.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.405 ' HB3' HD21 ' A' ' 130' ' ' ASN . . . -60.97 -8.84 3.49 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.095 1.516 . . . . 0.77000000000000002 115.095 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -102.12 -21.78 14.35 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.15 1.38 . . . . 1.8500000000000001 113.134 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -79.03 147.68 70.32 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 113.251 0.834 . . . . 0.71999999999999997 113.251 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.59 166.98 21.38 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.965 2.443 . . . . 0.80000000000000004 111.605 168.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.86 86.01 3.43 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.629 1.972 . . . . 1.01 111.857 -172.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -147.11 -175.53 4.86 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.823 0.849 . . . . 0.78000000000000003 111.678 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -93.34 142.68 27.04 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.751 1.22 . . . . 2.46 113.868 170.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -135.72 169.12 18.05 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.342 2.257 . . . . 0.58999999999999997 110.029 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -137.95 152.91 49.41 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.526 0.73 . . . . 1.7 112.809 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.0 mp -112.12 138.9 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.166 0.986 . . . . 0.31 110.023 173.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -128.47 131.04 48.36 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.79 1.636 . . . . 1.8 110.229 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -95.11 78.92 3.54 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.038 0.935 . . . . 1.9199999999999999 111.448 -171.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.6 mm -82.95 101.66 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.519 0.727 . . . . 0.77000000000000002 110.17 -174.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -80.66 -1.44 42.47 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.422 1.267 . . . . 4.7800000000000002 114.422 -175.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 58.2 p -75.99 -15.36 60.17 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.288 -1.507 . . . . 1.71 115.057 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.38 -47.73 26.19 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.714 1.143 . . . . 2.9500000000000002 112.581 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.2 t -168.12 140.6 3.03 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.905 2.082 . . . . 4.8099999999999996 108.949 -176.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.3 m -134.74 146.76 49.72 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.174 1.176 . . . . 5.9400000000000004 114.174 -175.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -75.77 168.8 19.34 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 130.205 3.402 . . . . 5.8099999999999996 112.12 169.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 93.0 t -68.71 120.59 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 O-C-N 120.776 -1.203 . . . . 5.3799999999999999 109.816 172.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -165.19 -51.24 0.02 OUTLIER Glycine 0 CA--C 1.526 0.749 0 N-CA-C 115.87 1.108 . . . . 2.46 115.87 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.03 -7.04 25.79 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 119.106 1.453 . . . . 4.5300000000000002 113.347 173.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.13 4.81 0.81 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 130.046 3.338 . . . . 6.0599999999999996 115.709 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 105.23 2.07 41.46 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.59 1.566 . . . . 5.1600000000000001 114.842 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -77.82 174.87 10.53 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.646 1.578 . . . . 3.8799999999999999 113.776 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 22.5 p -69.5 41.36 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 127.283 2.233 . . . . 4.1600000000000001 112.941 167.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 36.1 mt -150.94 5.46 0.49 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 130.514 3.526 . . . . 3.79 110.544 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 13.3 t -84.77 139.89 31.63 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 115.463 1.653 . . . . 6.1900000000000004 115.463 -168.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.47 25.25 19.79 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 125.893 1.711 . . . . 2.8199999999999998 116.076 168.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.8 t -103.66 132.14 50.18 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.266 1.426 . . . . 2.6200000000000001 111.32 -169.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -91.88 115.86 28.42 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.479 1.912 . . . . 3.52 113.093 -168.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.03 132.52 36.01 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.266 0.555 . . . . 0.83999999999999997 109.695 167.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.1 149.08 35.96 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 123.684 0.794 . . . . 0.54000000000000004 110.759 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.99 159.39 48.05 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.843 2.362 . . . . 0.57999999999999996 112.182 -172.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.516 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.4 mp -123.93 134.44 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.014 1.725 . . . . 1.3100000000000001 109.168 -168.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -99.35 134.55 42.04 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.342 0.974 . . . . 4.2199999999999998 111.343 170.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.7 tt -130.73 140.58 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.936 1.694 . . . . 0.55000000000000004 110.284 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -107.91 150.5 26.98 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.489 1.116 . . . . 2.1099999999999999 108.911 170.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.1 mt -62.8 143.4 96.97 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 119.493 1.042 . . . . 1.05 111.91 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.9 107.25 1.07 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.292 2.662 . . . . 0.94999999999999996 111.799 -169.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.69 25.1 10.23 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.254 1.822 . . . . 3.0800000000000001 110.14 174.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -115.54 144.44 43.86 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.631 2.772 . . . . 2.9700000000000002 109.154 -171.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -73.14 42.7 0.12 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.756 1.622 . . . . 4.5499999999999998 114.993 -171.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 10.4 m -90.84 157.75 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.802 1.641 . . . . 1.1599999999999999 113.176 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 76.3 t -72.57 -37.99 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.755 1.622 . . . . 2.46 111.355 173.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.52 158.16 31.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.669 0.788 . . . . 3.54 111.525 169.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -96.03 140.07 31.3 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.025 0.93 . . . . 0.78000000000000003 112.179 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -136.63 165.16 26.52 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.066 1.506 . . . . 0.81999999999999995 115.066 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.33 142.93 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 126.241 1.816 . . . . 0.46999999999999997 111.119 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -136.38 70.61 60.85 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.448 1.499 . . . . 2.6200000000000001 113.236 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.516 ' HB3' HD11 ' A' ' 166' ' ' ILE . 18.6 Cg_endo -69.32 114.73 3.73 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.293 2.662 . . . . 0.92000000000000004 113.714 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -89.83 174.97 7.41 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 128.299 2.64 . . . . 2.0 111.939 173.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -108.3 167.28 10.13 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.432 1.493 . . . . 2.9399999999999999 111.363 170.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 9.0 t -114.37 -56.6 2.37 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.855 0.862 . . . . 2.7400000000000002 112.951 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -142.62 168.72 19.05 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.924 1.238 . . . . 5.3899999999999997 113.316 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -148.88 151.8 35.32 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.174 0.805 . . . . 6.21 113.174 -176.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.14 164.64 20.31 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 126.038 1.735 . . . . 9.5399999999999991 111.287 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.49 155.87 45.38 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.5 2.8 . . . . 9.0299999999999994 113.506 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -128.82 -14.71 4.47 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.853 1.797 . . . . 15.640000000000001 115.853 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.53 9.31 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 114.993 1.479 . . . . 14.56 114.993 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 80.8 mt -91.75 113.84 26.22 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.414 -0.804 . . . . 13.34 110.676 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 . . . . . 0 CA--C 1.552 1.056 0 C-N-CA 127.285 2.234 . . . . 16.91 111.236 -179.606 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 62.3 ttp . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 112.355 0.502 . . . . 28.710000000000001 112.355 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -78.98 163.32 25.31 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.358 1.614 . . . . 28.149999999999999 115.358 -168.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 t -146.9 151.3 36.82 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.646 1.978 . . . . 23.109999999999999 111.948 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.0 -12.33 47.75 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 115.406 1.632 . . . . 22.670000000000002 115.406 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.7 m -146.64 153.25 40.1 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.803 1.183 . . . . 18.890000000000001 113.087 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.6 -10.63 19.11 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.017 1.727 . . . . 15.06 115.486 -172.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.4 177.59 10.43 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.952 1.093 . . . . 12.9 113.952 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.9 t -78.64 153.62 30.89 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.617 1.567 . . . . 11.99 110.349 167.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.5 p -69.89 150.83 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.052 1.341 . . . . 10.51 113.617 -176.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -75.8 -179.84 5.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.053 1.741 . . . . 5.4000000000000004 112.257 169.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.73 -173.73 0.1 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.678 1.591 . . . . 6.5599999999999996 114.159 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -126.87 135.21 50.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.17 1.788 . . . . 6.7699999999999996 109.901 177.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.25 62.01 3.05 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.127 0.87 . . . . 4.1299999999999999 111.625 -169.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 p -139.91 144.61 37.23 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.304 1.442 . . . . 3.0499999999999998 110.997 -177.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.5 p -125.73 -9.67 6.73 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 117.797 2.518 . . . . 1.3200000000000001 117.797 -167.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 t -147.2 156.42 42.95 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 121.432 1.923 . . . . 1.99 114.622 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.7 p -100.89 -6.28 24.88 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.759 1.624 . . . . 1.1499999999999999 115.06 -172.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.5 p -147.5 156.73 43.12 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.878 1.671 . . . . 1.8899999999999999 113.794 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.76 140.45 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 127.893 2.477 . . . . 0.42999999999999999 109.112 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 36.2 m -114.17 127.54 55.95 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.353 0.979 . . . . 0.93000000000000005 111.383 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 p -96.34 136.55 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.202 1.001 . . . . 0.78000000000000003 110.695 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -131.37 107.21 8.77 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.824 1.65 . . . . 1.72 110.576 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.54 114.5 20.98 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 120.901 -1.125 . . . . 0.97999999999999998 111.436 -170.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.1 mt -99.36 154.41 18.22 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.539 1.136 . . . . 0.53000000000000003 112.416 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.6 mt -141.03 169.52 17.46 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.331 1.852 . . . . 1.73 110.209 169.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.5 150.4 23.43 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.89 0.876 . . . . 0.68999999999999995 111.016 169.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.9 p -76.64 -21.94 54.77 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.345 0.868 . . . . 1.1299999999999999 113.345 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -137.61 34.75 2.45 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.102 1.761 . . . . 2.1299999999999999 111.762 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.69 15.79 75.82 Favored Glycine 0 CA--C 1.539 1.551 0 O-C-N 119.864 -1.772 . . . . 1.0700000000000001 115.383 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.28 26.27 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 128.936 2.894 . . . . 1.8200000000000001 115.231 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -26.09 67.82 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.133 -1.604 . . . . 0.56000000000000005 113.367 -172.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -73.69 -46.36 46.77 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.41 1.004 . . . . 1.98 112.814 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -65.94 -43.27 88.51 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.203 -0.935 . . . . 2.0800000000000001 111.117 173.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 91.9 mt -50.65 -50.13 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 118.965 0.802 . . . . 0.60999999999999999 110.721 168.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.16 -32.64 70.07 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 120.807 1.639 . . . . 0.76000000000000001 113.657 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -74.31 -32.96 63.06 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.618 0.767 . . . . 0.94999999999999996 112.68 172.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -71.24 -23.66 62.04 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.626 1.171 . . . . 1.95 112.842 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.7 mt -92.32 -35.69 13.6 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.037 1.125 . . . . 0.93000000000000005 114.037 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -67.96 -28.14 67.21 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.977 0.808 . . . . 2.48 112.975 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 t -73.92 -12.49 60.67 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.42 1.488 . . . . 1.26 113.007 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.53 175.93 36.3 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.287 1.422 . . . . 0.96999999999999997 112.518 170.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -93.39 34.46 1.16 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.091 1.356 . . . . 2.3500000000000001 111.617 169.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -75.74 17.85 0.28 Allowed 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.459 -1.401 . . . . 1.8500000000000001 114.202 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.57 -23.83 49.93 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.261 1.024 . . . . 1.01 110.11 165.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -118.73 -59.33 0.27 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.862 1.696 . . . . 0.80000000000000004 112.709 172.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.281 0.0 OUTLIER -85.19 156.1 21.15 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.403 1.631 . . . . 1.4399999999999999 115.403 -169.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -60.09 149.17 33.35 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.447 0.906 . . . . 2.5099999999999998 113.447 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.5 t -62.68 124.42 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 121.87 -0.519 . . . . 0.68000000000000005 110.103 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.2 -47.02 25.04 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.709 -0.495 . . . . 0.80000000000000004 114.033 -171.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.0 t -145.59 116.21 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.66 1.584 . . . . 1.8400000000000001 108.551 176.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.2 mt -74.35 146.68 84.42 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 123.921 0.889 . . . . 0.73999999999999999 111.214 171.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.79 161.97 43.88 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.737 1.624 . . . . 0.58999999999999997 112.028 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.17 -33.72 65.53 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.198 0.599 . . . . 0.91000000000000003 112.257 174.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -83.39 1.54 40.89 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.393 1.877 . . . . 1.4099999999999999 115.629 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -95.97 152.04 18.88 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.963 1.256 . . . . 0.72999999999999998 112.677 169.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -148.95 167.62 25.27 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.71 1.604 . . . . 2.1400000000000001 111.462 169.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.26 141.68 51.38 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.828 0.851 . . . . 2.6099999999999999 110.774 -175.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.5 pt -126.82 141.55 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.403 1.081 . . . . 0.67000000000000004 112.144 -176.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.06 163.9 12.9 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.678 1.191 . . . . 0.57999999999999996 112.304 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.28 14.37 58.9 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.274 1.416 . . . . 0.64000000000000001 115.314 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.3 p -97.97 144.55 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.489 1.916 . . . . 0.72999999999999998 110.256 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 7.7 tpp -104.79 140.44 38.09 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.728 1.611 . . . . 0.55000000000000004 111.891 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.576 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.4 OUTLIER -143.92 157.03 44.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.492 1.517 . . . . 1.72 111.64 174.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.08 144.52 35.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 126.565 1.946 . . . . 0.40000000000000002 109.751 -176.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -85.81 146.99 26.52 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.916 1.341 . . . . 0.44 111.392 169.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.0 p -141.83 170.73 15.16 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.271 1.828 . . . . 0.41999999999999998 111.487 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.79 170.92 9.5 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.556 1.142 . . . . 1.5 112.414 168.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.5 p -33.32 -46.06 0.17 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.55 1.94 . . . . 1.79 114.351 172.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -90.98 29.49 1.36 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.574 1.15 . . . . 1.99 112.976 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.28 25.01 8.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 127.873 2.469 . . . . 1.1499999999999999 113.414 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -86.56 136.11 33.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.957 1.303 . . . . 1.78 111.515 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.9 mt -74.27 125.85 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 118.402 0.547 . . . . 0.47999999999999998 110.253 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.474 HG22 HG22 ' A' ' 97' ' ' THR . 2.1 pp -120.37 152.15 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.289 1.436 . . . . 1.0600000000000001 114.273 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -84.07 162.28 20.39 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.621 1.969 . . . . 1.3999999999999999 111.439 168.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -70.95 10.54 0.52 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 115.948 1.833 . . . . 2.3999999999999999 115.948 -169.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -115.22 -2.75 12.62 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 127.956 2.503 . . . . 2.7200000000000002 113.174 168.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.47 10.71 67.5 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.795 2.141 . . . . 0.57999999999999996 115.744 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -68.73 144.23 54.45 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.843 1.321 . . . . 2.2000000000000002 108.799 167.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.474 HG22 HG22 ' A' ' 91' ' ' ILE . 34.0 p -101.25 146.27 27.75 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.938 0.895 . . . . 0.63 112.076 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.88 -9.83 27.74 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.19 1.182 . . . . 0.65000000000000002 114.19 -171.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.63 25.33 42.76 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 119.738 1.154 . . . . 0.66000000000000003 113.903 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.1 t -133.66 150.41 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.939 1.695 . . . . 1.05 109.417 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -135.59 160.78 37.42 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 129.114 2.966 . . . . 1.47 110.688 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 57.2 mt -137.85 137.29 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.761 1.225 . . . . 0.75 110.417 -173.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -70.74 140.92 86.88 Favored Pre-proline 0 N--CA 1.476 0.837 0 CA-C-O 116.882 -1.532 . . . . 2.1499999999999999 111.05 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -72.32 -27.39 16.35 Favored 'Trans proline' 0 C--N 1.351 0.705 0 CA-C-N 122.935 2.084 . . . . 0.92000000000000004 112.567 174.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -88.19 -46.38 9.31 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 125.663 1.585 . . . . 1.71 112.795 -175.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.3 p -89.24 -24.66 22.05 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.357 0.873 . . . . 1.3899999999999999 113.357 -176.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 56.42 22.77 6.74 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.108 1.363 . . . . 1.9099999999999999 113.407 -168.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.98 148.75 21.86 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.956 1.303 . . . . 2.6000000000000001 112.488 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.1 mt -82.29 145.22 30.1 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.077 1.751 . . . . 0.95999999999999996 113.42 -174.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.1 p -76.38 5.56 6.96 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.348 1.24 . . . . 1.3799999999999999 114.348 170.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 177.12 -157.64 22.69 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.535 1.064 . . . . 0.88 113.652 -171.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -86.25 149.89 24.75 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.996 1.11 . . . . 0.93999999999999995 113.996 -174.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.5 tpt -51.43 126.05 28.26 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.962 1.705 . . . . 1.46 112.607 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.42 161.42 37.56 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.852 2.368 . . . . 0.79000000000000004 113.321 -170.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.62 -87.8 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 122.265 1.031 . . . . 1.0700000000000001 111.682 172.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 78.3 p -78.04 -1.05 30.36 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 116.067 1.876 . . . . 0.79000000000000004 116.067 -167.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.59 152.68 3.51 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.828 1.418 . . . . 0.48999999999999999 114.828 -171.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.7 ttt -78.6 95.1 5.14 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.993 1.317 . . . . 1.74 111.426 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.67 155.17 44.88 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.687 1.595 . . . . 2.3900000000000001 111.458 -177.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -169.2 164.26 11.02 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.785 1.634 . . . . 2.8700000000000001 111.301 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.9 mp -106.8 150.1 26.69 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.374 1.07 . . . . 0.58999999999999997 113.577 172.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.576 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 19.6 p -77.48 135.28 38.24 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 118.839 0.745 . . . . 0.60999999999999999 110.845 170.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -96.26 -58.65 2.02 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 115.345 1.609 . . . . 2.5699999999999998 115.345 -169.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -153.61 -35.23 0.11 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.101 1.36 . . . . 1.1100000000000001 112.142 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -100.67 -38.72 8.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.242 1.017 . . . . 3.71 112.075 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.86 -160.81 30.97 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.425 1.012 . . . . 0.68999999999999995 112.446 -174.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -134.82 123.68 23.93 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.381 1.872 . . . . 0.44 112.229 170.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -81.61 133.61 35.39 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.037 0.935 . . . . 2.46 112.29 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -120.58 141.27 50.46 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 128.955 2.902 . . . . 1.9199999999999999 109.493 174.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.436 HD21 ' HB3' ' A' ' 132' ' ' ALA . 2.8 t-20 -94.29 112.74 24.56 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.337 1.055 . . . . 2.9100000000000001 111.429 -174.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.2 p -94.25 1.27 56.0 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.21 1.189 . . . . 0.72999999999999998 114.21 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.436 ' HB3' HD21 ' A' ' 130' ' ' ASN . . . -59.91 -23.37 63.44 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.012 1.116 . . . . 0.71999999999999997 114.012 -176.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.14 -6.24 13.67 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.573 1.323 . . . . 2.1200000000000001 114.573 -170.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.22 132.16 70.78 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 119.278 0.945 . . . . 0.78000000000000003 113.324 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.08 168.45 23.98 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.468 2.112 . . . . 0.82999999999999996 111.106 169.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.0 83.13 0.68 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.468 1.907 . . . . 1.53 110.921 -177.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -135.38 173.57 11.57 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.505 1.522 . . . . 1.21 110.355 173.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -93.67 140.23 29.88 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.728 1.252 . . . . 3.4399999999999999 111.17 168.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -126.24 165.97 17.96 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.514 1.925 . . . . 0.71999999999999997 109.45 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -141.3 153.45 45.19 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.644 0.777 . . . . 1.6299999999999999 111.793 175.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.08 139.33 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.623 0.769 . . . . 0.44 110.449 173.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -127.62 140.31 52.18 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.486 1.914 . . . . 1.8200000000000001 110.488 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -102.43 130.76 49.31 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.065 1.346 . . . . 1.8100000000000001 111.108 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 37.6 mm -130.57 113.74 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.748 0.819 . . . . 0.92000000000000004 109.846 -169.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -77.08 -8.44 57.47 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.198 1.185 . . . . 3.5099999999999998 114.198 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.0 t -62.58 -28.74 70.09 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.149 1.537 . . . . 3.1299999999999999 115.149 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.48 6.79 16.02 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.927 1.691 . . . . 2.6800000000000002 114.255 -171.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 43.7 p -74.06 167.65 21.1 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.733 1.753 . . . . 4.6500000000000004 115.733 -169.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 79.9 p -114.47 -28.29 7.24 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.304 1.442 . . . . 5.2400000000000002 111.816 168.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -77.46 156.43 31.09 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.696 0.798 . . . . 6.1699999999999999 112.372 170.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.7 t -135.42 125.55 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.891 0.876 . . . . 4.3399999999999999 110.198 169.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -119.32 -12.88 6.6 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.329 1.442 . . . . 3.7400000000000002 115.196 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -87.85 -17.09 32.26 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.331 1.452 . . . . 5.46 114.794 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -97.24 27.98 3.88 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 116.529 2.048 . . . . 7.1500000000000004 116.529 -166.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 91.54 10.88 61.41 Favored Glycine 0 N--CA 1.477 1.399 0 O-C-N 120.671 -1.268 . . . . 4.9500000000000002 114.484 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.23 175.79 0.39 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.153 2.181 . . . . 3.5800000000000001 112.767 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.5 m -78.38 40.52 0.36 Allowed 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.211 -1.555 . . . . 2.98 111.328 169.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 80.2 mt -137.4 143.15 41.77 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 128.417 2.687 . . . . 1.8799999999999999 107.694 -171.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 77.3 p -73.55 -2.83 24.41 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 117.696 2.48 . . . . 3.6600000000000001 117.696 -166.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 65.12 9.32 40.78 Favored Glycine 0 CA--C 1.542 1.753 0 O-C-N 120.742 -1.224 . . . . 2.2000000000000002 115.221 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 75.3 m -74.05 163.49 27.82 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 127.404 2.282 . . . . 2.6699999999999999 112.916 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.67 147.65 32.73 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.548 1.539 . . . . 1.8400000000000001 113.131 -175.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.47 154.99 34.21 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.99 0.737 . . . . 0.82999999999999996 112.99 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.33 145.48 36.12 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.328 1.051 . . . . 0.56000000000000005 112.012 170.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.47 146.56 44.71 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.311 2.674 . . . . 0.5 113.366 -168.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.419 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.2 mp -117.1 128.93 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.359 1.863 . . . . 1.3500000000000001 108.81 -168.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -94.94 145.23 25.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.332 1.053 . . . . 2.9399999999999999 112.356 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.4 tt -150.84 157.28 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 125.625 1.57 . . . . 0.71999999999999997 110.533 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -136.56 -178.65 5.27 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.584 1.554 . . . . 2.5499999999999998 109.708 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.48 156.43 90.55 Favored Pre-proline 0 CA--C 1.552 1.051 0 O-C-N 120.811 -1.181 . . . . 2.1000000000000001 112.315 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -83.27 75.99 4.12 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.061 3.174 . . . . 1.6000000000000001 114.213 -167.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 4.5 tt -94.29 80.84 3.98 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 105.915 -1.883 . . . . 3.25 105.915 166.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -147.2 160.35 42.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.093 1.357 . . . . 3.8300000000000001 112.304 -168.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -74.37 -18.23 60.7 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.921 1.288 . . . . 3.21 113.553 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.2 m -65.83 150.72 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.887 1.675 . . . . 1.55 113.734 -173.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.13 -40.61 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.553 1.141 . . . . 2.0499999999999998 109.934 173.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -132.33 141.54 48.99 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.469 1.508 . . . . 2.8999999999999999 109.509 172.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -92.45 156.03 17.46 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.313 0.645 . . . . 0.56000000000000005 111.777 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -137.13 165.04 27.02 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.835 1.421 . . . . 0.54000000000000004 114.835 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.55 142.16 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 126.216 1.806 . . . . 0.51000000000000001 110.952 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -134.42 71.7 71.41 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 113.382 0.882 . . . . 1.9299999999999999 113.382 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.419 ' HB3' HD11 ' A' ' 166' ' ' ILE . 20.5 Cg_endo -62.75 144.35 93.66 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 124.006 3.137 . . . . 0.51000000000000001 113.824 -176.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -120.25 158.01 27.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.088 2.155 . . . . 1.55 112.184 -171.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -110.56 159.13 17.82 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.355 1.074 . . . . 3.1200000000000001 113.481 175.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 6.0 t -146.22 -169.57 3.29 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.66 2.384 . . . . 3.0 109.091 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -123.62 150.17 44.48 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.904 1.281 . . . . 5.8499999999999996 111.91 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -154.23 135.36 13.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.208 1.003 . . . . 6.2800000000000002 111.972 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -133.81 156.48 79.35 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 126.143 1.777 . . . . 10.01 111.035 170.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.58 162.71 39.24 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.019 2.479 . . . . 11.16 112.845 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -134.11 -8.59 2.65 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 115.818 1.784 . . . . 17.109999999999999 115.818 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.98 9.05 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 115.198 1.555 . . . . 18.899999999999999 115.198 172.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.1 tt -80.9 118.69 22.62 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.169 1.388 . . . . 16.07 109.883 176.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 . . . . . 0 C--O 1.24 0.584 0 C-N-CA 124.81 1.244 . . . . 22.289999999999999 112.417 -173.492 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 119.549 -0.262 . . . . 26.079999999999998 110.877 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.11 133.34 48.78 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.166 -0.679 . . . . 21.420000000000002 109.166 168.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.7 t -158.61 140.99 14.18 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.227 0.825 . . . . 20.670000000000002 113.227 177.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.52 0.82 1.02 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.13 2.172 . . . . 16.670000000000002 113.509 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.9 t -149.19 172.69 14.43 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.054 1.742 . . . . 17.170000000000002 114.269 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.98 -35.71 23.73 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.746 1.387 . . . . 18.66 114.746 -171.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -159.69 -29.61 0.06 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 116.194 1.924 . . . . 16.899999999999999 116.194 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.4 p -130.08 175.46 8.88 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.627 1.171 . . . . 13.83 113.006 -165.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.8 m -66.39 161.23 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.01 1.324 . . . . 8.8200000000000003 112.412 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -64.78 139.01 58.72 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.505 -0.554 . . . . 4.5999999999999996 109.505 167.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 61.81 160.07 0.06 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 127.179 2.191 . . . . 5.0999999999999996 116.109 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.84 110.31 4.45 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.862 -1.148 . . . . 6.6200000000000001 112.577 172.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.84 12.53 48.49 Favored Glycine 0 N--CA 1.475 1.27 0 N-CA-C 118.066 1.986 . . . . 3.48 118.066 175.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.9 p -70.65 155.02 41.28 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.673 1.989 . . . . 1.55 114.194 -172.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.2 p -88.73 -65.5 1.01 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.506 0.722 . . . . 1.8600000000000001 112.487 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 m -91.92 144.71 25.19 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.917 1.287 . . . . 2.3199999999999998 113.019 -169.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.5 p -101.43 -2.13 31.56 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.975 1.71 . . . . 0.81000000000000005 114.665 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.1 m -151.29 150.71 30.86 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.267 -1.52 . . . . 1.98 110.952 170.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.24 149.09 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.864 2.066 . . . . 0.41999999999999998 109.936 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.5 m -117.16 124.94 50.37 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.18 0.592 . . . . 0.68999999999999995 111.305 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.42 131.73 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.387 1.075 . . . . 0.48999999999999999 110.637 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -126.76 96.63 4.71 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.017 1.327 . . . . 1.76 110.814 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -71.48 121.53 18.81 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.723 -1.236 . . . . 1.1399999999999999 110.805 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.5 mt -109.02 159.9 16.46 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.594 1.158 . . . . 0.67000000000000004 112.187 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.4 mt -142.45 161.07 39.0 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.624 1.97 . . . . 1.8700000000000001 109.973 168.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.2 163.98 15.88 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.839 0.856 . . . . 0.92000000000000004 111.783 168.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.1 p -85.59 -32.83 21.88 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.279 -0.888 . . . . 1.22 113.275 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -146.87 55.83 1.13 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.523 1.129 . . . . 2.6499999999999999 111.05 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.62 11.36 82.98 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.728 1.632 . . . . 1.04 115.446 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -69.94 18.09 0.05 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.339 2.255 . . . . 1.8100000000000001 115.534 -172.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -61.38 -31.09 70.99 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.875 -1.14 . . . . 0.82999999999999996 112.291 -176.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -61.47 -49.89 74.96 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.593 1.157 . . . . 2.25 112.636 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -72.44 -43.14 64.21 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.058 -1.026 . . . . 2.48 111.511 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.5 mt -48.98 -48.78 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 119.491 1.041 . . . . 0.65000000000000002 110.976 169.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.19 -30.46 70.43 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.072 1.305 . . . . 0.91000000000000003 113.052 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -77.3 -31.41 54.71 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.717 0.807 . . . . 1.0800000000000001 112.631 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -69.53 -20.35 63.7 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.276 1.03 . . . . 1.9199999999999999 113.558 169.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.6 mt -96.96 -36.06 10.66 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.08 1.141 . . . . 1.0900000000000001 114.08 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -21.91 66.85 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.414 1.006 . . . . 4.3099999999999996 112.919 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.5 t -69.29 -29.75 67.69 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.277 1.031 . . . . 1.8300000000000001 113.509 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.21 165.92 26.75 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.809 1.195 . . . . 1.29 113.568 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -83.89 43.04 0.89 Allowed 'General case' 0 N--CA 1.481 1.09 0 O-C-N 121.458 -1.025 . . . . 1.98 112.748 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -80.8 1.04 32.18 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.894 1.278 . . . . 2.23 114.282 -169.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.2 -25.87 65.93 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.715 -1.241 . . . . 1.0700000000000001 112.406 169.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.74 -51.66 0.41 Allowed Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.541 1.067 . . . . 0.70999999999999996 112.503 169.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -75.82 162.93 27.74 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.056 1.132 . . . . 2.98 114.056 -171.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -63.7 156.82 25.85 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.116 0.566 . . . . 3.0 111.6 167.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.411 HG23 ' CE2' ' A' ' 181' ' ' TYR . 73.6 t -66.01 143.3 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 122.996 0.518 . . . . 0.87 110.063 170.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.32 -64.78 2.83 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 123.807 0.718 . . . . 1.1399999999999999 113.508 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.2 t -142.88 134.16 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.88 1.672 . . . . 2.8300000000000001 110.157 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.5 mt -83.35 146.82 51.65 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.538 0.735 . . . . 1.29 111.962 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.01 159.17 54.17 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.639 1.559 . . . . 1.23 111.476 172.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.51 -24.87 66.46 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.565 -1.334 . . . . 2.0299999999999998 111.147 169.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.71 4.56 6.08 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.968 1.47 . . . . 1.45 114.968 169.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.2 155.16 29.88 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.595 1.958 . . . . 0.78000000000000003 111.98 169.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.24 163.34 34.75 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.738 0.815 . . . . 1.8 113.181 167.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -107.05 137.96 44.14 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.39 1.876 . . . . 2.75 110.353 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.51 145.96 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.546 1.138 . . . . 0.85999999999999999 111.78 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.93 153.37 33.71 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.645 1.178 . . . . 0.90000000000000002 112.642 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.36 19.71 40.85 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.41 1.005 . . . . 0.60999999999999999 114.161 -170.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 p -97.79 143.64 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.042 1.337 . . . . 0.72999999999999998 108.889 168.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -105.4 142.93 34.29 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.194 1.397 . . . . 0.52000000000000002 112.667 -174.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.545 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.5 OUTLIER -148.82 152.32 36.3 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.304 1.442 . . . . 1.6899999999999999 111.716 175.654 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.23 146.57 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 127.002 2.121 . . . . 0.29999999999999999 109.313 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -88.99 143.07 27.11 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.176 0.988 . . . . 0.40999999999999998 112.502 170.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.5 p -133.96 164.15 27.95 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.451 1.901 . . . . 0.40000000000000002 112.845 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -88.18 169.62 11.74 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.922 1.289 . . . . 1.72 110.723 166.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.57 -21.51 66.6 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.301 1.223 . . . . 2.8100000000000001 114.301 -170.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -77.55 19.36 0.37 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.886 0.874 . . . . 1.74 112.817 168.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 56.25 29.14 14.36 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.257 1.823 . . . . 0.76000000000000001 113.117 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -90.0 140.54 29.53 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.099 1.359 . . . . 2.3700000000000001 111.39 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.1 mt -80.77 126.5 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 118.087 0.403 . . . . 0.54000000000000004 110.378 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.45 HG22 HG22 ' A' ' 97' ' ' THR . 2.2 pp -122.21 151.51 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.605 1.562 . . . . 1.2 114.134 -175.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.28 164.64 19.95 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 127.21 2.204 . . . . 2.3399999999999999 112.103 169.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.5 -17.93 48.57 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.823 1.786 . . . . 3.3500000000000001 115.823 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -92.72 4.71 53.24 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.913 1.285 . . . . 3.8300000000000001 111.557 172.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.51 10.38 85.75 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 127.294 2.378 . . . . 0.66000000000000003 115.492 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -63.88 135.89 56.93 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.236 1.018 . . . . 2.6600000000000001 108.553 169.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.45 HG22 HG22 ' A' ' 91' ' ' ILE . 51.9 p -90.79 139.88 30.31 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.111 0.482 . . . . 0.83999999999999997 111.726 178.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.18 -6.09 51.33 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.818 -1.176 . . . . 0.89000000000000001 113.913 -169.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.88 27.44 34.48 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 119.898 1.226 . . . . 1.0 113.695 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.3 t -136.9 148.93 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.267 1.427 . . . . 1.23 109.583 177.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -137.44 154.78 49.87 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 128.568 2.747 . . . . 1.28 110.745 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.434 HG12 HD23 ' A' ' 109' ' ' LEU . 33.0 mt -133.31 136.64 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.248 1.419 . . . . 0.63 110.179 -173.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -77.82 141.62 64.26 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-O 117.543 -1.217 . . . . 2.1899999999999999 111.933 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.0 -16.28 18.14 Favored 'Trans proline' 0 C--N 1.352 0.733 0 CA-C-N 122.139 1.8 . . . . 0.84999999999999998 113.416 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -101.92 -48.09 4.37 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.99 1.716 . . . . 1.3500000000000001 111.28 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 p -83.92 -28.65 27.73 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.953 0.723 . . . . 1.3999999999999999 112.953 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 56.34 23.28 7.12 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.883 1.673 . . . . 1.8500000000000001 113.484 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.85 153.67 21.14 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.528 -1.358 . . . . 2.4399999999999999 111.817 174.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.434 HD23 HG12 ' A' ' 102' ' ' ILE . 29.6 mt -92.04 139.03 31.04 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.679 1.192 . . . . 0.87 112.375 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.5 p -74.24 6.69 3.34 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.716 1.206 . . . . 1.4299999999999999 113.956 175.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.21 -158.72 20.44 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 126.446 1.974 . . . . 0.93999999999999995 111.068 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.99 155.14 32.83 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 122.065 -0.667 . . . . 1.04 112.429 175.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.8 tpt -59.48 125.28 78.99 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.877 0.871 . . . . 1.79 109.926 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -70.4 167.45 25.22 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 124.39 3.393 . . . . 0.93000000000000005 113.9 -172.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.69 -97.59 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.176 1.391 . . . . 1.6399999999999999 111.032 170.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 50.7 p -71.3 11.43 0.44 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.522 2.045 . . . . 1.01 116.522 -167.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.67 150.35 3.96 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.25 -0.906 . . . . 0.48999999999999999 112.943 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.2 tpt -78.27 88.45 4.32 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.081 2.152 . . . . 1.6599999999999999 110.713 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -147.66 135.05 20.69 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.039 1.736 . . . . 0.94999999999999996 111.32 -171.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -169.24 145.98 3.46 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.23 1.412 . . . . 3.5600000000000001 110.2 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.09 156.12 21.21 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.572 1.323 . . . . 0.5 114.572 -175.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.545 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 3.9 p -66.3 137.87 57.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 119.866 -1.771 . . . . 0.48999999999999999 110.319 169.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -98.82 -56.57 2.4 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.462 1.105 . . . . 2.6499999999999999 113.344 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -167.84 -39.95 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.598 1.959 . . . . 1.24 110.742 168.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -96.6 25.5 5.1 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.847 1.659 . . . . 5.0999999999999996 112.574 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.6 -150.94 19.74 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.033 1.778 . . . . 0.67000000000000004 111.348 -169.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.53 128.37 21.84 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.279 1.832 . . . . 0.39000000000000001 110.347 168.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -75.62 136.13 40.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.941 1.297 . . . . 1.55 110.927 172.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -128.11 117.46 21.65 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.282 1.833 . . . . 1.74 108.876 169.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -77.27 122.03 24.52 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.177 -0.952 . . . . 1.47 110.82 175.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.7 p -112.03 -4.64 14.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.934 1.294 . . . . 0.92000000000000004 114.069 -171.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.9 -15.69 5.34 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 115.918 1.822 . . . . 0.68000000000000005 115.918 -172.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -106.39 0.9 25.25 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.086 1.355 . . . . 2.7400000000000002 114.076 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.84 146.01 87.39 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 120.521 1.509 . . . . 0.83999999999999997 113.122 170.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.99 164.83 32.6 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.934 1.756 . . . . 1.1599999999999999 110.364 165.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.39 88.52 1.58 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.454 1.501 . . . . 1.47 110.3 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -139.95 -179.22 5.83 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.042 1.337 . . . . 1.1200000000000001 111.185 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -92.69 140.84 29.12 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.574 1.15 . . . . 2.25 111.813 168.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -132.55 169.93 15.9 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.988 1.715 . . . . 0.75 110.298 -169.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -152.53 147.59 26.38 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.43 1.092 . . . . 3.6299999999999999 112.264 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -105.25 136.38 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 123.797 0.839 . . . . 0.40999999999999998 109.024 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -123.44 122.41 38.19 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.376 1.47 . . . . 1.8500000000000001 110.019 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -83.36 75.75 9.96 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.993 1.317 . . . . 2.1299999999999999 111.109 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.0 mm -80.82 113.85 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.41 -0.959 . . . . 1.03 108.41 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -116.35 28.34 8.65 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.703 0.801 . . . . 5.0199999999999996 113.131 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.2 p -67.96 -26.61 66.02 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.226 1.01 . . . . 1.8400000000000001 111.572 168.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -76.77 47.5 0.51 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.324 1.85 . . . . 2.1699999999999999 108.776 165.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.3 m -54.15 118.06 3.75 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.178 1.791 . . . . 6.3099999999999996 111.687 -167.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.8 m -132.89 -52.29 0.91 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 117.501 -1.237 . . . . 4.29 114.172 -168.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -73.13 153.62 40.68 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 120.607 1.549 . . . . 5.6399999999999997 112.805 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 89.6 t -89.57 129.84 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.522 1.129 . . . . 4.6600000000000001 112.095 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -143.48 -15.04 0.28 Allowed Glycine 0 CA--C 1.536 1.35 0 N-CA-C 117.434 1.734 . . . . 2.2400000000000002 117.434 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -103.48 -20.25 14.11 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 120.799 2.299 . . . . 4.9000000000000004 114.718 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -83.22 39.98 0.68 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.242 1.417 . . . . 5.4699999999999998 113.503 -171.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 89.26 -8.97 78.66 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.502 1.525 . . . . 3.9399999999999999 115.257 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.53 158.64 9.47 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.903 1.681 . . . . 2.9300000000000002 114.006 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.1 m -74.38 52.5 0.49 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 127.625 2.37 . . . . 2.77 112.46 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -125.08 159.7 30.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.79 2.036 . . . . 2.2799999999999998 111.366 -171.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.5 t -110.49 143.93 40.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.257 1.423 . . . . 3.1600000000000001 113.108 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -82.21 64.68 4.21 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.705 1.145 . . . . 3.21 110.393 168.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.9 t -112.23 145.92 39.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.067 0.947 . . . . 2.9700000000000002 113.095 -172.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.428 ' HE3' HG13 ' A' ' 164' ' ' VAL . 21.9 ttpt -81.48 124.35 29.38 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.047 1.739 . . . . 2.5600000000000001 111.54 177.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.87 154.16 34.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.478 0.711 . . . . 0.98999999999999999 111.275 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.428 HG13 ' HE3' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -123.04 143.21 40.14 Favored Pre-proline 0 N--CA 1.477 0.898 0 O-C-N 121.521 -0.737 . . . . 0.84999999999999998 111.202 174.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.21 145.41 72.4 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.825 3.016 . . . . 0.56000000000000005 111.653 -168.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.461 HD11 ' HB3' ' A' ' 182' ' ' PRO . 1.3 mp -103.94 124.01 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.129 0.971 . . . . 1.3200000000000001 109.492 -171.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.87 138.05 32.44 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.84 0.746 . . . . 3.0699999999999998 112.894 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.3 tt -147.92 156.15 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.18 0.992 . . . . 0.42999999999999999 111.682 -172.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -134.46 166.55 22.6 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.099 1.76 . . . . 2.6099999999999999 109.481 169.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -61.5 155.55 58.29 Favored Pre-proline 0 CA--C 1.551 1.017 0 O-C-N 120.973 -1.079 . . . . 1.6100000000000001 111.932 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.42 94.9 0.92 Allowed 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.919 3.079 . . . . 0.87 112.111 -169.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.44 45.58 2.63 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.379 1.871 . . . . 2.3500000000000001 108.803 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -128.81 18.4 6.18 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 127.214 2.206 . . . . 3.1200000000000001 113.024 -167.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.3 t70 60.96 17.75 8.2 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 128.171 2.588 . . . . 4.0800000000000001 115.639 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.3 m -86.58 153.03 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 114.282 1.215 . . . . 1.1000000000000001 114.282 -172.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.13 -32.26 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.083 1.753 . . . . 1.74 112.095 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -153.78 141.03 19.55 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.737 1.215 . . . . 2.4300000000000002 110.19 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -101.86 140.77 35.7 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.208 0.818 . . . . 0.48999999999999999 113.208 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -136.8 166.04 24.54 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.032 1.493 . . . . 0.53000000000000003 115.032 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.76 143.55 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 127.2 2.2 . . . . 0.46999999999999997 111.485 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.411 ' CE2' HG23 ' A' ' 66' ' ' VAL . 97.7 m-85 -133.06 82.74 53.66 Favored Pre-proline 0 CA--C 1.553 1.066 0 N-CA-C 113.584 0.957 . . . . 1.9299999999999999 113.584 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.461 ' HB3' HD11 ' A' ' 166' ' ' ILE . 6.6 Cg_exo -58.0 143.99 95.28 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.699 2.932 . . . . 0.60999999999999999 115.51 175.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -133.6 165.93 23.78 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 128.55 2.74 . . . . 1.5 112.623 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -119.62 173.3 7.09 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.002 2.121 . . . . 2.8799999999999999 111.154 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 6.5 t -150.46 -23.96 0.24 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 117.352 2.352 . . . . 2.9300000000000002 117.352 -169.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -150.82 169.92 20.51 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 120.712 -1.243 . . . . 6.6900000000000004 114.348 -175.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -90.07 142.99 27.17 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.555 1.142 . . . . 5.1200000000000001 113.451 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -142.39 160.26 55.08 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 125.193 1.397 . . . . 12.960000000000001 112.119 176.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.5 144.4 55.26 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.227 1.951 . . . . 10.07 111.765 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -102.47 -4.85 24.77 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 115.576 1.695 . . . . 14.970000000000001 115.576 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.74 -8.09 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 125.934 1.694 . . . . 14.970000000000001 114.642 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.35 118.6 36.28 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.539 1.136 . . . . 13.5 109.511 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 . . . . . 0 CA--C 1.539 0.523 0 C-N-CA 124.694 1.198 . . . . 19.510000000000002 112.265 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 109.961 -0.385 . . . . 27.18 109.961 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.94 151.64 51.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.748 1.619 . . . . 22.82 111.584 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 59.3 p -109.83 3.56 20.83 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.805 1.242 . . . . 19.940000000000001 113.844 175.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.28 151.69 12.31 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.672 1.189 . . . . 16.18 113.331 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.6 p -158.44 0.04 0.1 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 116.656 2.095 . . . . 15.609999999999999 116.656 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -111.68 -6.18 14.38 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.832 1.79 . . . . 12.49 115.832 -172.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 59.8 -52.9 0.07 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 129.284 3.034 . . . . 10.84 118.9 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 35.5 p -121.13 173.3 7.38 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.876 1.27 . . . . 8.8900000000000006 113.91 -166.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.7 m -67.0 151.73 10.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 124.424 1.09 . . . . 6.1200000000000001 111.804 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -86.71 131.16 34.22 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.82 0.848 . . . . 3.1200000000000001 112.581 -172.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.77 137.77 6.72 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.932 1.293 . . . . 4.4900000000000002 111.208 -171.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.75 14.5 0.55 Allowed 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.257 1.577 . . . . 6.0199999999999996 115.257 175.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.92 39.38 88.66 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 126.046 1.784 . . . . 2.6000000000000001 114.268 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.0 p -92.86 179.21 5.53 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.543 1.937 . . . . 1.5700000000000001 115.774 -168.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.2 p -121.7 0.11 9.78 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.324 1.45 . . . . 1.45 114.029 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 m -156.41 158.32 37.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.976 1.711 . . . . 2.6000000000000001 110.42 -170.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 43.1 p -117.27 -11.66 10.6 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 126.425 1.89 . . . . 1.1899999999999999 115.552 -174.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 p -143.68 153.31 42.35 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.903 1.681 . . . . 2.2200000000000002 113.064 -175.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.3 p -130.93 135.2 60.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 126.426 1.891 . . . . 0.52000000000000002 109.119 174.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.8 m -114.62 126.04 54.44 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 118.254 0.479 . . . . 0.84999999999999998 110.509 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.2 p -96.89 132.38 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.225 1.01 . . . . 0.80000000000000004 110.318 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -129.59 98.31 4.8 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.584 1.554 . . . . 2.0699999999999998 109.732 -174.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.09 126.18 30.49 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.619 -1.3 . . . . 0.94999999999999996 111.842 -169.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.6 mt -103.59 151.67 22.64 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.37 1.068 . . . . 0.60999999999999999 113.322 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.53 161.63 35.33 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.567 1.547 . . . . 2.0600000000000001 109.451 169.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.553 ' HB1' ' H ' ' A' ' 48' ' ' ASP . . . -97.18 154.03 17.63 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.732 0.813 . . . . 0.66000000000000003 112.027 172.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.4 p -87.64 -20.19 26.68 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.29 1.219 . . . . 1.1000000000000001 114.29 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -151.5 51.99 0.83 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.882 1.673 . . . . 2.1699999999999999 112.455 170.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.99 23.79 70.92 Favored Glycine 0 CA--C 1.536 1.388 0 O-C-N 120.439 -1.413 . . . . 1.1100000000000001 115.989 172.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.553 ' H ' ' HB1' ' A' ' 44' ' ' ALA . 4.2 m-20 -81.1 10.95 4.54 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 128.213 2.605 . . . . 1.8600000000000001 115.622 -174.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -57.81 -31.25 66.41 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.37 -1.456 . . . . 0.82999999999999996 112.629 -171.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.42 -49.75 52.17 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.788 1.235 . . . . 2.3100000000000001 113.465 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -69.7 -33.06 72.01 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 120.968 -1.082 . . . . 3.1800000000000002 111.495 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.42 -52.67 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.502 1.121 . . . . 0.78000000000000003 110.095 168.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.86 -34.99 70.34 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.127 0.876 . . . . 0.84999999999999998 112.484 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -67.62 -32.47 73.21 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.405 0.891 . . . . 0.95999999999999996 113.405 173.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.99 -28.24 65.36 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.063 1.301 . . . . 1.98 113.017 171.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.4 mt -87.2 -40.95 14.11 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.673 0.99 . . . . 1.01 113.673 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -67.41 -21.21 65.59 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.437 0.903 . . . . 2.8500000000000001 113.437 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.4 t -75.79 -25.69 56.62 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 121.393 -0.817 . . . . 1.54 112.88 169.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.46 161.19 32.3 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 126.141 1.829 . . . . 1.0600000000000001 113.918 174.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -84.27 33.47 0.5 Allowed 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.945 -1.326 . . . . 2.3100000000000001 113.78 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -72.1 8.44 1.28 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.595 1.702 . . . . 2.2999999999999998 115.595 -169.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.1 -30.17 71.09 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.219 -0.925 . . . . 1.04 109.881 165.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.25 -83.74 1.75 Allowed Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.067 1.318 . . . . 0.79000000000000004 112.476 171.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -65.99 151.8 46.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.608 1.336 . . . . 1.5700000000000001 114.608 -173.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -59.16 143.37 49.06 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.075 1.35 . . . . 4.0300000000000002 111.3 172.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.8 t -53.89 136.24 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.343 0.657 . . . . 1.03 111.181 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.7 -64.42 3.32 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.682 0.658 . . . . 0.91000000000000003 112.515 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.4 t -137.52 125.86 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.581 1.152 . . . . 1.9299999999999999 110.623 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.8 mt -80.73 143.78 54.95 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.316 0.647 . . . . 0.85999999999999999 110.896 172.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.91 162.18 42.7 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.141 1.894 . . . . 0.68999999999999995 112.158 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.63 -21.63 66.47 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.646 0.98 . . . . 0.93000000000000005 113.646 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -92.55 -1.48 56.9 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 115.082 1.512 . . . . 1.53 115.082 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.41 152.41 21.5 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.853 0.861 . . . . 0.80000000000000004 113.147 169.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.7 pttt -146.43 167.73 22.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.577 1.551 . . . . 1.95 111.77 168.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -118.4 143.44 46.66 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.864 1.666 . . . . 2.3999999999999999 109.931 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.1 pt -126.93 142.91 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 114.468 1.285 . . . . 0.71999999999999997 114.468 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.66 153.22 20.34 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.823 1.649 . . . . 0.67000000000000004 112.316 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.63 7.07 61.93 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.964 1.745 . . . . 0.65000000000000002 115.28 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.0 p -90.42 143.75 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 118.547 1.173 . . . . 0.80000000000000004 110.112 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 1.3 tpp -111.67 132.85 54.31 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.105 1.762 . . . . 0.62 112.016 -172.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.55 153.06 48.69 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.39 1.476 . . . . 1.73 111.53 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.81 143.19 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 126.346 1.859 . . . . 0.41999999999999998 109.514 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -84.78 145.99 27.6 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 122.817 1.294 . . . . 0.34999999999999998 111.244 169.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.3 p -140.27 170.69 15.35 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.29 1.836 . . . . 0.33000000000000002 111.527 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.75 173.23 9.59 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.525 0.73 . . . . 2.0099999999999998 112.926 169.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.7 p -64.1 -16.91 62.82 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 120.744 -1.223 . . . . 1.4199999999999999 113.513 170.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 -80.96 8.1 9.18 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.418 1.487 . . . . 2.73 113.014 168.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.52 25.54 9.89 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.129 2.172 . . . . 0.71999999999999997 113.28 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -89.29 141.46 28.52 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.633 1.573 . . . . 2.52 110.612 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.423 HD11 ' CD2' ' A' ' 109' ' ' LEU . 10.8 mt -76.66 126.98 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.416 -0.587 . . . . 0.5 109.416 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.459 HG22 HG22 ' A' ' 97' ' ' THR . 3.2 pt -122.07 154.38 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 114.637 1.347 . . . . 0.5 114.637 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.29 163.32 24.04 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.168 2.187 . . . . 1.74 111.336 167.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.74 -1.18 3.53 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 115.499 1.666 . . . . 2.3300000000000001 115.499 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -105.14 -1.57 25.34 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.907 1.683 . . . . 3.96 113.218 169.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.16 -0.68 64.21 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.436 1.969 . . . . 0.66000000000000003 115.853 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -69.66 139.18 53.48 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 119.185 1.492 . . . . 2.3199999999999998 110.893 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.459 HG22 HG22 ' A' ' 91' ' ' ILE . 5.5 p -99.21 141.26 32.21 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.732 0.813 . . . . 0.77000000000000002 112.402 -172.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.23 -8.0 46.62 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.475 1.287 . . . . 0.80000000000000004 114.475 -168.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.5 24.0 57.32 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.052 0.842 . . . . 0.81999999999999995 113.661 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.95 147.08 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.214 1.406 . . . . 1.1699999999999999 109.311 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -133.67 158.22 43.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.839 1.656 . . . . 1.29 111.656 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 60.0 mt -133.19 141.04 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.912 1.285 . . . . 0.62 110.684 -170.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -81.98 145.91 54.37 Favored Pre-proline 0 N--CA 1.477 0.91 0 O-C-N 120.862 -1.149 . . . . 1.8100000000000001 112.659 174.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.68 -19.38 12.84 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 CA-C-N 122.139 1.8 . . . . 0.85999999999999999 113.243 175.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -97.93 -47.74 5.43 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.821 1.649 . . . . 1.4199999999999999 112.47 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.8 p -80.49 -29.18 37.35 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.286 0.635 . . . . 0.92000000000000004 111.879 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 57.74 16.34 3.46 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.531 1.532 . . . . 1.9299999999999999 113.539 -170.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.79 149.23 21.41 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.742 1.217 . . . . 2.6499999999999999 111.718 -175.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.423 ' CD2' HD11 ' A' ' 90' ' ' ILE . 8.2 mt -84.17 138.64 32.89 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.932 1.293 . . . . 0.93999999999999995 111.955 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.1 t -87.02 20.24 2.75 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.685 0.994 . . . . 2.8399999999999999 113.685 172.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -177.42 174.07 46.67 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 126.882 2.182 . . . . 1.21 111.905 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.6 162.78 28.84 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.306 0.854 . . . . 1.01 113.306 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 mmt -51.91 132.45 39.01 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.712 1.205 . . . . 1.6299999999999999 113.074 -175.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -78.59 155.67 27.85 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.323 3.349 . . . . 1.0700000000000001 113.682 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.15 -35.92 23.26 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.893 1.812 . . . . 1.5800000000000001 115.893 -176.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.2 p -131.46 10.22 4.79 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.832 1.653 . . . . 0.90000000000000002 113.035 -168.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.85 152.29 16.22 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.689 1.366 . . . . 0.54000000000000004 114.689 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.1 ttt -80.19 85.31 5.74 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.85 1.66 . . . . 1.8899999999999999 111.712 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -135.45 153.85 51.63 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.005 1.722 . . . . 1.23 112.456 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -164.02 158.34 19.4 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.124 1.77 . . . . 1.8700000000000001 110.747 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 mp -98.28 147.29 24.79 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.31 1.044 . . . . 0.57999999999999996 112.469 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.2 p -65.1 125.68 25.72 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 120.329 1.422 . . . . 0.64000000000000001 109.822 169.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.52 -52.02 7.24 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.372 1.619 . . . . 2.02 115.372 -169.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.78 -46.07 0.1 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.784 1.634 . . . . 1.3700000000000001 109.075 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -116.01 -17.03 11.02 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.524 1.305 . . . . 4.0899999999999999 114.524 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 172.57 -169.5 42.62 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.093 1.33 . . . . 0.65000000000000002 112.593 -172.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.52 126.82 18.64 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.281 1.832 . . . . 0.45000000000000001 112.413 170.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -80.19 136.7 36.54 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.873 1.269 . . . . 1.25 112.388 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -127.52 142.38 51.4 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.321 2.649 . . . . 2.0699999999999998 108.671 171.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.46 HD21 ' HB3' ' A' ' 132' ' ' ALA . 2.2 t-20 -105.91 111.97 24.84 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.93 0.892 . . . . 2.1400000000000001 110.619 -175.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.0 p -94.15 -8.41 39.53 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.314 1.228 . . . . 0.80000000000000004 114.314 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.46 ' HB3' HD21 ' A' ' 130' ' ' ASN . . . -54.23 -14.85 1.26 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.885 1.674 . . . . 0.96999999999999997 115.357 -176.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.92 -21.71 13.09 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.556 1.542 . . . . 2.6200000000000001 112.866 -176.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -72.21 144.57 87.33 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 119.779 1.172 . . . . 0.77000000000000002 112.523 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.94 168.16 25.45 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.84 2.36 . . . . 0.73999999999999999 111.99 172.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -72.35 76.38 1.01 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.625 1.97 . . . . 1.0700000000000001 111.818 -176.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -142.03 -173.54 3.84 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.115 1.366 . . . . 0.78000000000000003 111.305 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -104.66 154.7 19.63 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.233 1.413 . . . . 3.0099999999999998 112.201 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -145.3 169.8 17.55 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 127.456 2.302 . . . . 0.58999999999999997 110.178 -173.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -137.97 154.66 49.34 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.866 1.061 . . . . 1.6699999999999999 113.866 175.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.6 mp -113.58 136.9 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.566 1.146 . . . . 0.45000000000000001 110.763 174.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -125.9 149.65 48.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.746 2.018 . . . . 1.8400000000000001 110.558 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -112.05 120.16 40.89 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.581 1.152 . . . . 1.8899999999999999 110.72 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 22.9 mm -129.07 113.96 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.352 1.061 . . . . 0.58999999999999997 109.421 -169.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -98.91 15.32 25.98 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.687 1.195 . . . . 5.3200000000000003 113.544 -174.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 82.5 p -77.51 -21.89 52.02 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.253 1.205 . . . . 2.1099999999999999 114.253 -176.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.35 177.03 1.2 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.464 1.105 . . . . 3.04 110.168 167.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 28.7 t -44.03 -53.44 6.3 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.624 1.17 . . . . 5.71 112.45 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.1 m 58.19 158.1 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 128.355 2.662 . . . . 5.3399999999999999 116.432 167.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -62.24 172.63 1.4 Allowed 'General case' 0 CA--C 1.547 0.837 0 O-C-N 120.49 -1.381 . . . . 5.7400000000000002 112.247 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.1 p -127.89 148.13 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.775 1.23 . . . . 3.77 111.545 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.66 -29.37 0.83 Allowed Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.799 1.19 . . . . 2.4500000000000002 113.211 171.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -76.36 -10.96 59.79 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.984 2.114 . . . . 4.1799999999999997 115.451 -171.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -90.0 16.68 7.87 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.3 1.44 . . . . 5.3700000000000001 113.92 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 101.68 13.23 32.87 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.055 1.312 . . . . 3.79 115.222 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.37 165.24 22.83 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.16 0.984 . . . . 2.79 112.606 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.0 m -81.37 55.9 2.74 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.117 1.367 . . . . 2.7599999999999998 110.378 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.6 mt -142.71 163.8 31.84 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.88 2.072 . . . . 1.8899999999999999 110.3 -173.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 34.5 p -92.58 -34.46 14.02 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 115.755 1.761 . . . . 3.79 115.755 -168.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.88 25.04 75.74 Favored Glycine 0 CA--C 1.539 1.563 0 O-C-N 120.97 -1.081 . . . . 2.3199999999999998 112.083 -166.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 68.1 p -89.42 -168.38 2.14 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.114 1.365 . . . . 2.7400000000000002 112.135 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.81 152.58 40.53 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.402 1.481 . . . . 3.3700000000000001 112.436 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.07 155.45 40.29 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.091 0.775 . . . . 1.48 113.091 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.74 150.78 37.34 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 124.469 1.108 . . . . 0.60999999999999999 110.018 167.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.6 140.51 32.89 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.894 2.396 . . . . 0.80000000000000004 113.244 -168.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.9 mp -111.23 139.27 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.146 1.779 . . . . 1.3899999999999999 109.874 -173.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -107.45 141.32 39.04 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.914 1.079 . . . . 2.7599999999999998 113.914 173.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.8 tt -145.38 155.37 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 125.326 1.45 . . . . 0.56999999999999995 111.779 -170.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -134.89 160.21 38.98 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.669 1.988 . . . . 1.99 110.382 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.95 144.54 81.85 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.347 -0.846 . . . . 2.0600000000000001 112.573 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.4 113.57 3.52 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.148 2.565 . . . . 0.82999999999999996 113.793 -169.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 4.2 tt -126.18 79.05 1.81 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 105.388 -2.079 . . . . 3.5099999999999998 105.388 166.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -149.79 156.07 41.2 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.085 2.154 . . . . 3.4900000000000002 109.686 -169.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -80.54 33.47 0.31 Allowed 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.787 -1.196 . . . . 4.0800000000000001 113.94 -177.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 32.9 m -110.25 169.18 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.216 1.406 . . . . 2.0699999999999998 112.481 -173.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 61.4 t -101.93 -29.06 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.651 1.181 . . . . 2.77 110.384 171.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.49 140.79 41.39 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.266 1.426 . . . . 3.2599999999999998 111.434 173.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -91.31 152.88 20.29 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.848 0.859 . . . . 0.47999999999999998 110.626 173.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -138.87 153.13 48.28 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.337 0.865 . . . . 0.96999999999999997 113.337 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.38 140.57 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.106 1.762 . . . . 0.72999999999999998 111.002 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -128.97 74.11 81.31 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.735 0.814 . . . . 2.2400000000000002 112.907 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.61 150.05 44.77 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.141 3.227 . . . . 0.88 113.818 -175.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -132.01 165.01 24.93 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 127.48 2.312 . . . . 1.5 113.014 -169.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -108.67 161.0 15.5 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.415 1.486 . . . . 3.0499999999999998 113.613 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 5.3 t -147.82 170.78 16.89 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 126.075 1.75 . . . . 3.1499999999999999 108.613 167.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -88.84 -90.06 0.14 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.726 0.811 . . . . 5.4400000000000004 111.676 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . 53.4 -79.29 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.884 2.474 . . . . 7.1699999999999999 115.635 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . 0.275 23.6 pttm 49.48 148.1 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.094 1 C-N-CA 133.611 4.765 . . . . 9.2400000000000002 118.117 -176.506 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -79.71 160.84 24.79 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.637 2.891 . . . . 13.65 115.743 -172.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -125.32 -11.54 6.9 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.025 1.861 . . . . 15.76 116.025 -173.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 191' ' ' ILE . 3.0 mp -93.85 -62.21 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 120.4 1.455 . . . . 20.66 109.943 -175.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 98.8 mt 53.1 177.09 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 129.346 3.059 . . . . 21.219999999999999 116.024 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.531 0 C-N-CA 126.853 2.061 . . . . 27.489999999999998 110.01 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 15.9 tpt . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 110.428 -0.212 . . . . 22.469999999999999 110.428 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 61.27 -72.58 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 127.819 2.447 . . . . 22.010000000000002 114.992 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 p -75.54 155.09 36.41 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.342 0.974 . . . . 18.850000000000001 112.317 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 58.71 23.79 11.49 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.115 1.766 . . . . 14.68 115.146 -174.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.3 m -74.47 -24.67 59.07 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.826 1.417 . . . . 12.640000000000001 114.826 -171.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.52 -25.43 21.41 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.143 0.883 . . . . 10.460000000000001 112.502 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.75 -37.87 20.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.421 1.488 . . . . 9.5500000000000007 113.668 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.0 p -125.09 135.11 52.38 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.716 1.006 . . . . 8.4399999999999995 113.716 -169.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.5 m -61.31 158.65 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.162 1.385 . . . . 6.3899999999999997 114.108 -171.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -88.22 46.13 1.35 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.392 1.477 . . . . 3.6000000000000001 112.154 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 56.06 -173.64 0.06 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 126.039 1.735 . . . . 3.6499999999999999 114.877 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.05 133.41 35.42 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.862 1.665 . . . . 4.9100000000000001 110.562 173.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.14 26.93 0.06 OUTLIER Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.942 -0.921 . . . . 1.77 115.21 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.5 p -150.79 171.85 16.54 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 118.993 1.396 . . . . 1.1499999999999999 113.678 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.4 p -89.9 -20.4 23.43 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 115.014 1.487 . . . . 1.71 115.014 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.6 t -154.51 156.07 36.0 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.376 1.47 . . . . 2.2400000000000002 110.775 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.4 p -80.67 -4.56 54.73 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.497 1.666 . . . . 1.3700000000000001 115.497 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.9 p -149.69 161.87 41.35 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.596 1.702 . . . . 1.7 115.596 -170.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.6 p -128.4 143.65 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 127.043 2.137 . . . . 0.44 110.003 173.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.0 m -113.89 118.39 34.06 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.223 1.009 . . . . 0.70999999999999996 109.073 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 p -94.49 130.93 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 122.061 0.934 . . . . 0.65000000000000002 109.289 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -108.56 -179.47 3.88 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.174 1.79 . . . . 1.9199999999999999 109.424 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.53 122.3 9.29 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 120.168 -1.583 . . . . 1.3200000000000001 111.656 169.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.6 mt -111.63 151.21 29.07 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.249 1.02 . . . . 0.56999999999999995 112.688 -171.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.78 159.85 38.56 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.163 1.785 . . . . 1.9199999999999999 110.917 175.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.61 165.27 11.32 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.513 1.125 . . . . 0.77000000000000002 112.358 173.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.6 p -97.84 -17.12 19.49 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.874 1.435 . . . . 1.3999999999999999 114.874 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -152.04 49.05 0.78 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.903 1.681 . . . . 2.8199999999999998 110.572 169.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.29 11.28 85.11 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 116.497 1.359 . . . . 1.04 116.497 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.56 16.02 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 128.674 2.789 . . . . 2.3100000000000001 116.749 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -19.92 60.2 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.572 -1.33 . . . . 0.77000000000000002 112.926 -176.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -82.3 -47.65 12.13 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.409 1.483 . . . . 2.8700000000000001 113.167 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -65.25 -41.3 94.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.7 1.136 . . . . 2.79 111.099 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.8 mt -52.05 -52.96 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 119.56 1.073 . . . . 0.58999999999999997 110.282 168.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.8 -30.88 62.07 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 120.676 1.58 . . . . 0.81000000000000005 113.618 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -77.49 -37.22 51.68 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.504 0.927 . . . . 1.1799999999999999 113.504 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -63.85 -22.68 67.03 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.856 0.863 . . . . 1.95 112.631 169.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.7 mt -88.79 -44.86 10.21 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.337 0.865 . . . . 0.94999999999999996 113.337 173.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -69.57 -15.08 63.15 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.851 1.205 . . . . 2.6499999999999999 114.092 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.7 t -75.19 -28.36 59.99 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.515 1.126 . . . . 1.3500000000000001 112.242 169.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.73 166.98 38.05 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.944 1.259 . . . . 1.03 112.786 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -85.76 35.73 0.63 Allowed 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.947 -1.325 . . . . 1.6799999999999999 111.743 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -75.64 4.77 7.11 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.938 1.088 . . . . 1.9399999999999999 113.938 -171.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.72 -30.87 71.04 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.517 1.127 . . . . 1.0700000000000001 110.003 164.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.32 -76.56 0.75 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.358 1.456 . . . . 0.68000000000000005 112.51 171.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.254 0.0 OUTLIER -71.01 154.74 41.56 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.212 1.56 . . . . 1.5600000000000001 115.212 -169.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.56 151.05 29.74 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.949 0.9 . . . . 4.8099999999999996 112.522 -177.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.412 HG23 ' CE2' ' A' ' 181' ' ' TYR . 73.6 t -60.36 123.3 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 109.751 -0.463 . . . . 0.91000000000000003 109.751 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.84 -53.45 40.77 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.262 0.458 . . . . 1.26 113.823 -170.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.8 t -150.5 127.73 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.942 1.697 . . . . 2.9100000000000001 108.408 171.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.8 mt -75.99 152.55 84.53 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 124.343 1.057 . . . . 1.1899999999999999 112.808 173.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.35 162.72 41.48 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.396 2.064 . . . . 0.64000000000000001 112.071 175.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.4 -30.9 69.89 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.373 -0.829 . . . . 0.90000000000000002 111.916 170.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.29 5.66 8.16 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 115.68 1.733 . . . . 1.3600000000000001 115.68 173.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.84 157.02 21.9 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.433 1.493 . . . . 0.53000000000000003 113.435 170.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -148.02 169.55 19.68 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.427 1.491 . . . . 1.8799999999999999 111.736 169.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -121.11 139.12 53.76 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.798 1.239 . . . . 1.9099999999999999 110.288 -173.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.3 pt -127.98 142.36 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 121.421 -0.799 . . . . 0.76000000000000001 112.272 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.98 145.25 43.77 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.012 1.325 . . . . 0.67000000000000004 111.699 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.16 23.98 6.16 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.225 1.393 . . . . 0.80000000000000004 114.969 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.3 p -109.78 142.86 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 127.373 2.269 . . . . 0.82999999999999996 110.337 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.0 tpp -98.78 143.79 28.73 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.36 1.464 . . . . 0.70999999999999996 113.415 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -148.09 151.94 36.5 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.672 1.589 . . . . 1.7 111.512 174.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 m -125.29 144.9 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.166 1.786 . . . . 0.53000000000000003 110.153 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -86.04 149.06 25.43 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.69 1.233 . . . . 0.40999999999999998 112.477 170.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.0 p -144.45 170.92 15.11 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.737 2.015 . . . . 0.53000000000000003 111.661 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.66 177.52 5.99 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.208 1.003 . . . . 2.2200000000000002 113.121 169.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 42.3 p -59.96 -29.8 68.66 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.84 0.856 . . . . 1.6000000000000001 113.225 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -78.06 13.74 1.35 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.896 1.279 . . . . 2.0800000000000001 113.823 173.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.7 28.19 15.44 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.332 1.853 . . . . 0.93000000000000005 112.044 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -88.62 138.58 31.29 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.086 1.754 . . . . 2.1000000000000001 110.466 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -78.2 127.22 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.818 -0.438 . . . . 0.68000000000000005 109.818 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.469 HG22 HG22 ' A' ' 97' ' ' THR . 3.0 pt -120.69 157.31 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.812 1.245 . . . . 0.67000000000000004 114.109 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -86.16 163.92 17.54 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.409 1.884 . . . . 1.8500000000000001 110.473 166.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -61.42 -12.72 15.65 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.981 1.474 . . . . 2.29 114.981 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -94.71 0.25 54.86 Favored 'General case' 0 CA--C 1.55 0.947 0 O-C-N 120.656 -1.277 . . . . 3.8900000000000001 112.165 172.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.18 7.47 86.81 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 126.092 1.806 . . . . 0.59999999999999998 115.293 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -64.55 131.17 46.29 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.599 1.2 . . . . 2.5899999999999999 107.974 168.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.469 HG22 HG22 ' A' ' 91' ' ' ILE . 5.9 p -89.95 145.94 24.75 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.66 0.664 . . . . 0.70999999999999996 110.605 175.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.94 -6.07 49.37 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.177 0.806 . . . . 0.88 113.177 -169.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.71 32.43 57.25 Favored Glycine 0 CA--C 1.531 1.073 0 O-C-N 121.399 -0.813 . . . . 1.01 112.468 -173.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.1 t -135.7 148.53 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.797 1.639 . . . . 1.3799999999999999 109.805 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -135.97 154.69 51.01 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.473 2.309 . . . . 1.6499999999999999 111.079 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 54.8 mt -132.77 134.9 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.99 1.316 . . . . 0.91000000000000003 112.248 -171.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -69.25 135.12 89.05 Favored Pre-proline 0 CA--C 1.546 0.804 0 O-C-N 120.635 -1.291 . . . . 2.1299999999999999 111.166 170.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.65 -17.71 25.99 Favored 'Trans proline' 0 C--N 1.35 0.617 0 CA-C-N 122.548 1.946 . . . . 0.98999999999999999 113.657 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -96.08 -43.66 7.67 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.009 1.723 . . . . 1.8999999999999999 112.555 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.3 p -94.24 -22.55 18.34 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.5 1.12 . . . . 1.1299999999999999 113.948 -174.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 53.95 20.41 2.39 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 125.421 1.488 . . . . 2.46 113.975 -169.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.73 144.77 31.94 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.404 -1.435 . . . . 3.0299999999999998 111.511 176.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 mt -90.42 148.24 22.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.899 1.68 . . . . 1.1599999999999999 112.073 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 84.2 p -74.28 9.75 1.54 Allowed 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.152 1.167 . . . . 1.6499999999999999 114.152 170.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.32 -160.47 24.63 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 126.081 1.801 . . . . 1.0700000000000001 113.034 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.89 160.91 21.02 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.808 1.243 . . . . 0.98999999999999999 112.101 172.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -52.27 130.92 42.59 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.378 1.071 . . . . 1.8 113.484 -174.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -68.94 152.35 73.49 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.975 3.117 . . . . 1.03 114.368 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.31 -64.27 0.89 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.763 1.225 . . . . 1.05 113.653 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.7 p -101.61 7.78 42.03 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.173 1.546 . . . . 0.79000000000000004 115.173 -168.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.78 146.67 13.22 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.205 1.187 . . . . 0.52000000000000002 114.205 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.6 ttt -77.06 89.36 3.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.942 1.697 . . . . 2.1000000000000001 111.513 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -143.87 145.16 32.11 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.894 1.678 . . . . 1.0800000000000001 112.244 -174.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -164.85 159.88 18.86 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.89 1.676 . . . . 1.9099999999999999 111.046 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.38 146.97 26.89 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.815 1.246 . . . . 0.85999999999999999 113.365 174.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.2 p -65.05 125.82 26.13 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.533 -0.73 . . . . 0.67000000000000004 110.814 172.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -87.94 -57.53 2.9 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.471 1.286 . . . . 2.7000000000000002 114.471 -172.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -151.11 -41.25 0.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.02 0.928 . . . . 1.1499999999999999 111.654 -172.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -118.62 -22.44 7.49 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.83 1.252 . . . . 4.4000000000000004 113.503 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 171.52 -160.0 31.84 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 126.079 1.799 . . . . 0.75 111.326 -175.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -139.9 132.94 29.51 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.657 1.983 . . . . 0.53000000000000003 111.272 169.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -87.32 139.91 30.08 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.299 1.44 . . . . 1.6899999999999999 113.72 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -132.32 129.79 39.95 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.538 2.735 . . . . 1.77 108.594 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -92.55 120.78 33.34 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.515 -0.741 . . . . 1.74 110.092 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.6 p -103.42 -2.0 27.63 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.398 1.479 . . . . 0.67000000000000004 113.367 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -52.68 -29.25 25.49 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.872 1.269 . . . . 0.68999999999999995 113.521 173.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -97.42 -15.54 20.6 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.113 1.765 . . . . 1.8899999999999999 114.437 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.52 154.8 81.55 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 119.623 1.101 . . . . 0.72999999999999998 113.064 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -82.72 170.2 12.93 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.303 2.669 . . . . 0.72999999999999998 110.419 165.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.94 98.85 3.67 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.752 1.221 . . . . 0.96999999999999997 109.956 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -153.29 179.08 9.08 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.025 0.93 . . . . 0.66000000000000003 111.878 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -91.12 150.88 21.21 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.091 1.356 . . . . 2.5099999999999998 111.211 168.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -146.13 170.7 16.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.28 1.832 . . . . 0.56999999999999995 110.056 -173.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -140.64 154.63 46.5 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.043 0.937 . . . . 1.8200000000000001 113.043 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.9 mp -114.94 141.52 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.907 1.283 . . . . 0.69999999999999996 110.768 172.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -126.9 117.97 23.63 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.075 2.15 . . . . 1.8999999999999999 110.571 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -82.53 75.4 9.44 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.251 1.02 . . . . 1.79 111.398 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 40.7 mm -71.54 114.26 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 123.232 0.613 . . . . 1.2 109.383 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.36 -5.84 59.28 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.995 1.48 . . . . 3.9199999999999999 114.995 -169.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.6 m -51.78 -35.91 45.65 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.536 1.535 . . . . 1.6799999999999999 114.054 -177.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.11 -9.0 34.88 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.143 1.164 . . . . 2.1699999999999999 114.143 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 74.8 m -58.31 135.19 57.11 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.706 1.139 . . . . 6.3700000000000001 111.935 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.3 t -125.64 -7.69 6.82 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.451 1.5 . . . . 4.7800000000000002 114.066 -169.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -65.6 161.03 21.23 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.761 0.825 . . . . 5.4000000000000004 111.784 171.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.4 138.96 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.542 0.737 . . . . 4.1799999999999997 112.716 -174.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -120.31 -17.31 4.46 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.953 1.263 . . . . 3.23 114.115 174.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -93.74 -8.92 39.34 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.208 2.203 . . . . 5.8700000000000001 115.19 -173.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -96.8 30.54 2.62 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.36 1.064 . . . . 7.0999999999999996 113.35 -172.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 110.58 -13.78 30.09 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.403 1.477 . . . . 5.4699999999999998 115.361 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.62 167.91 5.29 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.279 1.432 . . . . 4.0700000000000003 113.394 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 15.3 t -110.66 69.34 0.69 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.708 1.242 . . . . 4.0999999999999996 109.841 172.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.0 tt -133.99 122.96 23.79 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.679 1.192 . . . . 1.95 111.232 -167.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 15.2 t -85.18 140.14 31.13 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.094 0.958 . . . . 3.0800000000000001 113.39 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -81.62 49.2 4.0 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.938 1.732 . . . . 2.1099999999999999 114.517 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 88.5 p -63.2 166.59 5.95 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 117.147 2.277 . . . . 3.6000000000000001 117.147 -169.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.73 116.22 32.25 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.276 1.83 . . . . 2.3900000000000001 111.828 172.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.6 147.32 35.71 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.103 0.561 . . . . 0.87 111.212 168.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.7 m -110.86 151.93 43.24 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.761 1.224 . . . . 0.94999999999999996 110.002 172.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.71 161.22 46.81 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.52 2.147 . . . . 0.81000000000000005 113.378 -170.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.3 mp -124.87 128.66 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.783 1.233 . . . . 1.6699999999999999 110.522 -169.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -96.0 138.29 33.83 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.244 1.018 . . . . 2.98 112.955 172.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.4 tt -143.43 151.2 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.376 1.47 . . . . 0.51000000000000001 111.863 -172.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -130.03 149.87 51.56 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.756 1.622 . . . . 2.0800000000000001 109.373 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 15.2 mt -65.71 154.68 88.12 Favored Pre-proline 0 N--CA 1.478 0.95 0 N-CA-C 115.008 1.484 . . . . 0.96999999999999997 115.008 -168.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.8 102.85 1.25 Allowed 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 123.296 2.664 . . . . 0.77000000000000002 114.437 -168.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 16.1 mt -137.39 21.08 2.95 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.262 2.625 . . . . 2.6699999999999999 110.86 170.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -85.78 19.72 2.41 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.958 1.703 . . . . 3.3999999999999999 113.106 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 21.1 t70 61.72 25.72 15.54 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.674 2.39 . . . . 3.5899999999999999 114.367 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 16.5 m -99.1 144.48 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.979 1.312 . . . . 1.0700000000000001 113.093 -174.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 57.6 t -70.78 -34.61 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.705 0.802 . . . . 1.49 111.511 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -140.59 142.34 35.1 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.177 1.391 . . . . 2.6800000000000002 111.807 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -107.38 141.67 38.4 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.411 1.085 . . . . 0.52000000000000002 112.661 -174.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -140.59 166.74 23.92 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.595 1.702 . . . . 0.70999999999999996 115.595 -175.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.91 139.77 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.421 1.888 . . . . 0.66000000000000003 111.56 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.412 ' CE2' HG23 ' A' ' 66' ' ' VAL . 80.6 m-85 -133.33 74.38 72.21 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.723 1.209 . . . . 2.0699999999999998 113.373 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.81 152.13 77.77 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 124.976 3.784 . . . . 0.59999999999999998 113.622 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -133.19 -156.94 0.78 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.389 2.676 . . . . 2.1099999999999999 111.008 -167.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -144.15 163.59 33.16 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.41 1.484 . . . . 2.8900000000000001 112.08 168.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 4.6 t -127.89 -30.13 2.52 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.45 1.278 . . . . 2.48 114.45 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -145.96 169.57 18.36 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.043 1.127 . . . . 6.4199999999999999 114.043 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -79.17 146.71 32.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.132 0.973 . . . . 5.5199999999999996 112.305 170.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 3.0 pptp? -142.5 152.43 60.15 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 125.422 1.489 . . . . 13.27 110.49 170.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.77 129.83 14.97 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.319 2.013 . . . . 10.98 112.148 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -85.33 -40.66 16.28 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.732 0.641 . . . . 17.469999999999999 112.732 168.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.561 ' H ' HD12 ' A' ' 191' ' ' ILE . 1.8 mp -73.7 -49.3 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.4 1.08 . . . . 15.43 110.575 -175.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.2 tt 48.4 101.24 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 129.272 3.029 . . . . 14.779999999999999 113.732 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 . . . . . 0 CA--C 1.539 0.553 0 C-N-CA 124.151 0.98 . . . . 15.93 112.42 -178.324 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.024 -0.732 . . . . 26.559999999999999 109.024 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -81.46 -26.4 35.3 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.799 0.727 . . . . 29.030000000000001 111.605 168.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.4 m -51.48 141.04 16.58 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.928 1.291 . . . . 23.100000000000001 111.877 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.52 154.95 5.88 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.379 1.072 . . . . 19.59 113.429 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.2 t -132.87 150.64 52.14 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.064 1.345 . . . . 16.949999999999999 111.207 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 54.05 60.1 3.82 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.212 1.805 . . . . 13.23 114.493 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.54 -20.27 64.49 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.48 1.289 . . . . 11.98 114.48 174.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.9 p -129.74 70.98 1.43 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.323 1.849 . . . . 10.609999999999999 110.667 -168.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.1 p -56.58 142.91 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 117.332 2.345 . . . . 6.4500000000000002 117.332 -167.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -136.6 177.03 8.17 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 129.195 2.998 . . . . 3.9700000000000002 108.815 168.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.67 139.75 40.43 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.534 1.134 . . . . 3.6000000000000001 111.299 172.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.82 105.66 4.52 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.681 1.192 . . . . 5.2699999999999996 111.936 -173.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.86 67.53 3.38 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.656 1.122 . . . . 1.8400000000000001 112.899 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.5 p -136.44 170.54 15.89 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.745 1.618 . . . . 1.3100000000000001 114.467 -169.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.3 p -93.22 -14.55 26.94 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.755 0.822 . . . . 1.5900000000000001 112.89 169.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.541 HG22 ' H ' ' A' ' 36' ' ' SER . 9.3 m -146.38 148.26 32.15 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.201 2.2 . . . . 2.5899999999999999 109.708 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 p -111.45 16.65 20.67 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.964 1.706 . . . . 1.6599999999999999 113.937 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.541 ' H ' HG22 ' A' ' 34' ' ' THR . 29.0 m -147.6 159.75 43.42 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.347 1.459 . . . . 1.6000000000000001 111.736 170.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -136.04 144.12 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.615 1.966 . . . . 0.33000000000000002 110.209 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.0 m -120.75 125.8 48.54 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.564 0.746 . . . . 0.65000000000000002 111.512 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p -100.28 138.15 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.571 1.148 . . . . 0.64000000000000001 111.183 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -136.21 113.71 10.88 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.364 1.465 . . . . 1.75 113.091 -171.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -81.79 127.43 32.96 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.043 -1.661 . . . . 1.28 113.069 -174.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.9 mt -114.25 155.36 26.29 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.552 1.541 . . . . 0.54000000000000004 112.767 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.5 mt -141.19 173.14 11.77 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.409 1.884 . . . . 1.6599999999999999 110.265 168.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.96 172.56 6.95 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.501 1.121 . . . . 0.92000000000000004 112.032 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.4 p -95.91 -31.75 12.96 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.042 0.756 . . . . 1.21 113.042 170.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -143.02 52.03 1.39 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.656 1.582 . . . . 2.6099999999999999 111.414 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.22 16.36 77.0 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 124.602 1.096 . . . . 0.97999999999999998 115.52 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.75 12.97 0.16 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.118 2.167 . . . . 2.1600000000000001 115.302 -174.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -61.53 -29.27 69.89 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 120.567 -1.333 . . . . 0.63 112.27 -173.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -75.9 -40.46 54.31 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.643 1.177 . . . . 2.2599999999999998 113.247 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -72.66 -38.64 67.58 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-O 117.945 -1.026 . . . . 2.2200000000000002 111.782 170.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 71.8 mt -53.23 -50.98 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.396 1.078 . . . . 0.59999999999999998 110.28 167.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.32 -31.11 68.86 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.731 1.151 . . . . 0.78000000000000003 112.571 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -77.81 -26.9 49.87 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.124 1.157 . . . . 1.26 114.124 171.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -71.21 -30.77 66.79 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.754 -1.216 . . . . 1.99 111.929 168.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.2 mt -90.63 -40.26 12.01 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.727 1.38 . . . . 0.82999999999999996 114.727 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -67.27 -25.18 65.94 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 120.123 1.329 . . . . 2.9100000000000001 112.714 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.7 t -80.2 -3.28 48.42 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.215 1.806 . . . . 1.7 112.961 173.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.34 160.88 14.9 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 126.321 1.915 . . . . 0.93000000000000005 112.164 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -79.29 35.56 0.27 Allowed 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.111 -1.229 . . . . 1.6499999999999999 113.153 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -78.45 7.7 6.24 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.447 1.099 . . . . 2.1200000000000001 113.599 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.54 -31.38 67.88 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.115 1.366 . . . . 1.3100000000000001 110.488 165.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.34 -48.34 0.15 Allowed Glycine 0 C--N 1.344 1.005 0 CA-C-O 119.748 -0.473 . . . . 0.94999999999999996 114.007 171.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -67.91 145.83 54.2 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.636 0.718 . . . . 2.77 111.648 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -68.34 149.09 49.83 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.04 0.836 . . . . 3.0600000000000001 112.144 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 69.5 t -59.81 126.28 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 122.832 0.453 . . . . 0.77000000000000002 111.313 -173.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.19 -50.71 31.71 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.107 1.337 . . . . 0.91000000000000003 113.924 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 98.3 t -142.73 120.12 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.097 1.359 . . . . 1.77 110.198 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.4 mt -82.91 141.92 44.4 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.26 0.624 . . . . 0.82999999999999996 110.137 168.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.8 161.24 42.92 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 121.381 1.388 . . . . 0.57999999999999996 112.36 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.56 -26.87 65.74 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.358 -0.839 . . . . 0.83999999999999997 112.233 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.77 5.39 40.27 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.948 1.699 . . . . 1.49 115.292 174.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.16 152.75 21.07 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.739 1.215 . . . . 0.65000000000000002 111.189 168.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -142.73 164.47 30.01 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.093 1.357 . . . . 2.5800000000000001 111.74 174.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -125.35 134.7 52.1 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.984 1.313 . . . . 2.2599999999999998 110.534 -169.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.8 pt -136.33 151.41 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.833 1.253 . . . . 0.79000000000000004 111.832 -176.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -119.86 174.04 6.69 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.44 1.496 . . . . 0.75 111.964 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.24 12.96 64.61 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.504 1.526 . . . . 0.51000000000000001 115.532 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.9 p -96.71 146.06 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.174 1.39 . . . . 0.66000000000000003 111.336 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 15.1 tpp -101.9 138.69 38.54 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.056 2.142 . . . . 1.0900000000000001 112.223 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.552 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.8 OUTLIER -145.73 152.78 40.13 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.565 1.546 . . . . 1.73 111.919 177.345 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.45 145.76 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 126.802 2.041 . . . . 0.29999999999999999 110.494 -174.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -87.8 146.26 25.71 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 122.552 1.168 . . . . 0.34999999999999998 113.084 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.8 p -143.26 167.87 21.13 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.104 1.761 . . . . 0.33000000000000002 112.793 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -92.0 175.3 6.92 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.201 1.001 . . . . 2.2200000000000002 112.328 168.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.8 p -67.94 -20.27 65.05 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.382 -1.449 . . . . 1.4399999999999999 113.657 -174.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -80.65 14.07 2.27 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.505 1.122 . . . . 1.73 111.976 167.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.41 31.85 19.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.944 2.497 . . . . 0.57999999999999996 113.213 175.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -87.23 138.96 31.04 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.322 1.049 . . . . 2.3399999999999999 110.489 176.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.9 mt -76.53 124.06 34.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.788 -0.819 . . . . 0.41999999999999998 108.788 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.489 HG22 HG22 ' A' ' 97' ' ' THR . 6.1 pt -118.86 154.69 21.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 123.169 1.461 . . . . 0.58999999999999997 113.432 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.56 160.12 19.72 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.298 2.239 . . . . 2.6800000000000002 108.041 166.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.54 -13.25 28.72 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.949 1.463 . . . . 2.1000000000000001 114.949 -169.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -93.87 2.55 56.14 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.711 1.204 . . . . 3.46 111.668 176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.39 3.27 81.84 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.701 1.619 . . . . 0.56000000000000005 114.69 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -68.93 142.76 54.63 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 123.98 0.912 . . . . 2.4900000000000002 109.676 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.489 HG22 HG22 ' A' ' 91' ' ' ILE . 30.4 p -102.58 145.35 29.75 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.161 0.984 . . . . 0.68999999999999995 111.553 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -97.95 -4.5 36.22 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.907 1.077 . . . . 0.65000000000000002 113.907 -170.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.0 25.3 45.5 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.029 0.824 . . . . 0.68999999999999995 113.412 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 p -141.06 152.31 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.07 1.348 . . . . 2.3999999999999999 109.687 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -138.21 155.47 48.63 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 128.471 2.709 . . . . 1.3400000000000001 110.193 -169.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 47.3 mt -136.36 131.23 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.3 1.44 . . . . 0.56000000000000005 110.668 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -75.25 138.83 71.79 Favored Pre-proline 0 N--CA 1.476 0.844 0 O-C-N 121.124 -0.985 . . . . 2.2599999999999998 110.759 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.03 -24.07 28.84 Favored 'Trans proline' 0 C--N 1.35 0.648 0 CA-C-N 121.737 1.656 . . . . 0.78000000000000003 112.743 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -90.18 -47.6 7.7 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.255 1.422 . . . . 1.3500000000000001 111.73 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.4 p -84.23 -27.37 28.0 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.524 0.73 . . . . 1.1299999999999999 112.961 -174.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 54.99 25.39 6.83 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.07 1.348 . . . . 1.8100000000000001 113.041 -172.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.83 153.79 19.5 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.164 1.385 . . . . 2.4500000000000002 111.616 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 18.0 mt -92.52 140.67 29.32 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.186 1.794 . . . . 0.70999999999999996 112.918 -172.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.9 p -71.49 -3.01 18.77 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.989 1.316 . . . . 1.24 114.492 172.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.14 -162.01 16.54 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 126.599 2.047 . . . . 0.81000000000000005 111.379 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.67 167.91 20.81 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.696 1.199 . . . . 0.94999999999999996 112.829 173.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.7 mmt -57.34 143.23 74.34 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.868 1.267 . . . . 1.3100000000000001 113.586 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -79.61 165.98 22.24 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.867 3.711 . . . . 0.77000000000000002 114.045 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.86 -48.62 9.16 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.344 1.609 . . . . 1.3100000000000001 115.344 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.4 p -130.38 13.89 5.55 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.243 1.417 . . . . 0.94999999999999996 113.807 -169.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.22 148.11 6.85 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.479 0.918 . . . . 0.40000000000000002 113.479 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 7.2 ttt -74.02 106.32 5.66 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 126.867 2.067 . . . . 1.8100000000000001 110.237 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.5 pttp -158.86 151.49 21.84 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.387 1.475 . . . . 0.93000000000000005 112.16 -172.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -161.98 171.74 17.12 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.682 1.193 . . . . 1.6599999999999999 110.919 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.5 mp -113.01 144.42 42.62 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.874 1.269 . . . . 0.41999999999999998 112.038 170.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.552 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 21.5 p -73.27 133.88 44.07 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.037 0.835 . . . . 0.56000000000000005 111.295 173.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -94.77 -52.88 4.08 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.02 1.489 . . . . 2.23 115.02 -171.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -175.07 -32.1 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 128.176 2.59 . . . . 1.4399999999999999 110.881 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -116.5 24.38 11.37 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.889 2.076 . . . . 4.4500000000000002 112.181 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.55 -158.76 22.21 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.788 1.661 . . . . 0.56000000000000005 113.794 -173.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -136.66 132.39 34.91 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.983 2.113 . . . . 0.35999999999999999 111.834 169.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -91.27 134.06 34.89 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.097 1.359 . . . . 1.26 113.534 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -127.31 119.09 25.48 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.46 2.704 . . . . 1.6499999999999999 108.21 176.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -84.12 124.48 31.17 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.153 -0.967 . . . . 1.9099999999999999 109.765 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 47.5 p -108.94 5.56 24.45 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.828 1.651 . . . . 0.56999999999999995 113.589 -170.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.17 -27.46 54.45 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.829 0.852 . . . . 0.80000000000000004 112.968 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -89.52 -13.46 37.33 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.911 1.284 . . . . 1.72 113.074 -173.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -83.53 145.3 47.62 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 114.02 1.119 . . . . 0.64000000000000001 114.02 175.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.33 166.96 21.92 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.406 2.071 . . . . 0.77000000000000002 110.968 165.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.39 82.95 3.13 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.458 1.903 . . . . 1.1100000000000001 111.598 -174.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -138.63 -177.27 4.79 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.676 1.191 . . . . 0.79000000000000004 111.625 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -93.18 151.49 19.8 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.712 0.768 . . . . 3.96 111.201 167.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -142.0 169.13 18.17 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.024 2.13 . . . . 0.56000000000000005 109.647 -173.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -139.41 145.31 38.76 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.16 0.984 . . . . 1.75 112.001 174.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -102.82 138.1 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.152 0.981 . . . . 0.37 109.572 171.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -121.69 133.88 54.96 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.893 1.677 . . . . 1.8600000000000001 110.24 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -99.83 124.65 45.34 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.459 1.104 . . . . 1.8999999999999999 110.185 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 15.6 mm -132.35 110.55 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.044 0.937 . . . . 0.67000000000000004 110.281 -169.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -73.2 -11.15 60.42 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 120.408 -1.432 . . . . 3.5 114.158 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 2.9 m -74.72 -10.27 59.37 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 115.644 1.72 . . . . 1.95 115.644 -169.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 57.9 tp -129.12 67.98 1.41 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.594 1.958 . . . . 3.1499999999999999 109.125 -173.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 32.8 t 69.08 137.76 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 128.019 2.528 . . . . 4.8700000000000001 113.639 -166.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.1 t -158.11 147.64 19.72 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.681 0.753 . . . . 5.6200000000000001 112.386 172.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -66.89 162.04 22.65 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 107.612 -1.255 . . . . 7.1299999999999999 107.612 164.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.5 p -118.12 122.43 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.632 0.73 . . . . 3.7200000000000002 111.561 176.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.634 ' HA2' ' HB3' ' A' ' 156' ' ' ALA . . . -97.81 -54.71 1.19 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.076 1.322 . . . . 2.4500000000000002 111.942 175.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -62.79 -11.49 18.18 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.541 1.682 . . . . 5.1100000000000003 115.541 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.67 -24.14 65.4 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.959 1.304 . . . . 4.8200000000000003 113.644 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 148.95 1.26 0.42 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.757 1.17 . . . . 3.7400000000000002 115.07 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.634 ' HB3' ' HA2' ' A' ' 152' ' ' GLY . . . -71.55 170.35 13.56 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.861 1.664 . . . . 2.8500000000000001 111.291 169.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.8 m -84.37 35.11 0.53 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.412 -1.43 . . . . 3.1000000000000001 112.738 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.89 177.06 11.76 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.964 1.706 . . . . 2.5800000000000001 111.898 -175.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.9 t -147.01 153.69 40.33 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.53 1.532 . . . . 4.8499999999999996 111.088 173.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.468 ' HA3' ' HE3' ' A' ' 190' ' ' LYS . . . -76.68 55.27 3.38 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.771 1.177 . . . . 3.8399999999999999 114.451 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 11.1 p -65.09 164.42 13.01 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.234 2.213 . . . . 3.25 115.684 -174.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -70.58 98.29 1.46 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.41 1.884 . . . . 2.4100000000000001 111.149 -172.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.87 139.15 42.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.109 0.964 . . . . 0.90000000000000002 110.672 171.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.9 m -99.78 145.97 31.06 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 123.883 0.873 . . . . 0.88 110.312 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.63 132.98 21.31 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.553 2.169 . . . . 0.69999999999999996 111.943 -169.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.403 ' H ' HD12 ' A' ' 166' ' ' ILE . 2.1 mp -95.95 115.62 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 124.559 1.143 . . . . 1.3600000000000001 108.415 -171.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -84.82 142.36 29.82 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.022 0.374 . . . . 3.0899999999999999 111.628 172.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.4 tt -146.36 150.02 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.926 1.29 . . . . 0.48999999999999999 110.648 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -122.05 157.23 31.86 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.341 1.457 . . . . 2.1200000000000001 109.862 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.31 143.93 92.27 Favored Pre-proline 0 CA--C 1.545 0.77 0 O-C-N 120.905 -1.122 . . . . 1.6699999999999999 111.64 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.27 110.75 1.63 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.662 2.908 . . . . 0.83999999999999997 112.221 -169.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 20.0 tp -143.0 56.57 1.4 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.468 1.907 . . . . 2.71 109.589 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -144.95 23.31 1.54 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.472 1.509 . . . . 3.2599999999999998 112.594 -169.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 54.03 32.39 15.45 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 127.124 2.169 . . . . 4.1699999999999999 114.113 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.3 m -91.57 147.26 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.52 1.128 . . . . 0.91000000000000003 110.127 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.84 -39.73 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.402 0.681 . . . . 1.48 110.025 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -128.13 137.26 52.03 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.905 1.682 . . . . 3.0099999999999998 109.921 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -96.29 144.75 26.18 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.667 0.787 . . . . 0.35999999999999999 111.82 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -137.99 171.5 14.33 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.991 1.478 . . . . 0.56999999999999995 114.991 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -139.4 142.7 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 127.204 2.202 . . . . 0.54000000000000004 110.669 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -130.31 74.66 80.13 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 113.742 1.015 . . . . 2.0499999999999998 113.742 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.63 148.91 90.51 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 124.367 3.378 . . . . 0.79000000000000004 112.972 175.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -136.69 -155.86 0.65 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.932 2.093 . . . . 2.1299999999999999 109.876 -168.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -134.74 164.32 27.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.518 1.527 . . . . 3.96 109.096 166.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 7.5 t -123.94 -27.38 3.92 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.361 0.875 . . . . 2.5 113.361 169.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -133.65 142.81 48.23 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.641 1.976 . . . . 6.2199999999999998 109.224 -174.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -104.4 9.05 35.87 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.938 1.459 . . . . 6.0800000000000001 114.938 -169.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -56.01 141.86 66.73 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 112.614 0.598 . . . . 9.8900000000000006 112.614 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -72.02 153.75 57.73 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.122 2.548 . . . . 9.5099999999999998 112.107 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.468 ' HE3' ' HA3' ' A' ' 160' ' ' GLY . 21.4 pttp -94.57 -23.13 17.79 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.243 1.201 . . . . 17.129999999999999 114.243 174.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.05 -23.44 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 114.482 1.29 . . . . 16.120000000000001 114.482 176.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 53.06 36.13 21.38 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 127.062 2.145 . . . . 12.24 114.705 176.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 . . . . . 0 C--N 1.324 -0.508 0 C-N-CA 126.114 1.765 . . . . 17.449999999999999 110.349 177.596 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 113.358 0.873 . . . . 30.350000000000001 113.358 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -117.76 155.72 29.54 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.812 1.645 . . . . 27.739999999999998 112.272 -172.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.9 m -73.22 145.57 46.13 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.675 1.19 . . . . 21.91 112.858 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.81 -6.46 0.51 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.917 1.687 . . . . 18.640000000000001 114.19 173.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 p -131.43 -173.58 3.16 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.729 -1.232 . . . . 15.42 113.359 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.17 -4.73 59.0 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.24 1.016 . . . . 11.710000000000001 113.503 173.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.26 -136.63 1.09 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.601 1.56 . . . . 11.51 113.76 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.2 p -70.72 152.89 43.34 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.172 1.389 . . . . 11.09 113.716 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 p -60.98 133.95 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.017 1.727 . . . . 8.1999999999999993 113.605 -173.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -75.01 177.15 6.56 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.869 1.268 . . . . 3.5899999999999999 112.234 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.58 157.41 0.07 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.045 2.138 . . . . 4.0499999999999998 115.203 -175.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.56 18.72 2.71 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.211 1.804 . . . . 6.0099999999999998 113.923 -175.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.7 17.2 62.3 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.517 2.008 . . . . 3.7799999999999998 116.65 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 67.4 p -73.68 172.42 11.48 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.447 1.899 . . . . 1.72 115.676 -168.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.6 p -85.57 -23.68 27.54 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 114.412 1.264 . . . . 1.8600000000000001 114.412 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.7 t -132.59 158.28 42.61 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 128.442 2.697 . . . . 2.48 109.126 172.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.423 ' HB ' ' HB2' ' A' ' 132' ' ' ALA . 15.6 p -110.47 8.09 22.96 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.408 1.483 . . . . 0.93000000000000005 113.595 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.2 m -137.52 163.47 31.08 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.938 1.295 . . . . 1.8400000000000001 111.11 168.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.14 140.43 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.291 1.836 . . . . 0.39000000000000001 109.457 173.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.6 m -115.95 121.32 41.95 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.236 0.615 . . . . 0.64000000000000001 111.388 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -99.55 137.49 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.929 1.292 . . . . 0.57999999999999996 111.364 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -134.54 112.27 10.74 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.335 1.454 . . . . 1.6899999999999999 111.372 -174.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.73 126.86 35.52 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 120.541 -1.349 . . . . 1.02 112.468 -171.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.7 mt -116.28 150.88 36.89 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.048 1.339 . . . . 0.56999999999999995 112.855 -171.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.0 mt -140.97 178.93 7.02 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.849 2.059 . . . . 1.46 110.081 168.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.07 160.93 18.36 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.901 1.28 . . . . 0.72999999999999998 112.44 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -89.14 -21.21 23.45 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 114.863 1.431 . . . . 1.05 114.863 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -129.23 28.67 5.23 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.31 1.444 . . . . 2.4500000000000002 111.132 168.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.71 15.31 80.76 Favored Glycine 0 CA--C 1.538 1.501 0 O-C-N 120.456 -1.402 . . . . 0.90000000000000002 114.792 -177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.56 28.6 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 129.744 3.218 . . . . 1.98 117.069 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -18.56 65.15 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.07 -1.643 . . . . 0.64000000000000001 113.56 -172.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -81.89 -45.34 15.6 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.393 0.997 . . . . 2.23 112.678 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -66.28 -43.6 85.95 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.549 1.068 . . . . 2.48 111.167 172.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.2 mt -50.14 -49.34 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.106 0.962 . . . . 0.67000000000000004 110.997 169.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.62 70.86 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 120.043 1.292 . . . . 0.84999999999999998 113.479 178.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -74.75 -31.05 61.68 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.217 -0.927 . . . . 1.03 113.21 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -65.54 -18.21 65.15 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.26 -0.9 . . . . 2.0600000000000001 112.514 169.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.4 mt -95.43 -36.81 11.2 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 114.453 1.279 . . . . 1.29 114.453 176.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -64.85 -19.81 66.08 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.836 1.198 . . . . 2.8500000000000001 113.759 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.5 t -72.22 -19.52 61.71 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.687 1.365 . . . . 1.3700000000000001 114.687 170.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.41 179.22 33.27 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.878 1.704 . . . . 1.54 114.801 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -102.64 36.17 2.26 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.852 1.261 . . . . 3.1299999999999999 111.21 174.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.402 ' CE1' ' HA ' ' A' ' 66' ' ' VAL . 15.6 m-85 -74.11 3.98 6.24 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 115.18 1.548 . . . . 2.2000000000000002 115.18 -168.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.58 -19.95 63.66 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 121.283 -0.886 . . . . 1.26 112.08 168.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.6 -65.86 0.37 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.139 1.352 . . . . 0.95999999999999996 112.288 169.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.283 0.0 OUTLIER -76.89 155.37 32.91 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.831 1.419 . . . . 1.72 114.831 -173.032 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -56.98 154.08 10.19 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.327 0.651 . . . . 2.5299999999999998 112.505 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.402 ' HA ' ' CE1' ' A' ' 61' ' ' TYR . 55.9 t -64.49 129.73 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 109.835 -0.432 . . . . 1.02 109.835 171.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.47 -55.09 16.42 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 122.932 0.301 . . . . 1.05 112.853 -176.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.0 t -141.66 121.89 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.029 0.932 . . . . 1.75 109.855 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.0 mt -78.63 137.35 58.83 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-O 118.919 -0.562 . . . . 1.1899999999999999 109.528 168.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.56 166.36 29.62 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.859 2.373 . . . . 0.59999999999999998 112.712 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -51.59 -41.95 61.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.263 0.625 . . . . 0.95999999999999996 112.547 172.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -76.21 -3.07 34.37 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.894 2.078 . . . . 1.4399999999999999 115.657 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.05 153.7 18.55 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.563 1.074 . . . . 0.56000000000000005 113.344 172.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.6 pttt -144.7 167.01 23.58 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.883 1.673 . . . . 2.2200000000000002 111.824 171.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -122.02 151.7 40.55 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.275 1.43 . . . . 2.1000000000000001 110.061 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.7 pt -139.97 137.65 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.356 0.662 . . . . 0.90000000000000002 111.528 171.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -112.68 161.39 16.91 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.592 1.557 . . . . 0.73999999999999999 112.276 173.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.71 29.19 36.13 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.136 1.351 . . . . 0.66000000000000003 113.423 -170.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 p -107.95 141.93 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.618 1.967 . . . . 0.69999999999999996 109.195 169.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -104.98 137.47 42.68 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.695 1.598 . . . . 0.51000000000000001 112.354 -173.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.559 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.7 OUTLIER -143.52 152.86 41.97 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.545 1.138 . . . . 2.02 111.784 177.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.13 144.85 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.968 2.107 . . . . 0.31 109.612 -174.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -85.9 147.64 26.17 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 122.886 1.326 . . . . 0.38 112.462 169.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 38.6 p -142.32 171.23 14.34 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.783 2.033 . . . . 0.31 111.747 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.16 -178.92 4.63 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.048 1.129 . . . . 2.0800000000000001 114.048 171.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.9 p -59.16 -28.08 66.26 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.899 1.074 . . . . 1.6100000000000001 113.899 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -85.54 16.73 3.64 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.48 1.112 . . . . 1.76 113.12 173.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 58.76 24.89 12.79 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.07 2.148 . . . . 0.65000000000000002 112.901 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -88.03 137.03 32.69 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.845 1.258 . . . . 2.23 110.747 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.4 mt -72.26 124.19 28.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.358 -0.608 . . . . 0.42999999999999999 109.358 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.509 HG22 HG22 ' A' ' 97' ' ' THR . 3.2 pt -113.21 152.15 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 125.543 1.537 . . . . 0.56999999999999995 115.109 175.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -81.21 160.66 24.25 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.647 2.379 . . . . 1.3799999999999999 108.944 165.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -62.48 -15.46 50.12 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.754 -1.216 . . . . 1.95 114.043 -176.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -89.19 3.45 51.88 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.173 1.389 . . . . 3.6299999999999999 112.675 174.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.47 0.07 89.32 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 126.494 1.997 . . . . 0.62 115.24 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -68.08 136.74 54.24 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.76 1.224 . . . . 2.2599999999999998 109.984 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.509 HG22 HG22 ' A' ' 91' ' ' ILE . 2.2 p -98.33 145.68 26.44 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.456 0.702 . . . . 0.83999999999999997 111.225 -175.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -94.5 -7.64 40.7 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.428 1.27 . . . . 0.73999999999999999 114.428 -168.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.14 30.16 47.62 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 118.935 0.789 . . . . 0.71999999999999997 113.797 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.8 t -140.22 145.2 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.677 1.591 . . . . 1.24 109.235 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -125.86 162.84 24.25 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.439 2.696 . . . . 1.49 111.015 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.6 mt -135.24 135.35 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.597 1.159 . . . . 0.63 110.947 -173.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.45 143.74 90.8 Favored Pre-proline 0 N--CA 1.477 0.904 0 CA-C-O 117.424 -1.274 . . . . 2.25 111.225 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.84 -20.76 10.17 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 122.325 1.866 . . . . 0.91000000000000003 112.944 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -88.97 -47.01 8.43 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.089 0.955 . . . . 1.3200000000000001 112.315 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.5 p -92.8 -28.5 16.52 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.41 1.084 . . . . 0.85999999999999999 113.242 -172.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 57.25 19.01 4.6 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.407 1.483 . . . . 2.1899999999999999 113.677 -167.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 146.63 49.73 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.018 -1.676 . . . . 3.3700000000000001 110.376 172.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.3 mt -86.68 138.88 31.3 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.338 1.055 . . . . 0.76000000000000001 111.314 176.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.1 p -71.49 0.23 8.89 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.132 1.16 . . . . 1.4099999999999999 114.132 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -171.93 -156.54 12.3 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 127.367 2.413 . . . . 1.1699999999999999 111.5 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.32 171.83 12.97 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.86 1.059 . . . . 1.3999999999999999 113.86 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.4 tpt -66.41 136.72 95.13 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.985 0.914 . . . . 1.8700000000000001 109.629 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.39 164.99 25.94 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.793 2.329 . . . . 0.87 113.329 -174.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.8 -77.23 0.26 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.592 1.157 . . . . 1.1399999999999999 112.346 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 69.3 p -83.07 5.83 21.05 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.656 2.095 . . . . 1.24 116.656 -167.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.67 143.0 43.14 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.203 1.557 . . . . 0.44 115.203 -171.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.6 ttt -74.34 102.27 4.33 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.626 1.97 . . . . 1.8 111.036 177.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -153.64 146.8 24.66 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.955 1.302 . . . . 0.93000000000000005 112.368 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -161.01 157.5 26.37 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.798 1.239 . . . . 1.9299999999999999 110.613 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 mp -91.91 144.59 25.32 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.048 0.939 . . . . 0.63 112.677 168.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.559 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 2.0 p -65.01 131.43 46.57 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.754 -0.591 . . . . 0.51000000000000001 109.43 169.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -85.83 -56.25 3.57 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.361 0.875 . . . . 2.5099999999999998 113.361 -173.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -159.79 -45.79 0.05 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.251 1.421 . . . . 1.05 110.122 169.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -89.35 -18.81 26.16 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.273 1.029 . . . . 4.79 113.191 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 153.43 -159.55 28.68 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.879 2.181 . . . . 0.58999999999999997 110.718 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.412 ' HB2' ' HA ' ' A' ' 122' ' ' THR . . . -142.81 132.12 23.42 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.907 2.083 . . . . 0.35999999999999999 110.237 168.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -93.34 143.45 26.26 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.605 0.965 . . . . 1.73 113.605 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -128.75 121.96 29.57 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 127.276 2.23 . . . . 1.96 107.274 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.563 HD21 ' HB3' ' A' ' 132' ' ' ALA . 11.4 t30 -83.33 106.34 15.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 118.433 0.56 . . . . 1.6699999999999999 109.768 -173.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.1 p -84.28 -5.12 59.22 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.831 1.048 . . . . 0.72999999999999998 113.831 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.563 ' HB3' HD21 ' A' ' 130' ' ' ASN . . . -55.1 -20.08 9.03 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.894 1.442 . . . . 1.0700000000000001 114.894 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -96.17 -15.11 22.28 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.091 1.356 . . . . 1.8600000000000001 113.635 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -80.64 151.62 71.6 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 119.908 1.231 . . . . 0.93999999999999995 113.427 176.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.88 170.38 9.95 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.597 2.865 . . . . 1.02 111.208 166.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.42 98.07 1.74 Allowed 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.59 1.156 . . . . 1.1899999999999999 109.414 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -153.12 177.54 10.7 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.631 1.173 . . . . 0.84999999999999998 111.78 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -90.49 151.34 21.41 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.38 1.072 . . . . 2.6099999999999999 112.663 168.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -144.69 174.4 11.01 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.84 2.056 . . . . 0.66000000000000003 110.892 -174.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -142.7 160.67 39.86 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.805 1.242 . . . . 1.5800000000000001 113.177 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.8 145.77 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.375 1.47 . . . . 0.42999999999999999 110.921 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -131.45 140.52 49.61 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.245 1.818 . . . . 1.8700000000000001 110.964 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -97.66 108.66 21.42 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.391 1.077 . . . . 2.1099999999999999 111.062 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.0 mm -117.34 113.61 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.181 0.993 . . . . 0.77000000000000002 109.836 -173.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -91.36 -5.79 53.97 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.059 1.133 . . . . 5.2800000000000002 114.059 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 86.9 p -72.94 0.83 10.11 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.148 1.536 . . . . 2.1899999999999999 115.148 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -95.4 -57.55 2.37 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.227 1.411 . . . . 3.3999999999999999 111.133 173.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.1 t -156.63 162.49 39.85 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.302 1.841 . . . . 4.6900000000000004 110.135 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.5 m -154.8 144.16 21.24 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.053 -1.03 . . . . 5.5999999999999996 111.324 173.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -60.37 159.25 10.43 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.977 1.311 . . . . 8.0 111.98 168.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 98.0 t -77.29 100.54 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.47 1.108 . . . . 5.4900000000000002 110.165 176.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -109.87 -30.04 3.61 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.762 0.696 . . . . 3.0800000000000001 112.814 172.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -75.8 1.34 15.16 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 116.046 1.869 . . . . 5.9100000000000001 116.046 -173.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -116.48 33.86 5.34 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.891 2.076 . . . . 6.1699999999999999 112.771 -169.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 101.76 -0.09 52.39 Favored Glycine 0 N--CA 1.478 1.475 0 O-C-N 120.719 -1.238 . . . . 4.3899999999999997 116.114 176.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -73.88 157.52 36.16 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 118.462 1.131 . . . . 3.3100000000000001 111.394 169.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.9 m -86.92 55.36 3.54 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 120.819 -1.176 . . . . 2.8500000000000001 111.672 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.2 mt -100.32 146.14 27.31 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.928 -1.107 . . . . 1.8999999999999999 113.243 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.9 m -101.21 133.31 45.97 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.005 1.722 . . . . 3.3599999999999999 111.746 -173.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -74.52 34.96 0.98 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.617 2.056 . . . . 2.6600000000000001 114.512 175.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 24.6 p -84.87 173.73 10.38 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.458 1.503 . . . . 2.6200000000000001 112.49 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.3 118.84 35.72 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.694 1.998 . . . . 1.8100000000000001 109.602 -172.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.18 147.86 47.89 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.309 0.644 . . . . 0.88 110.657 171.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.7 146.23 41.11 Favored Pre-proline 0 N--CA 1.473 0.677 0 C-N-CA 123.783 0.833 . . . . 0.59999999999999998 109.734 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.17 152.76 45.61 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.845 2.363 . . . . 0.48999999999999999 112.796 -167.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.656 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.6 mp -107.33 132.2 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.984 1.314 . . . . 1.28 109.233 -171.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -97.94 140.16 32.7 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.873 0.76 . . . . 4.21 111.279 169.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.8 tt -147.42 150.56 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.217 1.007 . . . . 0.46999999999999997 112.396 -171.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -127.33 158.27 37.69 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.418 1.887 . . . . 2.0600000000000001 109.121 169.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.22 159.79 84.46 Favored Pre-proline 0 CA--C 1.554 1.104 0 N-CA-C 113.913 1.079 . . . . 1.1299999999999999 113.913 -173.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -79.4 80.36 3.1 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.372 2.715 . . . . 1.22 113.298 -169.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 48.9 mt -107.02 46.79 0.91 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.043 2.137 . . . . 3.2799999999999998 108.938 169.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -123.36 175.37 6.76 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 128.199 2.6 . . . . 3.1800000000000002 109.653 -172.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -74.78 12.7 0.77 Allowed 'General case' 0 CA--C 1.557 1.222 0 O-C-N 120.035 -1.666 . . . . 3.5499999999999998 114.699 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.3 m -89.51 152.82 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.073 1.749 . . . . 1.05 113.661 -168.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.17 -30.17 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.668 1.187 . . . . 1.6799999999999999 111.964 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.03 156.22 42.39 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.688 0.795 . . . . 2.98 111.302 169.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -102.72 141.61 35.24 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.554 1.141 . . . . 0.40999999999999998 111.878 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -136.64 167.96 20.41 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.496 1.295 . . . . 0.58999999999999997 114.496 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -138.29 142.82 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.234 1.414 . . . . 0.54000000000000004 111.901 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -130.77 84.07 59.69 Favored Pre-proline 0 N--CA 1.465 0.304 0 C-N-CA 125.484 1.514 . . . . 2.3999999999999999 111.553 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.656 ' HB3' HD11 ' A' ' 166' ' ' ILE . 18.8 Cg_endo -72.82 133.2 19.71 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.25 2.633 . . . . 0.81999999999999995 110.177 167.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.7 167.46 21.09 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.697 1.999 . . . . 2.29 110.969 175.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -95.8 178.61 5.39 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.855 1.262 . . . . 2.9100000000000001 110.861 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 15.0 t -152.19 -26.17 0.17 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 115.421 1.637 . . . . 2.8700000000000001 115.421 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -135.61 171.24 14.74 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.617 1.567 . . . . 6.7000000000000002 111.831 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -83.76 154.37 23.62 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.24 1.016 . . . . 4.8099999999999996 112.658 173.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -66.23 152.72 93.72 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-O 118.804 -0.617 . . . . 12.76 111.336 169.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.4 158.73 56.39 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.775 2.316 . . . . 9.6099999999999994 113.484 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -93.11 -30.12 15.42 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.336 1.606 . . . . 12.039999999999999 115.336 -173.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.543 HD13 ' H ' ' A' ' 191' ' ' ILE . 0.2 OUTLIER -108.03 5.03 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.397 1.479 . . . . 13.289999999999999 113.335 -176.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 94.8 mt -126.0 157.77 37.0 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.051 1.741 . . . . 14.83 110.252 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.411 0 C-N-CA 124.711 1.204 . . . . 17.489999999999998 110.283 172.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 61.3 mtt . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 110.715 -0.105 . . . . 20.719999999999999 110.715 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.67 159.19 43.78 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.243 1.417 . . . . 20.300000000000001 112.514 173.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.0 p -90.61 -4.27 56.95 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.696 1.369 . . . . 16.489999999999998 114.696 -176.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.13 -27.78 62.13 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.986 1.476 . . . . 16.210000000000001 114.986 -170.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.4 m -125.47 33.22 5.17 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.857 1.663 . . . . 17.02 111.869 175.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.33 149.68 16.13 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 115.505 1.668 . . . . 12.08 115.505 -169.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.86 166.7 25.9 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.076 2.15 . . . . 10.57 110.391 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 77.6 p 43.62 41.79 3.72 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.76 1.624 . . . . 9.9199999999999999 114.961 170.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.6 m -63.71 156.13 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 113.09 0.774 . . . . 6.9699999999999998 113.09 -168.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -69.53 157.84 36.38 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.191 0.596 . . . . 3.9500000000000002 112.226 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.82 160.96 41.03 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.249 1.02 . . . . 3.4399999999999999 113.512 -168.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.43 31.66 0.29 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.599 1.559 . . . . 5.4400000000000004 114.776 -176.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.03 14.77 1.11 Allowed Glycine 0 CA--C 1.541 1.697 0 C-N-CA 126.142 1.829 . . . . 1.8700000000000001 117.654 -169.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.5 p -137.91 -172.69 3.31 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.848 2.459 . . . . 1.0700000000000001 111.04 -176.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.6 t -101.47 -16.98 16.65 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.351 0.871 . . . . 2.46 113.351 170.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.3 m -141.97 137.5 31.26 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.971 1.309 . . . . 2.5499999999999998 112.394 -171.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.4 p -83.56 -18.3 38.8 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.804 1.779 . . . . 0.97999999999999998 115.804 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.7 p -145.65 155.64 43.14 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.505 1.502 . . . . 1.46 113.834 174.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.5 p -113.21 140.99 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 127.335 2.254 . . . . 0.34000000000000002 109.98 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.9 m -107.94 116.45 31.98 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.383 0.673 . . . . 0.78000000000000003 109.601 173.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 p -92.38 124.6 44.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 123.947 0.899 . . . . 0.59999999999999998 109.18 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -102.78 176.78 5.05 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.084 1.754 . . . . 1.78 109.608 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.67 120.74 12.13 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 120.292 -1.505 . . . . 1.03 112.383 168.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.0 mt -106.62 159.45 16.19 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.749 1.22 . . . . 0.90000000000000002 111.958 -173.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.97 168.13 21.62 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.969 1.308 . . . . 2.1899999999999999 109.972 169.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.07 156.97 19.01 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.191 0.996 . . . . 1.3899999999999999 111.532 171.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.1 p -81.88 -32.6 30.93 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.323 -0.861 . . . . 2.0899999999999999 113.194 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -138.19 34.92 2.32 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.607 1.563 . . . . 3.6200000000000001 111.367 -174.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.35 11.35 82.26 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 125.209 1.385 . . . . 1.8200000000000001 116.538 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.08 31.48 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 129.485 3.114 . . . . 2.3500000000000001 116.514 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -31.86 72.92 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.405 -1.434 . . . . 1.1200000000000001 113.395 -175.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.86 -52.04 65.76 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.395 0.998 . . . . 2.71 113.678 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -67.69 -39.59 84.43 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 118.366 -0.826 . . . . 3.0099999999999998 111.432 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.1 mt -55.84 -49.98 71.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 119.075 0.852 . . . . 0.90000000000000002 110.599 171.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.39 -34.85 77.52 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.862 1.21 . . . . 1.28 113.057 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -74.06 -27.29 60.84 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.217 0.821 . . . . 1.49 113.217 172.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -73.13 -22.45 60.53 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.026 -1.046 . . . . 2.1499999999999999 113.109 169.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.6 mt -94.24 -39.78 10.35 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.1 1.148 . . . . 1.49 114.1 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -65.59 -22.01 66.64 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.054 0.843 . . . . 3.73 112.685 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 t -75.87 -26.58 57.22 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.126 0.97 . . . . 2.0899999999999999 113.181 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.04 164.71 46.49 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.571 1.081 . . . . 1.6299999999999999 113.512 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -83.42 35.07 0.49 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.17 1.388 . . . . 3.3399999999999999 112.81 169.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -76.61 1.5 16.7 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.183 1.179 . . . . 2.1699999999999999 114.183 -169.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.55 -23.9 67.58 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.04 -1.037 . . . . 1.49 111.036 166.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.13 -82.3 1.48 Allowed Glycine 0 CA--C 1.535 1.329 0 C-N-CA 123.829 0.728 . . . . 0.91000000000000003 112.448 168.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.02 154.06 40.64 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 116.435 2.013 . . . . 1.5700000000000001 116.435 -169.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -60.78 146.72 45.09 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.384 1.474 . . . . 2.4300000000000002 112.461 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.404 HG23 ' CE2' ' A' ' 181' ' ' TYR . 47.7 t -58.02 133.34 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.799 1.24 . . . . 1.26 111.848 -172.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.08 -52.71 45.65 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 123.117 0.389 . . . . 1.51 113.978 -175.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.1 t -149.44 134.36 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 127.648 2.379 . . . . 2.0 109.175 176.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.15 144.04 40.53 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 125.753 1.621 . . . . 1.1899999999999999 111.119 169.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.02 158.24 49.87 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.337 2.025 . . . . 0.87 111.371 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.72 -23.67 67.32 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.197 -0.939 . . . . 1.2 112.562 172.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -80.89 1.9 28.87 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.799 1.407 . . . . 1.52 114.799 172.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.81 159.42 15.07 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.841 1.256 . . . . 0.94999999999999996 113.567 170.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -150.59 169.76 20.76 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.098 1.759 . . . . 2.1699999999999999 111.446 167.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -124.4 135.58 53.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.367 1.067 . . . . 2.2000000000000002 111.155 -168.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.1 pt -135.35 151.91 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.798 1.239 . . . . 0.82999999999999996 112.65 -175.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.21 -179.24 4.63 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.339 1.456 . . . . 0.75 113.027 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.23 10.78 81.89 Favored Glycine 0 N--CA 1.476 1.301 0 O-C-N 121.37 -0.831 . . . . 0.62 115.164 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.3 p -101.14 144.66 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.569 1.948 . . . . 0.69999999999999996 110.042 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 2.9 tpp -101.57 138.74 38.16 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.305 1.442 . . . . 0.57999999999999996 112.166 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.494 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.6 OUTLIER -141.22 149.88 41.96 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.611 1.165 . . . . 1.6100000000000001 111.365 173.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.1 m -120.43 149.57 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.924 2.09 . . . . 0.42999999999999999 109.328 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -94.42 148.01 22.66 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 122.433 1.111 . . . . 0.5 112.217 171.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.4 p -143.56 166.99 23.3 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.482 1.513 . . . . 0.38 112.551 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -85.19 172.58 11.07 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.598 -0.689 . . . . 1.96 111.308 166.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.0 p -58.2 -30.45 66.46 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.056 0.943 . . . . 1.45 113.518 -172.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -87.43 29.24 0.88 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.659 1.183 . . . . 2.77 113.86 171.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 57.12 28.77 15.48 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.782 2.033 . . . . 1.1699999999999999 113.476 169.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -84.4 135.12 34.41 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.489 1.116 . . . . 2.0 110.941 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.2 mt -77.2 126.01 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.563 -0.532 . . . . 0.54000000000000004 109.563 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.424 HG22 HG22 ' A' ' 97' ' ' THR . 6.6 pt -122.53 157.63 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 114.766 1.395 . . . . 0.67000000000000004 114.766 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -88.08 164.66 15.62 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.594 1.958 . . . . 1.53 110.494 167.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.49 -1.55 6.85 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.942 1.83 . . . . 2.3399999999999999 115.942 -169.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -105.29 -1.64 24.98 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.072 1.749 . . . . 2.6600000000000001 113.489 169.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.96 8.24 59.24 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 125.234 1.397 . . . . 0.73999999999999999 116.443 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -70.07 127.55 33.23 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.733 1.213 . . . . 3.7999999999999998 110.333 171.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.424 HG22 HG22 ' A' ' 91' ' ' ILE . 1.0 OUTLIER -95.0 128.77 42.08 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.458 0.703 . . . . 1.1100000000000001 111.984 -178.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.64 -6.04 50.39 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 114.11 1.152 . . . . 0.91000000000000003 114.11 -167.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.7 15.95 62.58 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.601 1.572 . . . . 0.79000000000000004 114.027 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.4 t -122.05 146.93 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.501 1.52 . . . . 1.3799999999999999 109.335 -176.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -136.05 159.61 41.17 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.407 1.883 . . . . 1.3300000000000001 111.363 -175.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 48.4 mt -137.03 143.37 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 125.668 1.587 . . . . 0.75 110.311 -171.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -78.97 147.35 69.93 Favored Pre-proline 0 N--CA 1.479 1.009 0 O-C-N 120.026 -1.671 . . . . 1.8300000000000001 111.933 173.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.28 -20.0 11.5 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 CA-C-N 122.468 1.917 . . . . 0.94999999999999996 113.683 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -98.4 -37.76 9.48 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.64 1.976 . . . . 1.6200000000000001 113.317 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.2 p -95.3 -26.74 15.8 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.03 0.932 . . . . 1.04 112.76 -178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 54.82 19.47 2.6 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.901 1.28 . . . . 1.6399999999999999 113.245 -169.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.11 148.18 24.58 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.085 1.354 . . . . 2.7400000000000002 111.072 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 mt -85.94 147.29 26.31 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.558 1.543 . . . . 0.75 112.733 -173.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 96.7 p -66.41 -16.66 64.27 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.599 0.963 . . . . 1.55 113.599 172.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -166.98 -150.44 6.42 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 126.426 1.965 . . . . 0.88 112.36 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.37 167.69 21.27 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.078 1.14 . . . . 1.05 114.078 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.4 mmt -55.92 136.92 72.89 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.626 1.171 . . . . 1.6200000000000001 112.717 171.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -80.84 164.52 20.34 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.837 3.025 . . . . 0.80000000000000004 112.906 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.11 -90.39 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.022 0.929 . . . . 1.3600000000000001 111.246 169.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.5 p -77.65 15.27 0.85 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 116.514 2.042 . . . . 0.91000000000000003 116.514 -167.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.7 146.06 32.23 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.527 1.131 . . . . 0.57999999999999996 113.802 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.1 tpt -73.75 102.11 3.9 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.571 2.349 . . . . 1.46 110.636 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.3 pttp -156.04 149.59 24.85 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.575 1.55 . . . . 1.0900000000000001 112.305 -173.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -165.83 160.54 17.1 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.761 1.624 . . . . 2.6099999999999999 110.105 169.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.7 mp -91.71 146.9 23.4 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.411 1.084 . . . . 0.5 112.062 170.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.494 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 1.2 p -65.67 133.71 51.7 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 119.289 0.95 . . . . 0.5 109.751 169.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -84.72 -70.56 0.57 Allowed 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 113.951 1.093 . . . . 2.48 113.951 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.47 -39.85 0.43 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.526 1.131 . . . . 1.0600000000000001 111.447 173.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -99.54 -29.45 12.7 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.613 0.968 . . . . 4.4500000000000002 113.613 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.483 ' HA2' HG22 ' A' ' 122' ' ' THR . . . 168.76 -164.37 38.0 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.595 1.093 . . . . 0.68999999999999995 111.678 -170.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -139.98 131.79 27.5 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.464 1.906 . . . . 0.5 111.453 169.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -80.42 135.53 36.17 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.771 1.228 . . . . 1.29 112.453 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -126.79 123.15 36.72 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.747 2.019 . . . . 1.8300000000000001 108.406 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -71.37 130.15 40.62 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 121.166 -0.959 . . . . 2.0099999999999998 110.951 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 34.1 p -116.79 5.91 13.13 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.742 1.617 . . . . 0.89000000000000001 113.402 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.17 -20.56 64.26 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.196 1.398 . . . . 0.89000000000000001 114.19 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -111.99 -14.08 13.51 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.523 1.129 . . . . 2.4900000000000002 113.216 -171.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.3 142.62 84.73 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 119.083 0.856 . . . . 0.95999999999999996 112.258 171.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.85 163.66 28.48 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.442 2.095 . . . . 1.1699999999999999 111.37 167.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.13 53.87 0.13 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 128.79 2.836 . . . . 2.3300000000000001 115.969 -169.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -116.71 -179.65 3.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.862 2.065 . . . . 0.95999999999999996 112.829 -170.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -90.22 148.38 22.96 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.733 1.213 . . . . 3.1299999999999999 112.123 169.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -143.84 172.65 12.56 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.268 2.627 . . . . 0.63 109.998 -174.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -141.5 149.94 41.56 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.069 0.948 . . . . 1.77 112.947 173.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.15 139.06 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.307 1.043 . . . . 0.46000000000000002 110.351 172.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -125.11 129.92 51.18 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.157 1.783 . . . . 1.8400000000000001 110.285 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -92.87 118.93 31.67 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.474 1.11 . . . . 2.0800000000000001 110.261 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 47.1 mm -116.28 110.74 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 118.708 0.685 . . . . 0.67000000000000004 109.629 -171.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -79.4 -15.35 57.99 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.567 0.951 . . . . 3.98 113.567 -169.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 4.9 p -66.92 -15.31 63.58 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.265 1.58 . . . . 1.74 115.265 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -103.8 -5.63 22.23 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 119.865 1.211 . . . . 2.21 113.141 170.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.8 t -62.38 140.48 58.55 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.665 1.586 . . . . 5.5099999999999998 115.06 -167.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 33.9 m -91.6 -30.11 16.54 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.197 1.399 . . . . 5.0499999999999998 109.81 167.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.61 153.03 43.27 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.313 2.245 . . . . 5.9299999999999997 112.955 171.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.9 p -153.14 141.5 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 126.601 1.961 . . . . 5.0700000000000003 108.634 166.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -120.85 -29.38 1.54 Allowed Glycine 0 N--CA 1.475 1.247 0 N-CA-C 115.071 0.789 . . . . 3.3300000000000001 115.071 -176.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -86.3 -10.55 54.27 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.168 1.787 . . . . 5.4400000000000004 115.12 -174.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -96.99 34.22 1.77 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.34 1.856 . . . . 7.0899999999999999 112.589 -170.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.68 3.73 58.24 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.553 1.549 . . . . 4.6299999999999999 115.679 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -69.78 167.84 16.33 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.482 1.513 . . . . 3.3999999999999999 113.823 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 28.2 m -80.13 54.26 1.91 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.712 1.205 . . . . 3.0699999999999998 110.008 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.6 mt -137.04 144.86 43.44 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.919 2.088 . . . . 2.1899999999999999 108.247 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 22.2 m -61.71 -17.62 56.43 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 119.158 0.89 . . . . 4.6100000000000003 113.39 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 79.94 -5.22 62.89 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 120.755 -1.216 . . . . 2.7000000000000002 115.552 172.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 12.5 m -57.55 158.14 6.22 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.873 1.669 . . . . 2.7599999999999998 113.781 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.51 164.53 13.41 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.499 1.12 . . . . 2.3399999999999999 111.803 174.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -94.3 156.51 16.48 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.084 1.142 . . . . 0.93999999999999995 114.084 173.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.91 150.86 51.63 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 126.47 1.908 . . . . 0.92000000000000004 110.501 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.2 145.38 38.9 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.452 2.101 . . . . 0.63 113.737 -167.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.7 mp -113.35 125.12 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.695 1.198 . . . . 1.47 110.105 -171.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -86.1 139.77 30.82 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.678 1.191 . . . . 2.8100000000000001 111.475 174.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.1 tt -146.87 146.99 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.633 1.173 . . . . 0.56000000000000005 112.104 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -118.6 154.42 32.66 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.209 1.403 . . . . 2.0 109.041 168.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.0 mt -61.61 154.66 64.36 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 114.157 1.169 . . . . 0.93999999999999995 114.157 -175.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.86 103.55 0.88 Allowed 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.035 2.49 . . . . 0.76000000000000001 110.957 -173.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.1 mt -139.27 42.37 2.06 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.717 2.407 . . . . 3.2200000000000002 109.084 174.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -117.51 12.91 14.28 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 128.636 2.774 . . . . 3.5299999999999998 111.698 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 18.3 t0 57.2 28.51 15.19 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.558 2.343 . . . . 4.6100000000000003 114.74 -174.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.3 m -81.49 150.58 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.626 0.77 . . . . 1.1299999999999999 112.734 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.83 -38.47 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.554 1.142 . . . . 1.5 110.701 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -147.23 142.81 27.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.54 1.536 . . . . 2.4300000000000002 110.084 -175.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -105.71 141.48 37.08 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.246 1.018 . . . . 0.51000000000000001 111.92 -173.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -139.18 165.96 25.79 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.974 1.472 . . . . 0.54000000000000004 114.974 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.1 t -135.9 139.11 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 125.677 1.591 . . . . 0.51000000000000001 111.957 176.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.404 ' CE2' HG23 ' A' ' 66' ' ' VAL . 99.1 m-85 -131.66 78.87 69.92 Favored Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 124.927 1.291 . . . . 2.0099999999999998 112.241 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.79 149.18 87.01 Favored 'Trans proline' 0 C--N 1.349 0.57 1 C-N-CA 125.387 4.058 . . . . 0.52000000000000002 114.013 176.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -131.62 167.41 19.49 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.893 2.077 . . . . 1.54 111.974 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -116.58 162.54 17.46 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.061 0.934 . . . . 3.1200000000000001 113.517 -174.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 9.3 t -152.92 170.14 21.12 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.632 1.973 . . . . 3.3199999999999998 109.317 169.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 50.49 113.89 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.255 2.222 . . . . 6.54 116.515 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -71.35 -36.57 71.54 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.471 -1.393 . . . . 6.1500000000000004 114.075 -175.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -149.54 154.58 38.33 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 125.286 1.435 . . . . 10.119999999999999 111.968 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -76.42 175.17 11.69 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.528 2.818 . . . . 8.7699999999999996 111.811 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -69.17 -22.35 63.92 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.378 1.622 . . . . 14.449999999999999 115.378 -175.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.505 HD13 ' H ' ' A' ' 191' ' ' ILE . 0.2 OUTLIER -129.86 21.08 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 116.273 1.953 . . . . 13.140000000000001 116.273 -166.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.9 mt -137.17 116.04 12.28 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 119.397 0.998 . . . . 12.43 110.972 170.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.862 0 C-N-CA 125.433 1.493 . . . . 13.52 112.034 -170.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 118.011 -0.995 . . . . 32.409999999999997 111.868 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -64.58 100.78 0.4 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.889 1.222 . . . . 26.699999999999999 112.988 -174.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.4 p -133.72 -27.59 1.48 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.931 1.692 . . . . 25.780000000000001 113.118 -170.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -110.71 152.21 26.83 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.891 1.276 . . . . 21.510000000000002 111.467 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.3 m -109.35 164.69 12.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.572 1.149 . . . . 17.850000000000001 111.9 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.64 -47.85 68.4 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.954 0.902 . . . . 14.359999999999999 113.1 -173.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.3 -68.44 0.93 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.957 1.303 . . . . 12.539999999999999 110.88 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.3 p -141.46 130.96 23.84 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.74 1.616 . . . . 10.869999999999999 110.169 -176.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.5 p -68.49 127.98 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 122.182 0.992 . . . . 10.380000000000001 112.893 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -99.44 147.77 24.92 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.26 1.424 . . . . 4.0800000000000001 107.425 167.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 64.75 -27.47 0.09 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 117.481 2.4 . . . . 4.9299999999999997 117.481 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 44.74 45.97 8.42 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.869 2.068 . . . . 5.7599999999999998 116.376 169.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.94 33.83 80.49 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 124.785 1.183 . . . . 3.0800000000000001 115.672 169.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.5 p -86.33 154.98 20.82 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.245 1.818 . . . . 1.5800000000000001 114.673 -172.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.7 p -79.01 -13.66 59.66 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.046 1.128 . . . . 1.52 114.046 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 t -148.28 159.46 43.96 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.282 1.433 . . . . 2.52 111.684 170.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 p -94.35 -7.89 40.44 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.69 1.996 . . . . 1.1699999999999999 114.641 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.6 m -144.16 154.19 42.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.7 1.2 . . . . 2.04 113.243 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.3 p -117.77 147.53 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 127.622 2.369 . . . . 0.46000000000000002 110.182 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.5 m -110.8 116.28 31.0 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.481 0.658 . . . . 0.63 111.067 173.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 p -98.02 131.19 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.764 1.226 . . . . 0.88 109.294 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -112.63 -171.05 1.78 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.384 1.874 . . . . 2.1200000000000001 110.96 -174.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -145.53 123.41 11.98 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.163 -0.961 . . . . 1.3999999999999999 111.349 166.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.4 mt -110.49 150.96 28.14 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.857 0.863 . . . . 0.54000000000000004 111.281 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.28 165.92 27.03 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.676 1.59 . . . . 1.5900000000000001 110.966 -171.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.33 143.83 39.96 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.277 1.031 . . . . 1.3400000000000001 111.064 168.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.7 p -85.5 -44.67 12.5 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.326 1.45 . . . . 1.96 111.452 174.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -115.13 25.49 10.84 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 127.823 2.449 . . . . 3.2000000000000002 111.745 -171.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.63 7.43 84.41 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 126.267 1.889 . . . . 1.53 116.764 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -72.39 25.13 0.05 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.611 2.364 . . . . 2.0600000000000001 116.977 -171.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -27.0 66.72 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 119.369 -2.082 . . . . 1.29 114.072 -173.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -81.72 -41.35 21.4 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.567 0.951 . . . . 2.6600000000000001 113.567 -174.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -66.86 -38.29 86.06 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 120.284 1.402 . . . . 3.0499999999999998 111.286 169.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.2 mt -56.58 -48.39 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 120.014 1.279 . . . . 1.1499999999999999 110.72 168.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.05 -36.92 75.84 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.833 1.197 . . . . 1.4299999999999999 112.486 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -69.27 -32.84 72.29 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.859 0.864 . . . . 1.55 113.305 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -65.84 -35.02 79.5 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.262 0.937 . . . . 2.04 112.269 172.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.5 mt -84.31 -31.25 24.97 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.328 0.862 . . . . 1.5800000000000001 113.328 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -67.29 -30.49 70.37 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.141 0.882 . . . . 3.2799999999999998 113.261 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 t -80.09 -21.4 43.34 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.809 0.844 . . . . 1.9299999999999999 113.194 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.37 164.99 52.78 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.552 1.072 . . . . 1.4199999999999999 113.099 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -84.42 18.98 2.04 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.179 0.991 . . . . 1.8100000000000001 112.425 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -68.93 0.6 4.26 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 115.765 1.765 . . . . 2.3199999999999998 115.765 -167.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.66 -23.01 66.88 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 121.364 -0.835 . . . . 0.92000000000000004 111.273 165.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.85 -83.41 1.19 Allowed Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.898 1.713 . . . . 0.68000000000000005 113.176 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.22 160.4 26.92 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.623 1.342 . . . . 1.3999999999999999 114.623 -169.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -60.7 156.55 16.58 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.302 1.223 . . . . 2.9500000000000002 114.302 -173.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.3 t -58.16 129.53 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 121.815 -0.553 . . . . 0.75 110.484 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.77 -43.17 68.04 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.592 0.615 . . . . 0.79000000000000004 114.163 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.1 p -160.97 142.72 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.814 1.245 . . . . 2.73 110.241 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.9 mt -88.3 145.93 36.85 Favored Pre-proline 0 C--O 1.241 0.647 0 C-N-CA 123.774 0.829 . . . . 1.1599999999999999 112.099 176.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.492 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 37.6 Cg_endo -67.95 158.98 54.94 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.563 1.509 . . . . 0.76000000000000001 112.131 173.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.18 -1.64 3.47 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.894 1.278 . . . . 1.29 114.388 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.11 8.13 11.49 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 127.028 2.131 . . . . 1.5700000000000001 114.028 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.492 ' HB2' ' HG2' ' A' ' 70' ' ' PRO . . . -93.63 162.15 14.07 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.908 1.818 . . . . 0.90000000000000002 115.908 172.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -142.63 150.62 40.5 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 128.062 2.545 . . . . 4.0599999999999996 111.042 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -121.92 139.97 53.0 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.866 1.667 . . . . 2.1499999999999999 110.059 174.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.9 pt -132.79 152.73 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 113.53 0.937 . . . . 0.92000000000000004 113.53 -177.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.0 165.55 11.64 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.28 1.432 . . . . 0.81000000000000005 110.801 169.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.0 8.3 79.26 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 115.562 0.985 . . . . 0.76000000000000001 115.562 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.7 p -84.53 143.93 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 119.648 1.724 . . . . 1.05 110.216 169.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -102.01 136.42 41.88 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.417 1.487 . . . . 0.64000000000000001 112.113 175.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.45 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.3 OUTLIER -141.44 155.03 45.91 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.106 0.962 . . . . 1.73 112.802 171.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.15 146.57 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 126.99 2.116 . . . . 0.45000000000000001 109.969 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -90.94 146.53 23.81 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.322 1.058 . . . . 0.48999999999999999 112.716 172.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.6 p -143.6 170.78 15.19 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.979 1.712 . . . . 0.46000000000000002 112.521 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -97.8 174.74 6.45 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.448 1.099 . . . . 1.95 112.573 168.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.2 p -64.49 -18.45 64.8 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.476 -1.39 . . . . 1.45 114.321 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -76.22 7.35 4.32 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 126.029 1.732 . . . . 1.8500000000000001 113.241 167.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 55.71 33.31 21.09 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.4 2.28 . . . . 0.77000000000000002 111.603 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -94.37 138.94 31.73 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.697 1.599 . . . . 2.1600000000000001 110.395 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.4 mt -79.37 130.81 35.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 109.573 -0.528 . . . . 0.53000000000000003 109.573 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.483 HG22 HG22 ' A' ' 97' ' ' THR . 4.9 pt -125.3 155.53 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 114.689 1.366 . . . . 0.75 114.689 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -81.29 164.46 22.2 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 126.46 1.904 . . . . 1.54 109.536 167.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -64.67 -12.51 47.08 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.556 -1.34 . . . . 2.3300000000000001 114.0 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -97.66 4.86 50.0 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.714 1.605 . . . . 2.6699999999999999 112.992 173.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.75 10.48 85.08 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 120.551 -1.343 . . . . 0.71999999999999997 115.103 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -68.24 130.03 41.69 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.193 1.497 . . . . 3.0699999999999998 108.924 168.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.483 HG22 HG22 ' A' ' 91' ' ' ILE . 17.3 p -87.92 141.66 28.41 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.68 0.392 . . . . 0.73999999999999999 111.043 174.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -94.3 -11.07 30.84 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.688 1.366 . . . . 0.80000000000000004 114.688 -169.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.76 30.85 25.49 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.555 1.074 . . . . 0.68999999999999995 114.322 -172.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.0 t -133.95 146.06 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.37 1.585 . . . . 1.25 110.447 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -130.61 159.98 35.56 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.58 1.952 . . . . 1.28 110.641 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 54.1 mt -135.96 137.03 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 125.059 1.344 . . . . 0.52000000000000002 111.207 -174.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -71.53 141.22 85.1 Favored Pre-proline 0 N--CA 1.48 1.028 0 O-C-N 120.814 -1.179 . . . . 1.77 111.188 171.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.56 -24.41 13.85 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 122.494 1.926 . . . . 0.65000000000000002 112.64 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -89.77 -54.43 4.06 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.706 1.602 . . . . 1.46 111.79 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.4 p -78.91 -26.79 43.78 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.875 0.695 . . . . 0.78000000000000003 112.875 -174.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 56.37 19.14 3.82 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.792 1.237 . . . . 1.6699999999999999 113.896 -170.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.91 150.83 24.69 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.377 -1.452 . . . . 3.0699999999999998 111.528 176.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.9 mt -90.37 141.96 28.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.241 1.417 . . . . 0.82999999999999996 111.712 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.1 p -66.56 -4.11 7.84 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.535 1.309 . . . . 1.3100000000000001 114.535 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.4 -158.53 18.73 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 127.331 2.396 . . . . 0.89000000000000001 111.53 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.52 154.09 42.2 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.543 0.942 . . . . 0.91000000000000003 113.543 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.3 tpt -60.26 130.22 89.34 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 125.384 1.474 . . . . 1.6799999999999999 111.21 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -72.46 158.89 50.39 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.61 2.874 . . . . 0.94999999999999996 114.488 -173.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.91 -53.62 8.71 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.064 1.746 . . . . 1.0900000000000001 114.557 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.7 p -114.13 11.35 17.57 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.395 1.478 . . . . 1.01 114.148 -167.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.36 151.42 19.82 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.729 1.011 . . . . 0.60999999999999999 113.729 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.4 tpt -75.19 95.32 3.1 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.907 2.083 . . . . 1.5700000000000001 111.227 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -154.48 135.86 14.13 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.443 1.497 . . . . 0.93999999999999995 112.557 -173.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -168.46 142.65 3.26 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.971 1.309 . . . . 2.54 111.342 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.76 150.87 25.53 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.717 1.377 . . . . 0.67000000000000004 114.717 -173.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.45 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 11.4 p -62.12 132.8 54.03 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.243 -0.911 . . . . 0.67000000000000004 111.798 169.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -93.83 -55.0 3.39 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.587 1.155 . . . . 2.52 113.688 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -165.73 -52.78 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.2 2.2 . . . . 1.27 109.422 174.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -93.23 23.49 4.38 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.182 1.793 . . . . 5.2699999999999996 113.35 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.77 -151.78 17.73 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.244 1.878 . . . . 0.57999999999999996 111.692 -168.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.417 ' HB2' ' HA ' ' A' ' 122' ' ' THR . . . -142.77 129.96 20.89 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.068 2.147 . . . . 0.40000000000000002 111.14 169.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -82.04 133.5 35.29 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.531 1.133 . . . . 1.4199999999999999 111.556 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -124.77 124.48 42.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.299 1.84 . . . . 2.0899999999999999 109.143 173.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -73.68 118.43 16.63 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.462 1.105 . . . . 1.6599999999999999 110.576 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 22.5 p -101.97 -0.65 33.43 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.554 1.142 . . . . 0.66000000000000003 113.347 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.13 -16.01 4.54 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.61 1.707 . . . . 0.85999999999999999 115.61 -176.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -106.77 -4.57 19.22 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.904 1.076 . . . . 2.6000000000000001 113.904 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.46 152.73 67.64 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 114.131 1.16 . . . . 0.71999999999999997 114.131 172.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.54 174.29 5.93 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.205 3.27 . . . . 1.0800000000000001 112.218 167.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.47 100.08 3.74 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.328 -0.857 . . . . 1.1799999999999999 109.365 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -152.2 177.38 10.6 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.479 1.512 . . . . 0.79000000000000004 110.587 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -90.39 146.77 23.9 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.217 1.007 . . . . 2.27 112.04 168.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -140.07 167.9 21.06 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.879 2.071 . . . . 0.73999999999999999 109.294 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -139.72 148.01 41.72 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.928 0.891 . . . . 1.77 112.306 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -111.25 132.98 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.024 0.93 . . . . 0.42999999999999999 109.7 175.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -120.78 128.43 52.89 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.417 1.887 . . . . 1.98 110.287 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -104.39 105.3 15.38 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.79 1.636 . . . . 2.54 110.961 -169.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.6 mm -108.06 113.72 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.686 1.194 . . . . 0.72999999999999998 111.62 -167.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -88.7 23.08 2.4 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.291 1.219 . . . . 4.46 114.291 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 52.1 m -69.27 -39.72 78.24 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.094 -1.004 . . . . 1.5900000000000001 112.298 173.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.0 mp -77.63 88.47 3.92 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.137 0.88 . . . . 3.4399999999999999 111.49 172.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 14.2 m -54.57 118.14 3.93 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.954 1.302 . . . . 6.2300000000000004 110.413 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 52.1 m -148.31 -36.03 0.2 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.414 1.086 . . . . 4.3499999999999996 113.466 -169.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -138.65 160.88 38.53 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.831 1.653 . . . . 5.7699999999999996 111.607 176.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 60.7 t -121.84 136.14 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 113.157 0.799 . . . . 3.6899999999999999 113.157 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -117.74 -29.03 2.13 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 126.229 1.871 . . . . 2.6299999999999999 113.416 169.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.32 -13.99 62.51 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.647 1.721 . . . . 5.2000000000000002 115.647 -175.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -84.11 25.84 0.8 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.428 1.491 . . . . 5.9400000000000004 113.44 -171.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 81.84 14.55 77.34 Favored Glycine 0 CA--C 1.537 1.415 0 O-C-N 120.965 -1.084 . . . . 4.8300000000000001 114.408 -174.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.52 162.85 12.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.331 1.053 . . . . 3.71 113.152 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.7 t -75.68 44.02 0.27 Allowed 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 123.417 1.579 . . . . 4.54 111.695 169.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.4 tt -139.76 116.31 10.71 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.33 -1.481 . . . . 2.3300000000000001 109.812 -167.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 60.3 m -73.48 79.78 1.43 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.753 1.221 . . . . 4.3799999999999999 110.816 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -66.14 18.39 0.19 Allowed Glycine 0 CA--C 1.54 1.6 0 C-N-CA 127.409 2.433 . . . . 2.6699999999999999 117.343 -169.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 36.2 m -62.05 168.41 3.28 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 127.874 2.469 . . . . 2.98 114.164 175.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.7 147.91 44.49 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.851 0.86 . . . . 1.77 112.563 174.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -98.66 152.03 20.08 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.849 1.259 . . . . 0.94999999999999996 111.738 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.8 m -111.57 144.49 30.68 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 124.482 1.113 . . . . 0.56999999999999995 111.831 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.49 159.24 51.95 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.406 2.737 . . . . 0.81000000000000005 114.022 -167.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.405 HD13 HG12 ' A' ' 180' ' ' VAL . 1.3 mt -112.36 143.66 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.005 1.322 . . . . 1.8600000000000001 110.273 -176.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -110.15 140.83 43.84 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.54 1.136 . . . . 2.9300000000000002 111.694 171.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.6 tt -146.3 147.31 18.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.663 1.185 . . . . 0.68000000000000005 111.578 -175.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -126.18 151.51 47.25 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.011 1.325 . . . . 1.9299999999999999 109.484 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 5.3 mt -65.58 149.91 96.69 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 114.269 1.211 . . . . 0.96999999999999997 114.269 -171.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.31 92.43 0.92 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.632 2.888 . . . . 0.85999999999999999 114.382 -169.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -118.82 70.67 0.83 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 103.678 -2.712 . . . . 2.6699999999999999 103.678 164.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -145.7 -179.94 7.02 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.069 1.748 . . . . 2.6899999999999999 109.229 -166.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -79.74 6.58 10.47 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.871 1.668 . . . . 3.9300000000000002 114.57 -174.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -99.99 153.56 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.833 1.653 . . . . 0.97999999999999998 113.517 -168.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 44.8 t -96.76 -32.62 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.586 1.554 . . . . 1.6499999999999999 110.967 172.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -131.34 135.3 47.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.021 1.328 . . . . 4.4400000000000004 113.211 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -103.7 138.79 39.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.623 1.169 . . . . 0.44 111.121 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -134.63 168.54 18.8 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.481 1.289 . . . . 0.48999999999999999 114.481 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.405 HG12 HD13 ' A' ' 166' ' ' ILE . 0.2 OUTLIER -141.72 137.22 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.787 1.235 . . . . 0.62 112.549 -178.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -134.96 86.65 31.8 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 125.418 1.487 . . . . 2.0699999999999998 112.118 -173.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -71.5 152.77 60.36 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.325 3.35 . . . . 0.57999999999999996 113.756 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -132.18 172.47 12.36 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.974 2.509 . . . . 1.6200000000000001 112.338 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -101.73 -173.0 2.25 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.204 1.402 . . . . 2.77 109.767 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 14.1 t -152.25 -36.45 0.12 Allowed 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 116.698 2.11 . . . . 2.8199999999999998 116.698 -175.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -108.05 157.3 18.38 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.485 1.039 . . . . 6.2999999999999998 113.704 -174.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . 61.13 175.51 0.11 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.528 1.931 . . . . 6.9000000000000004 115.793 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -141.79 156.66 65.75 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 126.094 1.758 . . . . 13.390000000000001 110.525 170.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -61.03 141.28 93.81 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.066 1.844 . . . . 13.99 113.086 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -88.32 -9.72 51.85 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.645 1.35 . . . . 16.18 114.645 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 191' ' ' ILE . 1.4 mp -99.49 -56.03 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.244 1.418 . . . . 19.829999999999998 108.008 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.2 mt 68.56 145.97 0.05 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 117.68 2.474 . . . . 20.890000000000001 117.68 168.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 CA--C 1.545 0.766 0 C-N-CA 126.719 2.008 . . . . 27.16 110.723 168.73 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 109.15 -0.685 . . . . 25.059999999999999 109.15 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . 0.272 15.2 tt0 61.53 -124.01 0.83 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.205 1.802 . . . . 21.870000000000001 111.729 -169.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.0 m -81.93 -28.94 32.53 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.788 1.631 . . . . 17.469999999999999 113.446 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 55.3 24.71 6.72 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 116.419 2.007 . . . . 14.27 116.419 174.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.8 p -67.29 -12.72 60.86 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.101 1.519 . . . . 12.66 115.101 -174.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -139.67 162.84 34.13 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.641 1.576 . . . . 9.6899999999999995 111.081 169.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.94 -41.31 96.02 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.183 0.993 . . . . 8.8200000000000003 112.362 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.0 p -145.6 -173.85 4.24 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.201 1.801 . . . . 7.5099999999999998 109.785 -171.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.7 m -88.49 8.9 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.619 1.168 . . . . 6.1200000000000001 113.803 169.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 52.26 24.07 2.67 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.358 2.263 . . . . 3.3300000000000001 116.077 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 53.65 -162.89 0.11 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.342 1.857 . . . . 4.3200000000000003 114.314 176.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.56 153.83 46.28 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.07 1.748 . . . . 4.8600000000000003 110.618 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 159.61 26.43 0.02 OUTLIER Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.902 1.239 . . . . 1.95 114.659 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.4 p -150.76 156.05 40.49 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.024 1.412 . . . . 1.27 112.776 -170.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.8 p -98.75 -7.34 27.81 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.819 1.415 . . . . 1.3999999999999999 114.819 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.1 t -151.72 157.83 42.57 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.866 0.757 . . . . 2.1899999999999999 112.518 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 p -98.55 -4.46 34.16 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.95 2.9 . . . . 0.83999999999999997 114.82 -173.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.3 m -147.25 151.48 36.75 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.89 1.676 . . . . 1.9399999999999999 112.863 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.1 p -119.61 148.6 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 127.762 2.425 . . . . 0.44 110.291 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.2 m -121.48 127.54 51.16 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 121.414 -0.803 . . . . 0.72999999999999998 111.591 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 p -101.27 137.58 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.116 1.366 . . . . 0.64000000000000001 110.717 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -136.38 113.97 11.0 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.002 1.721 . . . . 1.75 111.209 -171.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.48 127.82 38.11 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 120.178 -1.576 . . . . 1.05 114.225 -168.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.6 mt -114.77 152.82 31.45 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.683 1.193 . . . . 0.53000000000000003 113.835 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.3 mt -140.3 176.33 8.86 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.86 2.064 . . . . 1.98 110.464 169.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.492 ' HB1' ' H ' ' A' ' 48' ' ' ASP . . . -106.51 163.82 12.56 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.925 1.083 . . . . 0.85999999999999999 113.925 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.3 p -84.13 -38.45 20.69 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.488 1.115 . . . . 1.0 113.352 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -146.89 63.19 1.19 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.953 1.701 . . . . 2.52 110.703 169.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.11 27.88 73.55 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 120.893 -1.129 . . . . 1.1699999999999999 115.419 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.492 ' H ' ' HB1' ' A' ' 44' ' ' ALA . 1.6 m-20 -74.41 15.27 0.36 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.053 2.141 . . . . 2.3999999999999999 114.448 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.33 -28.96 69.67 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.129 -1.607 . . . . 0.67000000000000004 113.01 -173.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -69.64 -45.79 67.67 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.246 0.93 . . . . 2.25 112.519 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -71.08 -41.86 70.12 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 118.18 -0.914 . . . . 2.0899999999999999 111.463 176.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 86.6 mt -51.74 -50.21 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.441 1.019 . . . . 0.57999999999999996 110.34 167.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.51 -31.33 70.4 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.566 -1.334 . . . . 0.81000000000000005 113.231 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -74.08 -34.56 64.05 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.51 1.124 . . . . 1.1499999999999999 113.199 172.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -66.26 -32.64 74.19 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.863 -1.148 . . . . 1.9399999999999999 112.174 170.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.1 mt -83.63 -36.7 23.65 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.854 1.057 . . . . 1.0 113.854 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -65.33 -29.75 70.53 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.487 1.04 . . . . 2.9900000000000002 112.481 177.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.0 t -79.7 -24.54 41.63 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.346 0.869 . . . . 1.3300000000000001 113.346 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.65 160.31 39.28 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.53 1.062 . . . . 0.93000000000000005 113.345 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -83.01 26.06 0.64 Allowed 'General case' 0 CA--C 1.552 1.035 0 O-C-N 121.367 -1.078 . . . . 1.95 112.369 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -68.82 0.28 4.55 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 116.339 1.977 . . . . 2.1200000000000001 116.339 -167.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.75 -25.18 66.29 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.694 1.134 . . . . 0.92000000000000004 112.704 171.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.04 -81.42 1.34 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.709 1.147 . . . . 0.72999999999999998 113.122 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.46 163.07 25.92 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.538 1.135 . . . . 1.48 113.035 -176.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -59.08 161.23 5.34 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.993 1.479 . . . . 2.2000000000000002 114.993 -171.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.84 109.88 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.115 -0.698 . . . . 0.93000000000000005 109.115 168.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.81 -25.16 65.35 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 119.171 -0.794 . . . . 1.1599999999999999 114.134 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.2 t -142.07 118.24 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.275 1.43 . . . . 2.1099999999999999 110.939 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -88.32 146.91 38.91 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.548 1.539 . . . . 0.91000000000000003 109.809 167.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.69 157.51 39.87 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.098 1.866 . . . . 0.81999999999999995 111.552 171.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.23 -24.03 67.23 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.213 -0.929 . . . . 1.3 112.716 173.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 40.7 p30 -77.76 -8.89 58.63 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.844 1.424 . . . . 2.1000000000000001 114.844 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.2 155.78 19.19 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.372 1.469 . . . . 0.58999999999999997 111.922 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.5 pttt -141.25 159.72 41.62 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.958 1.303 . . . . 2.1899999999999999 111.885 170.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -122.68 146.74 47.21 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.914 1.286 . . . . 2.3300000000000001 110.042 -175.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.6 pt -141.07 151.2 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.26 1.024 . . . . 0.88 111.795 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -113.65 170.0 8.57 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.716 1.607 . . . . 0.64000000000000001 111.242 173.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.2 15.53 74.18 Favored Glycine 0 CA--C 1.534 1.267 0 O-C-N 121.388 -0.82 . . . . 0.55000000000000004 114.702 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.5 p -98.8 139.73 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 127.179 2.192 . . . . 0.91000000000000003 109.611 173.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.8 tpp -103.87 136.87 42.74 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.769 2.027 . . . . 0.44 112.84 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.581 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.6 OUTLIER -141.65 152.83 44.3 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.656 1.583 . . . . 1.6699999999999999 111.761 174.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.12 143.53 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 126.757 2.023 . . . . 0.33000000000000002 109.474 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -86.8 149.04 25.13 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 122.2 1.0 . . . . 0.37 111.847 169.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 57.3 p -145.62 165.92 27.28 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.789 1.635 . . . . 0.46000000000000002 112.532 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -89.59 167.29 13.06 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.807 0.843 . . . . 2.27 111.082 166.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 49.3 p -61.57 -26.46 67.97 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.436 1.273 . . . . 1.3899999999999999 114.436 -168.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -76.29 16.66 0.44 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.367 1.467 . . . . 2.2000000000000002 114.477 169.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.52 30.2 17.12 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 128.142 2.577 . . . . 0.90000000000000002 113.204 175.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -92.65 140.03 29.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.28 1.432 . . . . 2.3100000000000001 111.775 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -82.95 124.84 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.037 0.446 . . . . 0.69999999999999996 110.273 -178.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.475 HG22 HG22 ' A' ' 97' ' ' THR . 5.9 pt -120.63 156.15 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 114.815 1.413 . . . . 0.58999999999999997 114.815 -177.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -79.89 158.94 26.57 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.85 2.86 . . . . 2.04 111.227 168.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -56.82 -8.05 0.54 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 127.282 2.233 . . . . 2.3700000000000001 116.317 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.86 1.32 19.16 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.476 1.51 . . . . 2.8900000000000001 115.021 172.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.79 4.2 63.7 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.359 1.457 . . . . 0.62 115.27 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -67.97 143.55 55.56 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.883 1.341 . . . . 2.5600000000000001 109.371 170.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.475 HG22 HG22 ' A' ' 91' ' ' ILE . 60.5 p -102.7 147.8 26.38 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.81000000000000005 111.368 -175.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -104.45 -5.86 21.24 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.847 1.425 . . . . 0.90000000000000002 114.847 -168.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.78 28.93 40.58 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 121.193 -0.942 . . . . 1.24 113.396 -177.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.8 t -133.48 147.26 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.969 1.308 . . . . 1.3400000000000001 110.063 177.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -134.73 155.06 51.22 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 128.205 2.602 . . . . 1.47 110.447 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.409 HG12 HD23 ' A' ' 109' ' ' LEU . 49.4 mt -133.42 133.82 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.213 1.405 . . . . 0.64000000000000001 110.854 -173.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -68.61 142.65 94.3 Favored Pre-proline 0 N--CA 1.476 0.849 0 O-C-N 120.633 -1.292 . . . . 2.0899999999999999 111.296 173.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.35 -24.12 16.89 Favored 'Trans proline' 0 C--N 1.35 0.636 0 CA-C-N 122.38 1.886 . . . . 0.70999999999999996 112.94 175.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -92.91 -52.19 4.71 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.382 1.873 . . . . 1.3300000000000001 112.692 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.9 p -80.73 -23.67 39.28 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.983 0.735 . . . . 0.94999999999999996 112.983 -175.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 54.89 18.06 2.05 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 125.747 1.619 . . . . 2.1499999999999999 113.839 -171.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.15 149.88 24.35 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.648 -1.283 . . . . 2.2799999999999998 111.789 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.409 HD23 HG12 ' A' ' 102' ' ' ILE . 38.6 mt -87.17 146.38 26.04 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.156 1.782 . . . . 1.1299999999999999 113.222 -175.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 97.3 p -76.98 0.64 20.4 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.446 1.276 . . . . 1.53 114.446 174.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.11 -158.26 15.86 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 127.176 2.322 . . . . 1.3100000000000001 110.762 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.07 156.18 25.95 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 118.534 1.167 . . . . 1.8 112.917 174.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 tpt -56.35 130.01 75.21 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 124.068 0.947 . . . . 2.0499999999999998 111.663 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.93 166.1 30.49 Favored 'Trans proline' 0 CA--C 1.537 0.64 1 C-N-CA 125.53 4.154 . . . . 1.1499999999999999 115.587 -172.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.63 -81.17 0.07 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.492 1.517 . . . . 1.3999999999999999 113.281 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.9 p -86.48 12.36 10.49 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.664 1.357 . . . . 0.91000000000000003 114.664 -169.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.7 148.59 16.01 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.21 -0.931 . . . . 0.41999999999999998 113.082 174.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.1 tpt -77.36 87.88 3.75 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.775 2.03 . . . . 1.6000000000000001 110.881 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -142.6 146.24 34.35 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.218 1.407 . . . . 1.0600000000000001 112.761 -173.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 43.5 tttp -162.01 159.73 26.74 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.524 1.13 . . . . 1.78 112.046 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 mp -102.2 145.74 28.97 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.595 1.158 . . . . 0.46999999999999997 112.824 169.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.581 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 8.7 p -70.26 139.78 52.24 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 119.335 0.97 . . . . 0.78000000000000003 112.332 174.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.63 -69.44 0.67 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.835 1.254 . . . . 3.1200000000000001 114.1 -174.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.43 -41.28 0.08 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.681 2.393 . . . . 1.1499999999999999 109.143 169.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -91.55 -10.62 39.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.986 1.714 . . . . 4.2800000000000002 114.216 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 143.23 -156.31 26.44 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.845 1.688 . . . . 0.91000000000000003 112.304 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.72 127.58 20.54 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.233 1.813 . . . . 0.52000000000000002 109.958 167.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -77.16 139.69 39.99 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.962 1.305 . . . . 1.3899999999999999 111.565 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -130.03 116.33 18.4 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.971 1.708 . . . . 1.9299999999999999 109.198 169.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.424 HD21 ' HB3' ' A' ' 132' ' ' ALA . 2.6 t-20 -72.34 115.44 11.6 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.915 1.286 . . . . 2.8799999999999999 111.006 176.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.8 p -104.02 -5.75 21.86 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.565 1.321 . . . . 0.56000000000000005 114.565 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.424 ' HB3' HD21 ' A' ' 130' ' ' ASN . . . -54.78 -27.69 43.33 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.456 1.28 . . . . 0.67000000000000004 114.456 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.68 -14.99 31.16 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.551 0.945 . . . . 2.25 113.551 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.52 147.91 85.2 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 119.603 1.092 . . . . 0.70999999999999996 112.792 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -75.44 167.24 27.04 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.21 1.94 . . . . 0.77000000000000002 110.95 167.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.03 94.8 1.93 Allowed 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.532 1.533 . . . . 1.1299999999999999 109.539 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -152.32 175.55 12.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.831 1.253 . . . . 0.65000000000000002 111.418 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -86.36 149.89 24.71 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.786 1.235 . . . . 2.7599999999999998 111.139 168.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -142.03 171.95 13.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.257 2.223 . . . . 0.44 109.735 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -142.19 154.82 45.13 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.359 1.064 . . . . 1.6399999999999999 111.962 176.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.09 135.93 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.939 0.895 . . . . 0.40000000000000002 110.773 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -121.65 142.31 50.26 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.801 2.04 . . . . 1.8500000000000001 110.575 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -108.69 118.09 35.88 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.076 0.951 . . . . 2.1899999999999999 110.648 -176.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.6 mm -114.08 113.51 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 108.67 -0.863 . . . . 0.87 108.67 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -74.26 -20.95 59.98 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.038 -1.039 . . . . 3.5800000000000001 113.077 -175.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.3 m -58.83 -16.65 18.18 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 116.894 2.183 . . . . 1.9399999999999999 116.894 -175.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -111.5 0.54 16.53 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 119.979 1.263 . . . . 2.29 112.94 175.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.6 p -65.47 143.52 57.63 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.814 -1.179 . . . . 5.2300000000000004 113.652 -170.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.5 m -97.62 -28.38 13.95 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.061 1.345 . . . . 5.4100000000000001 111.909 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.15 165.62 24.93 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.324 1.05 . . . . 5.5099999999999998 112.547 172.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 95.4 t -123.23 124.74 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.55 1.14 . . . . 3.54 110.224 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -142.75 -29.62 0.13 Allowed Glycine 0 N--CA 1.474 1.18 0 N-CA-C 116.119 1.208 . . . . 3.04 116.119 177.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -95.81 -16.9 21.56 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.687 1.595 . . . . 5.5599999999999996 114.077 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -89.42 55.3 3.2 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.953 1.094 . . . . 8.0299999999999994 113.953 -168.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.12 -3.88 84.75 Favored Glycine 0 CA--C 1.535 1.324 0 O-C-N 121.192 -0.942 . . . . 6.1399999999999997 114.377 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -80.82 165.65 21.67 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.862 1.265 . . . . 4.8099999999999996 111.492 171.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.7 m -94.96 -10.74 30.12 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.224 1.41 . . . . 5.8099999999999996 112.305 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.19 -33.94 72.91 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.32 1.048 . . . . 3.6000000000000001 113.54 -173.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.0 m -146.02 106.71 4.1 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.177 0.898 . . . . 6.2000000000000002 112.938 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -99.42 -21.12 15.58 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.14 1.353 . . . . 3.3999999999999999 113.428 168.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 37.3 m -93.01 156.28 16.99 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.292 1.437 . . . . 3.04 113.498 -173.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -91.91 142.53 27.46 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.858 1.663 . . . . 2.1200000000000001 112.503 173.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.59 154.9 39.6 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.777 -1.202 . . . . 0.90000000000000002 111.428 172.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.63 149.6 72.38 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 125.492 1.517 . . . . 0.63 110.625 174.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -74.47 145.81 34.16 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.282 2.654 . . . . 0.55000000000000004 114.64 -166.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.461 HD11 ' HB3' ' A' ' 182' ' ' PRO . 4.5 mt -98.35 140.2 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.191 1.396 . . . . 1.8300000000000001 110.019 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -113.89 121.46 44.03 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.988 1.315 . . . . 3.0699999999999998 111.491 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.7 tt -135.16 156.68 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.127 1.371 . . . . 0.40999999999999998 112.673 -168.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -138.49 159.66 41.51 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.953 1.701 . . . . 2.0699999999999998 109.022 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 19.0 mt -67.38 152.25 96.36 Favored Pre-proline 0 CA--C 1.551 1.008 0 O-C-N 121.282 -0.886 . . . . 0.94999999999999996 112.925 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.52 79.44 3.19 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 124.139 3.226 . . . . 0.95999999999999996 114.764 -167.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 1.6 tt -102.62 72.78 1.26 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.108 -1.442 . . . . 2.2400000000000002 107.108 167.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -146.44 -176.7 5.28 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.609 1.964 . . . . 2.8700000000000001 109.833 -168.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -79.85 0.0 32.87 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.127 1.528 . . . . 4.3499999999999996 115.127 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 1.4 m -80.41 159.05 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.535 1.134 . . . . 1.21 114.02 -169.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.2 t -99.23 -32.02 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 125.63 1.572 . . . . 1.73 111.507 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -142.25 128.61 20.0 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.736 1.614 . . . . 2.5099999999999998 108.781 -173.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -99.52 141.44 32.31 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.148 0.979 . . . . 0.54000000000000004 111.983 -172.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -142.38 169.59 17.29 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 115.725 1.75 . . . . 0.82999999999999996 115.725 -176.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.07 140.08 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.65 1.98 . . . . 0.59999999999999998 112.239 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -137.09 84.52 24.65 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 124.815 1.246 . . . . 2.3399999999999999 112.093 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.461 ' HB3' HD11 ' A' ' 166' ' ' ILE . 14.4 Cg_endo -69.34 148.47 67.89 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 124.08 3.186 . . . . 0.56000000000000005 113.689 174.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -131.82 162.94 29.35 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 127.773 2.429 . . . . 1.51 111.242 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -109.92 169.62 8.6 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.68 1.192 . . . . 3.1899999999999999 113.04 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 6.5 t -151.16 -163.23 1.72 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.123 2.169 . . . . 2.6099999999999999 111.575 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -124.92 145.1 50.0 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.858 1.663 . . . . 6.3499999999999996 113.071 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -165.55 -164.04 0.71 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.557 1.943 . . . . 6.2300000000000004 109.508 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -69.5 150.55 96.92 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-O 118.536 -0.745 . . . . 13.92 110.116 167.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -54.62 144.1 65.62 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.855 3.037 . . . . 10.380000000000001 115.264 -169.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.74 10.13 11.58 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.976 1.71 . . . . 15.779999999999999 114.645 175.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.3 mt -99.0 -52.54 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 126.198 1.799 . . . . 15.77 111.236 176.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 60.78 128.56 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 130.276 3.43 . . . . 15.369999999999999 115.857 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 . . . . . 0 CA--C 1.544 0.725 0 C-N-CA 126.457 1.903 . . . . 15.619999999999999 111.102 179.467 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 118.957 -0.544 . . . . 25.670000000000002 109.758 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -138.4 138.43 38.22 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.095 0.776 . . . . 23.620000000000001 113.095 170.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.0 p 60.5 151.29 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 127.935 2.494 . . . . 18.850000000000001 114.845 -171.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.17 178.29 7.39 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.0 1.32 . . . . 16.98 111.914 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.0 m -52.58 115.36 1.74 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.852 0.861 . . . . 15.73 111.12 170.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -127.09 -6.48 6.04 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.612 1.338 . . . . 11.83 114.612 -172.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 59.52 143.28 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.741 2.816 . . . . 9.7200000000000006 116.212 -174.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.9 p 52.9 -155.95 0.18 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.865 1.666 . . . . 8.1999999999999993 113.911 170.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.3 m -135.38 170.26 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 128.071 2.548 . . . . 7.25 111.767 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -99.79 167.8 10.31 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.05 1.34 . . . . 4.6100000000000003 110.734 168.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -125.6 152.97 44.42 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.546 1.138 . . . . 3.9300000000000002 112.702 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.07 96.94 10.91 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.724 1.21 . . . . 5.3300000000000001 113.233 -169.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.81 8.63 23.67 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.847 1.213 . . . . 2.0699999999999998 115.262 -176.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.4 p -134.45 177.47 7.74 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.668 1.587 . . . . 1.1399999999999999 113.442 -169.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.7 p -105.21 -1.62 25.14 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.825 1.25 . . . . 1.8799999999999999 113.809 170.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 m -146.74 148.66 32.19 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.683 1.993 . . . . 2.7799999999999998 109.05 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 42.2 p -111.0 -11.82 14.28 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.222 1.409 . . . . 1.1200000000000001 114.72 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.1 p -147.67 159.07 44.19 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.765 1.394 . . . . 2.0600000000000001 114.765 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.74 138.19 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.825 2.05 . . . . 0.56000000000000005 110.194 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.0 m -114.72 122.15 45.54 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.846 0.858 . . . . 0.67000000000000004 110.962 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.62 135.12 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.667 1.187 . . . . 0.59999999999999998 111.852 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -133.27 106.67 7.68 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.015 1.726 . . . . 1.8100000000000001 112.163 -172.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.58 132.98 34.88 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 120.138 -1.601 . . . . 1.28 112.98 -171.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.5 mt -122.43 163.17 20.31 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.495 1.518 . . . . 0.78000000000000003 112.904 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 42.7 mt -143.12 167.95 20.89 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.593 1.957 . . . . 1.5700000000000001 110.914 168.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.15 169.95 10.01 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.54 1.136 . . . . 1.02 113.373 169.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.6 p -94.49 -32.99 13.26 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.578 1.325 . . . . 1.5700000000000001 114.578 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -140.53 44.49 1.85 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.598 1.159 . . . . 2.5899999999999999 111.963 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.75 12.9 82.26 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.515 1.531 . . . . 1.3899999999999999 115.832 177.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.16 19.65 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 127.767 2.427 . . . . 2.6499999999999999 116.572 -171.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mmt -64.14 -19.55 65.37 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.103 -1.623 . . . . 0.83999999999999997 114.678 -173.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -76.39 -51.9 10.96 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.934 0.894 . . . . 2.3999999999999999 111.613 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -62.05 -40.91 97.35 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.881 -1.137 . . . . 2.3599999999999999 111.372 172.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 98.8 mt -53.32 -47.92 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 119.613 1.097 . . . . 0.76000000000000001 110.9 169.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.03 -29.28 70.17 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.715 1.143 . . . . 0.81999999999999995 113.3 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -73.31 -39.04 65.62 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.922 0.783 . . . . 1.0900000000000001 111.993 171.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -61.7 -32.83 73.06 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.428 1.091 . . . . 1.8899999999999999 112.444 172.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.7 mt -88.49 -36.12 16.62 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.789 1.403 . . . . 1.01 114.789 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.38 -20.53 64.69 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.613 1.097 . . . . 2.3900000000000001 113.121 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.2 t -80.93 -12.19 59.44 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.079 1.352 . . . . 1.4099999999999999 114.525 175.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.39 161.33 21.4 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.261 1.41 . . . . 1.3 112.236 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -79.02 37.59 0.31 Allowed 'General case' 0 N--CA 1.477 0.92 0 O-C-N 120.855 -1.379 . . . . 2.0299999999999998 112.27 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -77.19 -0.88 26.76 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.246 1.202 . . . . 2.3100000000000001 114.246 -173.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.79 -27.08 66.25 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 121.091 -1.005 . . . . 1.21 110.593 166.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.28 -54.62 0.38 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.204 0.907 . . . . 1.0 113.347 169.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -76.02 160.34 29.93 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.478 1.111 . . . . 2.7000000000000002 113.343 -169.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -68.72 155.36 40.26 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.222 -0.924 . . . . 2.8300000000000001 111.687 171.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.2 t -67.9 119.82 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 109.795 -0.446 . . . . 1.26 109.795 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.11 -42.77 83.4 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 119.624 -0.542 . . . . 1.5900000000000001 113.93 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.9 t -142.44 130.77 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.722 1.609 . . . . 2.21 110.671 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.69 142.94 29.66 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.489 1.116 . . . . 1.2 110.956 168.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.16 162.57 42.13 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.442 2.095 . . . . 0.96999999999999997 112.215 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.8 -29.01 69.96 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.865 -1.147 . . . . 1.29 112.531 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -79.8 1.88 25.17 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.806 1.642 . . . . 1.4099999999999999 114.966 173.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.43 157.06 16.91 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.705 1.202 . . . . 1.1599999999999999 112.815 169.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -147.32 167.97 22.96 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.774 1.63 . . . . 3.1400000000000001 112.067 170.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -126.8 144.17 51.04 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.533 1.133 . . . . 2.6800000000000002 112.296 -169.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.1 pt -142.15 146.2 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.72 1.608 . . . . 1.1200000000000001 111.046 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.03 158.82 43.49 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.315 1.046 . . . . 1.1000000000000001 111.99 173.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.65 15.86 21.5 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.03 1.3 . . . . 0.65000000000000002 114.855 -171.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 p -101.4 144.44 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 127.997 2.519 . . . . 0.87 110.501 175.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.4 tpp -97.38 139.33 33.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.555 1.942 . . . . 0.57999999999999996 113.374 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.569 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.6 OUTLIER -141.64 154.34 45.31 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.988 1.315 . . . . 1.6499999999999999 111.31 171.775 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.5 m -125.68 146.13 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.097 1.759 . . . . 0.34000000000000002 109.82 -174.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -85.67 147.0 26.58 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.76 1.266 . . . . 0.40000000000000002 112.548 169.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.6 p -141.33 172.02 13.25 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.761 2.024 . . . . 0.35999999999999999 112.493 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.11 -169.75 1.91 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 115.283 1.586 . . . . 1.8700000000000001 115.283 177.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 66.9 p -62.19 -33.68 75.0 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.663 -1.273 . . . . 2.1899999999999999 112.143 173.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -80.53 12.96 2.71 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.342 1.057 . . . . 2.1899999999999999 113.289 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.39 26.74 14.48 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.498 1.519 . . . . 0.68000000000000005 111.761 -172.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -93.35 143.48 26.24 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.93 1.292 . . . . 1.9299999999999999 111.751 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.4 mt -78.38 124.46 36.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.358 0.663 . . . . 0.46999999999999997 110.36 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.533 HG22 HG22 ' A' ' 97' ' ' THR . 2.2 pt -113.83 154.3 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.605 1.562 . . . . 0.53000000000000003 114.95 177.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.14 157.74 18.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.429 2.692 . . . . 1.79 108.666 167.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -54.76 -24.42 22.36 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.634 1.716 . . . . 2.3799999999999999 115.634 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . 0.261 0.0 OUTLIER -86.89 7.05 28.93 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 119.355 0.98 . . . . 2.9300000000000002 112.42 176.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.42 19.05 77.1 Favored Glycine 0 C--N 1.343 0.931 0 C-N-CA 125.909 1.719 . . . . 0.76000000000000001 113.417 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -80.66 137.88 36.36 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.299 0.64 . . . . 2.1499999999999999 110.261 169.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.533 HG22 HG22 ' A' ' 91' ' ' ILE . 20.1 p -96.19 146.17 24.91 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.829 0.852 . . . . 0.76000000000000001 111.099 -177.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.1 -6.04 29.09 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.579 1.325 . . . . 0.75 114.579 -168.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.27 28.03 46.26 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.193 0.902 . . . . 0.67000000000000004 113.802 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 36.6 t -134.48 147.89 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.103 1.361 . . . . 1.1299999999999999 110.501 176.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -129.8 158.44 39.43 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 128.973 2.909 . . . . 1.3300000000000001 111.091 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 74.7 mt -132.83 139.33 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 125.559 1.544 . . . . 0.54000000000000004 111.13 -174.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -75.79 139.06 69.8 Favored Pre-proline 0 CA--C 1.546 0.806 0 O-C-N 120.272 -1.518 . . . . 2.1600000000000001 111.97 171.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.19 -20.6 24.6 Favored 'Trans proline' 0 C--N 1.349 0.602 0 CA-C-N 122.645 1.981 . . . . 0.66000000000000003 113.517 176.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -98.21 -44.4 6.6 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.934 1.693 . . . . 1.28 112.018 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.9 p -90.2 -21.29 22.24 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.992 0.738 . . . . 0.81000000000000005 112.992 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 54.5 18.92 2.14 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.48 1.512 . . . . 1.8200000000000001 113.943 -172.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.1 148.92 21.81 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.728 -1.232 . . . . 2.6600000000000001 112.73 -177.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.9 mt -87.74 142.53 27.75 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.069 1.748 . . . . 0.83999999999999997 113.313 -170.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.8 p -71.26 -7.26 45.77 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.042 1.127 . . . . 1.3200000000000001 114.042 171.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.99 -161.26 14.64 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.959 1.266 . . . . 1.02 112.881 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.83 162.56 29.33 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.359 1.063 . . . . 1.29 113.333 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -51.51 137.09 32.12 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.777 1.231 . . . . 2.02 112.91 174.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.8 154.79 26.65 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.858 3.038 . . . . 1.01 114.199 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.17 -60.92 2.11 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.337 1.236 . . . . 1.24 114.337 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.6 p -119.84 15.64 12.61 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 114.363 1.245 . . . . 0.96999999999999997 114.363 -169.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.35 146.78 11.57 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.914 1.079 . . . . 0.46000000000000002 113.914 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.6 ttt -74.77 102.86 4.81 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.655 1.982 . . . . 1.97 110.605 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -156.25 146.21 21.22 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.018 1.727 . . . . 0.94999999999999996 112.211 -173.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -163.75 156.81 18.36 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.448 1.499 . . . . 1.79 110.627 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.1 mp -92.72 146.74 23.42 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.527 0.731 . . . . 0.62 112.03 173.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.569 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 5.2 p -65.3 140.57 58.7 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 121.054 -1.029 . . . . 0.62 110.183 169.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -98.08 -62.81 1.19 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.473 0.916 . . . . 2.1699999999999999 113.473 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -170.37 -31.14 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.439 2.296 . . . . 1.3899999999999999 110.682 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.14 24.03 10.75 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.045 2.138 . . . . 4.75 112.32 172.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.9 -151.63 27.71 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.94 1.257 . . . . 0.62 112.801 -170.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.3 129.77 24.06 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.63 1.972 . . . . 0.44 111.416 169.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -83.75 135.85 34.39 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.677 1.591 . . . . 1.3899999999999999 112.89 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -127.35 130.61 49.75 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.27 2.228 . . . . 1.6899999999999999 108.602 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -93.17 104.09 16.31 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.428 -0.795 . . . . 2.0499999999999998 111.608 -173.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.1 p -86.41 -0.8 56.74 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.69 1.196 . . . . 1.01 113.49 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.39 -25.49 59.58 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.94 0.896 . . . . 0.91000000000000003 113.222 169.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -87.74 -14.94 38.4 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.329 1.451 . . . . 2.1400000000000001 113.433 -174.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -90.4 150.19 42.41 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 113.881 1.067 . . . . 0.63 113.881 177.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -85.45 172.21 8.28 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.09 3.194 . . . . 0.77000000000000002 111.011 166.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.6 85.27 2.08 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.995 2.118 . . . . 1.1000000000000001 111.054 -174.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -141.56 176.1 9.16 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.159 1.384 . . . . 0.80000000000000004 111.256 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -91.28 145.7 24.44 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.621 1.2 . . . . 2.71 111.981 169.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -136.11 176.17 8.94 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.854 2.062 . . . . 0.58999999999999997 109.983 -172.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.95 156.74 43.0 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.642 1.177 . . . . 3.5899999999999999 113.411 177.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.0 142.38 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.66 1.184 . . . . 0.45000000000000001 111.354 172.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -131.1 142.21 50.24 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.722 2.009 . . . . 1.8100000000000001 111.891 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -103.78 126.85 51.2 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.246 1.418 . . . . 2.1099999999999999 112.843 -175.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 25.0 mm -128.01 143.64 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.434 1.493 . . . . 1.1299999999999999 110.246 -169.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -114.7 -1.48 13.28 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.093 1.516 . . . . 4.9100000000000001 115.093 -178.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.4 p -64.08 -17.85 63.81 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 120.06 -1.65 . . . . 2.3100000000000001 113.221 171.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -118.1 123.17 44.94 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 105.826 -1.916 . . . . 2.9100000000000001 105.826 165.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 28.9 t -159.15 142.17 14.41 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.372 0.669 . . . . 4.8600000000000003 111.241 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.5 t -136.51 31.12 2.86 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.177 0.991 . . . . 5.7300000000000004 111.958 175.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -128.85 175.63 8.48 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.492 1.117 . . . . 5.79 111.776 172.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.8 p -146.52 148.91 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.913 1.285 . . . . 3.8399999999999999 110.598 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -110.78 -32.5 2.65 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.273 0.463 . . . . 2.9500000000000002 113.626 170.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -80.22 5.19 15.25 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.326 1.85 . . . . 5.4199999999999999 115.33 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -97.37 21.94 9.43 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.968 1.707 . . . . 6.5599999999999996 113.333 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.42 0.51 89.4 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.629 1.109 . . . . 4.7400000000000002 114.099 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.96 158.78 7.9 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.217 1.407 . . . . 3.52 112.365 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.9 m -81.12 56.06 2.71 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.062 -1.024 . . . . 3.7799999999999998 111.717 -174.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -107.23 165.54 11.3 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.412 1.485 . . . . 2.3799999999999999 114.022 -170.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.9 m -142.62 125.51 16.11 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.415 1.486 . . . . 3.71 107.555 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.55 -10.84 61.28 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 115.846 1.099 . . . . 2.1200000000000001 115.846 -170.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 69.8 m -54.17 143.86 21.48 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.969 1.708 . . . . 3.3100000000000001 114.273 -176.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.64 149.66 24.75 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.306 1.595 . . . . 1.96 115.306 -168.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -87.47 158.5 18.94 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.089 1.356 . . . . 0.91000000000000003 112.526 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.7 m -122.91 145.23 45.03 Favored Pre-proline 0 N--CA 1.468 0.472 0 C-N-CA 124.497 1.119 . . . . 0.57999999999999996 111.198 178.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.9 161.95 43.39 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.049 2.499 . . . . 0.52000000000000002 112.476 -170.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.3 mp -126.85 119.33 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.861 1.264 . . . . 1.3899999999999999 111.067 -168.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -74.33 140.26 44.74 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.818 0.735 . . . . 3.29 110.853 168.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.9 tt -144.81 144.62 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.55 1.14 . . . . 0.47999999999999998 111.622 174.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -115.81 157.68 24.03 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.434 1.094 . . . . 2.1099999999999999 110.975 169.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.79 151.48 72.55 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.407 1.483 . . . . 1.1399999999999999 112.949 177.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -83.16 116.57 2.42 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.85 2.366 . . . . 1.1100000000000001 113.998 -169.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.75 57.64 1.67 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 104.864 -2.273 . . . . 2.3999999999999999 104.864 165.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -128.37 170.17 13.41 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 127.226 2.211 . . . . 3.5699999999999998 110.478 -167.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -71.88 -11.13 60.65 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 120.632 -1.293 . . . . 3.1899999999999999 114.242 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.0 m -77.41 148.69 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 114.733 1.383 . . . . 1.03 114.733 -171.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.1 t -80.58 -38.36 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.982 1.313 . . . . 1.8400000000000001 111.689 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -149.35 147.32 28.18 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.229 1.412 . . . . 2.5899999999999999 110.728 170.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -97.05 161.57 13.77 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.524 1.305 . . . . 0.59999999999999998 114.524 -168.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -133.97 169.89 16.44 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.074 1.509 . . . . 0.64000000000000001 115.074 174.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -138.55 144.78 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.623 1.969 . . . . 0.59999999999999998 111.148 173.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -137.06 83.25 28.31 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.685 1.594 . . . . 2.2200000000000002 111.032 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -69.72 151.15 69.24 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.501 2.801 . . . . 0.56000000000000005 113.241 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -131.17 156.62 45.01 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.968 2.107 . . . . 1.5900000000000001 112.037 -171.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -89.61 177.31 6.57 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 122.913 1.339 . . . . 3.79 113.369 173.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 32.3 p -125.14 178.39 5.58 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.321 1.848 . . . . 3.3100000000000001 112.171 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -71.61 -5.52 34.08 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.107 2.163 . . . . 7.5899999999999999 114.991 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -102.64 149.93 23.94 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.919 1.288 . . . . 4.7999999999999998 113.569 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -131.16 151.08 78.27 Favored Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 125.389 1.476 . . . . 9.1899999999999995 113.626 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -84.96 163.44 11.76 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.724 2.949 . . . . 9.7200000000000006 114.464 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -108.36 -15.77 14.39 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.116 1.766 . . . . 12.550000000000001 115.486 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.61 3.79 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 116.762 2.134 . . . . 14.800000000000001 116.762 -167.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 40.8 mt -90.05 62.85 5.71 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 123.118 1.437 . . . . 15.34 111.348 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 CA--C 1.538 0.482 0 C-N-CA 124.958 1.303 . . . . 16.16 113.429 -168.941 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.3 ppp? . . . . . 0 N--CA 1.476 0.862 0 CA-C-O 120.97 0.414 . . . . 26.219999999999999 110.982 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -84.01 101.33 11.67 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.794 0.807 . . . . 24.149999999999999 112.595 -170.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.5 t -149.75 151.48 33.68 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.69 1.996 . . . . 20.260000000000002 110.638 169.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -100.69 154.83 18.27 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.343 1.057 . . . . 16.489999999999998 113.353 -174.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 m -93.5 -28.91 15.8 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.182 0.993 . . . . 16.149999999999999 113.266 174.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -138.5 137.33 37.01 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.249 1.82 . . . . 11.68 111.179 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.38 166.95 14.46 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.741 1.386 . . . . 9.4199999999999999 114.741 -169.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.4 t -64.78 141.69 58.69 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.329 1.451 . . . . 8.9299999999999997 111.173 169.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.5 p -135.25 148.86 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.043 1.337 . . . . 5.8799999999999999 110.643 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -126.18 156.64 39.86 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.255 1.022 . . . . 4.7400000000000002 112.046 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.99 134.12 49.23 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.108 1.363 . . . . 4.21 111.119 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -159.25 151.84 21.55 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.675 1.59 . . . . 5.0800000000000001 110.418 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.78 31.14 0.28 Allowed Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.802 1.667 . . . . 3.0499999999999998 116.59 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.4 p -80.43 145.47 31.94 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 115.688 1.736 . . . . 1.1299999999999999 115.688 -168.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.7 p -89.13 -14.53 35.97 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.558 1.318 . . . . 1.45 114.558 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 t -147.18 165.29 30.46 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.452 1.901 . . . . 2.3599999999999999 111.365 171.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -103.89 -0.09 29.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.971 2.509 . . . . 1.02 114.83 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.413 ' HA ' ' H ' ' A' ' 131' ' ' THR . 88.6 p -149.28 165.43 31.94 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.553 1.141 . . . . 1.73 113.349 175.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.66 136.63 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 127.474 2.309 . . . . 0.53000000000000003 109.757 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.0 m -104.89 115.28 30.02 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.771 0.796 . . . . 0.88 110.796 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 p -95.24 134.56 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.28 1.432 . . . . 0.82999999999999996 110.486 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -116.98 179.1 4.12 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.583 1.953 . . . . 1.8400000000000001 109.988 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.96 129.35 18.93 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 120.35 1.432 . . . . 1.01 113.204 171.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.3 mt -115.0 148.24 39.08 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.422 1.089 . . . . 0.56000000000000005 113.85 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.5 mt -135.94 177.13 8.07 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.24 2.216 . . . . 1.99 109.995 169.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.418 ' HB1' ' H ' ' A' ' 48' ' ' ASP . . . -111.96 166.8 10.9 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.845 1.258 . . . . 0.81000000000000005 112.545 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.3 p -85.67 -32.98 21.68 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.593 -1.317 . . . . 0.92000000000000004 113.309 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -133.24 15.37 4.15 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.106 1.363 . . . . 2.4900000000000002 113.624 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.22 34.86 8.41 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 120.722 -1.236 . . . . 1.1299999999999999 113.379 -173.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.418 ' H ' ' HB1' ' A' ' 44' ' ' ALA . 1.7 m-20 -79.59 12.5 2.51 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.977 2.511 . . . . 2.04 114.614 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -60.17 -20.22 57.56 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.768 -1.207 . . . . 0.79000000000000004 113.081 -172.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.44 -56.04 19.38 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.033 1.733 . . . . 2.8999999999999999 113.041 172.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -38.87 70.45 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.173 -0.954 . . . . 4.3799999999999999 111.704 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 84.4 mt -53.21 -50.28 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.352 1.061 . . . . 0.67000000000000004 110.922 169.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.08 -32.66 72.31 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.826 1.194 . . . . 0.92000000000000004 112.987 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -70.51 -34.34 72.22 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.998 0.74 . . . . 1.3 112.998 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -67.79 -28.05 67.27 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.717 0.69 . . . . 1.95 112.57 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.9 mt -85.99 -36.28 19.88 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.952 1.093 . . . . 1.25 113.952 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -65.42 -25.48 67.55 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.214 0.916 . . . . 2.8599999999999999 113.137 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.1 t -76.37 -34.05 58.91 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.42 -0.8 . . . . 1.6799999999999999 112.868 173.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.62 167.86 48.99 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.559 1.076 . . . . 1.23 113.876 176.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -93.85 32.12 1.5 Allowed 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.199 -1.177 . . . . 2.1699999999999999 112.99 -173.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -70.95 3.01 3.64 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 116.057 1.873 . . . . 2.27 116.057 -167.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.0 -23.98 67.71 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.103 -0.998 . . . . 1.29 111.942 167.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.98 -76.68 0.85 Allowed Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.405 1.478 . . . . 0.95999999999999996 112.581 170.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.36 158.13 31.73 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.983 1.475 . . . . 1.48 114.983 -170.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -62.92 147.75 49.43 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.188 0.995 . . . . 4.0599999999999996 111.58 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.5 t -56.52 140.29 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.848 0.859 . . . . 1.1499999999999999 111.867 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.58 -66.21 2.65 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.404 1.002 . . . . 1.21 112.861 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.0 t -149.14 125.01 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.975 2.11 . . . . 2.02 109.62 174.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt -74.89 145.48 81.39 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.316 -0.865 . . . . 1.21 112.505 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -72.59 161.69 43.36 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.937 2.425 . . . . 0.62 112.188 -176.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.38 -15.62 63.79 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.405 1.261 . . . . 0.87 114.405 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -96.52 -1.3 47.44 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.607 1.563 . . . . 1.73 114.193 173.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.49 150.86 24.98 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.291 -0.881 . . . . 0.56000000000000005 112.556 169.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -141.6 151.44 43.15 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.595 1.558 . . . . 2.4100000000000001 110.975 169.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.14 138.75 53.7 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.051 0.941 . . . . 3.1000000000000001 110.7 -171.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.4 pt -131.85 153.03 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 115.403 1.631 . . . . 0.83999999999999997 115.403 -169.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -113.53 156.54 23.4 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.292 1.837 . . . . 0.65000000000000002 112.31 172.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.29 13.69 59.83 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.953 1.263 . . . . 0.53000000000000003 114.882 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.86 142.35 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.079 1.751 . . . . 0.81999999999999995 110.613 172.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -103.74 136.83 42.7 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.8 1.64 . . . . 0.55000000000000004 113.661 -175.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.462 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.9 OUTLIER -141.85 152.29 43.51 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.121 1.368 . . . . 1.6499999999999999 111.76 175.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.15 146.74 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 127.306 2.242 . . . . 0.41999999999999998 109.361 -176.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -88.91 147.61 24.26 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.396 1.093 . . . . 0.40000000000000002 112.287 169.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.2 p -136.68 165.1 26.68 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.025 1.73 . . . . 0.34000000000000002 112.395 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.02 168.67 13.1 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.092 1.357 . . . . 1.55 111.22 167.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . 0.267 1.3 t -67.15 -14.65 63.1 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 115.0 1.481 . . . . 2.8199999999999998 115.0 -168.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -83.69 19.07 1.73 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.717 1.607 . . . . 3.3799999999999999 113.055 167.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.72 23.31 12.16 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.233 1.813 . . . . 0.64000000000000001 113.558 -175.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -83.89 136.67 34.01 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.659 1.584 . . . . 2.6099999999999999 112.904 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.4 mt -77.79 128.79 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 121.602 -0.686 . . . . 0.47999999999999998 110.516 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.78 150.66 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 126.386 1.874 . . . . 1.03 114.326 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -77.73 161.61 27.59 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.331 2.252 . . . . 1.5800000000000001 110.965 168.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -56.6 -21.78 29.33 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 116.025 1.861 . . . . 2.46 116.025 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . 0.257 0.0 OUTLIER -87.87 -0.58 57.15 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 120.829 1.65 . . . . 2.7200000000000002 113.558 171.438 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.62 17.6 65.71 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.895 1.236 . . . . 0.75 114.405 -175.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -75.27 145.3 41.99 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.107 0.953 . . . . 2.6899999999999999 108.966 167.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.4 p -106.21 145.42 31.59 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.084 0.954 . . . . 1.0 112.416 -171.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -103.06 -4.98 23.8 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.126 1.158 . . . . 0.78000000000000003 114.126 -170.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.85 30.17 52.72 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 119.722 1.146 . . . . 0.70999999999999996 113.905 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 45.1 t -138.85 145.81 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.124 1.369 . . . . 1.2 110.308 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -126.49 159.29 33.83 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.644 2.778 . . . . 1.5 110.942 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 51.4 mt -136.91 134.15 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.302 1.441 . . . . 0.76000000000000001 110.387 -174.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -75.56 140.06 71.49 Favored Pre-proline 0 N--CA 1.476 0.854 0 CA-C-O 117.687 -1.149 . . . . 2.2400000000000002 111.836 176.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -72.17 -24.12 20.46 Favored 'Trans proline' 0 C--N 1.351 0.679 0 CA-C-N 122.154 1.805 . . . . 0.93999999999999995 113.136 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -88.01 -52.03 5.49 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.814 1.646 . . . . 1.3 111.777 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.0 p -83.21 -23.8 32.66 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.959 0.904 . . . . 1.0 113.15 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 52.52 23.4 2.54 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.056 1.743 . . . . 2.1200000000000001 113.653 -173.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . 0.252 2.2 ptmt -104.38 162.61 13.08 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.052 -1.03 . . . . 3.71 112.887 176.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.9 mt -94.48 149.57 21.11 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.474 1.51 . . . . 1.0900000000000001 114.629 -167.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.8 p -75.1 0.76 15.07 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.986 1.106 . . . . 1.29 113.986 169.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.23 -152.33 9.54 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.187 1.375 . . . . 1.01 112.277 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.76 155.07 19.44 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.017 0.927 . . . . 1.0900000000000001 113.345 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 tpt -51.08 130.78 30.96 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.806 1.642 . . . . 1.96 112.069 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.34 168.03 25.46 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.706 2.937 . . . . 1.0 113.425 -175.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.19 -91.53 0.07 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.764 1.226 . . . . 1.6399999999999999 110.83 168.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.4 p -74.56 10.87 1.17 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 116.49 2.033 . . . . 0.75 116.49 -167.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.57 147.46 14.22 Favored 'General case' 0 CA--C 1.55 0.95 0 O-C-N 120.437 -1.415 . . . . 0.46000000000000002 113.259 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.3 ttt -74.51 102.53 4.53 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.469 1.508 . . . . 1.72 109.98 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -156.85 145.29 19.71 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.622 1.569 . . . . 0.93999999999999995 111.656 -174.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -168.13 156.82 9.04 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.272 1.829 . . . . 2.6099999999999999 109.93 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.2 mp -87.45 150.08 24.0 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.335 1.454 . . . . 0.48999999999999999 113.585 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.531 HG22 ' HA2' ' A' ' 126' ' ' GLY . 1.2 p -63.98 129.77 41.37 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.218 -0.927 . . . . 0.55000000000000004 110.193 169.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -80.75 -57.38 3.58 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 120.771 -1.206 . . . . 2.0800000000000001 114.032 -174.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -153.03 -43.12 0.1 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.921 1.688 . . . . 1.1799999999999999 109.796 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -104.6 -33.15 8.62 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.039 0.936 . . . . 4.5800000000000001 113.239 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.531 ' HA2' HG22 ' A' ' 122' ' ' THR . . . 172.61 -170.65 43.72 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 126.218 1.866 . . . . 0.71999999999999997 110.865 -169.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -135.12 136.39 41.89 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.175 1.79 . . . . 0.56999999999999995 110.637 171.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -97.05 128.9 44.45 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.016 0.926 . . . . 1.3600000000000001 111.949 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -117.98 136.23 53.64 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.8 2.04 . . . . 1.75 107.738 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -96.66 104.41 16.4 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.553 -1.342 . . . . 1.8999999999999999 111.817 -169.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.413 ' H ' ' HA ' ' A' ' 36' ' ' SER . 39.4 p -86.77 1.65 51.51 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.655 1.182 . . . . 0.72999999999999998 113.349 -174.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.3 -29.12 68.64 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.412 -0.805 . . . . 0.88 112.093 169.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.7 m120 -86.92 -20.78 26.87 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.35 1.46 . . . . 2.2999999999999998 113.187 -175.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -79.06 144.22 62.82 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 119.474 1.034 . . . . 0.92000000000000004 113.253 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.22 169.46 20.18 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.643 2.229 . . . . 1.1899999999999999 110.733 166.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.97 89.68 1.92 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.054 1.742 . . . . 1.3300000000000001 110.771 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -149.09 177.81 9.27 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.827 0.851 . . . . 0.90000000000000002 112.052 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -87.04 146.37 26.12 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.107 0.963 . . . . 2.7200000000000002 111.628 166.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -135.84 170.49 15.9 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.993 2.117 . . . . 0.68999999999999995 109.718 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -140.25 149.72 43.21 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.549 0.739 . . . . 1.6699999999999999 111.788 171.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.2 mp -104.03 140.4 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.281 0.632 . . . . 0.44 110.072 173.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -124.75 135.94 53.42 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.926 1.69 . . . . 1.8700000000000001 109.852 174.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -97.55 123.84 41.58 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.122 0.969 . . . . 1.8400000000000001 109.392 178.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 40.3 mm -122.57 97.12 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.743 0.817 . . . . 0.70999999999999996 109.074 -172.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.7 -12.03 60.32 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.579 1.325 . . . . 4.21 114.579 -169.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 79.8 p -63.76 -19.97 65.39 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.271 1.211 . . . . 1.7 114.271 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -108.33 -4.61 17.3 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.543 1.537 . . . . 2.6899999999999999 113.326 172.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 56.2 m -59.28 135.56 57.69 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.245 1.384 . . . . 6.1399999999999997 111.722 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 16.7 p -82.74 -35.73 26.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.649 0.78 . . . . 5.0999999999999996 113.008 178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -90.03 114.13 25.94 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.387 0.675 . . . . 7.5499999999999998 111.275 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.75 132.35 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 122.772 0.429 . . . . 3.9300000000000002 110.683 176.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -110.14 -27.29 4.58 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 114.496 0.559 . . . . 2.23 114.496 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -77.36 -8.5 57.78 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.977 1.473 . . . . 4.7300000000000004 114.977 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -79.96 -13.34 59.42 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.285 1.834 . . . . 5.0499999999999998 114.609 -171.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 134.74 -10.26 4.57 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.115 1.341 . . . . 3.6699999999999999 115.175 -173.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.34 168.99 1.81 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.036 1.335 . . . . 2.73 112.61 172.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.8 t -70.19 9.03 0.64 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.416 -1.428 . . . . 3.52 114.739 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 11.2 mt -88.9 -176.74 5.29 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.864 1.665 . . . . 1.8899999999999999 111.018 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 34.2 p -133.04 153.7 51.24 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.599 1.56 . . . . 2.8799999999999999 110.444 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -77.2 29.42 1.65 Allowed Glycine 0 CA--C 1.541 1.661 0 C-N-CA 124.686 1.136 . . . . 2.1899999999999999 114.94 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.4 t -78.3 -176.75 4.83 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.764 1.226 . . . . 2.7200000000000002 112.582 -172.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -116.46 132.56 56.64 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 115.209 1.559 . . . . 2.1400000000000001 115.209 -171.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.62 152.96 29.74 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.099 0.96 . . . . 0.80000000000000004 111.857 168.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.56 149.04 54.63 Favored Pre-proline 0 N--CA 1.478 0.975 0 C-N-CA 125.337 1.455 . . . . 0.66000000000000003 110.784 174.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.9 162.72 29.21 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.894 3.063 . . . . 0.78000000000000003 115.299 -165.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.605 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.6 mp -126.41 133.47 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.742 2.017 . . . . 1.25 110.701 -168.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -98.14 130.88 44.89 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.438 1.095 . . . . 3.3900000000000001 111.838 174.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.4 tt -135.94 147.84 28.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.927 1.291 . . . . 0.67000000000000004 110.816 -174.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -127.48 152.93 46.94 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.986 1.315 . . . . 1.95 109.125 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.09 143.97 98.97 Favored Pre-proline 0 CA--C 1.543 0.688 0 O-C-N 120.94 -1.1 . . . . 1.05 111.614 -176.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -66.81 92.04 0.31 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 124.506 3.47 . . . . 0.79000000000000004 115.599 -165.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.2 tt -122.73 77.53 1.44 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.678 1.991 . . . . 2.3700000000000001 105.783 168.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -157.63 177.02 11.86 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.155 2.182 . . . . 2.6499999999999999 108.574 -167.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -84.33 34.36 0.52 Allowed 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.163 -1.585 . . . . 3.23 114.135 -175.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.63 156.51 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.845 1.258 . . . . 1.22 111.637 -174.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 78.2 t -108.88 -33.85 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.267 1.827 . . . . 1.8100000000000001 111.558 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -129.07 134.64 48.18 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.265 1.426 . . . . 3.7400000000000002 109.167 172.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -98.34 137.82 36.5 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.226 1.01 . . . . 0.40999999999999998 111.494 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -133.72 166.93 21.49 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.068 1.136 . . . . 0.63 114.068 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.28 135.91 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.2 1.4 . . . . 0.59999999999999998 111.568 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -134.18 82.52 47.5 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.569 1.147 . . . . 2.0800000000000001 111.466 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.605 ' HB3' HD11 ' A' ' 166' ' ' ILE . 60.4 Cg_endo -69.78 151.08 68.87 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 124.559 3.506 . . . . 0.58999999999999997 112.274 175.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -131.58 158.94 39.65 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.083 1.753 . . . . 1.6899999999999999 111.679 -178.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -88.64 175.01 7.72 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.311 1.044 . . . . 2.71 110.997 168.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 13.2 t -147.56 -56.6 0.24 Allowed 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.409 -0.807 . . . . 2.48 113.063 169.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 64.53 129.6 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.67 1.988 . . . . 6.4000000000000004 115.453 -174.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -96.57 -41.07 8.72 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.069 1.348 . . . . 6.79 112.607 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -149.69 151.89 33.76 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 126.317 1.847 . . . . 10.67 110.906 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.91 149.5 83.06 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.031 2.488 . . . . 8.0299999999999994 113.909 -171.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -147.28 26.78 1.06 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.642 1.977 . . . . 12.67 112.984 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.32 -9.34 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 115.902 1.816 . . . . 13.539999999999999 115.902 -167.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.87 168.08 20.69 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.072 0.949 . . . . 12.27 112.953 -171.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 193' ' ' GLU . 2.5 pm0 . . . . . 0 CA--C 1.549 0.936 0 C-N-CA 127.385 2.274 . . . . 15.83 114.532 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 109.638 -0.505 . . . . 26.379999999999999 109.638 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -121.57 172.73 7.89 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.939 1.296 . . . . 24.98 112.571 -170.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.7 p -71.52 10.02 0.72 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 115.16 1.541 . . . . 21.809999999999999 115.16 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.27 132.89 53.11 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.657 1.183 . . . . 17.550000000000001 113.819 -169.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.3 t -89.53 120.25 30.67 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.712 1.205 . . . . 13.98 110.822 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -116.24 174.02 6.28 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.885 1.274 . . . . 11.98 113.021 -174.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 65.19 -71.28 0.08 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.11 2.564 . . . . 9.1199999999999992 115.04 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.4 p -112.92 145.78 40.15 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.042 1.497 . . . . 7.1100000000000003 115.042 -167.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.1 m -98.93 3.13 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 126.58 1.952 . . . . 8.1999999999999993 115.493 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 55.61 168.92 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.75 2.02 . . . . 5.0 113.696 -169.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.43 -37.95 0.09 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 116.33 1.974 . . . . 5.3600000000000003 116.33 -170.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.49 -162.96 1.66 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.628 1.171 . . . . 4.8399999999999999 112.06 -167.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.49 1.07 43.62 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 126.888 2.185 . . . . 2.0899999999999999 114.454 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.9 p -152.7 164.7 37.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.204 1.802 . . . . 1.1299999999999999 113.416 -168.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 43.4 p -98.21 -8.48 27.33 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.343 1.457 . . . . 1.9399999999999999 114.067 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.0 m -147.5 146.02 29.34 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.478 1.911 . . . . 2.73 110.054 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.4 p -108.96 -14.48 14.55 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 116.901 2.186 . . . . 1.05 116.901 -172.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.6 m -138.61 149.62 45.43 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.019 1.328 . . . . 1.8200000000000001 111.589 170.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.5 p -115.7 142.66 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 127.071 2.149 . . . . 0.37 110.382 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 36.0 m -111.0 121.61 45.8 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.582 0.753 . . . . 0.73999999999999999 109.564 172.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 p -96.65 127.38 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.945 0.879 . . . . 0.58999999999999997 109.346 174.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -103.66 -172.47 2.12 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.02 1.728 . . . . 1.8999999999999999 109.029 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.8 134.19 13.47 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 120.411 -1.431 . . . . 0.93999999999999995 112.611 168.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.0 mt -121.06 150.57 40.98 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.852 1.261 . . . . 0.66000000000000003 112.971 -172.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.3 mt -140.81 169.66 17.22 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.332 1.853 . . . . 1.6899999999999999 109.761 167.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.98 172.97 7.07 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.993 0.917 . . . . 0.80000000000000004 112.029 173.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.8 p -102.31 -25.78 13.54 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 114.417 1.266 . . . . 1.02 114.417 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -134.95 45.22 2.55 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.668 1.987 . . . . 2.5499999999999998 110.365 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.47 14.63 67.17 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 120.741 -1.224 . . . . 0.87 116.007 175.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.63 27.24 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.982 2.513 . . . . 2.2000000000000002 115.921 -171.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.13 -19.06 65.8 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 119.617 -1.927 . . . . 0.68000000000000005 114.13 -171.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -85.14 -43.38 13.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.385 1.474 . . . . 2.2799999999999998 112.583 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -69.94 -39.09 76.28 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-O 117.941 -1.028 . . . . 3.4100000000000001 110.955 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.3 mt -51.6 -50.37 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.499 1.12 . . . . 0.98999999999999999 110.09 167.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.37 -27.47 66.0 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.554 0.946 . . . . 1.04 113.554 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -79.72 -32.22 41.23 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.063 -1.023 . . . . 1.23 112.937 174.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -67.97 -16.01 63.86 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.792 0.837 . . . . 2.1000000000000001 112.596 169.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.4 mt -97.46 -37.61 9.92 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.072 1.349 . . . . 1.1100000000000001 114.22 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -70.15 -15.93 63.02 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.57 -1.331 . . . . 2.5099999999999998 114.448 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.4 t -71.78 -30.2 65.3 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.01 0.924 . . . . 1.8999999999999999 113.25 170.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.38 164.6 28.29 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.48 1.514 . . . . 1.22 113.053 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -87.32 53.41 2.8 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.131 -1.217 . . . . 1.6299999999999999 111.412 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -89.41 8.01 33.0 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.378 1.251 . . . . 1.8899999999999999 114.378 -170.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.03 -25.79 63.74 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.139 -0.976 . . . . 0.92000000000000004 111.69 168.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.28 -82.53 1.21 Allowed Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.064 0.84 . . . . 0.67000000000000004 111.888 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 161.52 29.67 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.774 1.23 . . . . 1.74 112.708 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -60.36 158.13 12.44 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.804 1.242 . . . . 2.5099999999999998 114.341 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 52.6 t -59.04 126.73 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 121.881 -0.512 . . . . 0.71999999999999997 110.6 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.38 -48.84 75.19 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.061 1.315 . . . . 0.90000000000000002 113.301 -175.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.0 129.16 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.804 1.241 . . . . 2.5899999999999999 111.228 173.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.9 mt -79.62 144.54 61.04 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.066 0.946 . . . . 0.88 111.532 174.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.64 166.94 28.51 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.65 2.234 . . . . 0.65000000000000002 113.045 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.64 -23.83 65.38 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 121.015 -1.053 . . . . 0.90000000000000002 113.452 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -83.92 -1.43 54.52 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.373 1.249 . . . . 1.6399999999999999 114.373 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.09 158.19 16.47 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.282 1.433 . . . . 0.54000000000000004 114.162 172.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.77 159.45 44.34 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.55 1.14 . . . . 1.97 112.729 166.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -105.29 150.04 25.51 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.847 1.659 . . . . 2.8999999999999999 111.263 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.9 pt -137.92 139.29 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 120.067 1.303 . . . . 0.78000000000000003 114.282 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.74 146.95 25.97 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.759 1.223 . . . . 0.84999999999999998 113.102 172.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.8 14.36 27.25 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.341 1.448 . . . . 0.54000000000000004 115.42 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.43 144.44 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 125.287 1.435 . . . . 0.76000000000000001 109.795 169.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 1.3 tpt -105.25 140.26 38.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.554 1.542 . . . . 0.48999999999999999 112.115 176.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.52 155.67 43.23 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.841 1.257 . . . . 2.04 112.625 172.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.3 m -120.23 149.62 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 127.033 2.133 . . . . 0.40999999999999998 109.709 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -90.26 147.58 23.44 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 122.619 1.199 . . . . 0.35999999999999999 112.106 169.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.4 p -139.72 166.85 23.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.31 1.844 . . . . 0.42999999999999999 111.385 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.78 172.93 11.73 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.544 -0.722 . . . . 1.99 112.529 168.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.8 t -61.58 -23.98 66.36 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.437 1.273 . . . . 2.8999999999999999 114.437 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -87.9 20.99 2.83 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 125.379 1.472 . . . . 2.2599999999999998 113.347 171.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 56.75 27.47 12.81 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.779 2.832 . . . . 0.65000000000000002 114.742 175.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -82.7 140.56 33.03 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.013 0.925 . . . . 2.1600000000000001 110.31 172.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.4 mt -76.21 125.68 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.225 -0.657 . . . . 0.58999999999999997 109.225 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.471 HG22 HG22 ' A' ' 97' ' ' THR . 3.3 pt -121.86 156.91 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 114.644 1.35 . . . . 0.52000000000000002 114.644 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -90.1 164.09 14.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.619 2.367 . . . . 1.5700000000000001 110.115 168.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -68.97 2.9 2.31 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 116.689 2.107 . . . . 2.3999999999999999 116.689 -168.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -110.89 0.79 17.27 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.422 1.489 . . . . 2.8399999999999999 114.105 168.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.24 3.0 60.35 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.255 1.407 . . . . 0.62 115.644 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -65.31 132.13 48.25 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.042 1.421 . . . . 2.8799999999999999 108.932 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.471 HG22 HG22 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -96.05 142.41 28.29 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 118.134 0.425 . . . . 0.92000000000000004 111.43 176.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.22 -12.76 45.83 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.233 1.198 . . . . 1.1000000000000001 114.233 -168.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.56 22.72 23.34 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.053 1.311 . . . . 0.78000000000000003 114.511 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.0 t -134.79 149.55 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.373 1.469 . . . . 1.26 110.195 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -128.28 157.5 40.74 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.68 2.792 . . . . 1.29 111.292 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 57.1 mt -134.04 126.82 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.423 1.489 . . . . 0.63 110.321 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -68.64 137.71 90.71 Favored Pre-proline 0 N--CA 1.477 0.888 0 O-C-N 121.029 -1.045 . . . . 2.3300000000000001 111.046 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.06 -15.17 29.14 Favored 'Trans proline' 0 C--N 1.35 0.623 0 CA-C-N 121.924 1.723 . . . . 0.84999999999999998 113.785 176.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -97.19 -47.43 5.75 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.627 1.571 . . . . 2.1499999999999999 111.419 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.9 p -90.34 -22.03 21.73 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.728 1.211 . . . . 1.1499999999999999 113.458 -174.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 56.43 16.32 2.4 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.582 1.553 . . . . 1.74 113.923 -171.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.81 146.13 24.01 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.94 -1.1 . . . . 2.79 113.124 -175.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.9 mt -81.56 142.73 32.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.102 1.361 . . . . 0.95999999999999996 112.648 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 83.8 p -77.67 4.4 11.57 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.418 1.266 . . . . 1.3700000000000001 114.418 172.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.83 -162.52 29.63 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 126.106 1.813 . . . . 1.1599999999999999 112.388 -176.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.66 154.75 39.57 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.827 1.047 . . . . 1.3899999999999999 113.827 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 mtp -51.8 138.18 33.4 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.39 1.076 . . . . 2.1299999999999999 112.64 174.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -83.48 171.2 11.23 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.536 3.491 . . . . 0.82999999999999996 113.895 -172.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.12 -96.19 0.09 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.583 1.553 . . . . 1.3899999999999999 110.545 168.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.1 p -72.77 13.51 0.36 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 116.627 2.084 . . . . 1.02 116.627 -168.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.61 145.09 19.78 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.042 -1.036 . . . . 0.53000000000000003 112.812 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.1 ttt -75.0 107.89 7.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.872 2.469 . . . . 1.8100000000000001 110.353 176.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -157.73 143.24 17.11 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 127.303 2.241 . . . . 1.04 112.702 -174.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -164.91 158.1 16.84 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.013 1.325 . . . . 1.8700000000000001 111.859 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.8 mp -101.79 144.99 29.78 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.991 1.317 . . . . 0.53000000000000003 113.981 175.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.8 p -64.54 136.17 56.76 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.721 0.638 . . . . 0.54000000000000004 112.721 173.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.03 -59.13 1.86 Allowed 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 114.965 1.468 . . . . 2.3300000000000001 114.965 -172.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.25 -39.61 0.14 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.184 0.994 . . . . 1.0 111.871 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -115.35 -27.01 7.36 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.09 0.956 . . . . 5.2000000000000002 112.515 174.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 179.64 -156.04 17.2 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 123.836 0.732 . . . . 0.58999999999999997 112.263 -178.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.74 131.12 23.67 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.023 2.129 . . . . 0.41999999999999998 111.5 171.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -83.49 140.64 32.19 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.945 1.298 . . . . 1.27 113.579 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -134.39 118.74 17.77 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.989 2.516 . . . . 1.7 108.977 175.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.483 ' ND2' HD21 ' A' ' 133' ' ' ASN . 17.0 t30 -76.27 113.14 13.5 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.569 1.148 . . . . 1.6000000000000001 109.427 177.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 35.9 p -103.61 0.66 31.08 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.921 1.288 . . . . 0.69999999999999996 113.219 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -53.41 -18.48 2.66 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.756 2.422 . . . . 1.0600000000000001 115.276 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.483 HD21 ' ND2' ' A' ' 130' ' ' ASN . 0.0 OUTLIER -105.81 -23.81 12.62 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.373 1.869 . . . . 2.4199999999999999 113.088 -174.508 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.57 140.03 96.31 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 119.318 0.963 . . . . 0.94999999999999996 112.458 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.09 169.18 23.14 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.581 2.187 . . . . 0.82999999999999996 111.482 169.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.47 93.05 2.4 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.978 1.311 . . . . 1.3300000000000001 109.614 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -144.51 178.79 7.7 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.478 1.111 . . . . 0.96999999999999997 111.079 174.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -94.95 141.69 28.35 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.335 1.054 . . . . 3.29 110.988 169.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -135.34 166.72 22.5 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.222 1.809 . . . . 0.63 110.272 -172.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -141.49 149.17 40.56 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.24 0.83 . . . . 1.74 113.24 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 mp -105.91 142.34 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.572 1.149 . . . . 0.46000000000000002 110.201 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -129.43 127.29 40.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.891 1.676 . . . . 1.96 111.491 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -91.84 75.21 5.68 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.967 0.907 . . . . 1.95 112.656 -171.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.0 mm -77.75 107.99 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.742 0.817 . . . . 0.72999999999999998 109.908 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.78 9.07 40.43 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.763 1.023 . . . . 4.2400000000000002 113.763 -174.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.9 t -70.68 -19.15 62.81 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.752 1.019 . . . . 2.3900000000000001 113.752 -176.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.3 mp -86.26 166.19 15.88 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.158 0.983 . . . . 2.46 111.533 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.79 112.08 1.35 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.008 0.923 . . . . 5.9100000000000001 111.743 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.4 p -141.63 171.09 14.53 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.498 2.319 . . . . 5.0199999999999996 113.269 -167.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -56.97 155.82 7.62 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.694 1.597 . . . . 5.3899999999999997 113.642 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 91.1 t -110.73 133.4 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.952 1.301 . . . . 3.54 112.501 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -121.89 -35.81 0.76 Allowed Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.539 1.542 . . . . 2.3599999999999999 115.253 170.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.63 -6.35 48.18 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.38 1.622 . . . . 4.7800000000000002 115.38 -170.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -69.21 -15.54 63.41 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.244 1.817 . . . . 5.5800000000000001 114.459 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 126.98 -2.23 7.32 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.302 1.43 . . . . 3.8500000000000001 114.625 -175.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.96 168.05 2.59 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.066 1.747 . . . . 2.9300000000000002 113.937 175.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . 0.269 6.5 t -78.36 43.66 0.47 Allowed 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 123.249 1.5 . . . . 3.4399999999999999 113.406 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -122.02 130.31 53.18 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.143 2.577 . . . . 2.5299999999999998 107.966 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -100.07 158.27 15.96 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 118.939 0.79 . . . . 3.4399999999999999 112.793 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -79.1 42.1 2.3 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.615 1.579 . . . . 2.7200000000000002 115.276 -174.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 t -76.14 153.75 35.99 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.089 1.356 . . . . 3.04 112.705 -174.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -104.66 119.14 38.3 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.403 1.081 . . . . 2.29 111.788 -170.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.33 128.85 36.66 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.996 0.816 . . . . 1.04 111.79 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.2 m -100.46 149.6 36.24 Favored Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 124.24 1.016 . . . . 0.76000000000000001 110.356 172.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.74 161.29 46.59 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.797 2.331 . . . . 0.75 113.058 -170.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 1.5 mp -121.84 127.87 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.347 1.059 . . . . 1.55 110.761 -169.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -93.02 139.37 30.6 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.896 1.279 . . . . 2.7200000000000002 112.466 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.8 tt -147.48 146.57 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.965 1.306 . . . . 0.48999999999999999 111.964 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -120.88 155.73 33.52 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.047 1.339 . . . . 2.2999999999999998 110.639 169.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -67.53 148.61 98.6 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 123.793 0.837 . . . . 1.3 112.139 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.0 112.1 3.04 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.527 2.818 . . . . 1.1399999999999999 114.008 -168.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 tp -119.04 0.98 11.39 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 125.239 1.416 . . . . 2.79 110.854 165.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -76.85 169.16 18.82 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 129.585 3.154 . . . . 2.8999999999999999 111.53 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -74.16 19.54 0.12 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 116.46 2.022 . . . . 4.21 116.46 -171.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . 0.252 1.2 m -95.41 147.53 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 O-C-N 121.04 -1.038 . . . . 1.27 113.672 -169.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 41.2 t -88.31 -32.35 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.079 1.352 . . . . 1.6399999999999999 112.129 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -147.13 127.38 13.86 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.544 1.537 . . . . 2.54 108.645 -174.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -101.57 143.15 31.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.561 1.144 . . . . 0.41999999999999998 112.449 -169.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -139.02 170.62 15.65 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.329 1.603 . . . . 0.65000000000000002 115.329 -178.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.4 t -139.74 139.94 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.752 2.021 . . . . 0.57999999999999996 111.336 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -132.97 82.79 54.03 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.96 1.304 . . . . 2.23 112.988 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -65.89 143.53 73.44 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.689 3.593 . . . . 0.58999999999999997 113.913 171.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -140.71 166.68 24.1 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 129.08 2.952 . . . . 1.8999999999999999 111.027 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -117.93 169.52 9.57 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.927 0.891 . . . . 2.9500000000000002 113.06 -171.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 12.8 t -144.77 171.44 14.41 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.662 1.985 . . . . 2.54 111.74 -178.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 53.41 -63.25 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 130.604 3.562 . . . . 5.8799999999999999 118.087 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . 61.89 173.94 0.13 Allowed 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 127.182 2.193 . . . . 5.6600000000000001 115.6 -169.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -147.22 155.7 46.6 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 125.621 1.568 . . . . 10.140000000000001 111.733 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.03 160.01 51.65 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.759 2.306 . . . . 8.8000000000000007 112.99 177.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 23.3 mtmm -85.33 -25.14 27.31 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 116.402 2.001 . . . . 15.449999999999999 116.402 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.5 mp -83.99 -68.36 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 118.827 0.74 . . . . 14.24 111.726 -169.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 77.8 mt 56.62 177.41 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 126.047 1.739 . . . . 12.35 115.058 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 . . . . . 0 N--CA 1.474 0.737 0 O-C-N 120.595 -1.316 . . . . 15.85 112.265 -176.88 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.702 0.287 . . . . 28.370000000000001 111.388 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -120.87 135.89 55.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.11 1.364 . . . . 25.440000000000001 112.224 176.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.6 p -96.65 175.41 6.39 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.006 1.323 . . . . 22.030000000000001 109.079 166.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.88 -25.09 26.58 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 120.84 -1.162 . . . . 18.699999999999999 113.471 173.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.0 m 51.24 28.75 4.38 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.816 2.046 . . . . 18.949999999999999 116.057 168.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.99 155.87 30.17 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.152 1.381 . . . . 14.449999999999999 112.209 -175.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.07 -83.86 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.332 1.053 . . . . 11.779999999999999 112.85 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.3 p -101.08 143.34 31.31 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.236 1.415 . . . . 9.1999999999999993 112.885 -169.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.29 144.05 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.421 1.088 . . . . 7.7599999999999998 112.649 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -124.12 156.07 37.3 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.95 2.1 . . . . 5.2800000000000002 111.279 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -147.47 157.74 43.69 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 117.172 2.286 . . . . 5.4000000000000004 117.172 -166.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 40.86 20.43 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 131.59 3.956 . . . . 5.4400000000000004 121.332 167.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.54 -16.31 73.8 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.765 1.174 . . . . 2.3199999999999998 114.111 174.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.1 p -146.12 172.18 13.81 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.088 1.755 . . . . 1.3100000000000001 112.8 -171.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.4 p -92.8 -15.4 26.58 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.391 1.076 . . . . 1.47 113.754 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.4 HG21 ' HA ' ' A' ' 177' ' ' ASP . 98.9 m -148.37 124.44 10.73 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.008 1.723 . . . . 2.2599999999999998 108.9 171.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 45.2 p -90.86 23.63 3.07 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.181 1.548 . . . . 1.8500000000000001 115.181 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 m -149.17 165.79 30.76 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.057 1.343 . . . . 1.75 110.523 168.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.4 p -144.05 142.6 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.007 1.723 . . . . 0.34000000000000002 109.793 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.2 m -116.01 124.83 51.47 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.717 0.807 . . . . 0.65000000000000002 110.273 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -101.98 131.19 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.803 1.241 . . . . 0.63 110.599 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -128.15 104.67 7.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.227 1.411 . . . . 1.8100000000000001 110.888 -172.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.74 116.95 20.21 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.493 -1.379 . . . . 1.24 111.575 -172.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.3 mt -106.6 151.75 24.63 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.039 1.336 . . . . 0.66000000000000003 111.762 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.9 mt -138.16 171.55 14.24 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.33 1.452 . . . . 1.6000000000000001 111.137 169.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.56 162.77 13.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.356 1.063 . . . . 0.71999999999999997 112.678 170.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.6 p -91.39 -24.73 19.66 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 114.751 1.389 . . . . 0.93000000000000005 114.751 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -138.11 38.61 2.33 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.113 1.765 . . . . 2.1000000000000001 111.601 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.19 14.39 79.08 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 120.84 -1.163 . . . . 0.92000000000000004 115.659 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.01 25.26 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 128.889 2.876 . . . . 1.8400000000000001 116.221 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -24.59 67.59 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 119.883 -1.761 . . . . 0.69999999999999996 113.202 -173.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -75.28 -40.13 59.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.769 1.168 . . . . 2.1200000000000001 113.481 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.1 ptmm? -70.48 -41.41 72.75 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 117.448 -1.263 . . . . 2.79 111.357 170.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.6 mt -55.64 -52.88 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 120.252 1.387 . . . . 0.81999999999999995 111.47 170.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.61 -34.08 70.73 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.08 -1.013 . . . . 1.1699999999999999 112.785 -178.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -77.2 -30.75 54.88 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.715 1.005 . . . . 1.4099999999999999 113.715 175.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -66.35 -30.71 71.16 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.133 0.879 . . . . 2.1200000000000001 111.789 169.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.6 mt -86.4 -37.57 18.26 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.483 1.29 . . . . 1.3400000000000001 114.483 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -72.64 -23.89 60.97 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.063 0.764 . . . . 3.6800000000000002 113.063 -177.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.0 t -76.81 -28.43 55.57 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.673 0.62 . . . . 2.2000000000000002 112.673 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.6 156.65 35.23 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.106 1.336 . . . . 1.3500000000000001 112.745 172.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -83.57 31.45 0.47 Allowed 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.21 -1.171 . . . . 2.3500000000000001 112.817 -173.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -71.08 5.42 2.1 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.786 1.402 . . . . 2.0699999999999998 114.786 -169.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.95 -22.35 62.37 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.007 -1.058 . . . . 1.1299999999999999 112.289 167.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.69 -82.11 1.15 Allowed Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.263 1.411 . . . . 0.84999999999999998 113.455 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.42 157.09 38.66 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.491 1.916 . . . . 1.5 114.933 -172.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.9 157.14 19.06 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.687 1.195 . . . . 3.4900000000000002 113.793 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.477 HG23 ' CE2' ' A' ' 181' ' ' TYR . 25.1 t -63.67 130.98 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.907 0.883 . . . . 1.0800000000000001 110.539 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.67 -51.65 29.41 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 119.776 -0.458 . . . . 1.1100000000000001 113.723 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 t -146.73 136.36 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.227 1.411 . . . . 2.0600000000000001 109.629 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.1 mt -84.96 150.71 56.17 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.723 0.809 . . . . 1.04 113.151 171.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.429 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 72.9 Cg_endo -72.99 159.13 48.62 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.566 2.178 . . . . 0.73999999999999999 111.564 171.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.29 -30.17 66.41 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.421 -0.799 . . . . 1.1299999999999999 112.889 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -87.43 1.89 52.07 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.635 1.717 . . . . 1.48 115.635 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HB2' ' HG2' ' A' ' 70' ' ' PRO . . . -88.95 154.35 20.3 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.771 1.169 . . . . 0.56000000000000005 113.915 172.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -146.78 169.86 18.21 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.699 2.0 . . . . 2.04 112.329 171.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -128.31 138.42 52.38 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.3 1.44 . . . . 2.2000000000000002 111.248 -173.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.0 pt -126.96 141.56 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 114.096 1.147 . . . . 0.80000000000000004 114.096 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -112.97 158.31 20.41 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.833 1.253 . . . . 0.70999999999999996 112.993 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.64 4.88 82.44 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.789 1.185 . . . . 0.75 114.654 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -86.61 141.2 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.052 1.341 . . . . 0.80000000000000004 110.75 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -104.81 134.3 48.18 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.851 1.66 . . . . 0.66000000000000003 113.193 -173.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.438 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.7 OUTLIER -141.02 154.03 45.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.761 1.224 . . . . 1.71 112.278 177.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 m -127.04 144.32 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 126.513 1.925 . . . . 0.40999999999999998 110.067 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -87.18 147.69 25.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.595 1.188 . . . . 0.41999999999999998 112.024 170.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.5 p -140.99 167.24 22.66 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.881 2.072 . . . . 0.40000000000000002 111.13 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.8 171.57 11.46 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.949 0.722 . . . . 2.1499999999999999 112.949 169.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.2 t -63.13 -23.99 67.69 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.566 1.321 . . . . 3.1499999999999999 114.566 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -87.6 24.42 1.7 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.649 1.18 . . . . 2.3100000000000001 113.085 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.52 27.44 16.61 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 128.105 2.562 . . . . 0.80000000000000004 114.602 172.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -89.88 143.26 26.95 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.169 1.388 . . . . 1.8100000000000001 111.795 174.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.2 mt -79.3 127.48 39.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 123.28 0.632 . . . . 0.48999999999999999 110.034 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.731 HG22 HG22 ' A' ' 97' ' ' THR . 3.3 pt -121.61 153.94 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.991 1.716 . . . . 0.52000000000000002 115.139 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -84.6 165.55 17.88 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.429 2.291 . . . . 2.1000000000000001 110.574 167.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -64.91 -12.57 50.67 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.139 1.533 . . . . 2.5099999999999998 115.139 -170.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -96.98 6.11 49.24 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.319 1.448 . . . . 2.6200000000000001 113.564 173.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.62 5.12 82.21 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.938 1.256 . . . . 0.68999999999999995 115.066 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -73.69 142.71 46.39 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 124.321 1.048 . . . . 2.1099999999999999 110.403 173.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.731 HG22 HG22 ' A' ' 91' ' ' ILE . 30.6 p -104.94 147.29 27.94 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.974 0.91 . . . . 0.72999999999999998 112.499 -171.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.12 2.54 37.56 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.229 1.566 . . . . 0.81000000000000005 115.229 -168.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.88 23.43 74.82 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 120.529 -1.357 . . . . 0.75 114.733 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.2 p -138.05 143.38 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.709 1.204 . . . . 2.7400000000000002 109.749 177.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.14 164.59 18.37 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.7 2.4 . . . . 1.49 110.755 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 66.5 mt -135.61 131.13 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 124.873 1.269 . . . . 0.67000000000000004 110.321 -177.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -69.02 138.81 90.1 Favored Pre-proline 0 CA--C 1.543 0.696 0 O-C-N 121.038 -1.039 . . . . 2.29 110.813 175.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.07 -18.4 21.26 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 CA-C-N 122.12 1.793 . . . . 0.71999999999999997 113.21 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.77 -52.4 3.75 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.416 1.886 . . . . 1.8200000000000001 110.892 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.3 p -80.45 -25.75 38.73 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.019 0.748 . . . . 0.91000000000000003 113.019 -176.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 58.24 12.86 2.09 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.406 1.482 . . . . 1.6699999999999999 113.842 -171.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.02 150.66 26.21 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.624 -1.297 . . . . 2.4700000000000002 111.737 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.3 mt -85.52 140.63 30.49 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.68 0.993 . . . . 0.84999999999999998 113.68 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.2 t -88.66 35.93 0.79 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.533 1.533 . . . . 2.6899999999999999 111.397 169.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 170.46 -168.81 41.81 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.678 2.085 . . . . 1.1699999999999999 111.702 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.54 163.09 26.6 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.425 0.69 . . . . 1.01 111.396 170.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.7 tpt -59.87 127.19 85.09 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.081 0.952 . . . . 1.6299999999999999 110.778 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -69.91 171.57 14.39 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 124.818 3.679 . . . . 0.83999999999999997 113.671 -172.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.37 -92.18 0.07 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.332 1.053 . . . . 1.5700000000000001 110.722 169.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.8 p -73.83 6.65 3.09 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.7 2.0 . . . . 0.70999999999999996 116.398 -167.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.12 147.16 7.82 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.427 1.091 . . . . 0.42999999999999999 113.8 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.1 tpt -74.76 92.03 2.45 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.933 2.093 . . . . 1.55 112.196 -177.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.9 pttm -143.61 148.16 35.44 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.013 1.325 . . . . 2.1800000000000002 113.636 -175.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -162.85 165.6 25.07 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.186 1.395 . . . . 2.3300000000000001 111.356 172.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 148' ' ' SER . 5.2 mp -98.14 150.03 21.9 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.876 1.67 . . . . 0.63 113.25 172.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.438 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 2.5 p -67.23 135.9 54.13 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 119.632 1.105 . . . . 0.53000000000000003 111.131 168.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -89.01 -53.04 4.77 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 115.225 1.565 . . . . 2.1099999999999999 115.225 -175.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.55 -45.51 0.07 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.911 1.284 . . . . 1.1799999999999999 110.647 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -116.72 -18.77 10.18 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.015 1.117 . . . . 5.3799999999999999 114.015 176.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 177.35 -163.93 32.83 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.986 1.279 . . . . 0.62 112.216 -176.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -143.17 132.15 22.91 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 127.542 2.337 . . . . 0.41999999999999998 110.942 169.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -84.51 144.18 28.86 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.246 1.418 . . . . 1.3 112.323 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -135.5 124.37 24.05 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.969 2.107 . . . . 1.8300000000000001 108.708 172.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -73.11 134.59 44.56 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.504 -0.748 . . . . 1.76 111.216 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 71.9 p -121.37 6.14 10.16 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.412 1.485 . . . . 0.56000000000000005 113.671 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.7 -36.24 69.41 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.654 1.115 . . . . 0.94999999999999996 113.168 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -91.36 -21.48 20.99 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.835 1.254 . . . . 1.78 111.088 -169.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.1 139.95 96.0 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 119.819 1.19 . . . . 0.59999999999999998 112.663 170.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.67 169.65 20.48 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.997 2.464 . . . . 0.71999999999999997 111.192 167.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.2 89.34 3.67 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.547 1.539 . . . . 0.94999999999999996 111.26 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -146.84 -179.56 6.88 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.355 1.062 . . . . 0.67000000000000004 112.394 -175.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -98.4 137.54 36.94 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.199 1.399 . . . . 2.96 112.183 173.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -135.91 167.47 21.14 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.327 1.451 . . . . 0.52000000000000002 111.287 -169.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -139.78 153.17 47.07 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.159 0.799 . . . . 1.6399999999999999 113.159 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.9 mp -110.54 144.58 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.437 1.095 . . . . 0.40000000000000002 110.367 170.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -130.57 144.09 51.19 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.792 2.037 . . . . 1.8899999999999999 110.691 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -103.66 112.33 25.21 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.349 1.06 . . . . 2.1400000000000001 109.849 -175.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 19.7 mm -124.33 85.9 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.389 1.076 . . . . 0.97999999999999998 110.061 -168.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -14.79 60.64 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.438 -0.789 . . . . 4.04 113.063 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.4 t -59.24 -27.49 65.82 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.651 1.18 . . . . 2.1899999999999999 113.62 170.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.9 tp -86.75 -35.26 19.29 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 120.298 1.408 . . . . 3.6200000000000001 111.442 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.491 ' HB2' HD21 ' A' ' 121' ' ' LEU . 17.3 m -158.23 132.68 8.19 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.564 1.146 . . . . 5.8499999999999996 109.67 169.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.3 m -108.3 143.46 37.14 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.181 0.993 . . . . 6.3200000000000003 112.414 -169.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -100.84 140.05 35.66 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.404 1.082 . . . . 6.2999999999999998 108.923 168.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -69.79 149.58 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 O-C-N 121.641 -0.662 . . . . 3.6699999999999999 111.405 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -135.03 -40.42 0.16 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 123.426 0.536 . . . . 2.6600000000000001 113.44 168.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -79.26 1.43 24.84 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 116.593 2.071 . . . . 5.04 116.593 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -91.42 21.94 4.23 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.209 1.804 . . . . 6.4699999999999998 113.559 -176.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 103.47 -9.2 52.9 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.228 1.394 . . . . 4.8200000000000003 115.334 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.92 151.13 31.07 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 117.889 0.844 . . . . 3.54 111.193 169.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.7 m -83.15 40.44 0.7 Allowed 'General case' 0 N--CA 1.482 1.148 0 O-C-N 120.813 -1.18 . . . . 2.8300000000000001 111.809 -173.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.1 mt -96.11 166.29 11.82 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.776 2.03 . . . . 2.0600000000000001 114.274 -169.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.8 p -134.47 155.72 49.86 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.618 1.967 . . . . 2.9900000000000002 112.829 -170.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -78.9 -0.69 82.61 Favored Glycine 0 CA--C 1.54 1.651 0 N-CA-C 116.314 1.286 . . . . 2.6499999999999999 116.314 -177.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 4.9 m -57.18 147.71 24.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.973 1.709 . . . . 3.1099999999999999 113.533 176.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.44 143.18 31.77 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.868 1.267 . . . . 2.1600000000000001 114.043 -170.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.21 150.94 45.93 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.357 -0.84 . . . . 0.95999999999999996 112.308 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.35 147.43 40.54 Favored Pre-proline 0 N--CA 1.478 0.975 0 C-N-CA 125.069 1.347 . . . . 0.68999999999999995 111.169 174.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.93 138.69 23.54 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.411 2.741 . . . . 0.5 112.825 -168.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.0 mp -100.74 119.6 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 124.854 1.261 . . . . 1.3 109.982 -171.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.2 pm0 -88.51 138.99 30.93 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.829 0.852 . . . . 4.7800000000000002 113.161 174.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.2 tt -148.49 156.67 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.316 1.446 . . . . 0.59999999999999998 111.408 -173.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -127.58 152.49 47.58 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.473 1.509 . . . . 1.8400000000000001 110.092 170.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.2 138.68 97.32 Favored Pre-proline 0 CA--C 1.548 0.897 0 O-C-N 120.98 -1.075 . . . . 1.3100000000000001 111.226 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -72.64 111.6 3.28 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.575 2.183 . . . . 0.84999999999999998 114.844 -168.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.91 58.48 1.09 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 104.936 -2.246 . . . . 2.6400000000000001 104.936 165.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -144.15 144.59 31.64 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.13 2.572 . . . . 2.7000000000000002 108.512 -166.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -76.68 57.79 1.31 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.451 1.278 . . . . 3.9100000000000001 114.451 -170.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 1.6 m -112.94 151.15 14.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 125.114 1.365 . . . . 1.1599999999999999 110.538 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 96.4 t -88.13 -30.68 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.129 1.372 . . . . 1.53 110.802 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.4 ' HA ' HG21 ' A' ' 34' ' ' THR . 8.1 t0 -146.95 142.36 27.47 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.108 0.963 . . . . 2.5499999999999998 111.512 175.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -102.93 143.81 32.04 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.267 -0.896 . . . . 0.40000000000000002 112.702 -175.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -139.95 170.87 15.07 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.682 1.734 . . . . 0.52000000000000002 115.682 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -140.37 142.89 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.673 1.989 . . . . 0.45000000000000001 111.508 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.477 ' CE2' HG23 ' A' ' 66' ' ' VAL . 98.0 m-85 -131.77 76.42 74.39 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 113.814 1.042 . . . . 1.98 113.814 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.534 ' HB3' HD11 ' A' ' 166' ' ' ILE . 5.1 Cg_endo -62.51 146.9 95.5 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.528 2.819 . . . . 0.68000000000000005 113.912 176.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 15.8 mtmt -121.4 -168.7 1.73 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 128.609 2.764 . . . . 1.73 111.057 -174.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.259 0.6 OUTLIER -137.41 172.84 12.38 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.868 1.667 . . . . 3.4300000000000002 110.793 167.454 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 15.2 t -152.46 -178.32 6.76 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.18 1.392 . . . . 2.71 109.711 173.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.46 135.94 38.61 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 115.694 1.739 . . . . 6.5800000000000001 115.694 -167.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -166.09 173.3 10.44 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.523 2.729 . . . . 5.2599999999999998 108.337 168.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -59.82 140.89 89.68 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 121.771 -0.58 . . . . 10.970000000000001 112.248 173.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -74.21 127.92 11.68 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.376 2.718 . . . . 9.1300000000000008 114.01 -168.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 190' ' ' LYS . 0.0 OUTLIER -81.74 44.51 0.83 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.8 1.037 . . . . 14.65 113.8 179.746 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.33 -18.99 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 127.645 2.378 . . . . 15.67 114.042 175.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 85.1 mt -116.68 99.05 6.87 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.99 1.316 . . . . 12.83 110.286 -177.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 115.574 1.694 . . . . 16.239999999999998 115.574 -179.534 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 110.022 -0.362 . . . . 22.140000000000001 110.022 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -135.06 128.82 33.0 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.938 1.295 . . . . 17.960000000000001 111.204 172.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.5 p -136.43 156.31 48.8 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.765 1.626 . . . . 16.27 112.898 -168.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.92 162.75 39.72 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.818 1.247 . . . . 13.41 112.816 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.9 m -84.8 -17.52 37.89 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.121 1.156 . . . . 13.529999999999999 114.121 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 62.93 -5.39 0.21 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 127.657 2.383 . . . . 12.220000000000001 115.9 -173.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -162.8 151.52 14.64 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.091 2.157 . . . . 12.039999999999999 111.553 169.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . 0.317 44.0 p 48.98 54.81 10.26 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.708 2.403 . . . . 11.66 115.244 176.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.7 p -70.34 158.5 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.74 1.216 . . . . 6.6399999999999997 112.298 174.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.71 25.45 0.07 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 128.597 2.759 . . . . 4.4500000000000002 116.485 -168.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.76 134.78 40.36 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 125.965 1.706 . . . . 4.6100000000000003 113.066 -169.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 49.45 26.93 1.82 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.881 1.672 . . . . 5.7699999999999996 114.693 -171.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.44 -11.5 84.1 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.034 1.302 . . . . 2.1699999999999999 114.474 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.7 p -144.47 164.23 31.48 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 127.168 2.187 . . . . 1.1799999999999999 111.541 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.7 p -88.74 -17.12 30.55 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.335 0.865 . . . . 1.8 113.335 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 84.9 m -146.12 128.45 15.84 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.675 1.59 . . . . 2.7999999999999998 110.149 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 p -88.43 7.77 31.08 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 116.1 1.889 . . . . 1.26 116.1 -173.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.6 m -150.65 165.76 32.41 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.461 1.504 . . . . 1.77 111.811 171.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.73 144.59 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.266 1.827 . . . . 0.52000000000000002 110.938 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.01 111.33 17.76 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.934 1.293 . . . . 1.46 110.704 -170.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 p -98.9 133.73 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 120.376 -1.453 . . . . 0.54000000000000004 110.696 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -134.95 104.75 6.09 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.451 1.5 . . . . 1.8100000000000001 111.669 -171.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.53 126.03 30.72 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 119.887 -1.758 . . . . 1.1699999999999999 111.738 -173.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.4 mt -112.99 155.88 24.02 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.918 1.287 . . . . 0.48999999999999999 112.64 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.98 167.77 21.1 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.211 1.404 . . . . 1.9199999999999999 111.063 175.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.81 168.87 8.82 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.143 1.377 . . . . 0.68999999999999995 112.219 173.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.0 p -97.04 -27.69 14.49 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.612 0.968 . . . . 0.94999999999999996 113.612 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -145.3 37.59 1.13 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.455 1.102 . . . . 2.4700000000000002 112.807 172.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.62 14.38 59.88 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.87 1.224 . . . . 0.93999999999999995 115.449 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.38 14.34 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 128.232 2.613 . . . . 1.97 116.411 -174.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -63.09 -20.29 65.22 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.217 -1.552 . . . . 0.78000000000000003 113.939 -172.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -84.8 -38.84 19.1 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.647 1.179 . . . . 2.46 112.721 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -68.37 -40.39 81.46 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 120.901 -1.124 . . . . 2.6200000000000001 110.016 169.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.8 mt -54.86 -46.7 75.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 118.954 0.797 . . . . 0.71999999999999997 110.375 168.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.55 -29.46 69.16 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 120.372 1.442 . . . . 0.96999999999999997 113.655 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -77.44 -29.78 53.06 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.076 0.95 . . . . 1.4099999999999999 113.401 170.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -64.57 -28.08 69.39 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.135 -0.978 . . . . 2.4700000000000002 110.911 167.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.0 mt -87.82 -38.95 15.26 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.454 1.279 . . . . 1.1799999999999999 114.454 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.15 -25.78 67.95 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.833 1.049 . . . . 3.1200000000000001 113.833 -176.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.9 t -74.51 -25.81 59.59 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.534 0.734 . . . . 1.8799999999999999 112.977 174.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.16 166.69 38.86 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.174 1.369 . . . . 1.3 113.323 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -90.63 31.19 1.06 Allowed 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.323 -1.104 . . . . 1.6699999999999999 113.381 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -69.29 5.72 1.2 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.213 1.56 . . . . 2.1899999999999999 115.213 -169.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.32 -22.3 66.9 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.108 -0.995 . . . . 1.0800000000000001 111.486 166.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.87 -81.63 1.16 Allowed Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.881 1.705 . . . . 0.80000000000000004 113.52 170.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.24 172.19 12.26 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.031 1.332 . . . . 1.6100000000000001 114.582 -175.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -76.02 162.03 28.4 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 115.293 1.59 . . . . 3.3300000000000001 115.293 -169.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.422 HG23 ' CE2' ' A' ' 181' ' ' TYR . 21.9 t -55.18 130.64 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.433 1.093 . . . . 1.3500000000000001 110.526 172.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.36 -46.8 24.91 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 121.801 -0.562 . . . . 0.96999999999999997 113.808 -177.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.0 p -160.73 141.26 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.864 2.066 . . . . 3.1899999999999999 110.267 177.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.4 mt -84.84 147.67 49.16 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 121.466 -0.771 . . . . 1.3999999999999999 112.744 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.58 158.02 51.57 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.232 1.954 . . . . 0.81999999999999995 111.53 169.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.58 -19.6 65.98 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 120.708 -1.245 . . . . 1.1100000000000001 113.023 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -89.54 0.77 56.68 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.576 1.95 . . . . 1.3999999999999999 114.962 172.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.0 162.76 12.89 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.212 1.005 . . . . 0.67000000000000004 111.852 168.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -156.25 171.46 20.16 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.376 1.47 . . . . 2.02 111.56 169.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -123.35 148.87 45.59 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.643 1.177 . . . . 2.0800000000000001 110.592 -175.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.2 pt -137.24 137.01 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.683 1.193 . . . . 0.68999999999999995 110.715 175.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.95 161.59 14.07 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.321 1.048 . . . . 0.56999999999999995 111.005 171.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.01 15.84 62.12 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 121.315 -0.866 . . . . 0.51000000000000001 114.747 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -95.13 140.99 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.457 1.503 . . . . 0.68000000000000005 109.358 168.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.42 ' HG2' ' HB2' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -104.62 137.49 42.37 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.296 1.438 . . . . 0.53000000000000003 113.321 -173.156 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.43 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.8 OUTLIER -142.17 151.15 41.93 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.472 1.109 . . . . 1.5800000000000001 112.922 177.197 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 m -122.37 145.75 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.962 2.105 . . . . 0.34000000000000002 110.133 -176.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -86.61 145.94 26.53 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 122.301 1.048 . . . . 0.39000000000000001 112.124 169.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 35.8 p -140.88 170.15 16.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.66 1.984 . . . . 0.35999999999999999 112.223 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.36 -170.46 2.75 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 115.731 1.752 . . . . 1.9099999999999999 115.731 174.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.9 p -54.85 -42.37 71.9 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.641 1.176 . . . . 2.3100000000000001 111.646 171.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -88.94 20.03 3.8 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.974 1.31 . . . . 2.27 112.877 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.88 29.04 16.95 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.336 1.454 . . . . 0.67000000000000004 111.781 175.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -84.41 141.57 30.75 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 125.927 1.691 . . . . 2.5499999999999998 109.84 174.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.9 mt -78.69 125.31 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 109.356 -0.609 . . . . 0.52000000000000002 109.356 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.3 pt -120.44 155.13 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.614 1.166 . . . . 0.55000000000000004 114.118 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -86.38 166.11 15.83 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.372 1.869 . . . . 1.47 110.405 168.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -59.62 -21.36 60.31 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.921 1.452 . . . . 2.1400000000000001 114.921 -174.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -90.86 4.52 51.58 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.894 1.277 . . . . 2.8199999999999998 112.816 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.35 9.73 86.19 Favored Glycine 0 CA--C 1.533 1.195 0 O-C-N 120.523 -1.36 . . . . 0.55000000000000004 114.866 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -69.47 143.99 53.37 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.588 1.194 . . . . 2.23 109.192 168.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.9 p -105.45 140.04 39.16 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.112 1.365 . . . . 0.81000000000000005 111.765 -172.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.26 2.68 54.9 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.601 0.963 . . . . 0.76000000000000001 113.601 -170.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.44 25.35 70.61 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.75 -1.219 . . . . 0.72999999999999998 113.663 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 54.1 t -131.69 149.04 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.488 1.915 . . . . 1.1599999999999999 109.397 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -130.03 158.16 40.36 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.999 2.52 . . . . 1.4199999999999999 111.52 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.0 mt -135.94 128.37 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.631 1.572 . . . . 0.58999999999999997 109.802 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -69.02 141.44 92.03 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 117.565 -1.207 . . . . 1.8100000000000001 111.012 174.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -73.91 -22.13 17.75 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 CA-C-N 122.828 2.046 . . . . 0.60999999999999999 113.236 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 68.6 mm-40 -93.29 -53.46 4.09 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 127.034 2.134 . . . . 1.4099999999999999 112.158 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.9 p -78.29 -24.36 46.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.093 0.557 . . . . 0.81000000000000005 112.381 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 53.8 17.27 1.24 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.721 1.209 . . . . 1.6299999999999999 112.718 -171.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.46 138.2 31.68 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.021 0.928 . . . . 2.5699999999999998 111.257 -174.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.0 mt -78.08 144.18 36.77 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.021 0.928 . . . . 0.85999999999999999 111.394 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 95.2 p -72.72 3.93 4.58 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.892 1.071 . . . . 1.47 113.892 170.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.16 -153.85 13.04 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.719 1.152 . . . . 1.26 113.941 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.28 160.12 21.78 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.046 1.339 . . . . 1.26 112.712 176.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 mmt -51.42 140.95 24.13 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.57 1.548 . . . . 1.5800000000000001 114.062 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.71 167.26 27.0 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 124.543 3.495 . . . . 0.91000000000000003 114.242 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.37 -48.15 13.37 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 116.072 1.878 . . . . 1.72 116.072 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 46.1 p -134.11 10.84 3.88 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.408 1.083 . . . . 0.81999999999999995 113.887 -169.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.95 152.74 7.09 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 116.062 1.875 . . . . 0.55000000000000004 116.062 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.6 tpt -75.41 96.75 3.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.638 2.375 . . . . 1.52 111.889 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -150.81 150.27 30.75 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.711 1.204 . . . . 1.1599999999999999 113.317 -174.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -160.74 161.89 32.31 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.624 1.17 . . . . 3.2000000000000002 111.789 173.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.7 mp -93.37 152.14 19.32 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.154 0.982 . . . . 0.63 111.924 167.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.43 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 1.7 p -67.56 128.49 36.66 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 108.796 -0.816 . . . . 0.59999999999999998 108.796 167.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -80.35 -60.31 2.37 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.569 0.951 . . . . 2.1000000000000001 113.569 -173.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.51 -37.58 0.16 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.675 1.19 . . . . 1.04 111.254 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -121.56 -9.27 8.97 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.637 1.347 . . . . 3.8300000000000001 114.637 176.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 164.95 -168.31 39.08 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.141 1.353 . . . . 0.60999999999999999 112.619 -174.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.88 133.6 27.04 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.975 1.71 . . . . 0.55000000000000004 112.713 169.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -90.05 134.08 34.45 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.984 1.713 . . . . 1.53 112.378 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -126.35 128.47 47.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.292 1.837 . . . . 1.7 108.353 173.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.514 HD21 ' HB3' ' A' ' 132' ' ' ALA . 16.1 t30 -83.01 122.56 28.46 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.511 -0.743 . . . . 1.6699999999999999 110.989 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.9 p -103.56 -2.67 26.36 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.534 1.134 . . . . 0.65000000000000002 113.265 -176.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.514 ' HB3' HD21 ' A' ' 130' ' ' ASN . . . -56.07 -17.85 8.12 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.802 1.241 . . . . 0.73999999999999999 113.868 176.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -94.76 -17.34 22.26 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.595 1.958 . . . . 1.8899999999999999 114.127 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -90.42 147.23 36.15 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 114.455 1.28 . . . . 0.68000000000000005 114.455 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -84.27 170.5 10.68 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.796 2.997 . . . . 0.77000000000000002 111.991 167.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.42 79.1 2.47 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.912 2.085 . . . . 1.1699999999999999 112.607 -172.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -136.52 177.49 7.81 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.16 1.384 . . . . 0.84999999999999998 110.797 -177.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -97.7 140.34 32.24 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 123.049 1.404 . . . . 2.8500000000000001 112.08 171.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -129.04 177.73 6.92 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.87 1.668 . . . . 0.63 109.911 -173.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.79 152.74 40.02 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.375 1.07 . . . . 3.6499999999999999 112.276 175.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.0 mp -115.76 134.23 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.055 0.942 . . . . 0.34000000000000002 110.06 172.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -122.13 140.9 51.99 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.692 1.997 . . . . 1.9299999999999999 110.535 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -107.42 114.22 28.09 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.697 1.199 . . . . 2.0499999999999998 110.08 -175.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.5 mm -117.36 114.26 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.464 1.106 . . . . 0.69999999999999996 109.854 -168.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -80.92 -13.64 58.72 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.381 1.252 . . . . 3.9199999999999999 114.381 -171.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 56.1 p -60.2 -30.84 69.63 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.799 1.182 . . . . 2.0499999999999998 113.742 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.42 ' HB2' ' HG2' ' A' ' 80' ' ' MET . 3.6 mm? -104.45 1.29 29.85 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.517 1.127 . . . . 2.5699999999999998 113.578 177.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.9 m -65.07 138.46 58.34 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.565 1.075 . . . . 6.0499999999999998 112.001 176.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 24.8 m -84.74 -39.5 18.39 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.794 1.237 . . . . 5.1299999999999999 111.463 174.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.74 166.94 19.83 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.934 0.894 . . . . 5.9900000000000002 112.33 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p -147.61 157.45 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.139 1.376 . . . . 3.8700000000000001 110.938 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -115.89 -37.33 1.06 Allowed Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.158 0.885 . . . . 2.3799999999999999 114.252 171.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -69.79 -7.53 40.5 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 115.022 1.49 . . . . 4.71 115.022 -176.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -75.91 18.78 0.24 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.745 1.618 . . . . 4.9000000000000004 113.314 175.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 91.21 7.02 66.0 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.536 1.541 . . . . 3.7599999999999998 114.741 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -77.0 156.63 31.72 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.464 1.132 . . . . 2.7599999999999998 112.724 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 28.9 m -73.82 70.24 1.42 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.131 1.772 . . . . 2.73 110.834 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.7 mt -144.42 126.09 15.12 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.299 2.24 . . . . 2.0 109.392 -177.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.4 t -71.68 -20.04 61.99 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 115.876 1.806 . . . . 3.6499999999999999 115.876 -169.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 77.93 3.81 84.91 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 117.015 1.566 . . . . 2.04 117.015 169.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 5.4 m -62.09 157.21 19.54 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.465 1.133 . . . . 3.1299999999999999 112.559 171.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.77 143.01 44.25 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.476 0.917 . . . . 1.98 113.476 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.72 157.57 30.03 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.696 0.76 . . . . 1.05 111.767 170.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.57 151.65 57.18 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 126.579 1.951 . . . . 0.89000000000000001 110.668 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -79.2 155.18 25.45 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.624 2.216 . . . . 0.63 111.301 -172.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 5.3 mt -109.48 133.19 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.492 1.117 . . . . 1.8999999999999999 109.622 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -93.75 136.65 33.82 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.165 0.893 . . . . 3.6299999999999999 111.137 168.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.0 tt -141.54 151.27 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.876 1.27 . . . . 0.63 111.471 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -121.09 157.53 29.89 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.306 1.842 . . . . 1.8400000000000001 108.026 169.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 5.7 mt -65.41 155.39 85.27 Favored Pre-proline 0 CA--C 1.544 0.748 0 O-C-N 120.536 -1.353 . . . . 1.0700000000000001 113.71 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -69.32 114.37 3.61 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.364 2.043 . . . . 1.0700000000000001 111.825 -176.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 17.0 tp -122.01 22.99 10.16 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.323 1.849 . . . . 2.8900000000000001 110.462 168.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -105.15 148.19 27.15 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.582 2.353 . . . . 3.2200000000000002 110.65 -169.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -75.87 61.48 1.46 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.148 1.379 . . . . 4.1100000000000003 111.976 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.0 m -122.01 158.22 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 127.541 2.336 . . . . 1.0900000000000001 112.405 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 59.2 t -82.98 -37.07 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.889 0.875 . . . . 1.6200000000000001 111.07 174.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -142.35 147.65 36.63 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.314 1.046 . . . . 2.9900000000000002 110.684 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -98.57 144.41 27.91 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.576 0.751 . . . . 0.38 111.009 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -133.43 166.36 22.71 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.314 1.227 . . . . 0.81000000000000005 114.314 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.57 146.64 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 127.089 2.156 . . . . 0.69999999999999996 111.437 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.422 ' CE2' HG23 ' A' ' 66' ' ' VAL . 87.9 m-85 -135.63 81.94 40.28 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 113.512 0.93 . . . . 2.0800000000000001 113.512 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -65.41 146.26 84.99 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.467 2.778 . . . . 0.63 113.345 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -124.2 -165.16 1.32 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.613 2.365 . . . . 2.3100000000000001 110.823 -173.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -134.02 169.81 16.58 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.0 1.32 . . . . 3.6000000000000001 110.579 168.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 13.6 t -134.92 -171.08 2.7 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.179 0.992 . . . . 2.0899999999999999 110.724 -176.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -66.57 160.01 26.2 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.19 1.796 . . . . 6.5700000000000003 113.123 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . 0.251 . . 80.36 117.72 0.06 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 129.569 3.148 . . . . 5.0099999999999998 115.514 -173.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -137.22 158.29 72.74 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 128.073 2.549 . . . . 11.19 110.858 174.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -60.95 157.4 38.91 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.526 2.817 . . . . 9.0099999999999998 112.58 175.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -87.26 -1.09 57.66 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.328 1.603 . . . . 11.140000000000001 115.328 173.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.416 ' N ' HD13 ' A' ' 191' ' ' ILE . 0.1 OUTLIER -140.84 45.16 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.391 1.877 . . . . 12.91 111.763 -169.584 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 53.8 mt -70.83 77.72 0.62 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.234 1.413 . . . . 14.289999999999999 112.167 174.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 CA--C 1.539 0.539 0 C-N-CA 126.251 1.82 . . . . 16.539999999999999 113.536 178.714 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 109.936 -0.394 . . . . 27.640000000000001 109.936 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 59.62 179.87 0.09 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.92 1.688 . . . . 26.469999999999999 115.538 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.3 m -101.09 145.63 28.5 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 127.01 2.124 . . . . 21.66 110.955 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -107.2 -12.01 15.47 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.27 1.428 . . . . 17.699999999999999 114.828 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.4 m 55.44 21.03 4.01 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.114 1.766 . . . . 17.649999999999999 115.58 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.03 158.26 16.14 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.468 1.507 . . . . 12.529999999999999 112.954 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.09 -179.99 5.67 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.119 1.367 . . . . 9.0199999999999996 113.299 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -72.33 22.49 0.06 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 127.022 2.129 . . . . 8.3599999999999994 114.213 176.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 29' ' ' ALA . 5.8 p -153.0 146.24 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 127.472 2.309 . . . . 6.9199999999999999 108.575 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -129.58 22.05 5.52 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.906 1.076 . . . . 3.46 113.906 175.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.432 ' H ' HG22 ' A' ' 27' ' ' VAL . . . 62.47 -32.86 0.1 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 128.944 2.898 . . . . 4.1600000000000001 117.796 177.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.15 36.01 21.3 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 120.147 1.339 . . . . 4.9800000000000004 114.356 -178.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.11 23.92 4.28 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 127.037 2.256 . . . . 1.98 115.876 -173.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 38.9 p -126.42 174.8 8.34 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.256 1.822 . . . . 1.1499999999999999 112.161 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.6 p -98.5 -16.77 19.05 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.356 0.872 . . . . 1.5700000000000001 113.356 174.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.8 t -144.92 167.55 22.37 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.022 1.729 . . . . 1.8200000000000001 110.002 169.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.4 p -112.68 5.49 17.74 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.614 1.966 . . . . 0.84999999999999998 114.416 -169.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.8 p -138.57 162.58 34.21 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.114 1.153 . . . . 2.6200000000000001 114.114 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.67 146.7 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 126.516 1.926 . . . . 0.53000000000000003 109.408 169.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -125.12 114.2 18.72 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.591 1.156 . . . . 1.4399999999999999 110.401 -171.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.28 129.87 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 O-C-N 120.886 -1.134 . . . . 0.51000000000000001 111.312 -175.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -128.92 101.9 6.28 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.092 1.357 . . . . 1.78 111.157 -172.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.23 123.66 24.95 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.654 -1.279 . . . . 1.6000000000000001 111.548 -173.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.9 mt -106.04 156.42 18.41 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.129 1.372 . . . . 0.56000000000000005 112.681 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.64 161.89 37.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.313 1.845 . . . . 1.6799999999999999 109.912 175.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.8 162.14 13.27 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.682 0.793 . . . . 0.80000000000000004 111.852 169.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.3 p -86.76 -27.48 23.59 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.252 0.834 . . . . 0.95999999999999996 113.252 176.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -146.67 46.77 1.19 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.482 1.113 . . . . 3.1299999999999999 113.025 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.0 7.19 88.19 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 125.186 1.374 . . . . 0.93999999999999995 116.053 175.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.04 18.92 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 128.145 2.578 . . . . 1.8799999999999999 115.731 -174.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -59.91 -31.51 69.9 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.497 -1.377 . . . . 0.68999999999999995 112.315 -177.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.58 -52.84 63.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.75 1.62 . . . . 2.4399999999999999 112.548 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -71.71 -39.62 70.02 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-O 118.033 -0.984 . . . . 2.0699999999999998 111.583 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.2 mt -51.59 -55.04 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 119.266 0.939 . . . . 0.57999999999999996 110.34 168.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.73 -32.01 71.29 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.643 1.11 . . . . 0.94999999999999996 113.137 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -69.69 -27.26 64.86 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.786 1.032 . . . . 1.1599999999999999 113.786 172.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -73.77 -28.71 61.8 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.764 0.711 . . . . 2.1299999999999999 111.419 168.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.0 mt -85.1 -34.97 22.08 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.113 -0.992 . . . . 1.0600000000000001 113.292 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -71.3 -25.47 62.44 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.236 0.828 . . . . 3.1600000000000001 113.236 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.4 t -84.17 -24.13 30.3 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.274 1.03 . . . . 1.8 113.633 177.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.69 171.69 55.15 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.39 0.995 . . . . 1.0900000000000001 113.233 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -85.35 34.01 0.57 Allowed 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.959 -1.319 . . . . 1.8600000000000001 113.116 171.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -77.53 4.72 10.5 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 120.253 -1.529 . . . . 2.0800000000000001 113.385 -170.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.56 -10.82 60.2 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.035 -1.041 . . . . 1.6000000000000001 113.12 168.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.05 -74.07 0.26 Allowed Glycine 0 N--CA 1.474 1.178 0 CA-C-N 119.713 1.142 . . . . 1.1699999999999999 113.033 169.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -68.73 159.35 32.41 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.158 1.383 . . . . 1.96 113.052 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -61.18 155.99 19.45 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.749 1.22 . . . . 2.27 113.199 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.4 HG23 ' CD2' ' A' ' 181' ' ' TYR . 55.2 t -56.83 117.95 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 109.077 -0.712 . . . . 0.77000000000000002 109.077 172.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.77 -41.62 73.27 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.052 0.358 . . . . 0.88 112.908 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.1 t -138.51 123.95 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.29 1.036 . . . . 2.2000000000000002 111.165 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt -92.46 144.14 28.36 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.069 1.348 . . . . 0.87 110.544 168.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.19 159.32 37.12 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.949 2.433 . . . . 0.71999999999999997 112.0 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.84 -26.13 68.61 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.365 -0.835 . . . . 1.1799999999999999 112.86 172.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.99 3.65 22.25 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.398 1.629 . . . . 1.4299999999999999 115.398 172.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.68 153.98 20.04 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.823 1.249 . . . . 0.72999999999999998 113.577 170.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -143.89 160.69 40.35 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.562 1.545 . . . . 1.8100000000000001 111.641 169.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.96 139.54 50.04 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.268 1.027 . . . . 2.5899999999999999 110.414 -174.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 20.2 pt -133.48 147.23 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 116.396 1.999 . . . . 1.1299999999999999 116.396 -169.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.81 167.66 12.3 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.446 1.898 . . . . 0.96999999999999997 110.14 167.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.99 17.78 62.43 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 116.242 1.257 . . . . 0.64000000000000001 116.242 168.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.2 p -118.42 138.21 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.271 1.428 . . . . 0.66000000000000003 110.832 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 8.9 tpp -96.84 134.91 39.54 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.14 1.376 . . . . 0.52000000000000002 113.584 -177.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.44 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.8 OUTLIER -137.12 148.49 46.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.332 1.453 . . . . 2.0299999999999998 112.002 174.359 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.7 m -121.48 144.28 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.769 2.027 . . . . 0.34999999999999998 109.766 -175.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -88.23 148.39 24.38 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 122.648 1.213 . . . . 0.41999999999999998 112.754 171.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.9 p -143.93 172.79 12.38 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.848 2.059 . . . . 0.40999999999999998 112.217 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -94.61 169.31 10.27 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.453 1.501 . . . . 1.6000000000000001 112.242 168.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 67.9 p -62.66 -25.21 68.02 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.818 0.847 . . . . 1.45 112.702 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -74.78 7.31 3.19 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.686 1.594 . . . . 1.8200000000000001 113.383 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . 0.252 0.3 OUTLIER 63.18 26.38 15.22 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.744 2.418 . . . . 0.64000000000000001 114.291 179.217 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -88.77 145.04 25.85 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.655 1.582 . . . . 2.1000000000000001 111.631 175.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.7 mt -80.83 128.72 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.342 0.657 . . . . 0.42999999999999999 111.087 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.515 HG22 HG22 ' A' ' 97' ' ' THR . 2.2 pp -121.44 149.35 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 115.045 1.498 . . . . 0.95999999999999996 115.045 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -79.64 161.71 25.71 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 127.873 2.469 . . . . 2.3700000000000001 110.598 169.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -58.39 -22.61 54.45 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.315 1.228 . . . . 2.2999999999999998 114.315 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -90.52 3.71 53.21 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.306 1.043 . . . . 3.6200000000000001 111.955 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.59 20.93 75.98 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 127.234 2.349 . . . . 0.5 115.471 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -75.25 137.39 41.18 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.074 -1.084 . . . . 3.0699999999999998 108.074 167.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.515 HG22 HG22 ' A' ' 91' ' ' ILE . 17.6 p -93.74 135.17 35.31 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.945 0.898 . . . . 0.69999999999999996 111.414 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.69 -4.84 59.27 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.954 1.094 . . . . 0.59999999999999998 113.954 -168.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.02 25.96 56.65 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.265 0.936 . . . . 0.63 113.779 -176.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.8 t -130.36 146.7 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.886 1.674 . . . . 1.05 109.471 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -124.22 165.2 18.02 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.94 2.096 . . . . 3.8599999999999999 111.183 173.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.7 mt -134.87 140.78 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.887 1.275 . . . . 0.52000000000000002 109.841 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -76.31 137.91 68.02 Favored Pre-proline 0 CA--C 1.545 0.784 0 O-C-N 120.742 -1.224 . . . . 1.78 112.313 173.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.49 -11.46 20.61 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.061 1.841 . . . . 0.91000000000000003 113.854 174.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.48 -53.79 3.11 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.945 1.698 . . . . 2.0 111.102 177.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 p -80.48 -25.38 38.87 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.859 0.864 . . . . 0.77000000000000002 113.027 -174.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 59.13 15.89 4.43 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.771 1.629 . . . . 1.6799999999999999 113.9 -172.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.51 152.0 19.45 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.21 1.004 . . . . 2.6099999999999999 111.79 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.6 mt -78.56 145.21 34.95 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.682 1.593 . . . . 0.92000000000000004 112.648 -174.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.1 p -72.25 -8.19 53.46 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.665 0.987 . . . . 1.3400000000000001 113.665 173.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -171.9 -152.11 8.23 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.213 1.863 . . . . 0.87 111.848 -171.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.91 148.86 26.03 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.809 0.844 . . . . 0.93000000000000005 113.024 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.6 tpt -52.96 128.69 47.38 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.945 1.698 . . . . 1.3500000000000001 111.867 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.48 161.32 28.39 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.809 3.006 . . . . 0.87 114.441 -174.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.28 -61.79 1.89 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.272 1.829 . . . . 1.1100000000000001 114.105 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.1 p -105.88 10.79 32.37 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.855 1.262 . . . . 0.71999999999999997 114.266 -169.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.2 145.73 16.73 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.965 -1.084 . . . . 0.44 113.002 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.3 tpt -74.38 94.62 2.58 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.846 2.059 . . . . 1.53 110.574 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -148.71 140.15 23.4 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.462 1.105 . . . . 0.94999999999999996 113.454 -169.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -160.04 160.96 33.82 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.482 1.113 . . . . 1.78 111.842 -175.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.4 mp -103.04 149.52 24.49 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.804 1.242 . . . . 0.47999999999999998 112.214 173.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.44 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 1.9 p -66.83 132.05 47.2 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.759 -0.588 . . . . 0.54000000000000004 109.997 171.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.84 -61.13 1.95 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.646 1.178 . . . . 2.4700000000000002 113.79 -170.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -146.63 -34.43 0.28 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.999 1.319 . . . . 1.23 111.37 176.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -126.31 -17.97 5.05 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.524 1.305 . . . . 4.1699999999999999 114.524 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 179.61 -166.28 35.45 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.57 1.081 . . . . 0.59999999999999998 111.894 -172.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -145.25 134.32 22.67 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.869 1.668 . . . . 0.5 111.891 169.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -87.43 138.17 31.7 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.96 1.304 . . . . 1.53 112.858 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -128.51 130.02 46.88 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.162 2.185 . . . . 1.75 107.716 171.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.428 HD21 ' HB3' ' A' ' 132' ' ' ALA . 8.0 t30 -91.49 101.99 14.65 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.953 -1.092 . . . . 2.02 110.489 -177.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.1 p -82.47 -0.54 46.86 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.118 1.367 . . . . 0.65000000000000002 113.727 -172.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.428 ' HB3' HD21 ' A' ' 130' ' ' ASN . . . -55.48 -32.0 62.47 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.766 0.826 . . . . 0.88 112.987 172.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -83.66 -20.86 32.84 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.006 0.922 . . . . 1.9299999999999999 112.682 -173.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.44 145.34 82.36 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 123.811 0.844 . . . . 0.68000000000000005 113.009 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -74.49 168.45 24.79 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.658 2.239 . . . . 0.89000000000000001 110.938 167.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.49 91.97 1.08 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.926 1.29 . . . . 1.0900000000000001 110.359 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -149.51 175.17 11.74 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.884 0.85 . . . . 0.77000000000000002 113.169 -174.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -94.15 147.19 23.4 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.385 1.874 . . . . 3.5499999999999998 109.347 169.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -143.9 170.12 16.51 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.651 1.581 . . . . 0.55000000000000004 110.438 -169.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.2 mttt -137.68 159.78 41.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.193 0.997 . . . . 2.0800000000000001 113.127 171.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.7 mp -118.56 142.2 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.02 1.328 . . . . 0.46999999999999997 109.899 172.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -129.58 147.21 51.36 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.435 1.894 . . . . 1.8999999999999999 110.495 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -109.16 124.26 50.54 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.637 1.175 . . . . 1.8700000000000001 111.26 -175.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 29.9 mm -128.09 98.96 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.921 0.888 . . . . 0.75 109.83 -169.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -73.12 4.32 4.54 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 115.064 1.505 . . . . 4.5300000000000002 115.064 -172.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.4 m -57.99 -31.26 66.75 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.548 -1.345 . . . . 1.75 112.406 172.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.85 120.47 42.6 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.888 1.275 . . . . 3.3300000000000001 108.181 168.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 33.3 t -154.3 146.24 23.53 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.02 0.748 . . . . 5.4299999999999997 113.02 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 26.0 m -127.46 4.77 6.23 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.755 2.422 . . . . 6.1600000000000001 111.08 171.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.63 86.79 2.18 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.663 1.585 . . . . 6.8899999999999997 108.657 171.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.21 129.92 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.501 -0.749 . . . . 4.0800000000000001 109.541 172.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -122.73 -3.36 9.23 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.715 1.626 . . . . 3.3700000000000001 113.582 -175.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -112.15 34.98 3.95 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.024 1.73 . . . . 5.5700000000000003 113.726 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -138.32 3.66 2.38 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 115.179 1.548 . . . . 6.6900000000000004 115.179 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 110.81 15.17 11.23 Favored Glycine 0 N--CA 1.482 1.715 0 O-C-N 120.72 -1.237 . . . . 4.1799999999999997 114.867 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -72.75 -178.21 2.61 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.644 1.978 . . . . 3.0 113.665 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 16.0 p -66.79 -21.88 66.03 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.28 1.032 . . . . 4.7999999999999998 112.845 168.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.19 169.0 14.27 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 120.917 -1.115 . . . . 2.71 113.01 169.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 12.2 t -118.05 154.35 32.18 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.052 1.341 . . . . 3.2200000000000002 112.169 168.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -81.31 21.33 6.13 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 126.193 1.854 . . . . 2.04 117.328 -171.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 68.4 m -64.71 159.01 23.15 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.897 1.848 . . . . 2.6899999999999999 114.104 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.416 ' H ' ' HB3' ' A' ' 186' ' ' GLU . 0.5 OUTLIER -94.65 119.55 33.47 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.614 1.565 . . . . 2.27 113.121 -168.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.36 150.31 47.46 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.016 1.327 . . . . 0.81999999999999995 113.323 174.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.51 153.71 52.07 Favored Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 124.515 1.126 . . . . 0.64000000000000001 111.604 -178.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.15 130.26 12.96 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.879 2.386 . . . . 0.73999999999999999 114.08 -166.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.447 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.6 mp -94.12 130.35 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 125.677 1.591 . . . . 1.47 109.259 -173.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.6 129.88 54.95 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.716 1.206 . . . . 4.96 112.129 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.2 tt -137.73 156.45 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.206 1.402 . . . . 0.53000000000000003 111.038 -169.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -139.89 148.91 42.72 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.794 1.238 . . . . 1.8899999999999999 109.871 170.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 12.4 mt -62.68 153.67 77.54 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 116.152 1.908 . . . . 1.0700000000000001 116.152 -168.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.1 116.73 4.82 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.84 2.36 . . . . 0.75 113.258 -170.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.6 tp -123.41 34.17 5.17 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.023 1.729 . . . . 2.2599999999999998 111.061 166.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -116.44 157.53 24.99 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 128.499 2.719 . . . . 2.6800000000000002 111.487 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.47 30.98 0.18 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.324 1.85 . . . . 4.1299999999999999 114.445 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 30.2 m -93.81 155.09 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.287 1.435 . . . . 1.8300000000000001 112.319 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 54.8 t -74.34 -35.95 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.185 0.994 . . . . 2.25 110.137 173.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -152.26 146.72 25.63 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.46 1.504 . . . . 3.4399999999999999 110.643 -174.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -98.75 156.7 16.71 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.036 0.934 . . . . 0.52000000000000002 112.304 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -136.71 162.02 34.32 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.04 1.496 . . . . 0.60999999999999999 115.04 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.64 144.65 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 127.225 2.21 . . . . 0.45000000000000001 110.815 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.4 ' CD2' HG23 ' A' ' 66' ' ' VAL . 97.1 m-85 -134.94 76.48 58.88 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 113.96 1.096 . . . . 2.0 113.96 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.447 ' HB3' HD11 ' A' ' 166' ' ' ILE . 13.5 Cg_endo -65.87 146.38 82.95 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.011 3.141 . . . . 0.62 114.468 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 31.5 mtmm -140.0 167.27 22.5 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 128.699 2.8 . . . . 1.9399999999999999 111.952 -169.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -117.51 167.03 11.66 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.656 1.354 . . . . 3.25 114.656 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 10.8 t -149.84 -33.01 0.19 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.504 1.668 . . . . 2.2000000000000002 115.504 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.416 ' HB3' ' H ' ' A' ' 162' ' ' LYS . 12.2 pt-20 46.48 27.57 0.63 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 115.72 1.748 . . . . 6.6399999999999997 115.72 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.74 152.49 44.57 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.974 1.472 . . . . 7.2300000000000004 114.974 -168.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -70.66 154.4 94.37 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 123.952 0.901 . . . . 12.59 113.058 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -66.99 170.47 12.9 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.209 2.606 . . . . 14.619999999999999 114.139 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -131.08 -8.82 3.85 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.182 1.393 . . . . 21.07 114.611 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.44 -32.22 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 126.322 1.849 . . . . 23.949999999999999 113.138 176.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 48.31 81.89 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.174 2.59 . . . . 21.359999999999999 113.867 -176.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 CA--C 1.545 0.752 0 C-N-CA 128.51 2.724 . . . . 24.77 114.187 -169.99 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 34.7 mtt . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 110.202 -0.296 . . . . 27.690000000000001 110.202 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.34 152.04 42.51 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.743 1.386 . . . . 27.149999999999999 114.743 -169.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.3 t -153.18 156.74 39.15 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.195 1.398 . . . . 21.350000000000001 113.342 174.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.03 172.66 8.68 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 115.098 1.518 . . . . 18.140000000000001 115.098 -170.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.3 p -72.88 -5.5 38.74 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 116.578 2.066 . . . . 18.16 116.578 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.99 170.79 16.14 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.413 1.485 . . . . 13.69 113.914 -174.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.79 -114.94 0.05 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.427 1.491 . . . . 10.01 110.694 171.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.9 t -148.1 123.19 10.13 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.358 -0.839 . . . . 8.6699999999999999 112.959 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.2 p -135.04 136.8 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 125.831 1.652 . . . . 7.4100000000000001 111.421 170.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -138.91 178.03 7.45 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.109 2.164 . . . . 3.5499999999999998 109.458 169.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -135.23 148.28 49.56 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.69 1.196 . . . . 4.1299999999999999 113.05 -172.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.74 57.09 1.57 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.574 1.949 . . . . 5.8899999999999997 111.355 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.02 42.72 1.38 Allowed Glycine 0 CA--C 1.536 1.346 0 C-N-CA 126.508 2.004 . . . . 2.2999999999999998 112.556 169.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.4 p -129.9 168.98 15.8 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.124 2.169 . . . . 1.5600000000000001 111.488 -171.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 65.8 p -82.81 -10.32 58.92 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 113.966 1.098 . . . . 1.8200000000000001 113.966 176.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 t -151.89 163.17 39.81 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.705 2.002 . . . . 2.5499999999999998 110.032 174.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.7 p -92.76 5.11 52.33 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.086 1.755 . . . . 1.1399999999999999 114.252 176.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.402 ' HA ' ' H ' ' A' ' 131' ' ' THR . 54.9 p -151.26 164.86 35.66 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.23 1.196 . . . . 1.72 114.23 -175.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.5 p -131.21 143.5 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.486 1.915 . . . . 0.38 109.964 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.7 m -110.74 112.62 24.61 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.676 0.79 . . . . 0.68999999999999995 111.411 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -93.11 132.9 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.004 -1.06 . . . . 0.58999999999999997 110.432 176.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -115.73 -173.93 2.43 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.69 1.596 . . . . 1.74 110.998 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -140.26 129.98 24.41 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 120.929 -1.107 . . . . 1.3400000000000001 111.439 168.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.4 mt -111.84 146.06 38.34 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.749 1.219 . . . . 0.85999999999999999 110.835 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.9 168.29 19.6 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.341 1.856 . . . . 1.6299999999999999 111.186 176.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.57 145.58 40.08 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.788 1.235 . . . . 0.72999999999999998 112.281 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.0 p -80.92 -32.54 34.62 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.318 1.229 . . . . 1.1499999999999999 114.318 -173.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -114.45 -15.55 12.05 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 119.882 1.219 . . . . 2.3700000000000001 113.295 175.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.68 11.08 1.95 Allowed Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.478 1.513 . . . . 1.1599999999999999 115.413 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.66 24.23 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 130.175 3.39 . . . . 1.8400000000000001 116.738 -169.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.94 -31.92 73.11 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 119.6 -1.937 . . . . 0.77000000000000002 114.022 -174.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -71.3 -43.79 66.44 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.114 0.87 . . . . 2.52 111.727 -175.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt -72.44 -38.85 68.19 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.267 -0.896 . . . . 4.0999999999999996 111.939 175.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.6 mt -52.68 -48.17 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 119.471 1.032 . . . . 0.66000000000000003 109.956 167.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.1 -34.83 75.57 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 121.092 -1.005 . . . . 0.93000000000000005 113.453 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -65.33 -39.28 92.22 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.794 0.838 . . . . 1.5700000000000001 112.069 171.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.15 -23.82 64.92 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.972 -1.08 . . . . 2.6800000000000002 112.841 177.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.1 mt -91.28 -32.24 15.8 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.315 1.228 . . . . 1.1799999999999999 114.315 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -70.61 -20.59 62.74 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.065 1.135 . . . . 2.96 114.065 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.7 t -78.86 -21.26 47.79 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.986 0.914 . . . . 1.5800000000000001 113.375 169.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.55 172.32 53.44 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.544 1.068 . . . . 1.3200000000000001 112.909 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -94.74 21.57 7.3 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.036 -1.273 . . . . 2.0099999999999998 112.348 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -70.87 18.05 0.06 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.421 1.488 . . . . 2.23 114.962 -170.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.98 -23.15 55.3 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 120.814 -1.179 . . . . 1.21 110.249 166.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -114.86 -57.35 0.36 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.52 1.057 . . . . 0.92000000000000004 113.684 172.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -81.68 162.81 22.87 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.952 1.301 . . . . 3.1499999999999999 113.381 -172.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -63.54 151.94 40.01 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.056 0.762 . . . . 2.3999999999999999 113.056 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 71.7 t -66.32 120.48 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 122.844 0.458 . . . . 0.81999999999999995 109.895 172.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.59 -37.9 33.89 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 114.83 0.692 . . . . 1.1000000000000001 114.83 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.6 t -142.61 116.59 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 118.387 1.093 . . . . 2.3700000000000001 111.041 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.8 mt -83.23 144.36 46.75 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.842 1.257 . . . . 1.0700000000000001 111.621 170.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.09 161.46 38.48 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.914 2.409 . . . . 0.89000000000000001 112.371 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.2 -8.84 42.4 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.039 1.126 . . . . 1.29 114.039 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.2 p30 -98.87 -3.92 34.24 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.548 1.539 . . . . 1.74 114.496 171.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.22 158.83 17.02 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.778 1.029 . . . . 0.71999999999999997 113.778 174.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.9 pttt -150.38 169.04 22.37 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.809 1.643 . . . . 2.25 111.741 167.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -124.37 130.62 52.82 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.013 1.325 . . . . 2.6299999999999999 112.146 -174.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.417 HG21 HD21 ' A' ' 158' ' ' LEU . 39.0 pt -121.81 151.46 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.075 0.95 . . . . 0.92000000000000004 113.397 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.98 156.02 29.27 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.263 1.425 . . . . 0.90000000000000002 111.97 171.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.57 12.93 42.8 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.09 1.328 . . . . 0.71999999999999997 115.654 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 p -86.02 148.12 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 119.228 1.514 . . . . 0.92000000000000004 110.679 169.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -105.64 137.75 42.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.483 1.513 . . . . 0.52000000000000002 112.565 176.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.67 157.79 44.31 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.097 1.359 . . . . 1.6299999999999999 112.441 173.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 m -125.62 147.35 30.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 126.771 2.028 . . . . 0.33000000000000002 110.083 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -89.91 149.08 22.77 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.397 1.079 . . . . 0.34999999999999998 112.975 171.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.7 p -144.8 167.71 21.94 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.409 1.884 . . . . 0.34000000000000002 112.618 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -90.83 171.54 9.25 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.199 1.0 . . . . 2.2200000000000002 112.074 167.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 66.9 p -61.04 -23.53 65.5 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.154 -0.966 . . . . 1.3600000000000001 113.577 -177.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -70.86 4.83 2.29 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 126.222 1.809 . . . . 2.8700000000000001 114.003 169.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.26 27.79 14.2 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.916 2.087 . . . . 0.66000000000000003 112.964 -172.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -86.01 138.61 31.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.458 1.503 . . . . 2.5299999999999998 110.414 177.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.3 mt -81.2 129.33 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.139 0.495 . . . . 0.65000000000000002 110.164 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.478 HG22 HG22 ' A' ' 97' ' ' THR . 6.2 pt -123.86 154.27 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 114.567 1.321 . . . . 0.56000000000000005 114.567 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -84.84 159.44 20.39 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.972 2.109 . . . . 1.49 108.37 166.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -62.8 -8.69 7.34 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.862 1.801 . . . . 2.29 115.862 -172.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -91.31 -1.22 57.7 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.556 1.143 . . . . 3.4500000000000002 112.706 172.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.34 3.72 84.27 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.65 1.595 . . . . 0.48999999999999999 114.476 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -68.14 140.38 56.17 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.813 1.245 . . . . 2.6000000000000001 109.1 173.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.478 HG22 HG22 ' A' ' 91' ' ' ILE . 16.2 p -103.56 146.07 29.1 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.594 0.758 . . . . 0.66000000000000003 112.077 -173.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.62 -11.02 25.84 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.983 0.734 . . . . 0.80000000000000004 112.983 -169.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.74 21.91 48.67 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.706 1.146 . . . . 1.0600000000000001 114.616 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.3 p -138.57 146.19 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.626 1.57 . . . . 2.6000000000000001 110.262 -173.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -127.89 155.04 44.8 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 128.087 2.555 . . . . 1.45 111.364 -172.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 61.4 mt -126.96 142.85 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.97 1.308 . . . . 0.60999999999999999 110.849 -174.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -76.23 132.69 72.86 Favored Pre-proline 0 CA--C 1.54 0.565 0 O-C-N 120.611 -1.306 . . . . 2.3999999999999999 110.57 170.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -70.09 -8.46 23.67 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.074 1.849 . . . . 1.02 114.819 174.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -106.98 -47.55 3.68 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.06 1.344 . . . . 1.6200000000000001 112.346 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.7 p -87.86 -23.16 24.07 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.131 0.972 . . . . 0.93000000000000005 113.331 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 55.52 17.07 2.09 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.896 1.678 . . . . 1.75 114.146 -169.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.64 156.46 20.68 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.909 -1.119 . . . . 2.3700000000000001 111.387 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 mt -98.1 146.44 25.55 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.701 1.2 . . . . 0.92000000000000004 112.623 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 90.7 p -73.1 3.3 5.69 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.204 1.002 . . . . 1.26 113.475 171.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.55 -157.75 16.03 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.689 2.09 . . . . 1.0900000000000001 111.306 -172.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.02 155.27 27.69 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 117.96 0.88 . . . . 1.0700000000000001 112.159 174.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.63 131.66 88.53 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.796 0.838 . . . . 1.8 110.701 175.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.18 156.26 46.76 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 125.197 3.931 . . . . 1.1599999999999999 115.634 -172.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.29 -62.67 1.28 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.745 1.618 . . . . 1.23 114.383 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.8 p -102.26 5.9 40.29 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.804 1.409 . . . . 1.21 114.804 -168.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.85 149.86 10.78 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.0 1.111 . . . . 0.65000000000000002 114.0 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.1 ttt -76.62 90.74 3.37 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.031 1.732 . . . . 1.74 111.629 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -141.81 144.62 34.02 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.552 1.541 . . . . 1.3400000000000001 111.97 -173.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -166.47 156.73 12.1 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 126.337 1.855 . . . . 1.97 111.028 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.9 mp -97.49 148.8 22.86 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.168 1.173 . . . . 0.51000000000000001 114.168 174.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.7 p -64.45 124.6 22.23 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 121.354 -0.841 . . . . 0.58999999999999997 111.34 170.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -80.41 -57.6 3.52 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.373 -0.83 . . . . 2.2000000000000002 112.457 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -173.06 -51.37 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.727 2.811 . . . . 1.8899999999999999 107.963 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -74.18 20.9 0.1 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.121 2.168 . . . . 6.1500000000000004 113.962 173.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.04 -152.31 31.21 Favored Glycine 0 CA--C 1.538 1.53 0 N-CA-C 110.526 -1.03 . . . . 0.77000000000000002 110.526 -165.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -135.33 130.93 35.79 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.587 1.955 . . . . 0.39000000000000001 109.625 169.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -93.82 139.69 30.56 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.479 0.711 . . . . 1.6000000000000001 112.87 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -125.56 124.59 41.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.171 2.589 . . . . 1.6899999999999999 107.893 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -85.58 100.11 11.72 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.423 -0.798 . . . . 1.6699999999999999 110.074 -174.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.402 ' H ' ' HA ' ' A' ' 36' ' ' SER . 73.1 p -78.66 -6.68 56.37 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.139 -0.975 . . . . 0.64000000000000001 113.48 -175.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -51.25 -27.1 8.32 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.568 1.147 . . . . 0.90000000000000002 113.459 175.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -92.98 -10.39 36.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.641 1.576 . . . . 1.8300000000000001 113.697 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -89.59 148.42 40.14 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 120.182 1.356 . . . . 0.76000000000000001 114.163 170.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.18 170.18 13.74 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.937 3.092 . . . . 0.78000000000000003 112.293 168.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.56 63.91 2.14 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.958 2.103 . . . . 1.53 114.397 -170.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -125.54 178.33 5.71 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.756 1.622 . . . . 0.79000000000000004 112.941 -175.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -87.58 151.66 22.81 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.271 1.428 . . . . 2.5499999999999998 110.807 168.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -145.39 171.37 14.72 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.666 1.987 . . . . 0.51000000000000001 109.253 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -137.83 148.31 45.35 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.725 0.81 . . . . 1.8899999999999999 112.648 170.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.4 mp -105.44 138.28 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.247 1.019 . . . . 0.34999999999999998 109.747 171.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -123.65 131.58 53.65 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.405 1.882 . . . . 1.8999999999999999 110.25 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -95.36 104.51 16.41 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.777 0.831 . . . . 2.2599999999999998 110.635 -173.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 38.9 mm -113.0 94.5 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.998 0.919 . . . . 0.65000000000000002 109.611 -169.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -84.45 12.54 6.7 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.537 0.94 . . . . 4.3899999999999997 113.537 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.0 m -68.58 -21.54 64.52 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.021 1.119 . . . . 2.0600000000000001 114.021 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.0 mp -92.12 163.05 14.09 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.223 1.009 . . . . 2.46 111.329 173.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 54.0 m -52.65 117.56 2.99 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.648 1.579 . . . . 5.8799999999999999 111.485 -178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.1 t -140.64 170.01 16.58 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.257 1.823 . . . . 5.0199999999999996 112.119 -167.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -66.22 112.58 4.02 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.446 1.098 . . . . 7.6299999999999999 109.608 169.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.5 p -76.59 130.53 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 121.583 -0.698 . . . . 3.6899999999999999 110.719 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -115.27 -20.56 5.5 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.531 1.062 . . . . 2.1499999999999999 113.901 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -82.61 -16.36 48.69 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.033 1.494 . . . . 4.4900000000000002 115.033 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -97.72 24.49 6.74 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 116.414 2.005 . . . . 5.5099999999999998 116.414 -164.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 109.29 9.06 26.27 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.09 1.329 . . . . 3.8599999999999999 115.003 -178.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -93.44 168.36 11.11 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.754 1.621 . . . . 2.8799999999999999 112.542 174.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.6 m -79.63 44.55 0.63 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.027 1.731 . . . . 3.4100000000000001 113.202 -172.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.417 HD21 HG21 ' A' ' 76' ' ' ILE . 15.4 mt -130.86 164.7 24.66 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.678 1.591 . . . . 1.78 113.241 -170.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.8 t -95.36 -35.75 11.64 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.371 1.468 . . . . 3.2200000000000002 112.663 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.92 -16.63 0.8 Allowed Glycine 0 CA--C 1.541 1.678 0 C-N-CA 126.307 1.908 . . . . 3.29 115.164 -174.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 36.6 m -56.21 159.48 3.46 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.134 2.573 . . . . 3.2200000000000002 116.127 -169.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.61 114.99 1.73 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.003 2.121 . . . . 1.95 114.032 -169.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.41 166.59 22.92 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.568 1.547 . . . . 0.89000000000000001 111.808 169.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.44 144.97 54.53 Favored Pre-proline 0 N--CA 1.483 1.211 0 O-C-N 120.541 -1.349 . . . . 0.57999999999999996 112.224 176.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.08 151.88 61.94 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.584 3.522 . . . . 0.56000000000000005 114.255 -167.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.549 HD11 ' HB3' ' A' ' 182' ' ' PRO . 2.1 mp -114.19 125.68 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.742 1.217 . . . . 1.1599999999999999 111.139 -169.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -86.78 136.22 33.07 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.006 1.322 . . . . 3.0299999999999998 111.578 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.7 tt -144.78 150.14 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 125.227 1.411 . . . . 0.56000000000000005 111.741 -177.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -127.0 149.25 49.98 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.87 1.268 . . . . 2.2599999999999998 110.031 169.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 13.3 mt -61.44 142.56 93.86 Favored Pre-proline 0 CA--C 1.548 0.868 0 O-C-N 120.778 -1.201 . . . . 1.1699999999999999 112.771 -176.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -71.54 99.29 0.92 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.961 3.108 . . . . 0.90000000000000002 114.273 -167.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 1.2 tt -116.58 39.42 3.16 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.14 1.776 . . . . 2.3199999999999998 108.053 167.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -104.93 172.72 6.64 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.552 2.341 . . . . 3.46 111.378 -168.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -76.35 40.17 0.21 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.098 0.959 . . . . 3.8700000000000001 113.561 169.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.7 m -121.24 144.54 29.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.106 1.362 . . . . 1.1899999999999999 112.699 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.9 p -64.87 -45.4 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.937 2.095 . . . . 3.77 113.375 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -156.22 156.77 34.69 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.686 1.995 . . . . 2.98 110.956 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -103.6 146.63 28.28 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.815 1.413 . . . . 0.40999999999999998 114.815 -168.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -135.44 168.52 19.07 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.745 1.387 . . . . 0.69999999999999996 114.745 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 1.5 t -137.88 139.96 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.524 1.53 . . . . 0.46000000000000002 112.027 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -131.76 86.15 49.34 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 125.688 1.595 . . . . 2.1800000000000002 112.548 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.549 ' HB3' HD11 ' A' ' 166' ' ' ILE . 30.4 Cg_endo -71.14 147.4 53.98 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.574 3.516 . . . . 0.59999999999999998 113.59 172.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -131.68 176.42 8.35 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.644 2.378 . . . . 1.48 111.386 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -111.9 174.52 5.84 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.614 1.566 . . . . 2.6000000000000001 112.121 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 4.9 t -136.83 -36.41 0.69 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.862 1.06 . . . . 2.3500000000000001 113.862 173.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -66.38 135.31 54.15 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.541 0.736 . . . . 7.4199999999999999 110.731 172.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -80.71 164.31 22.89 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.719 1.208 . . . . 6.6900000000000004 113.102 -176.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -64.25 150.32 92.85 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 114.336 1.236 . . . . 14.640000000000001 114.336 -173.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.37 159.51 49.17 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.401 2.734 . . . . 11.57 116.42 -169.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -72.18 -26.46 62.08 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.213 0.82 . . . . 14.19 113.213 168.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.419 ' H ' HD12 ' A' ' 191' ' ' ILE . 4.3 mp -73.48 -76.35 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.822 1.249 . . . . 15.949999999999999 109.556 -177.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 44.16 54.98 5.73 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.516 1.926 . . . . 17.530000000000001 113.57 169.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 116.276 1.954 . . . . 20.350000000000001 116.276 -168.308 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.9 ttt . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 119.464 -0.303 . . . . 24.469999999999999 111.061 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -63.62 -23.46 67.39 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.772 1.397 . . . . 23.940000000000001 114.772 -169.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 59.8 p -88.06 -4.76 58.74 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.567 1.321 . . . . 18.449999999999999 114.567 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 44.9 -99.75 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.788 2.035 . . . . 16.199999999999999 115.403 169.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.7 m -63.95 -11.32 27.34 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.962 1.468 . . . . 14.93 114.962 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -121.23 151.79 39.59 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.22 1.808 . . . . 11.08 111.686 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.94 165.76 26.57 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.54 1.536 . . . . 8.9499999999999993 111.197 176.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.2 t -57.14 158.79 4.86 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.356 1.062 . . . . 8.7100000000000009 113.106 175.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.7 p -84.54 139.78 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.164 -0.96 . . . . 7.3300000000000001 111.7 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -109.34 24.24 13.36 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.693 1.368 . . . . 4.1699999999999999 114.693 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.07 -27.27 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 129.932 3.293 . . . . 4.5899999999999999 118.805 169.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.0 30.06 15.49 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 127.281 2.232 . . . . 4.8899999999999997 115.877 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.68 53.76 3.29 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.38 1.467 . . . . 1.73 113.645 177.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.4 p -136.27 172.61 12.76 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.251 1.82 . . . . 1.27 113.38 -169.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.3 p -110.08 -1.12 17.7 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.659 1.984 . . . . 1.29 113.138 175.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -164.1 157.72 18.51 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.638 1.575 . . . . 1.8700000000000001 111.095 -178.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.9 p -112.78 -6.23 13.85 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.404 1.882 . . . . 0.93000000000000005 115.555 -170.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 94.4 p -148.18 166.13 28.82 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.728 2.011 . . . . 1.72 112.517 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.96 136.75 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.23 1.812 . . . . 0.44 110.343 177.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.5 m -104.69 112.33 25.37 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.366 0.603 . . . . 0.68000000000000005 110.725 176.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.4 p -93.19 125.84 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.723 1.209 . . . . 0.52000000000000002 109.679 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -105.19 -170.23 1.72 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.307 1.843 . . . . 1.73 110.81 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -148.72 127.53 12.59 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.246 -1.534 . . . . 1.4099999999999999 113.889 170.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.9 mt -118.59 160.56 21.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.86 1.264 . . . . 0.93000000000000005 113.181 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.7 mt -145.41 165.12 29.44 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 128.002 2.521 . . . . 1.4399999999999999 109.572 168.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.97 165.8 16.43 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.758 -0.589 . . . . 0.80000000000000004 112.224 169.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.5 p -89.12 -35.98 15.98 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.508 0.929 . . . . 1.02 113.508 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -141.77 50.38 1.56 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.614 1.166 . . . . 2.1099999999999999 111.637 174.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.2 14.68 76.27 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 116.621 1.408 . . . . 1.1299999999999999 116.621 173.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.89 15.69 0.1 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.999 2.119 . . . . 2.3999999999999999 115.633 -177.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.4 mmt -61.09 -27.81 68.63 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 119.824 -1.798 . . . . 0.77000000000000002 112.887 -177.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -66.93 -38.17 85.67 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.314 0.961 . . . . 2.1499999999999999 113.178 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -81.74 -38.69 25.3 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.605 -1.309 . . . . 2.4500000000000002 112.582 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 89.1 mt -54.46 -47.83 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 119.915 1.234 . . . . 0.68999999999999995 110.796 168.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.74 -34.96 73.63 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 120.242 -1.536 . . . . 0.92000000000000004 112.557 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -71.23 -34.83 71.16 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.321 1.048 . . . . 1.1299999999999999 112.759 172.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -62.97 -36.07 82.27 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.339 0.972 . . . . 2.0499999999999998 112.225 171.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.3 mt -82.07 -41.21 20.89 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.173 0.805 . . . . 1.1299999999999999 113.173 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -68.26 -25.68 65.3 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.527 1.058 . . . . 3.3399999999999999 113.384 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 t -78.28 -16.44 57.77 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.148 0.979 . . . . 2.0899999999999999 113.055 174.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.32 163.7 32.96 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 127.172 2.32 . . . . 1.3200000000000001 113.993 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -88.8 33.86 0.78 Allowed 'General case' 0 N--CA 1.478 0.953 0 O-C-N 120.866 -1.373 . . . . 2.3199999999999998 112.409 172.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -73.98 0.18 14.35 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.031 -1.043 . . . . 2.0699999999999998 113.466 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.94 -30.0 63.63 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.996 -1.065 . . . . 0.92000000000000004 110.815 167.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.02 -49.67 0.62 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 123.933 0.777 . . . . 0.66000000000000003 113.194 169.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -75.67 158.51 32.26 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.348 1.24 . . . . 2.4399999999999999 114.348 -169.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.18 159.88 33.14 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.559 -0.713 . . . . 3.4199999999999999 110.29 165.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.31 127.2 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 116.54 -0.3 . . . . 0.76000000000000001 110.259 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.94 -48.7 25.75 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.826 -0.546 . . . . 0.91000000000000003 113.243 -176.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.4 t -137.32 127.97 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.048 1.339 . . . . 2.0600000000000001 110.147 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.5 mt -85.57 143.7 38.95 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.731 0.813 . . . . 1.1399999999999999 110.567 169.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.85 162.6 37.14 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.219 1.946 . . . . 0.71999999999999997 111.958 172.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.36 -19.22 65.75 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.266 -0.896 . . . . 1.0800000000000001 112.682 172.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -87.12 0.06 55.89 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.662 1.585 . . . . 1.9399999999999999 115.0 174.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.81 146.4 25.97 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 114.429 1.27 . . . . 0.56999999999999995 114.429 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -130.72 149.04 52.56 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.461 2.704 . . . . 2.4900000000000002 111.614 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -123.4 137.57 54.79 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.409 1.484 . . . . 2.2599999999999998 112.684 -175.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.3 pt -141.29 149.17 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.375 1.47 . . . . 0.85999999999999999 112.136 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -108.51 169.56 8.57 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.563 1.545 . . . . 0.67000000000000004 111.698 169.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.45 20.93 55.76 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.376 0.989 . . . . 0.68000000000000005 115.53 175.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.5 p -88.09 149.52 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 118.422 1.111 . . . . 1.01 109.736 168.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -107.66 137.6 45.4 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.932 1.293 . . . . 0.54000000000000004 112.164 175.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -141.11 156.92 45.9 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.893 1.277 . . . . 1.75 112.633 172.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.5 m -122.04 147.01 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 126.874 2.07 . . . . 0.40000000000000002 109.874 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -89.09 148.18 23.83 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 122.582 1.182 . . . . 0.33000000000000002 113.12 169.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.1 p -142.6 168.56 19.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.806 2.042 . . . . 0.37 112.246 178.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -88.71 172.93 8.88 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.734 0.814 . . . . 1.8999999999999999 112.924 168.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.1 p -57.77 -27.97 63.54 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.378 1.071 . . . . 1.5 113.426 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -90.24 24.07 2.67 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.692 1.197 . . . . 2.3799999999999999 113.79 172.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.54 25.25 14.06 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.562 2.345 . . . . 0.58999999999999997 115.15 173.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -83.09 139.49 33.19 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.281 -0.887 . . . . 1.9399999999999999 109.499 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.7 mt -75.76 128.68 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 118.457 0.571 . . . . 0.56999999999999995 109.821 174.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.761 HG22 HG22 ' A' ' 97' ' ' THR . 6.4 pt -122.02 155.68 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 123.181 1.467 . . . . 0.63 114.613 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -87.01 164.44 16.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.003 1.721 . . . . 1.6599999999999999 110.234 167.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -66.15 2.27 1.22 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.135 1.774 . . . . 2.6499999999999999 115.351 -176.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -107.0 5.17 27.85 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.71 2.404 . . . . 3.21 113.319 169.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.48 6.32 80.39 Favored Glycine 0 CA--C 1.532 1.153 0 O-C-N 120.073 -1.642 . . . . 0.68000000000000005 114.011 -176.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -68.8 139.32 55.26 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 117.905 0.852 . . . . 2.0499999999999998 109.226 169.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.761 HG22 HG22 ' A' ' 91' ' ' ILE . 76.3 p -101.29 139.7 36.61 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.382 1.073 . . . . 0.94999999999999996 110.778 -177.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.99 -9.98 54.27 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.296 1.221 . . . . 0.93000000000000005 114.296 -168.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.48 21.62 47.34 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.897 1.237 . . . . 0.93999999999999995 113.414 -173.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.7 t -130.48 148.17 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.688 1.595 . . . . 1.25 109.512 -177.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -127.9 159.35 35.19 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.334 1.854 . . . . 4.1799999999999997 111.802 174.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 73.5 mt -131.41 127.85 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.978 1.311 . . . . 0.56999999999999995 110.658 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.61 136.74 94.88 Favored Pre-proline 0 N--CA 1.476 0.833 0 CA-C-O 117.986 -1.007 . . . . 1.8500000000000001 111.081 174.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -69.76 -20.31 35.0 Favored 'Trans proline' 0 C--N 1.352 0.756 0 CA-C-N 122.082 1.779 . . . . 0.62 112.774 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -96.42 -43.65 7.55 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.254 1.422 . . . . 1.1200000000000001 112.553 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 p -86.29 -25.33 25.53 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.099 0.96 . . . . 0.89000000000000001 112.61 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 52.65 24.42 3.14 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.34 1.456 . . . . 1.6399999999999999 113.329 -171.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.63 157.64 16.8 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.888 -1.133 . . . . 2.4100000000000001 111.578 -177.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.2 mt -94.38 146.96 23.69 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.256 1.422 . . . . 0.75 113.028 -169.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.0 p -72.07 -7.64 50.03 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.236 1.199 . . . . 1.3300000000000001 114.236 173.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.87 -158.45 10.04 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 128.165 2.793 . . . . 0.87 110.446 177.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.59 166.7 21.62 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 119.411 1.605 . . . . 1.01 112.274 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 mmt -51.16 143.3 17.13 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 125.229 1.411 . . . . 1.6799999999999999 113.882 -177.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.7 165.41 26.89 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 124.166 3.244 . . . . 0.79000000000000004 114.526 174.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.37 -52.19 6.75 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.138 1.775 . . . . 1.1299999999999999 115.001 -177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.9 p -109.18 -3.12 17.52 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.107 1.363 . . . . 0.95999999999999996 114.477 -169.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.68 151.18 2.47 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.186 1.394 . . . . 0.41999999999999998 114.069 -173.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.4 ttt -76.13 89.56 3.05 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.404 1.082 . . . . 1.79 111.139 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -146.01 123.13 11.47 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.044 1.737 . . . . 1.4199999999999999 113.896 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -164.73 145.32 7.65 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.532 1.133 . . . . 2.8399999999999999 111.221 -169.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.36 157.19 17.24 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.081 1.512 . . . . 0.47999999999999998 115.081 -171.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 80.1 p -72.97 139.52 46.76 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.34 -0.85 . . . . 0.57999999999999996 112.993 169.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.63 -54.97 3.06 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 116.152 1.908 . . . . 2.46 116.152 -169.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.09 -40.57 0.15 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.628 1.171 . . . . 1.25 110.837 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -116.17 -26.15 7.33 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.795 1.035 . . . . 3.7999999999999998 113.795 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.33 -163.31 34.74 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.62 1.105 . . . . 0.67000000000000004 110.73 -169.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -137.17 130.75 31.54 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.345 1.858 . . . . 0.40999999999999998 110.54 173.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.7 ttpt -82.02 134.98 35.4 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.36 0.527 . . . . 1.77 110.922 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -122.78 130.87 53.42 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.95 2.1 . . . . 2.0600000000000001 108.211 173.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -85.05 121.77 28.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.513 1.125 . . . . 3.2000000000000002 110.503 -176.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 46.0 p -109.38 -3.81 16.83 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.743 1.386 . . . . 0.56999999999999995 114.743 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.94 -19.69 19.43 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.385 1.474 . . . . 0.69999999999999996 114.944 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.02 -4.29 20.66 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.848 1.259 . . . . 2.3700000000000001 113.613 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.25 141.83 54.16 Favored Pre-proline 0 CA--C 1.535 0.386 0 O-C-N 121.006 -1.059 . . . . 0.63 111.233 167.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.56 168.29 24.74 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.633 2.222 . . . . 0.69999999999999996 110.928 168.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.71 91.88 0.64 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.955 1.702 . . . . 0.96999999999999997 109.697 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -147.9 -178.64 6.38 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.415 1.086 . . . . 0.73999999999999999 111.077 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -97.17 153.98 17.66 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.253 1.421 . . . . 4.6399999999999997 110.792 168.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -146.01 170.21 17.1 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.226 1.81 . . . . 0.56000000000000005 109.893 -169.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -138.89 145.98 40.56 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.354 0.872 . . . . 1.74 113.354 174.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.2 mp -104.1 135.97 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.483 1.113 . . . . 0.45000000000000001 110.075 173.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -119.86 128.02 53.27 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.101 1.761 . . . . 1.8200000000000001 110.062 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -87.85 109.89 20.1 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.678 0.791 . . . . 1.9199999999999999 110.3 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 41.5 mm -116.5 87.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.188 0.995 . . . . 0.66000000000000003 108.605 -173.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . 0.283 7.6 p80 -94.91 44.2 1.1 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.195 -0.941 . . . . 3.8199999999999998 112.492 -178.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.7 p -92.95 -21.08 20.01 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.897 1.679 . . . . 1.75 112.743 169.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.85 167.0 22.32 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.555 1.142 . . . . 2.8100000000000001 111.983 170.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 15.9 m -57.97 122.98 14.31 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.582 -0.698 . . . . 5.9199999999999999 109.56 168.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.9 p -148.91 174.56 12.12 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.96 2.104 . . . . 4.9800000000000004 111.252 -167.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -60.05 126.97 29.58 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.579 -1.326 . . . . 7.5300000000000002 111.159 173.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.4 p -80.64 125.09 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.14 0.976 . . . . 3.54 111.674 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -111.65 -12.53 14.53 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.379 0.99 . . . . 2.2000000000000002 115.024 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -100.76 18.07 20.37 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.59 1.956 . . . . 4.7599999999999998 114.618 -177.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.51 8.64 5.44 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.739 1.385 . . . . 5.1100000000000003 114.739 -171.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 132.84 -7.55 5.19 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.808 1.671 . . . . 4.2699999999999996 115.597 174.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -69.34 169.75 11.68 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.551 1.54 . . . . 3.1800000000000002 113.992 178.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.7 m -77.29 49.4 0.7 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.566 1.946 . . . . 3.54 112.514 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.9 mt -135.02 163.09 30.66 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.611 1.564 . . . . 2.1400000000000001 112.192 -170.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.6 t -140.48 -179.96 6.32 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.703 1.601 . . . . 3.7400000000000002 110.936 -175.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -76.95 48.27 2.68 Favored Glycine 0 CA--C 1.535 1.328 0 O-C-N 120.746 -1.221 . . . . 2.5600000000000001 114.134 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.7 p -74.46 158.52 33.69 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.549 1.939 . . . . 3.8199999999999998 113.934 -177.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.67 136.82 36.26 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.912 0.885 . . . . 2.2200000000000002 113.014 170.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.46 159.73 19.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.143 0.973 . . . . 0.96999999999999997 112.807 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.6 m -116.6 144.99 34.31 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 125.119 1.368 . . . . 0.75 109.549 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.18 139.69 42.9 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.445 2.097 . . . . 0.60999999999999999 112.646 -167.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 3.0 mp -105.28 129.33 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.424 1.09 . . . . 1.25 111.187 -168.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -89.17 133.61 34.34 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.475 1.51 . . . . 4.5700000000000003 112.619 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.3 tt -141.71 156.92 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 125.779 1.632 . . . . 0.67000000000000004 111.188 -175.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -132.65 152.15 51.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.531 1.532 . . . . 2.0299999999999998 109.983 173.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.63 155.98 46.89 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 113.001 0.741 . . . . 0.93999999999999995 113.001 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.26 96.88 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.086 1.857 . . . . 1.03 111.643 -169.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 28.7 tp -124.5 59.18 1.19 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 104.361 -2.459 . . . . 2.2999999999999998 104.361 166.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -139.5 151.67 46.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.283 2.633 . . . . 3.8599999999999999 109.334 -166.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -82.26 41.01 0.67 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.185 0.994 . . . . 3.3500000000000001 113.286 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.9 m -110.45 138.88 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 125.57 1.548 . . . . 1.2 111.419 -175.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.97 -46.92 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.261 1.824 . . . . 3.6899999999999999 112.281 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -153.07 152.89 31.85 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 127.336 2.255 . . . . 3.23 110.571 174.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -92.98 149.42 21.24 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.081 0.953 . . . . 0.42999999999999999 112.644 -173.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -139.28 167.26 22.48 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 115.128 1.529 . . . . 0.55000000000000004 115.128 175.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.34 139.06 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.032 1.733 . . . . 0.60999999999999999 110.644 172.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -130.8 81.09 68.32 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 126.235 1.814 . . . . 2.73 109.357 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.98 159.59 52.01 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 125.107 3.871 . . . . 0.80000000000000004 112.731 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -125.77 -157.63 0.8 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.33 1.852 . . . . 2.2999999999999998 112.582 -167.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -143.54 167.14 22.94 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 130.473 3.509 . . . . 3.3100000000000001 107.953 174.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 12.7 t -143.92 -33.89 0.4 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.244 0.831 . . . . 2.3999999999999999 113.244 174.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -130.72 137.39 49.5 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.126 1.37 . . . . 6.2199999999999998 111.177 -169.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -117.72 143.24 46.39 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.779 1.231 . . . . 6.2599999999999998 111.104 171.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -146.16 157.98 48.85 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 124.991 1.316 . . . . 9.8599999999999994 111.679 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.35 157.9 59.47 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.168 2.579 . . . . 9.1099999999999994 114.495 -172.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -65.99 -24.17 66.72 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.223 1.194 . . . . 15.789999999999999 114.223 172.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.89 -30.75 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.003 1.321 . . . . 12.949999999999999 110.953 -174.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 97.8 mt -89.51 78.79 7.02 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.503 1.121 . . . . 12.199999999999999 111.743 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 N--CA 1.473 0.685 0 C-N-CA 125.286 1.434 . . . . 17.41 110.569 172.531 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 15.0 mmt . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 109.264 -0.643 . . . . 31.18 109.264 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -83.27 -28.14 29.37 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.692 0.797 . . . . 32.149999999999999 112.421 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.9 p -144.5 161.7 38.41 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.734 1.613 . . . . 26.0 111.199 170.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.55 39.31 3.5 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.572 1.549 . . . . 22.379999999999999 112.56 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.5 m -79.5 126.78 31.31 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.509 1.123 . . . . 20.260000000000002 111.647 -173.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -150.4 -171.56 3.95 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.917 0.887 . . . . 16.41 112.83 -168.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.93 176.02 9.91 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.17 1.788 . . . . 14.279999999999999 114.073 171.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -69.92 157.48 37.36 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.396 1.878 . . . . 10.59 113.008 173.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.6 p -148.86 155.56 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 126.919 2.088 . . . . 7.0999999999999996 110.355 -175.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -113.1 72.0 0.76 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.758 1.623 . . . . 3.23 109.234 168.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.02 156.93 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 118.851 2.908 . . . . 3.5899999999999999 118.851 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.39 49.59 1.01 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.304 1.842 . . . . 5.6299999999999999 114.096 -174.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.29 -4.17 90.51 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.095 1.331 . . . . 1.8600000000000001 114.973 175.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.4 p -134.83 160.65 37.56 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.68 1.592 . . . . 1.1599999999999999 111.928 -175.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.8 p -93.9 -7.08 44.12 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.347 1.24 . . . . 1.3100000000000001 114.347 -173.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 t -152.43 154.42 35.52 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.625 1.97 . . . . 2.3500000000000001 109.135 166.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.6 p -95.27 4.91 53.01 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 127.341 2.256 . . . . 0.95999999999999996 114.856 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.1 m -153.19 154.19 34.23 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 120.069 -1.644 . . . . 1.9299999999999999 113.195 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -129.53 147.0 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 127.793 2.437 . . . . 0.40000000000000002 110.537 -175.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.4 m -113.55 117.7 32.39 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.082 0.953 . . . . 0.78000000000000003 110.806 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.91 135.82 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.685 0.794 . . . . 0.66000000000000003 109.513 172.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -114.08 -179.25 3.58 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.25 1.82 . . . . 1.8999999999999999 111.006 -176.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -138.02 118.24 13.6 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 120.534 -1.354 . . . . 2.21 112.176 165.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.6 mt -107.28 152.93 23.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.222 1.409 . . . . 0.55000000000000004 111.19 177.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.6 mt -144.25 172.23 13.2 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.143 1.777 . . . . 1.4199999999999999 110.422 169.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.04 164.21 12.27 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.675 1.19 . . . . 0.80000000000000004 112.272 170.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.4 p -90.98 -23.33 20.44 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.691 1.367 . . . . 1.02 114.691 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -139.15 41.45 2.09 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.861 1.21 . . . . 2.3799999999999999 112.073 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.9 14.32 82.29 Favored Glycine 0 CA--C 1.536 1.362 0 O-C-N 120.796 -1.19 . . . . 0.89000000000000001 114.971 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.42 19.85 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.94 2.496 . . . . 2.3799999999999999 116.067 -175.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.1 mmt -62.83 -28.39 69.98 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 119.592 -1.942 . . . . 0.68999999999999995 114.33 -171.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -71.84 -45.77 60.29 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.405 1.002 . . . . 2.7000000000000002 112.999 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -67.49 -35.98 80.2 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.693 -1.255 . . . . 2.0899999999999999 111.677 173.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.6 mt -58.41 -44.91 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 119.306 0.957 . . . . 0.64000000000000001 110.547 167.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.68 -37.04 77.69 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.372 -1.455 . . . . 0.77000000000000002 112.489 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -68.28 -35.89 78.54 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.631 0.772 . . . . 0.94999999999999996 112.484 170.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -63.03 -19.3 64.24 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 119.431 1.014 . . . . 1.8999999999999999 113.179 170.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 25.8 mt -101.76 -36.2 8.79 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.745 1.757 . . . . 0.83999999999999997 115.745 177.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -64.24 -24.42 67.66 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.583 1.083 . . . . 2.3399999999999999 112.503 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.9 t -74.01 -20.24 60.38 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.5 2.32 . . . . 1.25 114.45 175.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.64 172.16 27.07 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.547 1.07 . . . . 1.03 113.743 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -84.18 29.15 0.58 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.633 1.173 . . . . 2.1299999999999999 113.02 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -75.42 3.88 8.36 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.928 1.455 . . . . 1.9199999999999999 114.928 -168.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.66 -26.53 68.71 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.034 -1.042 . . . . 1.1899999999999999 111.577 168.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.86 -82.02 1.36 Allowed Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.56 1.076 . . . . 0.88 112.993 174.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.5 163.03 28.23 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.436 1.273 . . . . 1.79 114.436 -172.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -55.64 152.78 8.8 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.306 1.042 . . . . 2.3700000000000001 113.058 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.8 t -69.9 98.37 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 107.915 -1.143 . . . . 1.24 107.915 169.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.38 -25.74 75.21 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.229 0.443 . . . . 1.5900000000000001 114.191 -173.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.5 t -141.13 125.04 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.444 1.498 . . . . 1.9399999999999999 109.037 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.5 mt -92.62 160.2 34.94 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 126.08 1.752 . . . . 1.22 111.079 169.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.17 166.89 28.76 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 121.413 1.409 . . . . 0.92000000000000004 111.169 168.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.43 -20.74 58.68 Favored 'General case' 0 CA--C 1.548 0.865 0 O-C-N 120.864 -1.147 . . . . 1.0600000000000001 113.296 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.0 p30 -79.68 -4.79 53.33 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.558 1.543 . . . . 1.8200000000000001 114.406 170.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.75 154.31 20.38 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 113.997 1.11 . . . . 0.64000000000000001 113.997 174.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.8 pttt -145.92 161.75 39.34 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.71 2.004 . . . . 2.52 112.066 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -133.45 123.57 25.52 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.608 1.163 . . . . 2.23 112.424 -169.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.7 pt -120.98 143.63 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.151 0.98 . . . . 0.81000000000000005 112.129 -177.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -114.49 163.41 15.4 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.654 1.181 . . . . 0.71999999999999997 112.263 173.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.75 3.74 55.99 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.101 1.81 . . . . 0.71999999999999997 115.919 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.0 p -83.03 145.85 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 125.733 1.613 . . . . 0.68000000000000005 112.127 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -101.83 136.25 41.99 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.599 1.56 . . . . 0.56000000000000005 113.46 175.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.412 ' CZ ' HG23 ' A' ' 122' ' ' THR . 0.4 OUTLIER -141.41 158.5 43.79 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.621 1.568 . . . . 1.6200000000000001 112.319 173.58 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.2 m -124.18 146.16 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 126.873 2.069 . . . . 0.42999999999999999 109.726 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -87.41 148.03 25.17 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 122.312 1.053 . . . . 0.42999999999999999 112.283 170.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.3 p -142.46 171.26 14.3 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.601 1.96 . . . . 0.34000000000000002 112.952 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.21 -176.44 3.42 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 115.279 1.585 . . . . 1.98 115.279 174.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 47.3 p -57.73 -30.99 66.0 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.037 -1.04 . . . . 1.78 113.187 175.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -86.98 18.22 3.68 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.806 1.242 . . . . 1.95 113.192 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.97 22.09 4.14 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.288 1.835 . . . . 0.56999999999999995 113.634 -176.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -77.7 140.36 39.53 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.867 1.267 . . . . 2.1000000000000001 110.31 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.7 mt -79.79 124.5 37.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.082 -0.71 . . . . 0.53000000000000003 109.082 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.427 HG22 HG22 ' A' ' 97' ' ' THR . 4.6 pt -123.55 157.19 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 114.23 1.196 . . . . 0.58999999999999997 114.23 -174.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -89.96 166.0 13.74 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.364 1.466 . . . . 1.6699999999999999 110.221 167.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.35 5.43 1.31 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.978 1.711 . . . . 2.0600000000000001 115.332 -171.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -112.96 4.42 16.76 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 128.291 2.636 . . . . 2.7400000000000002 112.841 172.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.55 10.72 84.92 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.682 1.134 . . . . 0.57999999999999996 114.666 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -75.37 138.57 41.83 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.082 1.441 . . . . 2.0899999999999999 110.066 168.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.427 HG22 HG22 ' A' ' 91' ' ' ILE . 1.0 OUTLIER -104.8 140.57 37.91 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.095 0.958 . . . . 0.93000000000000005 112.339 -173.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -95.21 6.28 49.46 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 115.647 1.721 . . . . 0.77000000000000002 115.647 -166.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.1 28.64 61.91 Favored Glycine 0 CA--C 1.533 1.177 0 O-C-N 121.248 -0.908 . . . . 0.64000000000000001 113.73 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.7 t -137.64 149.52 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.579 1.152 . . . . 1.22 109.9 175.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -132.97 153.41 51.47 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 129.011 2.924 . . . . 1.3300000000000001 110.906 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 51.9 mt -131.93 128.83 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.924 1.289 . . . . 0.55000000000000004 112.034 -173.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -70.6 141.0 87.31 Favored Pre-proline 0 N--CA 1.477 0.907 0 CA-C-O 117.423 -1.275 . . . . 2.1000000000000001 111.84 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -73.84 -24.53 15.34 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 CA-C-N 122.355 1.877 . . . . 0.81000000000000005 112.967 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -91.13 -38.11 12.95 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.53 1.532 . . . . 1.22 113.104 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.4 p -93.62 -27.72 16.42 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.0 0.92 . . . . 0.89000000000000001 113.19 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 55.13 19.91 3.07 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.271 1.428 . . . . 2.1800000000000002 112.932 -169.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.59 147.09 25.46 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.575 1.15 . . . . 3.1299999999999999 111.69 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.3 mt -88.78 141.39 28.55 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.645 1.578 . . . . 0.92000000000000004 112.73 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.0 p -75.25 10.63 1.48 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.353 1.061 . . . . 1.3100000000000001 113.746 172.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.39 -155.21 13.87 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.552 2.025 . . . . 1.03 111.632 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -96.4 163.97 12.83 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.357 1.463 . . . . 1.05 112.698 175.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.5 mmt -51.58 139.32 29.16 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 114.289 1.218 . . . . 1.52 114.289 -176.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -78.41 163.89 26.83 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 124.617 3.544 . . . . 0.88 113.78 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.45 -67.31 0.7 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.222 1.193 . . . . 1.03 114.222 174.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.5 p -101.83 4.88 40.77 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 115.884 1.809 . . . . 0.69999999999999996 115.884 -167.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.82 147.76 11.35 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.682 1.364 . . . . 0.46999999999999997 114.682 -175.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.8 ttt -73.08 95.04 1.98 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.517 1.927 . . . . 1.75 111.561 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.6 pttp -147.07 137.58 23.57 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.803 1.641 . . . . 1.1799999999999999 111.65 -174.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -161.55 158.18 25.99 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.605 1.562 . . . . 1.8700000000000001 110.211 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -96.25 150.04 20.98 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.908 1.447 . . . . 0.46999999999999997 114.908 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.412 HG23 ' CZ ' ' A' ' 81' ' ' PHE . 7.0 p -65.73 134.99 54.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.35 -0.844 . . . . 0.54000000000000004 111.968 169.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -94.26 -65.04 1.01 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.778 1.399 . . . . 2.2999999999999998 114.778 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.72 -45.91 0.1 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.053 0.941 . . . . 0.95999999999999996 111.666 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -93.49 -35.32 13.01 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.854 0.462 . . . . 4.1299999999999999 111.648 173.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 176.42 -149.96 10.17 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.216 1.389 . . . . 0.65000000000000002 111.034 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -137.16 129.05 29.04 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.947 1.699 . . . . 0.48999999999999999 110.492 169.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -90.09 138.33 31.6 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.318 1.047 . . . . 2.8300000000000001 112.286 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -130.34 130.87 45.0 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 128.591 2.756 . . . . 1.9399999999999999 109.214 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -88.37 123.76 33.26 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.772 1.229 . . . . 1.75 109.677 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.2 p -109.81 2.65 20.08 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.062 1.345 . . . . 0.56000000000000005 113.342 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.26 -21.72 9.87 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 115.13 1.53 . . . . 0.73999999999999999 115.13 -176.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -108.36 -9.56 15.44 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.808 1.04 . . . . 2.3399999999999999 113.808 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.04 149.0 92.09 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 120.481 1.492 . . . . 0.66000000000000003 113.313 175.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -83.91 168.8 12.1 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.898 3.066 . . . . 0.81999999999999995 111.344 167.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.39 90.46 2.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.847 2.059 . . . . 1.02 110.567 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -147.3 179.24 7.79 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.416 1.086 . . . . 0.78000000000000003 111.743 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -90.13 152.49 21.1 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.99 0.916 . . . . 3.5299999999999998 110.618 167.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -142.74 176.86 8.72 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.132 1.773 . . . . 0.53000000000000003 109.441 -173.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.89 155.88 43.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.006 0.922 . . . . 3.2599999999999998 113.199 175.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.6 mp -121.98 134.53 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.172 0.989 . . . . 0.46000000000000002 110.618 172.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -122.28 135.1 54.68 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.411 1.885 . . . . 1.9099999999999999 111.148 -176.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -86.84 109.66 19.44 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.822 0.849 . . . . 2.77 110.931 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 28.3 mm -116.64 92.29 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.871 0.868 . . . . 1.05 108.76 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -83.14 2.4 35.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.518 1.127 . . . . 4.79 113.854 -174.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.9 p -71.29 -20.16 62.24 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 115.087 1.514 . . . . 1.8300000000000001 115.087 -174.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.0 mp -80.84 -62.19 1.74 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.265 1.393 . . . . 3.3399999999999999 109.032 168.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 34.4 t -157.61 160.97 38.63 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.314 1.846 . . . . 4.2699999999999996 109.608 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.6 t -147.3 -175.11 4.71 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.469 1.108 . . . . 6.1699999999999999 110.287 168.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -66.02 167.1 10.36 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.378 1.471 . . . . 5.5899999999999999 112.664 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 55.0 t -89.52 124.42 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.929 0.892 . . . . 5.5099999999999998 111.275 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -136.19 -29.21 0.34 Allowed Glycine 0 CA--C 1.541 1.66 0 CA-C-O 118.112 -1.382 . . . . 2.9199999999999999 115.973 174.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . 0.276 10.9 pt-20 -88.05 -0.87 57.58 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 121.318 2.559 . . . . 6.3099999999999996 115.186 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -79.84 24.85 0.38 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.241 1.417 . . . . 7.3200000000000003 113.49 176.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 102.68 8.82 42.08 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.483 1.516 . . . . 4.7999999999999998 116.143 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -87.93 161.25 17.56 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 118.721 1.26 . . . . 3.4100000000000001 113.315 -178.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.8 t -80.63 54.65 2.14 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.378 1.471 . . . . 4.0999999999999996 112.061 174.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 30.1 mt -129.63 150.25 51.03 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.979 1.712 . . . . 2.2000000000000002 110.734 -174.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 42.9 p -135.15 150.07 50.1 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.691 0.796 . . . . 3.73 111.622 174.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -74.34 46.84 1.63 Allowed Glycine 0 CA--C 1.537 1.457 0 C-N-CA 126.046 1.784 . . . . 2.6400000000000001 114.348 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.4 t -81.18 160.25 24.4 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.178 1.391 . . . . 2.8900000000000001 112.241 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.2 115.66 24.75 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.799 1.407 . . . . 2.7799999999999998 114.799 -167.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.55 137.05 47.76 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.993 1.717 . . . . 0.85999999999999999 110.157 168.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.54 148.55 37.67 Favored Pre-proline 0 N--CA 1.481 1.097 0 CA-C-N 119.629 1.104 . . . . 0.66000000000000003 112.386 174.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -72.56 140.46 32.93 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.65 2.233 . . . . 0.69999999999999996 111.202 -173.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 4.6 mt -88.52 127.27 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.611 0.765 . . . . 1.8200000000000001 110.377 -171.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -86.25 127.96 34.83 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.371 1.468 . . . . 3.6699999999999999 109.573 168.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.3 tt -144.23 147.67 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 119.087 0.858 . . . . 0.65000000000000002 112.951 -173.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -124.8 149.38 47.46 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.927 1.691 . . . . 2.0600000000000001 109.513 169.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 28.1 mt -64.74 162.06 39.75 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 114.377 1.251 . . . . 1.1899999999999999 114.377 -171.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.66 98.32 1.2 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.011 2.474 . . . . 0.77000000000000002 111.893 -173.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.2 tt -123.05 62.29 1.01 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 104.823 -2.288 . . . . 2.2400000000000002 104.823 167.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -140.67 156.82 46.13 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.907 2.083 . . . . 3.3300000000000001 108.853 -168.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -70.33 17.62 0.06 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.966 1.839 . . . . 3.9199999999999999 115.966 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.7 m -95.97 144.32 10.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 124.367 1.067 . . . . 1.1100000000000001 112.886 -168.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 50.8 t -73.69 -36.66 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.935 -0.478 . . . . 1.6100000000000001 110.739 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -140.29 131.29 26.19 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.195 1.398 . . . . 2.6099999999999999 110.763 -170.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -97.11 140.97 30.82 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.971 0.908 . . . . 0.47999999999999998 112.396 -176.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -137.19 166.48 23.63 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.106 1.521 . . . . 0.57999999999999996 115.106 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.43 137.32 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.64 1.976 . . . . 0.62 113.152 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -131.01 89.8 41.34 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.502 1.521 . . . . 1.8899999999999999 111.58 -177.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.87 154.36 71.13 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.157 3.238 . . . . 0.89000000000000001 112.819 175.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -133.17 163.07 30.11 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.207 1.403 . . . . 1.45 112.772 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -100.68 146.61 26.98 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.615 2.366 . . . . 3.71 110.328 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 7.1 t -135.93 -47.83 0.67 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 113.788 1.033 . . . . 2.29 113.788 171.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 43.34 122.77 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 130.761 3.625 . . . . 7.21 119.053 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -144.53 124.86 13.81 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.047 1.739 . . . . 6.8099999999999996 109.912 168.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -127.07 155.24 76.26 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 125.468 1.507 . . . . 8.6799999999999997 112.463 -170.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -62.8 148.41 93.46 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.589 2.193 . . . . 10.699999999999999 112.637 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -81.7 -38.62 25.53 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.706 1.002 . . . . 15.56 113.706 175.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.482 HD13 ' H ' ' A' ' 191' ' ' ILE . 0.2 OUTLIER -114.97 -28.27 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.755 1.222 . . . . 15.119999999999999 114.18 -174.006 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.6 tt 59.21 106.32 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.829 2.451 . . . . 15.75 112.99 -176.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 CA--C 1.544 0.735 0 C-N-CA 126.24 1.816 . . . . 21.25 112.711 -172.614 . . . . . . . . 0 0 . 1 stop_ save_